PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Shi, QM; Chien, YH; Leckband, D				Shi, Quanming; Chien, Yuan-Hung; Leckband, Deborah			Biophysical properties of cadherin bonds do not predict cell sorting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-CADHERIN; FUNCTIONAL-ANALYSIS; ADHESION MOLECULES; STRUCTURAL BASIS; KINETICS; BINDING; SPECIFICITY	Differential binding between cadherin subtypes is widely believed to mediate cell sorting during embryogenesis. However, a fundamental unanswered question is whether cell sorting is dictated by the biophysical properties of cadherin bonds, or by broader, cadherin-dependent differences in intercellular adhesion or membrane tension. This report describes atomic force microscope measurements of the strengths and dissociation rates of homophilic and heterophilic cadherin (CAD) bonds. Measurements conducted with chicken N-CAD, canine E-CAD, and Xenopus C-CAD demonstrated that all three cadherins cross-react and form multiple, intermolecular bonds. The mechanical and kinetic properties of the heterophilic bonds are similar to the homophilic interactions. The thus quantified bond parameters, together with previously reported adhesion energies were further compared with in vitro cell aggregation and sorting assays, which are thought to mimic in vivo cell sorting. Trends in quantified biophysical properties of the different cadherin bonds do not correlate with sorting outcomes. These results suggest that cell sorting in vivo and in vitro is not governed solely by biophysical differences between cadherin subtypes.	[Shi, Quanming; Leckband, Deborah] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Chien, Yuan-Hung; Leckband, Deborah] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Leckband, Deborah] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Leckband, D (corresponding author), 600 S Mathews Ave, Urbana, IL 61820 USA.	Leckband@uiuc.edu	Shi, Quanming/J-8390-2014	Shi, Quanming/0000-0003-2109-5048	National Institutes of Health [RO1 GM51338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM51338. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bayas MV, 2007, J BIOL CHEM, V282, P5589, DOI 10.1074/jbc.M607968200; Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583; Beck J.V, 1977, PARAMETER ESTIMATION; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; BRONNERFRASER M, 1992, DEV BIOL, V153, P291, DOI 10.1016/0012-1606(92)90114-V; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Chien YH, 2008, J BIOL CHEM, V283, P1848, DOI 10.1074/jbc.M708044200; DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hukkanen EJ, 2005, BIOPHYS J, V89, P3434, DOI 10.1529/biophysj.105.061606; Hummer G, 2003, BIOPHYS J, V85, P5, DOI 10.1016/S0006-3495(03)74449-X; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MATSUNAGA M, 1988, NEURON, V1, P289, DOI 10.1016/0896-6273(88)90077-3; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Perret E, 2004, P NATL ACAD SCI USA, V101, P16472, DOI 10.1073/pnas.0402085101; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Prakasam AK, 2006, P NATL ACAD SCI USA, V103, P15434, DOI 10.1073/pnas.0606701103; ROTH SA, 1967, P NATL ACAD SCI USA, V58, P974, DOI 10.1073/pnas.58.3.974; Scott D. W., 1992, MULTIVARIATE DENSITY, DOI 10.1002/9780470316849; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Sivasankar S, 2001, BIOPHYS J, V80, P1758, DOI 10.1016/S0006-3495(01)76146-2; Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Takeichi M., 2001, CURR PROTOC CELL BIO; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Wieland JA, 2005, J BIOL CHEM, V280, P41037, DOI 10.1074/jbc.M503975200; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7	51	50	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28454	28463		10.1074/jbc.M802563200	http://dx.doi.org/10.1074/jbc.M802563200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18552401	Green Published, hybrid			2022-12-25	WOS:000259969300047
J	Rozeboom, HJ; Bjerkan, TM; Kalk, KH; Ertesvag, H; Holtan, S; Aachmann, FL; Valla, S; Dijkstra, BW				Rozeboom, Henriette J.; Bjerkan, Tonje M.; Kalk, Kor H.; Ertesvag, Helga; Holtan, Synnove; Aachmann, Finn L.; Valla, Svein; Dijkstra, Bauke W.			Structural and mutational characterization of the catalytic A-module of the mannuronan C-5-epimerase AlgE4 from Azotobacter vinelandii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALGINATE LYASE A1-III; CRYSTAL-STRUCTURE; ACTIVE-SITE; SECONDARY STRUCTURE; C-5 EPIMERASES; PROTEIN; EPIMERIZATION; PATTERN; FAMILY; GENES	Alginate is a family of linear copolymers of (1 -> 4)-linked beta-D-mannuronic acid and its C-5 epimer alpha-L-guluronic acid. The polymer is first produced as polymannuronic acid and the guluronic acid residues are then introduced at the polymer level by mannuronan C-5-epimerases. The structure of the catalytic A-module of the Azotobacter vinelandii mannuronan C-5-epimerase AlgE4 has been determined by x-ray crystallography at 2.1-angstrom resolution. AlgE4A folds into a right-handed parallel beta-helix structure originally found in pectate lyase C and subsequently in several polysaccharide lyases and hydrolases. The beta-helix is composed of four parallel beta-sheets, comprising 12 complete turns, and has an amphipathic alpha-helix near the N terminus. The catalytic site is positioned in a positively charged cleft formed by loops extending from the surface encompassing Asp(152), an amino acid previously shown to be important for the reaction. Site-directed mutagenesis further implicates Tyr(149), His(154), and Asp(178) as being essential for activity. Tyr(149) probably acts as the proton acceptor, whereas His(154) is the proton donor in the epimerization reaction.	[Rozeboom, Henriette J.; Kalk, Kor H.; Dijkstra, Bauke W.] Univ Groningen, Biophys Chem Lab, GBB, NL-9747 AG Groningen, Netherlands; [Bjerkan, Tonje M.; Ertesvag, Helga; Holtan, Synnove; Aachmann, Finn L.; Valla, Svein] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway	University of Groningen; Norwegian University of Science & Technology (NTNU)	Dijkstra, BW (corresponding author), Univ Groningen, Biophys Chem Lab, GBB, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.w.dijkstra@rug.nl	Heggeset, Tonje Marita Bjerkan/I-9077-2019; Dijkstra, Bauke W./H-4308-2019; Aachmann, Finn/G-4136-2015	Dijkstra, Bauke W./0000-0001-9731-6586; Aachmann, Finn/0000-0003-1613-4663; Heggeset, Tonje/0000-0002-1221-8598; Ertesvag, helga/0000-0001-9437-9469; Rozeboom, Henriette/0000-0002-1656-6477	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by a grant from the Norwegian Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aachmann FL, 2006, J BIOL CHEM, V281, P7350, DOI 10.1074/jbc.M510069200; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bjerkan TM, 2004, BIOCHEM J, V381, P813, DOI 10.1042/BJ20031580; Blatny JM, 1997, PLASMID, V38, P35, DOI 10.1006/plas.1997.1294; BLUHM MM, 1958, PROC R SOC LON SER-A, V246, P369, DOI 10.1098/rspa.1958.0145; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campa C, 2004, BIOCHEM J, V381, P155, DOI 10.1042/BJ20031265; Campos ME, 1996, J BACTERIOL, V178, P1793, DOI 10.1128/jb.178.7.1793-1799.1996; Coutinho PM, 1999, ROY SOC CH, P3; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Donati I, 2005, BIOMACROMOLECULES, V6, P1031, DOI 10.1021/bm049306e; Douthit SA, 2005, J BACTERIOL, V187, P4573, DOI 10.1128/JB.187.13.4573-4583.2005; DRUMMOND DW, 1962, J CHEM SOC, P1208, DOI 10.1039/jr9620001208; ERTESVAG H, 1995, MOL MICROBIOL, V16, P719, DOI 10.1111/j.1365-2958.1995.tb02433.x; Ertesvag H, 1999, J BACTERIOL, V181, P3033; FISCHER FG, 1955, H-S Z PHYSIOL CHEM, V302, P186, DOI 10.1515/bchm2.1955.302.1-2.186; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; GORIN PAJ, 1966, CAN J CHEMISTRY, V44, P993, DOI 10.1139/v66-147; Hartmann M, 2002, BIOPOLYMERS, V63, P77, DOI 10.1002/bip.10017.abs; Hoidal HK, 1999, J BIOL CHEM, V274, P12316, DOI 10.1074/jbc.274.18.12316; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIN LP, 1969, J BACTERIOL, V100, P480, DOI 10.1128/JB.100.1.480-486.1969; LINKER A, 1964, NATURE, V204, P187, DOI 10.1038/204187a0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McPherson A, 2001, PROTEIN SCI, V10, P418, DOI 10.1110/ps.32001; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nyvall P, 2003, PLANT PHYSIOL, V133, P726, DOI 10.1104/pp.103.025981; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramstad MV, 1999, ENZYME MICROB TECH, V24, P636, DOI 10.1016/S0141-0229(98)00148-3; Rehm BH, 1996, J BACTERIOL, V178, P5884, DOI 10.1128/jb.178.20.5884-5889.1996; Rye CS, 2006, CHEMBIOCHEM, V7, P631, DOI 10.1002/cbic.200500428; Sabra W, 2000, APPL ENVIRON MICROB, V66, P4037, DOI 10.1128/AEM.66.9.4037-4044.2000; SADOFF HL, 1975, BACTERIOL REV, V39, P516, DOI 10.1128/MMBR.39.4.516-539.1975; Sambrook J., 2001, MOL CLONING LAB MANU; Sletmoen M, 2004, BIOMACROMOLECULES, V5, P1288, DOI 10.1021/bm0345211; Svanem BIG, 2001, J BIOL CHEM, V276, P31542, DOI 10.1074/jbc.M102562200; Svanem BIG, 1999, J BACTERIOL, V181, P68, DOI 10.1128/JB.181.1.68-77.1999; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Valla S, 2001, BIOCHIMIE, V83, P819, DOI 10.1016/S0300-9084(01)01313-X; van Pouderoyen G, 2003, FEBS LETT, V554, P462, DOI 10.1016/S0014-5793(03)01221-3; van Santen Y, 1999, J BIOL CHEM, V274, P30474, DOI 10.1074/jbc.274.43.30474; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Yoon HJ, 1999, J MOL BIOL, V290, P505, DOI 10.1006/jmbi.1999.2883; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509	53	35	37	2	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23819	23828		10.1074/jbc.M804119200	http://dx.doi.org/10.1074/jbc.M804119200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18574239	hybrid, Green Published			2022-12-25	WOS:000258638900036
J	Wilsbacher, JL; Zhang, Q; Tucker, LA; Hubbard, RD; Sheppard, GS; Bamaung, NY; Fidanze, SD; Wang, GT; Hu, XM; Davidsen, SK; Bell, RL; Wang, J				Wilsbacher, Julie L.; Zhang, Qian; Tucker, Lora A.; Hubbard, Robert D.; Sheppard, George S.; Bamaung, Nwe Y.; Fidanze, Steve D.; Wang, Gary T.; Hu, Xiaoming; Davidsen, Steven K.; Bell, Randy L.; Wang, Jieyi			Insulin-like growth factor-1 receptor and ErbB kinase inhibitor combinations block proliferation and induce apoptosis through cyclin D1 reduction and Bax activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; HUMAN BREAST; HEMATOLOGIC MALIGNANCIES; ANTITUMOR-ACTIVITY; RESISTANCE; EXPRESSION; PATHWAY; HETERODIMERIZATION; TRANSACTIVATION; SENSITIVITY	The insulin-like growth factor-1 receptor (IGF-1R) and ErbB family of receptors are receptor tyrosine kinases that play important roles in cancer. Lack of response and resistance to therapies targeting ErbB receptors occur and are often associated with activation of the IGF-1R pathway. Combinations of agents that inhibit IGF-1R and ErbB receptors have been shown to synergistically block cancer cell proliferation and xenograft tumor growth. To determine the mechanism by which targeting both IGF-1R and ErbB receptors causes synergistic effects on cell growth and survival, we investigated the effects of combinations of selective IGF-1R and ErbB kinase inhibitors on proliferative and apoptotic signaling. We identified A431 squamous cell carcinoma cells as most sensitive to combinations of ErbB and IGF-1R inhibitors. The inhibitor combinations resulted in not only blockade of A431 cell proliferation, but also induced apoptosis, which was not seen with either agent alone. Upon examining phosphorylation states and expression levels of proteins in the IGF-1R and ErbB signaling pathways, we found a correlation between the ability of combinations to inhibit proliferation and to decrease levels of phosphorylated Akt and cyclin D1. In addition, the massive cell death induced by combined IGF-1R/ErbB inhibition was associated with Mcl-1 reduction and Bax activation. Thus, targeting both IGF-1R and ErbB receptors simultaneously results in cell cycle arrest and apoptosis through combined effects on Akt, cyclin D1, and Bax activation.	[Wilsbacher, Julie L.; Zhang, Qian; Tucker, Lora A.; Hubbard, Robert D.; Sheppard, George S.; Bamaung, Nwe Y.; Fidanze, Steve D.; Wang, Gary T.; Hu, Xiaoming; Davidsen, Steven K.; Bell, Randy L.; Wang, Jieyi] Abbott Labs, GPRD Canc Res, Abbott Pk, IL 60064 USA	Abbott Laboratories	Wang, J (corresponding author), Abbott Labs, GPRD Canc Res, R47A,AP9-2124, Abbott Pk, IL 60064 USA.	Jieyi.Wang@abbott.com						Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Armstrong RC, 1997, J NEUROSCI, V17, P553; Baserga R, 2005, EXPERT OPIN THER TAR, V9, P753, DOI 10.1517/14728222.9.4.753; Bohula EA, 2003, ANTI-CANCER DRUG, V14, P669, DOI 10.1097/01.cad.0000092782.37568.04; Camirand A, 2005, BREAST CANCER RES, V7, pR570, DOI 10.1186/bcr1028; Camirand Anne, 2002, Med Sci Monit, V8, pBR521; CAPRARO H, 2002, Patent No. 02092599; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Cui XJ, 2006, CANCER RES, V66, P5304, DOI 10.1158/0008-5472.CAN-05-2858; Desbois-Mouthon C, 2006, INT J CANCER, V119, P2557, DOI 10.1002/ijc.22221; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Germain M, 2008, J BIOL CHEM, V283, P6384, DOI 10.1074/jbc.M707762200; GIBSON K, 1996, Patent No. 96033980; Gilmore AP, 2002, J BIOL CHEM, V277, P27643, DOI 10.1074/jbc.M108863200; Gladden AB, 2005, J CELL BIOCHEM, V96, P906, DOI 10.1002/jcb.20613; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; Hofmann F, 2005, DRUG DISCOV TODAY, V10, P1041, DOI 10.1016/S1359-6446(05)03512-9; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hubbard RD, 2007, CHEMMEDCHEM, V2, P41, DOI 10.1002/cmdc.200600174; Hurbin A, 2005, J BIOL CHEM, V280, P19757, DOI 10.1074/jbc.M413516200; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jones HE, 2004, ENDOCR-RELAT CANCER, V11, P793, DOI 10.1677/erc.1.00799; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lu D, 2004, J BIOL CHEM, V279, P2856, DOI 10.1074/jbc.M310132200; Mandelin AM, 2007, EXPERT OPIN THER TAR, V11, P363, DOI 10.1517/14728222.11.3.363; Matar P, 2004, CLIN CANCER RES, V10, P6487, DOI 10.1158/1078-0432.CCR-04-0870; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; MERLINO GT, 1984, SCIENCE, V224, P417, DOI 10.1126/science.6200934; Mitsiades CS, 2005, EXPERT REV ANTICANC, V5, P487, DOI 10.1586/14737140.5.3.487; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; O'Connor R, 2003, HORM METAB RES, V35, P771; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Rabindran SK, 2005, CANCER LETT, V227, P9, DOI 10.1016/j.canlet.2004.11.015; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Yakar S, 2005, CYTOKINE GROWTH F R, V16, P407, DOI 10.1016/j.cytogfr.2005.01.010; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492	50	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23721	23730		10.1074/jbc.M708360200	http://dx.doi.org/10.1074/jbc.M708360200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18559346	Green Published, hybrid			2022-12-25	WOS:000258638900026
J	Feng, W; Wu, H; Chan, LN; Zhang, MJ				Feng, Wei; Wu, Hao; Chan, Ling-Nga; Zhang, Mingjie			Par-3-mediated junctional localization of the lipid phosphatase PTEN is required for cell polarity establishment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ-DOMAIN; TUMOR-SUPPRESSOR; C-ELEGANS; PROTEIN STRUCTURES; PAR-3; MEMBRANE; NMR; COMPLEX; CDC42; MORPHOGENESIS	PDZ domain-containing scaffold protein Par-3 is the central organizer of the evolutionarily conserved cell polarity-regulatory Par-3.Par-6.atypical protein kinase C complex. The PDZ domains of Par-3 have also been implicated as potential phosphoinositide signaling integrators, since its second PDZ domain binds to phosphoinositides, and the third PDZ interacts with phosphoinositide phosphatase PTEN. However, the molecular basis of Par-3/PTEN interaction is still poorly understood. Additionally, it is not known whether the regulatory function of PTEN in cell polarity is specifically mediated by its interaction with Par-3. The structures of Par-3 PDZ3 in both its free and PTEN tail peptide-bound forms determined in this work reveal that Par-3 PDZ3 binds to PTEN with two discrete binding sites: a canonical PDZ-ligand interaction site and a distal, opposite charge-charge interaction site. This distinct target recognition mechanism confers the interaction specificity of the Par-3.PTEN complex. We show that the Par-3 PDZ3-PTEN binding is required for the enrichment of PTEN at the junctional membranes of Madin-Darby canine kidney cells. Finally, we demonstrate that the junctional membrane-localized PTEN is specifically required for the polarization of Madin-Darby canine kidney cells. These results, together with earlier data, firmly establish that Par-3 functions as a scaffold in integrating phosphoinositide signaling events during cellular polarization.	[Feng, Wei; Wu, Hao; Chan, Ling-Nga; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wu, Hao/B-6557-2012; FENG, WEI/C-8966-2012	Zhang, Mingjie/0000-0001-9404-0190	Research Grants Council of Hong Kong [HKUST6419/05M, 6442/06M, 663407, AoE/B-15/01-II, CA07/08.SC01]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by Research Grants Council of Hong Kong Grants HKUST6419/05M, 6442/06M, 663407, AoE/B-15/01-II, and CA07/ 08.SC01 (to M. Z.).	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Comer FI, 2007, CELL, V128, P239, DOI 10.1016/j.cell.2007.01.010; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Elkins JM, 2007, PROTEIN SCI, V16, P683, DOI 10.1110/ps.062657507; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Feng W, 2007, EMBO J, V26, P2786, DOI 10.1038/sj.emboj.7601702; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hung TJ, 1999, DEVELOPMENT, V126, P127; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Jan YN, 2000, CELL, V100, P599, DOI 10.1016/S0092-8674(00)80695-9; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kay LE, 1997, CURR OPIN STRUC BIOL, V7, P722, DOI 10.1016/S0959-440X(97)80084-X; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nicholls A., 1992, GRASP GRAPHICAL REPR; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhang MJ, 2003, ACCOUNTS CHEM RES, V36, P530, DOI 10.1021/ar020210b	48	96	98	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23440	23449		10.1074/jbc.M802482200	http://dx.doi.org/10.1074/jbc.M802482200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550519	hybrid			2022-12-25	WOS:000258455400053
J	Sczaniecka, M; Feoktistova, A; May, KM; Chen, JS; Blyth, J; Gould, KL; Hardwick, KG				Sczaniecka, Matylda; Feoktistova, Anna; May, Karen M.; Chen, Jun-Song; Blyth, Julie; Gould, Kathleen L.; Hardwick, Kevin G.			The spindle checkpoint functions of Mad3 and Mad2 depend on a Mad3 KEN box-mediated interaction with Cdc20-anaphase-promoting complex (APC/C)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; CHROMOSOME SEGREGATION ROLES; FISSION YEAST; ASSEMBLY CHECKPOINT; DESTRUCTION BOX; MITOTIC CHECKPOINT; SACCHAROMYCES-CEREVISIAE; PSEUDOSUBSTRATE INHIBITOR; GENETICALLY INTERACTS; PROTEIN BUBR1	Mitotic progression is driven by proteolytic destruction of securin and cyclins. These proteins are labeled for destruction by an ubiquitin-protein isopeptide ligase (E3) known as the anaphase-promoting complex or cyclosome (APC/C). The APC/C requires activators (Cdc20 or Cdh1) to efficiently recognize its substrates, which are specified by destruction ( D box) and/or KEN box signals. The spindle assembly checkpoint responds to unattached kinetochores and to kinetochores lacking tension, both of which reflect incomplete biorientation of chromosomes, by delaying the onset of anaphase. It does this by inhibiting Cdc20-APC/C. Certain checkpoint proteins interact directly with Cdc20, but it remains unclear how the checkpoint acts to efficiently inhibit Cdc20-APC/C activity. In the fission yeast, Schizosaccharomyces pombe, we find that the Mad3 and Mad2 spindle checkpoint proteins interact stably with the APC/C in mitosis. Mad3 contains two KEN boxes, conserved from yeast Mad3 to human BubR1, and mutation of either of these abrogates the spindle checkpoint. Strikingly, mutation of the N-terminal KEN box abolishes incorporation of Mad3 into the mitotic checkpoint complex (Mad3-Mad2-Slp1 in S. pombe, where Slp1 is the Cdc20 homolog that we will refer to as Cdc20 hereafter) and stable association of both Mad3 and Mad2 with the APC/C. Our findings demonstrate that this Mad3 KEN box is a critical mediator of Cdc20-APC/C inhibition, without which neither Mad3 nor Mad2 can associate with the APC/C or inhibit anaphase onset.	[Sczaniecka, Matylda; May, Karen M.; Blyth, Julie; Hardwick, Kevin G.] Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Feoktistova, Anna; Chen, Jun-Song; Gould, Kathleen L.] Vanderbilt Univ, Howard Hughes Med Inst, Sch Med, Nashville, TN 37232 USA; [Feoktistova, Anna; Chen, Jun-Song; Gould, Kathleen L.] Vanderbilt Univ, Dept Cell & Dev Biol, Sch Med, Nashville, TN 37232 USA	University of Edinburgh; Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University	Hardwick, KG (corresponding author), Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	Kevin.Hardwick@ed.ac.uk		Hardwick, Kevin/0000-0002-6462-1047; Gould, Kathleen/0000-0002-3810-4070	HHMI; Wellcome Trust	HHMI(Howard Hughes Medical Institute); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the HHMI (to J.S.C., A.F., and K.L.G.) and the Wellcome Trust (to J.B., K.M., and K.G.H.).	Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; He XW, 1998, J CELL SCI, V111, P1635; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Ikui AE, 2002, J CELL SCI, V115, P1603; Kadura S, 2005, MOL BIOL CELL, V16, P385, DOI 10.1091/mbc.E04-07-0558; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kitamura K, 1998, MOL BIOL CELL, V9, P1065, DOI 10.1091/mbc.9.5.1065; Kominami K, 1998, EMBO J, V17, P5388, DOI 10.1093/emboj/17.18.5388; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Matsumoto T, 1997, MOL CELL BIOL, V17, P742, DOI 10.1128/MCB.17.2.742; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nabetani A, 2001, CHROMOSOMA, V110, P322, DOI 10.1007/s004120100153; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Poddar A, 2005, EUKARYOT CELL, V4, P867, DOI 10.1128/EC.4.5.867-878.2005; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tagwerker C, 2006, YEAST, V23, P623, DOI 10.1002/yea.1380; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tange Y, 2007, GENETICS, V175, P1571, DOI 10.1534/genetics.106.061309; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Vanoosthuyse V, 2004, MOL CELL BIOL, V24, P9786, DOI 10.1128/MCB.24.22.9786-9801.2004; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Warren CD, 2002, MOL BIOL CELL, V13, P3029, DOI 10.1091/mbc.E02-04-0203; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172	60	72	74	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23039	23047		10.1074/jbc.M803594200	http://dx.doi.org/10.1074/jbc.M803594200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556659	Green Published, hybrid			2022-12-25	WOS:000258455400017
J	Sugeno, N; Takeda, A; Hasegawa, T; Kobayashi, M; Kikuchi, A; Mori, F; Wakabayashi, K; Itoyama, Y				Sugeno, Naoto; Takeda, Atsushi; Hasegawa, Takafumi; Kobayashi, Michiko; Kikuchi, Akio; Mori, Fumiaki; Wakabayashi, Koichi; Itoyama, Yasuto			Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SPORADIC PARKINSONS-DISEASE; LEWY BODIES; IN-VIVO; NEURODEGENERATIVE DISEASES; PROTEASOMAL FUNCTION; INCLUSION FORMATION; SUBSTANTIA-NIGRA; OXIDATIVE STRESS; BODY FORMATION	alpha-Synuclein is a major protein component deposited in Lewy bodies and Lewy neurites that is extensively phosphorylated at Ser(129), although its role in neuronal degeneration is still elusive. In this study, several apoptotic pathways were examined in alpha-synuclein-overexpressing SH-SY5Y cells. Following the treatment with rotenone, a mitochondrial complex I inhibitor, wildtype alpha-synuclein-overexpressing cells demonstrated intracellular aggregations, which shared a number of features with Lewy bodies, although cells overexpressing the S129A mutant, in which phosphorylation at Ser129 was blocked, showed few aggregations. In wildtype alpha-synuclein cells treated with rotenone, the proportion of phosphorylated alpha-synuclein was about 1.6 times higher than that of untreated cells. Moreover, induction of unfolded protein response (UPR) markers was evident several hours before the induction of mitochondrial disruption and caspase-3 activation. Eukaryotic initiation factor 2 alpha, a member of the PERK pathway family, was remarkably activated at early phases. On the other hand, the S129A mutant failed to activate UPR. Casein kinase 2 inhibitor, which decreased alpha-synuclein phosphorylation, also reduced UPR activation. The alpha-synuclein aggregations were colocalized with a marker for the endoplasmic reticulum-Golgi intermediate compartment. Taken together, it seems plausible that alpha-synuclein toxicity is dependent on the phosphorylation at Ser129 that induces the UPRs, possibly triggered by the disturbed endoplasmic reticulum-Golgi trafficking.	[Sugeno, Naoto; Takeda, Atsushi; Hasegawa, Takafumi; Kobayashi, Michiko; Kikuchi, Akio; Itoyama, Yasuto] Tohoku Univ, Dept Neurol, Sch Med, Sendai, Miyagi 9808574, Japan; [Mori, Fumiaki; Wakabayashi, Koichi] Hirosaki Univ, Dept Neuropathol, Inst Brain Sci, Sch Med, Hirosaki, Aomori 0368562, Japan	Tohoku University; Hirosaki University	Takeda, A (corresponding author), 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	atakeda@em.neurol.med.tohoku.ac.jp	MORI, Fumiaki/L-5789-2019					Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P14, DOI 10.1016/S0028-3908(03)00140-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Eriksen JL, 2003, NEURON, V40, P453, DOI 10.1016/S0896-6273(03)00684-6; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Furukawa Y, 2002, ANN NEUROL, V51, P779, DOI 10.1002/ana.10207; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; GOLDMAN JE, 1983, SCIENCE, V221, P1082, DOI 10.1126/science.6308771; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Holtz WA, 2006, J NEUROCHEM, V99, P54, DOI 10.1111/j.1471-4159.2006.04025.x; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kanemoto S, 2005, BIOCHEM BIOPH RES CO, V331, P1146, DOI 10.1016/j.bbrc.2005.04.039; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu C, 2007, J BIOL CHEM, V282, P14558, DOI 10.1074/jbc.M700422200; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; Martin-Clemente B, 2004, J BIOL CHEM, V279, P52984, DOI 10.1074/jbc.M409028200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuzaki M, 2004, BRAIN RES, V1004, P83, DOI 10.1016/j.brainres.2004.01.017; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Munoz E, 1997, NEUROSCI LETT, V235, P57, DOI 10.1016/S0304-3940(97)00710-6; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Ryu MY, 2008, J NEUROL SCI, V266, P9, DOI 10.1016/j.jns.2007.08.027; Sasakawa H, 2007, BIOCHEM BIOPH RES CO, V363, P795, DOI 10.1016/j.bbrc.2007.09.048; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Sherer TB, 2001, BRAIN RES, V891, P94, DOI 10.1016/S0006-8993(00)03203-0; Sherer TB, 2007, J NEUROCHEM, V100, P1469, DOI 10.1111/j.1471-4159.2006.04333.x; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Takahashi M, 2003, NEUROSCI LETT, V336, P155, DOI 10.1016/S0304-3940(02)01258-2; Takahashi M, 2006, J NEUROPATH EXP NEUR, V65, P1157, DOI 10.1097/01.jnen.0000248542.82681.12; Takeda A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/19365; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wang HQ, 2007, ANTIOXID REDOX SIGN, V9, P553, DOI 10.1089/ars.2006.1524; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	65	101	102	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23179	23188		10.1074/jbc.M802223200	http://dx.doi.org/10.1074/jbc.M802223200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562315	hybrid			2022-12-25	WOS:000258455400031
J	Hashemy, SI; Holmgren, A				Hashemy, Seyed Isaac; Holmgren, Arne			Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTISCHEMIC MYOCARDIAL APOPTOSIS; PROTEIN-TYROSINE PHOSPHATASES; NITRIC-OXIDE; HYDROGEN-PEROXIDE; PHYSIOLOGICAL MESSENGER; DISULFIDE-ISOMERASE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; REDOX REGULATION	The mammalian cytosolic/nuclear thioredoxin system, comprising thioredoxin (Trx), selenoenzyme thioredoxin reductase (TrxR), and NADPH, is the major protein-disulfide reductase of the cell and has numerous functions. The active site of reduced Trx comprises Cys(32)-Gly-Pro-Cys(35) thiols that catalyze target disulfide reduction, generating a disulfide. Human Trx1 has also three structural Cys residues in positions 62, 69, and 73 that upon diamide oxidation induce a second Cys(62)-Cys(69) disulfide as well as dimers and multimers. We have discovered that after incubation with H2O2 only monomeric two-disulfide molecules are generated, and they are inactive but able to regain full activity in an autocatalytic process in the presence of NADPH and TrxR. There are conflicting results regarding the effects of S-nitrosylation on Trx antioxidant functions and which residues are involved. We found that S-nitrosoglutathione-mediated S-nitrosylation at physiological pH is critically dependent on the redox state of Trx. Starting from fully reduced human Trx, both Cys(69) and Cys(73) were nitrosylated, and the active site formed a disulfide; the nitrosylated Trx was not a substrate for TrxR but regained activity after a lag phase consistent with autoactivation. Treatment of a two-disulfide form of Trx1 with S-nitrosoglutathione resulted in nitrosylation of Cys(73), which can act as a trans-nitrosylating agent as observed by others to control caspase 3 activity (Mitchell, D. A., and Marletta, M. A. (2005) Nat. Chem. Biol. 1, 154158). The reversible inhibition of human Trx1 activity by H2O2 and NO donors is suggested to act in cell signaling via temporal control of reduction for the transmission of oxidative and/or nitrosative signals in thiol redox control.	[Hashemy, Seyed Isaac; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden	Karolinska Institutet	Holmgren, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden.	arne.holmgren@ki.se	Hashemy, Seyed Isaac/A-2693-2017	Hashemy, Seyed Isaac/0000-0002-1323-5250				Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Barrett DM, 2005, J BIOL CHEM, V280, P14453, DOI 10.1074/jbc.M411523200; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Bizzarri C, 2005, ANTIOXID REDOX SIGN, V7, P1189, DOI 10.1089/ars.2005.7.1189; Boje KMK, 2004, FRONT BIOSCI-LANDMRK, V9, P763, DOI 10.2741/1268; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Holmgren A, 2008, SCIENCE, V320, P1019, DOI 10.1126/science.1159246; KEISARI Y, 1983, IMMUNOBIOLOGY, V165, P78, DOI 10.1016/S0171-2985(83)80048-5; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kuster GM, 2006, ANTIOXID REDOX SIGN, V8, P2153, DOI 10.1089/ars.2006.8.2153; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; RAND MJ, 1995, ANNU REV PHYSIOL, V57, P659; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560; Sayre Lawrence M, 2005, Ann Ist Super Sanita, V41, P143; Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Sumbayev VV, 2003, ARCH BIOCHEM BIOPHYS, V415, P133, DOI 10.1016/S0003-9861(03)00199-1; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tao L, 2006, BRIT J PHARMACOL, V149, P311, DOI 10.1038/sj.bjp.0706853; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; Tao L, 2006, CIRCULATION, V114, P1395, DOI 10.1161/CIRCULATIONAHA.106.625061; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Thippeswamy T, 2006, HISTOL HISTOPATHOL, V21, P445, DOI 10.14670/HH-21.445; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vincent JL, 2000, AM J RESP CRIT CARE, V161, P1781, DOI 10.1164/ajrccm.161.6.9812004; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Weichsel A, 2007, BIOCHEMISTRY-US, V46, P1219, DOI 10.1021/bi061878r; Yasinska IM, 2004, ARCH BIOCHEM BIOPHYS, V428, P198, DOI 10.1016/j.abb.2004.06.004; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	60	144	146	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21890	21898		10.1074/jbc.M801047200	http://dx.doi.org/10.1074/jbc.M801047200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544525	hybrid			2022-12-25	WOS:000258114700008
J	Haglund, E; Lindberg, MO; Oliveberg, M				Haglund, Ellinor; Lindberg, Magnus O.; Oliveberg, Mikael			Changes of protein folding pathways by circular permutation - Overlapping nuclei promote global cooperativity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-DOMAIN PROTEINS; TRANSITION-STATE; ENERGY LANDSCAPE; REPEAT PROTEINS; CONTACT ORDER; NATIVE-STATE; AGGREGATION; S6; KINETICS; FAMILY	The evolved properties of proteins are not limited to structure and stability but also include their propensity to undergo local conformational changes. The latter, dynamic property is related to structural cooperativity and is controlled by the folding-energy landscape. Here we demonstrate that the structural cooperativity of the ribosomal protein S6 is optimized by geometric overlap of two competing folding nuclei: they both include the central beta-strand 1. In this way, folding of one nucleus catalyzes the formation of the other, contributing to make the folding transition more concerted overall. The experimental evidence is provided by an extended set of circular permutations of S6 that allows quantitative analysis of pathway plasticity at the level of individual side chains. Because similar overlap between competing nuclei also has been discerned in other proteins, we hypothesize that the coupling of several small nuclei into extended "supernuclei" represents a general principle for propagating folding cooperativity across large structural distances.	[Haglund, Ellinor; Lindberg, Magnus O.; Oliveberg, Mikael] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden	Stockholm University	Oliveberg, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden.	mikael.oliveberg@dbb.su.se			Swedish Research Council; Sven and Lilly Lawski Foundation; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Sven and Lilly Lawski Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council, the Sven and Lilly Lawski Foundation, and the Knut and Alice Wallenberg Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Chavez LL, 2006, P NATL ACAD SCI USA, V103, P10254, DOI 10.1073/pnas.0510110103; Chen J, 2004, PROTEINS, V57, P153, DOI 10.1002/prot.20175; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Ferguson N, 2001, P NATL ACAD SCI USA, V98, P13002, DOI 10.1073/pnas.221467198; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P7735, DOI 10.1073/pnas.0702682104; Ferreiro DU, 2005, J MOL BIOL, V354, P679, DOI 10.1016/j.jmb.2005.09.078; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Guo ZF, 2006, P NATL ACAD SCI USA, V103, P8042, DOI 10.1073/pnas.0602607103; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Lappalainen I, 2008, J MOL BIOL, V375, P547, DOI 10.1016/j.jmb.2007.09.088; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Lindberg MO, 2007, CURR OPIN STRUC BIOL, V17, P21, DOI 10.1016/j.sbi.2007.01.008; Lindberg MO, 2006, P NATL ACAD SCI USA, V103, P4083, DOI 10.1073/pnas.0508863103; Lindberg MO, 2001, J MOL BIOL, V314, P891, DOI 10.1006/jmbi.2001.5186; Lowe AR, 2007, P NATL ACAD SCI USA, V104, P2679, DOI 10.1073/pnas.0604653104; MATTHEWS JM, 1995, BIOCHEMISTRY-US, V34, P6805, DOI 10.1021/bi00020a027; Matysiak S, 2004, J MOL BIOL, V343, P235, DOI 10.1016/j.jmb.2004.08.006; Matysiak S, 2006, J MOL BIOL, V363, P297, DOI 10.1016/j.jmb.2006.07.088; Miller EJ, 2002, P NATL ACAD SCI USA, V99, P10359, DOI 10.1073/pnas.162219099; Nordlund A, 2006, P NATL ACAD SCI USA, V103, P10218, DOI 10.1073/pnas.0601696103; Oliveberg M, 1998, ACCOUNTS CHEM RES, V31, P765, DOI 10.1021/ar970089m; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Olofsson M, 2007, J MOL BIOL, V365, P237, DOI 10.1016/j.jmb.2006.09.016; Otzen DE, 2002, J MOL BIOL, V317, P613, DOI 10.1006/jmbi.2002.5423; Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Panchenko AR, 1997, J MOL BIOL, V272, P95, DOI 10.1006/jmbi.1997.1205; Panchenko AR, 1996, P NATL ACAD SCI USA, V93, P2008, DOI 10.1073/pnas.93.5.2008; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Plotkin SS, 2000, P NATL ACAD SCI USA, V97, P6509, DOI 10.1073/pnas.97.12.6509; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Sandelin E, 2007, J BIOL CHEM, V282, P21230, DOI 10.1074/jbc.M700765200; Silow M, 1999, BIOCHEMISTRY-US, V38, P13006, DOI 10.1021/bi9909997; Stoycheva AD, 2004, J MOL BIOL, V340, P571, DOI 10.1016/j.jmb.2004.04.073; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Weikl TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P67, DOI 10.1016/j.abb.2007.06.018; Weikl TR, 2003, J MOL BIOL, V332, P953, DOI 10.1016/S0022-2836(03)00884-2; Werbeck ND, 2007, P NATL ACAD SCI USA, V104, P7863, DOI 10.1073/pnas.0610315104; Wu L, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031914; Yang SC, 2004, P NATL ACAD SCI USA, V101, P13786, DOI 10.1073/pnas.0403724101; Zarrine-Afsar A, 2005, CURR OPIN STRUC BIOL, V15, P42, DOI 10.1016/j.sbi.2005.01.011	45	48	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27904	27915		10.1074/jbc.M801776200	http://dx.doi.org/10.1074/jbc.M801776200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18562318	hybrid			2022-12-25	WOS:000259719200061
J	Ndozangue-Touriguine, O; Sebbagh, M; Merino, D; Micheau, O; Bertoglio, J; Breard, J				Ndozangue-Touriguine, O.; Sebbagh, M.; Merino, D.; Micheau, O.; Bertoglio, J.; Breard, J.			A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma	ONCOGENE			English	Article						TRAIL; colon cancer; metastasis; resistance	CYTOCHROME-C RELEASE; PROTEASOME INHIBITOR BORTEZOMIB; BCL-2 FAMILY-MEMBERS; X-LINKED INHIBITOR; NF-KAPPA-B; CANCER CELLS; MEDIATED APOPTOSIS; TUMOR-METASTASIS; DEATH RECEPTORS; DECOY RECEPTORS	A pair of isogenic colon carcinoma cells, SW480 and 620, was used to investigate the mechanisms of acquired tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistance during tumour progression. Whereas primary tumour SW480 cells are sensitive to TRAIL-induced apoptosis, metastatic SW620 cells are resistant. The apoptotic signalling activated by TRAIL in SW480 cells is a type II pathway. We show that in SW620 cells, although caspase-8 is recruited and activated at the death-inducing-signalling complex and Bid is cleaved, this does not lead to caspase-9 activation. Comparison of Bcl-2, Bcl-xL and Mcl-1 levels in both cell lines showed no difference. In SW620 cells transfected with a tBid-GFP construct, tBid-GFP was correctly localized to the mitochondria. Thus, the resistance of SW620 cells is at the level of the mitochondria that can withstand large amounts of tBid. Although caspase-3 was directly cleaved by caspase-8 in SW620 cells to yield the p20 fragment, no further autocatalytic maturation into the p17 fragment was observed. We show that, in contrast to SW480 cells, the SW620 cell line expresses high amounts of X-linked inhibitor of apoptosis ( XIAP). Downregulation of XIAP with bortezomib or small-interfering RNA was sufficient to restore the sensitivity of SW620 cells to TRAIL-induced apoptosis in the absence of SMAC/Diablo or cytochrome c release from the mitochondria. Thus, SW620 cells have developed a dual resistance to TRAIL-induced apoptosis: a block at the level of the mitochondria and, after a conversion to a type I pathway, an increased expression of XIAP which inhibits this pathway.	[Ndozangue-Touriguine, O.; Bertoglio, J.; Breard, J.] Fac Pharm Chatenay Malabry, INSERM, U749, F-92290 Chatenay Malabry, Hauts Seine, France; [Sebbagh, M.] INSERM, UMR 891, Inst Paoli Calmettes, F-13258 Marseille, Bouches Rhone, France; [Merino, D.; Micheau, O.] INSERM, U866, Dijon, Cote Or, France; [Merino, D.; Micheau, O.] Univ Bourgogne, Dijon, Cote Or, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne	Breard, J (corresponding author), Fac Pharm Chatenay Malabry, INSERM, U749, 5 Rue JB Clement, F-92290 Chatenay Malabry, Hauts Seine, France.	jacqueline.breard@u-psud.fr	Merino, Delphine/L-9159-2017; micheau, olivier/C-3574-2011; Sebbagh, Michael/E-8502-2017	Merino, Delphine/0000-0002-8075-6275; micheau, olivier/0000-0001-8499-7984; Sebbagh, Michael/0000-0003-2468-7006	INSERM; Ligue Nationale contre le Cancer; Olivia Ndozangue-Touriguine; ARC	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Olivia Ndozangue-Touriguine; ARC(Australian Research Council)	We thank Valerie Nicolas for her assistance in confocal microscopy and G Ortiz-Ferron for providing FLBid-GFP vector. This work was supported by INSERM and the Ligue Nationale contre le Cancer (equipe labellisee). Olivia Ndozangue-Touriguine was a recipient of a fellowship from the Ministry of Research and Education and is a recipient of an ARC fellowship for her fourth year of PhD.	Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Ceballos-Cancino G, 2007, ONCOGENE, V26, P7569, DOI 10.1038/sj.onc.1210560; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; GAGOS S, 1995, ANTICANCER RES, V15, P369; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P659, DOI 10.1038/sj.cdd.4401585; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Henson ES, 2003, J CELL BIOCHEM, V89, P1177, DOI 10.1002/jcb.10597; Hewitt RE, 2000, J PATHOL, V192, P446; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Huerta S, 2007, J SURG RES, V142, P184, DOI 10.1016/j.jss.2006.12.551; Johnson TR, 2003, ONCOGENE, V22, P4953, DOI 10.1038/sj.onc.1206656; Kashkar H, 2007, BLOOD, V109, P3982, DOI 10.1182/blood-2006-10-053959; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Koschny R, 2007, CLIN CANCER RES, V13, P6541, DOI 10.1158/1078-0432.CCR-07-1759; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Kyritsis AP, 2007, CLIN CANCER RES, V13, P6540, DOI 10.1158/1078-0432.CCR-07-1447; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leverkus M, 2003, MOL CELL BIOL, V23, P777, DOI 10.1128/MCB.23.3.777-790.2003; Liu J, 2004, APOPTOSIS, V9, P533, DOI 10.1023/B:APPT.0000038034.16230.ea; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P484, DOI 10.1038/sj.cdd.4402280; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Menoret E, 2006, BLOOD, V108, P1346, DOI 10.1182/blood-2005-12-007971; Nagy K, 2006, PATHOL ONCOL RES, V12, P133, DOI 10.1007/BF02893359; Nikrad M, 2005, MOL CANCER THER, V4, P443; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ortiz-Ferron G, 2006, CELL DEATH DIFFER, V13, P1857, DOI 10.1038/sj.cdd.4401875; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Ravi R, 2006, CANCER RES, V66, P1730, DOI 10.1158/0008-5472.CAN-05-3377; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Sayers TJ, 2003, BLOOD, V102, P303, DOI 10.1182/blood-2002-09-2975; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Sun XM, 2002, J BIOL CHEM, V277, P11345, DOI 10.1074/jbc.M109893200; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Tyurin VA, 2007, CELL DEATH DIFFER, V14, P872, DOI 10.1038/sj.cdd.4402068; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Voelkel-Johnson C, 2005, MOL CANCER THER, V4, P1320, DOI 10.1158/1535-7163.MCT-05-0086; Voortman J, 2007, MOL CANCER THER, V6, P2103, DOI 10.1158/1535-7163.MCT-07-0167; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zhu HB, 2005, CANCER BIOL THER, V4, P781, DOI 10.4161/cbt.4.7.1897; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	58	75	75	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 9	2008	27	46					6012	6022		10.1038/onc.2008.197	http://dx.doi.org/10.1038/onc.2008.197			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	358BO	18560353				2022-12-25	WOS:000259891600004
J	Sveinbjornsson, B; Rasmuson, A; Baryawno, N; Wan, M; Pettersen, I; Ponthan, F; Orrego, A; Haeggstrom, JZ; Johnsen, JI; Kogner, P				Sveinbjornsson, Baldur; Rasmuson, Agnes; Baryawno, Ninib; Wan, Min; Pettersen, Ingvild; Ponthan, Frida; Orrego, Abiel; Haeggstrom, Jesper Z.; Johnsen, John I.; Kogner, Per			Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy	FASEB JOURNAL			English	Article						eicosanoids; 5-lipoxygenase; apoptosis	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INTESTINAL EPITHELIAL-CELLS; GROWTH IN-VIVO; 5-LIPOXYGENASE-ACTIVATING PROTEIN; ARACHIDONIC-ACID; MULTIDRUG-RESISTANCE; INDUCE APOPTOSIS; PROSTATE-CANCER; C-4 SYNTHASE; LIPOXYGENASE	The metabolism of arachidonic acid by the cyclooxygenase (COX) or lipoxygenase (LO) pathways generates eicosanoids that have been implicated in the pathogenesis of a variety of human diseases, including cancer. In this study, we examined the expression and significance of components within the 5-LO pathway in human neuroblastoma, an embryonal tumor of the sympathetic nervous system. High expression of 5-LO, 5-LO-activating protein (FLAP), leukotriene A(4) hydrolase, leukotriene C-4 synthase, and leukotriene receptors was detected in a majority of primary neuroblastoma tumors and all cell lines investigated. Expression of 5-LO and FLAP was evident in tumor cells but not in nonmalignant adrenal medulla where neuroblastomas typically arise. Moreover, neuroblastoma cells produce leukotrienes, and stimulation of neuroblastoma cells with leukotrienes increased neuroblastoma cell viability. Inhibitors of 5-LO (AA-861), FLAP (MK- 886), or the leukotriene receptor antagonist montelukast inhibited neuroblastoma cell growth by induction of G(1)-cell cycle arrest and apoptosis. Similarly, specific 5-LO and leukotriene receptor silencing by small interfering RNA decreased neuroblastoma cell growth. These findings provide new insights into the pathobiology of neuroblastoma, and the use of leukotriene pathway inhibitors as a novel adjuvant therapy for children with neuroblastoma warrants further consideration.	[Sveinbjornsson, Baldur; Rasmuson, Agnes; Baryawno, Ninib; Ponthan, Frida; Johnsen, John I.; Kogner, Per] Karolinska Inst, Childhood Canc Res Unit, Dept Woman & Child Hlth, Stockholm, Sweden; [Wan, Min; Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Orrego, Abiel] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; [Sveinbjornsson, Baldur; Pettersen, Ingvild] Univ Tromso, Fac Med, Dept Cell Biol & Histol, Tromso, Norway; [Ponthan, Frida] Univ Newcastle Upon Tyne, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; UiT The Arctic University of Tromso; Newcastle University - UK	Sveinbjornsson, B (corresponding author), Karolinska Hosp, Childhood Canc Res Unit, Astrid Lindgren Childrens Hosp, Q6 05, S-17176 Stockholm, Sweden.	baldur.sveinbjornsson@ki.se		Baryawno, Ninib/0000-0001-8211-8368; Kogner, Per/0000-0002-2202-9694; Johnsen, John Inge/0000-0003-1277-812X; Baryawno, Ninib/0000-0001-6054-4163	Swedish Research Council; Swedish Children Cancer Foundation; Swedish Cancer Society; Stockholm Cancer Society (Sweden); Wenner-Gren Foundation (Stockholm, Sweden); EC FP6 [LSHM-CT-2004-005033]; Aakre Foundation (University of Tromso, Tromso, Norway)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Children Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Stockholm Cancer Society (Sweden); Wenner-Gren Foundation (Stockholm, Sweden); EC FP6(European CommissionEuropean Commission Joint Research Centre); Aakre Foundation (University of Tromso, Tromso, Norway)	We thank Lotta Elfman, Anja Pedersen, and Roy Lysaa for technical assistance. This work was supported by the Swedish Research Council, the Swedish Children Cancer Foundation, the Swedish Cancer Society, the Stockholm Cancer Society (Sweden), the Wenner-Gren Foundation (Stockholm, Sweden), EC FP6 (LSHM-CT-2004-005033), and the Aakre Foundation (University of Tromso, Tromso, Norway).	Abel F, 2005, EUR J CANCER, V41, P635, DOI 10.1016/j.ejca.2004.12.021; ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; Avis IM, 1996, J CLIN INVEST, V97, P806, DOI 10.1172/JCI118480; BOADO RJ, 1992, P NATL ACAD SCI USA, V89, P9044, DOI 10.1073/pnas.89.19.9044; Bogatcheva NV, 2005, MICROVASC RES, V69, P107, DOI 10.1016/j.mvr.2005.01.007; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chen XX, 2003, J NATL CANCER I, V95, P1053, DOI 10.1093/jnci/95.14.1053; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gasparini G, 2003, LANCET ONCOL, V4, P605, DOI 10.1016/S1470-2045(03)01220-8; GEKELER V, 1995, BIOCHEM BIOPH RES CO, V208, P345, DOI 10.1006/bbrc.1995.1344; Ghosh J, 1998, P NATL ACAD SCI USA, V95, P13182, DOI 10.1073/pnas.95.22.13182; Goodman JE, 2004, CARCINOGENESIS, V25, P2467, DOI 10.1093/carcin/bgh260; Gunning WT, 2002, CANCER RES, V62, P4199; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; Hennig R, 2005, CANCER RES, V65, P6011, DOI 10.1158/0008-5472.CAN-04-4090; Hennig R, 2004, CANCER LETT, V210, P41, DOI 10.1016/j.canlet.2004.02.023; Hennig R, 2002, AM J PATHOL, V161, P421, DOI 10.1016/S0002-9440(10)64198-3; HIRAI A, 1985, PROSTAGLANDINS, V30, P749, DOI 10.1016/0090-6980(85)90005-X; Hoque A, 2005, CARCINOGENESIS, V26, P785, DOI 10.1093/carcin/bgi026; IZUMI T, 1986, BIOCHEM BIOPH RES CO, V135, P139, DOI 10.1016/0006-291X(86)90953-8; JANSSENTIMMEN U, 1995, P NATL ACAD SCI USA, V92, P6966, DOI 10.1073/pnas.92.15.6966; Jiang WG, 2006, PROSTAG LEUKOTR ESS, V74, P125, DOI 10.1016/j.plefa.2005.10.005; Johnsen JI, 2005, CANCER LETT, V228, P195, DOI 10.1016/j.canlet.2005.01.058; Johnsen JI, 2004, CANCER RES, V64, P7210, DOI 10.1158/0008-5472.CAN-04-1795; JONES DB, 1987, J ENDOCRINOL, V112, P253, DOI 10.1677/joe.0.1120253; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Knorr B, 2006, J CLIN PHARMACOL, V46, P620, DOI 10.1177/0091270006288324; Lam BK, 2003, PROSTAG LEUKOTR ESS, V69, P111, DOI 10.1016/S0952-3278(03)00071-1; Lee KS, 2004, J ALLERGY CLIN IMMUN, V114, P1093, DOI 10.1016/j.jaci.2004.07.039; Luo M, 2003, HISTOL HISTOPATHOL, V18, P587, DOI 10.14670/HH-18.587; Maeba S, 2005, ANN ALLERG ASTHMA IM, V94, P670, DOI 10.1016/S1081-1206(10)61326-9; MANCINI JA, 1993, FEBS LETT, V318, P277, DOI 10.1016/0014-5793(93)80528-3; Matsuyama M, 2007, ONCOL REP, V18, P99; Migoya E, 2004, J CLIN PHARMACOL, V44, P487, DOI 10.1177/0091270004264970; MILLER DK, 1990, NATURE, V343, P278, DOI 10.1038/343278a0; Nie DT, 2004, SEMIN THROMB HEMOST, V30, P119; Norris MD, 2005, MOL CANCER THER, V4, P547, DOI 10.1158/1535-7163.MCT-04-0161; Ohd JF, 2003, GASTROENTEROLOGY, V124, P57, DOI 10.1053/gast.2003.50011; OMURA M, 1990, PROSTAG LEUKOTR ESS, V40, P93, DOI 10.1016/0952-3278(90)90150-J; PALMBLAD J, 1981, BLOOD, V58, P658; Paruchuri S, 2005, J BIOL CHEM, V280, P13538, DOI 10.1074/jbc.M409811200; Paruchuri S, 2003, J BIOL CHEM, V278, P45577, DOI 10.1074/jbc.M302881200; Paruchuri S, 2002, J CELL SCI, V115, P1883; Peaston AE, 2001, BRIT J CANCER, V85, P1564, DOI 10.1054/bjoc.2001.2144; Pettersen I, 2002, BIOCHEM BIOPH RES CO, V296, P671, DOI 10.1016/S0006-291X(02)00916-6; Ponthan F, 2003, INT J CANCER, V104, P418, DOI 10.1002/ijc.10954; Ponthan F, 2007, CLIN CANCER RES, V13, P1036, DOI 10.1158/1078-0432.CCR-06-1908; Ramires R, 2004, BIOCHEM BIOPH RES CO, V324, P815, DOI 10.1016/j.bbrc.2004.09.125; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Reynolds LM, 2001, NEUROSCI LETT, V309, P193, DOI 10.1016/S0304-3940(01)02071-7; Romano M, 2003, FASEB J, V17, P1986, DOI 10.1096/fj.03-0053rev; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Schroder O, 2005, CELL MOL LIFE SCI, V62, P87, DOI 10.1007/s00018-004-4366-7; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Tong WG, 2002, MOL CANCER THER, V1, P929; Uz T, 2001, EUR J PHARMACOL, V418, P15, DOI 10.1016/S0014-2999(01)00924-4; van Rossum GSAT, 2002, CELL MOL LIFE SCI, V59, P181, DOI 10.1007/s00018-002-8414-x; Wada K, 2006, FASEB J, V20, P1785, DOI 10.1096/fj.06-5809com; Zhi HY, 2003, INT J CANCER, V106, P327, DOI 10.1002/ijc.11225	64	56	59	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2008	22	10					3525	3536		10.1096/fj.07-103457	http://dx.doi.org/10.1096/fj.07-103457			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18591367				2022-12-25	WOS:000259642600015
J	Ordonez, E; Thiyagarajan, S; Cook, JD; Stemmler, TL; Gil, JA; Mateos, LM; Rosen, BP				Ordonez, Efren; Thiyagarajan, Saravanamuthu; Cook, Jeremy D.; Stemmler, Timothy L.; Gil, Jose A.; Mateos, Luis M.; Rosen, Barry P.			Evolution of metal(loid) binding sites in transcriptional regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CADC CD(II)/PB(II)/ZN(II)-RESPONSIVE REPRESSOR; BREVIBACTERIUM-LACTOFERMENTUM; CORYNEBACTERIUM-GLUTAMICUM; METALLOREGULATORY PROTEINS; CRYSTAL-STRUCTURE; ARS OPERON; METAL; RESISTANCE; FAMILY; GENES	Expression of the genes for resistance to heavy metals and metalloids is transcriptionally regulated by the toxic ions themselves. Members of the ArsR/SmtB family of small metalloregulatory proteins respond to transition metals, heavy metals, and metalloids, including As(III), Sb(III), Cd(II), Pb(II), Zn(II), Co(II), and Ni(II). These homodimeric repressors bind to DNA in the absence of inducing metal(loid) ion and dissociate from the DNA when inducer is bound. The regulatory sites are often three- or four-coordinate metal binding sites composed of cysteine thiolates. Surprisingly, in two different As(III)-responsive regulators, the metalloid binding sites were in different locations in the repressor, and the Cd(II) binding sites were in two different locations in two Cd(II)-responsive regulators. We hypothesize that ArsR/SmtB repressors have a common backbone structure, that of a winged helix DNA-binding protein, but have considerable plasticity in the location of inducer binding sites. Here we show that an As(III)-responsive member of the family, CgArsR1 from Corynebacterium glutamicum, binds As(III) to a cysteine triad composed of Cys(15), Cys(16), and Cys(55). This binding site is clearly unrelated to the binding sites of other characterized ArsR/SmtB family members. This is consistent with our hypothesis that metal(loid) binding sites in DNA binding proteins evolve convergently in response to persistent environmental pressures.	[Thiyagarajan, Saravanamuthu; Cook, Jeremy D.; Stemmler, Timothy L.; Rosen, Barry P.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Ordonez, Efren; Gil, Jose A.; Mateos, Luis M.] Univ Leon, Fac Biol Ambientales, Area Microbiol, Dept Biol Mol, E-24071 Leon, Spain	Wayne State University; Universidad de Leon	Rosen, BP (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	brosen@med.wayne.edu	MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; Gil, Jose A./C-3902-2009; Gil, José A./L-1800-2019; S, Thiyagarajan/AAU-3934-2021	MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; Gil, Jose A./0000-0002-5069-2637; Gil, José A./0000-0002-5069-2637; Rosen, Barry P./0000-0002-5230-4271; Thiyagarajan, Saravanamuthu/0000-0001-6960-2729	National Institutes of Health [R01 AI043428, R01 DK068139, LE040A07, BIO2005-02723, BIO2008-00519]; Department of Energy, Office of Biological and Environmental Research; National Center for Research Resources; Biomedical Technology Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI043428 ( to B. P. R.), R01 DK068139 ( to T. L. S.), and LE040A07, BIO2005-02723, and BIO2008-00519 ( to J.A.G. and L. M. M.). The Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ankudinov AL, 1997, PHYS REV B, V56, pR1712, DOI 10.1103/PhysRevB.56.R1712; Banci L, 2007, J BIOL CHEM, V282, P30181, DOI 10.1074/jbc.M701119200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Butcher BG, 2002, MICROBIOL-SGM, V148, P3983, DOI 10.1099/00221287-148-12-3983; Campbell DR, 2007, J BIOL CHEM, V282, P32298, DOI 10.1074/jbc.M703451200; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; DeLano W. L., 2001, PYMOL USERS MANUAL; FernandezGonzalez C, 1996, APPL MICROBIOL BIOT, V46, P554, DOI 10.1007/s002530050860; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Harvie DR, 2006, MOL MICROBIOL, V59, P1341, DOI 10.1111/j.1365-2958.2006.05029.x; KOSOWER NS, 1979, P NATL ACAD SCI USA, V76, P3382, DOI 10.1073/pnas.76.7.3382; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letek M, 2006, J BACTERIOL, V188, P409, DOI 10.1128/JB.188.2.409-423.2006; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Mateos LM, 1996, J BACTERIOL, V178, P5768, DOI 10.1128/jb.178.19.5768-5775.1996; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Qin J, 2007, J BIOL CHEM, V282, P34346, DOI 10.1074/jbc.M706565200; Ramirez-Solis A, 2004, INORG CHEM, V43, P2954, DOI 10.1021/ic0351592; Ramos A, 2003, MICROBIOL-SGM, V149, P3531, DOI 10.1099/mic.0.26653-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANFRANCISCO MJD, 1990, NUCLEIC ACIDS RES, V18, P619; SHI WP, 1994, J BIOL CHEM, V269, P19826; Turner JS, 1996, NUCLEIC ACIDS RES, V24, P3714, DOI 10.1093/nar/24.19.3714; Wong MD, 2002, J BIOL CHEM, V277, P40930, DOI 10.1074/jbc.M206536200; WU JH, 1993, J BIOL CHEM, V268, P52; Xu C, 1999, METALS AND GENETICS, P5; Ye J, 2005, J BACTERIOL, V187, P4214, DOI 10.1128/JB.187.12.4214-4221.2005; YOON KP, 1991, J BACTERIOL, V173, P7643, DOI 10.1128/jb.173.23.7643-7649.1991	29	55	56	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25706	25714		10.1074/jbc.M803209200	http://dx.doi.org/10.1074/jbc.M803209200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18591244	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000259012700065
J	Preumont, A; Snoussi, K; Stroobant, V; Collet, JF; Van Schaftingen, E				Preumont, Alice; Snoussi, Karim; Stroobant, Vincent; Collet, Jean-Francois; Van Schaftingen, Emile			Molecular identification of pseudouridine-metabolizing enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; ESCHERICHIA-COLI; BLUE PIGMENT; SYNTHETASE; BIOSYNTHESIS; ACID; NUCLEOSIDES; EVOLUTION; EXCRETION; DIAGNOSIS	Pseudouridine, a non-classical nucleoside present in human urine as a degradation product of RNAs, is one of the few molecules that has a glycosidic C-C bond. Through a data base mining approach involving transcriptomic data, we have molecularly identified two enzymes that are involved in the metabolism of pseudouridine in uropathogenic Escherichia coli, the principal agent of urinary tract infections in humans. The first enzyme, coded by the gene yeiC, specifically phosphorylates pseudouridine to pseudouridine 5'-phosphate. Accordingly, yeiC-mutants are unable to metabolize pseudouridine, in contrast to wild-type E. coli UTI89. The second enzyme, encoded by the gene yeiN belonging to the same operon as yeiC, catalyzes the conversion of pseudouridine 5'-phosphate to uracil and ribose 5-phosphate in a divalent cation-dependent manner. Remarkably, the glycosidic C-C bond of pseudouridine is cleaved in the course of this reaction, indicating that YeiN is the first molecularly identified enzyme able to hydrolyze a glycosidic C-C bond. Though this reaction is easily reversible, the association of YeiN with pseudouridine kinase indicates that it serves physiologically to metabolize pseudouridine 5'-phosphate rather than to form it. YeiN is homologous to Thermotoga maritima IndA, a protein with a new fold, which we now show to act also as a pseudouridine-5'-phosphate glycosidase. Data base mining indicates that most eukaryotes possess homologues of pseudouridine kinase and pseudouridine-5'-phosphate glycosidase and that these are most often associated in a single bifunctional protein. The gene encoding this bifunctional protein is absent from the genomes of man and other mammals, indicating that the capacity for metabolizing pseudouridine has been lost late in evolution.	[Preumont, Alice; Collet, Jean-Francois; Van Schaftingen, Emile] Catholic Univ Louvain, Physiol Chem Lab, de Duve Inst, B-1200 Brussels, Belgium; [Snoussi, Karim] Catholic Univ Louvain, Dept Chim, B-1348 Louvain, Belgium; [Stroobant, Vincent] Ludwig Inst Canc Res, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Ludwig Institute for Cancer Research	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Physiol Chem Lab, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Collet, Jean Francois/F-2105-2010; Van+Schaftingen, Emile/AAF-5532-2020	Collet, Jean-Francois/0000-0001-8069-7036; Van Schaftingen, Emile/0000-0002-6199-7647	Directorate General Higher Education and Scientific Research; French Community of Belgium; Fund for Medical Scientific Research; Interuniversity Attraction Poles Program [P6/05]	Directorate General Higher Education and Scientific Research; French Community of Belgium; Fund for Medical Scientific Research(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Program(Belgian Federal Science Policy Office)	This work was supported in part by the Directorate General Higher Education and Scientific Research, French Community of Belgium, the Fund for Medical Scientific Research, and the Interuniversity Attraction Poles Program (Network P6/05), Belgian Science Policy. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADAMS WS, 1960, AM J MED, V28, P726, DOI 10.1016/0002-9343(60)90130-3; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BORK P, 1993, PROTEIN SCI, V2, P31; BREITMAN TR, 1970, J BACTERIOL, V103, P263, DOI 10.1128/JB.103.1.263-264.1970; BREITMAN TR, 1968, J BACTERIOL, V96, P1873, DOI 10.1128/JB.96.5.1873-1874.1968; CAMICI M, 1980, ARCH BIOCHEM BIOPHYS, V205, P191, DOI 10.1016/0003-9861(80)90098-3; Charette M, 2000, IUBMB LIFE, V49, P341; DUGAICZYK A, 1970, BIOCHEMISTRY-US, V9, P1557, DOI 10.1021/bi00809a013; Feng B, 2005, J GASTROEN HEPATOL, V20, P1913, DOI 10.1111/j.1440-1746.2005.03888.x; Follens A, 1999, J BACTERIOL, V181, P2001, DOI 10.1128/JB.181.7.2001-2007.1999; Furmanek A, 2000, ACTA BIOCHIM POL, V47, P781, DOI 10.18388/abp.2000_3996; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; HEINRIKSON RL, 1964, J BIOL CHEM, V239, P1177; HEINRIKSON RL, 1963, J BIOL CHEM, V238, P485; Levin I, 2005, PROTEINS, V59, P864, DOI 10.1002/prot.20420; Maliekal P, 2006, GLYCOBIOLOGY, V16, P165, DOI 10.1093/glycob/cwj050; MATSUSHITA T, 1971, BIOCHIM BIOPHYS ACTA, V238, P165, DOI 10.1016/0005-2787(71)90082-7; MUTING D, 1963, H-S Z PHYSIOL CHEM, V332, P276, DOI 10.1515/bchm2.1963.332.1.276; MUTING D, 1954, H-S Z PHYSIOL CHEM, V297, P61, DOI 10.1515/bchm2.1954.297.1.61; NEUMANN JM, 1980, EUR J BIOCHEM, V108, P457, DOI 10.1111/j.1432-1033.1980.tb04742.x; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Reverchon S, 2002, J BACTERIOL, V184, P654, DOI 10.1128/JB.184.3.654-665.2002; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1; Seidel A, 2006, BRIT J CANCER, V94, P1726, DOI 10.1038/sj.bjc.6603164; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; SOLOMON LR, 1971, J BACTERIOL, V107, P535, DOI 10.1128/JB.107.2.535-542.1971; SOLOMON LR, 1971, BIOCHEM BIOPH RES CO, V44, P299, DOI 10.1016/0006-291X(71)90599-7; SUZUKI T, 1966, CAN J BIOCHEM CELL B, V44, P259, DOI 10.1139/o66-029; Takahashi H, 2007, J BIOL CHEM, V282, P9073, DOI 10.1074/jbc.M611319200; Vassiliadis G, 2007, ANTIMICROB AGENTS CH, V51, P3546, DOI 10.1128/AAC.00261-07; VITA A, 1983, ARCH BIOCHEM BIOPHYS, V226, P687, DOI 10.1016/0003-9861(83)90339-9; WARD DC, 1969, J BIOL CHEM, V244, P3243; WEISSMAN S, 1962, J LAB CLIN MED, V59, P852; WESTHEAD JE, 1974, ANTIMICROB AGENTS CH, V5, P90, DOI 10.1128/AAC.5.1.90; Yoshikawa T, 2002, FOOD CHEM TOXICOL, V40, P1165, DOI 10.1016/S0278-6915(02)00060-1; Zhu J, 2000, J BACTERIOL, V182, P3885, DOI 10.1128/JB.182.14.3885-3895.2000	37	33	37	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25238	25246		10.1074/jbc.M804122200	http://dx.doi.org/10.1074/jbc.M804122200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18591240	hybrid			2022-12-25	WOS:000259012700016
J	Manenti, G; Trincucci, G; Pettinicchio, A; Amendola, E; Scarfo, M; Dragani, TA				Manenti, G.; Trincucci, G.; Pettinicchio, A.; Amendola, E.; Scarfo, M.; Dragani, T. A.			Cis-acting genomic elements of the Pas1 locus control Kras mutability in lung tumors	ONCOGENE			English	Article						mouse; heredity; genetic susceptibility; lung cancer	K-RAS GENE; TRANSGENIC MICE; H-RAS; N-RAS; MOUSE; SUSCEPTIBILITY; CANCER; TUMORIGENESIS; ACTIVATION; CARCINOGENESIS	The Pas1 locus is the major tumor modi. er of lung tumorigenesis in mouse inbred strains. Of six genes contained in a conserved haplotype, three (Casc1, Kras and Ifltd1) have been proposed as Pas1 candidates, but mechanistic evidence is sparse. Herein, we examined urethane-induced lung tumorigenesis in a new mouse model developed by replacing the Kras gene with an Hras gene in the susceptible A/J-type Pas1 locus and crossing these mice with either C57BL/6J or A/J mice. Heterozygous mice carrying the Hras-replacement gene were more susceptible than wild-type mice to lung carcinogenesis, indicating that Hras replacement not only compensates for Kras functions, but is more active. Indeed, most lung tumors carried a Gln61Leu mutation in the Hras-replacement gene, whereas no mutations were observed in the endogenous Hras gene. Thus, the context of the Kras locus determined mutability of ras genes. In mice carrying the Hras-replacement gene, the mutation frequency affecting the wild-type Kras gene was much higher when this gene was located in the A/J type than in the C57BL/6J-type Pas1 locus (12 versus 0%, -log P = 5.0). These findings identify cis-acting elements in the Pas1 locus as the functional components controlling genetic susceptibility to lung tumorigenesis by modulating mutability of the Kras gene.	[Manenti, G.; Trincucci, G.; Pettinicchio, A.; Dragani, T. A.] Ist Nazl Tumori, Fdn IRCCS, Dept Expt Oncol & Labs, I-20133 Milan, Italy; [Amendola, E.; Scarfo, M.] Staz Zoolog Anton Dohrn, Naples, Italy; [Amendola, E.; Scarfo, M.] Biogem SC Ar L, IRGS, Ariano Irpino, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Stazione Zoologica Anton Dohrn di Napoli	Dragani, TA (corresponding author), Ist Nazl Tumori, Fdn IRCCS, Dept Expt Oncol, Via G Venezian 1, I-20133 Milan, Italy.	tommaso.dragani@istitutotumori.mi.it	Dragani, Tommaso A./K-4493-2016; Manenti, Giacomo/J-3339-2017	Dragani, Tommaso A./0000-0001-5915-4598; Manenti, Giacomo/0000-0002-4887-4482	Associazione and Fondazione Italiana Ricerca Cancro (AIRC and FIRC)	Associazione and Fondazione Italiana Ricerca Cancro (AIRC and FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was funded in part by grants from Associazione and Fondazione Italiana Ricerca Cancro (AIRC and FIRC). The funders had no role in the design and conduct of the study, in the collection, analysis and interpretation of the data, and in the preparation, review or approval of the article.	CHEN B, 1994, CARCINOGENESIS, V15, P2031, DOI 10.1093/carcin/15.9.2031; De Gregorio L, 1998, INT J CANCER, V79, P269, DOI 10.1002/(SICI)1097-0215(19980619)79:3<269::AID-IJC10>3.3.CO;2-J; Dragani TA, 2000, CANCER RES, V60, P5017; Dragani TA, 1995, ADV CANCER RES, V67, P83, DOI 10.1016/S0065-230X(08)60711-3; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Jones-Bolin SE, 1998, CARCINOGENESIS, V19, P1503, DOI 10.1093/carcin/19.8.1503; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; MAHER J, 1995, ONCOGENE, V11, P1639; Manenti G, 2005, CARCINOGENESIS, V26, P875, DOI 10.1093/carcin/bgh299; Manenti G, 2004, ONCOGENE, V23, P4495, DOI 10.1038/sj.onc.1207584; MANENTI G, 1995, GENOMICS, V29, P438, DOI 10.1006/geno.1995.9984; Manenti G, 2006, CARCINOGENESIS, V27, P1386, DOI 10.1093/carcin/bgi332; MARONPOT RR, 1991, EXP LUNG RES, V17, P305, DOI 10.3109/01902149109064420; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Ogawa K, 1996, CARCINOGENESIS, V17, P341, DOI 10.1093/carcin/17.2.341; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; To MD, 2006, NAT GENET, V38, P926, DOI 10.1038/ng1836; Tomisawa M, 2003, TOXICOL LETT, V142, P111, DOI 10.1016/S0378-4274(03)00018-3; Umemura T, 1999, CANCER LETT, V145, P101, DOI 10.1016/S0304-3835(99)00237-2; Wang M, 2005, ONCOGENE, V24, P1958, DOI 10.1038/sj.onc.1208295; YOU M, 1992, P NATL ACAD SCI USA, V89, P5804, DOI 10.1073/pnas.89.13.5804; Zhang ZQ, 2003, P NATL ACAD SCI USA, V100, P12642, DOI 10.1073/pnas.2133947100	24	11	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2008	27	43					5753	5758		10.1038/onc.2008.194	http://dx.doi.org/10.1038/onc.2008.194			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	352HM	18560355				2022-12-25	WOS:000259487100010
J	Sankar, N; Baluchamy, S; Kadeppagari, RK; Singhal, G; Weitzman, S; Thimmapaya, B				Sankar, N.; Baluchamy, S.; Kadeppagari, R-K; Singhal, G.; Weitzman, S.; Thimmapaya, B.			p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc	ONCOGENE			English	Article						c-Myc; p300; gene expression; cell cycle; YY1; HDAC3	TRANSCRIPTIONAL REPRESSION; BINDING PROTEIN; CELL-GROWTH; G(1) EXIT; PROMOTER; ACETYLATION; CBP; ASSOCIATION; ACTIVATION; DEPLETION	We showed earlier that p300/CBP plays an important role in G1 progression by negatively regulating c-Myc and thereby preventing premature G1 exit. Here, we have studied the mechanism by which p300 represses c-Myc and show that in quiescent cells p300 cooperates with histone deacetylase 3 (HDAC3) to repress transcription. p300 and HDAC3 are recruited to the upstream YY1-binding site of the c-Myc promoter resulting in chromatin deacetylation and repression of c-Myc transcription. Consistent with this, ablation of p300, YY1 or HDAC3 expression results in chromatin acetylation and induction of c-Myc. These three proteins exist as a complex in vivo and form a multiprotein complex with the YY1-binding site in vitro. The C-terminal region of p300 is both necessary and sufficient for the repression of c-Myc. These and other results suggest that in quiescent cells the C-terminal region of p300 provides corepressor function and facilitates the recruitment of p300 and HDAC3 to the YY1-binding site and represses the c-Myc promoter. This corepressor function of p300 prevents the inappropriate induction of c-Myc and S phase.	[Sankar, N.; Baluchamy, S.; Kadeppagari, R-K; Singhal, G.; Thimmapaya, B.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Weitzman, S.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Thimmapaya, B (corresponding author), Northwestern Univ, Sch Med, Dept Microbiol & Immunol, 303 E Chicago Ave,Olson 8452, Chicago, IL 60611 USA.	b-thimmapaya@northwestern.edu	Natesan, Sankar/C-9866-2015; KADEPPAGARI, RAVI KUMAR/C-1682-2015	KADEPPAGARI, RAVI KUMAR/0000-0003-0576-9508	NIH [CA73303]; NATIONAL CANCER INSTITUTE [R43CA073303] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are very grateful to Drs E Seto (Moffits Cancer Center), Dr Wu (University of Oregon), Yang Shi (Harvard University), N Perkins and R Hayward (University of Dundee, UK), and G Chinnadurai (St Louis University) for providing various plasmids and viruses. We also thank Dr Kathy Rundell for helpful discussion and editing this article. This work was supported by the NIH Grant CA73303.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Albert T, 2001, J BIOL CHEM, V276, P20482, DOI 10.1074/jbc.M100265200; Baluchamy S, 2007, ONCOGENE, V26, P781, DOI 10.1038/sj.onc.1209825; Baluchamy S, 2003, P NATL ACAD SCI USA, V100, P9524, DOI 10.1073/pnas.1633700100; Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Dang CV, 1999, MOL CELL BIOL, V19, P1; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goodman RH, 2000, GENE DEV, V14, P1553; Guermah M, 2006, CELL, V125, P275, DOI 10.1016/j.cell.2006.01.055; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hong R, 2003, J BIOL CHEM, V278, P44505, DOI 10.1074/jbc.M303138200; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Iyer NG, 2007, ONCOGENE, V26, P21, DOI 10.1038/sj.onc.1209771; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Izzo MW, 1999, J BIOL CHEM, V274, P19498, DOI 10.1074/jbc.274.27.19498; Jayaraman G, 1999, J BIOL CHEM, V274, P17342, DOI 10.1074/jbc.274.24.17342; Kolli S, 2001, P NATL ACAD SCI USA, V98, P4646, DOI 10.1073/pnas.081141998; Kung AL, 2000, GENE DEV, V14, P272; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Murphy DJ, 1999, MOL CELL BIOL, V19, P2724; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Rajabi HN, 2005, J BIOL CHEM, V280, P361, DOI 10.1074/jbc.M408633200; Santoso BY, 2006, NAT STRUCT MOL BIOL, V13, P131, DOI 10.1038/nsmb1048; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; SOULE HD, 1990, CANCER RES, V50, P6075; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; YACIUK P, 1991, MOL CELL BIOL, V11, P5389, DOI 10.1128/MCB.11.11.5389; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zou X, 1997, CURR TOP MICROBIOL, V224, P57	39	54	56	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2008	27	43					5717	5728		10.1038/onc.2008.181	http://dx.doi.org/10.1038/onc.2008.181			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	352HM	18542060				2022-12-25	WOS:000259487100007
J	Valente, P; Garcia-Sanz, N; Gomis, A; Fernandez-Carvajal, A; Fernandez-Ballester, G; Viana, F; Belmonte, C; Ferrer-Montiel, A				Valente, Pierluigi; Garcia-Sanz, Nuria; Gomis, Ana; Fernandez-Carvajal, Asia; Fernandez-Ballester, Gregorio; Viana, Felix; Belmonte, Carlos; Ferrer-Montiel, Antonio			Identification of molecular determinants of channel gating in the transient receptor potential box of vanilloid receptor I	FASEB JOURNAL			English	Article						structure-function; thermoreceptor; functional coupling; nociceptor; sensory transduction; oligomerization	TRP CHANNELS; CAPSAICIN-RECEPTOR; VOLTAGE SENSOR; COLD RECEPTOR; PAIN PATHWAY; ACTIVATION; HEAT; DOMAIN; THERMOSENSATION; DESENSITIZATION	Transient receptor potential vanilloid receptor subtype I (TRPV1) is an ion channel gated by physical and chemical stimuli that belongs to the TRPV protein family. TRPV receptors contain a highly conserved, 6-mer segment near the channel gate, known as the TRP box, whose function remains unknown. Here, we performed an alanine scanning mutagenesis of the TRP box of TRPV1 (IWKLQR) and found that mutation of this motif affected channel gating by raising the free energy of channel activation. Functional characterization of TRPV1 mutants showed that substitution of I696, W697, and R701 by alanine severely affected voltage- and heat-dependent activation and notably reduced the capsaicin responsiveness and tachyphylaxia, while mutation of K698, L699, and Q700 had minor effects. In addition, mutation of I696 to alanine promoted a strong outward rectification at negative membrane potentials, and slowed the kinetics of channel activation. Taken together, our findings suggest that modification of I696, W697, and R701 to alanine altered channel function by affecting events downstream of the initial stimuli-sensing step and imply that inter-subunit interactions within the TRP box play an important role in TRPV1 gating.	[Valente, Pierluigi; Garcia-Sanz, Nuria; Fernandez-Carvajal, Asia; Fernandez-Ballester, Gregorio; Ferrer-Montiel, Antonio] Univ Miguel Hernandez, Inst Mol & Cellular Biol, Alicante 03202, Spain; [Gomis, Ana; Viana, Felix; Belmonte, Carlos] Univ Miguel Hernandez, Consejo Super Invest Cient, Inst Neurociencias Alicante, Alicante 03202, Spain	Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Ferrer-Montiel, A (corresponding author), Univ Miguel Hernandez, Inst Mol & Cellular Biol, Av Univ S-N, Alicante 03202, Spain.	aferrer@umh.es	Valente, Pierluigi/AAF-2802-2021; Gomis, Ana/S-1854-2017; Viana, Felix/U-8533-2017; Ferrer-Montiel, Antonio/C-3072-2015; Carvajal, Asia Fernandez/G-8877-2015	Gomis, Ana/0000-0003-4651-7673; Viana, Felix/0000-0003-1439-949X; Ferrer-Montiel, Antonio/0000-0002-2973-6607; Fernandez-Carvajal, Asia/0000-0003-2741-1427	Spanish Ministry of Education and Science (MEC) [SAF2006-2580, BFU2005-03986]; Fundacion Ramon Areces; Generalitat Valenciana [GV-ACOMP06/202, GV05/076]	Spanish Ministry of Education and Science (MEC)(Spanish Government); Fundacion Ramon Areces; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	We thank Drs. Rosa Planells and Marco Caprini for critically reading the manuscript; and Reme Torres for cDNA and cRNA preparation, oocyte injection, and manipulation. We are indebted to Dr. Davis Julius (University of California, San Francisco, CA, USA) for the cDNA encoding rat TRPV1. This work was supported by grants from the Spanish Ministry of Education and Science (MEC) (SAF2006-2580 to A.F.-M. and BFU2005-03986 to A.G.), the Fundacion Ramon Areces (to A.F.-M), and the Generalitat Valenciana (GV-ACOMP06/202 to A.F-M. and GV05/076 to A.G.).	Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caprini M, 2005, J BIOL CHEM, V280, P18253, DOI 10.1074/jbc.M413389200; Caprini M, 2001, J BIOL CHEM, V276, P21070, DOI 10.1074/jbc.M100487200; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; FERRERMONTIEL AV, 1995, P NATL ACAD SCI USA, V92, P8021, DOI 10.1073/pnas.92.17.8021; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Jung J, 2002, J BIOL CHEM, V277, P44448, DOI 10.1074/jbc.M207103200; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Novakova-Tousova K, 2007, NEUROSCIENCE, V149, P144, DOI 10.1016/j.neuroscience.2007.07.039; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V455, P157, DOI 10.1007/s00424-007-0275-6; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Wang T, 2005, J CELL BIOL, V171, P685, DOI 10.1083/jcb.200508030; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882	39	70	72	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3298	3309		10.1096/fj.08-107425	http://dx.doi.org/10.1096/fj.08-107425			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18559878	Green Submitted			2022-12-25	WOS:000258761300022
J	Lee, K; Song, EH; Kim, HS; Yoo, JH; Han, HJ; Jung, MS; Lee, SM; Kim, KE; Kim, MC; Cho, MJ; Chung, WS				Lee, Kyunghee; Song, Eun Hyeon; Kim, Ho Soo; Yoo, Jae Hyuk; Han, Hay Ju; Jung, Mi Soon; Lee, Sang Min; Kim, Kyung Eun; Kim, Min Chul; Cho, Moo Je; Chung, Woo Sik			Regulation of MAPK phosphatase 1 (AtMKP1) by calmodulin in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CATALYTIC DOMAIN; TARGET RECOGNITION; CYTOSOLIC CALCIUM; CRYSTAL-STRUCTURE; BINDING PROTEINS; ABSCISIC-ACID; PHOSPHATASE; PLANTS; STRESS	The mitogen-activated protein kinases ( MAPKs) are key signal transduction molecules, which respond to various external stimuli. The MAPK phosphatases ( MKPs) are known to be negative regulators of MAPKs in eukaryotes. We screened an Arabidopsis cDNA library using horseradish peroxidase- conjugated calmodulin ( CaM), and isolated AtMKP1 as a CaM- binding protein. Recently, tobacco NtMKP1 and rice OsMKP1, two orthologs of Arabidopsis AtMKP1, were reported to bind CaM via a single putative CaM binding domain ( CaMBD). However, little is known about the regulation of phosphatase activity of plant MKP1s by CaM binding. In this study, we identified two Ca2+-dependent CaMBDs within AtMKP1. Specific binding of CaM to two different CaMBDs was verified using a gel mobility shift assay, a competition assay with a Ca2+/CaM-dependent enzyme, and a split- ubiquitin assay. The peptides for two CaMBDs, CaMBDI and CaMBDII, bound CaM in a Ca2+-dependent manner, and the binding affinity of CaMBDII was found to be higher than that of CaMBDI. CaM overlay assays using mutated CaMBDs showed that four amino acids, Trp453 and Leu456 in CaMBDI and Trp678 and Ile684 in CaMBDII, play a pivotal role in CaM binding. Moreover, the phosphatase activity ofAtMKP1was increased byCaMin a Ca2+-dependent manner. Our results suggest that two important signaling pathways, Ca2+ signaling and the MAPK signaling cascade, are connected in plants via the regulation of AtMKP1 activity. To our knowledge, this is the first report to show that the biochemical activity of MKP1 in plants is regulated by CaM.	[Lee, Kyunghee; Song, Eun Hyeon; Han, Hay Ju; Jung, Mi Soon; Lee, Sang Min; Kim, Kyung Eun; Kim, Min Chul; Cho, Moo Je; Chung, Woo Sik] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Program BK21, Div Appl Life Sci, Jinju 660701, South Korea; [Lee, Kyunghee; Yoo, Jae Hyuk; Lee, Sang Min; Chung, Woo Sik] Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju 660701, South Korea	Gyeongsang National University; Gyeongsang National University	Chung, WS (corresponding author), Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Program BK21, Div Appl Life Sci, Jinju 660701, South Korea.	chungws@gnu.ac.kr	Cho, Moo Je/F-1649-2010	Song, Eun Hyeon/0000-0001-9524-2595				Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Carafoli E, 2005, FEBS J, V272, P1073, DOI 10.1111/j.1742-4658.2005.04546.x; Chen L, 1996, BIOCHEMISTRY-US, V35, P9349, DOI 10.1021/bi960700+; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; ERICKSONVIITANEN S, 1987, METHOD ENZYMOL, V139, P455; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; Gottlin EB, 1996, J BIOL CHEM, V271, P27445, DOI 10.1074/jbc.271.44.27445; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Katou S, 2005, J BIOL CHEM, V280, P39569, DOI 10.1074/jbc.M508115200; Katou S, 2007, PLANT CELL PHYSIOL, V48, P332, DOI 10.1093/pcp/pcm007; Kerk D, 2002, PLANT PHYSIOL, V129, P908, DOI 10.1104/pp.004002; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kim HS, 2007, J BIOL CHEM, V282, P36292, DOI 10.1074/jbc.M705217200; Kim MC, 2002, NATURE, V416, P447, DOI 10.1038/416447a; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kudla J, 1999, P NATL ACAD SCI USA, V96, P4718, DOI 10.1073/pnas.96.8.4718; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Laser H, 2000, P NATL ACAD SCI USA, V97, P13732, DOI 10.1073/pnas.250400997; Lee JS, 2007, J BIOL CHEM, V282, P25020, DOI 10.1074/jbc.M701888200; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 1999, BBA-PROTEIN STRUCT M, V1433, P56, DOI 10.1016/S0167-4838(99)00149-1; Liang L, 2000, J BIOL CHEM, V275, P30075, DOI 10.1074/jbc.M004843200; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Monroe-Augustus M, 2003, PLANT CELL, V15, P2979, DOI 10.1105/tpc.017046; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PRICE AH, 1994, PLANT CELL, V6, P1301, DOI 10.1105/tpc.6.9.1301; Quettier AL, 2006, PLANT J, V47, P711, DOI 10.1111/j.1365-313X.2006.02823.x; Rainaldi M, 2007, J BIOL CHEM, V282, P6031, DOI 10.1074/jbc.M608970200; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Reddy VS, 2002, J BIOL CHEM, V277, P9840, DOI 10.1074/jbc.M111626200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Samuel MA, 2000, PLANT J, V22, P367, DOI 10.1046/j.1365-313x.2000.00741.x; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; Takahashi Y, 2003, PLANT J, V36, P820, DOI 10.1046/j.1365-313X.2003.01923.x; Theodosiou A, 2002, GENOME BIOL, V3; Ulm R, 2002, EMBO J, V21, P6483, DOI 10.1093/emboj/cdf646; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WurglerMurphy SM, 1997, TRENDS BIOCHEM SCI, V22, P172, DOI 10.1016/S0968-0004(97)01036-0; Yamakawa H, 2004, J BIOL CHEM, V279, P928, DOI 10.1074/jbc.M310277200; Yoo JH, 2004, J BIOL CHEM, V279, P848, DOI 10.1074/jbc.M310709200; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526	51	39	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23581	23588		10.1074/jbc.M801549200	http://dx.doi.org/10.1074/jbc.M801549200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579522	hybrid, Green Published			2022-12-25	WOS:000258638900010
J	Koenig, P; Oreb, M; Rippe, K; Muhle-Goll, C; Sinning, I; Schleiff, E; Tews, I				Koenig, Patrick; Oreb, Mislav; Rippe, Karsten; Muhle-Goll, Claudia; Sinning, Irmgard; Schleiff, Enrico; Tews, Ivo			On the significance of Toc-GTPase homodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST PROTEIN IMPORT; SIGNAL-RECOGNITION PARTICLE; CRYSTAL-STRUCTURE; PREPROTEIN RECEPTOR; ALUMINUM FLUORIDE; OUTER ENVELOPE; BINDING; TRANSLOCON; DIMERIZATION; INSIGHTS	Precursor protein translocation across the outer chloroplast membrane depends on the action of the Toc complex, containing GTPases as recognizing receptor components. The G domains of the GTPases are known to dimerize. In the dimeric conformation an arginine contacts the phosphate moieties of bound nucleotide in trans. Kinetic studies suggested that the arginine in itself does not act as an arginine finger of a reciprocal GTPase-activating protein (GAP). Here we investigate the specific function of the residue in two GTPase homologues. Arginine to alanine replacement variants have significantly reduced affinities for dimerization compared with wild-type GTPases. The amino acid exchange does not impact on the overall fold and nucleotide binding, as seen in the monomeric x-ray crystallographic structure of the Arabidopsis Toc33 arginine-alanine replacement variant at 2.0 A. We probed the catalytic center with the transition state analogue GDP/AlFx using NMR and analytical ultracentrifugation. AlFx binding depends on the arginine, suggesting the residue can play a role in catalysis despite the non-GAP nature of the homodimer. Two non-exclusive functional models are discussed: 1) the coGAP hypothesis, in which an additional factor activates the GTPase in homodimeric form; and 2) the switch hypothesis, in which a protein, presumably the large Toc159 GTPase, exchanges with one of the homodimeric subunits, leading to activation.	[Koenig, Patrick; Sinning, Irmgard; Tews, Ivo] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Oreb, Mislav; Schleiff, Enrico] JWGU Frankfurt Main, Cluster Excellence Macromol Complexes, Dept Biosci, D-60439 Frankfurt, Germany; [Rippe, Karsten] Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; [Rippe, Karsten] Res Grp Genome Org & Funct, BIOQUANT, D-69120 Heidelberg, Germany; [Muhle-Goll, Claudia] Karlsruhe Inst Technol, Inst Biol Grenzflachen, D-76021 Karlsruhe, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Tews, I (corresponding author), Heidelberg Univ, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ivo.tews@bzh.uni-heidelberg.de	Muhle-Goll, Claudia/AAM-6070-2021; Schleiff, Enrico/C-5105-2017; Tews, Ivo/A-2750-2010; Rippe, Karsten/A-3562-2012; Sinning, Irmgard/A-2982-2010	Schleiff, Enrico/0000-0002-0518-3489; Tews, Ivo/0000-0002-4704-1139; Rippe, Karsten/0000-0001-9951-9395; Oreb, Mislav/0000-0002-6118-1517	Deutsche Forschungsgemeinschaft [SFB594-B11]; Volkswagenstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagenstiftung(Volkswagen)	The work was supported by Deutsche Forschungsgemeinschaft Grant SFB594-B11 (to E. S.) and by a grant from the Volkswagenstiftung (to E. S. and K. R.).	Ahmadian MR, 1997, FEBS LETT, V408, P315, DOI 10.1016/S0014-5793(97)00422-5; Aronsson H, 2003, FEBS LETT, V544, P79, DOI 10.1016/S0014-5793(03)00478-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bange G, 2007, P NATL ACAD SCI USA, V104, P13621, DOI 10.1073/pnas.0702570104; Becker T, 2004, EMBO J, V23, P520, DOI 10.1038/sj.emboj.7600089; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Chen KH, 2000, PLANT PHYSIOL, V122, P813, DOI 10.1104/pp.122.3.813; Dam J, 2004, METHOD ENZYMOL, V384, P185; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P3396; Hiltbrunner A, 2001, J CELL BIOL, V154, P309, DOI 10.1083/jcb.200104022; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jarvis P, 2004, CURR BIOL, V14, pR1064, DOI 10.1016/j.cub.2004.11.049; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jelic M, 2003, BIOCHEMISTRY-US, V42, P5906, DOI 10.1021/bi034001q; Jelic M, 2002, BIOL CHEM, V383, P1875, DOI 10.1515/BC.2002.211; Kessler F, 2004, TRENDS CELL BIOL, V14, P334, DOI 10.1016/j.tcb.2004.05.004; KESSLER F, 1994, SCIENCE, V266, P1035, DOI 10.1126/science.7973656; Kikuchi S, 2006, PLANT CELL PHYSIOL, V47, P363, DOI 10.1093/pcp/pcj002; Koenig P, 2008, STRUCTURE, V16, P585, DOI 10.1016/j.str.2008.01.008; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; MARUTA S, 1993, J BIOL CHEM, V268, P7093; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; Oreb M, 2008, J EXP BOT, V59, P2309, DOI 10.1093/jxb/ern095; Oreb M, 2008, TRENDS CELL BIOL, V18, P19, DOI 10.1016/j.tcb.2007.10.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Praefcke GJK, 1999, J MOL BIOL, V292, P321, DOI 10.1006/jmbi.1999.3062; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Reddick LE, 2007, J BIOL CHEM, V282, P11410, DOI 10.1074/jbc.M609491200; Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Smith MD, 2002, J CELL BIOL, V159, P833, DOI 10.1083/jcb.200208017; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sun YJ, 2002, NAT STRUCT BIOL, V9, P95, DOI 10.1038/nsb744; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vojta A, 2004, J BIOL CHEM, V279, P21401, DOI 10.1074/jbc.M401968200; Wallas TR, 2003, J BIOL CHEM, V278, P44289, DOI 10.1074/jbc.M307873200; Weibel P, 2003, J BIOL CHEM, V278, P37321, DOI 10.1074/jbc.M305946200; Wittinghofer A, 1997, CURR BIOL, V7, pR682, DOI 10.1016/S0960-9822(06)00355-1; Yeh YH, 2007, J BIOL CHEM, V282, P13845, DOI 10.1074/jbc.M608385200	54	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23104	23112		10.1074/jbc.M710576200	http://dx.doi.org/10.1074/jbc.M710576200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18541539	hybrid			2022-12-25	WOS:000258455400023
J	Park, HJ; Ding, L; Dai, MQ; Lin, RC; Wang, HY				Park, Hee-Jin; Ding, Lei; Dai, Mingqiu; Lin, Rongcheng; Wang, Haiyang			Multisite phosphorylation of Arabidopsis HFR1 by casein kinase II and a plausible role in regulating its degradation rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-DEPENDENT DEGRADATION; TRANSCRIPTION FACTOR; PHYTOCHROME-A; SHADE AVOIDANCE; OSCILLATOR FUNCTION; CIRCADIAN CLOCK; GENE-EXPRESSION; LIGHT; PROTEIN; CK2	Arabidopsis Long Hypocotyl in Far-Red Light 1 (HFR1), a bHLH transcription factor, plays a critical role in promoting seedling photomorphogenesis and in balancing the shade-avoidance response under canopy shade conditions. Previous studies have established that HFR1 protein is degraded in darkness and is stabilized under light conditions to promote light signaling. How light regulates HFR1 stability is not well understood. In this study, we show that Arabidopsis HFR1 can be phosphorylated by recombinant casein kinase II (CKII) and plant extract in vitro and that phosphorylation of HFR1 can be effectively reduced by treatments with two CKII-specific inhibitors, 5,6-dichloro-1-beta-D-ribofuranosyl-benzimidazole (DRB) and heparin. We demonstrate that HFR1 physically interacts with the CKB1 and CKB2 regulatory subunits of CKII. Mutagenesis studies indicate that HFR1 is phosphorylated at multiple serine (Ser) residues in the N-terminal regulatory domain of HFR1. We also show that phosphorylation of HFR1 is promoted by light and that a predicted CKII site, Ser(122), represents a major phosphorylation site of HFR1 under both dark and light conditions. Comparison of wild-type, phosphorylation-deficient, and phosphorylation-mimic mutant proteins suggests that phosphorylation acts to reduce the degradation rate of HFR1. Together, our results suggest that CKII-mediated phosphorylation represents an important post-translational modification influencing the stability and signaling activity of Arabidopsis HFR1.	[Park, Hee-Jin; Ding, Lei; Dai, Mingqiu; Lin, Rongcheng; Wang, Haiyang] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research	Wang, HY (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	hw75@cornell.edu	Lin, Rongcheng/I-8105-2014	Lin, Rongcheng/0000-0001-8346-3390; Dai, Mingqiu/0000-0001-6737-8209	Div Of Molecular and Cellular Bioscience [1004808] Funding Source: National Science Foundation	Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Andronis C, 2008, MOL PLANT, V1, P58, DOI 10.1093/mp/ssm005; Briggs WR, 2001, PLANT PHYSIOL, V125, P85, DOI 10.1104/pp.125.1.85; Daniel X, 2004, P NATL ACAD SCI USA, V101, P3292, DOI 10.1073/pnas.0400163101; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Duek PD, 2004, CURR BIOL, V14, P2296, DOI 10.1016/j.cub.2004.12.026; Duek PD, 2003, PLANT J, V34, P827, DOI 10.1046/j.1365-313X.2003.01770.x; Fairchild CD, 2000, GENE DEV, V14, P2377; Fittinghoff K, 2006, PLANT J, V47, P577, DOI 10.1111/j.1365-313X.2006.02812.x; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Hardtke CS, 2000, EMBO J, V19, P4997, DOI 10.1093/emboj/19.18.4997; Huq E, 2006, TRENDS PLANT SCI, V11, P4, DOI 10.1016/j.tplants.2005.11.005; Hussain A, 2005, PLANT J, V44, P88, DOI 10.1111/j.1365-313X.2005.02512.x; Itoh H, 2003, TRENDS PLANT SCI, V8, P492, DOI 10.1016/j.tplants.2003.08.002; Jang IC, 2005, GENE DEV, V19, P593, DOI 10.1101/gad.1247205; KLIMCZAK LJ, 1992, PLANT CELL, V4, P87, DOI 10.1105/tpc.4.1.87; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lee Y, 1999, PLANT PHYSIOL, V119, P989, DOI 10.1104/pp.119.3.989; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; MCNELLIS TW, 1995, PLANT CELL, V7, P1749, DOI 10.1105/tpc.7.11.1749; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Neff MM, 2000, GENE DEV, V14, P257; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Perales M, 2006, PLANT J, V46, P849, DOI 10.1111/j.1365-313X.2006.02744.x; Portoles S, 2007, PLANT J, V51, P966, DOI 10.1111/j.1365-313X.2007.03186.x; Riera M, 2001, MOL CELL BIOCHEM, V227, P119, DOI 10.1023/A:1013141713277; Ryu JS, 2005, CELL, V120, P395, DOI 10.1016/j.cell.2004.12.019; Salinas P, 2006, PLANT CELL PHYSIOL, V47, P1295, DOI 10.1093/pcp/pcj100; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Sessa G, 2005, GENE DEV, V19, P2811, DOI 10.1101/gad.364005; Shalitin D, 2002, NATURE, V417, P763, DOI 10.1038/nature00815; Shen H, 2005, PLANT J, V44, P1023, DOI 10.1111/j.1365-313X.2005.02606.x; Shen Y, 2007, PLANT PHYSIOL, V145, P1043, DOI 10.1104/pp.107.105601; Smith H, 1997, PLANT CELL ENVIRON, V20, P840, DOI 10.1046/j.1365-3040.1997.d01-104.x; Soh MS, 2000, PLANT CELL, V12, P2061, DOI 10.1105/tpc.12.11.2061; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; Yang JP, 2006, PLANT J, V47, P564, DOI 10.1111/j.1365-313X.2006.02811.x; Yang JP, 2005, PLANT J, V43, P131, DOI 10.1111/j.1365-313X.2005.02433.x; Yang JP, 2005, PLANT CELL, V17, P804, DOI 10.1105/tpc.104.030205; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Zhu YX, 2000, P NATL ACAD SCI USA, V97, P13419, DOI 10.1073/pnas.230433797	54	35	39	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23264	23273		10.1074/jbc.M801720200	http://dx.doi.org/10.1074/jbc.M801720200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556661	hybrid			2022-12-25	WOS:000258455400039
J	Raman, J; Fritz, TA; Gerken, TA; Jamison, O; Live, D; Liu, M; Tabak, LA				Raman, Jayalakshmi; Fritz, Timothy A.; Gerken, Thomas A.; Jamison, Oliver; Live, David; Liu, Mian; Tabak, Lawrence A.			The catalytic and lectin domains of UDP-GalNAc: Polypeptide alpha-N-acetylgalactosaminyltransferase function in concert to direct glycosylation site selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-D-GALACTOSAMINE; MUCIN TANDEM REPEAT; O-GLYCOSYLATION; STREPTOMYCES-LIVIDANS; SUBMAXILLARY-GLAND; KINETIC MECHANISM; XYLAN-BINDING; IN-VIVO; GLYCOPEPTIDE; FAMILY	UDP-GalNAc: polypeptide alpha-N-Acetylgalactosaminyltransferases (ppGalNAcTs), a family (EC 2.4.1.41) of enzymes that initiate mucin-type O-glycosylation, are structurally composed of a catalytic domain and a lectin domain. Previous studies have suggested that the lectin domain modulates the glycosylation of glycopeptide substrates and may underlie the strict glycopeptide specificity of some isoforms (ppGalNAcT-7 and -10). Using a set of synthetic peptides and glycopeptides based upon the sequence of the mucin, MUC5AC, we have examined the activity and glycosylation site preference of lectin domain deletion and exchange constructs of the peptide/glycopeptide transferase ppGalNAcT-2 (hT2) and the glycopeptide transferase ppGal-NAcT- 10 (hT10). We demonstrate that the lectin domain of hT2 directs glycosylation site selection for glycopeptide substrates. Pre-steady-state kinetic measurements show that this effect is attributable to two mechanisms, either lectin domain-aided substrate binding or lectin domain-aided product release following glycosylation. We find that glycosylation of peptide substrates by hT10 requires binding of existing GalNAcs on the substrate to either its catalytic or lectin domain, thereby resulting in its apparent strict glycopeptide specificity. These results highlight the existence of two modes of site selection used by these ppGalNAcTs: local sequence recognition by the catalytic domain and the concerted recognition of distal sites of prior glycosylation together with local sequence binding mediated, respectively, by the lectin and catalytic domains. The latter mode may facilitate the glycosylation of serine or threonine residues, which occur in sequence contexts that would not be efficiently glycosylated by the catalytic domain alone. Local sequence recognition by the catalytic domain differs between hT2 and hT10 in that hT10 requires a pre-existing GalNAc residue while hT2 does not.	[Raman, Jayalakshmi; Fritz, Timothy A.; Tabak, Lawrence A.] NIDDK, Sect Biol Chem, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Gerken, Thomas A.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Gerken, Thomas A.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Gerken, Thomas A.; Jamison, Oliver] Case Western Reserve Univ, Sch Med, WA Bernbaum Ctr Cyst Fibrosis Res, Cleveland, OH 44106 USA; [Live, David; Liu, Mian] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University System of Georgia; University of Georgia	Tabak, LA (corresponding author), NIDDK, Sect Biol Chem, NIH, US Dept HHS, Bethesda, MD 20892 USA.	tabakl@mail.nih.gov			National Institutes of Health; NIDDK;  [NCI-RO1 CA-78834];  [NIGMS-RO1 GM-066148]; NATIONAL CANCER INSTITUTE [R01CA078834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK070012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health, through funds of the intramural program of the NIDDK and Grants NCI-RO1 CA-78834 (to T.A.G.) and NIGMS-RO1 GM-066148 (to D.L.).	Bashor C, 2002, BIOCHEMISTRY-US, V41, P4020, DOI 10.1021/bi0158730; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2000, BIOCHEM J, V350, P933, DOI 10.1042/0264-6021:3500933; Dupont C, 1998, BIOCHEM J, V330, P41, DOI 10.1042/bj3300041; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Gerken TA, 1998, J BIOL CHEM, V273, P26580, DOI 10.1074/jbc.273.41.26580; Gerken TA, 2002, J BIOL CHEM, V277, P49850, DOI 10.1074/jbc.M205851200; Gerken TA, 1997, J BIOL CHEM, V272, P9709; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Hagen FK, 1999, J BIOL CHEM, V274, P6797, DOI 10.1074/jbc.274.10.6797; Hagen FK, 1997, J BIOL CHEM, V272, P13843, DOI 10.1074/jbc.272.21.13843; Hanisch FG, 2001, GLYCOBIOLOGY, V11, P731, DOI 10.1093/glycob/11.9.731; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; HANSEN JE, 1995, BIOCHEM J, V308, P801, DOI 10.1042/bj3080801; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Liu M, 2005, CARBOHYD RES, V340, P2111, DOI 10.1016/j.carres.2005.05.023; Nakagawa T, 2007, CLIN CANCER RES, V13, P4105, DOI 10.1158/1078-0432.CCR-07-0419; Nehrke K, 1997, GLYCOBIOLOGY, V7, P1053, DOI 10.1093/glycob/7.8.1053-c; Nehrke K, 1998, GLYCOBIOLOGY, V8, P367, DOI 10.1093/glycob/8.4.367; OCONNELL BC, 1992, J BIOL CHEM, V267, P25010; OCONNELL BC, 1993, ANAL BIOCHEM, V210, P423, DOI 10.1006/abio.1993.1219; ROTH J, 1994, P NATL ACAD SCI USA, V91, P8935, DOI 10.1073/pnas.91.19.8935; Rottger S, 1998, J CELL SCI, V111, P45; Sparrow LG, 2007, PROTEINS, V66, P261, DOI 10.1002/prot.21261; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; Tenno M, 2002, J BIOL CHEM, V277, P47088, DOI 10.1074/jbc.M207369200; Tetaert D, 2001, BIOCHEM J, V357, P313, DOI 10.1042/0264-6021:3570313; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; WRAGG S, 1995, J BIOL CHEM, V270, P16947, DOI 10.1074/jbc.270.28.16947; Xu YM, 1997, BIOCHEMISTRY-US, V36, P3700, DOI 10.1021/bi9616007	36	63	65	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22942	22951		10.1074/jbc.M803387200	http://dx.doi.org/10.1074/jbc.M803387200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562306	Green Published, hybrid			2022-12-25	WOS:000258455400007
J	Yamamoto, S; Fukumoto, E; Yoshizaki, K; Iwamoto, T; Yamada, A; Tanaka, K; Suzuki, H; Aizawa, S; Arakaki, M; Yuasa, K; Oka, K; Chai, Y; Nonaka, K; Fukumoto, S				Yamamoto, Shinya; Fukumoto, Emiko; Yoshizaki, Keigo; Iwamoto, Tsutomu; Yamada, Aya; Tanaka, Kojiro; Suzuki, Hiroharu; Aizawa, Shizuko; Arakaki, Makiko; Yuasa, Kenji; Oka, Kyoko; Chai, Yang; Nonaka, Kazuaki; Fukumoto, Satoshi			Platelet-derived growth factor receptor regulates salivary gland morphogenesis via fibroblast growth factor expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRANIAL NEURAL CREST; SUBMANDIBULAR-GLAND; BRANCHING MORPHOGENESIS; PDGF-A; DENTAL EPITHELIUM; LAMININ ALPHA-5; IN-VIVO; MOUSE; LUNG; FGF10	A coordinated reciprocal interaction between epithelium and mesenchyme is involved in salivary gland morphogenesis. The submandibular glands (SMGs) of Wnt1-Cre/R26R mice have been shown positive for mesenchyme, whereas the epithelium is beta-galactosidase-negative, indicating that most mesenchymal cells are derived from cranial neural crest cells. Platelet-derived growth factor (PDGF) receptor alpha is one of the markers of neural crest-derived cells. In this study, we analyzed the roles of PDGFs and their receptors in the morphogenesis of mouse SMGs. PDGF-A was shown to be expressed in SMG epithelium, whereas PDGF-B, PDGFR alpha, and PDGFR beta were expressed in mesenchyme. Exogenous PDGF-AA and -BB in SMG organ cultures demonstrated increased levels of branching and epithelial proliferation, although their receptors were found to be expressed in mesenchyme. In contrast, short interfering RNA for Pdgfa and -b as well as neutralizing antibodies for PDGF-AB and -BB showed decreased branching. PDGF-AA induced the expression of the fibroblast growth factor genes Fgf3 and -7, and PDGF-BB induced the expression of Fgf1, -3, -7, and -10, whereas short interfering RNA for Pdgfa and Pdgfb inhibited the expression of Fgf3, -7, and -10, indicating that PDGFs regulate Fgf gene expression in SMG mesenchyme. The PDGF receptor inhibitor AG-17 inhibited PDGF-induced branching, whereas exogenous FGF7 and -10 fully recovered. Together, these results indicate that fibroblast growth factors function downstream of PDGF signaling, which regulates Fgf expression in neural crest-derived mesenchymal cells and SMG branching morphogenesis. Thus, PDGF signaling is a possible mechanism involved in the interaction between epithelial and neural crest-derived mesenchyme.	[Yamada, Aya; Tanaka, Kojiro; Suzuki, Hiroharu; Aizawa, Shizuko; Arakaki, Makiko; Fukumoto, Satoshi] Tohoku Univ, Div Pediat Dent, Dept Oral Hlth & Dev Sci, Grad Sch Dent, Sendai, Miyagi 9808575, Japan; [Yamamoto, Shinya; Yoshizaki, Keigo; Iwamoto, Tsutomu; Yamada, Aya; Yuasa, Kenji; Oka, Kyoko; Nonaka, Kazuaki; Fukumoto, Satoshi] Kyushu Univ, Sect Pediat Dent, Div Oral Hlth Growth & Dev, Fac Dent Sci, Fukuoka 8128582, Japan; [Fukumoto, Emiko] Nagasaki Univ, Div Prevent Dent, Dept Dev & Reconstruct Med, Grad Sch Biomed Sci, Nagasaki 8528588, Japan; [Chai, Yang] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA	Tohoku University; Kyushu University; Nagasaki University; University of Southern California	Fukumoto, S (corresponding author), Tohoku Univ, Div Pediat Dent, Dept Oral Hlth & Dev Sci, Grad Sch Dent, Sendai, Miyagi 9808575, Japan.	fukumoto@mail.tains.tohoku.ac.jp	Iwamoto, Tsutomu/AAA-6597-2019; Iwamoto, Tsutomu/AAI-8952-2021	Iwamoto, Tsutomu/0000-0001-8472-605X; Yoshizaki, Keigo/0000-0002-0598-5879; Fukumoto, Satoshi/0000-0002-5046-6891				Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Celli G, 1998, EMBO J, V17, P1642, DOI 10.1093/emboj/17.6.1642; Chai Y, 2000, DEVELOPMENT, V127, P1671; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Ding H, 2000, MECH DEVELOP, V96, P209, DOI 10.1016/S0925-4773(00)00425-1; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Entesarian M, 2005, NAT GENET, V37, P125, DOI 10.1038/ng1507; Fukumoto E, 2003, J DENT RES, V82, P17, DOI 10.1177/154405910308200105; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Govindarajan V, 2000, DEV BIOL, V225, P188, DOI 10.1006/dbio.2000.9812; HANSCH GM, 1995, J CELL PHYSIOL, V163, P451, DOI 10.1002/jcp.1041630304; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; Jaskoll T, 2002, CELLS TISSUES ORGANS, V170, P83, DOI 10.1159/000046183; Kashimata M, 2000, DEV BIOL, V220, P183, DOI 10.1006/dbio.2000.9639; Kashimata M, 1997, DEV DYNAM, V208, P149, DOI 10.1002/(SICI)1097-0177(199702)208:2<149::AID-AJA2>3.0.CO;2-I; Kingsley K, 2002, BIOCHEM BIOPH RES CO, V294, P1017, DOI 10.1016/S0006-291X(02)00592-2; Klinghoffer RA, 2001, MOL CELL, V7, P343, DOI 10.1016/S1097-2765(01)00182-4; Larsen M, 2003, DEV BIOL, V255, P178, DOI 10.1016/S0012-1606(02)00047-7; Li J, 2001, DEV BIOL, V239, P338, DOI 10.1006/dbio.2001.0441; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Lindahl P, 1998, CURR OPIN NEPHROL HY, V7, P21, DOI 10.1097/00041552-199801000-00004; Makarenkova HP, 2000, DEVELOPMENT, V127, P2563; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Melnick M, 2000, CRIT REV ORAL BIOL M, V11, P199, DOI 10.1177/10454411000110020401; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Milunsky JM, 2006, CLIN GENET, V69, P349, DOI 10.1111/j.1399-0004.2006.00597.x; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Miner JH, 2000, DEV BIOL, V217, P278, DOI 10.1006/dbio.1999.9546; Morita K, 1999, DEV DYNAM, V215, P148; MORRISONGRAHAM K, 1992, DEVELOPMENT, V115, P133; Nishiguchi M, 2007, ARCH ORAL BIOL, V52, P237, DOI 10.1016/j.archoralbio.2006.09.016; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; ORRURTREGER A, 1992, DEVELOPMENT, V115, P1045; ORRURTREGER A, 1992, DEVELOPMENT, V115, P289; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Payne J, 1997, DEV DYNAM, V209, P105; Rebustini IT, 2007, DEV BIOL, V308, P15, DOI 10.1016/j.ydbio.2007.04.031; Robbins JR, 1999, DEV BIOL, V212, P255, DOI 10.1006/dbio.1999.9373; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; SCHATTEMAN GC, 1992, DEVELOPMENT, V115, P123; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Simian M, 2001, DEVELOPMENT, V128, P3117; Soriano P, 1997, DEVELOPMENT, V124, P2691; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; TAN SS, 1986, J EMBRYOL EXP MORPH, V98, P21; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; Xu X, 2005, DEV DYNAM, V232, P75, DOI 10.1002/dvdy.20197; Yamada A, 2005, ARCH ORAL BIOL, V50, P393, DOI 10.1016/j.archoralbio.2004.09.014; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Yoshizaki K, 2008, J BIOL CHEM, V283, P3385, DOI 10.1074/jbc.M704913200	60	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23139	23149		10.1074/jbc.M710308200	http://dx.doi.org/10.1074/jbc.M710308200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18559345	hybrid			2022-12-25	WOS:000258455400027
J	Karkan, D; Pfeifer, C; Vitalis, TZ; Arthur, G; Ujiie, M; Chen, QQ; Tsai, S; Koliatis, G; Gabathuler, R; Jefferies, WA				Karkan, Delara; Pfeifer, Cheryl; Vitalis, Timothy Z.; Arthur, Gavin; Ujiie, Maki; Chen, Qingqi; Tsai, Sam; Koliatis, Gerrasimo; Gabathuler, Reinhard; Jefferies, Wilfred A.			A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier	PLOS ONE			English	Article							ANTITRANSFERRIN RECEPTOR ANTIBODY; MELANOMA-ASSOCIATED ANTIGEN-P97; GLYCOPROTEIN-MEDIATED EFFLUX; CENTRAL-NERVOUS-SYSTEM; 1ST TOTAL-SYNTHESIS; TRANSFERRIN RECEPTOR; ALZHEIMERS-DISEASE; DRUG-DELIVERY; IN-VITRO; P-GLYCOPROTEIN	Background: Therapeutic intervention in many neurological diseases is thwarted by the physical obstacle formed by the blood-brain barrier (BBB) that excludes most drugs from entering the brain from the blood. Thus, identifying efficacious modes of drug delivery to the brain remains a "holy grail'' in molecular medicine and nanobiotechnology. Brain capillaries, that comprise the BBB, possess an endogenous receptor that ferries an iron-transport protein, termed p97 (melanotransferrin), across the BBB. Here, we explored the hypothesis that therapeutic drugs "piggybacked'' as conjugates of p97 can be shuttled across the BBB for treatment of otherwise inoperable brain tumors. Approach: Human p97 was covalently linked with the chemotherapeutic agents paclitaxel (PTAX) or adriamycin (ADR) and following intravenous injection, measured their penetration into brain tissue and other organs using radiolabeled and fluorescent derivatives of the drugs. In order to establish efficacy of the conjugates, we used nude mouse models to assess p97-drug conjugate activity towards glioma and mammary tumors growing subcutaneously compared to those growing intracranially. Principal Findings: Bolus-injected p97-drug conjugates and unconjugated p97 traversed brain capillary endothelium within a few minutes and accumulated to 1-2% of the injected by 24 hours. Brain delivery with p97-drug conjugates was quantitatively 10 fold higher than with free drug controls. Furthermore, both free-ADR and p97-ADR conjugates equally inhibited the subcutaneous growth of gliomas growing outside the brain. Evocatively, only p97-ADR conjugates significantly prolonged the survival of animals bearing intracranial gliomas or mammary tumors when compared to similar cumulated doses of free-ADR. Significance: This study provides the initial proof of concept for p97 as a carrier capable of shuttling therapeutic levels of drugs from the blood to the brain for the treatment of neurological disorders, including classes of resident and metastatic brain tumors. It may be prudent, therefore, to consider implementation of this novel delivery platform in various clinical settings for therapeutic intervention in acute and chronic neurological diseases.	[Karkan, Delara; Vitalis, Timothy Z.; Arthur, Gavin; Chen, Qingqi; Tsai, Sam; Koliatis, Gerrasimo; Gabathuler, Reinhard] BioMarin Pharmaceut Inc, Vancouver, BC, Canada; [Pfeifer, Cheryl; Vitalis, Timothy Z.; Ujiie, Maki; Tsai, Sam; Koliatis, Gerrasimo; Gabathuler, Reinhard; Jefferies, Wilfred A.] Univ British Columbia, Biomed Res Ctr, Dept Med Genet, Michael Smith Lab, Vancouver, BC, Canada; [Pfeifer, Cheryl; Vitalis, Timothy Z.; Ujiie, Maki; Tsai, Sam; Koliatis, Gerrasimo; Gabathuler, Reinhard; Jefferies, Wilfred A.] Univ British Columbia, Biomed Res Ctr, Dept Microbiol & Immunol, Michael Smith Lab, Vancouver, BC, Canada; [Pfeifer, Cheryl; Vitalis, Timothy Z.; Ujiie, Maki; Tsai, Sam; Koliatis, Gerrasimo; Gabathuler, Reinhard; Jefferies, Wilfred A.] Univ British Columbia, Biomed Res Ctr, Dept Zool, Michael Smith Lab, Vancouver, BC, Canada	BioMarin Pharmaceutical Inc.; University of British Columbia; University of British Columbia; University of British Columbia	Karkan, D (corresponding author), BioMarin Pharmaceut Inc, Vancouver, BC, Canada.	wilf@brc.ubc.ca		Pfeifer, Cheryl/0000-0001-8584-228X	BioMarin Pharmaceutical (Canada) Inc.; Canadian Institute of Health Research	BioMarin Pharmaceutical (Canada) Inc.; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Financial support for this study was provided by BioMarin Pharmaceutical (Canada) Inc. (Formerly Synapse Technologies Inc.) and by grants to WAJ from the Canadian Institute of Health Research. These studies were performed at BioMarin Pharmaceutical (Canada) Inc. (Formerly Synapse Technologies Inc., Vancouver, Canada) and in the laboratory of WAJ at the University of British Columbia, Canada.	Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; Ambruosi A, 2006, J MICROENCAPSUL, V23, P582, DOI 10.1080/02652040600788080; ARCAMONE F, 1969, BIOTECHNOL BIOENG, V11, P1101, DOI 10.1002/bit.260110607; Ayrton A, 2001, XENOBIOTICA, V31, P469, DOI 10.1080/00498250110060969; BANKS WA, 1994, J NEUROCHEM, V62, P2404; Bartus R T, 1999, Curr Opin Drug Discov Devel, V2, P152; Bicamumpaka C, 1998, ONCOL REP, V5, P1381; BLASBERG RG, 1983, ANN NEUROL, V14, P202, DOI 10.1002/ana.410140207; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P215, DOI 10.1038/jcbfm.1983.29; Boado RJ, 2007, BIOCONJUGATE CHEM, V18, P447, DOI 10.1021/bc060349x; Brigger I, 2004, J CONTROL RELEASE, V100, P29, DOI 10.1016/j.jconrel.2004.07.019; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; *BRIST MYERSSQUIBB, 2004, GREEN SYNTH PATHW AW; BROWN JP, 1982, NATURE, V296, P171, DOI 10.1038/296171a0; Chen Y., 2004, Current Drug Delivery, V1, P361, DOI 10.2174/1567201043334542; Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050; Coloma MJ, 2000, PHARMACEUT RES, V17, P266, DOI 10.1023/A:1007592720793; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Demeule M, 2003, BLOOD, V102, P1723, DOI 10.1182/blood-2003-01-0166; Demeule M, 2002, J NEUROCHEM, V83, P924, DOI 10.1046/j.1471-4159.2002.01201.x; Egleton Richard D, 2005, NeuroRx, V2, P44, DOI 10.1007/BF03206641; Fillebeen C, 1999, J BIOL CHEM, V274, P7011, DOI 10.1074/jbc.274.11.7011; Fine RL, 2006, CLIN CANCER RES, V12, P5770, DOI 10.1158/1078-0432.CCR-05-2356; FOOD MR, 1994, J BIOL CHEM, V269, P3034; FORNARI FA, 1994, MOL PHARMACOL, V45, P649; FRIDEN PM, 1993, ADV EXP MED BIOL, V331, P129; Gao KP, 2006, INT J PHARMACEUT, V310, P213, DOI 10.1016/j.ijpharm.2005.11.040; Goodman J., 2001, STORY TAXOL NATURE P; GUTIERREZ EG, 1993, J NEUROIMMUNOL, V47, P169, DOI 10.1016/0165-5728(93)90027-V; Habgood MD, 2000, CELL MOL NEUROBIOL, V20, P231, DOI 10.1023/A:1007001923498; HEIMANS JJ, 1994, ANN ONCOL, V5, P951, DOI 10.1093/oxfordjournals.annonc.a058736; HELLSTROM I, 1983, INT J CANCER, V31, P553, DOI 10.1002/ijc.2910310505; HOLTON RA, 1994, J AM CHEM SOC, V116, P1597, DOI 10.1021/ja00083a066; HOLTON RA, 1994, J AM CHEM SOC, V116, P1599, DOI 10.1021/ja00083a067; HOLTON RA, 1995, SCI APPL, P97; Hubensack M, 2008, J CANCER RES CLIN, V134, P597, DOI 10.1007/s00432-007-0323-9; JEFFERIES WA, 1985, IMMUNOLOGY, V54, P333; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Kas HS, 2004, ADV EXP MED BIOL, V553, P221; KAYE AH, 1986, CANCER RES, V46, P1367; KENNARD ML, 1993, BIOTECHNOL BIOENG, V42, P480, DOI 10.1002/bit.260420411; Kennard ML, 1996, NAT MED, V2, P1230, DOI 10.1038/nm1196-1230; Kim DK, 2001, NEUROPSYCHOPHARMACOL, V25, P84, DOI 10.1016/S0893-133X(00)00230-X; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; KONDO A, 1987, BRAIN RES, V412, P73, DOI 10.1016/0006-8993(87)91441-7; Kratz F, 1998, J PHARM SCI-US, V87, P338, DOI 10.1021/js970246a; Kreuter J, 2004, J NANOSCI NANOTECHNO, V4, P484, DOI 10.1166/jnn.2003.077; Lee HJ, 2000, J PHARMACOL EXP THER, V292, P1048; Lee HJ, 2002, J CEREBR BLOOD F MET, V22, P223, DOI 10.1097/00004647-200202000-00010; *MAYOCLINIC MICR, 2007, DOX INTR ROUT; McAllister LD, 2000, NEUROSURGERY, V46, P51, DOI 10.1093/neurosurgery/46.1.51; Michaelis K, 2006, J PHARMACOL EXP THER, V317, P1246, DOI 10.1124/jpet.105.097139; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Moos T, 2001, J NEUROCHEM, V79, P119, DOI 10.1046/j.1471-4159.2001.00541.x; Moroo I, 2003, MICROCIRCULATION, V10, P457, DOI 10.1038/sj.mn.7800213; NEUWELT EA, 1980, NEUROSURGERY, V6, P49, DOI 10.1227/00006123-198001000-00007; NEUWELT EA, 1979, J CLIN INVEST, V64, P684, DOI 10.1172/JCI109509; NEUWELT EA, 1980, NEUROSURGERY, V7, P44, DOI 10.1227/00006123-198007000-00007; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; OHKAWA K, 1993, CANCER RES, V53, P4238; OHNISHI T, 1995, BIOCHEM PHARMACOL, V49, P1541, DOI 10.1016/0006-2952(95)00082-B; Olivier Jean-Christophe, 2005, NeuroRx, V2, P108, DOI 10.1007/BF03206647; Pan WH, 1999, EXP NEUROL, V160, P454, DOI 10.1006/exnr.1999.7215; PAPOIAN T, 1990, AM J PATHOL, V136, P1201; Pardridge W M, 1991, Semin Cell Biol, V2, P419; PARDRIDGE WM, 1991, J PHARMACOL EXP THER, V259, P66; PARDRIDGE WM, 1987, METABOLISM, V36, P892, DOI 10.1016/0026-0495(87)90099-0; Pardridge WM, 1998, J NEUROCHEM, V70, P1781; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; Pardridge WM., 2007, J CONTROL RELEASE; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Rapoport SI, 2000, CELL MOL NEUROBIOL, V20, P217, DOI 10.1023/A:1007049806660; RAUB TJ, 1991, J CELL PHYSIOL, V149, P141, DOI 10.1002/jcp.1041490118; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; RISAU W, 1986, DEV BIOL, V117, P537, DOI 10.1016/0012-1606(86)90321-0; Roney C, 2005, J CONTROL RELEASE, V108, P193, DOI 10.1016/j.jconrel.2005.07.024; Rothenberger S, 1996, BRAIN RES, V712, P117, DOI 10.1016/0006-8993(96)88505-2; Rousselle C, 2000, MOL PHARMACOL, V57, P679, DOI 10.1124/mol.57.4.679; ROYER I, 1995, RAPID COMMUN MASS SP, V9, P495, DOI 10.1002/rcm.1290090605; Saleh M, 1999, J NATL CANCER I, V91, P438, DOI 10.1093/jnci/91.5.438; Saleh M, 1997, INT J CANCER, V72, P664, DOI 10.1002/(SICI)1097-0215(19970807)72:4<664::AID-IJC19>3.3.CO;2-3; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P85, DOI 10.1046/j.1440-1681.1999.02987.x; Saunders NR, 2000, CELL MOL NEUROBIOL, V20, P29, DOI 10.1023/A:1006991809927; SELCMAN M, 1995, GLIOBLASTOMA MALIGNA, P449; Shan K, 1996, ANN INTERN MED, V125, P47, DOI 10.7326/0003-4819-125-1-199607010-00008; Sharma US, 1997, PHARM RES-DORDR, V14, P992, DOI 10.1023/A:1012136925030; SILBERGELD DL, 1995, ANTI-CANCER DRUG, V6, P270, DOI 10.1097/00001813-199504000-00011; Smith MW, 2006, J DRUG TARGET, V14, P191, DOI 10.1080/10611860600650086; SPARREBOOM A, 1995, J CHROMATOGR B, V664, P383, DOI 10.1016/0378-4347(94)00495-Q; SPETH PAJ, 1988, CLIN PHARMACOKINET, V15, P15, DOI 10.2165/00003088-198815010-00002; Stewart PA, 2000, CELL MOL NEUROBIOL, V20, P149, DOI 10.1023/A:1007026504843; Strandberg JJ, 2006, TOXICOL LETT, V166, P11, DOI 10.1016/j.toxlet.2006.05.007; Takamiya Y, 1997, BRIT J CANCER, V76, P445, DOI 10.1038/bjc.1997.408; Temsamani J, 2001, EXPERT OPIN BIOL TH, V1, P773, DOI 10.1517/14712598.1.5.773; Trail PA, 1997, CANCER RES, V57, P100; Tsuji A, 1998, THER DRUG MONIT, V20, P588, DOI 10.1097/00007691-199810000-00024; Tsuji Akira, 2005, NeuroRx, V2, P54, DOI 10.1007/BF03206642; UEDA F, 1993, J NEUROCHEM, V60, P106, DOI 10.1111/j.1471-4159.1993.tb05828.x; WALL ME, 1995, CANCER RES, V55, P753; Wolff JEA, 1999, J CANCER RES CLIN, V125, P481, DOI 10.1007/s004320050305; Yamada T, 1999, BRAIN RES, V845, P1, DOI 10.1016/S0006-8993(99)01767-9; Yang J, 2004, PROTEIN EXPRES PURIF, V34, P28, DOI 10.1016/j.pep.2003.09.007; Zhou QY, 2007, CLIN CANCER RES, V13, P4271, DOI 10.1158/1078-0432.CCR-07-0658; Zhou QY, 2007, J PHARMACOL EXP THER, V321, P265, DOI 10.1124/jpet.106.118265	106	71	94	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2469	10.1371/journal.pone.0002469	http://dx.doi.org/10.1371/journal.pone.0002469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575595	gold, Green Published			2022-12-25	WOS:000263288000002
J	Munson, L; Terio, KA; Kock, R; Mlengeya, T; Roelke, ME; Dubovi, E; Summers, B; Sinclair, ARE; Packer, C				Munson, Linda; Terio, Karen A.; Kock, Richard; Mlengeya, Titus; Roelke, Melody E.; Dubovi, Edward; Summers, Brian; Sinclair, Anthony R. E.; Packer, Craig			Climate Extremes Promote Fatal Co-Infections during Canine Distemper Epidemics in African Lions	PLOS ONE			English	Article							SOUTH-AFRICA; SERENGETI; MORTALITY; ECOLOGY; DISEASE; TICKS; INFECTION; PARASITES; VIRUS	Extreme climatic conditions may alter historic host-pathogen relationships and synchronize the temporal and spatial convergence of multiple infectious agents, triggering epidemics with far greater mortality than those due to single pathogens. Here we present the first data to clearly illustrate how climate extremes can promote a complex interplay between epidemic and endemic pathogens that are normally tolerated in isolation, but with co-infection, result in catastrophic mortality. A 1994 canine distemper virus (CDV) epidemic in Serengeti lions (Panthera leo) coincided with the death of a third of the population, and a second high-mortality CDV epidemic struck the nearby Ngorongoro Crater lion population in 2001. The extent of adult mortalities was unusual for CDV and prompted an investigation into contributing factors. Serological analyses indicated that at least five "silent'' CDV epidemics swept through the same two lion populations between 1976 and 2006 without clinical signs or measurable mortality, indicating that CDV was not necessarily fatal. Clinical and pathology findings suggested that hemoparsitism was a major contributing factor during fatal epidemics. Using quantitative real-time PCR, we measured the magnitude of hemoparasite infections in these populations over 22 years and demonstrated significantly higher levels of Babesia during the 1994 and 2001 epidemics. Babesia levels correlated with mortalities and extent of CDV exposure within prides. The common event preceding the two high mortality CDV outbreaks was extreme drought conditions with wide-spread herbivore die-offs, most notably of Cape buffalo (Syncerus caffer). As a consequence of high tick numbers after the resumption of rains and heavy tick infestations of starving buffalo, the lions were infected by unusually high numbers of Babesia, infections that were magnified by the immunosuppressive effects of coincident CDV, leading to unprecedented mortality. Such mass mortality events may become increasingly common if climate extremes disrupt historic stable relationships between co- existing pathogens and their susceptible hosts.	[Munson, Linda] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Terio, Karen A.] Univ Illinois, Zool Pathol Program, Maywood, IL USA; [Kock, Richard] African Union Int Bureau Anim Resources, Nairobi, Kenya; [Mlengeya, Titus; Roelke, Melody E.] Tanzania Natl Parks, Arusha, Tanzania; [Roelke, Melody E.] NCI Frederick, SAIC Frederick Inc, Lab Genom Diversity, Frederick, MD USA; [Dubovi, Edward] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY USA; [Summers, Brian] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY USA; [Sinclair, Anthony R. E.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Packer, Craig] Univ Minnesota, Dept Ecol, Evolut, & Behavior, St Paul, MN USA	University of California System; University of California Davis; University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Cornell University; Cornell University; University of British Columbia; University of Minnesota System; University of Minnesota Twin Cities	Munson, L (corresponding author), Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	packer@umn.edu	Terio, Karen/AAC-5376-2019	Kock, Richard/0000-0002-6561-3209	Morris Foundation; NSF [DEB-0343960, DEB-9903416, BE-0308486]; Morris Animal Foundation; University of Illinois Research Board; Messerli Foundation, Zurich, Switzerland	Morris Foundation; NSF(National Science Foundation (NSF)); Morris Animal Foundation; University of Illinois Research Board; Messerli Foundation, Zurich, Switzerland	Lab assays were performed with funding from the Morris Foundation, while the field work was supported by NSF. This work was supported by the Morris Animal Foundation, University of Illinois Research Board, and National Science Foundation Grants for Ecology of Infectious Diseases (DEB-0343960), Long-Term Research in Environmental Biology (DEB-9903416) and Biocomplexity (BE-0308486), and the Messerli Foundation, Zurich, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; De Vos AJ, 1994, INFECT DIS LIVESTOCK, P278; Fosbrooke H. A., 1963, East African Wildlife Journal, V1, P124; Fyumagwa RD, 2007, S AFR J WILDL RES, V37, P79, DOI 10.3957/0379-4369-37.1.79; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Horak IG, 2007, ONDERSTEPOORT J VET, V74, P231; Horak IG, 2000, ONDERSTEPOORT J VET, V67, P239; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; Kocan A. Alan, 2001, P524, DOI 10.1002/9780470377000.ch18b; MOLLER TAGE, 1964, PATHOL VETERINARIA, V1, P189; Nijhof AM, 2003, J CLIN MICROBIOL, V41, P2249, DOI 10.1128/JCM.41.5.2249-2254.2003; OLMSTED RA, 1992, J VIROL, V66, P6008, DOI 10.1128/JVI.66.10.6008-6018.1992; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; PACKER C, 1991, CONSERV BIOL, V5, P219, DOI 10.1111/j.1523-1739.1991.tb00127.x; Packer C, 1999, J ANIM ECOL, V68, P1161, DOI 10.1046/j.1365-2656.1999.00360.x; Penzhorn BL, 2006, VET PARASITOL, V138, P11, DOI 10.1016/j.vetpar.2006.01.036; Penzhorn BL, 2001, J PARASITOL, V87, P681, DOI 10.1645/0022-3395(2001)087[0681:BLNSFL]2.0.CO;2; REED WM, 1985, J AM VET MED ASSOC, V187, P1264; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; SINCLAIR ARE, 1995, ECOLOGY, V76, P882, DOI 10.2307/1939353; Soulsby E. J. L., 1982, HEALMINTHS ARTHROPOD, V7th, P456; SOULSBY EJL, 1982, HELMINTHS ARTHROPODS, P706; Stokstad E, 2007, SCIENCE, V317, P1304, DOI 10.1126/science.317.5843.1304; Tasker S, 2003, J CLIN MICROBIOL, V41, P439, DOI 10.1128/JCM.41.1.439-441.2003; VANHEERDEN J, 1989, J WILDLIFE DIS, V25, P70, DOI 10.7589/0090-3558-25.1.70; Williams Elizabeth S., 2001, P50	27	141	144	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2545	10.1371/journal.pone.0002545	http://dx.doi.org/10.1371/journal.pone.0002545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575601	gold, Green Published, Green Accepted			2022-12-25	WOS:000263288000048
J	Hunter, MG; McLemore, M; Link, DC; Loveland, M; Copelan, A; Avalos, BR				Hunter, Melissa G.; McLemore, Morgan; Link, Daniel C.; Loveland, Megan; Copelan, Alexander; Avalos, Belinda R.			Divergent Pathways in COS-7 Cells Mediate Defective Internalization and Intracellular Routing of Truncated G-CSFR Forms in SCN/AML	PLOS ONE			English	Article								Background: Expression of truncated G-CSFR forms in patients with SCN/AML induces hyperproliferation and prolonged cell survival. Previously, we showed that ligand internalization is delayed and degradation of truncated G-CSFR forms is defective in patients with SCN/AML. Methodology/Principal Findings: In this study, we investigated the potential roles of dileucine and tyrosine-based motifs within the cytoplasmic domain of the G-CSFR in modulating ligand/receptor internalization. Using standard binding assays with radiolabeled ligand and COS-7 cells, substitutions in the dileucine motif or deletion of tyrosine residues in the G-CSFR did not alter internalization. Attachment of the transferrin receptor YTRF internalization motif to a truncated G-CSFR form from a patient with SCN/AML corrected defective internalization, but not receptor degradation suggesting that receptor internalization and degradation occur independently via distinct domains and/or processes. Conclusions: Our data suggest that distinct domains within the G-CSFR mediate separate processes for receptor internalization and degradation. Our findings using standard binding assays differ from recently published data utilizing flow cytometry.	[Hunter, Melissa G.] Ohio State Univ, Columbus, OH 43210 USA; [Hunter, Melissa G.; Avalos, Belinda R.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH USA; [McLemore, Morgan] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA; [Link, Daniel C.] Washington Univ, Division of Bone Marrow Transplant & Stem Cell, St Louis, MO USA; [Loveland, Megan; Avalos, Belinda R.] Ohio State Univ, Div Hematol Oncol, Columbus, OH USA; [Copelan, Alexander] Johns Hopkins Univ, Baltimore, MD USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Emory University; Washington University (WUSTL); University System of Ohio; Ohio State University; Johns Hopkins University	Hunter, MG (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.	Belinda.Avalos@osumc.edu			National Institute of Diabetes and Digestive and Kidney Diseases [R21-DK068639]; National Cancer Institute [R01-CA75226, R01-CA82859, P30-CA16058]; NATIONAL CANCER INSTITUTE [R01CA082859, P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK068639] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R21-DK068639), and the National Cancer Institute (R01-CA75226, R01-CA82859, and P30-CA16058).	Aarts LHJ, 2004, BLOOD, V103, P571, DOI 10.1182/blood-2003-07-2250; ACCILI D, 1989, EMBO J, V8, P2509, DOI 10.1002/j.1460-2075.1989.tb08388.x; ANAGUCHI H, 1995, J BIOL CHEM, V270, P27845, DOI 10.1074/jbc.270.46.27845; Arcasoy MO, 1997, BLOOD, V89, P4628, DOI 10.1182/blood.V89.12.4628; AVALOS BR, 1995, BLOOD, V85, P3117, DOI 10.1182/blood.V85.11.3117.bloodjournal85113117; Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bresciani R, 1997, BIOCHEM J, V327, P811, DOI 10.1042/bj3270811; Cassard S, 1998, J IMMUNOL, V160, P1767; DITTRICH E, 1994, J BIOL CHEM, V269, P19014; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; DUQUESNOY P, 1994, EMBO J, V13, P1386, DOI 10.1002/j.1460-2075.1994.tb06392.x; FUKUNAGA R, 1991, EMBO J, V10, P2855, DOI 10.1002/j.1460-2075.1991.tb07835.x; Germeshausen M, 2007, BLOOD, V109, P93, DOI 10.1182/blood-2006-02-004275; Govers P, 1998, J BIOL CHEM, V273, P16426, DOI 10.1074/jbc.273.26.16426; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Govers R, 1997, EMBO J, V16, P4851, DOI 10.1093/emboj/16.16.4851; Graeve L, 1996, FEBS LETT, V399, P131, DOI 10.1016/S0014-5793(96)01305-1; HAFT CR, 1994, J BIOL CHEM, V269, P26286; Hamer I, 1997, J BIOL CHEM, V272, P21685, DOI 10.1074/jbc.272.35.21685; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hermans MHA, 1999, J EXP MED, V189, P683, DOI 10.1084/jem.189.4.683; Hunter MG, 1999, BLOOD, V93, P440, DOI 10.1182/blood.V93.2.440.402k23_440_446; Hunter MG, 1998, J IMMUNOL, V160, P4979; Hunter MG, 2000, BLOOD, V95, P2132, DOI 10.1182/blood.V95.6.2132; KOIVISTO UM, 1994, P NATL ACAD SCI USA, V91, P10526, DOI 10.1073/pnas.91.22.10526; LARSEN A, 1990, J EXP MED, V172, P1559, DOI 10.1084/jem.172.6.1559; Link DC, 2007, BLOOD, V110, P1648, DOI 10.1182/blood-2007-03-081216; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; Miura M, 1997, BIOCHEM BIOPH RES CO, V239, P182, DOI 10.1006/bbrc.1997.7449; Morrison P, 1996, BIOCHEMISTRY-US, V35, P14618, DOI 10.1021/bi961630+; Patel M, 2003, J BIOL CHEM, V278, P44799, DOI 10.1074/jbc.M308982200; SORKIN A, 1993, J CELL PHYSIOL, V156, P373, DOI 10.1002/jcp.1041560221; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Szymczak AL, 2005, J IMMUNOL, V174, P4153, DOI 10.4049/jimmunol.174.7.4153; Thiel S, 1999, BIOCHEM J, V339, P15, DOI 10.1042/0264-6021:3390015; Touw IP, 1996, LEUKEMIA RES, V20, P629, DOI 10.1016/0145-2126(96)00017-3; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Ward AC, 1999, BLOOD, V93, P447, DOI 10.1182/blood.V93.2.447; Welte K, 1997, SEMIN HEMATOL, V34, P267	42	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2452	10.1371/journal.pone.0002452	http://dx.doi.org/10.1371/journal.pone.0002452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560579	Green Submitted, Green Published, gold			2022-12-25	WOS:000263280700035
J	Taylor, JA; Thoroughman, KA				Taylor, Jordan A.; Thoroughman, Kurt A.			Motor Adaptation Scaled by the Difficulty of a Secondary Cognitive Task	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; ERROR-DETECTION; VISUOMOTOR ADAPTATION; PARKINSONS-DISEASE; RESPONSE CONFLICT; FRONTAL-CORTEX; STEADY-STATE; SHORT-TERM; ATTENTION	Background: Motor learning requires evaluating performance in previous movements and modifying future movements. The executive system, generally involved in planning and decision-making, could monitor and modify behavior in response to changes in task difficulty or performance. Here we aim to identify the quantitative cognitive contribution to responsive and adaptive control to identify possible overlap between cognitive and motor processes. Methodology/Principal Findings: We developed a dual-task experiment that varied the trial-by-trial difficulty of a secondary cognitive task while participants performed a motor adaptation task. Subjects performed a difficulty-graded semantic categorization task while making reaching movements that were occasionally subjected to force perturbations. We find that motor adaptation was specifically impaired on the most difficult to categorize trials. Conclusions/Significance: We suggest that the degree of decision-level difficulty of a particular categorization differentially burdens the executive system and subsequently results in a proportional degradation of adaptation. Our results suggest a specific quantitative contribution of executive control in motor adaptation.			Taylor, JA (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	thoroughman@wustl.edu		Taylor, Jordan/0000-0001-9300-1229	McDonnell Center for Higher Brain Function through the Cognitive, Computational, and Systems Neuroscience Pathway at Washington University in St. Louis; National Institutes of Health [HD055851]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055851] Funding Source: NIH RePORTER	McDonnell Center for Higher Brain Function through the Cognitive, Computational, and Systems Neuroscience Pathway at Washington University in St. Louis; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Jordan Taylor was supported by the McDonnell Center for Higher Brain Function through the Cognitive, Computational, and Systems Neuroscience Pathway at Washington University in St. Louis. Kurt Thoroughman was supported by the National Institutes of Health (NIH) grant HD055851. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Ashby FG, 2003, NEUROPSYCHOLOGY, V17, P115, DOI 10.1037/0894-4105.17.1.115; Balota D.A., 2002, ENGLISH LEXICON PROJ; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Bock O, 2005, EXP BRAIN RES, V160, P259, DOI 10.1007/s00221-004-2133-5; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Broadbent D. E., 1971, DECISION STRESS; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; COHEN A, 1990, J EXP PSYCHOL LEARN, V16, P17, DOI 10.1037/0278-7393.16.1.17; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; CURRAN T, 1993, J EXP PSYCHOL LEARN, V19, P189, DOI 10.1037/0278-7393.19.1.189; DEMB JB, 1995, J NEUROSCI, V15, P5870; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Duff SV, 2007, EXP BRAIN RES, V179, P551, DOI 10.1007/s00221-006-0811-1; Floyer-Lea A, 2005, J NEUROPHYSIOL, V94, P512, DOI 10.1152/jn.00717.2004; Floyer-Lea A, 2004, J NEUROPHYSIOL, V92, P2405, DOI 10.1152/jn.01092.2003; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Garner W. R., 1974, PROCESSING INFORM ST; GARNER WR, 1970, AM PSYCHOL, V25, P350, DOI 10.1037/h0029456; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Grossman M, 2002, NEUROIMAGE, V17, P1549, DOI 10.1006/nimg.2002.1273; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ingram HA, 2000, EXP BRAIN RES, V132, P114, DOI 10.1007/s002219900322; Jordan M., 1999, COGNITIVE NEUROSCIEN, P601; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; KOUNIOS J, 1994, J EXP PSYCHOL LEARN, V20, P804, DOI 10.1037/0278-7393.20.4.804; Lang CE, 2002, J NEUROPHYSIOL, V87, P1336, DOI 10.1152/jn.00368.2001; LUND K, 1995, COGNITIVE SCI P, P660; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Price AL, 2006, NEUROPSYCHOLOGY, V20, P249, DOI 10.1037/0894-4105.20.2.249; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; REDDING GM, 1992, J MOTOR BEHAV, V24, P238, DOI 10.1080/00222895.1992.9941619; Regnaux JP, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-19; Regnaux JP, 2005, NEUROREHAB NEURAL RE, V19, P125, DOI 10.1177/1545968305275612; ROSCH E, 1975, J EXP PSYCHOL GEN, V104, P192, DOI 10.1037/0096-3445.104.3.192; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Suminski AJ, 2007, J NEUROPHYSIOL, V97, P1527, DOI 10.1152/jn.01160.2006; Taylor JA, 2007, J NEUROPHYSIOL, V98, P317, DOI 10.1152/jn.01070.2006; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Ullsperger M, 2004, CORTEX, V40, P593, DOI 10.1016/S0010-9452(08)70155-2; West WC, 2002, COGNITIVE BRAIN RES, V13, P363, DOI 10.1016/S0926-6410(01)00129-X; Wolpert DM, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P485	60	45	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2485	10.1371/journal.pone.0002485	http://dx.doi.org/10.1371/journal.pone.0002485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406FP	18560546	Green Published, Green Submitted, gold			2022-12-25	WOS:000263280700052
J	Faux, MC; Coates, JL; Catimel, B; Cody, S; Clayton, AHA; Layton, MJ; Burgess, AW				Faux, M. C.; Coates, J. L.; Catimel, B.; Cody, S.; Clayton, A. H. A.; Layton, M. J.; Burgess, A. W.			Recruitment of adenomatous polyposis coli and beta-catenin to axin-puncta	ONCOGENE			English	Article						APC; axin; beta-catenin	WNT-SIGNALING PATHWAY; TUMOR-SUPPRESSOR PROTEIN; F-BOX PROTEIN; SINGLE-PARTICLE TRACKING; PLASMA-MEMBRANE; NEGATIVE REGULATOR; CELL-MIGRATION; APC PROTEIN; IN-VITRO; MICROTUBULES	The adenomatous polyposis coli (APC) tumour suppressor is a multifunctional protein involved in the regulation of Wnt signalling and cytoskeletal dynamics. Little is known about how APC controls these disparate functions. In this study, we have used APC- and axin-fluorescent fusion proteins to examine the interactions between these proteins and show that the functionally distinct populations of APC are also spatially separate. Axin-RFP forms cytoplasmic punctate structures, similar to endogenous axin puncta. Axin-RFP recruits beta-catenin destruction complex proteins, including APC, b-catenin, glycogen synthase kinase-3-beta (GSK3-beta) and casein kinase-1-alpha (CK1-alpha). Recruitment into axin-RFP puncta sequesters APC from clusters at cell extensions and this prevents its microtubule-associated functions. The interaction between APC-GFP and axin-RFP within the cytoplasmic puncta is direct and dramatically alters the dynamic properties of APC-GFP. However, recruitment of APC to axin puncta is not absolutely required for beta-catenin degradation. Instead, formation of axin puncta, mediated by the DIX domain, is required for beta-catenin degradation. An axin Delta DIX mutant did not form puncta, but still mediated recruitment of destruction complex proteins and phosphorylation of beta-catenin. We conclude that there are distinct pools of APC and that the formation of axin puncta, rather than the axin/APC complex, is essential for beta-catenin destruction.	[Faux, M. C.; Coates, J. L.; Catimel, B.; Cody, S.; Clayton, A. H. A.; Layton, M. J.; Burgess, A. W.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Epithelial Biol Lab, Melbourne Tumour Biol Branch, Parkville, Vic 3050, Australia	Ludwig Institute for Cancer Research; Royal Melbourne Hospital	Faux, MC (corresponding author), Royal Melbourne Hosp, Ludwig Inst Canc Res, Epithelial Biol Lab, Melbourne Tumour Biol Branch, POB 2008, Parkville, Vic 3050, Australia.	maree.faux@ludwig.edu.au		CATIMEL, Bruno/0000-0002-4350-6875	NHMRC program [234703]; NH&MRC RD Wright Research	NHMRC program(National Health and Medical Research Council (NHMRC) of Australia); NH&MRC RD Wright Research(National Health and Medical Research Council (NHMRC) of Australia)	We thank Dr M Prescott, Dr F Costantini and Dr D Capelluto for cDNA constructs. MCF, MJL and AWB are supported by NH&MRC program grant 234703; AHAC is an NH&MRC RD Wright Research Fellow.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Barth AIM, 2002, J CELL SCI, V115, P1583; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Catimel B, 2006, BIOMED CHROMATOGR, V20, P569, DOI 10.1002/bmc.648; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Dayanandan R, 2003, CELL MOTIL CYTOSKEL, V54, P237, DOI 10.1002/cm.10096; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Fodde R, 2003, NAT CELL BIOL, V5, P190, DOI 10.1038/ncb0303-190; Hanley QS, 2005, J MICROSC-OXFORD, V218, P62, DOI 10.1111/j.1365-2818.2005.01463.x; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; Langford KJ, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-3; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Levina E, 2004, ONCOGENE, V23, P4444, DOI 10.1038/sj.onc.1207587; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Magde D, 1999, PHOTOCHEM PHOTOBIOL, V70, P737, DOI 10.1111/j.1751-1097.1999.tb08277.x; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; MUNEMITSU S, 1994, CANCER RES, V54, P3676; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Penman GA, 2005, J CELL SCI, V118, P4741, DOI 10.1242/jcs.02589; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Sakanaka C, 1999, J BIOL CHEM, V274, P14090, DOI 10.1074/jbc.274.20.14090; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Sharma M, 2006, J BIOL CHEM, V281, P17140, DOI 10.1074/jbc.M513027200; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; SU LK, 1995, CANCER RES, V55, P2972; van Munster EB, 2004, CYTOM PART A, V58A, P185, DOI 10.1002/cyto.a.20013; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wiechens N, 2004, J BIOL CHEM, V279, P5263, DOI 10.1074/jbc.M307253200; Wilson KM, 1996, J CELL SCI, V109, P2101; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	62	49	49	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 2	2008	27	44					5808	5820		10.1038/onc.2008.205	http://dx.doi.org/10.1038/onc.2008.205			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	355QC	18591934				2022-12-25	WOS:000259722400005
J	Horn, HF; Vousden, KH				Horn, H. F.; Vousden, K. H.			Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway	ONCOGENE			English	Article						p53; MDM2; L5; L11	POLYMERASE-III TRANSCRIPTION; UBIQUITIN LIGASE ACTIVITY; TUMOR-SUPPRESSOR P53; RING FINGER DOMAIN; 5S RNA; ONCOPROTEIN MDM2; MOLECULAR-BASIS; NUCLEAR EXPORT; CELL-CYCLE; IN-VITRO	MDM2 is a ubiquitin ligase that plays a key role in regulating the stability of the p53 tumor suppressor protein. Several proteins have been shown to activate the p53 pathway by interacting with and inhibiting the E3 function of MDM2, thereby leading to an accumulation of p53. These include the alternate reading frame (ARF) proteins and the ribosomal proteins L5 and L11. We found that when overexpressed alone, L11 is much less potent in inhibiting MDM2 than p14(ARF). However, L11 cooperates with L5, resulting in a robust inhibition of the E3 activity of MDM2, and a stabilization and activation of p53 approaching that achieved by p14(ARF). We further showed that the ability of L11 to bind the 5S rRNA is important for the cooperation with L5, and a mutant L11, which cannot bind the 5S rRNA, cannot cooperate with L5 in inhibiting MDM2.	[Horn, H. F.; Vousden, K. H.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Vousden, KH (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk		Horn, Henning/0000-0002-5885-8996	Cancer Research, UK	Cancer Research, UK(Cancer Research UK)	We are grateful to Professor Dr Joachim Hauber for sending us a human L5 expression plasmid (p3L5) and anti-human L5 antibody. This work was funded by Cancer Research, UK.	Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P1881, DOI 10.1073/pnas.68.8.1881; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Cairns CA, 1998, EMBO J, V17, P3112, DOI 10.1093/emboj/17.11.3112; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; CHEN JD, 1995, MOL MED, V1, P142, DOI 10.1007/BF03401562; Chesnokov I, 1996, MOL CELL BIOL, V16, P7084; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Crighton D, 2003, EMBO J, V22, P2810, DOI 10.1093/emboj/cdg265; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Elenbaas B, 1996, MOL MED, V2, P439, DOI 10.1007/BF03401903; GRAY PN, 1972, EUR J BIOCHEM, V28, P412, DOI 10.1111/j.1432-1033.1972.tb01927.x; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Iwasaki K, 2002, BIOSCI BIOTECH BIOCH, V66, P103, DOI 10.1271/bbb.66.103; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; KNIGHT E, 1967, J MOL BIOL, V28, P491, DOI 10.1016/S0022-2836(67)80099-8; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lowe SW, 1999, ENDOCR-RELAT CANCER, V6, P45, DOI 10.1677/erc.0.0060045; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; MARION MJ, 1981, BIOCHIM BIOPHYS ACTA, V652, P193, DOI 10.1016/0005-2787(81)90222-7; MARSTON NJ, 1994, ONCOGENE, V9, P2707; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nakashima T, 2001, RNA, V7, P692, DOI 10.1017/S1355838201002345; Perederina A, 2002, RNA, V8, P1548, DOI 10.1017/S1355838202029953; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Schatz O, 1998, P NATL ACAD SCI USA, V95, P1607, DOI 10.1073/pnas.95.4.1607; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; SPIERER P, 1978, BIOCHEMISTRY-US, V17, P2474, DOI 10.1021/bi00606a002; STEITZ JA, 1988, J CELL BIOL, V106, P545, DOI 10.1083/jcb.106.3.545; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Szymanski M, 2003, BIOCHEM J, V371, P641, DOI 10.1042/BJ20020872; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; White RJ, 2004, ONCOGENE, V23, P3208, DOI 10.1038/sj.onc.1207547; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	64	100	104	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 2	2008	27	44					5774	5784		10.1038/onc.2008.189	http://dx.doi.org/10.1038/onc.2008.189			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	355QC	18560357				2022-12-25	WOS:000259722400002
J	Song, LL; Peng, Y; Yun, J; Rizzo, P; Chaturvedi, V; Weijzen, S; Kast, WM; Stone, PJB; Santos, L; Loredo, A; Lendahl, U; Sonenshein, G; Osborne, B; Qin, JZ; Pannuti, A; Nickoloff, BJ; Miele, L				Song, L. L.; Peng, Y.; Yun, J.; Rizzo, P.; Chaturvedi, V.; Weijzen, S.; Kast, W. M.; Stone, P. J. B.; Santos, L.; Loredo, A.; Lendahl, U.; Sonenshein, G.; Osborne, B.; Qin, J. -Z; Pannuti, A.; Nickoloff, B. J.; Miele, L.			Notch-1 associates with IKK alpha and regulates IKK activity in cervical cancer cells	ONCOGENE			English	Article						Notch; NF-kappa B; apoptosis; IKK alpha	NF-KAPPA-B; KINASE-ALPHA; SIGNALING PATHWAY; EXPRESSION; ACTIVATION; APOPTOSIS; TRANSFORMATION; TRANSCRIPTION; DEREPRESSION; PROTEINS	Notch-1 inhibits apoptosis in some transformed cells through incompletely understood mechanisms. Notch-1 can increase nuclear factor-kappa B (NF-kappa B) activity through a variety of mechanisms. Overexpression of cleaved Notch-1 in T-cell acute lymphoblastic leukemia cells activates NF-kappa B via interaction with the I kappa B kinase (IKK) signalosome. Concomitant activation of the Notch and NF-kappa B pathways has been described in a large series of cervical cancer specimens. Here, we show that wild-type, spontaneously expressed Notch-1 stimulates NF-kappa B activity in CaSki cervical cancer cells by associating with the IKK signalosome through IKK alpha. A significant fraction of tumor necrosis factor (TNF)-alpha-stimulated I kappa B kinase activity in CaSki cells is Notch-1-dependent. In addition, Notch-1 is found in the nucleus in association with IKK alpha at IKK alpha-stimulated promoters and is required for association of IKK alpha with these promoters under basal and TNF-alpha-stimulated conditions. Notch-1-IKK alpha complexes are found in normal human keratinocytes as well, suggesting that IKK regulation is a physiological function of Notch-1. Both Notch-1 and IKK alpha knockdown sensitize CaSki cells to cisplatin-induced apoptosis to equivalent extents. Our data indicate that Notch-1 regulates NF-kappa B in cervical cancer cells at least in part via cytoplasmic and nuclear IKK-mediated pathways.	[Song, L. L.; Peng, Y.; Yun, J.; Rizzo, P.; Pannuti, A.; Miele, L.] Loyola Univ Chicago, Cardinal Bernardin Canc Ctr, Breast Canc Program, Maywood, IL USA; [Chaturvedi, V.; Qin, J. -Z; Nickoloff, B. J.] Loyola Univ Chicago, Cardinal Bernardin Canc Ctr, Dept Pathol, Maywood, IL USA; [Chaturvedi, V.; Qin, J. -Z; Nickoloff, B. J.] Loyola Univ Chicago, Cardinal Bernardin Canc Ctr, Skin Can Program, Maywood, IL USA; [Weijzen, S.] Loyola Univ Chicago, Cardinal Bernardin Canc Ctr, Canc Immunol Program, Maywood, IL USA; [Kast, W. M.; Stone, P. J. B.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Santos, L.] Inst Sci & Technol Res San Luis Potosi, Dept Mol Biol, San Luis Potosi, Mexico; [Santos, L.] Mexican Inst Social Secur, Dept Pathol, Mexico City, DF, Mexico; [Lendahl, U.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Sonenshein, G.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Osborne, B.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; University of Southern California; Instituto Potosino Investigacion Cientifica y Tecnologica; Instituto Mexicano del Seguro Social; Karolinska Institutet; Boston University; University of Massachusetts System; University of Massachusetts Amherst	Miele, L (corresponding author), Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, 2160 S 1st Ave,Bldg 112,Room 236, Maywood, IL 60153 USA.	lmiele@lumc.edu		Kast, W Martin/0000-0003-2321-3159; Miele, Lucio/0000-0002-5853-7287; rizzo, paola/0000-0001-7174-9674; Lendahl, Urban/0000-0001-9543-8141	NIH [RO1 CA084065, 1 PO1 AG025531]; V + Whittier Foundation; NATIONAL CANCER INSTITUTE [R01CA084065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025531] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V + Whittier Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants RO1 CA084065 and 1 PO1 AG025531, and the V + Whittier Foundation (WMK). WMK holds the Walter A Richter Cancer Research Chair. We are grateful to Anna Bigas for critical reading of this manuscript and to Raphael Kopan for helpful discussion of our data and for the gift of the Notch-1/Renilla construct used for quantitative immunoprecipitation.	Aguilera C, 2004, P NATL ACAD SCI USA, V101, P16537, DOI 10.1073/pnas.0404429101; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; Daniel B, 1997, J GEN VIROL, V78, P1095, DOI 10.1099/0022-1317-78-5-1095; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Gray GE, 1999, AM J PATHOL, V154, P785, DOI 10.1016/S0002-9440(10)65325-4; Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kim SH, 2004, J CANCER RES CLIN, V130, P551, DOI 10.1007/s00432-004-0567-6; Lathion S, 2003, CANCER RES, V63, P8687; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Manna SK, 2000, J IMMUNOL, V165, P4927, DOI 10.4049/jimmunol.165.9.4927; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Nair A, 2003, ONCOGENE, V22, P50, DOI 10.1038/sj.onc.1206043; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; PROCHASKA HJ, 1988, ANAL BIOCHEM, V169, P328, DOI 10.1016/0003-2697(88)90292-8; Prusty BK, 2005, FRONT BIOSCI-LANDMRK, V10, P1510, DOI 10.2741/1635; Ramdass B, 2007, GYNECOL ONCOL, V104, P352, DOI 10.1016/j.ygyno.2006.08.054; Rangarajan A, 2001, VIROLOGY, V286, P23, DOI 10.1006/viro.2001.0867; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Vacca A, 2006, EMBO J, V25, P1000, DOI 10.1038/sj.emboj.7600996; Venkatraman M, 2005, MOL CARCINOGEN, V44, P51, DOI 10.1002/mc.20116; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Wang JH, 2001, J IMMUNOL, V167, P289, DOI 10.4049/jimmunol.167.1.289; Wei LH, 2005, ONCOGENE, V24, P390, DOI 10.1038/sj.onc.1208192; Weijzen S, 2003, J CELL PHYSIOL, V194, P356, DOI 10.1002/jcp.10217; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Woo SH, 2004, INT J CANCER, V112, P596, DOI 10.1002/ijc.20433; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414	40	103	114	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 2	2008	27	44					5833	5844		10.1038/onc.2008.190	http://dx.doi.org/10.1038/onc.2008.190			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	355QC	18560356				2022-12-25	WOS:000259722400007
J	Saresella, M; Marventano, I; Longhi, R; Lissoni, F; Trabattoni, D; Mendozzi, L; Caputo, D; Clerici, M				Saresella, Marina; Marventano, Ivana; Longhi, Renato; Lissoni, Francesca; Trabattoni, Daria; Mendozzi, Laura; Caputo, Domenico; Clerici, Mario			CD4+CD25+FoxP3+PD1 - regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy	FASEB JOURNAL			English	Article						immunology; T lymphocytes; glatiramer acetate; copaxone; neurology	GLATIRAMER ACETATE COPAXONE; CENTRAL-NERVOUS-SYSTEM; SUPPRESSIVE FUNCTION; TH2 CELLS; MYELIN; FOXP3; EXPRESSION; TOLERANCE; DYSFUNCTION; PROGRESSION	The intracellular expression of the programmed death receptor 1 (PD1) identifies a subset of naive T-reg cells with enhanced suppressive ability; antigen stimulation results in the surface expression of PD1. Because the role of T-reg impairments in multiple sclerosis (MS) is still contradictory, we analyzed naive PD1- and PD1+T-reg cells in peripheral blood and cerebrospinal fluid (CSF) of relapsing-remitting multiple sclerosis (RR-MS) patients and of healthy control subjects. Results showed that 1) CSF PD1-T-reg cells were significantly augmented in MS patients; 2) PD1-Treg g cells were significantly increased in the peripheral blood of patients with stable disease (SMS) compared to those with acute (AMS) disease, and in patients responding to glatiramer acetate (COPA) compared to AMS- and COPA-unresponsive patients; and 3) PD1+ T-reg cells were similar in CSF and peripheral blood of all groups analyzed. PD1-T-reg cells were not increased in the peripheral blood of interferon-beta (IFN beta)-responsive patients, but the suppressive ability of T-reg cells was significantly higher in SMS and in COPA- or IFN beta-responsive compared to AMS- and COPA-unresponsive individuals. The data herein suggest that PD1-T-reg cells play a pivotal role in MS and offer a biological explanation for disease relapse and for the mechanism associated with response to COPA and IFN beta.	[Clerici, Mario] Univ Milan, Dept Biomed Sci & Technol, I-20090 Milan, Italy; [Saresella, Marina; Marventano, Ivana; Clerici, Mario] IRCCS, Lab Mol Med & Biotechnol, Don C Gnocchi ONLUS Fdn, Milan, Italy; [Mendozzi, Laura; Caputo, Domenico] IRCCS, Multiple Sclerosis Unit, Don C Gnocchi ONLUS Fdn, Milan, Italy; [Longhi, Renato] CNR, ICRM, I-20133 Milan, Italy; [Lissoni, Francesca; Trabattoni, Daria] DISP LITA Vialba, Milan, Italy	University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus; IRCCS Fondazione Don Carlo Gnocchi Onlus; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Clerici, M (corresponding author), Univ Milan, Dept Biomed Sci & Technol, Via Fratelli Cervi 93, I-20090 Milan, Italy.	mario.clerici@unimi.it	Saresella, Marina/G-7810-2012; Trabattoni, Daria/G-7424-2012	Saresella, Marina/0000-0002-2295-3043; Trabattoni, Daria/0000-0001-9535-3359; Clerici, Mario/0000-0001-5920-6191; Mendozzi, Laura/0000-0001-7394-4588; Marventano, Ivana/0000-0001-8111-3522	Japan Health Science Foundation; 2007 Ricerca Finalizzata (Italian Ministry of Health); 2007 Ricerca Corrente (Italian Ministry of Health); Rete Italiana Chimica Farmaceutica; CHEM-PROFARMA-NET [RBPR05NWWC]	Japan Health Science Foundation; 2007 Ricerca Finalizzata (Italian Ministry of Health)(Ministry of Health, Italy); 2007 Ricerca Corrente (Italian Ministry of Health)(Ministry of Health, Italy); Rete Italiana Chimica Farmaceutica; CHEM-PROFARMA-NET	This study was supported by grants from the Istituto Superiore di Sanita "Programma Nazionale di Ricerca sull' AIDS," the EMPRO and AVIP EC WP6 projects, the Japan Health Science Foundation, 2007 Ricerca Finalizzata (Italian Ministry of Health), 2007 Ricerca Corrente (Italian Ministry of Health), and project FIRB RETI, Rete Italiana Chimica Farmaceutica, CHEM-PROFARMA-NET (RBPR05NWWC). M.C. designed research and wrote the paper; M.S designed and performed research; I.M. analyzed results and drew figures; and R.L., F.L., D.T., L.M., and D.C. performed research. The authors declare no competing financial interests.	Aharoni R, 2000, P NATL ACAD SCI USA, V97, P11472, DOI 10.1073/pnas.97.21.11472; Aharoni R, 2002, J NEUROIMMUNOL, V126, P58, DOI 10.1016/S0165-5728(02)00053-X; Aharoni R, 2007, IMMUNOL LETT, V112, P110, DOI 10.1016/j.imlet.2007.07.009; Arnon R, 2004, P NATL ACAD SCI USA, V101, P14593, DOI 10.1073/pnas.0404887101; Blanco Y, 2006, NEUROSCI LETT, V406, P270, DOI 10.1016/j.neulet.2006.07.043; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Fehervari Z, 2004, J CLIN INVEST, V114, P1209, DOI 10.1172/JCI200434495; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Friese MA, 2007, BRAIN, V130, P2755, DOI 10.1093/brain/awm246; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; Huan J, 2005, J NEUROSCI RES, V81, P45, DOI 10.1002/jnr.20522; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Karandikar NJ, 2002, J CLIN INVEST, V109, P641, DOI 10.1172/JCI200214380; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Kumar M, 2006, J NEUROIMMUNOL, V180, P178, DOI 10.1016/j.jneuroim.2006.08.003; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Magri G, 2005, VACCINE, V23, P2862, DOI 10.1016/j.vaccine.2004.11.067; MARTIN R, 1990, J IMMUNOL, V145, P540; Miller SD, 2007, ANN NY ACAD SCI, V1103, P179, DOI 10.1196/annals.1394.023; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; PETTE M, 1990, NEUROLOGY, V40, P1770, DOI 10.1212/WNL.40.11.1770; Piccirillo CA, 2004, TRENDS IMMUNOL, V25, P374, DOI 10.1016/j.it.2004.04.009; Putheti P, 2003, J NEUROIMMUNOL, V144, P125, DOI 10.1016/j.jneuroim.2003.08.001; Putheti P, 2004, J CLIN IMMUNOL, V24, P155, DOI 10.1023/B:JOCI.0000019780.93817.82; Raimondi G, 2006, J IMMUNOL, V176, P2808, DOI 10.4049/jimmunol.176.5.2808; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Sela M, 2006, REJUV RES, V9, P126, DOI 10.1089/rej.2006.9.126; Steinman L, 2001, J EXP MED, V194, pF27, DOI 10.1084/jem.194.5.F27; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; Tennakoon DK, 2006, J IMMUNOL, V176, P7119, DOI 10.4049/jimmunol.176.11.7119; THOMPSON AJ, 1991, ANN NEUROL, V29, P53, DOI 10.1002/ana.410290111; Valenzuela RM, 2007, MULT SCLER J, V13, P754, DOI 10.1177/1352458506074510; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Venken K, 2007, J IMMUNOL METHODS, V322, P1, DOI 10.1016/j.jim.2007.01.025; Venken K, 2006, J NEUROSCI RES, V83, P1432, DOI 10.1002/jnr.20852; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	53	55	60	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3500	3508		10.1096/fj.08-110650	http://dx.doi.org/10.1096/fj.08-110650			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18587005				2022-12-25	WOS:000259642600012
J	Zeng, H; Chen, YH; Yu, M; Xue, LQ; Gao, X; Morris, SW; Wang, DM; Wen, RR				Zeng, Hu; Chen, Yuhong; Yu, Mei; Xue, Liquan; Gao, Xiang; Morris, Stephan W.; Wang, Demin; Wen, Renren			T cell receptor-mediated activation of CD4(+)CD44(hi) T cells bypasses Bcl10 - An implication of differential NF-kappa B dependence of naive and memory T cells during T cell receptor-mediated responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECEPTOR; LYMPHOCYTE-PROLIFERATION; EXHIBIT DEFECTS; MICE LACKING; REQUIREMENT; CARMA1; KINASE; EXPRESSION; GENERATION; IMMUNITY	Previous studies have demonstrated that Bcl10 (B-cell leukemia/lymphoma 10) is essential for T cell receptor-mediated NF-kappa B activation and subsequent proliferation and interleukin 2 (IL2) production. However, here we demonstrate that, contrary to expectations, Bcl10 is differentially required for T cell activation, including for both proliferation and cytokine production. When CD4(+) and CD8(+) T cells were divided based on expression levels of CD44, which distinguishes naive cells (CD44(lo)) versus those that are antigen-experienced (CD44(hi)), IL2 production by and proliferation of CD4(+) CD44(lo) naive cells and both subpopulations of CD8(+) T cells were clearly Bcl10-dependent, whereas these same functional properties of CD4(+) CD44(hi) T cells occurred largely independent of Bcl10. As with the other subpopulations of T cells, CD4(+) CD44(hi) T cells did not activate the NF-kappa B pathway in the absence of Bcl10; nevertheless, these CD4(+) CD44(hi) antigen-experienced T cells efficiently secreted IL2 after T cell receptor stimulation. Strikingly, therefore, T cell receptor-mediated IL2 production in these cells is NF-kappa B-independent. Our studies suggest that antigen-experienced CD4(+) T cells differ from their naive counterparts and from CD8(+) T cells in their ability to achieve activation independent of the Bcl10/NF-kappa B pathway.	[Zeng, Hu; Chen, Yuhong; Yu, Mei; Wang, Demin; Wen, Renren] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; [Zeng, Hu; Yu, Mei; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 225001, Peoples R China; [Xue, Liquan; Morris, Stephan W.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Xue, Liquan; Morris, Stephan W.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Wang, Demin] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Nanjing University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Medical College of Wisconsin	Wen, RR (corresponding author), Blood Ctr Wisconsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA.	renren.wen@bcw.edu	Yu, Mei/K-2206-2017; Zeng, Hu/AAA-2706-2020; Wang, Demin/AAX-4449-2020	Zeng, Hu/0000-0002-9909-7732; Wang, Demin/0000-0001-5549-3795	National Institutes of Health [AI52327, U19 AI062627, HL073284, CA87064, CA21765]; American Cancer Society [RSG CCG-106204]; American Lebanese Syrian Associated Charities; St.Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA087064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062627, R01AI052327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St.Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI52327 (to R.W.), U19 AI062627 pilot grant (to R.W.), HL073284 (to D.W.), CA87064 (NCI, to S.W.M.), and CA21765 (NCI Cancer Center CORE, to L.X.and S.W.M.). This work was also supported by American Cancer Society Grant RSG CCG-106204 (to D.W.) and by the American Lebanese Syrian Associated Charities, St.Jude Children's Research Hospital.	Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; Boyman O, 2006, J EXP MED, V203, P1817, DOI 10.1084/jem.20052495; Dienz O, 2007, P NATL ACAD SCI USA, V104, P7175, DOI 10.1073/pnas.0610442104; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Farber DL, 1997, EUR J IMMUNOL, V27, P2094, DOI 10.1002/eji.1830270838; Gerondakis S, 1996, P NATL ACAD SCI USA, V93, P3405, DOI 10.1073/pnas.93.8.3405; Hall SR, 1999, EUR J IMMUNOL, V29, P2098, DOI 10.1002/(SICI)1521-4141(199907)29:07<2098::AID-IMMU2098>3.3.CO;2-2; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Tewari K, 2006, P NATL ACAD SCI USA, V103, P16388, DOI 10.1073/pnas.0602565103; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8	31	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24392	24399		10.1074/jbc.M802344200	http://dx.doi.org/10.1074/jbc.M802344200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18583339	hybrid, Green Published			2022-12-25	WOS:000258820000013
J	Li, Y; Anderson, DH; Liu, Q; Zhou, Y				Li, Yang; Anderson, Deborah H.; Liu, Qiang; Zhou, Yan			Mechanism of influenza A virus NS1 protein interaction with the p85 beta, but not the p85 alpha, subunit of phosphatidylinositol 3-kinase (PI3K) and up-regulation of PI3K activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-KINASE; CATALYTIC SUBUNIT; PATHWAY; ACTIVATION; DOMAINS; INSULIN; KINASE; BINDS; GENERATION; MUTATIONS	Influenza A virus infection activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by binding influenza A virus NS1 protein to the p85 beta regulatory subunit of PI3K. In this study, we report that NS1 binds to the inter-SH2 (iSH2) domain of p85 beta. Mutational analyses on p85 beta iSH2 domain defined that Val-573 is the critical amino acid (AA) that mediates NS1 and p85 beta interaction. In reciprocal gain of function experiments with p85 alpha, we demonstrated that mutation to Val at Met-582 leads to NS1 binding and increased PI3K activity. Molecular modeling based on our experimental results suggested that, in addition to the interaction interface between the NS1 SH3 binding motif 1 (AA 164-167) and p85 beta Val-573, AA 137-142 in NS1 might interact with p85 beta. Indeed, mutations of AA 141 and 142 in NS1 disrupted the interaction between NS1 and p85 beta. Mutant virus PR8-NS1-141/142 was not able to activate Akt phosphorylation. Furthermore, PI3K assays demonstrated that, in wild-type virus-infected cells, p85 beta-associated PI3K activity was increased significantly. In contrast, in the mutant virus-infected cells containing mutant NS1 unable to interact with p85 beta, the p85 beta-associated PI3K activity up-regulation was not seen, suggesting that PI3K up-regulation is dependent upon the interaction between NS1 and p85 beta. Competition experiments and the immunoprecipitation studies demonstrated that NS1, p85 beta, and p110 form a complex in cells. Finally, the mechanism by which binding of NS1 to p85 beta regulates PI3K activity was discussed based on a predicted structural model of NS1-p85-p110 complex.	[Li, Yang; Liu, Qiang; Zhou, Yan] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada; [Anderson, Deborah H.] Saskatoon Canc Agcy, Canc Res Unit, Hlth Res Div, Saskatoon, SK S7N 4H4, Canada	University of Saskatchewan; University of Saskatchewan	Zhou, Y (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada.	yan.zhou@usask.ca	Li, Yang/GVT-7396-2022	Li, Yang/0000-0002-6065-4706				Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hale BG, 2008, J BIOL CHEM, V283, P1372, DOI 10.1074/jbc.M708862200; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; KLIPPEL A, 1993, MOL CELL BIOL, V13, P5560, DOI 10.1128/MCB.13.9.5560; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; OKKENHAUG K, 2001, SCI STKE, pE1; Ren SY, 2005, MOL CELL BIOL, V25, P8001, DOI 10.1128/MCB.25.18.8001-8008.2005; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Shekar SC, 2005, J BIOL CHEM, V280, P27850, DOI 10.1074/jbc.M506005200; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	36	46	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23397	23409		10.1074/jbc.M802737200	http://dx.doi.org/10.1074/jbc.M802737200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18534979	hybrid			2022-12-25	WOS:000258455400049
J	Barinova, N; Kuznedelov, K; Severinov, K; Kulbachinskiy, A				Barinova, Nataliya; Kuznedelov, Konstantin; Severinov, Konstantin; Kulbachinskiy, Andrey			Structural modules of RNA polymerase required for transcription from promoters containing downstream basal promoter element GGGA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN COMPLEX-FORMATION; C-TERMINAL DOMAIN; ALPHA-SUBUNIT; RECOGNITION ELEMENT; SIGMA-SUBUNIT; UPSTREAM DNA; FLAP DOMAIN; HOLOENZYME; SEQUENCE; BINDING	We recently described a novel basal bacterial promoter element that is located downstream of the -10 consensus promoter element and is recognized by region 1.2 of the sigma subunit of RNA polymerase (RNAP). In the case of Thermus aquaticus RNAP, this element has a consensus sequence GGGA and allows transcription initiation in the absence of the -35 element. In contrast, the Escherichia coli RNAP is unable to initiate transcription from GGGA-containing promoters that lack the -35 element. In the present study, we demonstrate that sigma subunits from both E. coli and T. aquaticus specifically recognize the GGGA element and that the observed species specificity of recognition of GGGA-containing promoters is determined by the RNAP core enzyme. We further demonstrate that transcription initiation by T. aquaticus RNAP on GGGA-containing promoters in the absence of the -35 element requires sigma region 4 and C-terminal domains of the alpha subunits, which interact with upstream promoter DNA. When in the context of promoters containing the -35 element, the GGGA element is recognized by holoenzyme RNAPs from both E. coli and T. aquaticus and increases stability of promoter complexes formed on these promoters. Thus, GGGA is a bona fide basal promoter element that can function in various bacteria and, depending on the properties of the RNAP core enzyme and the presence of additional promoter elements, determine species-specific differences in promoter recognition.	[Kuznedelov, Konstantin; Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Barinova, Nataliya; Severinov, Konstantin; Kulbachinskiy, Andrey] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Rutgers State University New Brunswick; Russian Academy of Sciences	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu; akulb@img.ras.ru	Kulbachinskiy, Andrey/P-5401-2016; Severinov, Konstantin/C-8545-2016	Kulbachinskiy, Andrey/0000-0002-2292-6424; 	NIGMS NIH HHS [R01 GM64530] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064530] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANISKOVITCH LP, 1995, J BACTERIOL, V177, P6301, DOI 10.1128/jb.177.21.6301-6303.1995; Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Davis CA, 2005, P NATL ACAD SCI USA, V102, P285, DOI 10.1073/pnas.0405779102; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Kulbachinskiy A, 2004, J BACTERIOL, V186, P7818, DOI 10.1128/JB.186.22.7818-7820.2004; Kuznedelov K, 2003, METHOD ENZYMOL, V370, P94; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Kuznedelov K. D., 2006, Doklady Akademii Nauk, V410, P263, DOI 10.1134/S1607672906050036; Kuznedelov K, 2006, J MOL BIOL, V359, P110, DOI 10.1016/j.jmb.2006.03.009; Minakhin L, 2003, J BIOL CHEM, V278, P29710, DOI 10.1074/jbc.M304906200; Minakhin L, 2001, J BACTERIOL, V183, P71, DOI 10.1128/JB.183.1.71-76.2001; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; Ross W, 2003, GENE DEV, V17, P1293, DOI 10.1101/gad.1079403; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Ross W, 2005, P NATL ACAD SCI USA, V102, P291, DOI 10.1073/pnas.0405814102; Sclavi B, 2005, P NATL ACAD SCI USA, V102, P4706, DOI 10.1073/pnas.0408218102; Tang Y, 1996, J BACTERIOL, V178, P6945, DOI 10.1128/jb.178.23.6945-6951.1996; TRAVERS AA, 1980, J BACTERIOL, V141, P973, DOI 10.1128/JB.141.2.973-976.1980; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wada T, 2000, J BIOL CHEM, V275, P16057, DOI 10.1074/jbc.275.21.16057; WILSON KS, 1994, J MOL BIOL, V244, P36, DOI 10.1006/jmbi.1994.1702	26	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22482	22489		10.1074/jbc.M802445200	http://dx.doi.org/10.1074/jbc.M802445200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18574242	Green Published, hybrid			2022-12-25	WOS:000258321000016
J	Burman, JL; Bourbonniere, L; Philie, J; Stroh, T; Dejgaard, SY; Presley, JF; McPherson, PS				Burman, Jonathon L.; Bourbonniere, Lyne; Philie, Jacynthe; Stroh, Thomas; Dejgaard, Selma Y.; Presley, John F.; McPherson, Peter S.			Scyl1, mutated in a recessive form of spinocerebellar neurodegeneration, regulates COPI-mediated retrograde traffic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY SPASTIC PARAPLEGIA; TO-GOLGI TRANSPORT; VESICLE FORMATION; BINDING-SITE; PROTEIN; CLATHRIN; ER; KINASE; MOTIFS; COATOMER	Scy1-like 1 (Scyl1), a member of the Scy1-like family of catalytically inactive protein kinases, was recently identified as the gene product altered in muscle- deficient mice, which suffer from motor neuron degeneration and cerebellar atrophy. To determine the function of Scyl1, we have now used a mass spectrometry-based screen to search for Scyl1-binding partners and identified components of coatomer I (COPI) coats. The interaction was confirmed in pull- down assays, and Scyl1 co-immunoprecipitates with beta COP from brain lysates. Interestingly, and unique for a non-transmembrane domain protein, Scyl1 binds COPI coats using a C-terminal RKLD-COO- sequence, similar to the KKXX-COO- COPI- binding motif found in transmembrane endoplasmic reticulum (ER) proteins. Scyl1 co-localizes with beta COP and is localized, in an Arf1-independent manner, to the ER- Golgi intermediate compartment and the cis-Golgi, sites of COPI-mediated membrane budding. The localization and binding properties of Scyl1 strongly suggest a function in COPI transport, and inhibitory RNA-mediated knock down of the protein disrupts COPI- mediated retrograde traffic of the KDEL receptor to the ER without affecting anterograde traffic from the ER. Our data demonstrate a function for Scyl1 as an accessory factor in COPI trafficking and suggest for the first time that alterations in the COPI pathway result in neurodegenerative disease.	[Burman, Jonathon L.; Bourbonniere, Lyne; Philie, Jacynthe; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Dejgaard, Selma Y.; Presley, John F.; McPherson, Peter S.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	McGill University; McGill University	McPherson, PS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca						Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Bakowska JC, 2005, BIOCHEM BIOPH RES CO, V334, P1042, DOI 10.1016/j.bbrc.2005.06.201; Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; BLOT S, 1995, J NEUROPATH EXP NEUR, V54, P812; Brett TJ, 2006, CURR OPIN CELL BIOL, V18, P395, DOI 10.1016/j.ceb.2006.06.014; Cabanes C, 2007, NEUROBIOL DIS, V26, P408, DOI 10.1016/j.nbd.2007.01.008; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Coleman R Edward, 1998, Clin Positron Imaging, V1, P15, DOI 10.1016/S1095-0397(97)00004-6; Conner SD, 2005, J BIOL CHEM, V280, P21539, DOI 10.1074/jbc.M502462200; Contino G, 2006, EXPERT OPIN PHARMACO, V7, P1849, DOI 10.1517/14656566.7.14.1849; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Dejgaard SY, 2007, J HISTOCHEM CYTOCHEM, V55, P709, DOI 10.1369/jhc.6A7090.2007; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Duwel M, 2006, MOL BIOL CELL, V17, P4513, DOI 10.1091/mbc.E06-05-0390; Elsner M, 2003, MOL MEMBR BIOL, V20, P221, DOI 10.1080/0968768031000114024; Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; Gao YS, 1998, J BIOL CHEM, V273, P33825, DOI 10.1074/jbc.273.50.33825; Gao YS, 2001, J CELL BIOL, V152, P877, DOI 10.1083/jcb.152.5.877; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; GUO Q, 1994, J CELL BIOL, V125, P1213, DOI 10.1083/jcb.125.6.1213; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Harter C, 1998, P NATL ACAD SCI USA, V95, P11649, DOI 10.1073/pnas.95.20.11649; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; Kato M, 2002, GENOMICS, V79, P760, DOI 10.1006/geno.2002.6774; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Lippincott-Schwartz J., 2006, TRENDS CELL BIOL, V16, P1; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Liu SCH, 2000, BBA-GENE STRUCT EXPR, V1517, P148, DOI 10.1016/S0167-4781(00)00234-7; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; McPherson PS, 2005, MOL NEUROBIOL, V32, P73, DOI 10.1385/MN:32:1:073; Metzler M, 2003, EMBO J, V22, P3254, DOI 10.1093/emboj/cdg334; Metzler M, 2001, J BIOL CHEM, V276, P39271, DOI 10.1074/jbc.C100401200; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Michelsen K, 2007, J CELL BIOL, V179, P209, DOI 10.1083/jcb.200704142; Murshid A, 2004, CELL MOL LIFE SCI, V61, P133, DOI 10.1007/s00018-003-3352-9; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Namekawa M, 2007, MOL CELL NEUROSCI, V35, P1, DOI 10.1016/j.mcn.2007.01.012; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Olesen LE, 2008, J BIOL CHEM, V283, P5099, DOI 10.1074/jbc.M708621200; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Ritter B, 2004, EMBO J, V23, P3701, DOI 10.1038/sj.emboj.7600378; Sanderson CM, 2006, HUM MOL GENET, V15, P307, DOI 10.1093/hmg/ddi447; Scales SJ, 2000, INT REV CYTOL, V195, P67; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schmidt WM, 2007, EMBO REP, V8, P691, DOI 10.1038/sj.embor.7401001; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Soderblom C, 2006, PHARMACOL THERAPEUT, V109, P42, DOI 10.1016/j.pharmthera.2005.06.001; Storrie B, 2000, TRENDS CELL BIOL, V10, P385, DOI 10.1016/S0962-8924(00)01818-3; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Sullivan BM, 2000, MOL BIOL CELL, V11, P3155, DOI 10.1091/mbc.11.9.3155; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Wieland F, 1999, CURR OPIN CELL BIOL, V11, P440, DOI 10.1016/S0955-0674(99)80063-5; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200	65	63	68	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22774	22786		10.1074/jbc.M801869200	http://dx.doi.org/10.1074/jbc.M801869200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18556652	hybrid			2022-12-25	WOS:000258321000045
J	Kappler, U; Bernhardt, PV; Kilmartin, J; Riley, MJ; Teschner, J; McKenzie, KJ; Hanson, GR				Kappler, Ulrike; Bernhardt, Paul V.; Kilmartin, James; Riley, Mark J.; Teschner, Julia; McKenzie, Kirsty J.; Hanson, Graeme R.			SoxAX cytochromes, a new type of heme copper protein involved in bacterial energy generation from sulfur compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC CIRCULAR-DICHROISM; PARACOCCUS-PANTOTROPHUS; THIOSULFATE OXIDATION; SULFITE DEHYDROGENASE; COMPLEX SOXXA; EPR; REDUCTION; IDENTIFICATION; LIGATION; SPECTRUM	SoxAX cytochromes are essential for the function of the only confirmed pathway for bacterial thiosulfate oxidation, the so-called "Sox pathway," in which they catalyze the initial formation of a S-S bond between thiosulfate and the SoxYZ carrier protein. Our work using the Starkeya novella diheme SoxAX protein reveals for the first time that in addition to two active site heme groups, SoxAX contains a mononuclear Cu-II center with a distorted tetragonal geometry and three to four nitrogen ligands, one of which is a histidine. The Cu-II center enhanced SoxAX activity in a newly developed, glutathione-based assay system that mimics the natural reaction of SoxAX with SoxYZ. EPR spectroscopy confirmed that the SoxAX CuII center is reduced by glutathione. At pH 7 a K-m app of 0.19 +/- 0.028 mM and a k(cat app) of 5.7 +/- 0.25s(-1) were determined for glutathione. We propose that SoxAX cytochromes are a new type of heme-copper proteins, with SoxAX-mediated S-S bond formation involving both the copper and heme centers.	[Teschner, Julia] Univ Queensland, Sch Mol & Microbial Sci, Ctr Met Biol, Brisbane, Qld 4072, Australia; [Hanson, Graeme R.] Univ Queensland, Ctr Magnet Resonance, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Teschner, J (corresponding author), Univ Queensland, Sch Mol & Microbial Sci, Ctr Met Biol, Cooper Rd,Bldg76, Brisbane, Qld 4072, Australia.	u.kappler@uq.edu.au	/C-3940-2008; Bernhardt, Paul V/J-8008-2013; Riley, Mark/E-1251-2011; Kappler, Ulrike/A-9483-2013	/0000-0003-0306-4360; Bernhardt, Paul V/0000-0001-6839-1763; Kappler, Ulrike/0000-0002-2642-1319				Alric J, 2004, J BIOL CHEM, V279, P26090, DOI 10.1074/jbc.M400361200; Appia-Ayme C, 2001, J BACTERIOL, V183, P6107, DOI 10.1128/JB.183.20.6107-6118.2001; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Bardischewsky F, 2005, BIOCHEMISTRY-US, V44, P7024, DOI 10.1021/bi047334b; Bernhardt PV, 2006, J BIOL INORG CHEM, V11, P930, DOI 10.1007/s00775-006-0148-z; Cheesman MR, 2001, BIOCHEMISTRY-US, V40, P10562, DOI 10.1021/bi0100081; Codd R, 2002, J BIOL INORG CHEM, V7, P338, DOI 10.1007/s00775-001-0303-5; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; DASILVA JJR, 2001, BIOL CHEM ELEMENTS I, P345; Dhawan IK, 1999, BIOCHEMISTRY-US, V38, P12805, DOI 10.1021/bi991303c; EATON WA, 1967, J CHEM PHYS, V46, P2533, DOI 10.1063/1.1841081; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; GADSBY PMA, 1990, J AM CHEM SOC, V112, P5003, DOI 10.1021/ja00169a002; GEUE RJ, 1984, J AM CHEM SOC, V106, P5478, DOI 10.1021/ja00331a016; Hanson GR, 2004, J INORG BIOCHEM, V98, P903, DOI 10.1016/j.jinorgbio.2004.02.003; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Kappler U, 2005, FEBS LETT, V579, P2491, DOI 10.1016/j.febslet.2005.03.060; Kappler U, 2004, J BIOL CHEM, V279, P6252, DOI 10.1074/jbc.M310644200; Kappler U, 2002, FEBS LETT, V529, P208, DOI 10.1016/S0014-5793(02)03344-6; Kappler U, 2008, MICROBIAL SULFUR METABOLISM, P151, DOI 10.1007/978-3-540-72682-1_13; Klarskov K, 1998, BIOCHEMISTRY-US, V37, P10555, DOI 10.1021/bi9806706; LU WP, 1985, BIOCHIM BIOPHYS ACTA, V828, P116, DOI 10.1016/0167-4838(85)90046-9; MCKNIGHT J, 1993, EUR J BIOCHEM, V213, P683, DOI 10.1111/j.1432-1033.1993.tb17808.x; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; MYER YP, 1979, J BIOL CHEM, V254, P1202; Pires RH, 2006, BIOCHEMISTRY-US, V45, P249, DOI 10.1021/bi0515265; Quentmeier A, 2003, BIOCHEM BIOPH RES CO, V312, P1011, DOI 10.1016/j.bbrc.2003.11.021; Quentmeier A, 2000, ARCH MICROBIOL, V173, P117, DOI 10.1007/s002039900118; Reijerse EJ, 2007, BIOCHEMISTRY-US, V46, P7804, DOI 10.1021/bi7003526; Riley MJ, 2003, J INORG BIOCHEM, V96, P217, DOI 10.1016/S0162-0134(03)80749-3; Rother D, 2002, BBA-PROTEINS PROTEOM, V1598, P65, DOI 10.1016/S0167-4838(02)00332-1; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; Swem LR, 2003, EMBO J, V22, P4699, DOI 10.1093/emboj/cdg461; TAYLOR CPS, 1977, BIOCHIM BIOPHYS ACTA, V491, P137, DOI 10.1016/0005-2795(77)90049-6; THOMSON AJ, 1993, METHOD ENZYMOL, V226, P232; Walker FA, 1999, COORDIN CHEM REV, V185-6, P471, DOI 10.1016/S0010-8545(99)00029-6; Wodara C, 1997, J BACTERIOL, V179, P5014, DOI 10.1128/jb.179.16.5014-5023.1997; WODARA C, 1994, J BACTERIOL, V176, P6188, DOI 10.1128/jb.176.20.6188-6191.1994; Yatsunyk LA, 2003, J AM CHEM SOC, V125, P15986, DOI 10.1021/ja036398r	40	21	22	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22206	22214		10.1074/jbc.M800315200	http://dx.doi.org/10.1074/jbc.M800315200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18552405	hybrid			2022-12-25	WOS:000258114700040
J	Pechous, RD; McCarthy, TR; Mohapatra, NP; Soni, S; Penoske, RM; Salzman, NH; Frank, DW; Gunn, JS; Zahrt, TC				Pechous, Roger D.; McCarthy, Travis R.; Mohapatra, Nrusingh P.; Soni, Shilpa; Penoske, Renee M.; Salzman, Nita H.; Frank, Dara W.; Gunn, John S.; Zahrt, Thomas C.			A Francisella tularensis Schu S4 Purine Auxotroph Is Highly Attenuated in Mice but Offers Limited Protection against Homologous Intranasal Challenge	PLOS ONE			English	Article							AEROSOL INFECTION; TULAREMIA VACCINE; VIRULENCE; CONSTRUCTION	Background: Francisella tularensis is a Gram-negative coccobacillus that causes the febrile illness tularemia. Subspecies that are pathogenic for humans include those comprising the type A (subspecies tularensis) or type B (subspecies holarctica) biovars. An attenuated live vaccine strain (LVS) developed from a type B isolate has previously been used to vaccinate at-risk individuals, but offers limited protection against high dose (> 1000 CFUs) challenge with type A strains delivered by the respiratory route. Due to differences between type A and type B F. tularensis strains at the genetic level, it has been speculated that utilization of an attenuated type A strain as a live vaccine might offer better protection against homologous respiratory challenge compared with LVS. Here, we report the construction and characterization of an unmarked Delta purMCD mutant in the highly virulent type A strain Schu S4. Methodology/Principal Findings: Growth of Schu S4 DpurMCD was severely attenuated in primary human peripheral blood monocyte-derived macrophages and in the A549 human lung epithelial cell line. The Schu S4 DpurMCD mutant was also highly attenuated in mice when delivered via either the intranasal or intradermal infection route. Mice vaccinated intranasally with Schu S4 DpurMCD were well protected against high dose intradermal challenge with virulent type A or type B strains of F. tularensis. However, intranasal vaccination with Schu S4 DpurMCD induced tissue damage in the lungs, and conferred only limited protection against high dose Schu S4 challenge delivered by the same route. The level of protection observed was similar to that conferred following vaccination with wild-type LVS or the analogous LVS DpurMCD mutant. Conclusions/Significance: Collectively, these results argue that development of the next generation live attenuated vaccine for Francisella should be based on use of the less pathogenic type B biovar rather than the more reactogenic type A biovar.	[Pechous, Roger D.; McCarthy, Travis R.; Penoske, Renee M.; Salzman, Nita H.; Frank, Dara W.; Zahrt, Thomas C.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Salzman, Nita H.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI USA; [Mohapatra, Nrusingh P.; Soni, Shilpa; Gunn, John S.] Ohio State Univ, Dept Mol Biol, Immunol & Med Genet, Columbus, OH USA	Medical College of Wisconsin; Medical College of Wisconsin; University System of Ohio; Ohio State University	Pechous, RD (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	tzahrt@mcw.edu	Gunn, John/E-3167-2011	Salzman, Nita/0000-0003-0939-6139	NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program [1-U54-AI-057153, R01-AI063441-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI063441, R01AI057757] Funding Source: NIH RePORTER	NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by the NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program. The authors also wish to acknowledge membership within and support from the Region V 'Great Lakes' RCE (NIH award 1-U54-AI-057153). D.W.F. and T.C.Z. were also supported by NIAID grant (R01-AI063441-03).	Andersson H, 2006, J MED MICROBIOL, V55, P263, DOI 10.1099/jmm.0.46313-0; BACON GA, 1950, BRIT J EXP PATHOL, V31, P714; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; Cross AS, 2007, CLIN INFECT DIS, V45, pS61, DOI 10.1086/518150; Feldman KA, 2003, J AM VET MED ASSOC, V222, P725, DOI 10.2460/javma.2003.222.725; Foshay L, 1942, AM J PUBLIC HEALTH N, V32, P1131, DOI 10.2105/AJPH.32.10.1131; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Griffin KF, 2007, FEMS IMMUNOL MED MIC, V49, P315, DOI 10.1111/j.1574-695X.2007.00219.x; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Henry T, 2007, CELL MICROBIOL, V9, P2543, DOI 10.1111/j.1462-5822.2007.01022.x; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Lee BY, 2006, INFECT IMMUN, V74, P4002, DOI 10.1128/IAI.00257-06; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; LoVullo ED, 2006, MICROBIOL-SGM, V152, P3425, DOI 10.1099/mic.0.29121-0; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; Pechous R, 2006, INFECT IMMUN, V74, P4452, DOI 10.1128/IAI.00666-06; QIN A, 2008, INFECT IMMUN; *SAS I INC, SAS 9 1 ONL DOC; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; Thomas RM, 2007, INFECT IMMUN, V75, P371, DOI 10.1128/IAI.01241-06; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; VANMETRE TE, 1959, ANN INTERN MED, V50, P621, DOI 10.7326/0003-4819-50-3-621; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005	27	60	67	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2487	10.1371/journal.pone.0002487	http://dx.doi.org/10.1371/journal.pone.0002487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575611	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000015
J	Poinsignon, A; Cornelie, S; Mestres-Simon, M; Lanfrancotti, A; Rossignol, M; Boulanger, D; Cisse, B; Sokhna, C; Arca, B; Simondon, F; Remoue, F				Poinsignon, Anne; Cornelie, Sylvie; Mestres-Simon, Montserrat; Lanfrancotti, Alessandra; Rossignol, Marie; Boulanger, Denis; Cisse, Badara; Sokhna, Cheikh; Arca, Bruno; Simondon, Francois; Remoue, Franck			Novel Peptide Marker Corresponding to Salivary Protein gSG6 Potentially Identifies Exposure to Anopheles Bites	PLOS ONE			English	Article							ANTIBODY-RESPONSE; ARTHROPOD SALIVA; MALARIA; ANTIGENS; GAMBIAE; TRANSCRIPTOME; MOSQUITOS; VECTORS; SIALOME; INSIGHT	Background: In order to improve malaria control, and under the aegis of WHO recommendations, many efforts are being devoted to developing new tools for identifying geographic areas with high risk of parasite transmission. Evaluation of the human antibody response to arthropod salivary proteins could be an epidemiological indicator of exposure to vector bites, and therefore to risk of pathogen transmission. In the case of malaria, which is transmitted only by anopheline mosquitoes, maximal specificity could be achieved through identification of immunogenic proteins specific to the Anopheles genus. The objective of the present study was to determine whether the IgG response to the Anopheles gambiae gSG6 protein, from its recombinant form to derived synthetic peptides, could be an immunological marker of exposure specific to Anopheles gambiae bites. Methodology/Principal Findings: Specific IgG antibodies to recombinant gSG6 protein were observed in children living in a Senegalese area exposed to malaria. With the objective of optimizing Anopheles specificity and reproducibility, we designed five gSG6-based peptide sequences using a bioinformatic approach, taking into consideration i) their potential antigenic properties and ii) the absence of cross-reactivity with protein sequences of other arthropods/organisms. The specific anti-peptide IgG antibody response was evaluated in exposed children. The five gSG6 peptides showed differing antigenic properties, with gSG6-P1 and gSG6-P2 exhibiting the highest antigenicity. However, a significant increase in the specific IgG response during the rainy season and a positive association between the IgG level and the level of exposure to Anopheles gambiae bites was significant only for gSG6-P1. Conclusions/Significance: This step-by-step approach suggests that gSG6-P1 could be an optimal candidate marker for evaluating exposure to Anopheles gambiae bites. This marker could be employed as a geographic indicator, like remote sensing techniques, for mapping the risk of malaria. It could also represent a direct criterion of efficacy in evaluation of vector control strategies.	[Poinsignon, Anne] IRD, Epidemiol & Prevent UR024, Dakar, Senegal; [Cornelie, Sylvie; Rossignol, Marie; Boulanger, Denis; Simondon, Francois; Remoue, Franck] IRD, UR024 Epidemiol Prevent, Montpellier, France; [Mestres-Simon, Montserrat; Lanfrancotti, Alessandra; Arca, Bruno] Sapienza Univ, Dept Publ Hlth, Parasitol Sect, Rome, Italy; [Cisse, Badara; Sokhna, Cheikh] Paludol Afro trop, UR077, Dakar, Senegal; [Cisse, Badara] Univ Cheikh Anta Diop, Dept Parasitol, Dakar, Senegal; [Arca, Bruno] Univ Federico II, Dept Structural & Funct Biol, Naples, Italy	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Sapienza University Rome; University Cheikh Anta Diop Dakar; University of Naples Federico II	Poinsignon, A (corresponding author), IRD, Epidemiol & Prevent UR024, Dakar, Senegal.	anne.poinsignon@ird.fr	BOULANGER, Denis/G-9644-2016; Arca, Bruno/C-8383-2012	BOULANGER, Denis/0000-0002-8757-0350; Arca, Bruno/0000-0002-4029-0984; Poinsignon, Anne/0000-0003-2921-4486; Simondon, Francois/0000-0003-0395-1314; cornelie, sylvie/0000-0003-3662-1450	Research Ministry of France [scholarship]; Inkerman Fundation; Compagnia di San Paolo-IMI (Torino Italy); EU-RTN [ERBFMRXCT2000-00080]; French Ministry of Research (PAL+ Program); French Ministry of Defense (Delegation Generale pour Armement); IRD; Gates Malaria Program; Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme [LSHP-CT-2004-503578]	Research Ministry of France(European Commission); Inkerman Fundation; Compagnia di San Paolo-IMI (Torino Italy)(Compagnia di San Paolo); EU-RTN; French Ministry of Research (PAL+ Program)(Ministry of Research, France); French Ministry of Defense (Delegation Generale pour Armement); IRD; Gates Malaria Program; Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme	Anne Poinsignon was supported by a scholarship provided by the Research Ministry of France. Sylvie Cornelie was supported by the Inkerman Fundation. Alessandra Lanfrancotti was supported by Compagnia di San Paolo-IMI (Torino Italy) and Montserrat Mestres-Simon by the EU-RTN Project ERBFMRXCT2000-00080. This work was supported by the French Ministry of Research (PAL+ Program), the French Ministry of Defense (Delegation Generale pour Armement) and the IRD. The malaria field study in Niakhar area was funded by the Gates Malaria Program. This work is part of the activities of the BioMalPar European Network of Excellence supported by a European grant (LSHP-CT-2004-503578) from the Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740; Billingsley PF, 2006, PARASITE IMMUNOL, V28, P143, DOI 10.1111/j.1365-3024.2006.00805.x; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Champagne DE, 2005, PATHOPHYSIOL HAEMO T, V34, P221, DOI 10.1159/000092428; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Cornelie S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-75; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116; Lane RS, 1999, AM J TROP MED HYG, V61, P850, DOI 10.4269/ajtmh.1999.61.850; Lanfrancotti A, 2002, FEBS LETT, V517, P67, DOI 10.1016/S0014-5793(02)02578-4; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Lombardo F., 2006, Parassitologia (Rome), V48, P573; Mussi ADH, 2007, ACTA TROP, V104, P108, DOI 10.1016/j.actatropica.2007.07.011; Nascimento RJ, 2001, AM J TROP MED HYG, V65, P219, DOI 10.4269/ajtmh.2001.65.219; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Poinsignon A, 2008, AM J TROP MED HYG, V78, P750, DOI 10.4269/ajtmh.2008.78.750; Poinsignon A, 2007, AM J TROP MED HYG, V76, P327, DOI 10.4269/ajtmh.2007.76.327; Remoue F., 2005, Update in tropical immunology, P377; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Ribeiro JMC, 2003, INSECT BIOCHEM MOLEC, V33, P865, DOI 10.1016/S0965-1748(03)00080-8; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Robert V, 1998, TROP MED INT HEALTH, V3, P667, DOI 10.1046/j.1365-3156.1998.00288.x; Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197; Schonbach C, 2002, NUCLEIC ACIDS RES, V30, P226, DOI 10.1093/nar/30.1.226; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1199, DOI 10.1016/S0965-1748(02)00083-8; Valenzuela JG, 2003, INSECT BIOCHEM MOLEC, V33, P717, DOI 10.1016/S0965-1748(03)00067-5; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004; *WHO DEP RBM UNICE, 2005, WHOHTMMAL20051102 UN	36	98	101	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2472	10.1371/journal.pone.0002472	http://dx.doi.org/10.1371/journal.pone.0002472			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575604	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000004
J	Beer, S; Komatsubara, K; Bellovin, DI; Kurobe, M; Sylvester, K; Felsher, DW				Beer, Shelly; Komatsubara, Kimberly; Bellovin, David I.; Kurobe, Masashi; Sylvester, Karl; Felsher, Dean W.			Hepatotoxin-Induced Changes in the Adult Murine Liver Promote MYC-Induced Tumorigenesis	PLOS ONE			English	Article								Background: Overexpression of the human c-MYC (MYC) oncogene is one of the most frequently implicated events in the pathogenesis of hepatocellular carcinoma (HCC). Previously, we have shown in a conditional transgenic mouse model that MYC overexpression is restrained from inducing mitotic cellular division and tumorigenesis in the adult liver; whereas, in marked contrast, MYC induces robust proliferation associated with the very rapid onset of tumorigenesis in embryonic and neonatal mice. Methodology/Principal Findings: Here, we show that non-genotoxic hepatotoxins induce changes in the liver cellular context associated with increased cellular proliferation and enhanced tumorigenesis. Both 5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) and carbon tetrachloride (CCl(4)) cooperate with MYC to greatly accelerate the onset of liver cancer in an adult host to less than 7 days versus a mean latency of onset of over 35 weeks for MYC alone. These hepatotoxin-enhanced liver tumors grossly and histologically resemble embryonic and neonatal liver tumors. Importantly, we found that MYC overexpression is only capable of inducing expression of the mitotic Cyclin B1 in embryonic/neonatal hosts or adult hosts that were treated with either carcinogen. Conclusion/Significance: Our results suggest a model whereby oncogenes can remain latently activated, but exposure of the adult liver to hepatotoxins that promote hepatocyte proliferation can rapidly uncover their malignant potential.	[Beer, Shelly; Komatsubara, Kimberly; Bellovin, David I.; Felsher, Dean W.] Stanford Univ, Dept Med, Ctr Clin Sci Res, Sch Med,Div Oncol, Stanford, CA 94305 USA; [Beer, Shelly; Komatsubara, Kimberly; Bellovin, David I.; Felsher, Dean W.] Stanford Univ, Ctr Clin Sci Res, Sch Med, Dept Pathol, Div Oncol, Stanford, CA USA; [Kurobe, Masashi; Sylvester, Karl] Stanford Univ, Sch Med, Dept Surg, Div Pediat Surg, Stanford, CA USA	Stanford University; Stanford University; Stanford University	Beer, S (corresponding author), Stanford Univ, Dept Med, Ctr Clin Sci Res, Sch Med,Div Oncol, Stanford, CA 94305 USA.	dfelsher@stanford.edu		Sylvester, Karl G./0000-0002-8559-0155	National Cancer Institute (NCI) [R01-CA85610, R01-CA105102, 3R01CA089305-03S1, P50, 1P20 CA112973]; National Institutes of Health (NIH) [P50, 1P20 CA112973]; Leukemia and Lymphoma Society; Burroughs Wellcome Fund; Damon Runyon Lilly Clinical Investigator Award; American College of Surgeons; American Pediatric Surgical Association Foundation; Office of Technology Licensing- Stanford University; NIH NIDDK [DK56399]; Oak Foundation; Harmon Scholarship; Packard Foundation; NATIONAL CANCER INSTITUTE [R01CA089305, R01CA105102, R01CA085610] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Lilly Clinical Investigator Award; American College of Surgeons; American Pediatric Surgical Association Foundation; Office of Technology Licensing- Stanford University; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Oak Foundation; Harmon Scholarship; Packard Foundation(The David & Lucile Packard Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (NCI), Grants R01-CA85610, R01-CA105102, 3R01CA089305-03S1; National Institutes of Health (NIH)_NCI In Vivo Cellular and Molecular Imaging Center Grant P50; NIH_NCI Grant 1P20 CA112973; the Leukemia and Lymphoma Society; the Burroughs Wellcome Fund; and the Damon Runyon Lilly Clinical Investigator Award (to DWF). Support from the American College of Surgeons, American Pediatric Surgical Association Foundation, Office of Technology Licensing- Stanford University, NIH NIDDK (pilot grant DK56399: Digestive Disease Center at Stanford) as well as additional support from the Oak Foundation, the Harmon Scholarship, and the Packard Foundation (to KGS).	Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Bralet MP, 2002, HEPATOLOGY, V36, P623, DOI 10.1053/jhep.2002.35540; Bruccoleri A, 1997, HEPATOLOGY, V25, P133, DOI 10.1002/hep.510250125; CHANDAR N, 1989, P NATL ACAD SCI USA, V86, P2703, DOI 10.1073/pnas.86.8.2703; Chang THT, 1996, J CELL BIOCHEM, V60, P161, DOI 10.1002/(SICI)1097-4644(19960201)60:2<161::AID-JCB1>3.0.CO;2-V; Dang CV, 1999, MOL CELL BIOL, V19, P1; DUNSFORD HA, 1989, CANCER RES, V49, P4894; EDWARDS MJ, 1993, TOXICOL APPL PHARM, V119, P275, DOI 10.1006/taap.1993.1069; ENGELHARDT NV, 1990, DIFFERENTIATION, V45, P29, DOI 10.1111/j.1432-0436.1990.tb00453.x; EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737; FARBER E, 1977, AM J PATHOL, V89, P477; FARBER JL, 1975, AM J PATHOL, V81, P237; Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fickert P, 2002, AM J PATHOL, V161, P2019, DOI 10.1016/S0002-9440(10)64480-X; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; GRASSO P, 1991, ANNU REV PHARMACOL, V31, P253; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; KAUFMANN WK, 1995, CANCER RES, V55, P7; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; MACSWEEN RN, 1973, J CLIN PATHOL, V26, P936, DOI 10.1136/jcp.26.12.936; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; MURAKAMI H, 1993, CANCER RES, V53, P1719; NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223; NAGY P, 1988, CANCER RES, V48, P5522; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; PERRAUD F, 1991, EXP CELL RES, V195, P59, DOI 10.1016/0014-4827(91)90500-T; Preisegger KH, 1999, LAB INVEST, V79, P103; Rechnagel R O, 1973, CRC Crit Rev Toxicol, V2, P263, DOI 10.3109/10408447309082019; REUBER MD, 1968, ARCH PATHOL, V85, P275; Sanders S, 2000, MOL CARCINOGEN, V28, P168, DOI 10.1002/1098-2744(200007)28:3<168::AID-MC5>3.0.CO;2-E; SANDGREN EP, 1989, ONCOGENE, V4, P715; Santoni-Rugiu E, 1998, CANCER RES, V58, P123; SantoniRugiu E, 1996, AM J PATHOL, V149, P407; SELL S, 1991, CANCER RES, V51, P1278; SELL S, 1989, AM J PATHOL, V134, P1347; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; SHIOJIRI N, 1991, CANCER RES, V51, P2611; Slagle BL, 1996, MOL CARCINOGEN, V15, P261, DOI 10.1002/(SICI)1098-2744(199604)15:4<261::AID-MC3>3.0.CO;2-J; TAKAGI H, 1993, CANCER RES, V53, P4329; WAGNER VO, 1993, ARCH ENVIRON CON TOX, V25, P260; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Yamada Y, 1998, AM J PATHOL, V152, P1577; YASWEN P, 1985, MOL CELL BIOL, V5, P780, DOI 10.1128/MCB.5.4.780; Yin XY, 2001, CANCER RES, V61, P6487	47	32	33	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2493	10.1371/journal.pone.0002493	http://dx.doi.org/10.1371/journal.pone.0002493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560566	gold, Green Submitted, Green Published			2022-12-25	WOS:000263280700056
J	Huurman, VAL; Hilbrands, R; Pinkse, GGM; Gillard, P; Duinkerken, G; van de Linde, P; van der Meer-Prins, PMW; Maarschalk, MFJV; Verbeeck, K; Alizadeh, BZ; Mathieu, C; Gorus, FK; Roelen, DL; Claas, FHJ; Keymeulen, B; Pipeleers, DG; Roep, BO				Huurman, Volkert A. L.; Hilbrands, Robert; Pinkse, Gabrielle G. M.; Gillard, Pieter; Duinkerken, Gaby; van de Linde, Pieter; van der Meer-Prins, Petronella M. W.; Maarschalk, Minke F. J. Versteeg-van der Voort; Verbeeck, Koen; Alizadeh, Behrooz Z.; Mathieu, Chantal; Gorus, Frans K.; Roelen, Dave L.; Claas, Frans H. J.; Keymeulen, Bart; Pipeleers, Daniel G.; Roep, Bart O.			Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation	PLOS ONE			English	Article							DIABETES-MELLITUS; T-CELLS; AUTOANTIBODY; DESTRUCTION; RECURRENCE; PREVENTION; ALLOGRAFT; GRAFT; RECIPIENTS; DISEASE	Background: Islet cell transplantation can cure type 1 diabetes (T1D), but only a minority of recipients remains insulin independent in the following years. We tested the hypothesis that allograft rejection and recurrent autoimmunity contribute to this progressive loss of islet allograft function. Methodology/Principal Findings: Twenty-one T1D patients received cultured islet cell grafts prepared from multiple donors and transplanted under anti-thymocyte globulin (ATG) induction and tacrolimus plus mycophenolate mofetil (MMF) maintenance immunosuppression. Immunity against auto-and alloantigens was measured before and during one year after transplantation. Cellular auto-and alloreactivity was assessed by lymphocyte stimulation tests against autoantigens and cytotoxic T lymphocyte precursor assays, respectively. Humoral reactivity was measured by auto-and alloantibodies. Clinical outcome parameters-including time until insulin independence, insulin independence at one year, and C-peptide levels over one year-remained blinded until their correlation with immunological parameters. All patients showed significant improvement of metabolic control and 13 out of 21 became insulin-independent. Multivariate analyses showed that presence of cellular autoimmunity before and after transplantation is associated with delayed insulin-independence (p = 0.001 and p = 0.01, respectively) and lower circulating C-peptide levels during the first year after transplantation (p = 0.002 and p = 0.02, respectively). Seven out of eight patients without pre-existent T-cell autoreactivity became insulin-independent, versus none of the four patients reactive to both islet autoantigens GAD and IA-2 before transplantation. Autoantibody levels and cellular alloreactivity had no significant association with outcome. Conclusions/Significance: In this cohort study, cellular islet-specific autoimmunity associates with clinical outcome of islet cell transplantation under ATG-tacrolimus-MMF immunosuppression. Tailored immunotherapy targeting cellular islet autoreactivity may be required. Monitoring cellular immune reactivity can be useful to identify factors influencing graft survival and to assess efficacy of immunosuppression. Trial Registration: Clinicaltrials.gov NCT00623610	[Huurman, Volkert A. L.; Pinkse, Gabrielle G. M.; Duinkerken, Gaby; van der Meer-Prins, Petronella M. W.; Maarschalk, Minke F. J. Versteeg-van der Voort; Alizadeh, Behrooz Z.; Roelen, Dave L.; Claas, Frans H. J.; Roep, Bart O.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Huurman, Volkert A. L.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Hilbrands, Robert; Gillard, Pieter; Verbeeck, Koen; Gorus, Frans K.; Keymeulen, Bart; Pipeleers, Daniel G.] Brussels Free Univ VUB, Diabetes Res Ctr, Brussels, Belgium; [Gillard, Pieter; Mathieu, Chantal] Catholic Univ Leuven KUL, Univ Hosp Gasthuisberg, LEGENDO, Louvain, Belgium; [Huurman, Volkert A. L.; Hilbrands, Robert; Pinkse, Gabrielle G. M.; Gillard, Pieter; Duinkerken, Gaby; van de Linde, Pieter; van der Meer-Prins, Petronella M. W.; Maarschalk, Minke F. J. Versteeg-van der Voort; Verbeeck, Koen; Alizadeh, Behrooz Z.; Mathieu, Chantal; Gorus, Frans K.; Roelen, Dave L.; Claas, Frans H. J.; Keymeulen, Bart; Pipeleers, Daniel G.; Roep, Bart O.] JDRF Ctr Beta Cell Therapy Diabetes, Brussels, Belgium	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Brussel; KU Leuven; University Hospital Leuven	Huurman, VAL (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	boroep@lumc.nl	Gillard, Pieter/AAA-9820-2020; Hilbrands, Robert/B-7561-2014; Gillard, Pieter/GPX-1490-2022; Alizadeh, Behrooz Z Ziad/J-2921-2017; Roep, Bart/AAD-7609-2021; mathieu, chantal/ABD-5505-2021; Gillard, Pieter/AAY-1483-2020	Hilbrands, Robert/0000-0003-0228-699X; Gillard, Pieter/0000-0001-9111-4561; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; mathieu, chantal/0000-0002-4055-5233; Gillard, Pieter/0000-0001-9111-4561; Pipeleers, Daniel/0000-0002-6440-2485; Gorus, Frans/0000-0002-9007-6177; Keymeulen, Bart/0000-0002-8671-4527	Juvenile Diabetes Research Foundation [4/2001/434]; Dutch Diabetes Foundation [2001.06.001]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Dutch Diabetes Foundation	This study was supported by the Juvenile Diabetes Research Foundation (grant 4/2001/434) and the Dutch Diabetes Foundation (grant 2001.06.001). These organizations had no role in the conduction of the study nor the preparation of the mansucript.	Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bartlett ST, 1997, TRANSPLANTATION, V63, P299, DOI 10.1097/00007890-199701270-00021; Bosi E, 2001, DIABETES, V50, P2464, DOI 10.2337/diabetes.50.11.2464; BOUGNERES PF, 1990, DIABETES, V39, P1264, DOI 10.2337/diabetes.39.10.1264; BOUMA GJ, 1992, HUM IMMUNOL, V35, P85, DOI 10.1016/0198-8859(92)90015-F; Braghi S, 2000, DIABETES, V49, P218, DOI 10.2337/diabetes.49.2.218; Decochez K, 2000, DIABETES CARE, V23, P838, DOI 10.2337/diacare.23.6.838; EISENBARTH GS, 1985, DIABETES RES CLIN EX, V2, P271; Goudy KS, 2005, INT REV IMMUNOL, V24, P307, DOI 10.1080/08830180500379721; Hering BJ, 2004, AM J TRANSPLANT, V4, P390, DOI 10.1046/j.1600-6143.2003.00351.x; Jaeger C, 1997, DIABETES, V46, P1907, DOI 10.2337/diabetes.46.11.1907; Jaeger C, 2000, EXP CLIN ENDOCR DIAB, V108, P328, DOI 10.1055/s-2000-8125; Jansson L, 2002, DIABETOLOGIA, V45, P749, DOI 10.1007/s00125-002-0827-4; Keymeulen B, 1998, DIABETOLOGIA, V41, P452, DOI 10.1007/s001250050929; Keymeulen B, 2006, P NATL ACAD SCI USA, V103, P17444, DOI 10.1073/pnas.0608141103; LEHMANN PV, 1993, IMMUNOL TODAY, V14, P203, DOI 10.1016/0167-5699(93)90163-F; Maleux G, 2005, J VASC INTERV RADIOL, V16, P1693, DOI 10.1097/01.RVI.0000182506.88739.39; Martin S, 2001, NEW ENGL J MED, V345, P1036, DOI 10.1056/NEJMoa010465; Naftanel MA, 2004, PLOS MED, V1, P198, DOI 10.1371/journal.pmed.0010058; Nanji SA, 2004, BIODRUGS, V18, P315, DOI 10.2165/00063030-200418050-00004; PATEL R, 1969, NEW ENGL J MED, V280, P735, DOI 10.1056/NEJM196904032801401; Peakman M, 2001, DIABETES, V50, P1749, DOI 10.2337/diabetes.50.8.1749; Petruzzo P, 2000, DIABETES METAB, V26, P215; Pinkse GGM, 2006, DIABETES, V55, P312, DOI 10.2337/diabetes.55.02.06.db04-0195; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Ricordi C, 2005, TRANSPLANTATION, V79, P1298, DOI 10.1097/01.TP.0000157275.64874.84; ROEP BO, 1995, DIABETES, V44, P278, DOI 10.2337/diabetes.44.3.278; Roep BO, 1996, DIABETES, V45, P1147, DOI 10.2337/diabetes.45.9.1147; Roep BO, 1999, DIABETOLOGIA, V42, P636; Roep BO, 1999, DIABETES, V48, P484, DOI 10.2337/diabetes.48.3.484; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; Rother KI, 2004, J CLIN INVEST, V114, P877, DOI 10.1172/JC1200423235; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sasaki TM, 1998, TRANSPLANTATION, V65, P1510, DOI 10.1097/00007890-199806150-00021; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SIBLEY RK, 1985, LAB INVEST, V53, P132; SILVERSTEIN J, 1988, NEW ENGL J MED, V319, P599, DOI 10.1056/NEJM198809083191002; Slover RH, 1997, ENDOCR REV, V18, P241, DOI 10.1210/er.18.2.241; Sosenko JM, 2004, DIABETES, V53, pA425; Stobbe I, 1999, DIABETOLOGIA, V42, P1379; STRIJBOSCH LWG, 1988, INT J BIOMED COMPUT, V23, P279, DOI 10.1016/0020-7101(88)90020-7; SUTHERLAND DER, 1989, DIABETES, V38, P85, DOI 10.2337/diab.38.1.S85; Sutherland DER, 2001, WORLD J SURG, V25, P487, DOI 10.1007/s002680020342; Terasaki PI, 2005, CURR OPIN IMMUNOL, V17, P541, DOI 10.1016/j.coi.2005.07.018; Tyden G, 1996, NEW ENGL J MED, V335, P860, DOI 10.1056/NEJM199609193351205; Uchikoshi F, 1999, DIABETES, V48, P652, DOI 10.2337/diabetes.48.3.652; van Kampen CA, 2005, TRANSPLANTATION, V80, P118, DOI 10.1097/01.TP.0000164143.22287.E3; Verge CF, 1998, DIABETES, V47, P1857, DOI 10.2337/diabetes.47.12.1857	49	140	144	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2435	10.1371/journal.pone.0002435	http://dx.doi.org/10.1371/journal.pone.0002435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560516	Green Published, gold, Green Submitted			2022-12-25	WOS:000263280700020
J	Addessi, E; Mancini, A; Crescimbene, L; Padoa-Schioppa, C; Visalberghi, E				Addessi, Elsa; Mancini, Alessandra; Crescimbene, Lara; Padoa-Schioppa, Camillo; Visalberghi, Elisabetta			Preference Transitivity and Symbolic Representation in Capuchin Monkeys (Cebus apella)	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; QUANTITY; DELAY	Background: Can non-human animals comprehend and employ symbols? The most convincing empirical evidence comes from language-trained apes, but little is known about this ability in monkeys. Tokens can be regarded as symbols since they are inherently non-valuable objects that acquire an arbitrarily assigned value upon exchange with an experimenter. Recent evidence suggested that capuchin monkeys, which diverged from the human lineage 35 million years ago, can estimate, represent and combine token quantities. A fundamental and open question is whether monkeys can reason about symbols in ways similar to how they reason about real objects. Methodology/Principal Findings: Here we examined this broad question in the context of economic choice behavior. Specifically, we assessed whether, in a symbolic context, capuchins' preferences satisfy transitivity - a fundamental trait of rational decision-making. Given three options A, B and C, transitivity holds true if A >= B, B >= C and A >= C ( where >= indicates preference). In this study, we trained monkeys to exchange three types of tokens for three different foods. We then compared choices monkeys made between different types of tokens with choices monkeys made between the foods. Qualitatively, capuchins' preferences revealed by the way of tokens were similar to those measured with the actual foods. In particular, when choosing between tokens, monkeys displayed strict economic preferences and their choices satisfied transitivity. Quantitatively, however, values measured by the way of tokens differed systematically from those measured with the actual foods. In particular, for any pair of foods, the relative value of the preferred food increased when monkeys chose between the corresponding tokens. Conclusions/Significance: These results indicate that indeed capuchins are capable of treating tokens as symbols. However, as they do so, capuchins experience the cognitive burdens imposed by symbolic representation.	[Addessi, Elsa; Mancini, Alessandra; Crescimbene, Lara; Visalberghi, Elisabetta] CNR, Inst Cognit Sci & Technol, Unit Cognit Primatol, Rome, Italy; [Mancini, Alessandra; Crescimbene, Lara] Univ Roma La Sapienza, Rome, Italy; [Padoa-Schioppa, Camillo] Harvard Med Sch, Dept Neurobiol, Boston, MA USA; [Padoa-Schioppa, Camillo] Washington Univ, Sch Med, St Louis, MO USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Sapienza University Rome; Harvard University; Harvard Medical School; Washington University (WUSTL)	Addessi, E (corresponding author), CNR, Inst Cognit Sci & Technol, Unit Cognit Primatol, Rome, Italy.	elsa.addessi@istc.cnr.it	Addessi, Elsa/B-8329-2015	Addessi, Elsa/0000-0002-5553-7732; Padoa-Schioppa, Camillo/0000-0002-7519-8790; Mancini, Alessandra/0000-0003-1139-2890; Visalberghi, Elisabetta/0000-0001-7407-5468	VI Framework, NEST Pathfinder Initiative [12984]; SEDSU [29088]	VI Framework, NEST Pathfinder Initiative; SEDSU	Funded by VI Framework, NEST Pathfinder Initiative, What it means to be human, Contract n 12984, Stages in the Evolution and Development of Sign Use - SEDSU, and Contract n 29088, Humans: The Analogy-Making Species - ANALOGY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addessi E, 2007, P ROY SOC B-BIOL SCI, V274, P2579, DOI 10.1098/rspb.2007.0726; Addessi E, 2008, ANIM COGN, V11, P275, DOI 10.1007/s10071-007-0111-6; Bates E., 1979, EMERGENCE SYMBOLS CO, P33, DOI 10.1016/B978-0-12-081540-1.50008-9; Boysen Sarah T., 2006, P489; Boysen ST, 1996, J EXP PSYCHOL-ANIM B, V22, P76, DOI 10.1037/0097-7403.22.1.76; BOYSEN ST, 1995, J EXP PSYCHOL ANIM B, V21, P82, DOI 10.1037/0097-7403.21.1.82; Brosnan SF, 2007, CURR BIOL, V17, P1704, DOI 10.1016/j.cub.2007.08.059; Brosnan SF, 2004, FOLIA PRIMATOL, V75, P317, DOI 10.1159/000080209; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Carlson SM, 2005, PSYCHOL SCI, V16, P609, DOI 10.1111/j.1467-9280.2005.01583.x; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; DEACON T, 1997, SYMBOLIC SPECIES COE, P527; DeLoache J. S., 2007, BLACKWELL HDB CHILDH, P206, DOI [10.1002/9780470996652.ch10, DOI 10.1002/9780470996652.CH10]; DeLoache JS, 2004, TRENDS COGN SCI, V8, P66, DOI 10.1016/j.tics.2003.12.004; DeLoache JS, 2002, MINN SYM CHILD PSYCH, V32, P73; Dubreuil D, 2006, P ROY SOC B-BIOL SCI, V273, P1223, DOI 10.1098/rspb.2005.3433; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; KREPS DM, 1990, COURSE MICROECONOMIC, P850; MISCHEL W, 1975, J PERS SOC PSYCHOL, V31, P254, DOI 10.1037/h0076272; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2006, COGNITION, V99, pB1, DOI 10.1016/j.cognition.2005.04.008; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Peirce Charles S., 1931, COLLECTED WRITINGS; Ramseyer A, 2006, P ROY SOC B-BIOL SCI, V273, P179, DOI 10.1098/rspb.2005.3300; Roma PG, 2006, J COMP PSYCHOL, V120, P67, DOI 10.1037/0735-7036.120.1.67; SAVAGERUMBAUGH ES, 1978, SCIENCE, V201, P641, DOI 10.1126/science.675251; SAVAGERUMBAUGH ES, 1980, SCIENCE, V210, P922, DOI 10.1126/science.7434008; SAVAGERUMBAUGH ES, 1986, APE LANGUAGE CONDITI, P433; SCHMANDTBESSERAT D, 1978, SCI AM, V238, P50, DOI 10.1038/scientificamerican0678-50; SIGEL IE, 1990, METHODS FAMILY RES B, V1, P87; Sigel IE., 1970, MIAM S PRED BEH 1968, P99; von Neumann J., 1947, THEORY GAMES EC BEHA, DOI [DOI 10.1177/1468795X06065810, 10.1177/1468795X06065810]; VONNEUMANN J, 1963, SYMBOL FORMATION ORG, P530	34	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2414	10.1371/journal.pone.0002414	http://dx.doi.org/10.1371/journal.pone.0002414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	405UD	18545670	Green Published, gold, Green Submitted			2022-12-25	WOS:000263248800051
J	Attardo, A; Calegari, F; Haubensak, W; Wilsch-Brauninger, M; Huttner, WB				Attardo, Alessio; Calegari, Federico; Haubensak, Wulf; Wilsch-Braeuninger, Michaela; Huttner, Wieland B.			Live Imaging at the Onset of Cortical Neurogenesis Reveals Differential Appearance of the Neuronal Phenotype in Apical versus Basal Progenitor Progeny	PLOS ONE			English	Article								The neurons of the mammalian brain are generated by progenitors dividing either at the apical surface of the ventricular zone (neuroepithelial and radial glial cells, collectively referred to as apical progenitors) or at its basal side (basal progenitors, also called intermediate progenitors). For apical progenitors, the orientation of the cleavage plane relative to their apical-basal axis is thought to be of critical importance for the fate of the daughter cells. For basal progenitors, the relationship between cell polarity, cleavage plane orientation and the fate of daughter cells is unknown. Here, we have investigated these issues at the very onset of cortical neurogenesis. To directly observe the generation of neurons from apical and basal progenitors, we established a novel transgenic mouse line in which membrane GFP is expressed from the beta-III-tubulin promoter, an early pan-neuronal marker, and crossed this line with a previously described knock-in line in which nuclear GFP is expressed from the Tis21 promoter, a pan-neurogenic progenitor marker. Mitotic Tis21-positive basal progenitors nearly always divided symmetrically, generating two neurons, but, in contrast to symmetrically dividing apical progenitors, lacked apical-basal polarity and showed a nearly randomized cleavage plane orientation. Moreover, the appearance of beta-III-tubulin-driven GFP fluorescence in basal progenitor-derived neurons, in contrast to that in apical progenitor-derived neurons, was so rapid that it suggested the initiation of the neuronal phenotype already in the progenitor. Our observations imply that (i) the loss of apical-basal polarity restricts neuronal progenitors to the symmetric mode of cell division, and that (ii) basal progenitors initiate the expression of neuronal phenotype already before mitosis, in contrast to apical progenitors.	[Attardo, Alessio; Calegari, Federico; Haubensak, Wulf; Wilsch-Braeuninger, Michaela; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society	Attardo, A (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	huttner@mpi-cbg.de	Huttner, Wieland B./P-4080-2018; Attardo, Alessio/ABE-5208-2021; Calegari, Federico/N-7827-2019; Calegari, Federico/A-2422-2009	Attardo, Alessio/0000-0003-0665-6011; calegari, federico/0000-0002-3703-2802; Haubensak, Wulf/0000-0002-2034-9184	DFG [SPP 1109, Hu 275/7-3, SPP 1111, Hu 275/8-3, SFB/TR 13, B1, SFB 655, A2]; Fonds der Chemischen Industrie; Federal Ministry of Education and Research (BMBF) [NGFN-2, SMP RNAi, 01GR0402, PRI-S08T05]	DFG(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	W.B.H. was supported by grants from the DFG (SPP 1109, Hu 275/7-3; SPP 1111, Hu 275/8-3; SFB/TR 13, B1; SFB 655, A2), by the DFG-funded Center for Regenerative Therapies Dresden, by the Fonds der Chemischen Industrie and by the Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN-2, SMP RNAi, 01GR0402, PRI-S08T05).	Aaku-Saraste E, 1997, MECH DEVELOP, V69, P71, DOI 10.1016/S0925-4773(97)00156-1; AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; des Portes V, 1998, CELL, V92, P51; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Ishii Y, 2000, DEV BRAIN RES, V119, P307, DOI 10.1016/S0165-3806(99)00186-8; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P14176; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; LIU YC, 1994, J NEUROSCI, V14, P5807; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; McCarthy RA, 2002, J BIOL CHEM, V277, P25660, DOI 10.1074/jbc.M201933200; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; OLMSTED JB, 1986, ANNU REV CELL BIOL, V2, P421, DOI 10.1146/annurev.cb.02.110186.002225; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; SMART IHM, 1973, J ANAT, V116, P67; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Takahashi M, 2002, DIFFERENTIATION, V70, P155, DOI 10.1046/j.1432-0436.2002.700405.x; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wilcock AC, 2007, DEVELOPMENT, V134, P1943, DOI 10.1242/dev.002519; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	59	130	130	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2388	10.1371/journal.pone.0002388	http://dx.doi.org/10.1371/journal.pone.0002388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545663	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000263248800027
J	Unno, H; Yamashita, T; Ujita, S; Okumura, N; Otani, H; Okumura, A; Nagai, K; Kusunoki, M				Unno, Hideaki; Yamashita, Tetsuo; Ujita, Sayuri; Okumura, Nobuaki; Otani, Hiroto; Okumura, Akiko; Nagai, Katsuya; Kusunoki, Masami			Structural basis for substrate recognition and hydrolysis by mouse carnosinase CN2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTALLOGRAPHIC CHARACTERIZATION; RENAL SYMPATHETIC-NERVE; CRYSTAL-STRUCTURE; AEROMONAS AMINOPEPTIDASE; LEUCINE AMINOPEPTIDASE; ZINC AMINOPEPTIDASE; REFINEMENT; PROGRAM; ENZYME; IDENTIFICATION	L-Carnosine is a bioactive dipeptide (beta-alanyl-L-histidine) present in mammalian tissues, including the central nervous system, and has potential neuroprotective and neurotransmitter functions. In mammals, two types of L-carnosine-hydrolyzing enzymes (CN1 and CN2) have been cloned thus far, and they have been classified as metallopeptidases of the M20 family. The enzymatic activity of CN2 requires Mn2+, and CN2 is inhibited by a nonhydrolyzable substrate analog, bestatin. Here, we present the crystal structures of mouse CN2 complexed with bestatin together with Zn2+ at a resolution of 1.7 angstrom and that with Mn2+ at 2.3 angstrom. CN2 is a homodimer in a noncrystallographic asymmetric unit, and the Mn2+ and Zn2+ complexes closely resemble each other in the overall structure. Each subunit is composed of two domains: domain A, which is complexed with bestatin and two metal ions, and domain B, which provides the major interface for dimer formation. The bestatin molecule bound to domain A interacts with several residues of domain B of the other subunit, and these interactions are likely to be essential for enzyme activity. Since the bestatin molecule is not accessible to the bulk water, substrate binding would require conformational flexibility between domains A and B. The active site structure and substrate-binding model provide a structural basis for the enzymatic activity and substrate specificity of CN2 and related enzymes.	[Okumura, Nobuaki] Osaka Univ, Lab Homeostat Integrat, Div Integrated Prot Funct, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University	Okumura, N (corresponding author), Osaka Univ, Lab Homeostat Integrat, Div Integrated Prot Funct, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	nokumura@protein.osaka-u.ac.jp; mkusunoki@yamanashi.ac.jp	Hideaki, UNNO/ABG-9471-2020	Hideaki, UNNO/0000-0001-5917-269X				BANDO K, 1984, ANN CLIN BIOCHEM, V21, P510, DOI 10.1177/000456328402100613; Baran EJ, 2000, BIOCHEMISTRY-MOSCOW+, V65, P789; BARRETT AJ, 1998, HDB PROTEOLYTIC ENZY, P1412; BAYLISS ME, 1986, BIOCHEMISTRY-US, V25, P8113, DOI 10.1021/bi00372a047; Bonfanti L, 1999, PROG NEUROBIOL, V59, P333, DOI 10.1016/S0301-0082(99)00010-6; BURLEY SK, 1991, P NATL ACAD SCI USA, V88, P6916, DOI 10.1073/pnas.88.16.6916; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Copik AJ, 2005, BIOCHEMISTRY-US, V44, P121, DOI 10.1021/bi048123+; De Marchis S, 2000, J COMP NEUROL, V426, P378, DOI 10.1002/1096-9861(20001023)426:3<378::AID-CNE3>3.0.CO;2-1; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W, 2002, PYMOL 0 99; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Fundoiano-Hershcovitz Y, 2004, FEBS LETT, V571, P192, DOI 10.1016/j.febslet.2004.07.001; HANGAUER DG, 1984, BIOCHEMISTRY-US, V23, P5730, DOI 10.1021/bi00319a011; HANSON HT, 1949, J BIOL CHEM, V179, P789; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jozic D, 2002, STRUCTURE, V10, P1097, DOI 10.1016/S0969-2126(02)00805-5; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; KIM HD, 1993, J MOL BIOL, V230, P722, DOI 10.1006/jmbi.1993.1193; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNZE N, 1986, EUR J BIOCHEM, V160, P605, DOI 10.1111/j.1432-1033.1986.tb10081.x; MARGOLIS FL, 1983, BIOCHIM BIOPHYS ACTA, V744, P237, DOI 10.1016/0167-4838(83)90196-6; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagai K, 2003, EXP BIOL MED, V228, P1138, DOI 10.1177/153537020322801007; Niijima A, 2002, AUTON NEUROSCI-BASIC, V97, P99, DOI 10.1016/S1566-0702(02)00048-6; OTANI H, 2005, J BIOCHEM-TOKYO, V37, P167; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PRESCOTT JM, 1983, BIOCHEM BIOPH RES CO, V114, P646, DOI 10.1016/0006-291X(83)90829-X; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Speno HS, 1999, MOL PHARMACOL, V55, P179, DOI 10.1124/mol.55.1.179; Stamper CC, 2004, BIOCHEMISTRY-US, V43, P9620, DOI 10.1021/bi049126p; STURA EA, 1999, PRACT APPROACH SER, V210, P177; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Tanida M, 2005, AM J PHYSIOL-REG I, V288, pR447, DOI 10.1152/ajpregu.00275.2004; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Trombley PQ, 2000, BIOCHEMISTRY-MOSCOW+, V65, P807; VONGERICHTEN KF, 1994, MICROBIOL-SGM, V140, P2591, DOI 10.1099/00221287-140-10-2591; WOLOS A, 1978, INT J BIOCHEM, V9, P57, DOI 10.1016/0020-711X(78)90139-8; WOOD T, 1957, NATURE, V180, P39, DOI 10.1038/180039a0; Yamano T, 2001, NEUROSCI LETT, V313, P78, DOI 10.1016/S0304-3940(01)02231-5; Yamashita T, 2006, ACTA CRYSTALLOGR F, V62, P996, DOI 10.1107/S1744309106034701	44	41	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27289	27299		10.1074/jbc.M801657200	http://dx.doi.org/10.1074/jbc.M801657200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18550540	hybrid			2022-12-25	WOS:000259586600048
J	van Houwelingen, AH; Weathington, NM; Verweij, V; Blalock, JE; Nijkamp, FP; Folkerts, G				van Houwelingen, Anneke H.; Weathington, Nathaniel M.; Verweij, Vivienne; Blalock, J. Edwin; Nijkamp, Frans P.; Folkerts, Gert			Induction of lung emphysema is prevented by L-arginine-threonine-arginine	FASEB JOURNAL			English	Article						collagen breakdown; COPD; chemotaxis; neutrophil; inflammation	OBSTRUCTIVE PULMONARY-DISEASE; NEUTROPHIL CHEMOATTRACTANT; PEPTIDE; INFLAMMATION; EXPRESSION; PROLINE; SPUTUM	In patients with chronic obstructive pulmonary disease (COPD), an inflammatory process is ongoing in the lungs, with concomitant damage of the alveolar structures and loss of airway function. In this inflammatory process, extracellular matrix degradation is observed. During this lung matrix degradation, small peptide fragments consisting of proline and glycine repeats generated from collagen fibers are liberated from the matrix by matrix metalloproteinases. Chemotactic activities of these collagen-derived peptides such as N-acetyl-proline-glycine-proline (PGP) via CXCR1 and CXCR2 have been reported. We show here that PGP induces neutrophil migration in vivo, which is dose dependent. Moreover, PGP is involved in the development of emphysema-like changes in the airways. The complementary peptide, L-arginine-threonine-arginine (RTR), has been shown to bind to PGP sequences and inhibit neutrophil infiltration. We show that RTR impedes both PGP- and interleukin-8-induced chemotaxis in vitro. In vivo, RTR prevents both migration and activation of neutrophils induced by PGP. Furthermore, RTR completely inhibits PGP- induced lung emphysema, assessed by changes in alveolar enlargement and right ventricular hypertrophy. In conclusion, these data indicate that collagen breakdown products, especially PGP, are important in the pathogenesis of COPD and that PGP antagonism via RTR ameliorates lung emphysema.	[van Houwelingen, Anneke H.; Verweij, Vivienne; Nijkamp, Frans P.; Folkerts, Gert] Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Div Pharmacol & Pathophysiol, NL-3508 TB Utrecht, Netherlands; [Weathington, Nathaniel M.; Blalock, J. Edwin] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	Utrecht University; University of Alabama System; University of Alabama Birmingham	van Houwelingen, AH (corresponding author), Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Div Pharmacol & Pathophysiol, POB 800 82, NL-3508 TB Utrecht, Netherlands.	a.h.vanhouwelingen@uu.nl	Verweij, Vivienne G.M/F-8447-2016	Blalock, J. Edwin/0000-0001-5303-8123	U. S. National Institute of Health [HL077783, HL090999, ES013874-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077783, R01HL090999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES013874] Funding Source: NIH RePORTER	U. S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was supported by U. S. National Institute of Health grants HL077783, HL090999, and ES013874-03.	Babusyte A, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-81; Baraldo S, 2004, THORAX, V59, P308, DOI 10.1136/thx.2003.012146; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; BATTAGLIA S, 2006, J CLIN PATHOL ON AUG, pE1; Beeh KM, 2003, CHEST, V123, P1240, DOI 10.1378/chest.123.4.1240; Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505; Churg A, 2002, AM J RESP CELL MOL, V27, P368, DOI 10.1165/rcmb.4791; Culpitt SV, 2005, RESP MED, V99, P703, DOI 10.1016/j.rmed.2004.10.022; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Haddox JL, 2001, INVEST OPHTH VIS SCI, V42, P2769; Haddox JL, 1999, INVEST OPHTH VIS SCI, V40, P2427; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; Malik M, 2007, J IMMUNOL, V178, P1013, DOI 10.4049/jimmunol.178.2.1013; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; PFISTER RR, 1995, INVEST OPHTH VIS SCI, V36, P1306; Pfister RR, 2000, CORNEA, V19, P384, DOI 10.1097/00003226-200005000-00025; Vernooy JHJ, 2002, AM J RESP CELL MOL, V26, P152, DOI 10.1165/ajrcmb.26.1.4652; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361	19	56	56	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3403	3408		10.1096/fj.07-096230	http://dx.doi.org/10.1096/fj.07-096230			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18556462	Green Published			2022-12-25	WOS:000258761300032
J	Andreev, YA; Kozlov, SA; Koshelev, SG; Ivanova, EA; Monastyrnaya, MM; Kozlovskaya, EP; Grishin, EV				Andreev, Yaroslav A.; Kozlov, Sergey A.; Koshelev, Sergey G.; Ivanova, Ekaterina A.; Monastyrnaya, Margarita M.; Kozlovskaya, Emma P.; Grishin, Eugene V.			Analgesic compound from sea anemone Heteractis crispa is the first polypeptide inhibitor of vanilloid receptor 1 (TRPV1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; PANCREATIC TRYPSIN-INHIBITOR; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; RADIANTHUS-MACRODACTYLUS; STICHODACTYLA-HELIANTHUS; PROTEINASE-INHIBITOR; SODIUM-CHANNEL; HIGH-AFFINITY; PAIN PATHWAY	Venomous animals from distinct phyla such as spiders, scorpions, snakes, cone snails, or sea anemones produce small toxic proteins interacting with a variety of cell targets. Their bites often cause pain. One of the ways of pain generation is the activation of TRPV1 channels. Screening of 30 different venoms from spiders and sea anemones for modulation of TRPV1 activity revealed inhibitors in tropical sea anemone Heteractis crispa venom. Several separation steps resulted in isolation of an inhibiting compound. This is a 56-residue-long polypeptide named APHC1 that has a Bos taurus trypsin inhibitor (BPTI)/Kunitztype fold, mostly represented by serine protease inhibitors and ion channel blockers. APHC1 acted as a partial antagonist of capsaicin-induced currents (32 +/- 9% inhibition) with half-maximal effective concentration (EC50) 54 +/- 4 nM. In vivo, a 0.1 mg/kg dose of APHC1 significantly prolonged tail-flick latency and reduced capsaicin-induced acute pain. Therefore, our results can make an important contribution to the research into molecular mechanisms of TRPV1 modulation and help to solve the problem of overactivity of this receptor during a number of pathological processes in the organism.	[Andreev, Yaroslav A.; Kozlov, Sergey A.; Koshelev, Sergey G.; Ivanova, Ekaterina A.; Grishin, Eugene V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Monastyrnaya, Margarita M.; Kozlovskaya, Emma P.] Russian Acad Sci, Pacific Inst Bioorgan Chem, Far Eastern Branch, Vladivostok 690022, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Elyakov Pacific Institute of Bioorganic Chemistry; Russian Academy of Sciences	Andreev, YA (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	ay@land.ru	Kozlov, Sergey A/D-1548-2012; Andreev, Yaroslav A/C-6627-2012; Kozlovskaya, Emma/G-3618-2017	Kozlov, Sergey A/0000-0002-0242-4240; Andreev, Yaroslav/0000-0002-7628-0980	Russian Federation Federal Agency for Science and Innovations [02.467.11.3003 of 20.04.2005]; Russian Foundation for Basic Research; Cellular and Molecular Biology program of Russian Academy of Science; Zoological Institute of the Russian Academy of Sciences, Sankt-Peterburg; Pacific Institute of Bioorganic Chemistry, Far East Branch of the Russian Academy of Sciences, Vladivostok; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences	Russian Federation Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Cellular and Molecular Biology program of Russian Academy of Science(Russian Academy of Sciences); Zoological Institute of the Russian Academy of Sciences, Sankt-Peterburg(Russian Academy of Sciences); Pacific Institute of Bioorganic Chemistry, Far East Branch of the Russian Academy of Sciences, Vladivostok(Russian Academy of Sciences); Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the Russian Federation Federal Agency for Science and Innovations (the State Contract 02.467.11.3003 of 20.04.2005), the Russian Foundation for Basic Research, and the Cellular and Molecular Biology program of Russian Academy of Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.; We gratefully acknowledge the scientific support of S. D. Grebelny (Zoological Institute of the Russian Academy of Sciences, Sankt-Peterburg); E. I. Vozhova, E. V. Leychenko, and I. N. Lie (Pacific Institute of Bioorganic Chemistry, Far East Branch of the Russian Academy of Sciences, Vladivostok), and T. A. Egorov, and A. Kh. Musolyamov (Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences) for technical assistance.	Ahern GP, 2006, J BIOL CHEM, V281, P8991, DOI 10.1074/jbc.M513429200; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; ANEIROS A, 1993, BIOCHIM BIOPHYS ACTA, V1157, P86, DOI 10.1016/0304-4165(93)90082-J; ANTUCH W, 1993, EUR J BIOCHEM, V212, P675, DOI 10.1111/j.1432-1033.1993.tb17705.x; Beress L, 2004, J TOXICOL-TOXIN REV, V23, P451, DOI 10.1081/TXR-200038380; Carlton SM, 2001, NEUROSCI LETT, V310, P53, DOI 10.1016/S0304-3940(01)02093-6; CASTANEDA O, 1995, TOXICON, V33, P605; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CREIGHTON TE, 1987, J MOL BIOL, V194, P11, DOI 10.1016/0022-2836(87)90711-X; Cuypers E, 2006, FEBS LETT, V580, P5728, DOI 10.1016/j.febslet.2006.09.030; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Delfin J, 1996, TOXICON, V34, P1367, DOI 10.1016/S0041-0101(96)00114-6; Diochot S, 1998, J BIOL CHEM, V273, P6744, DOI 10.1074/jbc.273.12.6744; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; FRITZ H, 1972, H-S Z PHYSIOL CHEM, V353, P19, DOI 10.1515/bchm2.1972.353.1.19; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; Garcia-Martinez C, 2006, J PAIN, V7, P735, DOI 10.1016/j.jpain.2006.03.008; Gasparini S, 1998, J BIOL CHEM, V273, P25393, DOI 10.1074/jbc.273.39.25393; Grotendorst GR, 1999, TOXICON, V37, P1779, DOI 10.1016/S0041-0101(99)00120-8; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; JOUBERT FJ, 1980, H-S Z PHYSIOL CHEM, V361, P661, DOI 10.1515/bchm2.1980.361.1.661; KAWAI N, 1993, NATURAL SYNTHETIC NE, P319; Kitaguchi T, 2005, BIOCHEMISTRY-US, V44, P15544, DOI 10.1021/bi051494l; Klionsky L, 2006, J PHARMACOL EXP THER, V319, P192, DOI 10.1124/jpet.106.108092; Krause James E, 2005, Curr Opin Investig Drugs, V6, P48; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; MILJANICH GP, 1997, SCI MED, V4, P6; Mortari MR, 2007, PHARMACOL THERAPEUT, V114, P171, DOI 10.1016/j.pharmthera.2007.01.009; NORTON RS, 1991, TOXICON, V29, P1051, DOI 10.1016/0041-0101(91)90205-6; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Planells-Cases R, 2000, FEBS LETT, V481, P131, DOI 10.1016/S0014-5793(00)01982-7; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; SCHWEITZ H, 1995, J BIOL CHEM, V270, P25121, DOI 10.1074/jbc.270.42.25121; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Smith LA, 1997, BIOCHEMISTRY-US, V36, P7690, DOI 10.1021/bi963105g; Standker L, 2006, TOXICON, V48, P211, DOI 10.1016/j.toxicon.2006.05.001; STRYDOM DJ, 1977, BIOCHIM BIOPHYS ACTA, V491, P361, DOI 10.1016/0005-2795(77)90279-3; Suput D, 2001, TOXICON, V39, P1421, DOI 10.1016/S0041-0101(01)00102-7; Szallasi A, 2002, LANCET NEUROL, V1, P167, DOI 10.1016/S1474-4422(02)00072-8; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tang L, 2007, J PHARMACOL EXP THER, V321, P791, DOI 10.1124/jpet.106.117572; Valtschanoff JG, 2001, J COMP NEUROL, V436, P225, DOI 10.1002/cne.1063; Wang YW, 2000, BBA-PROTEIN STRUCT M, V1478, P9, DOI 10.1016/S0167-4838(99)00289-7; Watters MR, 2005, SEMIN NEUROL, V25, P278, DOI 10.1055/s-2005-917664; ZYKOVA TA, 1985, BIOORG KHIM+, V11, P293; ZYKOVA TA, 1985, BIOORG KHIM+, V11, P302	51	118	130	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23914	23921		10.1074/jbc.M800776200	http://dx.doi.org/10.1074/jbc.M800776200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579526	Green Published, hybrid			2022-12-25	WOS:000258638900046
J	Chan, AYM; Dolinsky, VW; Soltys, CLM; Viollet, B; Baksh, S; Light, PE; Dyck, JRB				Chan, Anita Y. M.; Dolinsky, Vernon W.; Soltys, Carrie-Lynn M.; Viollet, Benoit; Baksh, Shairaz; Light, Peter E.; Dyck, Jason R. B.			Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; REGULATES PHOSPHORYLATION; ELONGATION FACTOR-2; HEART; MYOCYTES; INSULIN; ISCHEMIA; GROWTH; LKB1; CARDIOMYOCYTES	Whereas studies involving animal models of cardiovascular disease demonstrated that resveratrol is able to inhibit hypertrophic growth, the mechanisms involved have not been elucidated. Because studies in cells other than cardiomyocytes revealed that AMP-activated protein kinase ( AMPK) and Akt are affected by resveratrol, we hypothesized that resveratrol prevents cardiac myocyte hypertrophy via these two kinase systems. Herein, we demonstrate that resveratrol reduces phenylephrine-induced protein synthesis and cell growth in rat cardiac myocytes via alterations of intracellular pathways involved in controlling protein synthesis (p70S6 kinase and eukaryotic elongation factor-2). Additionally, we demonstrate that resveratrol negatively regulates the calcineurin-nuclear factor of activated T cells pathway thus modifying a critical component of the transcriptional mechanism involved in pathological cardiac hypertrophy. Our data also indicate that these effects of resveratrol are mediated via AMPK activation and Akt inhibition, and in the case of AMPK, is dependent on the presence of the AMPK kinase, LKB1. Taken together, our data suggest that resveratrol exerts anti-hypertrophic effects by activating AMPK via LKB1 and inhibiting Akt, thus suppressing protein synthesis and gene transcription.	[Chan, Anita Y. M.; Dolinsky, Vernon W.; Soltys, Carrie-Lynn M.; Light, Peter E.; Dyck, Jason R. B.] Univ Alberta, Cardiovasc Res Grp, Edmonton, AB T6G 2S2, Canada; [Chan, Anita Y. M.; Dolinsky, Vernon W.; Soltys, Carrie-Lynn M.; Baksh, Shairaz; Dyck, Jason R. B.] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2S2, Canada; [Chan, Anita Y. M.; Light, Peter E.; Dyck, Jason R. B.] Univ Alberta, Dept Pharmacol, Fac Med & Dent, Edmonton, AB T6G 2S2, Canada; [Viollet, Benoit] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; [Viollet, Benoit] INSERM, U567, F-75014 Paris, France	University of Alberta; University of Alberta; University of Alberta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Dyck, JRB (corresponding author), Univ Alberta, Cardiovasc Res Grp, 430 Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada.	jason.dyck@ualberta.ca	Viollet, Benoit/N-2397-2019; Baksh, Shairaz/GRX-2106-2022; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Dyck, Jason/0000-0002-7045-2884	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada (HSFC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada)	This research was supported in part by grants from the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation of Canada (HSFC). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Barac YD, 2005, CARDIOVASC RES, V68, P75, DOI 10.1016/j.cardiores.2005.05.015; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Benjamin EJ, 1999, AM J MED SCI, V317, P168, DOI 10.1097/00000441-199903000-00006; Bertrand L, 2006, AM J PHYSIOL-HEART C, V291, pH239, DOI 10.1152/ajpheart.01269.2005; Boluyt MO, 1997, CIRC RES, V81, P176, DOI 10.1161/01.RES.81.2.176; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Everett AD, 2001, AM J PHYSIOL-HEART C, V281, pH161, DOI 10.1152/ajpheart.2001.281.1.H161; Folmes KD, 2007, AM J PHYSIOL-HEART C, V293, pH3456, DOI 10.1152/ajpheart.00936.2007; FRUMAN DA, 1992, EUR J IMMUNOL, V22, P2513, DOI 10.1002/eji.1830221008; Haider UGB, 2002, MOL PHARMACOL, V62, P772, DOI 10.1124/mol.62.4.772; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Horman S, 2003, J BIOL CHEM, V278, P41970, DOI 10.1074/jbc.M302403200; HOU X, 2008, J BIOL CHEM; Juric D, 2007, AM J PHYSIOL-HEART C, V292, pH2138, DOI 10.1152/ajpheart.00852.2006; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Li RF, 2007, FEBS LETT, V581, P3311, DOI 10.1016/j.febslet.2007.06.017; Liu ZP, 2005, CLIN EXP PHARMACOL P, V32, P1049, DOI 10.1111/j.1440-1681.2005.04303.x; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Soltys CLM, 2006, AM J PHYSIOL-HEART C, V290, pH2472, DOI 10.1152/ajpheart.01206.2005; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Wang LJ, 2002, FEBS LETT, V531, P285, DOI 10.1016/S0014-5793(02)03536-6; Wang LJ, 2000, AM J PHYSIOL-HEART C, V278, pH1056, DOI 10.1152/ajpheart.2000.278.4.H1056; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	40	196	203	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24194	24201		10.1074/jbc.M802869200	http://dx.doi.org/10.1074/jbc.M802869200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18562309	Green Published, hybrid			2022-12-25	WOS:000258638900073
J	Hachet-Haas, M; Balabanian, K; Rohmer, F; Pons, F; Franchet, C; Lecat, S; Chow, KYC; Dagher, R; Gizzi, P; Didier, B; Lagane, B; Kellenberger, E; Bonnet, D; Baleux, F; Haiech, J; Parmentier, M; Frossard, N; Arenzana-Seisdedos, F; Hibert, M; Galzi, JL				Hachet-Haas, Muriel; Balabanian, Karl; Rohmer, Francois; Pons, Francoise; Franchet, Christel; Lecat, Sandra; Chow, Ken Y. C.; Dagher, Rania; Gizzi, Patrick; Didier, Bruno; Lagane, Bernard; Kellenberger, Esther; Bonnet, Dominique; Baleux, Francoise; Haiech, Jacques; Parmentier, Marc; Frossard, Nelly; Arenzana-Seisdedos, Fernando; Hibert, Marcel; Galzi, Jean-luc			Small neutralizing molecules to inhibit actions of the chemokine CXCL12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DERIVED FACTOR-1-ALPHA; BREAST-CANCER METASTASIS; TROPIC HIV-1 INFECTION; RECEPTOR CXCR4; FACTOR-I; FLAVONOID BAICALIN; PHARMACOPHORE IDENTIFICATION; CRYSTAL-STRUCTURE; FACTOR 1-ALPHA; T-LYMPHOCYTES	The chemokine CXCL12 and the receptor CXCR4 play pivotal roles in normal vascular and neuronal development, in inflammatory responses, and in infectious diseases and cancer. For instance, CXCL12 has been shown to mediate human immunodeficiency virus-induced neurotoxicity, proliferative retinopathy and chronic inflammation, whereas its receptor CXCR4 is involved in human immunodeficiency virus infection, cancer metastasis and in the rare disease known as the warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis (WHIM) syndrome. As we screened chemical libraries to find inhibitors of the interaction between CXCL12 and the receptor CXCR4, we identified synthetic compounds from the family of chalcones that reduce binding of CXCL12 to CXCR4, inhibit calcium responses mediated by the receptor, and prevent CXCR4 internalization in response to CXCL12. We found that the chemical compounds display an original mechanism of action as they bind to the chemokine but not to CXCR4. The highest affinity molecule blocked chemotaxis of human peripheral blood lymphocytes ex vivo. It was also active in vivo in a mouse model of allergic eosinophilic airway inflammation in which we detected inhibition of the inflammatory infiltrate. The compound showed selectivity for CXCL12 and not for CCL5 and CXCL8 chemokines and blocked CXCL12 binding to its second receptor, CXCR7. By analogy to the effect of neutralizing antibodies, this molecule behaves as a small organic neutralizing compound that may prove to have valuable pharmacological and therapeutic potential.	[Hachet-Haas, Muriel; Rohmer, Francois; Franchet, Christel; Lecat, Sandra; Dagher, Rania; Gizzi, Patrick; Didier, Bruno; Kellenberger, Esther; Bonnet, Dominique; Haiech, Jacques; Hibert, Marcel; Galzi, Jean-luc] Univ Strasbourg 1, Inst Gilbert Laustriat Biomol Biotechnol Innovat, UMR 7175, IFR 85, F-67401 Illkirch Graffenstaden, France; [Balabanian, Karl; Chow, Ken Y. C.; Lagane, Bernard; Baleux, Francoise; Arenzana-Seisdedos, Fernando] Inst Pasteur, Unite Pathogenie Virale Mol, F-75015 Paris, France; [Pons, Francoise; Frossard, Nelly] Fac Pharm, IFR 85, Inflammat & Environm Astheme EA 3771, F-67401 Illkirch Graffenstaden, France; [Parmentier, Marc] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite Libre de Bruxelles	Galzi, JL (corresponding author), Ecole Super Biotechnol, CNRS, UMR 7175, IFR 85 Gilbert Laustriat Biomol & Innovat Therape, Bld Sebastien Brant BP 10413, F-67412 Illkirch Graffenstaden, France.	galzi@esbs.u-strasbg.fr	Arenzana-Seisdedos, Fernando/E-5835-2016; Kellenberger, Esther/AFN-2081-2022; Balabanian, Karl/S-6250-2019; Bonnet, Dominique/N-7275-2014; Frossard, Nelly/F-8301-2013; Lagane, Bernard/K-8446-2016; haiech, jacques J/F-2890-2010; Lagane, Bernard/AAA-2205-2019; Balabanian, Karl/I-2990-2016	Kellenberger, Esther/0000-0002-9320-4840; Balabanian, Karl/0000-0002-0534-3198; Bonnet, Dominique/0000-0002-8252-9199; Lagane, Bernard/0000-0002-3459-7867; Balabanian, Karl/0000-0002-0534-3198; Parmentier, Marc/0000-0001-8081-4685; haiech, jacques/0000-0003-2908-8053				Akihisa T, 2006, J NAT PROD, V69, P38, DOI 10.1021/np058080d; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Anuradha V, 2006, BIOORGAN MED CHEM, V14, P6820, DOI 10.1016/j.bmc.2006.06.048; Arakaki R, 1999, J VIROL, V73, P1719, DOI 10.1128/JVI.73.2.1719-1723.1999; Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chen S, 2001, CELL PROLIFERAT, V34, P293, DOI 10.1046/j.0960-7722.2001.00213.x; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; De Leon EJ, 2003, INFLAMM RES, V52, P246, DOI 10.1007/s00011-003-1164-x; De Leon EJ, 2003, J PHARM PHARMACOL, V55, P1313, DOI 10.1211/0022357021747; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; Delayre-Orthez C, 2005, INT ARCH ALLERGY IMM, V138, P298, DOI 10.1159/000088867; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gicquiaux H, 2002, J BIOL CHEM, V277, P6645, DOI 10.1074/jbc.M107224200; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; GranelliPiperno A, 1996, J EXP MED, V184, P2433, DOI 10.1084/jem.184.6.2433; Herencia F, 1999, FEBS LETT, V453, P129, DOI 10.1016/S0014-5793(99)00707-3; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Holmes WD, 2001, PROTEIN EXPRES PURIF, V21, P367, DOI 10.1006/prep.2001.1402; Ilien B, 2003, J NEUROCHEM, V85, P768, DOI 10.1046/j.1471-4159.2003.01717.x; Kellenberger E, 2006, J CHEM INF MODEL, V46, P717, DOI 10.1021/ci050372x; Kitamura K, 1998, ANTIVIR RES, V37, P131, DOI 10.1016/S0166-3542(97)00069-7; Krier M, 2006, J CHEM INF MODEL, V46, P512, DOI 10.1021/ci050352v; Kuhn I, 2006, BIOCHEMISTRY-US, V45, P11867, DOI 10.1021/bi060930g; Li BQ, 2000, BIOCHEM BIOPH RES CO, V276, P534, DOI 10.1006/bbrc.2000.3485; Li BQ, 2000, IMMUNOPHARMACOLOGY, V49, P295, DOI 10.1016/S0162-3109(00)00244-7; LI BQ, 1993, CELL MOL BIOL RES, V39, P119; Li RS, 1995, J MED CHEM, V38, P5031, DOI 10.1021/jm00026a010; Lin YM, 2002, BIOORGAN MED CHEM, V10, P2795, DOI 10.1016/S0968-0896(02)00094-9; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murakami T, 1997, J EXP MED, V186, P1389, DOI 10.1084/jem.186.8.1389; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nagase H, 2001, J ALLERGY CLIN IMMUN, V108, P563, DOI 10.1067/mai.2001.118292; Ohnishi Y, 2000, J INTERF CYTOK RES, V20, P691, DOI 10.1089/10799900050116390; Palanche T, 2001, J BIOL CHEM, V276, P34853, DOI 10.1074/jbc.M104363200; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Schijlen EGW, 2004, PHYTOCHEMISTRY, V65, P2631, DOI 10.1016/j.phytochem.2004.07.028; Schols D, 1997, ANTIVIR RES, V35, P147, DOI 10.1016/S0166-3542(97)00025-9; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tamamura H, 2000, BIOORG MED CHEM LETT, V10, P2633, DOI 10.1016/S0960-894X(00)00535-7; Tamamura H, 1998, BIOORGAN MED CHEM, V6, P1033, DOI 10.1016/S0968-0896(98)00061-3; Taylor R, 2002, ACTA CRYSTALLOGR D, V58, P879, DOI 10.1107/S090744490200358X; Valenzuela-Fernandez A, 2001, J BIOL CHEM, V276, P26550, DOI 10.1074/jbc.M100411200; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Vollmer JY, 1999, J BIOL CHEM, V274, P37915, DOI 10.1074/jbc.274.53.37915; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	58	77	87	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23189	23199		10.1074/jbc.M803947200	http://dx.doi.org/10.1074/jbc.M803947200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556651	Green Published, hybrid			2022-12-25	WOS:000258455400032
J	Kiely, PA; Baillie, GS; Lynch, MJ; Houslay, MD; O'Connor, R				Kiely, Patrick A.; Baillie, George S.; Lynch, Martin J.; Houslay, Miles D.; O'Connor, Rosemary			Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and beta 1 integrin and for tumor cell proliferation and migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; CAMP-SPECIFIC PHOSPHODIESTERASE; RECEPTOR-INTERACTING PROTEIN; SIGNALING SCAFFOLD PROTEINS; KINASE-C; MEMBRANE SUPPORTS; AKT ACTIVATION; PEPTIDE ARRAYS; SPOT SYNTHESIS; BETA-ARRESTIN	Insulin-like growth factor (IGF)-I regulates a mutually exclusive interaction of PP2A and beta 1 integrin with the WD repeat scaffolding protein RACK1. This interaction is required for the integration of IGF-I receptor (IGF-IR) and adhesion signaling. Here we investigated the nature of the binding site for PP2A and beta 1 integrin in RACK1. A WD7 deletion mutant of RACK1 did not associate with PP2A but retained some interaction with beta 1 integrin, whereas a WD6/WD7 mutant lost the ability to bind to both PP2A and beta 1 integrin. Using immobilized peptide arrays representing the entire RACK1 protein, we identified a common cluster of amino acids (FAGY) at positions 299-302 within WD7 of RACK1 which were essential for binding of both PP2A and beta 1 integrin to RACK1. PP2A showed a higher level of association with a peptide in which Tyr-302 was phosphorylated compared with an unphosphorylated peptide, whereas beta 1 integrin binding was not affected by phosphorylation. RACK1 mutants in which either the FAGY cluster or Tyr- 302 were mutated to AAAF, or Phe, respectively, did not interact with either PP2A or beta 1 integrin. These mutants were unable to rescue the decrease in PP2A activity caused by suppression of RACK1 in MCF-7 cells with small interfering RNA. MCF-7 cells and R+ (IGF-IR-overexpressing fibroblasts) expressing these mutants exhibited decreased proliferation and migration, whereas R-cells (IGF-IR null fibroblasts) were unaffected. Taken together, the data demonstrate that Tyr-302 in RACK1 is required for interaction with PP2A and beta 1 integrin, for regulation of PP2A activity, and for IGF-I-mediated cell migration and proliferation.	[Kiely, Patrick A.; O'Connor, Rosemary] Natl Univ Ireland Univ Coll Cork, BioSci Inst, Dept Biochem, Cell Biol Lab, Cork, Ireland; [Baillie, George S.; Lynch, Martin J.; Houslay, Miles D.] Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland	University College Cork; University of Glasgow	O'Connor, R (corresponding author), Natl Univ Ireland Univ Coll Cork, BioSci Inst, Dept Biochem, Cell Biol Lab, Cork, Ireland.	r.oconnor@ucc.ie	Houslay, Miles/AAM-5281-2020; Houslay, Miles D/A-6825-2011; O'Connor, Rosemary/B-7902-2014	O'Connor, Rosemary/0000-0002-0687-3422; Houslay, Miles/0000-0002-3826-8091	Health Research Board of Ireland; Cancer Research Ireland; Science Foundation Ireland; Medical Research Council [G8604010, G0400053]; European Union [037189]; Foundation Leducq (Paris); MRC [G0400053, G8604010, G0600765] Funding Source: UKRI; Medical Research Council [G0600765] Funding Source: researchfish	Health Research Board of Ireland; Cancer Research Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Foundation Leducq (Paris)(Leducq Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by the Health Research Board of Ireland, Cancer Research Ireland, and Science Foundation Ireland. Work in the laboratories of G. S. B. and M. D. H. Laboratory was supported by Medical Research Council Grants G8604010 and G0400053, the European Union Grant 037189, and the Foundation Leducq ( Paris).	Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Blakesley VA, 1998, J BIOL CHEM, V273, P18411, DOI 10.1074/jbc.273.29.18411; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Chung HY, 1999, CELL SIGNAL, V11, P575, DOI 10.1016/S0898-6568(99)00033-9; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; Frank R, 1996, Methods Mol Biol, V66, P149; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Hongo A, 1996, ONCOGENE, V12, P1231; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kramer A, 1998, METH MOL B, V87, P25; Leahy M, 2004, J BIOL CHEM, V279, P18306, DOI 10.1074/jbc.M309234200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; MOCHLYROSEN D, 1995, BIOCHEM SOC T, V23, P596, DOI 10.1042/bst0230596; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; OConnor R, 1997, MOL CELL BIOL, V17, P427, DOI 10.1128/MCB.17.1.427; Rodriguez-Viciana P, 2006, P NATL ACAD SCI USA, V103, P19290, DOI 10.1073/pnas.0609343103; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; Sachs BD, 2007, J CELL BIOL, V177, P1119, DOI 10.1083/jcb.200701040; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Sieburth DS, 1999, GENE DEV, V13, P2562, DOI 10.1101/gad.13.19.2562; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Smith KJ, 2007, CELL SIGNAL, V19, P2612, DOI 10.1016/j.cellsig.2007.08.015; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; Zhao WQ, 2003, NEUROBIOL DIS, V14, P458, DOI 10.1016/S0969-9961(03)00124-4	39	60	62	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22952	22961		10.1074/jbc.M800802200	http://dx.doi.org/10.1074/jbc.M800802200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18567578	hybrid			2022-12-25	WOS:000258455400008
J	Liu, P; Li, K; Garofalo, RP; Brasier, AR				Liu, Ping; Li, Kui; Garofalo, Roberto P.; Brasier, Allan R.			Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acid-inducible gene-I center dot NF-kappa B-inducing kinase signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; EPITHELIAL-CELLS; RIG-I; NUCLEAR TRANSLOCATION; TRANSCRIPTION FACTOR; RNA VIRUSES; ACTIVATION; PROTEIN; P100; EXPRESSION	Respiratory syncytial virus (RSV) is a primary cause of severe lower respiratory tract infection in children world wide. RSV infects airway epithelial cells, where it activates inflammatory genes via the NF-kappa B pathway. NF-kappa B is controlled by two pathways, a canonical pathway that releases sequestered RelA complexes from the I kappa B alpha inhibitor, and a second, the noncanonical pathway, that releases RelB from the 100-kDa NF-kappa B2 complex. Recently we found that the retinoic acid-inducible gene I (RIG-I) is a major intracellular RSV sensor upstream of the canonical pathway. In this study, we surprisingly found that RIG-I silencing also inhibited p100 processing to 52-kDa NF-kappa B2 ("p52"), suggesting that RIG-I was functionally upstream of the noncanonical regulatory kinase complex composed of (NIKIKK)-I-.alpha subunits. Co-immunoprecipitation experiments not only demonstrated that NIK associated with RIG-I and its downstream adaptor, mitochondrial antiviral signaling (MAVS), but also showed the association between IKK alpha and MAVS. To further understand the role of the (NIKIKK)-I-.alpha pathway, we compared RSV-induced NF-kappa B activation using wild type, Ikk gamma(-/-), Nik(-/-), and Ikk alpha(-/-)-deficient MEF cells. Interestingly, we found that in canonical pathway-defective Ikk gamma(-/-) cells, RSV induced RelA by liberation from p100 complexes. RSV was still able to activate IP10, Rantes, and Gro beta gene expression in Ikk gamma(-/-) cells, and this induction was inhibited by small interfering RNA-mediated RelA knockdown but not RelB silencing. These data suggest that part of the RelA activation in response to RSV infection was induced by a "cross-talk" pathway involving the noncanonical (NIKIKK)-I-.alpha complex downstream of RIG-I(.)MAVS. This pathway may be a potential target for RSV treatment.	[Liu, Ping; Brasier, Allan R.] Univ Texas Galveston, Dept Med, Med Branch, Galveston, TX 77555 USA; [Liu, Ping; Brasier, Allan R.] Univ Texas Galveston, Dept Biochem & Mol Biol, Med Branch, Galveston, TX 77555 USA; [Li, Kui; Garofalo, Roberto P.] Univ Texas Galveston, Dept Microbiol & Immunol, Med Branch, Galveston, TX 77555 USA; [Garofalo, Roberto P.] Univ Texas Galveston, Dept Pediat, Med Branch, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Texas Galveston, Sealy Ctr Mol Med, Med Branch, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Brasier, AR (corresponding author), Univ Texas Galveston, Dept Med, Med Branch, MRB 8-128,301 Univ Blvd, Galveston, TX 77555 USA.	arbrasie@utmb.edu	Garofalo, Roberto P./ABL-2322-2022; Garofalo, Roberto P./AAF-7385-2022	Brasier, Allan/0000-0002-5012-4090	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NHLBI NIH HHS [BAA-HL-02-04] Funding Source: Medline; NIAID NIH HHS [AI062885] Funding Source: Medline; NIEHS NIH HHS [P30 ES06676] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AHERNE W, 1970, J CLIN PATHOL, V23, P7, DOI 10.1136/jcp.23.1.7; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Choudhary S, 2005, J VIROL, V79, P8948, DOI 10.1128/JVI.79.14.8948-8959.2005; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; GAROUFALIS E, 1994, J VIROL, V68, P4707, DOI 10.1128/JVI.68.8.4707-4715.1994; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Haeberle HA, 2004, J VIROL, V78, P2232, DOI 10.1128/JVI.78.5.2232-2241.2004; Hu WH, 2004, J BIOL CHEM, V279, P35975, DOI 10.1074/jbc.M405699200; Jamaluddin M, 1998, J VIROL, V72, P4849, DOI 10.1128/JVI.72.6.4849-4857.1998; KANNO T, 1994, P NATL ACAD SCI USA, V91, P12634, DOI 10.1073/pnas.91.26.12634; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim YS, 2005, MOL CELL BIOL, V25, P2130, DOI 10.1128/MCB.25.6.2130-2137.2005; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; Liu TS, 2004, J BIOL CHEM, V279, P2461, DOI 10.1074/jbc.M307251200; Luftig MA, 2001, J BIOL CHEM, V276, P14602, DOI 10.1074/jbc.C100103200; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; NAUMANN M, 1993, ONCOGENE, V8, P2275; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Paramore LC, 2004, PHARMACOECONOMICS, V22, P275, DOI 10.2165/00019053-200422050-00001; SCHEINMAN RI, 1993, MOL CELL BIOL, V13, P6089, DOI 10.1128/MCB.13.10.6089; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Tian B, 2003, RECENT PROG HORM RES, V58, P95, DOI 10.1210/rp.58.1.95; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; UEBA O, 1978, ACTA MED OKAYAMA, V32, P265; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xiao GT, 2000, J BIOL CHEM, V275, P21081, DOI 10.1074/jbc.M002552200; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zhang YH, 2001, J VIROL, V75, P9044, DOI 10.1128/JVI.75.19.9044-9058.2001; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	44	54	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23169	23178		10.1074/jbc.M802729200	http://dx.doi.org/10.1074/jbc.M802729200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550535	hybrid, Green Published			2022-12-25	WOS:000258455400030
J	Cloutier, P; Toutant, J; Shkreta, L; Goekjian, S; Revil, TE; Chabot, B				Cloutier, Philippe; Toutant, Johanne; Shkreta, Lulzim; Goekjian, Serge; Revil, Timothee E.; Chabot, Benoit			Antagonistic effects of the SRp30c protein and cryptic 5 ' splice sites on the alternative splicing of the apoptotic regulator Bcl-x	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; MOTOR-NEURON SMN; EXON-7 INCLUSION; HNRNP-G; SELECTION; EXPRESSION; IDENTIFICATION; ENHANCERS; MECHANISM; CERAMIDE	Alternative 5' splice site selection allows Bcl-x to produce two isoforms with opposite effects on apoptosis. The pro-apoptotic Bcl-x(S) variant is up-regulated by ceramide and down-regulated by protein kinase C through specific cis-acting exonic elements, one of which is bound by SAP155. Splicing to the Bcl-xS 5' splice site is also enforced by heterogeneous nuclear ribonucleoprotein (hnRNP) F/H proteins and by Sam68 in cooperation with hnRNP A1. Here, we have characterized exon elements that influence splicing to the 5' splice site of the anti-apoptotic Bcl-x(L) isoform. Within a 86-nucleotide region (B3) located immediately upstream of the Bcl-x(L) donor site we have identified two elements (ML2 and AM2) that stimulate splicing to the Bcl-x(L) 5' splice site. SRp30c binds to these elements and can shift splicing to the 5' splice site of Bcl-xL in an ML2/AM2-dependent manner in vitro and in vivo. The B3 region also contains an element that represses the use of Bcl-x(L). This element is bound by U1 small nuclear ribonucleoprotein and contains two 5' splice sites that can be used when the Bcl-x(L) 5' splice site is mutated or the ML2/AM2 elements are deleted. Conversely, mutating the cryptic 5' splice sites stimulates splicing to the Bcl-x(L) site. Thus, SRp30c stimulates splicing to the downstream 5' splice site of Bcl-x(L), thereby attenuating the repressive effect of upstream U1 snRNP binding sites.	[Cloutier, Philippe; Toutant, Johanne; Shkreta, Lulzim; Revil, Timothee E.; Chabot, Benoit] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA RNP Grp, Sherbrooke, PQ J1H 5N4, Canada; [Goekjian, Serge] Bishops Univ, Dept Biochem, Lennoxville, PQ J1M 1Z7, Canada	University of Sherbrooke; Bishops University	Chabot, B (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA RNP Grp, Sherbrooke, PQ J1H 5N4, Canada.	Benoit.Chabot@USherbrooke.ca		Chabot, Benoit/0000-0003-0994-0042				Amundson SA, 2000, CANCER RES, V60, P6101; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Chabot B, 2003, Prog Mol Subcell Biol, V31, P59; CHABOT B, 1992, NUCLEIC ACIDS RES, V20, P5197, DOI 10.1093/nar/20.19.5197; CHABOT B, 1994, RNA PROCESSING PRACT, P1; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; CUNNINGHAM SA, 1991, J MOL BIOL, V217, P265, DOI 10.1016/0022-2836(91)90541-D; Decaudin D, 1997, CANCER RES, V57, P62; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EPERON IC, 1993, EMBO J, V12, P3607, DOI 10.1002/j.1460-2075.1993.tb06034.x; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Gendron D, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-5; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Krajewska M, 1996, CANCER RES, V56, P2422; Krajewska M, 1996, AM J PATHOL, V148, P1567; Li CY, 2004, CELL RES, V14, P473, DOI 10.1038/sj.cr.7290250; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Nasim FUH, 2002, RNA, V8, P1078, DOI 10.1017/S1355838202024056; Nasim MT, 2003, HUM MOL GENET, V12, P1337, DOI 10.1093/hmg/ddg136; Olopade OI, 1997, CANCER J SCI AM, V3, P230; Paradis C, 2007, RNA, V13, P1287, DOI 10.1261/rna.403607; Park E, 2006, J BIOL CHEM, V281, P401, DOI 10.1074/jbc.M505814200; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Reeve JG, 1996, BRIT J CANCER, V73, P1193, DOI 10.1038/bjc.1996.230; Revil T, 2007, MOL CELL BIOL, V27, P8431, DOI 10.1128/MCB.00565-07; Sanford J R, 2003, Prog Mol Subcell Biol, V31, P33; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; SCREATON GR, 1995, EMBO J, V14, P4336, DOI 10.1002/j.1460-2075.1995.tb00108.x; Shen HH, 2006, GENE DEV, V20, P1755, DOI 10.1101/gad.1422106; SIEBEL CW, 1994, GENE DEV, V8, P1713, DOI 10.1101/gad.8.14.1713; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; Simard MJ, 2002, MOL CELL BIOL, V22, P4001, DOI 10.1128/MCB.22.12.4001-4010.2002; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Strasser A, 2004, TRENDS IMMUNOL, V25, P610, DOI 10.1016/j.it.2004.08.012; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; Taylor JK, 1999, NAT BIOTECHNOL, V17, P1097, DOI 10.1038/15079; Taylor JK, 1999, ONCOGENE, V18, P4495, DOI 10.1038/sj.onc.1202836; Tu YP, 1998, CANCER RES, V58, P256; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang YZ, 2005, J BIOL CHEM, V280, P14230, DOI 10.1074/jbc.M413846200; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhuo DG, 2007, P NATL ACAD SCI USA, V104, P882, DOI 10.1073/pnas.0604777104	59	53	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21315	21324		10.1074/jbc.M800353200	http://dx.doi.org/10.1074/jbc.M800353200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18534987	hybrid			2022-12-25	WOS:000257898800003
J	Wang, IC; Chen, YJ; Hughes, DE; Ackerson, T; Major, ML; Kalinichenko, VV; Costa, RH; Raychaudhuri, P; Tyner, AL; Lau, LF				Wang, I-Ching; Chen, Yi-Ju; Hughes, Douglas E.; Ackerson, Timothy; Major, Michael L.; Kalinichenko, Vladimir V.; Costa, Robert H.; Raychaudhuri, Pradip; Tyner, Angela L.; Lau, Lester F.			FoxM1 regulates transcription of JNK1 to promote the G(1)/S transition and tumor cell invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; CYCLIN D1 EXPRESSION; TERMINAL KINASE JNK; C-JUN; PROTEIN-KINASE; MATRIX METALLOPROTEINASES; P53-DEPENDENT SENESCENCE; LIVER-REGENERATION; GLIOMA-CELLS; A PROMOTER	The Forkhead box M1 (FoxM1) protein is a proliferation-specific transcription factor that plays a key role in controlling both the G(1)/S and G(2)/M transitions through the cell cycle and is essential for the development of various cancers. We show here that FoxM1 directly activates the transcription of the c-Jun N-terminal kinase (JNK1) gene in U2OS osteosarcoma cells. Expression of JNK1, which regulates the expression of genes important for the G(1)/S transition, rescues the G(1)/S but not the G(2)/M cell cycle block in FoxM1-deficient cells. Knockdown of either FoxM1 or JNK1 inhibits tumor cell migration, invasion, and anchorage-independent growth. However, expression of JNK1 in FoxM1-depleted cells does not rescue these defects, indicating that JNK1 is a necessary but insufficient downstream mediator of FoxM1 in these processes. Consistent with this interpretation, FoxM1 regulates the expression of the matrix metalloproteinases MMP-2 and MMP-9, which play a role in tumor cell invasion, through JNK1-independent and -dependent mechanisms in U2OS cells, respectively. Taken together, these findings identify JNK1 as a critical transcriptional target of FoxM1 that contributes to FoxM1-regulated cell cycle progression, tumor cell migration, invasiveness, and anchorage-independent growth.	[Wang, I-Ching; Chen, Yi-Ju; Hughes, Douglas E.; Ackerson, Timothy; Major, Michael L.; Costa, Robert H.; Raychaudhuri, Pradip; Tyner, Angela L.; Lau, Lester F.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Kalinichenko, Vladimir V.] Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cincinnati Children's Hospital Medical Center	Lau, LF (corresponding author), Univ Illinois, Dept Biochem & Mol Genet MC 669, 900 S Ashland Ave, Chicago, IL 60607 USA.	LFLau@uic.edu		Wang, I-Ching/0000-0003-4398-2975; Tyner, Angela/0000-0001-7448-8625; Lau, Lester/0000-0002-4364-2914	NATIONAL CANCER INSTITUTE [R01CA124488, R01CA100035, R01CA046565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044525, R01DK056283, R01DK044525, R01DK068503, R01DK054687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021842] Funding Source: NIH RePORTER; NCI NIH HHS [CA 124488, CA 46565, CA 100035] Funding Source: Medline; NHLBI NIH HHS [HL 081390] Funding Source: Medline; NIA NIH HHS [AG 21842, R01 AG021842-05, R01 AG021842] Funding Source: Medline; NIDDK NIH HHS [R01 DK056283-04, DK 68503, R01 DK044525, R01 DK054687-09, R01 DK044525-14, R01 DK054687, DK 54687, R01 DK056283, DK 44525] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; Arai K, 2003, GLIA, V43, P254, DOI 10.1002/glia.10255; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Beier F, 2000, J BIOL CHEM, V275, P12948, DOI 10.1074/jbc.275.17.12948; Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Cheung LWT, 2006, CANCER RES, V66, P10902, DOI 10.1158/0008-5472.CAN-06-2217; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Dai Y, 2005, BLOOD, V105, P1706, DOI 10.1182/blood-2004-07-2767; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Hall JF, 2000, P NATL ACAD SCI USA, V97, P14022, DOI 10.1073/pnas.97.26.14022; Hennigan RF, 2001, MOL BIOL CELL, V12, P2352, DOI 10.1091/mbc.12.8.2352; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kaestner KH, 2000, GENE DEV, V14, P142; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2003, J BIOL CHEM, V278, P37888, DOI 10.1074/jbc.M305555200; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Katabami M, 2005, J BIOL CHEM, V280, P16728, DOI 10.1074/jbc.M413892200; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Keum YS, 2003, PHARM RES-DORDR, V20, P1351, DOI 10.1023/A:1025737622815; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Kuntzen C, 2005, CANCER RES, V65, P6780, DOI 10.1158/0008-5472.CAN-04-2618; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Leaner VD, 2003, ONCOGENE, V22, P5619, DOI 10.1038/sj.onc.1206644; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; MINDEN A, 1997, BIOCHIM BIOPHYS ACTA, V10, P205; Petrovic V, 2008, J BIOL CHEM, V283, P453, DOI 10.1074/jbc.M705792200; Robinson WP, 2006, AM J PHYSIOL-HEART C, V290, pH1988, DOI 10.1152/ajpheart.00344.2005; Sabapathy K, 2004, CELL CYCLE, V3, P1520, DOI 10.4161/cc.3.12.1315; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Shimizu M, 1998, EXP CELL RES, V239, P93, DOI 10.1006/excr.1997.3884; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Teh MT, 2002, CANCER RES, V62, P4773; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; WANT IC, 2008, ONCOGENE; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Xie ZL, 2004, J BIOL CHEM, V279, P39513, DOI 10.1074/jbc.M405844200; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zou XH, 2002, GENE DEV, V16, P2923, DOI 10.1101/gad.1033002	63	106	116	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20770	20778		10.1074/jbc.M709892200	http://dx.doi.org/10.1074/jbc.M709892200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18524773	hybrid, Green Published			2022-12-25	WOS:000257746100018
J	Hampshire, A; Thompson, R; Duncan, J; Owen, AM				Hampshire, Adam; Thompson, Russell; Duncan, John; Owen, Adrian M.			The Target Selective Neural Response - Similarity, Ambiguity, and Learning Effects	PLOS ONE			English	Article							PRIMATE PREFRONTAL CORTEX; EVENT-RELATED FMRI; LATERAL FRONTAL-CORTEX; WORKING-MEMORY; FUNCTIONAL-ORGANIZATION; ATTENTION; MONKEY; TASK; REPRESENTATION; INFORMATION	A network of frontal and parietal brain regions is commonly recruited during tasks that require the deliberate 'top-down' control of thought and action. Previously, using simple target detection, we have demonstrated that within this frontoparietal network, the right ventrolateral prefrontal cortex (VLPFC) in particular is sensitive to the presentation of target objects. Here, we use a range of target/non-target morphs to plot the target selective response within distinct frontoparietal sub-regions in greater detail. The increased resolution allows us to examine the extent to which different cognitive factors can predict the blood oxygenation level dependent (BOLD) response to targets. Our results reveal that both probability of positive identification (similarity to target) and proximity to the 50% decision boundary (ambiguity) are significant predictors of BOLD signal change, particularly in the right VLPFC. Furthermore, the profile of target related signal change is not static, with the degree of selectivity increasing as the task becomes familiar. These findings demonstrate that frontoparietal sub-regions are recruited under increased cognitive demand and that when recruited, they adapt, using both fast and slow mechanisms, to selectively respond to those items that are of the most relevance to current intentions.	[Hampshire, Adam; Thompson, Russell; Duncan, John; Owen, Adrian M.] MRC, Cognit & Brain Sci Unit, Cambridge, Cambs, England		Hampshire, A (corresponding author), MRC, Cognit & Brain Sci Unit, Cambridge, Cambs, England.	adam.hampshire@mrc-cbu.cam.ac.uk	Owen, Adrian M/B-4997-2015	Duncan, John/0000-0002-9695-2764	Medical Research Council UK.; Medical Research Council [MC_U105559847, MC_U105580448] Funding Source: researchfish; MRC [MC_U105580448, MC_U105559847] Funding Source: UKRI	Medical Research Council UK.(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Reasearch funded by the Medical Research Council UK.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Bor D, 2001, SCAND J PSYCHOL, V42, P217, DOI 10.1111/1467-9450.00232; Brett M., 2002, 8 INT C FUNCT MAPP H; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dias R, 1997, J NEUROSCI, V17, P9285; Duncan J, 2006, Q J EXP PSYCHOL, V59, P2, DOI 10.1080/17470210500260674; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Hampshire A, 2007, J NEUROSCI, V27, P6219, DOI 10.1523/JNEUROSCI.0851-07.2007; Hampshire A, 2006, CEREB CORTEX, V16, P1679, DOI 10.1093/cercor/bhj116; Hasegawa RP, 2000, J NEUROPHYSIOL, V84, P1692, DOI 10.1152/jn.2000.84.3.1692; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007; NORMAN DA, 1980, CONSCIOUSNESS SELF R; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; PETRIDES M, 1995, J NEUROSCI, V15, P359; PETRIDES M, 1994, HDB NEUROPSYCHOLOGY, P59; Postle BR, 2000, PSYCHOBIOLOGY, V28, P132; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rubia K, 2001, NEUROIMAGE, V13, pS351; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740	39	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2520	10.1371/journal.pone.0002520	http://dx.doi.org/10.1371/journal.pone.0002520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IK	18575585	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000036
J	Liu, WW; Goodhouse, J; Jeon, NL; Enquist, LW				Liu, Wendy W.; Goodhouse, Joseph; Jeon, Noo Li; Enquist, L. W.			A Microfluidic Chamber for Analysis of Neuron-to-Cell Spread and Axonal Transport of an Alpha-Herpesvirus	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; AUJESZKYS-DISEASE VIRUS; RAT SENSORY NEURONS; PSEUDORABIES VIRUS; VACCINE STRAINS; EPIDERMAL-CELLS; ENVELOPE GLYCOPROTEIN-GP50; ANTEROGRADE TRANSPORT; PERIPHERAL INFECTION; TRANSNEURONAL SPREAD	Alpha-herpesviruses, including herpes simplex virus and pseudorabies virus (PRV), infect the peripheral nervous system (PNS) of their hosts. Here, we describe an in vitro method for studying neuron-to-cell spread of infection as well as viral transport in axons. The method centers on a novel microfluidic chamber system that directs growth of axons into a fluidically isolated environment. The system uses substantially smaller amounts of virus inoculum and media than previous chamber systems and yet offers the flexibility of applying multiple virology and cell biology assays including live-cell optical imaging. Using PRV infection of cultured PNS neurons, we demonstrate that the microfluidic chamber recapitulates all known facets of neuron-to-cell spread demonstrated in animals and other compartmented cell systems.	[Liu, Wendy W.; Goodhouse, Joseph; Enquist, L. W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Jeon, Noo Li] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA	Princeton University; University of California System; University of California Irvine	Liu, WW (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	lenquist@princeton.edu		Liu, Wendy/0000-0002-1648-4068	Princeton Class of 1943 endowment funds; American Society for Microbiology [Undergraduate Research Fellowship]; NIH [RO1 33506]	Princeton Class of 1943 endowment funds; American Society for Microbiology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	WWL was supported by the Princeton Class of 1943 endowment funds and the American Society for Microbiology Undergraduate Research Fellowship. This work was supported in part by NIH RO1 33506 to LWE.	ANDERSSON H, 2004, LAB ON CHIPS CELLOMI, P1; Antinone SE, 2006, J VIROL, V80, P11235, DOI 10.1128/JVI.01441-06; BABIC N, 1993, J VIROL, V67, P4421, DOI 10.1128/JVI.67.7.4421-4426.1993; Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g; Brideau AD, 2000, J VIROL, V74, P834, DOI 10.1128/JVI.74.2.834-845.2000; CARD JP, 1991, NEURON, V6, P957, DOI 10.1016/0896-6273(91)90236-S; CARD JP, 1993, J NEUROSCI, V13, P2515, DOI 10.1523/JNEUROSCI.13-06-02515.1993; Ch'ng TH, 2006, VET MICROBIOL, V113, P193, DOI 10.1016/j.vetmic.2005.11.010; Ch'ng TH, 2005, J VIROL, V79, P10875, DOI 10.1128/JVI.79.17.10875-10889.2005; Ch'ng Toh Hean, 2005, Methods Mol Biol, V292, P299; De Regge N, 2006, VET MICROBIOL, V113, P251, DOI 10.1016/j.vetmic.2005.11.004; del Rio T, 2005, J VIROL, V79, P3903, DOI 10.1128/JVI.79.7.3903-3919.2005; Demmin GL, 2001, J VIROL, V75, P10856, DOI 10.1128/JVI.75.22.10856-10869.2001; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Enquist LW, 2003, CURR OPIN NEUROBIOL, V13, P603, DOI 10.1016/j.conb.2003.08.001; Enquist LW, 1999, ADV VIRUS RES, V51, P237; Feierbach B, 2007, J VIROL, V81, P6846, DOI 10.1128/JVI.00069-07; Holland DJ, 1999, J VIROL, V73, P8503, DOI 10.1128/JVI.73.10.8503-8511.1999; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Jons A, 1997, J VIROL METHODS, V66, P283, DOI 10.1016/S0166-0934(97)00065-7; KRITAS SK, 1994, VET MICROBIOL, V40, P323, DOI 10.1016/0378-1135(94)90120-1; LaVail JH, 2005, J VIROL, V79, P11142, DOI 10.1128/JVI.79.17.11142-11150.2005; LaVail JH, 2003, J VIROL, V77, P6117, DOI 10.1128/JVI.77.11.6117-6126.2003; Lin F, 2004, BIOCHEM BIOPH RES CO, V319, P576, DOI 10.1016/j.bbrc.2004.05.029; LOMNICZI B, 1984, J VIROL, V52, P198, DOI 10.1128/JVI.52.1.198-205.1984; LOMNICZI B, 1984, J VIROL, V49, P970, DOI 10.1128/JVI.49.3.970-979.1984; Luxton GWG, 2005, P NATL ACAD SCI USA, V102, P5832, DOI 10.1073/pnas.0500803102; LYCKE E, 1984, J GEN VIROL, V65, P55, DOI 10.1099/0022-1317-65-1-55; Lyman MG, 2007, J VIROL, V81, P11363, DOI 10.1128/JVI.01281-07; MARCHAND CF, 1986, BRAIN RES, V383, P262, DOI 10.1016/0006-8993(86)90024-7; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; MCLAUCHLAN J, 1992, J GEN VIROL, V73, P269, DOI 10.1099/0022-1317-73-2-269; METTENLEITER TC, 1985, J VIROL, V56, P307, DOI 10.1128/JVI.56.1.307-311.1985; Mikloska Z, 1999, J VIROL, V73, P5934, DOI 10.1128/JVI.73.7.5934-5944.1999; Mikloska Z, 2001, J VIROL, V75, P11821, DOI 10.1128/JVI.75.23.11821-11826.2001; Miranda-Saksena M, 2000, J VIROL, V74, P1827, DOI 10.1128/JVI.74.4.1827-1839.2000; Mulder W, 1996, J VIROL, V70, P2191, DOI 10.1128/JVI.70.4.2191-2200.1996; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; PEETERS B, 1992, J VIROL, V66, P894, DOI 10.1128/JVI.66.2.894-905.1992; PEETERS B, 1993, J VIROL, V67, P170, DOI 10.1128/JVI.67.1.170-177.1993; PENFOLD MET, 1994, P NATL ACAD SCI USA, V91, P6529, DOI 10.1073/pnas.91.14.6529; PETROVSKIS EA, 1986, J VIROL, V60, P1166, DOI 10.1128/JVI.60.3.1166-1169.1986; PLATT KB, 1979, ARCH VIROL, V60, P13, DOI 10.1007/BF01318093; Potel C, 2003, J GEN VIROL, V84, P2613, DOI 10.1099/vir.0.19279-0; RAUH I, 1991, J VIROL, V65, P5348, DOI 10.1128/JVI.65.10.5348-5356.1991; Rhee SW, 2005, LAB CHIP, V5, P102, DOI 10.1039/b403091e; Saadi W, 2006, BIOMED MICRODEVICES, V8, P109, DOI 10.1007/s10544-006-7706-6; Smith GA, 2004, P NATL ACAD SCI USA, V101, P16034, DOI 10.1073/pnas.0404686101; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Smith GA, 2001, P NATL ACAD SCI USA, V98, P3466, DOI 10.1073/pnas.061029798; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Taylor Anne M., 2006, V321, P167; Tomishima MJ, 2001, J CELL BIOL, V154, P741, DOI 10.1083/jcb.200011146; Tomishima MJ, 2001, TRAFFIC, V2, P429, DOI 10.1034/j.1600-0854.2001.020701.x; Tourovskaia A, 2005, LAB CHIP, V5, P14, DOI 10.1039/b405719h; Wang SJ, 2004, EXP CELL RES, V300, P180, DOI 10.1016/j.yexcr.2004.06.030; Yang M, 1999, J VIROL, V73, P4350, DOI 10.1128/JVI.73.5.4350-4359.1999; ZIEGLER RJ, 1981, INFECT IMMUN, V34, P588, DOI 10.1128/IAI.34.2.588-595.1981; ZIEGLER RJ, 1980, INFECT IMMUN, V28, P620	61	68	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2382	10.1371/journal.pone.0002382	http://dx.doi.org/10.1371/journal.pone.0002382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560518	gold, Green Published			2022-12-25	WOS:000263280700003
J	Li, ZY; Lee, JH; Chu, FX; Burlingame, AL; Gunzl, A; Wang, CC				Li, Ziyin; Lee, Ju Huck; Chu, Feixia; Burlingame, Alma L.; Gunzl, Arthur; Wang, Ching C.			Identification of a Novel Chromosomal Passenger Complex and Its Unique Localization during Cytokinesis in Trypanosoma brucei	PLOS ONE			English	Article								Aurora B kinase is a key component of the chromosomal passenger complex (CPC), which regulates chromosome segregation and cytokinesis. An ortholog of Aurora B was characterized in Trypanosoma brucei (TbAUK1), but other conserved components of the complex have not been found. Here we identified four novel TbAUK1 associated proteins by tandem affinity purification and mass spectrometry. Among these four proteins, TbKIN-A and TbKIN-B are novel kinesin homologs, whereas TbCPC1 and TbCPC2 are hypothetical proteins without any sequence similarity to those known CPC components from yeasts and metazoans. RNAi-mediated silencing of each of the four genes led to loss of spindle assembly, chromosome segregation and cytokinesis. TbKIN-A localizes to the mitotic spindle and TbKIN-B to the spindle midzone during mitosis, whereas TbCPC1, TbCPC2 and TbAUK1 display the dynamic localization pattern of a CPC. After mitosis, the CPC disappears from the central spindle and re-localizes at a dorsal mid-point of the mother cell, where the anterior tip of the daughter cell is tethered, to start cell division toward the posterior end, indicating a most unusual CPC-initiated cytokinesis in a eukaryote.	[Li, Ziyin; Chu, Feixia; Burlingame, Alma L.; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Lee, Ju Huck; Gunzl, Arthur] Univ Connecticut Hlth Ctr, Dept Genet & Dev Biol, Farmington, CT USA	University of California System; University of California San Francisco; University of Connecticut	Li, ZY (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu		Gunzl, Arthur/0000-0002-7487-2261; Li, Ziyin/0000-0002-3960-9716	NIH [AI21786, AI059377, RR01614, RR12961, RR15804]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR012961, P41RR001614, S10RR015804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059377, R01AI021786] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH R01 grants AI21786 (C.C.W.) and AI059377 (A.G.) NIH grants RR01614, RR12961 and RR15804 (A.L.B.)	Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Berberich C, 1998, BBA-GENE STRUCT EXPR, V1442, P230, DOI 10.1016/S0167-4781(98)00176-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bishop JD, 2005, MOL BIOL CELL, V16, P742, DOI 10.1091/mbc.E04-08-0682; Brandenburg J, 2007, EMBO J, V26, P4856, DOI 10.1038/sj.emboj.7601905; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; CARRUTHERS VB, 1992, P NATL ACAD SCI USA, V89, P8818, DOI 10.1073/pnas.89.18.8818; Eckley DM, 1997, J CELL BIOL, V136, P1169, DOI 10.1083/jcb.136.6.1169; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kwon M, 2004, MOL BIOL CELL, V15, P219, DOI 10.1091/mbc.E03-07-0489; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Li FZ, 2000, J BIOL CHEM, V275, P6707, DOI 10.1074/jbc.275.10.6707; Li Z, 2007, J CELL SCI, V120, P3883, DOI 10.1242/jcs.007955; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Li ZY, 2002, J BIOL CHEM, V277, P42686, DOI 10.1074/jbc.M207183200; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Ploubidou A, 1999, J CELL SCI, V112, P4641; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; SASSE R, 1988, J CELL SCI, V90, P577; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; STEBECK CE, 1995, MOL BIOCHEM PARASIT, V71, P1, DOI 10.1016/0166-6851(95)00022-S; Thomas S, 2007, MOL BIOL CELL, V18, P3820, DOI 10.1091/mbc.E07-03-0201; TOLSON DL, 1994, INFECT IMMUN, V62, P4893, DOI 10.1128/IAI.62.11.4893-4899.1994; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Vaughan S, 2003, J CELL SCI, V116, P757, DOI 10.1242/jcs.00287; Walczak CE, 1996, CELL, V85, P943, DOI 10.1016/S0092-8674(00)81295-7; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49	53	64	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2354	10.1371/journal.pone.0002354	http://dx.doi.org/10.1371/journal.pone.0002354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545648	gold, Green Submitted, Green Published			2022-12-25	WOS:000263248800012
J	Matigian, NA; McCurdy, RD; Feron, F; Perry, C; Smith, H; Filippich, C; McLean, D; McGrath, J; Mackay-Sim, A; Mowry, B; Hayward, NK				Matigian, Nicholas A.; McCurdy, Richard D.; Feron, Francois; Perry, Christopher; Smith, Heather; Filippich, Cheryl; McLean, Duncan; McGrath, John; Mackay-Sim, Alan; Mowry, Bryan; Hayward, Nicholas K.			Fibroblast and Lymphoblast Gene Expression Profiles in Schizophrenia: Are Non-Neural Cells Informative?	PLOS ONE			English	Article							MICROARRAY ANALYSIS; SKIN FIBROBLASTS; BIPOLAR DISORDER; ALTERED ADHESION; BLOOD; DYSFUNCTION; DISCORDANT; CULTURE	Lymphoblastoid cell lines (LCLs) and fibroblasts provide conveniently derived non-neuronal samples in which to investigate the aetiology of schizophrenia (SZ) using gene expression profiling. This assumes that heritable mechanisms associated with risk of SZ have systemic effects and result in changes to gene expression in all tissues. The broad aim of this and other similar studies is that comparison of the transcriptomes of non-neuronal tissues from SZ patients and healthy controls may identify gene/pathway dysregulation underpinning the neurobiological defects associated with SZ. Using microarrays consisting of 18,664 probes we compared gene expression profiles of LCLs from SZ cases and healthy controls. To identify robust associations with SZ that were not patient or tissue specific, we also examined fibroblasts from an independent series of SZ cases and controls using the same microarrays. In both tissue types ANOVA analysis returned approximately the number of differentially expressed genes expected by chance. No genes were significantly differentially expressed in either tissue when corrected for multiple testing. Even using relaxed parameters (p <= 0.05, without multiple testing correction) there were still no differentially expressed genes that also displayed >= 2-fold change between the groups of SZ cases and controls common to both LCLs and fibroblasts. We conclude that despite encouraging data from previous microarray studies assessing non-neural tissues, the lack of a convergent set of differentially expressed genes associated with SZ using fibroblasts and LCLs indicates the utility of non-neuronal tissues for detection of gene expression differences and/or pathways associated with SZ remains to be demonstrated.	[Matigian, Nicholas A.; Smith, Heather; Filippich, Cheryl; Mowry, Bryan; Hayward, Nicholas K.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Matigian, Nicholas A.; Smith, Heather; Filippich, Cheryl; McLean, Duncan; McGrath, John; Mowry, Bryan] Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia; [McCurdy, Richard D.] Sick Kids Res Inst, Toronto, ON, Canada; [Feron, Francois] CNRS, UMR 6184, Marseille, France; [Perry, Christopher] Univ Queensland, Dept Surg, St Lucia, Qld, Australia; [McGrath, John; Mackay-Sim, Alan] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld, Australia; [Mowry, Bryan] Univ Queensland, Dept Psychiat, St Lucia, Qld, Australia	QIMR Berghofer Medical Research Institute; Queensland Centre for Mental Health Research; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Centre National de la Recherche Scientifique (CNRS); University of Queensland; Griffith University; University of Queensland	Matigian, NA (corresponding author), Queensland Inst Med Res, Bramston Terrace, Herston, Qld 4006, Australia.	Nick.Hayward@qimr.edu.au	Mackay-Sim, Alan/C-3431-2008; hayward, nick/AAV-8802-2020; anand, amit/A-7222-2009; Feron, Francois/J-5639-2014; Matigian, Nicholas A/A-4935-2009; hayward, nicholas k/C-1367-2015; McGrath, John Joseph/G-5493-2010; Feron, François/A-3947-2010; Matigian, Nicholas/AAF-9390-2020; Mowry, Bryan/G-5046-2010	Mackay-Sim, Alan/0000-0003-4446-5371; Matigian, Nicholas A/0000-0001-7735-9415; hayward, nicholas k/0000-0003-4760-1033; McGrath, John Joseph/0000-0002-4792-6068; Matigian, Nicholas/0000-0001-7735-9415; McLean, Duncan/0000-0002-1125-8424; Mowry, Bryan/0000-0002-4115-5645	Ipswich Hospital Foundation; Garnett Passe and Rodney Williams Memorial Foundation	Ipswich Hospital Foundation; Garnett Passe and Rodney Williams Memorial Foundation	This work was supported by grants from the Ipswich Hospital Foundation and the Garnett Passe and Rodney Williams Memorial Foundation. Neither agency had any further role in study design, analysis and interpretation of data, writing of the report or decision to submit the manuscript for publication.	Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; Cheung VG, 2002, NAT GENET, V32, P522, DOI 10.1038/ng1036; Chung C, 2003, SYNAPSE, V50, P29, DOI 10.1002/syn.10228; Eady JJ, 2005, PHYSIOL GENOMICS, V22, P402, DOI 10.1152/physiolgenomics.00080.2005; Feron F, 1998, ARCH OTOLARYNGOL, V124, P861, DOI 10.1001/archotol.124.8.861; Feron F, 1999, SCHIZOPHR RES, V40, P211, DOI 10.1016/S0920-9964(99)00055-9; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Kakiuchi C, 2003, NAT GENET, V35, P171, DOI 10.1038/ng1235; Mahadik SP, 1996, J PSYCHIATR RES, V30, P421, DOI 10.1016/S0022-3956(96)00025-8; MAHADIK SP, 1991, PSYCHIAT RES, V37, P309, DOI 10.1016/0165-1781(91)90066-X; Marcotte ER, 2003, PHARMACOL THERAPEUT, V100, P63, DOI 10.1016/S0163-7258(03)00086-X; MATIGIAN N, 2007, MOL PSYCHIAT; McCurdy RD, 2006, SCHIZOPHR RES, V82, P163, DOI 10.1016/j.schres.2005.10.012; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; McGrath J, 2002, ARCH GEN PSYCHIAT, V59, P458, DOI 10.1001/archpsyc.59.5.458; Middleton FA, 2005, AM J MED GENET B, V136B, P12, DOI 10.1002/ajmg.b.30171; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Miyamae Y, 1998, PSYCHIAT CLIN NEUROS, V52, P345, DOI 10.1046/j.1440-1819.1998.00386.x; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; Pongrac J, 2002, NEUROCHEM RES, V27, P1049, DOI 10.1023/A:1020904821237; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; *SIL GEN, 2002, CROSS GEN ERR MOD; Sourlingas TG, 2003, PSYCHIAT RES, V118, P55, DOI 10.1016/S0165-1781(03)00041-6; Sullivan PF, 2005, PLOS MED, V2, P614, DOI 10.1371/journal.pmed.0020212; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161; Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8; Vawter MP, 2001, BRAIN RES BULL, V55, P641, DOI 10.1016/S0361-9230(01)00522-6; Weinberger DR, 1999, BIOL PSYCHIAT, V46, P3; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499	40	43	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2412	10.1371/journal.pone.0002412	http://dx.doi.org/10.1371/journal.pone.0002412			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545665	Green Submitted, gold, Green Published			2022-12-25	WOS:000263248800049
J	Fukuyama, R; Niculaita, R; Ng, KP; Obusez, E; Sanchez, J; Kalady, M; Aung, PP; Casey, G; Sizemore, N				Fukuyama, R.; Niculaita, R.; Ng, K. P.; Obusez, E.; Sanchez, J.; Kalady, M.; Aung, P. P.; Casey, G.; Sizemore, N.			Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription	ONCOGENE			English	Article						colorectal cancer; MCC; Wnt; beta-catenin; serrated	NF-KAPPA-B; NUCLEAR EXPORT; E-CADHERIN; TNF-ALPHA; GENE; MCC; IDENTIFICATION; LOCALIZATION; EXPRESSION; PROTEIN	Mutated in colorectal cancer (MCC) was originally identified as a candidate gene for familial adenomatous polyposis (FAP) but further study identified adenomatous polyposis coli (APC) as responsible for FAP and the physiologic/pathologic roles of MCC remained poorly understood. Recently, MCC promoter methylation was discovered as a frequent early event in a distinct subset of precursor lesions and colorectal cancer (CRC) associated with the serrated CRC pathway. Here we provide the first evidence of the biological significance of MCC loss in CRC and the molecular pathways involved. We show MCC expression is dramatically decreased in many CRC cell lines and the distinct subset of sporadic CRC characterized by the CpG island methylator phenotype and BRAFV600E mutation due to promoter methylation as reported previously. Importantly, we find MCC interacts with beta-catenin and that reexpression of MCC in CRC cells specifically inhibits Wnt signaling, beta-catenin/T-cell factor/lymphoid-enhancer factor-dependent transcription and cellular proliferation even in the presence of oncogenic mutant APC. We also show that MCC is localized in the nucleus and identify two functional nuclear localization signals. Taken together, MCC is a nuclear, beta-cateninin-interacting protein that can act as a potential tumor suppressor in the serrated CRC	[Fukuyama, R.; Niculaita, R.; Ng, K. P.; Aung, P. P.; Casey, G.; Sizemore, N.] Cleveland Clin, Dept Canc Biol, Cleveland, OH 44195 USA; [Niculaita, R.; Sizemore, N.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Obusez, E.; Casey, G.; Sizemore, N.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44106 USA; [Sanchez, J.; Kalady, M.; Casey, G.; Sizemore, N.] Cleveland Clin, Dept Colorectal Surg, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sizemore, N (corresponding author), Cleveland Clin, Dept Canc Biol ND50, 9500 Euclid Ave, Cleveland, OH 44195 USA.	sizemon@ccf.org		Aung, Phyu/0000-0002-3398-0573	National Cancer Institute [CA 100748]; NATIONAL CANCER INSTITUTE [R01CA100748] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Kenneth W Kinzler, Dr Kazuo Maruyama, Dr Inder Verma, Dr Bert Vogelstein and Dr Bryan Williams for the various reagents used for this work as well as Lisa Krumroy and Alona Merkulova for technical assistance. This work was supported by grants to NS from the Cleveland Clinic Taussig Cancer Center/Scott Hamilton CARES Initiative and the National Cancer Institute Grant CA 100748.	Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; ASHTONRICKARDT PG, 1991, ONCOGENE, V6, P1881; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Eleftheriou A, 2001, J BIOL CHEM, V276, P25883, DOI 10.1074/jbc.M102656200; Fukuyama R, 2007, MOL CARCINOGEN, V46, P402, DOI 10.1002/mc.20288; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Heyer J, 1999, ONCOGENE, V18, P5325, DOI 10.1038/sj.onc.1203036; Ishikawa S, 2001, GENE, V267, P101, DOI 10.1016/S0378-1119(01)00378-X; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 2003, J CLIN PATHOL, V56, P69, DOI 10.1136/jcp.56.1.69; Jass JR, 2005, NAT CLIN PRACT ONCOL, V2, P398, DOI 10.1038/ncponc0248; Jass JR, 2002, GASTROENTEROLOGY, V123, P862, DOI 10.1053/gast.2002.35392; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kohonen-Corish MRJ, 2007, ONCOGENE, V26, P4435, DOI 10.1038/sj.onc.1210210; Lindor Noralane M., 2006, Cancer Biomarkers, V2, P5; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Matsumine A, 1996, J BIOL CHEM, V271, P10341, DOI 10.1074/jbc.271.17.10341; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; NOURRY C, 2003, SCI STKE; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Prall F, 2007, HUM PATHOL, V38, P1696, DOI 10.1016/j.humpath.2007.04.002; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Senda T, 1999, J HISTOCHEM CYTOCHEM, V47, P1149, DOI 10.1177/002215549904700907; Shinto E, 2005, LAB INVEST, V85, P257, DOI 10.1038/labinvest.3700199; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Zhang F, 2000, P NATL ACAD SCI USA, V97, P12577, DOI 10.1073/pnas.230435597; Zlobec I, 2007, J PATHOL, V212, P260, DOI 10.1002/path.2164	36	63	67	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2008	27	46					6044	6055		10.1038/onc.2008.204	http://dx.doi.org/10.1038/onc.2008.204			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	358BO	18591935	Green Accepted			2022-12-25	WOS:000259891600007
J	Alvarez, AR; Klein, A; Castro, J; Cancino, GI; Amigo, J; Mosqueira, M; Vargas, LM; Yevenes, LF; Bronfman, FC; Zanlungo, S				Alvarez, Alejandra R.; Klein, Andres; Castro, Juan; Cancino, Gonzalo I.; Amigo, Julio; Mosqueira, Matias; Vargas, Lina M.; Yevenes, L. Fernanda; Bronfman, Francisca C.; Zanlungo, Silvana			Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease	FASEB JOURNAL			English	Article						neurodegeneration; c-Abl/p73; cholesterol	ABL TYROSINE KINASE; AMYOTROPHIC-LATERAL-SCLEROSIS; UNFOLDED PROTEIN RESPONSE; CELL-DEATH; NEURONAL DEATH; ENDOPLASMIC-RETICULUM; CEREBROSPINAL-FLUID; ANTICANCER DRUG; P73; MICE	Niemann-Pick type C (NPC) disease is a fatal autosomal recessive disorder characterized by the accumulation of free cholesterol and glycosphingo-lipids in the endosomal-lysosomal system. Patients with NPC disease have markedly progressive neuronal loss, mainly of cerebellar Purkinje neurons. There is strong evidence indicating that cholesterol accumulation and trafficking defects activate apoptosis in NPC brains. The purpose of this study was to analyze the relevance of apoptosis and particularly the proapoptotic c-Abl/p73 system in cerebellar neuron degeneration in NPC disease. We used the NPC1 mouse model to evaluate c-Abl/p73 expression and activation in the cerebellum and the effect of therapy with the c-Abl-specific inhibitor imatinib. The proapoptotic c-Abl/p73 system and the p73 target genes are expressed in the cerebellums of NPC mice. Furthermore, inhibition of c-Abl with imatinib preserved Purkinje neurons and reduced general cell apoptosis in the cerebellum, improved neurological symptoms, and increased the survival of NPC mice. Moreover, this prosurvival effect correlated with reduced mRNA levels of p73 proapoptotic target genes. Our results suggest that the c-Abl/p73 pathway is involved in NPC neurodegeneration and show that treatment with c-Abl inhibitors is useful in delaying progressive neurodegeneration, supporting the use of imatinib for clinical treatment of patients with NPC disease.	[Alvarez, Alejandra R.; Cancino, Gonzalo I.; Amigo, Julio; Vargas, Lina M.; Yevenes, L. Fernanda] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago, Chile; [Klein, Andres; Castro, Juan; Mosqueira, Matias; Zanlungo, Silvana] Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Santiago, Chile; [Bronfman, Francisca C.] Pontificia Univ Catolica Chile, Joaquin V Luco CRCP, Dept Ciencias Fisiol, Fac Ciencias Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Alvarez, AR (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Alameda 340,Casilla 114-D, Santiago, Chile.	aalvarez@bio.puc.cl; silvana@med.puc.cl	Mosqueira, Matias/C-5899-2019; Cancino, Gonzalo/ABF-6049-2021	Mosqueira, Matias/0000-0001-7744-9138; Cancino, Gonzalo/0000-0001-8697-7282; amigo, julio/0000-0002-6481-8034; Zanlungo, Silvana/0000-0001-8383-9829; KLEIN, ANDRES/0000-0002-9951-2174; Alvarez Rojas, Alejandra/0000-0002-8129-9280	Ara Parseghian Medical Research Foundation; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1040782, 1080221, 1030415, 1070622]	Ara Parseghian Medical Research Foundation; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by grants from the Ara Parseghian Medical Research Foundation and by Fondo Nacional de Desarrollo Cientifico y Tecnologico (grants 1040782 and 1080221 to A.R.A. and 1030415 and 1070622 to S.Z.). The authors thank the Ara Parseghian Medical Research Foundation for their continued support.	Alvarez AR, 2004, NEUROBIOL DIS, V17, P326, DOI 10.1016/j.nbd.2004.06.007; Amigo L, 2002, HEPATOLOGY, V36, P819, DOI 10.1053/jhep.2002.35617; Bascunan-Castillo Eric C., 2004, Journal of Applied Genetics, V45, P461; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Brady RO, 2006, REJUV RES, V9, P237, DOI 10.1089/rej.2006.9.237; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Bu BT, 2002, J NEUROSCI, V22, P6515; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Cabrera-Socorro A, 2006, EUR J NEUROSCI, V23, P2109, DOI 10.1111/j.1460-9568.2006.04750.x; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Erickson RP, 2002, J NEUROSCI RES, V68, P738, DOI 10.1002/jnr.10257; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Feng B, 2003, P NATL ACAD SCI USA, V100, P10423, DOI 10.1073/pnas.1732494100; Garver WS, 2007, AM J MED GENET A, V143A, P1204, DOI 10.1002/ajmg.a.31735; Garver WS, 2007, J CELL BIOCHEM, V101, P498, DOI 10.1002/jcb.21200; Gong JG, 1999, NATURE, V399, P806; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; Hoshino M, 2006, J CELL BIOL, V172, P589, DOI 10.1083/jcb.200509132; Huang JQ, 1997, HUM MOL GENET, V6, P1879, DOI 10.1093/hmg/6.11.1879; Ito Y, 2001, MOL CELL BIOL, V21, P6233, DOI 10.1128/MCB.21.18.6233-6242.2001; Jacobs WB, 2004, NEUROSCIENTIST, V10, P443, DOI 10.1177/1073858404263456; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Koh CHV, 2006, CELL SIGNAL, V18, P1572, DOI 10.1016/j.cellsig.2005.12.006; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; Liscum L, 1998, CURR OPIN LIPIDOL, V9, P131, DOI 10.1097/00041433-199804000-00009; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Oyama K, 2006, TOHOKU J EXP MED, V209, P263, DOI 10.1620/tjem.209.263; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Patterson MC, 2003, NEUROLOGIST, V9, P301, DOI 10.1097/01.nrl.0000094627.78754.5b; Pentchev P., 1995, METABOLIC MOL BASES, P2625; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pozniak CD, 2002, J NEUROSCI, V22, P9800; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Simakajornboon N, 2001, BRAIN RES, V895, P111, DOI 10.1016/S0006-8993(01)02054-6; Sullivan D, 2005, AM J PSYCHIAT, V162, P1021, DOI 10.1176/appi.ajp.162.5.1021-a; TANAKA J, 1988, J NEUROPATH EXP NEUR, V47, P291, DOI 10.1097/00005072-198805000-00008; Terrinoni A, 2004, ONCOGENE, V23, P3721, DOI 10.1038/sj.onc.1207342; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029; Tsai KKC, 2003, CANCER RES, V63, P3418; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Voikar V, 2002, BEHAV BRAIN RES, V132, P1, DOI 10.1016/S0166-4328(01)00380-1; Walkley SU, 2004, BBA-MOL CELL BIOL L, V1685, P48, DOI 10.1016/j.bbalip.2004.08.011; Walterfang M, 2006, J NEUROPSYCH CLIN N, V18, P158, DOI 10.1176/appi.neuropsych.18.2.158; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Wilson C, 2004, NEUROPATH APPL NEURO, V30, P19, DOI 10.1046/j.0305-1846.2003.00496.x; Wolff NC, 2003, BLOOD, V101, P5010, DOI 10.1182/blood-2002-10-3059; Wu YP, 2005, MOL GENET METAB, V84, P9, DOI 10.1016/j.ymgme.2004.08.017; Yu WX, 2005, J BIOL CHEM, V280, P11731, DOI 10.1074/jbc.M412898200; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zhang SXL, 2003, FASEB J, V17, P1709, DOI 10.1096/fj.02-1111fje; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	62	75	83	5	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3617	3627		10.1096/fj.07-102715	http://dx.doi.org/10.1096/fj.07-102715			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18591368				2022-12-25	WOS:000259642600023
J	Chen, JQ; Hui, ST; Couto, FM; Mungrue, IN; Davis, DB; Attie, AD; Lusis, AJ; Davis, RA; Shalev, A				Chen, Junqin; Hui, Simon T.; Couto, Francesca M.; Mungrue, Imran N.; Davis, Dawn B.; Attie, Alan D.; Lusis, Aldons J.; Davis, Roger A.; Shalev, Anath			Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes	FASEB JOURNAL			English	Article						apoptosis; islets; obesity; insulin sensitivity; bTKO; TXNIP	UP-REGULATED PROTEIN-1; INSULIN-RESISTANCE; GLUCOSE; MICE; STREPTOZOTOCIN; APOPTOSIS; EXPRESSION; TXNIP; SUSCEPTIBILITY; AUTOIMMUNE	Pancreatic beta-cell loss through apoptosis represents a key factor in the pathogenesis of diabetes; however, no effective approaches to block this process and preserve endogenous beta-cell mass are currently available. To study the role of thioredoxin-interacting protein (TXNIP), a proapoptotic beta-cell factor we recently identified, we used HcB-19 (TXNIP nonsense mutation) and beta-cell-specific TXNIP knockout (bTKO) mice. Interestingly, HcB-19 mice demonstrate increased adiposity, but have lower blood glucose levels and increased pancreatic beta-cell mass (as assessed by morphometry). Moreover, HcB-19 mice are resistant to streptozotocin-induced diabetes. When intercrossed with obese, insulin-resistant, and diabetic mice, double-mutant BTBRlep(ob/ob) txnip(hcb/hcb) are even more obese, but are protected against diabetes and beta-cell apoptosis, resulting in a 3-fold increase in beta-cell mass. Beta-cell-specific TXNIP deletion also enhanced beta-cell mass (P < 0.005) and protected against diabetes, and terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL) revealed a similar to 50-fold reduction in beta-cell apoptosis in streptozotocin-treated bTKO mice. We further discovered that TXNIP deficiency induces Akt/Bcl-xL signaling and inhibits mitochondrial beta-cell death, suggesting that these mechanisms may mediate the beta-cell protective effects of TXNIP deficiency. These results suggest that lowering beta-cell TXNIP expression could serve as a novel strategy for the treatment of type 1 and type 2 diabetes by promoting endogenous beta-cell survival.	[Chen, Junqin; Couto, Francesca M.; Davis, Dawn B.; Shalev, Anath] Univ Wisconsin, Dept Med, Madison, WI 53792 USA; [Davis, Dawn B.; Attie, Alan D.] Univ Wisconsin, Dept Biochem, Madison, WI 53792 USA; [Hui, Simon T.; Davis, Roger A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Mungrue, Imran N.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; California State University System; San Diego State University; University of California System; University of California Los Angeles	Shalev, A (corresponding author), Univ Wisconsin, Endocrine Sect, Clin Sci Ctr H4 526, 600 Highland Ave, Madison, WI 53792 USA.	as7@medicine.wisc.edu	Davis, Dawn/B-1624-2013	Davis, Dawn/0000-0002-0239-4715; Mungrue, Imran/0000-0002-0870-7161	American Diabetes Association [ADA; 7-07-CD-22]; Juvenile Diabetes Research Foundation [1-2007-790]; National Institutes of Health [NIH; R01DK-078752]; ADA [1-05-IN-06]; NIH [R01HL-51648]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078752] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Geetu Saxena, Hyunjoo Cha-Molstad, and Mary Rabaglia for their excellent technical assistance. This work was Supported by grants from the American Diabetes Association (ADA; 7-07-CD-22), Juvenile Diabetes Research Foundation (1-2007-790) and National Institutes of Health (NIH; R01DK-078752) to A.S. and from ADA (1-05-IN-06) and NIH (R01HL-51648) to R.D.	Babaya N, 2005, BIOCHEM BIOPH RES CO, V328, P158, DOI 10.1016/j.bbrc.2004.12.149; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; BONNERWEIR S, 1994, RECENT PROG HORM RES, V49, P91; Cardinal JW, 2001, MOL CELL BIOL, V21, P5605, DOI 10.1128/MCB.21.16.5605-5613.2001; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; Clee Susanne M, 2005, Am J Ther, V12, P491, DOI 10.1097/01.mjt.0000178781.89789.25; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Herold KC, 1996, J IMMUNOL, V156, P3521; Hotta M, 1998, J EXP MED, V188, P1445, DOI 10.1084/jem.188.8.1445; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Lan H, 2003, DIABETES, V52, P688, DOI 10.2337/diabetes.52.3.688; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Mandrup-Poulsen T, 2003, BIOCHEM PHARMACOL, V66, P1433, DOI 10.1016/S0006-2952(03)00494-5; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Minn AH, 2005, BIOCHEM BIOPH RES CO, V336, P770, DOI 10.1016/j.bbrc.2005.08.161; Minn AH, 2005, MOL ENDOCRINOL, V19, P794, DOI 10.1210/me.2004-0119; Muller A, 2002, IMMUNOBIOLOGY, V205, P35, DOI 10.1078/0171-2985-00109; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nishiyama A, 2001, IUBMB LIFE, V52, P29, DOI 10.1080/15216540252774739; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; STOCHR JP, 2000, DIABETES, V49, P1946; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699	39	159	164	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3581	3594		10.1096/fj.08-111690	http://dx.doi.org/10.1096/fj.08-111690			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18552236	Green Published			2022-12-25	WOS:000259642600020
J	Nechama, M; Ben-Dov, IZ; Briata, P; Gherzi, R; Naveh-Many, T				Nechama, Morris; Ben-Dov, Iddo Z.; Briata, Paola; Gherzi, Roberto; Naveh-Many, Tally			The mRNA decay promoting factor K-homology splicing regulator protein post-transcriptionally determines parathyroid hormone mRNA levels	FASEB JOURNAL			English	Article						AUF1; Unr; ARE; calcium; phosphorus; chronic kidney disease	AU-RICH ELEMENT; GENE-EXPRESSION; 3'-UNTRANSLATED REGION; BINDING PROTEIN; KSRP; CALCIUM; IDENTIFICATION; DEGRADATION; STABILITY; EXOSOME	Serum calcium and phosphate concentrations and experimental chronic kidney failure control parathyroid hormone (PTH) gene expression post-transcriptionally through regulated binding of the transacting proteins AUF1 and upstream of N-ras (Unr) to an AU-rich element (ARE) in PTH mRNA 3'-untranslated region (3'UTR). We show that the mRNA decay promoting K-homology splicing regulator protein (KSRP) binds to PTH mRNA in intact parathyroid glands and in transfected cells. This binding is decreased in glands from calcium-depleted or experimental chronic kidney failure rats in which PTH mRNA is more stable compared to parathyroid glands from control and phosphorus-depleted rats in which PTH mRNA is less stable. PTH mRNA decay depends on the KSRP-recruited exosome in parathyroid extracts. In transfected cells, KSRP overexpression and knockdown experiments show that KSRP decreases PTH mRNA stability and steady-state levels through the PTH mRNA ARE. Overexpression of isoform p45 of the PTH mRNA stabilizing protein AUF1 blocks KSRP-PTH mRNA binding and partially prevents the KSRP mediated decrease in PTH mRNA levels. Therefore, calcium or phosphorus depletion, as well as chronic kidney failure, regulate the interaction of KSRP and AUF1 with PTH mRNA and its half-life. Our data indicate a novel role for KSRP in PTH gene expression.	[Nechama, Morris; Ben-Dov, Iddo Z.; Naveh-Many, Tally] Hadassah Hebrew Univ, Minerva Ctr Calcium & Bone Metab, Med Ctr, Serv Nephrol, IL-91120 Jerusalem, Israel; [Briata, Paola; Gherzi, Roberto] Ist Nazl Ric Canc, I-16132 Genoa, Italy	Hebrew University of Jerusalem; Hadassah University Medical Center; University of Genoa; IRCCS AOU San Martino IST	Naveh-Many, T (corresponding author), Hadassah Hebrew Univ, Minerva Ctr Calcium & Bone Metab, Med Ctr, Serv Nephrol, POB 12000, IL-91120 Jerusalem, Israel.	tally@cc.huji.ac.il	Ben-Dov, Iddo/F-3282-2010; Briata, Paola/AAC-6039-2020; Gherzi, Roberto/AAA-7256-2020	Ben-Dov, Iddo/0000-0002-9180-3604; Briata, Paola/0000-0003-3470-0454; Gherzi, Roberto/0000-0001-8654-0611	Italian Istituto Superiore di Sanita [526D/39]; Associazione Italiana Ricerca sul Cancro; German Federal Ministry of Education and Research (BMBF)	Italian Istituto Superiore di Sanita; Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Calcium and Bone Metabolism (T.N.M.), by a grant from the Italian Istituto Superiore di Sanita (526D/39), an American-Italian Senior Scholar Consultancy 2006/2007 (P.B), and by a grant from the Associazione Italiana Ricerca sul Cancro (R.G.). Minerva is funded through the German Federal Ministry of Education and Research (BMBF).	Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bell O, 2005, MOL ENDOCRINOL, V19, P516, DOI 10.1210/me.2004-0108; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Dinur M, 2006, MOL ENDOCRINOL, V20, P1652, DOI 10.1210/me.2005-0333; Epstein E, 2000, J CLIN INVEST, V105, P505, DOI 10.1172/JCI8557; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Kilav R, 2004, J BIOL CHEM, V279, P2109, DOI 10.1074/jbc.M305302200; KILAV R, 1995, J CLIN INVEST, V96, P327, DOI 10.1172/JCI118038; Kilav R, 2001, J BIOL CHEM, V276, P8727, DOI 10.1074/jbc.M005471200; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; Levi R, 2006, J AM SOC NEPHROL, V17, P107, DOI 10.1681/ASN.2005070679; LEVY S, 1991, P NATL ACAD SCI USA, V88, P3319, DOI 10.1073/pnas.88.8.3319; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Moallem E, 1998, J BIOL CHEM, V273, P5253, DOI 10.1074/jbc.273.9.5253; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Naveh-Many T, 2007, CURR OPIN NEPHROL HY, V16, P305, DOI 10.1097/MNH.0b013e3281c55ede; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Ruggiero T, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-28; Sela-Brown A, 2000, J BIOL CHEM, V275, P7424, DOI 10.1074/jbc.275.10.7424; SILVER J, 2002, PRINCIPLES BONE BIOL, P407; Snee M, 2002, J CELL SCI, V115, P4661, DOI 10.1242/jcs.00137; TADESSE H, 2007, HUM MOL GENET, P506; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001	30	47	49	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3458	3468		10.1096/fj.08-107250	http://dx.doi.org/10.1096/fj.08-107250			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18583400				2022-12-25	WOS:000259642600008
J	Venkatesan, B; Ghosh-Choudhury, N; Das, F; Mahimainathan, L; Kamat, A; Kasinath, BS; Abboud, HE; Choudhury, GG				Venkatesan, Balachandar; Ghosh-Choudhury, Nandini; Das, Falguni; Mahimainathan, Lenin; Kamat, Amrita; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh			Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B	FASEB JOURNAL			English	Article						SIRT1; Akt kinase; CDK2	INDUCED DNA-SYNTHESIS; PROTEIN-TYROSINE PHOSPHATASES; GROWTH-FACTOR; INSULIN SENSITIVITY; C-FOS; CALORIC RESTRICTION; AKT KINASE; YEAST SIR2; CYCLIN D1; IN-VIVO	Mesangioproliferative glomerulonephritis is associated with overactive PDGF receptor signal transduction. We show that the phytoalexin resveratrol dose dependently inhibits PDGF-induced DNA synthesis in mesangial cells with an IC50 of 10 mu M without inducing apoptosis. Remarkably, the increased SIRT1 deacetylase activity induced by resveratrol was not necessary for this inhibitory effect. Resveratrol significantly blocked PDGF-stimulated c-Src and Akt kinase activation, resulting in reduced cyclin D1 expression and attenuated pRb phosphorylation and cyclin-dependent kinase-2 (CDK2) activity. Furthermore, resveratrol inhibited PDGFR phosphorylation at the PI 3 kinase and Grb-2 binding sites tyrosine-751 and tyrosine-716, respectively. This deficiency in PDGFR phosphorylation resulted in significant inhibition of PI 3 kinase and Erk1/2 MAPK activity. Interestingly, resveratrol increased the activity of protein tyrosine phosphatase PTP1B, which dephosphorylates PDGF-stimulated phosphorylation at tyrosine-751 and tyrosine-716 on PDGFR with concomitant reduction in Akt and Erk1/2 kinase activity. PTP1B significantly inhibited PDGF-induced DNA synthesis without inducing apoptosis. These results for the first time provide evidence that the stilbene resveratrol targets PTP1B to inhibit PDGFR mitogenic signaling.	[Venkatesan, Balachandar; Das, Falguni; Mahimainathan, Lenin; Kamat, Amrita; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, OBrien Kidney Res Ctr, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, OBrien Kidney Res Ctr, Dept Pathol, San Antonio, TX 78229 USA; [Kamat, Amrita; Choudhury, Goutam Ghosh] Audie L Murphy Mem Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78284 USA; [Ghosh-Choudhury, Nandini; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, OBrien Kidney Res Ctr, Dept Med, Mail Code 7882,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu		/0000-0001-5077-3552	National Institutes of Health (NIH) [RO1 DK 50190]; Juvenile Diabetes Research Foundation; NIH [RO1 AR52425, RO1 DK 33665]; VA Merit Review and Morrison Trust; VA VISN; American Diabetes Association [077295]; VA Research Service Merit; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033665, R01DK077295, R01DK050190] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review and Morrison Trust(US Department of Veterans Affairs); VA VISN; American Diabetes Association(American Diabetes Association); VA Research Service Merit(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Brent Wagner for critically reading the manuscript. This work was supported by National Institutes of Health (NIH) grant RO1 DK 50190, the Juvenile Diabetes Research Foundation, and a VA Merit Review grant to G.G.C., who is a research career scientist in the Department of Veterans Affairs. N.G.C. is supported by NIH RO1 AR52425 and VA Merit Review and Morrison Trust grants. A.K. is a recipient of a VA VISN grant. B.S.K. is supported by grants from the NIH O'Brien Kidney Center, NIH RO1 DK 077295, the American Diabetes Association, and a VA Research Service Merit. Review grant. H.E.A. is supported by NIH RO1 DK 33665 and VA Merit Review grants.	ABBOUD HE, 1995, ANNU REV PHYSIOL, V57, P297; Ahmad KA, 2007, MOL CANCER THER, V6, P1006, DOI 10.1158/1535-7163.MCT-06-0491; Ahmad N, 2001, CLIN CANCER RES, V7, P1466; Alkhalaf M, 2007, PHARMACOLOGY, V80, P134, DOI 10.1159/000103253; Alkhalaf M, 2006, FREE RADICAL BIO MED, V41, P318, DOI 10.1016/j.freeradbiomed.2006.04.019; ARVIDSSON AK, 1994, MOL CELL BIOL, V14, P6715, DOI 10.1128/MCB.14.10.6715; Aziz MH, 2006, MOL CANCER THER, V5, P1335, DOI 10.1158/1535-7163.MCT-05-0526; Banerjee S, 2002, CANCER RES, V62, P4945; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chang YZ, 2006, ARTERIOSCL THROM VAS, V26, P501, DOI 10.1161/01.ATV.0000201070.71787.b8; Chiara F, 2004, J BIOL CHEM, V279, P19732, DOI 10.1074/jbc.M314070200; CHOUDHURY GG, 1991, J BIOL CHEM, V266, P8068; CHOUDHURY GG, 1994, KIDNEY INT, V46, P37, DOI 10.1038/ki.1994.242; Choudhury GG, 2003, CELL SIGNAL, V15, P161, DOI 10.1016/S0898-6568(02)00057-8; Choudhury GG, 2001, J BIOL CHEM, V276, P35636, DOI 10.1074/jbc.M100946200; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Choudhury GG, 1997, AM J PHYSIOL-RENAL, V273, pF931, DOI 10.1152/ajprenal.1997.273.6.F931; Choudhury GG, 2000, KIDNEY INT, V57, P908, DOI 10.1046/j.1523-1755.2000.00907.x; Choudhury GG, 2006, CELL SIGNAL, V18, P1854, DOI 10.1016/j.cellsig.2006.02.003; Choundhury GG, 1999, J BIOL CHEM, V274, P10897; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Das F, 2007, FEBS LETT, V581, P5259, DOI 10.1016/j.febslet.2007.10.014; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; de Boer VCJ, 2006, MECH AGEING DEV, V127, P618, DOI 10.1016/j.mad.2006.02.007; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Dorrie J, 2001, CANCER RES, V61, P4731; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Egawa K, 2001, J BIOL CHEM, V276, P10207, DOI 10.1074/jbc.M009489200; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Floege J, 1999, AM J PATHOL, V154, P169, DOI 10.1016/S0002-9440(10)65263-7; FLOEGE J, 1993, J CLIN INVEST, V92, P2952, DOI 10.1172/JCI116918; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Fulda S, 2006, CANCER DETECT PREV, V30, P217, DOI 10.1016/j.cdp.2006.03.007; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Gilbert RE, 2001, KIDNEY INT, V59, P1324, DOI 10.1046/j.1523-1755.2001.0590041324.x; Godichaud S, 2006, INT J BIOCHEM CELL B, V38, P629, DOI 10.1016/j.biocel.2005.11.001; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Heldin CH, 2002, ARCH BIOCHEM BIOPHYS, V398, P284, DOI 10.1006/abbi.2001.2707; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jefferson JA, 1999, J NEPHROL, V12, P297; JOHNSON RJ, 1992, J EXP MED, V175, P1413, DOI 10.1084/jem.175.5.1413; Kaeberlein M, 2007, AGING CELL, V6, P415, DOI 10.1111/j.1474-9726.2007.00314.x; Kaeberlein M, 2006, NATURE, V444, P280, DOI 10.1038/nature05308; Kim AL, 2006, EXP DERMATOL, V15, P538, DOI 10.1111/j.1600-0625.2006.00445.x; KIYOMOTO H, 1994, FEBS LETT, V353, P217, DOI 10.1016/0014-5793(94)01039-0; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kuwajerwala N, 2002, CANCER RES, V62, P2488; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Liu YL, 2004, BIOCHEM PHARMACOL, V67, P777, DOI 10.1016/j.bcp.2003.09.025; Mahimainathan L, 2005, AM J PHYSIOL-RENAL, V289, pF72, DOI 10.1152/ajprenal.00277.2004; Mgbonyebi OP, 1998, INT J ONCOL, V12, P865; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakamura H, 2001, KIDNEY INT, V59, P2134, DOI 10.1046/j.1523-1755.2001.0590062134.x; Olson ER, 2005, AM J PHYSIOL-HEART C, V288, pH1131, DOI 10.1152/ajpheart.00763.2004; Paternot S, 2006, CELL CYCLE, V5, P61, DOI 10.4161/cc.5.1.2265; Pozo-Guisado E, 2004, INT J CANCER, V109, P167, DOI 10.1002/ijc.11720; Rahman I, 2006, BIOCHEM PHARMACOL, V72, P1439, DOI 10.1016/j.bcp.2006.07.004; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimizu S, 2002, ENDOCRINOLOGY, V143, P4563, DOI 10.1210/en.2002-220517; SHULTZ PJ, 1988, AM J PHYSIOL, V255, pF674, DOI 10.1152/ajprenal.1988.255.4.F674; SILVER BJ, 1989, P NATL ACAD SCI USA, V86, P1056, DOI 10.1073/pnas.86.3.1056; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; Venkatesan BA, 2006, CELL SIGNAL, V18, P508, DOI 10.1016/j.cellsig.2005.05.022; Venkatesan B, 2007, J CELL PHYSIOL, V211, P457, DOI 10.1002/jcp.20953; WENZEL UO, 1995, J CLIN INVEST, V95, P1244, DOI 10.1172/JCI117774; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zabolotny JM, 2007, CELL METAB, V6, P247, DOI 10.1016/j.cmet.2007.09.004; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhang W, 2007, J NEURO-ONCOL, V81, P231, DOI 10.1007/s11060-006-9226-x	94	33	35	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3469	3482		10.1096/fj.08-109488	http://dx.doi.org/10.1096/fj.08-109488			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18567737	Green Published			2022-12-25	WOS:000259642600009
J	Jacquet, E; Girard, JM; Ramaen, O; Pamlard, O; Levaique, H; Betton, JM; Dassa, E; Chesneau, O				Jacquet, Eric; Girard, Jean-Marie; Ramaen, Odile; Pamlard, Olivier; Levaique, Helene; Betton, Jean-Michel; Dassa, Elie; Chesneau, Olivier			ATP hydrolysis and pristinamycin IIA inhibition of the Staphylococcus aureus vga(A), a dual ABC protein involved in streptogramin a resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTERS; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; CARBOXYLATE RESIDUES; ERYTHROMYCIN RESISTANCE; SUBSTRATE-SPECIFICITY; MULTIDRUG-RESISTANCE; STRUCTURAL BASIS; CATALYTIC CYCLE; P-GLYCOPROTEIN	In Gram-positive bacteria, a large subfamily of dual ATP-binding cassette proteins confers acquired or intrinsic resistance to macrolide, lincosamide, and streptogramin antibiotics by a far from well understood mechanism. Here, we report the first biochemical characterization of one such protein, Vga(A), which is involved in streptogramin A (SgA) resistance among staphylococci. Vga(A) is composed of two nucleotide-binding domains (NBDs), separated by a charged linker, with a C-terminal extension and without identified transmembrane domains. Highly purified Vga(A) displays a strong ATPase activity (K-m = 78 mu M, V-m = 6.8 min(-1)) that was hardly inhibited by orthovanadate. Using mutants of the conserved catalytic glutamate residues, the two NBDs of Vga(A) were shown to contribute unequally to the total ATPase activity, the mutation at NBD2 being more detrimental than the other. ATPase activity of both catalytic sites was essential for Vga(A) biological function because each single Glu mutant was unable to confer SgA resistance in the staphylococcal host. Of great interest, Vga(A) ATPase was specifically inhibited in a non-competitive manner by the SgA substrate, pristinamycin IIA (PIIA). A deletion of the last 18 amino acids of Vga(A) slightly affected the ATPase activity without modifying the PIIA inhibition values. In contrast, this deletion reduced 4-fold the levels of SgA resistance. Altogether, our results suggest a role for the C terminus in regulation of the SgA antibiotic resistance mechanism conferred by Vga(A) and demonstrate that this dual ATP-binding cassette protein interacts directly and specifically with PIIA, its cognate substrate.	[Jacquet, Eric; Girard, Jean-Marie; Ramaen, Odile; Pamlard, Olivier; Levaique, Helene] CNRS, Inst Chim Subst Nat, UPR 2301, F-91190 Gif Sur Yvette, France; [Dassa, Elie; Chesneau, Olivier] Inst Pasteur, CNRS, Unite Membranes Bacteriennes, URA 2172, F-75724 Paris, France; [Betton, Jean-Michel] Inst Pasteur, CNRS, Unite Biochim Struct, URA 2172, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Jacquet, E (corresponding author), CNRS, Inst Chim Subst Nat, UPR 2301, Ave Terrasse, F-91190 Gif Sur Yvette, France.	Eric.Jacquet@icsn.cnrs-gif.fr		JACQUET, Eric/0000-0001-6366-8436	Institut de Chimie des Substances Naturelles; CNRS; Gif-sur-Yvette, France	Institut de Chimie des Substances Naturelles; CNRS(Centre National de la Recherche Scientifique (CNRS)); Gif-sur-Yvette, France	We are grateful to Cecile Wandersman and Jean-Yves Lallemand for their continuous support and helpful discussions during this work. We thank Jean-Pierre Lecaer (Institut de Chimie des Substances Naturelles, CNRS, Gif-sur-Yvette, France) for performing mass spectrometry measurements, and Cecile Wandersman and Christina Sizun for critical reading of the manuscript.	ALLIGNET J, 1992, GENE, V117, P45, DOI 10.1016/0378-1119(92)90488-B; Barriere JC, 1998, CURR PHARM DESIGN, V4, P155; Benabdelhak H, 2005, BIOCHEM J, V386, P489, DOI 10.1042/BJ20041282; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Carrier I, 2008, FEBS J, V275, P3312, DOI 10.1111/j.1742-4658.2008.06479.x; Casey AL, 2007, INT J ANTIMICROB AG, V29, pS23, DOI 10.1016/S0924-8579(07)72175-1; Chesneau O, 2005, ANTIMICROB AGENTS CH, V49, P973, DOI 10.1128/AAC.49.3.973-980.2005; CRANE RK, 1953, J BIOL CHEM, V201, P235; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; ELSOLH N, 1986, ANTIMICROB AGENTS CH, V30, P161, DOI 10.1128/AAC.30.1.161; Gurk-Turner C, 2000, Proc (Bayl Univ Med Cent), V13, P83; Harms JM, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-4; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Huda N, 2003, ANTIMICROB AGENTS CH, V47, P2413, DOI 10.1128/AAC.47.8.2413-2417.2003; HUNKE S, 1995, BIOCHEM BIOPH RES CO, V216, P589, DOI 10.1006/bbrc.1995.2663; Jin HJ, 2002, PROTEIN EXPRES PURIF, V25, P149, DOI 10.1006/prep.2002.1621; KASHIWAGI K, 1995, J BIOL CHEM, V270, P25377, DOI 10.1074/jbc.270.43.25377; Kehoe LE, 2003, J BIOL CHEM, V278, P29963, DOI 10.1074/jbc.M303766200; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Korczynska M, 2007, P NATL ACAD SCI USA, V104, P10388, DOI 10.1073/pnas.0701809104; Leclercq R, 1998, LANCET, V352, P591, DOI 10.1016/S0140-6736(05)79570-2; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Mendez C, 2001, RES MICROBIOL, V152, P341, DOI 10.1016/S0923-2508(01)01205-0; Mukhtar TA, 2005, CHEM REV, V105, P529, DOI 10.1021/cr030110z; Murat D, 2006, J BIOL CHEM, V281, P6850, DOI 10.1074/jbc.M509926200; Ng J, 2005, J ANTIMICROB CHEMOTH, V55, P1008, DOI 10.1093/jac/dki108; Novotna G, 2006, ANTIMICROB AGENTS CH, V50, P4070, DOI 10.1128/AAC.00799-06; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Payen LF, 2003, J BIOL CHEM, V278, P38537, DOI 10.1074/jbc.M305786200; Poelarends GJ, 2000, DRUG RESIST UPDATE, V3, P330, DOI 10.1054/drup.2000.0173; RICHARME G, 1993, J BIOL CHEM, V268, P9473; Roge J, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-18; ROSS JI, 1990, MOL MICROBIOL, V4, P1207, DOI 10.1111/j.1365-2958.1990.tb00696.x; Ross JI, 1996, GENE, V183, P143, DOI 10.1016/S0378-1119(96)00541-0; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P14138, DOI 10.1021/bi001128w; Vannuffel P, 1996, DRUGS, V51, P20, DOI 10.2165/00003495-199600511-00006; Verdon G, 2003, J MOL BIOL, V334, P255, DOI 10.1016/j.jmb.2003.08.065; Zaitseva J, 2005, BIOCHEM SOC T, V33, P990, DOI 10.1042/BST0330990; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	47	29	30	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25332	25339		10.1074/jbc.M800418200	http://dx.doi.org/10.1074/jbc.M800418200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18562322	hybrid			2022-12-25	WOS:000259012700027
J	Feijoo-Cuaresma, M; Mendez, F; Maqueda, A; Esteban, MA; Naranjo-Suarez, S; Castellanos, MC; del Cerro, MH; Vazquez, SN; Garcia-Pardo, A; Landazuri, MO; Calzada, MJ				Feijoo-Cuaresma, Monica; Mendez, Fernando; Maqueda, Alfredo; Esteban, Miguel A.; Naranjo-Suarez, Salvador; Castellanos, Maria C.; Hernandez del Cerro, Mercedes; Vazquez, Silvia N.; Garcia-Pardo, Angeles; Landazuri, Manuel O.; Calzada, Maria J.			Inadequate Activation of the GTPase RhoA Contributes to the Lack of Fibronectin Matrix Assembly in von Hippel-Lindau Protein-defective Renal Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HYPOXIA-INDUCIBLE FACTORS; CARCINOMA-CELLS; BARRIER FUNCTION; DOWN-REGULATION; GENE-PRODUCT; E-CADHERIN; HIF-ALPHA; VHL; GROWTH	The von Hippel-Lindau (VHL) tumor suppressor gene regulates extracellular matrix deposition. InVHLnegative renal cancer cells, VHL(-), the lack of fibronectin matrix assembly is thought to promote and maintain tumor angiogenesis allowing vessels to infiltrate tumors. Therefore, and considering the importance of this process in tumor growth, we aimed to study why VHL(-) renal cancer cells fail to form a proper extracellular matrix. Our results showed that VHL(-) cells were not defective in fibronectin production and that the fibronectin produced by these cells was equally functional in promoting cell adhesion and matrix assembly as that produced by VHL(-) cells. We have previously reported that VHL(-) cells fail to form beta 1 integrin fibrillar adhesions and have a diminished organization of actin stress fibers; therefore, we aimed to study if the small GTPase family is involved in this process. We found that activation of the RhoA GTPase was defective in VHL(-) cells, and this was possibly mediated by an increased activation of its inhibitor, p190RhoGAP. Additionally, the expression of constitutively active RhoA in VHL(-) cells resulted in formation of a fibronectin matrix. These results strongly suggest an important role for RhoA in some of the defects observed in renal cancer cells.	[Feijoo-Cuaresma, Monica; Mendez, Fernando; Naranjo-Suarez, Salvador; Castellanos, Maria C.; Vazquez, Silvia N.; Landazuri, Manuel O.; Calzada, Maria J.] Univ Autonoma Madrid, Dept Med, Hosp Princesa, Serv Immunol, Madrid 28006, Spain; [Maqueda, Alfredo; Hernandez del Cerro, Mercedes; Garcia-Pardo, Angeles] CSIC, Ctr Invest Biol, Dept Fisiopathol Celular & Mol, Madrid 28040, Spain; [Esteban, Miguel A.] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510663, Guangdong, Peoples R China	Autonomous University of Madrid; Hospital de La Princesa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Calzada, MJ (corresponding author), Univ Autonoma Madrid, Dept Med, Hosp Princesa, Serv Immunol, Diego de Leon 62, Madrid 28006, Spain.	mcalzada.hlpr@salud.madrid.org	Suarez, Salvador Naranjo/K-8450-2017; Garcia Pardo, Angeles/G-5987-2015	Suarez, Salvador Naranjo/0000-0002-7038-0753; Garcia Pardo, Angeles/0000-0001-5577-2954; Vazquez Cuesta, Silvia Noemi/0000-0002-9065-9487; Maqueda Fernandez, Alfredo/0000-0002-0117-5422	Ministerio de Educacion y Ciencia [SAF2006-04013, SAF2007-60592]; Ministerio de Sanidad y Consumo [PI060400]; Fundacion de Investigacion Medica Mutua Madrilena;  [RECAVA C03/01]	Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Fundacion de Investigacion Medica Mutua Madrilena; 	This work was supported in part by SAF2006-04013 from the Ministerio de Educacion y Ciencia (MEC) (to M. J. C.), SAF2007-60592 and RECAVA C03/01 (to M. O. L.), and PI060400 from the Ministerio de Sanidad y Consumo and the Fundacion de Investigacion Medica Mutua Madrilena (to A. G. -P.).	Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bindra RS, 2002, CANCER RES, V62, P3014; Bluyssen HAR, 2004, FEBS LETT, V556, P137, DOI 10.1016/S0014-5793(03)01392-9; Cali G, 1999, J CELL SCI, V112, P957; Calzada MJ, 2006, CANCER RES, V66, P1553, DOI 10.1158/0008-5472.CAN-05-3236; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Davidowitz EJ, 2001, MOL CELL BIOL, V21, P865, DOI 10.1128/MCB.21.3.865-874.2001; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Esteban MA, 2006, J AM SOC NEPHROL, V17, P1801, DOI 10.1681/ASN.2006020181; Esteban-Barragan MA, 2002, CANCER RES, V62, P2929; Grosfeld A, 2007, J BIOL CHEM, V282, P13264, DOI 10.1074/jbc.M611648200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harrington EO, 2005, EXP CELL RES, V308, P407, DOI 10.1016/j.yexcr.2005.05.005; He Z, 2004, CANCER GENET CYTOGEN, V152, P89, DOI 10.1016/j.cancergencyto.2003.11.001; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; Hsu T, 2006, J BIOL CHEM, V281, P12069, DOI 10.1074/jbc.M511621200; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Iturrioz X, 2006, BIOCHEM J, V397, P109, DOI 10.1042/BJ20060354; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang YD, 2003, MOL CANCER RES, V1, P453; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kamada M, 2001, CANCER RES, V61, P4184; Kim M, 2004, BIOCHEM BIOPH RES CO, V320, P945, DOI 10.1016/j.bbrc.2004.06.042; Koochekpour S, 1999, MOL CELL BIOL, V19, P5902; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; Kurban G, 2007, ONCOGENE, V13; Lewis MD, 2003, ONCOGENE, V22, P3992, DOI 10.1038/sj.onc.1206683; Li XY, 2003, ONCOL RES, V13, P323; Lolkema MP, 2007, FEBS LETT, V581, P4571, DOI 10.1016/j.febslet.2007.08.050; LOLKEMA MP, 2007, EUR J HUM GENET, V3, P3; Mack FA, 2003, CANCER CELL, V3, P75, DOI 10.1016/S1535-6108(02)00240-4; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Moyano JV, 2003, MOL BIOL CELL, V14, P3699, DOI 10.1091/mbc.E02-10-0667; Naranjo-Suarez S, 2003, J BIOL CHEM, V278, P31895, DOI 10.1074/jbc.M304079200; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Pal S, 1997, J BIOL CHEM, V272, P27509, DOI 10.1074/jbc.272.44.27509; Pang HP, 2005, AM J PHYSIOL-CELL PH, V289, pC982, DOI 10.1152/ajpcell.00364.2004; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Tang N, 2006, MOL CELL BIOL, V26, P2519, DOI 10.1128/MCB.26.7.2519-2530.2006; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	56	13	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24982	24990		10.1074/jbc.M709390200	http://dx.doi.org/10.1074/jbc.M709390200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18567581	Green Published, hybrid			2022-12-25	WOS:000271617300009
J	Lezhneva, L; Kuras, R; Ephritikhine, G; de Vitry, C				Lezhneva, Lina; Kuras, Richard; Ephritikhine, Genevieve; de Vitry, Catherine			A novel pathway of cytochrome c biogenesis is involved in the assembly of the cytochrome b(6)f complex in Arabidopsis chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; STATE TRANSITIONS; PHOTOSYSTEM-I; PROTEIN; HEME; THALIANA; BINDING; GENE; MATURATION; DISULFIDE	We recently characterized a novel heme biogenesis pathway required for heme c(i)' covalent binding to cytochrome b(6) in Chlamydomonas named system IV or CCB (cofactor assembly, complex C (b(6)f), subunit B (PetB)). To find out whether this CCB pathway also operates in higher plants and extend the knowledge of the c-type cytochrome biogenesis, we studied Arabidopsis insertion mutants in the orthologs of the CCB genes. The ccb1, ccb2, and ccb4 mutants show a phenotype characterized by a deficiency in the accumulation of the subunits of the cytochrome b(6)f complex and lack covalent heme binding to cytochrome b(6). These mutants were functionally complemented with the corresponding wild type cDNAs. Using fluorescent protein reporters, we demonstrated that the CCB1, CCB2, CCB3, and CCB4 proteins are targeted to the chloroplast compartment of Arabidopsis. We have extended our study to the YGGT family, to which CCB3 belongs, by studying insertion mutants of two additional members of this family for which no mutants were previously characterized, and we showed that they are not functionally involved in the CCB system. Thus, we demonstrate the ubiquity of the CCB proteins in chloroplast heme c(i)' binding.	[Lezhneva, Lina; Kuras, Richard; de Vitry, Catherine] Univ Paris 06, UMR 7141, F-75005 Paris, France; [Lezhneva, Lina; Kuras, Richard; de Vitry, Catherine] Inst Biol Phys Chim, Lab Physiol Membranaire & Mol Chloroplaste, UMR 7141, CNRS, F-75005 Paris, France; [Ephritikhine, Genevieve] CNRS, Inst Sci Vegetal, UPR 2355, F-91198 Gif Sur Yvette, France; [Ephritikhine, Genevieve] Univ Paris Diderot, UFR Sci Vivant, F-75251 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	de Vitry, C (corresponding author), Univ Paris 06, UMR 7141, F-75005 Paris, France.	catherine.devitry@ibpc.fr			CNRS; UPMC Universite Paris 6; Universite Paris-Diderot	CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC Universite Paris 6; Universite Paris-Diderot	This work was supported in part by the CNRS, the UPMC Universite Paris 6, and the Universite Paris-Diderot. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alergand T, 2006, PLANT CELL PHYSIOL, V47, P540, DOI 10.1093/pcp/pcj023; Allen JF, 2004, TRENDS PLANT SCI, V9, P130, DOI 10.1016/j.tplants.2004.01.009; Alric J, 2005, P NATL ACAD SCI USA, V102, P15860, DOI 10.1073/pnas.0508102102; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Baymann F, 2007, P NATL ACAD SCI USA, V104, P519, DOI 10.1073/pnas.0606369104; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Bennoun Pierre, 1998, Advances in Photosynthesis, V7, P451; Caprara MG, 1996, CELL, V87, P1135, DOI 10.1016/S0092-8674(00)81807-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; de Vitry C, 2004, BIOCHEMISTRY-US, V43, P3956, DOI 10.1021/bi036093p; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; DEVITRY C, 2007, CHLAMYDOMONAS SOURCE, V2, P603; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fadda D, 2003, J BACTERIOL, V185, P6209, DOI 10.1128/JB.185.20.6209-6214.2003; Finazzi G, 2005, J EXP BOT, V56, P383, DOI 10.1093/jxb/erh230; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; GAVEL Y, 1991, FEBS LETT, V282, P41, DOI 10.1016/0014-5793(91)80440-E; Giege P, 2008, MITOCHONDRION, V8, P61, DOI 10.1016/j.mito.2007.10.001; Hadi MZ, 2002, PLANT CELL REP, V21, P130, DOI 10.1007/s00299-002-0473-9; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Inoue K, 1997, J BIOL CHEM, V272, P31747, DOI 10.1074/jbc.272.50.31747; JOLIOT P, 1988, BIOCHIM BIOPHYS ACTA, V933, P319, DOI 10.1016/0005-2728(88)90039-4; Joliot Pierre, 2006, V24, P639; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; KONCZ C, 1994, PLANT MOL BIOL MAN B, V2, P1; Kranz R, 1998, MOL MICROBIOL, V29, P383, DOI 10.1046/j.1365-2958.1998.00869.x; Kuras R, 1997, J BIOL CHEM, V272, P32427, DOI 10.1074/jbc.272.51.32427; Kuras R, 2007, P NATL ACAD SCI USA, V104, P9906, DOI 10.1073/pnas.0702340104; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; LAVERGNE J, 1983, BIOCHIM BIOPHYS ACTA, V725, P25, DOI 10.1016/0005-2728(83)90220-7; Lennartz K, 2001, PLANT CELL, V13, P2539, DOI 10.1105/tpc.13.11.2539; Lyska D, 2007, PLANT CELL PHYSIOL, V48, P1737, DOI 10.1093/pcp/pcm146; Merchant S, 2005, PLANT CELL, V17, P648, DOI 10.1105/tpc.105.030676; Meurer J, 1996, PLANTA, V198, P385, DOI 10.1007/BF00620055; Mollier P, 2002, CURR GENET, V40, P405, DOI 10.1007/s00294-002-0271-5; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakamoto SS, 2000, BIOCHIMIE, V82, P603, DOI 10.1016/S0300-9084(00)00605-2; Page MLD, 2004, J BIOL CHEM, V279, P32474, DOI 10.1074/jbc.M404285200; Perron K, 1999, EMBO J, V18, P6481, DOI 10.1093/emboj/18.22.6481; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; Reiss B, 1996, P NATL ACAD SCI USA, V93, P3094, DOI 10.1073/pnas.93.7.3094; Rolland N, 2003, PHOTOSYNTH RES, V78, P205, DOI 10.1023/B:PRES.0000006891.12416.6c; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Thony-Meyer L, 2002, BIOCHEM SOC T, V30, P633; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Xie ZY, 1996, J BIOL CHEM, V271, P4632; Xie ZY, 1998, GENETICS, V148, P681; Yamashita E, 2007, J MOL BIOL, V370, P39, DOI 10.1016/j.jmb.2007.04.011; Zatsman AI, 2006, J AM CHEM SOC, V128, P14246, DOI 10.1021/ja065798m; Zhang HM, 2004, BIOCHEMISTRY-US, V43, P16329, DOI 10.1021/bi048363p	58	29	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24608	24616		10.1074/jbc.M803869200	http://dx.doi.org/10.1074/jbc.M803869200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18593701	Green Published, hybrid			2022-12-25	WOS:000258820000033
J	O'Brien, DP; Romero-Gallo, J; Schneider, BG; Chaturvedi, R; Delgado, A; Harris, EJ; Krishna, U; Ogden, SR; Israel, DA; Wilson, KT; Peek, RM				O'Brien, Daniel P.; Romero-Gallo, Judith; Schneider, Barbara G.; Chaturvedi, Rupesh; Delgado, Alberto; Harris, Elizabeth J.; Krishna, Uma; Ogden, Seth R.; Israel, Dawn A.; Wilson, Keith T.; Peek, Richard M., Jr.			Regulation of the Helicobacter pylori cellular receptor decay-accelerating factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; ACTIVATED PROTEIN-KINASES; KAPPA-B; CAGA PROTEIN; IV SECRETION; FACTOR GENE; IN-VITRO; EXPRESSION; CANCER; INFECTION	Chronic gastritis induced by Helicobacter pylori is the strongest known risk factor for peptic ulceration and distal gastric cancer, and adherence of H. pylori to gastric epithelial cells is critical for induction of inflammation. One H. pylori constituent that increases disease risk is the cag pathogenicity island, which encodes a secretion system that translocates bacterial effector molecules into host cells. Decay-accelerating factor (DAF) is a cellular receptor for H. pylori and a mediator of the inflammatory response to this pathogen. H. pylori induces DAF expression in human gastric epithelial cells; therefore, we sought to define the mechanism by which H. pylori up-regulates DAF and to extend these findings into a murine model of H. pylori-induced injury. Co-culture of MKN28 gastric epithelial cells with the wild-type H. pylori cag(+) strain J166 induced transcriptional expression of DAF, which was attenuated by disruption of a structural component of the cag secretion system (cagE). H. pylori-induced expression of DAF was dependent upon activation of the p38 mitogen-activated protein kinase pathway but not NF-kappa B. Hypergastrinemic INS-GAS mice infected with wildtype H. pylori demonstrated significantly increased DAF expression in gastric epithelium versus uninfected controls or mice infected with an H. pylori cagE(-) isogenic mutant strain. These results indicate that H. pylori cag(+) strains induce up-regulation of a cognate cellular receptor in vitro and in vivo in a cag-dependent manner, representing the first evidence of regulation of an H. pylori host receptor by the cag pathogenicity island.	[O'Brien, Daniel P.; Romero-Gallo, Judith; Schneider, Barbara G.; Chaturvedi, Rupesh; Delgado, Alberto; Krishna, Uma; Ogden, Seth R.; Israel, Dawn A.; Wilson, Keith T.; Peek, Richard M., Jr.] Vanderbilt Univ, Sch Med, Div Gastroenterol, Dept Med, Nashville, TN 37232 USA; [Harris, Elizabeth J.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [O'Brien, Daniel P.; Romero-Gallo, Judith; Chaturvedi, Rupesh; Krishna, Uma; Ogden, Seth R.; Israel, Dawn A.; Wilson, Keith T.; Peek, Richard M., Jr.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Peek, Richard M., Jr.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Peek, RM (corresponding author), Vanderbilt Univ, Sch Med, Div Gastroenterol, Dept Med, 2215 Garland Ave,1030C MRB 4, Nashville, TN 37232 USA.	richard.peek@vanderbilt.edu		Wilson, Keith/0000-0003-4421-1830; Schneider, Barbara/0000-0003-4421-1355	National Institutes of Health [DK73902, DK58587, DK7795, DK053620]; Vanderbilt Digestive Diseases Research Center [DK058404]; Office of Medical Research, Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058587, R01DK073902, R01DK053620, P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Diseases Research Center; Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK73902, DK58587, and DK7795 (to R. M. P.) and DK053620 (to K. T. W.). This work was also supported by Vanderbilt Digestive Diseases Research Center Grant DK058404 and by the Office of Medical Research, Department of Veterans Affairs (to K. T. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; Andoh A, 2001, J IMMUNOL, V167, P3887, DOI 10.4049/jimmunol.167.7.3887; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; BACKERT S, 2008, CELL MICROB IN PRESS; BERGELSON JM, 1995, J VIROL, V69, P1903, DOI 10.1128/JVI.69.3.1903-1906.1995; Berstad AE, 1998, GUT, V42, P522, DOI 10.1136/gut.42.4.522; Beswick EJ, 2006, WORLD J GASTROENTERO, V12, P5599, DOI 10.3748/wjg.v12.i35.5599; Betis F, 2003, INFECT IMMUN, V71, P1068, DOI 10.1128/IAI.71.3.1068-1074.2003; Blanchard TG, 2004, CURR OPIN GASTROEN, V20, P10, DOI 10.1097/00001574-200401000-00004; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Camorlinga-Ponce M, 2004, J CLIN PATHOL, V57, P822, DOI 10.1136/jcp.2004.017087; CLARKSON NA, 1995, J VIROL, V69, P5497, DOI 10.1128/JVI.69.9.5497-5501.1995; Correa P, 2004, GUT, V53, P1217, DOI 10.1136/gut.2004.039834; Crawford HC, 2003, GASTROENTEROLOGY, V125, P1125, DOI 10.1016/S0016-5085(03)01206-X; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Ernst PB, 2006, GASTROENTEROLOGY, V130, P188, DOI 10.1053/j.gastro.2005.06.032; EWULONU UK, 1991, P NATL ACAD SCI USA, V88, P4675, DOI 10.1073/pnas.88.11.4675; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; Fox JG, 2003, GASTROENTEROLOGY, V124, P1879, DOI 10.1016/S0016-5085(03)00406-2; Fox JG, 2003, CANCER RES, V63, P942; Franco AT, 2008, CANCER RES, V68, P379, DOI 10.1158/0008-5472.CAN-07-0824; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gelderman KA, 2004, TRENDS IMMUNOL, V25, P158, DOI 10.1016/j.it.2004.01.008; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Glocker E, 1998, INFECT IMMUN, V66, P2346, DOI 10.1128/IAI.66.5.2346-2348.1998; HESSEY SJ, 1990, GUT, V31, P134, DOI 10.1136/gut.31.2.134; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Holla VR, 2005, J BIOL CHEM, V280, P476, DOI 10.1074/jbc.M407403200; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Jurianz K, 1999, MOL IMMUNOL, V36, P929, DOI 10.1016/S0161-5890(99)00115-7; Keates S, 1999, J IMMUNOL, V163, P5552; Kiso T, 2002, HISTOPATHOLOGY, V40, P339, DOI 10.1046/j.1365-2559.2002.01350.x; Kobayashi M, 2007, J HISTOCHEM CYTOCHEM, V55, P263, DOI 10.1369/jhc.6A7097.2006; Kudo T, 2007, GASTROENTEROLOGY, V132, P1024, DOI 10.1053/j.gastro.2007.01.009; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lidington EA, 2000, BLOOD, V96, P2784; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Moss SF, 2003, CURR OPIN INFECT DIS, V16, P445, DOI 10.1097/00001432-200310000-00011; NOWICKI B, 1993, J EXP MED, V178, P2115, DOI 10.1084/jem.178.6.2115; O'Brien DP, 2006, J BIOL CHEM, V281, P13317, DOI 10.1074/jbc.M601805200; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohtani M, 2007, CARCINOGENESIS, V28, P2597, DOI 10.1093/carcin/bgm150; Opitz B, 2006, J IMMUNOL, V176, P484, DOI 10.4049/jimmunol.176.1.484; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Peek RM, 1999, CANCER RES, V59, P6124; Rautemaa R, 2001, GASTROENTEROLOGY, V120, P470, DOI 10.1053/gast.2001.21197; Romero-Gallo J, 2008, LAB INVEST, V88, P328, DOI 10.1038/labinvest.3700719; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Servin AL, 2005, CLIN MICROBIOL REV, V18, P264, DOI 10.1128/CMR.18.2.264-292.2005; Shafren DR, 1998, J VIROL, V72, P9407, DOI 10.1128/JVI.72.11.9407-9412.1998; Sharma SA, 1998, J IMMUNOL, V160, P2401; Shattuck-Brandt RL, 1999, MOL CARCINOGEN, V24, P177, DOI 10.1002/(SICI)1098-2744(199903)24:3<177::AID-MC4>3.0.CO;2-6; Solnick JV, 2004, P NATL ACAD SCI USA, V101, P2106, DOI 10.1073/pnas.0308573100; Steele IA, 2007, AM J PHYSIOL-GASTR L, V293, pG347, DOI 10.1152/ajpgi.00076.2007; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; THOMAS DJ, 1993, J IMMUNOL, V150, P151; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; ZENG H, 2006, AM J PHYSIOL-GASTR L, V290, P96, DOI 10.1152/ajpgi.00273.2005	65	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23922	23930		10.1074/jbc.M801144200	http://dx.doi.org/10.1074/jbc.M801144200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579524	Green Published, hybrid			2022-12-25	WOS:000258638900047
J	Saxena, R; Kanudia, P; Datt, M; Dar, HH; Karthikeyan, S; Singh, B; Chakraborti, PK				Saxena, Rahul; Kanudia, Pavitra; Datt, Manish; Dar, Haider Hussain; Karthikeyan, Subramanian; Singh, Balvinder; Chakraborti, Pradip K.			Three consecutive arginines are important for the mycobacterial peptide deformylase enzyme activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM LEPTOSPIRA-INTERROGANS; TERMINAL METHIONINE EXCISION; POLYPEPTIDE DEFORMYLASE; ESCHERICHIA-COLI; METHIONYL-TRNA(F)(MET) FORMYLTRANSFERASE; STAPHYLOCOCCUS-AUREUS; TUBERCULOSIS; INHIBITORS; TARGET; TRANSLATION	Genes encoding the peptide deformylase enzyme (def) are present in all eubacteria and are involved in the deformylation of the N-formyl group of newly synthesized polypeptides during protein synthesis. We compared the amino acid sequences of this enzyme in different mycobacterial species and found that they are highly conserved (76% homology with 62% identity); however, when this comparison was extended to other eubacterial homologs, it emerged that the mycobacterial proteins have an insertion region containing three consecutive arginine residues (residues 77-79 in Mycobacterium tuberculosis peptide deformylase (mPDF)). Here, we demonstrate that these three arginines are important for the activity of mPDF. Circular dichroism studies of wild-type mPDF and of mPDF containing individual conservative substitutions (R77K, R78K, or R79K) or combined substitutions incorporated into a triple mutant (R77K/R78K/R79K) indicate that such mutations cause mPDF to undergo structural alterations. Molecular modeling of mPDF suggests that the three arginines are distal to the active site. Molecular dynamics simulations of wild-type and mutant mPDF structures indicate that the arginines may be involved in the stabilization of substrate binding pocket residues for their proper interaction with peptide(s). Treatment with 5 '-phosphothiorate-modified antisense oligodeoxyribonucleotides directed against different regions of def from M. tuberculosis inhibits growth of Mycobacterium smegmatis in culture. Taken together, these results hold out the possibility of future design of novel mycobacteria-specific PDF inhibitors.	[Saxena, Rahul; Kanudia, Pavitra; Datt, Manish; Dar, Haider Hussain; Karthikeyan, Subramanian; Singh, Balvinder; Chakraborti, Pradip K.] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Chakraborti, PK (corresponding author), CSIR, Inst Microbial Technol, Sector 39A, Chandigarh 160036, India.	pradip@imtech.res.in	Dar, Haider/AAE-3582-2021; DAR, HILAL/HHM-3664-2022; Karthikeyan, Subramanian/F-8808-2010; Datt, Manish/AAD-6989-2019	Dar, Haider H./0000-0001-9586-7288; Datt, Manish/0000-0002-9578-4113	Council of Scientific and Industrial Research, New Delhi [SMM003]; Department of Biotechnology (New Delhi, India)	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (New Delhi, India)(Department of Biotechnology (DBT) India)	This work was supported by Council of Scientific and Industrial Research, New Delhi (under network program SMM003) and Department of Biotechnology (New Delhi, India) and financial support in the form of research fellowships (to R. S., P. K., H. H. D., and M. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Becker A, 1998, NAT STRUCT BIOL, V5, P1053, DOI 10.1038/4162; Boggetto N, 2002, BIOL CHEM, V383, P1321, DOI 10.1515/BC.2002.150; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Cynamon MH, 2004, J ANTIMICROB CHEMOTH, V53, P403, DOI 10.1093/jac/dkh054; DeLano WL, 1998, PYMOL MOL GRAPHICS S; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fieulaine S, 2005, J BIOL CHEM, V280, P42315, DOI 10.1074/jbc.M507155200; Flint JL, 2004, P NATL ACAD SCI USA, V101, P12598, DOI 10.1073/pnas.0404892101; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Giglione C, 2003, EMBO J, V22, P13, DOI 10.1093/emboj/cdg007; Giglione C, 2001, TRENDS PLANT SCI, V6, P566, DOI 10.1016/S1360-1385(01)02151-3; Giglione C, 2000, MOL MICROBIOL, V36, P1197, DOI 10.1046/j.1365-2958.2000.01908.x; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Harth G, 2002, P NATL ACAD SCI USA, V99, P15614, DOI 10.1073/pnas.242612299; Harth G, 2000, P NATL ACAD SCI USA, V97, P418, DOI 10.1073/pnas.97.1.418; KOZAK M, 1983, MICROBIOL REV, V47, P1; Kreusch A, 2003, J MOL BIOL, V330, P309, DOI 10.1016/S0022-2836(03)00596-5; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leeds JA, 2006, CURR OPIN PHARMACOL, V6, P445, DOI 10.1016/j.coph.2006.06.003; Li YK, 2002, BIOCHEM BIOPH RES CO, V295, P884, DOI 10.1016/S0006-291X(02)00777-5; Margolis PS, 2000, ANTIMICROB AGENTS CH, V44, P1825, DOI 10.1128/AAC.44.7.1825-1831.2000; Mazel D, 1997, J MOL BIOL, V266, P939, DOI 10.1006/jmbi.1996.0835; MAZEL D, 1994, EMBO J, V13, P914, DOI 10.1002/j.1460-2075.1994.tb06335.x; Meinnel T, 1996, FEBS LETT, V385, P91, DOI 10.1016/0014-5793(96)00357-2; MEINNEL T, 1993, BIOCHIMIE, V75, P1061, DOI 10.1016/0300-9084(93)90005-D; MEINNEL T, 1994, J BACTERIOL, V176, P7387, DOI 10.1128/JB.176.23.7387-7390.1994; MEINNEL T, 1993, J BACTERIOL, V175, P7737, DOI 10.1128/JB.175.23.7737-7740.1993; Nguyen KT, 2003, BIOCHEMISTRY-US, V42, P9952, DOI 10.1021/bi0346446; Rajagopalan PTR, 1997, BIOCHEMISTRY-US, V36, P13910, DOI 10.1021/bi971155v; Rajagopalan PTR, 1998, J BIOL CHEM, V273, P22305, DOI 10.1074/jbc.273.35.22305; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sarin J, 2001, J BIOL CHEM, V276, P44590, DOI 10.1074/jbc.M105401200; Saxena R, 2005, J BACTERIOL, V187, P8216, DOI 10.1128/JB.187.23.8216-8220.2005; Saxena R, 2005, BIOCHEM BIOPH RES CO, V332, P418, DOI 10.1016/j.bbrc.2005.04.142; SHIRLEY K, 1995, PCR PRIMER LAB MANUA, P143; Smith KJ, 2003, PROTEIN SCI, V12, P349, DOI 10.1110/ps.0229303; Teo JWP, 2006, ANTIMICROB AGENTS CH, V50, P3665, DOI 10.1128/AAC.00555-06; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Yuan ZY, 2006, BIOCHEM PHARMACOL, V71, P1042, DOI 10.1016/j.bcp.2005.10.015; Zhou ZC, 2004, J MOL BIOL, V339, P207, DOI 10.1016/j.jmb.2004.03.045	45	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23754	23764		10.1074/jbc.M709672200	http://dx.doi.org/10.1074/jbc.M709672200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18574247	Green Published, hybrid			2022-12-25	WOS:000258638900029
J	El-Sayed, A; Khalil, IA; Kogure, K; Futaki, S; Harashima, H				El-Sayed, Ayman; Khalil, Ikramy A.; Kogure, Kentaro; Futaki, Shiroh; Harashima, Hideyoshi			Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PENETRATING PEPTIDES; ARGININE-RICH PEPTIDES; TAT-FUSION PROTEINS; HUMAN IMMUNODEFICIENCY VIRUS; INTRACELLULAR TRAFFICKING; NUCLEAR DELIVERY; MEMBRANE-FUSION; ENTERS CELLS; NANO DEVICE; TRANSDUCTION	The present study examines the role of surface modification with an octaarginine peptide (R8) in liposomal escape from endocytic vesicles, using octalysine (K8) as a control cationic peptide; the mechanism of endosomal escape of liposomes was also investigated. Gene expression of condensed plasmid DNA encapsulated in R8-modified nanoparticles was more than 1 order of magnitude higher than that of K8-modified nanoparticles, and 2 orders of magnitude higher than gene expression using unmodified nanoparticles. The difference in gene expression could not be attributed to differences in uptake, as R8- and K8-modified liposomes were taken up primarily via macropinocytosis with comparable efficiency. The extent of R8-nanoparticle escape to the cytosol was double that of K8-nanoparticles. Suppression of endosome acidification inhibited R8-nanoparticle endosomal escape, but enhanced that of K8-nanoparticles. Using spectral imaging in live cells, we showed that R8- and K8-liposomes escaped from endocytic vesicles via fusion between the liposomes and the endosomal membrane. R8- liposomes fused efficiently at both acidic and neutral pH, whereas K8- liposomes fused only at neutral pH. Similar behavior was observed during in vitro lipid mixing and calcein-release experiments. Co-incubation of cells with distinctly labeled K8- and R8-modified nanoparticles confirmed a common uptake pathway and different rates of endosomal escape particularly at longer time intervals. Therefore, it was concluded that R8 on the liposome surface stimulates efficient escape from endocytic vesicles via a fusion mechanism that works at both neutral and acidic pH; in contrast, K8 mediates escape mainly at neutral pH.	[El-Sayed, Ayman; Khalil, Ikramy A.; Kogure, Kentaro; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0608012, Japan; [Kogure, Kentaro] Kyoto Pharmaceut Univ, Yamashina Ku, Kyoto 6078414, Japan; [Futaki, Shiroh] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [El-Sayed, Ayman; Khalil, Ikramy A.; Harashima, Hideyoshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Futaki, Shiroh] Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3320012, Japan	Hokkaido University; Kyoto Pharmaceutical University; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Harashima, H (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0608012, Japan.	harasima@pharm.hokudai.ac.jp	Harashima, Hideyoshi/D-8390-2012; khalil, ikramy A./T-7523-2019	khalil, ikramy A./0000-0001-9417-7437; Futaki, Shiroh/0000-0002-0124-4002; El-Sayed, Ayman/0000-0001-6740-7639	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in part, by grants-in-aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by grants-in-aid for Scientific Research on Priority Areas from the Japan Society for the Promotion of Science.	Abes S, 2006, J CONTROL RELEASE, V110, P595, DOI 10.1016/j.jconrel.2005.10.026; Akita H, 2004, MOL THER, V9, P443, DOI 10.1016/j.ymthe.2004.01.005; Al-Taei S, 2006, BIOCONJUGATE CHEM, V17, P90, DOI 10.1021/bc050274h; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brabec M, 2005, J VIROL, V79, P1008, DOI 10.1128/JVI.79.2.1008-1016.2005; Caron NJ, 2004, BIOCHEM BIOPH RES CO, V319, P12, DOI 10.1016/j.bbrc.2004.04.180; Cryan SA, 2006, MOL PHARMACEUT, V3, P104, DOI 10.1021/mp050070i; DEKRUIJFF B, 1985, BIOCHIM BIOPHYS ACTA, V820, P295, DOI 10.1016/0005-2736(85)90124-5; DEKRUIJFF B, 1980, BIOCHIM BIOPHYS ACTA, V601, P235, DOI 10.1016/0005-2736(80)90528-3; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Hitz T, 2006, BIOCHEMISTRY-US, V45, P5817, DOI 10.1021/bi060285d; Inoue Y, 2007, J VIROL, V81, P8722, DOI 10.1128/JVI.00253-07; Iwasa A, 2006, BBA-BIOMEMBRANES, V1758, P713, DOI 10.1016/j.bbamem.2006.04.015; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Kogure K, 2004, J CONTROL RELEASE, V98, P317, DOI 10.1016/j.jconrel.2004.04.024; Magzoub M, 2005, BIOCHEMISTRY-US, V44, P14890, DOI 10.1021/bi051356w; Mai JC, 2002, J BIOL CHEM, V277, P30208, DOI 10.1074/jbc.M204202200; Malecki J, 2002, EMBO J, V21, P4480, DOI 10.1093/emboj/cdf472; MEERS P, 1988, BIOCHEMISTRY-US, V27, P4430, DOI 10.1021/bi00412a033; Michiue H, 2005, J BIOL CHEM, V280, P8285, DOI 10.1074/jbc.M412430200; Midoux P, 1999, BIOCONJUGATE CHEM, V10, P406, DOI 10.1021/bc9801070; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakamura Y, 2007, J CONTROL RELEASE, V119, P360, DOI 10.1016/j.jconrel.2007.03.010; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Potocky TB, 2005, J AM CHEM SOC, V127, P3686, DOI 10.1021/ja042566j; Potocky TB, 2003, J BIOL CHEM, V278, P50188, DOI 10.1074/jbc.M308719200; Potocky TB, 2007, CHEMBIOCHEM, V8, P917, DOI 10.1002/cbic.200600563; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rothbard JB, 2005, ADV DRUG DELIVER REV, V57, P495, DOI 10.1016/j.addr.2004.10.003; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; ROUX M, 1988, EUR BIOPHYS J BIOPHY, V16, P267, DOI 10.1007/BF00254062; Sakai N, 2003, J AM CHEM SOC, V125, P14348, DOI 10.1021/ja037601l; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; SUBTIL A, 1994, J CELL SCI, V107, P3461; Tachibana R, 2003, METHOD ENZYMOL, V372, P349; Thoren PEG, 2005, BIOPHYS CHEM, V114, P169, DOI 10.1016/j.bpc.2004.11.016; Tilstra J, 2007, BIOCHEM SOC T, V35, P811, DOI 10.1042/BST0350811; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270; Yang LL, 2003, CANCER RES, V63, P831	53	162	164	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23450	23461		10.1074/jbc.M709387200	http://dx.doi.org/10.1074/jbc.M709387200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550548	hybrid			2022-12-25	WOS:000258455400054
J	Figueiredo, AC; Wasmeier, C; Tarafder, AK; Ramalho, JS; Baron, RA; Seabra, MC				Figueiredo, Ana C.; Wasmeier, Christina; Tarafder, Abul K.; Ramalho, Jose S.; Baron, Rudi A.; Seabra, Miguel C.			Rab3GEP is the non-redundant guanine nucleotide exchange factor for Rab27a in melanocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL G-PROTEINS; MELANOSOME TRANSPORT; REGULATED SECRETION; COILED-COIL; GTPASES; FAMILY; SPECIFICITY; EXOCYTOSIS; DOMAIN; GERANYLGERANYLATION	Rab GTPases regulate discrete steps in vesicular transport pathways. Rabs require activation by specific guanine nucleotide exchange factors (GEFs) that stimulate the exchange of GDP for GTP. Rab27a controls motility and regulated exocytosis of secretory granules and related organelles. In melanocytes, Rab27a regulates peripheral transport of mature melanosomes by recruiting melanophilin and myosin Va. Here, we studied the activation of Rab27a in melanocytes. We identify Rab3GEP, previously isolated as a GEF for Rab3a, as the non-redundant Rab27a GEF. Similar to Rab27a-deficient ashen melanocytes, Rab3GEP-depleted cells show both clustering of melanosomes in the perinuclear area and loss of the Rab27a effector Mlph. Consistent with a role as an activator, levels of Rab27a-GTP are decreased in cells lacking Rab3GEP. Recombinant Rab3GEP exhibits guanine nucleotide exchange activity against Rab27a and Rab27b in vitro, in addition to its previously documented activity against Rab3. Our results indicate promiscuity in Rab GEF action and suggest that members of related but functionally distinct Rab subfamilies can be controlled by common activators.	[Figueiredo, Ana C.; Wasmeier, Christina; Tarafder, Abul K.; Baron, Rudi A.; Seabra, Miguel C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Ramalho, Jose S.] Univ Coimbra, Ctr Ophthalmol Biomed, Inst Res Light & Image, P-3004548 Coimbra, Portugal	Imperial College London; Universidade de Coimbra	Seabra, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England.	m.seabra@imperial.ac.uk	Seabra, Miguel C/M-3280-2013; Seabra, Miguel/AAC-3099-2019; Ramalho, Jose/M-6415-2015; Figueiredo, Ana/K-1384-2013	Seabra, Miguel C/0000-0002-6404-4892; Ramalho, Jose/0000-0002-1927-164X; Figueiredo, Ana/0000-0001-8386-8216; Tarafder, Abul/0000-0002-0368-6111	Wellcome Trust [075498] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; Araki K, 2000, PIGM CELL RES, V13, P332, DOI 10.1034/j.1600-0749.2000.130505.x; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hume AN, 2007, J CELL SCI, V120, P3111, DOI 10.1242/jcs.010207; Hume AN, 2006, MOL BIOL CELL, V17, P4720, DOI 10.1091/mbc.E06-05-0457; Iwasaki K, 1997, NEURON, V18, P613, DOI 10.1016/S0896-6273(00)80302-5; Izumi T, 2003, CELL STRUCT FUNCT, V28, P465, DOI 10.1247/csf.28.465; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Leung KF, 2007, J BIOL CHEM, V282, P1487, DOI 10.1074/jbc.M605557200; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Miyoshi J, 2004, TRENDS MOL MED, V10, P476, DOI 10.1016/j.molmed.2004.08.002; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Munro S, 2002, CURR OPIN CELL BIOL, V14, P506, DOI 10.1016/S0955-0674(02)00350-2; Oishi H, 1998, J BIOL CHEM, V273, P34580, DOI 10.1074/jbc.273.51.34580; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sato Y, 2007, P NATL ACAD SCI USA, V104, P8305, DOI 10.1073/pnas.0701550104; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tanaka M, 2001, MOL BIOL CELL, V12, P1421, DOI 10.1091/mbc.12.5.1421; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Yamaguchi K, 2002, P NATL ACAD SCI USA, V99, P14536, DOI 10.1073/pnas.212511399; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810; Zhao SL, 2002, ENDOCRINOLOGY, V143, P1817, DOI 10.1210/en.143.5.1817	40	45	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23209	23216		10.1074/jbc.M804134200	http://dx.doi.org/10.1074/jbc.M804134200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18559336	Green Published, hybrid			2022-12-25	WOS:000258455400034
J	Hong, K; Lou, L; Gupta, S; Ribeiro-Neto, F; Altschuler, DL				Hong, Kyoungja; Lou, Liguang; Gupta, Sandhya; Ribeiro-Neto, Fernando; Altschuler, Daniel L.			A novel Epac-Rap-PP2A signaling module controls cAMP-dependent Akt regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; AKT/PROTEIN-KINASE-B; PLECKSTRIN HOMOLOGY DOMAIN; PP2A CATALYTIC SUBUNIT; CYCLIC-AMP; PHOSPHATIDYLINOSITOL 3-KINASE; CARBOXYL METHYLATION; CELL-PROLIFERATION; CROSS-TALK; MEMBRANE LOCALIZATION	Rap1b has been implicated in the transduction of the cAMP mitogenic signal. It is phosphorylated and activated by cAMP, and its expression in models where cAMP is mitogenic leads to proliferation and tumorigenesis. Akt is a likely downstream effector of cAMP-Rap1 action. cAMP elevation induced a rapid and transient Akt inhibition that required activated and phosphorylated Rap1b. However, the mechanism(s) by which cAMP-Rap regulates Akt remains unclear. Here we show that (i) upstream regulators, PIK and PDK1, are not the target(s) of the cAMP inhibitory action; (ii) constitutively active Akt and calyculin A-stimulated Akt are resistant to cAMP inhibition, suggesting the action of a phosphatase; (iii) cAMP increases the rate of Akt dephosphorylation, directly implicating an Akt-phosphatase; (iv) Epac- and protein kinase A(PKA)-specific analogs synergistically inhibit Akt, indicating the involvement of both cAMP-dependent effector pathways; (v) H89 and dominant negative Epac 279E block cAMP-inhibitory action; (vi) Epac associates in a complex with Akt and PP2A, and the associated-phosphatase activity is positively modulated by cAMP in a PKA- and Rap1-dependent manner; (vii) like its action on Akt inhibition, PKA- and Epac- specific analogs synergistically activate Epac- associated PP2A; and (viii) dominant negative PP2A blocks cAMP-inhibitory action. Thus, we uncovered a novel cAMP-Epac/PKA-Rap1b-PP2A signaling module involved in Akt regulation that may represent a physiological event in the process of cAMP stimulation of thyroid mitogenesis.	[Hong, Kyoungja; Lou, Liguang; Gupta, Sandhya; Ribeiro-Neto, Fernando; Altschuler, Daniel L.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Altschuler, DL (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, 200 Lothrop St,W1346 BSTWR, Pittsburgh, PA 15261 USA.	altschul@pitt.edu			NATIONAL CANCER INSTITUTE [R29CA071649, R01CA071649] Funding Source: NIH RePORTER; NCI NIH HHS [CA071649] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bommakanti RK, 2000, J BIOL CHEM, V275, P38870, DOI 10.1074/jbc.M007403200; Brennesvik EO, 2005, CELL SIGNAL, V17, P1551, DOI 10.1016/j.cellsig.2005.03.011; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Cazzolli R, 2001, DIABETES, V50, P2210, DOI 10.2337/diabetes.50.10.2210; Chen CS, 2005, J BIOL CHEM, V280, P38879, DOI 10.1074/jbc.M505733200; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Coulonval K, 2000, BIOCHEM J, V348, P351, DOI 10.1042/0264-6021:3480351; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Feschenko MS, 2002, J PHARMACOL EXP THER, V302, P111, DOI 10.1124/jpet.302.1.111; Filippa N, 1999, MOL CELL BIOL, V19, P4989; FLOER M, 1994, BIOCHEM BIOPH RES CO, V198, P372, DOI 10.1006/bbrc.1994.1052; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fujita H, 2006, BRAIN RES, V1113, P10, DOI 10.1016/j.brainres.2006.06.079; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; Grader-Beck T, 2003, BLOOD, V101, P998, DOI 10.1182/blood-2002-06-1665; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kagawa T, 2002, AM J PHYSIOL-CELL PH, V283, pC1655, DOI 10.1152/ajpcell.00041.2002; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kim AH, 2003, J BIOL CHEM, V278, P29830, DOI 10.1074/jbc.M305349200; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Kloeker S, 1997, BIOCHEM J, V327, P481, DOI 10.1042/bj3270481; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lee HT, 2003, INVEST OPHTH VIS SCI, V44, P3816, DOI 10.1167/iovs.03-0147; Lei HT, 2007, J BIOL CHEM, V282, P9364, DOI 10.1074/jbc.M608985200; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Li LW, 2006, J BIOL CHEM, V281, P3237, DOI 10.1074/jbc.M512167200; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Liu W, 2003, CELL DEATH DIFFER, V10, P772, DOI 10.1038/sj.cdd.4401238; Lou LG, 2002, J BIOL CHEM, V277, P32799, DOI 10.1074/jbc.M201491200; Machida K, 2005, AM J PHYSIOL-LUNG C, V288, pL860, DOI 10.1152/ajplung.00131.2004; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Meroni SB, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740195; Monje PV, 2006, GLIA, V53, P649, DOI 10.1002/glia.20330; Moon EY, 2003, BLOOD, V101, P4122, DOI 10.1182/blood-2002-10-3208; Mora A, 2002, CELL SIGNAL, V14, P557, DOI 10.1016/S0898-6568(01)00282-0; Morisco C, 2005, CIRC RES, V96, P180, DOI 10.1161/01.RES.0000152968.71868.c3; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Poser S, 2003, J NEUROSCI, V23, P4420; Remy I, 2004, MOL CELL BIOL, V24, P1493, DOI 10.1128/MCB.24.4.1493-1504.2004; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; Ribeiro-Neto F, 2004, J BIOL CHEM, V279, P46868, DOI 10.1074/jbc.M406858200; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Roger PP, 1995, VITAM HORM, V51, P59, DOI 10.1016/S0083-6729(08)61038-9; Saito J, 2001, THYROID, V11, P339, DOI 10.1089/10507250152039073; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schild A, 2006, MECH DEVELOP, V123, P362, DOI 10.1016/j.mod.2006.03.003; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Usui H, 1998, FEBS LETT, V430, P312, DOI 10.1016/S0014-5793(98)00684-X; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Wang L, 2001, J BIOL CHEM, V276, P37242, DOI 10.1074/jbc.M105089200; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Xu WP, 2003, CANCER RES, V63, P7777; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; YAMAMOTO K, 1992, J BIOL CHEM, V267, P11337; Yellaturu CR, 2002, J BIOL CHEM, V277, P40148, DOI 10.1074/jbc.M206376200; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348; Zmuda-Trzebiatowska E, 2007, CELL SIGNAL, V19, P81, DOI 10.1016/j.cellsig.2006.05.024; Zuluaga S, 2007, CELL SIGNAL, V19, P62, DOI 10.1016/j.cellsig.2006.05.032	97	44	44	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23129	23138		10.1074/jbc.M800478200	http://dx.doi.org/10.1074/jbc.M800478200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550542	hybrid, Green Published			2022-12-25	WOS:000258455400026
J	Laurence, TA; Kwon, Y; Johnson, A; Hollars, CW; O'Donnell, M; Camarero, JA; Barsky, D				Laurence, Ted A.; Kwon, Youngeun; Johnson, Aaron; Hollars, Christopher W.; O'Donnell, Mike; Camarero, Julio A.; Barsky, Daniel			Motion of a DNA sliding clamp observed by single molecule fluorescence spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III HOLOENZYME; CELL NUCLEAR ANTIGEN; ESCHERICHIA-COLI; LAGGING-STRAND; COMPLEX; PCNA; BETA; PROTEINS; TRANSCRIPTION; REPLICATION	DNA sliding clamps attach to polymerases and slide along DNA to allow rapid, processive replication of DNA. These clamps contain many positively charged residues that could curtail the sliding due to attractive interactions with the negatively charged DNA. By single-molecule spectroscopy we have observed a fluorescently labeled sliding clamp (polymerase III beta subunit or beta clamp) loaded onto freely diffusing, single-stranded M13 circular DNA annealed with fluorescently labeled DNA oligomers of up to 90 bases. We find that the diffusion constant for the beta clamp diffusing along DNA is on the order of 10(-14) m(2)/s, at least 3 orders of magnitude less than that for diffusion through water alone. We also find evidence that the beta clamp remains at the 3' end in the presence of Escherichia coli single-stranded-binding protein. These results may imply that the clamp not only acts to hold the polymerase on the DNA but also prevents excessive drifting along the DNA.	[Laurence, Ted A.; Kwon, Youngeun; Hollars, Christopher W.; Camarero, Julio A.; Barsky, Daniel] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Johnson, Aaron; O'Donnell, Mike] Rockefeller Univ, New York, NY 10065 USA; [Johnson, Aaron; O'Donnell, Mike] Howard Hughes Med Inst, New York, NY 10065 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Rockefeller University; Howard Hughes Medical Institute	Laurence, TA (corresponding author), Lawrence Livermore Natl Lab, POB 5508, Livermore, CA 94550 USA.	laurence2@llnl.gov; barsky@llnl.gov	Camarero, Julio A./A-9628-2015; Laurence, Ted A/E-4791-2011	Camarero, Julio A./0000-0001-9150-0665; Laurence, Ted A/0000-0003-1474-779X; O'Donnell, Michael/0000-0001-9002-4214	Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; National Institutes of Health [GM38839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R01GM038839] Funding Source: NIH RePORTER	Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was performed under the auspices of the United States Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. We thank Ceslovas Venclovas, Michael E. Colvin, and Kenneth S. Kim for valuable input on this project.; This work was supported, in whole or in part, by National Institutes of Health Grant GM38839 (to M.O.D.). This work was also supported by the laboratory directed research and development program at Lawrence Livermore National Laboratory (to T.A.L., J.A.C., and D.B.).	Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1468; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; FAY PJ, 1981, J BIOL CHEM, V256, P976; FRADKIN LG, 1992, J BIOL CHEM, V267, P10318; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Graneli A, 2006, P NATL ACAD SCI USA, V103, P1221, DOI 10.1073/pnas.0508366103; GRIEP MA, 1990, J BIOL CHEM, V265, P20356; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Laurence TA, 2004, J PHYS CHEM B, V108, P3051, DOI 10.1021/jp036499b; Laurence TA, 2005, P NATL ACAD SCI USA, V102, P17348, DOI 10.1073/pnas.0508584102; Laurence TA, 2007, BIOPHYS J, V92, P2184, DOI 10.1529/biophysj.106.093591; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; ODONNELL ME, 1985, J BIOL CHEM, V260, P2884; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; Redner S, 2001, GUIDE 1 PASSAGE PROC, P39; SCHURR JM, 1979, BIOPHYS CHEM, V9, P413, DOI 10.1016/0301-4622(75)80057-3; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Smiley RD, 2006, BIOCHEMISTRY-US, V45, P7990, DOI 10.1021/bi0603322; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Turner J, 1995, METHOD ENZYMOL, V262, P442; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Vivona JB, 2003, FEBS LETT, V546, P167, DOI 10.1016/S0014-5793(03)00622-7; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yao N, 2000, J BIOL CHEM, V275, P1421, DOI 10.1074/jbc.275.2.1421	38	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22895	22906		10.1074/jbc.M800174200	http://dx.doi.org/10.1074/jbc.M800174200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556658	hybrid, Green Published			2022-12-25	WOS:000258455400003
J	Mak, BC; Wang, Q; Laschinger, C; Lee, W; Ron, D; Harding, HP; Kaufman, RJ; Scheuner, D; Austin, RC; McCulloch, CA				Mak, Baldwin C.; Wang, Qin; Laschinger, Carol; Lee, Wilson; Ron, David; Harding, Heather P.; Kaufman, Randal J.; Scheuner, Donalyn; Austin, Richard C.; McCulloch, Christopher A.			Novel function of PERK as a mediator of force-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; TRANSLATIONAL CONTROL; TRANSCRIPTION FACTOR; MESSENGER-RNA; ER STRESS; ACTIN; ATF6; MECHANOPROTECTION	Induction of apoptosis by tensile forces is an important determinant of connective tissue destruction in osteoarthritis and periodontal diseases. We examined the role of molecular components of the unfolded protein response in force-induced apoptosis. Magnetic fields were used to apply tensile force through integrins to cultured fibroblasts bound with collagen-coated magnetite beads. Tensile force induced caspase 3 cleavage, DNA fragmentation, depolarization of mitochondria, and induction of CHOP10, all indicative of activation of apoptosis. Immunoblotting, immunocytochemistry, and release of Ca2+ from the endoplasmic reticulum showed evidence for both physical and functional associations between bound beads and the endoplasmic reticulum. Force-induced apoptosis was not detected in PERK null cells, but reconstitution of wild-type PERK in PERK null cells restored the apoptotic response. Force-induced apoptosis did not require PKR, GCN2, eIF2 alpha, or CHOP10. Furthermore, force more than 24 h did not activate other initiators of the unfolded protein response including IRE-1 and ATF6. However, force-induced activation of caspase 3 was dependent on caspase 9 but was independent of mitochondria. We conclude that force-induced apoptosis depends on a novel function of PERK that occurs in addition to its canonical role in the unfolded protein response.	[Mak, Baldwin C.; Wang, Qin; Laschinger, Carol; Lee, Wilson; McCulloch, Christopher A.] Univ Toronto, CIHR Grp Matrix Dynam, Toronto, ON M5S 3E2, Canada; [Ron, David; Harding, Heather P.] NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; [Kaufman, Randal J.; Scheuner, Donalyn] Univ Michigan, Med Ctr, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.; Scheuner, Donalyn] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.; Scheuner, Donalyn] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; [Austin, Richard C.] McMaster Univ, Div Nephrol, Hamilton, ON L8N 4A6, Canada	University of Toronto; New York University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; McMaster University	McCulloch, CA (corresponding author), Univ Toronto, CIHR Grp Matrix Dynam, Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	mcculloch@utoronto.ca		Harding, Heather P/0000-0002-7359-7974; Ron, David/0000-0002-3014-5636	National Institutes of Health [DK47119, ES08681, HL052173, DK42394]; Canadian Institutes of Health Research [418386]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173, P01HL057346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042394, R01DK047119, R29DK047119, R01DK042394, R37DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK47119 and ES08681 (to D. R. and H. P. H.) and HL052173 and DK42394 (to R. J. K.). This work was also supported by Canadian Institutes of Health Research Grant 418386 (to B. C. M., Q. W., C. L., W. L., and C. A. M.).	Arora PD, 2001, J BIOL CHEM, V276, P14100, DOI 10.1074/jbc.M010298200; CHENG W, 1995, J CLIN INVEST, V96, P2247, DOI 10.1172/JCI118280; GLOGAUER M, 1995, AM J PHYSIOL-CELL PH, V269, pC1093, DOI 10.1152/ajpcell.1995.269.5.C1093; Glogauer M, 1997, J CELL SCI, V110, P11; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hughes-Fulford Millie, 2004, Sci STKE, V2004, pRE12; Kainulainen T, 2002, J BIOL CHEM, V277, P21998, DOI 10.1074/jbc.M200715200; Kuhn K, 2004, OSTEOARTHR CARTILAGE, V12, P1, DOI 10.1016/j.joca.2003.09.015; KULKARNI GV, 1995, J CELL PHYSIOL, V165, P119, DOI 10.1002/jcp.1041650115; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Malek AM, 1996, J CELL SCI, V109, P713; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; PENDER N, 1991, J CELL SCI, V100, P187; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; ROBERTS WE, 1974, ARCH ORAL BIOL, V19, P665, DOI 10.1016/0003-9969(74)90135-6; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Tran H, 2002, J CELL SCI, V115, P2031; Wang J, 2005, BIOCHEM BIOPH RES CO, V330, P123, DOI 10.1016/j.bbrc.2005.02.140; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamaguchi M, 2005, ARCH IMMUNOL THER EX, V53, P388; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	38	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23462	23472		10.1074/jbc.M803194200	http://dx.doi.org/10.1074/jbc.M803194200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550523	hybrid, Green Published			2022-12-25	WOS:000258455400055
J	Buzza, MS; Dyson, JM; Choi, H; Gardiner, EE; Andrews, RK; Kaiserman, D; Mitchell, CA; Berndt, MC; Dong, JF; Bird, PI				Buzza, Marguerite S.; Dyson, Jennifer M.; Choi, Hiuwan; Gardiner, Elizabeth E.; Andrews, Robert K.; Kaiserman, Dion; Mitchell, Christina A.; Berndt, Michael C.; Dong, Jing-Fei; Bird, Phillip I.			Antihemostatic activity of human granzyme B mediated by cleavage of von Willebrand factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE GLYCOPROTEIN-IB; INDUCED PLATELET-AGGREGATION; VONWILLEBRAND-FACTOR; IIB-IIIA; IX-V; RHEUMATOID-ARTHRITIS; PROTEASE GRANZYME; FACTOR-BINDING; CATHEPSIN-G; CELL-DEATH	The cytotoxic lymphocyte protease granzyme B (GrB) is elevated in the plasma of individuals with diseases that elicit a cytotoxic lymphocyte-mediated immune response. Given the recently recognized ability of GrB to cleave extracellular matrix proteins, we examined the effect of GrB on the pro-hemostatic molecule von Willebrand factor (VWF). GrB delays ristocetin-induced platelet aggregation and inhibits platelet adhesion and spreading on immobilized VWF under static conditions. It efficiently cleaves VWF at two sites within the A1-3 domains that are essential for the VWF-platelet interaction. Like the VWF regulatory proteinase ADAMTS-13, GrB-mediated cleavage is dependent upon VWF conformation. In vitro, GrB cannot cleave the VWF conformer found in solution, but cleavage is induced when VWF is artificially unfolded or presented as a matrix. GrB cleaves VWF with comparable efficiency to ADAMTS-13 and rapidly processes ultra-large VWF multimers released from activated endothelial cells under physiological shear. GrB also cleaves the matrix form of fibrinogen at several sites. These studies suggest extracellular GrB may help control localized coagulation during inflammation.	[Buzza, Marguerite S.; Dyson, Jennifer M.; Kaiserman, Dion; Mitchell, Christina A.; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Choi, Hiuwan; Dong, Jing-Fei] Baylor Coll Med, Thrombosis Res Sect, Dept Med, Houston, TX 77030 USA; [Gardiner, Elizabeth E.; Andrews, Robert K.; Berndt, Michael C.] Monash Univ, Dept Immunol, Alfred Med Res & Educ Precinct, Melbourne, Vic 3004, Australia	Monash University; Baylor College of Medicine; Monash University	Bird, PI (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	phil.bird@med.monash.edu.au	Gardiner, Elizabeth/P-8716-2019; Berndt, Michael C/D-5580-2012; Gardiner, Elizabeth/E-7774-2011	Gardiner, Elizabeth/0000-0001-9453-9688; Bird, Phillip/0000-0002-6695-606X; Andrews, Robert Keith/0000-0001-9577-8082; Mitchell, Christina A/0000-0001-9372-3192				Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020; Andrews RK, 2003, INT J BIOCHEM CELL B, V35, P1170, DOI 10.1016/S1357-2725(02)00280-7; ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8326, DOI 10.1021/bi00447a010; Banno F, 2006, BLOOD, V107, P3161, DOI 10.1182/blood-2005-07-2765; Bennett JS, 2001, ANN NY ACAD SCI, V936, P340; BERNDT MC, 1985, EUR J BIOCHEM, V151, P637, DOI 10.1111/j.1432-1033.1985.tb09152.x; BERNDT MC, 1988, BIOCHEMISTRY-US, V27, P633, DOI 10.1021/bi00402a021; Bird CH, 2005, MOL CELL BIOL, V25, P7854, DOI 10.1128/MCB.25.17.7854-7867.2005; Bonnefoy A, 2000, THROMB RES, V98, P323, DOI 10.1016/S0049-3848(99)00242-X; BOOTH WJ, 1984, BIOCHEM BIOPH RES CO, V118, P495, DOI 10.1016/0006-291X(84)91330-5; Borthakur G, 2003, J THROMB HAEMOST, V1, P1288, DOI 10.1046/j.1538-7836.2003.00156.x; Buzza MS, 2006, BIOL CHEM, V387, P827, DOI 10.1515/BC.2006.106; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; Canobbio H, 2004, CELL SIGNAL, V16, P1329, DOI 10.1016/j.cellsig.2004.05.008; Chamberlain CM, 2007, CAN J PHYSIOL PHARM, V85, P89, DOI 10.1139/Y06-090; Chang AK, 2005, J BACTERIOL, V187, P6909, DOI 10.1128/JB.187.20.6909-6916.2005; Choy JC, 2004, ARTERIOSCL THROM VAS, V24, P2245, DOI 10.1161/01.ATV.0000147162.51930.b7; Choy JC, 2003, MODERN PATHOL, V16, P460, DOI 10.1097/01.MP.0000067424.12280.BC; CLEMETSON KJ, 1981, P NATL ACAD SCI-BIOL, V78, P2712, DOI 10.1073/pnas.78.5.2712; De Cristofaro R, 2005, J BIOL CHEM, V280, P23295, DOI 10.1074/jbc.M501143200; De Cristofaro R, 2006, J BIOL CHEM, V281, P30400, DOI 10.1074/jbc.M603321200; De Luca M, 2000, BLOOD, V95, P164; Dong JF, 2005, J THROMB HAEMOST, V3, P1710, DOI 10.1111/j.1538-7836.2005.01360.x; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Dyson JM, 2003, BLOOD, V102, P940, DOI 10.1182/blood-2002-09-2897; ESCOLAR G, 1988, BRIT J HAEMATOL, V69, P379, DOI 10.1111/j.1365-2141.1988.tb02377.x; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; FURLAN M, 1987, BIOCHIM BIOPHYS ACTA, V924, P27, DOI 10.1016/0304-4165(87)90067-5; Goldbach-Mansky R, 2005, ANN RHEUM DIS, V64, P715, DOI 10.1136/ard.2003.007039; Hamako J, 1998, THROMB HAEMOSTASIS, V80, P499, DOI 10.1055/s-0037-1615236; Hermsen CC, 2003, CLIN EXP IMMUNOL, V132, P467, DOI 10.1046/j.1365-2249.2003.02160.x; HOWARD MA, 1971, THROMB DIATH HAEMOST, V26, P362; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Kim WJ, 2007, IMMUNOL LETT, V111, P57, DOI 10.1016/j.imlet.2007.05.004; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Majerus EM, 2005, J BIOL CHEM, V280, P21773, DOI 10.1074/jbc.M502529200; Marshall SJ, 2002, BIOCHEM J, V361, P297, DOI 10.1042/0264-6021:3610297; MEYER D, 1991, MAYO CLIN PROC, V66, P516, DOI 10.1016/S0025-6196(12)62394-5; MOAKE JL, 1986, J CLIN INVEST, V78, P1456, DOI 10.1172/JCI112736; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Nishio K, 2004, P NATL ACAD SCI USA, V101, P10578, DOI 10.1073/pnas.0402041101; Pardo J, 2007, CELL DEATH DIFFER, V14, P1768, DOI 10.1038/sj.cdd.4402183; PETERSON DM, 1987, BLOOD, V69, P625; Pimanda J, 2002, BLOOD REV, V16, P185, DOI 10.1016/S0268-960X(02)00017-6; POE M, 1991, J BIOL CHEM, V266, P98; Rayes J, 2007, J THROMB HAEMOST, V5, P321, DOI 10.1111/j.1538-7836.2007.02296.x; Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; SADLER JE, 1993, THROMB HAEMOSTASIS, V69, P185; SADLER JE, 1991, J BIOL CHEM, V266, P22777; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Skjelland M, 2007, ATHEROSCLEROSIS, V195, pE142, DOI 10.1016/j.atherosclerosis.2007.05.001; Strik MCM, 2007, MOL IMMUNOL, V44, P3462, DOI 10.1016/j.molimm.2007.03.024; Suidan HS, 1996, BIOCHEM J, V315, P939, DOI 10.1042/bj3150939; Tao ZY, 2005, BLOOD, V106, P141, DOI 10.1182/blood-2004-11-4188; TITANI K, 1987, P NATL ACAD SCI USA, V84, P5610, DOI 10.1073/pnas.84.16.5610; TSAI HM, 1994, BLOOD, V83, P2171; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Tsuru R, 2008, HEART, V94, P305, DOI 10.1136/hrt.2006.110023; Wowk ME, 2004, MICROBES INFECT, V6, P752, DOI 10.1016/j.micinf.2004.03.008	62	42	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22498	22504		10.1074/jbc.M709080200	http://dx.doi.org/10.1074/jbc.M709080200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18577516	hybrid			2022-12-25	WOS:000258321000018
J	Ichimura, Y; Kumanomidou, T; Sou, YS; Mizushima, T; Ezaki, J; Ueno, T; Kominami, E; Yamane, T; Tanaka, K; Komatsu, M				Ichimura, Yoshinobu; Kumanomidou, Taichi; Sou, Yu-shin; Mizushima, Tsunehiro; Ezaki, Junji; Ueno, Takashi; Kominami, Eiki; Yamane, Takashi; Tanaka, Keiji; Komatsu, Masaaki			Structural basis for sorting mechanism of p62 in selective autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN P62; CONSTITUTIVE AUTOPHAGY; MAMMALIAN HOMOLOG; CRYSTAL-STRUCTURE; ELECTRON-DENSITY; GENE-EXPRESSION; GABARAP; INCLUSIONS; SYSTEM; YEAST	Impairment of autophagic degradation of the ubiquitin- and LC3-binding protein "p62" leads to the formation of cytoplasmic inclusion bodies. However, little is known about the sorting mechanism of p62 to autophagic degradation. Here we identified a motif of murine p62 consisting of 11 amino acids (Ser(334)-Ser(344)) containing conserved acidic and hydrophobic residues across species, as an LC3 recognition sequence (LRS). The crystal structure of the LC3-LRS complex at 1.56 angstrom resolution revealed interaction of Trp(340) and Leu(343) of p62 with different hydrophobic pockets on the ubiquitin fold of LC3. In vivo analyses demonstrated that p62 mutants lacking LC3 binding ability accumulated without entrapping into autophagosomes in the cytoplasm and subsequently formed ubiquitin- positive inclusion bodies as in autophagy-deficient cells. These results demonstrate that the intracellular level of p62 is tightly regulated by autophagy through the direct interaction of LC3 with p62 and reveal that selective turnover of p62 via autophagy controls inclusion body formation.	[Ichimura, Yoshinobu; Sou, Yu-shin; Ezaki, Junji; Ueno, Takashi; Kominami, Eiki; Komatsu, Masaaki] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan; [Kumanomidou, Taichi; Mizushima, Tsunehiro; Yamane, Takashi] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Sou, Yu-shin; Tanaka, Keiji; Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Komatsu, Masaaki] Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan	Juntendo University; Nagoya University; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST)	Komatsu, M (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan.	mkomatsu@rinshoken.or.jp	Komatsu, Masaaki/B-8321-2011; Kominami, Eiki/D-3802-2009	Komatsu, Masaaki/0000-0001-7672-7722; Sou, Yu-shin/0000-0002-7219-9106; Mizushima, Tsunehiro/0000-0002-6631-2889				Amar N, 2006, EMBO REP, V7, P635, DOI 10.1038/sj.embor.7400698; Bavro VN, 2002, EMBO REP, V3, P183, DOI 10.1093/embo-reports/kvf026; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; LEE GH, 1995, AM J PATHOL, V147, P1811; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano T, 2004, ACTA NEUROPATHOL, V107, P359, DOI 10.1007/s00401-004-0821-7; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Watsuji T, 1997, BIOCHEM BIOPH RES CO, V234, P769, DOI 10.1006/bbrc.1997.6705; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	44	567	586	2	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22847	22857		10.1074/jbc.M802182200	http://dx.doi.org/10.1074/jbc.M802182200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18524774	hybrid			2022-12-25	WOS:000258321000052
J	Sumandea, MP; Rybin, VO; Hinken, AC; Wang, C; Kobayashi, T; Harleton, E; Sievert, G; Balke, CW; Feinmark, SJ; Solaro, RJ; Steinberg, SF				Sumandea, Marius P.; Rybin, Vitalyi O.; Hinken, Aaron C.; Wang, Chaojian; Kobayashi, Tomoyoshi; Harleton, Erin; Sievert, Gail; Balke, C. William; Feinmark, Steven J.; Solaro, R. John; Steinberg, Susan F.			Tyrosine phosphorylation modifies protein kinase C delta-dependent phosphorylation of cardiac troponin I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION LOOP PHOSPHORYLATION; OXIDATIVE STRESS; PKC-EPSILON; CARDIOMYOCYTES; SITES; CONTRACTILITY; MYOFILAMENTS; MYOCARDIUM; MECHANISMS; KNOCKOUT	Our study identifies tyrosine phosphorylation as a novel protein kinase C delta(PKC delta) activation mechanism that modifies PKC delta-dependent phosphorylation of cardiac troponin I (cTnI), a myofilament regulatory protein. PKC delta phosphorylates cTnI at Ser(23)/Ser(24) when activated by lipid cofactors; Src phosphorylates PKC delta at Tyr(311) and Tyr(332) leading to enhanced PKC delta autophosphorylation at Thr(505) (its activation loop) and PKC delta-dependent cTnI phosphorylation at both Ser(23)/Ser(24) and Thr(144). The Src-dependent acquisition of cTnI-Thr(144) kinase activity is abrogated by Y311F or T505A substitutions. Treatment of detergent-extracted single cardiomyocytes with lipid-activated PKC delta induces depressed tension at submaximum but not maximum [Ca2+] as expected for cTnI-Ser(23)/ Ser(24) phosphorylation. Treatment of myocytes with Src-activated PKC delta leads to depressed maximum tension and cross-bridge kinetics, attributable to a dominant effect of cTnI-Thr144 phosphorylation. Our data implicate PKC delta-Tyr311/ Thr505 phosphorylation as dynamically regulated modifications that alter PKC delta enzymology and allow for stimulus-specific control of cardiac mechanics during growth factor stimulation and oxidative stress.	[Rybin, Vitalyi O.; Wang, Chaojian; Harleton, Erin; Feinmark, Steven J.; Steinberg, Susan F.] Columbia Univ, Dept Pharmacol, Coll Phys & Surg, New York, NY 10032 USA; [Sumandea, Marius P.; Sievert, Gail; Balke, C. William] Univ Kentucky, Cardiovasc Res Ctr, Dept Internal Med, Lexington, KY 40536 USA; [Hinken, Aaron C.; Kobayashi, Tomoyoshi; Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Cardiovasc Res Ctr, Chicago, IL 60612 USA	Columbia University; University of Kentucky; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Steinberg, SF (corresponding author), Columbia Univ, Dept Pharmacol, Coll Phys & Surg, 630 W 168 St, New York, NY 10032 USA.	sfs1@columbia.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064035, R01HL071865, P01HL062426, R01HL077860, T32HL007692] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 62426, P01 HL062426, HL 71865, T32 HL007692, HL 64035, R01 HL077860, R01 HL064035, HL 77860] Funding Source: Medline; PHS HHS [T32 007692] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P99, DOI 10.1023/B:MCBI.0000041852.42291.aa; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Hinken AC, 2004, AM J PHYSIOL-CELL PH, V287, pC500, DOI 10.1152/ajpcell.00049.2004; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Huang XP, 1999, CIRC RES, V84, P1; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Kruger M, 2005, J PHYSIOL-LONDON, V564, P347, DOI 10.1113/jphysiol.2004.079095; LeWinter MM, 2002, J CARD FAIL, V8, pS271, DOI 10.1054/jcaf.2002.129276; Liu Y, 2006, J BIOL CHEM, V281, P12102, DOI 10.1074/jbc.M600508200; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Newton AC, 2004, TRENDS PHARMACOL SCI, V25, P175, DOI 10.1016/j.tips.2004.02.010; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; Patel JR, 2001, AM J PHYSIOL-HEART C, V280, pH2732, DOI 10.1152/ajpheart.2001.280.6.H2732; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Rybin VO, 2007, J BIOL CHEM, V282, P23631, DOI 10.1074/jbc.M701676200; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; Rybin VO, 2003, J BIOL CHEM, V278, P14555, DOI 10.1074/jbc.M212644200; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Sumandea MP, 2004, ANN NY ACAD SCI, V1015, P39, DOI 10.1196/annals.1302.004; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Westfall MV, 2005, J BIOL CHEM, V280, P41324, DOI 10.1074/jbc.M506043200; Wolska BM, 1996, AM J PHYSIOL-HEART C, V270, pH24, DOI 10.1152/ajpheart.1996.270.1.H24	28	51	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22680	22689		10.1074/jbc.M802396200	http://dx.doi.org/10.1074/jbc.M802396200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18550549	Green Published, hybrid			2022-12-25	WOS:000258321000037
J	Luo, RB; Randazzo, PA				Luo, Ruibai; Randazzo, Paul A.			Kinetic analysis of Arf GAP1 indicates a regulatory role for coatomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; ADP-RIBOSYLATION FACTOR; COPI VESICLES; N-TERMINUS; ARFGAP1; DOMAIN; HYDROLYSIS; ASAP1; PURIFICATION; DYNAMICS	Arf GAPs are a family of enzymes that catalyze the hydrolysis of GTP bound to Arf. Arf GAP1 is one member of the family that has a critical role in membrane traffic at the Golgi apparatus. Two distinct models for the regulation of Arf GAP1 in membrane traffic have been proposed. In one model, Arf GAP1 functions in a ternary complex with coat proteins and is inhibited by cargo proteins. In another model, Arf GAP1 is recruited to a membrane surface that has defects created by the increased membrane curvature that accompanies transport vesicle formation. Here we have used kinetic and mutational analysis to test predictions of models of regulation of Arf GAP1. We found that Arf GAP1 has a similar affinity for Arf1.GTP as another Arf GAP, ASAP1, but the catalytic rate is approximate to 0.5% that of ASAP1. Coatomer stimulated Arf GAP1 activity; however, different from that predicted from the current model, coatomer affected the K-m and not the k(cat) values. Effects of most mutations in Arf GAP1 paralleled those in ASAP1. Mutation of an arginine that aligned with an arginine presumed to be catalytic in ASAP1 abrogated activity. Peptide from the cytoplasmic tail of cargo proteins inhibited Arf GAP1; however, the unrelated Arf GAP ASAP1 was also inhibited. The curvature of the lipid bilayer had a small effect on activity of Arf GAP1 under the conditions of our experiments. We conclude that coatomer is an allosteric regulator of Arf GAP1. The relevance of the results to the two models of Arf GAP1-mediated regulation of Arf1 is discussed.	[Luo, Ruibai; Randazzo, Paul A.] NCI, NIH, Cellular & Mol Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Randazzo, PA (corresponding author), NCI, NIH, Cellular & Mol Biol Lab, Ctr Canc Res, Bldg 37,Rm 2042, Bethesda, MD 20892 USA.	randazzo@helix.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC007365, Z01BC007365] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; CASSEL D, 2003, ARF FAMILY GTPASES, P157; CHA S, 1968, J BIOL CHEM, V243, P820; Che MM, 2005, METHOD ENZYMOL, V404, P147, DOI 10.1016/S0076-6879(05)04015-2; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Frigerio G, 2007, TRAFFIC, V8, P1644, DOI 10.1111/j.1600-0854.2007.00631.x; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Huber I, 1998, J BIOL CHEM, V273, P24786, DOI 10.1074/jbc.273.38.24786; Huber I, 2001, METHOD ENZYMOL, V329, P307; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Luo RB, 2005, CURR BIOL, V15, P2164, DOI 10.1016/j.cub.2005.10.065; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Mesmin B, 2007, BIOCHEMISTRY-US, V46, P1779, DOI 10.1021/bi062288w; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; NIXON AE, 1995, BIOCHEMISTRY-US, V34, P15592, DOI 10.1021/bi00047a026; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; RANDAZZO PA, 1995, METHOD ENZYMOL, V250, P394; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Randazzo PA, 2001, METHOD ENZYMOL, V329, P343; RANDAZZO PA, 1994, J BIOL CHEM, V269, P29490; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Rothman JE, 2002, NAT MED, V8, P1059, DOI 10.1038/nm770; Szafer E, 2000, J BIOL CHEM, V275, P23615, DOI 10.1074/jbc.M003171200; Weiss M, 2003, TRAFFIC, V4, P65, DOI 10.1034/j.1600-0854.2003.40202.x; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Yoon HY, 2004, CELL SIGNAL, V16, P1033, DOI 10.1016/j.cellsig.2004.02.008; Zhang CJ, 2003, YEAST, V20, P315, DOI 10.1002/yea.966; Zhang CJ, 1998, J BIOL CHEM, V273, P19792, DOI 10.1074/jbc.273.31.19792; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418	50	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21965	21977		10.1074/jbc.M802268200	http://dx.doi.org/10.1074/jbc.M802268200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18541532	hybrid, Green Published			2022-12-25	WOS:000258114700016
J	Le Rouzic, E; Morel, M; Ayinde, D; Belaidouni, N; Letienne, J; Transy, C; Margottin-Goguet, F				Le Rouzic, Erwann; Morel, Marina; Ayinde, Diana; Belaidouni, Nadia; Letienne, Justine; Transy, Catherine; Margottin-Goguet, Florence			Assembly with the Cul4A-DDB1(DCAF1) ubiquitin ligase protects HIV-1 vpr from proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-CYCLE ARREST; E7 ONCOPROTEIN; X-PROTEIN; BETA-TRCP; COMPLEX; BINDING; INTERACTS; STATE; DDB1	Many viruses subvert the host ubiquitin-proteasome system to optimize their life cycle. We recently documented such a mechanism for the human immunodeficiency virus type 1 Vpr protein, which promotes cell cycle arrest by recruiting the DCAF1 adaptor of the Cul4A-DDB1 ubiquitin ligase, a finding now confirmed by several groups. Here we examined the impact of Cul4A-DDB1(DCAF1) on Vpr stability. We show that the Vpr(Q65R) mutant, which is defective in DCAF1 binding, undergoes proteasome-mediated degradation at a higher rate than wild-type Vpr. DCAF1 overexpression stabilizes wild-type Vpr and leads to its cytoplasmic accumulation, whereas it has no effect on the Vpr(Q65R) mutant. Conversely, small interfering RNA-mediated silencing of DCAF1 decreases the steady state amount of the viral protein. Stabilization by DCAF1, which is conserved by Vpr species from human immunodeficiency virus type 2 and the SIVmac strain, results in increased G(2) arrest and requires the presence of DDB1, indicating that it occurs through assembly of Vpr with a functional Cul4A-DDB1(DCAF1) complex. Furthermore, in human immunodeficiency virus type 1-infected cells, the Vpr protein, issued from the incoming viral particle, is destabilized under DCAF1 or DDB1 silencing. Together with our previous findings, our data suggest that Cul4A-DDB1(DCAF1) acts at a dual level by providing Vpr with the equipment for the degradation of specific host proteins and by counteracting its proteasome targeting by another cellular E3 ubiquitin ligase. This protection mechanism may represent an efficient way to optimize the activity of Vpr molecules that are delivered by the incoming virus before neosynthesis takes place. Targeting the Vpr-DCAF1 interaction might therefore present therapeutic interest.	[Transy, Catherine] Univ Paris 05, CNRS, UMR 8104, Inst Cochin,Dept Malad Infect, F-75014 Paris, France; [Le Rouzic, Erwann; Morel, Marina; Ayinde, Diana; Belaidouni, Nadia; Letienne, Justine; Transy, Catherine] INSERM, U567, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Transy, C (corresponding author), Univ Paris 05, CNRS, UMR 8104, Inst Cochin,Dept Malad Infect, Batiment Gustave Roussy,27 Rue Faubourg St Jacque, F-75014 Paris, France.	transy@cochin.inserm.fr; margottin-goguet@cochin.inserm.fr	Margottin-Goguet, Florence/F-9272-2013	Margottin-Goguet, Florence/0000-0002-3124-6690; Morel, Marina/0000-0001-6610-3772				Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5; Barry Michele, 2006, Sci STKE, V2006, ppe21; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Bergametti F, 2002, J BIOMED SCI, V9, P706, DOI 10.1159/000067287; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; Estrabaud E, 2007, PLOS PATHOG, V3, P995, DOI 10.1371/journal.ppat.0030104; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; Kehmeier E, 2002, VIROLOGY, V299, P72, DOI 10.1006/viro.2002.1502; Kewalramani VN, 1996, VIROLOGY, V218, P159, DOI 10.1006/viro.1996.0176; LANG SM, 1993, J VIROL, V67, P902, DOI 10.1128/JVI.67.2.902-912.1993; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Leupin O, 2003, J VIROL, V77, P6274, DOI 10.1128/JVI.77.11.6274-6283.2003; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Oh KJ, 2004, J VIROL, V78, P5338, DOI 10.1128/JVI.78.10.5338-5346.2004; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Poon B, 1998, SCIENCE, V281, P266, DOI 10.1126/science.281.5374.266; Precious BL, 2007, VIROLOGY, V368, P114, DOI 10.1016/j.virol.2007.06.024; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wu JT, 2006, TRENDS CELL BIOL, V16, P362, DOI 10.1016/j.tcb.2006.05.001; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang SG, 2001, GENE, V263, P131, DOI 10.1016/S0378-1119(00)00583-7; Zhu YH, 2001, J VIROL, V75, P3791, DOI 10.1128/JVI.75.8.3791-3801.2001	33	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21686	21692		10.1074/jbc.M710298200	http://dx.doi.org/10.1074/jbc.M710298200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18524771	hybrid			2022-12-25	WOS:000257898800042
J	Pandey, MS; Harris, EN; Weigel, JA; Weigel, PH				Pandey, Madhu S.; Harris, Edward N.; Weigel, Janet A.; Weigel, Paul H.			The cytoplasmic domain of the hyaluronan receptor for endocytosis (HARE) contains multiple endocytic motifs targeting coated pit-mediated internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER ENDOTHELIAL-CELLS; DENSITY-LIPOPROTEIN RECEPTOR; FACTOR-II RECEPTOR; RAPID INTERNALIZATION; ALPHA-ADAPTIN; NPXY MOTIFS; BINDING; PROTEIN; ACID; SIGNALS	The hyaluronic acid (HA) receptor for endocytosis (HARE) is the primary scavenger receptor for HA and chondroitin sulfates in mammals. The two human isoforms of HARE (full-length 315-kDa and a 190-kDa proteolytic cleavage product), which are type I single-pass membrane proteins, are highly expressed in sinusoidal endothelial cells of lymph nodes, liver, and spleen. Their identical HARE cytoplasmic domains contain four candidate AP-2/clathrin-mediated endocytic signaling motifs as follows: YSYFRI2485, FQHF(2495), NPLY2519, and DPF2534 (315-HARE numbering). Stably transfected cells expressing 190-HARE(Delta YSYFRI), 190-HARE(Delta FQHF), or 190-HARE(Delta NPLY) (lacking Motifs 1,2, or 3) had decreased I-125-HA endocytosis rates of similar to 49, similar to 39, and similar to 56%, respectively (relative to wild type). In contrast, 190-HARE(Delta DPF) cells (lacking Motif 4) showed no change in HA endocytic rate. Deletions of motifs 1 and 2 or of 1, 2, and 4 decreased the rate of HA endocytosis by only similar to 41%. Endocytosis was similar to 95% decreased in mutants lacking all four motifs. Cells expressing a 190-HARE(Y2519A) mutant of the NPLY motif retained 85-90% of wild type endocytosis, whereas this mutation in the triple motif deletant decreased endocytosis to similar to 7% of wild type. Tyr in NPLY2519 is thus important for endocytosis. All HARE mutants showed similar HA binding and degradation of the internalized HA, indicating that altering endocytic motifs did not affect ectodomain binding of HA or targeting of internalized HA to lysosomes. We conclude that, although NPLY may be the most important motif, it functions together with two other endocytic motifs; thus three signal sequences (YSYFRI, FQHF, and NPLY) provide redundancy to mediate coated pit targeting and endocytosis of HARE.	Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Weigel, PH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	paul-weigel@ouhsc.edu	Harris, Edward N/A-1596-2011		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069961] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 69961, R01 GM069961] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Clague MJ, 2001, J CELL SCI, V114, P3075; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; FILARDO EJ, 1995, J CELL BIOL, V130, P441, DOI 10.1083/jcb.130.2.441; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Hjalm G, 1996, EUR J BIOCHEM, V239, P132, DOI 10.1111/j.1432-1033.1996.0132u.x; HSU D, 1994, ENDOCRINOLOGY, V134, P744, DOI 10.1210/en.134.2.744; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; IACOPETTA BJ, 1988, CELL, V54, P485, DOI 10.1016/0092-8674(88)90069-4; JADOT M, 1992, J BIOL CHEM, V267, P11069; Kawakami K, 2001, J BIOL CHEM, V276, P25114, DOI 10.1074/jbc.M100936200; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; McDonald J, 2002, J BIOL CHEM, V277, P4575, DOI 10.1074/jbc.R100064200; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; McGary CT, 2003, METHOD ENZYMOL, V363, P354; MCGARY CT, 1993, HEPATOLOGY, V18, P1465, DOI 10.1002/hep.1840180628; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mills IG, 2007, SEMIN CELL DEV BIOL, V18, P459, DOI 10.1016/j.semcdb.2007.07.001; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; RAJA RH, 1984, ANAL BIOCHEM, V139, P168, DOI 10.1016/0003-2697(84)90402-0; RAJA RH, 1988, J BIOL CHEM, V263, P16661; RAJASEKARAN AK, 1994, MOL BIOL CELL, V5, P1093, DOI 10.1091/mbc.5.10.1093; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; SMEDSROD B, 1988, CELL TISSUE RES, V253, P39; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; TAMMI R, 1991, J INVEST DERMATOL, V97, P126, DOI 10.1111/1523-1747.ep12478553; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; THOMAS WG, 1995, J BIOL CHEM, V270, P22153, DOI 10.1074/jbc.270.38.22153; Vignoud L, 1997, J CELL SCI, V110, P1421; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; Weigel JA, 2003, J BIOL CHEM, V278, P42802, DOI 10.1074/jbc.M307201200; WEIGEL PH, 1983, ANAL BIOCHEM, V133, P437, DOI 10.1016/0003-2697(83)90106-9; Weigel PH, 2003, METHOD ENZYMOL, V363, P382; Weigel PH, 2002, BBA-GEN SUBJECTS, V1572, P341, DOI 10.1016/S0304-4165(02)00318-5; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; YannarielloBrown J, 1997, GLYCOBIOLOGY, V7, P15, DOI 10.1093/glycob/7.1.15; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zhou B, 1999, J BIOL CHEM, V274, P33831, DOI 10.1074/jbc.274.48.33831; Zhou B, 2003, GLYCOBIOLOGY, V13, P339, DOI 10.1093/glycob/cwg029; Zhou B, 2002, MOL BIOL CELL, V13, P2853, DOI 10.1091/mbc.02-03-0048; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200	64	50	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21453	21461		10.1074/jbc.M800886200	http://dx.doi.org/10.1074/jbc.M800886200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539600	Green Published, hybrid			2022-12-25	WOS:000257898800017
J	Archange, C; Nowak, J; Garcia, S; Moutardier, V; Calvo, EL; Dagorn, JC; Iovanna, JL				Archange, Cendrine; Nowak, Jonathan; Garcia, Stephane; Moutardier, Vincent; Calvo, Ezequiel Luis; Dagorn, Jean-Charles; Iovanna, Juan Lucio			The WSB1 Gene Is Involved in Pancreatic Cancer Progression	PLOS ONE			English	Article								Background: Pancreatic cancer cells generate metastases because they can survive the stress imposed by the new environment of the host tissue. To mimic this process, pancreatic cancer cells which are not stressed in standard culture conditions are injected into nude mice. Because they develop xenografts, they should have developed adequate stress response. Characterizing that response might provide new strategies to interfere with pancreatic cancer metastasis. Methodology/Principal Findings: In the human pancreatic cancer cell lines Panc-1, Mia-PaCa2, Capan-1, Capan-2 and BxPC3, we used Affymetrix DNA microarrays to compare the expressions of 22.000 genes in vitro and in the corresponding xenografts. We identified 228 genes overexpressed in xenografts and characterized the implication of one of them, WSB1, in the control of apoptosis and cell proliferation. WSB1 generates 3 alternatively spliced transcripts encoding distinct protein isoforms. In xenografts and in human pancreatic tumors, global expression of WSB1 mRNA is modestly increased whereas isoform 3 is strongly overexpressed and isoforms 1 and 2 are down-regulated. Treating Mia-PaCa2 cells with stress-inducing agents induced similar changes. Whereas retrovirus-forced expression of WSB1 isoforms 1 and 2 promoted cell growth and sensitized the cells to gemcitabine- and doxorubicin-induced apoptosis, WSB1 isoform 3 expression reduced cell proliferation and enhanced resistance to apoptosis, showing that stress-induced modulation of WSB1 alternative splicing increases resistance to apoptosis of pancreatic cancer cells. Conclusions/Significance: Data on WSB1 regulation support the hypothesis that activation of stress-response mechanisms helps cancer cells establishing metastases and suggest relevance to cancer development of other genes overexpressed in xenografts.	[Archange, Cendrine; Nowak, Jonathan; Garcia, Stephane; Moutardier, Vincent; Dagorn, Jean-Charles; Iovanna, Juan Lucio] INSERM, U624, F-13258 Marseille, France; [Calvo, Ezequiel Luis] CHUL Res Ctr, Mol Endocrinol & Oncol Res Ctr, Ste Foy, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Laval University	Archange, C (corresponding author), INSERM, U624, Parc Sci & Technol Luminy, F-13258 Marseille, France.	iovanna@marseille.inserm.fr	Iovanna, Juan/M-9805-2017	Iovanna, Juan/0000-0003-1822-2237	INSERM; La Ligue; Canceropole PACA; INCA	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); La Ligue; Canceropole PACA(Region Grand-Est); INCA(Institut National du Cancer (INCA) France)	INSERM, La Ligue, Canceropole PACA, INCA	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; Brand R, 2001, CANCER J, V7, P287; Brand RE, 2000, MED CLIN N AM, V84, P665, DOI 10.1016/S0025-7125(05)70249-2; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Dias CS, 2006, CANCER RES, V66, P9467, DOI 10.1158/0008-5472.CAN-05-3013; Ghanima A, 2002, BRAIN RES PROTOC, V9, P1, DOI 10.1016/S1385-299X(01)00123-4; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; Missiaglia E, 2004, INT J CANCER, V112, P100, DOI 10.1002/ijc.20376; Postier RG, 2003, AM J SURG, V186, P579, DOI 10.1016/j.amjsurg.2003.08.018; Tamm E, 2001, CANCER J, V7, P298; Tanabe N, 2007, PLANT CELL PHYSIOL, V48, P1036, DOI 10.1093/pcp/pcm069; Turpin E, 1999, ONCOGENE, V18, P7834, DOI 10.1038/sj.onc.1203196; Vasiliauskas D, 1999, MECH DEVELOP, V82, P79, DOI 10.1016/S0925-4773(99)00014-3; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25	17	29	31	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2475	10.1371/journal.pone.0002475	http://dx.doi.org/10.1371/journal.pone.0002475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575577	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000007
J	Casas, F; Pessemesse, L; Grandemange, S; Seyer, P; Gueguen, N; Baris, O; Lepourry, L; Cabello, G; Wrutniak-Cabello, C				Casas, Francois; Pessemesse, Laurence; Grandemange, Stephanie; Seyer, Pascal; Gueguen, Naig; Baris, Olivier; Lepourry, Laurence; Cabello, Gerard; Wrutniak-Cabello, Chantal			Overexpression of the Mitochondrial T3 Receptor p43 Induces a Shift in Skeletal Muscle Fiber Types	PLOS ONE			English	Article								In previous studies, we have characterized a new hormonal pathway involving a mitochondrial T3 receptor (p43) acting as a mitochondrial transcription factor and consequently stimulating mitochondrial activity and mitochondrial biogenesis. We have established the involvement of this T3 pathway in the regulation of in vitro myoblast differentiation. We have generated mice overexpressing p43 under control of the human alpha-skeletal actin promoter. In agreement with the previous characterization of this promoter, northern-blot and western-blot experiments confirmed that after birth p43 was specifically overexpressed in skeletal muscle. As expected from in vitro studies, in 2-month old mice, p43 overexpression increased mitochondrial genes expression and mitochondrial biogenesis as attested by the increase of mitochondrial mass and mt-DNA copy number. In addition, transgenic mice had a body temperature 0.8 degrees C higher than control ones and displayed lower plasma triiodothyronine levels. Skeletal muscles of transgenic mice were redder than wild-type animals suggesting an increased oxidative metabolism. In line with this observation, in gastrocnemius, we recorded a strong increase in cytochrome oxidase activity and in mitochondrial respiration. Moreover, we observed that p43 drives the formation of oxidative fibers: in soleus muscle, where MyHC IIa fibers were partly replaced by type I fibers; in gastrocnemius muscle, we found an increase in MyHC IIa and IIx expression associated with a reduction in the number of glycolytic fibers type IIb. In addition, we found that PGC-1 alpha and PPARd, two major regulators of muscle phenotype were up regulated in p43 transgenic mice suggesting that these proteins could be downstream targets of mitochondrial activity. These data indicate that the direct mitochondrial T3 pathway is deeply involved in the acquisition of contractile and metabolic features of muscle fibers in particular by regulating PGC-1 alpha and PPAR delta.	[Casas, Francois; Pessemesse, Laurence; Grandemange, Stephanie; Seyer, Pascal; Gueguen, Naig; Baris, Olivier; Lepourry, Laurence; Cabello, Gerard; Wrutniak-Cabello, Chantal] INRA, Differenciat Cellulaire & Croissance UMR866, F-34060 Montpellier, France; [Casas, Francois; Pessemesse, Laurence; Grandemange, Stephanie; Seyer, Pascal; Gueguen, Naig; Baris, Olivier; Lepourry, Laurence; Cabello, Gerard; Wrutniak-Cabello, Chantal] Univ Montpellier I, Montpellier, France; [Casas, Francois; Pessemesse, Laurence; Grandemange, Stephanie; Seyer, Pascal; Gueguen, Naig; Baris, Olivier; Lepourry, Laurence; Cabello, Gerard; Wrutniak-Cabello, Chantal] Univ Montpellier 2, Montpellier, France	INRAE; Universite de Montpellier; Universite de Montpellier	Casas, F (corresponding author), INRA, Differenciat Cellulaire & Croissance UMR866, F-34060 Montpellier, France.	casasf@supagro.inra.fr	Grandemange, Stéphanie/G-7928-2015; Baris, Olivier R/L-3463-2016	Baris, Olivier R/0000-0003-0974-6856; Francois, Casas/0000-0002-5535-8195	Institut National de la Recherche Agronomique (INRA); Association Francaise contre les Myopathies (AFM); Ministere de la Recherche et de l'Enseignement [fellowships]; INRA [fellowships]	Institut National de la Recherche Agronomique (INRA); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Ministere de la Recherche et de l'Enseignement; INRA	This work was supported by grants from the Institut National de la Recherche Agronomique (INRA), the Association Francaise contre les Myopathies (AFM). Stephanie Grandemange, Pascal Seyer, Naig Gueguen and Olivier Baris are recipient of fellowships from, respectively, the Ministere de la Recherche et de l'Enseignement (SG and MB) and INRA (PS, NG and OB).	AUSONI S, 1990, J NEUROSCI, V10, P153; BERGMEYER HU, 1963, ENZYMES BIOL REAGENT, V1, P443; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; BRENT GA, 1991, ANNU REV PHYSIOL, V53, P17, DOI 10.1146/annurev.ph.53.030191.000313; BUTLERBROWNE GS, 1984, FEBS LETT, V166, P71, DOI 10.1016/0014-5793(84)80047-2; Casas F, 1999, MOL CELL BIOL, V19, P7913; Casas F, 2000, FEBS LETT, V478, P4, DOI 10.1016/S0014-5793(00)01814-7; Casas F, 2003, FASEB J, V17, P426, DOI 10.1096/fj.02-0732com; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Grandemange S, 2005, CANCER RES, V65, P4282, DOI 10.1158/0008-5472.CAN-04-3652; Gueguen N, 2005, COMP BIOCHEM PHYS B, V140, P287, DOI 10.1016/j.cbpc.2004.10.014; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; KING DB, 1987, J EXP ZOOL, P291; Kunz WS, 2000, J BIOL CHEM, V275, P27741; Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; MUSCAT GEO, 1987, MOL CELL BIOL, V7, P4089, DOI 10.1128/MCB.7.11.4089; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Potts W, 2000, BIOCHEM BIOPH RES CO, V273, P1015, DOI 10.1006/bbrc.2000.3013; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Saelim N, 2004, J CELL BIOL, V167, P915, DOI 10.1083/jcb.200409011; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; SEYER PGS, 2008, MITOCHONDRIAL ACTIVI; SUGIE H, 1985, MUSCLE NERVE, V8, P654, DOI 10.1002/mus.880080805; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wharton DC., 1967, METHOD ENZYMOL, P245; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347; Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067	34	47	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2501	10.1371/journal.pone.0002501	http://dx.doi.org/10.1371/journal.pone.0002501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575627	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288000023
J	Greenstein, RJ; Su, LY; Juste, RA; Brown, ST				Greenstein, Robert J.; Su, Liya; Juste, Ramon A.; Brown, Sheldon T.			On the Action of Cyclosporine A, Rapamycin and Tacrolimus on M. avium Including Subspecies paratuberculosis	PLOS ONE			English	Article							CROHNS-DISEASE; MYCOBACTERIUM-PARATUBERCULOSIS; IMMUNOSUPPRESSIVE DRUGS; OPEN-LABEL; PHARMACOKINETICS; METHOTREXATE; MANAGEMENT; AY-22,989; EFFICACY; THERAPY	Background: Mycobacterium avium subspecies paratuberculosis (MAP) may be zoonotic. Recently the "immuno-modulators'' methotrexate, azathioprine and 6-MP and the "anti-inflammatory'' 5-ASA have been shown to inhibit MAP growth in vitro. We concluded that their most plausible mechanism of action is as antiMAP antibiotics. The "immunosuppressants'' Cyclosporine A, Rapamycin and Tacrolimus (FK 506) treat a variety of "autoimmune'' and "inflammatory'' diseases. Rapamycin and Tacrolimus are macrolides. We hypothesized that their mode of action may simply be to inhibit MAP growth. Methodology: The effect on radiometric MAP (CO2)-C-14 growth kinetics of Cyclosporine A, Rapamycin and Tacrolimus on MAP cultured from humans (Dominic & UCF 4) or ruminants (ATCC 19698 & 303) and M. avium subspecies avium (ATCC 25291 & 101) are presented as "percent decrease in cumulative GI'' (%-Delta cGI.) Principal Findings: The positive control clofazimine has 99%-Delta cGI at 0.5 mu g/ml (Dominic). Phthalimide, a negative control has no dose dependent inhibition on any strain. Against MAP there is dose dependent inhibition by the immunosuppressants. Cyclosporine has 97%-Delta cGI by 32 mu g/ml (Dominic), Rapamycin has 74%-Delta cGI by 64 mu g/ml (UCF 4) and Tacrolimus 43%-Delta cGI by 64 mu g/ml (UCF 4) Conclusions: We show heretofore-undescribed inhibition of MAP growth in vitro by "immunosuppressants;'' the cyclic undecapeptide Cyclosporine A, and the macrolides Rapamycin and Tacrolimus. These data are compatible with our thesis that, unknowingly, the medical profession has been treating MAP infections since 1942 when 5-ASA and subsequently azathioprine, 6-MP and methotrexate were introduced in the therapy of some "autoimmune'' and "inflammatory'' diseases.	[Greenstein, Robert J.] Vet Affairs Med Ctr, Dept Surg, Bronx, NY USA; [Greenstein, Robert J.; Su, Liya] Vet Affairs Med Ctr, Lab Mol Surg Res, Bronx, NY USA; [Brown, Sheldon T.] Vet Affairs Med Ctr, Dept Med, Bronx, NY USA; [Juste, Ramon A.] Inst Vasco Investigat Desarrollo Agrario, Derio, Spain	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Greenstein, RJ (corresponding author), Vet Affairs Med Ctr, Dept Surg, Bronx, NY USA.	BGAxis@aol.com	Juste, Ramon/C-3570-2008	Juste, Ramon/0000-0001-6037-5873				Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; Ayele WY, 2005, APPL ENVIRON MICROB, V71, P1210, DOI 10.1128/AEM.71.3.1210-1214.2005; Balfour IC, 2006, J HEART LUNG TRANSPL, V25, P518, DOI 10.1016/j.healun.2006.01.004; BARROW WW, 1993, ANTIMICROB AGENTS CH, V37, P652, DOI 10.1128/AAC.37.4.652; Baumgart DC, 2006, AM J GASTROENTEROL, V101, P1048, DOI 10.1111/j.1572-0241.2006.00524.x; BERTRAM MA, 1986, J INFECT DIS, V154, P194, DOI 10.1093/infdis/154.1.194; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Borody TJ, 2002, DIGEST LIVER DIS, V34, P29, DOI 10.1016/S1590-8658(02)80056-1; Bowman LJ, 2008, EXPERT OPIN PHARMACO, V9, P635, DOI 10.1517/14656566.9.4.635; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; BRYNSKOV J, 1992, SCAND J GASTROENTERO, V27, P961, DOI 10.3109/00365529209000171; BRYNSKOV J, 1991, DIGEST DIS, V9, P236, DOI 10.1159/000171308; Bull TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001229; BUSCHMAN E, 1997, NONSPECIFIC RESISTAN, P51; Caprilli R, 2005, DIGEST LIVER DIS, V37, P407, DOI 10.1016/j.dld.2004.12.013; CARLSON RP, 1993, J PHARMACOL EXP THER, V266, P1125; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; DALZEIL TK, 1913, BRIT MED J, V2, P1068; DAMATO JJ, 1990, VET MICROBIOL, V22, P31, DOI 10.1016/0378-1135(90)90122-C; Dasananjali K, 1997, INT J LEPROSY, V65, P28; de Oca J, 2003, REV ESP ENFERM DIG, V95, P465; Ellingson JLE, 2005, J FOOD PROTECT, V68, P966, DOI 10.4315/0362-028X-68.5.966; Flytstrom I, 2008, BRIT J DERMATOL, V158, P116, DOI 10.1111/j.1365-2133.2007.08284.x; Foroncewicz B, 2005, TRANSPL INT, V18, P366, DOI 10.1111/j.1432-2277.2004.00070.x; Grant IR, 2002, APPL ENVIRON MICROB, V68, P602, DOI 10.1128/AEM.68.2.602-607.2002; Greenstein RJ, 2004, LANCET, V364, P396, DOI 10.1016/S0140-6736(04)16781-0; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000161; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000516; HANAUER SB, 1993, AM J GASTROENTEROL, V88, P646; Hermon-Taylor J, 2004, PATHOGENIC MYCOBACTE, P74; Hines ME, 2007, VET MICROBIOL, V120, P261, DOI 10.1016/j.vetmic.2006.10.030; Hughes AP, 2000, JAMA-J AM MED ASSOC, V284, P1546, DOI 10.1001/jama.284.12.1546; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; JOHNE HA, 1895, DTSCH Z TIERMED PATH, V21, P438; KAY AB, 1994, ALLERGY PROC, V15, P147, DOI 10.2500/108854194778702838; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; Kitahara K, 2007, CURR OPIN RHEUMATOL, V19, P238, DOI 10.1097/BOR.0b013e328099af80; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; LINDHOLM A, 1993, CLIN PHARMACOL THER, V54, P205, DOI 10.1038/clpt.1993.132; Liu SF, 1997, EMBO J, V16, P143, DOI 10.1093/emboj/16.1.143; LOBO AJ, 1991, J CLIN GASTROENTEROL, V13, P42, DOI 10.1097/00004836-199102000-00010; Masuda S, 2006, PHARMACOL THERAPEUT, V112, P184, DOI 10.1016/j.pharmthera.2006.04.006; MEINGASSNER JG, 1992, J INVEST DERMATOL, V98, P851, DOI 10.1111/1523-1747.ep12456939; Meng Q, 1997, ALLERGY, V52, P1095, DOI 10.1111/j.1398-9995.1997.tb00181.x; Mishina D, 1996, P NATL ACAD SCI USA, V93, P9816, DOI 10.1073/pnas.93.18.9816; Murphy GJ, 2003, TRANSPL INT, V16, P347, DOI 10.1111/j.1432-2277.2003.tb00311.x; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Ng SC, 2007, INFLAMM BOWEL DIS, V13, P129, DOI 10.1002/ibd.20052; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Okada T, 2007, HEPATO-GASTROENTEROL, V54, P2129; RASTOGI N, 1992, ANTIMICROB AGENTS CH, V36, P2843, DOI 10.1128/AAC.36.12.2843; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; Selby W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/j.gastro.2007.03.031; Shin SJ, 2008, ANTIMICROB AGENTS CH, V52, P418, DOI 10.1128/AAC.00678-07; SINGH K, 1979, J ANTIBIOT, V32, P630, DOI 10.7164/antibiotics.32.630; Small PM, 2001, NEW ENGL J MED, V345, P189, DOI 10.1056/NEJM200107193450307; Spencer CM, 1997, DRUGS, V54, P925, DOI 10.2165/00003495-199754060-00009; Sugawara Y, 2002, CLIN TRANSPLANT, V16, P102, DOI 10.1034/j.1399-0012.2002.1o106.x; TAMURA F, 1990, TRANSPLANTATION, V49, P20, DOI 10.1097/00007890-199001000-00005; vanderPijl JW, 1996, TRANSPLANTATION, V62, P456, DOI 10.1097/00007890-199608270-00006; Verstappen SMM, 2007, ANN RHEUM DIS, V66, P1443, DOI 10.1136/ard.2007.071092; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; WERA S, 1995, FEBS LETT, V358, P158, DOI 10.1016/0014-5793(94)01416-X; Wong SHY, 2001, CLIN CHIM ACTA, V313, P241, DOI 10.1016/S0009-8981(01)00678-7; Yeager N, 2008, CANCER RES, V68, P444, DOI 10.1158/0008-5472.CAN-07-3030; Zhou JY, 2008, VACCINE	68	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2496	10.1371/journal.pone.0002496	http://dx.doi.org/10.1371/journal.pone.0002496			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575598	Green Submitted, gold, Green Published			2022-12-25	WOS:000263288000020
J	Park, S; Hwang, H; Nam, SW; Martinez, F; Austin, RH; Ryu, WS				Park, Sungsu; Hwang, Hyejin; Nam, Seong-Won; Martinez, Fernando; Austin, Robert H.; Ryu, William S.			Enhanced Caenorhabditis elegans Locomotion in a Structured Microfluidic Environment	PLOS ONE			English	Article								Background: Behavioral studies of Caenorhabditis elegans traditionally are done on the smooth surface of agar plates, but the natural habitat of C. elegans and other nematodes is the soil, a complex and structured environment. In order to investigate how worms move in such environments, we have developed a technique to study C. elegans locomotion in microstructures fabricated from agar. Methodology/Principal Findings: When placed in open, liquid-filled, microfluidic chambers containing a square array of posts, we discovered that worms are capable of a novel mode of locomotion, which combines the fast gait of swimming with the more efficient movements of crawling. When the wavelength of the worms matched the periodicity of the post array, the microstructure directed the swimming and increased the speed of C. elegans ten-fold. We found that mutants defective in mechanosensation (mec-4, mec-10) or mutants with abnormal waveforms (unc-29) did not perform this enhanced locomotion and moved much more slowly than wild-type worms in the microstructure. Conclusion/Significance: These results show that the microstructure can be used as a behavioral screen for mechanosensory and uncoordinated mutants. It is likely that worms use mechanosensation in the movement and navigation through heterogeneous environments.	[Park, Sungsu; Hwang, Hyejin; Nam, Seong-Won] Ewha Womans Univ, Div Nanosci BK21, Seoul, South Korea; [Martinez, Fernando; Austin, Robert H.] Princeton Univ, Dept Phys, Princeton, NJ USA; [Ryu, William S.] Princeton Univ, Lewis Sigler Inst Integrative Genom, Princeton, NJ USA	Ewha Womans University; Princeton University; Princeton University	Park, S (corresponding author), Ewha Womans Univ, Div Nanosci BK21, Seoul, South Korea.	wsryu@princeton.edu	Park, Sungsu/AAF-4792-2020; Park, Sungsu/L-1920-2013	Park, Sungsu/0000-0003-3062-1302; 	Nano/Bio Science & Technology Program, Ministry of Science and Technology (MOST) [M10536090002-05, N3609-00210]; SRC program of the Korea Science and Engineering Foundation (KOSEF)	Nano/Bio Science & Technology Program, Ministry of Science and Technology (MOST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); SRC program of the Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation)	Nano/Bio Science & Technology Program (M10536090002-05 N3609-00210) of the Ministry of Science and Technology (MOST) and the SRC program of the Korea Science and Engineering Foundation (KOSEF)	Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1985, J NEUROSCI, V5, P956; CROLL NA, 1975, J ZOOL, V176, P159, DOI 10.1111/j.1469-7998.1975.tb03191.x; DiLuzio WR, 2005, NATURE, V435, P1271, DOI 10.1038/nature03660; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Goodman MB, 2003, ANNU REV PHYSIOL, V65, P429, DOI 10.1146/annurev.physiol.65.092101.142659; GRAY J, 1964, J EXP BIOL, V41, P135; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; LOCKERY SR, 2008, J NEUROPHYSIOLOGY; Park S, 2003, P NATL ACAD SCI USA, V100, P13910, DOI 10.1073/pnas.1935975100; Qin JH, 2007, LAB CHIP, V7, P186, DOI 10.1039/b613414a; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Stiernagle T., 1999, C ELEGANS PRACTICAL, P51; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	17	83	86	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2550	10.1371/journal.pone.0002550	http://dx.doi.org/10.1371/journal.pone.0002550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575618	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288000051
J	Yu, KM; Ge, J; Summers, JB; Li, F; Liu, X; Ma, P; Kaminski, J; Zhuang, J				Yu, Keming; Ge, Jian; Summers, James Bradley; Li, Fan; Liu, Xuan; Ma, Ping; Kaminski, Joseph; Zhuang, Jing			TSP-1 Secreted by Bone Marrow Stromal Cells Contributes to Retinal Ganglion Cell Neurite Outgrowth and Survival	PLOS ONE			English	Article								Background: Bone marrow stromal cells (BMSCs) are pluripotent and thereby a potential candidate for cell replacement therapy for central nervous system degenerative disorders and traumatic injury. However, the mechanism of their differentiation and effect on neural tissues has not been fully elucidated. This study evaluates the effect of BMSCs on neural cell growth and survival in a retinal ganglion cell (RGCs) model by assessing the effect of changes in the expression of a BMSC-secreted protein, thrombospondin-1 (TSP-1), as a putative mechanistic agent acting on RGCs. Methods and Findings: The effect of co-culturing BMSCs and RGCs in vitro was evaluated by measuring the following parameters: neurite outgrowth, RGC survival, BMSC neural-like differentiation, and the effect of TSP-1 on both cell lines under basal secretion conditions and when TSP-1 expression was inhibited. Our data show that BMSCs improved RGC survival and neurite outgrowth. Synaptophysin, MAP-2, and TGF-beta expression are up-regulated in RGCs co-cultured with BMSCs. Interestingly, the BMSCs progressively displayed neural-like morphology over the seven-day study period. Restriction display polymerase chain reaction (RD-PCR) was performed to screen for differentially expressed genes in BMSCs cultured alone or co-cultured with RGCs. TSP-1, a multifactorial extracellular matrix protein, is critically important in the formation of neural connections during development, so its function in our co-culture model was investigated by small interfering RNA (siRNA) transfection. When TSP-1 expression was decreased with siRNA silencing, BMSCs had no impact on RGC survival, but reduced neurite outgrowth and decreased expression of synaptophysin, MAP-2 and TGF-beta in RGCs. Furthermore, the number of BMSCs with neural-like characteristics was significantly decreased by more than two-fold using siRNA silencing. Conclusions: Our data suggest that the TSP-1 signaling pathway might have an important role in neural-like differentiation in BMSCs and neurite outgrowth in RGCs. This study provides new insights into the potential reparative mechanisms of neural cell repair.	[Yu, Keming; Ge, Jian; Li, Fan; Liu, Xuan; Ma, Ping; Zhuang, Jing] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Summers, James Bradley] Univ S Alabama, Dept Radiol, Mobile, AL USA; [Kaminski, Joseph] Med Coll Georgia, Dept Radiol, Augusta, GA USA	Sun Yat Sen University; University of South Alabama; University System of Georgia; Augusta University	Yu, KM (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	joseph.kaminski@gmail.com; zhuangj@mail.sysu.edu.cn	Kaminski, Joseph/AAB-6493-2020	Kaminski, Joseph/0000-0002-7518-4962	Ministry of Science and Technology of P. R. China, Guangdong Province; Ministry of Education of P. R. China [2007CB512200, 06021308, 7001573, 20070558283]	Ministry of Science and Technology of P. R. China, Guangdong Province; Ministry of Education of P. R. China(Ministry of Education, China)	This research was supported by the grants from the Ministry of Science and Technology of P. R. China, Guangdong Province and the Ministry of Education of P. R. China)(#1 2007CB512200; #2 06021308; #3 7001573;#4 20070558283).	Adams JC, 1997, INT J BIOCHEM CELL B, V29, P861, DOI 10.1016/S1357-2725(96)00171-9; Adams JC, 2000, DEV DYNAM, V218, P280; ADAMS JC, 1993, J CELL SCI, V104, P1061; Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; ALDER J, 1992, SCIENCE, V257, P657, DOI 10.1126/science.1353905; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; BUEE L, 1992, AM J PATHOL, V141, P783; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; CHAMAK B, 1994, J NEUROSCI RES, V38, P221, DOI 10.1002/jnr.490380213; Chatila Khaled, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P21; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; CHEN Y, 2006, CELL MOL, V63, P1420; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Deng ZR, 2006, INT J CARDIOL, V113, P92, DOI 10.1016/j.ijcard.2006.06.014; Dhandapani KM, 2003, CELL BIOCHEM BIOPHYS, V39, P13, DOI 10.1385/CBB:39:1:13; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Geng L, 2004, CANCER RES, V64, P4893, DOI 10.1158/0008-5472.CAN-03-3955; Gomes FCA, 2005, INT J DEV NEUROSCI, V23, P413, DOI 10.1016/j.ijdevneu.2005.04.001; Goolsby J, 2003, P NATL ACAD SCI USA, V100, P14926, DOI 10.1073/pnas.2434383100; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Hoffman JR, 1999, BRAIN RES BULL, V48, P413, DOI 10.1016/S0361-9230(99)00021-0; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; HOGG PJ, 1993, J BIOL CHEM, V268, P21811; Hudson JE, 2004, J NEUROSCI RES, V76, P255, DOI 10.1002/jnr.20043; Irons H, 2004, CELL TRANSPLANT, V13, P283, DOI 10.3727/000000004783983990; ISAKOVA IA, 2006, STEM CELLS, V24, P2483; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOANNE E, 2001, J CLIN INVEST, V107, P785; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Koc ON, 2001, BONE MARROW TRANSPL, V27, P235, DOI 10.1038/sj.bmt.1702791; Konig HG, 2005, J CELL BIOL, V168, P1077, DOI 10.1083/jcb.200407027; Koshizuka S, 2004, J NEUROPATH EXP NEUR, V63, P64, DOI 10.1093/jnen/63.1.64; Liu CH, 2003, J BIOCHEM MOL BIOL, V36, P349; Liu GZ, 2007, FOREIGN LIT STUD, V29, P80; LIU Z, 2006, J NEUROSCI RES, V83, P1485; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mizobe Takashi, 2006, Kobe Journal of Medical Sciences, V52, P119; Ono K, 2003, J NEUROSCI RES, V72, P503, DOI 10.1002/jnr.10588; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; *OS INC, PHAS 3 TRIAL GRAFT V; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; Petrik JJ, 2002, BIOL REPROD, V67, P1522, DOI 10.1095/biolreprod.102.007153; Pira GL, 2006, HUM IMMUNOL, V67, P976, DOI 10.1016/j.humimm.2006.08.298; Ratajczak MZ, 2004, LEUKEMIA, V18, P29, DOI 10.1038/sj.leu.2403184; Saumet A, 2005, BLOOD, V106, P658, DOI 10.1182/blood-2004-09-3585; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Sun ZH, 2005, WORLD J GASTROENTERO, V11, P7579, DOI 10.3748/wjg.v11.i48.7579; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Uchida H, 2005, EXP EYE RES, V80, P23, DOI 10.1016/j.exer.2004.08.004; Uno K, 2005, HISTOL HISTOPATHOL, V20, P493, DOI 10.14670/HH-20.493; Uno K, 2004, BIOCHEM BIOPH RES CO, V315, P928, DOI 10.1016/j.bbrc.2004.01.146; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yamasaki M, 2005, BRAIN RES, V1050, P15, DOI 10.1016/j.brainres.2005.05.037; Yu KM, 2007, BIOCHEM BIOPH RES CO, V358, P990, DOI 10.1016/j.bbrc.2007.05.004; [余克明 Yu Keming], 2005, [中国病理生理杂志, Chinese Journal of Pathophysiology], V21, P6; Zhang C, 2006, NEUROSCIENCE, V141, P687, DOI 10.1016/j.neuroscience.2006.04.054; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhang J, 2004, BRAIN RES, V1030, P19, DOI 10.1016/j.brainres.2004.09.061; Zhang J, 2006, J NEUROSCI RES, V84, P587, DOI 10.1002/jnr.20962; ZHUANG J, 2001, ACAD J SUMS, V23, P24; ZHUANG J, 2002, J HISTO CYTO, V11, P121	68	42	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2470	10.1371/journal.pone.0002470	http://dx.doi.org/10.1371/journal.pone.0002470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575624	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000003
J	Bouchez, V; Caro, V; Levillain, E; Guigon, G; Guiso, N				Bouchez, Valerie; Caro, Valerie; Levillain, Erwan; Guigon, Ghislaine; Guiso, Nicole			Genomic Content of Bordetella pertussis Clinical Isolates Circulating in Areas of Intensive Children Vaccination	PLOS ONE			English	Article								Background: The objective of the study was to analyse the evolution of Bordetella pertussis population and the influence of herd immunity in different areas of the world where newborns and infants are highly vaccinated. Methodology: The analysis was performed using DNA microarray on 15 isolates, PCR on 111 isolates as well as GS-FLX sequencing technology on 3 isolates and the B. pertussis reference strain, Tohama I. Principal Findings: Our analyses demonstrate that the current circulating isolates are continuing to lose genetic material as compared to isolates circulating during the pre-vaccine era whatever the area of the world considered. The lost genetic material does not seem to be important for virulence. Our study confirms that the use of whole cell vaccines has led to the control of isolates that were similar to vaccine strains. GS-FLX sequencing technology shows that current isolates did not acquire any additional material when compared with vaccine strains or with isolates of the pre-vaccine era and that the sequenced strain Tohama I is not representative of the isolates. Furthermore, this technology allowed us to observe that the number of Insertion Sequence elements contained in the genome of the isolates is temporally increasing or varying between isolates. Conclusions: B. pertussis adaptation to humans is still in progress by losing genetic material via Insertion Sequence elements. Furthermore, recent isolates did not acquire any additional material when compared with vaccine strains or with isolates of the pre-vaccine era. Herd immunity, following intensive vaccination of infants and children with whole cell vaccines, has controlled isolates similar to the vaccine strains without modifying significantly the virulence of the isolates. With the replacement of whole cell vaccines by subunit vaccines, containing only few bacterial antigens targeting the virulence of the bacterium, one could hypothesize the circulation of isolates expressing less or modified vaccine antigens.	[Bouchez, Valerie; Caro, Valerie; Guiso, Nicole] Inst Pasteur, CNRS, Unite Prevent & Therapie Mol Malad Humaines, URA 3012, Paris, France; [Levillain, Erwan] Inst Pasteur, Lab Etudes Transcriptom Genom Appl, UMR 8161, IFR 142, Lille, France; [Guigon, Ghislaine] Inst Pasteur, Plateforme Sante Publ, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bouchez, V (corresponding author), Inst Pasteur, CNRS, Unite Prevent & Therapie Mol Malad Humaines, URA 3012, Paris, France.	nguiso@pasteur.fr	Bouchez, Valerie/AAG-1021-2020	Bouchez, Valerie/0000-0002-5947-6383	Institut Pasteur Fondation; URA [CNRS3012]; GlaxoSmithKline laboratories; Group Malakoff	Institut Pasteur Fondation; URA; GlaxoSmithKline laboratories(GlaxoSmithKline); Group Malakoff	This work was performed with the financial help of the Institut Pasteur Fondation, URA CNRS3012, GlaxoSmithKline laboratories and the Group Malakoff.	Brinig MM, 2006, J BACTERIOL, V188, P2375, DOI 10.1128/JB.188.7.2375-2382.2006; Caro V, 2005, MICROBES INFECT, V7, P976, DOI 10.1016/j.micinf.2005.04.005; Caro V, 2007, VACCINE, V25, P4335, DOI 10.1016/j.vaccine.2006.08.024; Caro V, 2006, MICROBES INFECT, V8, P2228, DOI 10.1016/j.micinf.2006.04.014; Caro V, 2006, EMERG INFECT DIS, V12, P987, DOI 10.3201/eid1206.051283; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; EDWARDS KM, 2004, VACCINES, P471; Gogol EB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-122; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; GUEIRARD P, 1995, J CLIN MICROBIOL, V33, P2002, DOI 10.1128/JCM.33.8.2002-2006.1995; Hallander H, 2007, J CLIN MICROBIOL, V45, P3257, DOI 10.1128/JCM.00864-07; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; KHELEF N, 1993, INFECT IMMUN, V61, P486, DOI 10.1128/IAI.61.2.486-490.1993; Kourova N, 2003, J CLIN MICROBIOL, V41, P3706, DOI 10.1128/JCM.41.8.3706-3711.2003; LAUTROP H, 1971, LANCET, V1, P1195; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; MOOI FR, 2007, BORDETELLA MOL MICRO, P17; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; NJAMKEPO E, 2006, BORDETELLA PERTUSSIS; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Soubeyrand B, 2002, NATURE, V417, P609, DOI 10.1038/417609b; Weber C, 2001, J CLIN MICROBIOL, V39, P4396, DOI 10.1128/JCM.39.12.4396-4403.2001; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; Wolfe DN, 2007, INFECT IMMUN, V75, P4972, DOI 10.1128/IAI.00763-07	27	53	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2437	10.1371/journal.pone.0002437	http://dx.doi.org/10.1371/journal.pone.0002437			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560590	Green Published, Green Submitted, gold			2022-12-25	WOS:000263280700022
J	Desikan, R; Horak, J; Chaban, C; Mira-Rodado, V; Witthoft, J; Elgass, K; Grefen, C; Cheung, MK; Meixner, AJ; Hooley, R; Neill, SJ; Hancock, JT; Harter, K				Desikan, Radhika; Horak, Jakub; Chaban, Christina; Mira-Rodado, Virtudes; Witthoeft, Janika; Elgass, Kirstin; Grefen, Christopher; Cheung, Man-Kim; Meixner, Alfred J.; Hooley, Richard; Neill, Steven John; Hancock, John Travers; Harter, Klaus			The Histidine Kinase AHK5 Integrates Endogenous and Environmental Signals in Arabidopsis Guard Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; INDUCED STOMATAL CLOSURE; HYDROGEN-PEROXIDE; ABSCISIC-ACID; REACTIVE OXYGEN; RESPONSE REGULATOR; FUNCTIONAL-ANALYSIS; OXIDATIVE STRESS; INNATE IMMUNITY; RECEPTOR FLS2	Background: Stomatal guard cells monitor and respond to environmental and endogenous signals such that the stomatal aperture is continually optimised for water use efficiency. A key signalling molecule produced in guard cells in response to plant hormones, light, carbon dioxide and pathogen-derived signals is hydrogen peroxide (H2O2). The mechanisms by which H2O2 integrates multiple signals via specific signalling pathways leading to stomatal closure is not known. Principal Findings: Here, we identify a pathway by which H2O2, derived from endogenous and environmental stimuli, is sensed and transduced to effect stomatal closure. Histidine kinases (HK) are part of two-component signal transduction systems that act to integrate environmental stimuli into a cellular response via a phosphotransfer relay mechanism. There is little known about the function of the HK AHK5 in Arabidopsis thaliana. Here we report that in addition to the predicted cytoplasmic localisation of this protein, AHK5 also appears to co-localise to the plasma membrane. Although AHK5 is expressed at low levels in guard cells, we identify a unique role for AHK5 in stomatal signalling. Arabidopsis mutants lacking AHK5 show reduced stomatal closure in response to H2O2, which is reversed by complementation with the wild type gene. Over-expression of AHK5 results in constitutively less stomatal closure. Abiotic stimuli that generate endogenous H2O2, such as darkness, nitric oxide and the phytohormone ethylene, also show reduced stomatal closure in the ahk5 mutants. However, ABA caused closure, dark adaptation induced H2O2 production and H2O2 induced NO synthesis in mutants. Treatment with the bacterial pathogen associated molecular pattern (PAMP) flagellin, but not elf peptide, also exhibited reduced stomatal closure and H2O2 generation in ahk5 mutants. Significance: Our findings identify an integral signalling function for AHK5 that acts to integrate multiple signals via H2O2 homeostasis and is independent of ABA signalling in guard cells.	[Desikan, Radhika] Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England; [Horak, Jakub; Chaban, Christina; Mira-Rodado, Virtudes; Witthoeft, Janika; Grefen, Christopher; Harter, Klaus] Univ Tubingen, Zentrum Molekularbiol Pflanzen Pflanzenphysiol, Tubingen, Germany; [Elgass, Kirstin; Meixner, Alfred J.] Univ Tubingen, Inst Phys & Theoretical Chem, Dept Nano Opt, Tubingen, Germany; [Hooley, Richard] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Desikan, Radhika; Cheung, Man-Kim; Neill, Steven John; Hancock, John Travers] Univ West England, Ctr Res Plant Sci, Bristol, Avon, England	Imperial College London; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Bath; University of West England	Desikan, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England.	r.desikan@ic.ac.uk; klaus.harter@zmbp.uni-tuebingen.de	Grefen, Christopher/AAH-4512-2020; Meixner, Alfred J./P-3260-2019	Grefen, Christopher/0000-0002-5820-4466; Meixner, Alfred J./0000-0002-0187-2906	Leverhulme Trust Early Career Fellowship; BBSRC; DFG [AFGN-Ha2146/5, Ha2146/7]	Leverhulme Trust Early Career Fellowship(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DFG(German Research Foundation (DFG))	This work was funded by a Leverhulme Trust Early Career Fellowship to RD, BBSRC grant to SJN, JTH and RH and DFG grants to KH (AFGN-Ha2146/5, Ha2146/7).	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bittel P, 2007, CURR OPIN PLANT BIOL, V10, P335, DOI 10.1016/j.pbi.2007.04.021; Blum C, 2001, J PHYS CHEM A, V105, P6983, DOI 10.1021/jp0031092; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; BRIGHT J, 2006, THESIS; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cooper CE, 2002, TRENDS BIOCHEM SCI, V27, P489, DOI 10.1016/S0968-0004(02)02191-6; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Desikan R, 2005, PLANT PHYSIOL, V137, P831, DOI 10.1104/pp.104.056994; Desikan R, 2004, FUNCT PLANT BIOL, V31, P913, DOI 10.1071/FP04035; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Desikan R, 2001, PLANT PHYSIOL, V126, P1579, DOI 10.1104/pp.126.4.1579; Desikan R, 1999, J EXP BOT, V50, P1863, DOI 10.1093/jexbot/50.341.1863; Desikan R, 2006, PLANT J, V47, P907, DOI 10.1111/j.1365-313X.2006.02842.x; Desikan R, 2005, BIOL SCI SER, P169, DOI 10.1002/9780470988565.ch7; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Grefen C, 2004, PLANTA, V219, P733, DOI 10.1007/s00425-004-1316-4; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Gudesblat GE, 2007, NEW PHYTOL, V173, P713, DOI 10.1111/j.1469-8137.2006.01953.x; Gupta R, 2003, PLANT PHYSIOL, V132, P1149, DOI 10.1104/pp.103.020792; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Horak J, 2003, PLANT BIOLOGY, V5, P245, DOI 10.1055/s-2003-40789; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; Hwang D, 2002, PLANT PHYSIOL, V129, P500, DOI 10.1104/pp.005504; Iwama A, 2007, PLANT CELL PHYSIOL, V48, P375, DOI 10.1093/pcp/pcl065; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Leymarie J, 1998, PLANT PHYSIOL BIOCH, V36, P539, DOI 10.1016/S0981-9428(98)80180-0; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Meinhard M, 2002, PLANTA, V214, P775, DOI 10.1007/s00425-001-0675-3; Meinhard M, 2001, FEBS LETT, V508, P443, DOI 10.1016/S0014-5793(01)03106-4; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Miao YC, 2006, PLANT CELL, V18, P2749, DOI 10.1105/tpc.106.044230; Mira-Rodado V, 2007, J EXP BOT, V58, P2595, DOI 10.1093/jxb/erm087; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Papon N, 2003, FEBS LETT, V537, P101, DOI 10.1016/S0014-5793(03)00102-9; Plesch G, 2001, PLANT J, V28, P455, DOI 10.1046/j.1365-313X.2001.01166.x; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; SCHLEIFENBAUM F, 2008, J PHYS CH B IN PRESS; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang PC, 2006, J INTEGR PLANT BIOL, V48, P62, DOI 10.1111/j.1744-7909.2006.00213.x; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	64	98	100	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2491	10.1371/journal.pone.0002491	http://dx.doi.org/10.1371/journal.pone.0002491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560512	gold, Green Published, Green Submitted			2022-12-25	WOS:000263280700055
J	Djelouadji, Z; Arnold, C; Gharbia, S; Raoult, D; Drancourt, M				Djelouadji, Zoheira; Arnold, Catherine; Gharbia, Saheer; Raoult, Didier; Drancourt, Michel			Multispacer Sequence Typing for Mycobacterium tuberculosis Genotyping	PLOS ONE			English	Article								Background: Genotyping methods developed to survey the transmission dynamics of Mycobacterium tuberculosis currently rely on the interpretation of restriction and amplification profiles. Multispacer sequence typing (MST) genotyping is based on the sequencing of several intergenic regions selected after complete genome sequence analysis. It has been applied to various pathogens, but not to M. tuberculosis. Methods and Findings: In M. tuberculosis, the MST approach yielded eight variable intergenic spacers which included four previously described variable number tandem repeat loci, one single nucleotide polymorphism locus and three newly evaluated spacers. Spacer sequence stability was evaluated by serial subculture. The eight spacers were sequenced in a collection of 101 M. tuberculosis strains from five phylogeographical lineages, and yielded 29 genetic events including 13 tandem repeat number variations (44.82%), 11 single nucleotide mutations (37.93%) and 5 deletions (17.24%). These 29 genetic events yielded 32 spacer alleles or spacer-types (ST) with an index of discrimination of 0.95. The distribution of M. tuberculosis isolates into ST profiles correlated with their assignment into phylogeographical lineages. Blind comparison of a further 93 M. tuberculosis strains by MST and restriction fragment length polymorphism-IS6110 fingerprinting and mycobacterial interspersed repetitive units typing, yielded an index of discrimination of 0.961 and 0.992, respectively. MST yielded 41 different profiles delineating 16 related groups and proved to be more discriminatory than IS6110-based typing for isolates containing M<8 IS6110 copies (P<0.0003). MST was successfully applied to 7/10 clinical specimens exhibiting a Cts <= 42 cycles in internal transcribed spacer-real time PCR. Conclusions: These results support MST as an alternative, sequencing-based method for genotyping low IS6110 copy-number M. tuberculosis strains. The M. tuberculosis MST database is freely available (http://ifr48.timone.univ-mrs.fr/MST_MTuberculosis/mst).	[Djelouadji, Zoheira; Raoult, Didier; Drancourt, Michel] Univ Mediterranee, Fac Med, CNRS, IFR 48,Unite Rickettsies UMR6236, Marseille, France; [Arnold, Catherine; Gharbia, Saheer] Hlth Protect Agcy, Ctr Infect, Appl & Funct Genom Unit, London, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Health Protection Agency	Djelouadji, Z (corresponding author), Univ Mediterranee, Fac Med, CNRS, IFR 48,Unite Rickettsies UMR6236, Marseille, France.	Michel.Drancourt@medecine.univ-mrs.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974	l'Oeuvre Antituberculeuse des Bouches-du-Rhone, Marseille	l'Oeuvre Antituberculeuse des Bouches-du-Rhone, Marseille	This work was supported by l'Oeuvre Antituberculeuse des Bouches-du-Rhone, Marseille.	Arnold C, 2006, FEMS MICROBIOL LETT, V256, P340, DOI 10.1111/j.1574-6968.2006.00142.x; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Barlow REL, 2001, J CLIN MICROBIOL, V39, P2453, DOI 10.1128/JCM.39.7.2453-2457.2001; Bauer J, 1999, J CLIN MICROBIOL, V37, P2602, DOI 10.1128/JCM.37.8.2602-2606.1999; Benson G, 1999, Proc Int Conf Intell Syst Mol Biol, P44; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Braden CR, 2002, EMERG INFECT DIS, V8, P1210; BRANDER E, 1992, J CLIN MICROBIOL, V30, P1972, DOI 10.1128/JCM.30.8.1972-1975.1992; Burman WJ, 1997, AM J RESP CRIT CARE, V155, P1140, DOI 10.1164/ajrccm.155.3.9117000; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowan LS, 2002, J CLIN MICROBIOL, V40, P1592, DOI 10.1128/JCM.40.5.1592-1602.2002; de la Salmoniere YOLG, 2004, J CLIN MICROBIOL, V42, P2913, DOI 10.1128/JCM.42.7.2913-2918.2004; DJELOUADJI Z, 2008, PLOS NTD IN PRESS; Djelouagji Z, 2006, J CLIN MICROBIOL, V44, P1594, DOI 10.1128/JCM.44.4.1594-1595.2006; Drancourt M, 2004, EMERG INFECT DIS, V10, P1585, DOI 10.3201/eid1009.030933; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Evans JT, 2004, J CLIN MICROBIOL, V42, P4175, DOI 10.1128/JCM.42.9.4175-4180.2004; Ferdinand S, 2004, RES MICROBIOL, V155, P647, DOI 10.1016/j.resmic.2004.04.013; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Foucault C, 2005, J CLIN MICROBIOL, V43, P41, DOI 10.1128/JCM.43.1.41-48.2005; Fournier PE, 2004, J CLIN MICROBIOL, V42, P5757, DOI 10.1128/JCM.42.12.5757-5766.2004; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Goyal M, 1997, J CLIN MICROBIOL, V35, P647, DOI 10.1128/JCM.35.3.647-651.1997; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Gutacker MM, 2002, GENETICS, V162, P1533; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kanduma E, 2003, J APPL MICROBIOL, V94, P781, DOI 10.1046/j.1365-2672.2003.01918.x; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Li WJ, 2006, J CLIN MICROBIOL, V44, P2499, DOI 10.1128/JCM.00498-06; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Radhakrishnan I, 2001, J CLIN MICROBIOL, V39, P1683, DOI 10.1128/JCM.39.4.1683.2001; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Sebban M, 2002, BIOINFORMATICS, V18, P235, DOI 10.1093/bioinformatics/18.2.235; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; van Coppenraet ESB, 2004, J CLIN MICROBIOL, V42, P2644, DOI 10.1128/JCM.42.6.2644-2650.2004; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; VARNEROT A, 1992, FEMS MICROBIOL LETT, V98, P155; ZHANG YS, 1992, J CLIN MICROBIOL, V30, P1551, DOI 10.1128/JCM.30.6.1551-1556.1992; Zhu Y, 2005, J CLIN MICROBIOL, V43, P4708, DOI 10.1128/JCM.43.9.4708-4712.2005	51	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2433	10.1371/journal.pone.0002433	http://dx.doi.org/10.1371/journal.pone.0002433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560597	Green Published, gold, Green Submitted			2022-12-25	WOS:000263280700018
J	Muller, MS; Brennecke, JF; Porter, ET; Ottinger, MA; Anderson, DJ				Mueller, Martina S.; Brennecke, Julius F.; Porter, Elaine T.; Ottinger, Mary Ann; Anderson, David J.			Perinatal Androgens and Adult Behavior Vary with Nestling Social System in Siblicidal Boobies	PLOS ONE			English	Article							NAZCA BOOBIES; SEXUAL-DIFFERENTIATION; YOLK ANDROGENS; TESTOSTERONE; EVOLUTION; PATTERNS; SULIDAE; PLASMA; BRAIN; QUAIL	Background: Exposure to androgens early in development, while activating adaptive aggressive behavior, may also exert long-lasting effects on non-target components of phenotype. Here we compare these organizational effects of perinatal androgens in closely related Nazca (Sula granti) and blue-footed (S. nebouxii) boobies that differ in neonatal social system. The older of two Nazca booby hatchlings unconditionally attacks and ejects the younger from the nest within days of hatching, while blue-footed booby neonates lack lethal aggression. Both Nazca booby chicks facultatively upregulate testosterone (T) during fights, motivating the prediction that baseline androgen levels differ between obligately siblicidal and other species. Methodology/Principal Findings: We show that obligately siblicidal Nazca boobies hatch with higher circulating androgen levels than do facultatively siblicidal blue-footed boobies, providing comparative evidence of the role of androgens in sociality. Although androgens confer a short-term benefit of increased aggression to Nazca booby neonates, exposure to elevated androgen levels during this sensitive period in development can also induce long-term organizational effects on behavior or morphology. Adult Nazca boobies show evidence of organizational effects of early androgen exposure in aberrant adult behavior: they visit unattended non-familial chicks in the colony and direct mixtures of aggression, affiliative, and sexual behavior toward them. In a longitudinal analysis, we found that the most active Non-parental Adult Visitors (NAVs) were those with a history of siblicidal behavior as a neonate, suggesting that the tendency to show social interest in chicks is programmed, in part, by the high perinatal androgens associated with obligate siblicide. Data from closely related blue-footed boobies provide comparative support for this interpretation. Lacking obligate siblicide, they hatch with a corresponding low androgen level, and blue-footed booby adults show a much lower frequency of NAV behavior and a lower probability of behaving aggressively during NAV interactions. This species difference in adult social behavior appears to have roots in both pleiotropic and experiential effects of nestling social system. Conclusions/Significance: Our results indicate that Nazca boobies experience life-long consequences of androgenic preparation for an early battle to the death.	[Mueller, Martina S.; Porter, Elaine T.; Anderson, David J.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Brennecke, Julius F.] Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY USA; [Ottinger, Mary Ann] Univ Maryland, College Pk, MD USA	Wake Forest University; Cold Spring Harbor Laboratory; University System of Maryland; University of Maryland College Park	Muller, MS (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	da@wfu.edu	Brennecke, Julius/C-1626-2015; Brennecke, Julius/T-5883-2019	Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814	National Science Foundation; Division Of Environmental Biology [0842199] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation	ADKINS E K, 1975, Journal of Comparative and Physiological Psychology, V89, P61, DOI 10.1037/h0076406; ADKINS EK, 1979, NEUROENDOCRINOLOGY, V29, P178, DOI 10.1159/000122920; ADKINSREGAN E, 1994, J NEUROBIOL, V25, P865, DOI 10.1002/neu.480250710; ANDERSON DJ, 1989, BEHAV ECOL SOCIOBIOL, V25, P363, DOI 10.1007/BF00302994; ANDERSON DJ, 1990, AM NAT, V135, P334, DOI 10.1086/285049; Anderson DJ, 2004, BEHAVIOUR, V141, P959, DOI 10.1163/1568539042360134; ANDERSON DJ, 1993, ECOLOGY, V74, P2462, DOI 10.2307/1939597; ANDERSON DJ, 1993, BIRDS N AM, V73; Apanius V., 2008, ORNITHOL MONOGR, V65; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CADIOU B, 1994, ANIM BEHAV, V47, P847, DOI 10.1006/anbe.1994.1116; Clifford LD, 2001, J ANIM ECOL, V70, P539, DOI 10.1046/j.1365-2656.2001.00521.x; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; DRUMMOND H, 1986, BEHAV ECOL SOCIOBIOL, V19, P365, DOI 10.1007/BF00295710; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Ferree ED, 2004, HORM BEHAV, V46, P655, DOI 10.1016/j.yhbeh.2004.06.009; Friesen VL, 1997, MOL PHYLOGENET EVOL, V7, P252, DOI 10.1006/mpev.1996.0397; Humphries CA, 2006, OECOLOGIA, V147, P379, DOI 10.1007/s00442-005-0264-4; Lougheed LW, 1999, BEHAV ECOL SOCIOBIOL, V45, P11, DOI 10.1007/s002650050535; Maness TJ, 2007, WATERBIRDS, V30, P10, DOI 10.1675/1524-4695(2007)030[0010:OSRVIN]2.0.CO;2; Navara KJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P570, DOI 10.1086/430689; NELSON J.B., 1978, SULIDAE GANNETS BOOB; Ottinger MA, 2001, POULTRY SCI, V80, P795, DOI 10.1093/ps/80.6.795; Pfaff D.W., 2002, HORMONES BRAIN BEHAV; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; PORTER ET, 2003, THESIS WAKE FOREST U; ROBINSON SK, 1988, ANIM BEHAV, V36, P1482, DOI 10.1016/S0003-3472(88)80219-7; Romano M, 2005, HORM BEHAV, V48, P342, DOI 10.1016/j.yhbeh.2005.03.007; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P549, DOI 10.1007/s00265-005-0080-1; Rubolini D, 2007, P ROY SOC B-BIOL SCI, V274, P137, DOI 10.1098/rspb.2006.3696; SAAL FSV, 1989, J ANIM SCI, V67, P1824; Strasser R, 2004, BEHAV ECOL SOCIOBIOL, V56, P491, DOI 10.1007/s00265-004-0810-9; Tarlow EM, 2003, HORM BEHAV, V43, P402, DOI 10.1016/S0018-506X(03)00011-4; Townsend HM, 2002, OECOLOGIA, V132, P419, DOI 10.1007/s00442-002-0992-7; Uller T, 2005, BEHAV ECOL SOCIOBIOL, V57, P584, DOI 10.1007/s00265-004-0886-2; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; [No title captured]	37	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2460	10.1371/journal.pone.0002460	http://dx.doi.org/10.1371/journal.pone.0002460			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560542	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000263280700041
J	Raby, E; Moyo, M; Devendra, A; Banda, J; De Haas, P; Ayles, H; Godfrey-Faussett, P				Raby, Edward; Moyo, Maureen; Devendra, Akash; Banda, Joseph; De Haas, Petra; Ayles, Helen; Godfrey-Faussett, Peter			The Effects of HIV on the Sensitivity of a Whole Blood IFN-gamma Release Assay in Zambian Adults with Active Tuberculosis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; T-CELLS; PREVALENCE; INFECTION; DIAGNOSIS; METAANALYSIS; RESPONSES; DISEASES	Background: Interferon gamma release assays (IGRA) are replacing the tuberculin skin test (TST) as a diagnostic tool for Mycobacterium tuberculosis infection. However research into the test's performance in the high HIV-TB burden setting is scarce. This study aimed to define the sensitivity of an IGRA, QuantiFERON-TB (R) Gold In-Tube (QGIT), in adult Zambian patients with active smear-positive tuberculosis. Secondary outcomes focussed on the effect of HIV on the test's performance. Principal Findings: Patients attending government health clinics were recruited within 1 month of starting treatment for TB. Subjects were tested with QGIT and TST. T lymphocyte counts were estimated (CD3(+), CD4(+), CD8(+)). QGIT was performed for 112 subjects. 83/112 were QGIT positive giving an overall sensitivity of 74% [95% CI: 66,82]. A marked decrease in sensitivity was observed in HIV positive patients with 37/59 (63%) being QGIT positive compared to 31/37 (84%) HIV negative patients [chi(2) p = 0.033]. Low CD4(+) count was associated with increases in both indeterminate and false-negative results. Low CD4(+) count in combination with high/normal CD8(+) count was associated with false-negative results. TST was recorded for 92 patients, 62/92 were positive, giving a sensitivity of 67% [95% CI: 58,77]. Although there was little difference in the overall sensitivities, agreement between TST and QGIT was poor. Conclusions: QGIT was technically feasible with results in HIV negative subjects comparable to those achieved elsewhere. However, where under-treated HIV is prevalent, an increased proportion of both indeterminate and false-negative QGIT results can be expected in patients with active TB. The implications of this for the diagnosis of LTBI by QGIT is unclear. The diagnostic and prognostic relevance of IGRAs in high burden settings needs to be better characterised.	[Raby, Edward; Devendra, Akash; De Haas, Petra; Ayles, Helen; Godfrey-Faussett, Peter] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England; [Moyo, Maureen; Banda, Joseph; De Haas, Petra; Ayles, Helen] Univ Teach Hosp, Dept Microbiol, Zambia AIDS Related TB ZAMBART Project, Lusaka, Zambia	University of London; London School of Hygiene & Tropical Medicine	Raby, E (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England.	Edward.Raby@lshtm.ac.uk	Raby, Edward/AAM-1815-2021	Raby, Edward/0000-0003-1671-6188; Ayles, Helen/0000-0003-4108-2842	Foundation for Innovative New Diagnostics (FIND); Bill and Melinda Gates Foundation [19790.01]; DFID via the TARGETS consortium	Foundation for Innovative New Diagnostics (FIND); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); DFID via the TARGETS consortium	Financial support for the study was from the Foundation for Innovative New Diagnostics (FIND) and also included support from the Bill and Melinda Gates Foundation as part of the Consortium to Respond Effectively to the AIDS-TB Epidemic (CREATE) project (19790.01), and also from DFID via the TARGETS consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Arnadottir T, 1996, TUBERCLE LUNG DIS, V77, P1, DOI 10.1016/S0962-8479(96)90127-6; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Brock I, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-56; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Cobelens FG, 2006, CLIN INFECT DIS, V43, P634, DOI 10.1086/506432; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; DUNCAN LE, 1995, T ROY SOC TROP MED H, V89, P37, DOI 10.1016/0035-9203(95)90649-5; Elias D, 2007, EXPERT REV ANTI-INFE, V5, P475, DOI 10.1586/14787210.5.3.475; Grant AD, 2005, JAMA-J AM MED ASSOC, V293, P2719, DOI 10.1001/jama.293.22.2719; Harada Nobuyuki, 2004, Kekkaku, V79, P725; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; Inokuchi N, 2003, DIAGN MICR INFEC DIS, V46, P109, DOI 10.1016/S0732-8893(03)00018-X; Laserson KF, 2007, B WORLD HEALTH ORGAN, V85, P377, DOI 10.2471/BLT.06.035329; Luetkemeyer AF, 2007, AM J RESP CRIT CARE, V175, P737, DOI 10.1164/rccm.200608-1088OC; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Perkins MD, 2000, INT J TUBERC LUNG D, V4, pS182; Rothel James S, 2005, Expert Rev Anti Infect Ther, V3, P981, DOI 10.1586/14787210.3.6.981; Soysal A, 2008, INT J TUBERC LUNG D, V12, P50; Tat D, 2005, CLIN INFECT DIS, V40, P246, DOI 10.1086/426816; Toman K., 2004, TOMANS TUBERCULOSIS, V2nd; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; Watkins RE, 2000, INT J TUBERC LUNG D, V4, P895; *WHO, 2004, WHO AFR REG TB COUNT; WOLDEHANNA S, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000171.PUB2; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2006, GLOB PLAN STOP TB 20	32	102	106	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2489	10.1371/journal.pone.0002489	http://dx.doi.org/10.1371/journal.pone.0002489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560573	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000263280700053
J	Bonevski, B; Wilson, A; Henry, DA				Bonevski, Billie; Wilson, Amanda; Henry, David A.			An Analysis of News Media Coverage of Complementary and Alternative Medicine	PLOS ONE			English	Article							NATIONAL-SURVEY; BREAST-CANCER; HEALTH; GENETICS; BENEFITS; THERAPY; STORIES; IMPACT; DRUGS	Background: To examine the accuracy and adequacy of lay media news stories about complementary and alternative medicines and therapies. Methodology/Principal Findings: A descriptive analysis of news stories about complementary and alternative medicine (CAM) in the Australian media using a national medical news monitoring website, mediadoctor.org.au. Each story was rated against 10 criteria by two individuals. Consensus scores of 222 news articles reporting therapeutic claims about complementary medicines posted on mediadoctor.org.au between 1 January 2004 and 1 September 2007 were calculated. The overall rating score for 222 CAM articles was 50% (95% CI 47% to 53%). There was a statistically significant (F = 3.68, p = 0.006) difference in cumulative mean scores according to type of therapy: biologically based practices (54%, 95% CI 50% to 58%); manipulative body based practices (46%, 95% CI 39% to 54%), whole medical systems (45%, 95% CI 32% to 58%), mind body medicine (41%, 95% CI 31% to 50%) and energy medicine (33%, 95% CI 11% to 55%). There was a statistically significant difference in cumulative mean scores (F = 3.72, p = 0.0001) according to the clinical outcome of interest with stories about cancer treatments (62%, 95% CI 54% to 70%) scoring highest and stories about treatments for children's behavioural and mental health concerns scoring lowest (31%, 95% CI 19% to 43%). Significant differences were also found in scores between media outlets. Conclusions/Significance: There is substantial variability in news reporting practices about CAM. Overall, although they may be improving, the scores remain generally low. It appears that much of the information the public receives about CAM is inaccurate or incomplete.	[Bonevski, Billie; Wilson, Amanda] Univ Newcastle, Discipline Clin Pharmacol, Newcastle, NSW 2308, Australia; [Henry, David A.] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Newcastle; University of Toronto	Bonevski, B (corresponding author), Univ Newcastle, Discipline Clin Pharmacol, Newcastle, NSW 2308, Australia.	billie.bonevski@newcastle.edu.au	Bonevski, Billie/G-7298-2013; Henry, David/AAU-4650-2020; Henry, David/AAJ-4332-2020	Bonevski, Billie/0000-0001-8505-622X; Henry, David/0000-0001-7169-7704; Henry, David/0000-0003-2934-2242; Wilson, Amanda/0000-0001-5681-9611	Hunter Medical Research Institute; University of Newcastle	Hunter Medical Research Institute; University of Newcastle	This research was funded by a grant from the Hunter Medical Research Institute and a grant from the University of Newcastle.	[Anonymous], 1994, MEDIA INFORM AUSTR; *AUSTR MED ASS, 2002, COMPL MED POS STAT; Berman B M, 1997, J Altern Complement Med, V3, P191, DOI 10.1089/acm.1997.3.191; Bubela TM, 2004, CAN MED ASSOC J, V170, P1399, DOI 10.1503/cmaj.1030762; BUCHER HC, 1994, BRIT MED J, V309, P761, DOI 10.1136/bmj.309.6957.761; Caspi O, 2003, ALTERN THER HEALTH M, V9, P58; Cassels A, 2003, CAN MED ASSOC J, V168, P1133; Chapman S, 2005, MED J AUSTRALIA, V183, P247, DOI 10.5694/j.1326-5377.2005.tb07029.x; Chapman S, 2001, HEALTH PROMOT INT, V16, P137, DOI 10.1093/heapro/16.2.137; Cohen MM, 2005, J ALTERN COMPLEM MED, V11, P995, DOI 10.1089/acm.2005.11.995; *COMM AUSTR, 2003, COMPL MED AUSTR HLTH, P163; Condit CM, 1998, AM J HUM GENET, V62, P979, DOI 10.1086/301784; Dolan G, 2004, INT J CONSUM STUD, V28, P147, DOI DOI 10.1111/J.1470-6431.2003.00363.X; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ernst E, 2000, BRIT MED J, V321, P707; ERNST E, 2002, CLIN RES COMPLEMENTA, P171; Fontanarosa PB, 1998, JAMA-J AM MED ASSOC, V280, P1618, DOI 10.1001/jama.280.18.1618; Haas JS, 2004, ANN INTERN MED, V140, P184, DOI 10.7326/0003-4819-140-3-200402030-00009; Hann D M, 2005, Integr Cancer Ther, V4, P294, DOI 10.1177/1534735405282109; Henderson L, 1999, SOCIOL HEALTH ILL, V21, P560, DOI 10.1111/1467-9566.00173; *HOUS LORDS SEL CO, 2000, SESS 1999 2000 REP C; HUX JE, 1995, MED DECIS MAKING, V15, P152, DOI 10.1177/0272989X9501500208; Johnson T, 1998, NEW ENGL J MED, V339, P87, DOI 10.1056/NEJM199807093390206; Lupton D, 1995, AUST J PUBLIC HEALTH, V19, P501; MacLennan AH, 2002, PREV MED, V35, P166, DOI 10.1006/pmed.2002.1057; McGinn T, 2004, CAN MED ASSOC J, V171, P1369, DOI 10.1503/cmaj.1031981; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; National Center for Complementary and Alternative Medicine, 2002, WHAT IS COMPL ALT ME; *R STARCH WORLDW I, 1997, AM TALK SCI MED NEWS; Ransohoff D F, 2001, Eff Clin Pract, V4, P185; Rutten LJF, 2005, PATIENT EDUC COUNS, V57, P250, DOI 10.1016/j.pec.2004.06.006; Schwartz LM, 2004, ANN INTERN MED, V140, P226, DOI 10.7326/0003-4819-140-3-200402030-00015; Shuchman M, 1997, ANN INTERN MED, V126, P976, DOI 10.7326/0003-4819-126-12-199706150-00008; Smith DE, 2005, MED J AUSTRALIA, V183, P190, DOI 10.5694/j.1326-5377.2005.tb06992.x; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; Vickers A, 2000, BRIT MED J, V321, P683, DOI 10.1136/bmj.321.7262.683; Voss M, 2002, AM J PUBLIC HEALTH, V92, P1158, DOI 10.2105/AJPH.92.7.1158; Wells J, 2001, ANN INTERN MED, V135, P1029, DOI 10.7326/0003-4819-135-12-200112180-00006; Wilkes MS, 1997, J HEALTH COMMUN, V2, P3, DOI 10.1080/108107397127888; WILKES MS, 1997, J HEALTH COMMUN, V2, P61; Woloshin S, 2002, JAMA-J AM MED ASSOC, V287, P2856, DOI 10.1001/jama.287.21.2856; Woloshin S, 2006, MED J AUSTRALIA, V184, P576, DOI 10.5694/j.1326-5377.2006.tb00384.x; Woodward KN, 2005, HUM EXP TOXICOL, V24, P219, DOI 10.1191/0960327105ht529oa; 2001, REP GUID	44	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2406	10.1371/journal.pone.0002406	http://dx.doi.org/10.1371/journal.pone.0002406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	405UD	18545688	Green Published, gold			2022-12-25	WOS:000263248800044
J	Kami, D; Shiojima, I; Makino, H; Matsumoto, K; Takahashi, Y; Ishii, R; Naito, AT; Toyoda, M; Saito, H; Watanabe, M; Komuro, I; Umezawa, A				Kami, Daisuke; Shiojima, Ichiro; Makino, Hatsune; Matsumoto, Kenji; Takahashi, Yoriko; Ishii, Ryuga; Naito, Atsuhiko T.; Toyoda, Masashi; Saito, Hirohisa; Watanabe, Masatoshi; Komuro, Issei; Umezawa, Akihiro			Gremlin Enhances the Determined Path to Cardiomyogenesis	PLOS ONE			English	Article								Background: The critical event in heart formation is commitment of mesodermal cells to a cardiomyogenic fate, and cardiac fate determination is regulated by a series of cytokines. Bone morphogenetic proteins (BMPs) and fibroblast growth factors have been shown to be involved in this process, however additional factors needs to be identified for the fate determination, especially at the early stage of cardiomyogenic development. Methodology/Principal Findings: Global gene expression analysis using a series of human cells with a cardiomyogenic potential suggested Gremlin (Grem1) is a candidate gene responsible for in vitro cardiomyogenic differentiation. Grem1, a known BMP antagonist, enhanced DMSO-induced cardiomyogenesis of P19CL6 embryonal carcinoma cells (CL6 cells) 10-35 fold in an area of beating differentiated cardiomyocytes. The Grem1 action was most effective at the early differentiation stage when CL6 cells were destined to cardiomyogenesis, and was mediated through inhibition of BMP2. Furthermore, BMP2 inhibited Wnt/beta-catenin signaling that promoted CL6 cardiomyogenesis. Conclusions/Significance: Grem1 enhances the determined path to cardiomyogenesis in a stage-specific manner, and inhibition of the BMP signaling pathway is involved in initial determination of Grem1-promoted cardiomyogenesis. Our results shed new light on renewal of the cardiovascular system using Grem1 in human.	[Kami, Daisuke; Makino, Hatsune; Takahashi, Yoriko; Ishii, Ryuga; Toyoda, Masashi; Umezawa, Akihiro] Natl Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan; [Matsumoto, Kenji; Saito, Hirohisa] Natl Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Kami, Daisuke; Watanabe, Masatoshi] Yokohama Natl Univ, Grad Sch Engn, Div Mat Sci & Chem Engn, Lab Med Engn, Yokohama, Kanagawa, Japan; [Shiojima, Ichiro; Naito, Atsuhiko T.; Komuro, Issei] Chiba Univ, Grad Scht Med, Dept Cardiovasc Sci & Med, Chiba, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Yokohama National University; Chiba University	Kami, D (corresponding author), Natl Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan.	umezawa@1985.jukuin.keio.ac.jp		Kami, Daisuke/0000-0002-9862-5513; Watanabe, Masatoshi/0000-0002-9423-0901; Saito, Hirohisa/0000-0002-6630-8337	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Health and Labor Sciences; Japan Health Science Foundation; Program for Promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; Terumo Life Science Foundation; Ministry of Health, Labor and Welfare (MHLW)	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences; Japan Health Science Foundation; Program for Promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; Terumo Life Science Foundation(Terumo Life Science Foundation); Ministry of Health, Labor and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and Health and Labor Sciences Research Grants; by a Research grant on Health Science Focusing on Drug Innovation from the Japan Health Science Foundation; by the Program for Promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; by a grant from the Terumo Life Science Foundation; by a Research Grant for Cardiovascular Disease from the Ministry of Health, Labor and Welfare (MHLW); and by a Grant for Child Health and Development from the MHLW.	Alsan BH, 2002, DEVELOPMENT, V129, P1935; Andree B, 1998, MECH DEVELOP, V70, P119, DOI 10.1016/S0925-4773(97)00186-X; Angello JC, 2006, DEV DYNAM, V235, P2122, DOI 10.1002/dvdy.20863; Ariizumi T, 2003, INT J DEV BIOL, V47, P405; Chien KR, 2004, SCIENCE, V306, P239, DOI 10.1126/science.1104769; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Frank NY, 2006, J CELL BIOL, V175, P99, DOI 10.1083/jcb.200511036; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Jin EJ, 2001, DEV BIOL, V233, P22, DOI 10.1006/dbio.2001.0222; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Olson EN, 2001, SCIENCE, V291, P2327, DOI 10.1126/science.1060063; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Park MY, 1996, DEV BIOL, V177, P104, DOI 10.1006/dbio.1996.0149; Reifers F, 2000, DEVELOPMENT, V127, P225; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Shi W, 2001, AM J PHYSIOL-LUNG C, V280, pL1030, DOI 10.1152/ajplung.2001.280.5.L1030; SINGH JP, 1983, J CELL BIOL, V96, P1497, DOI 10.1083/jcb.96.5.1497; Sugiki T, 2007, J CELL BIOCHEM, V100, P1240, DOI 10.1002/jcb.21125; Sutherland MK, 2004, BONE, V35, P828, DOI 10.1016/j.bone.2004.05.023; Terami H, 2004, BIOCHEM BIOPH RES CO, V325, P968, DOI 10.1016/j.bbrc.2004.10.103; Tzahor E, 2001, GENE DEV, V15, P255, DOI 10.1101/gad.871501; Tzahor E, 2003, GENE DEV, V17, P3087, DOI 10.1101/gad.1154103; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Yamagishi H, 2000, J CLIN INVEST, V105, P261, DOI 10.1172/JCI8856; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Zuniga AE, 2004, GENE DEV, V18, P1553, DOI 10.1101/gad.299904	37	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2407	10.1371/journal.pone.0002407	http://dx.doi.org/10.1371/journal.pone.0002407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545679	Green Published, Green Submitted, gold			2022-12-25	WOS:000263248800045
J	Ponts, N; Yang, JF; Chung, DWD; Prudhomme, J; Girke, T; Horrocks, P; Le Roch, KG				Ponts, Nadia; Yang, Jianfeng; Chung, Duk-Won Doug; Prudhomme, Jacques; Girke, Thomas; Horrocks, Paul; Le Roch, Karine G.			Deciphering the Ubiquitin-Mediated Pathway in Apicomplexan Parasites: A Potential Strategy to Interfere with Parasite Virulence	PLOS ONE			English	Article							PROTEIN CONJUGATION SYSTEM; PLASMODIUM-FALCIPARUM; GENOME SEQUENCE; DEUBIQUITINATING ENZYME; ISOPRENOID BIOSYNTHESIS; PROTEOLYTIC PATHWAY; PROTEASOME PATHWAY; TERMINAL REGION; DRUG DISCOVERY; BOX PROTEINS	Background: Reversible modification of proteins through the attachment of ubiquitin or ubiquitin-like modifiers is an essential post-translational regulatory mechanism in eukaryotes. The conjugation of ubiquitin or ubiquitin-like proteins has been demonstrated to play roles in growth, adaptation and homeostasis in all eukaryotes, with perturbation of ubiquitin-mediated systems associated with the pathogenesis of many human diseases, including cancer and neurodegenerative disorders. Methodology/Principal Findings: Here we describe the use of an HMM search of functional Pfam domains found in the key components of the ubiquitin-mediated pathway necessary to activate and reversibly modify target proteins in eight apicomplexan parasitic protozoa for which complete or late-stage genome projects exist. In parallel, the same search was conducted on five model organisms, single-celled and metazoans, to generate data to validate both the search parameters employed and aid paralog classification in Apicomplexa. For each of the 13 species investigated, a set of proteins predicted to be involved in the ubiquitylation pathway has been identified and demonstrates increasing component members of the ubiquitylation pathway correlating with organism and genome complexity. Sequence homology and domain architecture analyses facilitated prediction of apicomplexan-specific protein function, particularly those involved in regulating cell division during these parasite's complex life cycles. Conclusions/Significance: This study provides a comprehensive analysis of proteins predicted to be involved in the apicomplexan ubiquitin-mediated pathway. Given the importance of such pathway in a wide variety of cellular processes, our data is a key step in elucidating the biological networks that, in part, direct the pathogenicity of these parasites resulting in a massive impact on global health. Moreover, apicomplexan-specific adaptations of the ubiquitylation pathway may represent new therapeutic targets for much needed drugs against apicomplexan parasites.	[Ponts, Nadia; Yang, Jianfeng; Chung, Duk-Won Doug; Prudhomme, Jacques; Le Roch, Karine G.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Girke, Thomas] Univ Calif Riverside, Ctr Plant Cell Biol CEPCEB, Riverside, CA USA; [Horrocks, Paul] Keele Univ, Inst Sci & Technol Med, Dept Med, Keele, Staffs, England	University of California System; University of California Riverside; University of California System; University of California Riverside; Keele University	Ponts, N (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	karine.leroch@ucr.edu		Girke, Thomas/0000-0003-0710-3777				Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Ajuh P, 2001, J BIOL CHEM, V276, P42370, DOI 10.1074/jbc.M105453200; Al-Olayan EM, 2002, INT J PARASITOL, V32, P1133, DOI 10.1016/S0020-7519(02)00087-5; Arnot DE, 1998, ANN TROP MED PARASIT, V92, P361, DOI 10.1080/00034989859357; Artavanis-Tsakonas K, 2006, MOL MICROBIOL, V61, P1187, DOI 10.1111/j.1365-2958.2006.05307.x; Balakirev MY, 2002, J VIROL, V76, P6323, DOI 10.1128/JVI.76.12.6323-6331.2002; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brailoiu GC, 2003, BRAIN RES, V984, P215, DOI 10.1016/S0006-8993(03)03161-5; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen CH, 2006, RNA, V12, P765, DOI 10.1261/rna.2292106; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; CIECHANOVER A, 1994, FASEB J, V8, P182, DOI 10.1096/fasebj.8.2.8119489; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Doerig C, 2000, Prog Cell Cycle Res, V4, P163; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Durbin R., 1998, BIOL SEQUENCE ANAL P; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Frickel EM, 2007, CELL MICROBIOL, V9, P1601, DOI 10.1111/j.1462-5822.2007.00896.x; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Gao R, 2007, J BACTERIOL, V189, P6048, DOI 10.1128/JB.00459-07; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gissot M, 2007, PLOS PATHOG, V3, P709, DOI 10.1371/journal.ppat.0030077; GLASSNER BJ, 1994, RADIAT RES, V139, P24, DOI 10.2307/3578728; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; GOLDFEDER MB, 2007, J BIOL CHEM; Gonzalez J, 1996, J EXP MED, V184, P1909, DOI 10.1084/jem.184.5.1909; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Herrmann J, 2007, CIRC RES, V101, P865, DOI 10.1161/CIRCRESAHA.107.152959; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann K, 1998, J MOL BIOL, V282, P195, DOI 10.1006/jmbi.1998.1998; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Horrocks P, 2000, MOL BIOCHEM PARASIT, V105, P115, DOI 10.1016/S0166-6851(99)00174-7; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Hunt P, 2007, MOL MICROBIOL, V65, P27, DOI 10.1111/j.1365-2958.2007.05753.x; Hurd H, 2006, PARASITOLOGY, V132, pS33, DOI 10.1017/S0031182006000849; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Ju DH, 2006, BIOCHEM BIOPH RES CO, V341, P648, DOI 10.1016/j.bbrc.2006.01.013; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kipreos Edward T, 2005, WormBook, P1; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Komatsu M, 2001, J BIOL CHEM, V276, P9846, DOI 10.1074/jbc.M007737200; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Linares GEG, 2007, CURR MED CHEM, V14, P289; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oakley MSM, 2007, INFECT IMMUN, V75, P2012, DOI 10.1128/IAI.01236-06; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Picot S, 1997, T ROY SOC TROP MED H, V91, P590, DOI 10.1016/S0035-9203(97)90039-0; Ponder EL, 2007, EUKARYOT CELL, V6, P1943, DOI 10.1128/EC.00282-07; PRUDHOMME J, PLOS ONE IN PRESS; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; READ M, 1993, PARASITOLOGY, V106, P223, DOI 10.1017/S0031182000075041; Richardson Paul, 2007, Hematology Am Soc Hematol Educ Program, P317; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Scheel H, 2003, HUM MOL GENET, V12, P2845, DOI 10.1093/hmg/ddg297; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Srikanth M, 2008, EXPERT OPIN INV DRUG, V17, P1, DOI 10.1517/13543784.17.1.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TENG Y, 2007, EMBO REP; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOTINO PR, 2007, EXP PARASITOL; Uy GL, 2007, CLIN LYMPHOMA MYELOM, V7, P587, DOI 10.3816/CLM.2007.n.045; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; van der Kwast TH, 2006, NAT CLIN PRACT UROL, V3, P130, DOI 10.1038/ncpuro0431; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; *WHO UNICEF, 2005, WORLD MAL REP 2005 S; Wiesner J, 2007, CURR DRUG TARGETS, V8, P3, DOI 10.2174/138945007779315551; Wilkinson CRM, 2004, CURR BIOL, V14, P2283, DOI 10.1016/j.cub.2004.11.058; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wing SS, 2003, INT J BIOCHEM CELL B, V35, P590, DOI 10.1016/S1357-2725(02)00392-8; Wong BR, 2003, DRUG DISCOV TODAY, V8, P746, DOI 10.1016/S1359-6446(03)02780-6; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	127	63	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2386	10.1371/journal.pone.0002386	http://dx.doi.org/10.1371/journal.pone.0002386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545708	gold, Green Published, Green Accepted			2022-12-25	WOS:000263248800025
J	Zhang, JX; Addepalli, B; Yun, KY; Hunt, AG; Xu, RQ; Rao, S; Li, QQ; Falcone, DL				Zhang, Jingxian; Addepalli, Balasubramanyam; Yun, Kil-Young; Hunt, Arthur G.; Xu, Ruqiang; Rao, Suryadevara; Li, Qingshun Q.; Falcone, Deane L.			A Polyadenylation Factor Subunit Implicated in Regulating Oxidative Signaling in Arabidopsis thaliana	PLOS ONE			English	Article								Background: Plants respond to many unfavorable environmental conditions via signaling mediated by altered levels of various reactive oxygen species (ROS). To gain additional insight into oxidative signaling responses, Arabidopsis mutants that exhibited tolerance to oxidative stress were isolated. We describe herein the isolation and characterization of one such mutant, oxt6. Methodology/Principal Findings: The oxt6 mutation is due to the disruption of a complex gene (At1g30460) that encodes the Arabidopsis ortholog of the 30-kD subunit of the cleavage and polyadenylation specificity factor (CPSF30) as well as a larger, related 65-kD protein. Expression of mRNAs encoding Arabidopsis CPSF30 alone was able to restore wild-type growth and stress susceptibility to the oxt6 mutant. Transcriptional profiling and single gene expression studies show elevated constitutive expression of a subset of genes that encode proteins containing thioredoxin- and glutaredoxin-related domains in the oxt6 mutant, suggesting that stress can be ameliorated by these gene classes. Bulk poly(A) tail length was not seemingly affected in the oxt6 mutant, but poly(A) site selection was different, indicating a subtle effect on polyadenylation in the mutant. Conclusions/Significance: These results implicate the Arabidopsis CPSF30 protein in the posttranscriptional control of the responses of plants to stress, and in particular to the expression of a set of genes that suffices to confer tolerance to oxidative stress.	[Zhang, Jingxian; Yun, Kil-Young; Falcone, Deane L.] Univ Kentucky, Kentucky Tobacco Res & Dev Ctr, Lexington, KY USA; [Addepalli, Balasubramanyam; Hunt, Arthur G.; Rao, Suryadevara; Falcone, Deane L.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Xu, Ruqiang; Li, Qingshun Q.] Miami Univ, Dept Bot, Oxford, OH USA; [Yun, Kil-Young; Falcone, Deane L.] Univ Massachusetts, Dept Biol Sci, Lowell, MA USA	University of Kentucky; University of Kentucky; University System of Ohio; Miami University; University of Massachusetts System; University of Massachusetts Lowell	Zhang, JX (corresponding author), Univ Kentucky, Kentucky Tobacco Res & Dev Ctr, Lexington, KY USA.	aghunt00@uky.edu; Deane_Falcone@uml.edu	Xu, Ruqiang/GWQ-6267-2022; Hunt, Arthur/A-8040-2009; Zhang, Jing/GWZ-7332-2022; Zhang, Jing/HII-4294-2022; Li, Qingshun/C-5603-2009	Xu, Ruqiang/0000-0002-8966-2670; Li, Qingshun/0000-0003-4105-1480; Addepalli, Balasubrahmanyam/0000-0001-6257-7700; Hunt, Arthur/0000-0002-0008-4158	USDA NRI [2001-00911, 2005-05161]; NSF [MCB-0313472]; Kentucky Tobacco Research and Development Center; Center for Bioinformatics and Functional Genomics, Miami University	USDA NRI(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); Kentucky Tobacco Research and Development Center; Center for Bioinformatics and Functional Genomics, Miami University	This work was supported by USDA NRI grants 2001-00911 and 2005-05161 (DLF), NSF grant MCB-0313472 (AGH and QQL), and the Kentucky Tobacco Research and Development Center (DLF). RX was partially supported by a postdoctoral fund from the Center for Bioinformatics and Functional Genomics, Miami University.	Addepalli B, 2007, NUCLEIC ACIDS RES, V35, P4453, DOI 10.1093/nar/gkm457; Anthony RG, 2006, J BIOL CHEM, V281, P37536, DOI 10.1074/jbc.M607341200; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K., 1994, Causes of photooxidative stress and amelioration of defense systems in plants., P77; Barabino SML, 2000, EMBO J, V19, P3778, DOI 10.1093/emboj/19.14.3778; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; Clayton H, 1999, PLANT J, V17, P575, DOI 10.1046/j.1365-313X.1999.00411.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Delaney KJ, 2006, PLANT PHYSIOL, V140, P1507, DOI 10.1104/pp.105.070672; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Dong CH, 2006, MOL CELL BIOL, V26, P9533, DOI 10.1128/MCB.01063-06; Eshdat Y, 1997, PHYSIOL PLANTARUM, V100, P234, DOI 10.1034/j.1399-3054.1997.1000204.x; Evans NH, 2005, PLANT J, V41, P615, DOI 10.1111/j.1365-313X.2004.02325.x; Forbes KP, 2006, J BIOL CHEM, V281, P176, DOI 10.1074/jbc.M510964200; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Gong ZZ, 2002, P NATL ACAD SCI USA, V99, P11507, DOI 10.1073/pnas.172399299; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Jin YF, 2004, RNA, V10, P1695, DOI 10.1261/rna.7610404; Lee BH, 2006, PLANT CELL, V18, P1736, DOI 10.1105/tpc.106.042184; Levine A., 1999, PLANT RESPONSES ENV, P247, DOI 10.1201/9780203743157-11; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; MAY MJ, 1993, PLANT PHYSIOL, V103, P621, DOI 10.1104/pp.103.2.621; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2001, REDOX REP, V6, P69, DOI 10.1179/135100001101536067; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Ok SH, 2005, PLANT PHYSIOL, V139, P138, DOI 10.1104/pp.105.065649; PREKER PJ, 1995, CELL, V81, P379, DOI 10.1016/0092-8674(95)90391-7; PRICE AH, 1994, PLANT CELL, V6, P1301, DOI 10.1105/tpc.6.9.1301; RENNENBERG H, 1994, BIOCHEM SOC T, V22, P936, DOI 10.1042/bst0220936; Rentel MC, 2004, PLANT PHYSIOL, V135, P1471, DOI 10.1104/pp.104.042663; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rossel JB, 2007, PLANT CELL, V19, P4091, DOI 10.1105/tpc.106.045898; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Stoilov P, 2002, TRENDS BIOCHEM SCI, V27, P495, DOI 10.1016/S0968-0004(02)02189-8; Tacahashi Y, 2003, NUCLEIC ACIDS RES, V31, P1744, DOI 10.1093/nar/gkg265; Vranova E, 2002, P NATL ACAD SCI USA, V99, P10870, DOI 10.1073/pnas.152337999; Xu RQ, 2004, GENE, V324, P35, DOI 10.1016/j.gene.2003.09.025; Yang T, 2002, P NATL ACAD SCI USA, V99, P4097, DOI 10.1073/pnas.052564899	51	71	76	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2410	10.1371/journal.pone.0002410	http://dx.doi.org/10.1371/journal.pone.0002410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545667	gold, Green Published, Green Submitted			2022-12-25	WOS:000263248800047
J	Kreth, S; Ledderose, C; Kaufmann, I; Groeger, G; Thiel, M				Kreth, Simone; Ledderose, Carola; Kaufmann, Ines; Groeger, Gabriele; Thiel, Manfred			Differential expression of 5 '-UTR splice variants of the adenosine A(2A) receptor gene in human granulocytes: identification, characterization, and functional impact on activation	FASEB JOURNAL			English	Article						sepsis; 5 '-untranslated region; alternative transcripts	5' UNTRANSLATED REGION; OPEN READING FRAMES; NF-KAPPA-B; HUMAN NEUTROPHILS; MESSENGER-RNA; ALTERNATIVE PROMOTERS; ENDOTHELIAL-CELLS; IMMUNE-RESPONSE; PLASMA-MEMBRANE; TH1 CYTOKINES	A key step in the pathogenesis of sepsis is the excessive and uncontrolled activation of polymorphonuclear neutrophils (PMNs). An inflammation-controlling function of adenosine receptors has been presumed; however, their role in PMN of sepsis patients is poorly defined. We investigated the expression of adenosine receptors in resting and lipopolysaccharide (LPS)-activated human PMNs, and in PMNs of sepsis patients. Our studies revealed that native human PMNs express almost equal distributions of all four adenosine receptor subtype transcripts, whereas exclusively the A(2A) receptor (A(2A)R) was up-regulated in LPS-stimulated PMNs and PMNs of sepsis patients. As a possible mechanism, we identified and fully characterized eight 5'-untranslated region (UTR) splice variants of the A(2A)R gene resulting from alternative transcription and/or splicing of five noncoding exons. We report a differential, activation state-specific expression of 5'-UTR variants within the same cell type, indicating a new mechanism to modulate gene expression: In resting human PMNs, mainly A(2A)R transcripts with long 5'-UTRs are expressed, whereas in stimulated PMNs and PMNs of septic patients, short 5'-UTRs predominate. Transcripts with short 5'-UTRs are more efficiently translated into protein. The correlation between changes of transcript patterns and A(2A)R up-regulation offers interesting clues regarding the course of sepsis.	[Kreth, Simone; Ledderose, Carola; Kaufmann, Ines; Groeger, Gabriele; Thiel, Manfred] Univ Munich, Dept Anaesthesiol, Munich, Germany	University of Munich	Thiel, M (corresponding author), Klinikum Grosshadern, Clin Anaesthesiol, Marchioninistr 15, D-81375 Munich, Germany.	mthiel@med.uni-muenchen.de		Kreth, Simone/0000-0002-0073-2098				Anney RJ, 2002, MOL PSYCHIATR, V7, P493, DOI 10.1038/sj.mp.4001003; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bouma MG, 1997, J IMMUNOL, V158, P5400; CRONSTEIN BN, 1986, J CLIN INVEST, V78, P760, DOI 10.1172/JCI112638; CRONSTEIN BN, 1990, J CLIN INVEST, V85, P1150, DOI 10.1172/JCI114547; Engemaier E, 2006, GENOMICS, V87, P254, DOI 10.1016/j.ygeno.2005.10.001; Falleni A, 1999, J CELL BIOCHEM, V75, P235, DOI 10.1002/(SICI)1097-4644(19991101)75:2<235::AID-JCB6>3.0.CO;2-K; Fortin A, 2006, J LEUKOCYTE BIOL, V79, P574, DOI 10.1189/jlb.0505249; Fredholm BB, 1996, N-S ARCH PHARMACOL, V354, P262, DOI 10.1007/BF00171056; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Gessi S, 2002, MOL PHARMACOL, V61, P415, DOI 10.1124/mol.61.2.415; Gomez G, 2003, BLOOD, V102, P4472, DOI 10.1182/blood-2002-11-3624; Haschemi A, 2007, J IMMUNOL, V178, P5921, DOI 10.4049/jimmunol.178.9.5921; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hoesel LM, 2005, SHOCK, V24, P40, DOI 10.1097/01.shk.0000170353.80318.d5; Johnson JL, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-28; Khoa ND, 2006, MOL PHARMACOL, V69, P1311, DOI 10.1124/mol.105.016857; Khoa ND, 2003, J IMMUNOL, V171, P3991, DOI 10.4049/jimmunol.171.8.3991; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Kirkpatrick P, 2002, NAT REV DRUG DISCOV, V1, P99, DOI 10.1038/nrd738; Kos M, 2002, J BIOL CHEM, V277, P37131, DOI 10.1074/jbc.M206325200; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Linden J, 2006, J CLIN INVEST, V116, P1835, DOI 10.1172/JCI29125; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Morello S, 2006, J IMMUNOL, V177, P7173, DOI 10.4049/jimmunol.177.10.7173; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; Nakanishi T, 2006, CANCER RES, V66, P5007, DOI 10.1158/0008-5472.CAN-05-4572; Noon LA, 2006, J MOL ENDOCRINOL, V37, P415, DOI 10.1677/jme.1.02023; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Payton SG, 2007, BBA-GENE STRUCT EXPR, V1769, P131, DOI 10.1016/j.bbaexp.2006.12.006; Peters K, 2003, CARDIOVASC RES, V60, P49, DOI 10.1016/S0008-6363(03)00397-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429; Sauter KS, 2007, VET IMMUNOL IMMUNOP, V118, P92, DOI 10.1016/j.vetimm.2007.04.017; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Tamassia N, 2007, J IMMUNOL, V178, P7344, DOI 10.4049/jimmunol.178.11.7344; Thiel M, 1998, HEPATOLOGY, V28, P1538, DOI 10.1002/hep.510280614; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Van Der Zee J, 2002, INT J HYPERTHER, V18, P1; Varani K, 2006, AM J RESP CRIT CARE, V173, P398, DOI 10.1164/rccm.200506-869OC; Varani K, 2003, FASEB J, V17, P2148, DOI 10.1096/fj.03-0079fje; Walsh NC, 2003, GENE, V307, P111, DOI 10.1016/S0378-1119(03)00449-9; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Yu LQ, 2004, BRAIN RES, V1000, P156, DOI 10.1016/j.brainres.2003.11.072; Zhang N, 2006, BLOOD, V108, P38, DOI 10.1182/blood-2005-06-2599; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	22	26	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3276	3286		10.1096/fj.07-101097	http://dx.doi.org/10.1096/fj.07-101097			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18541693				2022-12-25	WOS:000258761300020
J	Prochazkova, K; Satchell, KJF				Prochazkova, Katerina; Satchell, Karla J. Fullner			Structure-function analysis of inositol hexakisphosphate-induced autoprocessing of the Vibrio cholerae multifunctional autoprocessing RTX toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING DOMAIN; CLEAVAGE; ACTIN; PENTAKISPHOSPHATE; PHOSPHATES; DEPENDS; CELLS; MICE	Vibrio cholerae secretes a large virulence-associated multifunctional autoprocessing RTX toxin ( MARTXVc). Autoprocessing of this toxin by an embedded cysteine protease domain (CPD) is essential for this toxin to induce actin depolymerization in a broad range of cell types. A homologous CPD is also present in the large clostridial toxin TcdB and recent studies showed that inositol hexakisphosphate (Ins(1,2,3,4,5,6) P6 or InsP6) stimulated the autoprocessing of TcdB dependent upon the CPD ( Egerer, M., Giesemann, T., Jank, T., Satchell, K. J., and Aktories, K. (2007) J. Biol. Chem. 282, 25314-25321). In this work, the autoprocessing activity of the CPD within MARTXVc is similarly found to be inducible by InsP6. The CPD is shown to bind InsP6 ( Kd, 0.6 mu M), and InsP6 is shown to stimulate intramolecular autoprocessing at both physiological concentrations and as low as 0.01 mu M. Processed CPD did not bind InsP6 indicating that, subsequent to cleavage, the activated CPD may shift to an inactive conformation. To further pursue the mechanism of autoprocessing, conserved residues among 24 identified CPDs were mutagenized. In addition to cysteine and histidine residues that form the catalytic site, 2 lysine residues essential for InsP6 binding and 5 lysine and arginine residues resulting in loss of activity at low InsP6 concentrations were identified. Overall, our data support a model in which basic residues located across the CPD structure form an InsP6 binding pocket and that the binding of InsP6 stimulates processing by altering the CPD to an activated conformation. After processing, InsP6 is shown to be recycled, while the cleaved CPD becomes incapable of further binding of InsP6.	[Prochazkova, Katerina; Satchell, Karla J. Fullner] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Satchell, KJF (corresponding author), 303 E Chicago Ave,Tarry 3-713, Chicago, IL 60611 USA.	k-satchell@northwestern.edu	Satchell, Karla/GSN-3100-2022		NIAID NIH HHS [R01 AI051490-06A1, R01 AI051490, R01 AI 051490, U54 AI 057153] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051490, U54AI057153] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2007, Wkly Epidemiol Rec, V82, P273; [Anonymous], 2001, Wkly Epidemiol Rec, V76, P117; BARROSO LA, 1994, MICROB PATHOGENESIS, V16, P297, DOI 10.1006/mpat.1994.1030; Cordero CL, 2007, J CLIN MICROBIOL, V45, P2289, DOI 10.1128/JCM.00349-07; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Dalsgaard A, 2001, J CLIN MICROBIOL, V39, P4086, DOI 10.1128/JCM.39.11.4086-4092.2001; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100; FRENCH PJ, 1991, P ROY SOC B-BIOL SCI, V245, P193, DOI 10.1098/rspb.1991.0109; JACKSON TR, 1987, EMBO J, V6, P49, DOI 10.1002/j.1460-2075.1987.tb04717.x; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; Kudryashov DS, 2008, J BIOL CHEM, V283, P445, DOI 10.1074/jbc.M703910200; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; SASAKAWA N, 1995, BIOCHEM PHARMACOL, V50, P137, DOI 10.1016/0006-2952(95)00059-9; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; VALLEJO M, 1987, NATURE, V330, P656, DOI 10.1038/330656a0	26	48	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23656	23664		10.1074/jbc.M803334200	http://dx.doi.org/10.1074/jbc.M803334200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18591243	Green Published, hybrid			2022-12-25	WOS:000258638900018
J	Xu, DK; Dwyer, J; Li, H; Duan, W; Liu, JP				Xu, Dakang; Dwyer, Julie; Li, He; Duan, Wei; Liu, Jun-Ping			Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; TELOMERASE ACTIVITY; TRANSCRIPTION FACTORS; MAMMARY-TUMORS; PROTEINS; DNA; FAMILY; ROLES; PHOSPHORYLATION; TRANSACTIVATION	Human telomerase reverse transcriptase ( hTERT) underlies cancer cell immortalization, and the expression of hTERTis regulated strictly at the gene transcription. Here, we report that transcription factor Ets2 is required for hTERT gene expression and breast cancer cell proliferation. Silencing Ets2 induces a decrease of hTERT gene expression and increase in human breast cancer cell death. Reconstitution with recombinant hTERT rescues the apoptosis induced by Ets2 depression. In vitro and in vivo analyses show that Ets2 binds to the EtsA and EtsB DNA motifs on the hTERT gene promoter. Mutation of either Ets2 binding site reduces the hTERT promoter transcriptional activity. Moreover, Ets2 forms a complex with c- Myc as demonstrated by co- immunoprecipitation and glutathione S- transferase pulldown assays. Immunological depletion of Ets2, or mutation of the EtsA DNA motif, disables c- Myc binding to the E- box, whereas removal of c- Myc or mutation of the E- box also compromises Ets2 binding to EtsA. Thus, hTERT gene expression is maintained by a mechanism involving Ets2 interactions with the c- Myc transcription factor and the hTERT gene promoter, a protein- DNA complex critical for hTERT gene expression and breast cancer cell proliferation.	[Xu, Dakang] Monash Inst Med Res, Ctr Canc Res, Clayton, Vic 3168, Australia; [Dwyer, Julie; Li, He; Liu, Jun-Ping] Monash Univ, Cent & Eastern Clin Sch, Dept Immunol, Prahran, Vic 3181, Australia; [Duan, Wei] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia	Monash University; Monash University; Deakin University	Xu, DK (corresponding author), Monash Inst Med Res, Ctr Canc Res, 246 Clayton Rd, Clayton, Vic 3168, Australia.	Dakang.xu@med.monash.edu.au; Jun-ping.liu@med.monash.edu.au	Duan, Wei/A-5181-2015; Liu, Jun-Ping/AAA-5521-2020	Duan, Wei/0000-0001-5782-9184; Liu, Jun-Ping/0000-0001-7442-2116; Xu, Dakang/0000-0003-2415-4920				Bayne S, 2007, ANN NY ACAD SCI, V1114, P48, DOI 10.1196/annals.1396.023; Cao Y, 2002, ONCOGENE, V21, P3130, DOI 10.1038/sj.onc.1205419; Carbone GM, 2004, NUCLEIC ACIDS RES, V32, P4358, DOI 10.1093/nar/gkh744; Dwyer J, 2007, ANN NY ACAD SCI, V1114, P36, DOI 10.1196/annals.1396.022; Foos G, 2000, ONCOGENE, V19, P5507, DOI 10.1038/sj.onc.1203946; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Hahne JC, 2005, ONCOGENE, V24, P5384, DOI 10.1038/sj.onc.1208761; Hsu CP, 2006, EUR J CANCER, V42, P1466, DOI 10.1016/j.ejca.2006.02.014; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Li H, 1998, J BIOL CHEM, V273, P33436, DOI 10.1074/jbc.273.50.33436; Li H, 2006, J BIOL CHEM, V281, P25588, DOI 10.1074/jbc.M602381200; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Li S, 2005, J BIOL CHEM, V280, P23709, DOI 10.1074/jbc.M502782200; Lindemann RK, 2003, BIOCHEM J, V372, P787, DOI 10.1042/BJ20030046; Liu JP, 1999, FASEB J, V13, P2091, DOI 10.1096/fasebj.13.15.2091; Maida Y, 2002, ONCOGENE, V21, P4071, DOI 10.1038/sj.onc.1205509; Man AK, 2003, MOL CELL BIOL, V23, P8614, DOI 10.1128/MCB.23.23.8614-8625.2003; Massard C, 2006, ONCOGENE, V25, P4505, DOI 10.1038/sj.onc.1209487; Mavrothalassitis G, 2000, ONCOGENE, V19, P6524, DOI 10.1038/sj.onc.1204045; Myers E, 2005, CLIN CANCER RES, V11, P2111, DOI 10.1158/1078-0432.CCR-04-1192; Neznanov N, 1999, CANCER RES, V59, P4242; Rahman R, 2005, ONCOGENE, V24, P1320, DOI 10.1038/sj.onc.1208232; Sapi E, 1998, CANCER RES, V58, P1027; Sementchenko VI, 1998, ONCOGENE, V17, P2883, DOI 10.1038/sj.onc.1202220; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Svensson S, 2005, ONCOGENE, V24, P4370, DOI 10.1038/sj.onc.1208626; Takahashi A, 2003, CANCER RES, V63, P8338; Xiao X, 2002, LEUKEMIA, V16, P1877, DOI 10.1038/sj.leu.2402607; Xiao XD, 2003, EXP MOL PATHOL, V75, P238, DOI 10.1016/S0014-4800(03)00092-3; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yang BS, 1996, MOL CELL BIOL, V16, P538; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	34	115	120	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23567	23580		10.1074/jbc.M800790200	http://dx.doi.org/10.1074/jbc.M800790200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586674	Green Published, hybrid			2022-12-25	WOS:000258638900009
J	Arias-Moreno, X; Velazquez-Campoy, A; Rodriguez, JC; Pocovi, M; Sancho, J				Arias-Moreno, Xabier; Velazquez-Campoy, Adrian; Rodriguez, Jose Carlos; Pocovi, Miguel; Sancho, Javier			Mechanism of low density lipoprotein (LDL) release in the endosome - Implications of the stability and Ca2+ affinity of the fifth binding module of the LDL receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS; LIGAND-BINDING; HUMAN FIBROBLASTS; CYSTEINE-RICH; CALCIUM-BINDING; 3-HYDROXY-3-METHYLGLUTARYL COENZYME; DIFFERENT PROTEINS; REDUCTASE-ACTIVITY; MOLECULAR-BASIS; PH-DEPENDENCE	Uptake of low density lipoproteins ( LDL) by their receptor, LDLR, is the primary mechanism by which cells incorporate cholesterol from plasma. Mutations in LDLR lead to familial hypercholesterolemia, a common disease affecting 1 in 500 of the human population. LDLR is a modular protein that uses several small repeats to bind LDL. The repeats contain around 40 residues, including three disulfide bonds and a calcium ion. Repeat 5 ( LR5) is critical for LDL and beta-migrating very low density lipoprotein binding. Based on the crystal structure of LDLR at endosomal pH ( but close to extracellular calcium concentration), LR5 has been proposed to bind to the epidermal growth factor ( EGF) precursor domain of LDLR in the endosome, thus releasing the LDL particles previously bound in extracellular conditions. We report here the conformational stability of LR5 as a function of temperature and calcium concentration under both extracellular and endosomal pH conditions. The repeat was very stable when it bore a bound calcium ion but was severely destabilized in the absence of calcium and even further destabilized at acidic versus neutral pH. The temperature and calcium concentration dependence of LR5 stability clearly indicate that under endosomal conditions the unfolded conformation of the repeat is largely dominant. We thus propose a new mechanism for LDL release in the endosome in which calcium depletion and decreased stability at acidic pH drives LR5 unfolding, which triggers LDL release from the receptor. Subsequent binding of LR5 to the EGF precursor domain, if it takes place at low calcium concentrations, would contribute to a further shifting of the equilibrium toward dissociation.	[Arias-Moreno, Xabier; Velazquez-Campoy, Adrian; Sancho, Javier] Univ Zaragoza, Biocomputat & Complex Syst Phys Inst, E-50009 Zaragoza, Spain; [Arias-Moreno, Xabier; Pocovi, Miguel; Sancho, Javier] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Fac Ciencias, E-50009 Zaragoza, Spain; [Rodriguez, Jose Carlos] Univ Cantabria, Dept Bioquim & Biol Mol, Fac Med, Santander 39011, Spain	University of Zaragoza; University of Zaragoza; Universidad de Cantabria	Sancho, J (corresponding author), Univ Zaragoza, Biocomputat & Complex Syst Phys Inst, E-50009 Zaragoza, Spain.	jsancho@unizar.es	Velazquez-Campoy, Adrian/E-7946-2012; MORENO, XABIER ARIAS/AAA-1176-2021; Sancho, javier/AAA-1225-2019	Velazquez-Campoy, Adrian/0000-0001-5702-4538; MORENO, XABIER ARIAS/0000-0001-8601-9092; Sancho, javier/0000-0002-2879-9200; Rodriguez-Rey, Jose/0000-0002-8369-3118				ANDERSON RGW, 1977, NATURE, V270, P695, DOI 10.1038/270695a0; ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; ANDERSON RGW, 1976, P NATL ACAD SCI USA, V73, P2434, DOI 10.1073/pnas.73.7.2434; ANDERSON RGW, 1978, CELL, V15, P919, DOI 10.1016/0092-8674(78)90276-3; Arias-Moreno X, 2008, J BIOL CHEM, V283, P13627, DOI 10.1074/jbc.M800755200; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Beglova N, 2004, BIOCHEM SOC T, V32, P721, DOI 10.1042/BST0320721; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Bu GJ, 2001, INT REV CYTOL, V209, P79; Campos LA, 2006, PROTEINS, V63, P581, DOI 10.1002/prot.20855; CHEN SH, 1986, J BIOL CHEM, V261, P2918; Cuesta-Lopez S, 2007, PROTEINS, V66, P87, DOI 10.1002/prot.21181; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DeBose-Boyd RA, 2004, MOL CELL, V16, P160, DOI 10.1016/j.molcel.2004.10.009; Dedoussis GVZ, 2004, HUM MUTAT, V24, P443, DOI 10.1002/humu.20105; Dolmer K, 1998, BIOCHEMISTRY-US, V37, P17016, DOI 10.1021/bi982022s; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Genzor CG, 1996, PROTEIN SCI, V5, P1376, DOI 10.1002/pro.5560050716; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; GOLDSTEIN JL, 1973, P NATL ACAD SCI USA, V70, P2804, DOI 10.1073/pnas.70.10.2804; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Griko YV, 1999, BIOPHYS CHEM, V79, P117, DOI 10.1016/S0301-4622(99)00047-2; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011; Koduri V, 2001, BIOCHEMISTRY-US, V40, P12801, DOI 10.1021/bi011344k; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Li YH, 2002, BIOCHEMISTRY-US, V41, P4921, DOI 10.1021/bi011894i; MAKHATADZE GI, 1993, PROTEIN SCI, V2, P2028, DOI 10.1002/pro.5560021204; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; Nielsen AD, 2003, ANAL BIOCHEM, V314, P227, DOI 10.1016/S0003-2697(02)00655-3; North CL, 2000, BIOCHEMISTRY-US, V39, P13127, DOI 10.1021/bi0015156; North CL, 1999, BIOCHEMISTRY-US, V38, P3926, DOI 10.1021/bi9821622; PACE CN, 1990, BIOCHEMISTRY-US, V29, P2564, DOI 10.1021/bi00462a019; Permyakov SE, 2006, PROTEINS, V65, P984, DOI 10.1002/prot.21159; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Rudenko G, 2003, CURR OPIN STRUC BIOL, V13, P683, DOI 10.1016/j.sbi.2003.10.001; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Saha S, 2001, STRUCTURE, V9, P451, DOI 10.1016/S0969-2126(01)00606-2; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; SCHNEIDER WJ, 1979, P NATL ACAD SCI USA, V76, P5577, DOI 10.1073/pnas.76.11.5577; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; STRAUME M, 1992, ANAL BIOCHEM, V203, P259, DOI 10.1016/0003-2697(92)90311-T; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Wilkins MR, 1999, METH MOL B, V112, P531; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Zhou HX, 2008, ARCH BIOCHEM BIOPHYS, V469, P76, DOI 10.1016/j.abb.2007.07.013	62	38	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22670	22679		10.1074/jbc.M802153200	http://dx.doi.org/10.1074/jbc.M802153200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18574243	hybrid			2022-12-25	WOS:000258321000036
J	Helms, MN; Jain, L; Self, JL; Eaton, DC				Helms, My N.; Jain, Lucky; Self, Julie L.; Eaton, Douglas C.			Redox regulation of epithelial sodium channels examined in alveolar type 1 and 2 cells patch-clamped in lung slice tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I CELLS; SUPEROXIDE; EXPRESSION; CLEARANCE; TRANSPORT	The alveolar surface of the lung is lined by alveolar type 1 (AT1) and type 2 (AT2) cells. Using single channel patch clamp analysis in lung slice preparations, we are able to uniquely study AT1 and AT2 cells separately from intact lung. We report for the first time the Na+ transport properties of type 2 cells accessed in live lung tissue (as we have done in type 1 cells). Type 2 cells in lung tissue slices express both highly selective cation and nonselective cation channels with average conductances of 8.8 +/- 3.2 and 22.5 +/- 6.3 picosiemens, respectively. Anion channels with 10-picosiemen conductance are also present in the apical membrane of type 2 cells. Our lung slice studies importantly verify the use of cultured cell model systems commonly used in lung epithelial sodium channel (ENaC) studies. Furthermore, we identify novel functional differences between the cells that make up the alveolar epithelium. One important difference is that exposure to the nitric oxide (NO) donor, PAPA-NONOate (1.5 mu M), significantly decreases average ENaC NPo in type 2 cells (from 1.38 +/- 0.26 to 0.82 +/- 0.16; p < 0.05 and n = 18) but failed to alter ENaC activity in alveolar type 1 cells. Elevating endogenous superoxide (O-2(radical anion)) levels with Ethiolat, a superoxide dismutase inhibitor, prevented NO inhibition of ENaC activity in type 2 cells, supporting the novel hypothesis that O-2(radical anion) and NO signaling plays an important role in maintaining lung fluid balance.	[Eaton, Douglas C.] Emory Univ, Dept Physiol, Ctr Cell & Mol Signaling, Sch Med, Atlanta, GA 30322 USA; [Jain, Lucky; Eaton, Douglas C.] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA	Emory University; Emory University	Eaton, DC (corresponding author), Emory Univ, Dept Physiol, Ctr Cell & Mol Signaling, Sch Med, 615 Michael St, Atlanta, GA 30322 USA.	deaton@emory.edu		Eaton, Douglas/0000-0002-2686-6692	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037963, R24DK064399] Funding Source: NIH RePORTER; NHLBI NIH HHS [2R01 HL063306-05A2, R01 HL063306] Funding Source: Medline; NIDDK NIH HHS [4R37 DK-37963, DK064399] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baines DL, 2001, J PHYSIOL-LONDON, V532, P105, DOI 10.1111/j.1469-7793.2001.0105g.x; Bhaskaran M, 2007, J BIOL CHEM, V282, P3968, DOI 10.1074/jbc.M609060200; CHEEK JM, 1989, EXP CELL RES, V184, P375, DOI 10.1016/0014-4827(89)90337-6; Chen JW, 2006, J PHYSIOL-LONDON, V572, P625, DOI 10.1113/jphysiol.2005.103465; Chen XJ, 2002, AM J PHYSIOL-LUNG C, V282, pL609, DOI 10.1152/ajplung.00356.2001; DANTO SI, 1992, AM J RESP CELL MOL, V6, P296, DOI 10.1165/ajrcmb/6.3.296; DANTO SI, 1995, AM J RESP CELL MOL, V12, P497, DOI 10.1165/ajrcmb.12.5.7742013; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dobbs LG, 1997, AM J PHYSIOL-LUNG C, V273, pL347, DOI 10.1152/ajplung.1997.273.2.L347; DOBBS LG, 1988, BIOCHIM BIOPHYS ACTA, V970, P146, DOI 10.1016/0167-4889(88)90173-5; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Elias N., 2006, AM ACAD PEDIAT, V7, pE88, DOI DOI 10.1542/neo.7-2-e88; Fang XH, 2004, AM J PHYSIOL-LUNG C, V287, pL104, DOI 10.1152/ajplung.00176.2003; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; FENG ZP, 1993, AM J RESP CELL MOL, V9, P248, DOI 10.1165/ajrcmb/9.3.248; FOUBERT L, 1992, LANCET, V339, P1615, DOI 10.1016/0140-6736(92)91886-D; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Helms MN, 2006, AM J PHYSIOL-LUNG C, V290, pL710, DOI 10.1152/ajplung.00486.2004; Helms MN, 2005, AM J PHYSIOL-CELL PH, V289, pC717, DOI 10.1152/ajpcell.00006.2005; Helms MN, 2006, AM J PHYSIOL-LUNG C, V291, pL610, DOI 10.1152/ajplung.00426.2005; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Jain L, 2001, AM J PHYSIOL-LUNG C, V280, pL646, DOI 10.1152/ajplung.2001.280.4.L646; Jain L, 1998, AM J PHYSIOL-LUNG C, V274, pL475, DOI 10.1152/ajplung.1998.274.4.L475; Liebler JM, 2004, J HISTOCHEM CYTOCHEM, V52, P759, DOI 10.1369/jhc.3A6184.2004; Matalon S, 2002, J APPL PHYSIOL, V93, P1852, DOI 10.1152/japplphysiol.01241.2001; Munzel T, 2002, ARTERIOSCL THROM VAS, V22, P1761, DOI 10.1161/01.ATV.0000034022.11764.EC; Planes C, 1997, AM J RESP CELL MOL, V17, P508, DOI 10.1165/ajrcmb.17.4.2680; Rafii B, 1998, AM J PHYSIOL-LUNG C, V275, pL764, DOI 10.1152/ajplung.1998.275.4.L764; Sheppard David N, 2004, J Cyst Fibros, V3 Suppl 2, P101, DOI 10.1016/j.jcf.2004.05.046; Thome UH, 2003, AM J PHYSIOL-LUNG C, V284, pL376, DOI 10.1152/ajplung.00218.2002; Wang PM, 2002, AM J PHYSIOL-LUNG C, V282, pL912, DOI 10.1152/ajplung.00303.2001; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF1666, DOI 10.1152/ajprenal.00444.2006; Yue HW, 2000, J BIOL CHEM, V275, P10030, DOI 10.1074/jbc.275.14.10030	33	50	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22875	22883		10.1074/jbc.M801363200	http://dx.doi.org/10.1074/jbc.M801363200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18541535	Green Published, hybrid			2022-12-25	WOS:000258321000055
J	Buglino, JA; Resh, MD				Buglino, John A.; Resh, Marilyn D.			Hhat is a palmitoylacyltransferase with specificity for N-palmitoylation of Sonic Hedgehog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL MODIFICATION; RAT-LIVER; PROTEIN PALMITOYLATION; ENDOPLASMIC-RETICULUM; LIPID MODIFICATIONS; SIGNALING PROTEINS; FATTY-ACYLATION; L-CARNITINE; ACYLTRANSFERASE; FAMILY	Palmitoylation of Sonic Hedgehog (Shh) is critical for effective long- and short-range signaling. Genetic screens uncovered a potential palmitoylacyltransferase (PAT) for Shh, Hhat, but the molecular mechanism of Shh palmitoylation remains unclear. Here, we have developed and exploited an in vitro Shh palmitoylation assay to purify Hhat to homogeneity. We provide direct biochemical evidence that Hhat is a PAT with specificity for attaching palmitate via amide linkage to the N-terminal cysteine of Shh. Other palmitoylated proteins (e. g. PSD95 and Wnt) are not substrates for Hhat, and Porcupine, a putative Wnt PAT, does not palmitoylate Shh. Neither autocleavage nor cholesterol modification is required for Shh palmitoylation. Both the Shh precursor and mature protein are N-palmitoylated by Hhat, and the reaction occurs during passage through the secretory pathway. This study establishes Hhat as a bona fide Shh PAT and serves as a model for understanding how secreted morphogens are modified by distinct PATs.	[Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Biochem Cell & Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10065 USA.	m-resh@ski.mskcc.org		Resh, Marilyn/0000-0001-6118-9466	NIGMS NIH HHS [GM008539, GM57966] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057966, T32GM008539] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERGE RK, 1979, BIOCHEM J, V181, P119, DOI 10.1042/bj1810119; BERTHIAUME L, 1995, METHOD ENZYMOL, V250, P454; Bhatnagar RS, 1997, BIOCHEMISTRY-US, V36, P6700, DOI 10.1021/bi970311v; Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chang CCY, 1998, J BIOL CHEM, V273, P35132, DOI 10.1074/jbc.273.52.35132; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dawber RJ, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-21; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gallet A, 2006, DEVELOPMENT, V133, P407, DOI 10.1242/dev.02212; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Gooding JM, 2004, EUR J BIOCHEM, V271, P954, DOI 10.1111/j.1432-1033.2004.03997.x; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Ho KS, 2002, CURR OPIN NEUROBIOL, V12, P57, DOI 10.1016/S0959-4388(02)00290-8; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Kleuss C, 2003, EMBO J, V22, P826, DOI 10.1093/emboj/cdg095; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; Liang XQ, 2001, J BIOL CHEM, V276, P30987, DOI 10.1074/jbc.M104018200; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; MENTLEIN R, 1988, BIOCHIM BIOPHYS ACTA, V964, P319, DOI 10.1016/0304-4165(88)90032-3; Micchelli CA, 2002, DEVELOPMENT, V129, P843; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Miura GI, 2006, CELL CYCLE, V5, P1184, DOI 10.4161/cc.5.11.2804; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PESECKIS SM, 1993, J BIOL CHEM, V268, P5107; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Roessler E, 1997, HUM MOL GENET, V6, P1847, DOI 10.1093/hmg/6.11.1847; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Rys-Sikora KE, 1998, J BIOL CHEM, V273, P32627, DOI 10.1074/jbc.273.49.32627; Sang SLW, 2005, J PEPT RES, V66, P169, DOI 10.1111/j.1399-3011.2005.00285.x; Schjerling CK, 1996, J BIOL CHEM, V271, P22514, DOI 10.1074/jbc.271.37.22514; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017	53	175	182	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22076	22088		10.1074/jbc.M803901200	http://dx.doi.org/10.1074/jbc.M803901200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18534984	Green Published, hybrid			2022-12-25	WOS:000258114700026
J	Yang, LL; Kasumov, T; Kombu, RS; Zhu, SH; Cendrowski, AV; David, F; Anderson, VE; Kelleher, JK; Brunengraber, H				Yang, Lili; Kasumov, Takhar; Kombu, Rajan S.; Zhu, Shu-Han; Cendrowski, Andrea V.; David, France; Anderson, Vernon E.; Kelleher, Joanne K.; Brunengraber, Henri			Metabolomic and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle - II. Heterogeneity of metabolite labeling pattern	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFUSED-RAT-LIVER; PHOSPHOENOLPYRUVATE CARBOXYKINASE; HEPATOCYTES; INHIBITION; MECHANISM; GLUCOSE; AMINOOXYACETATE; SPECTROMETRY; LIPOGENESIS; (CO2)-C-14	In this second of two companion articles, we compare the mass isotopomer distribution of metabolites of liver gluconeogenesis and citric acid cycle labeled from (NaHCO3)-C-13 or dimethyl [1,4-C-13(2)] succinate. The mass isotopomer distribution of intermediates reveals the reversibility of the isocitrate dehydrogenase + aconitase reactions, even in the absence of a source of alpha-ketoglutarate. In addition, in many cases, a number of labeling incompatibilities were found as follows: (i) glucose versus triose phosphates and phosphoenolpyruvate; (ii) differences in the labeling ratios C-4/C-3 of glucose versus (glyceraldehyde 3-phosphate)/(dihydroxyacetone phosphate); and (iii) labeling of citric acid cycle intermediates in tissue versus effluent perfusate. Overall, our data show that gluconeogenic and citric acid cycle intermediates cannot be considered as sets of homogeneously labeled pools. This probably results from the zonation of hepatic metabolism and, in some cases, from differences in the labeling pattern of mitochondrial versus extramitochondrial metabolites. Our data have implications for the use of labeling patterns for the calculation of metabolic rates or fractional syntheses in liver, as well as for modeling liver intermediary metabolism.	[Brunengraber, Henri] Case Western Reserve Univ, Sch Med WG48, Dept Nutr, Cleveland, OH 44106 USA; [Anderson, Vernon E.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Kelleher, Joanne K.] MIT, Dept Chem Engn, Cambridge, MA 02154 USA	Case Western Reserve University; Case Western Reserve University; Massachusetts Institute of Technology (MIT)	Brunengraber, H (corresponding author), Case Western Reserve Univ, Sch Med WG48, Dept Nutr, 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxb8@case.edu	Lorkiewicz, Pawel/A-2126-2011; Kombu, Rajan/A-6752-2008; Anderson, Vernon/W-2673-2019	Lorkiewicz, Pawel/0000-0002-1755-9826; Anderson, Vernon Emmett/0000-0002-1699-7621	NIDDK NIH HHS [R33DK070291] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bederman IR, 2004, J BIOL CHEM, V279, P43207, DOI 10.1074/jbc.M403838200; BEYLOT M, 1993, ANAL BIOCHEM, V212, P526, DOI 10.1006/abio.1993.1363; BLACKSHEAR PJ, 1975, BIOCHEM J, V148, P353, DOI 10.1042/bj1480353b; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; CHANG HC, 1966, J BIOL CHEM, V241, P2421; CORNELL NW, 1984, BIOCHEM J, V220, P707, DOI 10.1042/bj2200707; DEBEER LJ, 1982, FEBS LETT, V140, P159, DOI 10.1016/0014-5793(82)80884-3; DESROSIERS C, 1994, J BIOL CHEM, V269, P27179; ESENMO E, 1992, AM J PHYSIOL, V263, pE36, DOI 10.1152/ajpendo.1992.263.1.E36; FOLCH J, 1951, J BIOL CHEM, V191, P819; HELLERSTEIN MK, 1992, AM J PHYSIOL, V263, pE988; HELLERSTEIN MK, 1991, J BIOL CHEM, V266, P10920; JOMAINBAUM M, 1976, J BIOL CHEM, V251, P37; JUNGERMANN K, 1987, Diabetes Metabolism Reviews, V3, P269; LANDAU BERNARD R., 1955, JOUR BIOL CHEM, V214, P525; LANDAU BR, 1995, AM J PHYSIOL-ENDOC M, V269, pE18, DOI 10.1152/ajpendo.1995.269.1.E18; OCHS RS, 1980, BIOCHIM BIOPHYS ACTA, V632, P260, DOI 10.1016/0304-4165(80)90084-7; Previs SF, 1996, J MASS SPECTROM, V31, P643, DOI 10.1002/(SICI)1096-9888(199606)31:6<643::AID-JMS335>3.0.CO;2-B; PREVIS SF, 1995, J BIOL CHEM, V270, P19806, DOI 10.1074/jbc.270.34.19806; Puchowicz MA, 1999, AM J PHYSIOL-ENDOC M, V277, pE1022, DOI 10.1152/ajpendo.1999.277.6.E1022; ROGNSTAD R, 1974, ARCH BIOCHEM BIOPHYS, V161, P638, DOI 10.1016/0003-9861(74)90348-8; ROGNSTAD R, 1984, ARCH BIOCHEM BIOPHYS, V230, P605, DOI 10.1016/0003-9861(84)90441-7; ROGNSTAD R, 1982, J BIOL CHEM, V257, P1486; ROSE IA, 1962, J BIOL CHEM, V237, P3325; ROSIERS CD, 1995, J BIOL CHEM, V270, P10027, DOI 10.1074/jbc.270.17.10027; ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681; Yang LL, 2008, J BIOL CHEM, V283, P21978, DOI 10.1074/jbc.M803454200; Yang L, 2006, METABOLOMICS, V2, P85, DOI 10.1007/s11306-006-0019-1	28	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21988	21996		10.1074/jbc.M803455200	http://dx.doi.org/10.1074/jbc.M803455200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544526	hybrid, Green Published			2022-12-25	WOS:000258114700018
J	Riba, J; Kramer, UM; Heldmann, M; Richter, S; Munte, TF				Riba, Jordi; Kraemer, Ulrike M.; Heldmann, Marcus; Richter, Sylvia; Muente, Thomas F.			Dopamine Agonist Increases Risk Taking but Blunts Reward-Related Brain Activity	PLOS ONE			English	Article								The use of D2/D3 dopaminergic agonists in Parkinson's disease (PD) may lead to pathological gambling. In a placebo-controlled double-blind study in healthy volunteers, we observed riskier choices in a lottery task after administration of the D3 receptor-preferring agonist pramipexole thus mimicking risk-taking behavior in PD. Moreover, we demonstrate decreased activation in the rostral basal ganglia and midbrain, key structures of the reward system, following unexpected high gains and therefore propose that pathological gambling in PD results from the need to seek higher rewards to overcome the blunted response in this system.	[Riba, Jordi; Kraemer, Ulrike M.; Heldmann, Marcus; Richter, Sylvia; Muente, Thomas F.] Univ Magdeburg, Dept Neuropsychol, D-39106 Magdeburg, Germany; [Riba, Jordi] Univ Autonoma Barcelona, Hosp Santa Creu Sant Pau, Serv Farmacol Clin, Inst Recerca, Barcelona, Spain; [Heldmann, Marcus] Univ Magdeburg, Dept Neurol 2, Magdeburg, Germany; [Richter, Sylvia] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany; [Muente, Thomas F.] Ctr Behavioral Brain Sci, Magdeburg, Germany	Otto von Guericke University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Riba, J (corresponding author), Univ Magdeburg, Dept Neuropsychol, D-39106 Magdeburg, Germany.	Thomas.muente@med.uni-magdeburg.de	Münte, Thomas/C-2077-2014; Krämer, Ulrike M./A-8871-2019; Krämer, Ulrike/AAF-2966-2020	Krämer, Ulrike M./0000-0002-3841-1812; Riba, Jordi/0000-0002-9375-8421	Deutsche Forschungsgemeinschaft [SFB 779, TP A5]; BMBF; Alexander-von-Humboldt [fellowship]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Alexander-von-Humboldt(Alexander von Humboldt Foundation)	Supported by the Deutsche Forschungsgemeinschaft (SFB 779, TP A5) and the BMBF to TFM. JR was the recipient of an Alexander-von-Humboldt-fellowship. The sponsors had no role in the design, execution, analysis or interpretation of the reported research.	Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; Ashby CR, 2003, SYNAPSE, V48, P154, DOI 10.1002/syn.10188; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Di Ciano P, 2003, NEUROPSYCHOPHARMACOL, V28, P329, DOI 10.1038/sj.npp.1300148; Dodd ML, 2005, ARCH NEUROL-CHICAGO, V62, P1377, DOI 10.1001/archneur.62.9.noc50009; Driver-Dunckley E, 2003, NEUROLOGY, V61, P422, DOI 10.1212/01.WNL.0000076478.45005.EC; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; Kenny PJ, 2007, TRENDS PHARMACOL SCI, V28, P135, DOI 10.1016/j.tips.2007.01.008; Knutson B, 2004, NEURON, V43, P261, DOI 10.1016/j.neuron.2004.06.030; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Nieuwenhuis S, 2005, EUR J NEUROSCI, V21, P3161, DOI 10.1111/j.1460-9568.2005.04152.x; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Sokoloff P., 2006, CNS & Neurological Disorders-Drug Targets, V5, P25, DOI 10.2174/187152706784111551; Thanos PK, 2005, PHARMACOL BIOCHEM BE, V81, P190, DOI 10.1016/j.pbb.2005.03.013; Voon V, 2006, NEUROLOGY, V67, P1254, DOI 10.1212/01.wnl.0000238503.20816.13; Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969	18	110	111	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2479	10.1371/journal.pone.0002479	http://dx.doi.org/10.1371/journal.pone.0002479			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575579	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000010
J	Rotolo, S; Ceccarelli, S; Romano, F; Frati, L; Marchese, C; Angeloni, A				Rotolo, Sabrina; Ceccarelli, Simona; Romano, Ferdinando; Frati, Luigi; Marchese, Cinzia; Angeloni, Antonio			Silencing of Keratinocyte Growth Factor Receptor Restores 5-Fluorouracil and Tamoxifen Efficacy on Responsive Cancer Cells	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN BREAST-CANCER; FACTOR EXPRESSION; MCF-7 CELLS; KGF; INHIBITION; MIGRATION; APOPTOSIS; MOTILITY; DIFFERENTIATION	Background: Keratinocyte growth factor receptor (KGFR) is a splice variant of the FGFR2 gene expressed in epithelial cells. Activation of KGFR is a key factor in the regulation of physiological processes in epithelial cells such as proliferation, differentiation and wound healing. Alterations of KGFR signaling have been linked to the pathogenesis of different epithelial tumors. It has been also hypothesized that its specific ligand, KGF, might contribute to the development of resistance to 5-fluorouracil (5-FU) in epithelial cancers and tamoxifen in estrogen-positive breast cancers. Methodology/Principal Findings: Small interfering RNA was transfected into a human keratinocyte cell line (HaCaT), a breast cancer derived cell line (MCF-7) and a keratinocyte primary culture (KCs) to induce selective downregulation of KGFR expression. A strong and highly specific reduction of KGFR expression was observed at both RNA (reduction = 75.7%, P = 0.009) and protein level. KGFR silenced cells showed a reduced responsiveness to KGF treatment as assessed by measuring proliferation rate (14.2% versus 39.0% of the control cells, P<0.001) and cell migration (24.6% versus 96.4% of the control cells, P = 0.009). In mock-transfected MCF-7 cells, KGF counteracts the capacity of 5-FU to inhibit cell proliferation, whereas in KGFR silenced cells KGF weakly interferes with 5-FU antiproliferative effect (11.2% versus 28.4% of the control cells, P = 0.002). The capacity of 5-FU to induce cell death is abrogated by co-treatment with KGF, whereas in KGFR silenced cells 5-FU efficiently induces cell death even combined to KGF, as determined by evaluating cell viability. Similarly, the capacity of tamoxifen to inhibit MCF-7 and KCs proliferation is highly reduced by KGF treatment and is completely restored in KGFR silenced cells (12.3% versus 45.5% of the control cells, P<0.001). Conclusions/Significance: These findings suggest that selective inhibition of the KGF/KGFR pathway may provide a useful tool to ameliorate the efficacy of the therapeutic strategies for certain epithelial tumors.	[Rotolo, Sabrina; Ceccarelli, Simona; Romano, Ferdinando; Frati, Luigi; Marchese, Cinzia; Angeloni, Antonio] Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy; [Frati, Luigi] Ist Neurol Mediterraneo Neuromed, Pozzilli, Italy	Sapienza University Rome; IRCCS Neuromed	Rotolo, S (corresponding author), Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy.	antonio.angeloni@uniroma1.it	Frati, Luigi/ABI-7437-2020; Ceccarelli, Simona/J-4086-2018; Angeloni, Antonio/J-9392-2018; Marchese, Cinzia/J-1323-2018	Ceccarelli, Simona/0000-0001-8789-7719; Angeloni, Antonio/0000-0003-4969-9548; MARCHESE, CINZIA/0000-0002-9280-8917	MIUR; Cofin 2005; Regione Lazio; Progetto di Ricerca Finalizzata 2005	MIUR(Ministry of Education, Universities and Research (MIUR)); Cofin 2005(Ministry of Education, Universities and Research (MIUR)); Regione Lazio(Regione Lazio); Progetto di Ricerca Finalizzata 2005	This work was partially supported by grants from the MIUR, Cofin 2005, and from Regione Lazio grant issued for Progetto di Ricerca Finalizzata 2005. Funders were not directly nor indirectly involved in designing or conducting the study in any part.	Adamo V, 2007, ANN ONCOL, V18, P53, DOI 10.1093/annonc/mdm225; Bansal GS, 1997, BRIT J CANCER, V75, P1567, DOI 10.1038/bjc.1997.269; Carstens RP, 1997, ONCOGENE, V15, P3059, DOI 10.1038/sj.onc.1201498; Ceccarelli S, 2007, EXP CELL RES, V313, P1758, DOI 10.1016/j.yexcr.2007.03.013; Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083; Chang HL, 2006, ANTICANCER RES, V26, P1773; Cho K, 2007, AM J PATHOL, V170, P1964, DOI 10.2353/ajpath.2007.060935; Crescioli C, 2002, PROSTATE, V50, P15, DOI 10.1002/pros.10028; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Farrell CL, 1998, CANCER RES, V58, P933; Finch PW, 2006, JNCI-J NATL CANCER I, V98, P812, DOI 10.1093/jnci/djj228; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Galiacy S, 2003, EXP CELL RES, V283, P215, DOI 10.1016/S0014-4827(02)00049-6; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Hines MD, 1996, J BIOL CHEM, V271, P6245, DOI 10.1074/jbc.271.11.6245; Hishikawa Y, 2004, ARCH HISTOL CYTOL, V67, P455, DOI 10.1679/aohc.67.455; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; HUSEBY RA, 1984, CANCER RES, V44, P2654; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; KOOS RD, 1993, J STEROID BIOCHEM, V45, P217, DOI 10.1016/0960-0760(93)90335-T; Lee Grace M, 2005, Health Qual Life Outcomes, V3, P17, DOI 10.1186/1477-7525-3-17; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Lotti LV, 2007, J CELL PHYSIOL, V212, P633, DOI 10.1002/jcp.21056; Lu YB, 2003, J BIOL CHEM, V278, P10374, DOI 10.1074/jbc.M205875200; MARCHESE C, 1995, J EXP MED, V182, P1369, DOI 10.1084/jem.182.5.1369; MARCHESE C, 1990, J CELL PHYSIOL, V144, P326, DOI 10.1002/jcp.1041440219; Matsunobu T, 2006, INT J ONCOL, V28, P307; McLeskey SW, 1998, CLIN CANCER RES, V4, P697; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Nagy N, 2006, EXP DERMATOL, V15, P596, DOI 10.1111/j.1600-0625.2006.00450.x; Nguyen TN, 2002, PHARMACOL RES, V46, P179, DOI 10.1016/S1043-6618(02)00085-3; Nurcombe V, 2000, J BIOL CHEM, V275, P30009, DOI 10.1074/jbc.M003038200; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Panici PB, 2007, HUM REPROD, V22, P2025, DOI 10.1093/humrep/dem096; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SATO C, 1995, J INVEST DERMATOL, V104, P958, DOI 10.1111/1523-1747.ep12606221; Shin EY, 2000, J CANCER RES CLIN, V126, P519, DOI 10.1007/s004320000128; STAIANOCOICO L, 1993, J EXP MED, V178, P865, DOI 10.1084/jem.178.3.865; Tamaru N, 2004, LAB INVEST, V84, P1460, DOI 10.1038/labinvest.3700166; Tschaharganeh D, 2007, PATHOL ONCOL RES, V13, P84, DOI 10.1007/BF02893482; TSUBOI R, 1993, J INVEST DERMATOL, V101, P49, DOI 10.1111/1523-1747.ep12358892; Tsukioka Y, 2001, JPN J CLIN ONCOL, V31, P450, DOI 10.1093/jjco/hye091; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; Zang XP, 2003, ANTICANCER RES, V23, P4913; Zang XP, 2001, CLIN EXP METASTAS, V18, P573; Zhang N, 1998, ACTA PHYS SIN-OV ED, V7, P361; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P11336, DOI 10.1073/pnas.191377098	51	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2528	10.1371/journal.pone.0002528	http://dx.doi.org/10.1371/journal.pone.0002528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575591	Green Submitted, gold, Green Published			2022-12-25	WOS:000263288000043
J	Urich, T; Lanzen, A; Qi, J; Huson, DH; Schleper, C; Schuster, SC				Urich, Tim; Lanzen, Anders; Qi, Ji; Huson, Daniel H.; Schleper, Christa; Schuster, Stephan C.			Simultaneous Assessment of Soil Microbial Community Structure and Function through Analysis of the Meta-Transcriptome	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; NITRITE REDUCTASE; DIVERSITY; ARCHAEA; GENOME; DNA; CRENARCHAEOTA; METAGENOMICS; ASSIMILATION; EXPRESSION	Background: Soil ecosystems harbor the most complex prokaryotic and eukaryotic microbial communities on Earth. Experimental approaches studying these systems usually focus on either the soil community's taxonomic structure or its functional characteristics. Many methods target DNA as marker molecule and use PCR for amplification. Methodology/Principal Findings: Here we apply an RNA-centered meta-transcriptomic approach to simultaneously obtain information on both structure and function of a soil community. Total community RNA is random reversely transcribed into cDNA without any PCR or cloning step. Direct pyrosequencing produces large numbers of cDNA rRNA-tags; these are taxonomically profiled in a binning approach using the MEGAN software and two specifically compiled rRNA reference databases containing small and large subunit rRNA sequences. The pyrosequencing also produces mRNA-tags; these provide a sequence-based transcriptome of the community. One soil dataset of 258,411 RNA-tags of similar to 98 bp length contained 193,219 rRNA-tags with valid taxonomic information, together with 21,133 mRNA-tags. Quantitative information about the relative abundance of organisms from all three domains of life and from different trophic levels was obtained in a single experiment. Less frequent taxa, such as soil Crenarchaeota, were well represented in the data set. These were identified by more than 2,000 rRNA-tags; furthermore, their activity in situ was revealed through the presence of mRNA-tags specific for enzymes involved in ammonia oxidation and CO2 fixation. Conclusions/Significance: This approach could be widely applied in microbial ecology by efficiently linking community structure and function in a single experiment while avoiding biases inherent in other methods.	[Urich, Tim; Schleper, Christa] Univ Bergen, Dept Biol, Ctr Geobiol, Bergen, Norway; [Urich, Tim; Schleper, Christa] Univ Vienna, Vienna Ecol Ctr, Dept Genet Ecol, Vienna, Austria; [Lanzen, Anders] Univ Bergen, Bergen Ctr Computat Sci, Computat Biol Unit, Bergen, Norway; [Qi, Ji; Schuster, Stephan C.] Penn State Univ, Ctr Comparative Genom & Bioinformat, State Coll, PA USA; [Huson, Daniel H.] Tubingen Univ, Ctr Bioinformat, Tubingen, Germany	University of Bergen; University of Vienna; University of Bergen; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Eberhard Karls University of Tubingen	Urich, T (corresponding author), Univ Bergen, Dept Biol, Ctr Geobiol, Bergen, Norway.	Christa.Schleper@univie.ac.at; scs@bx.psu.edu	QI, JI/E-2797-2016; Lanzén, Anders/F-3818-2016; Lanzén, Anders/AAG-5048-2019; Huson, Daniel H./AAC-5494-2019; Schleper, Christa M/C-2567-2013; Urich, Tim/J-8241-2016; Urich, Tim/C-2887-2013	Lanzén, Anders/0000-0002-7138-6364; Lanzén, Anders/0000-0002-7138-6364; Urich, Tim/0000-0002-5718-1354; Schleper, Christa/0000-0002-1918-2735	EMBO [fellowship]; University of Bergen; Gordon and Betty Moore Foundation	EMBO(European Molecular Biology Organization (EMBO)); University of Bergen; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	TU was financially supported by an EMBO long-term fellowship. Part of this project was financed through funding of the University of Bergen given to CS. SCS is funded in part by the Gordon and Betty Moore Foundation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Beaumont HJE, 2004, MOL MICROBIOL, V54, P148, DOI 10.1111/j.1365-2958.2004.04248.x; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Bremer H, 1996, ESCHERICHIA COLI SAL; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; LIU Z, 2007, NUCL ACIDS RES; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Poretsky RS, 2005, APPL ENVIRON MICROB, V71, P4121, DOI 10.1128/AEM.71.7.4121-4126.2005; Prosser J.I., 2007, BOOKS SOILS PLANTS, V2nd Edition, P237; Pruesse E, 2007, NUCL ACIDS RES; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Quaiser A, 2002, ENVIRON MICROBIOL, V4, P603, DOI 10.1046/j.1462-2920.2002.00345.x; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SCHAEFER M, 1990, OECOLOGIA, V82, P128, DOI 10.1007/BF00318544; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Treusch AH, 2004, ENVIRON MICROBIOL, V6, P970, DOI 10.1111/j.1462-2920.2004.00663.x; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WELLER R, 1989, APPL ENVIRON MICROB, V55, P1818, DOI 10.1128/AEM.55.7.1818-1822.1989	45	511	550	2	206	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2527	10.1371/journal.pone.0002527	http://dx.doi.org/10.1371/journal.pone.0002527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575584	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288000042
J	Frokjaer-Jensen, C; Ailion, M; Lockery, SR				Frokjaer-Jensen, Christian; Ailion, Michael; Lockery, Shawn R.			Ammonium-Acetate Is Sensed by Gustatory and Olfactory Neurons in Caenorhabditis elegans	PLOS ONE			English	Article								Background: Caenorhabditis elegans chemosensation has been successfully studied using behavioral assays that treat detection of volatile and water soluble chemicals as separate senses, analogous to smell and taste. However, considerable ambiguity has been associated with the attractive properties of the compound ammonium-acetate (NH(4)Ac). NH(4)Ac has been used in behavioral assays both as a chemosensory neutral compound and as an attractant. Methodology/Main Findings: Here we show that over a range of concentrations NH(4)Ac can be detected both as a water soluble attractant and as an odorant, and that ammonia and acetic acid individually act as olfactory attractants. We use genetic analysis to show that NaCl and NH(4)Ac sensation are mediated by separate pathways and that ammonium sensation depends on the cyclic nucleotide gated ion channel TAX-2/TAX-4, but acetate sensation does not. Furthermore we show that sodium-acetate (NaAc) and ammonium-chloride (NH(4)Cl) are not detected as Na(+) and Cl(-) specific stimuli, respectively. Conclusions/Significance: These findings clarify the behavioral response of C. elegans to NH(4)Ac. The results should have an impact on the design and interpretation of chemosensory experiments studying detection and adaptation to soluble compounds in the nematode Caenorhabditis elegans.	[Frokjaer-Jensen, Christian; Ailion, Michael; Lockery, Shawn R.] Univ Oregon, Inst Neurosci, Eugene, OR USA	University of Oregon	Frokjaer-Jensen, C (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR USA.	shawn@chinook.uoregon.edu	Frøkjær-Jensen, Christian/ABB-4637-2020; Ailion, Michael/ABE-6210-2021	Ailion, Michael/0000-0002-8070-1362; Frokjaer-Jensen, Christian/0000-0002-3178-0906	American Heart Association Pacific Mountain Affiliate; Fonden af 17.12.1981; Helen Hay Whitney Postdoctoral Fellowship; National Institute of Health National Center for Research Resources (NCRR) [MH-051383]; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051383, R01MH051383, R21MH112105] Funding Source: NIH RePORTER	American Heart Association Pacific Mountain Affiliate(American Heart Association); Fonden af 17.12.1981; Helen Hay Whitney Postdoctoral Fellowship; National Institute of Health National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	CFJ was funded by predoctoral fellowships from "American Heart Association Pacific Mountain Affiliate" and "Fonden af 17.12.1981". MA was supported by a Helen Hay Whitney Postdoctoral Fellowship. The Caenorhabditis Genetics Center supplied strains and is funded by the National Institute of Health National Center for Research Resources (NCRR). Supported by National Institute of Health MH-051383.	BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Birnby DA, 2000, GENETICS, V155, P85; BRENNER S, 1974, GENETICS, V77, P71; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; DUSENBER.DB, 1974, J EXP ZOOL, V188, P41, DOI 10.1002/jez.1401880105; Fujiwara M, 1999, DEVELOPMENT, V126, P4839; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Jansen G, 2002, EMBO J, V21, P986, DOI 10.1093/emboj/21.5.986; Koga M, 2004, J MOL BIOL, V336, P579, DOI 10.1016/j.jmb.2003.12.037; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lanjuin A, 2004, CURR OPIN NEUROBIOL, V14, P22, DOI 10.1016/j.conb.2004.01.006; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Morton DB, 2004, MOL NEUROBIOL, V29, P97, DOI 10.1385/MN:29:2:097; Ortiz CO, 2006, GENETICS, V173, P131, DOI 10.1534/genetics.106.055749; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Saeki S, 2001, J EXP BIOL, V204, P1757; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; VOWELS JJ, 1994, GENETICS, V138, P303; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686	37	15	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2467	10.1371/journal.pone.0002467	http://dx.doi.org/10.1371/journal.pone.0002467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560547	Green Published, gold, Green Submitted			2022-12-25	WOS:000263280700048
J	Prins, KW; Lowe, DA; Ervasti, JM				Prins, Kurt W.; Lowe, Dawn A.; Ervasti, James M.			Skeletal Muscle-Specific Ablation of gamma(cyto)-Actin Does Not Exacerbate the mdx Phenotype	PLOS ONE			English	Article								We previously documented a ten-fold increase in gamma(cyto)-actin expression in dystrophin-deficient skeletal muscle and hypothesized that increased gamma(cyto)-actin expression may participate in an adaptive cytoskeletal remodeling response. To explore whether increased gamma(cyto)-actin fortifies the cortical cytoskeleton in dystrophic skeletal muscle, we generated double knockout mice lacking both dystrophin and gamma(cyto)-actin specifically in skeletal muscle (ms-DKO). Surprisingly, dystrophin-deficient mdx and ms-DKO mice presented with comparable levels of myofiber necrosis, membrane instability, and deficits in muscle function. The lack of an exacerbated phenotype in ms-DKO mice suggests gamma(cyt)o-actin and dystrophin function in a common pathway. Finally, because both mdx and ms-DKO skeletal muscle showed similar levels of utrophin expression and presented with identical dystrophies, we conclude utrophin can partially compensate for the loss of dystrophin independent of a gamma(cyto)-actin-utrophin interaction.	[Prins, Kurt W.; Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Lowe, Dawn A.] Univ Minnesota, Dept Phys Med & Rehabil, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Prins, KW (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	jervasti@umn.edu	Ervasti, James/AAZ-4786-2020	Lowe, Dawn/0000-0002-5784-9289; Prins, Kurt/0000-0002-0364-6742	University of Minnesota Graduate School [Fellowship]; NIH [AR007612, AR049899]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612, R01AR049899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG020990] Funding Source: NIH RePORTER	University of Minnesota Graduate School(University of Minnesota System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a University of Minnesota Graduate School Fellowship, the NIH Training Program in Muscle Research (AR007612), and a grant from the National Institutes of Health (AR049899).	Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Burkin DJ, 2001, J CELL BIOL, V152, P1207, DOI 10.1083/jcb.152.6.1207; Chung W, 1999, Mol Cell Biol Res Commun, V2, P162, DOI 10.1006/mcbr.1999.0168; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; EMERY AEH, 1993, NEUROMUSCULAR DISORD, V3, P263, DOI 10.1016/0960-8966(93)90018-F; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Hanft LM, 2006, P NATL ACAD SCI USA, V103, P5385, DOI 10.1073/pnas.0600980103; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Hodges BL, 1997, J CELL SCI, V110, P2873; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ishikawa-Sakurai M, 2004, HUM MOL GENET, V13, P693, DOI 10.1093/hmg/ddh087; Khurana T S, 1991, Neuromuscul Disord, V1, P185, DOI 10.1016/0960-8966(91)90023-L; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MATSUMURA K, 1994, MUSCLE NERVE, V17, P2, DOI 10.1002/mus.880170103; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Porter JD, 1998, J CELL SCI, V111, P1801; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Rooney JE, 2006, J CELL SCI, V119, P2185, DOI 10.1242/jcs.02952; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Rybakova IN, 2002, MOL BIOL CELL, V13, P1512, DOI 10.1091/mbc.01-09-0446; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; SHARP AH, 1989, J BIOL CHEM, V264, P2816; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; URAYAMA O, 1989, J BIOL CHEM, V264, P8271; Weir AP, 2004, NEUROMUSCULAR DISORD, V14, P19, DOI 10.1016/j.nmd.2003.09.004	33	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2419	10.1371/journal.pone.0002419	http://dx.doi.org/10.1371/journal.pone.0002419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545671	Green Published, gold, Green Submitted			2022-12-25	WOS:000263248800055
J	Mariotti, S; Sargentini, V; Marcantonio, C; Todero, E; Teloni, R; Gagliardi, MC; Ciccaglione, AR; Nisini, R				Mariotti, Sabrina; Sargentini, Valeria; Marcantonio, Cinzia; Todero, Emiliano; Teloni, Raffaela; Gagliardi, Maria Cristina; Ciccaglione, Anna Rita; Nisini, Roberto			T-cell-mediated and antigen-dependent differentiation of human monocyte into different dendritic cell subsets: a feedback control of Th1/Th2 responses	FASEB JOURNAL			English	Article						antigen presentation/processing; cytokines; cell differentiation; chronic inflammation; T-cell clones	COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; IN-VIVO; LANGERHANS CELLS; ANTITUMOR IMMUNITY; BLOOD MONOCYTES; SOLUBLE-ANTIGEN; STEADY-STATE; LYMPH-NODES; IFN-GAMMA	It is well established that human monocytes differentiate into dendritic cells (DCs) when cultured with certain cytokine cocktails, such as granulocyte-macrophage colony-stimulating factor and interleukin-4. Conversely, it is not completely established which cell population synthesizes the cytokines required for monocyte differentiation and how their secretion is regulated. We show that on specific activation T cells induce the differentiation into DCs of antigen-presenting and bystander monocytes. Monocytes exposed to cytokines released by Th1 and Th0 lymphocytes differentiate into DCs with a reduced antigen uptake and antigen presentation capacity. Moreover, these DCs show a limited capacity to induce Th1 polarization of naive T cells but are capable of priming interleukin-10-secreting T cells. Conversely, DCs derived from monocytes sensing cytokines released by Th2 lymphocytes are antigen-presenting-cell (APC) endowed with a marked Th1 polarization capacity. Monocytes are corecruited with lymphocytes in chronic inflammation sites; thus our results suggest that functionally different DCs can be generated in environments characterized by the prevalent release of Th1-, Th0-, or Th2-associated cytokines. Because the APC capacities of these DCs have opposite functional consequences, a contribution in the regulation of the ongoing immune response by monocyte-derived inflammatory DCs is envisaged.	[Mariotti, Sabrina; Sargentini, Valeria; Marcantonio, Cinzia; Todero, Emiliano; Teloni, Raffaela; Gagliardi, Maria Cristina; Ciccaglione, Anna Rita; Nisini, Roberto] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Nisini, R (corresponding author), Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, Viale Regina Elena 299, I-00161 Rome, Italy.	roberto.nisini@iss.it	Nisini, Roberto/M-4363-2015; MARCANTONIO, CINZIA/M-2963-2015; Gagliardi, Maria Cristina/AAA-9273-2019; CICCAGLIONE, ANNA RITA/M-2956-2015; MARIOTTI, SABRINA/M-4361-2015	Nisini, Roberto/0000-0003-1077-423X; MARCANTONIO, CINZIA/0000-0002-7392-9780; CICCAGLIONE, ANNA RITA/0000-0002-3791-3781; MARIOTTI, SABRINA/0000-0002-7009-7616; gagliardi, maria cristina/0000-0003-3176-5439	EC project MILD-TB [037326]	EC project MILD-TB	We thank Prof. Antonio Cassone and Prof. Vincenzo Barnaba for suggestions and critical reading of the manuscript. This paper was partially supported by the EC project MILD-TB, contract no. 037326. The authors declare no financial conflict of interest.	Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Brossart P, 1998, BLOOD, V92, P4238, DOI 10.1182/blood.V92.11.4238.423k16_4238_4247; Chang CCJ, 2000, J IMMUNOL, V165, P3584, DOI 10.4049/jimmunol.165.7.3584; Comes A, 2002, EUR J IMMUNOL, V32, P1914, DOI 10.1002/1521-4141(200207)32:7<1914::AID-IMMU1914>3.0.CO;2-P; Dannull J, 2005, BLOOD, V105, P3206, DOI 10.1182/blood-2004-10-3944; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; De Libero G, 2006, FEBS LETT, V580, P5580, DOI 10.1016/j.febslet.2006.08.029; Ebner S, 2002, J IMMUNOL, V168, P6199, DOI 10.4049/jimmunol.168.12.6199; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Gangenahalli GU, 2005, STEM CELLS DEV, V14, P140, DOI 10.1089/scd.2005.14.140; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Gogolak P, 2007, BLOOD, V109, P643, DOI 10.1182/blood-2006-04-016840; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hegde S, 2007, J LEUKOCYTE BIOL, V81, P1224, DOI 10.1189/jlb.1206718; Iwamoto S, 2007, J IMMUNOL, V179, P1449, DOI 10.4049/jimmunol.179.3.1449; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Levings MK, 2002, INT ARCH ALLERGY IMM, V129, P263, DOI 10.1159/000067596; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Liu GT, 2004, EUR J IMMUNOL, V34, P1680, DOI 10.1002/eji.200425081; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAGGI E, 1992, J IMMUNOL, V148, P2142; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Mohamadzadeh M, 2001, J EXP MED, V194, P1013, DOI 10.1084/jem.194.7.1013; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nisini R, 1997, J VIROL, V71, P2241, DOI 10.1128/JVI.71.3.2241-2251.1997; Okano F, 2005, J IMMUNOL, V174, P2645, DOI 10.4049/jimmunol.174.5.2645; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Prete SP, 2007, INT IMMUNOPHARMACOL, V7, P321, DOI 10.1016/j.intimp.2006.11.003; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001; Ullrich E, 2007, CANCER RES, V67, P851, DOI 10.1158/0008-5472.CAN-06-3766; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Villadangos JA, 2007, IMMUNITY, V26, P390, DOI 10.1016/j.immuni.2007.04.006; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x; Wirths S, 2002, CANCER RES, V62, P5065; Woerly G, 1999, J EXP MED, V190, P487, DOI 10.1084/jem.190.4.487; Yi HF, 2007, CYTOKINE, V37, P35, DOI 10.1016/j.cyto.2007.02.012; Zhang AL, 2007, BLOOD, V110, P2484, DOI 10.1182/blood-2007-02-076364; Zou GM, 2002, EUR CYTOKINE NETW, V13, P186	55	11	12	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2008	22	9					3370	3379		10.1096/fj.08-108209	http://dx.doi.org/10.1096/fj.08-108209			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18556459				2022-12-25	WOS:000258761300029
J	Wright, GL; Maroulakou, IG; Eldridge, J; Liby, TL; Sridharan, V; Tsichlis, PN; Muise-Helmericks, RC				Wright, Gary L.; Maroulakou, Ioanna G.; Eldridge, Juanita; Liby, Tiera L.; Sridharan, Vijayalakshmi; Tsichlis, Philip N.; Muise-Helmericks, Robin C.			VEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase	FASEB JOURNAL			English	Article						angiogenesis; VEGF signal transduction; Akt kinase; PGC-1 alpha; mitochondrial protein import	NF-KAPPA-B; SKELETAL-MUSCLE; PHOSPHATIDYLINOSITOL 3-KINASE; GAMMA COACTIVATOR-1; GLUCOSE-HOMEOSTASIS; ENDOTHELIAL-CELLS; MAMMALIAN-CELLS; PROTEIN IMPORT; GROWTH-FACTORS; RECEPTOR	The growth factor, vascular endothelial growth factor (VEGF), induces angiogenesis and promotes endothelial cell (EC) proliferation. Affymetrix gene array analyses show that VEGF stimulates the expression of a cluster of nuclear-encoded mitochondrial genes, suggesting a role for VEGF in the regulation of mitochondrial biogenesis. We show that the serine threonine kinase Akt3 specifically links VEGF to mitochondrial biogenesis. A direct comparison of Akt1 vs. Akt3 gene silencing was performed in ECs and has uncovered a discrete role for Akt3 in the control of mitochondrial biogenesis. Silencing of Akt3, but not Akt1, results in a decrease in mitochondrial gene expression and mtDNA content. Nuclear-encoded mitochondrial gene transcripts are also found to decrease when Akt3 expression is silenced. Concurrent with these changes in mitochondrial gene expression, lower O-2 consumption was observed. VEGF stimulation of the major mitochondrial import protein TOM70 is also blocked by Akt3 inhibition. In support of a role for Akt3 in the regulation of mitochondrial biogenesis, Akt3 silencing results in the cytoplasmic accumulation of the master regulator of mitochondrial biogenesis, PGC-1 alpha, and a reduction in known PGC-1 alpha target genes. Finally, a subtle but significant, abnormal mitochondrial phenotype is observed in the brain tissue of AKT3 knockout mice. These results suggest that Akt3 is important in coordinating mitochondrial biogenesis with growth factor-induced increases in cellular energy demands.	[Eldridge, Juanita; Liby, Tiera L.; Muise-Helmericks, Robin C.] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA; [Wright, Gary L.; Sridharan, Vijayalakshmi] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA; [Maroulakou, Ioanna G.; Tsichlis, Philip N.] Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Boston, MA USA	Medical University of South Carolina; Medical University of South Carolina; Tufts Medical Center	Muise-Helmericks, RC (corresponding author), Med Univ S Carolina, Dept Cell Biol & Anat, Hollings Canc Ctr Rm 320,86 Jonathan Lucas St, Charleston, SC 29425 USA.	musehelm@musc.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084565, R01HL084302] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR16434, P20 RR016434] Funding Source: Medline; NHLBI NIH HHS [R01 HL084565, HL084565, R01 HL084302] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; BOULUKOS KE, 1990, GENE DEV, V4, P401, DOI 10.1101/gad.4.3.401; Bouzakri K, 2006, DIABETES, V55, P785, DOI 10.2337/diabetes.55.03.06.db05-0796; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; COFFA S, 1998, MAT SCI SEMICON PROC, V1, P1; Cristiano BE, 2006, CANCER RES, V66, P11718, DOI 10.1158/0008-5472.CAN-06-1968; de Gannes FMP, 2000, NEUROCHEM INT, V36, P233; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Fieber CB, 2006, EXP CELL RES, V312, P1164, DOI 10.1016/j.yexcr.2006.01.022; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Goffart S, 2004, CARDIOVASC RES, V64, P198, DOI 10.1016/j.cardiores.2004.06.030; GRIMES GW, 1974, J CELL BIOL, V61, P565, DOI 10.1083/jcb.61.3.565; GWOSDOW G, 1976, RES COMMUN CHEM PATH, V14, P763; Hallmann Anna, 2004, Folia Morphol (Warsz), V63, P407; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Kurukulasuriya R, 2003, CURR MED CHEM, V10, P123, DOI 10.2174/0929867033368556; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; MacKenzie JA, 2007, BBA-MOL BASIS DIS, V1772, P509, DOI 10.1016/j.bbadis.2006.12.002; Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Mende I, 2001, ONCOGENE, V20, P4419, DOI 10.1038/sj.onc.1204486; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; OLDENDORF WH, 1977, ANN NEUROL, V1, P409, DOI 10.1002/ana.410010502; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pianetti S, 2001, ONCOGENE, V20, P1287, DOI 10.1038/sj.onc.1204257; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rantanen A, 2000, Hum Reprod, V15 Suppl 2, P86; Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Schmitz KJ, 2004, MODERN PATHOL, V17, P15, DOI 10.1038/modpathol.3800002; SCHNELLMANN RG, 1989, TOXICOL APPL PHARM, V99, P19, DOI 10.1016/0041-008X(89)90107-5; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Singh KK, 2004, ANN NY ACAD SCI, V1019, P260, DOI 10.1196/annals.1297.043; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tokunaga E, 2006, INT J CANCER, V118, P284, DOI 10.1002/ijc.21358; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yano M, 1997, J BIOL CHEM, V272, P8459, DOI 10.1074/jbc.272.13.8459; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	67	84	88	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3264	3275		10.1096/fj.08-106468	http://dx.doi.org/10.1096/fj.08-106468			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18524868	Green Published			2022-12-25	WOS:000258761300019
J	Chandra, S; Shao, J; Li, JX; Li, M; Longo, FM; Diamond, MI				Chandra, Shweta; Shao, Jieya; Li, Jennifer X.; Li, Mei; Longo, Frank M.; Diamond, Marc I.			A common motif targets huntingtin and the androgen receptor to the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; EXPANDED POLYGLUTAMINE PROTEIN; MUTANT HUNTINGTIN; NUCLEAR INCLUSIONS; MOUSE MODEL; AGGREGATION; DEGRADATION; AUTOPHAGY; DISEASE; LOCALIZATION	Huntington disease derives from a critically expanded polyglutamine tract in the huntingtin (Htt) protein; a similar polyglutamine expansion in the androgen receptor (AR) causes spinobulbar muscular atrophy. AR activity also plays an essential role in prostate cancer. Molecular mechanisms that regulate Htt and AR degradation are not well understood but could have important therapeutic implications. We find that a pentapeptide motif (FQKLL) within the Htt protein regulates its degradation and subcellular localization to cytoplasm puncta. Disruption of the motif by alanine substitution at the hydrophobic residues increases the steady state level of the protein. Pulse-chase analyses indicate that the motif regulates degradation. A similar motif (FQNLF) has corresponding activities in the AR protein. Transfer of the Htt motif with five flanking amino acids on either side to YFP reduces the steady state YFP level by rendering it susceptible to proteasome degradation. This work defines a novel proteasome-targeting motif that is necessary and sufficient to regulate the degradation of two disease-associated proteins.	[Chandra, Shweta; Shao, Jieya; Li, Jennifer X.; Li, Mei; Diamond, Marc I.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Chandra, Shweta; Shao, Jieya; Li, Jennifer X.; Li, Mei; Diamond, Marc I.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Longo, Frank M.] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Diamond, MI (corresponding author), GH-S572B,600 16th St, San Francisco, CA 94143 USA.	marc.diamond@ucsf.edu			National Institutes of Health [1R01CA131226-01, 1R01NS50284-01A1]; Sandler Family Supporting Foundation; Taube Family Foundation Program in Huntington's Disease Research; Prostate Cancer Foundation; National Science Foundation; Muscular Dystrophy Association; NATIONAL CANCER INSTITUTE [R01CA131226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Supporting Foundation; Taube Family Foundation Program in Huntington's Disease Research; Prostate Cancer Foundation; National Science Foundation(National Science Foundation (NSF)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01CA131226-01 and 1R01NS50284-01A1. This work was also supported by the Sandler Family Supporting Foundation, the Taube Family Foundation Program in Huntington's Disease Research, and funds from the Prostate Cancer Foundation (to M. I. D.), the National Science Foundation (to J. X. L.), and the Muscular Dystrophy Association (to J. S., M. L., and M. I. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bhutani N, 2007, EMBO J, V26, P1385, DOI 10.1038/sj.emboj.7601592; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Culig ZR, 2003, J UROLOGY, V170, P1363, DOI 10.1097/01.ju.0000075099.20662.7f; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HARDING AE, 1982, J NEUROL NEUROSUR PS, V45, P1012, DOI 10.1136/jnnp.45.11.1012; He B, 2002, MOL GENET METAB, V75, P293, DOI 10.1016/S1096-7192(02)00009-4; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Leavitt BR, 1999, SEMIN NEUROL, V19, P385, DOI 10.1055/s-2008-1040853; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Pandey UB, 2007, AUTOPHAGY, V3, P643, DOI 10.4161/auto.5050; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393	38	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23950	23955		10.1074/jbc.M800467200	http://dx.doi.org/10.1074/jbc.M800467200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586675	Green Published, hybrid			2022-12-25	WOS:000258638900050
J	Gao, Z; Wen, CK; Binder, BM; Chen, YF; Chang, J; Chiang, YH; Ill, RJK; Chang, C; Schaller, GE				Gao, Zhiyong; Wen, Chi-Kuang; Binder, Brad M.; Chen, Yi-Feng; Chang, Jianhong; Chiang, Yi-Hsuan; Ill, Robert J. Kerris; Chang, Caren; Schaller, G. Eric			Heteromeric interactions among ethylene receptors mediate signaling in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE KINASE-ACTIVITY; SEEDLING-GROWTH-RESPONSE; RAF-LIKE KINASE; ENDOPLASMIC-RETICULUM; GENE FAMILY; ETR1; PROTEIN; BINDING; DOMAIN; TRANSDUCTION	The gaseous hormone ethylene is perceived in Arabidopsis by a five member receptor family that consists of the subfamily 1 receptors ETR1 and ERS1 and the subfamily 2 receptors ETR2, ERS2, and EIN4. Previous work has demonstrated that the basic functional unit for the ethylene receptor, ETR1, is a disulfide-linked homodimer. We demonstrate here that ethylene receptors isolated from Arabidopsis also interact with each other through noncovalent interactions. Evidence that ETR1 associates with other ethylene receptors was obtained by co-purification of ETR1 with tagged versions of ERS1, ETR2, ERS2, and EIN4 from Arabidopsis membrane extracts. ETR1 preferentially associated with the subfamily 2 receptors compared with the subfamily 1 receptor ERS1, but ethylene treatment affected the interactions and relative composition of the receptor complexes. When transgenically expressed in yeast, ETR1 and ERS2 can form disulfide-linked heterodimers. In plant extracts, however, the association of ETR1 and ERS2 can be largely disrupted by treatment with SDS, supporting a higher order noncovalent interaction between the receptors. Yeast two-hybrid analysis demonstrated that the receptor GAF domains are capable of mediating heteromeric receptor interactions. Kinetic analysis of ethylene-insensitive mutants of ETR1 is consistent with their dominance being due in part to an ability to associate with other ethylene receptors. These data suggest that the ethylene receptors exist in plants as clusters in a manner potentially analogous to that found with the histidine kinase-linked chemoreceptors of bacteria and that interactions among receptors contribute to ethylene signal output.	[Gao, Zhiyong; Chen, Yi-Feng; Chiang, Yi-Hsuan; Ill, Robert J. Kerris; Schaller, G. Eric] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Binder, Brad M.] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Wen, Chi-Kuang; Chang, Jianhong; Chang, Caren] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	Dartmouth College; University of Wisconsin System; University of Wisconsin Madison; University System of Maryland; University of Maryland College Park	Schaller, GE (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	george.e.schaller@dartmouth.edu	Wen, Chi-Kuang/AAI-4308-2020; Chiang, Yi-Hsuan/B-2662-2014	Binder, Brad/0000-0002-8172-2034; Wen, Chi-Kuang/0000-0002-5345-0756	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071855] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01 GM 071855] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeles F, 1992, ETHYLENE PLANT BIOL; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Cancel JD, 2002, PLANT PHYSIOL, V129, P1557, DOI 10.1104/pp.003780; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; CHEN QHG, 1995, PLANT PHYSIOL, V108, P597, DOI 10.1104/pp.108.2.597; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen YF, 2007, J BIOL CHEM, V282, P24752, DOI 10.1074/jbc.M704419200; Cho YH, 2007, PLANT PHYSIOL, V143, P612, DOI 10.1104/pp.106.091504; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hall AE, 2000, PLANT PHYSIOL, V123, P1449, DOI 10.1104/pp.123.4.1449; HOFTE H, 1992, PLANT CELL, V4, P995, DOI 10.1105/tpc.4.8.995; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; Muller-Dieckmann HJ, 1999, STRUCT FOLD DES, V7, P1547, DOI 10.1016/S0969-2126(00)88345-8; O'Malley RC, 2005, PLANT J, V41, P651, DOI 10.1111/j.1365-313X.2004.02331.X; Qu X, 2004, PLANT PHYSIOL, V136, P2961, DOI 10.1104/pp.104.047126; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Schaller GE, 2000, ADV BOT RES, V32, P109, DOI 10.1016/S0065-2296(00)32023-7; Schaller GE, 2002, ARABIDOPSIS BOOK, V1, pe0071, DOI DOI 10.1199/TAB.0071; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Takahashi H, 2002, J EXP BOT, V53, P415, DOI 10.1093/jexbot/53.368.415; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; Wolanin PM, 2002, GENOME BIOL, V3; Xie F, 2006, PLANT PHYSIOL, V142, P492, DOI 10.1104/pp.106.082628; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Zhao XC, 2002, PLANT PHYSIOL, V130, P1983, DOI 10.1104/pp.011635	49	101	111	4	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23801	23810		10.1074/jbc.M800641200	http://dx.doi.org/10.1074/jbc.M800641200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577522	Green Published, hybrid			2022-12-25	WOS:000258638900034
J	Sharma, A; Yogavel, M; Akhouri, RR; Gill, J; Sharma, A				Sharma, Ashwani; Yogavel, M.; Akhouri, Reetesh Raj; Gill, Jasmita; Sharma, Amit			Crystal structure of soluble domain of malaria sporozoite protein UIS3 in complex with lipid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING PROTEIN; PLASMODIUM-FALCIPARUM; FATTY-ACIDS; LIVER; MEMBRANES; LIGANDS; CELLS	Malaria parasite UIS3 (up-regulated in infective sporozoites gene 3) is essential for sporozoite development in infected hepatocytes. UIS3 encodes for a membrane protein that is localized to the parasite parasitophorous vacuolar membrane in infected hepatocytes. We describe here 2.5-angstrom resolution crystal structure of Plasmodium falciparum UIS3 soluble domain (PfUIS3(130-229)) in complex with the lipid phosphatidylethanolamine ( PE). PfUIS3(130-229) is a novel, compact, and all alpha-helical structure bound to one molecule of PE. The PfUIS3(130-229)-PE complex structure reveals a novel binding site with specific interactions between PfUIS3(130-229) and the PE head group. One acyl chain of PE wraps around part of PfUIS3(130-229) and docks onto a hydrophobic channel. We additionally provide new structural and biochemical evidence of PfUIS3(130-229) interactions with lipids ( phosphatidylethanolamine), with phospholipid liposomes, and with the human liver fatty acid-binding protein. The direct interaction of PfUIS3(130-229) with liver fatty acid-binding protein most likely provides the parasite with a conduit for importing essential fatty acids/lipids. Therefore, our analyses have implications for lipid transport into the parasite during the rapid growth phases of sporozoites. Given that PfUIS3 is essential for establishment of liver stage infection by P. falciparum, our data provide a new target for abrogating parasite development within liver cells before typical symptoms of malaria can manifest.	[Sharma, Ashwani; Yogavel, M.; Akhouri, Reetesh Raj; Gill, Jasmita; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Sharma, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India.	amit.icgeb@gmail.com	Manickam, Yogavel/O-4570-2015	Manickam, Yogavel/0000-0002-2119-062X; Gill, Jasmita/0000-0002-7004-2850; Akhouri, Reetesh/0000-0001-5995-2418	Department of Biotechnology ( Government of India); Medical Research Council [G0500367] Funding Source: researchfish; MRC [G0500367] Funding Source: UKRI	Department of Biotechnology ( Government of India)(Department of Biotechnology (DBT) India); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by a Department of Biotechnology ( Government of India) career development award (to A.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Di Pietro SM, 2003, BIOCHEMISTRY-US, V42, P8192, DOI 10.1021/bi034213n; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falomir-Lockhart LJ, 2006, J BIOL CHEM, V281, P13979, DOI 10.1074/jbc.M511943200; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; Kaiser K, 2004, MOL MICROBIOL, V51, P1221, DOI 10.1046/j.1365-2958.2003.03909.x; LEVI AJ, 1969, J CLIN INVEST, V48, P2156, DOI 10.1172/JCI106182; LiCata VJ, 1998, PROTEINS, V33, P577, DOI 10.1002/(SICI)1097-0134(19981201)33:4<577::AID-PROT10>3.0.CO;2-2; Lingelbach K, 1998, J CELL SCI, V111, P1467; LINGELBACH KR, 1993, EXP PARASITOL, V76, P318, DOI 10.1006/expr.1993.1039; Mikolajczak SA, 2007, INT J PARASITOL, V37, P483, DOI 10.1016/j.ijpara.2007.01.002; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; STORCH J, 1993, MOL CELL BIOCHEM, V123, P45, DOI 10.1007/BF01076474; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; Thompson J, 1999, BBA-MOL CELL BIOL L, V1441, P117, DOI 10.1016/S1388-1981(99)00146-8; Thumser AEA, 2000, J LIPID RES, V41, P647	24	26	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24077	24088		10.1074/jbc.M801946200	http://dx.doi.org/10.1074/jbc.M801946200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577521	Green Published, hybrid			2022-12-25	WOS:000258638900062
J	Hoffmann, M; Wagner, M; Abbadi, A; Fulda, M; Feussner, I				Hoffmann, Mareike; Wagner, Martin; Abbadi, Amine; Fulda, Martin; Feussner, Ivo			Metabolic engineering of omega 3-very long chain polyunsaturated fatty acid production by an exclusively acyl-CoA-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONT-END DESATURASES; FUNCTIONAL-CHARACTERIZATION; EICOSAPENTAENOIC ACID; BIOSYNTHESIS; OMEGA-3-FATTY-ACIDS; IDENTIFICATION; MICROALGA; ELONGASES; CLONING; OMEGA-3	omega 3-Very long chain polyunsaturated fatty acids (VLCPUFA) are essential for human development and brain function and, thus, are indispensable components of the human diet. The current main source of VLCPUFAs is represented by ocean fish stocks, which are in severe decline, and the development of alternative, sustainable sources of VLCPUFAs is urgently required. Our research aims at exploiting the powerful infrastructure available for the large scale culture of oilseed crops, such as rapeseed, to produce VLCPUFAs such as eicosapentaenoic acid in transgenic plants. VLCPUFA biosynthesis requires repeated desaturation and repeated elongation of long chain fatty acid substrates. In previous experiments the production of eicosapentaenoic acid in transgenic plants was found to be limited by an unexpected bottleneck represented by the acyl exchange between the site of desaturation, endoplasmic reticulum-associated phospholipids, and the site of elongation, the cytosolic acyl-CoA pool. Here we report on the establishment of a coordinated, exclusively acyl-CoA-dependent pathway, which avoids the rate-limiting transesterification steps between the acyl lipids and the acyl-CoA pool during VLCPUFA biosynthesis. The pathway is defined by previously uncharacterized enzymes, encoded by cDNAs isolated from the microalga Mantoniella squamata. The conceptual enzymatic pathway was established and characterized first in yeast to provide proof-of-concept data for its feasibility and subsequently in seeds of Arabidopsis thaliana. The comparison of the acyl-CoA-dependent pathway with the known lipid-linked pathway for VLCPUFA biosynthesis showed that the acyl-CoA-dependent pathway circumvents the bottleneck of switching the Delta 6-desaturated fatty acids between lipids and acyl-CoA in Arabidopsis seeds.	[Hoffmann, Mareike; Wagner, Martin; Fulda, Martin; Feussner, Ivo] Albrecht von Haller Inst Pflanzenwissensch, Abt Biochem Pflanze, D-37077 Gottingen, Germany; [Abbadi, Amine; Fulda, Martin] Hans Georg Lembke KG, Norddeutsch Pflanzenzucht, D-24363 Holtsee, Germany		Feussner, I (corresponding author), Albrecht von Haller Inst Pflanzenwissensch, Abt Biochem Pflanze, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	ifeussn@uni-goettingen.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003				Abbadi A, 2004, PLANT CELL, V16, P2734, DOI 10.1105/tpc.104.026070; Abbadi A., 2007, P 12 INT RAP C SUST, VII, P152; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BAUMLEIN H, 1991, MOL GEN GENET, V225, P459; BUTTE W, 1982, CLIN CHEM, V28, P1778; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Domergue F, 2005, BIOCHEM J, V389, P483, DOI 10.1042/BJ20050111; Domergue F, 2003, J BIOL CHEM, V278, P35115, DOI 10.1074/jbc.M305990200; Domergue F, 2002, EUR J BIOCHEM, V269, P4105, DOI 10.1046/j.1432-1033.2002.03104.x; DONAHUE TF, 1990, METHOD ENZYMOL, V185, P366; Garcia-Maroto F, 2006, PHYTOCHEMISTRY, V67, P540, DOI 10.1016/j.phytochem.2005.12.005; Goyens PL, 2006, AM J CLIN NUTR, V84, P44, DOI 10.1093/ajcn/84.1.44; Graham IA, 2007, CURR OPIN BIOTECH, V18, P142, DOI 10.1016/j.copbio.2007.01.014; Hites RA, 2004, ENVIRON SCI TECHNOL, V38, P4945, DOI 10.1021/es049548m; Hornung E, 2005, BBA-MOL CELL BIOL L, V1686, P181, DOI 10.1016/j.bbalip.2004.11.001; KINNEY AJ, 2004, Patent No. 2004071467; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; MANTON I, 1960, J MAR BIOL ASSOC UK, V39, P275, DOI 10.1017/S0025315400013321; Meyer A, 2004, J LIPID RES, V45, P1899, DOI 10.1194/jlr.M400181-JLR200; Michaelson LV, 1998, J BIOL CHEM, V273, P19055, DOI 10.1074/jbc.273.30.19055; Napier JA, 1999, TRENDS PLANT SCI, V4, P2, DOI 10.1016/S1360-1385(98)01357-0; Napier JA, 2007, ANNU REV PLANT BIOL, V58, P295, DOI 10.1146/annurev.arplant.58.032806.103811; OKAYASU T, 1981, ARCH BIOCHEM BIOPHYS, V206, P21, DOI 10.1016/0003-9861(81)90061-8; Qi BX, 2004, NAT BIOTECHNOL, V22, P739, DOI 10.1038/nbt972; Qi BX, 2002, FEBS LETT, V510, P159, DOI 10.1016/S0014-5793(01)03247-1; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sayanova O, 2006, FEBS LETT, V580, P1946, DOI 10.1016/j.febslet.2006.02.062; Sayanova O, 2006, PLANTA, V224, P1269, DOI 10.1007/s00425-006-0306-0; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438; SPERLING P, 1995, EUR J BIOCHEM, V232, P798, DOI 10.1111/j.1432-1033.1995.0798a.x; Sprecher H, 1999, LIPIDS, V34, pS153, DOI 10.1007/BF02562271; Tocher DR, 1998, PROG LIPID RES, V37, P73, DOI 10.1016/S0163-7827(98)00005-8; Wallis JG, 1999, ARCH BIOCHEM BIOPHYS, V365, P307, DOI 10.1006/abbi.1999.1167; Wu GH, 2005, NAT BIOTECHNOL, V23, P1013, DOI 10.1038/nbt1107; Zank TK, 2002, PLANT J, V31, P255, DOI 10.1046/j.1365-313X.2002.01354.x	37	78	89	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22352	22362		10.1074/jbc.M802377200	http://dx.doi.org/10.1074/jbc.M802377200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18556660	hybrid			2022-12-25	WOS:000258321000003
J	Mi, LX; Xiao, Z; Hood, BL; Dakshanamurthy, S; Wang, XT; Govind, S; Conrads, TP; Veenstra, TD; Chung, FL				Mi, Lixin; Xiao, Zhen; Hood, Brian L.; Dakshanamurthy, Sivanesan; Wang, Xiantao; Govind, Sudha; Conrads, Thomas P.; Veenstra, Timothy D.; Chung, Fung-Lung			Covalent binding to tubulin by isothiocyanates - A mechanism of cell growth arrest and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENETHYL ISOTHIOCYANATE; CYCLE ARREST; ANTIPROLIFERATIVE ACTIVITY; SULFORAPHANE; INHIBITION; INDUCTION; PHOSPHORYLATION; MICROTUBULES; MITOCHONDRIA; PROTEINS	Isothiocyanates (ITCs) found in cruciferous vegetables, including benzyl-ITC (BITC), phenethyl-ITC (PEITC), and sulforaphane (SFN), inhibit carcinogenesis in animal models and induce apoptosis and cell cycle arrest in various cell types. The biochemical mechanisms of cell growth inhibition by ITCs are not fully understood. Our recent study showed that ITC binding to intracellular proteins may be an important initiating event for the induction of apoptosis. However, the specific protein target(s) and molecular mechanisms were not identified. In this study, two-dimensional gel electrophoresis of human lung cancer A549 cells treated with radiolabeled PEITC and SFN revealed that tubulin may be a major in vivo binding target for ITC. We examined whether binding to tubulin by ITCs could lead to cell growth arrest. The proliferation of A549 cells was significantly reduced by ITCs, with relative activities of BITC > PEITC > SFN. All three ITCs also induced mitotic arrest and apoptosis with the same order of activity. We found that ITCs disrupted microtubule polymerization in vitro and in vivo with the same order of potency. Mass spectrometry demonstrated that cysteines in tubulin were covalently modified by ITCs. Ellman assay results indicated that the modification levels follow the same order, BITC > PEITC > SFN. Together, these results support the notion that tubulin is a target of ITCs and that ITC-tubulin interaction can lead to downstream growth inhibition. This is the first study directly linking tubulin-ITC adduct formation to cell growth inhibition.	[Mi, Lixin; Dakshanamurthy, Sivanesan; Wang, Xiantao; Govind, Sudha; Chung, Fung-Lung] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Xiao, Zhen; Veenstra, Timothy D.] NCI Frederick, SAIC Frederick Inc, Lab Prote & Analyt Technol, Frederick, MD 21702 USA; [Hood, Brian L.; Conrads, Thomas P.] Univ Pittsburgh, Sch Med, Inst Canc, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Hood, Brian L.; Conrads, Thomas P.] Univ Pittsburgh, Sch Med, Inst Canc, Clin Prote Facil, Pittsburgh, PA 15213 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mi, LX (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, 3800 Reservoir Rd,LL 129,Box 571465, Washington, DC 20057 USA.	lm293@georgetown.edu; flc6@georgetown.edu	Dakshanamurthy, Sivanesan/CAF-4258-2022	Dakshanamurthy, Sivanesan/0000-0003-3681-4121	NCI NIH HHS [CA100853] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100853] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bonnesen C, 2001, CANCER RES, V61, P6120; Britto PJ, 2005, BIOCHEM J, V389, P549, DOI 10.1042/BJ20042118; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chiao JW, 2002, INT J ONCOL, V20, P631; Choi S, 2005, CANCER RES, V65, P2035, DOI 10.1158/0008-5472.CAN-04-3616; Conaway CC, 1996, CARCINOGENESIS, V17, P2423, DOI 10.1093/carcin/17.11.2423; Conrads TP, 2006, J BIOL CHEM, V281, P37836, DOI 10.1074/jbc.M604581200; COWAN N, 1984, OXFORD SURVEYS EUKAR, P26; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Hosono T, 2005, J BIOL CHEM, V280, P41487, DOI 10.1074/jbc.M507127200; Jackson SJT, 2004, CARCINOGENESIS, V25, P219, DOI 10.1093/carcin/bgg192; Jakubikova J, 2005, ANTICANCER RES, V25, P3375; Jiao D, 1996, CHEM RES TOXICOL, V9, P932, DOI 10.1021/tx9502094; Jordan MA, 1996, CANCER RES, V56, P816; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Ling YH, 2002, MOL PHARMACOL, V62, P529, DOI 10.1124/mol.62.3.529; Ling YH, 1998, J BIOL CHEM, V273, P18984, DOI 10.1074/jbc.273.30.18984; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mi LX, 2007, CANCER RES, V67, P6409, DOI 10.1158/0008-5472.CAN-07-0340; Mi LX, 2006, BIOMACROMOLECULES, V7, P38, DOI 10.1021/bm050157p; Moreno RL, 2001, ARCH BIOCHEM BIOPHYS, V391, P99, DOI 10.1006/abbi.2001.2390; MORSE MA, 1989, CARCINOGENESIS, V10, P1757, DOI 10.1093/carcin/10.9.1757; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Nakamura Y, 2002, J BIOL CHEM, V277, P8492, DOI 10.1074/jbc.M109760200; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Rose P, 2005, INT J BIOCHEM CELL B, V37, P100, DOI 10.1016/j.biocel.2004.05.018; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Simpson R. J, 2003, PROTEINS PROTEOMICS, P143; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Suh SK, 2004, PROTEOMICS, V4, P3401, DOI 10.1002/pmic.200400971; Tang L, 2005, MOL CANCER THER, V4, P1250, DOI 10.1158/1535-7163.MCT-05-0041; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tseng E, 2004, EXP BIOL MED, V229, P835, DOI 10.1177/153537020422900817; von Weymarn LB, 2006, CARCINOGENESIS, V27, P782, DOI 10.1093/carcin/bgi301; von Weymarn LB, 2007, CHEM RES TOXICOL, V20, P1252, DOI 10.1021/tx700078v; *WHO, 2004, IARC HDB CANC PREV, V9, P43; Widrow RJ, 2000, CYTOMETRY, V39, P126, DOI 10.1002/(SICI)1097-0320(20000201)39:2<126::AID-CYTO5>3.0.CO;2-V; Xiao D, 2005, CLIN CANCER RES, V11, P2670, DOI 10.1158/1078-0432.CCR-04-1545; Xiao D, 2004, MOL CANCER THER, V3, P567; Yang YM, 2005, CANCER RES, V65, P8538, DOI 10.1158/0008-5472.CAN-05-0236; Yao S, 2006, MOL CARCINOGEN, V45, P605, DOI 10.1002/mc.20206; Zhang YS, 2006, P NUTR SOC, V65, P68, DOI 10.1079/PNS2005475; Zhang YS, 2003, MOL CANCER THER, V2, P1045; Zhang YS, 1998, CANCER RES, V58, P4632	47	173	176	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22136	22146		10.1074/jbc.M802330200	http://dx.doi.org/10.1074/jbc.M802330200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18524779	Green Published, hybrid			2022-12-25	WOS:000258114700033
J	Piskounova, E; Viswanathan, SR; Janas, M; LaPierre, RJ; Daley, GQ; Sliz, P; Gregory, RI				Piskounova, Elena; Viswanathan, Srinivas R.; Janas, Maja; LaPierre, Robert J.; Daley, George Q.; Sliz, Piotr; Gregory, Richard I.			Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-SHOCK DOMAIN; ZINC-FINGER PROTEINS; POSTTRANSCRIPTIONAL REGULATION; MICROPROCESSOR COMPLEX; CRYSTAL-STRUCTURE; EXPRESSION; LET-7; CELLS; RECOGNITION; CANCERS	The developmentally regulated RNA-binding protein Lin28 blocks processing of let-7 family microRNAs (miRNAs) in embryonic cells. The molecular basis for this selective miRNA processing block is unknown. Here we find that Lin28 selectively binds the terminal loop region of let-7 precursors in vitro and that the loop mediates miRNA processing inhibition in vivo. Additionally, we identify the domains of Lin28 required for this inhibition. These findings establish a regulatory role for the terminal loop of precursors in miRNA maturation and provide insight into the mechanism by which Lin28 negatively regulates let-7 processing.	Harvard Stem Cell Inst, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Biol Chem & Mol Pharmacol,Stem Cell Program, Boston, MA 02115 USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School	Gregory, RI (corresponding author), Karp Bldg 09212,1 Blackfan Circle, Boston, MA 02115 USA.	rgregory@enders.tch.harvard.edu	Viswanathan, Srinivas/ABA-6316-2021	Viswanathan, Srinivas/0000-0003-1856-3023; Sliz, Piotr/0000-0002-6522-0835; Piskounova, Elena/0000-0002-8554-8475				Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; LANDSMAN D, 1992, NUCLEIC ACIDS RES, V20, P2861, DOI 10.1093/nar/20.11.2861; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; SCHINDELIN H, 1994, P NATL ACAD SCI USA, V91, P5119, DOI 10.1073/pnas.91.11.5119; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	33	268	286	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21310	21314		10.1074/jbc.C800108200	http://dx.doi.org/10.1074/jbc.C800108200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18550544	hybrid			2022-12-25	WOS:000257898800002
J	Kollner, TG; Schnee, C; Li, S; Svatos, A; Schneider, B; Gershenzon, J; Degenhardt, J				Koellner, Tobias G.; Schnee, Christiane; Li, Shenghong; Svatos, Ales; Schneider, Bernd; Gershenzon, Jonathan; Degenhardt, Joerg			Protonation of a neutral (S)-beta-bisabolene intermediate is involved in (S)-beta-macrocarpene formation by the maize sesquiterpene synthases TPS6 and TPS11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-HUMULENE SYNTHASE; DELTA-SELINENE SYNTHASE; BACTERIAL EXPRESSION; 5-EPI-ARISTOLOCHENE SYNTHASE; ARISTOLOCHENE SYNTHASE; GENE FAMILY; BIOSYNTHESIS; (E)-BETA-FARNESENE; (E)-NEROLIDOL; HYDROCARBONS	Terpene synthases are responsible for the large diversity of terpene carbon skeletons found in plants. The unique, carbocationic reaction mechanism of these enzymes can form multiple products from a single prenyl diphosphate substrate. Two maize genes were isolated that encode very similar sesquiterpene synthases, TPS6 and TPS11, which both produce beta-bisabolene, a common monocyclic sesquiterpene, and beta-macrocarpene, an uncommon bicyclic olefin. Investigation of the reaction mechanism showed that the formation of beta-macrocarpene proceeds via a neutral beta-bisabolene intermediate and requires reprotonation by a proton that may ultimately be abstracted from water. This reprotonation is dependent on the pH and the presence of a Mg2+ cofactor. Mutational analysis of the enzyme demonstrated that a highly conserved tyrosine residue in the active center of the enzymes is important for the protonation process. TPS6 and TPS11 are transcribed both in leaves and roots of maize, but the respective terpene products were only detected in roots. The expression in roots was up-regulated by herbivore damage to the leaves, suggesting a long distance signal transduction cascade between leaves and roots.	[Koellner, Tobias G.; Schnee, Christiane; Li, Shenghong; Svatos, Ales; Schneider, Bernd; Gershenzon, Jonathan; Degenhardt, Joerg] Max Planck Inst Chem Ecol, D-07745 Jena, Germany	Max Planck Society	Degenhardt, J (corresponding author), Max Planck Inst Chem Ecol, Hans Knoll Str 8, D-07745 Jena, Germany.	degenhardt@ice.mpg.de	Köllner, Tobias G/H-3375-2014; Svatos, Ales/A-3305-2014; Gershenzon, Jonathan/K-1331-2013; Schneider, Bernd/A-3287-2014	Köllner, Tobias G/0000-0002-7037-904X; Svatos, Ales/0000-0003-1032-7288; Gershenzon, Jonathan/0000-0002-1812-1551; Schneider, Bernd/0000-0003-4788-1565; Schnee, Christiane/0000-0001-7643-9114				Allemann RK, 2007, J AM CHEM SOC, V129, P13008, DOI 10.1021/ja0722067; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; BACK K, 1995, J BIOL CHEM, V270, P7375, DOI 10.1074/jbc.270.13.7375; Basse CW, 2005, PLANT PHYSIOL, V138, P1774, DOI 10.1104/pp.105.061200; BURR B, 1991, TRENDS GENET, V7, P55, DOI 10.1016/0168-9525(91)90232-F; Cane D.E., 1999, COMPR NAT PROD CHEM, V2, P155, DOI [10.1016/B978-0-08-091283-7.00039-4, DOI 10.1016/B978-0-08-091283-7.00039-4]; CANE DE, 1990, CHEM REV, V90, P1089, DOI 10.1021/cr00105a002; CANE DE, 1990, J AM CHEM SOC, V112, P3209, DOI 10.1021/ja00164a051; Cool LG, 2005, PHYTOCHEMISTRY, V66, P249, DOI 10.1016/j.phytochem.2004.11.002; Crock J, 1997, P NATL ACAD SCI USA, V94, P12833, DOI 10.1073/pnas.94.24.12833; CROTEAU R, 1987, CHEM REV, V87, P929, DOI 10.1021/cr00081a004; Degenhardt J, 2000, PLANTA, V210, P815, DOI 10.1007/s004250050684; Erb M, 2008, PLANT PHYSIOL, V146, P867, DOI 10.1104/pp.107.112169; FACCHINI PJ, 1992, P NATL ACAD SCI USA, V89, P11088, DOI 10.1073/pnas.89.22.11088; Gershenzon J., 1999, BIOCH PLANT SECONDAR, V2, P222; Iijima Y, 2004, PLANT PHYSIOL, V136, P3724, DOI 10.1104/pp.104.051318; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Kollner TG, 2006, ARCH BIOCHEM BIOPHYS, V448, P83, DOI 10.1016/j.abb.2005.10.011; Kollner TG, 2004, PLANT CELL, V16, P1115, DOI 10.1105/tpc.019877; Kollner TG, 2004, PHYTOCHEMISTRY, V65, P1895, DOI 10.1016/j.phytochem.2004.05.021; KONIG WA, 1994, HRC-J HIGH RES CHROM, V17, P315; Little DB, 2002, ARCH BIOCHEM BIOPHYS, V402, P120, DOI 10.1016/S0003-9861(02)00068-1; MacMillan J, 1997, NAT PROD REP, V14, P221, DOI 10.1039/np9971400221; Marschener H, 1998, FIELD CROP RES, V56, P203, DOI 10.1016/S0378-4290(97)00131-7; Picaud S, 2005, ARCH BIOCHEM BIOPHYS, V436, P215, DOI 10.1016/j.abb.2005.02.012; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Rising KA, 2000, J AM CHEM SOC, V122, P1861, DOI 10.1021/ja993584h; Schnee C, 2006, P NATL ACAD SCI USA, V103, P1129, DOI 10.1073/pnas.0508027103; Schnee C, 2002, PLANT PHYSIOL, V130, P2049, DOI 10.1104/pp.008326; Sharon-Asa L, 2003, PLANT J, V36, P664, DOI 10.1046/j.1365-313X.2003.01910.x; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Steele CL, 1998, J BIOL CHEM, V273, P2078, DOI 10.1074/jbc.273.4.2078; Xu MM, 2007, P NATL ACAD SCI USA, V104, P7397, DOI 10.1073/pnas.0611454104; YUAN YS, 2008, PLANT J IN PRESS	35	72	78	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20779	20788		10.1074/jbc.M802682200	http://dx.doi.org/10.1074/jbc.M802682200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18524777	hybrid, Green Published			2022-12-25	WOS:000257746100019
J	Abraham, JM; Cheng, YL; Hamilton, JP; Paun, B; Jin, Z; Agarwal, R; Kan, T; David, S; Olaru, A; Yang, J; Ito, T; Selaru, FM; Mori, Y; Meltzer, SJ				Abraham, John M.; Cheng, Yulan; Hamilton, James P.; Paun, Bogdan; Jin, Zhe; Agarwal, Rachana; Kan, Takatsugu; David, Stefan; Olaru, Alexandru; Yang, Jian; Ito, Tetsuo; Selaru, Florin M.; Mori, Yuriko; Meltzer, Stephen J.			Generation of Small P-32-Labeled Peptides as a Potential Approach to Colorectal Cancer Therapy	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; BREAST-CANCER; SOLID TUMORS; LOW-GRADE; RADIOIMMUNOTHERAPY; CHEMOTHERAPY; TRIAL; PLUS; TRASTUZUMAB	Cancers have been revealed to be extremely heterogenous in terms of the frequency and types of mutations present in cells from different malignant tumors. Thus, it is likely that uniform clinical treatment is not optimal for all patients, and that the development of individualized therapeutic regimens may be beneficial. We describe the generation of multiple, unique small peptides nine to thirty-four amino acids in length which, when labeled with the radioisotope P-32, bind with vastly differing efficiencies to cell lines derived from different colon adenocarcinomas. In addition, the most effective of these peptides permanently transfers the P-32 radioisotope to colorectal cancer cellular proteins within two hours at a rate that is more than 150 times higher than in cell lines derived from other cancers or from the normal tissues tested. Currently, the only two FDA-approved radioimmunotherapeutic agents in use both employ antibodies directed against the B cell marker CD20 for the treatment of non-Hodgkin's lymphoma. By using the method described herein, large numbers of different P-32-labeled peptides can be readily produced and assayed against a broad spectrum of cancer types. This report proposes the development and use of P-32-labeled peptides as potential individualized peptide-binding therapies for the treatment of colon adenocarcinoma patients.	[Abraham, John M.; Cheng, Yulan; Hamilton, James P.; Paun, Bogdan; Jin, Zhe; Agarwal, Rachana; Kan, Takatsugu; David, Stefan; Olaru, Alexandru; Yang, Jian; Ito, Tetsuo; Selaru, Florin M.; Mori, Yuriko; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehensive Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Abraham, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	Jabrah14@jhmi.edu		Selaru, Florin/0000-0001-7990-8238	National Cancer Institute [2RO1CA095323-14, 2RO1CA077057-09, 1R01CA001808-05, 7R21/R33CA106763]; NATIONAL CANCER INSTITUTE [R01CA077057, R01CA001808, R21CA106763, R01CA095323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067872] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants 2RO1CA095323-14, 2RO1CA077057-09, 1R01CA001808-05 and 7R21/R33CA106763 from the National Cancer Institute.	Abraham JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000964; Aina OH, 2005, MOL CANCER THER, V4, P806, DOI 10.1158/1535-7163.MCT-05-0029; Aina OH, 2002, BIOPOLYMERS, V66, P184, DOI 10.1002/bip.10257; Bertagnolli MM, 2005, CLIN CANCER RES, V11, P4637, DOI 10.1158/1078-0432.CCR-05-0485; Boerman OC, 2007, ANTI-CANCER AGENT ME, V7, P335, DOI 10.2174/187152007780618126; Brans B, 2006, EUR J CANCER, V42, P994, DOI 10.1016/j.ejca.2005.12.020; Cilley JC, 2007, EXPERT OPIN BIOL TH, V7, P739, DOI 10.1517/14712598.7.5.739; Davis TA, 2000, J CLIN ONCOL, V18, P3135, DOI 10.1200/JCO.2000.18.17.3135; EMIR EE, 2007, CANCER RES, V67, P11896; Jain M, 2007, CLIN CANCER RES, V13, P1374, DOI 10.1158/1078-0432.CCR-06-2436; Kreitman RJ, 2003, CURR OPIN MOL THER, V5, P44; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kreitman RJ, 2006, CURR DRUG TARGETS, V7, P1301, DOI 10.2174/138945006778559139; Okarvi SM, 2004, MED RES REV, V24, P357, DOI 10.1002/med.20002; Reilly RM, 2006, J NUCL MED, V47, P196; Rini BI, 2007, CLIN CANCER RES, V13, p741S, DOI 10.1158/1078-0432.CCR-06-2110; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tan-Chiu E, 2005, J CLIN ONCOL, V23, P7811, DOI 10.1200/JCO.2005.02.4091; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Vose JM, 2004, ONCOLOGIST, V9, P160, DOI 10.1634/theoncologist.9-2-160; Wangler C, 2007, PROTEIN PEPTIDE LETT, V14, P273, DOI 10.2174/092986607780090874; Wiseman GA, 2001, CRIT REV ONCOL HEMAT, V39, P181, DOI 10.1016/S1040-8428(01)00107-X; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141	26	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2508	10.1371/journal.pone.0002508	http://dx.doi.org/10.1371/journal.pone.0002508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575578	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288000027
J	Edwards, AO; Lee, SJ; Fridley, BL; Tosakulwong, N				Edwards, Albert O.; Lee, Sung J.; Fridley, Brooke L.; Tosakulwong, Nirubol			Density of Common Complex Ocular Traits in the Aging Eye: Analysis of Secondary Traits in Genome-Wide Association Studies	PLOS ONE			English	Article								Genetic association studies are identifying genetic risks for common complex ocular traits such as age-related macular degeneration (AMD). The subjects used for discovery of these loci have been largely from clinic-based, case-control studies. Typically, only the primary phenotype (e.g., AMD) being studied is systematically documented and other complex traits (e.g., affecting the eye) are largely ignored. The purpose of this study was to characterize these other or secondary complex ocular traits present in the cases and controls of clinic-based studies being used for genetic study of AMD. The records of 100 consecutive new patients (of any diagnosis) age 60 or older for which all traits affecting the eye had been recorded systematically were reviewed. The average patient had 3.5 distinct diagnoses. A subset of 10 complex traits was selected for further study because they were common and could be reliably diagnosed. The density of these 10 complex ocular traits increased by 0.017 log-traits/year (P = 0.03), ranging from a predicted 2.74 at age 60 to 4.45 at age 90. Trait-trait association was observed only between AMD and primary vitreomacular traction (P = 0.0009). Only 1% of subjects age 60 or older had no common complex traits affecting the eye. Extrapolations suggested that a study of 2000 similar subjects would have sufficient power to detect genetic association with an odds ratio of 2.0 or less for 4 of these 10 traits. In conclusion, the high prevalence of complex traits affecting the aging eye and the inherent biases in referral patterns leads to the potential for confounding by undocumented secondary traits within case-control studies. In addition to the primary trait, other common ocular phenotypes should be systematically documented in genetic association studies so that adjustments for potential trait-trait associations and other bias can be made and genetic risk variants identified in secondary analyses.	[Edwards, Albert O.; Lee, Sung J.; Tosakulwong, Nirubol] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA; [Fridley, Brooke L.] Mayo Clin, Div Biostat, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Edwards, AO (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.	edwardslab@mayo.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956	Foundation Fighting Blindness, Owing Mills, MD [EY014467]; American Health Assistance Foundation, Clarksburg, MD; Research to Prevent Blindness, New York, NY; Mayo Clinic Foundation; NATIONAL EYE INSTITUTE [R01EY014467] Funding Source: NIH RePORTER	Foundation Fighting Blindness, Owing Mills, MD; American Health Assistance Foundation, Clarksburg, MD; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Mayo Clinic Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was supported by EY014467, the Foundation Fighting Blindness, Owing Mills, MD, the American Health Assistance Foundation, Clarksburg, MD, unrestricted departmental grants from Research to Prevent Blindness, New York, NY, and the Mayo Clinic Foundation. The sole role of the sponsors was to provide funding.	Arnarsson A, 2007, ACTA OPHTHALMOL SCAN, V85, P822, DOI 10.1111/j.1600-0420.2007.01051.x; Black GCM, 2003, HUM MOL GENET, V12, P3269, DOI 10.1093/hmg/ddg356; Boutboul S, 2006, HUM MUTAT, V27, P553, DOI 10.1002/humu.20331; Brandt JD, 2001, OPHTHALMOLOGY, V108, P1779, DOI 10.1016/S0161-6420(01)00760-6; Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022; Chen CYC, 2007, HUM GENET, V121, P511, DOI 10.1007/s00439-006-0312-0; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; EDWARDS AO, 2007, ANGIOGENESI IN PRESS; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Girmens JF, 2008, EYE, V22, P308, DOI 10.1038/sj.eye.6702672; Go SL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1237, DOI 10.1001/archopht.123.9.1237; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; He MG, 2008, INVEST OPHTH VIS SCI, V49, P81, DOI 10.1167/iovs.07-1052; Hejtmancik JF, 2004, EXP EYE RES, V79, P3, DOI 10.1016/j.exer.2004.03.014; HEJTMANCIK JF, 2008, AM J HUM GE IN PRESS; Hopper JL, 2005, LANCET, V366, P1397, DOI 10.1016/S0140-6736(05)67570-8; HYMAN LG, 1983, AM J EPIDEMIOL, V118, P213, DOI 10.1093/oxfordjournals.aje.a113629; Khan AO, 2006, OPHTHALMOLOGY, V113, P2374, DOI 10.1016/j.ophtha.2006.07.020; Kitagawa K, 2002, OPHTHALMIC RES, V34, P135, DOI 10.1159/000063656; Klein AP, 2005, AM J EPIDEMIOL, V161, P707, DOI 10.1093/aje/kwi102; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P546; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Krebs I, 2007, AM J OPHTHALMOL, V144, P741, DOI 10.1016/j.ajo.2007.07.024; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Lalin SC, 2004, AM J OPHTHALMOL, V138, P608, DOI 10.1016/j.ajo.2004.06.013; Lee MM, 2003, OPHTHALMOLOGY, V110, P2418, DOI 10.1016/S0161-6420(03)00828-5; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Matsuda A, 2007, INVEST OPHTH VIS SCI, V48, P583, DOI 10.1167/iovs.06-0991; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Mitchell P, 1997, OPHTHALMOLOGY, V104, P581, DOI 10.1016/S0161-6420(97)30266-8; Mitchell P, 1999, ARCH OPHTHALMOL-CHIC, V117, P1319, DOI 10.1001/archopht.117.10.1319; Mitchell P, 1996, ARCH OPHTHALMOL-CHIC, V114, P1243, DOI 10.1001/archopht.1996.01100140443012; Mitchell P, 1997, OPHTHALMOLOGY, V104, P1033, DOI 10.1016/S0161-6420(97)30190-0; Nakano T, 2005, OPHTHALMOLOGY, V112, P609, DOI 10.1016/j.ophtha.2004.10.046; Nemesure B, 2003, HUM GENET, V112, P600, DOI 10.1007/s00439-003-0910-z; Ondes F, 2000, JPN J OPHTHALMOL, V44, P91, DOI 10.1016/S0021-5155(99)00174-4; Peet JA, 2007, INVEST OPHTH VIS SCI, V48, P4002, DOI 10.1167/iovs.06-1388; Rao G. Prasad, 1998, Indian Journal of Ophthalmology, V46, P145; Sandilands A, 2006, J INVEST DERMATOL, V126, P1770, DOI 10.1038/sj.jid.5700459; Schmidt JC, 2006, BRIT J OPHTHALMOL, V90, P1361, DOI 10.1136/bjo.2006.094201; Schmitz-Valckenberg S, 2006, INVEST OPHTH VIS SCI, V47, P2648, DOI 10.1167/iovs.05-0892; Scott A, 2007, AM J OPHTHALMOL, V143, P346, DOI 10.1016/j.ajo.2006.09.022; Snead MP, 2002, EYE, V16, P447, DOI 10.1038/sj.eye.6700198; SNEAD MP, 1994, EYE, V8, P204, DOI 10.1038/eye.1994.47; STRAATSMA BR, 1980, AUST J OPHTHALMOL, V8, P275, DOI 10.1111/j.1442-9071.1980.tb00283.x; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P3919, DOI 10.1167/iovs.05-1619; Szijarto Z, 2007, ANN OPHTHALMOL, V39, P134, DOI 10.1007/s12009-007-0014-9; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; van Koolwijk LME, 2007, INVEST OPHTH VIS SCI, V48, P3669, DOI 10.1167/iovs.06-1519; Weber-Krause Brigitte, 1996, Ophthalmologe, V93, P660, DOI 10.1007/s003470050054; Weger M, 2005, OPHTHALMOLOGY, V112, P1910, DOI 10.1016/j.ophtha.2005.05.019; WERBLIN TP, 1981, BRIT J OPHTHALMOL, V65, P401, DOI 10.1136/bjo.65.6.401; Whitehead AJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1038, DOI 10.1001/archopht.124.7.1038; Young AL, 2004, BRIT J OPHTHALMOL, V88, P193, DOI 10.1136/bjo.2003.021816; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; ZHU G, 2007, OPHTHALMOLOGY; Zoega GM, 2006, OPHTHALMOLOGY, V113, P565, DOI 10.1016/j.ophtha.2005.12.014	67	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2510	10.1371/journal.pone.0002510	http://dx.doi.org/10.1371/journal.pone.0002510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575587	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000029
J	Nosten-Bertrand, M; Kappeler, C; Dinocourt, C; Denis, C; Germain, J; Tuy, FPD; Verstraeten, S; Alvarez, C; Metin, C; Chelly, J; Giros, B; Miles, R; Depaulis, A; Francis, F				Nosten-Bertrand, Marika; Kappeler, Caroline; Dinocourt, Celine; Denis, Cecile; Germain, Johanne; Tuy, Francoise Phan Dinh; Verstraeten, Soraya; Alvarez, Chantal; Metin, Christine; Chelly, Jamel; Giros, Bruno; Miles, Richard; Depaulis, Antoine; Francis, Fiona			Epilepsy in Dcx Knockout Mice Associated with Discrete Lamination Defects and Enhanced Excitability in the Hippocampus	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; DOUBLE CORTEX SYNDROME; NEUROPEPTIDE-Y; KAINIC ACID; NEURONAL MIGRATION; SEIZURE SUSCEPTIBILITY; CORTICAL DYSPLASIA; DENTATE GYRUS; MOSSY FIBERS; ADULT-RAT	Patients with Doublecortin (DCX) mutations have severe cortical malformations associated with mental retardation and epilepsy. Dcx knockout (KO) mice show no major isocortical abnormalities, but have discrete hippocampal defects. We questioned the functional consequences of these defects and report here that Dcx KO mice are hyperactive and exhibit spontaneous convulsive seizures. Changes in neuropeptide Y and calbindin expression, consistent with seizure occurrence, were detected in a large proportion of KO animals, and convulsants, including kainate and pentylenetetrazole, also induced seizures more readily in KO mice. We show that the dysplastic CA3 region in KO hippocampal slices generates sharp wavelike activities and possesses a lower threshold for epileptiform events. Video-EEG monitoring also demonstrated that spontaneous seizures were initiated in the hippocampus. Similarly, seizures in human patients mutated for DCX can show a primary involvement of the temporal lobe. In conclusion, seizures in Dcx KO mice are likely to be due to abnormal synaptic transmission involving heterotopic cells in the hippocampus and these mice may therefore provide a useful model to further study how lamination defects underlie the genesis of epileptiform activities.	[Nosten-Bertrand, Marika; Denis, Cecile; Germain, Johanne; Verstraeten, Soraya; Giros, Bruno] Univ Paris 06, INSERM, U513, Paris, France; [Nosten-Bertrand, Marika; Denis, Cecile; Germain, Johanne; Verstraeten, Soraya; Giros, Bruno] Univ Paris 06, UMPC, Paris, France; [Kappeler, Caroline; Tuy, Francoise Phan Dinh; Chelly, Jamel; Francis, Fiona] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Kappeler, Caroline; Tuy, Francoise Phan Dinh; Chelly, Jamel; Francis, Fiona] INSERM, U567, Paris, France; [Dinocourt, Celine; Miles, Richard] CHU Pitie Salpetriere, UPMC, INSERM, U739, Paris, France; [Alvarez, Chantal; Metin, Christine] UPMC, Paris, France; [Alvarez, Chantal; Metin, Christine] Inst Fer Moulin, INSERM, U839, Paris, France; [Giros, Bruno] McGill Univ, Douglas Hosp Res Ctr, Dept Psychiat, Montreal, PQ, Canada; [Depaulis, Antoine] Univ Joseph Fourier, Grenoble Inst Neurosci, Inserm U836 UJF CEA CHU, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; McGill University; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Nosten-Bertrand, M (corresponding author), Univ Paris 06, INSERM, U513, Paris, France.	francis@cochin.inserm.fr	Francis, Fiona/B-5854-2016; Metin, Christine/E-4995-2017; Depaulis, Antoine/B-6098-2012; GIROS, Bruno/ABD-5790-2021; Chelly, Jamel/J-7528-2015	Depaulis, Antoine/0000-0001-6543-6700; GIROS, Bruno/0000-0001-5876-9822; Chelly, Jamel/0000-0002-0939-8719; Francis, Fiona/0000-0001-8542-7537; Metin, Christine/0000-0002-5936-0110	INSERM; CNRS; Federation pour la Recherche sur le Cerveau; EC [EPICURE-LSH-CT-2006-037315]; Ministere de Education Nationale, de la Recherche et de la Technologie, the Fondation pour la Recherche Medicale [fellowship]; ANR [A05183KS]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Federation pour la Recherche sur le Cerveau; EC(European CommissionEuropean Commission Joint Research Centre); Ministere de Education Nationale, de la Recherche et de la Technologie, the Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR))	The contribution of the Region Ile-de-France to the Institut Cochin animal care facility is acknowledged. This work was supported by INSERM, the CNRS and the Federation pour la Recherche sur le Cerveau (awarded to FF). C. Dinocourt was supported by the EC (EPICURE-LSH-CT-2006-037315). C. Kappeler was supported by a fellowship from the Ministere de Education Nationale, de la Recherche et de la Technologie, the Fondation pour la Recherche Medicale (FRM) and the ANR (A05183KS).	Andre V, 1998, EUR J NEUROSCI, V10, P2094, DOI 10.1046/j.1460-9568.1998.00223.x; BACCALA LA, 2006, HDB TIME SERIES ANAL, P413; BAKKER CE, 1994, CELL, V78, P23; BARKOVICH AJ, 1994, ANN NEUROL, V36, P609, DOI 10.1002/ana.410360409; Bast T, 2003, PROG NEUROBIOL, V70, P319, DOI 10.1016/S0301-0082(03)00112-6; BELLMANN R, 1991, J NEUROCHEM, V56, P525, DOI 10.1111/j.1471-4159.1991.tb08181.x; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; BENDOTTI C, 1991, NEUROSCI LETT, V132, P175, DOI 10.1016/0304-3940(91)90295-5; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bernasconi A, 2001, EPILEPSIA, V42, P1124, DOI 10.1046/j.1528-1157.2001.39900.x; BROWNING RA, 1985, FED PROC, V44, P2425; CAMPBELL AM, 1984, BRAIN RES, V323, P239, DOI 10.1016/0006-8993(84)90294-4; CHAFETZ RS, 1995, MOL BRAIN RES, V31, P111, DOI 10.1016/0169-328X(95)00041-P; Chevassus-au-Louis N, 1999, CELL MOL LIFE SCI, V55, P1206, DOI 10.1007/s000180050367; COHEN I, J PHYSL 2, V524, P485; Corbo JC, 2002, J NEUROSCI, V22, P7548; De Sarro G, 2004, NEUROSCI RES, V50, P37, DOI 10.1016/j.neures.2004.05.007; Deller T, 1999, EXP NEUROL, V156, P254, DOI 10.1006/exnr.1999.7021; DERIJKVANANDEL JF, 1992, NEUROPEDIATRICS, V23, P4, DOI 10.1055/s-2008-1071302; des Portes V, 1998, CELL, V92, P51; Fleck MW, 2000, J NEUROSCI, V20, P2439; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Friocourt G, 2007, J NEUROSCI, V27, P3875, DOI 10.1523/JNEUROSCI.4530-06.2007; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Goddyn H, 2006, BEHAV BRAIN RES, V173, P138, DOI 10.1016/j.bbr.2006.06.016; Grant AC, 2002, EPILEPSIA, V43, P403, DOI 10.1046/j.1528-1157.2002.42601.x; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; Guerrini R, 2006, EXP BRAIN RES, V173, P322, DOI 10.1007/s00221-006-0501-z; Harding B, 1996, DYSPLASIAS OF CEREBRAL CORTEX AND EPILEPSY, P81; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Janzen L, 2004, EPILEPSIA, V45, P555, DOI 10.1111/j.0013-9580.2004.53203.x; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007; Kubota D, 2003, J NEUROPHYSIOL, V89, P81, DOI 10.1152/jn.00542.2002; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; McCarthy JB, 1998, J NEUROCHEM, V70, P1950; NEUMANN PE, 1991, P NATL ACAD SCI USA, V88, P5408, DOI 10.1073/pnas.88.12.5408; Parent JM, 2007, EPILEPSIA, V48, P69, DOI 10.1111/j.1528-1167.2007.01355.x; Parent JM, 1997, J NEUROSCI, V17, P3727; Patrylo PR, 2006, EPILEPSIA, V47, P257, DOI 10.1111/j.1528-1167.2006.00417.x; Pillai-Nair N, 2005, J NEUROSCI, V25, P4659, DOI 10.1523/JNEUROSCI.0565-05.2005; PITKANEN A, 1989, NEUROPEPTIDES, V14, P197, DOI 10.1016/0143-4179(89)90045-0; Reibel S, 2001, PEPTIDES, V22, P529, DOI 10.1016/S0196-9781(01)00347-3; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Ruttimann E, 2004, BIOCHEM PHARMACOL, V68, P1613, DOI 10.1016/j.bcp.2004.07.019; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Schwartzkroin PA, 2004, ADV EXP MED BIOL, V548, P145; Todorova MT, 1999, EPILEPSIA, V40, P1697, DOI 10.1111/j.1528-1157.1999.tb01586.x; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; Wenzel HJ, 2001, J NEUROSCI, V21, P983, DOI 10.1523/JNEUROSCI.21-03-00983.2001; WHITE JD, 1987, MOL BRAIN RES, V3, P21, DOI 10.1016/0169-328X(87)90040-4; Yang Q, 1997, BRAIN RES BULL, V43, P551, DOI 10.1016/S0361-9230(97)00006-3; Yoshihara Y, 2003, NEUROSCIENCE, V117, P391, DOI 10.1016/S0306-4522(02)00876-X; Yuhas Y, 1999, INFECT IMMUN, V67, P1455, DOI 10.1128/IAI.67.3.1455-1460.1999	61	54	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2473	10.1371/journal.pone.0002473	http://dx.doi.org/10.1371/journal.pone.0002473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575605	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000005
J	Derivery, E; Fink, J; Martin, D; Houdusse, A; Piel, M; Stradal, TE; Louvard, D; Gautreau, A				Derivery, Emmanuel; Fink, Jenny; Martin, Davy; Houdusse, Anne; Piel, Matthieu; Stradal, Theresia E.; Louvard, Daniel; Gautreau, Alexis			Free Brick1 Is a Trimeric Precursor in the Assembly of a Functional Wave Complex	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; REGULATES ACTIN; ARP2/3 COMPLEX; WASP; SCAR; BRICK1/HSPC300; NUCLEATION; STABILITY; MIGRATION; SCAR/WAVE	Background: The Wave complex activates the Arp2/3 complex, inducing actin polymerization in lamellipodia and membrane ruffles. The Wave complex is composed of five subunits, the smallest of which, Brick1/Hspc300 (Brk1), is the least characterized. We previously reported that, unlike the other subunits, Brk1 also exists as a free form. Principal Findings: Here we report that this free form of Brk1 is composed of homotrimers. Using a novel assay in which purified free Brk1 is electroporated into HeLa cells, we were able to follow its biochemical fate in cells and to show that free Brk1 becomes incorporated into the Wave complex. Importantly, incorporation of free Brk1 into the Wave complex was blocked upon inhibition of protein synthesis and incorporated Brk1 was found to associate preferentially with neosynthesized subunits. Brk1 depleted HeLa cells were found to bleb, as were Nap1, Wave2 or ARPC2 depleted cells, suggesting that this blebbing phenotype of Brk1 depleted cells is due to an impairment of the Wave complex function rather than a specific function of free Brk1. Blebs of Brk1 depleted cells were emitted at sites where lamellipodia and membrane ruffles were normally emitted. In Brk1 depleted cells, the electroporation of free Brk1 was sufficient to restore Wave complex assembly and to rescue the blebbing phenotype. Conclusion: Together these results establish that the free form of Brk1 is an essential precursor in the assembly of a functional Wave complex.	[Derivery, Emmanuel; Louvard, Daniel; Gautreau, Alexis] Ctr Rech, Inst Curie, Morphogenesis & Cell Signal lab, Paris, France; [Fink, Jenny; Piel, Matthieu] Ctr Rech, Inst Curie, Syst Cell Biol Cell Polar & Cell Div lab, Paris, France; [Martin, Davy; Houdusse, Anne] Ctr Rech, Inst Curie, Struct Motil lab, Paris, France; [Derivery, Emmanuel; Fink, Jenny; Martin, Davy; Houdusse, Anne; Piel, Matthieu; Louvard, Daniel; Gautreau, Alexis] CNRS, UMR144, Paris, France; [Stradal, Theresia E.] HZI Helmholz Ctr Infect Res, Braunschweig, Germany	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Helmholtz Association; Helmholtz-Center for Infection Research	Derivery, E (corresponding author), Ctr Rech, Inst Curie, Morphogenesis & Cell Signal lab, Paris, France.	alexis.gautreau@lebs.cnrs-gif.fr	Gautreau, Alexis/AAT-2751-2020	Gautreau, Alexis/0000-0002-2369-4362; Martin, Davy/0000-0003-2421-716X; Stradal, Theresia/0000-0002-0352-9474	ENS-Lyon; Boehringer Ingelheim; Curie post-doctoral fellowship; DFG; Fondation pour la Recherche Medicale [INE20071110919]	ENS-Lyon; Boehringer Ingelheim(Boehringer Ingelheim); Curie post-doctoral fellowship; DFG(German Research Foundation (DFG)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	E.D. was supported by ENS-Lyon. J.F. was supported by a PhD grant from Boehringer Ingelheim. D.M. was supported by a Curie post-doctoral fellowship. TES was supported by a DFG grant. This work was supported by Fondation pour la Recherche Medicale (INE20071110919).	Basu D, 2005, PLANT CELL, V17, P502, DOI 10.1105/tpc.104.027987; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Djakovic S, 2006, DEVELOPMENT, V133, P1091, DOI 10.1242/dev.02280; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Frank MJ, 2002, CURR BIOL, V12, P849, DOI 10.1016/S0960-9822(02)00819-9; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Ibarra N, 2006, CURR BIOL, V16, P717, DOI 10.1016/j.cub.2006.02.068; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Iwaya K, 2007, CANCER SCI, V98, P992, DOI 10.1111/j.1349-7006.2007.00488.x; Iwaya K, 2007, MODERN PATHOL, V20, P339, DOI 10.1038/modpathol.3800741; Kammerer RA, 2005, P NATL ACAD SCI USA, V102, P13891, DOI 10.1073/pnas.0502390102; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kobayashi T, 1998, J MEMBRANE SCI, V140, P1, DOI 10.1016/S0376-7388(97)00251-2; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; Le J, 2006, CURR BIOL, V16, P895, DOI 10.1016/j.cub.2006.03.061; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Smith LG, 2005, ANNU REV CELL DEV BI, V21, P271, DOI 10.1146/annurev.cellbio.21.122303.114901; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yang LY, 2006, CLIN CANCER RES, V12, P5673, DOI 10.1158/1078-0432.CCR-06-0022; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zhang XG, 2005, PLANT CELL, V17, P2314, DOI 10.1105/tpc.104.028670	38	54	58	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2462	10.1371/journal.pone.0002462	http://dx.doi.org/10.1371/journal.pone.0002462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560548	Green Published, Green Submitted, gold			2022-12-25	WOS:000263280700043
J	Maitra, R; Clement, CC; Crisi, GM; Cobelli, N; Santambrogio, L				Maitra, Radhashree; Clement, Cristina C.; Crisi, Giovanna M.; Cobelli, Neil; Santambrogio, Laura			Immunogenecity of Modified Alkane Polymers Is Mediated through TLR1/2 Activation	PLOS ONE			English	Article							MOLECULAR-WEIGHT POLYETHYLENE; UHMWPE; RECOGNITION; OXIDATION; TISSUE; TLR2	Background: With the advancement of biomedical technology, artificial materials have been developed to replace diseased, damaged or nonfunctional body parts. Among such materials, ultra high molecular weight alkane or modified alkyl polymers have been extensively used in heart valves, stents, pacemakers, ear implants, as well as total joint replacement devices. Although much research has been undertaken to design the most non-reactive biologically inert polyethylene derivatives, strong inflammatory responses followed by rejection and failure of the implant have been noted. Methodology/Principal Findings: Purification of the alkane polymers from the site of inflammation revealed extensive "in vivo'' oxidation as detected by fourier transformed infra-red spectroscopy. Herein, we report the novel observation that oxidized alkane polymers induced activation of TLR1/2 pathway as determined by ligand dependent changes in intrinsic tyrosine fluorescence intensity and NF-kappa B luciferase gene assays. Oxidized polymers were very effective in activating dendritic cells and inducing secretion of pro-inflammatory cytokines. Molecular docking of the oxidized alkanes designated ligand specificity and polymeric conformations fitting into the TLR1/2 binding grooves. Conclusion/Significance: This is the first report of a synthetic polymer activating immune responses through TLR binding.	[Maitra, Radhashree; Clement, Cristina C.; Santambrogio, Laura] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [Crisi, Giovanna M.] Baystate Med Ctr, Dept Pathol, Springfield, MA USA; [Cobelli, Neil] Montefiore Med Ctr, Div Orthoped Surg, New York, NY USA	Yeshiva University; Baystate Medical Center; Montefiore Medical Center	Maitra, R (corresponding author), Albert Einstein Coll Med, Dept Pathol, New York, NY USA.	lsantamb@aecom.yu.edu	Clement, Cristina/ABG-4525-2021	Clement, Cristina/0000-0003-1464-407X	NIH [NS 07098]; Irene Diamond Professorships in Immunology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irene Diamond Professorships in Immunology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH (L.S.) and Irene Diamond Professorships in Immunology (L.S.). R.M. was supported by NIH training grant NS 07098.	Abu-Amer Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2170; Brach del Prever E M, 2003, Chir Organi Mov, V88, P291; Brodsky I, 2007, CELL, V130, P979, DOI 10.1016/j.cell.2007.09.009; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Chen L, 2006, AM J TRANSPLANT, V6, P2282, DOI 10.1111/j.1600-6143.2006.01489.x; Chiesa R, 2000, J BIOMED MATER RES, V50, P381, DOI 10.1002/(SICI)1097-4636(20000605)50:3<381::AID-JBM12>3.0.CO;2-P; Costa L, 1998, BIOMATERIALS, V19, P1371, DOI 10.1016/S0142-9612(98)00013-1; Fiorito S, 2001, J BIOMED MATER RES, V57, P35, DOI 10.1002/1097-4636(200110)57:1<35::AID-JBM1138>3.0.CO;2-B; Goodman S, 2005, ORTHOP CLIN N AM, V36, P41, DOI 10.1016/j.ocl.2004.06.015; Harris WH, 2004, CLIN ORTHOP RELAT R, P39, DOI 10.1097/01.blo.0000149821.72760.39; JAHAN MS, 1995, APPL RADIAT ISOTOPES, V46, P637, DOI 10.1016/0969-8043(95)00118-2; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Koseki H, 2005, J ORTHOP SCI, V10, P284, DOI 10.1007/s00776-005-0896-6; Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974; Kurth M, 1988, J Biomater Appl, V3, P33, DOI 10.1177/088532828800300102; KURTZ SM, 2005, SPINE J, V5; Lee AW, 2000, BIOMATERIALS, V21, P851, DOI 10.1016/S0142-9612(99)00257-4; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; Mukherjee DP, 2000, CRIT REV BIOMED ENG, V28, P445, DOI 10.1615/CritRevBiomedEng.v28.i34.160; Ren WP, 2006, BIOMATERIALS, V27, P5161, DOI 10.1016/j.biomaterials.2006.04.004; Reno F, 2003, BIOMATERIALS, V24, P2895, DOI 10.1016/S0142-9612(03)00128-5; Taddei P, 2006, BIOMACROMOLECULES, V7, P1912, DOI 10.1021/bm060007u; Trindade MCD, 1999, J BIOMED MATER RES, V48, P434, DOI 10.1002/(SICI)1097-4636(1999)48:4<434::AID-JBM6>3.3.CO;2-P; Wallace WE, 2007, CHEM COMMUN, P4525, DOI 10.1039/b711932a; Williams S, 2003, P I MECH ENG H, V217, P147, DOI 10.1243/09544110360579367; Witkiewicz H, 1993, Tech Orthop, V8, P254, DOI 10.1097/00013611-199300840-00006; Xing S, 2002, BIOMATERIALS, V23, P3595, DOI 10.1016/S0142-9612(02)00088-1	29	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2438	10.1371/journal.pone.0002438	http://dx.doi.org/10.1371/journal.pone.0002438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560588	gold, Green Submitted, Green Published			2022-12-25	WOS:000263280700023
J	Poncela, J; Gomez-Gardenes, J; Floria, LM; Sanchez, A; Moreno, Y				Poncela, Julia; Gomez-Gardenes, Jesus; Floria, Luis M.; Sanchez, Angel; Moreno, Yamir			Complex Cooperative Networks from Evolutionary Preferential Attachment	PLOS ONE			English	Article								In spite of its relevance to the origin of complex networks, the interplay between form and function and its role during network formation remains largely unexplored. While recent studies introduce dynamics by considering rewiring processes of a pre-existent network, we study network growth and formation by proposing an evolutionary preferential attachment model, its main feature being that the capacity of a node to attract new links depends on a dynamical variable governed in turn by the node interactions. As a specific example, we focus on the problem of the emergence of cooperation by analyzing the formation of a social network with interactions given by the Prisoner's Dilemma. The resulting networks show many features of real systems, such as scale-free degree distributions, cooperative behavior and hierarchical clustering. Interestingly, results such as the cooperators being located mostly on nodes of intermediate degree are very different from the observations of cooperative behavior on static networks. The evolutionary preferential attachment mechanism points to an evolutionary origin of scale-free networks and may help understand similar feedback problems in the dynamics of complex networks by appropriately choosing the game describing the interaction of nodes.	[Poncela, Julia; Gomez-Gardenes, Jesus; Floria, Luis M.; Sanchez, Angel; Moreno, Yamir] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Zaragoza, Spain; [Gomez-Gardenes, Jesus] Univ Catania, Scuola Superiore Catania, Catania, Italy; [Floria, Luis M.] Univ Zaragoza, Dept Fis Mat Condensada, Zaragoza, Spain; [Sanchez, Angel] Univ Carlos Madrid 3, Dept Matematicas, GISC, Leganes, Spain; [Moreno, Yamir] Univ Zaragoza, Dept Theoret Phys, Zaragoza, Spain	University of Zaragoza; University of Catania; University of Zaragoza; Universidad Carlos III de Madrid; University of Zaragoza	Poncela, J (corresponding author), Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Zaragoza, Spain.	yamir@unizar.es	Floria, Luis Mario/L-7261-2014; Sánchez, Angel/A-9229-2008; Poncela-Casasnovas, Julia/H-8931-2015; Gomez-Gardenes, Jesus/A-3226-2009; Gomez-Gardenes, Jesus/M-9825-2019; Gomez-Gardeñes, Jesus/B-5818-2009; Moreno, Yamir/A-1076-2009	Floria, Luis Mario/0000-0002-1406-8810; Sánchez, Angel/0000-0003-1874-2881; Poncela-Casasnovas, Julia/0000-0003-2791-7524; Gomez-Gardenes, Jesus/0000-0001-5204-1937; Gomez-Gardeñes, Jesus/0000-0001-5204-1937; Moreno, Yamir/0000-0002-0895-1893	Ministerio de Educacion y Ciencia through the Ramon y Cajal Program [FIS-2006-12781-C02-01, FIS-2005-00337, NAN2004-9087-C03-03]; MOSAICO; Comunidad de Madrid (Spain) [SIMUMAT-CM]	Ministerio de Educacion y Ciencia through the Ramon y Cajal Program(German Research Foundation (DFG)); MOSAICO; Comunidad de Madrid (Spain)(Comunidad de Madrid)	We acknowledge support from the Ministerio de Educacion y Ciencia through the Ramon y Cajal Program (Y.M.) and grants FIS-2006-12781-C02-01, FIS-2005-00337, MOSAICO and NAN2004-9087-C03-03. A.S. is also supported by the Comunidad de Madrid (Spain) under grant SIMUMAT-CM.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianconi G, 2001, EUROPHYS LETT, V54, P436, DOI 10.1209/epl/i2001-00260-6; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Donetti L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.188701; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Guimera R, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100082; Jimenez R, 2008, J THEOR BIOL, V250, P475, DOI 10.1016/j.jtbi.2007.10.010; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Lozano S, 2007, JASSS-J ARTIF SOC S, V10; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; SAXENIAN A, 1996, REGIONAL ADV CULTURE, V128; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036	23	146	147	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2449	10.1371/journal.pone.0002449	http://dx.doi.org/10.1371/journal.pone.0002449			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560601	gold, Green Published, Green Submitted			2022-12-25	WOS:000263280700034
J	Levy-Adam, F; Feld, S; Suss-Toby, E; Vlodavsky, I; Ilan, N				Levy-Adam, Flonia; Feld, Sari; Suss-Toby, Edith; Vlodavsky, Israel; Ilan, Neta			Heparanase Facilitates Cell Adhesion and Spreading by Clustering of Cell Surface Heparan Sulfate Proteoglycans	PLOS ONE			English	Article								Heparanase is a heparan sulfate (HS) degrading endoglycosidase participating in extracellular matrix degradation and remodeling. Apart of its well characterized enzymatic activity, heparanase was noted to exert also enzymatic-independent functions. Non-enzymatic activities of heparanase include enhanced adhesion of tumor-derived cells and primary T-cells. Attempting to identify functional domains of heparanase that would serve as targets for drug development, we have identified heparin binding domains of heparanase. A corresponding peptide (residues Lys(158)-Asp(171), termed KKDC) was demonstrated to physically associate with heparin and HS, and to inhibit heparanase enzymatic activity. We hypothesized that the pro-adhesive properties of heparanase are mediated by its interaction with cell surface HS proteoglycans, and utilized the KKDC peptide to examine this possibility. We provide evidence that the KKDC peptide interacts with cell membrane HS, resulting in clustering of syndecan-1 and syndecan-4. We applied classical analysis of cell morphology, fluorescent and time-lapse microscopy and demonstrated that the KKDC peptide efficiently stimulates the adhesion and spreading of various cell types, mediated by PKC, Src, and the small GTPase Rac1. These results support, and further substantiate the notion that heparanase function is not limited to its enzymatic activity.	[Levy-Adam, Flonia; Feld, Sari; Suss-Toby, Edith; Vlodavsky, Israel; Ilan, Neta] Technion Israel Inst Technol, Canc & Vasc Biol Res Ctr, Ruth & Bruce Rappaport Fac Med, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Levy-Adam, F (corresponding author), Technion Israel Inst Technol, Canc & Vasc Biol Res Ctr, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.	Vlodavsk@cc.huji.ac.il			Israel Science Foundation [549/06]; National Cancer Institute, NIH [RO1-CA106456]; Israel Cancer Research Fund; Rappaport Family Institute Fund; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israel Cancer Research Fund; Rappaport Family Institute Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Israel Science Foundation (grant 549/06); National Cancer Institute, NIH (grant RO1-CA106456); the Israel Cancer Research Fund; and the Rappaport Family Institute Fund.	BARKALOW FJB, 1991, J BIOL CHEM, V266, P7812; BARNER M, 1985, INT J CANCER, V35, P483, DOI 10.1002/ijc.2910350411; BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; FOLKMAN J, 1988, AM J PATHOL, V130, P393; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Levy-Adam F, 2005, J BIOL CHEM, V280, P20457, DOI 10.1074/jbc.M414546200; Levy-Adam F, 2003, BIOCHEM BIOPH RES CO, V308, P885, DOI 10.1016/S0006-291X(03)01478-5; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Miao HQ, 2006, CURR MED CHEM, V13, P2101, DOI 10.2174/092986706777935230; Nadav L, 2006, CANCER RES, V66, P8608, DOI 10.1158/0008-5472.CAN-06-1301; Nadir Y, 2006, J THROMB HAEMOST, V4, P2443, DOI 10.1111/j.1538-7836.2006.02212.x; NAKAJIMA M, 1983, SCIENCE, V220, P611, DOI 10.1126/science.6220468; Okawa T, 2005, CLIN CANCER RES, V11, P7995, DOI 10.1158/1078-0432.CCR-05-1103; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Sanderson RD, 2005, J CELL BIOCHEM, V96, P897, DOI 10.1002/jcb.20602; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Shafat I, 2006, J BIOL CHEM, V281, P23804, DOI 10.1074/jbc.M602762200; Simons M, 2001, CELL SIGNAL, V13, P855, DOI 10.1016/S0898-6568(01)00190-5; Sotnikov I, 2004, J IMMUNOL, V172, P5185, DOI 10.4049/jimmunol.172.9.5185; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tkachenko E, 2006, CIRC RES, V98, P1398, DOI 10.1161/01.RES.0000225283.71490.5a; Verrecchio A, 2000, J BIOL CHEM, V275, P7701, DOI 10.1074/jbc.275.11.7701; VLODAVSKY I, 1983, CANCER RES, V43, P2704; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; Vlodavsky I, 2006, PATHOPHYSIOL HAEMO T, V35, P116, DOI 10.1159/000093553; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WOODS A, 1993, MOL BIOL CELL, V4, P605, DOI 10.1091/mbc.4.6.605; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2007, BLOOD, V110, P2041, DOI 10.1182/blood-2007-04-082495; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zetser A, 2003, CANCER RES, V63, P7733	60	79	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2319	10.1371/journal.pone.0002319	http://dx.doi.org/10.1371/journal.pone.0002319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545691	Green Submitted, Green Published, gold			2022-12-25	WOS:000263248800004
J	Painter, CA; Cruz, A; Lopez, GE; Stern, LJ; Zavala-Ruiz, Z				Painter, Corrie A.; Cruz, Anthony; Lopez, Gustavo E.; Stern, Lawrence J.; Zavala-Ruiz, Zarixia			Model for the Peptide-Free Conformation of Class II MHC Proteins	PLOS ONE			English	Article								Background: Major histocompatibility complex proteins are believed to undergo significant conformational changes concomitant with peptide binding, but structural characterization of these changes has remained elusive. Methodology/Principal Findings: Here we use molecular dynamics simulations and experimental probes of protein conformation to investigate the peptide-free state of class II MHC proteins. Upon computational removal of the bound peptide from HLA-DR1-peptide complex, the alpha 50-59 region folded into the P1-P4 region of the peptide binding site, adopting the same conformation as a bound peptide. Strikingly, the structure of the hydrophobic P1 pocket is maintained by engagement of the side chain of Phe alpha 54. In addition, conserved hydrogen bonds observed in crystal structures between the peptide backbone and numerous MHC side chains are maintained between the alpha 51-55 region and the rest of the molecule. The model for the peptide-free conformation was evaluated using conformationally-sensitive antibody and superantigen probes predicted to show no change, moderate change, or dramatic changes in their interaction with peptide-free DR1 and peptide-loaded DR1. The binding observed for these probes is in agreement with the movements predicted by the model. Conclusion/Significance: This work presents a molecular model for peptide-free class II MHC proteins that can help to interpret the conformational changes known to occur within the protein during peptide binding and release, and can provide insight into possible mechanisms for DM action.	[Painter, Corrie A.; Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Cruz, Anthony; Lopez, Gustavo E.] Univ Puerto Rico, Dept Chem, Mayaguez, PR USA; [Stern, Lawrence J.] Univ Massachusetts, Med Sch, Dept Pathol, Worcester, MA USA; [Zavala-Ruiz, Zarixia] Univ Puerto Rico, Dept Chem, San Juan, PR USA	University of Massachusetts System; University of Massachusetts Worcester; University of Puerto Rico; University of Puerto Rico Mayaguez; University of Massachusetts System; University of Massachusetts Worcester; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Painter, CA (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	lawrence.stern@umassmed.edu; zarixiazavala@vmail.uprrp.edu		Zavala-Ruiz, Zarixia/0000-0003-1513-5840; Painter, Corrie/0000-0001-6174-1548	NIH [AI-38996, AI-48833, 5P20RR016439]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038996, R01AI038996, R01AI048833, R56AI038996] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following NIH grants: AI-38996 (LJS), AI-48833 (LJS) and 5P20RR016439 (GRL, ZZ-R).	Andersen PS, 1999, IMMUNITY, V10, P473, DOI 10.1016/S1074-7613(00)80047-3; Belmares MP, 2003, BIOCHEMISTRY-US, V42, P838, DOI 10.1021/bi020466p; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bolin DR, 2000, J MED CHEM, V43, P2135, DOI 10.1021/jm000034h; Boniface JJ, 1996, J EXP MED, V183, P119, DOI 10.1084/jem.183.1.119; Bouvier M, 1998, NAT STRUCT BIOL, V5, P377, DOI 10.1038/nsb0598-377; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Carven GJ, 2005, BIOCHEMISTRY-US, V44, P13625, DOI 10.1021/bi050972p; Carven GJ, 2004, J BIOL CHEM, V279, P16561, DOI 10.1074/jbc.M314315200; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; Cochran JR, 2000, CHEM BIOL, V7, P683, DOI 10.1016/S1074-5521(00)00019-3; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FAHNESTOCK ML, 1992, SCIENCE, V258, P1658, DOI 10.1126/science.1360705; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; FU XT, 1994, HUM IMMUNOL, V39, P253, DOI 10.1016/0198-8859(94)90268-2; Glithero A, 2006, J BIOL CHEM, V281, P12699, DOI 10.1074/jbc.M511683200; GROTENBREG GM, 2007, J BIOL CHEM; Gupta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001814; HAMMER J, 1992, J EXP MED, V176, P1007, DOI 10.1084/jem.176.4.1007; Hansen TH, 2005, IMMUNOL REV, V207, P100, DOI 10.1111/j.0105-2896.2005.00315.x; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joshi RV, 2000, BIOCHEMISTRY-US, V39, P3751, DOI 10.1021/bi9923656; Kasson PM, 2000, BIOCHEMISTRY-US, V39, P1048, DOI 10.1021/bi9921337; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Kony DB, 2007, PROTEIN SCI, V16, P1101, DOI 10.1110/ps.062323407; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; Laberge M, 2008, BIOPHYS J, V94, P2737, DOI 10.1529/biophysj.107.114942; Lovitch SB, 2005, IMMUNOL REV, V207, P293, DOI 10.1111/j.0105-2896.2005.00298.x; McFarland BJ, 2002, MED RES REV, V22, P168, DOI 10.1002/med.10006; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Natarajan SK, 1999, J IMMUNOL, V162, P4030; Natarajan SK, 1999, J IMMUNOL, V162, P3463; Nojima H, 2003, CHEM PHARM BULL, V51, P923; OSULLIVAN D, 1990, J IMMUNOL, V145, P1799; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; Reich Z, 1997, P NATL ACAD SCI USA, V94, P2495, DOI 10.1073/pnas.94.6.2495; Runnels HA, 1996, J EXP MED, V183, P127, DOI 10.1084/jem.183.1.127; SADEGHNASSERI S, 1994, NATURE, V370, P647, DOI 10.1038/370647a0; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; Schmitt L, 1999, J MOL BIOL, V286, P207, DOI 10.1006/jmbi.1998.2463; Schneider TR, 2000, ACTA CRYSTALLOGR D, V56, P714, DOI 10.1107/S0907444900003723; Sieker F, 2007, PROTEIN SCI, V16, P299, DOI 10.1110/ps.062568407; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Sundberg EJ, 2003, STRUCTURE, V11, P1151, DOI 10.1016/S0969-2126(03)00187-4; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Villa E, 2005, P NATL ACAD SCI USA, V102, P6783, DOI 10.1073/pnas.0409387102; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743; Zarutskie JA, 2001, P NATL ACAD SCI USA, V98, P12450, DOI 10.1073/pnas.211439398; Zarutskie JA, 1999, BIOCHEMISTRY-US, V38, P5878, DOI 10.1021/bi983048m; Zavala-Ruiz Z, 2004, CHEM BIOL, V11, P1395, DOI 10.1016/j.chembiol.2004.08.007; Zavala-Ruiz Z, 2004, P NATL ACAD SCI USA, V101, P13279, DOI 10.1073/pnas.0403371101; Zheng W, 2007, BIOPHYS J, V93, P2289, DOI 10.1529/biophysj.107.105270	59	52	52	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2403	10.1371/journal.pone.0002403	http://dx.doi.org/10.1371/journal.pone.0002403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545669	gold, Green Published, Green Submitted			2022-12-25	WOS:000263248800041
J	Li, Y; Lau, YFC				Li, Y.; Lau, Y-F Chris			TSPY and its X-encoded homologue interact with cyclin B but exert contrasting functions on cyclin-dependent kinase 1 activities	ONCOGENE			English	Article						TSPY; TSPX; sex chromosomes; cyclin B-CDK1; kinase activities; protein-protein interaction	TGF-BETA-1 TARGET DENTT; TESTIS-SPECIFIC PROTEIN; GERM-CELL TUMORS; HUMAN Y-CHROMOSOME; CARCINOMA IN-SITU; GONADOBLASTOMA LOCUS; CANDIDATE GENE; EXPRESSION; SET; IDENTIFICATION	Testis-specific protein Y-encoded ( TSPY) is the putative gene for the gonadoblastoma locus on the Y chromosome (GBY). TSPY and an X-homologue, TSPX, harbor a conserved domain, designated as SET/NAP domain, but differ at their C termini. Ectopic expression of TSPY accelerates cell proliferation by abbreviating the G(2)/M stage, whereas overexpression of TSPX retards cells at the same stage of the cell cycle. Previous studies demonstrated that the SET oncoprotein is capable of binding to cyclin B. Using various protein interaction techniques, we demonstrated that TSPY and TSPX indeed bind competitively to cyclin B at their SET/NAP domains in vitro and in vivo. TSPY colocalizes with cyclin B1 during the cell cycle, particularly on the mitotic spindles at metaphase. TSPY enhances while TSPX represses the cyclin B1-CDK1 phosphorylation activity. The inhibitory effect of TSPX on the cyclin B1-CDK1 complex has been mapped to its carboxyl acidic domain that is absent in TSPY, suggesting that TSPX could serve a normal function in modulating cell-cycle progression at the G(2)/M stage, whereas TSPY has acquired a specialized function in germ cell renewal and differentiation. Epigenetic dysregulation of TSPY in incompatible germ or somatic cells could promote cell proliferation and predispose susceptible cells to tumorigenesis.	[Li, Y.; Lau, Y-F Chris] Univ Calif San Francisco, Dept Med, VA Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco	Lau, YFC (corresponding author), Univ Calif San Francisco, Dept Med, VA Med Ctr, 111C5,4150 Clement St, San Francisco, CA 94121 USA.	chris.lau@ucsf.edu	Lau, Yun-Fai C/E-4465-2014	Lau, Yun-Fai C/0000-0002-9119-7050	Merit Review; Prostate Cancer REAP from the Department of Veterans Affairs; Department of Defense to Y-FCL	Merit Review(US Department of Veterans Affairs); Prostate Cancer REAP from the Department of Veterans Affairs(US Department of Veterans Affairs); Department of Defense to Y-FCL(United States Department of Defense)	We thank Dr Tatsuo Kido for assistance in immuno fluorescence of transfected cells presented in Figures 4f-h. This work was partially supported by a Merit Review grant and a Prostate Cancer REAP from the Department of Veterans Affairs and an Idea Grant from the Department of Defense to Y-FCL. Y-FC Lau is a research career scientist of the Department of Veterans Affairs.	ADACHI Y, 1994, J BIOL CHEM, V269, P2258; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Chai ZL, 2001, J BIOL CHEM, V276, P33665, DOI 10.1074/jbc.M007681200; Compagnone NA, 2000, MOL ENDOCRINOL, V14, P875, DOI 10.1210/me.14.6.875; Decordier I, 2008, MUTAT RES-GEN TOX EN, V651, P3, DOI 10.1016/j.mrgentox.2007.10.020; Delbridge ML, 2004, CHROMOSOME RES, V12, P345, DOI 10.1023/B:CHRO.0000034134.91243.1c; Estanyol JM, 1999, J BIOL CHEM, V274, P33161, DOI 10.1074/jbc.274.46.33161; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Gallagher WM, 2005, CARCINOGENESIS, V26, P1856, DOI 10.1093/carcin/bgi152; Gamble MJ, 2005, MOL CELL BIOL, V25, P797, DOI 10.1128/MCB.25.2.797-807.2005; Graves JAM, 1995, PHILOS T R SOC B, V350, P305, DOI 10.1098/rstb.1995.0166; Hoei-Hansen CE, 2006, J PATHOL, V209, P25, DOI 10.1002/path.1948; Honecker F, 2004, J PATHOL, V203, P849, DOI 10.1002/path.1587; Kandilci A, 2005, LEUKEMIA, V19, P1439, DOI 10.1038/sj.leu.2403826; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; Kersemaekers AMF, 2005, HUM PATHOL, V36, P512, DOI 10.1016/j.humpath.2005.02.016; Kido T, 2005, GENESIS, V42, P263, DOI 10.1002/gene.20147; Kido T, 2006, BIOCHEM BIOPH RES CO, V350, P56, DOI 10.1016/j.bbrc.2006.08.191; Krick R, 2003, GENE, V302, P11, DOI 10.1016/S0378-1119(02)01104-6; Lau YFC, 2003, CYTOGENET GENOME RES, V101, P250, DOI 10.1159/000074345; Lau YFC, 2000, CYTOGENET CELL GENET, V91, P160, DOI 10.1159/000056838; Lau YFC, 2000, MOL CARCINOGEN, V27, P308, DOI 10.1002/(SICI)1098-2744(200004)27:4<308::AID-MC9>3.0.CO;2-R; Lau YFC, 1999, AM J HUM GENET, V64, P921, DOI 10.1086/302353; LAU YFC, 2007, CHROM MAL GERM CELL, P73; LI Y, 2006, MOL CELL ENDOCRINOL, V256, P69; Li YM, 2007, HUM PATHOL, V38, P1470, DOI 10.1016/j.humpath.2007.03.011; Li YM, 2007, UROL ONCOL-SEMIN ORI, V25, P141, DOI 10.1016/j.urolonc.2006.08.002; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Looijenga LHJ, 2002, ANAL QUANT CYTOL, V24, P263; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Oh H, 2005, BIOL REPROD, V72, P407, DOI 10.1095/biolreprod.104.034447; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Oram SW, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-154; Ozbun LL, 2005, BBA-GENE STRUCT EXPR, V1728, P163, DOI 10.1016/j.bbaexp.2005.02.010; Ozbun LL, 2003, DEV DYNAM, V226, P491, DOI 10.1002/dvdy.10257; Ozbun LL, 2001, GENOMICS, V73, P179, DOI 10.1006/geno.2001.6505; PAGE DC, 1987, DEVELOPMENT, V101, P151; PINES J, 1992, CIBA F SYMP, V170, P187; PINES J, 1992, CIBA F SYMP, V170, P196; Porter Lisa A, 2003, Prog Cell Cycle Res, V5, P335; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Rajesh Changanarnkandath, 2006, V42, P343, DOI 10.1007/003; Rajpert-De Meyts E, 2006, HUM REPROD UPDATE, V12, P303, DOI 10.1093/humupd/dmk006; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Richter JD, 2001, P NATL ACAD SCI USA, V98, P7069, DOI 10.1073/pnas.111146498; SALO P, 1995, GENE CHROMOSOME CANC, V14, P210, DOI 10.1002/gcc.2870140309; Schmit TL, 2007, MOL CANCER THER, V6, P1920, DOI 10.1158/1535-7163.MCT-06-0781; Schnieders F, 1996, HUM MOL GENET, V5, P1801, DOI 10.1093/hmg/5.11.1801; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Tschop K, 2006, FEBS J, V273, P1681, DOI 10.1111/j.1742-4658.2006.05184.x; TSUCHIYA K, 1995, AM J HUM GENET, V57, P1400; Vera J, 2006, ONCOGENE, V25, P260, DOI 10.1038/sj.onc.1209050; Vijayakumar S, 2006, CANCER RES, V66, P4055, DOI 10.1158/0008-5472.CAN-05-3822; Vogel T, 1998, CYTOGENET CELL GENET, V81, P265, DOI 10.1159/000015042; Wang GS, 2004, NEURON, V42, P113, DOI 10.1016/S0896-6273(04)00139-4; Wang Q, 2004, DNA CELL BIOL, V23, P475, DOI 10.1089/1044549041562276; Whittaker SR, 2007, CELL CYCLE, V6, P3114, DOI 10.4161/cc.6.24.5142; Yin YH, 2005, BRIT J CANCER, V93, P458, DOI 10.1038/sj.bjc.6602716; Zhang Julie S., 1992, Human Molecular Genetics, V1, P717, DOI 10.1093/hmg/1.9.717	62	42	43	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2008	27	47					6141	6150		10.1038/onc.2008.206	http://dx.doi.org/10.1038/onc.2008.206			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	360UJ	18591933				2022-12-25	WOS:000260083100007
J	Klein, RM; Ufret-Vincenty, CA; Hua, L; Gordon, SE				Klein, Rebecca M.; Ufret-Vincenty, Carmen A.; Hua, Li; Gordon, Sharona E.			Determinants of molecular specificity in phosphoinositide regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ION CHANNELS; PLASMA-MEMBRANE; CELL-LINE; PIP2; INHIBITION; ACTIVATION; BINDING; TRPV1	Once thought of as simply an oily barrier that maintains cellular integrity, lipids are now known to play an active role in a large variety of cellular processes. Phosphoinositides are of particular interest because of their remarkable ability to affect many signaling pathways. Ion channels and transporters are an important target of phosphoinositide signaling, but identification of the specific phosphoinositides involved has proven elusive. TRPV1 is a good example; although phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P-2) can potently regulate its activation, we show that phosphatidylinositol (4)-phosphate (PI(4)P) and phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P-3) can as well. To determine the identity of the endogenous phosphoinositide regulating TRPV1, we applied recombinant pleckstrin homology domains to inside-out excised patches. Although a PI(4,5)P-2-specific pleckstrin homology domain inhibited TRPV1, a PI(3,4,5)P-3-specific pleckstrin homology domain had no effect. Simultaneous confocal imaging and electrophysiological recording of whole cells expressing a rapamycin-inducible lipid phosphatase also demonstrates that depletion of PI(4,5)P-2 inhibits capsaicin-activated TRPV1 current; the PI(4)P generated by the phosphatases was not sufficient to support TRPV1 function. We conclude that PI(4,5)P-2, and not other phosphoinositides or other lipids, is the endogenous phosphoinositide regulating TRPV1 channels.	[Klein, Rebecca M.; Ufret-Vincenty, Carmen A.; Hua, Li; Gordon, Sharona E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gordon, SE (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	seg@u.washington.edu			National Institutes of Health [R01EY017564]; University of Washington [2T32EY007031-31]; University of Washington Molecular Neuroscience [5T32NS007332-19]; NATIONAL EYE INSTITUTE [T32EY007031, R01EY017564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); University of Washington Molecular Neuroscience(University of Washington); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01EY017564 from the NEI (to S.E.G.). This work was also supported by the University of Washington Vision Training Grant 2T32EY007031-31 (to R.M.K.) and the University of Washington Molecular Neuroscience Training Grant 5T32NS007332-19 (to C.A.U.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Brown DA, 2007, J PHYSIOL-LONDON, V582, P917, DOI 10.1113/jphysiol.2007.132498; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FRANCEL PC, 1987, J NEUROCHEM, V48, P1624, DOI 10.1111/j.1471-4159.1987.tb05711.x; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; HARLAN JE, 1995, BIOCHEMISTRY-US, V34, P9859, DOI 10.1021/bi00031a006; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Jahnel R, 2003, EUR J BIOCHEM, V270, P4264, DOI 10.1046/j.1432-1033.2003.03811.x; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lee J, 2005, J GEN PHYSIOL, V126, P439, DOI 10.1085/jgp.200509314; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Schulze D, 2003, J PHYSIOL-LONDON, V552, P357, DOI 10.1113/jphysiol.2003.047035; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; TONER M, 1988, BIOCHEMISTRY-US, V27, P7435, DOI 10.1021/bi00419a039; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200	40	81	83	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26208	26216		10.1074/jbc.M801912200	http://dx.doi.org/10.1074/jbc.M801912200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18574245	Green Published, hybrid			2022-12-25	WOS:000259200100049
J	de Seigneux, S; Leroy, V; Ghzili, H; Rousselot, M; Nielsen, S; Rossier, BC; Martin, PY; Feraille, E				de Seigneux, Sophie; Leroy, Valerie; Ghzili, Hafida; Rousselot, Martine; Nielsen, Soren; Rossier, Bernard C.; Martin, Pierre-Yves; Feraille, Eric			NF-kappa B inhibits sodium transport via down-regulation of SGK1 in renal collecting duct principal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNILATERAL URETERAL OBSTRUCTION; INDUCIBLE PROTEIN-KINASE; SURFACE EXPRESSION; ALPHA-SUBUNIT; CHANNEL-ALPHA; RAT-KIDNEY; ALDOSTERONE; SERUM; NA+; ACTIVATION	Tubulointerstitial inflammation is a common feature of renal diseases. We have investigated the relationship between inflammation and Na+ transport in the collecting duct ( CD) using the mCCDc(l1) and mpkCDD(c14) principal cell models. Lipopolysaccharide (LPS) decreased basal and aldosterone-stimulated amiloride-sensitive transepithelial current in a time-dependent manner. This effect was associated with a decrease in serum and gucocorticoid-regulated kinase 1 ( SGK1) mRNA and protein levels followed by a decrease in epithelial sodium channel ( ENaC) alpha-subunit mRNA levels. The LPS-induced decrease in SGK1 expression was confirmed in isolated rat CD. This decreased expression of either SGK1 or the ENaC alpha-subunit was not due to enhanced degradation of mRNA. In contrast, LPS inhibited transcriptional activity of the SGK1 promoter measured by luciferase-reporter gene assay. The effect of LPS was not mediated by inhibition of mineralocorticoid or glucocorticoid receptor, because expression of both receptors was unchanged and blockade of either receptor by spironolactone or RU486, respectively, did not prevent the down-regulation of SGK1. The effect of LPS was mediated by the canonical NF-kappa B pathway, as overexpression of a constitutively active mutant, IKK beta ( inhibitor of nuclear factor kappa B kinase-beta) decreased SGK1 mRNA levels, and knockdown of p65 NF-kappa B subunit by small interfering RNA increased SGK1 mRNA levels. Chromatin immunoprecipitation showed that LPS increased p65 binding to two NF-kappa B sites along the SGK1 promoter. In conclusion, we show that activation of the NF-kappa B pathway down-regulates SGK1 expression, which might lead to decreased ENaC alpha-subunit expression, ultimately resulting in decreased Na+ transport.	[de Seigneux, Sophie; Leroy, Valerie; Ghzili, Hafida; Rousselot, Martine; Martin, Pierre-Yves; Feraille, Eric] Fdn Rech Med, Serv Nephrol, CH-1211 Geneva 4, Switzerland; [Rossier, Bernard C.] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Nielsen, Soren] Univ Aarhus, Inst Anat, Water & Salt Res Ctr, DK-8000 Aarhus, Denmark	University of Geneva; University of Lausanne; Aarhus University	Feraille, E (corresponding author), Fdn Rech Med, Serv Nephrol, 64 Ave Roseraie, CH-1211 Geneva 4, Switzerland.	Eric.Feraille@medecine.unige.ch		Feraille, Eric/0000-0003-1656-8365	Swiss National Foundation [31-109473]; Novartis Foundation; Ernest Boninchi Foundation; Societe Academique de Geneve; Ernst and Lucie Schmidheiny Foundation	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis Foundation(Novartis); Ernest Boninchi Foundation; Societe Academique de Geneve; Ernst and Lucie Schmidheiny Foundation	This work was supported by Swiss National Foundation Grant 31-109473 and by grants from the Novartis Foundation ( to E. F.), the Ernest Boninchi Foundation, the Societe Academique de Geneve, and the Ernst and Lucie Schmidheiny Foundation ( to S.d.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Bhalla V, 2006, AM J PHYSIOL-RENAL, V291, pF714, DOI 10.1152/ajprenal.00061.2006; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Carranza ML, 1996, AM J PHYSIOL-CELL PH, V271, pC136, DOI 10.1152/ajpcell.1996.271.1.C136; Chen SC, 2004, HYPERTENSION, V43, P866, DOI 10.1161/01.HYP.0000121883.55722.45; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gonzalez-Rodriguez E, 2007, KIDNEY INT, V71, P116, DOI 10.1038/sj.ki.5002018; GROSS JB, 1975, J CLIN INVEST, V55, P1284, DOI 10.1172/JCI108048; Henke G, 2002, KIDNEY BLOOD PRESS R, V25, P370, DOI 10.1159/000068699; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Kostadinova RM, 2005, FASEB J, V19, P650, DOI 10.1096/fj.04-2820fje; Lebowitz J, 2004, J BIOL CHEM, V279, P41985, DOI 10.1074/jbc.M403923200; Li CL, 2007, AM J PHYSIOL-RENAL, V293, pF333, DOI 10.1152/ajprenal.00372.2006; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; May A, 1997, J AM SOC NEPHROL, V8, P1813; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; REIF MC, 1986, J CLIN INVEST, V77, P1291, DOI 10.1172/JCI112433; Ryser S, 2007, J BIOL CHEM, V282, P5075, DOI 10.1074/jbc.M607847200; Schmidt C, 2007, J AM SOC NEPHROL, V18, P1072, DOI 10.1681/ASN.2006050454; Setiawan I, 2002, PFLUG ARCH EUR J PHY, V444, P426, DOI 10.1007/s00424-002-0823-z; Shi XZ, 2005, GASTROENTEROLOGY, V129, P1518, DOI 10.1053/j.gastro.2005.07.058; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Summa V, 2001, J BIOL CHEM, V276, P47087, DOI 10.1074/jbc.M107165200; Takase O, 2003, KIDNEY INT, V63, P501, DOI 10.1046/j.1523-1755.2003.00781.x; TOMITA K, 1985, J CLIN INVEST, V76, P132, DOI 10.1172/JCI111935; VERREY F, 1987, J CELL BIOL, V104, P1231, DOI 10.1083/jcb.104.5.1231; Vinciguerra M, 2005, J AM SOC NEPHROL, V16, P2576, DOI 10.1681/ASN.2005040448; WELLING PA, 1993, J BIOL CHEM, V268, P23469; Zecevic M, 2004, PFLUG ARCH EUR J PHY, V448, P29, DOI 10.1007/s00424-003-1222-9; Zhang LP, 2005, CANCER RES, V65, P457; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850	43	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25671	25681		10.1074/jbc.M803812200	http://dx.doi.org/10.1074/jbc.M803812200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18586672	hybrid			2022-12-25	WOS:000259012700062
J	An, NF; Blumer, JB; Bernard, ML; Lanier, SM				An, Ningfei; Blumer, Joe B.; Bernard, Michael L.; Lanier, Stephen M.			The PDZ and Band 4.1 Containing Protein Frmpd1 Regulates the Subcellular Location of Activator of G-protein Signaling 3 and Its Interaction with G-proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; ASYMMETRIC CELL-DIVISION; RECEPTOR-INDEPENDENT ACTIVATORS; HEROIN-SEEKING BEHAVIOR; SPINDLE ORIENTATION; DROSOPHILA NEUROBLASTS; CYCLE PROGRESSION; GOLGI MEMBRANES; MAMMALIAN PINS; ALPHA-SUBUNITS	Activator of G-protein signaling 3 (AGS3) is one of nine mammalian proteins containing one or more G-protein regulatory (GPR) motifs that stabilize the GDP-bound conformation of G alpha(i). Such proteins have revealed unexpected functional diversity for the "G-switch" in the control of events within the cell independent of the role of heterotrimeric G-proteins as transducers for G-protein-coupled receptors at the cell surface. A key question regarding this class of proteins is what controls their subcellular positioning and interaction with G-proteins. We conducted a series of yeast two-hybrid screens to identify proteins interacting with the tetratricopeptide repeat (TPR) of AGS3, which plays an important role in subcellular positioning of the protein. We report the identification of Frmpd1 (FERM and PDZ domain containing 1) as a regulatory binding partner of AGS3. Frmpd1 binds to the TPR domain of AGS3 and coimmunoprecipitates with AGS3 from cell lysates. Cell fractionation indicated that Frmpd1 stabilizes AGS3 in a membrane fraction. Upon cotransfection of COS7 cells with Frmpd1-GFP and AGS3-mRFP, AGS3-mRFP is observed in regions of the cell cortex and also in membrane extensions or processes where it appears to be colocalized with Frmpd1-GFP based upon the merged fluorescent signals. Frmpd1 knockdown (siRNA) in Cath.a-differentiated neuronal cells decreased the level of endogenous AGS3 in membrane fractions by similar to 50% and enhanced the alpha(2)-adrenergic receptor-mediated inhibition of forskolin-induced increases in cAMP. The coimmunoprecipitation of Frmpd1 with AGS3 is lost as the amount of G alpha(i3) in the cell is increased and AGS3 apparently switches its binding partner from Frmpd1 to G alpha(i3) indicating that the interaction of AGS3 with Frmpd1 and G alpha(i3) is mutually exclusive. Mechanistically, Frmpd1 may position AGS3 in a membrane environment where it then interacts with G alpha(i) in a regulated manner.	[An, Ningfei; Blumer, Joe B.; Bernard, Michael L.; Lanier, Stephen M.] Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29425 USA; [An, Ningfei; Blumer, Joe B.; Lanier, Stephen M.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA	Medical University of South Carolina; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Lanier, SM (corresponding author), Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29425 USA.	lanier@musc.edu	Bernard, Michael/AAW-3944-2021	Lanier, Stephen/0000-0002-2740-7607; Blumer, Joe/0000-0002-0020-3815	National Institutes of Health [MH90531, NS24821, F32MH65092]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH065092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS024821, R01NS024821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH90531 (to S. M. L.), NS24821 (to S. M. L.), and F32MH65092 (to J. B. B.).	Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Bompard G, 2003, J CELL SCI, V116, P2519, DOI 10.1242/jcs.00448; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cismowski MJ, 2005, REV PHYSIOL BIOCH P, V155, P57, DOI 10.1007/s10254-005-0042-z; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Diakowski W, 2006, FOLIA HISTOCHEM CYTO, V44, P231; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Petiot A, 1999, BIOCHEM J, V337, P289, DOI 10.1042/0264-6021:3370289; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; RAYMOND JR, 1993, BIOCHEMISTRY-US, V32, P11064, DOI 10.1021/bi00092a016; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Yao LN, 2006, P NATL ACAD SCI USA, V103, P7877, DOI 10.1073/pnas.0602661103; Yasumi M, 2005, J BIOL CHEM, V280, P6761, DOI 10.1074/jbc.C400440200; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	56	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24718	24728		10.1074/jbc.M803497200	http://dx.doi.org/10.1074/jbc.M803497200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18566450	hybrid, Green Published			2022-12-25	WOS:000271617300004
J	Frank, H; Groger, N; Diener, M; Becker, C; Braun, T; Boettger, T				Frank, Henning; Groeger, Nicole; Diener, Martin; Becker, Christoph; Braun, Thomas; Boettger, Thomas			Lactaturia and loss of sodium-dependent lactate uptake in the colon of SLC5A8-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; SUPPRESSOR GENE SLC5A8; APICAL IODIDE EFFLUX; TUMOR-SUPPRESSOR; C/EBP-DELTA; FUNCTIONAL-CHARACTERIZATION; BICARBONATE SECRETION; NONIONIC DIFFUSION; PENDRED-SYNDROME; RAT COLON	SLC5A8 is a member of the sodium/glucose cotransporter family. It has been proposed that SLC5A8 might act as an apical iodide transporter in the thyroid follicular cells or as a transporter of short chain monocarboxylates. We have directly addressed the functional role of SLC5A8 in vivo by generation of SLC5A8 mutant mice. We found that SLC5A8 is responsible for the re-absorption of lactate at the apical membrane of the kidney proximal tubules and of serous salivary gland ducts. In addition, SLC5A8 mediated the uptake of lactate into colonocytes under physiological conditions. We did not find any evidence of SLC5A8 being essential for the apical iodide transport in the thyroid gland, even if the ion-cotransporter SLC26A4, causing the human Pendred syndrome, is missing. Because SLC5A8 is transcriptionally silenced in many tumors, it has been proposed that SLC5A8-mediated transport of butyrate suppresses tumor formation. Treatment of Slc5a8(-/-) mice with carcinogens and breeding to the Apc(min) mouse line did not reveal a higher incidence of tumor formation. We conclude that SLC5A8 is instrumental in preventing lactaturia and loss of sodium dependent uptake of lactate in the colon but does not have any apparent role in the prevention of tumor formation and growth.	[Frank, Henning; Groeger, Nicole; Braun, Thomas; Boettger, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, D-61231 Bad Nauheim, Germany; [Diener, Martin] Univ Giessen, Inst Vet Physiol, D-35392 Giessen, Germany; [Becker, Christoph] Johannes Gutenberg Univ Mainz, Immunol Lab, I Med Clin, D-55131 Mainz, Germany	Max Planck Society; Justus Liebig University Giessen; Johannes Gutenberg University of Mainz	Boettger, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Pk Str 1, D-61231 Bad Nauheim, Germany.	thomas.boettger@mpi-bn.mpg.de	Boettger, Thomas/E-3406-2012; Becker, Christoph/A-6694-2008; Becker, Christoph/L-2996-2016; Braun, Thomas/B-2310-2008	Boettger, Thomas/0000-0003-4280-8449; Becker, Christoph/0000-0002-1388-1041; Braun, Thomas/0000-0002-6165-4804	Deutsche Forschungsgemeinschaft; Max-Planck Society; Excellence Cluster Cardiopulmonary System	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Society(Max Planck Society); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG))	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (to T. B.), by the Max-Planck Society, and by the Excellence Cluster Cardiopulmonary System. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARACNIETO M, 1980, AM J PHYSIOL, V239, pF496, DOI 10.1152/ajprenal.1980.239.5.F496; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder HJ, 2005, J CLIN GASTROENTEROL, V39, pS53, DOI 10.1097/01.mcg.0000155521.81382.3a; Bissahoyo A, 2005, TOXICOL SCI, V88, P340, DOI 10.1093/toxsci/kfi313; Charney AN, 1998, AM J PHYSIOL-GASTR L, V274, pG518, DOI 10.1152/ajpgi.1998.274.3.G518; Chu SY, 1996, J PHYSIOL-LONDON, V494, P783, DOI 10.1113/jphysiol.1996.sp021532; Coady MJ, 2004, J PHYSIOL-LONDON, V557, P719, DOI 10.1113/jphysiol.2004.063859; DIENER M, 1994, ACTA PHYSIOL SCAND, V151, P385, DOI 10.1111/j.1748-1716.1994.tb09758.x; DOHGEN M, 1994, JPN J PHYSIOL, V44, P519, DOI 10.2170/jjphysiol.44.519; Dong SM, 2005, MODERN PATHOL, V18, P170, DOI 10.1038/modpathol.3800261; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; FRASER GR, 1965, ANN HUM GENET, V28, P201; Ganapathy V, 2005, BIOCHEM SOC T, V33, P237, DOI 10.1042/BST0330237; Gillam MP, 2004, J BIOL CHEM, V279, P13004, DOI 10.1074/jbc.M313648200; Gopal E, 2007, BBA-BIOMEMBRANES, V1768, P2690, DOI 10.1016/j.bbamem.2007.06.031; Gopal E, 2004, J BIOL CHEM, V279, P44522, DOI 10.1074/jbc.M405365200; HARMATZ PR, 1987, J IMMUNOL METHODS, V102, P213, DOI 10.1016/0022-1759(87)90079-2; Hong CB, 2005, CANCER RES, V65, P3617, DOI 10.1158/0008-5472.CAN-05-0048; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Maritzen T, 2006, THYROID, V16, P725, DOI 10.1089/thy.2006.16.725; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; Nambiar PR, 2003, INT J ONCOL, V22, P145; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Paroder V, 2006, P NATL ACAD SCI USA, V103, P7270, DOI 10.1073/pnas.0602365103; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Porra V, 2005, J CLIN ENDOCR METAB, V90, P3028, DOI 10.1210/jc.2004-1394; Rodriguez AM, 2002, J CLIN ENDOCR METAB, V87, P3500, DOI 10.1210/jc.87.7.3500; Roy Claude C, 2006, Nutr Clin Pract, V21, P351, DOI 10.1177/0115426506021004351; Schagdarsurengin U, 2006, THYROID, V16, P633, DOI 10.1089/thy.2006.16.633; Srinivas SR, 2005, BIOCHEM J, V392, P655, DOI 10.1042/BJ20050927; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Thangaraju M, 2006, J BIOL CHEM, V281, P26769, DOI 10.1074/jbc.C600189200; Thangaraju M, 2006, CANCER RES, V66, P11560, DOI 10.1158/0008-5472.CAN-06-1950; Ueno M, 2004, TUMOR BIOL, V25, P134, DOI 10.1159/000079145; van den Hove MF, 2006, ENDOCRINOLOGY, V147, P1287, DOI 10.1210/en.2005-1149; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6	45	50	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24729	24737		10.1074/jbc.M802681200	http://dx.doi.org/10.1074/jbc.M802681200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18562324	Green Published, hybrid			2022-12-25	WOS:000258820000041
J	Sanchez-Olea, R; Ortiz, S; Barreto, O; Yang, Q; Xu, CJ; Zhu, H; Yuan, JY				Sanchez-Olea, Roberto; Ortiz, Sara; Barreto, Odmara; Yang, Qing; Xu, Chi-jie; Zhu, Hong; Yuan, Junying			Parcs is a dual regulator of cell proliferation and Apaf-1 function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; NEGATIVE REGULATION; CASPASE ACTIVATION; PROCASPASE-9; RNAI; REQUIREMENT; APOPTOSOME; DAMAGE; DATP	Here we identify a novel protein, named Parcs for pro-apoptotic protein required for cell survival, that is involved in both cell cycle progression and apoptosis. Parcs interacted with Apaf-1 by binding to the oligomerization domain of Apaf-1. Apaf-1-mediated activation of caspase-9 and caspase-3 was markedly decreased in a cytosolic fraction isolated from HeLa cells with reduced parcs expression. Interestingly, parcs deficiency blocked cell proliferation in non-tumorigenic cells but not in multiple tumor cell lines. In MCF-10A cells, parcs deficiency led to early G(1) arrest. Conditional inactivation of parcs in genetically modified primary mouse embryonic fibroblasts using the Cre-LoxP system also resulted in the inhibition of cell proliferation. We conclude that Parcs may define a molecular checkpoint in the control of cell proliferation for normal cells that is lost in tumor cells.	[Sanchez-Olea, Roberto; Ortiz, Sara; Barreto, Odmara; Yang, Qing; Xu, Chi-jie; Zhu, Hong; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	junying_yuan@hms.harvard.edu		Barreto Chang, Odmara/0000-0002-4781-404X; Zhu, Hong/0000-0002-2575-4031; Sanchez-Olea, Roberto/0000-0002-6523-7821	National Institutes of Health [R37-AG012859]; Department of Defense Breast Cancer Research Program [DAMD1702-1-0403]; NATIONAL INSTITUTE ON AGING [R37AG012859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R37-AG012859 from NIA (to J.Y.). This work was also supported by Department of Defense Breast Cancer Research Program Grant DAMD1702-1-0403 (to J.Y.).	Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Chau BN, 2000, MOL CELL, V6, P31, DOI 10.1016/S1097-2765(00)00005-8; Cho DH, 2004, J BIOL CHEM, V279, P39942, DOI 10.1074/jbc.M405747200; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Heidebrecht HJ, 2001, LAB INVEST, V81, P1163, DOI 10.1038/labinvest.3780328; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mouhamad S, 2007, CELL CYCLE, V6, P3103, DOI 10.4161/cc.6.24.5046; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	20	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24400	24405		10.1074/jbc.M804664200	http://dx.doi.org/10.1074/jbc.M804664200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18562310	Green Published, hybrid			2022-12-25	WOS:000258820000014
J	Caroline, G; Eric, F; Bohn, YST; Sylvie, E; Attree, I				Caroline, Gebus; Eric, Faudry; Bohn, Yu-Sing Tammy; Sylvie, Elsen; Attree, Ina			Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION SYSTEM; YOP TRANSLOCATION PORE; RECOMBINANT V-ANTIGEN; SHIGELLA-FLEXNERI; POLYMORPHONUCLEAR NEUTROPHILS; ACTIVE IMMUNIZATION; EUKARYOTIC CELLS; GENETIC-ANALYSIS; HOST MEMBRANES; TIP COMPLEX	Protective antigens of Pseudomonas aeruginosa (PcrV) and Yersinia pestis (LcrV) are key elements of specialized machinery, the type III secretion system ( T3SS), which enables the injection of effector molecules into eukaryotic cells. Being positioned at the injectisome extremity, V proteins participate in the translocation process across the host cell plasma membrane. In this study, we demonstrate the assembly of V proteins into oligomeric doughnut-like complexes upon controlled refolding of the proteins in vitro. The oligomeric nature of refolded PcrV was revealed by size exclusion chromatography, native gel electrophoresis, and native mass spectrometry, which ascertain the capacity of the protein to multimerize into higher-order species. Furthermore, transmission electron microscopy performed on oligomers of both PcrV and LcrV revealed the presence of distinct structures with approximate internal and external diameters of 3-4 and 8-10 nm, respectively. The C-terminal helix, alpha 12, of PcrV and notably the hydrophobic residues Val(255), Leu(262), and Leu(276) located within this helix, were shown to be crucial for oligomerization. Moreover, the corresponding mutant proteins produced in P. aeruginosa were found to be non-functional in in vivo type III-dependent cytotoxicity assays by directly affecting the correct assembly of PopB/D translocon within the host cell membranes. The detailed understanding of structure-function relationships of T3SS needle tip proteins will be of value in further developments of new vaccines and antimicrobials.	[Caroline, Gebus; Eric, Faudry; Bohn, Yu-Sing Tammy; Sylvie, Elsen; Attree, Ina] Univ Grenoble 1, Lab Biochim & Biophys Syst Integres, UMR 5092, CNRS,CEA,DSV,iRTSV, F-38054 Grenoble 09, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Attree, I (corresponding author), Commissariat Energie Atom Grenoble, iRTSV BBSI, 17 Rue Martyrs, F-38054 Grenoble 09, France.	iattreedelic@cea.fr	Faudry, Eric/I-9154-2014	Faudry, Eric/0000-0001-9958-6029; Attree, Ina/0000-0002-2580-764X	Delegation Generale pour l'Armement (DGA) [06.70.151.00.470.75.96]; French Cystic Fibrosis Association Vaincre la Mucoviscidose	Delegation Generale pour l'Armement (DGA); French Cystic Fibrosis Association Vaincre la Mucoviscidose	This work was supported in part by Research Contract 06.70.151.00.470.75.96 from Delegation Generale pour l'Armement (DGA) and the French Cystic Fibrosis Association Vaincre la Mucoviscidose. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Broms JE, 2003, J INFECT DIS, V188, P239, DOI 10.1086/376452; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; BURROWS TW, 1956, BRIT J EXP PATHOL, V37, P481; Chuanchuen R, 2002, BIOTECHNIQUES, V33, P760, DOI 10.2144/02334bm08; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dacheux D, 1999, INFECT IMMUN, V67, P6164, DOI 10.1128/IAI.67.11.6164-6167.1999; Dacheux D, 2000, INFECT IMMUN, V68, P2916, DOI 10.1128/IAI.68.5.2916-2924.2000; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; DeLano W, 2002, PYMOL 0 99; Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010; Espina M, 2007, PROTEIN SCI, V16, P704, DOI 10.1110/ps.062645007; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Frank DW, 2002, J INFECT DIS, V186, P64, DOI 10.1086/341069; Frithz-Lindsten E, 1998, MOL MICROBIOL, V29, P1155, DOI 10.1046/j.1365-2958.1998.00994.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; Hamad MA, 2007, J BACTERIOL, V189, P6734, DOI 10.1128/JB.00539-07; Hill J, 1997, INFECT IMMUN, V65, P4476, DOI 10.1128/IAI.65.11.4476-4482.1997; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; Holder IA, 2001, INFECT IMMUN, V69, P5908, DOI 10.1128/IAI.69.9.5908-5910.2001; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Lawton DG, 2002, J BIOL CHEM, V277, P38714, DOI 10.1074/jbc.M203632200; LEARY SEC, 1995, INFECT IMMUN, V63, P2854, DOI 10.1128/IAI.63.8.2854-2858.1995; Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200; Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Nanao M, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-21; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Nilles ML, 2004, STRUCTURE, V12, P357, DOI 10.1016/j.str.2004.02.026; Nilles ML, 1997, J BACTERIOL, V179, P1307, DOI 10.1128/jb.179.4.1307-1316.1997; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Sani M, 2007, BBA-GEN SUBJECTS, V1770, P307, DOI 10.1016/j.bbagen.2006.10.007; Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Stebbins CE, 2003, NAT REV MOL CELL BIO, V4, P738, DOI 10.1038/nrm1201; TOUSSAINT B, 1993, BIOCHEM BIOPH RES CO, V196, P416, DOI 10.1006/bbrc.1993.2265; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x; Weeks S, 2002, MICROB PATHOGENESIS, V32, P227, DOI 10.1006/mpat.2002.0498	53	34	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23940	23949		10.1074/jbc.M803146200	http://dx.doi.org/10.1074/jbc.M803146200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18583342	Green Published, hybrid			2022-12-25	WOS:000258638900049
J	Haugaard-Jonsson, LM; Hossain, MA; Daly, NL; Bathgate, RAD; Wade, JD; Craik, DJ; Rosengren, KJ				Haugaard-Jonsson, Linda M.; Hossain, Mohammed Akhter; Daly, Norelle L.; Bathgate, Ross A. D.; Wade, John D.; Craik, David J.; Rosengren, K. Johan			Structure of the R3/I5 chimeric relaxin peptide, a selective GPCR135 and GPCR142 agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING; IN-VITRO; INSULIN; IDENTIFICATION; FAMILY; LIGAND; RAT; SUGGESTS; MEMBER; GENE	The human relaxin family comprises seven peptide hormones with various biological functions mediated through interactions with G-protein-coupled receptors. Interestingly, among the hitherto characterized receptors there is no absolute selectivity toward their primary ligand. The most striking example of this is the relaxin family ancestor, relaxin-3, which is an agonist for three of the four currently known relaxin receptors: GPCR135, GPCR142, and LGR7. Relaxin-3 and its endogenous receptor GPCR135 are both expressed predominantly in the brain and have been linked to regulation of stress and feeding. However, to fully understand the role of relaxin-3 in neurological signaling, the development of selective GPCR135 agonists and antagonists for in vivo studies is crucial. Recent reports have demonstrated that such selective ligands can be achieved by making chimeric peptides comprising the relaxin-3 B-chain combined with the INSL5 A-chain. To obtain structural insights into the consequences of combining A-and B-chains from different relaxins we have determined the NMR solution structure of a human relaxin-3/INSL5 chimeric peptide. The structure reveals that the INSL5 A-chain adopts a conformation similar to the relaxin-3 A-chain, and thus has the ability to structurally support a native-like conformation of the relaxin-3 B-chain. These findings suggest that the decrease in activity at the LGR7 receptor seen for this peptide is a result of the removal of a secondary LGR7 binding site present in the relaxin-3 A-chain, rather than conformational changes in the primary B-chain receptor binding site.	[Haugaard-Jonsson, Linda M.; Rosengren, K. Johan] Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden; [Hossain, Mohammed Akhter; Bathgate, Ross A. D.; Wade, John D.] Univ Melbourne, Howard Florey Inst, Melbourne, Vic 3010, Australia; [Daly, Norelle L.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Linnaeus University; University of Kalmar; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Queensland	Rosengren, KJ (corresponding author), Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden.	johan.rosengren@hik.se	Haugaard-Kedstrom, Linda/O-7121-2014; Rosengren, K. Johan/P-4450-2016; Daly, Norelle L/D-4302-2013; Haugaard-Kedstrom, Linda/F-3705-2011; Bathgate, Ross/ABE-6471-2020; Craik, David/B-1695-2010	Haugaard-Kedstrom, Linda/0000-0003-0113-6535; Rosengren, K. Johan/0000-0002-5007-8434; Daly, Norelle L/0000-0002-4697-6602; Haugaard-Kedstrom, Linda/0000-0003-0113-6535; Bathgate, Ross/0000-0001-6301-861X; Craik, David/0000-0003-0007-6796; Wade, John/0000-0002-1352-6568; Hossain, Mohammed/0000-0002-9961-0006	NHMRC Project [350284]	NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by NHMRC Project Grant 350284 ( to J.D.W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate RAD, 2006, BIOCHEMISTRY-US, V45, P1043, DOI 10.1021/bi052233e; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bullesbach EE, 2000, J BIOL CHEM, V275, P35276, DOI 10.1074/jbc.M005728200; Bullesbach EE, 1999, BIOCHEMISTRY-US, V38, P3073, DOI 10.1021/bi982687u; Burazin TCD, 2002, J NEUROCHEM, V82, P1553, DOI 10.1046/j.1471-4159.2002.01114.x; BURKHARDT E, 1994, HUM GENET, V94, P91, DOI 10.1007/BF02272850; CHASSIN D, 1995, GENOMICS, V29, P465, DOI 10.1006/geno.1995.9980; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Conklin D, 1999, GENOMICS, V60, P50, DOI 10.1006/geno.1999.5899; EIGENBROT C, 1991, J MOL BIOL, V221, P15, DOI 10.1016/0022-2836(91)90796-9; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hossain MA, 2008, J BIOL CHEM, V283, P17287, DOI 10.1074/jbc.M801911200; Hossain MA, 2006, INT J PEPT RES THER, V12, P211, DOI 10.1007/s10989-006-9020-9; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; HUDSON P, 1984, EMBO J, V3, P2333, DOI 10.1002/j.1460-2075.1984.tb02135.x; HUDSON P, 1983, NATURE, V301, P628, DOI 10.1038/301628a0; Keller R., 2004, COMPUTER AIDED RESON, V1; Kuei C, 2007, J BIOL CHEM, V282, P25425, DOI 10.1074/jbc.M701416200; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Liu CL, 2005, J BIOL CHEM, V280, P292, DOI 10.1074/jbc.M409916200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Liu CL, 2003, J BIOL CHEM, V278, P50765, DOI 10.1074/jbc.M308996200; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Lok S, 2000, BIOL REPROD, V62, P1593, DOI 10.1095/biolreprod62.6.1593; Ma S, 2007, NEUROSCIENCE, V144, P165, DOI 10.1016/j.neuroscience.2006.08.072; McGowan BMC, 2005, ENDOCRINOLOGY, V146, P3295, DOI 10.1210/en.2004-1532; Rosengren KJ, 2006, J BIOL CHEM, V281, P28287, DOI 10.1074/jbc.M603829200; Rosengren KJ, 2006, J BIOL CHEM, V281, P5845, DOI 10.1074/jbc.M511210200; SCHWABE C, 1977, SCIENCE, V197, P914, DOI 10.1126/science.887933; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Sutton SW, 2004, NEUROENDOCRINOLOGY, V80, P298, DOI 10.1159/000083656; Tanaka M, 2005, EUR J NEUROSCI, V21, P1659, DOI 10.1111/j.1460-9568.2005.03980.x; WAGNER G, 1990, PROG NUCL MAG RES SP, V22, P101, DOI 10.1016/0079-6565(90)80003-Z; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	36	37	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23811	23818		10.1074/jbc.M800489200	http://dx.doi.org/10.1074/jbc.M800489200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577524	hybrid, Green Published			2022-12-25	WOS:000258638900035
J	Nesmelova, IV; Sham, Y; Gao, JL; Mayo, KH				Nesmelova, Irina V.; Sham, Yuk; Gao, Jiali; Mayo, Kevin H.			CXC and CC chemokines form mixed heterodimers - Association free energies from molecular dynamics simulations and experimental correlations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NMR SOLUTION STRUCTURE; SUBUNIT ASSOCIATION; BACKBONE DYNAMICS; CONTINUUM SOLVENT; 3-DIMENSIONAL STRUCTURE; BINDING AFFINITIES; PROGENITOR CELLS; PLATELET-FACTOR-4; INTERLEUKIN-8	CXC and CC chemokines are involved in numerous biological processes, and their function in situ may be significantly influenced by heterodimer formation, as was recently reported, for example, for CXC chemokines CXCL4/PF4 and CXCL8/IL8 that interact to form heterodimers that modulate chemotactic and cell proliferation activities. Here we used molecular dynamics simulations to determine relative association free energies (overall average and per residue) for homo- and heterodimer pairs of CXC (CXCL4/PF4, CXCL8/IL8, CXCL1/Gro-alpha, and CXCL7/NAP-2) and CC (CCL5/RANTES, CCL2/MCP-1, and CCL8/MCP-2) chemokines. Even though structural homology among monomer folds of all CXC and CC chemokines permits heterodimer assembly, our calculated association free energies depend upon the particular pair of chemokines in terms of the net electrostatic and nonelectrostatic forces involved, as well as (for CC/CXC mixed chemokines) the selection of dimer type (CC or CXC). These relative free energies indicate that association of some pairs of chemokines is more favorable than others. Our approach is validated by correlation of calculated and experimentally determined free energies. Results are discussed in terms of CXC and CC chemokine function and have significant biological implications.	[Nesmelova, Irina V.; Mayo, Kevin H.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Sham, Yuk] Univ Minnesota, Ctr Drug Design, Minneapolis, MN 55455 USA; [Gao, Jiali; Mayo, Kevin H.] Univ Minnesota, Inst Supercomp, Minneapolis, MN 55455 USA; [Gao, Jiali] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mayo, KH (corresponding author), 6-155 Jackson Hall,321 Church St, Minneapolis, MN 55455 USA.	mayox001@umn.edu	Nesmelova, Irina/D-6033-2015; Sham, Yuk Y/A-6472-2011	Nesmelova, Irina/0000-0002-1835-1533; Sham, Yuk Y/0000-0003-2601-8930	National Institutes of Health NRSA [HL 07062]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007062] Funding Source: NIH RePORTER	National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health NRSA training Grant HL 07062 ( to I.V.N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROXMEYER HE, 1993, J IMMUNOL, V150, P3448; BURROWS SD, 1994, BIOCHEMISTRY-US, V33, P12741, DOI 10.1021/bi00209a002; CASE DA, 1994, CURR OPIN STRUC BIOL, V4, P285, DOI 10.1016/S0959-440X(94)90321-2; CHEN MJ, 1991, BIOCHEMISTRY-US, V30, P6402, DOI 10.1021/bi00240a009; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; CLORE GM, 1995, FASEB J, V9, P57, DOI 10.1096/fasebj.9.1.7821760; Cornell W, 2001, J MOL GRAPH MODEL, V19, P136, DOI 10.1016/S1093-3263(00)00124-8; Crown SE, 2006, J BIOL CHEM, V281, P25438, DOI 10.1074/jbc.M601518200; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dudek AZ, 2003, BLOOD, V101, P4687, DOI 10.1182/blood-2002-08-2363; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gouwy M, 2004, J LEUKOCYTE BIOL, V76, P185, DOI 10.1189/jlb.1003479; Gouwy M, 2002, MOL PHARMACOL, V62, P173, DOI 10.1124/mol.62.1.173; GRASBERGER BL, 1993, J MOL BIOL, V230, P364, DOI 10.1006/jmbi.1993.1152; Guan E, 2001, J BIOL CHEM, V276, P12404, DOI 10.1074/jbc.M006327200; Handel TM, 1996, BIOCHEMISTRY-US, V35, P6569, DOI 10.1021/bi9602270; Hanzawa H, 1997, J BIOCHEM-TOKYO, V121, P835; Karlsson M, 2005, BIOCHEMISTRY-US, V44, P3487, DOI 10.1021/bi048610p; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lazaridis T, 2003, BIOPHYS CHEM, V100, P367, DOI 10.1016/S0301-4622(02)00293-4; LiWang AC, 1999, BIOCHEMISTRY-US, V38, P442, DOI 10.1021/bi9812726; Lowman HB, 1997, PROTEIN SCI, V6, P598; Luo HB, 2002, P NATL ACAD SCI USA, V99, P10399, DOI 10.1073/pnas.162365999; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAYO KH, 1991, BIOCHEMISTRY-US, V30, P925, DOI 10.1021/bi00218a007; MAYO KH, 1995, BIOCHEMISTRY-US, V34, P11399, DOI 10.1021/bi00036a012; MAYO KH, 1989, BIOCHEMISTRY-US, V28, P9469, DOI 10.1021/bi00450a034; Nesmelova IV, 2005, J BIOL CHEM, V280, P4948, DOI 10.1074/jbc.M405364200; Paoletti S, 2005, BLOOD, V105, P3405, DOI 10.1182/blood-2004-04-1648; PAOLINI JF, 1994, J IMMUNOL, V153, P2704; Rajarathnam K, 1997, J BIOL CHEM, V272, P1725, DOI 10.1074/jbc.272.3.1725; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHNITZEL W, 1994, J LEUKOCYTE BIOL, V55, P763, DOI 10.1002/jlb.55.6.763; Sham YY, 2000, PROTEINS, V39, P393, DOI 10.1002/(SICI)1097-0134(20000601)39:4<393::AID-PROT120>3.3.CO;2-8; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; SKELTON NJ, 1995, BIOCHEMISTRY-US, V34, P5329, DOI 10.1021/bi00016a004; Srinivasan J, 1998, J BIOMOL STRUCT DYN, V16, P671, DOI 10.1080/07391102.1998.10508279; STCHARLES R, 1989, J BIOL CHEM, V264, P2092; STRAATSMA TP, 1992, ANNU REV PHYS CHEM, V43, P407; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; Villa J, 2000, P NATL ACAD SCI USA, V97, P11899, DOI 10.1073/pnas.97.22.11899; von Hundelshausen P, 2005, BLOOD, V105, P924, DOI 10.1182/blood-2004-06-2475; Wang W, 2000, J MOL BIOL, V303, P567, DOI 10.1006/jmbi.2000.4057; Warshel A, 2003, ANNU REV BIOPH BIOM, V32, P425, DOI 10.1146/annurev.biophys.32.110601.141807; Warshel A, 2002, ACCOUNTS CHEM RES, V35, P385, DOI 10.1021/ar010033z; Weber C, 2006, TRENDS IMMUNOL, V27, P268, DOI 10.1016/j.it.2006.04.002; Xu Y, 2006, PROTEINS, V64, P1058, DOI 10.1002/prot.21044; YANG YQ, 1994, J BIOL CHEM, V269, P20110; Ye JQ, 1999, J BIOMOL NMR, V15, P115, DOI 10.1023/A:1008376728947; Ye JQ, 2001, BIOCHEMISTRY-US, V40, P7820, DOI 10.1021/bi010252s; Youn BS, 2000, IMMUNOL REV, V177, P150, DOI 10.1034/j.1600-065X.2000.17701.x; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	64	55	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24155	24166		10.1074/jbc.M803308200	http://dx.doi.org/10.1074/jbc.M803308200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18550532	Green Published, hybrid			2022-12-25	WOS:000258638900069
J	Solis, AS; Peng, R; Crawford, JB; Phillips, JA; Patton, JG				Solis, Amanda S.; Peng, Rui; Crawford, J. Barrett; Phillips, John A., III; Patton, James G.			Growth hormone deficiency and splicing fidelity - Two serine/arginine-rich proteins, ASF/SF2 and SC35, act antagonistically	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; SR PROTEINS; 5-SPLICE-SITE RECOGNITION; ENHANCER; INHIBITION; MUTATIONS; MECHANISM; SELECTION; SEQUENCE; ISOFORM	The majority of mutations that cause isolated growth hormone deficiency type II are the result of aberrant splicing of transcripts encoding human growth hormone. Such mutations increase skipping of exon 3 and encode a 17.5- kDa protein that acts as a dominant negative to block secretion of full- length protein produced from unaffected alleles. Previously, we identified a splicing regulatory element in exon 3 ( exonic splicing enhancer 2 ( ESE2)), but we had not determined the molecular mechanism by which this element prevents exon skipping. Here, we show that two members of the serine/ arginine- rich (SR) protein superfamily (ASF/ SF2 and SC35) act antagonistically to regulate exon 3 splicing. ASF/ SF2 activates exon 3 inclusion, but SC35, acting through a region just downstream of ESE2, can block such activation. These findings explain the disease- causing mechanism of a patient mutation in ESE2 that creates a functional SC35- binding site that then acts synergistically with the downstream SC35 site to produce pathological levels of exon 3 skipping. Although the precedent for SR proteins acting as repressors is established, this is the first example of a patient mutation that creates a site through which an SR protein represses splicing.	[Solis, Amanda S.; Peng, Rui; Crawford, J. Barrett; Patton, James G.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Phillips, John A., III] Vanderbilt Univ, Dept Pediat, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	Patton, JG (corresponding author), Vanderbilt Univ, Dept Biol Sci, 2301 Vanderbilt Pl,Stn B,Box 1820, Nashville, TN 37235 USA.	james.g.patton@vanderbilt.edu			NIDDK NIH HHS [DK 35592] Funding Source: Medline; NIGMS NIH HHS [GM 62487 M] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062487] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asada N, 2000, MOL CELL ENDOCRINOL, V162, P121, DOI 10.1016/S0303-7207(00)00202-1; Barnard DC, 2000, MOL CELL BIOL, V20, P3049, DOI 10.1128/MCB.20.9.3049-3057.2000; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4359, DOI 10.1093/nar/gkm444; Burge CB, 1999, RNA WORLD, P525; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cogan JD, 1997, HUM MOL GENET, V6, P909, DOI 10.1093/hmg/6.6.909; COGAN JD, 1995, J CLIN ENDOCR METAB, V80, P3591, DOI 10.1210/jc.80.12.3591; Crawford JB, 2006, MOL CELL BIOL, V26, P8791, DOI 10.1128/MCB.01677-06; DENOTO FM, 1981, NUCLEIC ACIDS RES, V9, P3719, DOI 10.1093/nar/9.15.3719; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; FU XD, 1995, RNA, V1, P663; Gallego ME, 1997, EMBO J, V16, P1772, DOI 10.1093/emboj/16.7.1772; JAMISON SF, 1995, NUCLEIC ACIDS RES, V23, P3260, DOI 10.1093/nar/23.16.3260; Jiang ZH, 1998, P NATL ACAD SCI USA, V95, P9155, DOI 10.1073/pnas.95.16.9155; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Kanopka A, 1996, NATURE, V381, P535, DOI 10.1038/381535a0; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; LECOMTE CM, 1987, NUCLEIC ACIDS RES, V15, P6331, DOI 10.1093/nar/15.16.6331; MASUDA N, 1988, BIOCHIM BIOPHYS ACTA, V949, P125, DOI 10.1016/0167-4781(88)90062-0; McCarthy EMS, 1998, HUM MOL GENET, V7, P1491, DOI 10.1093/hmg/7.9.1491; Millar DS, 2003, HUM MUTAT, V21, P424, DOI 10.1002/humu.10168; Moseley CT, 2002, J CLIN ENDOCR METAB, V87, P847, DOI 10.1210/jc.87.2.847; PALMETSHOFER A, 1995, MOL CELL ENDOCRINOL, V113, P225, DOI 10.1016/0303-7207(95)03633-I; Procter AM, 1998, HUM GENET, V103, P255, DOI 10.1007/s004390050815; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Ryther RCC, 2003, HUM GENET, V113, P140, DOI 10.1007/s00439-003-0949-x; Ryther RCC, 2004, ENDOCRINOLOGY, V145, P2988, DOI 10.1210/en.2003-1724; TIAN M, 1994, GENE DEV, V8, P1703, DOI 10.1101/gad.8.14.1703; WANG Z, 1995, RNA, V1, P21; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhu J, 2000, GENE DEV, V14, P3166, DOI 10.1101/gad.189500	34	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23619	23626		10.1074/jbc.M710175200	http://dx.doi.org/10.1074/jbc.M710175200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586677	Green Published, hybrid			2022-12-25	WOS:000258638900014
J	Hartleben, B; Schweizer, H; Lubben, P; Bartram, MP; Moller, CC; Herr, R; Wei, CL; Neumann-Haefelin, E; Schermer, B; Zentgraf, H; Kerjaschki, D; Reiser, J; Walz, G; Benzing, T; Huber, TB				Hartleben, Bjoern; Schweizer, Heiko; Luebben, Pauline; Bartram, Malte P.; Moeller, Clemens C.; Herr, Ronja; Wei, Changli; Neumann-Haefelin, Elke; Schermer, Bernhard; Zentgraf, Hanswalter; Kerjaschki, Dontscho; Reiser, Jochen; Walz, Gerd; Benzing, Thomas; Huber, Tobias B.			Neph-nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR SLIT DIAPHRAGM; ADHESION MOLECULE JAM; NEURONAL POLARITY; KIDNEY; GENE; MECHANISM; PAR-3; MICE	The kidney filter represents a unique assembly of podocyte epithelial cells that tightly enwrap the glomerular capillaries with their foot processes and the interposed slit diaphragm. So far, very little is known about the guidance cues and polarity signals required to regulate proper development and maintenance of the glomerular filtration barrier. We now identify Par3, Par6, and atypical protein kinase C( aPKC) polarity proteins as novel Neph1-Nephrin-associated proteins. The interaction was mediated through the PDZ domain of Par3 and conserved carboxyl terminal residues in Neph1 and Nephrin. Par3, Par6, and aPKC localized to the slit diaphragm as shown in immunofluorescence and immunoelectron microscopy. Consistent with a critical role for aPKC activity in podocytes, inhibition of glomerular aPKC activity with a pseudosubstrate inhibitor resulted in a loss of regular podocyte foot process architecture. These data provide an important link between cell recognition mediated through the Neph1-Nephrin complex and Par-dependent polarity signaling and suggest that this molecular interaction is essential for establishing the three-dimensional architecture of podocytes at the kidney filtration barrier.	[Bartram, Malte P.; Schermer, Bernhard; Benzing, Thomas] Univ Hosp Cologne, Div Renal, D-50937 Cologne, Germany; [Hartleben, Bjoern; Schweizer, Heiko; Luebben, Pauline; Herr, Ronja; Neumann-Haefelin, Elke; Walz, Gerd; Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; [Moeller, Clemens C.; Wei, Changli; Reiser, Jochen] Massachusetts Gen Hosp East, Div Nephrol, Boston, MA 02129 USA; [Moeller, Clemens C.; Wei, Changli; Reiser, Jochen] Massachusetts Gen Hosp East, Program Glomerular Dis, Boston, MA 02129 USA; [Zentgraf, Hanswalter] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria; [Kerjaschki, Dontscho] German Canc Res Ctr, Dept Tumor Virol, D-69120 Heidelberg, Germany	University of Cologne; University of Freiburg; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Medical University of Vienna; Helmholtz Association; German Cancer Research Center (DKFZ)	Benzing, T (corresponding author), Univ Hosp Cologne, Div Renal, Kerpener Str 62, D-50937 Cologne, Germany.	thomas.benzing@uk-koeln.de; tobias.huber@uniklinik-freiburg.de	Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014; Neumann-Haefelin, Elke/ABC-3089-2021	Schermer, Bernhard/0000-0002-5194-9000; Huber, Tobias B./0000-0001-7175-5062	National Institutes of Health [DK073495]; Kristyna M. Driehaus foundation; Deutsche Forschungsgemeinschaft [BE 2212, HU 1016/2-1]; Deutsche Forschungsgemeinschaft Sonderforschungsbereich [592]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kristyna M. Driehaus foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft Sonderforschungsbereich(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK073495 (to J.R). This work was also supported by a grant from the Kristyna M. Driehaus foundation (to J.R.), by Deutsche Forschungsgemeinschaft Grants BE 2212 (to T.B.) and HU 1016/2-1) (to T.B.H.), and by Deutsche Forschungsgemeinschaft Sonderforschungsbereich 592 (to T.B.H.).	Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Gerke P, 2005, J AM SOC NEPHROL, V16, P1693, DOI 10.1681/ASN.2004060439; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Standaert ML, 1999, J BIOL CHEM, V274, P14074, DOI 10.1074/jbc.274.20.14074; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696	31	84	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23033	23038		10.1074/jbc.M803143200	http://dx.doi.org/10.1074/jbc.M803143200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562307	Green Published, hybrid			2022-12-25	WOS:000258455400016
J	Hatori, Y; Hirata, A; Toyoshima, C; Lewis, D; Pilankatta, R; Inesi, G				Hatori, Yuta; Hirata, Ayami; Toyoshima, Chikashi; Lewis, David; Pilankatta, Rajendra; Inesi, Giuseppe			Intermediate phosphorylation reactions in the mechanism of ATP utilization by the copper ATPase (CopA) of Thermotoga maritima	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE-ATPASE; WILSONS-DISEASE PROTEIN; HEAVY-METAL TRANSPORT; FULGIDUS CU+-ATPASE; ARCHAEOGLOBUS-FULGIDUS; SARCOPLASMIC-RETICULUM; ESCHERICHIA-COLI; MEMBRANE-VESICLES; PHOSPHATE ANALOG; BINDING DOMAINS	Recombinant and purified Thermotoga maritima CopA sustains ATPase velocity of 1.78-2.73 mu mol/mg/min in the presence of Cu+ (pH 6, 60 degrees C) and 0.03-0.08 mu mol/mg/min in the absence of Cu+. High levels of enzyme phosphorylation are obtained by utilization of [gamma-P-32]ATP in the absence of Cu+. This phosphoenzyme decays at a much slower rate than observed with Cu.E1 similar to P. In fact, the phosphoenzyme is reduced to much lower steady state levels upon addition of Cu+, due to rapid hydrolytic cleavage. Negligible ATPase turnover is sustained by CopA following deletion of its N-metal binding domain (Delta NMBD) or mutation of NMBD cysteines (CXXC). Nevertheless, high levels of phosphoenzyme are obtained by utilization of [gamma-P-32]ATP by the Delta NMBD and CXXC mutants, with no effect of Cu+ either on its formation or hydrolytic cleavage. Phosphoenzyme formation (E2P) can also be obtained by utilization of Pi, and this reaction is inhibited by Cu+ (E2 to E1 transition) even in the Delta NMBD mutant, evidently due to Cu+ binding at a (transport) site other than the NMBD. E2P undergoes hydrolytic cleavage faster in Delta NMBD and slower in CXXC mutant. We propose that Cu+ binding to the NMBD is required to produce an "active" conformation of CopA, whereby additional Cu+ bound to an alternate (transmembrane transport) site initiates faster cycles including formation of Cu.E1 similar to P, followed by the E1 similar to P to E2-P conformational transition and hydrolytic cleavage of phosphate. An H479Q mutation (analogous to one found in Wilson disease) renders CopA unable to utilize ATP, whereas phosphorylation by P-i is retained.	[Hatori, Yuta; Hirata, Ayami; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Lewis, David; Pilankatta, Rajendra; Inesi, Giuseppe] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA	University of Tokyo; California Pacific Medical Center; California Pacific Medical Center Research Institute	Inesi, G (corresponding author), 475 Brannan St, San Francisco, CA 94107 USA.	ginesi@cpmcri.com	Toyoshima, Chikashi/R-4153-2019; Pilankatta, Rajendra/ABC-8821-2021	Pilankatta, Rajendra/0000-0002-8587-8212; Toyoshima, Chikashi/0000-0001-9640-0778	NHLBI NIH HHS [R01 HL069830-08, R01 HL069830] Funding Source: Medline; PHS HHS [R0301-69830] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069830] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Chintalapati S, 2008, J MOL BIOL, V378, P581, DOI 10.1016/j.jmb.2008.01.094; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Cobine PA, 2002, BIOCHEMISTRY-US, V41, P5822, DOI 10.1021/bi025515c; de Meis L, 1974, Biochemistry, V13, P5032, DOI 10.1021/bi00721a026; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Hatori Y, 2007, J BIOL CHEM, V282, P25213, DOI 10.1074/jbc.M703520200; INESI G, 1967, J BIOL CHEM, V242, P4637; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lubben M, 2007, J MOL BIOL, V369, P368, DOI 10.1016/j.jmb.2007.03.029; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Multhaup G, 2001, BIOCHEM BIOPH RES CO, V288, P172, DOI 10.1006/bbrc.2001.5757; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Okkeri J, 1999, BIOCHEMISTRY-US, V38, P14109, DOI 10.1021/bi9913956; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; Rice WJ, 2006, BIOCHEM BIOPH RES CO, V348, P124, DOI 10.1016/j.bbrc.2006.07.012; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P9949, DOI 10.1021/bi0610045; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Sharma R, 2000, J BIOL CHEM, V275, P3873, DOI 10.1074/jbc.275.6.3873; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217; SOLIOZ M, 1996, J BIOL CHEM, V271, P24465; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TSAI KJ, 1992, J BACTERIOL, V174, P116, DOI 10.1128/jb.174.1.116-121.1992; Tsivkovskii R, 2003, J BIOL CHEM, V278, P13302, DOI 10.1074/jbc.M300034200; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Williams LE, 2000, BBA-BIOMEMBRANES, V1465, P104, DOI 10.1016/S0005-2736(00)00133-4	49	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22541	22549		10.1074/jbc.M802735200	http://dx.doi.org/10.1074/jbc.M802735200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18562314	Green Published, hybrid			2022-12-25	WOS:000258321000022
J	Sfondouris, J; Rajagopalan, L; Pereira, FA; Brownell, WE				Sfondouris, John; Rajagopalan, Lavanya; Pereira, Fred A.; Brownell, William E.			Membrane composition modulates prestin-associated charge movement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR CELL MOTOR; TEMPERATURE-DEPENDENCE; NONLINEAR CAPACITANCE; VOLTAGE-DEPENDENCE; FORCE GENERATION; LIPID BILAYER; OUTER; CHOLESTEROL; PROTEIN; EXPRESSION	The lateral membrane of the cochlear outer hair cell (OHC) is the site of a membrane-based motor that powers OHC electromotility, enabling amplification and fine-tuning of auditory signals. The OHC membrane protein prestin plays a central role in this process. We have previously shown that membrane cholesterol modulates the peak voltage of prestin-associated nonlinear capacitance in vivo and in vitro. The present study explores the effects of membrane cholesterol and docosahexaenoic acid content on the peak and magnitude of prestin-associated charge movement in a human embryonic kidney (HEK 293) cell model. Increasing membrane cholesterol results in a hyperpolarizing shift in the peak voltage of the nonlinear capacitance (V-pkc) and a decrease in the total charge movement. Both measures depend linearly on membrane cholesterol concentration. Incubation of cholesterol-loaded cells in cholesterol-free media partially restores the V-pkc toward normal values but does not have a compensatory effect on the total charge movement. Decreasing membrane cholesterol results in a depolarizing shift in V-pkc that is restored toward normal values upon incubation in cholesterol-free media. However, cholesterol depletion does not alter the magnitude of charge movement. In contrast, increasing membrane docosahexaenoic acid results in a hyperpolarizing shift in V-pkc that is accompanied by an increase in total charge movement. Our results quantify the relation between membrane cholesterol concentration and prestin-associated charge movement and enhance our understanding of how membrane composition modulates prestin function.	[Sfondouris, John; Rajagopalan, Lavanya; Pereira, Fred A.; Brownell, William E.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Pereira, Fred A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Pereira, Fred A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Rajagopalan, Lavanya] Baylor Coll Med, Keck Ctr Interdisciplinary Biosci Training, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Brownell, WE (corresponding author), Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, 1 Baylor Plaza, Houston, TX 77030 USA.	brownell@bcm.edu		Pereira, Fred/0000-0003-2100-0280	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009622, R01DC000354, T32DC007367] Funding Source: NIH RePORTER; NIDCD NIH HHS [T32 DC007367, R01 DC009622, R01 DC00354] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Adler HJ, 2003, HEARING RES, V184, P27, DOI 10.1016/S0378-5955(03)00192-8; Albert AD, 2005, PROG LIPID RES, V44, P99, DOI 10.1016/j.plipres.2005.02.001; Albert AD, 1996, BBA-PROTEIN STRUCT M, V1297, P77, DOI 10.1016/0167-4838(96)00102-1; Albert AD, 1998, BBA-BIOMEMBRANES, V1368, P52, DOI 10.1016/S0005-2736(97)00200-9; ALBERTS R, 2002, MOL BIOL CELL, P588; Barnett DW, 1997, BIOPHYS J, V72, P1641, DOI 10.1016/S0006-3495(97)78810-6; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BOESZEBATTAGLIA K, 1989, J BIOL CHEM, V264, P8151; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P20727; BOESZEBATTAGLIA K, 1989, EXP EYE RES, V49, P699, DOI 10.1016/S0014-4835(89)80064-8; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Brownell WE, 2006, SPR HDB AUD, V27, P313; Brownell WE, 2000, CELL AND MOLECULAR BIOLOGY OF THE EAR, P69; Brownell WE, 2001, ANNU REV BIOMED ENG, V3, P169, DOI 10.1146/annurev.bioeng.3.1.169; COOPER GM, 2000, CELL MOL APPROACH, P469; DALLOS P, 1991, NATURE, V350, P155, DOI 10.1038/350155a0; Farrell B, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041930; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; FORGE A, 1991, CELL TISSUE RES, V265, P473, DOI 10.1007/BF00340870; Frank G, 1999, P NATL ACAD SCI USA, V96, P4420, DOI 10.1073/pnas.96.8.4420; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; Gale JE, 1997, PFLUG ARCH EUR J PHY, V434, P267, DOI 10.1007/s004240050395; Geleoc GSG, 1999, NAT NEUROSCI, V2, P713, DOI 10.1038/11174; Greeson JN, 2006, BRAIN RES, V1091, P140, DOI 10.1016/j.brainres.2006.02.084; HUANG GJ, 1994, P NATL ACAD SCI USA, V91, P12268, DOI 10.1073/pnas.91.25.12268; Huber T, 2002, J AM CHEM SOC, V124, P298, DOI 10.1021/ja011383j; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; KALINEC F, 1992, P NATL ACAD SCI USA, V89, P8671, DOI 10.1073/pnas.89.18.8671; Liao ZJ, 2005, J ACOUST SOC AM, V118, P3737, DOI 10.1121/1.2118387; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Lue AJC, 2001, OTOLARYNG HEAD NECK, V125, P71, DOI 10.1067/mhn.2001.116446; Meltzer J, 2001, NEUROSCI LETT, V313, P141, DOI 10.1016/S0304-3940(01)02266-2; MITCHELL DC, 1992, BIOCHEMISTRY-US, V31, P662, DOI 10.1021/bi00118a005; Murdock DR, 2005, BIOPHYS J, V89, P4090, DOI 10.1529/biophysj.105.069872; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Nguyen TVN, 1998, OTOLARYNG HEAD NECK, V119, P14, DOI 10.1016/S0194-5998(98)70167-6; Oghalai JS, 1998, J NEUROSCI, V18, P48; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Rajagopalan L, 2006, J NEUROSCI, V26, P12727, DOI 10.1523/JNEUROSCI.2734-06.2006; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Reisinger E, 2005, MOL CELL NEUROSCI, V28, P106, DOI 10.1016/j.mcn.2004.08.018; Reversi A, 2006, AM J PHYSIOL-REG I, V291, pR861, DOI 10.1152/ajpregu.00333.2006; Saiz L, 2001, BIOPHYS J, V81, P204, DOI 10.1016/S0006-3495(01)75692-5; SANTI PA, 1994, J HISTOCHEM CYTOCHEM, V42, P705, DOI 10.1177/42.6.8189033; Santos-Sacchi J, 1998, HEARING RES, V116, P99, DOI 10.1016/S0378-5955(97)00204-9; Santos-Sacchi J, 2004, J MEMBRANE BIOL, V200, P83, DOI 10.1007/s00232-004-0699-2; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2001, HEARING RES, V159, P69, DOI 10.1016/S0378-5955(01)00321-5; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Solsona C, 1998, BIOPHYS J, V74, P1061, DOI 10.1016/S0006-3495(98)74030-5; Sturm AK, 2007, OTOLARYNG HEAD NECK, V136, P434, DOI 10.1016/j.otohns.2006.10.030; Wu M, 1998, J MEMBRANE BIOL, V166, P111, DOI 10.1007/s002329900453; Yu N, 2006, BRAIN RES, V1095, P51, DOI 10.1016/j.brainres.2006.04.017; Zerouga M, 1996, ANTICANCER RES, V16, P2863; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	61	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22473	22481		10.1074/jbc.M803722200	http://dx.doi.org/10.1074/jbc.M803722200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18567583	Green Published, hybrid			2022-12-25	WOS:000258321000015
J	Hadjantonakis, AK; Pisano, E; Papaioannou, VE				Hadjantonakis, Anna-Katerina; Pisano, Elinor; Papaioannou, Virginia E.			Tbx6 Regulates Left/Right Patterning in Mouse Embryos through Effects on Nodal Cilia and Perinodal Signaling	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; FLUORESCENT PROTEIN FUSION; T-BOX GENES; PARAXIAL MESODERM; KUPFFERS VESICLE; LATERAL PLATE; EXPRESSION; MICE; FLOW	Background: The determination of left/right body axis during early embryogenesis sets up a developmental cascade that coordinates the development of the viscera and is essential to the correct placement and alignment of organ systems and vasculature. Defective left-right patterning can lead to congenital cardiac malformations, vascular anomalies and other serious health problems. Here we describe a novel role for the T-box transcription factor gene Tbx6 in left/right body axis determination in the mouse. Results: Embryos lacking Tbx6 show randomized embryo turning and heart looping. Our results point to multiple mechanisms for this effect. First, Dll1, a direct target of Tbx6, is down regulated around the node in Tbx6 mutants and there is a subsequent decrease in nodal signaling, which is required for laterality determination. Secondly, in spite of a lack of expression of Tbx6 in the node, we document a profound effect of the Tbx6 mutation on the morphology and motility of nodal cilia. This results in the loss of asymmetric calcium signaling at the periphery of the node, suggesting that unidirectional nodal flow is disrupted. To carry out these studies, we devised a novel method for direct labeling and live imaging cilia in vivo using a genetically-encoded fluorescent protein fusion that labels tubulin, combined with laser point scanning confocal microscopy for direct visualization of cilia movement. Conclusions: We conclude that the transcription factor gene Tbx6 is essential for correct left/right axis determination in the mouse and acts through effects on notch signaling around the node as well as through an effect on the morphology and motility of the nodal cilia.	[Hadjantonakis, Anna-Katerina] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Pisano, Elinor; Papaioannou, Virginia E.] Columbia Univ, Coll Physicians & Surgeons, Dept Genet & Dev, New York, NY USA	Memorial Sloan Kettering Cancer Center; Columbia University	Hadjantonakis, AK (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY USA.	vep1@columbia.edu		Hadjantonakis, Anna-Katerina/0000-0002-7580-5124; Papaioannou, Virginia/0000-0001-7558-8601	NIH [GM60561, HD033082, HD052115]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD033082, R01HD052115] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060561] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM60561 and HD033082 (V.E.P.) and HD052115 (A.-K.H).	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Amack JD, 2007, DEV BIOL, V310, P196, DOI 10.1016/j.ydbio.2007.05.039; Beckers J, 2000, MECH DEVELOP, V95, P23, DOI 10.1016/S0925-4773(00)00322-1; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Brennan J, 2002, GENE DEV, V16, P2339, DOI 10.1101/gad.1016202; Brown N, 1999, HEART DEV, P447; Chapman DL, 2003, MECH DEVELOP, V120, P837, DOI 10.1016/S0925-4773(03)00066-2; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chen JN, 1997, DEVELOPMENT, V124, P4373; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Fraser ST, 2005, GENESIS, V42, P162, DOI 10.1002/gene.20139; Gourronc F, 2007, DEV DYNAM, V236, P2131, DOI 10.1002/dvdy.21249; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hadjantonakis AK, 2003, NAT REV GENET, V4, P613, DOI 10.1038/nrg1126; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Karcher C, 2005, DIFFERENTIATION, V73, P425, DOI 10.1111/j.1432-0436.2005.00048.x; King T, 1998, MECH DEVELOP, V79, P29, DOI 10.1016/S0925-4773(98)00166-X; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Mohamed OA, 2004, DEV DYNAM, V231, P416, DOI 10.1002/dvdy.20135; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nagy A., 2003, MANIPULATING MOUSE E, P764; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Norris DP, 2002, DEVELOPMENT, V129, P3455; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Oki S, 2007, DEVELOPMENT, V134, P3893, DOI 10.1242/dev.009464; Pagan-Westphal SM, 1998, CELL, V93, P25, DOI 10.1016/S0092-8674(00)81143-5; PAPAIOANNOU V, 2000, GENE TARGETING PRACT, P133; Papaioannou VE, 2001, INT REV CYTOL, V207, P1; Papaioannou Virginia E., 2004, P686; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Przemeck GKH, 2003, DEVELOPMENT, V130, P3, DOI 10.1242/dev.00176; Raya A, 2004, CURR OPIN GENET DEV, V14, P575, DOI 10.1016/j.gde.2004.07.011; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Saijoh Y, 2003, DEV BIOL, V256, P160, DOI 10.1016/S0012-1606(02)00121-5; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Watabe-Rudolph M, 2002, MECH DEVELOP, V119, P251, DOI 10.1016/S0925-4773(02)00394-5; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; White PH, 2005, GENESIS, V42, P193, DOI 10.1002/gene.20140; White PH, 2003, DEVELOPMENT, V130, P1681, DOI 10.1242/dev.00367; WILKINSON DG, 1992, WHOLE MOUNT SITU HYB; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	67	63	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2511	10.1371/journal.pone.0002511	http://dx.doi.org/10.1371/journal.pone.0002511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575602	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000030
J	Paterson, S; Wilkes, C; Bleay, C; Viney, ME				Paterson, Steve; Wilkes, Clare; Bleay, Colin; Viney, Mark E.			Immunological Responses Elicited by Different Infection Regimes with Strongyloides ratti	PLOS ONE			English	Article							NIPPOSTRONGYLUS-BRASILIENSIS; GASTROINTESTINAL NEMATODES; IMMATURE PARASITES; MIGRATION ROUTES; IMMUNE-RESPONSES; CYTOKINE; CONSEQUENCES; PATHWAYS; DYNAMICS; PATTERNS	Nematode infections are a ubiquitous feature of vertebrate life. In nature, such nematode infections are acquired by continued exposure to infective stages over a prolonged period of time. By contrast, experimental laboratory infections are typically induced by the administration of a single (and often large) dose of infective stages. Previous work has shown that the size of an infection dose can have significant effects on anti-nematode immune responses. Here we investigated the effect of different infection regimes of Strongyloides ratti, comparing single and repeated dose infections, on the host immune response that was elicited. We considered and compared infections of the same size, but administered in different ways. We considered infection size in two ways: the maximum dose of worms administered and the cumulative worm exposure time. We found that both infection regimes resulted in Th2-type immune response, characterised by IL4 and IL13 produced by S. ratti stimulated mesenteric lymph node cells, anti-S. ratti IgG(1) and intestinal rat mast cell protease II (RMCPII) production. We observed some small quantitative immunological differences between different infection regimes, in which the concentration of IL4, IL13, anti-S. ratti IgG(1) and IgG(2a) and RMCPII were affected. However, these differences were quantitatively relatively modest compared with the temporal dynamics of the anti-S. ratti immune response as a whole.	[Paterson, Steve] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Wilkes, Clare; Bleay, Colin; Viney, Mark E.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Liverpool; University of Bristol	Paterson, S (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	s.paterson@liv.ac.uk	Paterson, Steve/D-2154-2009	Paterson, Steve/0000-0002-1307-2981	The Wellcome Trust, UK	The Wellcome Trust, UK(Wellcome Trust)	Funded by The Wellcome Trust, UK. The funders have had no role in the design and conduct of the study, or in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript.	Bancroft AJ, 2001, INT J PARASITOL, V31, P1627, DOI 10.1016/S0020-7519(01)00281-8; Behnke JM, 2008, PARASITOLOGY, V135, P751, DOI 10.1017/S0031182008000334; BERDING C, 1986, J THEOR BIOL, V122, P459, DOI 10.1016/S0022-5193(86)80186-2; Bleay C, 2007, INT J PARASITOL, V37, P1501, DOI 10.1016/j.ijpara.2007.04.023; Crawley M. J, 2002, STAT COMPUTING INTRO; Dawkins H. J. S., 1989, Strongyloidiasis: a major roundworm infection of man., P287; Else KJ, 2005, PARASITE IMMUNOL, V27, P407, DOI 10.1111/j.1365-3024.2005.00788.x; Faulkner H, 2002, J INFECT DIS, V185, P665, DOI 10.1086/339005; FERENS WA, 1990, J PARASITOL, V76, P684, DOI 10.2307/3282983; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; GRENFELL BT, 2002, ECOLOGY INFECT DIS; Jackson JA, 2004, INT J PARASITOL, V34, P1237, DOI 10.1016/j.ijpara.2004.07.009; Jackson JA, 2004, J INFECT DIS, V190, P1804, DOI 10.1086/425014; JENKINS DC, 1971, PARASITOLOGY, V62, P457, DOI 10.1017/S003118200007760X; JENKINS DC, 1974, PARASITOLOGY, V68, P13, DOI 10.1017/S0031182000045327; JENKINS DC, 1972, INT J PARASITOL, V22, P105; KEYMER AE, 1986, PROC R SOC SER B-BIO, V229, P47, DOI 10.1098/rspb.1986.0074; Maizels RM, 1998, CURR BIOL, V8, pR711, DOI 10.1016/S0960-9822(98)70455-5; MAIZELS RM, 1993, NATURE, V365, P797, DOI 10.1038/365797a0; Medley GF, 2002, PARASITOLOGY, V125, pS61, DOI 10.1017/S0031182002002354; OGILVIE B M, 1974, P81; OGILVIE BM, 1965, PARASITOLOGY, V55, P325, DOI 10.1017/S0031182000068797; OVINGTON KS, 1986, PARASITOL RES, V72, P851; Paterson S, 2003, P ROY SOC B-BIOL SCI, V270, P1023, DOI 10.1098/rspb.2003.2346; Paterson S, 2002, PARASITOLOGY, V125, P283, DOI 10.1017/S0031182002002056; Sokal RR, 1995, BIOMETRY; TINDALL NR, 1990, PARASITOLOGY, V100, P281, DOI 10.1017/S003118200006128X; TINDALL NR, 1988, PARASITOLOGY, V96, P551, DOI 10.1017/S0031182000080185; Turner JD, 2003, J INFECT DIS, V188, P1768, DOI 10.1086/379370; Wakelin D, 1996, IMMUNITY PARASITES; Wilkes CP, 2007, PARASITE IMMUNOL, V29, P339, DOI 10.1111/j.1365-3024.2007.00945.x; Wilkes CP, 2004, PARASITOLOGY, V128, P661, DOI 10.1017/S0031182004005062; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0	33	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2509	10.1371/journal.pone.0002509	http://dx.doi.org/10.1371/journal.pone.0002509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575588	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288000028
J	Kucherenko, MM; Pantoja, M; Yatsenko, AS; Shcherbata, HR; Fischer, KA; Maksymiv, DV; Chernyk, YI; Ruohola-Baker, H				Kucherenko, Mariya M.; Pantoja, Mario; Yatsenko, Andriy S.; Shcherbata, Halyna R.; Fischer, Karin A.; Maksymiv, Dariya V.; Chernyk, Yaroslava I.; Ruohola-Baker, Hannele			Genetic Modifier Screens Reveal New Components that Interact with the Drosophila Dystroglycan-Dystrophin Complex	PLOS ONE			English	Article								The Dystroglycan-Dystrophin (Dg-Dys) complex has a capacity to transmit information from the extracellular matrix to the cytoskeleton inside the cell. It is proposed that this interaction is under tight regulation; however the signaling/regulatory components of Dg-Dys complex remain elusive. Understanding the regulation of the complex is critical since defects in this complex cause muscular dystrophy in humans. To reveal new regulators of the Dg-Dys complex, we used a model organism Drosophila melanogaster and performed genetic interaction screens to identify modifiers of Dg and Dys mutants in Drosophila wing veins. These mutant screens revealed that the Dg-Dys complex interacts with genes involved in muscle function and components of Notch, TGF-beta and EGFR signaling pathways. In addition, components of pathways that are required for cellular and/or axonal migration through cytoskeletal regulation, such as Semaphorin-Plexin, Frazzled-Netrin and Slit-Robo pathways show interactions with Dys and/or Dg. These data suggest that the Dg-Dys complex and the other pathways regulating extracellular information transfer to the cytoskeletal dynamics are more intercalated than previously thought.	[Kucherenko, Mariya M.; Pantoja, Mario; Yatsenko, Andriy S.; Shcherbata, Halyna R.; Fischer, Karin A.; Maksymiv, Dariya V.; Chernyk, Yaroslava I.; Ruohola-Baker, Hannele] Univ Washington, Dept Biochem, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Kucherenko, Mariya M.; Yatsenko, Andriy S.; Maksymiv, Dariya V.; Chernyk, Yaroslava I.] Ivan Franko Natl Univ Lviv, Dept Genet & Biotechnol, Lvov, Ukraine	University of Washington; University of Washington Seattle; Ministry of Education & Science of Ukraine; Ivan Franko National University Lviv	Kucherenko, MM (corresponding author), Univ Washington, Dept Biochem, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	hannele@u.washington.edu	Shcherbata, Halyna/J-5712-2017; Yatsenko, Andriy/D-1895-2018	Shcherbata, Halyna/0000-0002-3855-0345; Yatsenko, Andriy/0000-0001-8730-5744; Kucherenko, Mariya/0000-0002-8637-2037	CRDF; MDA; NIH; AHA	CRDF; MDA(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association)	CRDF for M.M.K., A.S.Y., D.V.M. and Ya.I.C.; MDA for H.R.-B.; NIH for H.R.-B.; AHA for H.R.S.	Allikian MJ, 2007, HUM MOL GENET, V16, P2933, DOI 10.1093/hmg/ddm254; Alvarado D, 2004, GENETICS, V167, P187, DOI 10.1534/genetics.167.1.187; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; Bier E, 2000, CURR OPIN GENET DEV, V10, P393, DOI 10.1016/S0959-437X(00)00102-7; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; CARBONETTO S, COMMUNICATION; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chakkalakal JV, 2006, HUM MOL GENET, V15, P1423, DOI 10.1093/hmg/ddl065; Christoforou CP, 2008, DEV BIOL, V313, P519, DOI 10.1016/j.ydbio.2007.09.044; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cox DN, 2001, P NATL ACAD SCI USA, V98, P14475, DOI 10.1073/pnas.261565198; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; deCelis JF, 1997, DEVELOPMENT, V124, P1007; Deng WM, 2000, CURR BIOL, V10, P683, DOI 10.1016/S0960-9822(00)00514-5; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; Figueroa C, 2003, J BIOL CHEM, V278, P47922, DOI 10.1074/jbc.M307357200; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Guichard A, 1999, DEVELOPMENT, V126, P2663; Haenggi T, 2006, CELL MOL LIFE SCI, V63, P1614, DOI 10.1007/s00018-005-5461-0; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Johannes B, 2002, MECH DEVELOP, V115, P3, DOI 10.1016/S0925-4773(02)00083-7; Kadrmas JL, 2007, DEV DYNAM, V236, P2207, DOI 10.1002/dvdy.21217; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Kukekov NV, 2006, J BIOL CHEM, V281, P15517, DOI 10.1074/jbc.M601056200; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; Link N, 2007, J CELL BIOL, V178, P567, DOI 10.1083/jcb.200702125; Macioce P, 2003, J CELL SCI, V116, P4847, DOI 10.1242/jcs.00805; MADHAVAN R, 1992, BIOCHEM BIOPH RES CO, V185, P753, DOI 10.1016/0006-291X(92)91690-R; Magalhaes TR, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-59; Newbell BJ, 1997, BIOCHEMISTRY-US, V36, P1295, DOI 10.1021/bi962452n; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Parsons SA, 2007, J BIOL CHEM, V282, P10068, DOI 10.1074/jbc.M609368200; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Poulton JS, 2006, P NATL ACAD SCI USA, V103, P12775, DOI 10.1073/pnas.0603817103; Qian L, 2005, CURR BIOL, V15, P2271, DOI 10.1016/j.cub.2005.10.037; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Ralston A, 2005, DEV BIOL, V280, P187, DOI 10.1016/j.ydbio.2005.01.018; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Shcherbata HR, 2007, EMBO J, V26, P481, DOI 10.1038/sj.emboj.7601503; Steinhauer J, 2006, DEV DYNAM, V235, P1455, DOI 10.1002/dvdy.20770; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; TAGHLI L, 2008, AGING CELL, V7, P237; Takeya R, 2003, J CELL SCI, V116, P4567, DOI 10.1242/jcs.00769; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Tayler TD, 2004, DEVELOPMENT, V131, P5935, DOI 10.1242/dev.01465; van der Plas MC, 2007, MECH DEVELOP, V124, P617, DOI 10.1016/j.mod.2007.04.003; van der Plas MC, 2006, J NEUROSCI, V26, P333, DOI 10.1523/JNEUROSCI.4069-05.2006; Wang Y, 2007, CURR BIOL, V17, P1349, DOI 10.1016/j.cub.2007.06.067; Wehr K, 2006, DEV BIOL, V294, P406, DOI 10.1016/j.ydbio.2006.03.002; Yatsenko AS, 2007, J BIOL CHEM, V282, P15159, DOI 10.1074/jbc.M608800200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	62	49	51	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2418	10.1371/journal.pone.0002418	http://dx.doi.org/10.1371/journal.pone.0002418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545683	gold, Green Published, Green Submitted			2022-12-25	WOS:000263248800054
J	Rappoport, JZ; Heyman, KP; Kemal, S; Simon, SM				Rappoport, Joshua Z.; Heyman, Katherine P.; Kemal, Shahrnaz; Simon, Sanford M.			Dynamics of Dynamin during Clathrin Mediated Endocytosis in PC12 Cells	PLOS ONE			English	Article								Background: Members of the dynamin super-family of GTPases are involved in disparate cellular pathways. Dynamin1 and dynamin2 have been implicated in clathrin-mediated endocytosis. While some models suggest that dynamin functions specifically at the point of vesicle fission, evidence also exists for a role prior to fission during vesicle formation and it is unknown if there is a role for dynamin after vesicle fission. Although dynamin2 is ubiquitously expressed, dynamin1 is restricted to the nervous system. These two structurally similar endocytic accessory proteins have not been studied in cells that endogenously express both. Methodology/Principal Findings: The present study quantitatively assesses the dynamics of dynamin1 and dynamin2 during clathrin-mediated endocytosis in PC12 cells, which endogenously express both proteins. Both dynamin isoforms co-localized with clathrin and showed sharp increases in fluorescence intensity immediately prior to internalization of the nascent clathrin-coated vesicle. The fluorescence intensity of both proteins then decreased with two time constants. The slower time constant closely matched the time constant for the decrease of clathrin intensity and likely represents vesicle movement away from the membrane. The faster rate may reflect release of dynamin at the neck of nascent vesicle following GTP hydrolysis. Conclusions/Significance: This study analyses the role of dynamin in clathrin-mediated endocytosis in a model for cellular neuroscience and these results may provide direct evidence for the existence of two populations of dynamin associated with nascent clathrin-coated vesicles.	[Rappoport, Joshua Z.; Heyman, Katherine P.; Kemal, Shahrnaz; Simon, Sanford M.] Rockefeller Univ, Lab Cellular Biophys, New York, NY USA	Rockefeller University	Rappoport, JZ (corresponding author), Rockefeller Univ, Lab Cellular Biophys, New York, NY USA.	simon@rockefeller.edu		Simon, Sanford/0000-0002-8615-4224; Saunders, Katherine/0000-0003-4154-9975	NSF [BES-0620813]; NIH [P20 GM072015, 1F32 GM069200]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM072015, F32GM069200] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NSF BES-0620813 and NIH P20 GM072015 (to SMS), and NIH 1F32 GM069200 (to JZR)	Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cao S, 2003, J BIOL CHEM, V278, P5894, DOI 10.1074/jbc.M212546200; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cook T, 1996, J NEUROCHEM, V67, P927; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; HOLZ RW, 2006, CELL MOL NEUROBIOL; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; LICHTE B, 1992, EMBO J, V11, P2521, DOI 10.1002/j.1460-2075.1992.tb05317.x; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Rappoport J, 2004, TRAFFIC, V5, P327, DOI 10.1111/j.1600-0854.2004.00187.x; Rappoport JZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1072, DOI 10.1152/ajpcell.00160.2006; Rappoport JZ, 2003, J CELL SCI, V116, P1151; Rappoport JZ, 2005, TRAFFIC, V6, P539, DOI 10.1111/j.1600-0854.2005.00280.x; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; SONTAG JM, 1994, J BIOL CHEM, V269, P4547; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TSUBOI T, 2002, J BIOL CHEM; Tsuboi T, 2007, GENES CELLS, V12, P511, DOI 10.1111/j.1365-2443.2007.01070.x; Tsuboi T, 2007, J NEUROCHEM, V100, P770, DOI 10.1111/j.1471-4159.2006.04266.x; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Warnock Dale E., 1996, Bioessays, V18, P885, DOI 10.1002/bies.950181107	35	23	24	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2416	10.1371/journal.pone.0002416	http://dx.doi.org/10.1371/journal.pone.0002416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545672	Green Submitted, Green Published, gold			2022-12-25	WOS:000263248800053
J	Ross-Ibarra, J; Wright, SI; Foxe, JP; Kawabe, A; DeRose-Wilson, L; Gos, G; Charlesworth, D; Gaut, BS				Ross-Ibarra, Jeffrey; Wright, Stephen I.; Foxe, John Paul; Kawabe, Akira; DeRose-Wilson, Leah; Gos, Gesseca; Charlesworth, Deborah; Gaut, Brandon S.			Patterns of Polymorphism and Demographic History in Natural Populations of Arabidopsis lyrata	PLOS ONE			English	Article								Background: Many of the processes affecting genetic diversity act on local populations. However, studies of plant nucleotide diversity have largely ignored local sampling, making it difficult to infer the demographic history of populations and to assess the importance of local adaptation. Arabidopsis lyrata, a self-incompatible, perennial species with a circumpolar distribution, is an excellent model system in which to study the roles of demographic history and local adaptation in patterning genetic variation. Principal Findings: We studied nucleotide diversity in six natural populations of Arabidopsis lyrata, using 77 loci sampled from 140 chromosomes. The six populations were highly differentiated, with a median FST of 0.52, and STRUCTURE analysis revealed no evidence of admixed individuals. Average within-population diversity varied among populations, with the highest diversity found in a German population; this population harbors 3-fold higher levels of silent diversity than worldwide samples of A. thaliana. All A. lyrata populations also yielded positive values of Tajima's D. We estimated a demographic model for these populations, finding evidence of population divergence over the past 19,000 to 47,000 years involving non-equilibrium demographic events that reduced the effective size of most populations. Finally, we used the inferred demographic model to perform an initial test for local adaptation and identified several genes, including the flowering time gene FCA and a disease resistance locus, as candidates for local adaptation events. Conclusions: Our results underscore the importance of population-specific, non-equilibrium demographic processes in patterning diversity within A. lyrata. Moreover, our extensive dataset provides an important resource for future molecular population genetic studies of local adaptation in A. lyrata.	[Ross-Ibarra, Jeffrey; DeRose-Wilson, Leah; Gaut, Brandon S.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Wright, Stephen I.; Foxe, John Paul; Gos, Gesseca] York Univ, Dept Biol, Toronto, ON, Canada; [Kawabe, Akira; Charlesworth, Deborah] Univ Edinburgh, Sch Biol Sci, Inst Evol Biol, Edinburgh, Midlothian, Scotland	University of California System; University of California Irvine; York University - Canada; University of Edinburgh	Ross-Ibarra, J (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	bgaut@uci.edu	Charlesworth, Deborah/F-3071-2011; Wright, Stephen I/C-3113-2008; Kawabe, Akira/W-7485-2019; Ross-Ibarra, Jeffrey/D-7782-2011	Wright, Stephen I/0000-0001-9973-9697; Kawabe, Akira/0000-0001-5770-412X; Ross-Ibarra, Jeffrey/0000-0003-1656-4954	NSF [DEB-0426166]; NSERC; Natural Environment Research Council of Great Britain [NER/A/S/2003/00329];  [Sloan fellowship]; BBSRC [BB/E020909/1, BB/E024718/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E024718/1, BB/E020909/1] Funding Source: researchfish; Natural Environment Research Council [NER/A/S/2003/00329] Funding Source: researchfish	NSF(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Environment Research Council of Great Britain(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by NSF grant (DEB-0426166) to B.S.G.; by an NSERC grant and Sloan fellowship to S.I.W; and by a Natural Environment Research Council of Great Britain grant (NER/A/S/2003/00329) to D.C.	ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; Arunyawat U, 2007, MOL BIOL EVOL, V24, P2310, DOI 10.1093/molbev/msm162; Bakker EG, 2006, MOL ECOL, V15, P1405, DOI 10.1111/j.1365-294X.2006.02884.x; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Balana-Alcaide D, 2006, MOL ECOL, V15, P2059, DOI 10.1111/j.1365-294X.2006.02918.x; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Bergelson J, 2001, ANNU REV GENET, V35, P469, DOI 10.1146/annurev.genet.35.102401.090954; Bergelson J, 1998, GENETICS, V148, P1311; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clauss MJ, 2006, MOL ECOL, V15, P2753, DOI 10.1111/j.1365-294X.2006.02973.x; Clauss MJ, 2003, MOL ECOL, V12, P1287, DOI 10.1046/j.1365-294X.2003.01832.x; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fay JC, 2000, GENETICS, V155, P1405; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; Hamrick James L., 1996, P203; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hansson B, 2006, GENET RES, V87, P75, DOI 10.1017/S0016672306008020; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hudson RR, 2001, GENETICS, V159, P1805; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ingvarsson PK, 2002, EVOLUTION, V56, P2368, DOI 10.1111/j.0014-3820.2002.tb00162.x; Innan H, 2000, GENETICS, V155, P2015; Karkkainen K, 2004, EVOLUTION, V58, P2831, DOI 10.1111/j.0014-3820.2004.tb01634.x; Kawabe A, 2006, GENETICS, V174, P2021, DOI 10.1534/genetics.106.063628; Kawabe A, 2006, GENET RES, V88, P45, DOI 10.1017/S0016672306008287; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kivimaki M, 2007, MOL ECOL, V16, P453, DOI 10.1111/j.1365-294X.2007.03109.x; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Koch MA, 2007, P NATL ACAD SCI USA, V104, P6272, DOI 10.1073/pnas.0701338104; Kuittinen H, 2004, GENETICS, V168, P1575, DOI 10.1534/genetics.103.022343; LEWONTIN RC, 1973, GENETICS, V74, P175; Li HP, 2006, PLOS GENET, V2, P1580, DOI 10.1371/journal.pgen.0020166; Li Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000105; Liu F, 1999, GENETICS, V151, P343; Liu F, 1998, P ROY SOC B-BIOL SCI, V265, P293, DOI 10.1098/rspb.1998.0295; Ma XF, 2006, MOL BIOL EVOL, V23, P807, DOI 10.1093/molbev/msj100; Mable BK, 2007, MOL ECOL, V16, P3565, DOI 10.1111/j.1365-294X.2007.03416.x; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; McVean G, 2002, GENETICS, V160, P1231; Moeller DA, 2007, GENETICS, V176, P1799, DOI 10.1534/genetics.107.070631; Muller MH, 2008, HEREDITY, V100, P47, DOI 10.1038/sj.hdy.6801057; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 1997, GENETICS, V146, P1185; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Pagnol V, 2006, GENETICS, V172, P2441, DOI 10.1534/genetics.104.040311; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Pyhajarvi T, 2007, GENETICS, V177, P1713, DOI 10.1534/genetics.107.077099; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Ramos-Onsins SE, 2004, GENETICS, V166, P373, DOI 10.1534/genetics.166.1.373; Riihimaki M, 2005, GENETICA, V123, P63, DOI 10.1007/s10709-003-2711-7; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sandring S, 2007, J EVOLUTION BIOL, V20, P558, DOI 10.1111/j.1420-9101.2006.01260.x; Savolainen O, 2000, MOL BIOL EVOL, V17, P645, DOI 10.1093/oxfordjournals.molbev.a026343; Schlotterer C, 2002, GENETICS, V160, P753; Schmid K, 2006, THEOR APPL GENET, V112, P1104, DOI 10.1007/s00122-006-0212-7; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Stadler T, 2008, GENETICS, V178, P339, DOI 10.1534/genetics.107.081810; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Thornton K, 2006, GENETICS, V172, P1607, DOI 10.1534/genetics.105.048223; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Touzet P, 2004, TRENDS PLANT SCI, V9, P568, DOI 10.1016/j.tplants.2004.10.001; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wakeley J, 1997, GENETICS, V145, P847; Wakeley J, 2001, GENETICS, V159, P893; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weir B. S., 1990, Genetic data analysis. Methods for discrete population genetic data.; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wright S, 1943, GENETICS, V28, P114; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Wright SI, 2003, MOL ECOL, V12, P1247, DOI 10.1046/j.1365-294X.2003.01743.x; Wright SI, 2002, MOL BIOL EVOL, V19, P1407, DOI 10.1093/oxfordjournals.molbev.a004204; Wright SI, 2006, GENETICS, V174, P1421, DOI 10.1534/genetics.106.062588; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	95	137	139	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2411	10.1371/journal.pone.0002411	http://dx.doi.org/10.1371/journal.pone.0002411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545707	Green Published, gold			2022-12-25	WOS:000263248800048
J	Reddy, NM; Kleeberger, SR; Bream, JH; Fallon, PG; Kensler, TW; Yamamoto, M; Reddy, SP				Reddy, N. M.; Kleeberger, S. R.; Bream, J. H.; Fallon, P. G.; Kensler, T. W.; Yamamoto, M.; Reddy, S. P.			Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling	ONCOGENE			English	Article						oxidative stress; Nrf2; cell cycle; G(2)/M-checkpoint; Akt	ALVEOLAR EPITHELIAL-CELLS; DNA-DAMAGE; S-GLUTATHIONYLATION; DEPENDENT PHOSPHORYLATION; OXIDATIVE STRESS; MICE LACKING; KINASE-B; LUNG; MECHANISMS; EXPRESSION	Genetic disruption of Nrf2 greatly enhances susceptibility to prooxidant- and carcinogen-induced experimental models of various human disorders; but the mechanisms by which this transcription factor confers protection are unclear. Using Nrf2-proficient (Nrf2(+/+)) and Nrf2-deficient (Nrf2(-/-)) primary epithelial cultures as a model, we now show that Nrf2 deficiency leads to oxidative stress and DNA lesions, accompanied by impairment of cell-cycle progression, mainly G(2)/M-phase arrest. Both N-acetylcysteine and glutathione (GSH) supplementation ablated the DNA lesions and DNA damage-response pathways in Nrf2(-/-) cells; however only GSH could rescue the impaired colocalization of mitosis-promoting factors and the growth arrest. Akt activation was deregulated in Nrf2(-/-) cells, but GSH supplementation restored it. Inhibition of Akt signaling greatly diminished the GSH-induced Nrf2(-/-) cell proliferation and wild-type cell proliferation. GSH depletion impaired Akt signaling and mitosis-promoting factor colocalization in Nrf2(+/+) cells. Collectively, our findings uncover novel functions for Nrf2 in regulating oxidative stress-induced cell-cycle arrest, especially G(2)/M-checkpoint arrest, and proliferation, and GSH-regulated redox signaling and Akt are required for this process.	[Reddy, N. M.; Kensler, T. W.; Reddy, S. P.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Kleeberger, S. R.] Natl Inst Environm Hlth Sci, NIH, Res Triangle Pk, NC USA; [Bream, J. H.; Fallon, P. G.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Yamamoto, M.] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tohoku University	Reddy, SP (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Room E7610,615 N Wolfe St, Baltimore, MD 21205 USA.	sreddy@jhsph.edu	Yamamoto, Masayuki/A-4873-2010; Reddy, Narsa/AHE-5604-2022; Kensler, Thomas W/D-8686-2014; Kleeberger, Steven R/F-1807-2019	Yamamoto, Masayuki/0000-0002-9073-9436; Kensler, Thomas W/0000-0002-6676-261X; Kleeberger, Steven R/0000-0003-2948-8452; Bream, Jay/0000-0002-9149-7643	NIH [HL66109, ES11863]; SCCOR [P50 HL073994]; NIEHS [P30 ES 038819]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL073994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100513, R01ES011863] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCCOR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants HL66109, ES11863 and SCCOR P50 HL073994 (to SPR), and NIEHS center grant P30 ES 038819. We acknowledge the help provided for FACS analysis by Becton Dickinson Immune Function Laboratory, Johns Hopkins Bloomberg School of Public Health.	Aoki Y, 2001, TOXICOL APPL PHARM, V173, P154, DOI 10.1006/taap.2001.9176; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Buchold GM, 2007, MOL REPROD DEV, V74, P997, DOI 10.1002/mrd.20716; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chen XL, 2003, J BIOL CHEM, V278, P703, DOI 10.1074/jbc.M203161200; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Clavreul N, 2006, ARTERIOSCL THROM VAS, V26, P2454, DOI 10.1161/01.ATV.0000242791.28953.4c; Conour JE, 2004, PHYSIOL GENOMICS, V18, P196, DOI 10.1152/physiolgenomics.00058.2004; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V42, P583, DOI 10.1016/j.freeradbiomed.2006.11.026; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Fratelli M, 2005, P NATL ACAD SCI USA, V102, P13998, DOI 10.1073/pnas.0504398102; Fratelli M, 2004, EXPERT REV PROTEOMIC, V1, P365, DOI 10.1586/14789450.1.3.365; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gartel AL, 2003, EXP CELL RES, V283, P17, DOI 10.1016/S0014-4827(02)00020-4; Ghezzi P, 2005, ANTIOXID REDOX SIGN, V7, P964, DOI 10.1089/ars.2005.7.964; Golubnitschaja O, 2007, AMINO ACIDS, V32, P359, DOI 10.1007/s00726-006-0473-0; Helt CE, 2005, J BIOL CHEM, V280, P1186, DOI 10.1074/jbc.M410873200; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim SS, 2006, MOL CELL BIOL, V26, P6983, DOI 10.1128/MCB.00796-06; King FW, 2004, CELL CYCLE, V3, P634; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Klatt P, 2002, METHOD ENZYMOL, V348, P157, DOI 10.1016/S0076-6879(02)48635-1; Laine H, 2007, J NEUROSCI, V27, P1434, DOI 10.1523/JNEUROSCI.4956-06.2007; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Louria-Hayon I, 2003, J BIOL CHEM, V278, P33134, DOI 10.1074/jbc.M301264200; Marshall RP, 2002, CHEST, V121, p68S, DOI 10.1378/chest.121.3_suppl.68S; McAllister KA, 2002, BREAST CANCER RES, V4, P54, DOI 10.1186/bcr422; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Meulmeester E, 2005, CELL CYCLE, V4, P1166, DOI 10.4161/cc.4.9.1981; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Parra MT, 2002, CHROMOSOMA, V111, P53, DOI 10.1007/s00412-002-0185-5; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Qian XS, 2006, EUR J IMMUNOL, V36, P906, DOI 10.1002/eji.200535253; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Reddy NM, 2007, PHYSIOL GENOMICS, V32, P74, DOI 10.1152/physiolgenomics.00126.2007; Reddy NM, 2007, AM J RESP CELL MOL, V37, P3, DOI 10.1165/rcmb.2007-0004RC; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Serrano-Mollar A, 2007, AM J RESP CRIT CARE, V176, P1261, DOI 10.1164/rccm.200610-1491OC; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shtivelman E, 2003, MOL CANCER RES, V1, P959; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Sugahara K, 2006, RESPIROLOGY, V11, pS28, DOI 10.1111/j.1440-1843.2006.00804.x; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; Townsend DM, 2006, MOL PHARMACOL, V69, P501, DOI 10.1124/mol.105.018523; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Velu CS, 2007, BIOCHEMISTRY-US, V46, P7765, DOI 10.1021/bi700425y; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Ward NE, 2000, BIOCHEMISTRY-US, V39, P10319, DOI 10.1021/bi000781g; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003	71	107	110	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 2	2008	27	44					5821	5832		10.1038/onc.2008.188	http://dx.doi.org/10.1038/onc.2008.188			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	355QC	18542053	Green Accepted			2022-12-25	WOS:000259722400006
J	Kiyonari, S; Uchimura, M; Shirai, T; Ishino, Y				Kiyonari, Shinichi; Uchimura, Maiko; Shirai, Tsuyoshi; Ishino, Yoshizumi			Physical and functional interactions between uracil-DNA glycosylase and proliferating cell nuclear antigen from the euryarchaeon Pyrococcus furiosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; PYROBACULUM-AEROPHILUM; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; LIGASE-I; REPLICATION; PCNA; POLYMERASES; COMPLEX; BINDING	Uracil-DNA glycosylase (UDG) is an important repair enzyme in all organisms to remove uracil bases from DNA. Recent biochemical studies have revealed that human nuclear UDG (UNG2) forms a multiprotein complex in replication foci and initiates the base excision repair pathway by interacting with proliferating cell nuclear antigen ( PCNA). Here, we show the physical and functional interactions between UDG and PCNA from the hyperthermophilic euryarchaeon, Pyrococcus furiosus. The physical interaction between the two proteins was identified by a surface plasmon resonance analysis. Furthermore, the uracil glycosylase activity of P. furiosus UDG is stimulated by P. furiosus PCNA (PfuPCNA) in vitro. This stimulatory effect was observed only when wild type PfuPCNA, but not a monomeric PCNA mutant, was present in the reaction. Mutational analyses revealed that our predicted PCNA-binding region (AKTLF) in P. furiosus UDG is actually important for the interaction with PfuPCNA. This is the first report describing the functional interaction between archaeal UDG and PCNA.	[Kiyonari, Shinichi; Uchimura, Maiko; Ishino, Yoshizumi] Kyushu Univ, Dept Genet Resources Technol, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan; [Kiyonari, Shinichi; Ishino, Yoshizumi] BIRD Japan Sci & Technol Agcy, Fukuoka 8128581, Japan; [Shirai, Tsuyoshi] Nagahama Inst Biosci & Technol, Dept Biosci, Shiga 5260829, Japan; [Shirai, Tsuyoshi] BIRD Japan Sci & Technol Agcy, Shiga 5260829, Japan	Kyushu University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Ishino, Y (corresponding author), Kyushu Univ, Dept Genet Resources Technol, Fac Agr, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	ishino@agr.kyushu-u.ac.jp	Kiyonari, Shinichi/I-7329-2014	Ishino, Yoshizumi/0000-0001-9419-0826	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Hou-ansha Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hou-ansha Foundation	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan ( to Y.I.). This work was also supported by the Hou-ansha Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; Aravind L., 2000, GENOME BIOL; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Berti PJ, 2006, CHEM REV, V106, P506, DOI 10.1021/cr040461t; Cann IKO, 1999, J BACTERIOL, V181, P6591, DOI 10.1128/JB.181.21.6591-6599.1999; Connolly BA, 2003, BIOCHEM SOC T, V31, P699, DOI 10.1042/bst0310699; Dionne I, 2005, BIOCHEM J, V387, P859, DOI 10.1042/BJ20041661; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; Grogan DW, 1998, MOL MICROBIOL, V28, P1043, DOI 10.1046/j.1365-2958.1998.00853.x; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Hinks JA, 2002, J BIOL CHEM, V277, P16936, DOI 10.1074/jbc.M200668200; Hoseki J, 2003, J MOL BIOL, V333, P515, DOI 10.1016/j.jmb.2003.08.030; Ishino Y, 2001, GENES CELLS, V6, P699, DOI 10.1046/j.1365-2443.2001.00451.x; JARVIS TC, 1989, J BIOL CHEM, V264, P12709; Kiyonari S, 2007, EXTREMOPHILES, V11, P675, DOI 10.1007/s00792-007-0083-0; Kiyonari S, 2006, J BIOL CHEM, V281, P28023, DOI 10.1074/jbc.M603403200; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Ko R, 2005, DNA REPAIR, V4, P1421, DOI 10.1016/j.dnarep.2005.08.006; Komori K, 2000, PROTEIN ENG, V13, P41, DOI 10.1093/protein/13.1.41; Kosaka H, 2007, J MOL BIOL, V373, P839, DOI 10.1016/j.jmb.2007.08.022; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Matsumiya S, 2003, PROTEIN SCI, V12, P823, DOI 10.1110/ps.0234503; Matsumiya S, 2002, GENES CELLS, V7, P911, DOI 10.1046/j.1365-2443.2002.00572.x; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Oyama M, 2004, BIOCHEM BIOPH RES CO, V321, P183, DOI 10.1016/j.bbrc.2004.06.136; Parlanti E, 2007, NUCLEIC ACIDS RES, V35, P1569, DOI 10.1093/nar/gkl1159; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Sandigursky M, 2000, J BIOL CHEM, V275, P19146, DOI 10.1074/jbc.M001995200; Sartori AA, 2002, EMBO J, V21, P3182, DOI 10.1093/emboj/cdf309; Sartori AA, 2001, J BIOL CHEM, V276, P29979, DOI 10.1074/jbc.M102985200; SHIRAI T, 2008, PROTEINS IN PRESS; Starkuviene V, 2002, NUCLEIC ACIDS RES, V30, P2097, DOI 10.1093/nar/30.10.2097; Tom S, 2001, J BIOL CHEM, V276, P24817, DOI 10.1074/jbc.M101673200; Tori K, 2007, J BACTERIOL, V189, P5652, DOI 10.1128/JB.00073-07; Xia LQ, 2005, J MOL BIOL, V346, P1259, DOI 10.1016/j.jmb.2005.01.014; Yang HJ, 2002, J BIOL CHEM, V277, P22271, DOI 10.1074/jbc.M201820200	43	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24185	24193		10.1074/jbc.M802837200	http://dx.doi.org/10.1074/jbc.M802837200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18562313	Green Published, hybrid			2022-12-25	WOS:000258638900072
J	Fisk, JC; Ammerman, ML; Presnyak, V; Read, LK				Fisk, John C.; Ammerman, Michelle L.; Presnyak, Vladimir; Read, Laurie K.			TbRGG2, an essential RNA editing accessory factor in two Trypanosoma brucei life cycle stages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO ANALYSIS; MESSENGER-RNA; BINDING PROTEIN; ARGININE METHYLATION; GRNA-BINDING; BAND IV; COMPLEX; RBP16; IDENTIFICATION; EDITOSOME	In the mitochondria of kinetoplastid protozoa, including Trypanosoma brucei, RNA editing inserts and/or deletes uridines from pre-mRNAs to produce mature, translatable mRNAs. RNA editing is carried out by several related multiprotein complexes known as editosomes, which contain all of the enzymatic components required for catalysis of editing. In addition, noneditosome accessory factors necessary for editing of specific RNAs have also been described. Here, we report the in vitro and in vivo characterization of the mitochondrial TbRGG2 protein (originally termed TbRGGm) and demonstrate that it acts as an editing accessory factor. TbRGG2 is an RNA-binding protein with a preference for poly(U). TbRGG2 protein levels are up-regulated 10-fold in procyclic form T. brucei compared with bloodstream forms. Nevertheless, the protein is essential for growth in both life cycle stages. TbRGG2 associates with RNase-sensitive and RNase-insensitive mitochondrial complexes, and a small fraction of the protein co-immunoprecipitates with editosomes. RNA interference-mediated depletion of TbRGG2 in both procyclic and bloodstream form T. brucei leads to a dramatic decrease in pan-edited RNAs and in some cases a corresponding increase in the pre-edited RNA. TbRGG2 down-regulation also results in moderate stabilization of never-edited and minimally edited RNAs. Thus, our data are consistent with a model in which TbRGG2 is multifunctional, strongly facilitating the editing of pan-edited RNAs and modestly destabilizing minimally edited and never-edited RNAs. This is the first example of an RNA editing accessory factor that functions in the mammalian infective T. brucei life cycle stage.	[Fisk, John C.; Ammerman, Michelle L.; Presnyak, Vladimir; Read, Laurie K.] SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Read, LK (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.	lread@buffalo.edu		Presnyak, Vladimir/0000-0001-6695-7102; Ammerman, Michelle/0000-0002-4272-5822	National Institutes of Health [AI061580]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI061580 ( to L. K. R.).	Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; BUVOLI M, 1992, NUCLEIC ACIDS RES, V20, P5017, DOI 10.1093/nar/20.19.5017; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Ernst NL, 2003, MOL CELL, V11, P1525, DOI 10.1016/S1097-2765(03)00185-0; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; Goulah CC, 2007, J BIOL CHEM, V282, P7181, DOI 10.1074/jbc.M609485200; Goulah CC, 2006, RNA, V12, P1545, DOI 10.1261/rna.90106; Hajduk Steven L., 1997, Nucleic Acids Symposium Series, V36, P15; HARRIS ME, 1990, J BIOL CHEM, V265, P11368; Hayman ML, 1999, J BIOL CHEM, V274, P12067, DOI 10.1074/jbc.274.17.12067; Hitti E, 1998, NUCLEIC ACIDS RES, V26, P4382, DOI 10.1093/nar/26.19.4382; Huang CE, 2002, MOL CELL BIOL, V22, P3194, DOI 10.1128/MCB.22.9.3194-3203.2002; Huang CE, 2001, EMBO J, V20, P4694, DOI 10.1093/emboj/20.17.4694; Kang XD, 2005, P NATL ACAD SCI USA, V102, P1017, DOI 10.1073/pnas.0409275102; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; KOSLOWSKY DJ, 1992, NATURE, V356, P807, DOI 10.1038/356807a0; Lambert L, 1999, NUCLEIC ACIDS RES, V27, P1429, DOI 10.1093/nar/27.6.1429; Madison-Antenucci S, 1998, EMBO J, V17, P6368, DOI 10.1093/emboj/17.21.6368; Madison-Antenucci S, 2001, MOL CELL, V7, P879, DOI 10.1016/S1097-2765(01)00231-3; Mayer O, 2007, NUCLEIC ACIDS RES, V35, P1257, DOI 10.1093/nar/gkl1143; McManus MT, 2001, RNA, V7, P167, DOI 10.1017/S1355838201002072; Miller MM, 2006, RNA, V12, P1292, DOI 10.1261/rna.2331506; Ouaissi A, 2000, GENE, V253, P271, DOI 10.1016/S0378-1119(00)00253-5; Panigrahi AK, 2003, J AM SOC MASS SPECTR, V14, P728, DOI 10.1016/S1044-0305(03)00126-0; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Pelletier M, 2005, MOL BIOCHEM PARASIT, V144, P206, DOI 10.1016/j.molbiopara.2005.08.015; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; RILEY GR, 1994, J BIOL CHEM, V269, P6101; Ruiz FH, 2000, BIOCHEM BIOPH RES CO, V269, P491, DOI 10.1006/bbrc.2000.2270; Rusche LN, 2001, MOL CELL BIOL, V21, P979, DOI 10.1128/MCB.21.4.979-989.2001; Salavati R, 2006, RNA, V12, P819, DOI 10.1261/rna.2244106; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Shichijo S, 2003, INT J MOL MED, V12, P895; Trotter JR, 2005, MOL CELL, V20, P403, DOI 10.1016/j.molcel.2005.09.016; Vanhamme L, 1998, J BIOL CHEM, V273, P21825, DOI 10.1074/jbc.273.34.21825; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Wang BB, 2003, EUKARYOT CELL, V2, P578, DOI 10.1128/EC.2.3.578-587.2003; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Yamaguchi Y, 2001, J BIOCHEM, V129, P185, DOI 10.1093/oxfordjournals.jbchem.a002842; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Zeiner GM, 2003, EUKARYOT CELL, V2, P222, DOI 10.1128/EC.2.2.222-230.2003	46	59	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23016	23025		10.1074/jbc.M801021200	http://dx.doi.org/10.1074/jbc.M801021200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18583347	Green Published, hybrid			2022-12-25	WOS:000258455400014
J	Jiang, LI; Collins, J; Davis, R; Fraser, ID; Sternweis, PC				Jiang, Lily I.; Collins, Julie; Davis, Richard; Fraser, Iain D.; Sternweis, Paul C.			Regulation of cAMP responses by the G(12/13) pathway converges on adenylyl cyclase VII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ERYTHROLEUKEMIA CELL-LINE; SIGNAL-TRANSDUCTION; RNA INTERFERENCE; P115 RHOGEF; BETA-GAMMA; CROSS-TALK; G-PROTEINS; G-ALPHA(13); ACTIVATION	Regulation of intracellular cAMP by multiple pathways enables differential function of this ubiquitous second messenger in a context-dependent manner. Modulation of G(s)-stimulated intracellular cAMP has long been known to be modulated by the G(i) and Gq/Ca2+ pathways. Recently, the G(13) pathway was also shown to facilitate cAMP responses in murine macrophage cells. We report here that this synergistic regulation of cAMP synthesis by the G(s) and G(13) pathways is mediated by a specific isoform of adenylyl cyclase, AC7. Furthermore, this signaling paradigm exists in several hematopoietic lineages and can be recapitulated by exogenous expression of AC7 in HEK 293 cells. Mechanistic characterization of this synergistic interaction indicates that it occurs downstream of receptor activation and it can be mediated by the alpha subunit of either G(12) or G(13). Our results demonstrate that AC7 is a specific downstream effector of the G(12/13) pathway.	[Jiang, Lily I.; Collins, Julie; Davis, Richard; Sternweis, Paul C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Fraser, Iain D.] CALTECH, Div Biol, Pasadena, CA 91125 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; California Institute of Technology	Jiang, LI (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	lily.jiang@utsouthwestern.edu; paul.sternweis@utsouthwestern.edu	Fraser, Iain DC/L-4735-2017; Centeno, Patricia Pacios/O-8368-2016	Fraser, Iain DC/0000-0003-2272-3907; 	National Institutes of Health [GM62114, GM31954]; Robert A. Welch Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062114, R01GM031954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62114 and GM31954 (to P. C. S.). This work was also supported by grants from the Robert A. Welch Foundation (to P. C. S.) and the Alfred and Mabel Gilman Chair in Molecular Pharmacology (to P. C. S.).	Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BRASS LF, 1992, BIOCHEM J, V281, P73, DOI 10.1042/bj2810073; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Castro A, 2005, MED RES REV, V25, P229, DOI 10.1002/med.20020; Chin KV, 2002, ANN NY ACAD SCI, V968, P49, DOI 10.1111/j.1749-6632.2002.tb04326.x; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; Diel S, 2006, J BIOL CHEM, V281, P288, DOI 10.1074/jbc.M511045200; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HELLEVUO K, 1993, BIOCHEM BIOPH RES CO, V192, P311, DOI 10.1006/bbrc.1993.1415; Hines LM, 2006, J NEUROSCI, V26, P12609, DOI 10.1523/JNEUROSCI.1040-06.2006; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; Lania A, 2001, EUR J ENDOCRINOL, V145, P543, DOI 10.1530/eje.0.1450543; Lerner A, 2006, BIOCHEM J, V393, P21, DOI 10.1042/BJ20051368; Meigs TE, 2001, P NATL ACAD SCI USA, V98, P519, DOI 10.1073/pnas.021350998; Movsesian MA, 2005, CURR TOP DEV BIOL, V68, P25, DOI 10.1016/S0070-2153(05)68002-7; Niu JX, 2001, CURR BIOL, V11, P1686, DOI 10.1016/S0960-9822(01)00530-9; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Patel TB, 2001, GENE, V269, P13, DOI 10.1016/S0378-1119(01)00448-6; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Shi CS, 2000, J BIOL CHEM, V275, P24470, DOI 10.1074/jbc.M908449199; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; SINGER WD, 1994, J BIOL CHEM, V269, P19796; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; SUTKOWSKI EM, 1994, BIOCHEMISTRY-US, V33, P12852, DOI 10.1021/bi00209a017; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; TANG WJ, 1995, SCIENCE, V268, P1769, DOI 10.1126/science.7792604; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TURNER JT, 1992, J PHARMACOL EXP THER, V263, P708; VOYNOYASENETSKAYA T, 1994, J BIOL CHEM, V269, P4721; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; Yoshimura M, 1996, MOL PHARMACOL, V50, P43; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98	48	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23429	23439		10.1074/jbc.M803281200	http://dx.doi.org/10.1074/jbc.M803281200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18541530	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000258455400052
J	Sordet, O; Goldman, A; Redon, C; Solier, S; Rao, VA; Pommier, Y				Sordet, Olivier; Goldman, Abby; Redon, Christophe; Solier, Stephanie; Rao, V. Ashutosh; Pommier, Yves			Topoisomerase I requirement for death receptor-induced apoptotic nuclear fission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED DNA-DAMAGE; CARCINOMA CELL-LINES; TRAIL/APO2L-INDUCED APOPTOSIS; MITOCHONDRIAL-FUNCTION; RESISTANCE MECHANISM; CLEAVAGE COMPLEXES; ANTICANCER AGENTS; OXYGEN RADICALS; CYTOCHROME-C; CANCER-CELLS	Topoisomerase I (Top1) is known to relax DNA supercoiling generated by transcription, replication, and chromatin remodeling. However, it can be trapped on DNA as cleavage complexes (Top1cc) by oxidative and carcinogenic DNA lesions, base damage, and camptothecin treatment. We show here that Top1 is also functionally involved in death receptor-induced programmed cell death. In cells exposed to TRAIL or Fas ligand, Top1cc form at the onset of apoptosis. Those apoptotic Top1cc are prevented by caspase inhibition and Bax inactivation, indicating that both caspases and the mitochondrial death pathway are required for their formation. Accordingly, direct activation of the mitochondrial pathway by BH3 mimetic molecules induces apoptotic Top1cc. We also show that TRAIL-induced apoptotic Top1cc are preferentially formed by caspase-3-cleaved Top1 at sites of oxidative DNA lesions with an average of one apoptotic Top1cc/100 kbp. Examination of Top1 knockdown cells treated with TRAIL revealed similar DNA fragmentation but a marked decrease in apoptotic nuclear fission with reduced formation of nuclear bodies. Thus, we propose that Top1 contributes to the full apoptotic responses induced by TRAIL.	[Sordet, Olivier; Goldman, Abby; Redon, Christophe; Solier, Stephanie; Rao, V. Ashutosh; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bldg 37,Rm 5068, Bethesda, MD 20892 USA.	pommier@nih.gov	Rao, V Ashutosh/A-3569-2013; SOLIER, STEPHANIE/AAA-6851-2020; Sordet, Olivier/M-3271-2014	Rao, V Ashutosh/0000-0001-6817-8049; Sordet, Olivier/0000-0001-6027-4925; SOLIER, Stephanie/0000-0003-3867-4644	NATIONAL CANCER INSTITUTE [ZIABC006150, ZIABC006161, Z01BC006150, Z01BC006161] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; BERTRAND R, 1995, DRUG DEVELOP RES, V34, P138, DOI 10.1002/ddr.430340206; Bharti AK, 1996, J BIOL CHEM, V271, P1993, DOI 10.1074/jbc.271.4.1993; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cohen M, 2002, J STRUCT BIOL, V140, P232, DOI 10.1016/S1047-8477(02)00516-6; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daroui P, 2004, J BIOL CHEM, V279, P14587, DOI 10.1074/jbc.M311370200; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Desai SD, 2001, CANCER RES, V61, P5926; Durrieu F, 2000, CURR BIOL, V10, P923, DOI 10.1016/S0960-9822(00)00620-5; Gabler C, 2004, ANN RHEUM DIS, V63, P1135, DOI 10.1136/ard.2003.011452; Ganguly A, 2007, CANCER RES, V67, P11848, DOI 10.1158/0008-5472.CAN-07-1615; GOLDWASSER F, 1995, CANCER RES, V55, P2116; Grad JM, 2001, DRUG RESIST UPDATE, V4, P85, DOI 10.1054/drup.2001.0192; Haluska P, 1999, NUCLEIC ACIDS RES, V27, P2538, DOI 10.1093/nar/27.12.2538; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; KOHN KW, 1981, DNA REPAIR LABORATOR, P379; Lee MW, 2002, FEBS LETT, V512, P313, DOI 10.1016/S0014-5793(02)02225-1; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; Li TK, 1999, GENE DEV, V13, P1553, DOI 10.1101/gad.13.12.1553; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MATTERN MR, 1993, ONCOL RES, V5, P467; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; Miao ZH, 2007, CANCER RES, V67, P8752, DOI 10.1158/0008-5472.CAN-06-4554; Mo YY, 2000, J BIOL CHEM, V275, P41107, DOI 10.1074/jbc.M003135200; MOHR A, 2007, ONCOGENE; Morham SG, 1996, MOL CELL BIOL, V16, P6804; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nathan I, 2000, CYTOKINE, V12, P881, DOI 10.1006/cyto.1999.0638; Park SY, 2005, CANCER RES, V65, P3894, DOI 10.1158/0008-5472.CAN-04-4014; Pommier Y, 2000, P NATL ACAD SCI USA, V97, P10739, DOI 10.1073/pnas.190312697; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pourquier P, 1997, J BIOL CHEM, V272, P26441, DOI 10.1074/jbc.272.42.26441; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Rallabhandi P, 2002, J BIOL CHEM, V277, P40020, DOI 10.1074/jbc.M200388200; Ravi R, 2002, CANCER RES, V62, P1583; Reinhold WC, 2003, CANCER RES, V63, P1000; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Rockstroh A, 2007, ONCOGENE, V26, P123, DOI 10.1038/sj.onc.1209766; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Samejima K, 1999, J BIOL CHEM, V274, P4335, DOI 10.1074/jbc.274.7.4335; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Sen N, 2007, CELL DEATH DIFFER, V14, P358, DOI 10.1038/sj.cdd.4402002; Shakibaei M, 2005, ANTIOXID REDOX SIGN, V7, P482, DOI 10.1089/ars.2005.7.482; Shykind BM, 1997, GENE DEV, V11, P397, DOI 10.1101/gad.11.3.397; Sirikantaramas S, 2008, P NATL ACAD SCI USA, V105, P6782, DOI 10.1073/pnas.0801038105; Soe K, 2004, DNA REPAIR, V3, P387, DOI 10.1016/j.dnarep.2003.12.003; Sordet O, 2004, CELL CYCLE, V3, P1095; Sordet O, 2004, J BIOL CHEM, V279, P50499, DOI 10.1074/jbc.M410277200; Sordet O, 2004, J BIOL CHEM, V279, P33968, DOI 10.1074/jbc.M404620200; Sordet O, 2006, MOL CANCER THER, V5, P3139, DOI 10.1158/1535-7163.MCT-06-0463; Soret J, 2003, CANCER RES, V63, P8203; SUBRAMANIAN D, 1995, CANCER RES, V55, P2097; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wei MC, 2000, GENE DEV, V14, P2060; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	64	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23200	23208		10.1074/jbc.M801146200	http://dx.doi.org/10.1074/jbc.M801146200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556653	Green Published, hybrid			2022-12-25	WOS:000258455400033
J	Chen, Z; Gallie, DR				Chen, Zhong; Gallie, Daniel R.			Dehydroascorbate reductase affects non-photochemical quenching and photosynthetic performance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEAF ASCORBATE CONTENT; ELECTRON-TRANSPORT; CHLOROPHYLL FLUORESCENCE; PHOTOOXIDATIVE STRESS; ARABIDOPSIS MUTANTS; THYLAKOID LUMEN; PHOTOSYSTEM-II; SHADE LEAVES; HIGH LIGHT; ACID	Ascorbic acid (Asc) is a major antioxidant involved in photo-protection and photosynthetic function in plants. Dehydroascorbate reductase (DHAR) catalyzes the regeneration of Asc from its oxidized state and serves as an important regulator of Asc recycling. In this work, we used a molecular biochemical approach to investigate how the efficiency of Asc recycling affects non-photochemical quenching (NPQ). Suppression of DHAR expression resulted in a lower induction of NPQ that correlated with reductions in chlorophyll and xanthophyll pigments, quantum yield of photosystem II, and CO2 assimilation, whereas the level of reactive oxygen species increased. The quickly reversible component of NPQ decreased and the slowly reversible or irreversible component of NPQ increased following a reduction in DHAR expression. Significant photoinhibition was also observed following exposure to high light. Direct feeding with Asc restored the appropriate induction of NPQ in DHAR-suppressed leaves. In contrast, increasing DHAR expression increased the pool size of xanthophyll and chlorophyll pigments as well as the rate of CO2 assimilation, particularly at high light intensities, whereas the level of reactive oxygen species was reduced. Leaves with increased DHAR expression experienced less photoinhibition than did wild-type plants following exposure to high light. DHAR activity, therefore, can affect the appropriate induction of NPQ and level of photoprotection during exposure to high light.	[Chen, Zhong; Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Gallie, DR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	drgallie@citrus.ucr.edu						ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K., 1987, PHOTOINHIBITION, P227; Asada K, 1994, PHOTOINHIBITION PHOT, P129; Bartoli CG, 2000, PLANT PHYSIOL, V123, P335, DOI 10.1104/pp.123.1.335; Chen Z, 2005, PLANT PHYSIOL, V138, P1673, DOI 10.1104/pp.105.062000; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; Chen Z, 2006, PLANT PHYSIOL, V142, P775, DOI 10.1104/pp.106.085506; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; DEMMIGADAMS B, 1990, PHOTOSYNTH RES, V25, P187, DOI 10.1007/BF00033160; DEMMIGADAMS B, 1992, PLANT CELL ENVIRON, V15, P411, DOI 10.1111/j.1365-3040.1992.tb00991.x; DEMMIGADAMS B, 1989, PLANT PHYSIOL, V90, P881, DOI 10.1104/pp.90.3.881; FORTI G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P408, DOI 10.1016/0005-2728(93)90246-C; FOYER C, 1983, PLANTA, V157, P239, DOI 10.1007/BF00405188; Gay CA, 2002, ANAL BIOCHEM, V304, P42, DOI 10.1006/abio.2001.5566; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; GRACE S, 1995, BBA-BIOENERGETICS, V1229, P155, DOI 10.1016/0005-2728(94)00183-6; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Horemans N, 2000, PLANT PHYSIOL BIOCH, V38, P531, DOI 10.1016/S0981-9428(00)00782-8; HOREMANS N, 1999, DIFFERENT PATHWAYS L, P217; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ivanov BN, 2001, ARCH BIOCHEM BIOPHYS, V385, P145, DOI 10.1006/abbi.2000.2156; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kiddle G, 2003, ANTIOXID REDOX SIGN, V5, P23, DOI 10.1089/152308603321223513; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Mano J, 2004, ARCH BIOCHEM BIOPHYS, V429, P71, DOI 10.1016/j.abb.2004.05.022; Mano J, 1997, PHOTOSYNTH RES, V53, P197, DOI 10.1023/A:1005832022204; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; MIYAKE C, 1994, PLANT CELL PHYSIOL, V35, P539, DOI 10.1093/oxfordjournals.pcp.a078628; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Muller-Moule P, 2004, PLANT PHYSIOL, V134, P1163, DOI 10.1104/pp.103.032375; Muller-Moule P, 2003, PLANT PHYSIOL, V133, P748, DOI 10.1104/pp.103.026252; Muller-Moule P, 2002, PLANT PHYSIOL, V128, P970, DOI 10.1104/pp.010924; NISHIYAMA Y, 2006, BIOCHIM BIOPHYS ACTA, V7157, P742; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 2005, J EXP BOT, V56, P375, DOI 10.1093/jxb/eri056; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Noctor G, 2000, PHILOS T R SOC B, V355, P1465, DOI 10.1098/rstb.2000.0707; Osmond CB, 1994, PHOTOINHIBITION PHOT, P1; Pastori GM, 2003, PLANT CELL, V15, P939, DOI 10.1105/tpc.010538; Pavet V, 2005, PLANT PHYSIOL, V139, P1291, DOI 10.1104/pp.105.067686; Pignocchi C, 2003, PLANT PHYSIOL, V132, P1631, DOI 10.1104/pp.103.022798; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Siendones E, 1999, PLANT PHYSIOL, V120, P907, DOI 10.1104/pp.120.3.907; Smirnoff N, 1996, ANN BOT-LONDON, V78, P661, DOI 10.1006/anbo.1996.0175; Smirnoff N, 2000, PHILOS T R SOC B, V355, P1455, DOI 10.1098/rstb.2000.0706; Veljovic-Jovanovic SD, 2001, PLANT PHYSIOL, V127, P426, DOI 10.1104/pp.010141; WALTERS RG, 1991, PHOTOSYNTH RES, V27, P121, DOI 10.1007/BF00033251	54	31	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21347	21361		10.1074/jbc.M802601200	http://dx.doi.org/10.1074/jbc.M802601200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539599	hybrid			2022-12-25	WOS:000257898800006
J	Jewell, JL; Oh, E; Bennett, SM; Meroueh, SO; Thurmond, DC				Jewell, Jenna L.; Oh, Eunjin; Bennett, Sara M.; Meroueh, Samy O.; Thurmond, Debbie C.			The tyrosine phosphorylation of Munc18c induces a switch in binding specificity from syntaxin 4 to Doc2 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUT4 TRANSLOCATION; INSULIN-INDUCED TRANSLOCATION; NEURONAL SNARE COMPLEX; VESICLE EXOCYTOSIS; 3T3-L1 ADIPOCYTES; SEC1/MUNC18 PROTEINS; CLOSED CONFORMATION; GLUCOSE-TRANSPORT; TRANSGENIC MICE; T-SNARES	Glucose-stimulated insulin secretion is mediated by syntaxin 4-based SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) protein complexes and the Sec1/Munc18 protein Munc18c. Our laboratory recently reported that Munc18c-syntaxin 4 complexes are further regulated by the competitive binding of the double C2 domain protein Doc2 beta to Munc18c, although the underlying mechanism for this is unknown. Because the Doc2 beta binding region of Munc18c contained residue Tyr-219 and this residue becomes phosphorylated in response to glucose stimulation, we hypothesized that the mechanism would involve Munc18c phosphorylation. Coimmunoprecipitation analyses using detergent lysates prepared from pervanadate-treated MIN6 beta cells revealed that the tyrosine phosphorylation of Munc18c corresponded to a 60% decrease in Munc18c-syntaxin 4 association with a coordinate 2-fold increase in Munc18c-Doc2 beta binding. In vitro binding assays identified syntaxin 4 residues 118-194 as sufficient to confer its interaction with Munc18c; residues 118-194 contain the Hc alpha-helix and flexible linker region controlling transition of syntaxins between closed and open conformations. When overexpressed in MIN6 cells, this Hc-linker region functioned as a competitive inhibitor of endogenous syntaxin 4-Munc18c binding, increased syntaxin 4 binding to VAMP2, and significantly enhanced glucose-stimulated secretion. Molecular modeling of these new interactions yielded the predictions 1) that Tyr-219 of Munc18c remains buried under basal conditions in a conformation that is favorable for interaction with "closed" syntaxin 4 and 2) that stimulation leads to changes in syntaxin 4 contacts to facilitate exposure of Munc18c Tyr-219 for phosphorylation and Doc2 beta binding.	[Jewell, Jenna L.; Oh, Eunjin; Bennett, Sara M.; Meroueh, Samy O.; Thurmond, Debbie C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Thurmond, DC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	dthurmon@iupui.edu			NIDDK NIH HHS [DK 076614, DK 067912] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067912, R01DK076614] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araki S, 1997, BIOCHEM BIOPH RES CO, V234, P257, DOI 10.1006/bbrc.1997.6560; Betz A, 1997, J BIOL CHEM, V272, P2520; Bracher A, 2001, J MOL BIOL, V306, P7, DOI 10.1006/jmbi.2000.4347; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; Chen GL, 2003, FEBS LETT, V534, P54, DOI 10.1016/S0014-5793(02)03774-2; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; Cosen-Binker LI, 2007, J BIOL CHEM, V282, P13047, DOI 10.1074/jbc.M611132200; D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526; Macaulay SL, 2002, FEBS LETT, V528, P154, DOI 10.1016/S0014-5793(02)03279-9; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Misura KMS, 2001, J BIOL CHEM, V276, P41301, DOI 10.1074/jbc.M106853200; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Mulder H, 2001, J BIOL CHEM, V276, P6479, DOI 10.1074/jbc.M010364200; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Oh E, 2007, J BIOL CHEM, V282, P32613, DOI 10.1074/jbc.M706591200; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; PALMER ZJ, 2008, BIOCH J IN PRESS; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Saito T, 2003, J BIOL CHEM, V278, P36718, DOI 10.1074/jbc.M305114200; Sassa T, 1999, J NEUROSCI, V19, P4772; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Spurlin BA, 2004, DIABETES, V53, P2223, DOI 10.2337/diabetes.53.9.2223; Spurlin BA, 2003, DIABETES, V52, P1910, DOI 10.2337/diabetes.52.8.1910; Stenberg A, 1999, ACTA OBSTET GYN SCAN, V78, P436, DOI 10.1034/j.1600-0412.1999.780517.x; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Thurmond DC, 2001, MOL MEMBR BIOL, V18, P237; Thurmond Debbie C., 2007, P52, DOI 10.1007/978-0-387-72204-7_3; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	61	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21734	21746		10.1074/jbc.M710445200	http://dx.doi.org/10.1074/jbc.M710445200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18541526	Green Published, hybrid			2022-12-25	WOS:000257898800047
J	Burgevin, A; Saveanu, L; Kim, Y; Barilleau, E; Kotturi, M; Sette, A; van Endert, P; Peters, B				Burgevin, Anne; Saveanu, Loredana; Kim, Yohan; Barilleau, Emilie; Kotturi, Maya; Sette, Alessandro; van Endert, Peter; Peters, Bjoern			A Detailed Analysis of the Murine TAP Transporter Substrate Specificity	PLOS ONE			English	Article								Background: The transporter associated with antigen processing ( TAP) supplies cytosolic peptides into the endoplasmic reticulum for binding to major histocompatibility complex (MHC) class I molecules. Its specificity therefore influences the repertoire of peptides presented by MHC molecules. Compared to human TAP, murine TAP's binding specificity has not been characterized as well, even though murine systems are widely used for basic studies of antigen processing and presentation. Methodology/Principal Findings: We performed a detailed experimental analysis of murine TAP binding specificity by measuring the binding affinities of 323 peptides. Based on this experimental data, a computational model of murine TAP specificity was constructed. The model was compared to previously generated data on human and murine TAP specificities. In addition, the murine TAP specificities for known epitopes and random peptides were predicted and compared to assess the impact of murine TAP selectivity on epitope selection. Conclusions/Significance: Comparisons to a previously constructed model of human TAP specificity confirms the well-established differences for peptide substrates with positively charged C-termini. In addition these comparisons show that several residues at the N-terminus of peptides which strongly influence binding to human TAP showed little effect on binding to murine TAP, and that the overall influence of the aminoterminal residues on peptide affinity for murine TAP is much lower than for the human transporter. Murine TAP also partly prefers different hydrophobic amino acids than human TAP in the carboxyterminal position. These species-dependent differences in specificity determined in vitro are shown to correlate with the epitope repertoire recognized in vivo. The quantitative model of binding specificity of murine TAP developed herein should be useful for interpreting epitope mapping and immunogenicity data obtained in humanized mouse models.	[Burgevin, Anne; Saveanu, Loredana; Barilleau, Emilie; van Endert, Peter] INSERM, Paris, France; [Burgevin, Anne; Saveanu, Loredana; Barilleau, Emilie; van Endert, Peter] Univ Paris 05, Fac Med Rene Descartes, Paris, France; [Kim, Yohan; Kotturi, Maya; Sette, Alessandro; Peters, Bjoern] La Jolla Inst Allergy & Immunol, La Jolla, CA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; La Jolla Institute for Immunology	Burgevin, A (corresponding author), INSERM, Paris, France.	vanendert@necker.fr; bpeters@liai.org	van Endert, Peter/R-4606-2017; Sette, Alessandro/AFO-8916-2022; SAVEANU, Loredana/Q-1241-2019; Saveanu, Loredana/K-6821-2017; Pacific-Southwest, RCE/B-6155-2009	van Endert, Peter/0000-0003-3782-0750; SAVEANU, Loredana/0000-0003-3138-7968; 	National Institutes of Health [HHSN26620040006C]; PSWRCE [U54 AI065359]; European Commission [LSHB-CT-2003-503231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PSWRCE; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health contract HHSN26620040006C to AS and BP, PSWRCE grant U54 AI065359 to BP, and grant LSHB-CT-2003-503231 (Genomes to Vaccines) of the European Commission to PvE.	Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Choi C, 2005, BLOOD, V105, P2132, DOI 10.1182/blood-2004-01-0366; Daniel S, 1998, J IMMUNOL, V161, P617; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Fruci D, 2003, J IMMUNOL, V170, P2977, DOI 10.4049/jimmunol.170.6.2977; Gromme M, 1997, EUR J IMMUNOL, V27, P898, DOI 10.1002/eji.1830270415; Gubler B, 1998, MOL IMMUNOL, V35, P427, DOI 10.1016/S0161-5890(98)00059-5; HEEMELS MT, 1994, IMMUNITY, V1, P775, DOI 10.1016/S1074-7613(94)80019-7; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; Herberts CA, 2006, J IMMUNOL, V176, P2697, DOI 10.4049/jimmunol.176.5.2697; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Koopmann JO, 2000, IMMUNITY, V13, P117, DOI 10.1016/S1074-7613(00)00013-3; Kotturi MF, 2007, J VIROL, V81, P4928, DOI 10.1128/JVI.02632-06; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Lauvau G, 2004, EUR J IMMUNOL, V34, P913, DOI 10.1002/eji.200424944; Li Z, 2003, INFECT IMMUN, V71, P3920, DOI 10.1128/IAI.71.7.3920-3926.2003; Liblau RS, 2002, IMMUNITY, V17, P1, DOI 10.1016/S1074-7613(02)00338-2; McMurry JA, 2007, CURR MOL MED, V7, P351, DOI 10.2174/156652407780831584; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, CURR OPIN IMMUNOL, V6, P32, DOI 10.1016/0952-7915(94)90030-2; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; NEEFJES J, 1995, EUR J IMMUNOL, V25, P1133, DOI 10.1002/eji.1830250444; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; PAMER EG, 1994, J IMMUNOL, V152, P686; Pascolo S, 2005, EXPERT OPIN BIOL TH, V5, P919, DOI 10.1517/14712598.5.7.919; Peh CA, 2000, J IMMUNOL, V164, P292, DOI 10.4049/jimmunol.164.1.292; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Sette A, 2007, CURR OPIN IMMUNOL, V19, P106, DOI 10.1016/j.coi.2006.11.002; Sidney J, 2007, IMMUNOGENETICS, V59, P745, DOI 10.1007/s00251-007-0243-5; Swain SL, 2004, VIRAL IMMUNOL, V17, P197, DOI 10.1089/0882824041310577; Udaka K, 2002, J IMMUNOL, V169, P5744, DOI 10.4049/jimmunol.169.10.5744; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; van Endert PM, 2002, TRENDS BIOCHEM SCI, V27, P454, DOI 10.1016/S0968-0004(02)02090-X; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4	47	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2402	10.1371/journal.pone.0002402	http://dx.doi.org/10.1371/journal.pone.0002402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545702	Green Published, gold, Green Submitted			2022-12-25	WOS:000263248800040
J	Cabantous, S; Rogers, Y; Terwilliger, TC; Waldo, GS				Cabantous, Stephanie; Rogers, Yvonne; Terwilliger, Thomas C.; Waldo, Geoffrey S.			New Molecular Reporters for Rapid Protein Folding Assays	PLOS ONE			English	Article								The GFP folding reporter assay [1] uses a C-terminal GFP fusion to report on the folding success of upstream fused polypeptides. The GFP folding assay is widely-used for screening protein variants with improved folding and solubility [2-8], but truncation artifacts may arise during evolution, i.e. from de novo internal ribosome entry sites [9]. One way to reduce such artifacts would be to insert target genes within the scaffolding of GFP circular permuted variants. Circular permutants of fluorescent proteins often misfold and are non-fluorescent, and do not readily tolerate fused polypeptides within the fluorescent protein scaffolding [10-12]. To overcome these limitations, and to increase the dynamic range for reporting on protein misfolding, we have created eight GFP insertion reporters with different sensitivities to protein misfolding using chimeras of two previously described GFP variants, the GFP folding reporter [1] and the robustly-folding ''superfolder'' GFP [13]. We applied this technology to engineer soluble variants of Rv0113, a protein from Mycobacterium tuberculosis initially expressed as inclusion bodies in Escherichia coli. Using GFP insertion reporters with increasing stringency for each cycle of mutagenesis and selection led to a variant that produced large amounts of soluble protein at 37 degrees C in Escherichia coli. The new reporter constructs discriminate against truncation artifacts previously isolated during directed evolution of Rv0113 using the original C-terminal GFP folding reporter. Using GFP insertion reporters with variable stringency should prove useful for engineering protein variants with improved folding and solubility, while reducing the number of artifacts arising from internal cryptic ribosome initiation sites.	[Cabantous, Stephanie; Rogers, Yvonne; Terwilliger, Thomas C.; Waldo, Geoffrey S.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Cabantous, Stephanie] Ctr Natl Rech Sci, Inst Pharmacol Biol Structurale, Toulouse, France	United States Department of Energy (DOE); Los Alamos National Laboratory; Centre National de la Recherche Scientifique (CNRS)	Cabantous, S (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA.	waldo@lanl.gov	Cabantous, Stephanie/M-3282-2014; Terwilliger, Thomas C/K-4109-2012; Terwilliger, Thomas/AEF-4827-2022; Terwilliger, Thomas/AAM-4079-2020; Cabantous, Stephanie/AAB-5113-2020	Cabantous, Stephanie/0000-0002-8406-9421; Terwilliger, Thomas C/0000-0001-6384-0320; Terwilliger, Thomas/0000-0001-6384-0320; Cabantous, Stephanie/0000-0002-8406-9421	NIH;  [1 U54 GM074946-01US]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074946] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (grant NIH 1 U54 GM074946-01US, Integrated Center for Structure and Function Innovation, PI: Terwilliger).	ADHIN MR, 1990, J MOL BIOL, V213, P811, DOI 10.1016/S0022-2836(05)80265-7; Akemann W, 2001, PHOTOCHEM PHOTOBIOL, V74, P356, DOI 10.1562/0031-8655(2001)074<0356:FCOPEG>2.0.CO;2; Andre A, 2000, FEBS LETT, V468, P73, DOI 10.1016/S0014-5793(00)01198-4; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Baneyx Francois, 2003, Methods Mol Biol, V205, P171; Bernath K, 2005, J MOL BIOL, V345, P1015, DOI 10.1016/j.jmb.2004.11.017; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; CABANTOUS S, 2007, EXPRESSION SYSTEMS M; Cabantous Stephanie, 2005, Journal of Structural and Functional Genomics, V6, P113, DOI 10.1007/s10969-005-5247-5; Finucane MD, 1999, BIOCHEMISTRY-US, V38, P11604, DOI 10.1021/bi990765n; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Georgiou G, 1996, CURR OPIN BIOTECH, V7, P190, DOI 10.1016/S0958-1669(96)80012-7; Heddle C, 2007, PROTEIN ENG DES SEL, V20, P327, DOI 10.1093/protein/gzm024; Ito Y, 2004, J MOL EVOL, V58, P196, DOI 10.1007/s00239-003-2542-2; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; Jiang SM, 2007, BIOCHEM J, V402, P429, DOI 10.1042/BJ20061457; Jung S, 1999, J MOL BIOL, V294, P163, DOI 10.1006/jmbi.1999.3196; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kawasaki M, 2001, BIOCHEM BIOPH RES CO, V280, P842, DOI 10.1006/bbrc.2000.4229; Kim W, 2005, J BIOL CHEM, V280, P35069, DOI 10.1074/jbc.M505763200; Kim W, 2006, ACS CHEM BIOL, V1, P461, DOI 10.1021/cb600135w; Kristensen P, 1998, FOLD DES, V3, P321, DOI 10.1016/S1359-0278(98)00044-3; Matsuura T, 2003, FEBS LETT, V539, P24, DOI 10.1016/S0014-5793(03)00178-9; Maxwell KL, 1999, PROTEIN SCI, V8, P1908, DOI 10.1110/ps.8.9.1908; Olson CA, 2007, PROTEIN SCI, V16, P476, DOI 10.1110/ps.062498407; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pedelacq JD, 2002, NAT BIOTECHNOL, V20, P927, DOI 10.1038/nbt732; Roberts RW, 1999, CURR OPIN CHEM BIOL, V3, P268, DOI 10.1016/S1367-5931(99)80042-8; Sharkov NA, 2002, J BIOL CHEM, V277, P5796, DOI 10.1074/jbc.M106849200; Song LT, 2003, FASEB J, V17, P1674, DOI 10.1096/fj.03-0105com; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Tur MK, 2001, BIOTECHNIQUES, V30, P404, DOI 10.2144/01302rr04; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Waldo GS, 2003, CURR OPIN CHEM BIOL, V7, P33, DOI 10.1016/S1367-5931(02)00017-0; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wurth C, 2002, J MOL BIOL, V319, P1279, DOI 10.1016/S0022-2836(02)00399-6; Yang JK, 2003, P NATL ACAD SCI USA, V100, P455, DOI 10.1073/pnas.0137017100; Yokoyama S, 2003, CURR OPIN CHEM BIOL, V7, P39, DOI 10.1016/S1367-5931(02)00019-4	39	43	48	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2387	10.1371/journal.pone.0002387	http://dx.doi.org/10.1371/journal.pone.0002387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545698	Green Published, Green Submitted, gold			2022-12-25	WOS:000263248800026
J	Hayashi, H; Kume, T				Hayashi, Hisaki; Kume, Tsutomu			Foxc Transcription Factors Directly Regulate Dll4 and Hey2 Expression by Interacting with the VEGF-Notch Signaling Pathways in Endothelial Cells	PLOS ONE			English	Article								Background: Recent studies have shown that in the developing embryo, arterial and venous identity is established by genetic mechanisms before circulation begins. Vascular endothelial growth factor (VEGF) signaling and its downstream Notch pathway play critical roles in arterial cell fate determination. We have recently shown that Foxc1 and Foxc2, two closely related Fox transcription factors, are essential for arterial cell specification during development by directly inducing the transcription of Delta-like 4 (Dll4), a ligand for Notch receptors. However, the basic mechanisms whereby the VEGF and Notch signaling pathways control transcriptional regulation of arterial-specific genes have yet to be elucidated. Methodologies/Principal Findings: In the current study, we examined whether and how Foxc transcription factors are involved in VEGF and Notch signaling in induction of Dll4 as well as the Notch target gene Hey2 in endothelial cells. We found that Foxc1 and Foxc2 directly activate the Hey2 promoter via Foxc binding elements. Significantly, Foxc2 physically and functionally interacts with a Notch transcriptional activation complex containing Su(H) and Notch intracellular domain to induce Hey2 promoter activity. Moreover, activation of the Dll4 and Hey2 promoters is induced by VEGF in conjunction with either Foxc1 or Foxc2 more than by either component alone. VEGF-activated PI3K and ERK intracellular pathways modulate the transcriptional activity of Foxc proteins in Dll4 and Hey2 induction. Conclusions/Significance: Our new findings demonstrate that Foxc transcriptional factors interact with VEGF and Notch signaling to regulate arterial gene expression in multiple steps of the VEGF-Dll4-Notch-Hey2 signaling pathway.	[Hayashi, Hisaki; Kume, Tsutomu] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37235 USA	Vanderbilt University	Hayashi, H (corresponding author), Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37235 USA.	tsutomu.kume@vanderbilt.edu			NIH [HL67105, HL74121]; NATIONAL EYE INSTITUTE [R01EY019484] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074121, P01HL067105] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from the NIH to T. K. (HL67105 and HL74121).	Abid MR, 2006, J BIOL CHEM, V281, P35544, DOI 10.1074/jbc.M608620200; Berry FB, 2006, J BIOL CHEM, V281, P10098, DOI 10.1074/jbc.M513629200; Berry FB, 2002, J BIOL CHEM, V277, P10292, DOI 10.1074/jbc.M110266200; Blum S, 2001, J BIOL CHEM, V276, P33428, DOI 10.1074/jbc.M105474200; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fujita H, 2006, CIRC RES, V98, P626, DOI 10.1161/01.RES.0000207407.51752.3c; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Hong CC, 2006, CURR BIOL, V16, P1366, DOI 10.1016/j.cub.2006.05.046; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kokubo H, 2005, DEV BIOL, V278, P301, DOI 10.1016/j.ydbio.2004.10.025; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Kume T, 2000, DEVELOPMENT, V127, P1387; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Sakata Y, 2002, P NATL ACAD SCI USA, V99, P16197, DOI 10.1073/pnas.252648999; Samatar AA, 2002, J BIOL CHEM, V277, P28118, DOI 10.1074/jbc.M203686200; Seo S, 2006, DEV BIOL, V296, P421, DOI 10.1016/j.ydbio.2006.06.012; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zhang HM, 2007, AM J PATHOL, V171, P1113, DOI 10.2353/ajpath.2007.070226; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	44	133	143	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2401	10.1371/journal.pone.0002401	http://dx.doi.org/10.1371/journal.pone.0002401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545664	Green Published, gold, Green Submitted			2022-12-25	WOS:000263248800039
J	Lefevre, E; Roussel, B; Amblard, C; Sime-Ngando, T				Lefevre, Emilie; Roussel, Balbine; Amblard, Christian; Sime-Ngando, Telesphore			The Molecular Diversity of Freshwater Picoeukaryotes Reveals High Occurrence of Putative Parasitoids in the Plankton	PLOS ONE			English	Article							VIRUS-SIZED PARTICLES; RIBOSOMAL-RNA GENE; EUKARYOTIC DIVERSITY; MICROBIAL EUKARYOTES; COASTAL SITE; FOOD-WEB; SP-NOV.; LAKE; GROWTH; PHYTOPLANKTON	Eukaryotic microorganisms have been undersampled in biodiversity studies in freshwater environments. We present an original 18S rDNA survey of freshwater picoeukaryotes sampled during spring/summer 2005, complementing an earlier study conducted in autumn 2004 in Lake Pavin (France). These studies were designed to detect the small unidentified heterotrophic flagellates (HF, 0.6-5 mu m) which are considered the main bacterivores in aquatic systems. Alveolates, Fungi and Stramenopiles represented 65% of the total diversity and differed from the dominant groups known from microscopic studies. Fungi and Telonemia taxa were restricted to the oxic zone which displayed two fold more operational taxonomic units (OTUs) than the oxycline. Temporal forcing also appeared as a driving force in the diversification within targeted organisms. Several sequences were not similar to those in databases and were considered as new or unsampled taxa, some of which may be typical of freshwater environments. Two taxa known from marine systems, the genera Telonema and Amoebophrya, were retrieved for the first time in our freshwater study. The analysis of potential trophic strategies displayed among the targeted HF highlighted the dominance of parasites and saprotrophs, and provided indications that these organisms have probably been wrongfully regarded as bacterivores in previous studies. A theoretical exercise based on a new 'parasite/saprotroph-dominated HF hypothesis' demonstrates that the inclusion of parasites and saprotrophs may increase the functional role of the microbial loop as a link for carbon flows in pelagic ecosystems. New interesting perspectives in aquatic microbial ecology are thus opened.	[Lefevre, Emilie; Roussel, Balbine; Amblard, Christian; Sime-Ngando, Telesphore] Univ Blaise Pascal Clermont Ferrand II, CNRS, UMR 6023, LMGE, Aubiere, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA)	Lefevre, E (corresponding author), Univ Blaise Pascal Clermont Ferrand II, CNRS, UMR 6023, LMGE, Aubiere, France.	telesphore.sime-ngando@univ-bpclermont.fr	Sime-Ngando, Télesphore/M-4134-2019	Sime-Ngando, Télesphore/0000-0002-7240-5803	French Ministere de la Recherche et de la technologie (MRT) [fellowships]; French ANR Programme Blanc DREP	French Ministere de la Recherche et de la technologie (MRT); French ANR Programme Blanc DREP(French National Research Agency (ANR))	EL and BR were supported by fellowships from the French Ministere de la Recherche et de la technologie (MRT). This study was supported by a grant from the French ANR Programme Blanc DREP: Diversite et roles des Eumycetes dans le pelagos, Coordinator TSN.	Alster A, 2007, HYDROBIOLOGIA, V578, P131, DOI 10.1007/s10750-006-0439-y; Amaral Zettler Linda A., 2002, Nature (London), V417, P137, DOI 10.1038/417137a; Arndt H, 2000, SYST ASSOC SPEC VOL, V59, P240; Auer B, 2001, FRESHWATER BIOL, V46, P959, DOI 10.1046/j.1365-2427.2001.00730.x; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bass D, 2004, INT J SYST EVOL MICR, V54, P2393, DOI 10.1099/ijs.0.63229-0; Bettarel Y, 2005, AQUAT MICROB ECOL, V39, P205, DOI 10.3354/ame039205; BRUGEROLLE G, 1979, PROTISTOLOGICA, V15, P183; Brugerolle G, 2002, EUR J PROTISTOL, V37, P379, DOI 10.1078/0932-4739-00837; Burreson EM, 2005, J EUKARYOT MICROBIOL, V52, P258, DOI 10.1111/j.1550-7408.2005.05-00035.x; Carrias JF, 2001, AQUAT MICROB ECOL, V24, P163, DOI 10.3354/ame024163; Carrias JF, 1998, FRESHWATER BIOL, V39, P91, DOI 10.1046/j.1365-2427.1998.00263.x; Cleven EJ, 2001, AQUAT MICROB ECOL, V23, P147, DOI 10.3354/ame023147; Coats DW, 1996, AQUAT MICROB ECOL, V11, P1, DOI 10.3354/ame011001; Comte J, 2006, MICROB ECOL, V52, P72, DOI 10.1007/s00248-004-0230-4; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; DEBRES G, 1996, HELGOLAND MAR RES, V50, P497; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Domaizon I, 2003, FEMS MICROBIOL ECOL, V46, P317, DOI 10.1016/S0168-6496(03)00248-4; DUGAN CF, 2007, J EUKARYOT MICROBIOL, V54, P263; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; GASOL JM, 1993, LIMNOL OCEANOGR, V38, P657, DOI 10.4319/lo.1993.38.3.0657; Gestal C, 2006, ENVIRON MICROBIOL, V8, P1105, DOI 10.1111/j.1462-2920.2006.01008.x; GLEASON FH, 1989, MYCOLOGIA, V81, P811, DOI 10.2307/3759889; GONZALEZ JM, 1993, MAR ECOL PROG SER, V94, P1, DOI 10.3354/meps094001; HAGSTROM A, 1988, MAR ECOL PROG SER, V49, P171, DOI 10.3354/meps049171; Hausner G, 2000, CAN J BOT, V78, P124, DOI 10.1139/b99-177; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Ibelings BW, 2004, J PHYCOL, V40, P437, DOI 10.1111/j.1529-8817.2004.03117.x; James Timothy Y., 2000, Canadian Journal of Botany, V78, P336; Kagami M, 2004, LIMNOL OCEANOGR, V49, P680, DOI 10.4319/lo.2004.49.3.0680; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Kagami M, 2007, P R SOC B, V274, P1561, DOI 10.1098/rspb.2007.0425; Klaveness D, 2005, INT J SYST EVOL MICR, V55, P2595, DOI 10.1099/ijs.0.63652-0; Laybourn-Parry J, 2000, SYST ASSOC SPEC VOL, V59, P216; Leander BS, 2003, J EUKARYOT MICROBIOL, V50, P334, DOI 10.1111/j.1550-7408.2003.tb00145.x; Lee WJ, 1998, PROTIST, V149, P229, DOI 10.1016/S1434-4610(98)70031-8; Lefevre E, 2007, ENVIRON MICROBIOL, V9, P61, DOI 10.1111/j.1462-2920.2006.01111.x; Lefranc M, 2005, APPL ENVIRON MICROB, V71, P5935, DOI 10.1128/AEM.71.10.5935-5942.2005; Letcher PM, 2006, MYCOL RES, V110, P898, DOI 10.1016/j.mycres.2006.06.011; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Massana R, 2004, FEMS MICROBIOL ECOL, V50, P231, DOI 10.1016/j.femsec.2004.07.001; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Myl'nikov Alexander P., 2004, Protistology, V3, P201; Nikolaev SI, 2003, ACTA PROTOZOOL, V42, P183; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; Park MG, 2004, J EUKARYOT MICROBIOL, V51, P145, DOI 10.1111/j.1550-7408.2004.tb00539.x; Park MG, 2002, MAR ECOL PROG SER, V227, P281, DOI 10.3354/meps227281; PATTERSON DJ, 1993, J EUKARYOT MICROBIOL, V40, P606, DOI 10.1111/j.1550-7408.1993.tb06116.x; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; POMEROY LR, 1988, HYDROBIOLOGIA, V159, P7, DOI 10.1007/BF00007363; Richards TA, 2005, ENVIRON MICROBIOL, V7, P1413, DOI 10.1111/j.1462-2920.2005.00828.x; Romari K, 2004, LIMNOL OCEANOGR, V49, P784, DOI 10.4319/lo.2004.49.3.0784; Schnepf E, 2000, HELGOLAND MAR RES, V54, P18, DOI 10.1007/s101520050032; Shalchian-Tabrizi K, 2006, P ROY SOC B-BIOL SCI, V273, P1833, DOI 10.1098/rspb.2006.3515; SHERR E, 1988, LIMNOL OCEANOGR, V33, P1225, DOI 10.4319/lo.1988.33.5.1225; SHERR EB, 1988, NATURE, V335, P348, DOI 10.1038/335348a0; Sherr EB, 2007, MAR ECOL PROG SER, V352, P187, DOI 10.3354/meps07161; Siddall Mark E., 2001, American Museum Novitates, V3314, P1, DOI 10.1206/0003-0082(2001)314<0001:MDOTPP>2.0.CO;2; Slapeta J, 2005, P ROY SOC B-BIOL SCI, V272, P2073, DOI 10.1098/rspb.2005.3195; Sleigh MA, 2000, SYST ASSOC SPEC VOL, V59, P147; Sonntag B, 2006, AQUAT MICROB ECOL, V43, P193, DOI 10.3354/ame043193; Soudant P, 2005, J EUKARYOT MICROBIOL, V52, P492, DOI 10.1111/j.1550-7408.2005.00058.x; Takishita K, 2005, EXTREMOPHILES, V9, P185, DOI 10.1007/s00792-005-0432-9; TRANVIK LJ, 1993, MAR ECOL PROG SER, V92, P301, DOI 10.3354/meps092301; Vickerman K, 2002, PROTIST, V153, P9, DOI 10.1078/1434-4610-00079; Wieltschnig C, 2001, MICROBIAL ECOL, V42, P159	68	117	122	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2324	10.1371/journal.pone.0002324	http://dx.doi.org/10.1371/journal.pone.0002324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545660	Green Published, Green Submitted, gold			2022-12-25	WOS:000263248800005
J	Wu, ZP; Bowen, WD				Wu, Zhiping; Bowen, Wayne D.			Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation - Constitutive enhancement of calcium signaling in MCF-7 tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; INTERNAL CA2+ RELEASE; TYPE-1 SIGMA-RECEPTOR; AMINO-ACID-RESIDUES; LIGAND-BINDING; ANKYRIN; EXPRESSION; IDENTIFICATION; DOMAIN; BRAIN	Sigma-1 receptor (sigma-1R) agonists enhance inositol 1,4,5-trisphosphate (IP3)-dependent calcium release from endoplasmic reticulum by inducing dissociation of ankyrin B 220 (ANK 220) from the IP3 receptor (IP3R-3), releasing it from inhibition. MCF-7 breast tumor cells express little or no sigma-1R and were used here to investigate the effect of receptor overexpression and the role of its N-and C-terminal segments in function. We stably expressed intact sigma-1R (amino acids (aa) 1-223; lines 11 and 41), N-fragment (aa 1-100; line K3), or C-fragment (aa 102-223; line sg101). C-fragment expressed as a peripheral membrane-bound protein that was removable from the endoplasmic reticulum membrane by chaotropic salt wash, consistent with lack of a putative transmembrane domain. The expressed sigma-1R, N-fragment, and C-fragment exhibited normal, low affinity, and no [3H](+)-pentazocine binding activity, respectively. All transfected lines showed constitutive enhancement of bradykinin (BDK)-induced calcium release, because of a decrease in BDK ED50 values. Interestingly, sigma-1R and C-fragment had high activities, whereas the N-fragment was much less active. The antagonist BD1063 behaved as an inverse agonist in sigma-1R cells, whereas C-fragment was insensitive to ligand regulation. Like BDK, vasopressin-and ATP-induced calcium release was enhanced with the same pattern in cell lines. Anti-IP3R-3 immunoprecipitates from cells expressing sigma-1R or C-fragment contained significantly less ANK 220 compared with untransfected or N-fragment cells, indicating a higher amount of ankyrin-free IP3R-3. Anti-ankyrin B immunoprecipitates contained sigma-1R or C-fragment, with markedly lower levels of N-fragment present. These results suggest that sigma-1R overexpression drives sigma agonist-independent dissociation of ANK 220 from IP3R-3, resulting in activation. The C-terminal segment plays a key role in the interaction.	[Wu, Zhiping; Bowen, Wayne D.] Brown Univ, Div Biol & Med, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University	Bowen, WD (corresponding author), Brown Univ, Div Biol & Med, Dept Mol Pharmacol Physiol & Biotechnol, Box G-B389, Providence, RI 02912 USA.	Wayne_Bowen@brown.edu			2007 Salomon award	2007 Salomon award	This work was supported by a 2007 Salomon award (to W. D. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; BOURGUIGNON LYW, 1995, J BIOL CHEM, V270, P7257, DOI 10.1074/jbc.270.13.7257; BOURGUIGNON LYW, 1993, J BIOL CHEM, V268, P7290; Bowen W D, 2000, Pharm Acta Helv, V74, P211; Bowen Wayne D., 1993, Molecular Neuropharmacology, V3, P117; Brent PJ, 1997, J NEUROCHEM, V68, P2201; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Dixon CJ, 1997, BRIT J CANCER, V75, P34, DOI 10.1038/bjc.1997.6; ELA C, 1994, J PHARMACOL EXP THER, V269, P1300; Frey BM, 1999, FASEB J, V13, P2235, DOI 10.1096/fasebj.13.15.2235; Ganapathy ME, 1999, J PHARMACOL EXP THER, V289, P251; Greco S, 2006, J ENDOCRINOL, V188, P79, DOI 10.1677/joe.1.06433; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2000, J PHARMACOL EXP THER, V293, P788; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; HELLEWELL SB, 1990, BRAIN RES, V527, P244, DOI 10.1016/0006-8993(90)91143-5; HELLEWELL SB, 1994, EUR J PHARM-MOLEC PH, V268, P9, DOI 10.1016/0922-4106(94)90115-5; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; McConkey DJ, 1996, J LEUKOCYTE BIOL, V59, P775, DOI 10.1002/jlb.59.6.775; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; North WG, 1999, PEPTIDES, V20, P837, DOI 10.1016/S0196-9781(99)00070-4; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; QUIRION R, 1992, TRENDS PHARMACOL SCI, V13, P85, DOI 10.1016/0165-6147(92)90030-A; Sazuka T, 2004, DNA RES, V11, P101, DOI 10.1093/dnares/11.2.101; Seth P, 2001, BBA-MOL CELL RES, V1540, P59, DOI 10.1016/S0167-4889(01)00117-3; Seth P, 1998, J NEUROCHEM, V70, P922; SHARKEY J, 1988, EUR J PHARMACOL, V149, P171, DOI 10.1016/0014-2999(88)90058-1; SIMPSON PB, 1995, TRENDS NEUROSCI, V18, P299, DOI 10.1016/0166-2236(95)93919-O; Snyder S H, 1989, J Neuropsychiatry Clin Neurosci, V1, P7; Spruce BA, 2004, CANCER RES, V64, P4875, DOI 10.1158/0008-5472.CAN-03-3180; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Vilner B. J., 1995, Society for Neuroscience Abstracts, V21, P1608; Vilner BJ, 2000, J PHARMACOL EXP THER, V292, P900; VILNER BJ, 1995, CANCER RES, V55, P408; Wagstaff SC, 2000, CARCINOGENESIS, V21, P2175, DOI 10.1093/carcin/21.12.2175; WALKER JM, 1990, PHARMACOL REV, V42, P355; Wang B, 2004, BREAST CANCER RES TR, V87, P205, DOI 10.1007/s10549-004-6590-0; Yamamoto H, 1999, FEBS LETT, V445, P19, DOI 10.1016/S0014-5793(99)00084-8; Zhang HL, 2002, J NEUROPHYSIOL, V87, P2867, DOI 10.1152/jn.2002.87.6.2867	46	107	112	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28198	28215		10.1074/jbc.M802099200	http://dx.doi.org/10.1074/jbc.M802099200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18539593	hybrid, Green Published			2022-12-25	WOS:000259969300022
J	Suh, HC; Leeanansaksiri, W; Ji, M; Klarmann, KD; Renn, K; Gooya, J; Smith, D; McNiece, I; Lugthart, S; Valk, PJM; Delwel, R; Keller, JR				Suh, H. C.; Leeanansaksiri, W.; Ji, M.; Klarmann, K. D.; Renn, K.; Gooya, J.; Smith, D.; McNiece, I.; Lugthart, S.; Valk, P. J. M.; Delwel, R.; Keller, J. R.			Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo	ONCOGENE			English	Article						Id1; myeloproliferative disease; leukemia; therapeutic target; prevention	ACUTE MYELOID-LEUKEMIA; LOOP-HELIX PROTEINS; CELL-DEVELOPMENT; TRANSGENIC MICE; STEM-CELLS; TRANSCRIPTION FACTORS; BONE-MARROW; C/EBP-ALPHA; EXPRESSION; DIFFERENTIATION	Id1 is frequently overexpressed in many cancer cells, but the functional significance of these findings is not known. To determine if Id1 could contribute to the development of hematopoietic malignancy, we reconstituted mice with hematopoietic cells overexpressing Id1. We showed for the first time that deregulated expression of Id1 leads to a myeloproliferative disease in mice, and immortalizes myeloid progenitors in vitro. In human cells, we demonstrate that Id genes are expressed in human acute myelogenous leukemia cells, and that knock down of Id1 expression inhibits leukemic cell line growth, suggesting that Id1 is required for leukemic cell proliferation. These findings established a causal relationship between Id1 overexpression and hematologic malignancy. Thus, deregulated expression of Id1 may contribute to the initiation of myeloid malignancy, and Id1 may represent a potential therapeutic target for early stage intervention in the treatment of hematopoietic malignancy.	[Suh, H. C.; Leeanansaksiri, W.; Ji, M.; Klarmann, K. D.; Renn, K.; Gooya, J.; Keller, J. R.] NCI, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21702 USA; [Suh, H. C.; Leeanansaksiri, W.; Ji, M.; Klarmann, K. D.; Renn, K.; Gooya, J.; Keller, J. R.] NCI, Canc Res Ctr, Frederick, MD 21702 USA; [Smith, D.; McNiece, I.] Sidney Kimmel Comprehens Canc Ctr, Div Hematol Malignancies, Baltimore, MD USA; [Lugthart, S.; Valk, P. J. M.; Delwel, R.] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Medicine; Erasmus University Rotterdam; Erasmus MC	Keller, JR (corresponding author), NCI, Basic Res Program, SAIC Frederick Inc, Bldg 560,Room 12-03, Frederick, MD 21702 USA.	kellerj@ncifcrf.gov	Valk, Peter/AAX-2823-2020; Suh, Hyung/L-5912-2019; Ji, Ming/C-2795-2011; Keller, Jonathan R./O-6677-2018	Suh, Hyung/0000-0001-6912-4157; Lugthart, Sanne/0000-0003-3007-8303	National Cancer Institute; National Institutes of Health [NO1-CO-12400]; Intramural Research Program of NIH; Center for Cancer Research; Regional Oncology Research Center [5 P30 CA06973]; NATIONAL CANCER INSTITUTE [P30CA006973, ZIABC010001] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Regional Oncology Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge the technical support of Steve Stull, Kathleen Noer, Roberta Matthai and Samantha Bauchiero. We also thank Dr Nancy Colburn, Dr Sandra Ruscetti and Dr Kristbjorn Gudmundsson for their critical review of this article. This project has been funded, in part, with Federal funds from the National Cancer Institute, National Institutes of Health, under contract number NO1-CO-12400. This research was supported, in part, by the Intramural Research Program of NIH, National Cancer Institute, Center for Cancer Research. Clinical specimens were provided by the Sidney Kimmel Cancer Center at Johns Hopkins Tumor and Cell Procurement Bank, supported by the Regional Oncology Research Center Grant no. 5 P30 CA06973.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2000, CURR OPIN IMMUNOL, V12, P144, DOI 10.1016/S0952-7915(99)00064-3; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Alani RM, 1999, P NATL ACAD SCI USA, V96, P9637, DOI 10.1073/pnas.96.17.9637; Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Belletti B, 2002, EXP CELL RES, V277, P107, DOI 10.1006/excr.2002.5542; Buitenhuis M, 2005, BLOOD, V105, P4272, DOI 10.1182/blood-2004-12-4883; Bullinger L, 2005, J CLIN ONCOL, V23, P6296, DOI 10.1200/JCO.2005.05.020; Castilla LH, 1999, NAT GENET, V23, P144, DOI 10.1038/13776; Cooper CL, 1997, BLOOD, V89, P3155, DOI 10.1182/blood.V89.9.3155; Fong S, 2004, TRENDS MOL MED, V10, P387, DOI 10.1016/j.molmed.2004.06.008; Grisolano JL, 1997, BLOOD, V89, P376, DOI 10.1182/blood.V89.2.376; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Ishiguro A, 1995, LEUKEMIA RES, V19, P989, DOI 10.1016/0145-2126(95)00084-4; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kim D, 1999, MOL CELL BIOL, V19, P8240; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; Kunisato A, 2004, BLOOD, V103, P3336, DOI 10.1182/blood-2003-06-1935; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Leeanansaksiri W, 2005, J IMMUNOL, V174, P7014, DOI 10.4049/jimmunol.174.11.7014; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Nilsson L, 2007, BLOOD, V110, P3005, DOI 10.1182/blood-2007-03-079368; Norton JD, 2000, J CELL SCI, V113, P3897; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Pagliuca A, 2000, CANCER RES, V60, P1376; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Quesenberry PJ, 1996, J CELL BIOCHEM, V61, P478; Rosenbauer F, 2005, BLOOD, V106, P1519, DOI 10.1182/blood-2005-02-0717; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Suh HC, 2006, BLOOD, V107, P4308, DOI 10.1182/blood-2005-06-2216; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; WILSON RB, 1991, MOL CELL BIOL, V11, P6185, DOI 10.1128/MCB.11.12.6185; Wong YC, 2004, APOPTOSIS, V9, P279, DOI 10.1023/B:APPT.0000025804.25396.79; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042; Zhang JS, 2004, SCIENCE, V305, P1286, DOI 10.1126/science.1097937	49	42	43	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 18	2008	27	42					5612	5623		10.1038/onc.2008.175	http://dx.doi.org/10.1038/onc.2008.175			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	349KX	18542061	Green Accepted			2022-12-25	WOS:000259280800007
J	Chan, PM; Lim, L; Manser, E				Chan, Perry M.; Lim, Louis; Manser, Edward			PAK Is Regulated by PI3K, PIX, CDC42, and PP2C alpha and Mediates Focal Adhesion Turnover in the Hyperosmotic Stress-induced p38 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2C; P21-ACTIVATED KINASE PAK; PHOSPHATIDYLINOSITOL 3-KINASE; GROWTH-FACTOR; ALPHA-PAK; SIGNALING PATHWAY; TYROSINE KINASE; MAP KINASE; SERINE 338; ACTIVATION	Fractionation of brain extracts and functional biochemical assays identified PP2C alpha, a serine/threonine phosphatase, as the major biochemical activity inhibiting PAK1. PP2C alpha dephosphorylated PAK1 and p38, both of which were activated upon hyperosmotic shock with the same kinetics. In comparison to growth factors, hyperosmolality was a more potent activator of PAK1. Therefore we characterize the PAK signaling pathway in the hyperosmotic shock response. Endogenous PAKs were recruited to the p38 kinase complex in a phosphorylation-dependent manner. Overexpression of a PAK inhibitory peptide or dominant negative Cdc42 revealed that p38 activation was dependent on PAK and Cdc42 activities. PAK mutants deficient in binding to Cdc42 or PAK-interacting exchange factor were not activated. Using a panel of kinase inhibitors, we identified PI3K acting upstream of PAK, which correlated with PAK repression by pTEN overexpression. RNA interference knockdown of PAK expression reduced stress-induced p38 activation and conversely, PP2C alpha knockdown increased its activation. Hyperosmotic stress-induced PAK translocation away from focal adhesions to the perinuclear compartment and resulted in disassembly of focal adhesions, which are hallmarks of PAK activation. Inhibition of PAK by overexpression of PP2C alpha or the kinase inhibitory domain prevented sorbitol-induced focal adhesion dissolution. Inhibition of MAPK pathways showed that MEK-ERK signaling but not p38 is required for full PAK activation and focal adhesion turnover. We conclude that 1) PAK plays a required role in hyperosmotic signaling through the PI3K/pTEN/Cdc42/PP2C alpha/p38 pathway, and 2) PAK and PP2C alpha modulate the effects of this pathway on focal adhesion dynamics.	[Chan, Perry M.; Lim, Louis; Manser, Edward] GSK IMCB Grp, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Lim, Louis] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 1PJ, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); GlaxoSmithKline; University of London; University College London	Chan, PM (corresponding author), GSK IMCB Grp, Inst Mol & Cell Biol, Proteos Bldg,61 Biopolis Dr, Singapore 138673, Singapore.	perryc@imcb.a-star.edu.sg	Manser, Edward/ABD-2301-2020		GlaxoSmithKline-Singapore Research Fund	GlaxoSmithKline-Singapore Research Fund(GlaxoSmithKline)	This work was supported by the GlaxoSmithKline-Singapore Research Fund (to E. M. and L. L.).	BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Chan WH, 1999, J CELL PHYSIOL, V178, P397, DOI 10.1002/(SICI)1097-4652(199903)178:3<397::AID-JCP14>3.3.CO;2-U; Chang PM, 2003, MOL CELL BIOL, V23, P3067, DOI 10.1128/MCB.23.9.3067-3078.2003; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Clerk A, 1997, FEBS LETT, V403, P23, DOI 10.1016/S0014-5793(97)00020-3; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen P, 1997, FEBS LETT, V410, P3, DOI 10.1016/S0014-5793(97)00490-0; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Hanada M, 1998, FEBS LETT, V437, P172, DOI 10.1016/S0014-5793(98)01229-0; Kaur R, 2005, J BIOL CHEM, V280, P3323, DOI 10.1074/jbc.M406701200; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Koh CG, 2002, CURR BIOL, V12, P317, DOI 10.1016/S0960-9822(02)00652-8; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1995, J BIOL CHEM, V270, P25070, DOI 10.1074/jbc.270.42.25070; Manser E, 1999, Prog Mol Subcell Biol, V22, P115; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Meskiene I, 1998, P NATL ACAD SCI USA, V95, P1938, DOI 10.1073/pnas.95.4.1938; Miah SMS, 2004, MOL CELL BIOL, V24, P71, DOI 10.1128/MCB.24.1.71-83.2004; Mizuno T, 2004, EMBO J, V23, P2226, DOI 10.1038/sj.emboj.7600226; Papakonstanti EA, 2002, MOL BIOL CELL, V13, P2946, DOI 10.1091/mbc.02-01-0599; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Price NE, 1999, CURR OPIN NEUROBIOL, V9, P336, DOI 10.1016/S0959-4388(99)80049-X; Raitt DC, 2000, EMBO J, V19, P4623, DOI 10.1093/emboj/19.17.4623; Roig J, 2000, J BIOL CHEM, V275, P16933, DOI 10.1074/jbc.M001627200; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Sundberg-Smith LJ, 2005, J BIOL CHEM, V280, P2055, DOI 10.1074/jbc.M406013200; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Vadlamudi RK, 2003, CANCER METAST REV, V22, P385, DOI 10.1023/A:1023729130497; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Xia CZ, 2001, P NATL ACAD SCI USA, V98, P6174, DOI 10.1073/pnas.101137298; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936; Zhan Q, 2003, J IMMUNOL, V171, P3785, DOI 10.4049/jimmunol.171.7.3785; Zhang Z, 2000, AM J PHYSIOL-RENAL, V278, pF155, DOI 10.1152/ajprenal.2000.278.1.F155; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	57	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24949	24961		10.1074/jbc.M801728200	http://dx.doi.org/10.1074/jbc.M801728200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18586681	Green Published, hybrid			2022-12-25	WOS:000271617300008
J	Sun, F; Mi, ZB; Condliffe, SB; Bertrand, CA; Gong, XY; Lu, XL; Zhang, RL; Latoche, JD; Pilewski, JM; Robbins, PD; Frizzell, RA				Sun, Fei; Mi, Zhibao; Condliffe, Steven B.; Bertrand, Carol A.; Gong, Xiaoyan; Lu, Xiaoli; Zhang, Ruilin; Latoche, Joseph D.; Pilewski, Joseph M.; Robbins, Paul D.; Frizzell, Raymond A.			Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia	FASEB JOURNAL			English	Article						CFTR; Aha1; rescue; PTD	PROTEIN-KINASE-A; DELTA-F508 CFTR; IN-VIVO; MULTIDOMAIN PROTEIN; MOLECULAR-BASIS; WILD-TYPE; DEGRADATION; DOMAIN; TRANSDUCTION; MATURATION	Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause cystic fibrosis (CF). The most common mutation, Delta F508, omits the phenylalanine residue at position 508 in the first nucleotide binding domain (NBD1) of CFTR. The mutant protein is retained in the endoplasmic reticulum and degraded by the ubiquitin-proteasome system. We demonstrate that expression of NBD1 plus the regulatory domain (RD) of Delta F508 CFTR (Delta FRD) restores the biogenesis of mature Delta F508 CFTR protein. In addition, Delta FRD elicited a cAMP-stimulated anion conductance response in primary human bronchial epithelial (HBE) cells isolated from homozygous Delta F508 CF patients. A protein transduction domain (PTD) could efficiently transduce (similar to 90%) airway epithelial cells. When fused to a PTD, direct addition of the Delta FRD peptide conferred a dose-dependent, cAMP-stimulated anion efflux to Delta F508 HBE cells. Hsp70 and Hsp90 associated equally with WT and Delta F508 CFTR, whereas nearly twice as much of the Hsp90 cochaperone, Aha1, associated with Delta F508 CFTR. Expression of Delta FRD produced a dose-dependent removal of Aha1 from Delta F508 CFTR that correlated with its functional rescue. These findings indicate that disruption of the excessive association of the cochaperone, Aha1, with Delta F508 CFTR is associated with the correction of its maturation, trafficking and regulated anion channel activity in human airway epithelial cells. Thus, PTD-mediated Delta FRD fragment delivery may provide a therapy for CF.	[Sun, Fei; Condliffe, Steven B.; Bertrand, Carol A.; Gong, Xiaoyan; Zhang, Ruilin; Pilewski, Joseph M.; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Mi, Zhibao; Lu, Xiaoli; Robbins, Paul D.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Latoche, Joseph D.; Pilewski, Joseph M.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Frizzell, RA (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA.	frizzell@pitt.edu	Pilewski, Joseph/AAF-5149-2021; lu, xl/HDO-8340-2022	Latoche, Joseph/0000-0002-4800-5623	U. S. National Institutes of Health [DK68196, DK72506, DK725076]; Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068196, P30DK072506] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Yuee Wang for technical assistance, Dr. John R. Riordan (University of North Carolina, Chapel Hill, NC, USA) for M3A7 antibody, and Dr. William E. Balch (Scripps Research Institute, La Jolla, CA, USA) for polyclonal Aha1 antibody. Funding was provided by the U. S. National Institutes of Health (DK68196, DK72506, and DK725076) and the Cystic Fibrosis Foundation.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Brodsky JL, 2001, AM J PHYSIOL-LUNG C, V281, pL39, DOI 10.1152/ajplung.2001.281.1.L39; Cao GD, 2002, J NEUROSCI, V22, P5423; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clarke LL, 2004, AM J PHYSIOL-CELL PH, V287, pC192, DOI 10.1152/ajpcell.00337.2003; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Davis P B, 2001, Pediatr Rev, V22, P257, DOI 10.1542/pir.22-8-257; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Gius DR, 1999, CANCER RES, V59, P2577; HAMILTON RL, 1991, J LIPID RES, V32, P529; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnson LG, 1996, HUM GENE THER, V7, P51, DOI 10.1089/hum.1996.7.1-51; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Mi ZB, 2000, MOL THER, V2, P339, DOI 10.1006/mthe.2000.0137; Owsianik G, 2003, FEBS LETT, V554, P173, DOI 10.1016/S0014-5793(03)01162-1; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Rapp UK, 2003, TRENDS MICROBIOL, V11, P519, DOI 10.1016/j.tim.2003.09.001; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Schultz BD, 1999, J MEMBRANE BIOL, V170, P51, DOI 10.1007/s002329900537; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; VANGINKEL FW, 1995, HUM GENE THER, V6, P895, DOI 10.1089/hum.1995.6.7-895; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Wang W, 2004, TRENDS BIOTECHNOL, V22, P431, DOI 10.1016/j.tibtech.2004.07.002; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; YANG YP, 1993, HUM MOL GENET, V2, P1253, DOI 10.1093/hmg/2.8.1253; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180	48	48	49	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2008	22	9					3255	3263		10.1096/fj.07-105338	http://dx.doi.org/10.1096/fj.07-105338			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18556464	Green Published			2022-12-25	WOS:000258761300018
J	Ueki, T; Nishidate, T; Park, JH; Lin, ML; Shimo, A; Hirata, K; Nakamura, Y; Katagiri, T				Ueki, T.; Nishidate, T.; Park, J. H.; Lin, M. L.; Shimo, A.; Hirata, K.; Nakamura, Y.; Katagiri, T.			Involvement of elevated expression of multiple cell-cycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells	ONCOGENE			English	Article						cDNA microarray; molecular target; AURKB; multiple cell-cycle regulator; cytokinesis	SYNOVIAL SARCOMAS; MOLECULAR TARGETS; KINASE; GENE; IDENTIFICATION; THERAPY; COMPLEX; PHOSPHORYLATION; CARCINOGENESIS; CYTOKINESIS	To investigate the detailed molecular mechanism of mammary carcinogenesis and discover novel therapeutic targets, we previously analysed gene expression profiles of breast cancers. We here report characterization of a significant role of DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein) in mammary carcinogenesis. Semiquantitative RT-PCR and northern blot analyses confirmed upregulation of DTL/RAMP in the majority of breast cancer cases and all of breast cancer cell lines examined. Immunocytochemical and western blot analyses using anti-DTL/RAMP polyclonal antibody revealed cell-cycle-dependent localization of endogenous DTL/RAMP protein in breast cancer cells; nuclear localization was observed in cells at interphase and the protein was concentrated at the contractile ring in cytokinesis process. The expression level of DTL/RAMP protein became highest at G(1)/S phases, whereas its phosphorylation level was enhanced during mitotic phase. Treatment of breast cancer cells, T47D and HBC4, with small-interfering RNAs against DTL/RAMP effectively suppressed its expression and caused accumulation of G(2)/M cells, resulting in growth inhibition of cancer cells. We further demonstrate the in vitro phosphorylation of DTL/RAMP through an interaction with the mitotic kinase, Aurora kinase-B (AURKB). Interestingly, depletion of AURKB expression with siRNA in breast cancer cells reduced the phosphorylation of DTL/RAMP and decreased the stability of DTL/RAMP protein. These findings imply important roles of DTL/RAMP in growth of breast cancer cells and suggest that DTL/RAMP might be a promising molecular target for treatment of breast cancer.	[Ueki, T.; Nishidate, T.; Park, J. H.; Lin, M. L.; Shimo, A.; Nakamura, Y.; Katagiri, T.] Univ Tokyo, Mol Med Lab, Ctr Human Genome, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Ueki, T.; Hirata, K.] Sapporo Med Univ, Dept Surg, Chuo Ku, Sapporo, Hokkaido, Japan	University of Tokyo; Sapporo Medical University	Katagiri, T (corresponding author), Univ Tokyo, Mol Med Lab, Ctr Human Genome, Inst Med Sci,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tkatagi@ims.u-tokyo.ac.jp	Katagiri, Toyomasa/I-7344-2012					Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Bange J, 2001, NAT MED, V7, P548, DOI 10.1038/87872; Banks D, 2006, CELL CYCLE, V5, P1719, DOI 10.4161/cc.5.15.3150; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheung WMW, 2001, J BIOL CHEM, V276, P17083, DOI 10.1074/jbc.M010802200; Dechat T, 1998, EMBO J, V17, P4887, DOI 10.1093/emboj/17.16.4887; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hirota E, 2006, INT J ONCOL, V29, P799; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Nagayama S, 2004, ONCOGENE, V23, P5551, DOI 10.1038/sj.onc.1207710; Nagayama S, 2005, ONCOGENE, V24, P6201, DOI 10.1038/sj.onc.1208780; Navolanic PM, 2005, INT J ONCOL, V27, P1341; Nishidate T, 2004, INT J ONCOL, V25, P797; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; Park JH, 2006, CANCER RES, V66, P9186, DOI 10.1158/0008-5472.CAN-06-1601; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petricoin EF, 2002, NAT GENET, V32, P474, DOI 10.1038/ng1029; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Shimo A, 2007, CANCER SCI, V98, P174, DOI 10.1111/j.1349-7006.2006.00381.x; Shimokawa T, 2003, CANCER RES, V63, P6116; Terada Y, 2001, CELL STRUCT FUNCT, V26, P653, DOI 10.1247/csf.26.653; Togashi A, 2005, CANCER RES, V65, P4817, DOI 10.1158/0008-5472.CAN-05-0120	26	69	72	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2008	27	43					5672	5683		10.1038/onc.2008.186	http://dx.doi.org/10.1038/onc.2008.186			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	352HM	18542055				2022-12-25	WOS:000259487100003
J	Butkinaree, C; Cheung, WD; Park, S; Park, K; Barber, M; Hart, GW				Butkinaree, Chutikarn; Cheung, Win D.; Park, Sungjin; Park, Kyoungsook; Barber, Megan; Hart, Gerald W.			Characterization of beta-N-acetylglucosaminidase cleavage by caspase-3 during apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLCNAC TRANSFERASE; FAS-INDUCED APOPTOSIS; NUCLEOCYTOPLASMIC PROTEINS; CYTOSOLIC PROTEINS; SUBSTRATE-SPECIFICITY; DYNAMIC INTERPLAY; LINKED GLCNAC; CELL-FUNCTION; GLYCOSYLATION; PHOSPHORYLATION	beta-O-Linked N- acetylglucosamine is a dynamic post- translational modification involved in protein regulation in a manner similar to phosphorylation. Removal of N-acetylglucosamine is regulated by beta-N-acetylglucosaminidase (O-GlcNAcase), which was previously shown to be a substrate of caspase-3 in vitro. Here we show that O- GlcNAcase is cleaved by caspase- 3 into two fragments during apoptosis, an N- terminal fragment containing the O- GlcNAcase active site and a C- terminal fragment containing a region with homology to GCN5 histone acetyltransferases. The caspase- 3 cleavage site of O- GlcNAcase, mapped by Edman sequencing, is a noncanonical recognition site that occurs after Asp- 413 of the SVVD sequence in human O- GlcNAcase. A point mutation, D413A, abrogates cleavage by caspase- 3 both in vitro and in vivo. Finally, we show that O- GlcNAcase activity is not affected by caspase- 3 cleavage because the N- and C- terminal O- GlcNAcase fragments remain associated after the cleavage. Furthermore, when co- expressed simultaneously in the same cell, the N- terminal and C- terminal caspase fragments associate to reconstitute O- GlcNAcase enzymatic activity. These studies support the identification of O- GlcNAcase as a caspase- 3 substrate with a novel caspase- 3 cleavage site and provide insight about O- GlcNAcase regulation during apoptosis.	[Butkinaree, Chutikarn; Cheung, Win D.; Park, Kyoungsook; Barber, Megan; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Park, Sungjin] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu		Hart, Gerald/0000-0001-7812-4351	NCI NIH HHS [CA 42486] Funding Source: Medline; NICHD NIH HHS [HD 13563] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD013563, R37HD013563] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Fulop N, 2007, CARDIOVASC RES, V73, P288, DOI 10.1016/j.cardiores.2006.07.018; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Kipp M, 2000, J BIOL CHEM, V275, P5031, DOI 10.1074/jbc.275.7.5031; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Mukerjee N, 2001, BIOCHEM BIOPH RES CO, V285, P1192, DOI 10.1006/bbrc.2001.5278; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schlegel J, 1996, J BIOL CHEM, V271, P1841, DOI 10.1074/jbc.271.4.1841; Silke J, 2001, EMBO J, V20, P3114, DOI 10.1093/emboj/20.12.3114; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Ubeda M, 1997, J BIOL CHEM, V272, P19562, DOI 10.1074/jbc.272.31.19562; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Webb PR, 2000, APOPTOSIS, V5, P451, DOI 10.1023/A:1009601220552; WEIS M, 1995, EXP CELL RES, V219, P699, DOI 10.1006/excr.1995.1281; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2003, CIRC RES, V93, P1047, DOI 10.1161/01.RES.0000103190.20260.37; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	54	82	85	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23557	23566		10.1074/jbc.M804116200	http://dx.doi.org/10.1074/jbc.M804116200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586680	Green Published, hybrid			2022-12-25	WOS:000258638900008
J	Koike-Takeshita, A; Yoshida, M; Taguchi, H				Koike-Takeshita, Ayumi; Yoshida, Masasuke; Taguchi, Hideki			Revisiting the GroEL-GroES reaction cycle via the symmetric intermediate implied by novel aspects of the GroEL(D398A) mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONIN GROEL; SUBSTRATE PROTEIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; COMPLEXES; ATP; MECHANISM; POLYPEPTIDE; BINDING; CAVITY	The Escherichia coli chaperonin GroEL is a double-ring chaperone that assists in protein folding with the aid of GroES and ATP. It is believed that GroEL alternates the folding-active rings and that the substrate protein ( and GroES) can bind to the open trans-ring only after ATP in the cis-ring is hydrolyzed. However, we found that a substrate protein prebound to the trans-ring remained bound during the first ATP cycle, and this substrate was assisted by GroEL-GroES when the second cycle began. Moreover, a slow ATP-hydrolyzing GroEL mutant (D398A) in the ATP-bound form bound a substrate protein and GroES to the trans-ring. The apparent discrepancy with the results from an earlier study (Rye, H. S., Roseman, A. M., Chen, S., Furtak, K., Fenton, W. A., Saibil, H. R., and Horwich, A. L.(1999) Cell 97, 325-338) can be explained by the previously unnoticed fact that the ATP-bound form of the D398A mutant exists as a symmetric 1:2 GroEL-GroES complex (the "football"-shaped complex) and that the substrate protein (and GroES) in the medium is incorporated into the complex only after the slow turnover. In light of these results, the current model of the GroEL-GroES reaction cycle via the asymmetric 1:1 GroEL-GroES complex deserves reexamination.	[Koike-Takeshita, Ayumi; Taguchi, Hideki] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan; [Koike-Takeshita, Ayumi; Yoshida, Masasuke] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	University of Tokyo; Tokyo Institute of Technology	Taguchi, H (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, FSB401,5-1-5 Kashiwanoha, Chiba 2778562, Japan.	taguchi@k.u-tokyo.ac.jp	taguchi, hideki/AAM-2663-2021; Taguchi, Hideki/B-6946-2009	taguchi, hideki/0000-0002-6612-9339; Taguchi, Hideki/0000-0002-6612-9339	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [17049009, 19037007, 19058002]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aids for Scientific Research on Priority Areas 17049009, 19037007, and 19058002 (to H. T.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Ben-Zvi AP, 1998, P NATL ACAD SCI USA, V95, P15275, DOI 10.1073/pnas.95.26.15275; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; CORRALES FJ, 1995, P NATL ACAD SCI USA, V92, P5326, DOI 10.1073/pnas.92.12.5326; Corrales FJ, 1996, FOLD DES, V1, P265, DOI 10.1016/S1359-0278(96)00040-5; Fujiwara K, 2007, J BACTERIOL, V189, P5860, DOI 10.1128/JB.00493-07; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayer-Hartl MK, 1999, BIOL CHEM, V380, P531, DOI 10.1515/BC.1999.068; HISABORI T, 1992, J BIOL CHEM, V267, P4551; Horovitz A, 2005, CURR OPIN STRUC BIOL, V15, P646, DOI 10.1016/j.sbi.2005.10.001; Horowitz PM, 1999, P NATL ACAD SCI USA, V96, P2682, DOI 10.1073/pnas.96.6.2682; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Koike-Takeshita A, 2006, J BIOL CHEM, V281, P962, DOI 10.1074/jbc.M506298200; Li J, 1999, J BIOL CHEM, V274, P10790, DOI 10.1074/jbc.274.16.10790; LLORCA O, 1994, FEBS LETT, V345, P181, DOI 10.1016/0014-5793(94)00432-3; Lorimer G, 1997, NATURE, V388, P720, DOI 10.1038/41892; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sakikawa C, 1999, J BIOL CHEM, V274, P21251, DOI 10.1074/jbc.274.30.21251; Sameshima T, 2008, J BIOL CHEM, V283, P23765, DOI 10.1074/jbc.M802541200; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; Taguchi H, 2005, J BIOCHEM, V137, P543, DOI 10.1093/jb/mvi069; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; TAGUCHI H, 1995, FEBS LETT, V359, P195, DOI 10.1016/0014-5793(95)00041-7; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	41	40	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23774	23781		10.1074/jbc.M802542200	http://dx.doi.org/10.1074/jbc.M802542200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18567584	Green Published, hybrid			2022-12-25	WOS:000258638900031
J	Lee, DH; Jeong, HS; Jeong, HG; Kim, KM; Kim, H; Choi, SH				Lee, Dong Hwan; Jeong, Hye Sook; Jeong, Hee Gon; Kim, Kyung Mo; Kim, Heebal; Choi, Sang Ho			A consensus sequence for binding of SmcR, a Vibrio vulnificus LuxR homologue, and genome-wide identification of the SmcR regulon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE GENE-EXPRESSION; HARVEYI-LUXR; RECEPTOR PROTEIN; GLOBAL REGULATOR; CHOLERAE; BACTERIA; HAPR; METALLOPROTEASE; TRANSCRIPTION; RUGOSITY	Quorum sensing has been implicated as an important global regulatory system controlling the expression of numerous virulence factors in bacterial pathogens. In the present study, DNA targets of SmcR, a Vibrio vulnificus LuxR homologue, were selected from a random pool of DNA fragments by using a cycle selection procedure consisting of in vitro DNA- SmcR interaction, purification of SmcR- DNA complexes, and PCR amplification of SmcR- bound DNA. The amplified DNA fragments were cloned and analyzed separately by electrophoretic mobility shift assay to verify the specific binding of SmcR to the DNA. The DNA sequences bound by SmcR were determined by DNase I footprinting, and alignment of the resulting 29 sequences revealed a 22- bp consensus SmcR- binding sequence, 5'- TTATTGATWWRWTWNTNAATAA-3' (where W represents A or T, R is G or A, and N is any nucleotide), with an 8- bp ( TTATTGAT) inverted repeat. The consensus sequence revealed greater efficiency for the binding of SmcR than the SmcR- binding sequence previously identified within PvvpE. Mutational analysis demonstrated that the 9th and 10th bases from the center are the most essential for SmcR binding. A genome- wide search using the consensus sequence predicted that at least 121 genes are under the control of SmcR, and 10 of these newly identified SmcR regulon members were verified as being regulated by SmcR in V. vulnificus as well as in vitro. The consensus sequence and newly identified genes should be of use for elucidating the regulatory mechanism of SmcR and provide further insight into the role of the quorum sensing in V. vulnificus pathogenesis.	[Lee, Dong Hwan; Jeong, Hee Gon; Kim, Kyung Mo; Kim, Heebal; Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Lee, Dong Hwan; Jeong, Hye Sook; Jeong, Hee Gon; Choi, Sang Ho] Seoul Natl Univ, Ctr Agr Biomat, Natl Res Lab Mol Microbiol & Toxicol, Seoul 151921, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	choish@snu.ac.kr	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Jeong, Hee Gon/0000-0002-8103-2690; Kim, Kyung Mo/0000-0001-5125-5079; Choi, Sang Ho/0000-0003-3865-1039				Beyhan S, 2007, J BACTERIOL, V189, P388, DOI 10.1128/JB.00981-06; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Croxatto A, 2002, J BACTERIOL, V184, P1617, DOI 10.1128/JB.184.6.1617-1629.2002; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; De Silva RS, 2007, J BACTERIOL, V189, P5683, DOI 10.1128/JB.01807-06; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Jeong HG, 2008, J BACTERIOL, V190, P3768, DOI 10.1128/JB.00058-08; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Jobling MG, 1997, MOL MICROBIOL, V26, P1023, DOI 10.1046/j.1365-2958.1997.6402011.x; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kovacikova G, 2002, MOL MICROBIOL, V46, P1135, DOI 10.1046/j.1365-2958.2002.03229.x; Lee BC, 2008, INFECT IMMUN, V76, P1509, DOI 10.1128/IAI.01503-07; Lee JH, 2007, J MICROBIOL, V45, P146; Lee JH, 2007, J MICROBIOL BIOTECHN, V17, P325; Lee JH, 2006, MOL MICROBIOL, V60, P513, DOI 10.1111/j.1365-2958.2006.05115.x; McCarter LL, 1998, J BACTERIOL, V180, P3166, DOI 10.1128/JB.180.12.3166-3173.1998; McDougald D, 2001, J BACTERIOL, V183, P758, DOI 10.1128/JB.183.2.758-762.2001; McDougald D, 2000, GENE, V248, P213, DOI 10.1016/S0378-1119(00)00117-7; McLeod SM, 2001, CURR OPIN MICROBIOL, V4, P152, DOI 10.1016/S1369-5274(00)00181-8; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; MILLER JF, 1989, SCIENCE, V243, P916, DOI 10.1126/science.2537530; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Ochsner UA, 1996, P NATL ACAD SCI USA, V93, P4409, DOI 10.1073/pnas.93.9.4409; Rhee JE, 2005, J BACTERIOL, V187, P7870, DOI 10.1128/JB.187.22.7870-7875.2005; Roh JB, 2006, J BIOL CHEM, V281, P34775, DOI 10.1074/jbc.M607844200; Sambrook J, 2001, MOL CLONING LAB MANU; Shao CP, 2001, J BACTERIOL, V183, P1369, DOI 10.1128/JB.183.4.1369-1375.2001; SWARTZMAN E, 1993, J BIOL CHEM, V268, P16706; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Yildiz FH, 2004, MOL MICROBIOL, V53, P497, DOI 10.1111/j.1365-2958.2004.04154.x; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	34	39	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23610	23618		10.1074/jbc.M801480200	http://dx.doi.org/10.1074/jbc.M801480200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579523	Green Published, hybrid			2022-12-25	WOS:000258638900013
J	Manni, S; Mauban, JH; Ward, CW; Bond, M				Manni, Sabrina; Mauban, Joseph H.; Ward, Christopher W.; Bond, Meredith			Phosphorylation of the cAMP-dependent protein kinase (PKA) regulatory subunit modulates PKA-AKAP interaction, substrate phosphorylation, and calcium signaling in cardiac cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; HEART-FAILURE PROGRESSION; RAT VENTRICULAR MYOCYTES; SARCOPLASMIC-RETICULUM; ANCHORING PROTEINS; TROPONIN-I; MUSCLE; PHOSPHOLAMBAN; BINDING; PHOSPHODIESTERASES	Subcellular compartmentalization of the cAMP-dependent protein kinase (PKA) by protein kinase A-anchoring proteins (AKAPs) facilitates local protein phosphorylation. However, little is known about how PKA targeting to AKAPs is regulated in the intact cell. PKA binds to an amphipathic helical region of AKAPs via an N-terminal domain of the regulatory subunit. In vitro studies showed that autophosphorylation of type II regulatory subunit (RII) can alter its affinity for AKAPs and the catalytic subunit (PKA(cat)). We now investigate whether phosphorylation of serine 96 on RII regulates PKA targeting to AKAPs, downstream substrate phosphorylation and calcium cycling in primary cultured cardiomyocytes. We demonstrated that, whereas there is basal phosphorylation of RII subunits, persistent maximal activation of PKA results in a phosphatase-dependent loss of RII phosphorylation. To investigate the functional effects of RII phosphorylation, we constructed adenoviral vectors incorporating mutants which mimic phosphorylated (RIIS96D), nonphosphorylated (RIIS96A) RII, or wild-type (WT) RII and performed adenoviral infection of neonatal rat cardiomyocytes. Coimmunoprecipitation showed that more AKAP15/18 was pulled down by the phosphomimic, RIIS96D, than RIIS96A. Phosphorylation of phospholamban and ryanodine receptor was significantly increased in cells expressing RIIS96D versus RIIS96A. Expression of recombinant RII constructs showed significant effects on cytosolic calcium transients. We propose a model illustrating a central role of RII phosphorylation in the regulation of local PKA activity. We conclude that RII phosphorylation regulates PKA-dependent substrate phosphorylation and may have significant implications for modulation of cardiac function.	[Manni, Sabrina; Mauban, Joseph H.; Bond, Meredith] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Ward, Christopher W.] Univ Maryland, Sch Nursing, Dept Org Syst & Adult Hlth, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bond, M (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.	mbond@som.umaryland.edu	Manni, Sabrina/AAE-9182-2021	MANNI, SABRINA/0000-0001-6804-0680	National Institutes of Health [AG16613, HL79134]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG16613 and HL79134 ( to M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bodor GS, 1997, CIRCULATION, V96, P1495, DOI 10.1161/01.CIR.96.5.1495; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Dash R, 2001, J MOL CELL CARDIOL, V33, P1345, DOI 10.1006/jmcc.2001.1394; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Eckhart AD, 2002, MOL THER, V5, P74, DOI 10.1006/mthe.2001.0508; ERLICHMAN J, 1974, J BIOL CHEM, V249, P5000; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Freeman K, 2001, J CLIN INVEST, V107, P967, DOI 10.1172/JCI12083; GRANOT J, 1980, J BIOL CHEM, V255, P4569; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; Hoshijima M, 2002, NAT MED, V8, P864, DOI 10.1038/nm739; Houser SR, 2000, TRENDS CARDIOVAS MED, V10, P101, DOI 10.1016/S1050-1738(00)00057-8; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Li L, 2000, AM J PHYSIOL-HEART C, V278, pH769, DOI 10.1152/ajpheart.2000.278.3.H769; LOKUTA A, 1994, J CARDIOVASC ELECTR, V5, P50, DOI 10.1111/j.1540-8167.1994.tb01114.x; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; OTTEN AD, 1989, J BIOL CHEM, V264, P20255; PIESKE B, 2002, BASIC RES CARDIOL S1, V97, P163; Prinz A, 2006, CELL SIGNAL, V18, P1616, DOI 10.1016/j.cellsig.2006.01.013; RANGELALDAO R, 1979, J BIOL CHEM, V254, P2499; RANGELALDAO R, 1977, J BIOL CHEM, V252, P7140; Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e; Rodriguez-Vilarrupla A, 2005, MOL CELL BIOL, V25, P7364, DOI 10.1128/MCB.25.16.7364-7374.2005; ROSEN OM, 1975, J BIOL CHEM, V250, P7788; Ruehr ML, 1999, J BIOL CHEM, V274, P33092, DOI 10.1074/jbc.274.46.33092; Ruehr ML, 2004, J MOL CELL CARDIOL, V37, P653, DOI 10.1016/j.yjmcc.2004.04.017; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; SCOTT CW, 1985, J BIOL CHEM, V260, P2274; Sipido KR, 2005, CARDIOVASC RES, V68, P167, DOI 10.1016/j.cardiores.2005.08.011; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Trafford AW, 2002, FRONT BIOSCI, V7, pD843, DOI 10.2741/trafford; TYTGAT J, 1994, CARDIOVASC RES, V28, P280, DOI 10.1093/cvr/28.2.280; Waggoner Jason R, 2005, Heart Fail Clin, V1, P207, DOI 10.1016/j.hfc.2005.03.008; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wehrens XHT, 2004, ANN MED, V36, P70, DOI 10.1080/17431380410032481; Xiao BL, 2006, BIOCHEM J, V396, P7, DOI 10.1042/BJ20060116; YANG SM, 1995, BIOCHEMISTRY-US, V34, P6267, DOI 10.1021/bi00019a002; Zaccolo M, 2006, BIOCHEM SOC T, V34, P495, DOI 10.1042/BST0340495; Zaccolo M, 2006, EUR J CELL BIOL, V85, P693, DOI 10.1016/j.ejcb.2006.01.002; Zakhary DR, 2000, CIRCULATION, V101, P1459, DOI 10.1161/01.CIR.101.12.1459; Zakhary DR, 2000, J BIOL CHEM, V275, P41389, DOI 10.1074/jbc.M004212200	49	60	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24145	24154		10.1074/jbc.M802278200	http://dx.doi.org/10.1074/jbc.M802278200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18550536	Green Published, hybrid			2022-12-25	WOS:000258638900068
J	Pagel-Langenickel, I; Bao, JJ; Joseph, JJ; Schwartz, DR; Mantell, BS; Xu, XL; Raghavachari, N; Sack, MN				Pagel-Langenickel, Ines; Bao, Jianjun; Joseph, Joshua J.; Schwartz, Daniel R.; Mantell, Benjamin S.; Xu, Xiuli; Raghavachari, Nalini; Sack, Michael N.			PGC-1 alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; ADIPOSE-TISSUE; FATTY-ACID; OXIDATIVE-METABOLISM; GENE-EXPRESSION; GLUCOSE; OVEREXPRESSION; ROSIGLITAZONE; RESISTANCE; PROTECTS	The pathophysiology underlying mitochondrial dysfunction in insulin-resistant skeletal muscle is incompletely characterized. To further delineate this we investigated the interaction between insulin signaling, mitochondrial regulation, and function in C2C12 myotubes and in skeletal muscle. In myotubes elevated insulin and glucose disrupt insulin signaling, mitochondrial biogenesis, and mitochondrial bioenergetics. The insulin-sensitizing thiazolidinedione pioglitazone restores these perturbations in parallel with induction of the mitochondrial biogenesis regulator PGC-1 alpha. Overexpression of PGC-1 alpha rescues insulin signaling and mitochondrial bioenergetics, and its silencing concordantly disrupts insulin signaling and mitochondrial bioenergetics. In primary skeletal myoblasts pioglitazone also up-regulates PGC-1 alpha expression and restores the insulin-resistant mitochondrial bioenergetic profile. In parallel, pioglitazone upregulates PGC-1 alpha in db/db mouse skeletal muscle. Interestingly, the small interfering RNA knockdown of the insulin receptor in C2C12 myotubes down-regulates PGC-1 alpha and attenuates mitochondrial bioenergetics. Concordantly, mitochondrial bioenergetics are blunted in insulin receptor knock-out mouse-derived skeletal myoblasts. Taken together these data demonstrate that elevated glucose and insulin impairs and pioglitazone restores skeletal myotube insulin signaling, mitochondrial regulation, and bioenergetics. Pioglitazone functions in part via the induction of PGC-1 alpha. Moreover, PGC-1 alpha is identified as a bidirectional regulatory link integrating insulin-signaling and mitochondrial homeostasis in skeletal muscle.	[Pagel-Langenickel, Ines; Bao, Jianjun; Joseph, Joshua J.; Schwartz, Daniel R.; Mantell, Benjamin S.; Sack, Michael N.] NHLBI, Natl Inst Hlth, Translat Med Branch, Bethesda, MD 20892 USA; [Xu, Xiuli; Raghavachari, Nalini] NHLBI, Natl Inst Hlth, Genom Core, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sack, MN (corresponding author), NHLBI, Natl Inst Hlth, Translat Med Branch, Bldg 10-CRC,Rm 5-3150,10 Ctr Dr, Bethesda, MD 20892 USA.	sackm@nhlbi.nih.gov	Mantell, Benjamin/ABE-2117-2020	Mantell, Benjamin/0000-0002-7700-6975; Joseph, Joshua/0000-0001-9169-8261	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006018, ZIAHL005199, Z01HL005199] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Blendea MC, 2005, AM J PHYSIOL-ENDOC M, V288, pE353, DOI 10.1152/ajpendo.00402.2004; Boden G, 2005, DIABETES, V54, P880, DOI 10.2337/diabetes.54.3.880; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Deeg MA, 2007, DIABETES CARE, V30, P2458, DOI 10.2337/dc06-1903; Garcia-Martinez C, 2001, FASEB J, V15, P2033, DOI 10.1096/fj.00-0828fje; Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Karlsson HKR, 2006, DIABETES, V55, P1283, DOI 10.2337/db05-0853; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Mensink M, 2007, INT J OBESITY, V31, P1302, DOI 10.1038/sj.ijo.0803567; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pagel-Langenickel I, 2007, AM J PHYSIOL-HEART C, V293, pH2659, DOI 10.1152/ajpheart.00782.2007; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Skov V, 2007, DIABETES, V56, P2349, DOI 10.2337/db07-0275; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Storgaard H, 2001, DIABETES, V50, P2770, DOI 10.2337/diabetes.50.12.2770; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Yaspelkis BB, 2007, AM J PHYSIOL-ENDOC M, V293, pE941, DOI 10.1152/ajpendo.00230.2007	41	92	96	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22464	22472		10.1074/jbc.M800842200	http://dx.doi.org/10.1074/jbc.M800842200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18579525	Green Published, hybrid			2022-12-25	WOS:000258321000014
J	Bhaskaran, R; Palmier, MO; Lauer-Fields, JL; Fields, GB; Van Doren, SR				Bhaskaran, Rajagopalan; Palmier, Mark O.; Lauer-Fields, Janelle L.; Fields, Gregg B.; Van Doren, Steven R.			MMP-12 catalytic domain recognizes triple helical peptide models of collagen V with exosites and high activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE METALLOELASTASE MMP-12; MATRIX-METALLOPROTEINASE; SUBSTRATE-SPECIFICITY; INTERSTITIAL COLLAGENASE; MOLECULAR DETERMINANTS; FLUOROGENIC SUBSTRATE; CRYSTAL-STRUCTURES; ELASTASE MMP-12; CLEAVAGE SITE; GELATINASE-A	Matrix metalloproteinase (MMP)-12 ( or metalloelastase) efficiently hydrolyzed the gelatinase-selective alpha 1(V)436-447 fluorescent triple helical peptide (THP) when the substrate was sub-micromolar. The sequence of this THP was derived from collagen V, a component of collagen I fibrils. The hemopexin domains of MMP-12 and -9 each increased k(cat)/K-m toward this substrate by decreasing K-m, just as the hemopexin domain of MMP-1 enhances its triple helical peptidase activity. Non-fluorescent alpha 1(V) THP subtly perturbed amide NMR chemical shifts of MMP-12 not only in the active site cleft but also at remote sites of the beta-sheet and adjoining loops. The alpha 1(V) THP protected MMP-12 from the NMR line broadening effects of Gd center dot EDTA in the active site cleft and more dramatically in the V-B loop next to the primed subsites. Mutagenesis of the exosite in the V-B loop at Thr-205 and His-206 that vary among MMP sequences established that this site supports the high specific activity toward alpha 1(V) fluorescent THP without affecting general MMP activity. Surprisingly the alpha 1(V) THP also protected novel surfaces in the S-shaped metal-binding loop and beta-strands III and V that together form a pocket on the remote side of the zinc binding site. The patterns of protection suggest bending of the triple helical peptide partly around the catalytic domain to reach novel exosites. Partial unwinding or underwinding of the triple helix could accompany this to facilitate its hydrolysis.	[Bhaskaran, Rajagopalan; Palmier, Mark O.; Van Doren, Steven R.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Lauer-Fields, Janelle L.; Fields, Gregg B.] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA; [Lauer-Fields, Janelle L.; Fields, Gregg B.] Florida Atlantic Univ, Coll Biomed Sci, Boca Raton, FL 33431 USA	University of Missouri System; University of Missouri Columbia; State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Van Doren, SR (corresponding author), Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA.	vandorens@missouri.edu		Van Doren, Steven/0000-0003-2838-4598; Bhaskaran, Raj/0000-0001-8008-9962	NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057289, T32GM008396] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098799, R01 CA 98799] Funding Source: Medline; NIGMS NIH HHS [GM 008396, R01 GM 57289] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Arumugam S, 2003, BIOCHEMISTRY-US, V42, P7950, DOI 10.1021/bi034545s; Arumugam S, 1998, BIOCHEMISTRY-US, V37, P9650, DOI 10.1021/bi980128h; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bertini I, 2003, ANGEW CHEM INT EDIT, V42, P2673, DOI 10.1002/anie.200350957; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Bertini I, 2007, J AM CHEM SOC, V129, P2466, DOI 10.1021/ja065156z; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Bhaskaran R, 2006, J BIOMOL NMR, V36, P55, DOI 10.1007/s10858-006-9035-8; Bhaskaran R, 2007, J MOL BIOL, V374, P1333, DOI 10.1016/j.jmb.2007.10.028; Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958; Cha J, 1997, BIOCHEMISTRY-US, V36, P16019, DOI 10.1021/bi972223g; Chandler S, 1996, BIOCHEM BIOPH RES CO, V228, P421, DOI 10.1006/bbrc.1996.1677; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; CRABBE T, 1994, BIOCHEMISTRY-US, V33, P6684, DOI 10.1021/bi00187a039; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Ferreon JC, 2003, PROTEIN SCI, V12, P982, DOI 10.1110/ps.0238003; FESSLER JH, 1987, STRUCTURE FUNCTION C, P81; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fu JY, 2001, PROTEIN EXPRES PURIF, V21, P268, DOI 10.1006/prep.2000.1376; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gao GH, 2004, J BIOL CHEM, V279, P8441, DOI 10.1074/jbc.M309808200; Garimella R, 2006, BIOCHEMISTRY-US, V45, P6917, DOI 10.1021/bi060411d; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; Goddard T. D., 2000, SPARKY; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Gronski TJ, 1997, J BIOL CHEM, V272, P12189, DOI 10.1074/jbc.272.18.12189; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Johnson Jason Lee, 2007, Expert Rev Cardiovasc Ther, V5, P265, DOI 10.1586/14779072.5.2.265; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Lang R, 2001, J MOL BIOL, V312, P731, DOI 10.1006/jmbi.2001.4954; Lauer-Fields JL, 2007, J BIOL CHEM, V282, P142, DOI 10.1074/jbc.M605236200; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2003, ANAL BIOCHEM, V321, P105, DOI 10.1016/S0003-2697(03)00460-3; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Lauer-Fields JL, 2002, BIOL CHEM, V383, P1095, DOI 10.1515/BC.2002.118; Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190; Lian L. Y., 1993, NMR MACROMOLECULES P, P153; Liang JY, 2006, CIRCULATION, V113, P1993, DOI 10.1161/CIRCULATIONAHA.105.596031; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Linsenmayer TF, 1998, PROG RETIN EYE RES, V17, P231; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; LIOTTA LA, 1981, BIOCHEM BIOPH RES CO, V98, P184, DOI 10.1016/0006-291X(81)91886-6; LONG CG, 1993, BIOCHEMISTRY-US, V32, P11688, DOI 10.1021/bi00094a027; Mannino C, 2006, BIOORGAN MED CHEM, V14, P7392, DOI 10.1016/j.bmc.2006.07.028; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; Matsumoto S, 1998, AM J PATHOL, V153, P109, DOI 10.1016/S0002-9440(10)65551-4; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Morales R, 2004, J MOL BIOL, V341, P1063, DOI 10.1016/j.jmb.2004.06.039; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; MURPHY G, 1982, BIOCHEM J, V203, P209, DOI 10.1042/bj2030209; MURPHY G, 1985, BIOCHIM BIOPHYS ACTA, V831, P49, DOI 10.1016/0167-4838(85)90148-7; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nar H, 2001, J MOL BIOL, V312, P743, DOI 10.1006/jmbi.2001.4953; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; NIEDZWIECKI L, 1992, BIOCHEMISTRY-US, V31, P12618, DOI 10.1021/bi00165a011; NIYIBIZI C, 1994, BIOCHEM BIOPH RES CO, V202, P328, DOI 10.1006/bbrc.1994.1931; NIYIBIZI C, 1994, EUR J BIOCHEM, V224, P943, DOI 10.1111/j.1432-1033.1994.00943.x; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381; Okuyama K, 2006, BIOPOLYMERS, V84, P421, DOI 10.1002/bip.20499; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008; Park HI, 2000, J BIOL CHEM, V275, P20540, DOI 10.1074/jbc.M002349200; Parkar AA, 2000, PROTEIN EXPRES PURIF, V20, P152, DOI 10.1006/prep.2000.1280; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; RICH EA, 1983, AM REV RESPIR DIS, V128, P166, DOI 10.1164/arrd.1983.128.1.166; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; SAGE H, 1979, BIOCHEMISTRY-US, V18, P3815, DOI 10.1021/bi00584a027; SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5; Sakakura M, 2005, J AM CHEM SOC, V127, P5826, DOI 10.1021/ja047825j; Shapiro SD, 1999, THROMB HAEMOSTASIS, V82, P846; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Shipley JM, 1996, J BIOL CHEM, V271, P4335; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Sun HB, 2000, ANAL BIOCHEM, V283, P153, DOI 10.1006/abio.2000.4629; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Wang XF, 2004, AM J PATHOL, V165, P1375, DOI 10.1016/S0002-9440(10)63395-0; Williams J W, 1979, Methods Enzymol, V63, P437; Woessner J.F., 2000, PROTEIN PROFILE SER	96	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21779	21788		10.1074/jbc.M709966200	http://dx.doi.org/10.1074/jbc.M709966200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539597	hybrid, Green Published			2022-12-25	WOS:000257898800051
J	Wang, J; Ruan, NJ; Qian, L; Lei, WL; Chen, F; Luo, ZG				Wang, Jia; Ruan, Nan-Jie; Qian, Lei; Lei, Wen-Liang; Chen, Fei; Luo, Zhen-Ge			Wnt/beta-catenin signaling suppresses Rapsyn expression and inhibits acetylcholine receptor clustering at the neuromuscular junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; SYNAPSE FORMATION; WNT; MUSCLE; DIFFERENTIATION; PROTEIN; KINASE; AXON; TRANSCRIPTION; MUSK	The dynamic interaction between positive and negative signals is necessary for remodeling of postsynaptic structures at the neuromuscular junction. Here we report that Wnt3a negatively regulates acetylcholine receptor ( AChR) clustering by repressing the expression of Rapsyn, an AChR-associated protein essential for AChR clustering. In cultured myotubes, treatment with Wnt3a or overexpression of beta-catenin, the condition mimicking the activation of the Wnt canonical pathway, inhibited Agrin-induced formation of AChR clusters. Moreover, Wnt3a treatment promoted dispersion of AChR clusters, and this effect was prevented by DKK1, an antagonist of the Wnt canonical pathway. Next, we investigated possible mechanisms underlying Wnt3a regulation of AChR clustering in cultured muscle cells. Interestingly, we found that Wnt3a treatment caused a decrease in the protein level of Rapsyn. In addition, Rapsyn promoter activity in cultured muscle cells was inhibited by the treatment with Wnt3a or beta-catenin overexpression. Forced expression of Rapsyn driven by a promoter that is not responsive to Wnt3a prevented the dispersing effect of Wnt3a on AChR clusters, suggesting that Wnt3a indeed acts to disperse AChR clusters by down-regulating the expression of Rapsyn. The role of Wnt/beta-catenin signaling in dispersing AChR clusters was also investigated in vivo by electroporation of Wnt3a or beta-catenin into mouse limb muscles, where ectopic Wnt3a or beta-catenin caused disassembly of postsynaptic apparatus. Together, these results suggest that Wnt/beta-catenin signaling plays a negative role for postsynaptic differentiation at the neuromuscular junction, probably by regulating the expression of synaptic proteins, such as Rapsyn.	[Wang, Jia; Ruan, Nan-Jie; Qian, Lei; Lei, Wen-Liang; Chen, Fei; Luo, Zhen-Ge] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Luo, ZG (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	zgluo@ion.ac.cn	Lei, Wenliang/T-3156-2017; Qian, Lei/N-1796-2019; Qian, Lei/H-1977-2013; Luo, Zhen-Ge/GNM-7635-2022	Lei, Wenliang/0000-0002-7954-7214; Qian, Lei/0000-0002-3480-4248; Qian, Lei/0000-0002-3480-4248; 				Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7; Burden SJ, 2000, CELL, V100, P495, DOI 10.1016/S0092-8674(00)80685-6; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Cheusova T, 2006, GENE DEV, V20, P1800, DOI 10.1101/gad.375206; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Deardorff' MA, 1998, DEVELOPMENT, V125, P2687; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hippenmeyer S, 2007, NEURON, V55, P726, DOI 10.1016/j.neuron.2007.07.028; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kong XC, 2004, EMBO REP, V5, P183, DOI 10.1038/sj.embor.7400065; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; LAROCHELLE WJ, 1986, J BIOL CHEM, V261, P5270; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lucas FR, 1998, J CELL SCI, V111, P1351; Luo Z, 2003, NEURON, V40, P703, DOI 10.1016/S0896-6273(03)00695-0; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ohno K, 2003, HUM MOL GENET, V12, P739, DOI 10.1093/hmg/ddg089; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Phillips WD, 1997, MOL CELL NEUROSCI, V10, P16, DOI 10.1006/mcne.1997.0634; PHILLIPS WD, 1991, J CELL BIOL, V115, P1713, DOI 10.1083/jcb.115.6.1713; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; Qu ZC, 1996, MOL CELL NEUROSCI, V8, P171, DOI 10.1006/mcne.1996.0055; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Salinas PC, 2003, CURR BIOL, V13, pR60, DOI 10.1016/S0960-9822(02)01429-X; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sharma SK, 2003, J NEUROBIOL, V54, P346, DOI 10.1002/neu.10134; Strochlic L, 2004, P NATL ACAD SCI USA, V101, P18189, DOI 10.1073/pnas.0406905102; Trinidad JC, 2004, J BIOL CHEM, V279, P31622, DOI 10.1074/jbc.M400044200; Wang JM, 2003, NAT NEUROSCI, V6, P1017, DOI 10.1038/nn1128; Wang ZZ, 1999, J NEUROSCI, V19, P1998; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Wells DG, 1999, P NATL ACAD SCI USA, V96, P1112, DOI 10.1073/pnas.96.3.1112; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; WOODGETT JR, 2001, SCI STKE, pRE12; YOSHIHARA CM, 1993, J CELL BIOL, V122, P169, DOI 10.1083/jcb.122.1.169; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	57	63	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21668	21675		10.1074/jbc.M709939200	http://dx.doi.org/10.1074/jbc.M709939200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18541538	hybrid			2022-12-25	WOS:000257898800040
J	Janic, B; Iskander, ASM; Rad, AM; Soltanian-Zadeh, H; Arbab, AS				Janic, Branislava; Iskander, A. S. M.; Rad, Ali M.; Soltanian-Zadeh, Hamid; Arbab, Ali S.			Effects of Ferumoxides - Protamine Sulfate Labeling on Immunomodulatory Characteristics of Macrophage-like THP-1 Cells	PLOS ONE			English	Article								Superparamagnetic Iron Oxide (SPIO) complexed with cationic transfection agent is used to label various mammalian cells. Labeled cells can then be utilized as an in vivo magnetic resonance imaging (MRI) probes. However, certain number of in vivo administered labeled cells may be cleared from tissues by the host's macrophages. For successful translation to routine clinical application of SPIO labeling method it is important that this mode of in vivo clearance of iron does not elicit any diverse immunological effects. The purpose of this study was to demonstrate that SPIO agent ferumoxides-protamine sulfate (FePro) incorporation into macrophages does not alter immunological properties of these cells with regard to differentiation, chemotaxis, and ability to respond to the activation stimuli and to modulate T cell response. We used THP-1 cell line as a model for studying macrophage cell type. THP-1 cells were magnetically labeled with FePro, differentiated with 100 nM of phorbol ester, 12-Myristate-13-acetate (TPA) and stimulated with 100 ng/ml of LPS. The results showed 1) FePro labeling had no effect on the changes in morphology and expression of cell surface proteins associated with TPA induced differentiation; 2) FePro labeled cells responded to LPS with slightly higher levels of NFkB pathway activation, as shown by immunobloting; TNF-alpha secretion and cell surface expression levels of CD54 and CD83 activation markers, under these conditions, were still comparable to the levels observed in non-labeled cells; 3) FePro labeling exhibited differential, chemokine dependent, effect on THP-1 chemotaxis with a decrease in cell directional migration to MCP-1; 4) FePro labeling did not affect the ability of THP-1 cells to down-regulate T cell expression of CD4 and CD8 and to induce T cell proliferation. Our study demonstrated that intracellular incorporation of FePro complexes does not alter overall immunological properties of THP-1 cells. The described experiments provide the model for studying the effects of in vivo clearance of iron particles via incorporation into the host's macrophages that may follow after in vivo application of any type of magnetically labeled mammalian cells. To better mimic the complex in vivo scenario, this model may be further exploited by introducing additional cellular and biological, immunologically relevant, components.	[Janic, Branislava; Iskander, A. S. M.; Rad, Ali M.; Soltanian-Zadeh, Hamid; Arbab, Ali S.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Janic, B (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	bjanic@rad.hfh.edu	Soltanian-Zadeh, Hamid/K-2903-2016; Soltanian-Zadeh, Hamid/AAD-7027-2022; Arbab, Ali/AAS-1933-2020	Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856; 	NIH [R01-EB002450, R21-NS058589, R01-CA122031]; NATIONAL CANCER INSTITUTE [R01CA122031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058589] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by NIH grants R01-EB002450, R21-NS058589 and R01-CA122031	Ahrens ET, 2003, MAGN RESON MED, V49, P1006, DOI 10.1002/mrm.10465; Akasaka K, 2005, J VASC SURG, V41, P517, DOI 10.1016/j.jvs.2004.12.043; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; AUWERX J, 1992, LEUKEMIA RES, V16, P317, DOI 10.1016/0145-2126(92)90070-N; Bowen CV, 2002, MAGNET RESON MED, V48, P52, DOI 10.1002/mrm.10192; Conti P, 1998, ALLERGY ASTHMA PROC, V19, P121, DOI 10.2500/108854198778604176; Conti P, 2001, ALLERGY ASTHMA PROC, V22, P133, DOI 10.2500/108854101778148737; Czerniecki BJ, 2001, CRIT REV IMMUNOL, V21, P157; DI MP, 1994, J EXP MED, V179, P1731; Dodd CH, 2001, J IMMUNOL METHODS, V256, P89, DOI 10.1016/S0022-1759(01)00433-1; Edling CE, 2007, INT J BIOCHEM CELL B, V39, P1995, DOI 10.1016/j.biocel.2006.12.005; FERRUCCI JT, 1990, AM J ROENTGENOL, V155, P943, DOI 10.2214/ajr.155.5.2120963; Gordon S, 1998, RES IMMUNOL, V149, P685, DOI 10.1016/S0923-2494(99)80039-X; Hawiger J, 1999, BLOOD, V94, P1711, DOI 10.1182/blood.V94.5.1711.417k20_1711_1716; Heyn C, 2005, MAGN RESON MED, V53, P312, DOI 10.1002/mrm.20356; JAMALI I, 1992, J IMMUNOL, V148, P1613; Janic B, 2005, AM J PHYSIOL-LUNG C, V288, pL317, DOI 10.1152/ajplung.00125.2004; Jones MA, 2003, INFECT IMMUN, V71, P2626, DOI 10.1128/IAI.71.5.2626-2633.2003; Kemp K, 2001, J INTERF CYTOK RES, V21, P503, DOI 10.1089/10799900152434376; Kremlev SG, 1997, AM J PHYSIOL-LUNG C, V272, pL996, DOI 10.1152/ajplung.1997.272.5.L996; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Matuszewski L, 2005, RADIOLOGY, V235, P155, DOI 10.1148/radiol.2351040094; POULIQUEN D, 1991, MAGN RESON IMAGING, V9, P275, DOI 10.1016/0730-725X(91)90412-F; Prechtel AT, 2007, ARCH DERMATOL RES, V299, P59, DOI 10.1007/s00403-007-0743-z; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; Rad AM, 2007, J MAGN RESON IMAGING, V26, P366, DOI 10.1002/jmri.20978; Raynal I, 2004, INVEST RADIOL, V39, P56, DOI 10.1097/01.rli.0000101027.57021.28; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Ryan KA, 2004, INFECT IMMUN, V72, P2123, DOI 10.1128/IAI.72.4.2123-2130.2004; Schwende H, 1997, ADV EXP MED BIOL, V407, P491; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; SHACKELFORD DA, 1982, IMMUNOL REV, V66, P133, DOI 10.1111/j.1600-065X.1982.tb00437.x; Siglienti I, 2006, J NEUROIMMUNOL, V173, P166, DOI 10.1016/j.jneuroim.2005.11.011; Slavik JM, 1999, IMMUNOL RES, V19, P1, DOI 10.1007/BF02786473; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; STEIN M, 1991, EUR J IMMUNOL, V21, P431, DOI 10.1002/eji.1830210227; TVEDE N, 1988, SCAND J IMMUNOL, V27, P679, DOI 10.1111/j.1365-3083.1988.tb02401.x; VanGool SW, 1996, IMMUNOL REV, V153, P47; WANG JM, 1993, J EXP MED, V177, P699, DOI 10.1084/jem.177.3.699; Yano S, 2005, ENDOCRINOLOGY, V146, P2324, DOI 10.1210/en.2005-0065; Zhang Y, 2005, APOPTOSIS, V10, P545, DOI 10.1007/s10495-005-1885-0	46	20	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2499	10.1371/journal.pone.0002499	http://dx.doi.org/10.1371/journal.pone.0002499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575575	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288000022
J	Jiang, HY; Patel, JJ; Yi, M; Mu, JB; Ding, JH; Stephens, R; Cooper, RA; Ferdig, MT; Su, XZ				Jiang, Hongying; Patel, Jigar J.; Yi, Ming; Mu, Jianbing; Ding, Jinhui; Stephens, Robert; Cooper, Roland A.; Ferdig, Michael T.; Su, Xin-zhuan			Genome-Wide Compensatory Changes Accompany Drug-Selected Mutations in the Plasmodium falciparum crt Gene	PLOS ONE			English	Article							CHLOROQUINE-RESISTANCE TRANSPORTER; TRANSMEMBRANE PROTEIN PFCRT; DIGESTIVE VACUOLAR PH; MALARIA PARASITES; LINKAGE DISEQUILIBRIUM; MEFLOQUINE RESISTANCE; ANTIBIOTIC-RESISTANCE; PFMDR1 GENE; QUININE; SENSITIVITY	Mutations in PfCRT (Plasmodium falciparum chloroquine-resistant transporter), particularly the substitution at amino acid position 76, confer chloroquine (CQ) resistance in P. falciparum. Point mutations in the homolog of the mammalian multidrug resistance gene (pfmdr1) can also modulate the levels of CQ response. Moreover, parasites with the same pfcrt and pfmdr1 alleles exhibit a wide range of drug sensitivity, suggesting that additional genes contribute to levels of CQ resistance (CQR). Reemergence of CQ sensitive parasites after cessation of CQ use indicates that changes in PfCRT are deleterious to the parasite. Some CQR parasites, however, persist in the field and grow well in culture, which may reflect adaptive changes in the parasite genome to compensate for the mutations in PfCRT. Using three isogenic clones that have different drug resistance profiles corresponding to unique mutations in the pfcrt gene (106/1(K76), 106/1(76I), and 106/(76I-352K)), we investigated changes in gene expression in these parasites grown with and without CQ. We also conducted hybridizations of genomic DNA to identify copy number (CN) changes in parasite genes. RNA transcript levels from 45 genes were significantly altered in one or both mutants relative to the parent line, 106/1(K76). Most of the up-regulated genes are involved in invasion, cell growth and development, signal transduction, and transport activities. Of particular interest are genes encoding proteins involved in transport and/or regulation of cytoplasmic or compartmental pH such as the V-type H+ pumping pyrophosphatase 2 (PfVP2), Ca2+/H+ antiporter VCX1, a putative drug transporter and CN changes in pfmdr1. These changes may represent adaptations to altered functionality of PfCRT, a predicted member of drug/metabolite transporter superfamily found on the parasite food vacuole (FV) membrane. Further investigation of these genes may shed light on how the parasite compensates for functional changes accompanying drug resistance mutations in a gene coding for a membrane/drug transporter.	[Jiang, Hongying; Mu, Jianbing; Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Patel, Jigar J.; Ferdig, Michael T.] Univ Notre Dame, Ctr Glob Hlth & Infect Dis, Dept Biol Sci, Notre Dame, IN USA; [Yi, Ming; Stephens, Robert] NCI Frederick, Advanced Biomed Comput Ctr, Frederick, MD USA; [Ding, Jinhui] NIH, NIA, Lab Neurogenet, Bioinformat Unit, Bethesda, MD USA; [Cooper, Roland A.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Notre Dame; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Old Dominion University	Jiang, HY (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ferdig.1@nd.edu; xsu@niaid.nih.gov	Ferdig, Michael/C-6627-2016	Su, Xinzhuan/0000-0003-3246-3248; Yi, Ming/0000-0001-9098-1364	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health [AI071121]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892, R01AI071121] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in part supported by Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. MTF and RAC are supported by NIH grant AI071121.	Adagu IS, 2001, PARASITOLOGY, V123, P219, DOI 10.1017/S0031182001008344; Allen JD, 2000, CANCER RES, V60, P5761; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; Besier S, 2005, ANTIMICROB AGENTS CH, V49, P1426, DOI 10.1128/AAC.49.4.1426-1431.2005; BOLSTAD BM, 2005, STAT BIOL HLTH; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bray PG, 2006, MOL MICROBIOL, V62, P238, DOI 10.1111/j.1365-2958.2006.05368.x; Chen NH, 2002, J INFECT DIS, V185, P405, DOI 10.1086/338470; Cooper RA, 2005, ACTA TROP, V94, P170, DOI 10.1016/j.actatropica.2005.04.004; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Duraisingh MT, 2005, MOL MICROBIOL, V57, P874, DOI 10.1111/j.1365-2958.2005.04748.x; Duraisingh MT, 2000, PARASITOLOGY, V121, P1, DOI 10.1017/S0031182099006022; Dzekunov SM, 2000, MOL BIOCHEM PARASIT, V110, P107, DOI 10.1016/S0166-6851(00)00261-9; Fernandez V, 1998, INFECT IMMUN, V66, P2969, DOI 10.1128/IAI.66.6.2969-2975.1998; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Gaur D, 2003, INFECT IMMUN, V71, P6742, DOI 10.1128/IAI.71.12.6742-6746.2003; Gligorijevic B, 2008, MOL BIOCHEM PARASIT, V159, P7, DOI 10.1016/j.molbiopara.2007.12.014; Hastings IM, 2002, SCIENCE, V298, P74, DOI 10.1126/science.1077573; Hayton K., 2004, Current Drug Targets - Infectious Disorders, V4, P1, DOI 10.2174/1568005043480925; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Levin BR, 2000, GENETICS, V154, P985; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Luo SH, 1999, FEBS LETT, V460, P217, DOI 10.1016/S0014-5793(99)01353-8; Maisnier-Patin S, 2002, MOL MICROBIOL, V46, P355, DOI 10.1046/j.1365-2958.2002.03173.x; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; McIntosh MT, 2002, INT J PARASITOL, V32, P1, DOI 10.1016/S0020-7519(01)00325-3; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Naude B, 2005, J BIOL CHEM, V280, P25596, DOI 10.1074/jbc.M503227200; Nessler S, 2004, J BIOL CHEM, V279, P39438, DOI 10.1074/jbc.M404671200; Ouellette Marc, 1994, Trends in Microbiology, V2, P407, DOI 10.1016/0966-842X(94)90620-3; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Sanchez CP, 2007, TRENDS PARASITOL, V23, P332, DOI 10.1016/j.pt.2007.04.013; Sanchez CP, 2003, BIOCHEMISTRY-US, V42, P9383, DOI 10.1021/bi034269h; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Su XZ, 1998, EXP PARASITOL, V89, P262, DOI 10.1006/expr.1998.4299; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tran CV, 2004, MICROBIOL-SGM, V150, P1, DOI 10.1099/mic.0.26818-0; Wang XH, 2005, AM J TROP MED HYG, V72, P410, DOI 10.4269/ajtmh.2005.72.410; Warhurst DC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-31; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yi M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-30; Zhang HB, 2002, J BIOL CHEM, V277, P49767, DOI 10.1074/jbc.M204005200	60	66	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2484	10.1371/journal.pone.0002484	http://dx.doi.org/10.1371/journal.pone.0002484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575593	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288000014
J	Cross, A; Collard, M; Nelson, A				Cross, Alan; Collard, Mark; Nelson, Andrew			Body Segment Differences in Surface Area, Skin Temperature and 3D Displacement and the Estimation of Heat Balance during Locomotion in Hominins	PLOS ONE			English	Article							OPEN EQUATORIAL ENVIRONMENTS; THERMOREGULATORY ADVANTAGES; WATER BUDGETS; BIPEDALISM; ENERGY; WARM	The conventional method of estimating heat balance during locomotion in humans and other hominins treats the body as an undifferentiated mass. This is problematic because the segments of the body differ with respect to several variables that can affect thermoregulation. Here, we report a study that investigated the impact on heat balance during locomotion of inter-segment differences in three of these variables: surface area, skin temperature and rate of movement. The approach adopted in the study was to generate heat balance estimates with the conventional method and then compare them with heat balance estimates generated with a method that takes into account inter-segment differences in surface area, skin temperature and rate of movement. We reasoned that, if the hypothesis that inter-segment differences in surface area, skin temperature and rate of movement affect heat balance during locomotion is correct, the estimates yielded by the two methods should be statistically significantly different. Anthropometric data were collected on seven adult male volunteers. The volunteers then walked on a treadmill at 1.2 m/s while 3D motion capture cameras recorded their movements. Next, the conventional and segmented methods were used to estimate the volunteers' heat balance while walking in four ambient temperatures. Lastly, the estimates produced with the two methods were compared with the paired t-test. The estimates of heat balance during locomotion yielded by the two methods are significantly different. Those yielded by the segmented method are significantly lower than those produced by the conventional method. Accordingly, the study supports the hypothesis that inter-segment differences in surface area, skin temperature and rate of movement impact heat balance during locomotion. This has important implications not only for current understanding of heat balance during locomotion in hominins but also for how future research on this topic should be approached.	[Cross, Alan; Collard, Mark] Simon Fraser Univ, Dept Archaeol, Lab Human Evolutionary Studies, Burnaby, BC V5A 1S6, Canada; [Nelson, Andrew] Univ Western Ontario, Dept Anthropol, London, ON, Canada	Simon Fraser University; Western University (University of Western Ontario)	Cross, A (corresponding author), Simon Fraser Univ, Dept Archaeol, Lab Human Evolutionary Studies, Burnaby, BC V5A 1S6, Canada.	agc6@sfu.ca	Nelson, Andrew J/B-9090-2015	Collard, Mark/0000-0002-2725-4989	SSHRC-CGS [766-2004-0723, 767-2006-1902]; Canada Research Chairs Program; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Simon Fraser University	SSHRC-CGS; Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Simon Fraser University	This research was funded by SSHRC-CGS# 766-2004-0723, SSHRC-CGS# 767-2006-1902, the Canada Research Chairs Program, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, and Simon Fraser University. Funding bodies had no role in the study or the preparation of the manuscript.	Anderson GS, 1999, INT J BIOMETEOROL, V43, P99, DOI 10.1007/s004840050123; Ardigo LP, 2003, EUR J APPL PHYSIOL, V90, P365, DOI 10.1007/s00421-003-0882-7; Buono RJ, 2000, J THERM BIOL, V25, P263, DOI 10.1016/S0306-4565(99)00095-9; CHAPLIN G, 1994, J HUM EVOL, V27, P497, DOI 10.1006/jhev.1994.1066; Dennis SC, 1999, EUR J APPL PHYSIOL, V79, P280, DOI 10.1007/s004210050507; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Gordon C.C., 1989, 1988 ANTHROPOMETRIC; HOUDAS REF, 1982, HUMAN BODY TEMPERATU; Marino FE, 2004, J APPL PHYSIOL, V96, P124, DOI 10.1152/japplphysiol.00582.2003; Marino FE, 2000, PFLUG ARCH EUR J PHY, V441, P359, DOI 10.1007/s004240000432; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; Nielsen B, 1996, MED SCI SPORT EXER, V28, P665, DOI 10.1097/00005768-199606000-00004; Roberts D. F., 1978, CLIMATE HUMAN VARIAB; WHEELER PE, 1994, J HUM EVOL, V27, P511, DOI 10.1006/jhev.1994.1067; WHEELER PE, 1991, J HUM EVOL, V21, P107, DOI 10.1016/0047-2484(91)90002-D; WHEELER PE, 1993, J HUM EVOL, V24, P13, DOI 10.1006/jhev.1993.1003; WHEELER PE, 1994, J HUM EVOL, V26, P339, DOI 10.1006/jhev.1994.1021; WHEELER PE, 1991, J HUM EVOL, V21, P117, DOI 10.1016/0047-2484(91)90003-E; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65	19	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2464	10.1371/journal.pone.0002464	http://dx.doi.org/10.1371/journal.pone.0002464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406FP	18560580	Green Submitted, Green Published, gold			2022-12-25	WOS:000263280700045
J	Dylla, SJ; Beviglia, L; Park, IK; Chartier, C; Raval, J; Ngan, L; Pickell, K; Aguilar, J; Lazetic, S; Smith-Berdan, S; Clarke, MF; Hoey, T; Lewicki, J; Gurney, AL				Dylla, Scott J.; Beviglia, Lucia; Park, In-Kyung; Chartier, Cecile; Raval, Janak; Ngan, Lucy; Pickell, Kellie; Aguilar, Jorge; Lazetic, Sasha; Smith-Berdan, Stephanie; Clarke, Michael F.; Hoey, Tim; Lewicki, John; Gurney, Austin L.			Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy	PLOS ONE			English	Article								Background: Patients generally die of cancer after the failure of current therapies to eliminate residual disease. A subpopulation of tumor cells, termed cancer stem cells (CSC), appears uniquely able to fuel the growth of phenotypically and histologically diverse tumors. It has been proposed, therefore, that failure to effectively treat cancer may in part be due to preferential resistance of these CSC to chemotherapeutic agents. The subpopulation of human colorectal tumor cells with an ESA(+) CD44(+) phenotype are uniquely responsible for tumorigenesis and have the capacity to generate heterogeneous tumors in a xenograft setting (i.e. CoCSC). We hypothesized that if non-tumorigenic cells are more susceptible to chemotherapeutic agents, then residual tumors might be expected to contain a higher frequency of CoCSC. Methods and Findings: Xenogeneic tumors initiated with CoCSC were allowed to reach,400 mm 3, at which point mice were randomized and chemotherapeutic regimens involving cyclophosphamide or Irinotecan were initiated. Data from individual tumor phenotypic analysis and serial transplants performed in limiting dilution show that residual tumors are enriched for cells with the CoCSC phenotype and have increased tumorigenic cell frequency. Moreover, the inherent ability of residual CoCSC to generate tumors appears preserved. Aldehyde dehydrogenase 1 gene expression and enzymatic activity are elevated in CoCSC and using an in vitro culture system that maintains CoCSC as demonstrated by serial transplants and lentiviral marking of single cell-derived clones, we further show that ALDH1 enzymatic activity is a major mediator of resistance to cyclophosphamide: a classical chemotherapeutic agent. Conclusions: CoCSC are enriched in colon tumors following chemotherapy and remain capable of rapidly regenerating tumors from which they originated. By focusing on the biology of CoCSC, major resistance mechanisms to specific chemotherapeutic agents can be attributed to specific genes, thereby suggesting avenues for improving cancer therapy.	[Dylla, Scott J.; Beviglia, Lucia; Park, In-Kyung; Chartier, Cecile; Raval, Janak; Ngan, Lucy; Pickell, Kellie; Aguilar, Jorge; Lazetic, Sasha; Smith-Berdan, Stephanie; Hoey, Tim; Lewicki, John; Gurney, Austin L.] OncoMed Pharmaceut Inc, Redwood City, CA USA; [Clarke, Michael F.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA USA	Stanford University	Dylla, SJ (corresponding author), OncoMed Pharmaceut Inc, Redwood City, CA USA.	mnscott11@yahoo.com						Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bates RC, 2007, CELLS TISSUES ORGANS, V185, P29, DOI 10.1159/000101300; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Boddy AV, 2000, CLIN PHARMACOKINET, V38, P291, DOI 10.2165/00003088-200038040-00001; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Corti S, 2006, HUM MOL GENET, V15, P167, DOI 10.1093/hmg/ddi446; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; Donnenberg VS, 2005, J CLIN PHARMACOL, V45, P872, DOI 10.1177/0091270005276905; Fallon P, 2003, BRIT J HAEMATOL, V122, P99, DOI 10.1046/j.1365-2141.2003.04357.x; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Huff CA, 2006, EUR J CANCER, V42, P1293, DOI 10.1016/j.ejca.2006.01.045; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy James A, 2007, Science, V318, P1722; Kern SE, 2007, CANCER RES, V67, P8985, DOI 10.1158/0008-5472.CAN-07-1971; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; MAHMOUD MIE, 1993, ALCOHOL CLIN EXP RES, V17, P1223, DOI 10.1111/j.1530-0277.1993.tb05233.x; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; Moreb JS, 2007, CANCER CHEMOTH PHARM, V59, P127, DOI 10.1007/s00280-006-0233-6; Moreb JS, 2005, J PHARMACOL EXP THER, V312, P339, DOI 10.1124/jpet.104.072496; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Nolta JA, 1996, P NATL ACAD SCI USA, V93, P2414, DOI 10.1073/pnas.93.6.2414; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Polyak K, 2007, STEM CELL REV, V3, P107, DOI 10.1007/s12015-007-0020-8; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Russo J E, 1989, Prog Clin Biol Res, V290, P65; Russo JE, 1997, ADV EXP MED BIOL, V414, P217; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sladek NE, 1999, CURR PHARM DESIGN, V5, P607; Sladek NE, 2002, CANCER CHEMOTH PHARM, V49, P309, DOI 10.1007/s00280-001-0412-4; Staud F, 2005, INT J BIOCHEM CELL B, V37, P720, DOI 10.1016/j.biocel.2004.11.004; Tallman MS, 2004, SEMIN HEMATOL, V41, P27, DOI 10.1053/j.seminhematol.2004.02.004; Thompson MA, 1998, CANCER RES, V58, P5168; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Zhang J, 2005, DRUG METAB REV, V37, P611, DOI 10.1080/03602530500364023	49	455	501	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2428	10.1371/journal.pone.0002428	http://dx.doi.org/10.1371/journal.pone.0002428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560594	Green Submitted, Green Published, gold			2022-12-25	WOS:000263280700013
J	Ma, YQ; Malbon, CC; Williams, DL; Thorngate, FE				Ma, Yanqing; Malbon, Craig C.; Williams, David L.; Thorngate, Fayanne E.			Altered Gene Expression in Early Atherosclerosis Is Blocked by Low Level Apolipoprotein E	PLOS ONE			English	Article								Background: Mice deficient in apolipoprotein E (apoE(-/-)) develop atherosclerosis. The possible linkage between expression of adhesion molecules/cofactors and atherosclerosis was probed at the level of mRNA and protein expression. The hypothesis of a linkage between changes of adhesion molecules/cofactors and atherosclerosis was tested further by suppression of aortic lesion formation in apoE(-/)-mice by expression of very low levels of transgenic apolipoprotein E. Methodology/Principal Findings: We show that at 8.5 months of age, the apoE(-/)-mice display elevated expression of mRNA for LFA-1, MAC-1, VCAM-1, ICAM-1, and for CD44, as well as MCP-1, cathepsin B, and COX-2 (but not that for eNOS) in atherosclerotic aortic arches. At earlier age, (10-13 week old) apoE 2/2 mice already display elevated expression of mRNA of CD44, LFA-1, MAC-1, VCAM-1, ICAM-1, cathepsin, and of COX-2 in lesioned aortic arches. Expressing very low levels of transgenic apolipoprotein E suppresses both aortic lesions and the expression of mRNA of LFA-1, VCAM-1, MCP-1, cathepsin B, and of ICAM-1 in ApoE(-/)-mice. We tested at the level of protein, the observations obtained for mRNA expression. CD11a (a component of LFA-1), VCAM-1 and cathepsin B expression was found to be elevated in apoE 2/2 aortas at 8-9 months; low level expression of transgenic apolipoprotein E rectifies these changes. Conclusions/Significance: Atherosclerotic lesions in apoE(-/)-mice are detected as early as 4 weeks of age. Expression of low levels of apoE is shown to be both atheroprotective and to suppress these changes in key adhesion and inflammatory molecules observed in early atherosclerotic lesions.	[Ma, Yanqing; Malbon, Craig C.; Williams, David L.; Thorngate, Fayanne E.] SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ma, YQ (corresponding author), SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	thorngate@pharm.stonybrook.edu	malbon, craig/ABF-3604-2020		National Institutes of Health [HL-32868]; American Heart Association [postdoctoral fellowship]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by Grant HL-32868 (CCM and FET) from the National Institutes of Health and an American Heart Association postdoctoral fellowship to Yanqing Ma. Neither had any role aside from funding in the preparation of this manuscript.	Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; BOISVERT WA, 1995, J CLIN INVEST, V96, P1118, DOI 10.1172/JCI118098; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Burleigh ME, 2002, CIRCULATION, V105, P1816, DOI 10.1161/01.CIR.0000014927.74465.7F; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; CURTISS LK, 1977, J IMMUNOL, V118, P648; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; HUI DY, 1980, J BIOL CHEM, V255, P1775; Huo YQ, 2000, CIRC RES, V87, P153, DOI 10.1161/01.RES.87.2.153; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Johnson RC, 1997, J CLIN INVEST, V99, P1037, DOI 10.1172/JCI119231; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Lusis AJ, 2004, CIRCULATION, V110, P2066, DOI 10.1161/01.CIR.0000143098.98869.F8; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; MILLER BF, 1969, EXP MOL PATHOL, V10, P288, DOI 10.1016/0014-4800(69)90058-6; Nageh MF, 1997, ARTERIOSCL THROM VAS, V17, P1517, DOI 10.1161/01.ATV.17.8.1517; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; PEPE MG, 1986, J IMMUNOL, V136, P3716; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Riddell DR, 1997, J BIOL CHEM, V272, P89; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stannard AK, 2001, J BIOL CHEM, V276, P46011, DOI 10.1074/jbc.M104812200; Tertov VV, 1997, EXP MOL PATHOL, V64, P127, DOI 10.1006/exmp.1997.2216; Thorngate FE, 2000, ARTERIOSCL THROM VAS, V20, P1939, DOI 10.1161/01.ATV.20.8.1939; Thorngate FE, 2002, J LIPID RES, V43, P1920, DOI 10.1194/jlr.M200205-JLR200; Trogan E, 2002, P NATL ACAD SCI USA, V99, P2234, DOI 10.1073/pnas.042683999; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; VANDE SA, 1996, J MOL MED, V74, P13, DOI DOI 10.1007/BF00202069; Wuttge DM, 2001, MOL MED, V7, P383, DOI 10.1007/BF03402184; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zibara K, 2000, ARTERIOSCL THROM VAS, V20, P2288, DOI 10.1161/01.ATV.20.10.2288	38	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2503	10.1371/journal.pone.0002503	http://dx.doi.org/10.1371/journal.pone.0002503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560564	gold, Green Published, Green Submitted			2022-12-25	WOS:000263280700059
J	Scardigli, R; Gargioli, C; Tosoni, D; Borello, U; Sampaolesi, M; Sciorati, C; Cannata, S; Clementi, E; Brunelli, S; Cossu, G				Scardigli, Raffaella; Gargioli, Cesare; Tosoni, Daniela; Borello, Ugo; Sampaolesi, Maurilio; Sciorati, Clara; Cannata, Stefano; Clementi, Emilio; Brunelli, Silvia; Cossu, Giulio			Binding of sFRP-3 to EGF in the Extra-Cellular Space Affects Proliferation, Differentiation and Morphogenetic Events Regulated by the Two Molecules	PLOS ONE			English	Article								Background: sFRP-3 is a soluble antagonist of Wnts, widely expressed in developing embryos. The Wnt gene family comprises cysteine-rich secreted ligands that regulate cell proliferation, differentiation, organogenesis and oncogenesis of different organisms ranging from worms to mammals. In the canonical signal transduction pathway Wnt proteins bind to the extracellular domain of Frizzled receptors and consequently recruit Dishevelled (Dsh) to the cell membrane. In addition to Wnt membrane receptors belonging to the Frizzled family, several other molecules have been described which share homology in the CRD domain and lack the putative trans-membrane domain, such as sFRP molecules (soluble Frizzled Related Protein). Among them, sFRP-3 was originally isolated from bovine articular cartilage and also as a component of the Spemann organizer. sFRP-3 blocks Wnt-8 induced axis duplication in Xenopus embryos and binds to the surface of cells expressing a membrane-anchored form of Wnt-1. Injection of sFRP-3 mRNA blocks expression of XMyoD mRNA and leads to embryos with enlarged heads and shortened trunks. Methodology/Principal Findings: Here we report that sFRP-3 specifically blocks EGF-induced fibroblast proliferation and foci formation. Over-expression of sFRP-3 reverts EGF-mediated inhibition of hair follicle development in the mouse ectoderm while its ablation in Xenopus maintains EGF-mediated inhibition of ectoderm differentiation. Conversely, overexpression of EGF reverts the inhibition of somitic myogenesis and axis truncation in Xenopus and mouse embryos caused by sFRP-3. In vitro experiments demonstrated a direct binding of EGF to sFRP-3 both on heparin and on the surface of CHO cells where the molecule had been membrane anchored. Conclusions/Significance: sFRP-3 and EGF reciprocally inhibit their effects on cell proliferation, differentiation and morphogenesis and indeed are expressed in contiguous domains of the embryo, suggesting that in addition to their canonical ligands (Wnt and EGF receptor, respectively) these molecules bind to each other and regulate their activities during embryogenesis.	[Scardigli, Raffaella; Gargioli, Cesare; Cossu, Giulio] Inst Cell Biol & Tissue Engn, Dept Dev Biol, San Raffaele Biomed Sci Park Rome, Rome, Italy; [Scardigli, Raffaella; Gargioli, Cesare; Tosoni, Daniela; Borello, Ugo] Univ Roma La Sapienza, Med Sch, Dept Histol & Med Embryol, Rome, Italy; [Borello, Ugo; Sciorati, Clara; Clementi, Emilio; Brunelli, Silvia; Cossu, Giulio] Stem Cell Res Inst, Milan, Italy; [Sampaolesi, Maurilio] Univ Pavia, Dept Expt Med, Pavia, Italy; [Sampaolesi, Maurilio] Univ Hosp Gasthuisberg, Interdept Stem Cell Res Inst, Louvain, Belgium; [Cannata, Stefano] Univ Tor Vergata, Dept Biol, Rome, Italy; [Clementi, Emilio] Univ Milan, E Medea Sci Inst, Dept Preclin Sci, Milan, Italy; [Brunelli, Silvia] Univ Milano Bicocca, Dept Expt Med, Milan, Italy; [Cossu, Giulio] Univ Milan, Dept Biol, Milan, Italy	Sapienza University Rome; University of Pavia; KU Leuven; University Hospital Leuven; University of Rome Tor Vergata; University of Milan; University of Milano-Bicocca; University of Milan	Scardigli, R (corresponding author), Inst Cell Biol & Tissue Engn, Dept Dev Biol, San Raffaele Biomed Sci Park Rome, Rome, Italy.	cossu.giulio@hsr.it	Borello, Ugo/M-5213-2014; Tosoni, Daniela/K-4524-2014; Brunelli, Silvia/J-3248-2014; Sampaolesi, Maurilio/H-6509-2013; Brunelli, Silvia/P-3853-2019; sciorati, clara/K-4823-2016	Borello, Ugo/0000-0001-9812-579X; Brunelli, Silvia/0000-0003-1753-5346; Sampaolesi, Maurilio/0000-0002-2422-3757; Brunelli, Silvia/0000-0003-1753-5346; Gargioli, Cesare/0000-0003-1742-3969; sciorati, clara/0000-0003-2030-9366; Scardigli, Raffaella/0000-0003-1369-0496	AFM; MDA; Duchenne Parent Project; CARIPLO; Fondation Leducq; European Community; Italian Ministries of Health and Research	AFM(Association Francaise contre les Myopathies); MDA(Muscular Dystrophy Association); Duchenne Parent Project; CARIPLO(Fondazione Cariplo); Fondation Leducq(Leducq Foundation); European Community(European Commission); Italian Ministries of Health and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from AFM, MDA, Duchenne Parent Project, CARIPLO, Fondation Leducq, European Community, Italian Ministries of Health and Research.	Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Ball SG, 2007, J CELL BIOL, V177, P489, DOI 10.1083/jcb.200608093; Berghella L, 1999, HUM GENE THER, V10, P1607, DOI 10.1089/10430349950017617; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Borello U, 1999, MECH DEVELOP, V89, P173, DOI 10.1016/S0925-4773(99)00205-1; Borello U, 1999, DEVELOPMENT, V126, P4247; BRADBURY JM, 1994, ONCOGENE, V9, P2597; Brunelli S, 2003, GENE EXPR PATTERNS, V3, P755, DOI 10.1016/S1567-133X(03)00135-2; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carmena A, 1998, GENE DEV, V12, P3910, DOI 10.1101/gad.12.24.3910; Chen YJ, 2004, INT J DEV BIOL, V48, P867, DOI 10.1387/ijdb.041882yc; Chung YS, 2004, J BONE MINER RES, V19, P1395, DOI 10.1359/JBMR.040412; Clementi E, 1995, MOL PHARMACOL, V48, P1068; Cossu G, 1996, DEVELOPMENT, V122, P429; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dierick H, 1999, CURR TOP DEV BIOL, V43, P153, DOI 10.1016/S0070-2153(08)60381-6; Enomoto-Iwamoto M, 2002, DEV BIOL, V251, P142, DOI 10.1006/dbio.2002.0802; Freeman M, 2001, EMBO REP, V2, P157, DOI 10.1093/embo-reports/kve019; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Graham NA, 2004, J BIOL CHEM, V279, P23517, DOI 10.1074/jbc.M314055200; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Hoang B, 1996, J BIOL CHEM, V271, P26131, DOI 10.1074/jbc.271.42.26131; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; Kashiwagi M, 1997, DEV BIOL, V189, P22, DOI 10.1006/dbio.1997.8650; KIM SE, 2007, CELL SIGNAL; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; Kopp A, 1999, DEVELOPMENT, V126, P3495; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Kumar JP, 2001, DEVELOPMENT, V128, P2689; LAFLAMME SE, 1990, DEV BIOL, V137, P414, DOI 10.1016/0012-1606(90)90265-K; Lawrence PA, 2002, DEVELOPMENT, V129, P2749; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NUSSE R, 1992, J STEROID BIOCHEM, V43, P9, DOI 10.1016/0960-0760(92)90181-H; O'Keefe L, 1997, DEVELOPMENT, V124, P4837; PAN MG, 1995, ONCOGENE, V11, P2005; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; SALVATORI G, 1995, J CELL SCI, V108, P2733; Schroeder JA, 2000, ONCOGENE, V19, P3193, DOI 10.1038/sj.onc.1203652; Sciorati C, 1999, J IMMUNOL, V163, P1570; Shi W, 2000, J CELL BIOL, V148, P591, DOI 10.1083/jcb.148.3.591; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Tagliafico E, 2004, J CELL SCI, V117, P4377, DOI 10.1242/jcs.01291; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; van de Water S, 2001, DEVELOPMENT, V128, P3877; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; VELU TJ, 1989, J CELL BIOCHEM, V39, P153, DOI 10.1002/jcb.240390207; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	58	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2471	10.1371/journal.pone.0002471	http://dx.doi.org/10.1371/journal.pone.0002471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560570	Green Published, gold, Green Submitted			2022-12-25	WOS:000263280700049
J	Siroux, V; Bouzigon, E; Dizier, MH; Pin, I; Demenais, F; Kauffmann, F				Siroux, Valerie; Bouzigon, Emmanuelle; Dizier, Marie-Helene; Pin, Isabelle; Demenais, Florence; Kauffmann, Francine		EGEA Cooperative Grp	Replication of Association between ADAM33 Polymorphisms and Psoriasis	PLOS ONE			English	Article								Polymorphisms in ADAM33, the first gene identified in asthma by positional cloning, have been recently associated with psoriasis. No replication study of this association has been published so far. Data available in the French EGEA study (Epidemiological study on Genetics and Environment of Asthma, bronchial hyperresponsivensess and Atopy) give the opportunity to attempt to replicate the association between ADAM33 and psoriasis in 2002 individuals. Psoriasis (n = 150) has been assessed by questionnaire administered by an interviewer and a sub-sample of subjects with early-onset psoriasis (n = 74) has been identified based on the age of the subjects at time of interview (<40 years). Nine SNPs in ADAM33 and 11 SNPs in PSORS1 were genotyped. Association analysis was conducted by using two methods, GEE regression-based method and a likelihood-based method (LAMP program). The rs512625 SNP in ADAM33 was found associated with psoriasis at p = 0.01, the usual threshold required for replication (OR [95% CI] for heterozygotes compared to the reference group of homozygotes for the most frequent allele = 0.61 [0.42;0.89]). The rs628977 SNP, which was not in linkage disequilibrium with rs512625, was significantly associated with early-onset psoriasis (p = 0.01, OR [ 95% CI] for homozygotes for the minor allele compared to the reference group = 2.52 [1.31;4.86]). Adjustment for age, sex, asthma and a PSORS1 SNP associated with psoriasis in the EGEA data did not change the significance of these associations. This suggests independent effects of ADAM33 and PSORS1 on psoriasis. This is the first study that replicates an association between genetic variants in ADAM33 and psoriasis. Interestingly, the 2 ADAM33 SNPs associated with psoriasis in the present analysis were part of the 3-SNPs haplotypes showing the strongest associations in the initial study. The identification of a pleiotropic effect of ADAM33 on asthma and psoriasis may contribute to the understanding of these common immune-mediated diseases.	[Siroux, Valerie; Pin, Isabelle] Ctr Rech Albert Bonniot Epidemiol Canc & Affect G, INSERM, U823, La Tronche, France; [Siroux, Valerie; Pin, Isabelle] Univ Joseph Fourier, Grenoble, France; [Bouzigon, Emmanuelle; Demenais, Florence] Fdn Jean Dausset, CEPH, INSERM, U794, Paris, France; [Bouzigon, Emmanuelle; Demenais, Florence] Univ Evry, Evry, France; [Dizier, Marie-Helene] INSERM, U535, Villejuif, France; [Dizier, Marie-Helene; Kauffmann, Francine] Univ Paris Sud, IFR69, Villejuif, France; [Pin, Isabelle] CHU Grenoble, Grenoble, France; [Kauffmann, Francine] Inserm, U780, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Siroux, V (corresponding author), Ctr Rech Albert Bonniot Epidemiol Canc & Affect G, INSERM, U823, La Tronche, France.	valerie.siroux@ujf-grenoble.fr	PIN, Isabelle/N-3020-2013; Dizier, Marie-Hélène/K-8463-2018; siroux, valerie/N-1865-2013; Le Moual, Nicole/R-8976-2016; Bouzigon, Emmanuelle/L-2766-2017; Demenais, Florence/G-3298-2013; Le Moual, Nicole/GNP-5114-2022	Dizier, Marie-Hélène/0000-0001-8460-7667; siroux, valerie/0000-0001-7329-7237; Le Moual, Nicole/0000-0002-2723-5569; Bouzigon, Emmanuelle/0000-0001-5756-4286; Demenais, Florence/0000-0001-8361-0936; Le Moual, Nicole/0000-0002-2723-5569	Merck; ANR [05-SEST-020-02/05-9-97, ANR-06-CEBS]; PHRC-Paris	Merck(Merck & Company); ANR(French National Research Agency (ANR)); PHRC-Paris	Merck, ANR 05-SEST-020-02/05-9-97, ANR-06-CEBS and PHRC-Paris	BRANDRUP F, 1981, ACTA DERM-VENEREOL, V61, P344; Chang M, 2008, GENES IMMUN, V9, P176, DOI 10.1038/sj.gene.6364451; Del Mastro RG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-46; Dizier MH, 2000, AM J RESP CRIT CARE, V162, P1812, DOI 10.1164/ajrccm.162.5.2002113; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Gudjonsson JE, 2007, CLIN DERMATOL, V25, P535, DOI 10.1016/j.clindermatol.2007.08.007; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Holgate ST, 2006, PULM PHARMACOL THER, V19, P3, DOI 10.1016/j.pupt.2005.02.008; Iizuka H, 2004, J DERMATOL SCI, V35, P93, DOI 10.1016/j.jdermsci.2004.01.003; Ito I, 2007, J ALLERGY CLIN IMMUN, V119, P89, DOI 10.1016/j.jaci.2006.08.038; Kauffmann F, 1999, CLIN EXP ALLERGY, V29, P17; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lesueur F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000906; Lesueur F, 2007, J INVEST DERMATOL, V127, P1403, DOI 10.1038/sj.jid.5700749; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; NAIR RP, 2008, J INVEST DERMATOL; Nevitt GJ, 1996, BRIT J DERMATOL, V135, P533, DOI 10.1046/j.1365-2133.1996.d01-1035.x; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; SIROUX V, 2006, EUR RESP J S50, V28, pS143; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yoshinaka T, 2002, GENE, V282, P227, DOI 10.1016/S0378-1119(01)00818-6; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094	28	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2448	10.1371/journal.pone.0002448	http://dx.doi.org/10.1371/journal.pone.0002448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560587	Green Published, Green Submitted, gold			2022-12-25	WOS:000263280700033
J	Dossin, FD; Dufour, A; Dusch, E; Siqueira-Neto, JL; Moraes, CB; Yang, GS; Cano, MI; Genovesio, A; Freitas, LH				Dossin, Fernando de M.; Dufour, Alexandre; Dusch, Elodie; Siqueira-Neto, Jair L.; Moraes, Carolina B.; Yang, Gyong Seon; Cano, Maria Isabel; Genovesio, Auguste; Freitas-Junior, Lucio H.			Automated Nuclear Analysis of Leishmania major Telomeric Clusters Reveals Changes in Their Organization during the Parasite's Life Cycle	PLOS ONE			English	Article								Parasite virulence genes are usually associated with telomeres. The clustering of the telomeres, together with their particular spatial distribution in the nucleus of human parasites such as Plasmodium falciparum and Trypanosoma brucei, has been suggested to play a role in facilitating ectopic recombination and in the emergence of new antigenic variants. Leishmania parasites, as well as other trypanosomes, have unusual gene expression characteristics, such as polycistronic and constitutive transcription of protein-coding genes. Leishmania subtelomeric regions are even more unique because unlike these regions in other trypanosomes they are devoid of virulence genes. Given these peculiarities of Leishmania, we sought to investigate how telomeres are organized in the nucleus of Leishmania major parasites at both the human and insect stages of their life cycle. We developed a new automated and precise method for identifying telomere position in the three-dimensional space of the nucleus, and we found that the telomeres are organized in clusters present in similar numbers in both the human and insect stages. While the number of clusters remained the same, their distribution differed between the two stages. The telomeric clusters were found more concentrated near the center of the nucleus in the human stage than in the insect stage suggesting reorganization during the parasite's differentiation process between the two hosts. These data provide the first 3D analysis of Leishmania telomere organization. The possible biological implications of these findings are discussed.	[Dossin, Fernando de M.; Siqueira-Neto, Jair L.; Moraes, Carolina B.; Yang, Gyong Seon; Freitas-Junior, Lucio H.] Inst Pasteur Korea, Syst Biol Pathogens Grp, Seoul, South Korea; [Dufour, Alexandre; Dusch, Elodie; Genovesio, Auguste] Inst Pasteur Korea, Image Mining Grp, Seoul, South Korea; [Moraes, Carolina B.] Univ Fed Sao Paulo, Dept Microbiol, Imunol Parasitol, Sao Paulo, Brazil; [Cano, Maria Isabel] Univ Estadual Paulista, Inst Biocien, Dept Genet, Sao Paulo, Brazil	Institut Pasteur Korea; Institut Pasteur Korea; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista	Dossin, FD (corresponding author), Inst Pasteur Korea, Syst Biol Pathogens Grp, Seoul, South Korea.	junior@ip-korea.org	Cano, Maria Isabel/A-4020-2008; Freitas-Junior, Lucio H/C-8677-2011; Cano, Maria Isabel/M-7691-2019; GENOVESIO, Auguste/I-1656-2017; Dossin, Fernando/D-1503-2011; Moraes, Carolina Borsoi/I-4408-2014; Siqueira-Neto, Jair L/D-6040-2012; Siqueira-Neto, Jair/AAC-1173-2019	Freitas-Junior, Lucio H/0000-0002-8904-7897; Cano, Maria Isabel/0000-0001-9798-6627; Moraes, Carolina Borsoi/0000-0002-0689-2770; Siqueira-Neto, Jair L/0000-0001-9574-8174; Siqueira-Neto, Jair/0000-0001-9574-8174; Genovesio, Auguste/0000-0003-1877-5595; Dufour, Alexandre/0000-0002-9417-7389	Institut Pasteur Korea	Institut Pasteur Korea	This work was funded by Institut Pasteur Korea	BLACKBURN EH, 1990, J BIOL CHEM, V265, P5919; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Campbell DA, 2003, MICROBES INFECT, V5, P1231, DOI 10.1016/j.micinf.2003.09.005; Chuang TCY, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-12; Conte FF, 2005, INT J PARASITOL, V35, P1435, DOI 10.1016/j.ijpara.2005.05.011; CORCORAN LM, 1988, CELL, V53, P807, DOI 10.1016/0092-8674(88)90097-9; DUFOUR A, 2007, 3D AUTOMATED NUCL MO, P356; Dusch E, 2007, J MICROSC-OXFORD, V228, P132, DOI 10.1111/j.1365-2818.2007.01844.x; Elias MCQB, 2001, MOL BIOCHEM PARASIT, V112, P79, DOI 10.1016/S0166-6851(00)00349-2; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Glover L, 2006, EMBO REP, V7, P93, DOI 10.1038/sj.embor.7400575; Hediger F, 2002, NAT CELL BIOL, V4, pE53, DOI 10.1038/ncb0302-e53; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kozubek S, 2000, ANAL BIOCHEM, V282, P29, DOI 10.1006/abio.2000.4538; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Marty AJ, 2006, MOL MICROBIOL, V62, P72, DOI 10.1111/j.1365-2958.2006.05364.x; Navarro M, 2007, TRENDS MICROBIOL, V15, P263, DOI 10.1016/j.tim.2007.04.004; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Perez-Morga D, 2001, J EUKARYOT MICROBIOL, V48, P221, DOI 10.1111/j.1550-7408.2001.tb00306.x; Pombo A, 2007, CURR OPIN GENET DEV, V17, P451, DOI 10.1016/j.gde.2007.08.008; Ravel C, 1995, MOL BIOCHEM PARASIT, V74, P31, DOI 10.1016/0166-6851(95)02480-8; Ray A, 2000, FASEB J, V14, P1041, DOI 10.1096/fasebj.14.9.1041; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Summerton JE, 2003, LETT PEPT SCI, V10, P215, DOI 10.1007/BF02484560; Taddei A, 2004, BBA-GENE STRUCT EXPR, V1677, P120, DOI 10.1016/j.bbaexp.2003.11.014; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2313	10.1371/journal.pone.0002313	http://dx.doi.org/10.1371/journal.pone.0002313			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545650	gold, Green Submitted, Green Published			2022-12-25	WOS:000263248800003
J	Laaksonen, T; Negro, JJ; Lyytinen, S; Valkama, J; Ots, I; Korpimaki, E				Laaksonen, Toni; Negro, Juan J.; Lyytinen, Sami; Valkama, Jari; Ots, Indrek; Korpimaki, Erkki			Effects of Experimental Brood Size Manipulation and Gender on Carotenoid Levels of Eurasian Kestrels Falco tinnunculus	PLOS ONE			English	Article							REPRODUCING GREAT TITS; HEALTH STATE INDEXES; PLASMA CAROTENOIDS; SKIN COLOR; INTERSPECIFIC VARIATION; SEXUAL DIFFERENCES; TERRITORY QUALITY; GENETIC-VARIATION; IMMUNE-RESPONSE; FOOD LIMITATION	Background: Animals use carotenoid-pigments for coloration, as antioxidants and as enhancers of the immune system. Carotenoid-dependent colours can thus signal individual quality and carotenoids have also been suggested to mediate life-history trade-offs. Methodology: To examine trade-offs in carotenoid allocation between parents and the young, or between skin coloration and plasma of the parents at different levels of brood demand, we manipulated brood sizes of Eurasian kestrels (Falco tinnunculus). Principal Findings: Brood size manipulation had no overall effect on plasma carotenoid levels or skin hue of parents, but female parents had twice the plasma carotenoid levels of males. Males work physically harder than females and they might thus also use more carotenoids against oxidative stress than females. Alternatively, females could be gaining back the carotenoid stores they depleted during egg-laying by eating primarily carotenoid-rich food items during the early nestling stage. Fledglings in enlarged broods had higher plasma carotenoid concentrations than those in reduced broods. This difference was not explained by diet. In light of recent evidence from other species, we suggest it might instead be due to fledglings in enlarged broods having higher testosterone levels, which in turn increased plasma carotenoid levels. The partial cross-foster design of our experiment revealed evidence for origin effects (genetic or maternal) on carotenoid levels of fledglings, but no origin-environment interaction. Significance: These results from wild birds differ from studies in captivity, and thus offer new insights into carotenoid physiology in relation to division of parental care and demands of the brood.	[Laaksonen, Toni; Lyytinen, Sami; Valkama, Jari; Korpimaki, Erkki] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Laaksonen, Toni] Netherlands Inst Ecol NIOO KNAW, Dept Anim Populat Biol, Yerseke, Netherlands; [Negro, Juan J.] Estac Biol Donana, Lab Chem Ecol, Donana, Spain; [Ots, Indrek] Univ Tartu, Inst Zool & Hydrobiol, Tartu, Estonia	University of Turku; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Tartu	Laaksonen, T (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	tokrla@utu.fi	Laaksonen, Toni/B-4241-2014; Negro, Juan Jose/I-2653-2015	Laaksonen, Toni/0000-0001-9035-7131; Negro, Juan Jose/0000-0002-8697-5647; Valkama, Jari/0000-0002-0393-7320	Academy of Finland [8206140, 209198]	Academy of Finland(Academy of Finland)	Academy of Finland (grant 8206140 to EK and grant 209198 to TL). The funding organization had no involvement in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Andersson S., 2006, BIRD COLORATION, P76; Armstrong GA, 1996, FASEB J, V10, P228, DOI 10.1096/fasebj.10.2.8641556; Bertrand S, 2006, OECOLOGIA, V147, P576, DOI 10.1007/s00442-005-0317-8; Biard C, 2005, OECOLOGIA, V144, P32, DOI 10.1007/s00442-005-0048-x; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Blount JD, 2000, TRENDS ECOL EVOL, V15, P47, DOI 10.1016/S0169-5347(99)01774-7; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Blount JD, 2004, ARCH BIOCHEM BIOPHYS, V430, P10, DOI 10.1016/j.abb.2004.03.039; Blount JD, 2004, P ROY SOC B-BIOL SCI, V271, pS79, DOI 10.1098/rsbl.2003.0104; Bortolotti GR, 1996, P ROY SOC B-BIOL SCI, V263, P1171, DOI 10.1098/rspb.1996.0171; Bortolotti GR, 2000, P ROY SOC B-BIOL SCI, V267, P1433, DOI 10.1098/rspb.2000.1160; Bostrom MR, 2006, J FIELD ORNITHOL, V77, P392, DOI 10.1111/j.1557-9263.2006.00069.x; BRUSH AH, 1990, FASEB J, V4, P2969, DOI 10.1096/fasebj.4.12.2394316; Casagrande S, 2006, J AVIAN BIOL, V37, P190, DOI 10.1111/j.0908-8857.2006.03515.x; Casagrande S, 2007, J COMP PHYSIOL B, V177, P237, DOI 10.1007/s00360-006-0125-4; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Costantini D, 2007, J EXP BIOL, V210, P1238, DOI 10.1242/jeb.002741; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; Dawson RD, 2006, NATURWISSENSCHAFTEN, V93, P597, DOI 10.1007/s00114-006-0146-6; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; Fargallo JA, 2003, EVOL ECOL RES, V5, P549; Fargallo JA, 2002, ECOL LETT, V5, P95, DOI 10.1046/j.1461-0248.2002.00290.x; Fargallo JA, 2007, J ANIM ECOL, V76, P201, DOI 10.1111/j.1365-2656.2006.01193.x; Figuerola J, 1998, ARDEA, V86, P245; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Hill GE, 1995, AUK, V112, P1054, DOI 10.2307/4089041; Hill GE, 1995, AUK, V112, P1057, DOI 10.2307/4089042; Horak P, 1998, FUNCT ECOL, V12, P750, DOI 10.1046/j.1365-2435.1998.00244.x; Horak P, 2004, J AVIAN BIOL, V35, P63, DOI 10.1111/j.0908-8857.2004.03167.x; Horak P, 2003, BIOESSAYS, V25, P746, DOI 10.1002/bies.10325; KORPIMAKI E, 1985, Ornis Fennica, V62, P130; Korpimaki E, 1998, OIKOS, V83, P259, DOI 10.2307/3546837; Korpimaki E, 1996, ECOSCIENCE, V3, P264, DOI 10.1080/11956860.1996.11682341; Laaksonen T, 2004, J ANIM ECOL, V73, P342, DOI 10.1111/j.0021-8790.2004.00811.x; Laaksonen T, 2004, EVOL ECOL, V18, P215, DOI 10.1023/B:EVEC.0000035081.91292.17; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Martinez-Padilla J, 2007, BIOL LETTERS, V3, P161, DOI 10.1098/rsbl.2006.0593; McGraw KJ, 2003, AUK, V120, P400, DOI 10.1642/0004-8038(2003)120[0400:DPCASC]2.0.CO;2; McGraw KJ, 2005, EVOL ECOL RES, V7, P251; Merila J, 1996, FUNCT ECOL, V10, P465, DOI 10.2307/2389939; Merila J, 1998, GENETICS, V148, P1233; Minguez-Mosquera MI, 1997, CLOROFILAS CAROTENOI; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; Mougeot F, 2007, FUNCT ECOL, V21, P886, DOI 10.1111/j.1365-2435.2007.01302.x; Mougeot F, 2006, BIOL LETTERS, V2, P173, DOI 10.1098/rsbl.2005.0434; Negro JJ, 1998, FUNCT ECOL, V12, P307, DOI 10.1046/j.1365-2435.1998.00176.x; Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a; Negro JJ, 2001, FUNCT ECOL, V15, P297, DOI 10.1046/j.1365-2435.2001.00526.x; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Ots I, 1998, FUNCT ECOL, V12, P700, DOI 10.1046/j.1365-2435.1998.00219.x; PALOKANGAS P, 1992, ANIM BEHAV, V43, P659, DOI 10.1016/0003-3472(92)90087-P; Peters A, 2007, AM NAT, V169, pS122, DOI 10.1086/510139; Ros AFH, 2002, HORM BEHAV, V41, P334, DOI 10.1006/hbeh.2002.1768; Tella JL, 2004, J EVOLUTION BIOL, V17, P156, DOI 10.1046/j.1420-9101.2003.00634.x; Tella JL, 1998, PHYSIOL ZOOL, V71, P708, DOI 10.1086/515991; TOLONEN P, 1994, BEHAV ECOL SOCIOBIOL, V35, P355; Tschirren B, 2003, J EVOLUTION BIOL, V16, P91, DOI 10.1046/j.1420-9101.2003.00483.x; Velando A, 2006, OECOLOGIA, V149, P535, DOI 10.1007/s00442-006-0457-5; Village A., 1990, THE KESTREL; Wiehn J, 1997, ECOLOGY, V78, P2043, DOI 10.1890/0012-9658(1997)078[2043:FLOBSE]2.0.CO;2; Wiehn J, 1999, OIKOS, V84, P87, DOI 10.2307/3546869; Wiehn J, 1998, P ROY SOC B-BIOL SCI, V265, P1197, DOI 10.1098/rspb.1998.0419	63	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2374	10.1371/journal.pone.0002374	http://dx.doi.org/10.1371/journal.pone.0002374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545646	Green Published, gold, Green Submitted			2022-12-25	WOS:000263248800015
J	Vukojevic, V; Ming, Y; D'Addario, C; Hansen, M; Langel, U; Schulz, R; Johansson, B; Rigler, R; Terenius, L				Vukojevic, Vladana; Ming, Yu; D'Addario, Claudio; Hansen, Mats; Langel, Ulo; Schulz, Ruediger; Johansson, Bjoern; Rigler, Rudolf; Terenius, Lars			mu-opioid receptor activation in live cells	FASEB JOURNAL			English	Article						G protein-coupled receptor; GPCR; protein/lipid microdomains; fluorescence correlation spectroscopy; FCS	FLUORESCENCE CORRELATION SPECTROSCOPY; LIPID-PROTEIN INTERACTIONS; SINGLE DNA-MOLECULES; NERVE GROWTH-FACTOR; PC12 CELLS; CROSS-CORRELATION; CONFORMATIONAL TRANSITIONS; TRANSMEMBRANE RECEPTORS; LATERAL DIFFUSION; PLASMA-MEMBRANE	Interaction of the mu-opioid receptor (MOP) with selected ligands was investigated in live cells using advanced imaging by confocal laser scanning microscopy integrated with fluorescence correlation spectroscopy and fluorescence cross-correlation spectroscopy. In PC12 cells stably transformed to express the fluorescently labeled MOP-enhanced green fluorescent protein construct, two pools of MOP were identified that could be discriminated by differences in their lateral mobility in the cell membrane. The majority of MOP receptors (80 +/- 10%) were characterized by a diffusion coefficient D-MOP,D-1 = (4 +/- 2) X 10(-11) m(2) s(-1), compared with the slowly moving fraction, D-MOP,D- 2 = (4 +/- 2) x 10(-12) m(2) s(-1). On stimulation with selected agonists ([D-Ala(2),N-MePhe(4),Gly-ol(5)]enkephalin, enkephalin-heptapeptide Tyr-Gly-Gly-Phe-Met-Arg-Phe, morphine, and methadone), surface density of the MOP decreased, whereas the lateral mobility increased. In contrast, antagonists (naloxone and naltrexone) "froze" the receptor in the membrane, i.e., increased MOP surface density and decreased lateral mobility. Agonist activation was also accompanied by pronounced changes in the dynamics of plasma membrane lipids, as revealed by the general lipid marker 1,1'-dioctadecyl-3,3,3',3'-tetramethylindo-carbocyanine perchlorate dye. The results provide new information about MOP activation in live cells at the molecular level, with a special focus on the dynamics of the intricate interplay between this receptor and the surrounding lipids.	[Vukojevic, Vladana] Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden; [Rigler, Rudolf] Karolinska Inst, Dept Med Biochem & Biophys, S-17176 Stockholm, Sweden; [Hansen, Mats; Langel, Ulo] Stockholm Univ, Dept Neurochem, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden; [Schulz, Ruediger] Univ Munich, Inst Pharmacol Toxicol & Pharm, Munich, Germany	Karolinska Institutet; Karolinska Institutet; Stockholm University; University of Munich	Vukojevic, V (corresponding author), Karolinska Inst, Dept Clin Neurosci, CMM L8 01, S-17176 Stockholm, Sweden.	vladana.vnkojevic@ki.se	DAddario, Claudio/A-5970-2010; Vukojevic, Vladana B/AAY-3144-2021	d'addario, claudio/0000-0002-1275-098X; Langel, Ulo/0000-0001-6107-0844; Vukojevic, Vladana/0000-0003-0873-5653	Swedish Research Council; Cancerdegradome; The AFA Insurance	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerdegradome; The AFA Insurance	We thank Dr. Marcus Heidkamp (C. Zeiss) for excellent support and the Knut and Alice Wallenberg Foundation for funding (L.T., R.R.). Financial support from the Swedish Research Council, Cancerdegradome, and The AFA Insurance is gratefully acknowledged. We thank Agneta Gunnar for technical assistance.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; ARDEN JR, 1995, J NEUROCHEM, V65, P1636; Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Barnett-Norris J, 2005, LIFE SCI, V77, P1625, DOI 10.1016/j.lfs.2005.05.040; Bates IR, 2006, BIOCHEM CELL BIOL, V84, P825, DOI 10.1139/O06-189; Briddon SJ, 2007, TRENDS PHARMACOL SCI, V28, P637, DOI 10.1016/j.tips.2007.09.008; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Chen Y, 2006, METHODS, V39, P147, DOI 10.1016/j.ymeth.2006.05.008; CHIPKIN RE, 1984, LIFE SCI, V34, P1809, DOI 10.1016/0024-3205(84)90673-8; Edman L, 1996, P NATL ACAD SCI USA, V93, P6710, DOI 10.1073/pnas.93.13.6710; Edman L, 2000, P NATL ACAD SCI USA, V97, P8266, DOI 10.1073/pnas.130589397; EHRENBER.M, 1974, CHEM PHYS, V4, P390, DOI 10.1016/0301-0104(74)85005-6; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; GREENBERG ML, 1993, J MEMBRANE BIOL, V131, P115, DOI 10.1007/BF02791320; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Hebert TE, 2006, CELL BIOCHEM BIOPHYS, V45, P85, DOI 10.1385/CBB:45:1:85; Heinze KG, 2004, BIOPHYS J, V86, P506, DOI 10.1016/S0006-3495(04)74129-6; Horner KA, 2004, BRAIN RES, V1028, P121, DOI 10.1016/j.brainres.2004.07.055; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Koch T, 2001, J BIOL CHEM, V276, P31408, DOI 10.1074/jbc.M100305200; KOLB VM, 1983, LIFE SCI, V33, P423, DOI 10.1016/0024-3205(83)90532-5; KOPPEL DE, 1976, BIOPHYS J, V16, P1315, DOI 10.1016/S0006-3495(76)85776-1; KOPPEL DE, 1974, PHYS REV A, V10, P1938, DOI 10.1103/PhysRevA.10.1938; KRUMINS SA, 1987, NEUROCHEM RES, V12, P231, DOI 10.1007/BF00972131; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Leitenberger SM, 2008, LANGMUIR, V24, P1254, DOI 10.1021/la702319q; Levin MK, 2004, DIFFERENTIATION, V72, P1, DOI 10.1111/j.1432-0436.2004.07201002.x; Li J, 2001, MOL PHARMACOL, V60, P1064, DOI 10.1124/mol.60.5.1064; Licht SS, 2003, BIOCHEMISTRY-US, V42, P2916, DOI 10.1021/bi026059v; Loura LMS, 2000, BBA-BIOMEMBRANES, V1467, P101, DOI 10.1016/S0005-2736(00)00211-X; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Naji A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2739526; Peiro S, 2000, J BIOL CHEM, V275, P37846, DOI 10.1074/jbc.M000487200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pineyro G, 2007, CELL SIGNAL, V19, P8, DOI 10.1016/j.cellsig.2006.05.026; Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318; Rigler R, 1998, J BIOTECHNOL, V63, P97, DOI 10.1016/S0168-1656(98)00079-0; RIGLER R, 1973, Q REV BIOPHYS, V6, P139, DOI 10.1017/S003358350000113X; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Sanchez SA, 2005, ACCOUNTS CHEM RES, V38, P469, DOI 10.1021/ar040026l; Schulz R, 2002, J PHARMACOL EXP THER, V300, P376, DOI 10.1124/jpet.300.2.376; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Schwille P, 1999, CYTOMETRY, V36, P176, DOI 10.1002/(SICI)1097-0320(19990701)36:3<176::AID-CYTO5>3.0.CO;2-F; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Sun ZX, 2005, NEUROSCI LETT, V391, P71, DOI 10.1016/j.neulet.2005.08.034; Swinton DJ, 2000, ANAL CHEM, V72, P3725, DOI 10.1021/ac0000933; Tang N, 2007, EXP BRAIN RES, V183, P241, DOI 10.1007/s00221-007-1036-7; Thompson N. L., 1991, TOPICS FLUORESCENCE, V1, P337; Thompson NL, 2002, CURR OPIN STRUC BIOL, V12, P634, DOI 10.1016/S0959-440X(02)00368-8; TOCANNE JF, 1994, CHEM PHYS LIPIDS, V73, P139, DOI 10.1016/0009-3084(94)90179-1; Vukojevic V, 2005, CELL MOL LIFE SCI, V62, P535, DOI 10.1007/s00018-004-4305-7; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wang DX, 2007, J PHARMACOL EXP THER, V321, P544, DOI 10.1124/jpet.106.118810; Wennmalm S, 1999, CHEM PHYS, V247, P61, DOI 10.1016/S0301-0104(99)00125-1; Wennmalm S, 1997, P NATL ACAD SCI USA, V94, P10641, DOI 10.1073/pnas.94.20.10641; Widengren J, 1998, CELL MOL BIOL, V44, P857; Widengren J, 1999, CHEM PHYS, V250, P171, DOI 10.1016/S0301-0104(99)00255-4; WIDENGREN J, 1995, J PHYS CHEM-US, V99, P13368, DOI 10.1021/j100036a009; Widengren J., 1997, J FLUORESCENCE, V7, p211S; Xu W, 2006, J PHARMACOL EXP THER, V317, P1295, DOI 10.1124/jpet.105.099507; Xu ZQD, 2007, ACTA PHYSIOL, V190, P39, DOI 10.1111/j.1365-201X.2007.01695.x; Zarnegar P, 2006, NEUROSCI LETT, V396, P197, DOI 10.1016/j.neulet.2005.11.040; Zhao H, 2006, MOL PHARMACOL, V69, P1421, DOI 10.1124/mol.105.020024; Zollner C, 2007, Handb Exp Pharmacol, P31	72	27	27	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3537	3548		10.1096/fj.08-108894	http://dx.doi.org/10.1096/fj.08-108894			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18587007				2022-12-25	WOS:000259642600016
J	Suzuki, M; Ueno, T; Iizuka, R; Miura, T; Zako, T; Akahori, R; Miyake, T; Shimamoto, N; Aoki, M; Tanii, T; Ohdomari, I; Funatsu, T				Suzuki, Mihoko; Ueno, Taro; Iizuka, Ryo; Miura, Takahiro; Zako, Tamotsu; Akahori, Rena; Miyake, Takeo; Shimamoto, Naonobu; Aoki, Mutsuko; Tanii, Takashi; Ohdomari, Iwao; Funatsu, Takashi			Effect of the C-terminal truncation on the functional cycle of chaperonin GroEL - Implication that the C-terminal region facilitates the transition from the folding-arrested to the folding-competent state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; HYDROPHILIC RESIDUES; CRYSTAL-STRUCTURE; CENTRAL CAVITY; SUBSTRATE; POLYPEPTIDE; MECHANISM; ATP; MICROSCOPY; SEQUENCES	To elucidate the exact role of the C-terminal region of GroEL in its functional cycle, the C-terminal 20-amino acid truncated mutant of GroEL was constructed. The steady-state ATPase rate and duration of GroES binding showed that the functional cycle of the truncated GroEL is extended by similar to 2 s in comparison with that of the wild type, without interfering with the basic functions of GroEL. We have proposed a model for the functional cycle of GroEL, which consists of two rate-limiting steps of similar to 3- and similar to 5-s duration (Ueno, T., Taguchi, H., Tadakuma, H., Yoshida, M., and Funatsu, T. (2004) Mol. Cell 14, 423-434). According to the model, detailed kinetic studies were performed. We found that a 20-residue truncation of the C terminus extends the time until inorganic phosphate is generated and the time for arresting protein folding in the central cavity, i.e. the lifetime of the first rate-limiting step in the functional cycle, to an similar to 5-s duration. These results suggest that the integrity of the C-terminal region facilitates the transition from the first to the second rate-limiting state.	[Suzuki, Mihoko; Ueno, Taro; Iizuka, Ryo; Funatsu, Takashi] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Miura, Takahiro; Akahori, Rena; Miyake, Takeo; Aoki, Mutsuko; Tanii, Takashi; Ohdomari, Iwao] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Zako, Tamotsu] RIKEN, Bioengn Lab, Saitama 3510198, Japan; [Shimamoto, Naonobu; Tanii, Takashi; Ohdomari, Iwao] Waseda Univ, Nanotechnol Res Ctr, Shinjuku Ku, Tokyo 1620041, Japan; [Funatsu, Takashi] Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo; Waseda University; RIKEN; Waseda University; University of Tokyo	Funatsu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	funatsu@mail.ecc.u-tokyo.ac.jp	Zako, Tamotsu/C-3004-2012; Shimamoto, Naonobu/AGP-3424-2022; Miyake, Takeo/AAU-1388-2020; Shimamoto, Naonobu/D-6708-2012; Funatsu, Takashi/Q-1404-2015	Miyake, Takeo/0000-0002-7445-633X; Funatsu, Takashi/0000-0002-9656-8308; Iizuka, Ryo/0000-0002-9328-5628	Takeda Science Foundation; Ministry of Education, Science, Sports and Culture of Japan [18031008];  [17201031];  [18770126]; Grants-in-Aid for Scientific Research [20310069] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Takeda Science Foundation (to T. F.), Grant-in-aid for Scientific Research (A) 17201031 (to T. F.), Grant-in-aid for Young Scientists 18770126 (to T. U.), and Grant-in-aid for Scientific Research on Priority Areas 18031008 (to T. U.) from the Ministry of Education, Science, Sports and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aoki K, 1997, J BIOL CHEM, V272, P32158, DOI 10.1074/jbc.272.51.32158; Aoki K, 2000, J BIOL CHEM, V275, P13755, DOI 10.1074/jbc.275.18.13755; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brocchieri L, 2000, PROTEIN SCI, V9, P476; BURNETT BP, 1994, J BACTERIOL, V176, P6980, DOI 10.1128/JB.176.22.6980-6985.1994; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Cliff MJ, 2006, J BIOL CHEM, V281, P21266, DOI 10.1074/jbc.M601605200; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Makino Y, 1997, J BIOL CHEM, V272, P12468, DOI 10.1074/jbc.272.19.12468; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MCLENNAN NF, 1994, MOL MICROBIOL, V14, P309, DOI 10.1111/j.1365-2958.1994.tb01292.x; MCLENNAN NF, 1993, MOL MICROBIOL, V7, P49, DOI 10.1111/j.1365-2958.1993.tb01096.x; MCPHIE P, 1989, BIOCHEM BIOPH RES CO, V158, P115, DOI 10.1016/S0006-291X(89)80185-8; MIYAKE T, 2008, ANAL CHEM IN PRESS; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Sakikawa C, 1999, J BIOL CHEM, V274, P21251, DOI 10.1074/jbc.274.30.21251; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thiyagarajan P, 1996, STRUCTURE, V4, P79, DOI 10.1016/S0969-2126(96)00011-1; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; Viani MB, 2000, NAT STRUCT BIOL, V7, P644, DOI 10.1038/77936; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yokokawa M, 2006, EMBO J, V25, P4567, DOI 10.1038/sj.emboj.7601326	35	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23931	23939		10.1074/jbc.M804090200	http://dx.doi.org/10.1074/jbc.M804090200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18583344	Green Published, hybrid			2022-12-25	WOS:000258638900048
J	Guo, R; Yamashita, M; Zhang, Q; Zhou, Q; Chen, D; Reynolds, DG; Awad, HA; Yanoso, L; Zhao, L; Schwarz, EM; Zhang, YE; Boyce, BF; Xing, LP				Guo, Ruolin; Yamashita, Motozo; Zhang, Qian; Zhou, Quan; Chen, Di; Reynolds, David G.; Awad, Hani A.; Yanoso, Laura; Zhao, Lan; Schwarz, Edward M.; Zhang, Ying E.; Boyce, Brendan F.; Xing, Lianping			Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MURINE CLONAL OSTEOBLASTS; FACTOR-ALPHA; TNF-ALPHA; RHEUMATOID-ARTHRITIS; RUNX2 DEGRADATION; DIFFERENTIATION; EXPRESSION; APOPTOSIS; RECEPTOR	Chronic inflammatory disorders, such as rheumatoid arthritis, are often accompanied by systemic bone loss, which is thought to occur through inflammatory cytokine-mediated stimulation of osteoclast resorption and inhibition of osteoblast function. However, the mechanisms involved in osteoblast inhibition remain poorly understood. Here we test the hypothesis that increased Smad ubiquitin regulatory factor 1 (Smurf1)-mediated degradation of the bone morphogenetic protein pathway signaling proteins mediates reduced bone formation in inflammatory disorders. Osteoblasts derived from bone marrow or long bone samples of adult tumor necrosis factor (TNF) transgenic (TNF-Tg) mice were used in this study. TNF decreased the steady-state levels of Smad1 and Runx2 protein similarly to those in long bones of TNF-Tg mice. In the presence of the proteasome inhibitor MG132, TNF increased accumulation of ubiquitinated Smad1 protein. TNF administration over calvarial bones caused decreases in Smad1 and Runx2 protein levels and mRNA expression of osteoblast marker genes in wild-type, but not in Smurf1(-/-) mice. Vertebral bone volume and strength of TNF-Tg/Smurf1(-/-) mice were examined by a combination of micro-CT, bone histomorphometry, and biomechanical testing and compared with those from TNF-Tg littermates. TNF-Tg mice had significantly decreased bone volume and biomechanical properties, which were partially rescued in TNF-Tg/Smurf1(-/-) mice. We conclude that in chronic inflammatory disorders where TNF is increased, TNF induces the expression of ubiquitin ligase Smurf1 and promotes ubiquitination and proteasomal degradation of Smad1 and Runx2, leading to systemic bone loss. Inhibition of ubiquitin-mediated Smad1 and Runx2 degradation in osteoblasts could help to treat inflammation-induced osteoporosis.	[Guo, Ruolin; Zhang, Qian; Zhou, Quan; Zhao, Lan; Boyce, Brendan F.; Xing, Lianping] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Chen, Di; Reynolds, David G.; Awad, Hani A.; Yanoso, Laura; Schwarz, Edward M.; Boyce, Brendan F.; Xing, Lianping] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Yamashita, Motozo; Zhang, Ying E.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of Rochester; University of Rochester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Xing, LP (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA.	Lianping_xing@urmc.rochester.edu	Zhang, Ying E/G-3657-2015; Awad, Hani A/G-6976-2014; Mostafa, Taymour/H-6834-2019	Zhang, Ying E/0000-0003-2753-7601; Awad, Hani A/0000-0003-2197-2610; Mostafa, Taymour/0000-0003-3627-0662	National Institutes of Health [AR48697, AR53586, AR43510]; NATIONAL CANCER INSTITUTE [ZIABC011168, ZIABC010419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054465, R01AR043510, R21AR053586, R01AR051189, K02AR052411, R01AR048697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR48697 and AR53586 ( to L. X.) and AR43510 ( to B. F. B.).	Abbas S, 2003, CYTOKINE, V22, P33, DOI 10.1016/S1043-4666(03)00106-6; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cuevas BD, 2005, ONCOGENE, V24, P801, DOI 10.1038/sj.onc.1208239; Datto M, 2005, CELL, V121, P2, DOI 10.1016/j.cell.2005.03.017; Di Comite G, 2006, ANN NY ACAD SCI, V1069, P428, DOI 10.1196/annals.1351.041; Eigler A, 1997, Z GASTROENTEROL, V35, P899; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Gilbert LC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1011, DOI 10.1152/ajpendo.00534.2004; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Goldring SR, 2003, CALCIFIED TISSUE INT, V73, P97, DOI 10.1007/s00223-002-1049-y; Goldring SR, 2003, RHEUMATOLOGY, V42, P11, DOI 10.1093/rheumatology/keg327; Guo ZJ, 2002, MOL CELL BIOL, V22, P5761, DOI 10.1128/MCB.22.16.5761-5768.2002; Ito H, 2004, GENE THER, V11, P34, DOI 10.1038/sj.gt.3302102; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Kitajima I, 1996, J BONE MINER RES, V11, P200; Kitajima I, 1996, BONE, V19, P263, DOI 10.1016/8756-3282(96)00181-0; Li P, 2004, ARTHRITIS RHEUM, V50, P265, DOI 10.1002/art.11419; Li Y, 2007, J BONE MINER RES, V22, P646, DOI 10.1359/JBMR.070121; LI YP, 1992, J IMMUNOL, V148, P788; Mimura T, 2001, EXP EYE RES, V72, P71, DOI 10.1006/exer.2000.0925; Mukai T, 2007, BIOCHEM BIOPH RES CO, V356, P1004, DOI 10.1016/j.bbrc.2007.03.099; Nair SP, 2000, RHEUMATOLOGY, V39, P821, DOI 10.1093/rheumatology/39.8.821; Nakayama Hisanori, 2007, Clin Calcium, V17, P1607; Sangadala S, 2006, J BIOL CHEM, V281, P17212, DOI 10.1074/jbc.M511013200; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shen R, 2006, J BIOL CHEM, V281, P3569, DOI 10.1074/jbc.M506761200; Silva MJ, 2004, BONE, V35, P425, DOI 10.1016/j.bone.2004.03.027; Srivastava S, 1999, J CLIN INVEST, V104, P503, DOI 10.1172/JCI7094; TAICHMAN RS, 1992, INFLAMMATION, V16, P587, DOI 10.1007/BF00919342; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	42	106	112	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23084	23092		10.1074/jbc.M709848200	http://dx.doi.org/10.1074/jbc.M709848200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18567580	Green Published, hybrid			2022-12-25	WOS:000258455400021
J	Mangoni, ML; Epand, RF; Rosenfeld, Y; Peleg, A; Barra, D; Epand, RM; Shai, Y				Mangoni, Maria Luisa; Epand, Raquel F.; Rosenfeld, Yosef; Peleg, Adi; Barra, Donatella; Epand, Richard M.; Shai, Yechiel			Lipopolysaccharide, a key molecule involved in the synergism between temporins in inhibiting bacterial growth and in endotoxin neutralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; TUMOR-NECROSIS-FACTOR; CATIONIC ANTIMICROBIAL PEPTIDES; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; FACTOR-ALPHA; POLYMYXIN-B; IN-VITRO; MEMBRANE; DEFENSINS	Lipopolysaccharide (LPS) is the major structural component of the outer membrane of Gram-negative bacteria and shields them from a variety of host defense factors, including antimicrobial peptides (AMPs). LPS is also recognized by immune cells as a pathogen-associated molecular pattern and stimulates them to secrete pro-inflammatory cytokines that, in extreme cases, lead to a harmful host response known as septic shock. Previous studies have revealed that a few isoforms of the AMP temporin, produced within the same frog specimen, can synergize to overcome bacterial resistance imposed by the physical barrier of LPS. Here we found that temporins can synergize in neutralizing the LPS-induced macrophage activation. Furthermore, the synergism between temporins, to overcome the protective function of LPS as well as its endotoxic effect, depends on the length of the polysaccharide chain of LPS. Importantly, mode of action studies, using spectroscopic and thermodynamic methods, have pointed out different mechanisms underlying the synergism of temporins in antimicrobial and anti-endotoxin activities. To the best of our knowledge, such a dual synergism between isoforms of AMPs from the same species has not been observed before, and it might explain the ability of such amphibians to resist a large repertoire of microorganisms.	[Mangoni, Maria Luisa; Barra, Donatella] Univ Roma La Sapienza, Dipartimento Sci Biochim, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Epand, Raquel F.; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Rosenfeld, Yosef; Peleg, Adi; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Fondazione Cenci Bolognetti; Sapienza University Rome; McMaster University; Weizmann Institute of Science	Mangoni, ML (corresponding author), Azienda Osped S Andrea, Fac Med & Chirurg 2, Unita Diagnost Mol Avanzata, Via Grottarossa 1035, I-00189 Rome, Italy.	marialuisa.mangoni@uniroma1.it	, Richard/R-2316-2019; Barra, Donatella/D-1236-2011	, Richard/0000-0002-9602-9558; Mangoni, Maria Luisa/0000-0002-5991-5868	Canadian Institutes of Health Research [MOP 86608]; Italian Ministero dell'Universita e Ricerca [2005062410]; Universita di Roma La Sapienza; Istituto di Biologia e Patologia Molecolari of the National Research Council; Josef Cohn MINERVA Center for Biomembrane Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Italian Ministero dell'Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Universita di Roma La Sapienza; Istituto di Biologia e Patologia Molecolari of the National Research Council; Josef Cohn MINERVA Center for Biomembrane Research	This work was supported in part by the Canadian Institutes of Health Research (Grant MOP 86608), the Italian Ministero dell'Universita e Ricerca (PRIN 2005 protocol no. 2005062410), by grants from the Universita di Roma La Sapienza and Istituto di Biologia e Patologia Molecolari of the National Research Council, and by the Josef Cohn MINERVA Center for Biomembrane Research (to Y.S.).	Andra J, 2007, BIOCHEM J, V406, P297, DOI 10.1042/BJ20070279; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Aurell CA, 1998, BIOCHEM BIOPH RES CO, V253, P119, DOI 10.1006/bbrc.1998.9773; BERCZI I, 1966, CAN J MICROBIOL, V12, P1070, DOI 10.1139/m66-143; BOMAN HG, 1975, J BACTERIOL, V121, P455, DOI 10.1128/JB.121.2.455-464.1975; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Bommineni YR, 2007, FEBS J, V274, P418, DOI 10.1111/j.1742-4658.2006.05589.x; Brandenburg K, 2005, BIOPHYS J, V88, P1845, DOI 10.1529/biophysj.104.047944; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Byl B, 2001, EUR J CLIN MICROBIOL, V20, P804, DOI 10.1007/s100960100609; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Farnaud S, 2004, FEMS MICROBIOL LETT, V233, P193, DOI 10.1016/j.femsle.2004.01.039; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gee K, 2003, J BIOL CHEM, V278, P37275, DOI 10.1074/jbc.M302309200; Ghosh JK, 1997, J BIOL CHEM, V272, P31609, DOI 10.1074/jbc.272.50.31609; Giacometti A, 2006, ANTIMICROB AGENTS CH, V50, P2478, DOI 10.1128/AAC.01553-05; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; Howe J, 2007, BIOPHYS J, V92, P2796, DOI 10.1529/biophysj.106.095711; Iliev DB, 2005, FEBS LETT, V579, P6519, DOI 10.1016/j.febslet.2005.10.061; Kubo Y, 2007, INFLAMM RES, V56, P70, DOI 10.1007/s00011-006-6064-4; Lauth X, 2005, J BIOL CHEM, V280, P9272, DOI 10.1074/jbc.M411154200; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Lewis RE, 2002, J ANTIMICROB CHEMOTH, V49, P345, DOI 10.1093/jac/49.2.345; Li P, 2004, J BIOL CHEM, V279, P50150, DOI 10.1074/jbc.M405606200; LINDBERG B, 1981, CARBOHYD RES, V97, P105, DOI 10.1016/S0008-6215(00)80528-5; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Mangoni ML, 2007, J PEPT SCI, V13, P603, DOI 10.1002/psc.853; Mangoni ML, 2005, J BIOL CHEM, V280, P984, DOI 10.1074/jbc.M410795200; Mangoni ML, 2004, BIOCHEM J, V380, P859, DOI 10.1042/BJ20031975; Mangoni ML, 2000, EUR J BIOCHEM, V267, P1447, DOI 10.1046/j.1432-1327.2000.01143.x; MARVIN HJP, 1989, J BACTERIOL, V171, P5262, DOI 10.1128/jb.171.10.5262-5267.1989; MCINTIRE FC, 1969, BIOCHEMISTRY-US, V8, P4063, DOI 10.1021/bi00838a024; Mookherjee N, 2007, EXPERT OPIN THER TAR, V11, P993, DOI 10.1517/14728222.11.8.993; MOR A, 1994, J BIOL CHEM, V269, P31635; Mukhopadhyay S, 2004, IMMUNOLOGY, V112, P521, DOI 10.1111/j.1365-2567.2004.01941.x; Nagaoka I, 2000, INFLAMM RES, V49, P73, DOI 10.1007/s000110050561; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pag U, 2004, J ANTIMICROB CHEMOTH, V53, P230, DOI 10.1093/jac/dkh083; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Papo N, 2002, J BIOL CHEM, V277, P33913, DOI 10.1074/jbc.M204928200; PETERSON AA, 1985, J BACTERIOL, V162, P738, DOI 10.1128/JB.162.2.738-745.1985; PRINS JM, 1995, INFECT IMMUN, V63, P2236, DOI 10.1128/IAI.63.6.2236-2242.1995; RANA FR, 1991, BIOCHEMISTRY-US, V30, P5858, DOI 10.1021/bi00238a008; RIBI E, 1966, J BACTERIOL, V92, P1493, DOI 10.1128/JB.92.5.1493-1509.1966; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Simmaco M, 1996, EUR J BIOCHEM, V242, P788, DOI 10.1111/j.1432-1033.1996.0788r.x; Sitaram N, 2006, CURR MED CHEM, V13, P679, DOI 10.2174/092986706776055689; SORAVIA E, 1988, FEBS LETT, V228, P337, DOI 10.1016/0014-5793(88)80027-9; Srimal S, 1996, BIOCHEM J, V315, P679, DOI 10.1042/bj3150679; STONE R, 1994, SCIENCE, V264, P365, DOI 10.1126/science.8153620; Tong JH, 2004, BIOPHYS J, V86, P3759, DOI 10.1529/biophysj.103.037507; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	65	92	93	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22907	22917		10.1074/jbc.M800495200	http://dx.doi.org/10.1074/jbc.M800495200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550541	hybrid			2022-12-25	WOS:000258455400004
J	Wang, J; Zhang, H; Iyer, D; Feng, XH; Schwartz, RJ				Wang, Jun; Zhang, Hua; Iyer, Dinakar; Feng, Xin-Hua; Schwartz, Robert J.			Regulation of cardiac specific nkx2.5 gene activity by small ubiquitin-like modifier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; DNA-BINDING TARGETS; KAPPA-B ACTIVATION; SUMO-1 MODIFICATION; IN-VIVO; TRANSCRIPTION FACTOR; PROTEIN INHIBITOR; HEART DEVELOPMENT; TINMAN HOMOLOG; SUMOYLATION	The cardiac specific homeobox gene nkx2.5, a member of the nk-2 class family, plays a central role in cardiogenesis and is a target of the small ubiquitin-like modifier (SUMO). Nkx2.5 was modified by SUMO on its 51st amino acid, a lysine residue conserved across species but absent in other nk-2 members. Conversion of this lysine to an arginine (K51R) substantially reduced Nkx2.5 DNA binding and also its transcriptional activity. Unexpectedly, mutant K51R was targeted by ubiquitin. E3 ligase PIAS proteins PIAS1, PIASx, and PIASy, but not PIAS3, enhanced SUMO-1 attachment to Nkx2.5 on the primary SUMO acceptor site. SUMO-2 linkage to Nkx2.5 was catalyzed only by PIASx and not by other PIAS proteins. SUMO conjugation stabilized the formation of Nkx2.5-containing complexes that led to robust transcriptional activation. Thus, SUMO modification serves as a positive regulator for Nkx2.5 transcriptional activity.	[Wang, Jun; Zhang, Hua; Schwartz, Robert J.] Texas A&M Univ, Inst Biosci & Technol, Houston, TX 77030 USA; [Iyer, Dinakar] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA	Texas A&M University System; Baylor College of Medicine; Baylor College of Medicine	Wang, J (corresponding author), 2121 W Holcombe Blvd, Houston, TX 77030 USA.	junwang@ibt.tamhsc.edu						AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; BODMER R, 1993, DEVELOPMENT, V118, P719; BOURBON HM, 1995, J BIOL CHEM, V270, P11130, DOI 10.1074/jbc.270.19.11130; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Durocher D, 1996, MOL CELL BIOL, V16, P4648, DOI 10.1128/mcb.16.9.4648; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Iniguez-Lluhi JA, 2006, ACS CHEM BIOL, V1, P204, DOI 10.1021/cb600188m; Iyer D, 2006, P NATL ACAD SCI USA, V103, P4516, DOI 10.1073/pnas.0505338103; Kasahara H, 1999, MOL CELL BIOL, V19, P526; Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Matsuura T, 2005, EXP CELL RES, V308, P65, DOI 10.1016/j.yexcr.2005.04.022; Matsuzaki K, 2003, BIOCHEM BIOPH RES CO, V306, P32, DOI 10.1016/S0006-291X(03)00910-0; Nakagawa K, 2002, FEBS LETT, V530, P204, DOI 10.1016/S0014-5793(02)03486-5; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Nguyen HV, 2006, AM J PATHOL, V168, P1452, DOI 10.2353/ajpath.2006.050782; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Santti H, 2005, J MOL ENDOCRINOL, V34, P645, DOI 10.1677/jme.1.01666; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tanaka M, 1999, DEVELOPMENT, V126, P1269; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Wang J, 2005, MOL CELL BIOL, V25, P9829, DOI 10.1128/MCB.25.22.9829-9844.2005; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Willis MS, 2006, J MOL CELL CARDIOL, V41, P567, DOI 10.1016/j.yjmcc.2006.07.015; Wong KA, 2004, MOL CELL BIOL, V24, P5577, DOI 10.1128/MCB.24.12.5577-5586.2004	50	43	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23235	23243		10.1074/jbc.M709748200	http://dx.doi.org/10.1074/jbc.M709748200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18579533	hybrid, Green Published			2022-12-25	WOS:000258455400037
J	Zhu, X; Lee, JY; Timmins, JM; Brown, JM; Boudyguina, E; Mulya, A; Gebre, AK; Willingham, MC; Hiltbold, EM; Mishra, N; Maeda, N; Parks, JS				Zhu, Xuewei; Lee, Ji-Young; Timmins, Jenelle M.; Brown, J. Mark; Boudyguina, Elena; Mulya, Anny; Gebre, Abraham K.; Willingham, Mark C.; Hiltbold, Elizabeth M.; Mishra, Nilamadhab; Maeda, Nobuyo; Parks, John S.			Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; CASSETTE TRANSPORTER 1; APOLIPOPROTEIN-A-I; LIPID RAFTS; TANGIER-DISEASE; R230C VARIANT; KAPPA-B; GENE; EXPRESSION; RECEPTOR	Macrophage-specific Abca1 knock-out (Abca1(-M/-M)) mice were generated to determine the role of macrophage ABCA1 expression in plasma lipoprotein concentrations and the innate immune response of macrophages. Plasma lipid and lipoprotein concentrations in chow-fed Abca1(-M/-M) and wild-type (WT) mice were indistinguishable. Compared with WT macrophages, Abca1(-M/-M) macrophages had a > 95% reduction in ABCA1 protein, failed to efflux lipid to apoA-I, and had a significant increase in free cholesterol (FC) and membrane lipid rafts without induction of endoplasmic reticulum stress. Lipopolysaccharide (LPS)-treated Abca1(-M/-M) macrophages exhibited enhanced expression of pro-inflammatory cytokines and increased activation of the NF-kappa B and MAPK pathways, which could be diminished by silencing MyD88 or by chemical inhibition of NF-kappa B or MAPK. In vivo LPS injection also resulted in a higher pro-inflammatory response in Abca1(-M/-M) mice compared with WT mice. Furthermore, cholesterol depletion of macrophages with methyl-beta-cyclodextrin normalized FC content between the two genotypes and their response to LPS; cholesterol repletion of macrophages resulted in increased cellular FC accumulation and enhanced cellular response to LPS. Our results suggest that macrophage ABCA1 expression may protect against atherosclerosis by facilitating the net removal of excess lipid from macrophages and dampening pro-inflammatory MyD88-dependent signaling pathways by reduction of cell membrane FC and lipid raft content.	[Zhu, Xuewei; Lee, Ji-Young; Timmins, Jenelle M.; Brown, J. Mark; Boudyguina, Elena; Mulya, Anny; Gebre, Abraham K.; Parks, John S.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol Lipid Sci, Winston Salem, NC 27157 USA; [Willingham, Mark C.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol Tumor Biol, Winston Salem, NC 27157 USA; [Hiltbold, Elizabeth M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA; [Mishra, Nilamadhab] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med Rheumatol, Winston Salem, NC 27157 USA; [Maeda, Nobuyo] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Parks, JS (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol Lipid Sci, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jparks@wfubmc.edu			National Institutes of Health [HL49373, HL54176, AT27820, HL07115]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373, R00HL096166, R01HL094525, R01HL054176, R37HL042630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49373, HL54176, and AT27820 ( to J.S.P.) and HL07115 (cardiovascular pathology training grant; to J.M.T.).	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Attie AD, 2002, J LIPID RES, V43, P1610, DOI 10.1194/jlr.M200223-JLR200; Attie AD, 2001, J LIPID RES, V42, P1717; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Christiansen-Weber TA, 2000, AM J PATHOL, V157, P1017, DOI 10.1016/S0002-9440(10)64614-7; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Daimon M, 2005, BIOCHEM BIOPH RES CO, V329, P205, DOI 10.1016/j.bbrc.2005.01.119; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; Francone OL, 2005, ARTERIOSCL THROM VAS, V25, P1198, DOI 10.1161/01.ATV.0000166522.69552.99; Furbee JW, 2002, J LIPID RES, V43, P428; Furbee JW, 2002, J BIOL CHEM, V277, P3511, DOI 10.1074/jbc.M109883200; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Gerbod-Giannone MC, 2006, P NATL ACAD SCI USA, V103, P3112, DOI 10.1073/pnas.0510345103; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Haghpassand M, 2001, J CLIN INVEST, V108, P1315, DOI 10.1172/JCI200112810; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; KORITNIK DL, 1983, J LIPID RES, V24, P1639; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Lee JY, 2005, J LIPID RES, V46, P2233, DOI 10.1194/jlr.M500179-JLR200; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Mulligan JD, 2003, J BIOL CHEM, V278, P13356, DOI 10.1074/jbc.M212377200; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Oram JF, 2001, J LIPID RES, V42, P1173; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Porchay I, 2006, OBESITY, V14, P1874, DOI 10.1038/oby.2006.217; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SCHAEFER EJ, 1980, ANN INTERN MED, V93, P261, DOI 10.7326/0003-4819-93-2-261; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Schiller NK, 2004, J LIPID RES, V45, P1398, DOI 10.1194/jlr.M400036-JLR200; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Triantafilou M, 2002, J CELL SCI, V115, P2603; van Dam MJ, 2002, LANCET, V359, P37, DOI 10.1016/S0140-6736(02)07277-X; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Villarreal-Molina MT, 2008, DIABETES, V57, P509, DOI 10.2337/db07-0484; Villarreal-Molina MT, 2007, DIABETES, V56, P1881, DOI 10.2337/db06-0905; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhuang LY, 2002, CANCER RES, V62, P2227	68	279	281	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22930	22941		10.1074/jbc.M801408200	http://dx.doi.org/10.1074/jbc.M801408200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18552351	hybrid, Green Published			2022-12-25	WOS:000258455400006
J	Haffner, MC; Jurgeit, A; Berlato, C; Geley, S; Parajuli, N; Yoshimura, A; Doppler, W				Haffner, Michael C.; Jurgeit, Andreas; Berlato, Chiara; Geley, Stephan; Parajuli, Nirmala; Yoshimura, Akihiko; Doppler, Wolfgang			Interaction and functional interference of glucocorticoid receptor and SOCS1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; CYTOKINE SIGNALING-1; NUCLEAR RECEPTORS; GENE-EXPRESSION; ACTIVATION; PROTEIN; DEGRADATION; INHIBITION; MECHANISMS; SUPPRESSOR	Cytokine and glucocorticoid (GC) hormone signaling act in an integrated fashion to control inflammation and immune response. Here we establish a new mode of interaction of these two pathways and propose Suppressor of Cytokine Signaling (SOCS)-1 as an essential player in mediating cross-talk. We observed that glucocorticoid receptor (GR) and SOCS1 form an intracellular complex through an interaction, which required the SH2 domain of SOCS1 and the ligand binding domain of GR. Furthermore, GC stimulation was found to increase the nuclear level of SOCS1. SOCS1 binding to the GR did not require ligand binding of the receptor; however, it was abolished after long term GC stimulation, suggesting a functional role of the interaction for the early phase of GC action. The interaction between GR and SOCS1 appeared to negatively influence the transcription of the two GR-regulated genes, FKBP5 and MKP1, because the GC-dependent expression of these genes was inhibited by the SOCS1 inducer IFN gamma and enhanced in SOCS1-deficient murine embryonic fibroblasts as compared with IFN gamma treated wild-type cells. Our results suggest a prominent role of SOCS1 in the early phase of cross-talk between GR and cytokine signaling.	[Haffner, Michael C.; Jurgeit, Andreas; Berlato, Chiara; Parajuli, Nirmala; Doppler, Wolfgang] Innsbruck Med Univ, Div Med Biochem, Bioctr, A-6020 Innsbruck, Austria; [Geley, Stephan] Innsbruck Med Univ, Div Mol Pathophysiol, A-6020 Innsbruck, Austria; [Yoshimura, Akihiko] Kyushu Univ, Div Mol & Cellular Immunol, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan	Medical University of Innsbruck; Medical University of Innsbruck; Kyushu University	Doppler, W (corresponding author), Innsbruck Med Univ, Div Med Biochem, Bioctr, Fritz Pregl Str 3, A-6020 Innsbruck, Austria.	wolfgang.doppler@i-med.ac.at	Parajuli, Nirmala/V-9901-2019; Yoshimura, Akihiko/K-5515-2013	Parajuli, Nirmala/0000-0003-3994-5338	Austrian Science Fund FWF [W 1101] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Aittomaki S, 2000, J IMMUNOL, V164, P5689, DOI 10.4049/jimmunol.164.11.5689; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Cella N, 1998, MOL CELL BIOL, V18, P1783, DOI 10.1128/MCB.18.4.1783; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Cheshire JL, 1997, MOL CELL BIOL, V17, P6746, DOI 10.1128/MCB.17.11.6746; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Doppler W, 2001, MOL CELL BIOL, V21, P3266, DOI 10.1128/MCB.21.9.3266-3279.2001; Engblom D, 2007, GENE DEV, V21, P1157, DOI 10.1101/gad.426007; Gregorieff A, 2000, J BIOL CHEM, V275, P21596, DOI 10.1074/jbc.M910087199; Haffner MC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-136; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; Hu XY, 2003, J IMMUNOL, V170, P4833, DOI 10.4049/jimmunol.170.9.4833; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Isomaki P, 2007, RHEUMATOLOGY, V46, P1538, DOI 10.1093/rheumatology/kem198; Kamio M, 2004, ONCOGENE, V23, P3107, DOI 10.1038/sj.onc.1207453; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; LANZ RB, 1994, ENDOCRINOLOGY, V135, P2183, DOI 10.1210/en.135.5.2183; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; ONATE SA, 1995, SCIENCE, V270, P1354; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rogatsky I, 2006, TISSUE ANTIGENS, V68, P1, DOI 10.1111/j.1399-0039.2006.00599.x; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; Starr DB, 1996, GENE DEV, V10, P1271, DOI 10.1101/gad.10.10.1271; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Webster JC, 2001, P NATL ACAD SCI USA, V98, P6865, DOI 10.1073/pnas.121455098; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498	35	23	23	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22089	22096		10.1074/jbc.M801041200	http://dx.doi.org/10.1074/jbc.M801041200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18524780	hybrid			2022-12-25	WOS:000258114700027
J	Du, LK; Dunn-Walters, DK; Chrzanowska, KH; Stankovic, T; Kotnis, A; Li, X; Lu, JY; Eggertsen, G; Brittain, C; Popov, SW; Gennery, AR; Taylor, AMR; Pan-Hammarstrom, Q				Du, Likun; Dunn-Walters, Deborah K.; Chrzanowska, Krystyna H.; Stankovic, Tanja; Kotnis, Ashwin; Li, Xin; Lu, Jiayi; Eggertsen, Gosta; Brittain, Claire; Popov, Sergey W.; Gennery, Andrew R.; Taylor, A. Malcolm R.; Pan-Hammarstrom, Qiang			A Regulatory Role for NBS1 in Strand-Specific Mutagenesis during Somatic Hypermutation	PLOS ONE			English	Article								Activation-induced cytidine deaminase (AID) is believed to initiate somatic hypermutation (SHM) by deamination of deoxycytidines to deoxyuridines within the immunoglobulin variable regions genes. The deaminated bases can subsequently be replicated over, processed by base excision repair or mismatch repair, leading to introduction of different types of point mutations (G/C transitions, G/C transversions and A/T mutations). It is evident that the base excision repair pathway is largely dependent on uracil-DNA glycosylase (UNG) through its uracil excision activity. It is not known, however, which endonuclease acts in the step immediately downstream of UNG, i.e. that cleaves at the abasic sites generated by the latter. Two candidates have been proposed, an apurinic/apyrimidinic endonuclease (APE) and the Mre11-Rad50-NBS1 complex. The latter is intriguing as this might explain how the mutagenic pathway is primed during SHM. We have investigated the latter possibility by studying the in vivo SHM pattern in B cells from ataxia-telangiectasia-like disorder (Mre11 deficient) and Nijmegen breakage syndrome (NBS1 deficient) patients. Our results show that, although the pattern of mutations in the variable heavy chain (V-H) genes was altered in NBS1 deficient patients, with a significantly increased number of G (but not C) transversions occurring in the SHM and/or AID targeting hotspots, the general pattern of mutations in the V-H genes in Mre11 deficient patients was only slightly altered, with an increased frequency of A to C transversions. The Mre11-Rad50-NBS1 complex is thus unlikely to be the major nuclease involved in cleavage of the abasic sites during SHM, whereas NBS1 might have a specific role in regulating the strand-biased repair during phase Ib mutagenesis.	[Du, Likun; Kotnis, Ashwin; Li, Xin; Lu, Jiayi; Popov, Sergey W.; Pan-Hammarstrom, Qiang] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Immunol, Stockholm, Sweden; [Dunn-Walters, Deborah K.] Kings Coll London, Sch Med, Guys Hosp, Dept Immunobiol, London, England; [Chrzanowska, Krystyna H.] Childrens Memorial Hlth Inst, Dept Med Genet, Warsaw, Poland; [Stankovic, Tanja; Brittain, Claire; Taylor, A. Malcolm R.] Univ Birmingham, Med Sch Edghaston, CRC Inst Canc Stud, Birmingham, W Midlands, England; [Eggertsen, Gosta] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Chem, Stockholm, Sweden; [Gennery, Andrew R.] Newcastle Gen Hosp, Dept Pediat Immunol, Newcastle Upon Tyne, Tyne & Wear, England	Karolinska Institutet; Karolinska University Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Children's Memorial Health Institute; University of Birmingham; Karolinska Institutet; Karolinska University Hospital; Newcastle General Hospital	Du, LK (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Immunol, Stockholm, Sweden.	Qiang.Pan-Hammarstrom@ki.se	hammarstrom, qiang pan/ABA-4589-2021; Popov, Sergey/AAB-3225-2021	Dunn-Walters, Deborah/0000-0002-7172-3893; Du, Likun/0000-0002-8448-2187; Popov, Sergey/0000-0003-1172-3557; Stankovic, Tatjana/0000-0002-3780-274X; pan-hammarstrom, qiang/0000-0003-1990-8804; Chrzanowska, Krystyna/0000-0003-3888-0624	Swedish Research Council; Swedish Cancer Foundation; Swedish Society for Medicine; "KID" program of the Karolinska Institutet; CR-UK; Medical Research Council [G0000160] Funding Source: researchfish; MRC [G0000160] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Swedish Society for Medicine; "KID" program of the Karolinska Institutet; CR-UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Swedish Research Council, the Swedish Cancer Foundation, the Swedish Society for Medicine and the "KID" program of the Karolinska Institutet. A. M. Taylor acknowledges the continuing support of CR-UK.	Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; Difilippantonio S, 2007, CELL CYCLE, V6, P2366, DOI 10.4161/cc.6.19.4758; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; Faili A, 2004, J EXP MED, V199, P265, DOI 10.1084/jem.20031831; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Fernet M, 2005, HUM MOL GENET, V14, P307, DOI 10.1093/hmg/ddi027; Gennery AR, 2004, CLIN IMMUNOL, V113, P214, DOI 10.1016/j.clim.2004.03.024; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Gregorek H, 2002, CLIN EXP IMMUNOL, V130, P319, DOI 10.1046/j.1365-2249.2002.01971.x; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Hadi MZ, 2000, ENVIRON MOL MUTAGEN, V36, P312, DOI 10.1002/1098-2280(2000)36:4<312::AID-EM7>3.0.CO;2-K; Ide Y, 2004, BLOOD, V104, P4097, DOI 10.1182/blood-2004-04-1476; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Jansen JG, 2006, J EXP MED, V203, P319, DOI 10.1084/jem.20052227; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Kracker S, 2005, P NATL ACAD SCI USA, V102, P1584, DOI 10.1073/pnas.0409191102; Lahdesmaki A, 2004, J BIOL CHEM, V279, P16479, DOI 10.1074/jbc.M312796200; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Masuda K, 2007, J BIOL CHEM, V282, P17387, DOI 10.1074/jbc.M611849200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Pan Q, 2002, EUR J IMMUNOL, V32, P1300, DOI 10.1002/1521-4141(200205)32:5<1300::AID-IMMU1300>3.0.CO;2-L; Pan-Hammarstrom Q, 2006, J EXP MED, V203, P99, DOI 10.1084/jem.20050595; Pan-Hammarstrom Q, 2005, J EXP MED, V201, P189, DOI 10.1084/jem.20040772; Pan-Hammarstrom Q, 2003, J IMMUNOL, V170, P3707, DOI 10.4049/jimmunol.170.7.3707; Pan-Hammarstrom Q, 2007, ADV IMMUNOL, V93, P1, DOI 10.1016/S0065-2776(06)93001-6; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Spencer J, 2005, J IMMUNOL, V175, P5170, DOI 10.4049/jimmunol.175.8.5170; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Taylor AMR, 2004, DNA REPAIR, V3, P1219, DOI 10.1016/j.dnarep.2004.04.009; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Unniraman S, 2007, SCIENCE, V317, P1227, DOI 10.1126/science.1145065; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Xiao Z, 2007, MOL IMMUNOL, V44, P2659, DOI 10.1016/j.molimm.2006.12.006; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Yabuki M, 2005, NAT IMMUNOL, V6, P730, DOI 10.1038/ni1215; YAN CT, 2007, NATURE; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	62	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2482	10.1371/journal.pone.0002482	http://dx.doi.org/10.1371/journal.pone.0002482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575580	Green Submitted, gold, Green Published			2022-12-25	WOS:000263288000012
J	Laddy, DJ; Yan, J; Kutzler, M; Kobasa, D; Kobinger, GP; Khan, AS; Greenhouse, J; Sardesai, NY; Draghia-Akli, R; Weiner, DB				Laddy, Dominick J.; Yan, Jian; Kutzler, Michele; Kobasa, Darwyn; Kobinger, Gary P.; Khan, Amir S.; Greenhouse, Jack; Sardesai, Niranjan Y.; Draghia-Akli, Ruxandra; Weiner, David B.			Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens	PLOS ONE			English	Article								Background: The persistent evolution of highly pathogenic avian influenza (HPAI) highlights the need for novel vaccination techniques that can quickly and effectively respond to emerging viral threats. We evaluated the use of optimized consensus influenza antigens to provide broad protection against divergent strains of H5N1 influenza in three animal models of mice, ferrets, and non-human primates. We also evaluated the use of in vivo electroporation to deliver these vaccines to overcome the immunogenicity barrier encountered in larger animal models of vaccination. Methods and Findings: Mice, ferrets and non-human primates were immunized with consensus plasmids expressing H5 hemagglutinin (pH5HA), N1 neuraminidase (pN1NA), and nucleoprotein antigen (pNP). Dramatic IFN-gamma-based cellular immune responses to both H5 and NP, largely dependent upon CD8+ T cells were seen in mice. Hemaggutination inhibition titers classically associated with protection (>1:40) were seen in all species. Responses in both ferrets and macaques demonstrate the ability of synthetic consensus antigens to induce antibodies capable of inhibiting divergent strains of the H5N1 subtype, and studies in the mouse and ferret demonstrate the ability of synthetic consensus vaccines to induce protection even in the absence of such neutralizing antibodies. After challenge, protection from morbidity and mortality was seen in mice and ferrets, with significant reductions in viral shedding and disease progression seen in vaccinated animals. Conclusions: By combining several consensus influenza antigens with in vivo electroporation, we demonstrate that these antigens induce both protective cellular and humoral immune responses in mice, ferrets and non-human primates. We also demonstrate the ability of these antigens to protect from both morbidity and mortality in a ferret model of HPAI, in both the presence and absence of neutralizing antibody, which will be critical in responding to the antigenic drift that will likely occur before these viruses cross the species barrier to humans.	[Laddy, Dominick J.; Yan, Jian; Kutzler, Michele; Weiner, David B.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kobasa, Darwyn] Publ Hlth Agcy Canada, Natl Microbiol Lab, Resp Viruses, Winnipeg, MB, Canada; [Kobinger, Gary P.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens, Winnipeg, MB, Canada; [Kobinger, Gary P.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Khan, Amir S.; Sardesai, Niranjan Y.; Draghia-Akli, Ruxandra] VGX Pharm, Blue Bell, PA USA; [Greenhouse, Jack] Bioqual Inc, Rockville, MD USA	University of Pennsylvania; Public Health Agency of Canada; Public Health Agency of Canada; University of Manitoba; BIOQUAL Inc.	Laddy, DJ (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	dbweiner@mail.med.upenn.edu	Weiner, David B/H-8579-2014; Khan, Amir Sada/Q-8429-2019	Draghia-Akli, Ruxandra/0000-0001-6372-4039; Sardesai, Niranjan/0000-0001-6920-1167; Kutzler, Michele/0000-0001-5692-5617	Wyeth; Ichor; BMS; Virxsys	Wyeth(Wyeth); Ichor; BMS(Bristol-Myers Squibb); Virxsys	DBW serves as a consultant to VGX and has sponsored research grants from Wyeth, Ichor, BMS and Virxsys.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Babiuk S, 2002, VACCINE, V20, P3399, DOI 10.1016/S0264-410X(02)00269-4; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; DRAGHIAAKLI R, 2008, VACCINE; Epstein SL, 2000, INT IMMUNOL, V12, P91, DOI 10.1093/intimm/12.1.91; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Forde GM, 2005, NAT BIOTECHNOL, V23, P1059, DOI 10.1038/nbt0905-1059; Hebel H, 2006, VACCINE, V24, P4607, DOI 10.1016/j.vaccine.2005.08.049; HIRAO LA, 2008, VACCINE; Hirao LA, 2008, VACCINE, V26, P440, DOI 10.1016/j.vaccine.2007.10.041; Kadowaki S, 2000, VACCINE, V18, P2779, DOI 10.1016/S0264-410X(00)00087-6; Khan AS, 2005, DNA CELL BIOL, V24, P810, DOI 10.1089/dna.2005.24.810; Kim JJ, 1998, J CLIN INVEST, V102, P1112, DOI 10.1172/JCI3986; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Krohn K, 2005, MICROBES INFECT, V7, P1405, DOI 10.1016/j.micinf.2005.07.023; Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112; Laddy DJ, 2007, VACCINE, V25, P2984, DOI 10.1016/j.vaccine.2007.01.063; Laddy DJ, 2006, INT REV IMMUNOL, V25, P99, DOI 10.1080/08830180600785827; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Malm M, 2005, VIRAL IMMUNOL, V18, P678, DOI 10.1089/vim.2005.18.678; Otten G, 2004, VACCINE, V22, P2489, DOI 10.1016/j.vaccine.2003.11.073; RENEGAR KB, 1992, LAB ANIM SCI, V42, P222; ROBERT G, 2006, MICROBE, V1, P559; Roy S, 2007, VACCINE, V25, P6845, DOI 10.1016/j.vaccine.2007.07.035; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Weaver EA, 2006, J VIROL, V80, P6745, DOI 10.1128/JVI.02484-05; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; YAN J, 2006, MOL THERAPY; Zucchelli S, 2000, J VIROL, V74, P11598, DOI 10.1128/JVI.74.24.11598-11607.2000	34	124	152	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2517	10.1371/journal.pone.0002517	http://dx.doi.org/10.1371/journal.pone.0002517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575608	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288000034
J	Swaddle, JP; Calos, SE				Swaddle, John P.; Calos, Stavros E.			Increased Avian Diversity Is Associated with Lower Incidence of Human West Nile Infection: Observation of the Dilution Effect	PLOS ONE			English	Article							LYME-DISEASE; SPECIES-DIVERSITY; VIRUS-INFECTION; HOST; BIODIVERSITY; EPIDEMIOLOGY; COEXISTENCE; DENSITY; GEORGIA; BIRDS	Recent infectious disease models illustrate a suite of mechanisms that can result in lower incidence of disease in areas of higher disease host diversity-the 'dilution effect'. These models are particularly applicable to human zoonoses, which are infectious diseases of wildlife that spill over into human populations. As many recent emerging infectious diseases are zoonoses, the mechanisms that underlie the 'dilution effect' are potentially widely applicable and could contribute greatly to our understanding of a suite of diseases. The dilution effect has largely been observed in the context of Lyme disease and the predictions of the underlying models have rarely been examined for other infectious diseases on a broad geographic scale. Here, we explored whether the dilution effect can be observed in the relationship between the incidence of human West Nile virus (WNV) infection and bird (host) diversity in the eastern US. We constructed a novel geospatial contrasts analysis that compares the small differences in avian diversity of neighboring US counties (where one county reported human cases of WNV and the other reported no cases) with associated between-county differences in human disease. We also controlled for confounding factors of climate, regional variation in mosquito vector type, urbanization, and human socioeconomic factors that are all likely to affect human disease incidence. We found there is lower incidence of human WNV in eastern US counties that have greater avian (viral host) diversity. This pattern exists when examining diversity-disease relationships both before WNV reached the US (in 1998) and once the epidemic was underway ( in 2002). The robust disease-diversity relationships confirm that the dilution effect can be observed in another emerging infectious disease and illustrate an important ecosystem service provided by biodiversity, further supporting the growing view that protecting biodiversity should be considered in public health and safety plans.	[Swaddle, John P.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Swaddle, John P.; Calos, Stavros E.] Coll William & Mary, Inst Integrative Bird Behavior Stud, Biol Dept, Williamsburg, VA USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; William & Mary	Swaddle, JP (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.	jpswad@wm.edu			NSF [EF-0436318, DEB-0553768]; National Center for Ecological Analysis and Synthesis [Sabbatical Fellow]; University of California, Santa Barbara; State of California	NSF(National Science Foundation (NSF)); National Center for Ecological Analysis and Synthesis; University of California, Santa Barbara(University of California System); State of California	This work was funded by NSF (Grant #EF-0436318 to JPS) and partially conducted while a Sabbatical Fellow at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant #DEB-0553768), the University of California, Santa Barbara, and the State of California. The funders did not play any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, nor in the preparation, review, or approval of the manuscript.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bowen RA, 2007, CURR OPIN INFECT DIS, V20, P293, DOI 10.1097/QCO.0b013e32816b5cad; Caffrey C, 2005, CONDOR, V107, P128, DOI 10.1650/7646; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Eidson M, 2005, EMERG INFECT DIS, V11, P1370; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Garvin MC, 2004, AM J TROP MED HYG, V70, P566, DOI 10.4269/ajtmh.2004.70.566; Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P73, DOI 10.1089/vbz.2006.6.73; Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P57, DOI 10.1089/vbz.2006.6.57; Jourdain E, 2007, VECTOR-BORNE ZOONOT, V7, P448, DOI 10.1089/vbz.2006.0592; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Komar N, 2005, AM J TROP MED HYG, V73, P1031, DOI 10.4269/ajtmh.2005.73.1031; Krasnov BR, 2007, OECOLOGIA, V154, P185, DOI 10.1007/s00442-007-0824-x; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Male T, 2003, CONSERV BIOL, V17, P928, DOI 10.1046/j.1523-1739.2003.02424.x; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; McLean RG, 2001, ANN NY ACAD SCI, V951, P54; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Reisen W, 2007, PEST MANAG SCI, V63, P641, DOI 10.1002/ps.1325; Reisen WK, 2006, J MED ENTOMOL, V43, P356, DOI 10.1603/0022-2585(2006)043[0356:ROCIEO]2.0.CO;2; Roberts RS, 2006, VECTOR-BORNE ZOONOT, V6, P1, DOI 10.1089/vbz.2006.6.1; Roehrig JT, 2002, CURR TOP MICROBIOL, V267, P223; Rudolf VHW, 2005, AM NAT, V166, P112, DOI 10.1086/430674; SAUER JR, 2007, N AM BREEDING BIRD S; THRALL PH, 1993, AM NAT, V142, P543, DOI 10.1086/285554; VANBUSKIRK J, 1995, ECOL APPL, V5, P1133, DOI 10.2307/2269360	32	135	146	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2488	10.1371/journal.pone.0002488	http://dx.doi.org/10.1371/journal.pone.0002488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575599	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000016
J	Stjernman, M; Raberg, L; Nilsson, JA				Stjernman, Martin; Raberg, Lars; Nilsson, Jan-Ake			Maximum Host Survival at Intermediate Parasite Infection Intensities	PLOS ONE			English	Article								Background: Although parasitism has been acknowledged as an important selective force in the evolution of host life histories, studies of fitness effects of parasites in wild populations have yielded mixed results. One reason for this may be that most studies only test for a linear relationship between infection intensity and host fitness. If resistance to parasites is costly, however, fitness may be reduced both for hosts with low infection intensities (cost of resistance) and high infection intensities (cost of parasitism), such that individuals with intermediate infection intensities have highest fitness. Under this scenario one would expect a non-linear relationship between infection intensity and fitness. Methodology/Principal Findings: Using data from blue tits (Cyanistes caeruleus) in southern Sweden, we investigated the relationship between the intensity of infection of its blood parasite (Haemoproteus majoris) and host survival to the following winter. Presence and intensity of parasite infections were determined by microscopy and confirmed using PCR of a 480bp section of the cytochrome-b-gene. While a linear model suggested no relationship between parasite intensity and survival (F = 0.01, p = 0.94), a non-linear model showed a significant negative quadratic effect (quadratic parasite intensity: F = 4.65, p = 0.032; linear parasite intensity F = 4.47, p = 0.035). Visualization using the cubic spline technique showed maximum survival at intermediate parasite intensities. Conclusions/Significance: Our results indicate that failing to recognize the potential for a non-linear relationship between parasite infection intensity and host fitness may lead to the potentially erroneous conclusion that the parasite is harmless to its host. Here we show that high parasite intensities indeed reduced survival, but this effect was masked by reduced survival for birds heavily suppressing their parasite intensities. Reduced survival among hosts with low parasite intensities suggests costs of controlling parasite infections; however, the nature of such costs remains to be elucidated.	[Stjernman, Martin; Raberg, Lars; Nilsson, Jan-Ake] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden	Lund University	Stjernman, M (corresponding author), Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden.	martin.stjernman@zooekol.lu.se			Royal Physiographic Society in Lund; Royal Swedish Academy of Sciences; Lunds Djurskyddsfond; Swedish Research Council	Royal Physiographic Society in Lund; Royal Swedish Academy of Sciences; Lunds Djurskyddsfond; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study received financial support from the Royal Physiographic Society in Lund (to MS), the Royal Swedish Academy of Sciences, and Lunds Djurskyddsfond (to MS & LR), and from the Swedish Research Council (to J-AN). None of the sponsors/funders had any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; ATKINSON CT, 1988, J PARASITOL, V74, P228, DOI 10.2307/3282448; BENNETT GF, 1988, J WILDLIFE DIS, V24, P339, DOI 10.7589/0090-3558-24.2.339; BENNETT GF, 1993, J NAT HIST, V27, P993, DOI 10.1080/00222939300770621; BULL CM, 1993, OECOLOGIA, V96, P415, DOI 10.1007/BF00317513; Desser Sherwin S., 1993, P273; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Jankovic D, 2001, TRENDS IMMUNOL, V22, P450, DOI 10.1016/S1471-4906(01)01975-5; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; Raberg L, 2003, EVOLUTION, V57, P1670, DOI 10.1554/02-417; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; RICHNER H, 1995, P NATL ACAD SCI USA, V92, P1192, DOI 10.1073/pnas.92.4.1192; Sambrook J., 2002, MOL CLONING LAB MANU; SAS Institute, 1999, SAS ONL DOC V8; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sol D, 2003, OECOLOGIA, V135, P542, DOI 10.1007/s00442-003-1223-6; Stien A, 2002, J ANIM ECOL, V71, P937, DOI 10.1046/j.1365-2656.2002.00659.x; Stjernman M, 2004, P ROY SOC B-BIOL SCI, V271, P2387, DOI 10.1098/rspb.2004.2883; Svensson L., 1992, IDENTIFICATION GUIDE; Telfer S, 2002, J ANIM ECOL, V71, P558, DOI 10.1046/j.1365-2656.2002.00623.x; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; WEATHERHEAD PJ, 1992, CAN J ZOOL, V70, P1, DOI 10.1139/z92-001; Westneat DF, 1998, P ROY SOC B-BIOL SCI, V265, P1065, DOI 10.1098/rspb.1998.0400	27	42	43	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2463	10.1371/journal.pone.0002463	http://dx.doi.org/10.1371/journal.pone.0002463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560544	Green Submitted, Green Published, gold			2022-12-25	WOS:000263280700044
J	Wang, CH; Lee, DY; Deng, ZQ; Jeyapalan, Z; Lee, SC; Kahai, S; Lu, WY; Zhang, Y; Yang, BB				Wang, Chia-Hui; Lee, Daniel Y.; Deng, Zhaoqun; Jeyapalan, Zina; Lee, Shao-Chen; Kahai, Shireen; Lu, Wei-Yang; Zhang, Yaou; Yang, Burton B.			MicroRNA miR-328 Regulates Zonation Morphogenesis by Targeting CD44 Expression	PLOS ONE			English	Article								Morphogenesis is crucial to initiate physiological development and tumor invasion. Here we show that a microRNA controls zonation morphogenesis by targeting hyaluronan receptor CD44. We have developed a novel system to study microRNA functions by generating constructs expressing pre-miRNAs and mature miRNAs. Using this system, we have demonstrated that expression of miR-328 reduced cell adhesion, aggregation, and migration, and regulated formation of capillary structure. Protein analysis indicated that miR-328 repressed CD44 expression. Activities of luciferase constructs harboring the target site in CD44, but not the one containing mutation, were repressed by miR-328. Zonation morphogenesis appeared in cells transfected by miR-328: miR-328-transfected cells were present on the surface of zonating structures while the control cells stayed in the middle. MiR-328-mediated CD44 actions was validated by anti-CD44 antibody, hyaluronidase, CD44 siRNA, and CD44 expression constructs. In vivo experiments showed that CD44-silencing cells appeared as layers on the surfaces of nodules or zonating structures. Immuno-histochemistry also exhibited CD44-negative cells on the surface layers of normal rat livers and the internal zones of Portal veins. Our results demonstrate that miR-328 targets CD44, which is essential in regulating zonation morphogenesis: silencing of CD44 expression is essential in sealing the zonation structures to facilitate their extension and to inhibit complex expansion.	[Wang, Chia-Hui; Lee, Daniel Y.; Deng, Zhaoqun; Jeyapalan, Zina; Lee, Shao-Chen; Kahai, Shireen; Lu, Wei-Yang; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Wang, Chia-Hui; Lee, Daniel Y.; Deng, Zhaoqun; Jeyapalan, Zina; Lee, Shao-Chen; Kahai, Shireen; Yang, Burton B.] University of Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Lu, Wei-Yang] Univ Toronto, Dept Anaesthesia, Toronto, ON, Canada; [Zhang, Yaou] Tsinghua Univ, Grad Sch Shenzhen, Life Sci Div, Shenzhen, Peoples R China	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Wang, CH (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	byang@sri.utoronto.ca	Lu, Wei-Yang/K-4404-2013		Canadian Institutes of Health Research [MOP-62729]; Canadian Breast Cancer Foundation Ontario Chapter [5958]; Heart and Stroke Foundation of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation Ontario Chapter; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by a grant from Canadian Institutes of Health Research (MOP-62729) and a grant from Canadian Breast Cancer Foundation Ontario Chapter to Burton B. Yang who is the recipient of a Career Investigator Award (CI 5958) from the Heart and Stroke Foundation of Ontario.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; ARCH R, 1992, SCIENCE, V257, P682, DOI 10.1126/science.1496383; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Cullen BR, 2007, SCIENCE, V317, P329, DOI 10.1126/science.1146077; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gakunga P, 1997, DEVELOPMENT, V124, P3987; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Makunin IV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001133; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Mello CC, 2004, NAT MED, V10, P1297, DOI 10.1038/nm1204-1297; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pohl M, 2000, DEV BIOL, V224, P312, DOI 10.1006/dbio.2000.9783; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200; TERPE HJ, 1993, VIRCHOWS ARCH A, V422, P219, DOI 10.1007/BF01621805; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt1211; YEW L, 2008, PLOS ONE, V3, pE1719; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	66	84	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2420	10.1371/journal.pone.0002420	http://dx.doi.org/10.1371/journal.pone.0002420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560585	Green Submitted, Green Published, gold			2022-12-25	WOS:000263280700007
J	Guerreiro, RJ; Schymick, JC; Crews, C; Singleton, A; Hardy, J; Traynor, BJ				Guerreiro, Rita J.; Schymick, Jennifer C.; Crews, Cynthia; Singleton, Andrew; Hardy, John; Traynor, Bryan J.			TDP-43 Is Not a Common Cause of Sporadic Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article								Background: TAR DNA binding protein, encoded by TARDBP, was shown to be a central component of ubiquitin-positive, tau-negative inclusions in frontotemporal lobar degeneration (FTLD-U) and amyotrophic lateral sclerosis (ALS). Recently, mutations in TARDBP have been linked to familial and sporadic ALS. Methodology/Principal Findings: To further examine the frequency of mutations in TARDBP in sporadic ALS, 279 ALS cases and 806 neurologically normal control individuals of European descent were screened for sequence variants, copy number variants, genetic and haplotype association with disease. An additional 173 African samples from the Human Gene Diversity Panel were sequenced as this population had the highest likelihood of finding changes. No mutations were found in the ALS cases. Several genetic variants were identified in controls, which were considered as non-pathogenic changes. Furthermore, pathogenic structural variants were not observed in the cases and there was no genetic or haplotype association with disease status across the TARDBP locus. Conclusions: Our data indicate that genetic variation in TARDBP is not a common cause of sporadic ALS in North American.	[Guerreiro, Rita J.; Schymick, Jennifer C.; Crews, Cynthia; Singleton, Andrew; Traynor, Bryan J.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Guerreiro, Rita J.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Schymick, Jennifer C.] Univ Oxford, Dept Physiol, Anat & Genet, Oxford, England; [Hardy, John] Inst Neurol, Dept Mol Neurosci, Reta Lila Weston Inst, London, England; [Hardy, John] Inst Neurol, Dept Neurodegen Dis, Reta Lila Weston Inst, London, England; [Traynor, Bryan J.] NIH, NINDS, Neurogenet Branch, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universidade de Coimbra; University of Oxford; University of London; University College London; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Guerreiro, RJ (corresponding author), NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	portalegrer@nia.nih.gov	Traynor, Bryan J/G-5690-2010; Sander-Effron, Samuel/AAX-2231-2020; Singleton, Andrew B/C-3010-2009; Resource Center, NINDS Human Genetics/AGF-2474-2022; Guerreiro, Rita J L/A-1327-2011; Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423; Guerreiro, Rita/0000-0001-5879-3486	ALS Association; Packard Center for ALS Research at Hopkins; NIA [1 Z01 AG000951-06]; NINDS; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/27442/2006]; MRC [G0701075] Funding Source: UKRI; Medical Research Council [G0701075] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [Z01AG000951, ZIAAG000933, Z01AG000957] Funding Source: NIH RePORTER	ALS Association; Packard Center for ALS Research at Hopkins; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the ALS Association, the Packard Center for ALS Research at Hopkins, the intramural programs of NIA (1 Z01 AG000951-06) and NINDS and grant #SFRH/BD/27442/2006 from Fundacao para a Ciencia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI T, 2008, BIOCHEM BIOPH RES CO, V351, P602; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Cann HM, 2002, SCIENCE, V296, P261; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chio A, 2008, NEUROLOGY, V70, P533, DOI 10.1212/01.wnl.0000299187.90432.3f; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; GIJSELINCK I, 2007, NEUROBIOL AGING 1207; GITCHO MA, 2008, ANN NEUROL      0220; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; KABASHI E, 2008, NAT GENET       0330; LEIGH PN, 1991, BRAIN, V114, P775, DOI 10.1093/brain/114.2.775; Logroscino G, 2005, J NEUROL NEUROSUR PS, V76, P1094, DOI 10.1136/jnnp.2004.039180; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robertson J, 2007, NEUROSCI LETT, V420, P128, DOI 10.1016/j.neulet.2007.03.066; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tan CF, 2007, ACTA NEUROPATHOL, V113, P535, DOI 10.1007/s00401-007-0206-9; VANDEERLIN VM, 2008, LANCET NEUROL   0404; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; WINTON MJ, 2006, J BIOL CHEM     0227	30	57	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2450	10.1371/journal.pone.0002450	http://dx.doi.org/10.1371/journal.pone.0002450			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545701	Green Published, Green Submitted, gold			2022-12-25	WOS:000263248800058
J	Jelluma, N; Brenkman, AB; McLeod, I; Yates, JR; Cleveland, DW; Medema, RH; Kops, GJPL				Jelluma, Nannette; Brenkman, Arjan B.; McLeod, Ian; Yates, John R., III; Cleveland, Don W.; Medema, Rene H.; Kops, Geert J. P. L.			Chromosomal Instability by Inefficient Mps1 Auto-Activation Due to a Weakened Mitotic Checkpoint and Lagging Chromosomes	PLOS ONE			English	Article								Background: Chromosomal instability (CIN), a feature widely shared by cells from solid tumors, is caused by occasional chromosome missegregations during cell division. Two of the causes of CIN are weakened mitotic checkpoint signaling and persistent merotelic attachments that result in lagging chromosomes during anaphase. Principal Findings: Here we identify an autophosphorylation event on Mps1 that is required to prevent these two causes of CIN. Mps1 is phosphorylated in mitotic cells on at least 7 residues, 4 of which by autophosphorylation. One of these, T676, resides in the activation loop of the kinase domain and a mutant that cannot be phosphorylated on T676 is less active than wild-type Mps1 but is not kinase-dead. Strikingly, cells in which endogenous Mps1 was replaced with this mutant are viable but missegregate chromosomes frequently. Anaphase is initiated in the presence of misaligned and lagging chromosomes, indicative of a weakened checkpoint and persistent merotelic attachments, respectively. Conclusions/Significance: We propose that full activity of Mps1 is essential for maintaining chromosomal stability by allowing resolution of merotelic attachments and to ensure that single kinetochores achieve the strength of checkpoint signaling sufficient to prevent premature anaphase onset and chromosomal instability. To our knowledge, phosphorylation of T676 on Mps1 is the first post-translational modification in human cells of which the absence causes checkpoint weakening and CIN without affecting cell viability.	[Jelluma, Nannette; Brenkman, Arjan B.; Kops, Geert J. P. L.] UMC Utrecht, Canc Genom Ctr, Dept Physiol Chem, Utrecht, Netherlands; [Jelluma, Nannette; Medema, Rene H.; Kops, Geert J. P. L.] UMC Utrecht, Dept Med Oncol, Lab Expt Oncol, Utrecht, Netherlands; [McLeod, Ian; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA; [Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Scripps Research Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Jelluma, N (corresponding author), UMC Utrecht, Canc Genom Ctr, Dept Physiol Chem, Utrecht, Netherlands.	g.j.p.l.kops@umcutrecht.nl	Medema, Rene H/E-2981-2013; Cleveland, Don/AAN-9783-2021; Medema, Rene H/G-5415-2011	Medema, Rene/0000-0002-6754-0381; Cleveland, Don/0000-0002-1934-3682; Kops, Geert/0000-0003-3555-5295	EU [LSHC-CT-2004-503438];  [UU-2006-3664];  [VIDI-91776336];  [ZonMW 91846616]	EU(European Commission); ; ; 	This work was supported by grants awarded to G.J.P.L.K. (UU-2006-3664 and VIDI-91776336) and R.H.M. (ZonMW 91846616). A.B.B. was supported by a grant from the EU (LSHC-CT-2004-503438).	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cheeseman I. M., 2005, SCI STKE, V2005, P11; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Doak SH, 2004, MUTAT RES-FUND MOL M, V547, P133, DOI 10.1016/j.mrfmmm.2003.12.009; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Heim S, 1995, CANC CYTOGENETICS; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Luciano BS, 2004, J BIOL CHEM, V279, P52117, DOI 10.1074/jbc.M403716200; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Weitzel DH, 2000, CELL TISSUE RES, V300, P57, DOI 10.1007/s004410000189; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044	32	63	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2415	10.1371/journal.pone.0002415	http://dx.doi.org/10.1371/journal.pone.0002415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545697	Green Published, gold, Green Submitted			2022-12-25	WOS:000263248800052
J	Martin, B; Pearson, M; Brenneman, R; Golden, E; Keselman, A; Iyun, T; Carlson, OD; Egan, JM; Becker, KG; Wood, W; Prabhu, V; de Cabo, R; Maudsley, S; Mattson, MP				Martin, Bronwen; Pearson, Michele; Brenneman, Randall; Golden, Erin; Keselman, Alex; Iyun, Titilola; Carlson, Olga D.; Egan, Josephine M.; Becker, Kevin G.; Wood, William, III; Prabhu, Vinayakumar; de Cabo, Rafael; Maudsley, Stuart; Mattson, Mark P.			Conserved and Differential Effects of Dietary Energy Intake on the Hippocampal Transcriptomes of Females and Males	PLOS ONE			English	Article								The level of dietary energy intake influences metabolism, reproductive function, the development of age-related diseases, and even cognitive behavior. Because males and females typically play different roles in the acquisition and allocation of energy resources, we reasoned that dietary energy intake might differentially affect the brains of males and females at the molecular level. To test this hypothesis, we performed a gene array analysis of the hippocampus in male and female rats that had been maintained for 6 months on either ad libitum (control), 20% caloric restriction (CR), 40% CR, intermittent fasting (IF) or high fat/high glucose (HFG) diets. These diets resulted in expected changes in body weight, and circulating levels of glucose, insulin and leptin. However, the CR diets significantly increased the size of the hippocampus of females, but not males. Multiple genes were regulated coherently in response to energy restriction diets in females, but not in males. Functional physiological pathway analyses showed that the 20% CR diet down-regulated genes involved in glycolysis and mitochondrial ATP production in males, whereas these metabolic pathways were up-regulated in females. The 40% CR diet up-regulated genes involved in glycolysis, protein deacetylation, PGC-1 alpha and mTor pathways in both sexes. IF down-regulated many genes in males including those involved in protein degradation and apoptosis, but up-regulated many genes in females including those involved in cellular energy metabolism, cell cycle regulation and protein deacetylation. Genes involved in energy metabolism, oxidative stress responses and cell death were affected by the HFG diet in both males and females. The gender-specific molecular genetic responses of hippocampal cells to variations in dietary energy intake identified in this study may mediate differential behavioral responses of males and females to differences in energy availability.	[Martin, Bronwen; Pearson, Michele; Brenneman, Randall; Golden, Erin; Keselman, Alex; Iyun, Titilola; Maudsley, Stuart; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; [Carlson, Olga D.; Egan, Josephine M.] NIA, Lab Clin Invest, Intramural Res Program, Baltimore, MD USA; [Becker, Kevin G.; Wood, William, III; Prabhu, Vinayakumar] NIA, Gene Expression & Genom Unit, Intramural Res Program, Baltimore, MD USA; [de Cabo, Rafael] NIA, Lab Expt Gerontol, Intramural Res Program, Baltimore, MD USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Martin, B (corresponding author), NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA.	martinbro@grc.nia.nih.gov	Maudsley, Stuart/AAV-9929-2021; de Cabo, Rafael/E-7996-2010; Maudsley, Stuart/Q-4782-2019; de Cabo, Rafael Carlos/J-5230-2016; Mattson, Mark P/F-6038-2012; de Cabo, Rafael/J-5230-2016	Maudsley, Stuart/0000-0002-1868-184X; de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442; Martin, Bronwen/0000-0002-9185-6925; Becker, Kevin/0000-0002-6794-6656	Intramural Research Program of the National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000368, ZIAAG000315, Z01AG000368, ZIAAG000331, Z01AG000314, Z01AG000315, Z01AG000616, ZICAG000616, ZIAAG000330, ZIAAG000314] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program of the National Institute on Aging.	Antunes-Martins A, 2007, LEARN MEMORY, V14, P693, DOI 10.1101/lm.640307; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; Connan F, 2006, PSYCHIAT RES-NEUROIM, V146, P117, DOI 10.1016/j.pscychresns.2005.10.006; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Ferguson GD, 2004, HIPPOCAMPUS, V14, P964, DOI 10.1002/hipo.20013; Gatward N, 2007, EUR EAT DISORD REV, V15, P1, DOI 10.1002/erv.718; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Levine AS, 1997, ANNU REV NUTR, V17, P597, DOI 10.1146/annurev.nutr.17.1.597; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Mahmoud GS, 2006, J NEUROPHYSIOL, V95, P2962, DOI 10.1152/jn.00947.2005; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Mattson MP, 2002, NEUROBIOL AGING, V23, P695, DOI 10.1016/S0197-4580(02)00025-8; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Perreau VM, 2004, GENE EXPRESSION, V12, P107, DOI 10.3727/000000005783992115; Phillips GR, 2004, J NEUROSCI RES, V78, P38, DOI 10.1002/jnr.20224; Ross JL, 2005, HORM RES, V64, P89, DOI 10.1159/000089323; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sprott RL, 1997, EXP GERONTOL, V32, P205, DOI 10.1016/S0531-5565(96)00065-4; STRUPP BJ, 1986, NEUROPSYCHOBIOLOGY, V15, P89, DOI 10.1159/000118248; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang ZS, 2005, J BIOL CHEM, V280, P38153, DOI 10.1074/jbc.M508168200; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Weindruch R., 1988, RETARDATION AGING DI; Whitney LW, 1999, ANN NEUROL, V46, P425; Winocur G, 2005, BEHAV NEUROSCI, V119, P1389, DOI 10.1037/0735-7044.119.5.1389; Xu X, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r234	44	45	45	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2398	10.1371/journal.pone.0002398	http://dx.doi.org/10.1371/journal.pone.0002398			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545695	Green Submitted, Green Published, gold			2022-12-25	WOS:000263248800036
J	Block, K; Eid, A; Griendling, KK; Lee, DY; Wittrant, Y; Gorin, Y				Block, Karen; Eid, Assaad; Griendling, Kathy K.; Lee, Duck-Yoon; Wittrant, Yohann; Gorin, Yves			Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II - Role in mesangial cell hypertrophy and fibronectin expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; GROWTH-FACTOR RECEPTOR; HIGH GLUCOSE; NADPH OXIDASES; SIGNAL-TRANSDUCTION; INSULIN-RECEPTOR; DOWN-REGULATION; RENAL-DISEASE; PATHWAY; MECHANISMS	Activation of glomerular mesangial cells (MCs) by angiotensin II (Ang II) leads to hypertrophy and extracellular matrix accumulation. Here, we demonstrate that, in MCs, Ang II induces an increase in PDK-1 (3-phosphoinositide-dependent protein kinase-1) kinase activity that required its phosphorylation on tyrosine 9 and 373/376. Introduction into the cells of PDK-1, mutated on these tyrosine residues or kinase-inactive, attenuates Ang II-induced hypertrophy and fibronectin accumulation. Ang II-mediated PDK-1 activation and tyrosine phosphorylation ( total and on residues 9 and 373/376) are inhibited in cells transfected with small interfering RNA for Src, indicating that Src is upstream of PDK-1. In cells expressing oxidation-resistant Src mutant C487A, Ang II-induced hypertrophy and fibronectin expression are prevented, suggesting that the pathway is redox-sensitive. Ang II also up-regulates Nox4 protein, and siNox4 abrogates the Ang II-induced increase in intracellular reactive oxygen species (ROS) generation. Small interfering RNA for Nox4 also inhibits Ang II-induced activation of Src and PDK-1 tyrosine phosphorylation ( total and on residues 9 and 373/376), demonstrating that Nox4 functions upstream of Src and PDK-1. Importantly, inhibition of Nox4, Src, or PDK-1 prevents the stimulatory effect of Ang II on fibronectin accumulation and cell hypertrophy. This work provides the first evidence that Nox4-derived ROS are responsible for Ang II-induced PDK-1 tyrosine phosphorylation and activation through stimulation of Src. Importantly, this pathway contributes to Ang II-induced MC hypertrophy and fibronectin accumulation. These data shed light on molecular processes underlying the oxidative signaling cascade engaged by Ang II and identify potential targets for intervention to prevent renal hypertrophy and fibrosis.	[Gorin, Yves] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol MC 7882, San Antonio, TX 78229 USA; [Wittrant, Yohann] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Gorin, Yves] Univ Texas Hlth Sci Ctr San Antonio, George Obrien Kidney Res Ctr, San Antonio, TX 78229 USA; [Griendling, Kathy K.] Emory Univ, Div Cardiol, Atlanta, GA USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Emory University	Gorin, Y (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol MC 7882, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	gorin@uthscsa.edu		Griendling, Kathy/0000-0002-9456-8582; Gorin, Yves/0000-0003-4048-6925	National Institutes of Health [K01DK-076923]; NIDDK; George O'Brien Kidney Center; American Heart Association (National); American Heart Association (South Central Affiliate); Juvenile Diabetes Research Foundation; National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK076923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); George O'Brien Kidney Center; American Heart Association (National)(American Heart Association); American Heart Association (South Central Affiliate)(American Heart Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant K01DK-076923 (to K. B.) and the National Institutes of Health, NIDDK, George O'Brien Kidney Center (to Y.G.). This work was supported in part through an American Heart Association ( National) Scientist Development Grant (to Y.G.), a grant-in-aid from the American Heart Association (South Central Affiliate) (to Y.G.), a Juvenile Diabetes Research Foundation Regular Research Grant (to Y.G.), and a National Kidney Foundation Young Investigator Award (to Y.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Amiri F, 1999, AM J PHYSIOL-RENAL, V276, pF691, DOI 10.1152/ajprenal.1999.276.5.F691; ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2007, J BIOL CHEM, V282, P8019, DOI 10.1074/jbc.M611569200; Block K, 2006, ANTIOXID REDOX SIGN, V8, P1497, DOI 10.1089/ars.2006.8.1497; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brenner BM, 2002, J CLIN INVEST, V110, P1753, DOI 10.1172/JCI200217351; Brewster UC, 2003, AM J MED SCI, V326, P15, DOI 10.1097/00000441-200307000-00003; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chatziantoniou C, 2005, AM J PHYSIOL-RENAL, V289, pF227, DOI 10.1152/ajprenal.00453.2004; Chen H, 2001, BIOCHEMISTRY-US, V40, P11851, DOI 10.1021/bi010743c; Fiory F, 2005, MOL CELL BIOL, V25, P10803, DOI 10.1128/MCB.25.24.10803-10814.2005; Geiszt M, 2006, CARDIOVASC RES, V71, P289, DOI 10.1016/j.cardiores.2006.05.004; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gomez-Guerrero Carmen, 2005, Current Drug Targets - Inflammation and Allergy, V4, P341, DOI 10.2174/1568010054022169; Gooch JL, 2004, J BIOL CHEM, V279, P15561, DOI 10.1074/jbc.M308759200; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Gorin Y, 2004, BIOCHEM J, V381, P231, DOI 10.1042/BJ20031614; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Gorin Y, 2001, FASEB J, V15, P1909, DOI 10.1096/fj..01-0165com; Grillo S, 2000, EUR J BIOCHEM, V267, P6642, DOI 10.1046/j.1432-1327.2000.01759.x; Guo JF, 2006, CIRC RES, V99, P1367, DOI 10.1161/01.RES.0000252830.01581.fd; Hanna IR, 2002, ANTIOXID REDOX SIGN, V4, P899, DOI 10.1089/152308602762197443; Kim DW, 2003, MOL ENDOCRINOL, V17, P1382, DOI 10.1210/me.2002-0402; Kim S, 2000, PHARMACOL REV, V52, P11; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Mima A, 2006, LAB INVEST, V86, P927, DOI 10.1038/labinvest.3700445; Mukhin YV, 2000, BIOCHEM J, V347, P61, DOI 10.1042/0264-6021:3470061; Nakashima I, 2002, ANTIOXID REDOX SIGN, V4, P517, DOI 10.1089/15230860260196326; Okada H, 2005, CURR MOL MED, V5, P467, DOI 10.2174/1566524054553478; Orient A, 2007, NEPHROL DIAL TRANSPL, V22, P1281, DOI 10.1093/ndt/gfm077; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Prasad N, 2000, BIOCHEMISTRY-US, V39, P6929, DOI 10.1021/bi000387i; RINCONCHOLES H, 2002, KIDNEY INT S, V82, P8; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Steiler TL, 2003, ENDOCRINOLOGY, V144, P5259, DOI 10.1210/en.2003-0447; Taal MW, 1999, J HUM HYPERTENS, V13, pS51, DOI 10.1038/sj.jhh.1000742; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Taniyama Y, 2005, ARTERIOSCL THROM VAS, V25, P1142, DOI 10.1161/01.ATV.0000164313.17167.df; Taniyama Y, 2003, MOL CELL BIOL, V23, P8019, DOI 10.1128/MCB.23.22.8019-8029.2003; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Ushio-Fukai M, 2001, ARTERIOSCL THROM VAS, V21, P489, DOI 10.1161/01.ATV.21.4.489; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wu D, 2007, DIABETOLOGIA, V50, P2008, DOI 10.1007/s00125-007-0721-1; Xia L, 2006, AM J PHYSIOL-RENAL, V290, pF345, DOI 10.1152/ajprenal.00119.2005; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200; Yano N, 2007, J BIOL CHEM, V282, P18819, DOI 10.1074/jbc.M610537200	60	115	122	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24061	24076		10.1074/jbc.M803964200	http://dx.doi.org/10.1074/jbc.M803964200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18559349	Green Published, hybrid			2022-12-25	WOS:000258638900061
J	Ren, JG; Li, ZG; Sacks, DB				Ren, Jian-Guo; Li, Zhigang; Sacks, David B.			IQGAP1 integrates Ca2+/calmodulin and B-Raf signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-KINASE; ACTIN-BINDING; CELL-ADHESION; MAP KINASE; CALMODULIN; ACTIVATION; CALCIUM; CDC42; CA2+	Ca2+ and calmodulin modulate numerous cellular functions, ranging from muscle contraction to the cell cycle. Accumulating evidence indicates that Ca2+ and calmodulin regulate the MAPK signaling pathway at multiple positions in the cascade, but the molecular mechanism underlying these observations is poorly defined. We previously documented that IQGAP1 is a scaffold in the MAPK cascade. IQGAP1 binds to and regulates the activities of ERK, MEK, and B-Raf. Here we demonstrate that IQGAP1 integrates Ca2+ and calmodulin with B-Raf signaling. In vitro analysis reveals that Ca2+ promotes the direct binding of IQGAP1 to B-Raf. This interaction is inhibited by calmodulin in a Ca2+-regulated manner. Epidermal growth factor (EGF) is unable to stimulate B-Raf activity in fibroblasts treated with the Ca2+ ionophore A23187. In contrast, chelation of intracellular free Ca2+ concentrations ([Ca2+](i)) significantly enhances EGF-stimulated B-Raf activity, an effect that is dependent on IQGAP1. Incubation of cells with EGF augments the association of B-Raf with IQGAP1. Moreover, Ca2+ regulates the association of B-Raf with IQGAP1 in cells. Increasing [Ca2+](i) with Ca2+ ionophores significantly reduces co-immunoprecipitation of B- Raf and IQGAP1, whereas chelation of Ca2+ enhances the interaction. Consistent with these findings, increasing and decreasing [Ca2+](i) increase and decrease, respectively, co-immunoprecipitation of calmodulin with IQGAP1. Collectively, our data identify a previously unrecognized mechanism in which the scaffold protein IQGAP1 couples Ca2+ and calmodulin signaling to B-Raf function.	[Sacks, David B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sacks, DB (corresponding author), Brigham & Womens Hosp, Dept Pathol, Thorn 530,75 Francis St, Boston, MA 02115 USA.	dsacks@rics.bwh.harvard.edu		Sacks, David/0000-0003-3100-0735	NATIONAL CANCER INSTITUTE [R01CA075205] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA075205] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bosch M, 1998, J BIOL CHEM, V273, P22145, DOI 10.1074/jbc.273.34.22145; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cook SJ, 1997, J BIOL CHEM, V272, P13309, DOI 10.1074/jbc.272.20.13309; Cullen PJ, 2006, CURR OPIN CELL BIOL, V18, P157, DOI 10.1016/j.ceb.2006.02.012; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Egea J, 2000, MOL CELL BIOL, V20, P1931, DOI 10.1128/MCB.20.6.1931-1946.2000; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Ji QS, 2000, ONCOGENE, V19, P1853, DOI 10.1038/sj.onc.1203517; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; Mateer SC, 2003, CELL MOTIL CYTOSKEL, V55, P147, DOI 10.1002/cm.10118; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; MEDEMA JP, 1994, MOL CELL BIOL, V14, P7078, DOI 10.1128/MCB.14.11.7078; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Phillips-Mason PJ, 2006, J BIOL CHEM, V281, P4903, DOI 10.1074/jbc.M506414200; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Ritt DA, 2007, CURR BIOL, V17, P179, DOI 10.1016/j.cub.2006.11.061; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sacks DB, 2006, BIOCHEM SOC T, V34, P833, DOI 10.1042/BST0340833; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tebar F, 2002, MOL BIOL CELL, V13, P2057, DOI 10.1091/mbc.01-12-0571; Terai K, 2006, EMBO J, V25, P3556, DOI 10.1038/sj.emboj.7601241; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200	62	39	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22972	22982		10.1074/jbc.M804626200	http://dx.doi.org/10.1074/jbc.M804626200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18567582	hybrid, Green Accepted			2022-12-25	WOS:000258455400010
J	Hauenstein, SI; Perona, JJ				Hauenstein, Scott I.; Perona, John J.			Redundant synthesis of cysteinyl-tRNA(Cys) in Methanosarcina mazei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; DEPENDENT CYSTEINE BIOSYNTHESIS; AEROPYRUM-PERNIX K1; ESCHERICHIA-COLI; SELENOCYSTEINE SYNTHASE; AMINO-ACID; CYS-TRNA(CYS) FORMATION; ARCHAEOGLOBUS-FULGIDUS; STRUCTURAL INSIGHTS; METHANE FORMATION	A subset of methanogenic archaea synthesize the cysteinyl-tRNA(Cys) (Cys-tRNA(Cys)) needed for protein synthesis using both a canonical cysteinyl-tRNA synthetase (CysRS) as well as a set of two enzymes that operate via a separate indirect pathway. In the indirect route, phosphoseryl-tRNA(Cys) (Sep-tRNA(Cys)) is first synthesized by phosphoseryl-tRNA synthetase (SepRS), and this misacylated intermediate is then converted to Cys-tRNA(Cys) by Sep-tRNA: Cys-tRNA synthase (SepCysS) via a pyridoxal phosphate-dependent mechanism. Here, we explore the function of all three enzymes in the mesophilic methanogen Methanosarcina mazei. The genome of M. mazei also features three distinct tRNA(Cys) isoacceptors, further indicating the unusual and complex nature of Cys-tRNACys synthesis in this organism. Comparative aminoacylation kinetics by M. mazei CysRS and SepRS reveals that each enzyme prefers a distinct tRNA(Cys) isoacceptor or pair of isoacceptors. Recognition determinants distinguishing the tRNAs are shown to reside in the globular core of the molecule. Both enzymes also require the S-adenosylmethione-dependent formation of (m1)G37 in the anticodon loop for efficient aminoacylation. We further report a new, highly sensitive assay to measure the activity of SepCysS under anaerobic conditions. With this approach, we demonstrate that SepCysS functions as a multiple-turnover catalyst with kinetic behavior similar to bacterial selenocysteine synthase and the archaeal/ eukaryotic SepSecS enzyme. Together, these data suggest that both metabolic routes and all three tRNA(Cys) species in M. mazei play important roles in the cellular physiology of the organism.	[Hauenstein, Scott I.; Perona, John J.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Perona, John J.] Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Perona, JJ (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	perona@chem.ucsb.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063713] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63713] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambrogelly A, 2004, CELL MOL LIFE SCI, V61, P2437, DOI 10.1007/s00018-004-4194-9; Ashraf SS, 1999, RNA, V5, P503, DOI 10.1017/S1355838299981931; Bailly M, 2007, MOL CELL, V28, P228, DOI 10.1016/j.molcel.2007.08.017; BARE L, 1983, NATURE, V305, P554, DOI 10.1038/305554a0; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Deppenmeier U, 2002, PROG NUCLEIC ACID RE, V71, P223, DOI 10.1016/S0079-6603(02)71045-3; DIX DB, 1986, J BIOL CHEM, V261, P112; Ehlers C, 2005, MOL GENET GENOMICS, V273, P290, DOI 10.1007/s00438-005-1128-7; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; Fukunaga R, 2007, J MOL BIOL, V370, P128, DOI 10.1016/j.jmb.2007.04.050; Fukunaga R, 2007, NAT STRUCT MOL BIOL, V14, P272, DOI 10.1038/nsmb1219; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Ganichkin OM, 2008, J BIOL CHEM, V283, P5849, DOI 10.1074/jbc.M709342200; Hauenstein SI, 2008, J BIOL CHEM, V283, P21997, DOI 10.1074/jbc.M801838200; HIPPE H, 1979, P NATL ACAD SCI USA, V76, P494, DOI 10.1073/pnas.76.1.494; Hohn MJ, 2006, P NATL ACAD SCI USA, V103, P18095, DOI 10.1073/pnas.0608762103; HOU YM, 1993, P NATL ACAD SCI USA, V90, P6776, DOI 10.1073/pnas.90.14.6776; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; KOMATSOULIS GA, 1993, BIOCHEMISTRY-US, V32, P7435, DOI 10.1021/bi00080a014; Kruger MK, 1998, J MOL BIOL, V284, P609, DOI 10.1006/jmbi.1998.2197; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P53; Madore E, 1999, EUR J BIOCHEM, V266, P1128, DOI 10.1046/j.1432-1327.1999.00965.x; Maeder DL, 2006, J BACTERIOL, V188, P7922, DOI 10.1128/JB.00810-06; Major TA, 2004, FEMS MICROBIOL LETT, V239, P117, DOI 10.1016/j.femsle.2004.08.027; MARKHAM GD, 1980, J BIOL CHEM, V255, P9082; MILHARA H, 2002, APPL MICROBIOL BIOT, V60, P12; Mino K, 2003, J BACTERIOL, V185, P2277, DOI 10.1128/JB.185.7.2277-2284.2003; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; O'Donoghue P, 2005, P NATL ACAD SCI USA, V102, P19003, DOI 10.1073/pnas.0509617102; Oda Y, 2005, J MOL BIOL, V351, P334, DOI 10.1016/j.jmb.2005.05.064; PUTZ J, 1994, NAT STRUCT BIOL, V1, P580, DOI 10.1038/nsb0994-580; ROGERS KC, 1993, BIOCHEMISTRY-US, V32, P14210, DOI 10.1021/bi00214a021; Sakurai M, 2005, NUCLEIC ACIDS RES, V33, P1653, DOI 10.1093/nar/gki309; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Senger B, 1997, BIOCHEMISTRY-US, V36, P8269, DOI 10.1021/bi970206l; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; SOWERS KR, 1995, ARCHAEA LAB MANUAL, P38; Tormay P, 1998, EUR J BIOCHEM, V254, P655, DOI 10.1046/j.1432-1327.1998.2540655.x; WADA H, 1961, J BIOL CHEM, V236, P2089; WICH G, 1986, NUCLEIC ACIDS RES, V14, P2459, DOI 10.1093/nar/14.6.2459; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; Zhang CM, 2008, NAT STRUCT MOL BIOL, V15, P507, DOI 10.1038/nsmb.1423; Zhou XZ, 1999, BIOCHEMISTRY-US, V38, P311, DOI 10.1021/bi981455s	52	33	34	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22007	22017		10.1074/jbc.M801839200	http://dx.doi.org/10.1074/jbc.M801839200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18559341	Green Published, hybrid			2022-12-25	WOS:000258114700020
J	Losin, EAR; Russell, JL; Freeman, H; Meguerditchian, A; Hopkins, WD				Losin, Elizabeth A. Reynolds; Russell, Jamie L.; Freeman, Hani; Meguerditchian, Adrien; Hopkins, William D.			Left Hemisphere Specialization for Oro-Facial Movements of Learned Vocal Signals by Captive Chimpanzees	PLOS ONE			English	Article							SPECIES-SPECIFIC VOCALIZATIONS; ORIENTING ASYMMETRIES; FACIAL EXPRESSION; CEREBRAL LATERALIZATION; NEURAL LATERALIZATION; JAPANESE MACAQUES; RHESUS-MONKEYS; COMMUNICATION; HANDEDNESS; DOMINANCE	Background: The left hemisphere of the human brain is dominant in the production of speech and signed language. Whether similar lateralization of function for communicative signal production is present in other primates remains a topic of considerable debate. In the current study, we examined whether oro-facial movements associated with the production of learned attention-getting sounds are differentially lateralized compared to facial expressions associated with the production of species-typical emotional vocalizations in chimpanzees. Methodology/Principal Findings: Still images captured from digital video were used to quantify oro-facial asymmetries in the production of two attention-getting sounds and two species-typical vocalizations in a sample of captive chimpanzees. Comparisons of mouth asymmetries during production of these sounds revealed significant rightward biased asymmetries for the attention-getting sounds and significant leftward biased asymmetries for the species-typical sounds. Conclusions/Significance: These results suggest that the motor control of oro-facial movements associated with the production of learned sounds is lateralized to the left hemisphere in chimpanzees. Furthermore, the findings suggest that the antecedents for lateralization of human speech may have been present in the common ancestor of chimpanzees and humans similar to 5 mya and are not unique to the human lineage.	[Losin, Elizabeth A. Reynolds; Russell, Jamie L.; Freeman, Hani; Meguerditchian, Adrien; Hopkins, William D.] Yerkes Natl Primate Res Ctr, Div Psychobiol, Atlanta, GA USA; [Hopkins, William D.] Agnes Scott Coll, Dept Psychol, Decatur, GA USA; [Losin, Elizabeth A. Reynolds] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA USA	University of California System; University of California Los Angeles	Losin, EAR (corresponding author), Yerkes Natl Primate Res Ctr, Div Psychobiol, Atlanta, GA USA.	whopkin@emory.edu	Meguerditchian, Adrien/H-3047-2013; Meguerditchian, Adrien/AAB-6367-2022	Meguerditchian, Adrien/0000-0003-3754-6747; Meguerditchian, Adrien/0000-0003-3754-6747	NIH [NS-36605, NS-42867, HD-38105, HD-56232]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036605, R01NS042867] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This was was supported by NIH grants NS-36605, NS-42867, HD-38105 and HD-56232.	BAUER RH, 1993, PSYCHOBIOLOGY, V21, P243; Boesch C, 2000, CHIMPANZEES TAI FORE; Borod JC, 1997, NEUROPSYCHOL REV, V7, P41, DOI 10.1007/BF02876972; Boye M, 2005, EUR J NEUROSCI, V21, P1727, DOI 10.1111/j.1460-9568.2005.04005.x; Bradshaw John., 1998, HUMAN EVOLUTION NEUR; Cartmill EA, 2007, CURR BIOL, V17, P1345, DOI 10.1016/j.cub.2007.06.069; Corballis MC, 2002, HAND MOUTH ORIGINS L; Corina DP, 1999, LANG SPEECH, V42, P307, DOI 10.1177/00238309990420020801; Crow T, 2004, LATERALITY, V9, P233, DOI 10.1080/13576500342000374; Davidson Richard J., 1995, P361; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Fernandez-Carriba S, 2002, NEUROPSYCHOLOGIA, V40, P1523, DOI 10.1016/S0028-3932(02)00028-3; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; FOUNDAS AL, 1995, ARCH NEUROL-CHICAGO, V52, P501, DOI 10.1001/archneur.1995.00540290091023; George I, 2004, BEHAV NEUROSCI, V118, P597, DOI 10.1037/0735-7044.118.3.597; Ghazanfar AA, 1999, TRENDS COGN SCI, V3, P377, DOI 10.1016/S1364-6613(99)01379-0; Ghazanfar AA, 2001, BRAIN BEHAV EVOLUT, V58, P163, DOI 10.1159/000047270; Gil-da-Costa R, 2006, P ROY SOC B-BIOL SCI, V273, P2313, DOI 10.1098/rspb.2006.3580; Goodall J., 1986, CHIMPANZEES GOMBE PA; GRAVES R, 1990, INT J PSYCHOL, V25, P179, DOI 10.1080/00207599008247856; GRAVES R, 1982, NEUROPSYCHOLOGIA, V20, P371, DOI 10.1016/0028-3932(82)90037-9; Hauser M.D., 1999, DESIGN ANIMAL COMMUN; Hauser MD, 1998, ANIM BEHAV, V56, P41, DOI 10.1006/anbe.1998.0738; HAUSER MD, 1994, P NATL ACAD SCI USA, V91, P3946, DOI 10.1073/pnas.91.9.3946; HAUSER MD, 1993, SCIENCE, V261, P475, DOI 10.1126/science.8332914; Hausmann M, 1998, NEUROPSYCHOLOGIA, V36, P1397, DOI 10.1016/S0028-3932(98)00027-X; HEFFNER HE, 1984, SCIENCE, V226, P75, DOI 10.1126/science.6474192; Hellige J. B., 1993, HEMISPHERIC ASYMMETR; Holowka S, 2002, SCIENCE, V297, P1515, DOI 10.1126/science.1074941; Hook-Costigan MA, 1998, NEUROPSYCHOLOGIA, V36, P1265, DOI 10.1016/S0028-3932(98)00037-2; Hopkins WD, 2005, PSYCHOL SCI, V16, P487; Hopkins WD, 2004, NEUROPSYCHOLOGIA, V42, P990, DOI 10.1016/j.neuropsychologia.2003.11.017; HOPKINS WD, 2007, EVOUTION HEMISPHERIC; HOPKINS WD, 2003, PRIMATE PSYCHOL; Hopkins WD, 2007, ANIM BEHAV, V73, P281, DOI 10.1016/j.anbehav.2006.08.004; Hostetter AB, 2001, J COMP PSYCHOL, V115, P337, DOI 10.1037//0735-7036.115.4.337; Hostetter AB, 2007, ANIM COGN, V10, P55, DOI 10.1007/s10071-006-0031-x; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; JURGENS U, 1995, CURRENT TOPICS IN PRIMATE VOCAL COMMUNICATION, P199; Kay RF, 1998, P NATL ACAD SCI USA, V95, P5417, DOI 10.1073/pnas.95.9.5417; Kimura D., 1993, NEUROMOTOR MECH HUMA; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Leavens DA, 2004, ANIM BEHAV, V67, P467, DOI 10.1016/j.anbehav.2003.04.007; Liebal K, 2004, INTERACT STUD, V5, P199, DOI 10.1075/is.5.2.03lie; Liebesman S, 2003, QUAL PROG, V36, P62; Marshall AJ, 1999, ANIM BEHAV, V58, P825, DOI 10.1006/anbe.1999.1219; McGrew WC, 1997, YEARB PHYS ANTHROPOL, V40, P201; Meador KJ, 1999, NEUROLOGY, V53, P2028, DOI 10.1212/WNL.53.9.2028; Meguerditchian A, 2006, BEHAV BRAIN RES, V171, P170, DOI 10.1016/j.bbr.2006.03.018; Nottebohm F, 1999, DESIGN OF ANIMAL COMMUNICATION, P63; PETERSEN MR, 1984, BEHAV NEUROSCI, V98, P779, DOI 10.1037/0735-7044.98.5.779; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Provins KA, 1997, PSYCHOL REV, V104, P554, DOI 10.1037/0033-295X.104.3.554; Rasmussen T, 1977, Ann N Y Acad Sci, V299, P355, DOI 10.1111/j.1749-6632.1977.tb41921.x; Rogers L, 1993, EVOLUTION LATERAL AS; Rogers LJ., 2002, COMP VERTEBRATE LATE; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Shafer Dulce D., 1993, P267; Sherwood CC, 2005, ANAT REC PART A, V287A, P1067, DOI 10.1002/ar.a.20259; Sherwood CC, 2003, ANN NY ACAD SCI, V1000, P99, DOI 10.1196/annals.1280.016; Sherwood CC, 2005, J HUM EVOL, V48, P45, DOI 10.1016/j.jhevol.2004.10.003; Suthers RA, 1999, DESIGN OF ANIMAL COMMUNICATION, P37; TAGLIALATELA JP, 2004, THESIS GEORGIA STATE, P103; TAGLIALATELA JP, 2007, EVOLUTION HEMISPHERI; Teufel C, 2007, ANIM BEHAV, V73, P249, DOI 10.1016/j.anbehav.2006.04.011; Theall Laura A., 1999, Animal Cognition, V2, P207, DOI 10.1007/s100710050041; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; WILLIAMS H, 1992, J NEUROBIOL, V23, P1006, DOI 10.1002/neu.480230807	69	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2529	10.1371/journal.pone.0002529	http://dx.doi.org/10.1371/journal.pone.0002529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IK	18575610	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288000044
J	Dahiya, N; Sherman-Baust, CA; Wang, TL; Davidson, B; Shih, IM; Zhang, YQ; Wood, W; Becker, KG; Morin, PJ				Dahiya, Neetu; Sherman-Baust, Cheryl A.; Wang, Tian-Li; Davidson, Ben; Shih, Ie-Ming; Zhang, Yongqing; Wood, William, III; Becker, Kevin G.; Morin, Patrice J.			MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer	PLOS ONE			English	Article							HUMAN LUNG CANCERS; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; GENE-EXPRESSION; RISK-FACTORS; MICROARRAY; PROFILES; SURVIVAL; LET-7; DEREGULATION	Background: MicroRNAs (miRNAs) represent a class of small non-coding RNAs that control gene expression by targeting mRNAs and triggering either translation repression or RNA degradation. Emerging evidence suggests the potential involvement of altered regulation of miRNA in the pathogenesis of cancers, and these genes are thought to function as both tumor suppressors and oncogenes. Methodology/Principal Findings: Using microRNA microarrays, we identify several miRNAs aberrantly expressed in human ovarian cancer tissues and cell lines. miR-221 stands out as a highly elevated miRNA in ovarian cancer, while miR-21 and several members of the let-7 family are found downregulated. Public databases were used to reveal potential targets for the highly differentially expressed miRNAs. In order to experimentally identify transcripts whose stability may be affected by the differentially expressed miRNAs, we transfected precursor miRNAs into human cancer cell lines and used oligonucleotide microarrays to examine changes in the mRNA levels. Interestingly, there was little overlap between the predicted and the experimental targets or pathways, or between experimental targets/pathways obtained using different cell lines, highlighting the complexity of miRNA target selection. Conclusion/Significance: Our results identify several differentially expressed miRNAs in ovarian cancer and identify potential target transcripts that may be regulated by these miRNAs. These miRNAs and their targets may have important roles in the initiation and development of ovarian cancer.	[Dahiya, Neetu; Sherman-Baust, Cheryl A.; Morin, Patrice J.] Hopkins Med Inst, Cellular & Mol Biol Lab, Baltimore, MD USA; [Wang, Tian-Li; Shih, Ie-Ming; Morin, Patrice J.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD USA; [Davidson, Ben] Norwegian Radium Hosp, Oslo, Norway; [Zhang, Yongqing; Wood, William, III; Becker, Kevin G.] NIA, Res Resource Branch, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University of Oslo; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Dahiya, N (corresponding author), Hopkins Med Inst, Cellular & Mol Biol Lab, Baltimore, MD USA.	morinp@grc.nia.nih.gov	sdsd, shihieih/ABE-6190-2020; Dahiya, Neetu/E-5208-2011	Becker, Kevin/0000-0002-6794-6656	Intramural Research Program of the NIH, National Institute on Aging.; NATIONAL INSTITUTE ON AGING [Z01AG000398, ZIAAG000398, ZICAG000616, Z01AG000616, Z01AG000512] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the NIH, National Institute on Aging.	Akao Y, 2007, DNA CELL BIOL, V26, P311, DOI 10.1089/dna.2006.0550; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bottoni A, 2007, J CELL PHYSIOL, V210, P370, DOI 10.1002/jcp.20832; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; FRANKEL LB, 2007, J BIOL CHEM; GIANNAKAKIS A, 2007, CANC BIOL THER, V7; Gregoire L, 1998, IN VITRO CELL DEV-AN, V34, P636; HAYASHITA Y, 2005, CANCER RES, V65, P9628, DOI [DOI 10.1158/0008-5472.CAN-05-2352, 10.1158/0008-5472.CAN-05-2352]; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Joshi MBM, 2005, CLIN CANCER RES, V11, P2215; Kitada T, 2003, HISTOPATHOLOGY, V43, P550, DOI 10.1111/j.1365-2559.2003.01733.x; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michael MZ, 2003, MOL CANCER RES, V1, P882; NAKAJIMA T, 1995, CARCINOGENESIS, V16, P707, DOI 10.1093/carcin/16.4.707; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rangel LBA, 2003, CLIN CANCER RES, V9, P2567; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; VASUDEVAN S, 2007, SCIENCE; VISONE R, 2007, ONCOGENE; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	51	288	310	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2436	10.1371/journal.pone.0002436	http://dx.doi.org/10.1371/journal.pone.0002436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560586	Green Published, Green Submitted, gold			2022-12-25	WOS:000263280700021
J	Haslam, NJ; Whiteford, NE; Weber, G; Prugel-Bennett, A; Essex, JW; Neylon, C				Haslam, Niall J.; Whiteford, Nava E.; Weber, Gerald; Prugel-Bennett, Adam; Essex, Jonathan W.; Neylon, Cameron			Optimal Probe Length Varies for Targets with High Sequence Variation: Implications for Probe Library Design for Resequencing Highly Variable Genes	PLOS ONE			English	Article								Background: Sequencing by hybridisation is an effective method for obtaining large amounts of DNA sequence information at low cost. The efficiency of SBH depends on the design of the probe library to provide the maximum information for minimum cost. Long probes provide a higher probability of non-repeated sequences but lead to an increase in the number of probes required whereas short probes may not provide unique sequence information due to repeated sequences. We have investigated the effect of probe length, use of reference sequences, and thermal filtering on the design of probe libraries for several highly variable target DNA sequences. Results: We designed overlapping probe libraries for a range of highly variable drug target genes based on known sequence information and develop a formal terminology to describe probe library design. We find that for some targets these libraries can provide good coverage of a previously unseen target whereas for others the coverage is less than 30%. The optimal probe length varies from as short at 12 nt to as large as 19 nt and depends on the sequence, its variability, and the stringency of thermal filtering. It cannot be determined from inspection of an example gene sequence. Conclusions: Optimal probe length and the optimal number of reference sequences used to design a probe library are highly target specific for highly variable sequencing targets. The optimum design cannot be determined simply by inspection of input sequences or of alignments but only by detailed analysis of the each specific target. For highly variable sequences, shorter probes can in some cases provide better information than longer probes. Probe library design would benefit from a general purpose tool for analysing these issues. The formal terminology developed here and the analysis approaches it is used to describe will contribute to the development of such tools.	[Haslam, Niall J.; Whiteford, Nava E.; Weber, Gerald; Essex, Jonathan W.; Neylon, Cameron] Univ Southampton, Sch Chem, Southampton, Hants, England; [Weber, Gerald] Univ Federal Ouro Preto, Inst Ciencias Exatas Biol, Dept Fisica, Ouro Preto, Brazil; [Prugel-Bennett, Adam] Univ Southampton, Sch Engn Comp Sci, Southampton, Hants, England; [Neylon, Cameron] STFC Rutherford Appleton Lab, Harwell Sci & Innovat Campus, Didcot, Oxon, England	University of Southampton; Universidade Federal de Ouro Preto; University of Southampton; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Haslam, NJ (corresponding author), Univ Southampton, Sch Chem, Southampton, Hants, England.	haslam@embl.de	Essex, Jonathan/B-8341-2009; Weber, Gerald/A-8669-2010	Weber, Gerald/0000-0002-2935-1571; Haslam, Niall/0000-0001-7007-5137; Neylon, Cameron/0000-0002-0068-716X	Research Councils UK through the Basic Technology Programme	Research Councils UK through the Basic Technology Programme	The work was funded by the Research Councils UK through the Basic Technology Programme.	Blazewicz J, 2004, COMPUT BIOL CHEM, V28, P11, DOI 10.1016/j.compbiolchem.2003.12.002; Chan EY, 2005, MUTAT RES-FUND MOL M, V573, P13, DOI 10.1016/j.mrfmmm.2005.01.004; Chou CC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-232; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Drmanac Radoje, 2002, Adv Biochem Eng Biotechnol, V77, P75; Fedrigo O, 2004, NUCLEIC ACIDS RES, V32, P1208, DOI 10.1093/nar/gkh210; Gunderson KL, 1998, GENOME RES, V8, P1142, DOI 10.1101/gr.8.11.1142; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Koehler RT, 2005, BIOINFORMATICS, V21, P3333, DOI 10.1093/bioinformatics/bti530; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Lee I, 2004, NUCLEIC ACIDS RES, V32, P681, DOI 10.1093/nar/gkh196; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Mullins JI, 2006, CURR TOP MICROBIOL, V299, P171; Reeves JD, 2005, DRUGS, V65, P1747, DOI 10.2165/00003495-200565130-00002; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Topol EJ, 2007, NAT GENET, V39, P439, DOI 10.1038/ng0407-439; van Dam RM, 2002, GENOME RES, V12, P145, DOI 10.1101/gr.198901; WANG Z, 2002, EMERG INFECT DIS, V19, P402; Weber G, 2006, NAT PHYS, V2, P55, DOI 10.1038/nphys189; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170	21	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2500	10.1371/journal.pone.0002500	http://dx.doi.org/10.1371/journal.pone.0002500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18563203	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000263280700058
J	Hemminki, K; Forsti, A; Bermejo, JL				Hemminki, Kari; Foersti, Asta; Bermejo, Justo Lorenzo			The 'Common Disease-Common Variant' Hypothesis and Familial Risks	PLOS ONE			English	Article								The recent large genotyping studies have identified a new repertoire of disease susceptibility loci of unknown function, characterized by high allele frequencies and low relative risks, lending support to the common disease-common variant (CDCV) hypothesis. The variants explain a much larger proportion of the disease etiology, measured by the population attributable fraction, than of the familial risk. We show here that if the identified polymorphisms were markers of rarer functional alleles they would explain a much larger proportion of the familial risk. For example, in a plausible scenario where the marker is 10 times more common than the causative allele, the excess familial risk of the causative allele is over 10 times higher than that of the marker allele. However, the population attributable fractions of the two alleles are equal. The penetrance mode of the causative locus may be very difficult to deduce from the apparent penetrance mode of the marker locus.	[Hemminki, Kari; Foersti, Asta; Bermejo, Justo Lorenzo] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Hemminki, Kari; Foersti, Asta] Karolinska Inst, Ctr Family & Community Med, Huddinge, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); Karolinska Institutet	Hemminki, K (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.	k.hemminki@dkfz.de		Lorenzo Bermejo, Justo/0000-0002-6568-5333	Deutsche Krebshilfe; Swedish Cancer Society; Swedish Council for Working Life and Social Research; EU [LSHC-CT-2004-503465]; BMBF; NGFN plus [FOOD-CT-2005-016320]	Deutsche Krebshilfe(Deutsche Krebshilfe); Swedish Cancer Society(Swedish Cancer Society); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); EU(European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); NGFN plus	Supported by Deutsche Krebshilfe, the Swedish Cancer Society, The Swedish Council for Working Life and Social Research and the EU, LSHC-CT-2004-503465, BMBF through NGFN plus and FOOD-CT-2005-016320. The financers have not influenced the contents of the paper nor yet seen it.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHANOCK S, 2008, NATURE E PUB; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; HEMMINKI K, 2008, MUTAT RES REV E PUB; HEMMINKI K, 2008, BREAST CANC RES TREA; Hemminki K, 2007, CARCINOGENESIS, V28, P648, DOI 10.1093/carcin/bgl182; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Hernminki K, 2008, MUTAT RES-REV MUTAT, V658, P42, DOI 10.1016/j.mrrev.2007.07.001; Lewis CM, 2007, J MED GENET, V44, P689, DOI 10.1136/jmg.2007.051672; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Xu SZ, 2003, GENETICS, V165, P2259; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	24	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2504	10.1371/journal.pone.0002504	http://dx.doi.org/10.1371/journal.pone.0002504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560565	gold, Green Published, Green Submitted			2022-12-25	WOS:000263280700060
J	Kuhn, I; Harden, P; Bauzon, M; Chartier, C; Nye, J; Thorne, S; Reid, T; Ni, SH; Lieber, A; Fisher, K; Seymour, L; Rubanyi, GM; Harkins, RN; Hermiston, TW				Kuhn, Irene; Harden, Paul; Bauzon, Maxine; Chartier, Cecile; Nye, Julie; Thorne, Steve; Reid, Tony; Ni, Shaoheng; Lieber, Andre; Fisher, Kerry; Seymour, Len; Rubanyi, Gabor M.; Harkins, Richard N.; Hermiston, Terry W.			Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer	PLOS ONE			English	Article								Background: Viral-mediated oncolysis is a novel cancer therapeutic approach with the potential to be more effective and less toxic than current therapies due to the agents selective growth and amplification in tumor cells. To date, these agents have been highly safe in patients but have generally fallen short of their expected therapeutic value as monotherapies. Consequently, new approaches to generating highly potent oncolytic viruses are needed. To address this need, we developed a new method that we term "Directed Evolution'' for creating highly potent oncolytic viruses. Methodology/Principal Findings: Taking the "Directed Evolution'' approach, viral diversity was increased by pooling an array of serotypes, then passaging the pools under conditions that invite recombination between serotypes. These highly diverse viral pools were then placed under stringent directed selection to generate and identify highly potent agents. ColoAd1, a complex Ad3/Ad11p chimeric virus, was the initial oncolytic virus derived by this novel methodology. ColoAd1, the first described non-Ad5-based oncolytic Ad, is 2-3 logs more potent and selective than the parent serotypes or the most clinically advanced oncolytic Ad, ONYX-015, in vitro. ColoAd1's efficacy was further tested in vivo in a colon cancer liver metastasis xenograft model following intravenous injection and its ex vivo selectivity was demonstrated on surgically-derived human colorectal tumor tissues. Lastly, we demonstrated the ability to arm ColoAd1 with an exogenous gene establishing the potential to impact the treatment of cancer on multiple levels from a single agent. Conclusions/Significance: Using the "Directed Evolution'' methodology, we have generated ColoAd1, a novel chimeric oncolytic virus. In vitro, this virus demonstrated a >2 log increase in both potency and selectivity when compared to ONYX-015 on colon cancer cells. These results were further supported by in vivo and ex vivo studies. Furthermore, these results have validated this methodology as a new general approach for deriving clinically-relevant, highly potent anti-cancer virotherapies.	[Kuhn, Irene; Harden, Paul; Bauzon, Maxine; Chartier, Cecile; Nye, Julie; Rubanyi, Gabor M.; Harkins, Richard N.; Hermiston, Terry W.] Bayer Healthcare, Novel Technol, Richmond, CA USA; [Thorne, Steve; Reid, Tony] Stanford Univ, Palo Alto Vet Hosp, Palo Alto, CA USA; [Ni, Shaoheng; Lieber, Andre] Univ Washington, Dept Med, Div Med Genet, Seattle, WA USA; [Fisher, Kerry; Seymour, Len] Hybrid syst Ltd, Oxford, England	Bayer AG; Bayer Healthcare Pharmaceuticals; Stanford University; University of Washington; University of Washington Seattle	Kuhn, I (corresponding author), Bayer Healthcare, Novel Technol, Richmond, CA USA.	Terry.Hermiston@Bayer.com		Lieber, Andre/0000-0001-6742-6266; seymour, len/0000-0003-3825-0841	Bayer Healthcare Pharmaceutics	Bayer Healthcare Pharmaceutics	These studies were supported in their entirety by Bayer Healthcare Pharmaceutics.	Araujo RP, 2007, NAT REV DRUG DISCOV, V6, P871, DOI 10.1038/nrd2381; Bernal RM, 2002, CLIN CANCER RES, V8, P1915; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; Boyd KE, 1997, MOL CELL BIOL, V17, P2529, DOI 10.1128/MCB.17.5.2529; Branton PE, 2001, ONCOGENE, V20, P7855, DOI 10.1038/sj.onc.1204862; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Dingli D, 2003, J CELL BIOCHEM, V90, P1079, DOI 10.1002/jcb.10714; Doronin K, 2000, J VIROL, V74, P6147, DOI 10.1128/JVI.74.13.6147-6155.2000; Duque PM, 1999, CANCER GENE THER, V6, P554, DOI 10.1038/sj.cgt.7700077; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; Freytag SO, 2002, CANCER RES, V62, P4968; Fuxe J, 2003, INT J CANCER, V103, P723, DOI 10.1002/ijc.10891; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Gambhir SS, 2000, NEOPLASIA, V2, P118, DOI 10.1038/sj.neo.7900083; Garber K, 2006, J NATL CANCER I, V98, P298, DOI 10.1093/jnci/djj111; Geoerger B, 2003, BRIT J CANCER, V89, P577, DOI 10.1038/sj.bjc.6601102; Hann Christine L, 2007, Curr Treat Options Oncol, V8, P28, DOI 10.1007/s11864-007-0024-2; Hawkins LK, 2001, GENE THER, V8, P1123, DOI 10.1038/sj.gt.3301507; Hermiston T, 2000, J CLIN INVEST, V105, P1169, DOI 10.1172/JCI9973; Hermiston T, 2002, CURR OPIN MOL THER, V4, P334; Hermiston TW, 2002, CANCER GENE THER, V9, P1022, DOI 10.1038/sj.cgt.7700542; Holterman L, 2004, J VIROL, V78, P13207, DOI 10.1128/JVI.78.23.13207-13215.2004; Jee YS, 2002, ANTICANCER RES, V22, P2629; Jin F, 2005, MOL THER, V12, P1052, DOI 10.1016/j.ymthe.2005.07.696; Kanerva A, 2005, GENE THER, V12, P87, DOI 10.1038/sj.gt.3302387; Khuri FR, 2000, NAT MED, V6, P879, DOI 10.1038/78638; Kim M, 2003, BRIT J CANCER, V88, P1411, DOI 10.1038/sj.bjc.6600932; Kirn D, 2001, EXPERT OPIN BIOL TH, V1, P525, DOI 10.1517/14712598.1.3.525; KLEINBERGER T, 1993, J VIROL, V67, P7556, DOI 10.1128/JVI.67.12.7556-7560.1993; Kretschmer PJ, 2005, MOL THER, V12, P118, DOI 10.1016/j.ymthe.2005.03.019; Kuhn I, 2007, GENE THER, V14, P180, DOI 10.1038/sj.gt.3302851; Lamfers MLM, 2002, CANCER RES, V62, P5736; Li ZY, 2004, MOL THER, V9, P650, DOI 10.1016/j.ymthe.2004.01.021; Mathis JM, 2005, ONCOGENE, V24, P7775, DOI 10.1038/sj.onc.1209044; MCDOUGALL I, 1987, J GEN VIROL, V68, P1361, DOI 10.1099/0022-1317-68-5-1361; Mei YF, 2003, J GEN VIROL, V84, P2061, DOI 10.1099/vir.0.19178-0; Mel YF, 1998, VIROLOGY, V240, P254, DOI 10.1006/viro.1997.8904; Mi J, 2001, HUM GENE THER, V12, P1343, DOI 10.1089/104303401750270995; Miller CR, 1998, CANCER RES, V58, P5738; Molnar-Kimber KL, 1998, HUM GENE THER, V9, P2121, DOI 10.1089/hum.1998.9.14-2121; Okegawa T, 2000, CANCER RES, V60, P5031; Parato KA, 2005, NAT REV CANCER, V5, P965, DOI 10.1038/nrc1750; Peng KW, 2002, NAT MED, V8, P527, DOI 10.1038/nm0502-527; Phuong LK, 2003, CANCER RES, V63, P2462; Reid T, 2002, CANCER GENE THER, V9, P979, DOI 10.1038/sj.cgt.7700539; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Rogulski KR, 2000, HUM GENE THER, V11, P67, DOI 10.1089/10430340050016166; ROSA DD, 2007, CANC TREAT REV; Sachs MD, 2002, UROLOGY, V60, P531, DOI 10.1016/S0090-4295(02)01748-X; Sauthoff H, 2000, HUM GENE THER, V11, P379, DOI 10.1089/10430340050015851; Sauthoff H, 2002, HUM GENE THER, V13, P1859, DOI 10.1089/104303402760372954; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Shabram PW, 1997, HUM GENE THER, V8, P453, DOI 10.1089/hum.1997.8.4-453; Stone D, 2005, J VIROL, V79, P5090, DOI 10.1128/JVI.79.8.5090-5104.2005; Stone D, 2003, VIROLOGY, V309, P152, DOI 10.1016/S0042-6822(02)00085-5; TOLLEFSON A, 1999, ADENOVIRUS METHODS P; van Beusechem VW, 2002, CANCER RES, V62, P6165; Yan W, 2003, J VIROL, V77, P2640, DOI 10.1128/JVI.77.4.2640-2650.2003; YIP MCM, 1970, J BIOL CHEM, V245, P2199; Yu DC, 2002, CURR OPIN MOL THER, V4, P435; Zeimet AG, 2002, GENE THER, V9, P1093, DOI 10.1038/sj.gt.3301775	61	130	150	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2409	10.1371/journal.pone.0002409	http://dx.doi.org/10.1371/journal.pone.0002409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560559	gold, Green Published, Green Submitted			2022-12-25	WOS:000263280700005
J	Lynn, FC; Sanchez, L; Gomis, R; German, MS; Gasa, R				Lynn, Francis C.; Sanchez, Lidia; Gomis, Ramon; German, Michael S.; Gasa, Rosa			Identification of the bHLH Factor Math6 as a Novel Component of the Embryonic Pancreas Transcriptional Network	PLOS ONE			English	Article								Background: Basic helix-loop-helix (bHLH) transcription factors play important roles in differentiation processes during embryonic development of vertebrates. In the pancreas, the atonal-related bHLH gene Neurogenin3 (Neurog3) controls endocrine cell fate specification in uncommitted progenitor cells. Therefore, it is likely that Neurog3-regulated factors will have important functions during pancreatic endocrine cell differentiation. The gene for the atonal-related bHLH factor Math6 was recognized as a potential target of Neurog3 in a genomic scale profiling during endocrine differentiation. Herein we have explored the role of Math6 during endocrine pancreas development. Results: We demonstrate that the Math6 gene is a direct target of Neurog3 in vitro and that, during mouse development, Math6 is expressed in both endocrine and exocrine pancreatic precursor cells. We have investigated the role of Math6 in endocrine differentiation by over-expressing this factor in pancreatic duct cells. Math6 possesses intrinsic transcriptional repressor activity and, in contrast to Neurog3 it does not induce the endocrine differentiation program; however, it can modulate some of the pro-endocrine functions of Neurog3 in this system. In addition, we show that Math6 is broadly expressed in mouse embryonic tissues and its expression is induced by tissue-specific bHLH genes other than Neurog3. Furthermore, inactivation of the Math6 gene in the mouse results in early embryonic lethality demonstrating an essential role of this factor in organismal development. Conclusions: These data demonstrate that Math6 is a novel component of the pancreatic transcriptional network during embryonic development and suggest a potential role for Math6 as a modulator of the differentiation program initiated by the pro-endocrine factor Neurog3. Furthermore, our results demonstrate that Math6 is indispensable for early embryonic development and indicate a more widespread function for this factor in tissue-specific differentiation processes that are dependent on class II bHLH genes.	[Lynn, Francis C.; German, Michael S.] Univ Calif San Francisco, Hormone Res Inst, Ctr Diabet, San Francisco, CA 94143 USA; [Sanchez, Lidia; Gomis, Ramon; Gasa, Rosa] Univ Barcelona, Hosp Clin, IDIBAPS, Diabetes & Obesity Lab,Endocrinol & Nutr Unit, Barcelona, Spain; [Gomis, Ramon; Gasa, Rosa] CIBERDEM, Barcelona, Spain; [German, Michael S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of California System; University of California San Francisco	Lynn, FC (corresponding author), Univ Calif San Francisco, Hormone Res Inst, Ctr Diabet, San Francisco, CA 94143 USA.	rgasa@clinic.ub.es		Lynn, Francis/0000-0001-9318-1063	Spanish Ministry of Education and Science [BFU2005-06080, SAF2006-07382]; Larry L. Hillblom Foundation [2007/1B]; National Institutes of Health [R01 DK021344, P30 DK63720]; Juvenile Diabetes Research Foundation [3-2004-276, 10-2007-86]; Ramon y Cajal program from the Ministry of Education and Science of Spain; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021344, P30DK063720] Funding Source: NIH RePORTER	Spanish Ministry of Education and Science(Spanish Government); Larry L. Hillblom Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Ramon y Cajal program from the Ministry of Education and Science of Spain; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from: Spanish Ministry of Education and Science (BFU2005-06080 and SAF2006-07382), Larry L. Hillblom Foundation (2007/1B), National Institutes of Health (R01 DK021344) and cores laboratories supported by the National Institutes of Health (P30 DK63720). FCL is a recipient of Juvenile Diabetes Research Foundation fellowship awards 3-2004-276 & 10-2007-86. RG is a recipient of the Ramon y Cajal program from the Ministry of Education and Science of Spain. CIBER de Diabetes y Enfermedades Metabolicas Asociadas is a ISCIII Project.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Brentrup D, 2000, DEVELOPMENT, V127, P4729; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Farah MH, 2000, DEVELOPMENT, V127, P693; Friedrich C, 2006, AM J PHYSIOL-RENAL, V291, pF856, DOI 10.1152/ajprenal.00196.2005; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Gasa R, 2008, DIFFERENTIATION, V76, P381, DOI 10.1111/j.1432-0436.2007.00228.x; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Liu YH, 2004, MOL CELL BIOL, V24, P2662, DOI 10.1128/MCB.24.7.2662-2672.2004; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Petri A, 2006, J MOL ENDOCRINOL, V37, P301, DOI 10.1677/jme.1.02096; Rose SD, 2001, J BIOL CHEM, V276, P44018, DOI 10.1074/jbc.M106264200; Ross MD, 2006, DEV DYNAM, V235, P3102, DOI 10.1002/dvdy.20934; Rovira M, 2007, CLONING STEM CELLS, V9, P327, DOI 10.1089/clo.2006.0064; Sander M, 2000, DEVELOPMENT, V127, P5533; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Serafimidis I, 2008, STEM CELLS, V26, P3, DOI 10.1634/stemcells.2007-0194; Smith SB, 2004, MOL ENDOCRINOL, V18, P142, DOI 10.1210/me.2003-0037; Smith SB, 2003, J BIOL CHEM, V278, P38254, DOI 10.1074/jbc.M302229200; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Sussel L, 1998, DEVELOPMENT, V125, P2213; Tajbakhsh S, 2000, CURR TOP DEV BIOL, V48, P225; THAYER MJ, 1990, CELL, V63, P23, DOI 10.1016/0092-8674(90)90285-M; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wasserman SM, 2002, PHYSIOL GENOMICS, V12, P13, DOI 10.1152/physiolgenomics.00102.2002; Watada H, 2000, J BIOL CHEM, V275, P34224, DOI 10.1074/jbc.M004981200; Watada H, 2003, J BIOL CHEM, V278, P17130, DOI 10.1074/jbc.M213196200; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; Yang Y, 2003, NAT BIOTECHNOL, V21, P447, DOI 10.1038/nbt803; Zammit PS, 2004, DEV BIOL, V273, P454, DOI 10.1016/j.ydbio.2004.05.038; zur Lage PI, 2004, DEV CELL, V7, P687, DOI 10.1016/j.devcel.2004.09.015	55	33	38	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2430	10.1371/journal.pone.0002430	http://dx.doi.org/10.1371/journal.pone.0002430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560595	gold, Green Published, Green Submitted			2022-12-25	WOS:000263280700015
J	Garcia-Aragoncillo, E; Carrillo, J; Lalli, E; Agra, N; Gomez-Lopez, G; Pestana, A; Alonso, J				Garcia-Aragoncillo, E.; Carrillo, J.; Lalli, E.; Agra, N.; Gomez-Lopez, G.; Pestana, A.; Alonso, J.			DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells	ONCOGENE			English	Article						Ewing's tumors; EWS/FLI1 oncoprotein; DAX1; NR0B1; RNA interference	ADRENAL HYPOPLASIA CONGENITA; NUCLEAR RECEPTOR DAX-1; ETS FUSION PROTEINS; FAMILY TUMORS; DNA-BINDING; GENE; SARCOMA; COREPRESSOR; EXPRESSION; PATHWAYS	The molecular hallmark of the Ewing's family of tumors is the presence of balanced chromosomal translocations, leading to the formation of chimerical transcription factors (that is, EWS/FLI1) that play a pivotal role in the pathogenesis of Ewing's tumors by deregulating gene expression. We have recently demonstrated that DAX1 (NR0B1), an orphan nuclear receptor that was not previously implicated in cancer, is induced by the EWS/FLI1 oncoprotein and is highly expressed in Ewing's tumors, suggesting that DAX1 is a biologically relevant target of EWS/FLI1-mediated oncogenesis. In this study we demonstrate that DAX1 is a direct transcriptional target of the EWS/FLI1 oncoprotein through its binding to a GGAA-rich region in the DAX1 promoter and show that DAX1 is a key player of EWS/FLI1-mediated oncogenesis. DAX1 silencing using an inducible model of RNA interference induces growth arrest in the A673 Ewing's cell line and severely impairs its capability to grow in semisolid medium and form tumors in immuno deficient mice. Gene expression pro. le analysis demonstrated that about 10% of the genes regulated by EWS/FLI1 in Ewing's cells are DAX1 targets, confirming the importance of DAX1 in Ewing's oncogenesis. Functional genomic analysis, validated by quantitative RT-PCR, showed that genes implicated in cell-cycle progression, such as CDK2, CDC6, MCM10 or SKP2 were similarly regulated by EWS/FLI1 and DAX1. These findings indicate that DAX1 is important in the pathogenesis of the Ewing's family of tumors, identify new functions for DAX1 as a cell-cycle progression regulator and open the possibility to new therapeutic approaches based on DAX1 function interference.	[Garcia-Aragoncillo, E.; Carrillo, J.; Agra, N.; Pestana, A.; Alonso, J.] UAM, CSIC, Inst Invest Biomed A Sols, Dept Biol Mol & Celular Canc,Lab Genet & Patol Mo, Madrid 28029, Spain; [Lalli, E.] Univ Nice Sophia Antipolis, CNRS, UMR6097, Inst Pharmacol Mol & Cellulaire, Valbonne, France; [Gomez-Lopez, G.] Hosp Dorrebullon, Fdn Biomed CHUVI, CHU, Vigo, Pontevedra, Spain; [Gomez-Lopez, G.] Ctr Nacl Invest Oncol, Unidad Bioinformat, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Complexo Hospitalario Universitario de Vigo	Alonso, J (corresponding author), UAM, CSIC, Inst Invest Biomed A Sols, Dept Biol Mol & Celular Canc,Lab Genet & Patol Mo, C Arturo Duperier 4, Madrid 28029, Spain.	fjaviera@iib.uam.es	Lalli, Enzo/F-7052-2013; García, Jaime Carrillo/AAC-5144-2020; Gomez-Lopez, Gonzalo/D-9123-2016; Alonso, Javier/B-6012-2013	Lalli, Enzo/0000-0002-0584-5681; Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Alonso, Javier/0000-0002-6287-8391; Carrillo Garcia, Jaime/0000-0002-2861-3015				Altincicek B, 2000, J BIOL CHEM, V275, P7662, DOI 10.1074/jbc.275.11.7662; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; Carrillo J, 2007, CLIN CANCER RES, V13, P2429, DOI 10.1158/1078-0432.CCR-06-1762; Crawford PA, 1998, MOL CELL BIOL, V18, P2949, DOI 10.1128/MCB.18.5.2949; de Alava E, 2000, J CLIN ONCOL, V18, P204, DOI 10.1200/JCO.2000.18.1.204; Ferreira BI, 2008, ONCOGENE, V27, P2084, DOI 10.1038/sj.onc.1210845; Guo WW, 1996, J CLIN ENDOCR METAB, V81, P2481, DOI 10.1210/jc.81.7.2481; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Holter E, 2002, MOL ENDOCRINOL, V16, P515, DOI 10.1210/me.16.3.515; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Kim S, 2006, MOL CELL BIOL, V26, P2467, DOI 10.1128/MCB.26.7.2467-2478.2006; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Kovar H, 2005, SEMIN CANCER BIOL, V15, P189, DOI 10.1016/j.semcancer.2005.01.004; Kovar Heinrich, 1998, Current Opinion in Oncology, V10, P334, DOI 10.1097/00001622-199807000-00010; Lalli E, 2003, MOL ENDOCRINOL, V17, P1445, DOI 10.1210/me.2003-0159; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Nakatani F, 2003, J BIOL CHEM, V278, P15105, DOI 10.1074/jbc.M211470200; Nishimori H, 2002, ONCOGENE, V21, P8302, DOI 10.1038/sj.onc.1206025; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki T, 2002, ENDOCR RES, V28, P537, DOI 10.1081/ERC-120016835; Tamai KT, 1996, MOL ENDOCRINOL, V10, P1561, DOI 10.1210/me.10.12.1561; Tanaka K, 1997, J CLIN INVEST, V99, P239, DOI 10.1172/JCI119152; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; Welford SM, 2001, J BIOL CHEM, V276, P41977, DOI 10.1074/jbc.M106757200; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; Zhang H, 2000, J BIOL CHEM, V275, P39855, DOI 10.1074/jbc.C000567200	36	66	71	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2008	27	46					6034	6043		10.1038/onc.2008.203	http://dx.doi.org/10.1038/onc.2008.203			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	358BO	18591936				2022-12-25	WOS:000259891600006
J	Wang, HW; Liu, PY; Oyama, N; Rikitake, Y; Kitamoto, S; Gitlin, J; Liao, JK; Boisvert, WA				Wang, Hong-Wei; Liu, Ping-Yen; Oyama, Naotsugu; Rikitake, Yoshiyuki; Kitamoto, Shiro; Gitlin, Jonathan; Liao, James K.; Boisvert, William A.			Deficiency of ROCK1 in bone marrow-derived cells protects against atherosclerosis in LDLR-/- mice	FASEB JOURNAL			English	Article						Rho kinase; vascular; foam cell; cell migration	LOW-DENSITY-LIPOPROTEIN; RHO-KINASE INHIBITOR; TRANSENDOTHELIAL MIGRATION; SCAVENGER RECEPTORS; ENDOTHELIAL-CELLS; IN-VIVO; MACROPHAGES; HYPERTROPHY; ACTIVATION; MECHANISM	Rho kinases (ROCKS) are serine-threonine protein kinases that regulate the actin cytoskeleton. Recent studies suggest that ROCKs also play an important role in cardiovascular disease. However, the isoform- and tissue-specific role of ROCKS in mediating this process is unknown. Using homologous recombination, we generated mutant mice harboring alleles with homozygous deletion of ROCK1 (ROCK1(-/-)). Most ROCK1(-/-) mice die perinatally. However, a few ROCK1(-/-) mice survive to adulthood, are phenotypically normal, and have no apparent compensatory changes in ROCK2. Using these ROCK1(-/-) mice, we show that ROCK1 in bone marrow-derived macrophages is critical to the development of atherosclerosis, in part, by mediating foam cell formation and macrophage chemotaxis. Lipid accumulation and atherosclerotic lesions were reduced in atherosclerosis-prone LDLR-/- mice, whose bone marrows have been replaced with bone marrows derived from ROCK1(-/-) mice. Bone marrow-derived ROCK1-deficient macrophages exhibited impaired chemotaxis to monocyte chemotactic protein-1 and showed reduced ability to take up lipids and to develop into foam cells when exposed to modified low-density lipoprotein. These findings indicate that ROCK1 in bone marrow-derived cells is a critical mediator of atherogenesis and suggest that macrophage ROCK1 may be an important therapeutic target for vascular inflammation and atherosclerosis.	Brigham & Womens Hosp, Vasc Med Res Unit, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Liao, JK (corresponding author), Brigham & Womens Hosp, 65 Landsdowne St,Rm 275, Cambridge, MA 02139 USA.	jliao@rics.bwh.harvard.edu			National Institutes of Health [HL-052233, HL-069474]; Asahi-Kasei Pharmaceuticals, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069474, R01HL052233, R01HL080187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Asahi-Kasei Pharmaceuticals, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Daniela Ahl for help with bone marrow transplantation experiments. This study is supported by grants from the National Institutes of Health (HL-052233 to J.K.L. and HL-069474 to WAB.). J.K.L. is it consultant for Asahi-Kasei Pharmaceuticals, Inc.	Abe K, 2004, CIRC RES, V94, P385, DOI 10.1161/01.RES.0000111804.34509.94; Ashida N, 2001, J BIOL CHEM, V276, P16555, DOI 10.1074/jbc.M009068200; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Bolz SS, 2000, CIRCULATION, V102, P2402, DOI 10.1161/01.CIR.102.19.2402; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Essler M, 1999, J BIOL CHEM, V274, P30361, DOI 10.1074/jbc.274.43.30361; Fox R, 2007, EMBO J, V26, P505, DOI 10.1038/sj.emboj.7601522; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; Honing H, 2004, J LEUKOCYTE BIOL, V75, P523, DOI 10.1189/jlb.0203054; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katsumata N, 1997, CIRCULATION, V96, P4357; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu PY, 2007, J AM COLL CARDIOL, V49, P1619, DOI 10.1016/j.jacc.2006.12.043; Mallat Z, 2003, CIRC RES, V93, P884, DOI 10.1161/01.RES.0000099062.55042.9A; Miyata K, 2000, ARTERIOSCL THROM VAS, V20, P2351, DOI 10.1161/01.ATV.20.11.2351; Mukai Yasushi, 2001, FASEB Journal, V15, P1062; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rikitake Y, 2005, CIRCULATION, V112, P2959, DOI 10.1161/CIRCULATIONAHA.105.584623; Rikitake Y, 2005, STROKE, V36, P2251, DOI 10.1161/01.STR.0000181077.84981.11; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Sawada N, 2000, CIRCULATION, V101, P2030, DOI 10.1161/01.CIR.101.17.2030; Seibold S, 2004, J AM SOC NEPHROL, V15, P3026, DOI 10.1097/01.ASN.0000146425.58046.6A; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Simoes RL, 2005, J IMMUNOL, V175, P1843, DOI 10.4049/jimmunol.175.3.1843; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Stroeken PJM, 2006, J CELL PHYSIOL, V208, P620, DOI 10.1002/jcp.20699; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Toshima Y, 2000, STROKE, V31, P2245, DOI 10.1161/01.STR.31.9.2245; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wang YX, 2005, CIRCULATION, V111, P2219, DOI 10.1161/01.CIR.0000163544.17221.BE; Watanabe T, 2005, HYPERTENSION, V46, P738, DOI 10.1161/01.HYP.0000184226.99196.b5; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Wustner D, 2005, TRAFFIC, V6, P396, DOI 10.1111/j.1600-0854.2005.00285.x; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684	52	57	67	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2008	22	10					3561	3570		10.1096/fj.08-108829	http://dx.doi.org/10.1096/fj.08-108829			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18556458	Green Published			2022-12-25	WOS:000259642600018
J	Matsuura, K; Wakasugi, M; Yamashita, K; Matsunaga, T				Matsuura, Kenkyo; Wakasugi, Mitsuo; Yamashita, Katsumi; Matsunaga, Tsukasa			Cleavage-mediated activation of Chk1 during apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2AX PHOSPHORYLATION; DNA-DAMAGE RESPONSE; GENOTOXIC STRESS; SERINE 139; ATR; PATHWAY; CLASPIN; TOPBP1; DEGRADATION; CHECKPOINTS	The Chk1 kinase is highly conserved from yeast to humans and is well known to function in the cell cycle checkpoint induced by genotoxic or replication stress. The activation of Chk1 is achieved by ATR-dependent phosphorylation with the aid of additional factors. Robust genotoxic insults induce apoptosis instead of the cell cycle checkpoint, and some of the components in the ATR-Chk1 pathway are cleaved by active caspases, although it has been unclear whether the attenuation of the ATR-Chk1 pathway has some role in apoptosis induction. Here we show that Chk1 is activated by caspase-dependent cleavage when the cells undergo apoptosis. Treatment of chicken DT40 cells with various genotoxic agents, UV light, etoposide, or camptothecin induced Chk1 cleavage, which was inhibited by a pan-caspase inhibitor, benzyloxycarbonyl-VAD-fluoromethyl ketone. The cleavage of Chk1 was similarly observed in human Jurkat cells treated with a non-genotoxic apoptosis inducer, staurosporine. We have determined the cleavage site(s), Asp-299 in chicken and Asp-299 and Asp- 351 in human cells. We further show that a truncated form of human Chk1 mimicking the N-terminal cleavage fragment (residues 1-299) possesses strikingly elevated kinase activity. Moreover, the ectopic expression of Chk1-(1-299) in human U2OS cells induces abnormal nuclear morphology with localized chromatin condensation and phosphorylation of histone H2AX. These results suggest that Chk1 is activated by caspase-mediated cleavage during apoptosis and might be implicated in enhancing apoptotic reactions rather than attenuating the ATR-Chk1 pathway.	[Matsuura, Kenkyo; Wakasugi, Mitsuo; Yamashita, Katsumi; Matsunaga, Tsukasa] Kanazawa Univ, Grad Sch Nat Sci & Technol, Lab Human Mol Genet, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Matsunaga, T (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Lab Human Mol Genet, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	matsukas@kenroku.kanazawa-u.ac.jp	Wakasugi, Mitsuo/D-8417-2015	Wakasugi, Mitsuo/0000-0001-9593-0566; Matsuura, Kenkyo/0000-0003-4612-6031	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Clarke CAL, 2005, J BIOL CHEM, V280, P35337, DOI 10.1074/jbc.M506460200; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2006, CELL CYCLE, V5, P1265, DOI 10.4161/cc.5.12.2834; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lee MW, 2003, ONCOGENE, V22, P6340, DOI 10.1038/sj.onc.1206729; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; Okita N, 2007, BIOL PHARM BULL, V30, P359, DOI 10.1248/bpb.30.359; Perera D, 2005, CELL DEATH DIFFER, V12, P827, DOI 10.1038/sj.cdd.4401620; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Semple JI, 2007, CELL DEATH DIFFER, V14, P1433, DOI 10.1038/sj.cdd.4402134; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Wakasugi M, 2007, BIOCHEM BIOPH RES CO, V364, P771, DOI 10.1016/j.bbrc.2007.10.063; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	31	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25485	25491		10.1074/jbc.M803111200	http://dx.doi.org/10.1074/jbc.M803111200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18550533	hybrid			2022-12-25	WOS:000259012700044
J	Kahsai, AW; Cui, J; Kaniskan, HU; Garner, PP; Fenteany, G				Kahsai, Alem W.; Cui, Junru; Kaniskan, H. Uemit; Garner, Philip P.; Fenteany, Gabriel			Analogs of tetrahydroisoquinoline natural products that inhibit cell migration and target galectin-3 outside of its carbohydrate-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINOCARCIN ANALOG; WOUND CLOSURE; PROTEIN; ACTIN; DNA; MOVEMENT; CLEAVAGE; MOTILITY; ADHESION; PROTRUSION	Cell migration is central to a number of normal and disease processes. Small organic molecules that inhibit cell migration have potential as both research probes and therapeutic agents. We have identified two tetrahydroisoquinoline natural product analogs with antimigratory activities on Madin-Darby canine kidney epithelial cells: a semisynthetic derivative of quinocarmycin (also known as quinocarcin), DX-52-1, and a more complex synthetic molecule, HUK-921, related to the naphthyridinomycin family. It has been assumed that the cellular effects of reactive tetrahydroisoquinolines result from the alkylation of DNA. We have reported previously that the primary target of DX-52-1 relevant to cell migration appears to be the membrane-cytoskeleton linker protein radixin. Here we extend the analysis of the protein targets of DX-52-1, reporting that the multifunctional carbohydrate-binding protein galectin-3 is a secondary target of DX-52-1 that may also be relevant to the antimigratory effects of both DX-52-1 and HUK-921. All known inhibitors of galectin-3 target its beta-galactoside-binding site in the carbohydrate recognition domain. However, we found that DX-52-1 and HUK-921 bind galectin-3 outside of its beta-galactoside-binding site. Intriguingly HUK-921, although a less potent inhibitor of cell migration than DX-52-1, had far greater selectivity for galectin-3 over radixin, exhibiting little binding to radixin, both in vitro and in cells. Overexpression of galectin-3 in cells led to a dramatic increase in cell adhesion on different extracellular matrix substrata as well as changes in cell-cell adhesion and cell motility. Galectin-3-overexpressing cells had greatly reduced sensitivity to DX-52-1 and HUK-921, and these compounds caused a change in localization of the overexpressed galectin-3 and reversion of the cells to a more normal morphology. The converse manipulation, RNA interference-based silencing of galectin-3 expression, resulted in reduced cell-matrix adhesion and cell migration. In aggregate, the data suggest that DX-52-1 and HUK-921 inhibit a carbohydrate binding-independent function of galectin-3 that is involved in cell migration.	[Kahsai, Alem W.; Cui, Junru; Fenteany, Gabriel] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Kaniskan, H. Uemit; Garner, Philip P.] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	University of Connecticut; Washington State University	Fenteany, G (corresponding author), Univ Connecticut, Dept Chem, U-60, Storrs, CT 06269 USA.	gabriel.fenteany@uconn.edu	Fenteany, Gabriel/F-4944-2018	Fenteany, Gabriel/0000-0001-7407-2195; Garner, Philip/0000-0002-6503-9550; Kaniskan, Husnu Umit/0000-0001-5327-832X; Fenteany, Gabriel/0000-0003-0335-4587	National Cancer Institute [NSC 607097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077622] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank William S. Lane (Harvard Microchemistry and Proteomics Analysis Facility, Harvard University) for protein identification. We thank William B. Stallcup (Burnham Institute) and Walter Nickel (University of Heidelberg) for human galectin-3 cDNA. We also thank Carol E. Norris (University of Connecticut) for technical assistance with sorting cells by fluorescence-activated cell sorting. We are grateful to the National Cancer Institute for providing quinocarmycin analog DX-52-1 (NSC 607097).	Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Altan ZM, 2004, BIOCHEM BIOPH RES CO, V322, P56, DOI 10.1016/j.bbrc.2004.07.079; Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Chen HY, 2005, ARCH IMMUNOL THER EX, V53, P497; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Disanza A, 2005, CELL MOL LIFE SCI, V62, P955, DOI 10.1007/s00018-004-4472-6; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Dyer KD, 1996, LIFE SCI, V58, P2073, DOI 10.1016/0024-3205(96)00201-9; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Farooqui R, 2006, EXP CELL RES, V312, P1514, DOI 10.1016/j.yexcr.2006.01.018; Fenteany G, 2003, CURR TOP MED CHEM, V3, P593, DOI 10.2174/1568026033452348; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; FLANAGAN ME, 1995, CHEM BIOL, V2, P147, DOI 10.1016/1074-5521(95)90069-1; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Gorski JP, 2002, J BIOL CHEM, V277, P18840, DOI 10.1074/jbc.M109578200; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Herberich B, 2000, BIOORGAN MED CHEM, V8, P523, DOI 10.1016/S0968-0896(99)00314-4; HILL GC, 1988, J COMPUT AID MOL DES, V2, P91, DOI 10.1007/BF01532085; Hughes RC, 2002, GLYCOCONJUGATE J, V19, P621, DOI 10.1023/B:GLYC.0000014094.39168.fd; Ingrassia L, 2006, CURR MED CHEM, V13, P3513, DOI 10.2174/092986706779026219; JIA SH, 1988, J BIOL CHEM, V263, P6009; Kahsai AW, 2006, CHEM BIOL, V13, P973, DOI 10.1016/j.chembiol.2006.07.011; KANAMARU R, 1988, CANCER CHEMOTH PHARM, V22, P197, DOI 10.1007/BF00273410; Kaniskan HU, 2007, J AM CHEM SOC, V129, P15460, DOI 10.1021/ja077853c; Krzeslak A, 2004, CELL MOL BIOL LETT, V9, P305; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li S, 2005, ANNU REV BIOMED ENG, V7, P105, DOI 10.1146/annurev.bioeng.7.060804.100340; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Liu FT, 2007, DRUG NEWS PERSPECT, V20, P455, DOI 10.1358/dnp.2007.20.7.1149628; Mc Henry KT, 2008, J CELL BIOCHEM, V103, P972, DOI 10.1002/jcb.21470; Mc Henry KT, 2002, CHEMBIOCHEM, V3, P1105, DOI 10.1002/1439-7633(20021104)3:11<1105::AID-CBIC1105>3.0.CO;2-S; McFarlane S, 2005, BRIT J OPHTHALMOL, V89, P107, DOI 10.1136/bjo.2004.045914; Nangia-Makker P, 2007, J BIOENERG BIOMEMBR, V39, P79, DOI 10.1007/s10863-006-9063-9; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; OLIVER MH, 1989, J CELL SCI, V92, P513; Patterson RJ, 2002, GLYCOCONJUGATE J, V19, P499, DOI 10.1023/B:GLYC.0000014079.87862.c7; Pieters RJ, 2006, CHEMBIOCHEM, V7, P721, DOI 10.1002/cbic.200600011; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Stossel TP, 2006, J CELL SCI, V119, P3261, DOI 10.1242/jcs.02994; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; TOMITA F, 1984, J ANTIBIOT, V37, P1268, DOI 10.7164/antibiotics.37.1268; Vaiskunaite R, 2000, J BIOL CHEM, V275, P26206, DOI 10.1074/jbc.M001863200; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; WILLIAMS RM, 1992, J AM CHEM SOC, V114, P733, DOI 10.1021/ja00028a049; WILLIAMS RM, 1991, TETRAHEDRON, V47, P2629, DOI 10.1016/S0040-4020(01)81795-6; WILLIAMS RM, 1994, BIOCHEMISTRY-US, V33, P4086, DOI 10.1021/bi00179a038; Xing CG, 2004, P NATL ACAD SCI USA, V101, P5862, DOI 10.1073/pnas.0307476101; Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022; Zhu ST, 2005, CHEM BIOL, V12, P981, DOI 10.1016/j.chembiol.2005.07.007	55	28	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24534	24545		10.1074/jbc.M800006200	http://dx.doi.org/10.1074/jbc.M800006200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18556657	Green Published, hybrid			2022-12-25	WOS:000258820000028
J	Pontier, SM; Percherancier, Y; Galandrin, S; Breit, A; Gales, C; Bouvier, M				Pontier, Stephanie M.; Percherancier, Yann; Galandrin, Segolene; Breit, Andreas; Gales, Celine; Bouvier, Michel			Cholesterol-dependent Separation of the beta(2)-Adrenergic Receptor from Its Partners Determines Signaling Efficacy INSIGHT INTO NANOSCALE ORGANIZATION OF SIGNAL TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; METABOTROPIC GLUTAMATE-RECEPTOR; HETEROTRIMERIC G-PROTEINS; RESONANCE ENERGY-TRANSFER; LIVING CELL-MEMBRANES; GPI-ANCHORED PROTEINS; LIPID RAFTS; ADENYLYL-CYCLASE; PLASMA-MEMBRANE; CARDIAC MYOCYTES	Determining the role of lipid raft nanodomains in G protein-coupled receptor signaling remains fraught by the lack of assays directly monitoring rafts in native membranes. We thus combined extensive biochemical and pharmacological approaches to a nanoscale strategy based on bioluminescence resonance energy transfer (BRET) to assess the spatial and functional influence of cholesterol-rich liquid-ordered lipid nanodomains on beta(2) adrenergic receptor (beta(2)AR) signaling. The data revealed that whereas beta(2)AR did not partition within liquid-ordered lipid phase, a pool of G protein and adenylyl cyclase (AC) were sequestered in these domains. Destabilization of the liquid-ordered phase by cholesterol depletion led to a lateral redistribution of G alpha(s) and AC that favored interactions between the receptor and its signaling partners as assessed by BRET. This resulted in an increased basal and agonist-promoted beta(2)AR-stimulated cAMP production that was partially dampened as a result of constitutive protein kinase A-dependent phosphorylation and desensitization of the receptor. This restraining influence of nanodomains on beta(2)AR signaling was further substantiated by showing that liquid-ordered lipid phase stabilization using caveolin overexpression or increasing membrane cholesterol amount led to an inhibition of beta(2)AR-associated signaling. Given the emerging concept that clustering of receptors and effectors into signaling platforms contributes to the efficacy and selectivity of signal transduction, our results support a model whereby cholesterol-promoted liquid-ordered lipid phase-embedding G(s) and AC allows their lateral separation from the receptor, thus restraining the basal activity and controlling responsiveness of beta(2)AR signaling machinery within larger signaling platforms.	[Bouvier, Michel] Univ Montreal, Inst Rech Immunol & Cancerol, Dept Biochim, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Bouvier, M (corresponding author), Univ Montreal, Inst Rech Immunol & Cancerol, Dept Biochim, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	michel.bouvier@umontreal.ca	Pontier, Stéphanie/A-3836-2015; Bouvier, Michel/H-2758-2014	Pontier, Stéphanie/0000-0002-9124-9228; Bouvier, Michel/0000-0003-1128-0100; percherancier, yann/0000-0002-2410-5806; GALES, Celine/0000-0002-4938-1583	Institut National de la Sante et de la Recherche Medicale (INSERM, France); CIHR	Institut National de la Sante et de la Recherche Medicale (INSERM, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); CIHR(Canadian Institutes of Health Research (CIHR))	Recipient of a fellowship from the Institut National de la Sante et de la Recherche Medicale (INSERM, France) and a postdoctoral fellowship from the CIHR.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; ALOUSI AA, 1991, FASEB J, V5, P2300, DOI 10.1096/fasebj.5.9.1650314; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Becher A, 2001, J NEUROCHEM, V79, P787, DOI 10.1046/j.1471-4159.2001.00614.x; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BOUVIER M, 1991, FEBS LETT, V279, P243, DOI 10.1016/0014-5793(91)80159-Z; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; CARON MG, 1990, G PROTEINS, P295; Chidiac P, 1996, MOL PHARMACOL, V50, P662; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dupre DJ, 2007, CELL SIGNAL, V19, P481, DOI 10.1016/j.cellsig.2006.07.021; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Eroglu C, 2003, P NATL ACAD SCI USA, V100, P10219, DOI 10.1073/pnas.1737042100; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gao MH, 1998, P NATL ACAD SCI USA, V95, P1038, DOI 10.1073/pnas.95.3.1038; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Goodwin JS, 2005, BIOPHYS J, V89, P1398, DOI 10.1529/biophysj.104.055640; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Harikumar KG, 2005, J BIOL CHEM, V280, P2176, DOI 10.1074/jbc.M410385200; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; Ianoul A, 2005, NAT CHEM BIOL, V1, P196, DOI 10.1038/nchembio726; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Klein S, 2000, P NATL ACAD SCI USA, V97, P3219, DOI 10.1073/pnas.050015797; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Krumins AM, 1997, BIOCHEM PHARMACOL, V54, P61, DOI 10.1016/S0006-2952(97)00147-0; Kukkonen JP, 2001, TRENDS PHARMACOL SCI, V22, P616, DOI 10.1016/S0165-6147(00)01864-2; Lagane B, 2000, J BIOL CHEM, V275, P33197, DOI 10.1074/jbc.C000576200; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Levitzki A, 2002, CHEMBIOCHEM, V3, P815, DOI 10.1002/1439-7633(20020902)3:9<815::AID-CBIC815>3.0.CO;2-E; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; McCabe JB, 2001, MOL BIOL CELL, V12, P3601, DOI 10.1091/mbc.12.11.3601; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mishra S, 2007, J NEUROCHEM, V103, P135, DOI 10.1111/j.1471-4159.2007.04720.x; Miura Y, 2001, BIOCHEMISTRY-US, V40, P15418, DOI 10.1021/bi015574a; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Nichols BJ, 2003, CURR BIOL, V13, P686, DOI 10.1016/S0960-9822(03)00209-4; OCONNOR SW, 1984, BIOCHIM BIOPHYS ACTA, V778, P497, DOI 10.1016/0005-2736(84)90399-7; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; Ostrom RS, 2000, MOL PHARMACOL, V57, P1075; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; Pang L, 1999, BIOCHEMISTRY-US, V38, P12003, DOI 10.1021/bi990227a; Percherancier Y, 2003, J BIOL CHEM, V278, P3153, DOI 10.1074/jbc.M207371200; Pierini L, 1996, J CELL BIOL, V134, P1427, DOI 10.1083/jcb.134.6.1427; PRIETO JC, 1990, GEN PHARMACOL-VASC S, V21, P931, DOI 10.1016/0306-3623(90)90457-W; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SCARPACE PJ, 1985, BIOCHIM BIOPHYS ACTA, V845, P520, DOI 10.1016/0167-4889(85)90220-4; Seveau S, 2001, MOL BIOL CELL, V12, P3550, DOI 10.1091/mbc.12.11.3550; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tepe NM, 1999, BIOCHEMISTRY-US, V38, P16706, DOI 10.1021/bi991619k; THOMAS JL, 1994, J CELL BIOL, V125, P795, DOI 10.1083/jcb.125.4.795; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Uittenbogaard A, 2000, J BIOL CHEM, V275, P25595, DOI 10.1074/jbc.M003401200; Uittenbogaard A, 2000, J BIOL CHEM, V275, P11278, DOI 10.1074/jbc.275.15.11278; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200	79	100	102	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24659	24672		10.1074/jbc.M800778200	http://dx.doi.org/10.1074/jbc.M800778200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18566454	hybrid, Green Published			2022-12-25	WOS:000271617300002
J	Vargas, KJ; Terunuma, M; Tello, JA; Pangalos, MN; Moss, SJ; Couve, A				Vargas, Karina J.; Terunuma, Miho; Tello, Judith A.; Pangalos, Menelas N.; Moss, Stephen J.; Couve, Andres			The Availability of Surface GABA(B) Receptors Is Independent of gamma-Aminobutyric Acid but Controlled by Glutamate in Central Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SUBCELLULAR-LOCALIZATION; SYNAPTIC SITES; B RECEPTORS; TRAFFICKING; ENDOCYTOSIS; PATHWAY; PHOSPHORYLATION; SUBUNITS; DESENSITIZATION	The efficacy of synaptic transmission depends on the availability of ionotropic and metabotropic neurotransmitter receptors at the plasma membrane, but the contribution of the endocytic and recycling pathways in the regulation of gamma-aminobutyric acid type B (GABA(B)) receptors remains controversial. To understand the mechanisms that regulate the abundance of GABA(B) receptors, we have studied their turnover combining surface biotin labeling and a microscopic immunoendocytosis assay in hippocampal and cortical neurons. We report that internalization of GABA(B) receptors is agonist-independent. We also demonstrate that receptors endocytose in the cell body and dendrites but not in axons. Additionally, we show that GABA(B) receptors endocytose as heterodimers via clathrin- and dynamin-1-dependent mechanisms and that they recycle to the plasma membrane after endocytosis. More importantly, we show that glutamate decreases the levels of cell surface receptors in a manner dependent on an intact proteasome pathway. These observations indicate that glutamate and not GABA controls the abundance of surface GABA(B) receptors in central neurons, consistent with their enrichment at glutamatergic synapses.	[Vargas, Karina J.; Tello, Judith A.; Couve, Andres] Univ Chile, Fac Med, ICBM, Santiago, Chile; [Vargas, Karina J.] Univ Austral Chile, Valdivia, Chile; [Terunuma, Miho; Moss, Stephen J.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Pangalos, Menelas N.] Wyeth Ayerst Res, Neurosci Discovery, Princeton, NJ 08543 USA; [Moss, Stephen J.] UCL, Dept Pharmacol, London WC1E 6BT, England	Universidad de Chile; Universidad Austral de Chile; University of Pennsylvania; Pfizer; University of London; University College London	Couve, A (corresponding author), Univ Chile, Fac Med, ICBM, Independencia 1027, Santiago, Chile.	andres@neuro.med.uchile.cl	couve, andres/I-2249-2013	couve, andres/0000-0003-4216-8672; Terunuma, Miho/0000-0003-1876-9726	FONDECYT [1071001]; Iniciativa Cientifica Milenio;  [ICM-P04-068-F]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051195, R01NS048045, R01NS081986, R21NS080064] Funding Source: NIH RePORTER	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported byFONDECYT 1071001 and Iniciativa Cientifica Milenio ICM-P04- 068-F.	Bayer N, 2001, J BIOL CHEM, V276, P3952, DOI 10.1074/jbc.M004722200; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Correa SAL, 2004, NEUROPHARMACOLOGY, V47, P475, DOI 10.1016/j.neuropharm.2004.04.021; Cousins MS, 2002, DRUG ALCOHOL DEPEN, V65, P209, DOI 10.1016/S0376-8716(01)00163-6; Couve A, 2004, BIOCHEM PHARMACOL, V68, P1527, DOI 10.1016/j.bcp.2004.06.036; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Fourgeaud L, 2003, J BIOL CHEM, V278, P12222, DOI 10.1074/jbc.M205663200; Gonzalez-Maeso J, 2003, EUR J PHARMACOL, V481, P15, DOI 10.1016/j.ejphar.2003.09.002; Goslin K., 1991, CULTURING NERVE CELL, P251; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Hawrot E, 1998, FEBS LETT, V432, P103, DOI 10.1016/S0014-5793(98)00794-7; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Inoue A, 2003, CURR OPIN NEUROBIOL, V13, P332, DOI 10.1016/S0959-4388(03)00077-1; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kulik A, 2003, J NEUROSCI, V23, P11026; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Laffray S, 2007, EUR J NEUROSCI, V25, P1402, DOI 10.1111/j.1460-9568.2007.05398.x; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; Lujan R, 2006, EUR J NEUROSCI, V23, P1479, DOI 10.1111/j.1460-9568.2006.04669.x; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Melikova MS, 2006, CELL BIOL INT, V30, P31, DOI 10.1016/j.cellbi.2005.09.003; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Pin JP, 2004, BIOCHEM PHARMACOL, V68, P1565, DOI 10.1016/j.bcp.2004.06.035; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Ramoino P, 2006, J CELL SCI, V119, P2056, DOI 10.1242/jcs.02931; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014	39	45	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24641	24648		10.1074/jbc.M802419200	http://dx.doi.org/10.1074/jbc.M802419200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18579521	hybrid, Green Published			2022-12-25	WOS:000258820000068
J	Coulthurst, SJ; Lilley, KS; Hedley, PE; Liu, H; Toth, IK; Salmond, GPC				Coulthurst, Sarah J.; Lilley, Kathryn S.; Hedley, Peter E.; Liu, Hui; Toth, Ian K.; Salmond, George P. C.			DsbA plays a critical and multifaceted role in the production of secreted virulence factors by the phytopathogen Erwinia carotovora subsp atroseptica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PULLULANASE SECRETION; ENTERIC PHYTOPATHOGEN; PROTEIN SECRETION; ISOMERASE DSBC; CHRYSANTHEMI; PATHOGENESIS	Erwinia carotovora subsp. atroseptica is an enterobacterial phytopathogen causing economically significant soft rot disease. Pathogenesis is mediated by multiple secreted virulence factors, many of which are secreted by the type II (Out) secretion system. DsbA catalyzes the introduction of disulfide bonds into periplasmic and secreted proteins. In this study, the extracellular proteome (secretome) of wild type E. carotovora subsp. atroseptica SCRI1043, and dsbA and out mutants, was analyzed by spectral counting mass spectrometry. This revealed that dsbA inactivation had a huge impact on the secretome and identified diverse DsbA- and Out-dependent secreted proteins, representing known, predicted, and novel candidate virulence factors. Further characterization of the dsbA mutant showed that secreted enzyme activities, motility, production of the quorum-sensing signal, and virulence were absent or substantially reduced. The impact of DsbA on secreted virulence factor production was mediated at multiple levels, including impacting on the Out secretion system and the virulence gene regulatory network. Transcriptome analyses revealed that the abundance of a broad, but defined, set of transcripts, including many virulence factors, was altered in the dsbA mutant, identifying a new virulence regulon responsive to extracytoplasmic conditions. In conclusion, DsbA plays a crucial, multifaceted role in the pathogenesis of E. carotovora subsp. atroseptica.	[Coulthurst, Sarah J.; Lilley, Kathryn S.; Salmond, George P. C.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Lilley, Kathryn S.] Univ Cambridge, Cambridge Syst Biol Inst, Cambridge CB2 1QR, England; [Hedley, Peter E.; Liu, Hui; Toth, Ian K.] Invergowrie, Scottish Crop Res Inst, Dundee DD2 5DA, Scotland	University of Cambridge; University of Cambridge; James Hutton Institute	Salmond, GPC (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	gpcs@mole.bio.cam.ac.uk	Hedley, Peter/F-1149-2011; Lilley, Kathryn/ABF-5787-2020	Hedley, Peter/0000-0003-0866-324X; Lilley, Kathryn/0000-0003-0594-6543; Coulthurst, Sarah/0000-0002-0808-1875	Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Agudo D, 2004, PROTEOMICS, V4, P355, DOI 10.1002/pmic.200300554; Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Burr T, 2006, MOL MICROBIOL, V59, P113, DOI 10.1111/j.1365-2958.2005.04939.x; CHATTERJEE A, 1991, J BACTERIOL, V173, P1765, DOI 10.1128/jb.173.5.1765-1769.1991; Corbett M, 2005, MOL PLANT MICROBE IN, V18, P334, DOI 10.1094/MPMI-18-0334; Coulthurst SJ, 2006, MOL PLANT PATHOL, V7, P31, DOI 10.1111/J.1364-3703.2005.00314.X; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; Harris SJ, 1998, MOL MICROBIOL, V28, P705, DOI 10.1046/j.1365-2958.1998.00825.x; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Holeva MC, 2004, MOL PLANT MICROBE IN, V17, P943, DOI 10.1094/MPMI.2004.17.9.943; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kazemi-Pour N, 2004, PROTEOMICS, V4, P3177, DOI 10.1002/pmic.200300814; Laatu M, 2003, J BACTERIOL, V185, P1642, DOI 10.1128/JB.185.5.1642-1649.2003; Lasica AM, 2007, FEMS MICROBIOL REV, V31, P626, DOI 10.1111/j.1574-6976.2007.00081.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005; Mattinen L, 2007, PROTEOMICS, V7, P3527, DOI 10.1002/pmic.200600759; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Pemberton CL, 2005, MOL PLANT MICROBE IN, V18, P343, DOI 10.1094/MPMI-18-0343; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; Pugsley AP, 2001, J BACTERIOL, V183, P1312, DOI 10.1128/JB.183.4.1312-1319.2001; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; REEVES PJ, 1993, MOL MICROBIOL, V8, P443, DOI 10.1111/j.1365-2958.1993.tb01589.x; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sauvonnet N, 1998, MOL MICROBIOL, V27, P661, DOI 10.1046/j.1365-2958.1998.00722.x; SHEVCHIK VE, 1995, MOL MICROBIOL, V16, P745, DOI 10.1111/j.1365-2958.1995.tb02435.x; Thomson NR, 1999, METHOD MICROBIOL, V29, P347; TOTH I, 1993, J GEN MICROBIOL, V139, P2705, DOI 10.1099/00221287-139-11-2705; Toth IK, 2005, CURR OPIN PLANT BIOL, V8, P424, DOI 10.1016/j.pbi.2005.04.001; Toth IK, 2003, MOL PLANT PATHOL, V4, P17, DOI 10.1046/j.1364-3703.2003.00149.x; Venkatesh B, 2006, J BACTERIOL, V188, P3088, DOI 10.1128/JB.188.8.3088-3098.2006; Vertommen D, 2008, MOL MICROBIOL, V67, P336, DOI 10.1111/j.1365-2958.2007.06030.x; Vincent-Sealy LV, 1999, MICROBIOL-SGM, V145, P1945, DOI 10.1099/13500872-145-8-1945; WALKER DS, 1994, MOL PLANT MICROBE IN, V7, P425, DOI 10.1094/MPMI-7-0425; Whitehead NA, 2002, ANTON LEEUW INT J G, V81, P223, DOI 10.1023/A:1020570802717; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7	50	39	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23739	23753		10.1074/jbc.M801829200	http://dx.doi.org/10.1074/jbc.M801829200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18562317	Green Published, hybrid			2022-12-25	WOS:000258638900028
J	Guo, Q; Jureller, JE; Warren, JT; Solomaha, E; Florian, J; Tang, WJ				Guo, Qing; Jureller, Justin E.; Warren, Julia T.; Solomaha, Elena; Florian, Jan; Tang, Wei-Jen			Protein-protein docking and analysis reveal that two homologous bacterial adenylyl cyclase toxins interact with calmodulin differently	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY CALCULATIONS; BINDING FREE-ENERGIES; ANTHRAX EDEMA FACTOR; MOLECULAR-DYNAMICS; TARGET RECOGNITION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PEPTIDE COMPLEX; APO-CALMODULIN; HIV PROTEASE	Calmodulin (CaM), a eukaryotic calcium sensor that regulates diverse biological activities, consists of N- and C-terminal globular domains (N-CaM and C-CaM, respectively). CaM serves as the activator of CyaA, a 188-kDa adenylyl cyclase toxin secreted by Bordetella pertussis, which is the etiologic agent for whooping cough. Upon insertion of the N-terminal adenylyl cyclase domain (ACD) of CyaA to its targeted eukaryotic cells, CaM binds to this domain tightly (similar to 200 pM affinity). This interaction activates the adenylyl cyclase activity of CyaA, leading to a rise in intracellular cAMP levels to disrupt normal cellular signaling. We recently solved the structure of CyaA-ACD in complex with C-CaM to elucidate the mechanism of catalytic activation. However, the structure of the interface between N-CaM and CyaA, the formation of which contributes a 400-fold increase of binding affinity between CyaA and CaM, remains elusive. Here, we used site-directed mutations and molecular dynamic simulations to generate several working models of CaM-bound CyaA-ACD. The validity of these models was evaluated by disulfide bond cross-linking, point mutations, and fluorescence resonance energy transfer experiments. Our study reveals that a beta-hairpin region (amino acids 259-273) of CyaA-ACD likely makes contacts with the second calcium binding motif of the extended CaM. This mode of interaction differs from the interaction of N-CaM with anthrax edema factor, which binds N-CaM via its helical domain. Thus, two structurally conserved, bacterial adenylyl cyclase toxins have evolved to utilize distinct binding surfaces and modes of activation in their interaction with CaM, a highly conserved eukaryotic signaling protein.	[Jureller, Justin E.] Univ Chicago, Inst Biophys Dynam, NanoBiol Facil, Chicago, IL 60637 USA; [Warren, Julia T.] Univ Chicago, Biol Sci Collegiate Div, Chicago, IL 60637 USA; [Solomaha, Elena] Univ Chicago, Biophys Core Facil, Chicago, IL 60637 USA; [Florian, Jan] Loyola Univ Chicago, Dept Chem, Chicago, IL 60626 USA; [Guo, Qing; Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; Loyola University Chicago; University of Chicago	Tang, WJ (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@uchicago.edu	Florian, Jan/E-1554-2012	Florian, Jan/0000-0003-2669-4293; Warren, Julia/0000-0003-2017-6444; Tang, Wei-Jen/0000-0002-8267-8995	National Institutes of Health [GM62548]; Howard Hughes Medical Institute Undergraduate Research Fellowship; Institute for Biophysical Dynamics Yen Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Undergraduate Research Fellowship(Howard Hughes Medical Institute); Institute for Biophysical Dynamics Yen Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62548 (to W.-J.T.). This work was also supported by a Howard Hughes Medical Institute Undergraduate Research Fellowship (to J. T. W.) and an Institute for Biophysical Dynamics Yen Postdoctoral Fellowship (to J. E. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Almlof M, 2006, BIOPHYS J, V90, P433, DOI 10.1529/biophysj.105.073239; Aqvist J, 2002, ACCOUNTS CHEM RES, V35, P358, DOI 10.1021/ar010014p; AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Becker W, 2005, ADV TIME CORRELATED; Bertini I, 2004, P NATL ACAD SCI USA, V101, P6841, DOI 10.1073/pnas.0308641101; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Brandsdal BO, 2001, PROTEIN SCI, V10, P1584, DOI 10.1110/ps.940101; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; CORNELL SJ, 1995, PHYS REV LETT, V75, P2250, DOI 10.1103/PhysRevLett.75.2250; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Eldik LV, 1998, CALMODULIN SIGNAL TR; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; FARRAR YJK, 1993, J BIOL CHEM, V268, P4120; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Florian J, 2002, J PHYS CHEM B, V106, P5739, DOI 10.1021/jp020790u; Grabarek Z, 2005, J MOL BIOL, V346, P1351, DOI 10.1016/j.jmb.2005.01.004; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guo Q, 2005, EMBO J, V24, P3190, DOI 10.1038/sj.emboj.7600800; Guo Q, 2004, J BIOL CHEM, V279, P29427, DOI 10.1074/jbc.M402689200; Hansson T, 1998, J COMPUT AID MOL DES, V12, P27, DOI 10.1023/A:1007930623000; Hayashi N, 2000, PROTEIN SCI, V9, P1905, DOI 10.1110/ps.9.10.1905; Heifetz A, 2007, PROTEINS, V69, P816, DOI 10.1002/prot.21734; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishikita H, 2008, ANGEW CHEM INT EDIT, V47, P697, DOI 10.1002/anie.200704178; Johnson KA, 2006, EMBO J, V25, P1977, DOI 10.1038/sj.emboj.7601080; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Krueger JK, 2001, J BIOL CHEM, V276, P4535, DOI 10.1074/jbc.C000857200; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Lacy DB, 2005, P NATL ACAD SCI USA, V102, P16409, DOI 10.1073/pnas.0508259102; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; LEE FS, 1992, PROTEIN ENG, V5, P215, DOI 10.1093/protein/5.3.215; LEE SY, 1992, BRIT J MATH STAT PSY, V45, P93, DOI 10.1111/j.2044-8317.1992.tb00979.x; Marelius J, 1998, J MOL GRAPH MODEL, V16, P213, DOI 10.1016/S1093-3263(99)00012-1; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Moens PDJ, 2005, BIOCHEMISTRY-US, V44, P3298, DOI 10.1021/bi048015n; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Sham YY, 2000, PROTEINS, V39, P393, DOI 10.1002/(SICI)1097-0134(20000601)39:4<393::AID-PROT120>3.3.CO;2-8; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; Shen YQ, 2002, EMBO J, V21, P6721, DOI 10.1093/emboj/cdf681; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; TREWHELLA J, 1992, CELL CALCIUM, V13, P377, DOI 10.1016/0143-4160(92)90051-S; Ulmer TS, 2003, J BIOL CHEM, V278, P29261, DOI 10.1074/jbc.M302837200; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wang EZ, 1997, BIOCHEMISTRY-US, V36, P15026, DOI 10.1021/bi963075h; Warren JT, 2007, J MOL BIOL, V374, P517, DOI 10.1016/j.jmb.2007.09.048; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	60	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23836	23845		10.1074/jbc.M802168200	http://dx.doi.org/10.1074/jbc.M802168200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18583346	Green Published, hybrid			2022-12-25	WOS:000258638900038
J	Lucero, HA; Ravid, K; Grimsby, JL; Rich, CB; DiCamillo, SJ; Maki, JM; Myllyharju, J; Kagan, HM				Lucero, Hector A.; Ravid, Katya; Grimsby, Jessica L.; Rich, Celeste B.; DiCamillo, Sandra J.; Maki, Joni M.; Myllyharju, Johanna; Kagan, Herbert M.			Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMINOPROPIONITRILE; SIGNAL-TRANSDUCTION; BIOLOGICAL SAMPLES; FIBROGENIC CELLS; MESSENGER-RNA; CROSS-LINKING; MIGRATION; OXIDATION; ADHESION; COLLAGEN	Lysyl oxidase (LOX) is a potent chemokine inducing the migration of varied cell types. Here we demonstrate that inhibition of LOX activity by beta-aminopropionitrile ( BAPN) in cultured rat aortic smooth muscle cells (SMCs) reduced the chemotactic response and sensitivity of these cells toward LOX and toward PDGF-BB. The chemotactic activity of PDGF-BB was significantly enhanced in the presence of a non-chemotactic concentration of LOX. We considered the possibility that extracellular LOX may oxidize cell surface proteins, including the PDGF receptor-beta (PDGFR-beta), to affect PDGF-BB-induced chemotaxis. Plasma membranes purified from control SMC contained oxidized PDGFR-beta. The oxidation of this receptor and other membrane proteins was largely prevented in cells preincubated with BAPN. Addition of purified LOX to these cells restored the profile of oxidized proteins toward that of control cells. The high affinity and capacity for the binding of PDGF-BB by cells containing oxidized PDGFR-beta was diminished by similar to 2-fold when compared with cells in which oxidation by LOX was prevented by BAPN. Phosphorylated members of the PDGFR-beta dependent signal transduction pathway, including PDGFR-beta, SHP2, AKT1, and ERK1/ERK2 (p44/42 MAPK), turned over faster in BAPN-treated than in control SMCs. LOX knock-out mouse embryonic fibroblasts mirrored the effect obtained with SMCs treated with BAPN. These novel findings suggest that LOX activity is essential to generate optimal chemotactic sensitivity of cells to chemoattractants by oxidizing specific cell surface proteins, such as PDGFR-beta.	[Lucero, Hector A.; Ravid, Katya; Grimsby, Jessica L.; Rich, Celeste B.; DiCamillo, Sandra J.; Kagan, Herbert M.] Boston Univ, Dept Biochem, Sch Med, Boston, MA 02118 USA; [Maki, Joni M.; Myllyharju, Johanna] Univ Oulu, Collagen Res Unit, Bioctr Oulu, FIN-90014 Oulu, Finland; [Maki, Joni M.; Myllyharju, Johanna] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland	Boston University; University of Oulu; University of Oulu	Lucero, HA (corresponding author), Boston Univ, Dept Biochem, Sch Med, 715 Albany St, Boston, MA 02118 USA.	hlucero@bu.edu		Ravid, Katya/0000-0002-9918-3024	National Institutes of Health [HL13262-31]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL013262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL13262-31 ( to H. K. and K. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; Bouez C, 2006, CLIN CANCER RES, V12, P1463, DOI 10.1158/1078-0432.CCR-05-1456; Bulut T, 2004, J INVEST SURG, V17, P211, DOI 10.1080/08941930490472028; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Dean RT, 1997, BIOCHEM J, V324, P1; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Farjanel J, 2005, OSTEOARTHR CARTILAGE, V13, P120, DOI 10.1016/j.joca.2004.06.015; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Genestra M, 2007, CELL SIGNAL, V19, P1807, DOI 10.1016/j.cellsig.2007.04.009; Giampuzzi M, 2000, J BIOL CHEM, V275, P36341, DOI 10.1074/jbc.M003362200; Giampuzzi M, 2003, BBA-PROTEINS PROTEOM, V1647, P239, DOI 10.1016/S1570-9639(03)00058-X; Gilad GM, 2001, EUR J PHARMACOL, V430, P69, DOI 10.1016/S0014-2999(01)01354-1; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; KAGAN HM, 1995, METHOD ENZYMOL, V258, P122; KAGAN HM, 1984, J BIOL CHEM, V259, P1203; KAGAN HM, 1981, ARTERIOSCLEROSIS, V1, P287, DOI 10.1161/01.ATV.1.4.287; Karlsson S, 2006, MOL BIOL CELL, V17, P4846, DOI 10.1091/mbc.E06-04-0306; KENYON K, 1991, SCIENCE, V253, P802, DOI 10.1126/science.1678898; Kirschmann DA, 2002, CANCER RES, V62, P4478; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Laczko R, 2007, NEUROPATH APPL NEURO, V33, P631, DOI 10.1111/j.1365-2990.2007.00858.x; Lazarus HM, 1995, MATRIX BIOL, V14, P727, DOI 10.1016/S0945-053X(05)80015-0; Leskovac V, 2005, INT J BIOCHEM CELL B, V37, P731, DOI 10.1016/j.biocel.2004.10.014; Li WD, 2000, J CELL BIOCHEM, V78, P550, DOI 10.1002/1097-4644(20000915)78:4<550::AID-JCB4>3.3.CO;2-#; Li WD, 1997, P NATL ACAD SCI USA, V94, P12817, DOI 10.1073/pnas.94.24.12817; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; NAGAN N, 1994, J BIOL CHEM, V269, P22366; Nellaiappan K, 2000, J CELL BIOCHEM, V79, P576, DOI 10.1002/1097-4644(20001215)79:4<576::AID-JCB60>3.0.CO;2-A; NELSON JM, 1988, P SOC EXP BIOL MED, V188, P346; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; PINNELL SR, 1968, P NATL ACAD SCI USA, V61, P708, DOI 10.1073/pnas.61.2.708; Ronnstrand L, 2001, INT J CANCER, V91, P757, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1136>3.0.CO;2-J; SCHREIBER BM, 1988, ATHEROSCLEROSIS, V69, P69, DOI 10.1016/0021-9150(88)90290-0; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; Shimokado K, 1997, ANN NY ACAD SCI, V811, P130, DOI 10.1111/j.1749-6632.1997.tb51995.x; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TANG SS, 1983, J BIOL CHEM, V258, P4331; TANG SS, 1989, CONNECT TISSUE RES, V19, P93, DOI 10.3109/03008208909016817; Thomassin L, 2005, J BIOL CHEM, V280, P42848, DOI 10.1074/jbc.M506832200; TOSELLI P, 1992, MATRIX, V12, P321, DOI 10.1016/S0934-8832(11)80084-3; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vogel W, 1996, CELL GROWTH DIFFER, V7, P1589; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; WOLFE LB, 1993, J BIOL CHEM, V268, P12418	54	66	70	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24103	24117		10.1074/jbc.M709897200	http://dx.doi.org/10.1074/jbc.M709897200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586678	Green Published, hybrid			2022-12-25	WOS:000258638900064
J	Wallander, ML; Zumbrennen, KB; Rodansky, ES; Romney, SJ; Leibold, EA				Wallander, Michelle L.; Zumbrennen, Kimberly B.; Rodansky, Eva S.; Romney, S. Joshua; Leibold, Elizabeth A.			Iron-independent phosphorylation of iron regulatory protein 2 regulates ferritin during the cell cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING-PROTEIN; RESPONSIVE ELEMENT; TRANSFERRIN RECEPTORS; TARGETED DELETION; PHOSPHATASE CDC14; MOLECULAR CONTROL; RNA-BINDING; EXPRESSION; IDENTIFICATION; DEGRADATION	Iron regulatory protein 2 (IRP2) is a key iron sensor that post-transcriptionally regulates mammalian iron homeostasis by binding to iron- responsive elements ( IREs) in mRNAs that encode proteins involved in iron metabolism ( e. g. ferritin and transferrin receptor 1). During iron deficiency, IRP2 binds IREs to regulate mRNA translation or stability, whereas during iron sufficiency IRP2 is degraded by the proteasome. Here, we identify an iron- independent IRP2 phosphorylation site that is regulated by the cell cycle. IRP2 Ser- 157 is phosphorylated by Cdk1/ cyclin B1 during G2/ M and is dephosphorylated during mitotic exit by the phosphatase Cdc14A. Ser- 157 phosphorylation during G2/ M reduces IRP2 RNA- binding activity and increases ferritin synthesis, whereas Ser- 157 dephosphorylation during mitotic exit restores IRP2 RNA- binding activity and represses ferritin synthesis. These data show that reversible phosphorylation of IRP2 during G2/ M has a role in modulating the iron- independent expression of ferritin and other IRE- containing mRNAs during the cell cycle.	[Rodansky, Eva S.; Romney, S. Joshua; Leibold, Elizabeth A.] Univ Utah, Eccles Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; [Wallander, Michelle L.; Zumbrennen, Kimberly B.; Leibold, Elizabeth A.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Leibold, Elizabeth A.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Leibold, EA (corresponding author), Univ Utah, Eccles Program Human Mol Biol & Genet, 15 N 2030 E,Rm 3240A, Salt Lake City, UT 84112 USA.	betty.leibold@genetics.utah.edu			NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045201] Funding Source: NIH RePORTER; NCI NIH HHS [2P30 CA 42014] Funding Source: Medline; NIDDK NIH HHS [2T32 DK 007115] Funding Source: Medline; NIGMS NIH HHS [R01 GM 045201] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bembenek J, 2001, J BIOL CHEM, V276, P48237, DOI 10.1074/jbc.M108126200; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Bourdon E, 2003, BLOOD CELL MOL DIS, V31, P247, DOI 10.1016/S1079-9796(03)00161-X; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Buss JL, 2003, CURR MED CHEM, V10, P1021, DOI 10.2174/0929867033457638; CHITAMBAR CR, 1983, J CLIN INVEST, V72, P1314, DOI 10.1172/JCI111087; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Cmejla R, 2006, BIOCHEM BIOPH RES CO, V341, P158, DOI 10.1016/j.bbrc.2005.12.155; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; EISENSTEIN RS, 1993, J BIOL CHEM, V268, P27363; FRAZIER JL, 1982, J CLIN INVEST, V69, P853, DOI 10.1172/JCI110525; Fu D, 2007, BLOOD, V110, P752, DOI 10.1182/blood-2007-03-076737; GALBRAITH RM, 1981, IMMUNOLOGY, V44, P703; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Gray NK, 1996, P NATL ACAD SCI USA, V93, P4925, DOI 10.1073/pnas.93.10.4925; GUO B, 1994, J BIOL CHEM, V269, P24252; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hanson ES, 1998, J BIOL CHEM, V273, P7588, DOI 10.1074/jbc.273.13.7588; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Kakhlon O, 2001, BLOOD, V97, P2863, DOI 10.1182/blood.V97.9.2863; Kulp KS, 1996, EXP CELL RES, V229, P60, DOI 10.1006/excr.1996.0343; Lanzetti L, 2007, J BIOL CHEM, V282, P15258, DOI 10.1074/jbc.M700914200; LARRICK JW, 1979, J SUPRAMOL STR CELL, V11, P579, DOI 10.1002/jss.400110415; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Li LW, 1997, J BIOL CHEM, V272, P29403, DOI 10.1074/jbc.272.47.29403; MacDonald JA, 2002, MOL CELL PROTEOMICS, V1, P314, DOI 10.1074/mcp.M200002-MCP200; Mackey AJ, 2003, NUCLEIC ACIDS RES, V31, P3859, DOI 10.1093/nar/gkg513; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Nie GJ, 2006, BLOOD, V108, P2428, DOI 10.1182/blood-2006-04-018341; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NYHOLM S, 1993, J BIOL CHEM, V268, P26200; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Paulsen MT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-25; Phillips JD, 1996, BIOCHEMISTRY-US, V35, P15704, DOI 10.1021/bi960653l; Pitula JS, 2004, P NATL ACAD SCI USA, V101, P10907, DOI 10.1073/pnas.0404308101; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Sanchez M, 2006, J BIOL CHEM, V281, P22865, DOI 10.1074/jbc.M603876200; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; Schneider BD, 2003, BLOOD, V102, P3404, DOI 10.1182/blood-2003-02-0433; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Van Der Geer P., 1993, PROTEIN PHOSPHORYLAT, P31; Vazquez-Novelle MD, 2005, J BIOL CHEM, V280, P29144, DOI 10.1074/jbc.M413328200; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; WARREN G, 1984, EMBO J, V3, P2217, DOI 10.1002/j.1460-2075.1984.tb02119.x; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Yu Y, 2006, CLIN CANCER RES, V12, P6876, DOI 10.1158/1078-0432.CCR-06-1954; Yuan K, 2007, J BIOL CHEM, V282, P27414, DOI 10.1074/jbc.M703555200	69	16	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23589	23598		10.1074/jbc.M803005200	http://dx.doi.org/10.1074/jbc.M803005200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18574241	Green Published, hybrid			2022-12-25	WOS:000258638900011
J	Alter, J; Rozentzweig, D; Bengal, E				Alter, Joel; Rozentzweig, Dafna; Bengal, Eyal			Inhibition of myoblast differentiation by tumor necrosis factor alpha is mediated by c-Jun N-terminal kinase 1 and leukemia inhibitory factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; SKELETAL-MUSCLE DIFFERENTIATION; CELL-CYCLE PROGRESSION; TNF-ALPHA; P38 MAPK; MYOGENIC DIFFERENTIATION; TRANSCRIPTION FACTOR; MESSENGER-RNA; ACTIVATION; KINASE	The proinflammatory cytokine, TNF alpha plays a major role in muscle wasting occurring in chronic diseases and muscular dystrophies. Among its other functions, TNF alpha perturbs muscle regeneration by preventing satellite cell differentiation. In the present study, the role of c-Jun N-terminal kinase (JNK), a mediator of TNF alpha, was investigated in differentiating myoblast cell lines. Addition of TNF alpha to C2 myoblasts induced immediate and delayed phases of JNK activity. The delayed phase is associated with myoblast proliferation. Inhibition of JNK activity prevented proliferation and restored differentiation to TNF alpha-treated myoblasts. Studies with cell lines expressing MyoD: ER chimera and lacking JNK1 or JNK2 genes indicate that JNK1 activity mediates the effects of TNF alpha on myoblast proliferation and differentiation. TNF alpha does not induce proliferation or inhibit differentiation of JNK1-null myoblasts. However, differentiation of JNK1-null myoblasts is inhibited when they are grown in conditioned medium derived from cell lines affected by TNF alpha. We investigated the induced synthesis of several candidate growth factors and cytokines following treatment with TNF alpha. Expression of IL-6 and leukemia inhibitory factor (LIF) was induced by TNF alpha in wildtype and JNK2-null myoblasts. However, LIF expression was not induced by TNF alpha in JNK1-null myoblasts. Addition of LIF to the growth medium of JNK1-null myoblasts prevented their differentiation. Moreover, LIF-neutralizing antibodies added to the medium of C2 myoblasts prevented inhibition of differentiation mediated by TNF alpha. Hence, TNF alpha promotes myoblast proliferation through JNK1 and prevents myoblast differentiation through JNK1-mediated secretion of LIF.	[Alter, Joel; Rozentzweig, Dafna; Bengal, Eyal] Technion Israel Inst Technol, Dept Biochem, Rappaport Inst Res Med Sci, Fac Med, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Bengal, E (corresponding author), POB 9649, IL-31096 Haifa, Israel.	bengal@tx.technion.ac.il						Alvarez B, 2002, BBA-MOL CELL RES, V1542, P66, DOI 10.1016/S0167-4889(01)00167-7; Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N; AUSTIN L, 1991, J NEUROL SCI, V101, P193, DOI 10.1016/0022-510X(91)90045-9; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; BARNARD W, 1994, J NEUROL SCI, V123, P108, DOI 10.1016/0022-510X(94)90211-9; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Coletti D, 2002, EMBO J, V21, P631, DOI 10.1093/emboj/21.4.631; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Donati C, 2007, FEBS LETT, V581, P4384, DOI 10.1016/j.febslet.2007.08.007; Grounds MD, 2004, FASEB J, V18, P676, DOI 10.1096/fj.03-1024com; Guttridge DC, 2004, CURR OPIN CLIN NUTR, V7, P443, DOI 10.1097/01.mco.0000134364.61406.26; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; Jo C, 2005, BBA-MOL CELL RES, V1743, P187, DOI 10.1016/j.bbamcr.2004.11.002; Kurek J, 1996, NEUROSCI LETT, V212, P167, DOI 10.1016/0304-3940(96)12802-0; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; MacCorkle-Chosnek RA, 2001, BIOCHEM BIOPH RES CO, V289, P173, DOI 10.1006/bbrc.2001.5948; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; MILLER SC, 1988, MOL CELL BIOL, V8, P2295, DOI 10.1128/MCB.8.6.2295; Okazaki S, 1996, CELL PROLIFERAT, V29, P173; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Puri PL, 2000, GENE DEV, V14, P574; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Saini A, 2006, CYTOKINE GROWTH F R, V17, P475, DOI 10.1016/j.cytogfr.2006.09.006; SARTORELLI V, 2004, SCI STKE, pRE11, DOI DOI 10.1126/STKE.2442004RE11; Stewart CEH, 2004, J CELL PHYSIOL, V198, P237, DOI 10.1002/jcp.10387; Strle K, 2006, ENDOCRINOLOGY, V147, P4363, DOI 10.1210/en.2005-1541; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Tidball JG, 2005, CURR OPIN RHEUMATOL, V17, P707, DOI 10.1097/01.bor.0000179948.65895.1a; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhan M, 2007, J CELL SCI, V120, P692, DOI 10.1242/jcs.03372	45	51	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23224	23234		10.1074/jbc.M801379200	http://dx.doi.org/10.1074/jbc.M801379200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18552402	hybrid			2022-12-25	WOS:000258455400036
J	Jensen, PC; Thiele, S; Ulven, T; Schwartz, TW; Rosenkilde, MM				Jensen, Pia C.; Thiele, Stefanie; Ulven, Trond; Schwartz, Thue W.; Rosenkilde, Mette M.			Positive versus negative modulation of different endogenous chemokines for CC-chemokine receptor 1 by small molecule agonists through Allosteric Versus orthosteric binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPEPTIDE ANTAGONISTS; INTERNATIONAL UNION; RECEPTORS CCR1; LIGANDS; PROTEIN; ACTIVATION; NOMENCLATURE; PHARMACOLOGY; EXPRESSION; MECHANISM	7 transmembrane-spanning (7TM) chemokine receptors having multiple endogenous ligands offer special opportunities to understand the molecular basis for allosteric mechanisms. Thus, CC-chemokine receptor 1 (CCR1) binds CC-chemokine 3 and 5 (CCL3 and CCL5) with K-d values of 7.3 and 0.16 nM, respectively, as determined in homologous competition binding assays. However, CCL5 appears to have a > 10,000-fold lower affinity in competition against I-125-CCL3. Mutational mapping revealed that CCL3 and CCL5 both are strongly affected by systematic truncations of the N-terminal extension, whereas only CCL5 and not CCL3 activation is affected by substitutions in the main ligand binding pocket including the conserved GluVII:06 anchor point. A series of metal ion chelator complexes were found to act as full agonists on CCR1 and to be critically affected by the same substitutions in the main ligand binding pocket as CCL5 but not by mutations in the extracellular domain. In agreement with the overlapping binding sites, the small non-peptide agonists displaced radiolabeled CCL5 with high affinity. Interestingly, the same compounds acted as allosteric enhancers of the binding of CCL3, with which they did not overlap in binding site, leading to an increased B-max and affinity of this chemokine mainly due to an increased association rate. It is concluded that a small molecule agonist through binding deep in the main ligand binding pocket can act as an allosteric enhancer for one endogenous chemokine and at the same time as a competitive blocker of the binding of another endogenous chemokine.	[Jensen, Pia C.; Thiele, Stefanie; Schwartz, Thue W.; Rosenkilde, Mette M.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark; [Ulven, Trond] Univ So Denmark, Dept Chem & Phys, DK-5230 Odense, Denmark	University of Copenhagen; University of Southern Denmark	Rosenkilde, MM (corresponding author), Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	rosenkilde@sund.ku.dk	Ulven, Trond/H-5500-2015	Ulven, Trond/0000-0002-8135-1755; Rosenkilde, Mette Marie/0000-0001-9600-3254; Karlshoj, Stefanie/0000-0001-6505-0883; Schwartz, Thue W./0000-0002-0261-6904	Danish Medical Research Council; European Community's Sixth Framework Program [INNOCHEM: LSHB-CT-2005-518167]; NovoNordisk Foundation; AP-Moller foundation; Aase og Einer Danielsen Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community's Sixth Framework Program; NovoNordisk Foundation(Novo Nordisk Foundation); AP-Moller foundation; Aase og Einer Danielsen Foundation	This work was supported by the Danish Medical Research Council, the European Community's Sixth Framework Program (INNOCHEM: LSHB-CT-2005-518167), the NovoNordisk Foundation, the AP-Moller foundation, and the Aase og Einer Danielsen Foundation.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Ballesteros J. A., 1995, RECEPTOR MOL BIOL; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Blanpain C, 2001, J LEUKOCYTE BIOL, V69, P977; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Dautzenberg FM, 2005, PHARMACOLOGY, V75, P21, DOI 10.1159/000085897; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; GERALD C, 1995, J BIOL CHEM, V270, P26758, DOI 10.1074/jbc.270.45.26758; Hastrup H, 1996, FEBS LETT, V399, P264, DOI 10.1016/S0014-5793(96)01337-3; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Jakubik J, 1996, P NATL ACAD SCI USA, V93, P8705, DOI 10.1073/pnas.93.16.8705; Jensen PC, 2007, MOL PHARMACOL, V72, P327, DOI 10.1124/mol.106.035543; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; Kostenis E, 1998, J BIOL CHEM, V273, P17886, DOI 10.1074/jbc.273.28.17886; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Murphy PM, 2000, PHARMACOL REV, V52, P145; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Pease JE, 2005, EXPERT OPIN INV DRUG, V14, P785, DOI 10.1517/13543784.14.7.785; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Proudfoot AEI, 1999, J BIOL CHEM, V274, P32478, DOI 10.1074/jbc.274.45.32478; Rosenkilde MM, 2007, J BIOL CHEM, V282, P27354, DOI 10.1074/jbc.M704739200; Rosenkilde MM, 2007, MOL PHARMACOL, V71, P930, DOI 10.1124/mol.106.030031; Rosenkilde MM, 2006, CURR TOP MED CHEM, V6, P1319, DOI 10.2174/15680266106061319; ROSENKILDE MM, 1994, J BIOL CHEM, V269, P28160; Rosenkilde MM, 2000, MOL PHARMACOL, V57, P602, DOI 10.1124/mol.57.3.602; Saita Y, 2006, J IMMUNOL, V177, P3116, DOI 10.4049/jimmunol.177.5.3116; Schwartz TW, 2007, TRENDS PHARMACOL SCI, V28, P366, DOI 10.1016/j.tips.2007.06.008; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Schwarz MK, 2002, NAT REV DRUG DISCOV, V1, P347, DOI 10.1038/nrd795; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Struyf S, 1998, EUR J IMMUNOL, V28, P1262, DOI 10.1002/(SICI)1521-4141(199804)28:04<1262::AID-IMMU1262>3.0.CO;2-G; Thomas EA, 1997, P NATL ACAD SCI USA, V94, P14115, DOI 10.1073/pnas.94.25.14115; Zoffmann S, 2001, J MED CHEM, V44, P215, DOI 10.1021/jm000982i	39	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23121	23128		10.1074/jbc.M803458200	http://dx.doi.org/10.1074/jbc.M803458200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18559339	hybrid			2022-12-25	WOS:000258455400025
J	Ramazzina, I; Cendron, L; Folli, C; Berni, R; Monteverdi, D; Zanotti, G; Percudani, R				Ramazzina, Ileana; Cendron, Laura; Folli, Claudia; Berni, Rodolfo; Monteverdi, Daniela; Zanotti, Giuseppe; Percudani, Riccardo			Logical identification of an allantoinase analog (puuE) recruited from polysaccharide deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URIC-ACID DEGRADATION; CHITIN DEACETYLASE; BACILLUS-SUBTILIS; COLLETOTRICHUM-LINDEMUTHIANUM; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; PSEUDOMONAS-AERUGINOSA; CARBOHYDRATE ESTERASE; FUNCTIONAL EXPRESSION; ESCHERICHIA-COLI	The hydrolytic cleavage of the hydantoin ring of allantoin, catalyzed by allantoinase, is required for the utilization of the nitrogen present in purine-derived compounds. The allantoinase gene (DAL1), however, is missing in many completely sequenced organisms able to use allantoin as a nitrogen source. Here we show that an alternative allantoinase gene (puuE) can be precisely identified by analyzing its logic relationship with three other genes of the pathway. The novel allantoinase is annotated in structure and sequence data bases as polysaccharide deacetylase for its homology with enzymes that catalyze hydrolytic reactions on chitin or peptidoglycan substrates. The recombinant PuuE protein from Pseudomonas fluorescens exhibits metal-independent allantoinase activity and stereospecificity for the S enantiomer of allantoin. The crystal structures of the protein and of protein-inhibitor complexes reveal an overall similarity with the polysaccharide deacetylase alpha/beta barrel and remarkable differences in oligomeric assembly and active site geometry. The conserved Asp-His-His metal-binding triad is replaced by Glu-His-Trp, a configuration that is distinctive of PuuE proteins within the protein family. An extra domain at the top of the barrel offers a scaffold for protein tetramerization and forms a small substrate-binding cleft by hiding the large binding groove of polysaccharide deacetylases. Substrate positioning at the active site suggests an acid/base mechanism of catalysis in which only one member of the catalytic pair of polysaccharide deacetylases has been conserved. These data provide a structural rationale for the shifting of substrate specificity that occurred during evolution.	[Ramazzina, Ileana; Folli, Claudia; Berni, Rodolfo; Percudani, Riccardo] Univ Parma, Dept Biochem & Mol Biol, Parco Area Sci, I-43100 Parma, Italy; [Cendron, Laura; Zanotti, Giuseppe] Univ Padua, Dept Chem, I-35131 Padua, Italy	University of Parma; University of Padua	Percudani, R (corresponding author), Univ Parma, Dept Biochem & Mol Biol, Parco Area Sci, I-43100 Parma, Italy.	riccardo.percudani@unipr.it	cendron, Laura/A-5202-2014; percudani, riccardo/B-4872-2011	percudani, riccardo/0000-0001-8452-1062; Berni, Rodolfo/0000-0002-1839-0479; Zanotti, Giuseppe/0000-0002-0945-6501; Cendron, Laura/0000-0002-0125-0461; Ramazzina, Ileana/0000-0003-1009-2917				Barker D, 2005, PLOS COMPUT BIOL, V1, P24, DOI 10.1371/journal.pcbi.0010003; Blair DE, 2006, BIOCHEMISTRY-US, V45, P9416, DOI 10.1021/bi0606694; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; BUCKHOLZ RG, 1991, YEAST, V7, P913, DOI 10.1002/yea.320070903; Cendron L, 2007, J BIOL CHEM, V282, P18182, DOI 10.1074/jbc.M701297200; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; FLURI R, 1985, J GEN MICROBIOL, V131, P527; Fukushima T, 2002, J BACTERIOL, V184, P6007, DOI 10.1128/JB.184.21.6007-6015.2002; Gaines PJ, 2004, INSECT BIOCHEM MOLEC, V34, P203, DOI 10.1016/j.ibmb.2003.10.002; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; HAYASHI S, 1994, J BIOL CHEM, V269, P12269; Hekmat O, 2003, BIOCHEM J, V374, P369, DOI 10.1042/BJ20030204; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; JANSSEN DB, 1982, J BACTERIOL, V151, P1176, DOI 10.1128/JB.151.3.1176-1183.1982; JOHN M, 1993, P NATL ACAD SCI USA, V90, P625, DOI 10.1073/pnas.90.2.625; KAFETZOPOULOS D, 1993, P NATL ACAD SCI USA, V90, P2564, DOI 10.1073/pnas.90.7.2564; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; Kahn K, 2000, BIOORG CHEM, V28, P62, DOI 10.1006/bioo.2000.1162; Kalia A, 1999, ANAL BIOCHEM, V275, P1, DOI 10.1006/abio.1999.4259; Kim GJ, 2000, J BACTERIOL, V182, P7021, DOI 10.1128/JB.182.24.7021-7028.2000; Kim K, 2007, J BIOL CHEM, V282, P23457, DOI 10.1074/jbc.M703211200; LAPOINTE G, 1994, APPL ENVIRON MICROB, V60, P888, DOI 10.1128/AEM.60.3.888-895.1994; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; MATSUMOTO H, 1978, MOL GEN GENET, V167, P165, DOI 10.1007/BF00266910; Matsuo Y, 2005, FEBS LETT, V579, P2737, DOI 10.1016/j.febslet.2005.04.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mulrooney SB, 2003, J BACTERIOL, V185, P126, DOI 10.1128/JB.185.1.126-134.2003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oberbarnscheidt L, 2007, PROTEINS, V66, P250, DOI 10.1002/prot.21217; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Taylor EJ, 2006, J BIOL CHEM, V281, P10968, DOI 10.1074/jbc.M513066200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd CD, 2006, J EXP BOT, V57, P5, DOI 10.1093/jxb/erj013; Tokuyasu K, 2000, BIOCHEMISTRY-US, V39, P8837, DOI 10.1021/bi0005355; Vigetti D, 2002, GENE, V289, P13, DOI 10.1016/S0378-1119(02)00541-3; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; Yang JM, 2004, PLANT PHYSIOL, V134, P1037, DOI 10.1104/pp.103.034637; YOO HS, 1992, YEAST, V8, P997, DOI 10.1002/yea.320081202; Yu YM, 2006, J BIOL CHEM, V281, P36929, DOI 10.1074/jbc.M607703200; Zanotti G, 2006, J MOL BIOL, V363, P1, DOI 10.1016/j.jmb.2006.07.079	52	39	40	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23295	23304		10.1074/jbc.M801195200	http://dx.doi.org/10.1074/jbc.M801195200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550550	hybrid			2022-12-25	WOS:000258455400042
J	Beurel, E; Jope, RS				Beurel, Eleonore; Jope, Richard S.			Differential regulation of STAT family members by glycogen synthase kinase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; SIGNALING PATHWAY; INTERFERON-GAMMA; NUCLEAR EXPORT; IFN-GAMMA; CYTOKINE RECEPTORS; ALZHEIMERS-DISEASE; BETA-CATENIN; ACTIVATION; ASTROCYTES	Excessive neuroinflammation contributes to many neurological disorders and is poorly controlled therapeutically. The signal transducer and activator of transcription (STAT) family of transcription factors has a central role in inflammatory reactions, being stimulated by multiple cytokines and interferons and regulating the expression of many proteins involved in inflammation. We found that STAT3 activation is highly dependent on glycogen synthase kinase-3 (GSK3). Inhibitors of GSK3 greatly reduced (> 75%) the activating STAT3 tyrosine phosphorylation in mouse primary astrocytes, microglia, and macrophage-derived RAW264.7 cells induced by interferon-gamma (IFN gamma), IFN alpha, interleukin-6, or insulin. GSK3 inhibitors blocked STAT3 DNA binding activity and the expression of STAT3-induced GFAP and Bcl-3. GSK3 dependence was selective for activation of STAT3 and STAT5, whereas STAT1 and STAT6 activation were GSK3-independent. Knockdown of the two GSK3 isoforms showed STAT3 and STAT5 activation were dependent on GSK3 beta, but not GSK3 alpha. The regulatory mechanism involved GSK3 beta binding STAT3 and promoting its association with the IFN gamma receptor-associated intracellular signaling complex responsible for activating STAT3. Furthermore, GSK3 beta associated with the IFN gamma receptor and was activated by stimulation with IFN gamma. Thus, inhibitors of GSK3 reduce the activation of STAT3 and STAT5, providing a mechanism to differentially regulate STATs to modulate the inflammatory response.	[Beurel, Eleonore; Jope, Richard S.] Univ Alabama, Dept Psychiat & Behav Neurobiol, Sparks Ctr 1057, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Jope, RS (corresponding author), Univ Alabama, Dept Psychiat & Behav Neurobiol, Sparks Ctr 1057, 1720,7th Ave 5, Birmingham, AL 35294 USA.	jope@uab.edu			NIA NIH HHS [AG021045] Funding Source: Medline; NIMH NIH HHS [R01 MH038752, MH38752] Funding Source: Medline; NINDS NIH HHS [NS37768] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH038752, R01MH038752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021045] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahmed CML, 2003, J CELL SCI, V116, P3089, DOI 10.1242/jcs.00528; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Bhattacharya S, 2003, J CLIN INVEST, V111, P553, DOI 10.1172/JCI200315372; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bowman CC, 2003, GLIA, V43, P281, DOI 10.1002/glia.10256; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Brocke-Heidrich K, 2006, ONCOGENE, V25, P7297, DOI 10.1038/sj.onc.1209711; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Campbell IL, 2005, BRAIN RES REV, V48, P166, DOI 10.1016/j.brainresrev.2004.12.006; Cardona-Gomez P, 2004, MOL CELL NEUROSCI, V25, P363, DOI 10.1016/j.mcn.2003.10.008; Carpentier PA, 2005, GLIA, V49, P360, DOI 10.1002/glia.20117; Coffer PJ, 1997, ONCOGENE, V15, P2529, DOI 10.1038/sj.onc.1201429; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Ginger RS, 2000, EMBO J, V19, P5483, DOI 10.1093/emboj/19.20.5483; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jee Y, 2001, J NEUROIMMUNOL, V114, P40, DOI 10.1016/S0165-5728(00)00446-X; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jope RS, 1999, MOL PSYCHIATR, V4, P117, DOI 10.1038/sj.mp.4000494; Justicia C, 2000, GLIA, V30, P253, DOI 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li L, 2006, J BIOL CHEM, V281, P33172, DOI 10.1074/jbc.M606940200; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; Manoukian AS, 2002, ADV CANCER RES, V84, P203, DOI 10.1016/S0065-230X(02)84007-6; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nakashima K, 1999, J NEUROSCI, V19, P5429; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Plotnikov A, 2008, CANCER RES, V68, P1354, DOI 10.1158/0008-5472.CAN-07-6094; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Wang Y, 2005, GLIA, V50, P56, DOI 10.1002/glia.20152; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Williams LM, 2007, J BIOL CHEM, V282, P6965, DOI 10.1074/jbc.M609101200; Woodgett J. R., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P281, DOI 10.2174/1568008033340153; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhou W, 2006, BRIT J CANCER, V95, P164, DOI 10.1038/sj.bjc.6603234; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	68	132	135	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21934	21944		10.1074/jbc.M802481200	http://dx.doi.org/10.1074/jbc.M802481200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550525	Green Published, hybrid			2022-12-25	WOS:000258114700013
J	Mahmmoud, YA				Mahmmoud, Yasser A.			Capsaicin stimulates uncoupled ATP hydrolysis by the sarcoplasmic reticulum calcium pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-INSENSITIVE PHOSPHOENZYME; 1ST TRANSMEMBRANE HELIX; HEAT-PRODUCTION; SKELETAL-MUSCLE; THERMOGENIC ACTIVITY; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; CA2+ ATPASE; A-DOMAIN; CA2+-ATPASE	In muscle cells the sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA) couples the free energy of ATP hydrolysis to pump Ca2+ ions from the cytoplasm to the SR lumen. In addition, SERCA plays a key role in non-shivering thermogenesis through uncoupled reactions, where ATP hydrolysis takes place without active Ca2+ translocation. Capsaicin (CPS) is a naturally occurring vanilloid, the consumption of which is linked with increased metabolic rate and core body temperature. Here we document the stimulation by CPS of the Ca2+-dependent ATP hydrolysis by SERCA without effects on Ca2+ accumulation. The stimulation by CPS was significantly dependent on the presence of a Ca2+ gradient across the SR membrane. ATP activation assays showed that the drug reduced the nucleotide affinity at the catalytic site, whereas the affinity at the regulatory site increased. Several biochemical analyses indicated that CPS stabilizes an ADP-insensitive E2P-related conformation that dephosphorylates at a higher rate than the control enzyme. Under conditions where uncoupled SERCA was specifically inhibited by the treatment with fluoride, low temperatures, or dimethyl sulfoxide, CPS had no stimulatory effect on ATP hydrolysis by SERCA. It is concluded that CPS stabilizes a SERCA sub-conformation where Ca2+ is released from the phosphorylated intermediate to the cytoplasm instead of the SR lumen, increasing ATP hydrolysis not coupled with Ca2+ transport. To the best of our knowledge CPS is the first natural drug that augments uncoupled SERCA, presumably resulting in thermogenesis. The role of CPS as a SERCA modulator is discussed.	Aarhus Univ, Inst Phys & Biophys, DK-8000 Aarhus C, Denmark	Aarhus University	Mahmmoud, YA (corresponding author), Aarhus Univ, Inst Phys & Biophys, Ole Worms Alle 1185, DK-8000 Aarhus C, Denmark.	yam@biophys.au.dk						Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Barata H, 2002, J BIOL CHEM, V277, P16868, DOI 10.1074/jbc.M200648200; Bartolommei G, 2006, J BIOL CHEM, V281, P9547, DOI 10.1074/jbc.M510550200; Bhupathy P, 2007, J MOL CELL CARDIOL, V42, P903, DOI 10.1016/j.yjmcc.2007.03.738; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; CORNELIUS F, 1985, BIOCHIM BIOPHYS ACTA, V818, P211, DOI 10.1016/0005-2736(85)90572-3; DAIHO T, 1994, J BIOL CHEM, V269, P11060; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; de Meis L, 2003, J BIOL CHEM, V278, P41856, DOI 10.1074/jbc.M308280200; de Meis L, 2001, J BIOL CHEM, V276, P25078, DOI 10.1074/jbc.M103318200; Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005; Fortea MI, 2000, J BIOL CHEM, V275, P12521, DOI 10.1074/jbc.275.17.12521; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; Hua SM, 2005, J BIOL CHEM, V280, P17579, DOI 10.1074/jbc.M500472200; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Kobayashi A, 1998, AM J PHYSIOL-REG I, V275, pR92, DOI 10.1152/ajpregu.1998.275.1.R92; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; LINDBERG O, 1956, METHODS BIOCHEMICAL, V3, P1; Logan-Smith MJ, 2001, J BIOL CHEM, V276, P46905, DOI 10.1074/jbc.M108778200; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Mahmmoud YA, 2007, BRIT J PHARMACOL, V150, P200, DOI 10.1038/sj.bjp.0706970; Mahmmoud YA, 2005, BBA-BIOMEMBRANES, V1720, P110, DOI 10.1016/j.bbamem.2005.11.001; Mahmmoud YA, 2005, BRIT J PHARMACOL, V145, P236, DOI 10.1038/sj.bjp.0706185; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; MEIS LD, 1971, J BIOL CHEM, V246, P4759; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; Montigny C, 2007, BIOCHEMISTRY-US, V46, P15162, DOI 10.1021/bi701855r; Mori A, 2006, CANCER RES, V66, P3222, DOI 10.1158/0008-5472.CAN-05-0087; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Reis M, 2001, J BIOL CHEM, V276, P42793, DOI 10.1074/jbc.M107625200; SHIGEKAWA M, 1976, J BIOL CHEM, V251, P6947; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; STARLING AP, 1995, J BIOL CHEM, V270, P14467, DOI 10.1074/jbc.270.24.14467; Szallasi A, 1999, PHARMACOL REV, V51, P159; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Xin H, 2005, BIOCHEM BIOPH RES CO, V332, P756, DOI 10.1016/j.bbrc.2005.05.016; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361	53	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21418	21426		10.1074/jbc.M803654200	http://dx.doi.org/10.1074/jbc.M803654200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539598	hybrid			2022-12-25	WOS:000257898800013
J	Bafna, PA; Purohit, PG; Auerbach, A				Bafna, Pallavi A.; Purohit, Prasad G.; Auerbach, Anthony			Gating at the Mouth of the Acetylcholine Receptor Channel: Energetic Consequences of Mutations in the alpha M2-Cap	PLOS ONE			English	Article								Gating of nicotinic acetylcholine receptors from a C(losed) to an O(pen) conformation is the initial event in the postsynaptic signaling cascade at the vertebrate nerve-muscle junction. Studies of receptor structure and function show that many residues in this large, five-subunit membrane protein contribute to the energy difference between C and O. Of special interest are amino acids located at the two transmitter binding sites and in the narrow region of the channel, where C <-> O gating motions generate a low <-> high change in the affinity for agonists and in the ionic conductance, respectively. We have measured the energy changes and relative timing of gating movements for residues that lie between these two locations, in the C-terminus of the pore-lining M2 helix of the alpha subunit ('alpha M2-cap'). This region contains a binding site for noncompetitive inhibitors and a charged ring that influences the conductance of the open pore. alpha M2-cap mutations have large effects on gating but much smaller effects on agonist binding, channel conductance, channel block and desensitization. Three alpha M2-cap residues (alpha I260, alpha P265 and alpha S268) appear to move at the outset of channel-opening, about at the same time as those at the transmitter binding site. The results suggest that the alpha M2-cap changes its secondary structure to link gating motions in the extracellular domain with those in the channel that regulate ionic conductance.	[Bafna, Pallavi A.; Purohit, Prasad G.; Auerbach, Anthony] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bafna, PA (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA.	auerbach@buffalo.edu			NIH [NS-23513]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023513, R37NS023513] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH (NS-23513).	Akk G, 1996, J PHYSIOL-LONDON, V496, P185, DOI 10.1113/jphysiol.1996.sp021676; Arias HR, 1998, BBA-REV BIOMEMBRANES, V1376, P173, DOI 10.1016/S0304-4157(98)00004-5; Arias HR, 2006, INT J BIOCHEM CELL B, V38, P1254, DOI 10.1016/j.biocel.2006.01.006; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Auerbach A, 2007, J GEN PHYSIOL, V130, P543, DOI 10.1085/jgp.200709898; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; DILGER JP, 1992, PFLUG ARCH EUR J PHY, V420, P479, DOI 10.1007/BF00374622; DREYER EB, 1986, J BIOL CHEM, V261, P3727; Forman SA, 2007, BIOCHEMISTRY-US, V46, P11911, DOI 10.1021/bi701287a; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Hibbs RE, 2006, J BIOL CHEM, V281, P39708, DOI 10.1074/jbc.M604752200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Ho BK, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-14; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; KIENKER P, 1994, BIOPHYS J, V66, P325, DOI 10.1016/S0006-3495(94)80781-7; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Mitra A, 2005, P NATL ACAD SCI USA, V102, P15069, DOI 10.1073/pnas.0505090102; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; PEDERSEN SE, 1992, J BIOL CHEM, V267, P10489; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Purohit Y, 2006, J GEN PHYSIOL, V127, P703, DOI 10.1085/jgp.200509437; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Salamone FN, 1999, J PHYSIOL-LONDON, V516, P315, DOI 10.1111/j.1469-7793.1999.0315v.x; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	38	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2515	10.1371/journal.pone.0002515	http://dx.doi.org/10.1371/journal.pone.0002515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575616	Green Submitted, gold, Green Published			2022-12-25	WOS:000263288000032
J	Garbuzova-Davis, S; Sanberg, CD; Kuzmin-Nichols, N; Willing, AE; Gemma, C; Bickford, PC; Miller, C; Rossi, R; Sanberg, PR				Garbuzova-Davis, Svitlana; Sanberg, Cyndy Davis; Kuzmin-Nichols, Nicole; Willing, Alison E.; Gemma, Carmelina; Bickford, Paula C.; Miller, Christina; Rossi, Robert; Sanberg, Paul R.			Human Umbilical Cord Blood Treatment in a Mouse Model of ALS: Optimization of Cell Dose	PLOS ONE			English	Article								Background: Amyotrophic Lateral Sclerosis (ALS) is a multicausal disease characterized by motor neuron degeneration in the spinal cord and brain. Cell therapy may be a promising new treatment for this devastating disorder. We recently showed that a single low dose (10(6) cells) of mononuclear human umbilical cord blood (MNC hUCB) cells administered intravenously to G93A mice delayed symptom progression and modestly prolonged lifespan. The aim of this pre-clinical translation study is to optimize the dose of MNC hUCB cells to retard disease progression in G93A mice. Three different doses of MNC hUCB cells, 10610 6, 25610 6 and 50610 6, were administered intravenously into pre-symptomatic G93A mice. Motor function tests and various assays to determine cell effects were performed on these mice. Methodology/Principal Findings: Our results showed that a cell dose of 25 x 10(6) cells significantly increased lifespan of mice by 20-25% and delayed disease progression by 15%. The most beneficial effect on decreasing pro-inflammatory cytokines in the brain and spinal cord was found in this group of mice. Human Th2 cytokines were found in plasma of mice receiving 25 x 10(6) cells, although prevalent human Th1 cytokines were indicated in mice with 50 x 10(6) cells. High response of splenic cells to mitogen (PHA) was indicated in mice receiving 25 x 10(6) (mainly) and 10 x 10(6) cells. Significantly increased lymphocytes and decreased neutrophils in the peripheral blood were found only in animals receiving 25 x 10(6) cells. Stable reduction in microglia density in both cervical and lumbar spinal cords was also noted in mice administered with 25 x 10(6) cells. Conclusions/Significance: These results demonstrate that treatment for ALS with an appropriate dose of MNC hUCB cells may provide a neuroprotective effect for motor neurons through active involvement of these cells in modulating the host immune inflammatory system response.	[Garbuzova-Davis, Svitlana; Willing, Alison E.; Gemma, Carmelina; Bickford, Paula C.; Miller, Christina; Rossi, Robert; Sanberg, Paul R.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Willing, Alison E.; Gemma, Carmelina; Bickford, Paula C.; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL USA; [Garbuzova-Davis, Svitlana; Willing, Alison E.; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Garbuzova-Davis, Svitlana; Willing, Alison E.; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL USA; [Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Psychiat, Tampa, FL USA; [Sanberg, Cyndy Davis; Kuzmin-Nichols, Nicole] Saneron CCEL Therapeut Inc, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Garbuzova-Davis, S (corresponding author), Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	sgarbuzo@health.usf.edu	Willing, Alison/AAP-7759-2021; Garbuzova-Davis, Svitlana/Q-3687-2019; Willing, Alison/I-4946-2012; Bickford, Paula C/J-5970-2012	Bickford, Paula C/0000-0001-9657-7725; Sanberg, Paul/0000-0001-9130-4592; Gemma, Carmelina/0000-0002-4480-0056	NIH STTR [IR41NS46870-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R41NS046870] Funding Source: NIH RePORTER	NIH STTR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH STTR (Phase I) grant IR41NS46870-01A1.	Alexianu Maria E., 1995, Romanian Journal of Neurology and Psychiatry, V33, P215; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.3.CO;2-O; APPEL SH, 1994, J NEUROL SCI, V124, P14, DOI 10.1016/0022-510X(94)90171-6; Bicknese AR, 2002, CELL TRANSPLANT, V11, P261; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Broxmeyer H E, 1996, Cancer Treat Res, V84, P139; Bruijn LI, 2002, BIOTECHNIQUES, V32, P1112, DOI 10.2144/02325dd01; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Cardoso A A, 1993, J Hematother, V2, P275, DOI 10.1089/scd.1.1993.2.275; Chen N, 2005, STEM CELLS, V23, P1560, DOI 10.1634/stemcells.2004-0284; Chen Ruifeng, 2000, Journal of Medicine (Westbury), V31, P21; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Ende N, 2000, LIFE SCI, V67, P53, DOI 10.1016/S0024-3205(00)00602-0; Garbuzova-Davis S, 2001, AMYOTROPH LATERAL SC, V2, P175, DOI 10.1080/14660820152882179; Garbuzova-Davis S, 2002, EXP NEUROL, V174, P169, DOI 10.1006/exnr.2002.7860; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Garbuzova-Davis S, 2006, PROG BRAIN RES, V157, P207, DOI 10.1016/S0079-6123(06)57014-1; Gemma C, 2002, J NEUROSCI, V22, P6114; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hemendinger R, 2005, EXP NEUROL, V196, P235, DOI 10.1016/j.expneurol.2005.07.025; Hensley K, 2002, J NEUROCHEM, V82, P365, DOI 10.1046/j.1471-4159.2002.00968.x; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kuzmenok OI, 2006, J NEUROIMMUNOL, V172, P132, DOI 10.1016/j.jneuroim.2005.11.015; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Mayani H, 1998, STEM CELLS, V16, P153, DOI 10.1002/stem.160153; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Miller RG, 2000, NEUROLOGY, V54, P53, DOI 10.1212/WNL.54.1.53; NAKAHATA T, 1982, J CLIN INVEST, V70, P1324, DOI 10.1172/JCI110734; Nayar B, 2002, INT J GYNECOL OBSTET, V79, P31, DOI 10.1016/S0020-7292(02)00187-X; Niebroj-Dobosz I, 1999, ACTA NEUROL SCAND, V100, P238; Rainsford E, 2002, BRIT J HAEMATOL, V116, P702, DOI 10.1046/j.0007-1048.2001.03321.x; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sanberg PR, 2005, ANN NY ACAD SCI, V1049, P67, DOI 10.1196/annals.1334.008; SANBERG PR, 2004, 6174 IT PLANN SOC NE; Sanchez-Ramos JR, 2001, EXP NEUROL, V171, P109, DOI 10.1006/exnr.2001.7748; Todaro AM, 2000, BLOOD PURIFICAT, V18, P144, DOI 10.1159/000014438; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Vendrame M, 2006, EXP NEUROL, V199, P191, DOI 10.1016/j.expneurol.2006.03.017; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x	43	77	84	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2494	10.1371/journal.pone.0002494	http://dx.doi.org/10.1371/journal.pone.0002494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575617	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288000018
J	Gross, GG; Feldman, RMR; Ganguly, A; Wang, JH; Yu, H; Guo, M				Gross, Garrett G.; Feldman, R. M. Renny; Ganguly, Atish; Wang, Jinhui; Yu, Hong; Guo, Ming			Role of X11 and ubiquilin as In Vivo Regulators of the Amyloid Precursor Protein in Drosophila	PLOS ONE			English	Article								The Amyloid Precursor Protein (APP) undergoes sequential proteolytic cleavages through the action of beta- and gamma-secretase, which result in the generation of toxic beta- amyloid (A beta) peptides and a C-terminal fragment consisting of the intracellular domain of APP (AICD). Mutations leading to increased APP levels or alterations in APP cleavage cause familial Alzheimer's disease (AD). Thus, identification of factors that regulate APP steady state levels and/or APP cleavage by gamma-secretase is likely to provide insight into AD pathogenesis. Here, using transgenic flies that act as reporters for endogenous gamma-secretase activity and/or APP levels (GAMAREP), and for the APP intracellular domain (AICDREP), we identified mutations in X11L and ubiquilin (ubqn) as genetic modifiers of APP. Human homologs of both X11L (X11/Mint) and Ubqn (UBQLN1) have been implicated in AD pathogenesis. In contrast to previous reports, we show that overexpression of X11L or human X11 does not alter gamma-secretase cleavage of APP or Notch, another gamma-secretase substrate. Instead, expression of either X11L or human X11 regulates APP at the level of the AICD, and this activity requires the phosphotyrosine binding (PTB) domain of X11. In contrast, Ubqn regulates the levels of APP: loss of ubqn function leads to a decrease in the steady state levels of APP, while increased ubqn expression results in an increase in APP levels. Ubqn physically binds to APP, an interaction that depends on its ubiquitin-associated (UBA) domain, suggesting that direct physical interactions may underlie Ubqn-dependent regulation of APP. Together, our studies identify X11L and Ubqn as in vivo regulators of APP. Since increased expression of X11 attenuates A beta production and/or secretion in APP transgenic mice, but does not act on gamma-secretase directly, X11 may represent an attractive therapeutic target for AD.	[Gross, Garrett G.; Feldman, R. M. Renny; Ganguly, Atish; Wang, Jinhui; Yu, Hong; Guo, Ming] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Guo, Ming] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pharmacol, Los Angeles, CA USA; [Gross, Garrett G.; Guo, Ming] Univ Calif Los Angeles, David Geffen Sch Med, Dept Brain Res Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gross, GG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	mingfly@ucla.edu			UCLA; National Institute of Health [RO1, KO8]; Alfred P. Sloan Foundation; Alzheimer's Association; American Federation of Aging Foundation; Larry L. Hillblom Foundation; Glenn Family Foundation; Ellison Medical Foundation	UCLA(University of California System); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Alzheimer's Association(Alzheimer's Association); American Federation of Aging Foundation; Larry L. Hillblom Foundation; Glenn Family Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation)	This work was supported by a UCLA Neurobehavioral Genetics training grant to R.M.R.F., as well as grants and funds from the National Institute of Health (RO1 and KO8), the Alfred P. Sloan Foundation, the Alzheimer's Association, the American Federation of Aging Foundation, the Larry L. Hillblom Foundation, the Glenn Family Foundation and the Ellison Medical Foundation to M.G.	Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ashley J, 2005, J NEUROSCI, V25, P5943, DOI 10.1523/JNEUROSCI.1144-05.2005; Bensemain F, 2006, NEUROBIOL DIS, V22, P691, DOI 10.1016/j.nbd.2006.01.007; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Biederer T, 2002, J NEUROSCI, V22, P7340; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brouwers N, 2006, NEUROSCI LETT, V392, P72, DOI 10.1016/j.neulet.2005.08.064; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; Davidson JD, 2000, HUM MOL GENET, V9, P2305, DOI 10.1093/oxfordjournals.hmg.a018922; Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fossgreen A, 1998, P NATL ACAD SCI USA, V95, P13703, DOI 10.1073/pnas.95.23.13703; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Ganguly A, 2008, HUM MOL GENET, V17, P293, DOI 10.1093/hmg/ddm305; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Guo M, 2003, HUM MOL GENET, V12, P2669, DOI 10.1093/hmg/ddg292; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; Hase M, 2002, J NEUROCHEM, V81, P1223, DOI 10.1046/j.1471-4159.2002.00911.x; Hay BA, 2004, NAT REV GENET, V5, P911, DOI 10.1038/nrg1491; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Hoareau C, 2008, NEUROBIOL AGING, V29, P542, DOI 10.1016/j.neurobiolaging.2006.11.012; Hu Y, 2003, J CELL BIOL, V161, P685, DOI 10.1083/jcb.200304014; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Jacobs EH, 2006, NEUROSCIENCE, V138, P511, DOI 10.1016/j.neuroscience.2005.11.017; Kamboh MI, 2006, MOL PSYCHIATR, V11, P273, DOI 10.1038/sj.mp.4001775; Kim CM, 2003, VECTOR-BORNE ZOONOT, V3, P17, DOI 10.1089/153036603765627424; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; King GD, 2004, J NEUROCHEM, V88, P971, DOI 10.1046/j.1471-4159.2003.02234.x; King GD, 2003, NEUROSCIENCE, V120, P143, DOI 10.1016/S0306-4522(03)00284-7; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Lee BN, 2004, NEUROIMMUNOMODULAT, V11, P279, DOI 10.1159/000079408; Lee JH, 2003, J BIOL CHEM, V278, P47025, DOI 10.1074/jbc.M300503200; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li A, 2007, HUM MOL GENET, V16, P2626, DOI 10.1093/hmg/ddm219; Loewer A, 2004, EMBO REP, V5, P405, DOI 10.1038/sj.embor.7400122; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Marsh JL, 2006, NEURON, V52, P169, DOI 10.1016/j.neuron.2006.09.025; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; McLoughlin DM, 1996, FEBS LETT, V397, P197; Muller T, 2007, MOL BIOL CELL, V18, P201, DOI 10.1091/mbc.E06-04-0283; Myers A, 2002, AM J MED GENET, V114, P235, DOI 10.1002/ajmg.10183; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Sang Tzu-Kang, 2005, NeuroRx, V2, P438, DOI 10.1602/neurorx.2.3.438; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Slifer MA, 2006, AM J MED GENET B, V141B, P208, DOI 10.1002/ajmg.b.30298; Smemo S, 2006, ANN NEUROL, V59, P21, DOI 10.1002/ana.20673; Sumioka A, 2008, EXP CELL RES, V314, P1155, DOI 10.1016/j.yexcr.2007.12.006; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Vishnu S, 2006, DEV BIOL, V289, P296, DOI 10.1016/j.ydbio.2005.09.016; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zhang C, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-15; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104	76	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2495	10.1371/journal.pone.0002495	http://dx.doi.org/10.1371/journal.pone.0002495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575606	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000019
J	Timinszky, G; Bortfeld, M; Ladurner, AG				Timinszky, Gyula; Bortfeld, Miriam; Ladurner, Andreas G.			Repression of RNA Polymerase II Transcription by a Drosophila Oligopeptide	PLOS ONE			English	Article								Background: Germline progenitors resist signals that promote differentiation into somatic cells. This occurs through the transient repression in primordial germ cells of RNA polymerase II, specifically by disrupting Ser2 phosphorylation on its C-terminal domain. Methodology/Principal Findings: Here we show that contrary to expectation the Drosophila polar granule component (pgc) gene functions as a protein rather than a non-coding RNA. Surprisingly, pgc encodes a 71-residue, dimeric, alpha-helical oligopeptide repressor. In vivo data show that Pgc ablates Ser2 phosphorylation of the RNA polymerase II C-terminal domain and completely suppresses early zygotic transcription in the soma. Conclusions/Significance: We thus identify pgc as a novel oligopeptide that readily inhibits gene expression. Germ cell repression of transcription in Drosophila is thus catalyzed by a small inhibitor protein.	[Timinszky, Gyula; Bortfeld, Miriam; Ladurner, Andreas G.] European Mol Biol Lab, Gene Express Unit, Heidelberg, Germany; [Ladurner, Andreas G.] European Mol Biol Lab, Structural & Computat Biol Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Timinszky, G (corresponding author), European Mol Biol Lab, Gene Express Unit, Heidelberg, Germany.	ladurner@embl.de		Timinszky, Gyula/0000-0001-6342-8985; Ladurner, Andreas/0000-0003-3835-232X	EMBL; EU; Human Frontiers Science Program [Young Investigator Award]	EMBL; EU(European Commission); Human Frontiers Science Program(Human Frontier Science Program)	A.G.L. thanks the EMBL and the EU Network of Excellence "The Epigenome" for financial support. A.G.L. is the recipient of a Young Investigator Award from the Human Frontiers Science Program.	Deshpande G, 2004, DEVELOPMENT, V131, P1247, DOI 10.1242/dev.01004; Hanyu-Nakamura K, 2008, NATURE, V451, P730, DOI 10.1038/nature06498; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; Nakamura A, 1996, SCIENCE, V274, P2075, DOI 10.1126/science.274.5295.2075; Rothwell W.F., 2000, DROSOPHILA PROTOCOLS, P141; Till S, 2007, CELL, V131, P643, DOI 10.1016/j.cell.2007.10.044; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213	10	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2506	10.1371/journal.pone.0002506	http://dx.doi.org/10.1371/journal.pone.0002506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575576	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288000025
J	Sussman, M; Willis, BL; Victor, S; Bourne, DG				Sussman, Meir; Willis, Bette L.; Victor, Steven; Bourne, David G.			Coral Pathogens Identified for White Syndrome (WS) Epizootics in the Indo-Pacific	PLOS ONE			English	Article							CHOLERAE HEMAGGLUTININ PROTEASE; PLAGUE-LIKE DISEASE; VIBRIO-SHILOI; CAUSATIVE AGENT; SP-NOV.; POCILLOPORA-DAMICORNIS; INFECTIOUS-DISEASES; OCULINA-PATAGONICA; EPITHELIAL-CELLS; SHIGA TOXIN	Background: White Syndrome (WS), a general term for scleractinian coral diseases with acute signs of advancing tissue lesions often resulting in total colony mortality, has been reported from numerous locations throughout the Indo-Pacific, constituting a growing threat to coral reef ecosystems. Methodology/Principal Findings: Bacterial isolates were obtained from corals displaying disease signs at three WS outbreak sites: Nikko Bay in the Republic of Palau, Nelly Bay in the central Great Barrier Reef (GBR) and Majuro Atoll in the Republic of the Marshall Islands, and used in laboratory-based infection trials to satisfy Henle-Koch's postulates, Evan's rules and Hill's criteria for establishing causality. Infected colonies produced similar signs to those observed in the field following exposure to bacterial concentrations of 1x10(6) cells ml(-1). Phylogenetic 16S rRNA gene analysis demonstrated that all six pathogens identified in this study were members of the gamma-Proteobacteria family Vibrionacae, each with greater than 98% sequence identity with the previously characterized coral bleaching pathogen Vibrio coralliilyticus. Screening for proteolytic activity of more than 150 coral derived bacterial isolates by a biochemical assay and specific primers for a Vibrio family zinc-metalloprotease demonstrated a significant association between the presence of isolates capable of proteolytic activity and observed disease signs. Conclusion/Significance: This is the first study to provide evidence for the involvement of a unique taxonomic group of bacterial pathogens in the aetiology of Indo-Pacific coral diseases affecting multiple coral species at multiple locations. Results from this study strongly suggest the need for further investigation of bacterial proteolytic enzymes as possible virulence factors involved in Vibrio associated acute coral infections.	[Sussman, Meir; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Sussman, Meir; Bourne, David G.] Townsville MC, Australian Inst Marine Sci, PMB3, Townsville, Qld, Australia; [Victor, Steven] Palau Int Coral Reef Ctr, Koror, Palau	James Cook University; Australian Institute of Marine Science	Sussman, M (corresponding author), James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	dsmb007@jcu.edu.au	Bourne, David G/B-5073-2008	Bourne, David G/0000-0002-1492-8710	ARC [Discovery grant]; James Cook University [CRIG grant]	ARC(Australian Research Council); James Cook University	This study was funded by an ARC Discovery grant and a James Cook University CRIG grant to BL Willis. The authors wish to thank CD Harvell, Chair of the World Bank Coral Disease Working Group, L Raymundo, University of Guam, and A Hooten from the IOC-GEF/World Bank Coral Reef Targeted Research and Capacity Building Program for contributing funding and support for travel and field work in Palau. Work on the research vessel Lady Basten and in the PC2 laboratory at Cape Ferguson was funded by the Australian Institute of Marine Science.	Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; Ainsworth TD, 2007, MAR BIOL, V151, P19, DOI 10.1007/s00227-006-0449-3; Ainsworth TD, 2007, APPL ENVIRON MICROB, V73, P981, DOI 10.1128/AEM.02172-06; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amaro C, 1996, APPL ENVIRON MICROB, V62, P1454, DOI 10.1128/AEM.62.4.1454-1457.1996; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Banin E, 2001, FEMS MICROBIOL LETT, V199, P33; Barash Y, 2005, AQUAT MICROB ECOL, V40, P183, DOI 10.3354/ame040183; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Ben-Haim Y, 1999, ENVIRON MICROBIOL, V1, P223, DOI 10.1046/j.1462-2920.1999.00027.x; BOOTH BA, 1986, J INFECT DIS, V154, P183, DOI 10.1093/infdis/154.1.183; Bordas MA, 1996, APPL ENVIRON MICROB, V62, P3650, DOI 10.1128/AEM.62.10.3650-3654.1996; Bourne DG, 2005, CORAL REEFS, V24, P304, DOI 10.1007/s00338-005-0479-1; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; BOURNE DG, 2007, IZME ONLINE; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Cervino JM, 2004, APPL ENVIRON MICROB, V70, P6855, DOI 10.1128/AEM.70.11.6855-6864.2004; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Connolly SR, 2005, SCIENCE, V309, P1363, DOI 10.1126/science.1113281; DANE FC, 1990, RES METHODS, P258; Day T, 2002, P ROY SOC B-BIOL SCI, V269, P1317, DOI 10.1098/rspb.2002.2021; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Denkin SM, 1999, APPL ENVIRON MICROB, V65, P3555; Denkin SM, 2004, APPL ENVIRON MICROB, V70, P4193, DOI 10.1128/AEM.70.7.4193-4204.2004; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Dubos Ren?J., 1965, MAN ADAPTING; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Efrony R, 2007, CORAL REEFS, V26, P7, DOI 10.1007/s00338-006-0170-1; EVANS AS, 1976, YALE J BIOL MED, V49, P175; *FAO, 1995, CHALL SUST FOR MAN W, P128; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; FINKELSTEIN RA, 1983, P NATL ACAD SCI-BIOL, V80, P1092, DOI 10.1073/pnas.80.4.1092; FINKELSTEIN RA, 1992, INFECT IMMUN, V60, P472, DOI 10.1128/IAI.60.2.472-478.1992; FINKELSTEIN RA, 1982, INFECT IMMUN, V36, P1199, DOI 10.1128/IAI.36.3.1199-1208.1982; Fiorentini C, 1998, INFECT IMMUN, V66, P2660, DOI 10.1128/IAI.66.6.2660-2665.1998; Geiser DM, 1998, NATURE, V394, P137, DOI 10.1038/28079; Gil-Agudelo DL, 2007, CAN J MICROBIOL, V53, P465, DOI 10.1139/W07-002; GILAGUDELO DL, 2006, INT J TROP BIOL S3, V54, P59; Haapkyla J, 2007, J MAR BIOL ASSOC UK, V87, P403, DOI 10.1017/S0025315407055828; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; HASE CC, 1991, J BACTERIOL, V173, P3311; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hiney Maura, 1997, Bulletin of the European Association of Fish Pathologists, V17, P245; Hiney MP, 1998, AQUACULTURE, V162, P41, DOI 10.1016/S0044-8486(98)00207-5; HONDA T, 1989, INFECT IMMUN, V57, P2799, DOI 10.1128/IAI.57.9.2799-2803.1989; Israely T, 2001, AQUAT MICROB ECOL, V24, P1, DOI 10.3354/ame024001; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; KAMATA R, 1985, INFECT IMMUN, V48, P747, DOI 10.1128/IAI.48.3.747-753.1985; KEENAN KP, 1986, AM J PATHOL, V125, P69; Kim CM, 2007, FEMS MICROBIOL LETT, V269, P170, DOI 10.1111/j.1574-6968.2006.00622.x; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Koch R., 1891, BAKT FORSCH VERH 10, V1, P35; Kushmaro A, 1997, MAR ECOL PROG SER, V147, P159, DOI 10.3354/meps147159; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Kushmaro A, 1996, NATURE, V380, P396, DOI 10.1038/380396a0; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lightner D. V., 1988, Disease diagnosis and control in North American marine aquaculture., P42; Linkous DA, 1999, FEMS MICROBIOL LETT, V174, P207, DOI 10.1111/j.1574-6968.1999.tb13570.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maidak BL, 1996, NUCLEIC ACIDS RES, V24, P82, DOI 10.1093/nar/24.1.82; McCole DF, 2000, INFECT IMMUN, V68, P1710, DOI 10.1128/IAI.68.3.1710-1713.2000; MILTON DL, 1992, J BACTERIOL, V174, P7235, DOI 10.1128/jb.174.22.7235-7244.1992; MIYOSHI S, 1988, MICROBIOL IMMUNOL, V32, P1025, DOI 10.1111/j.1348-0421.1988.tb01467.x; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Negri A, 2005, MAR POLLUT BULL, V51, P370, DOI 10.1016/j.marpolbul.2004.10.053; NELSON ET, 1976, INFECT IMMUN, V14, P527, DOI 10.1128/IAI.14.2.527-547.1976; Osawa R, 2000, J MED MICROBIOL, V49, P565, DOI 10.1099/0022-1317-49-6-565; Palumbi SR, 2005, NATURE, V434, P713, DOI 10.1038/434713a; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Retief J D, 2000, Methods Mol Biol, V132, P243; Richie K., 1998, REV BIOL TROP, V46, P199; Ritchie KB, 1994, PROCEEDINGS OF THE FIFTH SYMPOSIUM ON THE NATURAL HISTORY OF THE BAHAMAS, P75; Roff G, 2006, CORAL REEFS, V25, P255, DOI 10.1007/s00338-006-0099-4; Rosenberg E, 2004, ANNU REV MICROBIOL, V58, P143, DOI 10.1146/annurev.micro.58.030603.123610; SNIESZKO SF, 1974, J FISH BIOL, V6, P197, DOI 10.1111/j.1095-8649.1974.tb04537.x; STAINER RY, 1971, GEN MICROBIOLOGY; STELMA GN, 1992, APPL ENVIRON MICROB, V58, P2776, DOI 10.1128/AEM.58.9.2776-2782.1992; Sussman M, 2003, ENVIRON MICROBIOL, V5, P250, DOI 10.1046/j.1462-2920.2003.00424.x; TAMPLIN ML, 1990, APPL ENVIRON MICROB, V56, P1977, DOI 10.1128/AEM.56.6.1977-1980.1990; Teo JWP, 2003, GENE, V303, P147, DOI 10.1016/S0378-1119(02)01151-4; Thomas SR, 2004, J INVERTEBR PATHOL, V85, P146, DOI 10.1016/j.jip.2004.01.006; Thompson FL, 2006, INT J SYST EVOL MICR, V56, P365, DOI 10.1099/ijs.0.63800-0; Thrusfield M., 2018, VET EPIDEMIOLOGY, DOI [10.1002/9781118280249, DOI 10.1002/9781118280249]; Valenti P, 1999, EXP CELL RES, V250, P197, DOI 10.1006/excr.1999.4500; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; WILESMITH JW, 1993, PREV VET MED, V18, P33, DOI 10.1016/0167-5877(93)90091-7; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Windle HJP, 1997, INFECT IMMUN, V65, P3132, DOI 10.1128/IAI.65.8.3132-3137.1997; *WORLD ORG AN HLTH, 2006, MAN DIAGN TESTS AQ A; Wu ZY, 1996, MICROB PATHOGENESIS, V21, P111, DOI 10.1006/mpat.1996.0047; Yokouchi H, 2006, ENVIRON MICROBIOL, V8, P1155, DOI 10.1111/j.1462-2920.2006.01005.x	104	197	200	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2393	10.1371/journal.pone.0002393	http://dx.doi.org/10.1371/journal.pone.0002393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560584	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000263280700004
J	Walker, S; Peto, TEA; O'Connor, L; Crook, DW; Wyllie, D				Walker, Sarah; Peto, Tim E. A.; O'Connor, Lily; Crook, Derrick W.; Wyllie, David			Are There Better Methods of Monitoring MRSA Control than Bacteraemia Surveillance? An Observational Database Study	PLOS ONE			English	Article								Background: Despite a substantial burden of non-bacteraemic methicillin resistant Staphylococcus aureus (MRSA) disease, most MRSA surveillance schemes are based on bacteraemias. Using bacteraemia as an outcome, trends at hospital level are difficult to discern, due to random variation. We investigated rates of nosocomial bacteraemic and non-bacteraemic MRSA infection as surveillance outcomes. Methods and Findings: We used microbiology and patient administration system data from an Oxford hospital to estimate monthly rates of first nosocomial MRSA bacteraemia, and nosocomial MRSA isolation from blood/respiratory/sterile site specimens ("sterile sites") or all clinical samples (screens excluded) in all patients admitted from the community for at least 2 days between April 1998 and June 2006. During this period there were 441 nosocomial MRSA bacteraemias, 1464 MRSA isolations from sterile sites, and 3450 isolations from clinical specimens (8% blood, 15% sterile site, 10% respiratory, 59% surface swabs, 8% urine) in over 2.6 million patient-days. The ratio of bacteraemias to sterile site and all clinical isolations was similar over this period (around 3 and 8-fold lower respectively), during which rates of nosocomial MRSA bacteraemia increased by 27% per year to July 2003 before decreasing by 18% per year thereafter (heterogeneity p < 0.001). Trends in sterile site and all clinical isolations were similar. Notably, a change in rate of all clinical MRSA isolations in December 2002 could first be detected with conventional statistical significance by August 2003 (p = 0.03). In contrast, when monitoring MRSA bacteraemia, identification of probable changes in trend took longer, first achieving p < 0.05 in July 2004. Conclusions: MRSA isolation from all sites of suspected infection, including bacteraemic and non-bacteraemic isolation, is a potential new surveillance method for MRSA control. It occurs about 8 times more frequently than bacteraemia, allowing robust statistical determination of changing rates over substantially shorter times or smaller areas than using bacteraemia as an outcome.	[Walker, Sarah; Peto, Tim E. A.; O'Connor, Lily; Crook, Derrick W.] John Radcliffe Hosp, Oxford Radcliffe Hosp NHS Trust, Oxford OX3 9DU, England; [Walker, Sarah] MRC Clin Trials Unit, London, England; [Wyllie, David] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; Medical Research Council Clinical Trials Unit; University of Oxford	Walker, S (corresponding author), John Radcliffe Hosp, Oxford Radcliffe Hosp NHS Trust, Oxford OX3 9DU, England.	david.wyllie@ndcls.ox.ac.uk		peto, tim/0000-0003-3477-8307	Oxford Biomedical Research Centre Programme	Oxford Biomedical Research Centre Programme	Supported by the Oxford Biomedical Research Centre Programme, which is an NIHR funded Biomedical Research Centre.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Coello R, 1997, J HOSP INFECT, V37, P39, DOI 10.1016/S0195-6701(97)90071-2; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; HORAN TC, 2004, HOSP EPIDEMIOLOGY IN, P1659; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; LANGMUIR AD, 1963, NEW ENGL J MED, V268, P182, DOI 10.1056/NEJM196301242680405; Loveday HP, 2006, J HOSP INFECT, V63, pS45, DOI 10.1016/j.jhin.2006.01.002; Mekontso-Dessap A, 2001, CLIN INFECT DIS, V32, P877, DOI 10.1086/319355; Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756; Pollard TCB, 2006, J HOSP INFECT, V63, P133, DOI 10.1016/j.jhin.2006.01.015; Roghmann MC, 2001, J HOSP INFECT, V47, P98, DOI 10.1053/jhin.2000.0903; Shorr AF, 2006, CRIT CARE MED, V34, P700, DOI 10.1097/01.CCM.0000201885.57697.21; Spiegelhalter DJ, 2005, BRIT MED J, V331, P1013, DOI 10.1136/bmj.331.7523.1013; *SURV HEALTHC ASS, 2007, SURV HEALTHC ASS INF; TAYLOR J, 2006, SURVEILLANCE SURG SI; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F; Wyllie DH, 2005, BMJ-BRIT MED J, V331, P992, DOI 10.1136/bmj.38558.453310.8F	18	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2378	10.1371/journal.pone.0002378	http://dx.doi.org/10.1371/journal.pone.0002378			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545686	Green Published, Green Submitted, gold			2022-12-25	WOS:000263248800018
J	Qiu, X; Aiken, KJ; Chokas, AL; Beachy, DE; Nick, HS				Qiu, Xiaolei; Aiken, Kimberly J.; Chokas, Ann L.; Beachy, Dawn E.; Nick, Harry S.			Distinct functions of CCAAT enhancer-binding protein isoforms in the regulation of manganese superoxide dismutase during interleukin-1 beta stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; C/EBP-BETA ISOFORM; TRANSCRIPTIONAL ACTIVATOR PROTEIN; SMOOTH-MUSCLE-CELLS; FACTOR-ALPHA; GENE-TRANSCRIPTION; MESSENGER-RNA; DNA-BINDING; MALIGNANT PHENOTYPE	The mitochondrial antioxidant enzyme manganese superoxide dismutase (Mn-SOD) is crucial in maintaining cellular and organismal homeostasis. Mn-SOD expression is tightly regulated in a manner that synchronizes its cytoprotective functions during inflammatory challenges. Induction of Mn-SOD gene expression by the proinflammatory cytokine IL-1 beta is mediated through a complex intronic enhancer element. To identify and characterize the transcription factors required for Mn-SOD enhancer function, a yeast one-hybrid assay was utilized, and two CCAAT enhancer-binding protein (C/EBP) members, C/EBP beta and C/EBP delta, were identified. These two transcription factors responded to IL-1 beta treatment with distinct expression profiles, different temporal yet inducible interactions with the endogenous Mn-SOD enhancer, and also opposite effects on Mn-SOD transcription. C/EBP beta is expressed as three isoforms, LAP* (liver-activating protein), LAP, and LIP (liver-inhibitory protein). Our functional analysis demonstrated that only the full-length C/EBP beta/LAP* served as a true activator for Mn-SOD, whereas LAP, LIP, and C/EBP delta functioned as potential repressors. Finally, our systematic mutagenesis of the unique N-terminal 21 amino acids further solidified the importance of LAP* in the induction of Mn-SOD and emphasized the crucial role of this isoform. Our data demonstrating the physiological relevance of the N-terminal peptide also provide a rationale for revisiting the role of LAP* in the regulation of other genes and in pathways such as lipogenesis and development.	[Nick, Harry S.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Qiu, Xiaolei; Aiken, Kimberly J.; Chokas, Ann L.; Nick, Harry S.] Univ Florida, McKnight Brian Inst, Gainesville, FL 32610 USA; [Qiu, Xiaolei; Nick, Harry S.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Nick, HS (corresponding author), Univ Florida, Coll Med, Dept Neurosci, POB 100244, Gainesville, FL 32610 USA.	hnick@ufl.edu			National Institutes of Health [HL39593, HL067456]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL067456, R01HL067456, R01HL039593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL39593 and HL067456 (to H. S. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Amstad PA, 1997, CARCINOGENESIS, V18, P479, DOI 10.1093/carcin/18.3.479; CAI DH, 2007, ONCOGENE; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; CHANG CJ, 1990, MOL CELL BIOL, V10, P6642, DOI 10.1128/MCB.10.12.6642; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; CHURCH SL, 1993, P NATL ACAD SCI USA, V90, P3113, DOI 10.1073/pnas.90.7.3113; CLEUTJENS CBJM, 1993, GENOMICS, V16, P520, DOI 10.1006/geno.1993.1220; Davis CA, 2004, J BIOL CHEM, V279, P12769, DOI 10.1074/jbc.M310623200; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DOUGALL WC, 1991, ENDOCRINOLOGY, V129, P2376, DOI 10.1210/endo-129-5-2376; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Fukuoka T, 1999, J BIOL CHEM, V274, P25576, DOI 10.1074/jbc.274.36.25576; GIBBS LS, 1992, FREE RADICAL BIO MED, V12, P107, DOI 10.1016/0891-5849(92)90003-Y; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; Greenberger JS, 2007, IN VIVO, V21, P141; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; INOUYE C, 1994, DNA CELL BIOL, V13, P731, DOI 10.1089/dna.1994.13.731; Ishiguro K, 2004, BLOOD, V103, P2248, DOI 10.1182/blood-2003-08-2671; Izutani R, 1998, J GASTROENTEROL, V33, P816, DOI 10.1007/s005350050181; JOHNSON PF, 1993, MOL CELL BIOL, V13, P6919, DOI 10.1128/MCB.13.11.6919; Jones PL, 1997, MOL CELL BIOL, V17, P6970, DOI 10.1128/MCB.17.12.6970; JONES PL, 1995, GENE, V153, P155, DOI 10.1016/0378-1119(94)00666-G; KAGEYAMA R, 1991, J BIOL CHEM, V266, P15525; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Li N, 1998, PROSTATE, V35, P221, DOI 10.1002/(SICI)1097-0045(19980515)35:3<221::AID-PROS8>3.0.CO;2-J; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; LIN PS, 1993, LYMPHOKINE CYTOK RES, V12, P303; Liu RG, 1997, HUM GENE THER, V8, P585, DOI 10.1089/hum.1997.8.5-585; Liu YM, 2005, CARCINOGENESIS, V26, P1335, DOI 10.1093/carcin/bgi083; Maehara K, 1999, FEBS LETT, V449, P115, DOI 10.1016/S0014-5793(99)00408-1; Maehara K, 2000, J CELL BIOCHEM, V77, P474, DOI 10.1002/(SICI)1097-4644(20000601)77:3<474::AID-JCB12>3.0.CO;2-H; MAGALINI A, 1995, CYTOKINE, V7, P753, DOI 10.1006/cyto.1995.0090; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Martinez-Jimenez CP, 2005, MOL PHARMACOL, V67, P2088, DOI 10.1124/mol.104.008169; MASUDA A, 1988, FASEB J, V2, P3087, DOI 10.1096/fasebj.2.15.3263930; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; OBERLEY LW, 1979, CANCER RES, V39, P1141; Osada S, 1996, J BIOL CHEM, V271, P3891; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Park MH, 2008, FEBS LETT, V582, P415, DOI 10.1016/j.febslet.2008.01.001; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; Pomerance M, 2005, THYROID, V15, P197, DOI 10.1089/thy.2005.15.197; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ranjan P, 2006, APOPTOSIS, V11, P1837, DOI 10.1007/s10495-006-9530-0; RAY A, 1995, J BIOL CHEM, V270, P7365, DOI 10.1074/jbc.270.13.7365; Rogers RJ, 2000, BIOCHEM J, V347, P233, DOI 10.1042/0264-6021:3470233; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Su WC, 2003, J BIOL CHEM, V278, P51150, DOI 10.1074/jbc.M305501200; Takiguchi M, 1998, INT J EXP PATHOL, V79, P369, DOI 10.1046/j.1365-2613.1998.00082.x; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; VALENTINE JF, 1992, GASTROENTEROLOGY, V103, P905, DOI 10.1016/0016-5085(92)90024-S; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; VISNER GA, 1991, AM J PHYSIOL, V260, pL444, DOI 10.1152/ajplung.1991.260.6.L444; VISNER GA, 1990, J BIOL CHEM, V265, P2856; WARREN JS, 1988, AM J PATHOL, V130, P489; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Weydert C, 2003, MOL CANCER THER, V2, P361; WHITE JE, 1994, AM J PHYSIOL, V266, pL664, DOI 10.1152/ajplung.1994.266.6.L664; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Yarwood SJ, 2008, J BIOL CHEM, V283, P6843, DOI 10.1074/jbc.M710342200; Zhong WX, 1999, FREE RADICAL BIO MED, V27, P1334, DOI 10.1016/S0891-5849(99)00181-1; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	85	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25774	25785		10.1074/jbc.M801178200	http://dx.doi.org/10.1074/jbc.M801178200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18559338	Green Published, hybrid			2022-12-25	WOS:000259200100003
J	Araki, K; Kawauchi, K; Tanaka, N				Araki, K.; Kawauchi, K.; Tanaka, N.			IKK/NF-kappa B signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors	ONCOGENE			English	Article						E2F; Rb; IKK; NF-kappa B; cell cycle; HAT	TUMOR-NECROSIS-FACTOR; FAMILY-MEMBERS; GROWTH; ALPHA; PHOSPHORYLATION; ACETYLATION; ACTIVATION; DISTINCT; TRANSFORMATION; PROLIFERATION	E2Fs are key regulators of cell-cycle progression, and their transcriptional activities are regulated by histone acetyltransferases (HATs). Retinoblastoma (Rb) family proteins (pRb, p107 and p130) bind to E2Fs and inhibit their transcriptional activities by disrupting HAT binding and recruitment of histone deacetylases. In this study, we show that I kappa B kinases (IKK alpha or IKK beta) activation inhibits cell growth and E2F-dependent transcription in normal human fibroblasts. The inhibition of E2F by IKKs was not observed in cells lacking nuclear factor (NF)-kappa B/p65; however, it was observed in cells lacking three Rb family genes. p65 disrupted the physical interaction between activator E2Fs (F2F1, E2F2 and E2F3) and the HAT cofactor transactivation/transformation-domain associated protein, resulting in a reduction in E2F-responsive gene expression. Furthermore, IKK alpha and IKK beta directly phosphorylated E2F4, resulting in nuclear accumulation and enhanced DNA binding of the E2F4/p130 repressor complex. Our study describes a novel growth inhibitory system that functions by Rb-independent suppression of E2Fs by the IKK/NF-kappa B signaling pathway.	[Araki, K.; Kawauchi, K.; Tanaka, N.] Nippon Med Sch, Dept Mol Oncol, Inst Gerontol, Nakahara Ku, Kawasaki, Kanagawa 2118533, Japan	Nippon Medical School	Tanaka, N (corresponding author), Nippon Med Sch, Dept Mol Oncol, Inst Gerontol, Nakahara Ku, Kosugicho 1-396, Kawasaki, Kanagawa 2118533, Japan.	nobuta@nms.ac.jp	Kawauchi, Keiko/G-4198-2010	Tanaka, Nobuyuki/0000-0002-6373-2220	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank M Ikeda, K Ohtani, S Sugano, T Doi, MD Cole, G Leone, DV Goeddel, J Sage and T Jacks for providing the materials; K Tobiume, E Oda-Sato, Y Abe, I Uehara, W Nakajima and M Ando for the useful discussion, and Y Asano, H Hiroike and M Kawagoe for technical assistance. This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AGGARWAL BB, 1995, FEBS LETT, V357, P1, DOI 10.1016/0014-5793(94)01299-G; Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Brantley DM, 2001, MOL BIOL CELL, V12, P1445, DOI 10.1091/mbc.12.5.1445; DeGregori J, 2006, CURR MOL MED, V6, P739; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Ferreira R, 2001, ONCOGENE, V20, P3128, DOI 10.1038/sj.onc.1204337; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lang SE, 2001, J BIOL CHEM, V276, P32627, DOI 10.1074/jbc.M102067200; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li QT, 2005, TRENDS IMMUNOL, V26, P318, DOI 10.1016/j.it.2005.04.003; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Rowland BD, 2006, CELL, V127, P871, DOI 10.1016/j.cell.2006.11.019; Seitz CS, 2000, CANCER RES, V60, P4085; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Spyridopoulos I, 1998, CIRCULATION, V98, P2883, DOI 10.1161/01.CIR.98.25.2883; Takahashi Y, 2000, GENE DEV, V14, P804; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Trouche D, 1996, NUCLEIC ACIDS RES, V24, P4139, DOI 10.1093/nar/24.21.4139; Tu Z, 2006, J BIOL CHEM, V281, P6699, DOI 10.1074/jbc.M512439200; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784	32	29	29	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2008	27	43					5696	5705		10.1038/onc.2008.184	http://dx.doi.org/10.1038/onc.2008.184			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	352HM	18542057				2022-12-25	WOS:000259487100005
J	Arbab, AS; Janic, B; Knight, RA; Anderson, SA; Pawelczyk, E; Rad, AM; Read, EJ; Pandit, SD; Frank, JA				Arbab, Ali S.; Janic, Branislava; Knight, Robert A.; Anderson, Stasia A.; Pawelczyk, Edyta; Rad, Ali M.; Read, Elizabeth J.; Pandit, Sunil D.; Frank, Joseph A.			Detection of migration of locally implanted AC133(+) stem cells by cellular magnetic resonance imaging with histological findings	FASEB JOURNAL			English	Article						MRI; magnetically labeled AC133(+) cells; tumors; angiogenesis	ENDOTHELIAL PROGENITOR CELLS; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; GROWTH-FACTOR; TUMOR ANGIOGENESIS; BLOOD; DIFFERENTIATION; TRAFFICKING; NEOVASCULARIZATION; MOBILIZATION; FERUMOXIDES	This study investigated the factors responsible for migration and homing of magnetically labeled AC133(+) cells at the sites of active angiogenesis in tumor. AC133(+) cells labeled with ferumoxide-protamine sulfate were mixed with either rat glioma or human melanoma cells and implanted in flank of nude mice. An MRI of the tumors including surrounding tissues was performed. Tumor sections were stained for Prussian blue (PB), platelet-derived growth factor (PDGF), hypoxia-inducible factor-1 alpha (HIF-1 alpha), stromal cell derived factor-1 (SDF-1), matrix metalloproteinase-2 (MMP-2), vascular endothelial growth factor (VEGF), and endothelial markers. Fresh snap-frozen strips from the central and peripheral parts of the tumor were collected for Western blotting. MRIs demonstrated hypointense regions at the periphery of the tumors where the PB+/AC133(+) cells were positive for endothelial cells markers. At the sites of PB+/AC133(+) cells, both HIF-1 alpha and SDF-1 were strongly positive and PDGF and MMP-2 showed generalized expression in the tumor and surrounding tissues. There was no significant association of PB+/AC133(+) cell localization and VEGF expression in tumor cells. Western blot demonstrated strong expression of the SDF-1, MMP-2, and PDGF at the peripheral parts of the tumors. HIF-1 alpha was expressed at both the periphery and central parts of the tumor. This work demonstrates that magnetically labeled cells can be used as probes for MRI and histological identification of administered cells.	[Arbab, Ali S.; Janic, Branislava; Knight, Robert A.; Rad, Ali M.] Henry Ford Hosp, Dept Radiol, Mol & Cellular Imaging Lab, Detroit, MI 48202 USA; [Anderson, Stasia A.] NHLBI, Mouse Core Imaging Facil, Bethesda, MD 20892 USA; [Pawelczyk, Edyta; Frank, Joseph A.] NIH, Expt Neuroimaging Sect, Lab Diagnost Radiol Res, Bethesda, MD 20892 USA; [Read, Elizabeth J.] NIH, Cell Proc Sect, Dept Transfus Med, Bethesda, MD 20892 USA; [Pandit, Sunil D.] NIH, Mol Imaging Lab, Ctr Clin, Bethesda, MD 20892 USA	Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Arbab, AS (corresponding author), Henry Ford Hlth Syst, Dept Radiol, 1 Ford Pl,2F,Box 82, Detroit, MI 48202 USA.	saali@rad.hfh.edu	Arbab, Ali/AAS-1933-2020; Frank, Joseph/W-2021-2019	Anderson, Stasia/0000-0002-2566-6947	Intramural Research Program; National Institutes of Health [5R01CA122031]; NATIONAL CANCER INSTITUTE [R01CA122031] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005909] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090007] Funding Source: NIH RePORTER	Intramural Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CLINICAL CENTER	We thank Gene T. Yocum for help during the labeling of AC133<SUP>+</SUP> cells at the National Institutes of Health. We thank Dr. A. S. M. Iskander for help in sectioning of collected tumor samples and collection of AC133<SUP>+</SUP> cells from cord blood, and Dr. Hanh M. Khuu for supervision during collection of AC133<SUP>+</SUP> from volunteers. This work was supported in part by the Intramural Research Program of the Clinical Center at the National Institutes of Health and an extramural funding grant (5R01CA122031).	Agbulut O, 2004, J AM COLL CARDIOL, V44, P458, DOI 10.1016/j.jacc.2004.03.083; Allanore Y, 2007, CLIN EXP RHEUMATOL, V25, P60; Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Anderson SA, 2004, ANN NEUROL, V55, P654, DOI 10.1002/ana.20066; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Arbab AS, 2004, HUM GENE THER, V15, P351, DOI 10.1089/104303404322959506; ARBAB AS, 2006, MOL IMAGING, V5, P233; Asahara T, 2004, AM J PHYSIOL-CELL PH, V287, pC572, DOI 10.1152/ajpcell.00330.2003; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Ellis LM, 2001, SEMIN ONCOL, V28, P94, DOI 10.1053/sonc.2001.28560; Fan CL, 2003, ACTA PHARMACOL SIN, V24, P212; Ferrari N, 2003, GENE THER, V10, P647, DOI 10.1038/sj.gt.3301883; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fomchenko EI, 2007, NEUROSURG CLIN N AM, V18, P39, DOI 10.1016/j.nec.2006.10.006; Gehling UM, 2000, BLOOD, V95, P3106; Gill M, 2001, CIRC RES, V88, P167; Hilbe W, 2004, J CLIN PATHOL, V57, P965, DOI 10.1136/jcp.2004.016444; Hotfilder M, 1997, KLIN PADIATR, V209, P265, DOI 10.1055/s-2008-1043960; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Jo DY, 2000, J CLIN INVEST, V105, P101, DOI 10.1172/JCI7954; Liekens S, 2001, BIOCHEM PHARMACOL, V61, P253, DOI 10.1016/S0006-2952(00)00529-3; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mohle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530; Moore XL, 2004, GENE THER, V11, P811, DOI 10.1038/sj.gt.3302151; Murohara T, 2001, TRENDS CARDIOVAS MED, V11, P303, DOI 10.1016/S1050-1738(01)00128-1; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Peterson DA, 2004, J CLIN INVEST, V114, P312, DOI 10.1172/jc1200422540; Pomyje J, 2003, EUR J HAEMATOL, V70, P143, DOI 10.1034/j.1600-0609.2003.00040.x; Rad AM, 2007, J MAGN RESON IMAGING, V26, P366, DOI 10.1002/jmri.20978; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Rigolin GM, 2007, EUR J HAEMATOL, V78, P365, DOI 10.1111/j.1600-0609.2007.00839.x; Rustemeyer P, 2007, J IMMUNOASS IMMUNOCH, V28, P13, DOI 10.1080/15321810601025549; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; SAMEJIMA N, 1988, JPN J SURG, V18, P235, DOI 10.1007/BF02471439; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tomanek RJ, 2000, ANAT RECORD, V261, P126, DOI 10.1002/1097-0185(20000615)261:3<126::AID-AR7>3.0.CO;2-4; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; WESTERMARK B, 1995, GLIA, V15, P257, DOI 10.1002/glia.440150307; Yoshida D, 2006, J NEURO-ONCOL, V76, P13, DOI 10.1007/s11060-005-3279-0; Yoshimura H, 2004, CLIN CANCER RES, V10, P8554, DOI 10.1158/1078-0432.CCR-0946-03; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	54	50	53	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3234	3246		10.1096/fj.07-105676	http://dx.doi.org/10.1096/fj.07-105676			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18556461	Green Published			2022-12-25	WOS:000258761300016
J	Davies, MN; O'Callaghan, BL; Towle, HC				Davies, Michael N.; O'Callaghan, Brennon L.; Towle, Howard C.			Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RESPONSE ELEMENT; PYRUVATE-KINASE GENE; LIPOGENIC ENZYME GENES; FATTY-ACID SYNTHASE; WILLIAMS-BEUREN-SYNDROME; BINDING PROTEIN CHREBP; CENTER-DOT-MLX; C-MYC; POSTTRANSCRIPTIONAL REGULATION; REGULATED TRANSCRIPTION	Carbohydrate response element-binding protein (ChREBP) is a glucose-responsive transcription factor that activates genes involved in de novo lipogenesis in mammals. The current model for glucose activation of ChREBP proposes that increased glucose metabolism triggers a cytoplasmic to nuclear translocation of ChREBP that is critical for activation. However, we find that ChREBP actively shuttles between the cytoplasm and nucleus in both low and high glucose in the glucose-sensitive beta cell-derived line, 832/13. Glucose stimulates a 3-fold increase in the rate of ChREBP nuclear entry, but trapping ChREBP in the nucleus by mutagenesis or with a nuclear export inhibitor does not lead to constitutive activation. In fact, mutational studies targeting the nuclear export signal of ChREBP also identified a distinct function essential for glucose-dependent transcriptional activation. From this, we conclude that an additional event independent of nuclear translocation is required for activation. The N-terminal segment of ChREBP ( amino acids 1-298) has previously been shown to repress activity under basal conditions. This segment has five highly conserved regions, Mondo conserved regions 1-5 (MCR1 to -5). Based on activating mutations in MCR2 and MCR5, we propose that these two regions act coordinately to repress ChREBP in low glucose. In addition, other mutations in MCR2 and mutations in MCR3 were found to prevent glucose activation. Hence, we conclude that both relief of repression and adoption of an activating form are required for ChREBP activation.	[Davies, Michael N.; O'Callaghan, Brennon L.; Towle, Howard C.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Towle, HC (corresponding author), 321 Church St SE,6-155 Jackson Hall, Minneapolis, MN 55455 USA.	towle001@umn.edu		O'Callaghan, Brennon L/0000-0002-0800-5856	National Institutes of Health [DK26919, P30 DK50456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026919, P30DK050456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK26919 and P30 DK50456 (to the Minnesota Obesity Center). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; Billin AN, 1999, J BIOL CHEM, V274, P36344, DOI 10.1074/jbc.274.51.36344; Billin AN, 2000, MOL CELL BIOL, V20, P8845, DOI 10.1128/MCB.20.23.8845-8854.2000; Burgess SC, 2008, J BIOL CHEM, V283, P1670, DOI 10.1074/jbc.M706540200; Collier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE48, DOI 10.1152/ajpendo.00357.2006; Collier JJ, 2003, J BIOL CHEM, V278, P6588, DOI 10.1074/jbc.M208011200; de Luis O, 2000, EUR J HUM GENET, V8, P215, DOI 10.1038/sj.ejhg.5200435; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Eilers AL, 2002, MOL CELL BIOL, V22, P8514, DOI 10.1128/MCB.22.24.8514-8526.2002; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; He ZB, 2004, AM J PHYSIOL-ENDOC M, V287, pE424, DOI 10.1152/ajpendo.00568.2003; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; KATSURADA A, 1989, BIOCHIM BIOPHYS ACTA, V1004, P103, DOI 10.1016/0005-2760(89)90219-1; KATSURADA A, 1990, EUR J BIOCHEM, V190, P427, DOI 10.1111/j.1432-1033.1990.tb15592.x; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Koo SH, 2001, J BIOL CHEM, V276, P9437, DOI 10.1074/jbc.M010029200; Li MV, 2008, MOL ENDOCRINOL, V22, P1658, DOI 10.1210/me.2007-0560; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; LIU ZR, 1993, J BIOL CHEM, V268, P12787; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Ma L, 2007, NUCLEIC ACIDS RES, V35, P35, DOI 10.1093/nar/gkl987; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Merla G, 2002, HUM GENET, V110, P429, DOI 10.1007/s00439-002-0710-x; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; NTAMBI JM, 1992, J BIOL CHEM, V267, P10925; O'Callaghan BL, 2001, J BIOL CHEM, V276, P16033, DOI 10.1074/jbc.M101557200; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Rufo C, 2001, J BIOL CHEM, V276, P21969, DOI 10.1074/jbc.M100461200; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; SHIH HM, 1994, J BIOL CHEM, V269, P9380; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Towle HC, 2005, TRENDS ENDOCRIN MET, V16, P489, DOI 10.1016/j.tem.2005.10.003; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029; Tsatsos NG, 2008, BIOCHEM J, V411, P261, DOI 10.1042/BJ20071156; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; VAULONT S, 1986, J BIOL CHEM, V261, P7621; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Xavier GD, 2006, J LIPID RES, V47, P2482, DOI 10.1194/jlr.M600289-JLR200; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298	50	77	81	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24029	24038		10.1074/jbc.M801539200	http://dx.doi.org/10.1074/jbc.M801539200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18591247	Green Published, hybrid			2022-12-25	WOS:000258638900058
J	Okamoto, K; Iwano, T; Tachibana, M; Shinkai, Y				Okamoto, Keiji; Iwano, Tomohiko; Tachibana, Makoto; Shinkai, Yoichi			Distinct roles of TRF1 in the regulation of telomere structure and lengthening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABERRANT HOMOLOGOUS RECOMBINATION; MAMMALIAN TELOMERES; DNA-DAMAGE; IN-VITRO; COMPLEX; POT1; END; PROTEIN; TIN2; LOCALIZATION	The telomere is a functional chromatin structure that consists of G-rich repetitive sequences and various associated proteins. Telomeres protect chromosomal ends from degradation, provide escape from the DNA damage response, and regulate telomere lengthening by telomerase. Multiple proteins that localize at telomeres form a complex called shelterin/telosome. One component, TRF1, is a double-stranded telomeric DNA binding protein. Inactivation of TRF1 disrupts telomeric localization of other shelterin components and induces chromosomal instability. Here, we examined how the telomeric localization of shelterin components is crucial for TRF1-mediated telomere-associated functions. We found that many of the mTRF1 deficient phenotypes, including chromosomal instability, growth defects, and dysfunctional telomere damage response, were suppressed by the telomere localization of shelterin components in the absence of functional mTRF1. However, abnormal telomere signals and telomere elongation phenotypes were either not rescued or only partially rescued, respectively. These data suggest that TRF1 regulates telomere length and function by at least two mechanisms; in one TRF1 acts through the recruiting/tethering of other shelterin components to telomeres, and in the other TRF1 seems to play a more direct role.	[Shinkai, Yoichi] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Sakyo Ku, Kawara, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kawara, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Shinkai, Y (corresponding author), Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Sakyo Ku, 53 Shogoin, Kawara, Kyoto 6068507, Japan.	yshinkai@virus.kyoto-u.ac.jp	Shinkai, Yoichi/N-3909-2014	Shinkai, Yoichi/0000-0002-6051-2484	Ministry of Education, Science, Technology, and Culture of Japan; Ministry of Education, Culture, Sports, Science, and Technology; Kyoto University; Institute for Virus Research	Ministry of Education, Science, Technology, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto University; Institute for Virus Research	This work was supported by a grant-in-aid from the Ministry of Education, Science, Technology, and Culture of Japan (to Y.S. and M.T.) and by the 21st Century COE Program of the Ministry of Education, Culture, Sports, Science, and Technology to Graduate School of Biostudies and Institute for Virus Research, Kyoto University (to K.O. and T.I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Grant JD, 2001, BIOTECHNIQUES, V31, P1314, DOI 10.2144/01316bc02; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; He H, 2006, EMBO J, V25, P5180, DOI 10.1038/sj.emboj.7601294; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kelleher C, 2005, MOL CELL BIOL, V25, P808, DOI 10.1128/MCB.25.2.808-818.2005; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kim SH, 2003, EMBO REP, V4, P685, DOI 10.1038/sj.embor.embor872; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; NANDA I, 1994, CYTOGENET CELL GENET, V65, P190, DOI 10.1159/000133630; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Riha K, 2006, ANNU REV GENET, V40, P237, DOI 10.1146/annurev.genet.39.110304.095755; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Wu YL, 2007, DNA REPAIR, V6, P157, DOI 10.1016/j.dnarep.2006.09.005; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200	36	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23981	23988		10.1074/jbc.M802395200	http://dx.doi.org/10.1074/jbc.M802395200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18587156	Green Published, hybrid			2022-12-25	WOS:000258638900054
J	Yoshikawa, D; Yamaguchi, N; Ishibashi, D; Yamanaka, H; Okimura, N; Yamaguchi, Y; Mori, T; Miyata, H; Shigematsu, K; Katamine, S; Sakaguchi, S				Yoshikawa, Daisuke; Yamaguchi, Naohiro; Ishibashi, Daisuke; Yamanaka, Hitoki; Okimura, Nobuhiko; Yamaguchi, Yoshitaka; Mori, Tsuyoshi; Miyata, Hironori; Shigematsu, Kazuto; Katamine, Shigeru; Sakaguchi, Suehiro			Dominant-negative effects of the N-terminal half of prion protein on neurotoxicity of prion protein-like protein/doppel in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRP-LIKE PROTEIN; PURKINJE-CELL DEGENERATION; TRANSGENIC MICE; SUPEROXIDE-DISMUTASE; ECTOPIC EXPRESSION; DEFICIENT MICE; TRUNCATED PRP; UP-REGULATION; BRAIN-DAMAGE; DOPPEL	Prion protein-like protein/doppel is neurotoxic, causing ataxia and Purkinje cell degeneration in mice, whereas prion protein antagonizes doppel-induced neurodegeneration. Doppel is homologous to the C-terminal half of prion protein but lacks the amino acid sequences corresponding to the N-terminal half of prion protein. We show here that transgenic mice expressing a fusion protein consisting of the N-terminal half, corresponding to residues 1-124, of prion protein and doppel in neurons failed to develop any neurological signs for up to 730 days in a background devoid of prion protein. In addition, the fusion protein prolonged the onset of ataxia in mice expressing exogenous doppel. These results suggested that the N-terminal part of prion protein has a neuroprotective potential acting both cis and trans on doppel. We also show that prion protein lacking the pre-octapeptide repeat (Delta 25-50) or octapeptide repeat (Delta 51-90) region alone could not impair the antagonistic function against doppel.	[Yamaguchi, Yoshitaka; Mori, Tsuyoshi; Sakaguchi, Suehiro] Univ Tokushima, Inst Enzyme Res, Div Mol Neurobiol, Tokushima 7708503, Japan; [Yoshikawa, Daisuke; Yamaguchi, Naohiro; Ishibashi, Daisuke; Okimura, Nobuhiko; Katamine, Shigeru; Sakaguchi, Suehiro] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 8528523, Japan; [Yamanaka, Hitoki; Sakaguchi, Suehiro] PRESTO Japan Sci & Technol Agcy, Saitama 3320012, Japan; [Miyata, Hironori] Univ Occupat & Environm Hlth, Anim Res Ctr, Kitakyushu, Fukuoka 8078555, Japan; [Shigematsu, Kazuto] Nagasaki Univ, Dept Pathol, Grad Sch Biomed Sci, Nagasaki 8528523, Japan	Tokushima University; Nagasaki University; Japan Science & Technology Agency (JST); University of Occupational & Environmental Health - Japan; Nagasaki University	Sakaguchi, S (corresponding author), Univ Tokushima, Inst Enzyme Res, Div Mol Cytol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	sakaguch@ier.tokushima-u.ac.jp	Yamaguchi, Yoshitaka/ABD-2499-2020		Ministry of Health, Labor and Welfare, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a Research on Specific Diseases grant from the Ministry of Health, Labor and Welfare, Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anderson L, 2004, P NATL ACAD SCI USA, V101, P3644, DOI 10.1073/pnas.0308681101; Atarashi R, 2003, J BIOL CHEM, V278, P28944, DOI 10.1074/jbc.M303655200; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Behrens A, 2002, TRENDS NEUROSCI, V25, P150, DOI 10.1016/S0166-2236(00)02089-0; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Drisaldi B, 2004, J BIOL CHEM, V279, P55443, DOI 10.1074/jbc.M404794200; Flechsig E, 2003, EMBO J, V22, P3095, DOI 10.1093/emboj/cdg285; Haigh CL, 2006, J NEUROCHEM, V98, P677, DOI 10.1111/j.1471-4159.2006.03906.x; Hoshino S, 2003, ACT NEUR S, V86, P297; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Li AM, 2000, CELL MOL NEUROBIOL, V20, P553, DOI 10.1023/A:1007059827541; Li AM, 2000, AM J PATHOL, V157, P1447, DOI 10.1016/S0002-9440(10)64782-7; Liu T, 2001, BRAIN RES, V896, P118, DOI 10.1016/S0006-8993(01)02050-9; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Nunziante M, 2003, J BIOL CHEM, V278, P3726, DOI 10.1074/jbc.M206313200; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Sakudo A, 2005, BIOCHEM BIOPH RES CO, V326, P600, DOI 10.1016/j.bbrc.2004.11.092; Sakudo A, 2003, BIOCHEM BIOPH RES CO, V308, P660, DOI 10.1016/S0006-291X(03)01459-1; Sakurai-Yamashita Y, 2005, NEUROSCIENCE, V136, P281, DOI 10.1016/j.neuroscience.2005.06.095; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1995, J BIOL CHEM, V270, P14793, DOI 10.1074/jbc.270.24.14793; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Walmsley AR, 2003, J BIOL CHEM, V278, P37241, DOI 10.1074/jbc.M302036200; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Weissmann C, 1999, SCIENCE, V286, P914, DOI 10.1126/science.286.5441.914; WILMUT I, 1991, J REPROD FERTIL, V92, P245, DOI 10.1530/jrf.0.0920245; Yamaguchi N, 2004, BIOCHEM BIOPH RES CO, V319, P1247, DOI 10.1016/j.bbrc.2004.05.115	46	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24202	24211		10.1074/jbc.M804212200	http://dx.doi.org/10.1074/jbc.M804212200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18562311	hybrid, Green Published			2022-12-25	WOS:000258638900074
J	Zhang, LL; Smit-McBride, Z; Pan, XY; Rheinhardt, J; Hershey, JWB				Zhang, Lili; Smit-McBride, Zeljka; Pan, Xiaoyu; Rheinhardt, Jeanette; Hershey, John W. B.			An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; MYC-DEPENDENT APOPTOSIS; MALIGNANT-TRANSFORMATION; PROSTATE-CANCER; GENETIC ALTERATIONS; OVARIAN-CANCER; AMPLIFICATION; BREAST; CELLS; CARCINOMAS	Dysregulation of protein synthesis has been implicated in oncogenesis through a mechanism whereby "weak" mRNAs encoding proteins involved in cell proliferation are strongly translated when the protein synthesis apparatus is activated. Previous work has determined that many cancer cells contain high levels of eIF3h, a protein subunit of translation initiation factor eIF3, and overexpression of eIF3h malignantly transforms immortal NIH-3T3 cells. This is a general feature of eIF3h, as high levels also affect translation, proliferation, and a number of malignant phenotypes of CHO-K1 and HeLa cells and, most significantly, of a primary prostate cell line. Furthermore, overexpressed eIF3h inhibits Myc-dependent induction of apoptosis of primary prostate cells. eIF3h appears to function through translation, as the initial appearance of overexpressed eIF3h in rapidly induced NIH-3T3 cells correlates tightly with the stimulation of protein synthesis and the generation of malignant phenotypes. This oncogenic potential of eIF3h is enhanced by phosphorylation at Ser(183). Finally, reduction of eIF3h levels in breast and prostate cancer cell lines by short interfering RNA methods reduces their rates of proliferation and anchorage-independent growth in soft agar. The results provide compelling evidence that high eIF3h levels directly stimulate protein synthesis, resulting in the establishment and maintenance of the malignant state in cells.	[Zhang, Lili; Hershey, John W. B.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Smit-McBride, Zeljka] Univ Calif Davis, Dept Ophthalmol & Vis Sci, Davis, CA 95616 USA; [Pan, Xiaoyu] Univ Calif Davis, Dept Mol & Cell Biol, Davis, CA 95616 USA; [Rheinhardt, Jeanette] Univ Calif Davis, Dept Pathol, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hershey, JWB (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA.	jwhershey@ucdavis.edu	Smit-McBride, Zeljka/F-5524-2010	Smit-McBride, Zeljka/0000-0003-0275-8088	National Institutes of Health [GM22135, GM07373]; American Cancer Society [IRG 95-125-04]; Institutional Research Grant Program; University of California Davis School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Institutional Research Grant Program; University of California Davis School of Medicine(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM22135 and GM07373 ( to J.W.B.H.). This work was also supported by American Cancer Society Grant IRG 95-125-04 from the Institutional Research Grant Program ( to Z.S.M.) and by the Dean, University of California Davis School of Medicine. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Arnold N, 1996, GENE CHROMOSOME CANC, V16, P46, DOI 10.1002/(SICI)1098-2264(199605)16:1<46::AID-GCC7>3.0.CO;2-3; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Forozan F, 1997, TRENDS GENET, V13, P405, DOI 10.1016/S0168-9525(97)01244-4; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; FukuchiShimogori T, 1997, CANCER RES, V57, P5041; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; Kim TH, 2004, PLANT CELL, V16, P3341, DOI 10.1105/tpc.104.026880; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Komarova AV, 2007, NUCLEIC ACIDS RES, V35, P1522, DOI 10.1093/nar/gkl1127; Koo SH, 1999, CANCER GENET CYTOGEN, V110, P87, DOI 10.1016/S0165-4608(98)00193-9; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Li S, 2003, J BIOL CHEM, V278, P3015, DOI 10.1074/jbc.M208821200; MAMIKO M, 2007, EMBO J, V26, P3373; Nupponen NN, 2000, GENE CHROMOSOME CANC, V28, P203; Nupponen NN, 1999, AM J PATHOL, V154, P1777, DOI 10.1016/S0002-9440(10)65433-8; Nupponen NN, 1998, AM J PATHOL, V153, P141, DOI 10.1016/S0002-9440(10)65554-X; Okamoto H, 2003, HEPATOLOGY, V38, P1242, DOI 10.1053/jhep.2003.50457; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Raught B., 2007, TRANSLATIONAL CONTRO, P369; Rooney PH, 1999, BRIT J CANCER, V80, P862, DOI 10.1038/sj.bjc.6690433; Saramaki O, 2001, AM J PATHOL, V159, P2089, DOI 10.1016/S0002-9440(10)63060-X; Savinainen KJ, 2004, BRIT J CANCER, V90, P1041, DOI 10.1038/sj.bjc.6601648; SCHNEIDER RJ, 2007, TRANSLATIONAL CONTRO, P401; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Smit-McBride Z, 1998, J VIROL, V72, P6646, DOI 10.1128/JVI.72.8.6646-6656.1998; Sonoda G, 1997, GENE CHROMOSOME CANC, V18, P115, DOI 10.1002/(SICI)1098-2264(199702)18:2<115::AID-GCC6>3.0.CO;2-5; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Tan A, 2000, ONCOGENE, V19, P1437, DOI 10.1038/sj.onc.1203446; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Wong N, 1999, AM J PATHOL, V154, P37, DOI 10.1016/S0002-9440(10)65248-0; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	40	61	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24047	24060		10.1074/jbc.M800956200	http://dx.doi.org/10.1074/jbc.M800956200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18544531	hybrid, Green Published			2022-12-25	WOS:000258638900060
J	Orth, JHC; Fester, I; Preuss, I; Agnoletto, L; Wilson, BA; Aktories, K				Orth, Joachim H. C.; Fester, Ines; Preuss, Inga; Agnoletto, Laura; Wilson, Brenda A.; Aktories, Klaus			Activation of G alpha(i) and subsequent uncoupling of receptor-G alpha(i) signaling by Pasteurella multocida toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERTUSSIS-TOXIN; ADP-RIBOSYLATION; ADENYLATE-CYCLASE; SWISS 3T3-CELLS; MITOGENIC TOXIN; POTENT MITOGEN; G-PROTEINS; BINDING; INVOLVEMENT; CELLS	Bacterial protein toxins are powerful tools for elucidating signaling mechanisms in eukaryotic cells. A number of bacterial protein toxins, e. g. cholera toxin, pertussis toxin (PTx), or Pasteurella multocida toxin (PMT), target heterotrimeric G proteins and have been used to stimulate or block specific signaling pathways or to demonstrate the contribution of their target proteins in cellular effects. PMT is a major virulence factor of P. multocida causing pasteurellosis in man and animals and is responsible for atrophic rhinitis in pigs. PMT modulates various signaling pathways, including phospholipase C beta and RhoA, by acting on the heterotrimeric G proteins G alpha(q) and G alpha(12/13), respectively. Here we report that PMT is a powerful activator of G(i) protein. We show that PMT decreases basal isoproterenol and forskolin-stimulated cAMP accumulation in intact Swiss 3T3 cells, inhibits adenylyl cyclase activity in cell membrane preparations, and enhances the inhibition of cAMP accumulation caused by lysophosphatidic acid via endothelial differentiation gene receptors. PMT-mediated inhibition of cAMP production is independent of toxin activation of G alpha(q) and/or G alpha(12/13). Although the effects of PMT are not inhibited by PTx, PMT blocks PTx-catalyzed ADP-ribosylation of Gi. PMT also inhibits steady-state GTPase activity and GTP binding of G(i) in Swiss 3T3 cell membranes stimulated by lysophosphatidic acid. The data indicate that PMT is a novel activator of G(i), modulating its GTPase activity and converting it into a PTx-insensitive state.	[Orth, Joachim H. C.; Fester, Ines; Preuss, Inga; Agnoletto, Laura; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmacol & Toxicol, D-79104 Freiburg, Germany; [Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Freiburg; University of Illinois System; University of Illinois Urbana-Champaign	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmacol & Toxicol, D-79104 Freiburg, Germany.	Klaus.Aktories@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Agnoletto, Laura/0000-0002-6236-362X	NIAID NIH HHS [R01 AI038396] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038396] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akam EC, 1997, BRIT J PHARMACOL, V121, P1203, DOI 10.1038/sj.bjp.0701238; Aminova LR, 2008, PROTEIN SCI, V17, P945, DOI 10.1110/ps.083445408; Busch C, 2001, INFECT IMMUN, V69, P3628, DOI 10.1128/IAI.69.6.3628-3634.2001; CASEY PJ, 1988, J BIOL CHEM, V263, P2577; GIL J, 1991, J CELL BIOL, V113, P943, DOI 10.1083/jcb.113.4.943; Gill D M, 1977, Adv Cyclic Nucleotide Res, V8, P85; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; JOHNSON RA, 1994, METHOD ENZYMOL, V238, P31; KATADA T, 1986, J BIOL CHEM, V261, P8182; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Kitadokoro K, 2007, P NATL ACAD SCI USA, V104, P5139, DOI 10.1073/pnas.0608197104; Lax AJ, 2001, INT J MED MICROBIOL, V291, P261, DOI 10.1078/1438-4221-00129; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Mullan PB, 1996, INFECT IMMUN, V64, P959, DOI 10.1128/IAI.64.3.959-965.1996; MURAYAMA T, 1983, J BIOL CHEM, V258, P3319; Nurnberg B, 1997, BACTERIAL TOXINS TOO, P47; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Orth JHC, 2005, J BIOL CHEM, V280, P36701, DOI 10.1074/jbc.M507203200; Orth JHC, 2004, J BIOL CHEM, V279, P34150, DOI 10.1074/jbc.M405353200; Orth JHC, 2003, BIOCHEMISTRY-US, V42, P4971, DOI 10.1021/bi0272959; Orth JHC, 2007, CELL SIGNAL, V19, P2174, DOI 10.1016/j.cellsig.2007.06.016; Orth JHC, 2007, J BIOL CHEM, V282, P3050, DOI 10.1074/jbc.M609018200; Pullinger GD, 2001, INFECT IMMUN, V69, P7839, DOI 10.1128/IAI.69.12.7839-7850.2001; ROZENGURT E, 1990, P NATL ACAD SCI USA, V87, P123, DOI 10.1073/pnas.87.1.123; SEIFERT R, 1992, EUR J BIOCHEM, V203, P143, DOI 10.1111/j.1432-1033.1992.tb19839.x; SPICHER K, 1994, BIOCHEM BIOPH RES CO, V198, P906, DOI 10.1006/bbrc.1994.1129; STADDON JM, 1991, J BIOL CHEM, V266, P4840; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; TOYOSHIGE M, 1994, BIOCHEMISTRY-US, V33, P4865, DOI 10.1021/bi00182a014; UI M, 1990, ADP RIBOSYLATING TOX, P45; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Ward PN, 1998, INFECT IMMUN, V66, P5636, DOI 10.1128/IAI.66.12.5636-5642.1998; Wilson BA, 2000, INFECT IMMUN, V68, P4531, DOI 10.1128/IAI.68.8.4531-4538.2000; Wilson BA, 2005, REV PHYSIOL BIOCH P, V152, P93, DOI 10.1007/s10254-004-0032-6; Wilson BA, 1997, J BIOL CHEM, V272, P1268, DOI 10.1074/jbc.272.20.12961; Wilson BA, 2005, COMPREHENSIVE SOURCE, P430; Zywietz A, 2001, J BIOL CHEM, V276, P3840, DOI 10.1074/jbc.M007819200	38	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23288	23294		10.1074/jbc.M803435200	http://dx.doi.org/10.1074/jbc.M803435200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18583341	hybrid			2022-12-25	WOS:000258455400041
J	Komenda, J; Nickelsen, J; Tichy, M; Prasil, O; Eichacker, LA; Nixon, PJ				Komenda, Josef; Nickelsen, Joerg; Tichy, Martin; Prasil, Ondrej; Eichacker, Lutz A.; Nixon, Peter J.			The cyanobacterial homologue of HCF136/YCF48 is a component of an early photosystem II assembly complex and is important for both the efficient assembly and repair of photosystem II in Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR D1 PROTEIN; THYLAKOID MEMBRANE; SPLIT-UBIQUITIN; PLASMA-MEMBRANE; MUTANTS; ACCUMULATION; MUTAGENESIS; BIOGENESIS; DYNAMICS; STRAIN	The role of the slr2034 (ycf48) gene product in the assembly and repair of photosystem II (PSII) has been studied in the cyanobacterium Synechocystis PCC 6803. YCF48 (HCF136) is involved in the assembly of Arabidopsis thaliana PSII reaction center (RC) complexes but its mode of action is unclear. We show here that YCF48 is a component of two cyanobacterial PSII RC-like complexes in vivo and is absent in larger PSII core complexes. Interruption of ycf48 slowed the formation of PSII complexes in wild type, as judged from pulse-labeling experiments, and caused a decrease in the final level of PSII core complexes in wild type and a marked reduction in the levels of PSII assembly complexes in strains lacking either CP43 or CP47. Absence of YCF48 also led to a dramatic decrease in the levels of the COOH-terminal precursor (pD1) and the partially processed form, iD1, in a variety of PSII mutants and only low levels of unassembled mature D1 were observed. Yeast two-hybrid analyses using the split ubiquitin system showed an interaction of YCF48 with unassembled pD1 and, to a lesser extent, unassembled iD1, but not with unassembled mature D1 or D2. Overall our results indicate a role for YCF48 in the stabilization of newly synthesized pD1 and in its subsequent binding to a D2-cytochrome b(559) pre-complex, also identified in this study. Besides a role in assembly, we show for the first time that YCF48 also functions in the selective replacement of photodamaged D1 during PSII repair.	[Komenda, Josef; Tichy, Martin; Prasil, Ondrej] Acad Sci Czech Republ, Inst Microbiol, Trebon 37981, Czech Republic; [Komenda, Josef; Tichy, Martin; Prasil, Ondrej] Univ S Bohemia, Inst Phys Biol, Nove Hrady 37333, Czech Republic; [Nickelsen, Joerg] Univ Munich, Inst Plant Mol Biol, D-80368 Munich, Germany; [Eichacker, Lutz A.] Univ Munich, Inst Bot, D-80368 Munich, Germany; [Nixon, Peter J.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Fac Nat Sci, London SW7 2AZ, England	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Munich; University of Munich; Imperial College London	Komenda, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Trebon 37981, Czech Republic.	komenda@alga.cz	Tichy, Martin/B-6545-2008; Nickelsen, Jörg/J-8896-2014; Komenda, Josef/H-4083-2014; Prasil, Ondrej/H-2454-2014	Tichy, Martin/0000-0003-2814-1959; Komenda, Josef/0000-0003-4588-0382; Nixon, Peter/0000-0003-1952-6937; Nickelsen, Joerg/0000-0003-4184-4560; Prasil, Ondrej/0000-0002-0012-4359	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANBUDURAI PR, 1994, P NATL ACAD SCI USA, V91, P8082, DOI 10.1073/pnas.91.17.8082; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Barber J, 2006, BIOCHEM SOC T, V34, P619, DOI 10.1042/BST0340619; Caldo RA, 2004, PLANT CELL, V16, P2514, DOI 10.1105/tpc.104.023382; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; EATONRYE JJ, 1991, PLANT MOL BIOL, V17, P1165, DOI 10.1007/BF00028733; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Huang F, 2002, MOL CELL PROTEOMICS, V1, P956, DOI 10.1074/mcp.M200043-MCP200; Inagaki N, 2001, FEBS LETT, V509, P197, DOI 10.1016/S0014-5793(01)03180-5; Jansen T, 2002, J PLANT PHYSIOL, V159, P1205, DOI 10.1078/0176-1617-00829; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Komenda J, 2005, PLANT CELL PHYSIOL, V46, P1477, DOI 10.1093/pcp/pci159; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; KOMENDA J, 1995, BIOCHEMISTRY-US, V34, P9625, DOI 10.1021/bi00029a040; Komenda J, 2002, EUR J BIOCHEM, V269, P610, DOI 10.1046/j.0014-2956.2001.02693.x; Komenda J, 2007, BBA-BIOENERGETICS, V1767, P829, DOI 10.1016/j.bbabio.2007.01.005; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10859, DOI 10.1021/bi00159a029; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; PAKRASI HB, 1988, EMBO J, V7, P325, DOI 10.1002/j.1460-2075.1988.tb02816.x; Pasch JC, 2005, APPL MICROBIOL BIOT, V69, P440, DOI 10.1007/s00253-005-0029-3; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; PRASIL O, 1992, PHOTOSYSTEMS STRUCTU, P295, DOI DOI 10.1016/B978-0-444-89440-3.50017-5; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Satoh K, 2007, PHOTOSYNTH RES, V94, P203, DOI 10.1007/s11120-007-9191-z; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; Sitte Nicolle, AGING MOL LEVEL, P27, DOI [10.1007/978-94-017-0667-4_3, DOI 10.1007/978-94-017-0667-4_3, DOI 10.1007/978-94-017-6368-4_3]; Srivastava R, 2006, ARCH MICROBIOL, V185, P238, DOI 10.1007/s00203-006-0086-8; Tichy M, 2003, BBA-BIOENERGETICS, V1605, P55, DOI 10.1016/S0005-2728(03)00064-1; VERMAAS WFJ, 1988, PHOTOSYNTH RES, V17, P97, DOI 10.1007/BF00047683; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Yokthongwattana K, 2006, ADV PHOTO RESPIRAT, V21, P175; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898	42	110	116	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22390	22399		10.1074/jbc.M801917200	http://dx.doi.org/10.1074/jbc.M801917200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18550538	hybrid			2022-12-25	WOS:000258321000007
J	Qian, YJ; Chen, XB				Qian, Yingjuan; Chen, Xinbin			ID1, inhibitor of differentiation/DNA binding, is an effector of the p53-dependent DNA damage response pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; BREAST-CANCER CELLS; GROWTH ARREST; ID-1 PROTEIN; P53 PATHWAY; TRANSCRIPTIONAL REPRESSION; NEGATIVE REGULATOR; PROSTATE-CANCER; TP53 MUTATIONS; C-TERMINUS	ID1, inhibitor of differentiation/DNA binding, plays an important role in cell proliferation, differentiation, and tumorigenesis. It has been shown that ID1 is de-regulated in multiple cancers and up-regulation of ID1 is correlated with high grades and poor prognosis of human cancers. In contrast, the p53 tumor suppressor was found to be mutated or inactivated in most human cancers and loss of p53 results in early onset of multiple cancers. Although the biological functions of the ID1 oncogene and the p53 tumor suppressor have been intensively investigated, little is known about the upstream regulators of ID1 and the cross-talk between ID1 and p53. Here, we showed that ID1 is down-regulated in cells treated with various DNA damage agents in a p53-dependent manner. Interestingly, we found that DEC1, which was recently identified as a p53 target and mediates p53-dependent cell cycle arrest and senescence, is capable of inhibiting ID1 expression. Conversely, we found that knockdown of DEC1 attenuates DNA damage-induced ID1 repression. In addition, we identified several potential DEC1 responsive elements in the proximal promoter region of the ID1 gene. Moreover, we showed that overexpression of ID1 or ID1', an isoform of ID1, promotes cell proliferation potentially through inhibition of p21 expression. Finally, we found that the extent of DNA damage-induced premature senescence was substantially decreased by overexpression of ID1 or ID1'. Taken together, our study suggests that p53 trans-repressional activity can be mediated by its own target DEC1 and ID1 is an effector of the p53-dependent DNA damage response pathway.	[Qian, Yingjuan; Chen, Xinbin] Univ Calif Davis, Ctr Comparat Oncol, Davis, CA 95616 USA; [Qian, Yingjuan] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham	Chen, XB (corresponding author), 2128 Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			NCI NIH HHS [CA081237, CA102188, CA076069] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102188, R01CA081237, R01CA076069, R29CA076069] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alani RM, 1999, P NATL ACAD SCI USA, V96, P9637, DOI 10.1073/pnas.96.17.9637; Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; BARONE MV, 1994, P NATL ACAD SCI USA, V91, P4985, DOI 10.1073/pnas.91.11.4985; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; CHEN XB, 1995, CANCER RES, V55, P4257; Damdinsuren B, 2006, ONCOL REP, V15, P401; Desprez PY, 2003, J MAMMARY GLAND BIOL, V8, P225, DOI 10.1023/A:1025957025773; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; EL DW, 1993, CELL, V75, P817; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; GARRELL J, 1990, CELL, V61, P39, DOI 10.1016/0092-8674(90)90213-X; Gasco M, 2003, HUM MUTAT, V21, P301, DOI 10.1002/humu.10173; HARA E, 1994, J BIOL CHEM, V269, P2139; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; HARPER JW, 1993, CELL, V75, P805; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hernandez-Vargas H, 2006, INT J CANCER, V119, P1164, DOI 10.1002/ijc.21938; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HU QJ, 1991, MOL CELL BIOL, V11, P5792, DOI 10.1128/MCB.11.11.5792; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; Li Y, 2006, ONCOGENE, V25, P3296, DOI 10.1038/sj.onc.1209363; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Lin CQ, 2000, CANCER RES, V60, P1332; Ling MT, 2002, BBA-GEN SUBJECTS, V1570, P145, DOI 10.1016/S0304-4165(02)00189-7; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Nemetski SM, 2007, J BIOL CHEM, V282, P240, DOI 10.1074/jbc.M607275200; Nickoloff BJ, 2000, J BIOL CHEM, V275, P27501; Norton JD, 2000, J CELL SCI, V113, P3897; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Ouyang XS, 2002, J UROLOGY, V167, P2598, DOI 10.1016/S0022-5347(05)65044-6; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Prives C, 1999, J PATHOL, V187, P112; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Schindl M, 2003, CLIN CANCER RES, V9, P779; Schindl M, 2001, CANCER RES, V61, P5703; Schoppmann SF, 2003, INT J CANCER, V104, P677, DOI 10.1002/ijc.11009; Seimiya M, 2004, EUR J IMMUNOL, V34, P1322, DOI 10.1002/eji.200324700; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Tamura Y, 1998, FEBS LETT, V436, P169, DOI 10.1016/S0014-5793(98)01117-X; Tepper CG, 2005, PROSTATE, V65, P375, DOI 10.1002/pros.20308; Wilson JW, 2001, CANCER RES, V61, P8803; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999	57	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22410	22416		10.1074/jbc.M800643200	http://dx.doi.org/10.1074/jbc.M800643200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18556654	hybrid, Green Published			2022-12-25	WOS:000258321000009
J	Zhang, J; Chen, C				Zhang, Jian; Chen, Chu			Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CB1 CANNABINOID RECEPTORS; SYNAPTIC-TRANSMISSION; INHIBITION; SYSTEM; CYCLOOXYGENASE-2; ANANDAMIDE; NEUROPROTECTION; PROSTAGLANDIN; EXPRESSION; 2-ARACHIDONYLGLYCEROL	Endocannabinoids are involved in synaptic signaling and neuronal protection; however, our understanding of the mechanisms by which endocannabinoids protect neurons from harmful insults remains elusive. 2-Arachidonoylglycerol (2-AG), the most abundant endogenous cannabinoid and a full agonist for cannabinoid receptors (CB1 and CB2), is a substrate for cyclooxygenase-2 (COX-2) and can be metabolized by COX-2. Here we show, however, that 2-AG is also capable of suppressing elevation of hippocampal COX-2 expression in response to proinflammatory and excitotoxic stimuli. 2-AG prevents neurodegeneration from toxic assaults that elevate COX-2 expression and inhibits the COX-2 elevation-enhanced excitatory glutamatergic synaptic transmission. The action of 2-AG on suppression of COX-2 appeared to be mediated via the pertussis toxin-sensitive G protein-coupled CB1 receptor and MAPK/NF-kappa B signaling pathways. Our results reveal that 2-AG functions as an endogenous COX-2 inhibitor protecting neurons from harmful insults by preventing excessive expression of COX-2, which provides a mechanistic basis for opening up new therapeutic approaches for protecting neurons from inflammation-and excitotoxicity-induced neurodegeneration.	[Zhang, Jian; Chen, Chu] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Chen, C (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, 2020 Gravier St, New Orleans, LA 70112 USA.	cchen@lsuhsc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054886] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS054886] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALGER BE, 2005, SCI STKE, V51, P1; Bisogno T, 2005, PHARMACOL BIOCHEM BE, V81, P224, DOI 10.1016/j.pbb.2005.01.027; BURSTEIN SH, 1989, MOL PHARMACOL, V35, P6; BURSTEIN SH, 1988, FASEB J, V2, P3022, DOI 10.1096/fasebj.2.14.2846397; Cabral GA, 2005, J LEUKOCYTE BIOL, V78, P1192, DOI 10.1189/jlb.0405216; Calandra B, 1999, EUR J PHARMACOL, V374, P445, DOI 10.1016/S0014-2999(99)00349-0; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Chang YH, 2001, J CELL BIOCHEM, V81, P715, DOI 10.1002/jcb.1103; Chen C, 2005, PROSTAG OTH LIPID M, V77, P65, DOI 10.1016/j.prostaglandins.2005.07.001; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; De Petrocellis L, 2005, LIFE SCI, V77, P1651, DOI 10.1016/j.lfs.2005.05.021; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Domoki F, 2000, NEUROREPORT, V11, P3435, DOI 10.1097/00001756-200011090-00007; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Ho L, 1999, J NEUROSCI RES, V57, P295; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Howlett AC, 2006, J NEUROIMMUNE PHARM, V1, P305, DOI 10.1007/s11481-006-9022-6; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kim EJ, 2001, BRAIN RES, V908, P1, DOI 10.1016/S0006-8993(01)02432-5; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; Kunz T, 2001, EUR J NEUROSCI, V13, P569, DOI 10.1046/j.1460-9568.2001.01420.x; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Makara JK, 2005, NAT NEUROSCI, V8, P1139, DOI 10.1038/nn1521; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Melis M, 2004, J NEUROSCI, V24, P10707, DOI 10.1523/JNEUROSCI.3502-04.2004; Melis M, 2006, NEUROBIOL DIS, V24, P15, DOI 10.1016/j.nbd.2006.04.010; Mestre L, 2006, BIOCHEM PHARMACOL, V72, P869, DOI 10.1016/j.bcp.2006.06.037; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Mukhopadhyay S, 2002, CHEM PHYS LIPIDS, V121, P91, DOI 10.1016/S0009-3084(02)00153-6; Nakayama M, 1998, P NATL ACAD SCI USA, V95, P10954, DOI 10.1073/pnas.95.18.10954; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Patrignani P, 2005, BRAIN RES REV, V48, P352, DOI 10.1016/j.brainresrev.2004.12.024; PEREZREYES M, 1991, LIFE SCI, V48, P507, DOI 10.1016/0024-3205(91)90465-N; Pertwee RG, 2001, PROG NEUROBIOL, V63, P569, DOI 10.1016/S0301-0082(00)00031-9; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Sang N, 2007, J NEUROCHEM, V102, P1966, DOI 10.1111/j.1471-4159.2007.04668.x; Sang N, 2006, NEUROSCIENTIST, V12, P425, DOI 10.1177/1073858406290794; Sarne Y, 2005, CNS NEUROL DISORD-DR, V4, P677, DOI 10.2174/156800705774933005; Sinha D, 1998, J NEUROIMMUNOL, V82, P13, DOI 10.1016/S0165-5728(97)00181-1; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Straiker A, 2005, J PHYSIOL-LONDON, V569, P501, DOI 10.1113/jphysiol.2005.091918; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; Suplita RL, 2006, NEUROPHARMACOLOGY, V50, P372, DOI 10.1016/j.neuropharm.2005.10.007; Szabo B, 2006, J PHYSIOL-LONDON, V577, P263, DOI 10.1113/jphysiol.2006.119362; van der Stelt M, 2005, NEUROMOL MED, V7, P37, DOI 10.1385/NMM:7:1-2:037; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Waksman Y, 1999, J PHARMACOL EXP THER, V288, P1357; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Walter L, 2004, BRIT J PHARMACOL, V141, P775, DOI 10.1038/sj.bjp.0705667; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	68	95	98	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22601	22611		10.1074/jbc.M800524200	http://dx.doi.org/10.1074/jbc.M800524200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18534982	Green Published, hybrid			2022-12-25	WOS:000258321000029
J	Wang, T; Gong, N; Liu, JN; Kadiu, I; Kraft-Terry, SD; Mosley, RL; Volsky, DJ; Ciborowski, P; Gendelman, HE				Wang, Tong; Gong, Nan; Liu, Jianuo; Kadiu, Irena; Kraft-Terry, Stephanie D.; Mosley, R. Lee; Volsky, David J.; Ciborowski, Pawel; Gendelman, Howard E.			Proteomic Modeling for HIV-1 Infected Microglia-Astrocyte Crosstalk	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; HEAT-SHOCK PROTEINS; PRODUCTIVE INFECTION; OXIDATIVE STRESS; HIV-1 INFECTION; GENE-EXPRESSION; NERVOUS-SYSTEM; HUMAN BRAIN	Background: HIV-1-infected and immune competent brain mononuclear phagocytes (MP; macrophages and microglia) secrete cellular and viral toxins that affect neuronal damage during advanced disease. In contrast, astrocytes can affect disease by modulating the nervous system's microenvironment. Interestingly, little is known how astrocytes communicate with MP to influence disease. Methods and Findings: MP-astrocyte crosstalk was investigated by a proteomic platform analysis using vesicular stomatitis virus pseudotyped HIV infected murine microglia. The microglial-astrocyte dialogue was significant and affected microglial cytoskeleton by modulation of cell death and migratory pathways. These were mediated, in part, through F-actin polymerization and filament formation. Astrocyte secretions attenuated HIV-1 infected microglia neurotoxicity and viral growth linked to the regulation of reactive oxygen species. Conclusions: These observations provide unique insights into glial crosstalk during disease by supporting astrocyte-mediated regulation of microglial function and its influence on the onset and progression of neuroAIDS. The results open new insights into previously undisclosed pathogenic mechanisms and open the potential for biomarker discovery and therapeutics that may influence the course of HIV-1-mediated neurodegeneration.	[Wang, Tong; Gong, Nan; Liu, Jianuo; Kadiu, Irena; Kraft-Terry, Stephanie D.; Mosley, R. Lee; Ciborowski, Pawel; Gendelman, Howard E.] Ctr Neurovirol & Neurodegenerat Disorders, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Volsky, David J.] Columbia Univ, Med Ctr, St Lukes Roosevelt Hosp Ctr, Mol Virol Div, New York, NY USA; [Wang, Tong] Jinan Univ, Inst Tissue Transplant & Immunol, Guangzhou, Peoples R China	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Jinan University	Wang, T (corresponding author), Ctr Neurovirol & Neurodegenerat Disorders, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	hegendel@unmc.edu	Wang, Tong/A-2750-2011; Gendelman, Howard E/G-8242-2012	Wang, Tong/0000-0002-5980-3380; Kraft-Terry, Stephanie/0000-0001-9838-1574	Frances and Louis Blumkin Foundation; Community Neuroscience Pride of Nebraska Research Initiative; Alan Baer Charitable Trust; NIH [5P01NS31492, DA17618, 2R37 NS36126, 2R01 NS034239, P20RR15635, U54NS43011, P01MH64570, P01 NS43985]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS043985, R37NS036126, U54NS043011, R01NS034239, R01NS036126, P01NS031492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017618] Funding Source: NIH RePORTER	Frances and Louis Blumkin Foundation; Community Neuroscience Pride of Nebraska Research Initiative; Alan Baer Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Frances and Louis Blumkin Foundation, the Community Neuroscience Pride of Nebraska Research Initiative, and the Alan Baer Charitable Trust, and NIH grant 5P01NS31492 and DA17618 (to D.J.V.) and 2R37 NS36126, 2R01 NS034239, P20RR15635, U54NS43011, P01MH64570, P01 NS43985 (to H.E.G.)	Abd-El-Basset EM, 2004, MED PRIN PRACT, V13, P325, DOI 10.1159/000080469; Adam SEI, 1999, VET HUM TOXICOL, V41, P5; Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; ALLEN LAH, 1995, J EXP MED, V182, P829, DOI 10.1084/jem.182.3.829; An SF, 1999, ACTA NEUROPATHOL, V98, P481, DOI 10.1007/s004010051113; Anderson E, 2002, JAIDS-J ACQ IMM DEF, V31, pS43, DOI 10.1097/00126334-200210012-00004; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; BENOS DJ, 1994, P NATL ACAD SCI USA, V91, P494, DOI 10.1073/pnas.91.2.494; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Blume J, 1994, Acad Radiol, V1, P253, DOI 10.1016/S1076-6332(05)80725-1; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; BUKRINSKY MI, 1995, J EXP MED, V181, P735, DOI 10.1084/jem.181.2.735; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; CAIROLI E, 2008, CLIN IMMUNOL; Calabrese V, 2000, J NEUROSCI RES, V60, P613, DOI 10.1002/(SICI)1097-4547(20000601)60:5<613::AID-JNR6>3.0.CO;2-8; Canki M, 2001, J VIROL, V75, P7925, DOI 10.1128/JVI.75.17.7925-7933.2001; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Chen YM, 2001, J NEUROCHEM, V77, P1601, DOI 10.1046/j.1471-4159.2001.00374.x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cheng XD, 2007, DNA CELL BIOL, V26, P116, DOI 10.1089/dna.2006.0541; Ciborowski P, 2007, VIROLOGY, V363, P198, DOI 10.1016/j.virol.2007.01.013; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Cosenza-Nashat MA, 2006, J NEUROIMMUNOL, V178, P87, DOI 10.1016/j.jneuroim.2006.05.020; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Deshpande M, 2005, NEUROTOX RES, V7, P183, DOI 10.1007/BF03036448; Dou HY, 2006, GLIA, V54, P81, DOI 10.1002/glia.20358; Dunfee R, 2006, CURR HIV RES, V4, P267, DOI 10.2174/157016206777709500; Emdad L, 2007, PHARMACOL THERAPEUT, V114, P155, DOI 10.1016/j.pharmthera.2007.01.010; EPSTEIN LG, 1993, ANN NEUROL, V33, P429, DOI 10.1002/ana.410330502; Faulkner NE, 2003, J VIROL, V77, P2276, DOI 10.1128/JVI.77.3.2276-2281.2003; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; Fust G, 2005, MOL IMMUNOL, V42, P79, DOI 10.1016/j.molimm.2004.07.003; Galey D, 2003, J NEUROVIROL, V9, P358, DOI 10.1080/13550280390201119; Garden GA, 2002, GLIA, V40, P240, DOI 10.1002/glia.10155; GENDELMAN HE, 1991, J EXP MED, V173, P277, DOI 10.1084/jem.173.1.277; GENDELMAN HE, 1994, J LEUKOCYTE BIOL, V56, P389, DOI 10.1002/jlb.56.3.389; GENDELMAN HE, 1994, RES IMMUNOL, V145, P679, DOI 10.1016/S0923-2494(05)80054-9; GENDELMAN HE, 2005, NEUROLOGY AIDS, P177; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Goffinet C, 2007, P NATL ACAD SCI USA, V104, P1015, DOI 10.1073/pnas.0607414104; Gorantla S, 2007, J IMMUNOL, V179, P4345, DOI 10.4049/jimmunol.179.7.4345; GRAY CW, 1995, BRAIN RES, V691, P169, DOI 10.1016/0006-8993(95)00669-H; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; Hadas E, 2007, AIDS, V21, P905, DOI 10.1097/QAD.0b013e3281574549; Hao HN, 1999, BRAIN RES, V823, P24, DOI 10.1016/S0006-8993(98)01371-7; Hao HN, 1997, BRAIN RES, V764, P149, DOI 10.1016/S0006-8993(97)00441-1; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Kadin I, 2007, J IMMUNOL, V178, P6404, DOI 10.4049/jimmunol.178.10.6404; Kalla R, 2003, GLIA, V41, P50, DOI 10.1002/glia.10176; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Kaul M, 2007, CELL DEATH DIFFER, V14, P296, DOI 10.1038/sj.cdd.4402006; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kawamura K, 2004, J BIOL CHEM, V279, P54862, DOI 10.1074/jbc.M408057200; Kim SY, 2004, J NEUROIMMUNOL, V157, P17, DOI 10.1016/j.jneuroim.2004.08.032; Kitamura Y, 2003, J PHARMACOL SCI, V92, P115; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; KURE K, 1990, ACTA NEUROPATHOL, V80, P393, DOI 10.1007/BF00307693; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Li JL, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-31; MA MH, 1994, J VIROL, V68, P6824, DOI 10.1128/JVI.68.10.6824-6828.1994; MAEDA Y, 1994, J EXP MED, V180, P2297, DOI 10.1084/jem.180.6.2297; Magrys A, 2007, J CLIN IMMUNOL, V27, P181, DOI 10.1007/s10875-006-9065-8; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; McCrossan M, 2006, BRAIN, V129, P503, DOI 10.1093/brain/awh695; McDaid J, 2005, FASEB J, V19, P458, DOI 10.1096/fj.04-2217fje; Mosley RL, 2006, CLIN NEUROSCI RES, V6, P261, DOI 10.1016/j.cnr.2006.09.006; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Nitkiewicz J, 2004, J NEUROVIROL, V10, P400, DOI 10.1080/13550280490890097; NOTTET HSLM, 1995, J IMMUNOL, V154, P3567; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; OUIMET CC, 1990, J NEUROSCI, V10, P1683; Peng H, 2006, GLIA, V54, P619, DOI 10.1002/glia.20409; Pentreath VW, 2000, HUM EXP TOXICOL, V19, P641, DOI 10.1191/096032700676221595; Persidsky Y, 1999, AM J PATHOL, V155, P1599, DOI 10.1016/S0002-9440(10)65476-4; Persidsky Y, 2006, IMMUNOL REV, V213, P180, DOI 10.1111/j.1600-065X.2006.00440.x; Pingle SC, 2007, MOL PHARMACOL, V72, P856, DOI 10.1124/mol.106.031427; Pocernich CB, 2005, MOL BRAIN RES, V133, P307, DOI 10.1016/j.molbrainres.2004.10.023; Pocernich CB, 2005, MOL BRAIN RES, V133, P299, DOI 10.1016/j.molbrainres.2004.10.024; Polazzi E, 1999, J NEUROPATH EXP NEUR, V58, P825, DOI 10.1097/00005072-199908000-00005; Poluektova L, 2004, J IMMUNOL, V172, P7610, DOI 10.4049/jimmunol.172.12.7610; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Potula R, 2005, BLOOD, V106, P2382, DOI 10.1182/blood-2005-04-1403; Prohaszka Z, 2004, MOL IMMUNOL, V41, P29, DOI 10.1016/j.molimm.2004.02.001; PULLIAM L, 1993, AIDS RES HUM RETROV, V9, P439, DOI 10.1089/aid.1993.9.439; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; ROSEN A, 1990, J EXP MED, V172, P1211, DOI 10.1084/jem.172.4.1211; Ruediger R, 1997, VIROLOGY, V238, P432, DOI 10.1006/viro.1997.8873; Saini M, 2007, VACCINE, V25, P8660, DOI 10.1016/j.vaccine.2007.10.019; SAITO Y, 1994, NEUROLOGY, V44, P474, DOI 10.1212/WNL.44.3_Part_1.474; Sas AR, 2007, AIDS, V21, P2151, DOI 10.1097/QAD.0b013e3282f08c2f; SCHWARTZ JP, 1994, BRAIN RES BULL, V35, P403, DOI 10.1016/0361-9230(94)90151-1; Schweighardt B, 2001, AIDS RES HUM RETROV, V17, P1133, DOI 10.1089/088922201316912745; Sherry B, 2000, MOL MED, V6, P542, DOI 10.1007/BF03401793; Speth C, 2005, MOL IMMUNOL, V42, P213, DOI 10.1016/j.molimm.2004.06.018; Su ZZ, 2003, J NEUROVIROL, V9, P372, DOI 10.1080/13550280390201263; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; Suh HS, 2007, J VIROL, V81, P9838, DOI 10.1128/JVI.00792-07; SWIERCZYNSKI SL, 1995, J BIOL CHEM, V270, P13436, DOI 10.1074/jbc.270.22.13436; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Tanaka J, 1999, GLIA, V28, P85, DOI 10.1002/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TORNATORE C, 1994, NEUROLOGY, V44, P481, DOI 10.1212/WNL.44.3_Part_1.481; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; Wainberg Z, 1997, VIROLOGY, V233, P364, DOI 10.1006/viro.1997.8618; Wang ZY, 2004, J NEUROVIROL, V10, P25, DOI 10.1080/13550280490270851; Wang ZY, 2003, VIROLOGY, V312, P60, DOI 10.1016/S0042-6822(03)00181-8; Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024; Willey SJ, 2003, J VIROL, V77, P6138, DOI 10.1128/JVI.77.11.6138-6152.2003; Wu J, 2007, J NEUROSCI, V27, P6510, DOI 10.1523/JNEUROSCI.1256-07.2007; Xie CS, 1998, FREE RADICAL BIO MED, V25, P979, DOI 10.1016/S0891-5849(98)00186-5; Zhou BY, 2004, MOL CELL NEUROSCI, V27, P296, DOI 10.1016/j.mcn.2004.07.003; Zink MC, 2006, CURR HIV RES, V4, P293; Zou W, 2007, AM J PATHOL, V171, P1923, DOI 10.2353/ajpath.2007.070333	120	39	42	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2507	10.1371/journal.pone.0002507	http://dx.doi.org/10.1371/journal.pone.0002507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575609	Green Submitted, gold, Green Published			2022-12-25	WOS:000263288000026
J	Soreq, L; Gilboa-Geffen, A; Berrih-Aknin, S; Lacoste, P; Darvasi, A; Soreq, E; Bergman, H; Soreq, H				Soreq, Lilach; Gilboa-Geffen, Adi; Berrih-Aknin, Sonia; Lacoste, Paul; Darvasi, Ariel; Soreq, Eyal; Bergman, Hagai; Soreq, Hermona			Identifying Alternative Hyper-Splicing Signatures in MG-Thymoma by Exon Arrays	PLOS ONE			English	Article								Background: The vast majority of human genes (> 70%) are alternatively spliced. Although alternative pre-mRNA processing is modified in multiple tumors, alternative hyper-splicing signatures specific to particular tumor types are still lacking. Here, we report the use of Affymetrix Human Exon Arrays to spot hyper-splicing events characteristic of myasthenia gravis (MG)-thymoma, thymic tumors which develop in patients with MG and discriminate them from colon cancer changes. Methodology/Principal Findings: We combined GO term to parent threshold-based and threshold-independent ad-hoc functional statistics with in-depth analysis of key modified transcripts to highlight various exon-specific changes. These denote alternative splicing in MG-thymoma tumors compared to healthy human thymus and to in-house and Affymetrix datasets from colon cancer and healthy tissues. By using both global and specific, term-to-parent Gene Ontology (GO) statistical comparisons, our functional integrative ad-hoc method allowed the detection of disease-relevant splicing events. Conclusions/Significance: Hyper-spliced transcripts spanned several categories, including the tumorogenic ERBB4 tyrosine kinase receptor and the connective tissue growth factor CTGF, as well as the immune function-related histocompatability gene HLA-DRB1 and interleukin (IL)19, two muscle-specific collagens and one myosin heavy chain gene; intriguingly, a putative new exon was discovered in the MG-involved acetylcholinesterase ACHE gene. Corresponding changes in spliceosome composition were indicated by co-decreases in the splicing factors ASF/SF(2) and SC35. Parallel tumor-associated changes occurred in colon cancer as well, but the majority of the apparent hyper-splicing events were particular to MG-thymoma and could be validated by Fluorescent In-Situ Hybridization (FISH), Reverse Transcription-Polymerase Chain Reaction (RT-PCR) and mass spectrometry (MS) followed by peptide sequencing. Our findings demonstrate a particular alternative hyper-splicing signature for transcripts over-expressed in MG-thymoma, supporting the hypothesis that alternative hyper-splicing contributes to shaping the biological functions of these and other specialized tumors and opening new venues for the development of diagnosis and treatment approaches.	[Soreq, Lilach; Bergman, Hagai] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91010 Jerusalem, Israel; [Gilboa-Geffen, Adi; Soreq, Hermona] Hebrew Univ Jerusalem, Fac Sci, Dept Biol Chem, Jerusalem, Israel; [Berrih-Aknin, Sonia; Lacoste, Paul] Univ Paris Sud, Hop Marie Lannelongue, UMR 8162, Paris, France; [Berrih-Aknin, Sonia; Lacoste, Paul] CNRS, Paris, France; [Darvasi, Ariel] Hebrew Univ Jerusalem, Fac Sci, Dept Genet, Jerusalem, Israel; [Soreq, Eyal] Bezalel Acad Arts & Design, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hopital Marie Lannelongue; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Hebrew University of Jerusalem	Soreq, L (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91010 Jerusalem, Israel.	soreq@cc.huji.ac.il	Berrih‐Aknin, Sonia/F-8025-2013; Soreq, Lilach/AAY-7139-2020; Bergman, Hagai/AAI-4683-2021; gilboa-geffen, adi/E-3028-2013	Berrih‐Aknin, Sonia/0000-0001-9199-4175; Bergman, Hagai/0000-0002-2402-6673; Soreq, Hermona/0000-0002-0955-526X; Soreq, Lilach/0000-0002-9447-2150; gilboa-geffen, adi/0000-0001-9549-4194; Soreq, Lilach/0000-0003-2907-097X	European Alternative Splicing Network of Excellence-EURASNET; The German Israel Project; United States-Israel Binational Science Foundation; Israel Ministry of Science and Technology; Israel Science Foundation; The Eric Roland Center for neurodegenerative diseases;  [LSH-2004-1.1.5-3];  [518238];  [LSHM-CT-2006-037378];  [EU LSHG-CT-2006-037277];  [DIP-G 3.2];  [2003028-01];  [3-2589];  [399/07]	European Alternative Splicing Network of Excellence-EURASNET; The German Israel Project; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Israel Science Foundation(Israel Science Foundation); The Eric Roland Center for neurodegenerative diseases; ; ; ; ; ; ; ; 	This work was supported by the European Alternative Splicing Network of Excellence-EURASNET LSH-2004-1.1.5-3 # 518238, LSHM-CT-2006-037378, EU LSHG-CT-2006-037277, The German Israel Project DIP-G 3.2, United States-Israel Binational Science Foundation (BSF No. 2003028-01), Israel Ministry of Science and Technology grant number 3-2589, Israel Science Foundation, Grant No. 399/07 and The Eric Roland Center for neurodegenerative diseases.	Adamowicz M, 2006, GENE CHROMOSOME CANC, V45, P829, DOI 10.1002/gcc.20343; *AFF, AFF HUM EX ARR TISS; *AFF GENECHIP EX A, 2005, GEN SIGN EST EX ARR; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai YD, 1999, NUCLEIC ACIDS RES, V27, P1126, DOI 10.1093/nar/27.4.1126; Balaguer F, 2007, CLIN GASTROENTEROL H, V5, P379, DOI 10.1016/j.cgh.2006.12.025; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Ben-Shaul Y, 2005, BIOINFORMATICS, V21, P1129, DOI 10.1093/bioinformatics/bti149; BENDOV C, 2007, J BIOL CHEM; Birney E, 2004, NUCLEIC ACIDS RES, V32, pD468, DOI 10.1093/nar/gkh038; Bjarnadottir TK, 2007, GENE, V387, P38, DOI 10.1016/j.gene.2006.07.039; Brenner T, 2003, FASEB J, V17, P214, DOI 10.1096/fj.02-0609com; Breslin T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-193; Buratti E, 2005, TRENDS MOL MED, V11, P5, DOI 10.1016/j.molmed.2004.11.007; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; BUSH CR, 2007, J BIOL CHEM; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Carter RJ, 2001, NUCLEIC ACIDS RES, V29, P3928, DOI 10.1093/nar/29.19.3928; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Espejo F, 2006, BIOCHEM BIOPH RES CO, V340, P860, DOI 10.1016/j.bbrc.2005.12.087; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Franciotta D, 2001, J NEUROL SCI, V190, P11, DOI 10.1016/S0022-510X(01)00573-1; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gilboa-Geffen A, 2007, BLOOD, V109, P4383, DOI 10.1182/blood-2006-07-033373; Giraud M, 2001, NEUROLOGY, V57, P1555, DOI 10.1212/WNL.57.9.1555; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Gross SS, 2006, J COMPUT BIOL, V13, P379, DOI 10.1089/cmb.2006.13.379; *HLA DRB, HLADRB1002; Hoffacker V, 2000, BLOOD, V96, P3872, DOI 10.1182/blood.V96.12.3872.h8003872_3872_3879; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Ishibashi H, 2005, CLIN CANCER RES, V11, P6495, DOI 10.1158/1078-0432.CCR-04-2495; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kalnina Z, 2005, GENE CHROMOSOME CANC, V42, P342, DOI 10.1002/gcc.20156; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim E, 2008, TRENDS GENET, V24, P7, DOI 10.1016/j.tig.2007.10.001; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Kuroda K, 1999, J INVEST DERMATOL, V112, P706, DOI 10.1046/j.1523-1747.1999.00563.x; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; LIBERMANN TA, 1984, CANCER RES, V44, P753; MAGLIETTA R, 2007, BIOINFORMATICS; Marie JC, 1999, J IMMUNOL, V162, P2103; *MATLAB, 2005, MATHW 7 0 4 365 R14; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; Meshorer E, 2006, TRENDS NEUROSCI, V29, P216, DOI 10.1016/j.tins.2006.02.005; Mesnard-Rouiller L, 2004, J NEUROIMMUNOL, V148, P97, DOI 10.1016/j.jneuroim.2003.11.013; Mignone F, 2003, NUCLEIC ACIDS RES, V31, P4639, DOI 10.1093/nar/gkg483; Mio F, 2007, AM J HUM GENET, V81, P1271, DOI 10.1086/522377; Miyata Y, 2006, UROLOGY, V68, P1360, DOI 10.1016/j.urology.2006.09.035; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; MOHAN S, 1994, CLIN IMMUNOL IMMUNOP, V70, P266, DOI 10.1006/clin.1994.1039; Mourra N, 2007, DIS COLON RECTUM, V50, P1881, DOI 10.1007/s10350-007-9040-3; Nerenberg Paul S., 2007, Cancer Genomics & Proteomics, V4, P319; Nilsson B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r74; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Parra G, 2003, GENOME RES, V13, P108, DOI 10.1101/gr.871403; Patel BB, 2007, J PROTEOME RES, V6, P2232, DOI 10.1021/pr060641e; Quackenbush J, 2006, METHOD INFORM MED, V45, P91; Singh NN, 2004, CRIT REV EUKAR GENE, V14, P271, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.30; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smit A, 1996, REPEATMASKER OPEN 30; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Stremmel C, 2007, DEUT MED WOCHENSCHR, V132, P2090, DOI 10.1055/s-2007-985647; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Vaughn MW, 2005, SCIENCE, V309, P1525, DOI 10.1126/science.1117805; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; VIEIRA ML, 1993, J NEUROIMMUNOL, V47, P115, DOI 10.1016/0165-5728(93)90021-P; Vincent A, 2002, NAT REV IMMUNOL, V2, P797, DOI 10.1038/nri916; Wang ZN, 2003, CANCER RES, V63, P655; Wu F, 2007, J IMMUNOL, V179, P6988, DOI 10.4049/jimmunol.179.10.6988; Xiong Z, 2006, J CLIN PATHOL, V59, P855, DOI 10.1136/jcp.2005.032961; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; YANG D, 2007, BIOINFORMATICS; Yang D, 2008, BIOINFORMATICS, V24, P265, DOI 10.1093/bioinformatics/btm558; YOSHIDA T, 1977, J NEUROL SCI, V32, P195, DOI 10.1016/0022-510X(77)90234-9; Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303; AFFYMETRIX ARRAY DES	91	17	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2392	10.1371/journal.pone.0002392	http://dx.doi.org/10.1371/journal.pone.0002392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545673	Green Published, Green Submitted, gold			2022-12-25	WOS:000263248800031
J	Erridge, C; Kennedy, S; Spickett, CM; Webb, DJ				Erridge, Clett; Kennedy, Simon; Spickett, Corinne M.; Webb, David J.			Oxidized phospholipid inhibition of Toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4 - Roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN-1; LOW-DENSITY-LIPOPROTEIN; LIPID RAFTS; OXIDATION-PRODUCTS; HEME OXYGENASE-1; ACTIVATION; INDUCE; COMPLEX; MD-2	The generation of reactive oxygen species is a central feature of inflammation that results in the oxidation of host phospholipids. Oxidized phospholipids, such as 1-palmitoyl-2-arachidonyl-sn-glycero-3- phosphorylcholine (OxPAPC), have been shown to inhibit signaling induced by bacterial lipopeptide or lipopolysaccharide (LPS), yet the mechanisms responsible for the inhibition of Toll-like receptor (TLR) signaling by OxPAPC remain incompletely understood. Here, we examined the mechanisms by which OxPAPC inhibits TLR signaling induced by diverse ligands in macrophages, smooth muscle cells, and epithelial cells. OxPAPC inhibited tumor necrosis factor-alpha production, I kappa B alpha degradation, p38 MAPK phosphorylation, and NF-kappa B-dependent reporter activation induced by stimulants of TLR2 and TLR4 (Pam(3)CSK(4) and LPS) but not by stimulants of other TLRs (poly(I.C), flagellin, loxoribine, single-stranded RNA, or CpG DNA) in macrophages and HEK-293 cells transfected with respective TLRs and significantly reduced inflammatory responses in mice injected subcutaneously or intraperitoneally with Pam(3)CSK(4). Serum proteins, including CD14 and LPS-binding protein, were identified as key targets for the specificity of TLR inhibition as supplementation with excess serum or recombinant CD14 or LBP reversed TLR2 inhibition by OxPAPC, whereas serum accessory proteins or expression of membrane CD14 potentiated signaling via TLR2 and TLR4 but not other TLRs. Binding experiments and functional assays identified MD2 as a novel additional target of OxPAPC inhibition of LPS signaling. Synthetic phospholipid oxidation products 1-palmitoyl-2-(5-oxovaleryl)-sn-glycero-3-phosphocholine and 1-palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine inhibited TLR2 signaling from similar to 30 mu M. Taken together, these results suggest that oxidized phospholipid-mediated inhibition of TLR signaling occurs mainly by competitive interaction with accessory proteins that interact directly with bacterial lipids to promote signaling via TLR2 or TLR4.	[Erridge, Clett; Spickett, Corinne M.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G1 1XW, Lanark, Scotland; [Kennedy, Simon] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Webb, David J.] Univ Edinburgh, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Strathclyde; University of Glasgow; University of Edinburgh	Erridge, C (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G1 1XW, Lanark, Scotland.	clett.erridge@strath.ac.uk		Spickett, Corinne Michelle/0000-0003-4054-9279; Kennedy, Simon/0000-0003-0887-5840; Erridge, Clett/0000-0003-2978-346X	British Heart Foundation [FS/03/97]	British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation (FS/03/97). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Barton GM, 2007, SEMIN IMMUNOL, V19, P33, DOI 10.1016/j.smim.2007.01.003; Berliner J, 2002, VASC PHARMACOL, V38, P187, DOI 10.1016/S1537-1891(02)00168-4; Bluml S, 2005, J IMMUNOL, V175, P501, DOI 10.4049/jimmunol.175.1.501; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Bowie AG, 1997, J BIOL CHEM, V272, P25941, DOI 10.1074/jbc.272.41.25941; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; DELAHOOKE DM, 1995, INFECT IMMUN, V63, P840, DOI 10.1128/IAI.63.3.840-846.1995; Erridge C, 2007, REDOX REP, V12, P76, DOI 10.1179/135100007X162121; Erridge C, 2007, ATHEROSCLEROSIS, V193, P77, DOI 10.1016/j.atherosclerosis.2006.08.032; Fischer H, 2007, CELL MICROBIOL, V9, P1239, DOI 10.1111/j.1462-5822.2006.00867.x; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Gruber F, 2007, J BIOL CHEM, V282, P16934, DOI 10.1074/jbc.M702523200; Hsu YW, 2001, J IMMUNOL, V166, P5388, DOI 10.4049/jimmunol.166.9.5388; JOSEPH CK, 1994, J BIOL CHEM, V269, P17606; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; Larbi A, 2004, EXP GERONTOL, V39, P551, DOI 10.1016/j.exger.2003.10.031; Lee H, 2000, CIRC RES, V87, P516; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Liaudet L, 2002, INFECT IMMUN, V70, P192, DOI 10.1128/IAI.70.1.192-198.2002; Loidl A, 2003, J BIOL CHEM, V278, P32921, DOI 10.1074/jbc.M306088200; Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muta T, 2001, EUR J BIOCHEM, V268, P4580, DOI 10.1046/j.1432-1327.2001.02385.x; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Reddy S, 2001, J BIOL CHEM, V276, P17030, DOI 10.1074/jbc.M011663200; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Sellati TJ, 1998, J IMMUNOL, V160, P5455; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Subbanagounder G, 2002, J BIOL CHEM, V277, P7271, DOI 10.1074/jbc.M107602200; Tobias P, 2005, J LIPID RES, V46, P404, DOI 10.1194/jlr.R400015-JLR200; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; Triantafilou M, 2002, J CELL SCI, V115, P2603; Tsuneyoshi N, 2006, CELL IMMUNOL, V244, P57, DOI 10.1016/j.cellimm.2007.02.010; van de Loo FAJ, 2003, AM J PATHOL, V163, P1525, DOI 10.1016/S0002-9440(10)63509-2; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Walton KA, 2006, J LIPID RES, V47, P1967, DOI 10.1194/jlr.M600060-JLR200; Wang PY, 1996, J INFLAMM, V47, P126; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang RL, 2002, BLOOD, V99, P1802, DOI 10.1182/blood.V99.5.1802.h8001802_1802_1810	53	172	177	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24748	24759		10.1074/jbc.M800352200	http://dx.doi.org/10.1074/jbc.M800352200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18559343	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000258820000043
J	Czyzyk, J; Chen, HC; Bottomly, K; Flavell, RA				Czyzyk, Jan; Chen, Hui-Chen; Bottomly, Kim; Flavell, Richard A.			p21 Ras/impedes mitogenic signal propagation regulates cytokine production and migration in CD4 T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE ACTIVATION; SPHINGOSINE-1-PHOSPHATE RECEPTOR-1; NEGATIVE SELECTION; ANTIGEN RECEPTOR; HA-RAS; PROTEIN; DIFFERENTIATION; THYMOCYTES; EXPRESSION; ERK	The propensity of T cells to generate coordinated cytokine responses is critical for the host to develop resistance to pathogens while maintaining the state of immunotolerance to self-antigens. The exact mechanisms responsible for preventing the overproduction of proinflammatory cytokines including interferon (IFN)-gamma are not fully understood, however. In this study, we examined the role of a recently described Ras GTPase effector and repressor of the Raf/MEK/ERK cascade called impedes mitogenic signal propagation ( Imp) in limiting the induction of T-cell cytokines. We found that stimulation of the T cell receptor complex leads to the rapid development of a physical association between Ras and Imp. Consistent with the hypothesis that Imp inhibits signal transduction, we also found that disengagement of this molecule by the Ras(V12G37) effector loop mutant or RNA interference markedly enhances the activation of the NFAT transcription factor and IFN-gamma secretion. A strong output of IFN-gamma is responsible for the distinct lymphocyte traffic pattern observed in vivo because the transgenic or retroviral expression of Ras(V12G37) caused T cells to accumulate preferentially in the lymph nodes and delayed their escape from the lymphoid tissue, respectively. Together, our results describe a hitherto unrecognized negative regulatory role for Imp in the production of IFN-gamma in T cells and point to Ras-Imp binding as an attractive target for therapeutic interventions in conditions involving the production of this inflammatory cytokine.	[Czyzyk, Jan] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Czyzyk, Jan; Chen, Hui-Chen; Bottomly, Kim; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Czyzyk, J (corresponding author), 300 Cedar St,TAC S546, New Haven, CT 06519 USA.	jan.czyzyk@yale.edu	Chen, Hui-Chen/L-8149-2013	Chen, Hui-Chen/0000-0001-9751-5729	National Institutes of Health [R01 5R37A1026791-18]; American Cancer Society Research Scholar	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar(American Cancer Society)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 5R37A1026791-18 (to K. B.). This work was also supported by an American Cancer Society Research Scholar Grant (to J.C.).	Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; BALDARI CT, 1993, J BIOL CHEM, V268, P2693; BALDARI CT, 1992, J BIOL CHEM, V267, P4289; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOS JL, 1997, CELL, V129, P865; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chi HB, 2005, J IMMUNOL, V174, P2485, DOI 10.4049/jimmunol.174.5.2485; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; CLARK GJ, 1993, P NATL ACAD SCI USA, V90, P4887, DOI 10.1073/pnas.90.11.4887; Cristofano A. D., 2001, J EXP MED, V194, P275; Czyzyk J, 2003, P NATL ACAD SCI USA, V100, P6003, DOI 10.1073/pnas.1031494100; Czyzyk J, 2000, MOL CELL BIOL, V20, P8740, DOI 10.1128/MCB.20.23.8740-8747.2000; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; FRANKLIN RA, 1994, J CLIN INVEST, V93, P2134, DOI 10.1172/JCI117209; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; IZQUIERDO M, 1994, J EXP MED, V180, P401, DOI 10.1084/jem.180.1.401; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Kinashi T, 2000, J BIOL CHEM, V275, P22590, DOI 10.1074/jbc.M000633200; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McCarty N, 2005, NAT IMMUNOL, V6, P65, DOI 10.1038/ni1145; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Murphy, 2003, FUNDAMENTAL IMMUNOLO, P801; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Olsen NJ, 2004, ARTHRITIS RES THER, V6, P120, DOI 10.1186/ar1190; Ory S, 2004, CURR BIOL, V14, pR277, DOI 10.1016/j.cub.2004.03.023; OWAKI H, 1993, EMBO J, V12, P4367, DOI 10.1002/j.1460-2075.1993.tb06121.x; RAYTER SI, 1992, EMBO J, V11, P4549, DOI 10.1002/j.1460-2075.1992.tb05556.x; Remans PHJ, 2004, J IMMUNOL, V173, P920, DOI 10.4049/jimmunol.173.2.920; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Yamanashi Y, 2000, GENE DEV, V14, P11; Yan F, 2004, J CLIN INVEST, V114, P1272, DOI 10.1172/JCI200421022; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zhao MM, 2001, J EXP MED, V194, P265, DOI 10.1084/jem.194.3.265; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	58	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23004	23015		10.1074/jbc.M804084200	http://dx.doi.org/10.1074/jbc.M804084200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18577512	Green Published, hybrid			2022-12-25	WOS:000258455400013
J	Becker, R; Loll, B; Meinhart, A				Becker, Roland; Loll, Bernhard; Meinhart, Anton			Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the carboxyl- terminal domain of RNA polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; CRYPTIC UNSTABLE TRANSCRIPTS; CAPPING ENZYME; YEAST; BINDING; RECOGNITION; INTERACTS; SNORNA; IICTD; NRD1	Concomitant with RNA polymerase II (Pol II) transcription, RNA maturation factors are recruited to the carboxyl- terminal domain (CTD) of Pol II, whose phosphorylation state changes during a transcription cycle. CTD phosphorylation triggers recruitment of functionally different factors involved in RNA processing and transcription termination; most of these factors harbor a conserved CTD interacting domain (CID). Orchestration of factor recruitment is believed to be conducted by CID recognition of distinct phosphorylated forms of the CTD. We show that the human RNA processing factor SCAF8 interacts weakly with the unphosphorylated CTD of Pol II. Upon phosphorylation, affinity for the CTD is increased; however, SCAF8 is promiscuous to the phosphorylation pattern on the CTD. Employing a combined structural and biophysical approach, we were able to distinguish motifs within CIDs that are involved in a generic CTD sequence recognition from items that confer phospho-specificity.	[Becker, Roland; Loll, Bernhard; Meinhart, Anton] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Max Planck Society	Meinhart, A (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.	Anton.Meinhart@mpimf-heidelberg.mpg.de	Meinhart, Anton/M-9647-2014; Becker, Roland/AAD-6900-2020; Loll, Bernhard/J-4815-2019	Loll, Bernhard/0000-0001-7928-4488				Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bienkiewicz EA, 2000, J MOL BIOL, V297, P119, DOI 10.1006/jmbi.2000.3545; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; Corden JL, 2007, SCIENCE, V318, P1735, DOI 10.1126/science.1152624; DAHMUS ME, 1995, BBA-GENE STRUCT EXPR, V1261, P171, DOI 10.1016/0167-4781(94)00233-S; DeLano W, 2002, PYMOL 0 99; Efron B., 1982, SOC IND APPL MATH CB, V38; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hausmann S, 2005, J BIOL CHEM, V280, P37681, DOI 10.1074/jbc.M505292200; Hirose Y, 2000, GENE DEV, V14, P1415; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Ho CK, 1998, J BIOL CHEM, V273, P9577, DOI 10.1074/jbc.273.16.9577; Hollingworth D, 2006, RNA, V12, P555, DOI 10.1261/rna.2304506; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Liu PD, 2008, MOL BIOL EVOL, V25, P719, DOI 10.1093/molbev/msn017; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Meinhart A, 2003, J BIOL CHEM, V278, P15917, DOI 10.1074/jbc.M301643200; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Morris DP, 1999, J BIOL CHEM, V274, P31583, DOI 10.1074/jbc.274.44.31583; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Patturajan M, 1998, MOL CELL BIOL, V18, P2406, DOI 10.1128/MCB.18.4.2406; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7440, DOI 10.1021/bi00484a013; Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sims RJ, 2004, CURR OPIN CELL BIOL, V16, P263, DOI 10.1016/j.ceb.2004.04.004; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; SUZUKI M, 1989, J MOL BIOL, V207, P61, DOI 10.1016/0022-2836(89)90441-5; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; WEST ML, 1995, GENETICS, V140, P1223; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975; ZHANG J, 1991, J BIOL CHEM, V266, P2297; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	62	44	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22659	22669		10.1074/jbc.M803540200	http://dx.doi.org/10.1074/jbc.M803540200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18550522	Green Published, hybrid			2022-12-25	WOS:000258321000035
J	Fukuda, K; Watanabe, T; Tokisue, T; Tsujita, T; Nishikawa, S; Hasegawa, T; Seya, T; Matsumoto, M				Fukuda, Kotaro; Watanabe, Tomoya; Tokisue, Takashi; Tsujita, Tadayuki; Nishikawa, Satoshi; Hasegawa, Tsunemi; Seya, Tsukasa; Matsumoto, Misako			Modulation of double-stranded RNA recognition by the N-terminal histidine-rich region of the human toll-like receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-BETA INDUCTION; CPG-DNA; PH; DOMAIN; LOCALIZATION; ECTODOMAIN; ADAPTER	Toll- like receptors (TLRs) are an essential component of the innate immune response to microbial pathogens. TLR3 is localized in intracellular compartments, such as endosomes, and initiates signals in response to virus- derived double-strandedRNA (dsRNA). The TLR3 ectodomain (ECD), which is implicated in dsRNA recognition, is a horseshoe-shaped solenoid composed of 23 leucine- rich repeats (LRRs). Recent mutagenesis studies on the TLR3 ECD revealed that TLR3 activation depends on a single binding site on the nonglycosylated surface in the C-terminal region, comprising H539 and several asparagines within LRR17 to -20. TLR3 localization within endosomes is required for ligand recognition, suggesting that acidic pH is the driving force for TLR3 ligand binding. To elucidate the pH- dependent binding mechanism of TLR3 at the structural level, we focused on three highly conserved histidine residues clustered at the N-terminal region of the TLR3 ECD: His(39) in the N-cap region, His(60) in LRR1, and His(108) in LRR3. Mutagenesis of these residues showed that His(39), His(60), and His(108) were essential for ligand-dependent TLR3 activation in a cell- based assay. Furthermore, dsRNA binding to recombinant TLR3 ECD depended strongly on pH and dsRNA length and was reduced by mutation of His(39), His(60), and His(108), demonstrating that TLR3 signaling is initiated from the endosome through a pH- dependent binding mechanism, and that a second dsRNA binding site exists in the N-terminal region of the TLR3 ECD characteristic solenoid. We propose a novel model for the formation of TLR3 ECD dimers complexed with dsRNA, which incorporates this second binding site.	[Fukuda, Kotaro; Watanabe, Tomoya; Tokisue, Takashi; Hasegawa, Tsunemi] Yamagata Univ, Dept Mat & Biol Chem, Fac Sci, Yamagata 9908560, Japan; [Tsujita, Tadayuki; Seya, Tsukasa; Matsumoto, Misako] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Nishikawa, Satoshi] Natl Inst Adv Ind Sci & Technol, Age Dimens Res Ctr, Tsukuba, Ibaraki 3058566, Japan	Yamagata University; Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST)	Fukuda, K (corresponding author), Yamagata Univ, Dept Mat & Biol Chem, Fac Sci, Yamagata 9908560, Japan.	kotaro.f@sci.kj.yamagata-u.ac.jp	Seya, Tsukasa/A-4336-2012; Tsujita, Tadayuki/AAH-2347-2019; 美佐子, 松本/A-4497-2012	Tsujita, Tadayuki/0000-0002-7189-0376; 				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; DOI T, 1994, J BIOL CHEM, V269, P25598; FUKUDA K, 1995, J BIOL CHEM, V270, P22527, DOI 10.1074/jbc.270.38.22527; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Gibbard RJ, 2006, J BIOL CHEM, V281, P27503, DOI 10.1074/jbc.M605003200; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Okahira S, 2005, DNA CELL BIOL, V24, P614, DOI 10.1089/dna.2005.24.614; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Takada E, 2007, MOL IMMUNOL, V44, P3633, DOI 10.1016/j.molimm.2007.04.021; Tsujita T, 2004, J BIOL CHEM, V279, P48588, DOI 10.1074/jbc.M407634200; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	25	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22787	22794		10.1074/jbc.M802284200	http://dx.doi.org/10.1074/jbc.M802284200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18544529	hybrid			2022-12-25	WOS:000258321000046
J	Hebenstreit, D; Giaisi, M; Treiber, MK; Zhang, XB; Mi, HF; Horejs-Hoeck, J; Andersen, KG; Krammer, PH; Duschl, A; Li-Weber, M				Hebenstreit, Daniel; Giaisi, Marco; Treiber, Monika K.; Zhang, Xiao-Bin; Mi, Huai-Feng; Horejs-Hoeck, Jutta; Andersen, Kristian G.; Krammer, Peter H.; Duschl, Albert; Li-Weber, Min			LEF-1 negatively controls interleukin-4 expression through a proximal promoter regulatory element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; T-CELLS; TRANSCRIPTION; TCF-1; PROTEIN; INVOLVEMENT; ACTIVATION	Lymphoid enhancer-binding factor 1 (LEF-1) and T cell factor (TCF-1) are downstream effectors of the Wnt signaling pathway and are involved in the regulation of T cell development in the thymus. LEF-1 and TCF-1 are also expressed in mature peripheral primary T cells, but their expression is down-regulated following T cell activation. Although the decisive roles of LEF-1 and TCF-1 in the early stages of T cell development are well documented, the functions of these factors in mature peripheral T cells are largely unknown. Recently, LEF-1 was shown to suppress Th2 cytokines interleukin-4 (IL-4), -5, and -13 expression from the developing Th2 cells that overexpress LEF-1 through retrovirus gene transduction. In this study, we further investigated the expression and functions of LEF-1 and TCF-1 in peripheral CD4(+) T cells and revealed that LEF-1 is dominantly expressed in Th1 but not in Th2 cells. We identified a high affinity LEF-1-binding site in the negative regulatory element of the IL-4 promoter. Knockdown LEF-1 expression by LEF-1-specific small interfering RNA resulted in an increase in the IL-4 mRNA expression. This study further confirms a negative regulatory role of LEF-1 in mature peripheral T cells. Furthermore, we found that IL-4 stimulation possesses a negative effect on the expressions of LEF-1 and TCF-1 in primary T cells, suggesting a positive feedback effect of IL-4 on IL-4 gene expression.	[Hebenstreit, Daniel; Horejs-Hoeck, Jutta; Duschl, Albert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Giaisi, Marco; Treiber, Monika K.; Krammer, Peter H.; Li-Weber, Min] German Canc Res Ctr, Tumorimmunol Program, D-69120 Heidelberg, Germany; [Zhang, Xiao-Bin; Mi, Huai-Feng] Nankai Univ, Inst Polymer Chem, Tianjin 300071, Peoples R China; [Hebenstreit, Daniel; Andersen, Kristian G.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Salzburg University; Helmholtz Association; German Cancer Research Center (DKFZ); Nankai University; MRC Laboratory Molecular Biology	Li-Weber, M (corresponding author), Deutsch Krebsforschungszentrum, German Canc Res Ctr, Tumor Immunol Program D030, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	m.li-weber@dkfz-heidelberg.de	Horejs-Hoeck, Jutta/E-5010-2011; hebenstreit, daniel/GWZ-2082-2022; Andersen, Kristian/D-5006-2009; Horejs-Hoeck, Jutta/AAF-1735-2019; Duschl, Albert/E-5872-2011	Horejs-Hoeck, Jutta/0000-0002-0984-204X; hebenstreit, daniel/0000-0003-0144-6728; Andersen, Kristian/0000-0001-6431-5982; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Duschl, Albert/0000-0002-7034-9860	MRC [MC_U105184296] Funding Source: UKRI; Austrian Science Fund FWF [P 18409] Funding Source: Medline; Medical Research Council [MC_U105184296] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chung EJ, 2002, BLOOD, V100, P982, DOI 10.1182/blood.V100.3.982; Dorfman DM, 2003, AM J PATHOL, V162, P1539, DOI 10.1016/S0002-9440(10)64287-3; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; HOSSAIN MB, 2008, IMMUNOLOGY IN PRESS; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; KRAMMER PH, 1983, IMMUNOL REV, V76, P5, DOI 10.1111/j.1600-065X.1983.tb01095.x; Li-Weber M, 2003, NAT REV IMMUNOL, V3, P534, DOI 10.1038/nri1128; Li-Weber M, 2002, EUR J IMMUNOL, V32, P3587, DOI 10.1002/1521-4141(200212)32:12<3587::AID-IMMU3587>3.0.CO;2-E; LIWEBER M, 1993, J IMMUNOL, V151, P1371; Lu BF, 2004, P NATL ACAD SCI USA, V101, P3023, DOI 10.1073/pnas.0307743100; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Prieve MG, 1999, MOL CELL BIOL, V19, P4503; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Schilham MW, 1998, J IMMUNOL, V161, P3984; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Staal FJT, 2003, CURR OPIN IMMUNOL, V15, P204, DOI 10.1016/S0952-7915(03)00003-7; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Weerkamp F, 2006, TRENDS IMMUNOL, V27, P125, DOI 10.1016/j.it.2006.01.006; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Wirnsberger G, 2006, EUR J IMMUNOL, V36, P1882, DOI 10.1002/eji.200635972; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008	35	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22490	22497		10.1074/jbc.M804096200	http://dx.doi.org/10.1074/jbc.M804096200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18579517	hybrid, Green Accepted			2022-12-25	WOS:000258321000017
J	Sun, H; Greathouse, DV; Andersen, OS; Koeppe, RE				Sun, Haiyan; Greathouse, Denise V.; Andersen, Olaf S.; Koeppe, Roger E., II			The preference of tryptophan for membrane interfaces - Insights from n-methylation of tryptophans in gramicidin channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE ION-CHANNEL; ACID SIDE-CHAINS; LIPID-BILAYER; SINGLE-CHANNEL; 3-DIMENSIONAL STRUCTURE; HYDROPHOBIC PEPTIDES; MAGNETIC-RESONANCE; CIRCULAR-DICHROISM; LINEAR GRAMICIDINS; CONFORMATION	To better understand the structural and functional roles of tryptophan at the membrane/water interface in membrane proteins, we examined the structural and functional consequences of Trp -> 1-methyl-tryptophan substitutions in membrane-spanning gramicidin A channels. Gramicidin A channels are miniproteins that are anchored to the interface by four Trps near the C terminus of each subunit in a membrane-spanning dimer. We masked the hydrogen bonding ability of individual or multiple Trps by 1-methylation of the indole ring and examined the structural and functional changes using circular dichroism spectroscopy, size exclusion chromatography, solid state H-2 NMR spectroscopy, and single channel analysis. N-Methylation causes distinct changes in the subunit conformational preference, channel-forming propensity, single channel conductance and lifetime, and average indole ring orientations within the membrane-spanning channels. The extent of the local ring dynamic wobble does not increase, and may decrease slightly, when the indole NH is replaced by the non-hydrogen-bonding and more bulky and hydrophobic N-CH3 group. The changes in conformational preference, which are associated with a shift in the distribution of the aromatic residues across the bilayer, are similar to those observed previously with Trp -> Phe substitutions. We conclude that indole N-H hydrogen bonding is of major importance for the folding of gramicidin channels. The changes in ion permeability, however, are quite different for Trp -> Phe and Trp -> 1-methyl-tryptophan substitutions, indicating that the indole dipole moment and perhaps also ring size and are important for ion permeation through these channels.	[Sun, Haiyan; Greathouse, Denise V.; Koeppe, Roger E., II] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Andersen, Olaf S.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA	University of Arkansas System; University of Arkansas Fayetteville; Cornell University	Andersen, OS (corresponding author), 119 Chem Bldg, Fayetteville, AR 72701 USA.	sparre@med.cornell.edu; rk2@uark.edu		Greathouse, Denise/0000-0001-7104-8499; Koeppe, Roger/0000-0003-0676-6413	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070971, T32GM007739] Funding Source: NIH RePORTER; NCRR NIH HHS [RR15569] Funding Source: Medline; NIGMS NIH HHS [R01 GM070971, GM70971] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRIBAT G, 1970, CR ACAD SCI C CHIM, V271, P1029; Andersen Olaf S., 2007, P33, DOI 10.1007/0-387-68919-2_2; Andersen Olaf S., 2007, V400, P543; ANDERSEN OS, 1983, BIOPHYS J, V41, P119, DOI 10.1016/S0006-3495(83)84414-2; Andersen OS, 1998, J AM CHEM SOC, V120, P5142, DOI 10.1021/ja980182l; ARSENIEV AS, 1986, BIOL MEMBRANY, V3, P1077; Ashrafuzzaman M, 2006, J PHYS-CONDENS MAT, V18, pS1235, DOI 10.1088/0953-8984/18/28/S08; BAK B, 1967, ACTA CHEM SCAND, V21, P1674, DOI 10.3891/acta.chem.scand.21-1674; BAK B, 1969, ACTA CHEM SCAND, V23, P3051, DOI 10.3891/acta.chem.scand.23-3051; BANO MD, 1988, J CHROMATOGR, V458, P105; BECKER MD, 1991, BIOCHEMISTRY-US, V30, P8830, DOI 10.1021/bi00100a015; Bouchard M, 2000, BIOPHYS J, V78, P1010, DOI 10.1016/S0006-3495(00)76659-8; Burkhart BM, 1998, P NATL ACAD SCI USA, V95, P12950, DOI 10.1073/pnas.95.22.12950; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; Busath DD, 1998, BIOPHYS J, V75, P2830, DOI 10.1016/S0006-3495(98)77726-4; Cole CD, 2002, BIOPHYS J, V83, P1974, DOI 10.1016/S0006-3495(02)73959-3; Cotten M, 1997, BIOPHYS J, V73, P614, DOI 10.1016/S0006-3495(97)78097-4; Cotten M, 1999, BIOCHEMISTRY-US, V38, P9185, DOI 10.1021/bi982981m; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; DURKIN JT, 1992, BIOPHYS J, V62, P145, DOI 10.1016/S0006-3495(92)81801-5; DURKIN JT, 1990, J MOL BIOL, V211, P221, DOI 10.1016/0022-2836(90)90022-E; FONSECA V, 1992, BIOCHEMISTRY-US, V31, P5340, DOI 10.1021/bi00138a014; GALL CM, 1981, J AM CHEM SOC, V103, P5039, DOI 10.1021/ja00407a012; Greathouse D V, 1999, Methods Enzymol, V294, P525; GREATHOUSE DV, 1994, BIOCHEMISTRY-US, V33, P4291, DOI 10.1021/bi00180a025; Greathouse DV, 2001, J PEPT RES, V57, P519, DOI 10.1034/j.1399-3011.2001.00849.x; HEITZ F, 1986, BIOPHYS CHEM, V24, P143, DOI 10.1016/0301-4622(86)80007-2; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; HU W, 1995, BIOCHEMISTRY-US, V34, P14138, DOI 10.1021/bi00043a019; HU W, 1995, BIOCHEMISTRY-US, V34, P14147, DOI 10.1021/bi00043a020; Jordan JB, 2006, BIOCHEMISTRY-US, V45, P14012, DOI 10.1021/bi061560z; Jude AR, 1999, BIOCHEMISTRY-US, V38, P1030, DOI 10.1021/bi982043m; KACHEL K, 1995, BIOCHEMISTRY-US, V34, P15475, DOI 10.1021/bi00047a012; KETCHEM RR, 1993, SCIENCE, V261, P1457, DOI 10.1126/science.7690158; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; KILLIAN JA, 1992, BIOCHEMISTRY-US, V31, P11283, DOI 10.1021/bi00161a004; KILLIAN JA, 1988, BIOCHEMISTRY-US, V27, P4848, DOI 10.1021/bi00413a040; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Koeppe RE, 2000, BIOCHEMISTRY-US, V39, P2235, DOI 10.1021/bi9920679; Koeppe RE, 2003, J AM CHEM SOC, V125, P12268, DOI 10.1021/ja035052d; KOEPPE RE, 1990, BIOCHEMISTRY-US, V29, P512, DOI 10.1021/bi00454a027; KOEPPE RE, 1992, PROTEINS, V12, P49, DOI 10.1002/prot.340120107; KOEPPE RE, 1994, BIOPHYS J, V66, P14, DOI 10.1016/S0006-3495(94)80748-9; Koeppe RE, 2007, J GEN PHYSIOL, V130, P223, DOI 10.1085/jgp.200709829; LANGS DA, 1988, SCIENCE, V241, P188, DOI 10.1126/science.2455345; LOGRASSO PV, 1988, BIOPHYS J, V54, P259, DOI 10.1016/S0006-3495(88)82955-2; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; MacCallum JL, 2007, J GEN PHYSIOL, V129, P371, DOI 10.1085/jgp.200709745; MATTICE GL, 1995, BIOCHEMISTRY-US, V34, P6827, DOI 10.1021/bi00020a029; MAZET JL, 1984, BIOPHYS J, V45, P263, DOI 10.1016/S0006-3495(84)84153-3; McClellan A. L., 1963, TABLES EXPT DIPOLE M, P280; Mobashery N, 1997, FEBS LETT, V412, P15, DOI 10.1016/S0014-5793(97)00709-6; Norman KE, 2006, BIOPHYS J, V91, P2046, DOI 10.1529/biophysj.105.080275; OCONNELL AM, 1990, SCIENCE, V250, P1256, DOI 10.1126/science.1700867; Persson S, 1998, BIOPHYS J, V75, P1365, DOI 10.1016/S0006-3495(98)74054-8; Pulay P, 2005, J AM CHEM SOC, V127, P17488, DOI 10.1021/ja054935x; RUSSELL EWB, 1986, BIOPHYS J, V49, P673, DOI 10.1016/S0006-3495(86)83694-3; Salom D, 1998, BIOCHEMISTRY-US, V37, P14279, DOI 10.1021/bi980733k; Samanta U, 2000, PROTEINS, V38, P288, DOI 10.1002/(SICI)1097-0134(20000215)38:3<288::AID-PROT5>3.3.CO;2-Z; SAWYER DB, 1989, BIOCHEMISTRY-US, V28, P6571, DOI 10.1021/bi00442a007; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; Sham SS, 2003, BIOCHEMISTRY-US, V42, P1401, DOI 10.1021/bi0204286; SIEBER P, 1987, TETRAHEDRON LETT, V28, P6147, DOI 10.1016/S0040-4039(00)61832-4; Subbiah RN, 2005, J PHYSIOL-LONDON, V569, P367, DOI 10.1113/jphysiol.2005.097386; Townsley LE, 2001, BIOCHEMISTRY-US, V40, P11676, DOI 10.1021/bi010942w; TURNER GL, 1983, BIOCHIM BIOPHYS ACTA, V756, P133, DOI 10.1016/0304-4165(83)90083-1; van der Wel PCA, 2007, BIOCHEMISTRY-US, V46, P7514, DOI 10.1021/bi700082v; van der Wel PCA, 2002, BIOPHYS J, V83, P1479, DOI 10.1016/S0006-3495(02)73918-0; VEATCH WR, 1974, BIOCHEMISTRY-US, V13, P5249, DOI 10.1021/bi00723a001; Wallace BA, 1999, ADV EXP MED BIOL, V467, P789; WALLACE BA, 1981, BIOCHEMISTRY-US, V20, P5754, DOI 10.1021/bi00523a018; WIMLEY WC, 1993, BIOCHEMISTRY-US, V32, P6307, DOI 10.1021/bi00076a001; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	75	79	80	4	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22233	22243		10.1074/jbc.M802074200	http://dx.doi.org/10.1074/jbc.M802074200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550546	hybrid, Green Published			2022-12-25	WOS:000258114700043
J	Corcoran, KE; Trzaska, KA; Fernandes, H; Bryan, M; Taborga, M; Srinivas, V; Packman, K; Patel, PS; Rameshwar, P				Corcoran, Kelly E.; Trzaska, Katarzyna A.; Fernandes, Helen; Bryan, Margarette; Taborga, Marcelo; Srinivas, Venkatesh; Packman, Kathryn; Patel, Prem S.; Rameshwar, Pranela			Mesenchymal Stem Cells in Early Entry of Breast Cancer into Bone Marrow	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; NEUROKININ RECEPTORS; TUMOR-GROWTH; IN-VITRO; EXPRESSION; METASTASIS; FACTOR-1-ALPHA; ACTIVATION; RELEVANCE; TARGETS	Background: An understanding of BC cell (BCC) entry into bone marrow ( BM) at low tumor burden is limited when compared to highly metastatic events during heavy tumor burden. BCCs can achieve quiescence, without interfering with hematopoiesis. This occurs partly through the generation of gap junctions with BM stroma, located close to the endosteum. These events are partly mediated by the evolutionary conserved gene, Tac1. Methodogy/Principal Findings: This study focuses on the role of mesenchymal stem cells (MSCs), Tac1, SDF-1 and CXCR4 in BCC entry into BM. The model is established in studies with low numbers of tumor cells, and focuses on cancer cells with low metastatic and invasion potential. This allowed us to recapitulate early event, and to study cancer cells with low invasive potential, even when they are part of larger numbers of highly metastatic cells. A novel migration assay showed a facilitating role of MSCs in BCC migration across BM endothelial cells. siRNA and ectopic expression studies showed a central role for Tac1 and secondary roles for SDF-1 alpha and CXCR4. We also observed differences in the mechanisms between low invasive and highly metastatic cells. The in vitro studies were verified in xenogeneic mouse models that showed a preference for low invasive BCCs to BM, but comparable movement to lung and BM by highly metastatic BCCs. The expressions of Tac1 and production of SDF-1 alpha were verified in primary BCCs from paired samples of BM aspirates and peripheral blood. Conclusions/Significance: MSC facilitate BCC entry into BM, partly through Tac1-mediated regulation of SDF-1 alpha and CXCR4. We propose a particular population of BCC with preference for BM could be isolated for characterization. This population might be the subset that enter BM at an early time period, and could be responsible for cancer resurgence and resistance to current therapies.	[Corcoran, Kelly E.; Trzaska, Katarzyna A.; Bryan, Margarette; Taborga, Marcelo; Srinivas, Venkatesh; Rameshwar, Pranela] UMDNJ, New Jersey Med Sch, Dept Med, Newark, NJ USA; [Fernandes, Helen] UMDNJ, New Jersey Med Sch, Dept Pathol, Lab Med, Newark, NJ USA; [Packman, Kathryn] Hoffmann La Roche, Discovery Oncol, Nutley, NJ USA; [Patel, Prem S.] Brookdale Univ Hosp, Med Ctr, Div Trauma, Brooklyn, NY USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Roche Holding	Corcoran, KE (corresponding author), UMDNJ, New Jersey Med Sch, Dept Med, Newark, NJ USA.	rameshwa@umdnj.edu						Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Beaujouan JC, 2004, PEPTIDES, V25, P339, DOI 10.1016/j.peptides.2004.02.011; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; BIGIONI M, 2007, ANTI-CANCER DRUG, V16, P1083; Braun S, 2005, J CLIN ONCOL, V23, P1623, DOI 10.1200/JCO.2005.10.073; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Claps CM, 2005, CURR NEUROVASC RES, V2, P319, DOI 10.2174/156720205774322593; Corcoran KE, 2005, BIOL PROCED ONLINE, V7, P8, DOI 10.1251/bpo100; Corcoran KE, 2007, MOL CANCER RES, V5, P373, DOI 10.1158/1541-7786.MCR-06-0396; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dewan MZ, 2006, BIOMED PHARMACOTHER, V60, P273, DOI 10.1016/j.biopha.2006.06.004; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; DONAHUE HJ, 2007, J MUSCULOSKEL NEURON, V3, P156; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Greco SJ, 2004, FRONT BIOSCI-LANDMRK, V9, P1782, DOI 10.2741/1373; Holland JD, 2006, CANCER RES, V66, P4117, DOI 10.1158/0008-5472.CAN-05-1631; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Juarez J, 2004, CURR PHARM DESIGN, V10, P1245, DOI 10.2174/1381612043452640; Kang H, 2005, BREAST CANCER RES, V7, pR402, DOI 10.1186/bcr1022; Kang HS, 2004, ARCH IMMUNOL THER EX, V52, P338; Kato M, 2003, BREAST CANCER RES, V5, pR144, DOI 10.1186/bcr627; Klein CA, 2004, CELL CYCLE, V3, P29; Koon HW, 2005, J PHARMACOL EXP THER, V314, P1393, DOI 10.1124/jpet.105.088013; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; LACROIX M, 2007, BREAST CANC RES TREA, V83, P249; Lapteva N, 2005, CANCER GENE THER, V12, P84, DOI 10.1038/sj.cgt.7700770; Loo WTY, 2005, BIOMED PHARMACOTHER, V59, pS384, DOI 10.1016/S0753-3322(05)80084-8; Moharita AL, 2006, BLOOD, V108, P3245, DOI 10.1182/blood-2006-01-017459; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Patel HJ, 2005, P NATL ACAD SCI USA, V102, P17436, DOI 10.1073/pnas.0506351102; Potian JA, 2003, J IMMUNOL, V171, P3426, DOI 10.4049/jimmunol.171.7.3426; RAMESHWAR P, 1995, BLOOD, V86, P482, DOI 10.1182/blood.V86.2.482.bloodjournal862482; Rao G, 2004, CANCER RES, V64, P2874, DOI 10.1158/0008-5472.CAN-03-3121; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Singh D, 2000, P NATL ACAD SCI USA, V97, P388, DOI 10.1073/pnas.97.1.388; Sotiropoulou PA, 2006, STEM CELLS, V24, P1409, DOI 10.1634/stemcells.2005-0654; Taborga M, 2007, MINI-REV MED CHEM, V7, P245, DOI 10.2174/138955707780059826; Trosko JE, 2005, BIOMED PHARMACOTHER, V59, pS326, DOI 10.1016/S0753-3322(05)80065-4; Wegner SA, 1998, J BIOL CHEM, V273, P4754, DOI 10.1074/jbc.273.8.4754; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705	42	119	125	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2563	10.1371/journal.pone.0002563	http://dx.doi.org/10.1371/journal.pone.0002563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575622	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288000053
J	De Gennaro, L; Fratello, F; Marzano, C; Moroni, F; Curcio, G; Tempesta, D; Pellicciari, MC; Pirulli, C; Ferrara, M; Rossini, PM				De Gennaro, Luigi; Fratello, Fabiana; Marzano, Cristina; Moroni, Fabio; Curcio, Giuseppe; Tempesta, Daniela; Pellicciari, Maria Concetta; Pirulli, Cornelia; Ferrara, Michele; Rossini, Paolo Maria			Cortical Plasticity Induced by Transcranial Magnetic Stimulation during Wakefulness Affects Electroencephalogram Activity during Sleep	PLOS ONE			English	Article							PAIRED ASSOCIATIVE STIMULATION; LONG-TERM POTENTIATION; HUMAN MOTOR CORTEX; EVOKED-POTENTIALS; EXCITABILITY; DEPRESSION; LTP; DEPRIVATION; EEG; TOPOGRAPHY	Background: Sleep electroencephalogram (EEG) brain oscillations in the low-frequency range show local signs of homeostatic regulation after learning. Such increases and decreases of slow wave activity are limited to the cortical regions involved in specific task performance during wakefulness. Here, we test the hypothesis that reorganization of motor cortex produced by long-term potentiation (LTP) affects EEG activity of this brain area during subsequent sleep. Methodology/Principal Findings: By pairing median nerve stimulation with transcranial magnetic stimulation over the contralateral motor cortex, one can potentiate the motor output, which is presumed to reflect plasticity of the neural circuitry. This paired associative stimulation increases M1 cortical excitability at interstimulus intervals of 25 ms. We compared the scalp distribution of sleep EEG power following paired associative stimulation at 25 ms to that following a control paradigm with 50 ms intervals. It is shown that the experimental manipulation by paired associative stimulation at 25 ms induces a 48% increase in amplitude of motor evoked potentials. This LTP-like potentiation, induced during waking, affects delta and theta EEG power in both REM and non-REM sleep, measured during the following night. Slow-wave activity increases in some frontal and prefrontal derivations and decreases at sites neighboring and contralateral to the stimulated motor cortex. The magnitude of increased amplitudes of motor evoked potentials by the paired associative stimulation at 25 ms predicts enhancements of slow-wave activity in prefrontal regions. Conclusions/Significance: An LTP-like paradigm, presumably inducing increased synaptic strength, leads to changes in local sleep regulation, as indexed by EEG slow-wave activity. Enhancement and depression of slow-wave activity are interpreted in terms of a simultaneous activation of both excitatory and inhibitory circuits consequent to the paired associative stimulation at 25 ms.	[De Gennaro, Luigi; Fratello, Fabiana; Marzano, Cristina; Moroni, Fabio; Curcio, Giuseppe] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [De Gennaro, Luigi; Pellicciari, Maria Concetta; Pirulli, Cornelia] Hosp Fatebenefratelli, IRCCS Centro S Giovanni Dio, Brescia, Italy; [Curcio, Giuseppe; Rossini, Paolo Maria] IRCCS S Raffaele Pisana, Casa Cura S Raffaele Cassino, Rome, Italy; [Tempesta, Daniela] Univ Laquila, Fac Psychol, Lab Sleep Psychophysiol, Laquila, Italy; [Ferrara, Michele] Univ Laquila, Dept Internal Med & Publ Hlth, Laquila, Italy; [Rossini, Paolo Maria] Isola Tiberina, Hosp Fatebenefratelli, Dept Neurosci, AFaR, Rome, Italy; [Rossini, Paolo Maria] Univ Campus Biomed, Neurol Clin, Rome, Italy	Sapienza University Rome; IRCCS Fatebenefratelli; IRCCS San Raffaele Pisana; University of L'Aquila; University of L'Aquila; University Campus Bio-Medico - Rome Italy	De Gennaro, L (corresponding author), Univ Roma La Sapienza, Dept Psychol, Rome, Italy.	luigi.degennaro@uniroma1.it	Tempesta, Daniela/AAB-7539-2022; Rossini, Paolo M./D-4994-2013; Ferrara, Michele/AAB-7574-2022; Pellicciari, Maria Concetta/A-6815-2012; De Gennaro, Luigi/L-8711-2015; Curcio, Giuseppe/M-1635-2014; Pirulli, Cornelia/K-1518-2016	Tempesta, Daniela/0000-0002-6942-5336; Rossini, Paolo M./0000-0003-2665-534X; Ferrara, Michele/0000-0003-2304-7576; Pellicciari, Maria Concetta/0000-0003-2455-8220; De Gennaro, Luigi/0000-0003-3613-6631; Pirulli, Cornelia/0000-0003-1865-5833; Moroni, Fabio/0000-0003-0587-0614; Curcio, Giuseppe/0000-0003-2248-781X	MUR [PRIN 2006-2006062871]	MUR(Ministry of Education, Universities and Research (MIUR))	This work is supported by the M.U.R. grant "PRIN 2006-2006062871" (to LDG).	Andersen P, 1977, Ciba Found Symp, P87; Bergmann TO, 2008, EUR J NEUROSCI, V27, P2241, DOI 10.1111/j.1460-9568.2008.06178.x; Bonato C, 2006, CLIN NEUROPHYSIOL, V117, P1699, DOI 10.1016/j.clinph.2006.05.006; Borbely A A, 1982, Hum Neurobiol, V1, P195; BORBELY AA, 1992, J SLEEP RES, V1, P63, DOI 10.1111/j.1365-2869.1992.tb00013.x; BRUNNER DP, 1993, SLEEP, V16, P100, DOI 10.1093/sleep/16.2.100; Buonomano DV, 1998, J NEUROPHYSIOL, V80, P1765, DOI 10.1152/jn.1998.80.4.1765; Classen Joseph, 2004, Suppl Clin Neurophysiol, V57, P563; Crupi D, 2008, BRAIN RES BULL, V75, P107, DOI 10.1016/j.brainresbull.2007.07.029; Enomoto H, 2001, CLIN NEUROPHYSIOL, V112, P2154, DOI 10.1016/S1388-2457(01)00667-8; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Esser SK, 2005, J NEUROPHYSIOL, V94, P622, DOI 10.1152/jn.01230.2004; Ferrara M, 2002, CEREB CORTEX, V12, P737, DOI 10.1093/cercor/12.7.737; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; Fratello F, 2006, CLIN NEUROPHYSIOL, V117, P2667, DOI 10.1016/j.clinph.2006.07.315; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2000, J NEUROPHYSIOL, V84, P1888, DOI 10.1152/jn.2000.84.4.1888; Huber R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000276; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Ishikawa S, 2007, CLIN NEUROPHYSIOL, V118, P1033, DOI 10.1016/j.clinph.2007.02.003; Litvak V, 2007, EUR J NEUROSCI, V25, P2862, DOI 10.1111/j.1460-9568.2007.05531.x; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; MARIORENZI R, 1991, ELECTROEN CLIN NEURO, V81, P90, DOI 10.1016/0168-5597(91)90002-F; Mima T, 2000, CLIN NEUROPHYSIOL, V111, P326, DOI 10.1016/S1388-2457(99)00229-1; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P374, DOI 10.1152/jn.1957.20.4.374; Murakami T, 2008, EXP BRAIN RES, V184, P339, DOI 10.1007/s00221-007-1103-0; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P259, DOI 10.1016/S0013-4694(97)00106-5; Oleksenko A.I., 1992, Journal of Sleep Research, V1, P40; Rattenborg NC, 1999, NATURE, V397, P397, DOI 10.1038/17037; RECHTSHAFFEN A, 1968, MANUAL STANDARDIZED; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2006, CEREB CORTEX, V16, P376, DOI 10.1093/cercorbhi116; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; TOBLER I, 1992, J SLEEP RES, V1, P125, DOI 10.1111/j.1365-2869.1992.tb00024.x; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tsuji T, 2002, J PHYSIOL-LONDON, V540, P367, DOI 10.1113/jphysiol.2001.013504; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2002, J NEUROPHYSIOL, V88, P2280, DOI 10.1152/jn.00304.2002; Wawryko P, 2004, BRAIN RES, V1029, P1, DOI 10.1016/j.brainres.2004.09.019; Weise D, 2006, BRAIN, V129, P2709, DOI 10.1093/brain/awl221; Wolters A, 2005, J PHYSIOL-LONDON, V565, P1039, DOI 10.1113/jphysiol.2005.084954; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004	50	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2483	10.1371/journal.pone.0002483	http://dx.doi.org/10.1371/journal.pone.0002483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575583	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288000013
J	Lee, DW; Freitag, M; Selker, EU; Aramayo, R				Lee, Dong W.; Freitag, Michael; Selker, Eric U.; Aramayo, Rodolfo			A Cytosine Methyltransferase Homologue Is Essential for Sexual Development in Aspergillus nidulans	PLOS ONE			English	Article								Background: The genome defense processes RIP (repeat-induced point mutation) in the filamentous fungus Neurospora crassa, and MIP (methylation induced premeiotically) in the fungus Ascobolus immersus depend on proteins with DNA methyltransferase (DMT) domains. Nevertheless, these proteins, RID and Masc1, respectively, have not been demonstrated to have DMT activity. We discovered a close homologue in Aspergillus nidulans, a fungus thought to have no methylation and no genome defense system comparable to RIP or MIP. Principal Findings: We report the cloning and characterization of the DNA methyltransferase homologue A (dmtA) gene from Aspergillus nidulans. We found that the dmtA locus encodes both a sense (dmtA) and an anti-sense transcript (tmdA). Both transcripts are expressed in vegetative, conidial and sexual tissues. We determined that dmtA, but not tmdA, is required for early sexual development and formation of viable ascospores. We also tested if DNA methylation accumulated in any of the dmtA/tmdA mutants we constructed, and found that in both asexual and sexual tissues, these mutants, just like wild-type strains, appear devoid of DNA methylation. Conclusions/Significance: Our results demonstrate that a DMT homologue closely related to proteins implicated in RIP and MIP has an essential developmental function in a fungus that appears to lack both DNA methylation and RIP or MIP. It remains formally possible that DmtA is a bona fide DMT, responsible for trace, undetected DNA methylation that is restricted to a few cells or transient but our work supports the idea that the DMT domain present in the RID/Masc1/DmtA family has a previously undescribed function.	[Lee, Dong W.; Aramayo, Rodolfo] Texas A&M Univ, Dept Biol, Coll Sci, College Stn, TX 77843 USA; [Freitag, Michael; Selker, Eric U.] Univ Oregon, Inst Mol Biol, Dept Biol, Eugene, OR USA	Texas A&M University System; Texas A&M University College Station; University of Oregon	Lee, DW (corresponding author), Texas A&M Univ, Dept Biol, Coll Sci, College Stn, TX 77843 USA.	raramayo@tamu.edu		Aramayo, Rodolfo/0000-0001-9702-6204	U. S. Public Health Service [GM58770, GM35690]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035690, R37GM035690, R01GM058770] Funding Source: NIH RePORTER	U. S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U. S. Public Health Service Grants GM58770 and GM35690 to R. A. and E. U. S., respectively.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; ARAMAYO R, 1993, EMBO J, V12, P2039, DOI 10.1002/j.1460-2075.1993.tb05853.x; ARAMAYO R, 1989, GENETICS, V122, P65; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Attard A, 2005, FUNGAL GENET BIOL, V42, P30, DOI 10.1016/j.fgb.2004.09.004; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BESTOR TH, 1990, PHILOS T ROY SOC B, V326, P179, DOI 10.1098/rstb.1990.0002; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bouhouche K, 2004, GENETICS, V167, P151, DOI 10.1534/genetics.167.1.151; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; CHRISTMAN JK, 1985, J BIOL CHEM, V260, P4059; Clutterbuck AJ, 2004, FUNGAL GENET BIOL, V41, P308, DOI 10.1016/j.fgb.2003.11.004; CLUTTERBUCK JC, 1974, BACTERIA BACTERIOPHA, P447; CREUSOT F, 1982, J BIOL CHEM, V257, P2041; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; FREEDMAN T, 1993, GENETICS, V135, P357; Freitag M, 2005, CURR OPIN GENET DEV, V15, P191, DOI 10.1016/j.gde.2005.02.003; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gowher H, 2001, FEMS MICROBIOL LETT, V205, P151, DOI 10.1111/j.1574-6968.2001.tb10939.x; GOYON C, 1989, MOL CELL BIOL, V9, P2818, DOI 10.1128/MCB.9.7.2818; Graia F, 2001, MOL MICROBIOL, V40, P586, DOI 10.1046/j.1365-2958.2001.02367.x; Hamann A, 2000, MOL GEN GENET, V263, P1061, DOI 10.1007/s004380050035; HAN D M, 1990, Korean Journal of Mycology, V18, P225; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Idnurm A, 2003, FUNGAL GENET BIOL, V39, P31, DOI 10.1016/S1087-1845(02)00588-1; JOHNSTONE IL, 1990, GENE, V90, P181, DOI 10.1016/0378-1119(90)90178-T; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; KIRK KE, 1991, GENE DEV, V5, P2014, DOI 10.1101/gad.5.11.2014; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; LAW DJ, 1980, J BACTERIOL, V144, P509, DOI 10.1128/JB.144.2.509-517.1980; Leonhardt H., 1993, DNA methylation: molecular biology and biological significance., P109; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; Malagnac F, 1997, CELL, V91, P281, DOI 10.1016/S0092-8674(00)80410-9; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Mautino MR, 1998, J THEOR BIOL, V192, P61, DOI 10.1006/jtbi.1997.0608; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Neuveglise C, 1996, NUCLEIC ACIDS RES, V24, P1428, DOI 10.1093/nar/24.8.1428; Nicosia MGL, 2001, MOL MICROBIOL, V39, P1330; Nielsen ML, 2001, MOL GENET GENOMICS, V265, P883, DOI 10.1007/s004380100484; NOYERWEIDNER M, 1993, DNA METHYLATION MOL, P39; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; POSFAI J, 1989, NUCLEIC ACIDS RES, V17, P2421, DOI 10.1093/nar/17.7.2421; Pratt RJ, 2002, FUNGAL GENET BIOL, V37, P56, DOI 10.1016/S1087-1845(02)00032-4; PRIDMORE RD, 1987, GENE, V56, P309, DOI 10.1016/0378-1119(87)90149-1; RAJU NB, 1980, EUR J CELL BIOL, V23, P208; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; RHOUNIM L, 1992, EMBO J, V11, P4451, DOI 10.1002/j.1460-2075.1992.tb05546.x; Rosa AL, 2004, MUTAT RES-FUND MOL M, V548, P85, DOI 10.1016/j.mrfmmm.2004.01.001; Sambrook J., 2002, MOL CLONING LAB MANU; SELKER EU, 1987, MOL CELL BIOL, V7, P1032, DOI 10.1128/MCB.7.3.1032; SELKER EU, 1985, P NATL ACAD SCI USA, V82, P8114, DOI 10.1073/pnas.82.23.8114; SELKER EU, 1987, CELL, V51, P741, DOI 10.1016/0092-8674(87)90097-3; SELKER EU, 1990, TRENDS BIOCHEM SCI, V15, P103, DOI 10.1016/0968-0004(90)90193-F; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; SELKER EU, 1988, P NATL ACAD SCI USA, V85, P6870, DOI 10.1073/pnas.85.18.6870; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; Steigele S, 2005, NUCLEIC ACIDS RES, V33, P5034, DOI 10.1093/nar/gki804; TAMAME M, 1983, MOL CELL BIOL, V3, P2287, DOI 10.1128/MCB.3.12.2287; TAMAME M, 1988, MOL CELL BIOL, V8, P3043, DOI 10.1128/MCB.8.8.3043; Tweedie S, 1999, NAT GENET, V23, P389, DOI 10.1038/70490; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Watanabe T, 2001, NUCLEIC ACIDS RES, V29, P2327, DOI 10.1093/nar/29.11.2327; WESSLER SR, 1988, SCIENCE, V242, P399, DOI 10.1126/science.2845581; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470	78	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2531	10.1371/journal.pone.0002531	http://dx.doi.org/10.1371/journal.pone.0002531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575630	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288000046
J	Chai, GL; Li, L; Zhou, W; Wu, LP; Zhao, Y; Wang, DL; Lu, SL; Yu, Y; Wang, HY; McNutt, MA; Hu, YG; Chen, YQ; Yang, Y; Wu, X; Otterson, GA; Zhu, WG				Chai, Guolin; Li, Lian; Zhou, Wen; Wu, Lipeng; Zhao, Ying; Wang, Donglai; Lu, Shaoli; Yu, Yu; Wang, Haiying; McNutt, Michael A.; Hu, Ye-Guang; Chen, Yingqi; Yang, Yang; Wu, Xin; Otterson, Gregory A.; Zhu, Wei-Guo			HDAC Inhibitors Act with 5-aza-2 '-Deoxycytidine to Inhibit Cell Proliferation by Suppressing Removal of Incorporated Abases in Lung Cancer Cells	PLOS ONE			English	Article							DNA N-GLYCOSYLASE; ANTINEOPLASTIC ACTION; PROTEIN-KINASE; APOPTOSIS; ATR; EXPRESSION; 5-AZA-2-DEOXYCYTIDINE; METHYLTRANSFERASE; PATHWAY; METHYLATION	5-aza-2 '-deoxycytidine (5-aza-CdR) is used extensively as a demethylating agent and acts in concert with histone deacetylase inhibitors (HDACl) to induce apoptosis or inhibition of cell proliferation in human cancer cells. Whether the action of 5-aza-CdR in this synergistic effect results from demethylation by this agent is not yet clear. In this study we found that inhibition of cell proliferation was not observed when cells with knockdown of DNA methyltransferase 1 (DNMT1), or double knock down of DNMT1-DNMT3A or DNMT1-DNMT3B were treated with HDACl, implying that the demethylating function of 5-aza-CdR may be not involved in this synergistic effect. Further study showed that there was a causal relationship between 5-aza-CdR induced DNA damage and the amount of [H-3]-5-aza-CdR incorporated in DNA. However, incorporated [H-3]-5-aza-CdR gradually decreased when cells were incubated in [H-3]-5-aza-CdR free medium, indicating that 5-aza-CdR, which is an abnormal base, may be excluded by the cell repair system. It was of interest that HDACl significantly postponed the removal of the incorporated [H-3]-5-aza-CdR from DNA. Moreover, HDAC inhibitor showed selective synergy with nucleoside analog-induced DNA damage to inhibit cell proliferation, but showed no such effect with other DNA damage stresses such as gamma-ray and UV, etoposide or cisplatin. This study demonstrates that HDACl synergistically inhibits cell proliferation with nucleoside analogs by suppressing removal of incorporated harmful nucleotide analogs from DNA.	[Chai, Guolin; Li, Lian; Zhou, Wen; Wu, Lipeng; Zhao, Ying; Wang, Donglai; Lu, Shaoli; Yu, Yu; Wang, Haiying; Chen, Yingqi; Yang, Yang; Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [McNutt, Michael A.] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing, Peoples R China; [Hu, Ye-Guang] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China; [Wu, Xin; Otterson, Gregory A.] Ohio State Univ, Comprehensive Canc Ctr, Dept Internal Med, Div Hematol Oncol, Columbus, OH USA	Peking University; Peking University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Chai, GL (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China.	zhuweiguo@bjmu.edu.cn	zhu, wei-guo/E-1334-2012; Zhou, Wen/A-5763-2010; Wu, Xin/B-2244-2010	Zhou, Wen/0000-0002-5496-5815; Yang, Yang/0000-0002-8737-590X; Zhu, Wei-Guo/0000-0001-8385-6581; Wang, Haiying/0000-0001-7729-0649	National Natural Science Foundation of China [30425017, 30670417, 30621002]; Ministry of Science and Technology of China [2005CB522403, 2006AA02Z101, 2006CB910300, B07001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study is supported by National Natural Science Foundation of China (No.30425017, 30670417 and 30621002), and grants (2005CB522403, 2006AA02Z101, 2006CB910300 and B07001) from the Ministry of Science and Technology of China.	Achanta G, 2001, CANCER RES, V61, P8723; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CANMAN CE, 1992, P NATL ACAD SCI USA, V89, P10474, DOI 10.1073/pnas.89.21.10474; Cheng JC, 2004, CANCER CELL, V6, P151, DOI 10.1016/j.ccr.2004.06.023; Choucroun P, 2001, MUTAT RES-FUND MOL M, V478, P89, DOI 10.1016/S0027-5107(01)00123-3; Claus R, 2003, ONCOGENE, V22, P6489, DOI 10.1038/sj.onc.1206814; Cline SD, 2003, NAT REV MOL CELL BIO, V4, P361, DOI 10.1038/nrm1101; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Dai ZY, 2006, BIOCHEM BIOPH RES CO, V351, P455, DOI 10.1016/j.bbrc.2006.10.055; DINCALCI M, 1985, CANCER RES, V45, P3197; Dizdaroglu M, 1996, NUCLEIC ACIDS RES, V24, P418, DOI 10.1093/nar/24.3.418; Eggert A, 2001, CANCER RES, V61, P1314; ELLERHORST JA, 1993, BRIT J CANCER, V67, P209, DOI 10.1038/bjc.1993.41; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Ferguson AT, 1997, J BIOL CHEM, V272, P32260, DOI 10.1074/jbc.272.51.32260; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; FURTH JJ, 1968, CANCER RES, V28, P2061; Gomyo Y, 2004, ONCOGENE, V23, P6779, DOI 10.1038/sj.onc.1207381; GRAHAM FL, 1970, CANCER RES, V30, P2636; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hammarsten O, 2000, J BIOL CHEM, V275, P1541, DOI 10.1074/jbc.275.3.1541; Harada K, 2002, CANCER RES, V62, P5897; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Helleday T, 2003, MUTAT RES-FUND MOL M, V532, P103, DOI 10.1016/j.mrfmmm.2003.08.013; Hurtubise A, 2006, CANCER CHEMOTH PHARM, V58, P618, DOI 10.1007/s00280-006-0225-6; INGRAHAM HA, 1980, CANCER RES, V40, P998; JacksonGrusby L, 1997, P NATL ACAD SCI USA, V94, P4681, DOI 10.1073/pnas.94.9.4681; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Karpf AR, 2004, MOL PHARMACOL, V65, P18, DOI 10.1124/mol.65.1.18; Karpf AR, 2001, MOL PHARMACOL, V59, P751, DOI 10.1124/mol.59.4.751; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LONN U, 1990, INT J CANCER, V45, P494, DOI 10.1002/ijc.2910450321; Maggio SC, 2004, CANCER RES, V64, P2590, DOI 10.1158/0008-5472.CAN-03-2631; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Primeau M, 2003, INT J CANCER, V103, P177, DOI 10.1002/ijc.10789; Sampath D, 2003, ONCOGENE, V22, P9063, DOI 10.1038/sj.onc.1207229; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Steiner FA, 2005, ONCOGENE, V24, P2386, DOI 10.1038/sj.onc.1208376; Vertino PM, 1996, MOL CELL BIOL, V16, P4555, DOI 10.1128/mcb.16.8.4555; VESELY J, 1977, CANCER RES, V37, P3684; Villar-Garea A, 2003, CANCER RES, V63, P4984; Wade PA, 2001, ONCOGENE, V20, P3166, DOI 10.1038/sj.onc.1204340; Wang H, 2008, J BIOL CHEM, V283, P2564, DOI 10.1074/jbc.M702454200; WARNER HR, 1980, J BACTERIOL, V141, P680, DOI 10.1128/JB.141.2.680-686.1980; Weiser TS, 2001, J IMMUNOTHER, V24, P151, DOI 10.1097/00002371-200103000-00010; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003; Zhu WG, 2001, ONCOGENE, V20, P7787, DOI 10.1038/sj.onc.1204970; Zhu WG, 2001, CANCER RES, V61, P1327; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	66	62	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2445	10.1371/journal.pone.0002445	http://dx.doi.org/10.1371/journal.pone.0002445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560576	Green Published, gold, Green Submitted			2022-12-25	WOS:000263280700030
J	Edelweiss, E; Balandin, TG; Ivanova, JL; Lutsenko, GV; Leonova, OG; Popenko, VI; Sapozhnikov, AM; Deyev, SM				Edelweiss, Evelina; Balandin, Taras G.; Ivanova, Julia L.; Lutsenko, Gennady V.; Leonova, Olga G.; Popenko, Vladimir I.; Sapozhnikov, Alexander M.; Deyev, Sergey M.			Barnase as a New Therapeutic Agent Triggering Apoptosis in Human Cancer Cells	PLOS ONE			English	Article							RIBONUCLEASE INHIBITOR; CYTOTOXIC RIBONUCLEASE; GOLD PROBES; IN-VITRO; BARSTAR; SELECTION; ANTIBODY; VECTOR; RNA; SUSCEPTIBILITY	Background: RNases are currently studied as non-mutagenic alternatives to the harmful DNA-damaging anticancer drugs commonly used in clinical practice. Many mammalian RNases are not potent toxins due to the strong inhibition by ribonuclease inhibitor (RI) presented in the cytoplasm of mammalian cells. Methodology/Principal Findings: In search of new effective anticancer RNases we studied the effects of barnase, a ribonuclease from Bacillus amyloliquefaciens, on human cancer cells. We found that barnase is resistant to RI. In MTT cell viability assay, barnase was cytotoxic to human carcinoma cell lines with half-inhibitory concentrations (IC50) ranging from 0.2 to 13 mu M and to leukemia cell lines with IC50 values ranging from 2.4 to 82 mu M. Also, we characterized the cytotoxic effects of barnase-based immunoRNase scFv 4D5-dibarnase, which consists of two barnase molecules serially fused to the single-chain variable fragment (scFv) of humanized antibody 4D5 that recognizes the extracellular domain of cancer marker HER2. The scFv 4D5-dibarnase specifically bound to HER2-positive cells and was internalized via receptor-mediated endocytosis. The intracellular localization of internalized scFv 4D5-dibarnase was determined by electronic microscopy. The cytotoxic effect of scFv 4D5-dibarnase on HER2-positive human ovarian carcinoma SKOV-3 cells (IC50 = 1.8 nM) was three orders of magnitude greater than that of barnase alone. Both barnase and scFv 4D5-dibarnase induced apoptosis in SKOV-3 cells accompanied by internucleosomal chromatin fragmentation, membrane blebbing, the appearance of phosphatidylserine on the outer leaflet of the plasma membrane, and the activation of caspase-3. Conclusions/Significance: These results demonstrate that barnase is a potent toxic agent for targeting to cancer cells.	[Edelweiss, Evelina; Balandin, Taras G.; Lutsenko, Gennady V.; Sapozhnikov, Alexander M.; Deyev, Sergey M.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Ivanova, Julia L.; Leonova, Olga G.; Popenko, Vladimir I.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Deyev, Sergey M.] Russian Acad Sci, Inst Gene Biol, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Edelweiss, E (corresponding author), Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	edelweiss.evelina@gmail.com; deyev@ibch.ru	Sapozhnikov, Alexander M/J-8704-2018; Lutsenko, Gennady/AAQ-2786-2021; Deyev, Sergey M/F-8191-2014	Deyev, Sergey M/0000-0002-3952-0631; Popenko, Vladimir/0000-0002-2108-0658; Sapozhnikov, Alexander/0000-0002-4934-677X	Russian Foundation for Basic research [07-02-00649, 07-04-00584, 06-04-49686-a]; SNSF [IB73AO-110842/1]; Program Molecular and Cell Biology RAS	Russian Foundation for Basic research(Russian Foundation for Basic Research (RFBR)); SNSF(Swiss National Science Foundation (SNSF)); Program Molecular and Cell Biology RAS	This work was supported by grants from the Russian Foundation for Basic research (Nos. 07-02-00649, 07-04-00584, 06-04-49686-a), SNSF (No. IB73AO-110842/1), and the Program Molecular and Cell Biology RAS.	Ardelt B, 2007, CELL CYCLE, V6, P3097, DOI 10.4161/cc.6.24.5045; Becerril B, 1999, BIOCHEM BIOPH RES CO, V255, P386, DOI 10.1006/bbrc.1999.0177; Bracale A, 2002, BIOCHEM J, V362, P553, DOI 10.1042/0264-6021:3620553; Chan SDH, 1996, ANAL BIOCHEM, V242, P214, DOI 10.1006/abio.1996.0455; CHO SW, 1989, ANAL BIOCHEM, V176, P175, DOI 10.1016/0003-2697(89)90289-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Choudhury A, 2004, Breast Dis, V20, P25; Colombo L, 1997, PLANT CELL, V9, P703, DOI 10.1105/tpc.9.5.703; Custers JBM, 1997, PLANT MOL BIOL, V35, P689, DOI 10.1023/A:1005846527674; De Lorenzo C, 2004, CANCER RES, V64, P4870; De Lorenzo C, 2002, FEBS LETT, V516, P208, DOI 10.1016/S0014-5793(02)02527-9; Dean GS, 1998, CLIN CANCER RES, V4, P2545; Deyev SM, 2003, NAT BIOTECHNOL, V21, P1486, DOI 10.1038/nbt916; Deyev SM, 1998, MOL GEN GENET, V259, P379, DOI 10.1007/s004380050825; DREXLER HG, 2001, MYELOID LEUKEMIA CEL, P632; Erickson HA, 2006, PROTEIN ENG DES SEL, V19, P37, DOI 10.1093/protein/gzi073; Fukumoto H, 1999, INT J CANCER, V82, P759, DOI 10.1002/(SICI)1097-0215(19990827)82:5<759::AID-IJC22>3.0.CO;2-H; Futami J, 2001, BIOCHEMISTRY-US, V40, P7518, DOI 10.1021/bi010248g; GOLDMAN MHS, 1994, EMBO J, V13, P2976, DOI 10.1002/j.1460-2075.1994.tb06596.x; Haigis MC, 2003, NUCLEIC ACIDS RES, V31, P1024, DOI 10.1093/nar/gkg163; Haigis MC, 2002, J BIOL CHEM, V277, P11576, DOI 10.1074/jbc.M112227200; HARTLEY RW, 1989, TRENDS BIOCHEM SCI, V14, P450, DOI 10.1016/0968-0004(89)90104-7; HARTLEY RW, 1972, PREP BIOCHEM, V2, P229; HARTLEY RW, 1997, RIBONUCLEASES STRUCT, P00051; Hellstrom I, 2001, CANCER RES, V61, P2420; Ilinskaya ON, 1997, TOXICOLOGY, V120, P55, DOI 10.1016/S0300-483X(97)03639-1; Iordanov MS, 2000, CANCER RES, V60, P1983; Johnson RJ, 2007, J MOL BIOL, V368, P434, DOI 10.1016/j.jmb.2007.02.005; Jucovic M, 1996, P NATL ACAD SCI USA, V93, P2343, DOI 10.1073/pnas.93.6.2343; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lanteri M, 2005, BREAST CANCER RES, V7, pR487, DOI 10.1186/bcr1034; Lee JE, 2008, BIODRUGS, V22, P53, DOI 10.2165/00063030-200822010-00006; Leland PA, 1998, P NATL ACAD SCI USA, V95, P10407, DOI 10.1073/pnas.95.18.10407; Leuchtenberger S, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.16.e76; LORENZO C, 2007, FEBS LETT, V581, P296; Makarov AA, 2003, FEBS LETT, V540, P15, DOI 10.1016/S0014-5793(03)00225-4; MARIANI C, 1990, NATURE, V347, P737, DOI 10.1038/347737a0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NEWTON DL, 1992, J BIOL CHEM, V267, P19572; NITTA K, 1994, CANCER RES, V54, P928; PRIOR TI, 1992, BIOCHEMISTRY-US, V31, P3555, DOI 10.1021/bi00129a001; Prior TI, 1996, BIOCONJUGATE CHEM, V7, P23, DOI 10.1021/bc9500655; Qin Q, 2005, J BIOCHEM MOL BIOL, V38, P41; Ragupathi G, 1996, CANCER IMMUNOL IMMUN, V43, P152, DOI 10.1007/s002620050316; RUSHIZKY GW, 1963, BIOCHEMISTRY-US, V2, P787, DOI 10.1021/bi00904a028; Rybak SM, 1999, EXP CELL RES, V253, P325, DOI 10.1006/excr.1999.4718; RYBAK SM, 1991, J BIOL CHEM, V266, P21202; Saxena SK, 2002, J BIOL CHEM, V277, P15142, DOI 10.1074/jbc.M108115200; Schreiber G, 2000, METH MOL B, V160, P213; Schulga A, 1998, PROTEIN ENG, V11, P775, DOI 10.1093/protein/11.9.775; Sevcik J, 2002, J BIOL CHEM, V277, P47325, DOI 10.1074/jbc.M208425200; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; SLOT JW, 1981, J CELL BIOL, V90, P533, DOI 10.1083/jcb.90.2.533; Smith MR, 1999, EXP CELL RES, V247, P220, DOI 10.1006/excr.1998.4317; Suzuki M, 1999, NAT BIOTECHNOL, V17, P265, DOI 10.1038/7010; UTSUGI T, 1991, CANCER RES, V51, P3062; Van Poucke K., 2001, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V66, P591; Viola M, 2005, INT J ONCOL, V27, P1071; Wang LC, 2001, P NATL ACAD SCI USA, V98, P7684, DOI 10.1073/pnas.121069998; Willuda J, 1999, CANCER RES, V59, P5758; WU YN, 1995, J BIOL CHEM, V270, P17476, DOI 10.1074/jbc.270.29.17476; WU YN, 1993, J BIOL CHEM, V268, P10686; Yang G, 2004, J BIOL CHEM, V279, P4339, DOI 10.1074/jbc.M311153200; Yazynin S, 1999, FEBS LETT, V452, P351, DOI 10.1016/S0014-5793(99)00661-4; Zelenikhin PV, 2005, MOL BIOL+, V39, P404, DOI 10.1007/s11008-005-0055-3	65	65	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2434	10.1371/journal.pone.0002434	http://dx.doi.org/10.1371/journal.pone.0002434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560598	Green Submitted, Green Published, gold			2022-12-25	WOS:000263280700019
J	Wood-Kaczmar, A; Gandhi, S; Yao, Z; Abramov, ASY; Miljan, EA; Keen, G; Stanyer, L; Hargreaves, I; Klupsch, K; Deas, E; Downward, J; Mansfield, L; Jat, P; Taylor, J; Heales, S; Duchen, MR; Latchman, D; Tabrizi, SJ; Wood, NW				Wood-Kaczmar, Alison; Gandhi, Sonia; Yao, Zhi; Abramov, Andrey S. Y.; Miljan, Erik A.; Keen, Gregory; Stanyer, Lee; Hargreaves, Iain; Klupsch, Kristina; Deas, Emma; Downward, Julian; Mansfield, Louise; Jat, Parmjit; Taylor, Joanne; Heales, Simon; Duchen, Michael R.; Latchman, David; Tabrizi, Sarah J.; Wood, Nicholas W.			PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons	PLOS ONE			English	Article							DROSOPHILA-PARKIN MUTANTS; OXIDATIVE STRESS; GENE-EXPRESSION; MUTATIONS; DISEASE; GLUTATHIONE; APOPTOSIS; INACTIVATION; DYSFUNCTION; PROTECTS	Parkinson's disease (PD) is a common age-related neurodegenerative disease and it is critical to develop models which recapitulate the pathogenic process including the effect of the ageing process. Although the pathogenesis of sporadic PD is unknown, the identification of the mendelian genetic factor PINK1 has provided new mechanistic insights. In order to investigate the role of PINK1 in Parkinson's disease, we studied PINK1 loss of function in human and primary mouse neurons. Using RNAi, we created stable PINK1 knockdown in human dopaminergic neurons differentiated from foetal ventral mesencephalon stem cells, as well as in an immortalised human neuroblastoma cell line. We sought to validate our findings in primary neurons derived from a transgenic PINK1 knockout mouse. For the first time we demonstrate an age dependent neurodegenerative phenotype in human and mouse neurons. PINK1 deficiency leads to reduced long-term viability in human neurons, which die via the mitochondrial apoptosis pathway. Human neurons lacking PINK1 demonstrate features of marked oxidative stress with widespread mitochondrial dysfunction and abnormal mitochondrial morphology. We report that PINK1 plays a neuroprotective role in the mitochondria of mammalian neurons, especially against stress such as staurosporine. In addition we provide evidence that cellular compensatory mechanisms such as mitochondrial biogenesis and upregulation of lysosomal degradation pathways occur in PINK1 deficiency. The phenotypic effects of PINK1 loss-of function described here in mammalian neurons provides mechanistic insight into the age-related degeneration of nigral dopaminergic neurons seen in PD.	[Wood-Kaczmar, Alison; Gandhi, Sonia; Yao, Zhi; Stanyer, Lee; Deas, Emma; Heales, Simon; Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Gandhi, Sonia; Latchman, David] Inst Child Hlth, Med Mol Biol Unit, London, England; [Abramov, Andrey S. Y.; Duchen, Michael R.] UCL, Dept Physiol, London, England; [Miljan, Erik A.] ReNeuron Ltd, Guildford, Surrey, England; [Keen, Gregory; Taylor, Joanne] Eisai London Res Lab Ltd, London, England; [Hargreaves, Iain; Heales, Simon] Natl Hosp Neurol & Neurosurg, Neurometabol Unit, London, England; [Klupsch, Kristina; Downward, Julian] Canc Res United Kingdom, London, England; [Mansfield, Louise; Jat, Parmjit; Tabrizi, Sarah J.] Inst Neurol, Dept Neurodegenerat Dis, London, England; [Latchman, David] Univ London, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Eisai Co Ltd; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Cancer Research UK; University of London; University College London; University of London; University College London; University of London	Wood-Kaczmar, A (corresponding author), Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England.	n.wood@ion.ucl.ac.uk	Downward, Julian/A-3251-2012; Hargreaves, Iain/AAJ-6757-2020; Abramov, Andrey Y/H-9053-2012; Deas, Emma/A-6755-2010; Wood, Nicholas W/C-2505-2009; duchen, michael/A-2116-2009; Miljan, Erik/AAH-7424-2020; Abramov, Andrey/AAC-6712-2019; Yao, Zhi/B-9047-2013; YAO, Zhi/C-6096-2009; Waldvogel, Henry/D-6691-2012	Abramov, Andrey Y/0000-0002-7646-7235; Wood, Nicholas W/0000-0002-9500-3348; duchen, michael/0000-0003-2548-4294; Abramov, Andrey/0000-0002-7646-7235; Yao, Zhi/0000-0001-6432-5734; Downward, Julian/0000-0002-2331-4729; Tabrizi, Sarah/0000-0003-2716-2045; Waldvogel, Henry/0000-0003-2165-8568	MRC UK; Wellcome Trust [research Training Fellowship]; MRC [G0601943, G0400000, G0700877] Funding Source: UKRI; Medical Research Council [G0400000, G0700877, G0601943] Funding Source: researchfish	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MRC UK program grant, Wellcome Trust research Training Fellowship	Abou-Sleiman PM, 2006, ANN NEUROL, V60, P414, DOI 10.1002/ana.20960; Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bharath S, 2002, BIOCHEM PHARMACOL, V64, P1037, DOI 10.1016/S0006-2952(02)01174-7; BOGAERTS V, 2007, GENES BRAIN BEHAV; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chinta SJ, 2006, FREE RADICAL BIO MED, V41, P1442, DOI 10.1016/j.freeradbiomed.2006.08.002; Clark IE, 2006, NATURE; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; GANDHI S, 2006, BRAIN; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074; Grunewald A, 2007, NEUROGENETICS, V8, P103, DOI 10.1007/s10048-006-0072-y; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Ibanez P, 2006, BRAIN, V129, P686, DOI 10.1093/brain/awl005; JAIN A, 1991, P NATL ACAD SCI USA, V88, P1913, DOI 10.1073/pnas.88.5.1913; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; PARK J, 2006, NATURE; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; Perier C, 2007, P NATL ACAD SCI USA, V104, P8161, DOI 10.1073/pnas.0609874104; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; PLUNFAVREAU H, 2007, NAT CELL BIOL; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Tan EK, 2007, HUM MUTAT, V28, P641, DOI 10.1002/humu.20507; Taymans JM, 2006, J NEUROCHEM, V98, P951, DOI 10.1111/j.1471-4159.2006.03919.x; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; WANG HL, 2007, NEUROBIOL DIS; Wei J, 2007, J BIOL CHEM, V282, P28904, DOI 10.1074/jbc.M703711200; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Wood-Kaczmar A, 2006, TRENDS MOL MED, V12, P521, DOI 10.1016/j.molmed.2006.09.007; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhou HX, 2007, INT J BIOL SCI, V3, P242; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	63	264	274	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2455	10.1371/journal.pone.0002455	http://dx.doi.org/10.1371/journal.pone.0002455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560593	Green Published, Green Accepted, gold			2022-12-25	WOS:000263280700037
J	Xin, DD; Hu, L; Kong, XY				Xin, Dedong; Hu, Landian; Kong, Xiangyin			Alternative Promoters Influence Alternative Splicing at the Genomic Level	PLOS ONE			English	Article								Background: More and more experiments have shown that transcription and mRNA processing are not two independent events but are tightly coupled to each other. Both promoter and transcription rate were found to influence alternative splicing. More than half of human genes have alternative promoters, but it is still not clear why there are so many alternative promoters and what their biological roles are. Methodology/Principal Findings: In this study, we explored whether there is a functional correlation between alternative promoters and alternative splicing by a genome-wide analysis of human and mouse genes. We constructed a large data set of genes with alternative promoter and alternative splicing annotations. By analyzing these genes, we showed that genes with alternative promoters tended to demonstrate alternative splicing compare to genes with single promoter, and, genes with more alternative promoters tend to have more alternative splicing variants. Furthermore, transcripts from different alternative promoters tended to splice differently. Conclusions/Significance: Thus at the genomic level, alternative promoters are positively correlated with alternative splicing.	[Xin, Dedong; Hu, Landian; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Xin, Dedong; Hu, Landian; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Xin, DD (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China.	xykong@sibs.ac.cn			National High Technology Research and Development Program of China [2006AA02Z330, 2006AA02A301]; National Basic Research Program of China [2007CB512202, 2007CB512100, 2004CB518603]; China Postdoctoral Science Foundation [20060400685]; National Natural Science Foundation of China, Key Program [30530450]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX1-YW-R-74]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China, Key Program(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This work is supported by the National High Technology Research and Development Program of China (863 Pro-gram) (2006AA02Z330, 2006AA02A301), the National Basic Research Program of China (973 program) (No. 2007CB512202, 2007CB512100, 2004CB518603), the China Postdoctoral Science Foundation (NO.20060400685), the National Natural Science Foundation of China, Key Program (No.30530450), and the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX1-YW-R-74).	Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bonham K, 2000, J BIOL CHEM, V275, P37604, DOI 10.1074/jbc.M004882200; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Jiang ZH, 2000, MOL CELL BIOL, V20, P4036, DOI 10.1128/MCB.20.11.4036-4048.2000; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; Kamat A, 2002, TRENDS ENDOCRIN MET, V13, P122, DOI 10.1016/S1043-2760(02)00567-2; Kim N, 2005, GENOME RES, V15, P566, DOI 10.1101/gr.3030405; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Landry JR, 2003, J VIROL, V77, P7459, DOI 10.1128/JVI.77.13.7459-7466.2003; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; MOORE MJ, 1993, NATURE, V365, P364, DOI 10.1038/365364a0; Morris DP, 2000, J BIOL CHEM, V275, P39935, DOI 10.1074/jbc.M004118200; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pagani F, 2003, J BIOL CHEM, V278, P1511, DOI 10.1074/jbc.M209676200; Robson-Dixon ND, 2004, J BIOL CHEM, V279, P29075, DOI 10.1074/jbc.M312747200; Rosonina E, 2005, MOL CELL BIOL, V25, P6734, DOI 10.1128/MCB.25.15.6734-6746.2005; Saleh A, 2002, J IMMUNOL, V168, P5163, DOI 10.4049/jimmunol.168.10.5163; Venables JP, 2002, CURR OPIN GENET DEV, V12, P615, DOI 10.1016/S0959-437X(02)00347-7; Viegas LR, 2004, J BIOL CHEM, V279, P9831, DOI 10.1074/jbc.M312402200; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	36	48	52	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2377	10.1371/journal.pone.0002377	http://dx.doi.org/10.1371/journal.pone.0002377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560582	Green Submitted, Green Published, gold			2022-12-25	WOS:000263280700002
J	Li, SF; Li, JH; Cheng, J; Zhou, BR; Tong, X; Dong, XB; Wang, ZX; Hu, QG; Chen, M; Hua, ZC				Li, Shufeng; Li, Jiahuang; Cheng, Jian; Zhou, Bingrong; Tong, Xin; Dong, Xiangbai; Wang, Zixing; Hu, Qingang; Chen, Meng; Hua, Zi-Chun			Non-Syndromic Tooth Agenesis in Two Chinese Families Associated with Novel Missense Mutations in the TNF Domain of EDA (Ectodysplasin A)	PLOS ONE			English	Article								Here we report two unrelated Chinese families with congenital missing teeth inherited in an X-linked manner. We mapped the affected locus to chromosome Xp11-Xq21 in one family. In the defined region, both families were found to have novel missense mutations in the ectodysplasin-A (EDA) gene. The mutation of c.947A > G caused the D316G substitution of the EDA protein. The mutation of c.1013C > T found in the other family resulted in the Thr to Met mutation at position 338 of EDA. The EDA gene has been reported responsible for X-linked hypohidrotic ectodermal dysplasia (XLHED) in humans characterized by impaired development of hair, eccrine sweat glands, and teeth. In contrast, all the affected individuals in the two families that we studied here had normal hair and skin. Structural analysis suggests that these two novel mutants may account for the milder phenotype by affecting the stability of EDA trimers. Our results indicate that these novel missense mutations in EDA are associated with the isolated tooth agenesis and provide preliminary explanation for the abnormal clinical phenotype at a molecular structural level.	[Li, Shufeng; Li, Jiahuang; Cheng, Jian; Zhou, Bingrong; Tong, Xin; Dong, Xiangbai; Wang, Zixing; Hu, Qingang; Chen, Meng; Hua, Zi-Chun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing Stomatol Hosp, Nanjing 210008, Peoples R China	Nanjing University	Li, SF (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing Stomatol Hosp, Nanjing 210008, Peoples R China.	zchua@nju.edu.cn			Chinese National Nature Sciences Foundation [30730030, 30425009]; Jiangsu Provincial Nature Sciences Foundation [BK2007715]	Chinese National Nature Sciences Foundation; Jiangsu Provincial Nature Sciences Foundation	The project was supported by grants from the Chinese National Nature Sciences Foundation (30730030, 30425009) and Jiangsu Provincial Nature Sciences Foundation (BK2007715) to Zi-Chun Hua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyuz S, 1993, J Clin Pediatr Dent, V17, P105; Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; CLARKE A, 1987, J MED GENET, V24, P659, DOI 10.1136/jmg.24.11.659; Das P, 2002, HUM GENET, V110, P371, DOI 10.1007/s00439-002-0699-1; Elomaa O, 2001, HUM MOL GENET, V10, P953, DOI 10.1093/hmg/10.9.953; Ezer S, 1999, HUM MOL GENET, V8, P2079, DOI 10.1093/hmg/8.11.2079; Frazier-Bowers SA, 2002, J DENT RES, V81, P129, DOI 10.1177/154405910208100209; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Hymowitz SG, 2003, STRUCTURE, V11, P1513, DOI 10.1016/j.str.2003.11.009; Jumlongras D, 2004, HUM GENET, V114, P242, DOI 10.1007/s00439-003-1066-6; Kapadia H, 2006, EUR J HUM GENET, V14, P403, DOI 10.1038/sj.ejhg.5201574; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Lammi L, 2003, EUR J HUM GENET, V11, P866, DOI 10.1038/sj.ejhg.5201060; MACKENZIE A, 1991, DEVELOPMENT, V111, P269; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Mostowska A, 2006, J HUM GENET, V51, P262, DOI 10.1007/s10038-005-0353-6; Nieminen P, 2001, EUR J HUM GENET, V9, P743, DOI 10.1038/sj.ejhg.5200715; Peters H, 1999, TRENDS GENET, V15, P59, DOI 10.1016/S0168-9525(98)01662-X; PINHEIRO M, 1994, AM J MED GENET, V53, P153, DOI 10.1002/ajmg.1320530207; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; SLAVKIN HC, 1998, MOL BASIS EPITHELIAL, P15; Stimson J M, 1997, J Clin Pediatr Dent, V21, P269; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Tao R, 2006, J HUM GENET, V51, P498, DOI 10.1007/s10038-006-0389-2; Tarpey P, 2007, AM J MED GENET A, V143A, P390, DOI 10.1002/ajmg.a.31567; Tucker AS, 2000, DEVELOPMENT, V127, P4691; Vieira AR, 2003, J DENT RES, V82, P162, DOI 10.1177/154405910308200303; Visinoni AF, 2003, AM J MED GENET A, V122A, P51, DOI 10.1002/ajmg.a.20276	31	28	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2396	10.1371/journal.pone.0002396	http://dx.doi.org/10.1371/journal.pone.0002396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545687	Green Published, Green Submitted, gold			2022-12-25	WOS:000263248800034
J	Lukasiak, S; Schiller, C; Oehlschlaeger, P; Schmidtke, G; Krause, P; Legler, DF; Autschbach, F; Schirmacher, P; Breuhahn, K; Groettrup, M				Lukasiak, S.; Schiller, C.; Oehlschlaeger, P.; Schmidtke, G.; Krause, P.; Legler, D. F.; Autschbach, F.; Schirmacher, P.; Breuhahn, K.; Groettrup, M.			Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon	ONCOGENE			English	Article						FAT10; ubiquitin-like modifiers; hepatocellular carcinoma; colon carcinoma; interferon-gamma	UBIQUITIN-LIKE PROTEIN; HUMAN HEPATOCELLULAR-CARCINOMA; INTERFERON-GAMMA; EXPRESSION; GENE; IDENTIFICATION; DEGRADATION; APOPTOSIS	The mRNA of the ubiquitin-like modifier FAT10 has been reported to be overexpressed in 90% of hepatocellular carcinoma (HCC) and in over 80% of colon, ovary and uterus carcinomas. Elevated FAT10 expression in malignancies was attributed to transcriptional upregulation upon the loss of p53. Moreover, FAT10 induced chromosome instability in long-term in vitro culture, which led to the hypothesis that FAT10 might be involved in carcinogenesis. In this study we show that interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha synergistically upregulated FAT10 expression in liver and colon cancer cells 10- to 100-fold. Real-time RT-PCR revealed that FAT10 mRNA was significantly overexpressed in 37 of 51 (72%) of human HCC samples and in 8 of 15 (53%) of human colon carcinomas. The FAT10 cDNA sequences in HCC samples were not mutated and intact FAT10 protein was detectable. FAT10 expression in both cancer tissues correlated with expression of the IFN-gamma- and TNF-alpha-dependent proteasome subunit LMP2 strongly suggesting that proinflammatory cytokines caused the joint overexpression of FAT10 and LMP2. NIH3T3 transformation assays revealed that FAT10 had no transforming capability. Taken together, FAT10 qualifies as a marker for an interferon response in HCC and colon carcinoma but is not significantly overexpressed in cancers lacking a proinflammatory environment.	[Lukasiak, S.; Oehlschlaeger, P.; Schmidtke, G.; Groettrup, M.] Univ Constance, Div Immunol, Dept Biol, D-78457 Constance, Germany; [Schiller, C.; Autschbach, F.; Schirmacher, P.; Breuhahn, K.] Univ Heidelberg, Inst Pathol, Univ Heidelberg Hosp, D-6900 Heidelberg, Germany; [Krause, P.; Legler, D. F.; Groettrup, M.] Univ Konstanz, Biotechnol Inst Thurgau, Kreuzlingen, Switzerland	University of Konstanz; Ruprecht Karls University Heidelberg	Groettrup, M (corresponding author), Univ Constance, Div Immunol, Dept Biol, Univ Str 10, D-78457 Constance, Germany.	marcus.groettrup@uni-konstanz.de	Groettrup, Marcus/AAT-2623-2020	Legler, Daniel F./0000-0001-8610-4764; Breuhahn, Kai/0000-0002-2462-1229	Fritz Thyssen Foundation [Az 10.05.1.145, Az 10.06.2.183]	Fritz Thyssen Foundation	We thank Klaus Scherrer for the contribution of the iota antibody and Gerardo Alvarez for excellent technical assistance. Darius Moradpour is acknowledged for the contribution of HCC cell lines. This work was supported from the grants Az 10.05.1.145 and Az 10.06.2.183 of the Fritz Thyssen Foundation.	Bates EFM, 1997, EUR J IMMUNOL, V27, P2471, DOI 10.1002/eji.1830271002; Breuhahn K, 2004, CANCER RES, V64, P6058, DOI 10.1158/0008-5472.CAN-04-0292; Canaan A, 2006, MOL CELL BIOL, V26, P5180, DOI 10.1128/MCB.00966-05; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; Fan WF, 1996, IMMUNOGENETICS, V44, P97, DOI 10.1007/s002510050095; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hipp MS, 2004, J BIOL CHEM, V279, P16503, DOI 10.1074/jbc.M310114200; Kern MA, 2002, ADV CANCER RES, V86, P67, DOI 10.1016/S0065-230X(02)86003-1; Khan S, 2001, J IMMUNOL, V167, P6859, DOI 10.4049/jimmunol.167.12.6859; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Legler DF, 2006, J IMMUNOL, V176, P966, DOI 10.4049/jimmunol.176.2.966; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Oliva J, 2008, EXP MOL PATHOL, V84, P102, DOI 10.1016/j.yexmp.2007.12.003; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Raasi S, 1999, EUR J IMMUNOL, V29, P4030, DOI 10.1002/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y; Ren JW, 2006, J BIOL CHEM, V281, P11413, DOI 10.1074/jbc.M507218200; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Stohwasser R, 1997, EUR J IMMUNOL, V27, P1182, DOI 10.1002/eji.1830270520; Zhang DW, 2006, ONCOGENE, V25, P2318, DOI 10.1038/sj.onc.1209220; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028	21	120	127	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 9	2008	27	46					6068	6074		10.1038/onc.2008.201	http://dx.doi.org/10.1038/onc.2008.201			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	358BO	18574467	Green Submitted			2022-12-25	WOS:000259891600009
J	Xenaki, G; Ontikatze, T; Rjaendran, R; Startford, IJ; Drive, C; Krstic-Demonacos, M; Demonacos, C				Xenaki, G.; Ontikatze, T.; Rjaendran, R.; Startford, I. J.; Drive, C.; Krstic-Demonacos, M.; Demonacos, C.			PCAF is an HIF-1 alpha cofactor that regulates p53 transcriptional activity in hypoxia	ONCOGENE			English	Article						transcription; p53; hypoxia-inducible factor; PCAF; apoptosis	HISTONE DEACETYLASE INHIBITORS; INDUCIBLE FACTOR-1 HIF-1; DNA-DAMAGE; GENE-EXPRESSION; CELLULAR-RESPONSE; INDUCED APOPTOSIS; STRUCTURAL BASIS; FACTOR 1-ALPHA; IN-VITRO; ACETYLATION	The p53 tumour suppressor is involved in several crucial cellular functions including cell-cycle arrest and apoptosis. p53 stabilization occurs under hypoxic and DNA damage conditions. However, only in the latter scenario is stabilized p53 capable of inducing the expression of its pro-apoptotic targets. Here we present evidence that under hypoxia-mimicking conditions p53 acetylation is reduced to a greater extent at K320 site targeted by P300/CBP-associated factor (PCAF) than at K382 site targeted by p300/CBP. The limited amounts of acetylated p53 at K320 are preferentially recruited to the promoter of the p21(WAF-1/CIP-1) gene, which appears to be unaffected by hypoxia, but are not recruited to the BID promoter and hence p53 is incapable of upregulating pro-apoptotic BID in hypoxic conditions. As the K320 p53 acetylation is the site predominantly affected in hypoxia, the PCAF histone acetyltransferase activity is the key regulator of the cellular fate modulated by p53 under these conditions. In addition, we provide evidence that PCAF acetylates hypoxia-inducible factor-1 alpha (HIF-1 alpha) in hypoxic conditions and that the acetylated HIF-1 alpha is recruited to a particular subset of its targets. In conclusion, PCAF regulates the balance between cell-cycle arrest and apoptosis in hypoxia by modulating the activity and protein stability of both p53 and HIF-alpha.	[Xenaki, G.; Ontikatze, T.; Rjaendran, R.; Startford, I. J.; Drive, C.; Demonacos, C.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PT, Lancs, England; [Drive, C.] Univ Manchester, Paterson Inst Canc Res, Manchester M13 9PT, Lancs, England; [Krstic-Demonacos, M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester; Paterson Institute for Cancer Research; University of Manchester; University of Manchester	Demonacos, C (corresponding author), Univ Manchester, Sch Pharm & Pharmaceut Sci, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	cdemonacos@manchester.ac.uk	Demonacos, Constantinos/K-1277-2019	Demonacos, Constantinos/0000-0002-4515-755X; Rajendran, Ramkumar/0000-0002-3610-8430; Dive, Caroline/0000-0002-1726-8850; stratford, ian/0000-0002-5222-4765	School of Pharmacy, University of Manchester; Cancer Research UK; MRC programme [G0500366]; Wellcome Trust [069024]; Medical Research Council [G0500366] Funding Source: researchfish; MRC [G0500366] Funding Source: UKRI	School of Pharmacy, University of Manchester; Cancer Research UK(Cancer Research UK); MRC programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank W El-Deiry for providing the BID-p53-Luc reporter construct; I Talianidis for the Flag-PCAF and Flag-PCAF-DHAT constructs; T Halazonetis for the p53K320R expression vector; K Williams for the HIF-1 alpha-responsive reporters of VEGF-Luc, CA-IX-Luc, PGK-1-Luc and LDH-A-Luc; M Blaylock and the Paterson Institute for Cancer Research for assistance with FACS analysis. Our research was supported by the School of Pharmacy, University of Manchester (CD), Cancer Research UK (CDive), MRC programme grant (G0500366) to IJS and Wellcome Trust (069024) to MKD.	Achison M, 2003, ONCOGENE, V22, P3431, DOI 10.1038/sj.onc.1206434; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bilton R, 2006, TRENDS CELL BIOL, V16, P616, DOI 10.1016/j.tcb.2006.10.002; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Brahimi-Horn C, 2005, CELL SIGNAL, V17, P1, DOI 10.1016/j.cellsig.2004.04.010; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chao C, 2006, MOL CELL BIOL, V26, P6859, DOI 10.1128/MCB.00062-06; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Demonacos C, 2004, NAT CELL BIOL, V6, P968, DOI 10.1038/ncb1170; Demonacos C, 2001, MOL CELL, V8, P71, DOI 10.1016/S1097-2765(01)00277-5; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Erler JT, 2004, MOL CELL BIOL, V24, P2875, DOI 10.1128/MCB.24.7.2875-2889.2004; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Goda N, 2003, ANTIOXID REDOX SIGN, V5, P467, DOI 10.1089/152308603768295212; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Hammond EM, 2006, MOL CELL BIOL, V26, P3492, DOI 10.1128/MCB.26.9.3492-3504.2006; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Hansson LO, 2002, P NATL ACAD SCI USA, V99, P10305, DOI 10.1073/pnas.122347199; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jin YT, 2002, J BIOL CHEM, V277, P30838, DOI 10.1074/jbc.M204078200; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Liang DM, 2006, CELL CYCLE, V5, P2430, DOI 10.4161/cc.5.21.3409; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Pan Y, 2004, ONCOGENE, V23, P4975, DOI 10.1038/sj.onc.1207657; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi035632n; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Ravi R, 2000, GENE DEV, V14, P34; Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Schmid T, 2004, BIOCHEM J, V380, P289, DOI 10.1042/BJ20031299; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Tyteca S, 2006, MOL CELL, V24, P807, DOI 10.1016/j.molcel.2006.12.005; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wykoff CC, 2000, CANCER RES, V60, P7075; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Zhu YH, 2002, J BIOL CHEM, V277, P22909, DOI 10.1074/jbc.M200042200	59	83	87	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 2	2008	27	44					5785	5796		10.1038/onc.2008.192	http://dx.doi.org/10.1038/onc.2008.192			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	355QC	18574470	Green Accepted			2022-12-25	WOS:000259722400003
J	Watson, CS; Jeng, YJ; Kochukov, MY				Watson, Cheryl S.; Jeng, Yow-Jiun; Kochukov, Mikhail Y.			Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation	FASEB JOURNAL			English	Article						calcium; ERK activation; prolactin release; nonmonotonic dose responses; membrane estrogen receptors	RECEPTOR-ALPHA LEVELS; BREAST-CANCER-CELLS; PROLACTIN-RELEASE; PLASMA-MEMBRANE; STEROID ACTIONS; DOWNS-SYNDROME; GROWTH-FACTOR; MCF-7 CELLS; BISPHENOL-A; ACTIVATION	Physiological estrogens, including estrone (E(1)), estradiol (E(2)), and estriol (E(3)), fluctuate with life stage, suggesting specific roles for them in biological and disease processes. We compared their non-genomic signaling and functional actions in GH3/B6/F10 rat pituitary tumor cells. All hormones caused prolactin release at 1 min; the lowest effective concentrations were 10(-11) M E(2), 10(-10) M E(1), and 10(-7) M E(3). All estrogens increased the oscillation frequency of calcium (Ca) spikes, with the same time delay (similar to 200 s) at all levels (10(-15) to 10(-9) M). At some concentrations, E(1) and E(3) provoked more Ca-responding cells than E(2). The amplitude and volume of Ca peaks were elevated by all hormones at >= 10(-15) M. All hormones caused cell proliferation, with the lowest effective concentrations of E(2) (10(-15) M) > E(1) (10(-12) M) > E(3) (10(-10) M); E(2) caused higher maximal cell numbers at most concentrations. All estrogens caused oscillating extracellular-regulated kinase (ERK) activations, with relative potencies of E(1) and E(2) > E(3). All estrogens were ineffective in activation of ERKs or causing proliferation in a subline expressing low levels of membrane estrogen receptor-alpha. Dose-response patterns were frequently non-monotonic. Therefore, the hormones E(1) and E(3), which have been designated "weak" estrogens in genomic actions, are strong estrogens in the nongenomic signaling pathways and functional responses in the pituitary.	[Watson, Cheryl S.; Jeng, Yow-Jiun; Kochukov, Mikhail Y.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Watson, CS (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.		Kochukov, Mikhail/P-5656-2018	Kochukov, Mikhail/0000-0002-8723-6360	National Institutes of Environmental Health Sciences; American Institute for Cancer Research	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Institute for Cancer Research	We gratefully acknowledge funding from the National Institutes of Environmental Health Sciences and the American Institute for Cancer Research that supported these studies. We also thank Dr. David Konkel for expert editing of our article.	ADAMS JB, 1992, INT J CANCER, V50, P854, DOI 10.1002/ijc.2910500603; Ahamed S, 2001, MOL CARCINOGEN, V30, P88, DOI 10.1002/1098-2744(200102)30:2&lt;88::AID-MC1017&gt;3.0.CO;2-E; Alonso-Magdalena P, 2005, ENVIRON HEALTH PERSP, V113, P969, DOI 10.1289/ehp.8002; ANDERSON JN, 1975, ENDOCRINOLOGY, V96, P160, DOI 10.1210/endo-96-1-160; Bulayeva NN, 2005, AM J PHYSIOL-ENDOC M, V288, pE388, DOI 10.1152/ajpendo.00349.2004; Bulayeva NN, 2004, ENVIRON HEALTH PERSP, V112, P1481, DOI 10.1289/ehp.7175; Bulayeva NN, 2004, STEROIDS, V69, P181, DOI 10.1016/j.steroids.2003.12.003; Campbell CH, 2001, STEROIDS, V66, P727, DOI 10.1016/S0039-128X(01)00106-4; CAMPBELL CH, 1997, CELL CYCLE REGULATIO; Chard T, 1995, J PERINAT MED, V23, P421; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; DANIELPOUR D, 1984, ENDOCRINOLOGY, V115, P1221, DOI 10.1210/endo-115-3-1221; DANNIES PS, 1985, BIOCHEM ACTION HORM, P289; DESLYPERE JP, 1985, J CLIN ENDOCR METAB, V61, P564, DOI 10.1210/jcem-61-3-564; DUFY B, 1979, SCIENCE, V204, P509, DOI 10.1126/science.107590; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Gorski J, 1997, PROG CLIN BIOL RES, V396, P233; Greenlee H, 2007, BREAST CANCER RES TR, V102, P111, DOI 10.1007/s10549-006-9308-7; Greenspan F. S., 2004, BASIC CLIN ENDOCRINO, P925; Jansson L, 2001, ARTHRITIS RHEUM, V44, P2168, DOI 10.1002/1529-0131(200109)44:9<2168::AID-ART370>3.0.CO;2-2; Meinhardt U, 2002, SEMIN REPROD MED, V20, P277, DOI 10.1055/s-2002-35374; Nevalainen MT, 1997, J CLIN INVEST, V99, P618, DOI 10.1172/JCI119204; Newby D, 2000, PLACENTA, V21, P263, DOI 10.1053/plac.1999.0469; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Norfleet AM, 1999, ENDOCRINOLOGY, V140, P3805, DOI 10.1210/en.140.8.3805; Norfleet AM, 2000, FASEB J, V14, P157, DOI 10.1096/fasebj.14.1.157; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; OGASAWARA M, 1988, IN VITRO CELL DEV B, V24, P911; PAPPAS TC, 1994, ENDOCRINE, V2, P813; PAPPAS TC, 1995, FASEB J, V9, P404, DOI 10.1096/fasebj.9.5.7896011; PIETRAS RJ, 1975, NATURE, V253, P357, DOI 10.1038/253357a0; Prior JC, 2005, ENDOCRINE, V26, P297, DOI 10.1385/ENDO:26:3:297; Richardson, 2000, Prim Care Update Ob Gyns, V7, P215, DOI 10.1016/S1068-607X(00)00049-4; RUCCI N, BONE, V34, P697; Shenhav S, 2003, ACTA OBSTET GYN SCAN, V82, P912, DOI 10.1034/j.1600-0412.2003.00250.x; Steiner M, 2003, J AFFECT DISORDERS, V74, P67, DOI 10.1016/S0165-0327(02)00432-9; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Vanson A, 1996, GEN COMP ENDOCR, V102, P342, DOI 10.1006/gcen.1996.0077; Watson CS, 2007, STEROIDS, V72, P124, DOI 10.1016/j.steroids.2006.11.002; Watson CS, 1999, P SOC EXP BIOL MED, V220, P9, DOI 10.1046/j.1525-1373.1999.d01-2.x; Watson CS, 2002, STEROIDS, V67, P429, DOI 10.1016/S0039-128X(01)00172-6; Watson CS, 1999, STEROIDS, V64, P5, DOI 10.1016/S0039-128X(98)00107-X; Watson CS, 2003, EXP BIOL MED, V228, P1272, DOI 10.1177/153537020322801106; WATSON CS, 1999, STKE, pPE1; Williams CL, 1998, HORM BEHAV, V34, P80, DOI 10.1006/hbeh.1998.1480; Wozniak AL, 2005, ENVIRON HEALTH PERSP, V113, P431, DOI 10.1289/ehp.7505; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR130, DOI 10.1186/bcr959; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR101, DOI 10.1186/bcr958; Zsarnovszky A, 2005, ENDOCRINOLOGY, V146, P5388, DOI 10.1210/en.2005-0565	49	63	69	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2008	22	9					3328	3336		10.1096/fj.08-107672	http://dx.doi.org/10.1096/fj.08-107672			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18541692	Green Published			2022-12-25	WOS:000258761300025
J	Dicker, IB; Terry, B; Lin, ZY; Li, ZF; Bollini, S; Samanta, HK; Gali, V; Walker, MA; Krystal, MR				Dicker, Ira B.; Terry, Brian; Lin, Zeyu; Li, Zhufang; Bollini, Sagarika; Samanta, Himadri K.; Gali, Volodymyr; Walker, Michael A.; Krystal, Mark R.			Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TERMINAL REPEAT; DNA INTEGRATION; DIKETO ACID; PROTEIN; RECOGNITION; MUTATIONS; MECHANISM; BINDING; ACCUMULATION	In this study, eight different HIV-1 integrase proteins containing mutations observed in strand transfer inhibitor- resistant viruses were expressed, purified, and used for detailed enzymatic analyses. All the variants examined were impaired for strand transfer activity compared with the wild type enzyme, with relative catalytic efficiencies ( kp/ Km) ranging from 0.6 to 50% of wild type. The origin of the reduced strand transfer efficiencies of the variant enzymes was predominantly because of poorer catalytic turnover ( kp) values. However, smaller secondorder effects were caused by up to 4- fold increases in Km values for target DNA utilization in some of the variants. All the variants were less efficient than the wild type enzyme in assembling on the viral long terminal repeat, as each variant required more protein than wild type to attain maximal activity. In addition, the variant integrases displayed up to 8- fold reductions in their catalytic efficiencies for 3'-processing. The Q148R variant was the most defective enzyme. The molecular basis for resistance of these enzymes was shown to be due to lower affinity binding of the strand transfer inhibitor to the integrase complex, a consequence of faster dissociation rates. In the case of the Q148R variant, the origin of reduced compound affinity lies in alterations to the active site that reduce the binding of a catalytically essential magnesium ion. Finally, except for T66I, variant viruses harboring the the resistance-inducing substitutions were defective for viral integration.	[Dicker, Ira B.; Terry, Brian; Lin, Zeyu; Li, Zhufang; Bollini, Sagarika; Samanta, Himadri K.; Gali, Volodymyr; Krystal, Mark R.] Bristol Myers Squibb Res & Dev, Dept Virol, Wallingford, CT 06492 USA; [Walker, Michael A.] Bristol Myers Squibb Res & Dev, Dept Med Chem, Wallingford, CT 06492 USA	Bristol-Myers Squibb; Bristol-Myers Squibb	Dicker, IB (corresponding author), Bristol Myers Squibb Co, Dept Virol, 5 Res Pkwy, Wallingford, CT 06492 USA.	Ira.Dicker@BMS.com						Asante-Appiah E, 1999, ADV VIRUS RES, V52, P351, DOI 10.1016/S0065-3527(08)60306-1; Bartz SR, 1996, J VIROL, V70, P2324, DOI 10.1128/JVI.70.4.2324-2331.1996; BLAIR W, 2003, Patent No. 2003001378; Bugreev DV, 2003, BIOCHEMISTRY-US, V42, P9235, DOI 10.1021/bi0300480; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Cheng HC, 2004, PHARMACOL RES, V50, P21, DOI 10.1016/j.phrs.2003.11.007; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chiu TK, 2004, CURR TOP MED CHEM, V4, P965, DOI 10.2174/1568026043388547; COOPER D, 2007, 14 C RETR OPP INF LO; CRAIGIE R, 1990, CELL, V62, P829, DOI 10.1016/0092-8674(90)90126-Y; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Deprez E, 2004, MOL PHARMACOL, V65, P85, DOI 10.1124/mol.65.1.85; Deprez E, 2001, P NATL ACAD SCI USA, V98, P10090, DOI 10.1073/pnas.181024498; Dicker IB, 2007, J BIOL CHEM, V282, P31186, DOI 10.1074/jbc.M704935200; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Fikkert V, 2004, AIDS, V18, P2019, DOI 10.1097/00002030-200410210-00006; Fikkert V, 2003, J VIROL, V77, P11459, DOI 10.1128/JVI.77.21.11459-11470.2003; FRANSEN S, 2008, 17 HIV DRUG RES WORK; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Gerton JL, 1998, J VIROL, V72, P5046, DOI 10.1128/JVI.72.6.5046-5055.1998; Hazuda DJ, 2004, P NATL ACAD SCI USA, V101, P11233, DOI 10.1073/pnas.0402357101; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; HAZUDA DJ, 2007, 16 INT HIV RES WORKS; JONES G, 2007, 14 C RETR OPP INF LO; JONES KS, 1992, J BIOL CHEM, V267, P16037; KATZ RA, 1990, CELL, V63, P87, DOI 10.1016/0092-8674(90)90290-U; Kehlenbeck S, 2006, J VIROL, V80, P6883, DOI 10.1128/JVI.00306-06; Lee DJ, 2006, ANTIMICROB AGENTS CH, V50, P134, DOI 10.1128/AAC.50.1.134-142.2006; Lee DJ, 2004, J VIROL, V78, P5835, DOI 10.1128/JVI.78.11.5835-5847.2004; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; MCCOLL DJ, 2007, 16 INT HIV RES WORKS; MILLER M, 2008, 17 INT HIV DRUG RES; Neamati N, 2002, EXPERT OPIN THER PAT, V12, P709, DOI 10.1517/13543776.12.5.709; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; REN C, 2007, 16 INT HIV RES WORKS; SEGEL IH, 1975, ENZYME KINETICS, P19; SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; Smolov M, 2006, FEBS J, V273, P1137, DOI 10.1111/j.1742-4658.2006.05139.x; VINCENT KA, 1990, NUCLEIC ACIDS RES, V18, P6045, DOI 10.1093/nar/18.20.6045; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; VINK C, 1993, TRENDS GENET, V9, P433, DOI 10.1016/0168-9525(93)90107-S; Wang LD, 2005, BIOCHEM BIOPH RES CO, V337, P313, DOI 10.1016/j.bbrc.2005.08.274; WISKERCHEN M, 1995, J VIROL, V69, P376, DOI 10.1128/JVI.69.1.376-386.1995; Yi JZ, 1999, BIOCHEMISTRY-US, V38, P8458, DOI 10.1021/bi982870n; YOSHINAGA T, 2008, 15 C RETR OPP INF BO	51	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23599	23609		10.1074/jbc.M804213200	http://dx.doi.org/10.1074/jbc.M804213200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577511	Green Published, hybrid			2022-12-25	WOS:000258638900012
J	Hayashi, H; Sano, H; Seo, S; Kume, T				Hayashi, Hisaki; Sano, Hideto; Seo, Seungwoon; Kume, Tsutomu			The Foxc2 transcription factor regulates angiogenesis via induction of integrin beta 3 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHEDEMA-DISTICHIASIS SYNDROME; INHIBITS TUMOR-GROWTH; VASCULAR DEVELOPMENT; CARDIOVASCULAR DEVELOPMENT; PATHOLOGICAL ANGIOGENESIS; ENDOTHELIAL-CELLS; MICE LACKING; MIGRATION; RECEPTOR; LETHALITY	Forkhead transcription factor Foxc2 is an essential regulator of the cardiovascular system in development and disease. However, the cellular and molecular functions of Foxc2 in vascular endothelial cells are still not fully understood. Here, through gene expression profiling in endothelial cells, we identified molecules associated with cell-extracellular matrix interactions, integrin beta 3 (Itgb3), integrin beta 5 (Itgb5), and fibronectin, as downstream targets of Foxc2. We found that Itgb3 expression is directly regulated by Foxc2 through multiple Forkhead-binding elements within two high homology regions in the Itgb3 promoter. Because Itgb3 is known to regulate angiogenesis, we further tested whether Foxc2 is directly involved in angiogenesis by regulating Itgb3 expression by in vitro experiments. Overexpression of Foxc2 significantly enhanced endothelial cell migration and adhesion, whereas this effect was strongly inhibited by Itgb3 neutralization antibody. In accordance with these results, pulmonary microvascular endothelial cells isolated from Foxc2 heterozygous mutant mice showed a marked reduction in Itgb3 expression and cell migration. Finally, ex vivo aortic ring assay to test the sprouting and microvessel formation revealed enhanced microvessel outgrowth by Foxc2 overexpression. Conversely, microvessel outgrowth from aortas of Foxc2 heterozygous mutant mice was reduced. Taken together, these results suggest that Foxc2 directly induces Itgb3 expression and regulates angiogenesis by Itgb3-mediated endothelial cell adhesion and migration.	[Hayashi, Hisaki; Sano, Hideto; Seo, Seungwoon; Kume, Tsutomu] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN 37232 USA	Vanderbilt University	Kume, T (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, 2220 Pierce Ave, Nashville, TN 37232 USA.	tsutomu.kume@vanderbilt.edu	Sano, Hideto/GZM-5074-2022	Sano, Hideto/0000-0002-4185-3224	National Institutes of Health [HL067105, DK068547, HL074121]; NATIONAL EYE INSTITUTE [R01EY019484] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067105, R01HL074121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK068547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL067105, DK068547, and HL074121 ( to T. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Dagenais SL, 2004, GENE EXPR PATTERNS, V4, P611, DOI 10.1016/j.modgep.2004.07.004; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Iida K, 1997, DEVELOPMENT, V124, P4627; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Kriederman BM, 2003, HUM MOL GENET, V12, P1179, DOI 10.1093/hmg/ddg123; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; Malin D, 2007, MOL CELL BIOL, V27, P2486, DOI 10.1128/MCB.01736-06; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Mellor RH, 2007, CIRCULATION, V115, P1912, DOI 10.1161/CIRCULATIONAHA.106.675348; Mulgrew K, 2006, MOL CANCER THER, V5, P3122, DOI 10.1158/1535-7163.MCT-06-0356; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Rolli M, 2003, P NATL ACAD SCI USA, V100, P9482, DOI 10.1073/pnas.1633689100; Rupp PA, 2001, CIRC RES, V89, P566, DOI 10.1161/hh1901.097747; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Seo S, 2006, DEV BIOL, V296, P421, DOI 10.1016/j.ydbio.2006.06.012; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Wierstra I, 2007, BIOCHEM BIOPH RES CO, V352, P61, DOI 10.1016/j.bbrc.2006.10.151; Wilkinson-Berka JL, 2006, INVEST OPHTH VIS SCI, V47, P1600, DOI 10.1167/iovs.05-1314; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; Zhang HM, 2007, AM J PATHOL, V171, P1113, DOI 10.2353/ajpath.2007.070226	41	69	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23791	23800		10.1074/jbc.M800190200	http://dx.doi.org/10.1074/jbc.M800190200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579532	Green Published, hybrid			2022-12-25	WOS:000258638900033
J	Sameshima, T; Ueno, T; Iizuka, R; Ishii, N; Terada, N; Okabe, K; Funatsu, T				Sameshima, Tomoya; Ueno, Taro; Iizuka, Ryo; Ishii, Noriyuki; Terada, Naofumi; Okabe, Kohki; Funatsu, Takashi			Football- and bullet-shaped GroEL-GroES complexes coexist during the reaction cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONIN GROEL; ATP HYDROLYSIS; PROTEIN; GROEL(14)(GROES(7))(2); POLYPEPTIDE; COOPERATIVITY; TRANSITION; MICROSCOPY; CATALYSIS; ADP	GroEL is an Escherichia coli chaperonin that is composed of two heptameric rings stacked back-to-back. GroEL assists protein folding with its cochaperonin GroES in an ATP-dependent manner in vitro and in vivo. However, it is still unclear whether GroES binds to both rings of GroEL simultaneously under physiological conditions. In this study, we monitored the GroEL-GroES interaction in the reaction cycle using fluorescence resonance energy transfer. We found that nearly equivalent amounts of symmetric GroEL-(GroES)(2) (football-shaped) complex and asymmetric GroEL-GroES (bullet-shaped) complex coexist during the functional reaction cycle. We also found that D398A, an ATP hydrolysis defective mutant of GroEL, forms a football-shaped complex with ATP bound to the two rings. Furthermore, we showed that ADP prevents the association of ATP to the trans-ring of GroEL, and as a consequence, the second GroES cannot bind to GroEL. Considering the concentrations of ADP and ATP in E. coli, ADP is expected to have a small effect on the inhibition of GroES binding to the trans-ring of GroEL in vivo. These results suggest that we should reconsider the chaperonin-mediated protein-folding mechanism that involves the football-shaped complex.	[Sameshima, Tomoya; Ueno, Taro; Iizuka, Ryo; Terada, Naofumi; Okabe, Kohki; Funatsu, Takashi] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bio Analyt Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Ishii, Noriyuki] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba, Ibaraki 3058566, Japan; [Funatsu, Takashi] Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Funatsu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bio Analyt Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	funatsu@mail.ecc.u-tokyo.ac.jp	Funatsu, Takashi/Q-1404-2015; Ishii, Noriyuki/E-5661-2011	Funatsu, Takashi/0000-0002-9656-8308; Ishii, Noriyuki/0000-0002-4120-6203; Iizuka, Ryo/0000-0002-9328-5628	Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [17201031]	Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Mitsubishi Foundation (to T. F.) and by Grant-in-Aid for Scientific Research (A) 17201031 (to T. F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of pagecharges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Beissinger M, 1999, J MOL BIOL, V289, P1075, DOI 10.1006/jmbi.1999.2780; BOCHKAREVA ES, 1992, J BIOL CHEM, V267, P6796; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; Danziger O, 2003, P NATL ACAD SCI USA, V100, P13797, DOI 10.1073/pnas.2333925100; ENGEL A, 1995, SCIENCE, V269, P832, DOI 10.1126/science.7638600; Gorovits BM, 1997, J BIOL CHEM, V272, P26999, DOI 10.1074/jbc.272.43.26999; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HAYERHARTL MK, 1995, SCIENCE, V269, P836, DOI 10.1126/science.7638601; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Iizuka R, 2005, J BIOL CHEM, V280, P40375, DOI 10.1074/jbc.M506785200; Inobe T, 2008, BIOPHYS J, V94, P1392, DOI 10.1529/biophysj.107.114710; LEHNINGER AL, 1993, PRINCIPLES BIOCH, P364; Lorimer GH, 1996, FASEB J, V10, P5, DOI 10.1096/fasebj.10.1.8566548; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Rye HS, 2001, METHODS, V24, P278, DOI 10.1006/meth.2001.1188; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Torok Z, 1996, J BIOL CHEM, V271, P16180, DOI 10.1074/jbc.271.27.16180; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; Walter S, 2002, CELL MOL LIFE SCI, V59, P1589, DOI 10.1007/PL00012485; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Yokokawa M, 2006, EMBO J, V25, P4567, DOI 10.1038/sj.emboj.7601326	37	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23765	23773		10.1074/jbc.M802541200	http://dx.doi.org/10.1074/jbc.M802541200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18567585	Green Published, hybrid			2022-12-25	WOS:000258638900030
J	Fujiwara, S; Wang, L; Han, LQ; Suh, SS; Salome, PA; McClung, CR; Somers, DE				Fujiwara, Sumire; Wang, Lei; Han, Linqu; Suh, Sung-Suk; Salome, Patrice A.; McClung, C. Robertson; Somers, David E.			Post-translational regulation of the Arabidopsis circadian clock through selective proteolysis and phosphorylation of pseudo-response regulator proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLAY ESSENTIAL ROLES; APRR1/TOC1 QUINTET; EARLY PHOTOMORPHOGENESIS; TARGETED DEGRADATION; ABERRANT EXPRESSION; GENE-EXPRESSION; FLOWERING TIME; SCFZTL COMPLEX; KINASE CK2; THALIANA	The circadian clock controls the period, phasing, and amplitude of processes that oscillate with a near 24-h rhythm. One core group of clock components in Arabidopsis that controls the pace of the central oscillator is comprised of five PRR (pseudo-response regulator) proteins whose biochemical function in the clock remains unclear. Peak expression of TOC1 (timing of cab expression 1)/PRR1, PRR3, PRR5, PRR7, and PRR9 are each phased differently over the course of the day and loss of any PRR protein alters period. Here we show that, together with TOC1, PRR5 is the only other likely proteolytic substrate of the E3 ubiquitin ligase SCFZTL within this PRR family. We further demonstrate a functional significance for the phosphorylated forms of PRR5, TOC1, and PRR3. Each PRR protein examined is nuclear-localized and is differentially phosphorylated over the circadian cycle. The more highly phosphorylated forms of PRR5 and TOC1 interact best with the F-box protein ZTL (ZEITLUPE), suggesting a mechanism to modulate their proteolysis. In vivo degradation of both PRR5 and ZTL is inhibited by blue light, likely the result of blue light photoperception by ZTL. TOC1 and PRR3 interact in vivo and phosphorylation of both is necessary for their optimal binding in vitro. Additionally, because PRR3 and ZTL both interact with TOC1 in vivo via the TOC1 N terminus, taken together these data suggest that the TOC1/PRR3 phosphorylation-dependent interaction may protect TOC1 from ZTL-mediated degradation, resulting in an enhanced amplitude of TOC1 cycling.	[Fujiwara, Sumire; Wang, Lei; Han, Linqu; Suh, Sung-Suk; Somers, David E.] Ohio State Univ, Dept Plant Cellular & Mol Biol, Ctr Plant Biotechnol, Columbus, OH 43210 USA; [Salome, Patrice A.; McClung, C. Robertson] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	University System of Ohio; Ohio State University; Dartmouth College	Somers, DE (corresponding author), 054 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	somers.24@osu.edu	Salome, Patrice/E-5702-2017; Somers, David E/A-9209-2010	McClung, C. Robertson/0000-0002-7875-3614; WANG, LEI/0000-0002-4912-5387; Salome, Patrice/0000-0003-4452-9064	National Science Foundation [MCB-0343887];  [IBN-0344377];  [MCB-0544137]	National Science Foundation(National Science Foundation (NSF)); ; 	This work was supported in part by National Science Foundation Grants MCB-0343887 (to C.R.M.) and IBN-0344377 and MCB-0544137 ( to D. E. S.).	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Daniel X, 2004, P NATL ACAD SCI USA, V101, P3292, DOI 10.1073/pnas.0400163101; David KM, 2006, FEBS LETT, V580, P1193, DOI 10.1016/j.febslet.2006.01.016; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Ding ZJ, 2007, GENETICS, V176, P1501, DOI 10.1534/genetics.107.072769; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Eriksson ME, 2003, PLANTA, V218, P159, DOI 10.1007/s00425-003-1106-4; Fang YS, 2007, GENE DEV, V21, P1506, DOI 10.1101/gad.1541607; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Farre EM, 2007, PLANT J, V52, P548, DOI 10.1111/j.1365-313X.2007.03258.x; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Guo FQ, 2001, PLANT CELL, V13, P1761, DOI 10.1105/tpc.13.8.1761; Han LQ, 2004, PLANT J, V40, P291, DOI 10.1111/j.1365-313X.2004.02207.x; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Ito S, 2003, PLANT CELL PHYSIOL, V44, P1237, DOI 10.1093/pcp/pcg136; Ito S, 2008, PLANT CELL PHYSIOL, V49, P201, DOI 10.1093/pcp/pcm178; Ito S, 2007, PLANT CELL PHYSIOL, V48, P1644, DOI 10.1093/pcp/pcm122; Itoh H, 2005, PLANT CELL PHYSIOL, V46, P1392, DOI 10.1093/pcp/pci152; Johnson CH, 2005, ANNU PLANT REV, V21, P237; Kaczorowski KA, 2003, PLANT CELL, V15, P2654, DOI 10.1105/tpc.015065; Kevei E, 2006, PLANT PHYSIOL, V140, P933, DOI 10.1104/pp.105.074864; Kiba T, 2007, PLANT CELL, V19, P2516, DOI 10.1105/tpc.107.053033; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Kim WY, 2003, P NATL ACAD SCI USA, V100, P4933, DOI 10.1073/pnas.0736949100; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Liu Y, 2005, METHOD ENZYMOL, V393, P379, DOI 10.1016/S0076-6879(05)93017-6; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; Matsushika A, 2002, PLANT CELL PHYSIOL, V43, P833, DOI 10.1093/pcp/pcf118; Matsushika A, 2007, BIOSCI BIOTECH BIOCH, V71, P527, DOI 10.1271/bbb.60583; Matsushika A, 2007, BIOSCI BIOTECH BIOCH, V71, P535, DOI 10.1271/bbb.60584; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Mizuno T, 2005, PLANT CELL PHYSIOL, V46, P677, DOI 10.1093/pcp/pci087; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P686, DOI 10.1093/pcp/pci086; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P609, DOI 10.1093/pcp/pci061; Para A, 2007, PLANT CELL, V19, P3462, DOI 10.1105/tpc.107.054775; Perales M, 2006, PLANT J, V46, P849, DOI 10.1111/j.1365-313X.2006.02744.x; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Sato E, 2002, PLANT CELL PHYSIOL, V43, P1374, DOI 10.1093/pcp/pcf166; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 2004, PLANT CELL, V16, P769, DOI 10.1105/tpc.016808; Song HR, 2005, PLANT MOL BIOL, V57, P761, DOI 10.1007/s11103-005-3096-z; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Yamamoto Y, 2003, PLANT CELL PHYSIOL, V44, P1119, DOI 10.1093/pcp/pcg148; Zachgo S, 2000, PLANT J, V23, P697, DOI 10.1046/j.1365-313x.2000.00826.x; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101	60	160	172	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23073	23083		10.1074/jbc.M803471200	http://dx.doi.org/10.1074/jbc.M803471200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562312	hybrid			2022-12-25	WOS:000258455400020
J	Reichard, JF; Sartor, MA; Puga, A				Reichard, John F.; Sartor, Maureen A.; Puga, Alvaro			BACH1 is a specific repressor of HMOX1 that is inactivated by arsenite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIALLY EXPRESSED GENES; ANTIOXIDANT RESPONSE ELEMENTS; MICROSOMAL HEME OXYGENASE; TRANSCRIPTION FACTOR NRF2; HUMAN SKIN FIBROBLASTS; LOCUS-CONTROL REGION; OXIDATIVE STRESS; ERYTHROID-DIFFERENTIATION; MICROARRAY EXPERIMENTS; BETA-GLOBIN	Intracellular heme is a redox active molecule that can be detrimental to cells at high concentrations or under oxidizing conditions. To prevent accumulation, the inducible enzyme heme oxygenase-1 (HMOX1) catalyzes degradation of heme. In the absence of elevated intracellular heme or oxidative stress, the basic region leucine zipper transcriptional regulator BACH1 binds HMOX1 antioxidant response elements and represses transcription. Conversely, increased intracellular heme or sulfhydryl oxidation inactivate BACH1, permitting transcriptional induction of HMOX1. Here, we investigate the effect of BACH1 inactivation on the induction of HMOX1 and as a mechanism for broader gene induction. We show that BACH1 is inactivated at low micromolar arsenite concentrations and that BACH1 inactivation is necessary and sufficient for transcriptional induction of HMOX1. Because BACH1 is thought to interact with antioxidant response element motifs, we further examined the role of BACH1 as a regulator of inducible antioxidant gene expression by assessing the global profile of gene expression following BACH1 knockdown using small interfering RNA. The loss of BACH1 function in human keratinocytes results almost exclusively in HMOX1 induction, suggesting that BACH1 may function as a rheostat regulating levels of intracellular free heme.	[Reichard, John F.] Childrens Hosp, Dept Pediat, Div Newborn Med, Boston, MA 02115 USA; [Sartor, Maureen A.; Puga, Alvaro] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Sartor, Maureen A.; Puga, Alvaro] Univ Cincinnati, Ctr Environm Genet, Cincinnati, OH 45267 USA	Harvard University; Boston Children's Hospital; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Reichard, JF (corresponding author), Childrens Hosp, Dept Pediat, Div Newborn Med, Boston, MA 02115 USA.		Sartor, Maureen/L-2902-2019	Reichard, John/0000-0001-9886-1623	NIEHS NIH HHS [T32 ES07250, P30 ES06096, R01 ES10807, R01 ES010807] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007250, R01ES010807, P30ES006096] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALAM J, 1989, J BIOL CHEM, V264, P6371; Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Dohl Y, 2006, ANTIOXID REDOX SIGN, V8, P60, DOI 10.1089/ars.2006.8.60; Dudoit S, 2002, STAT SINICA, V12, P111; EISENSTEIN RS, 1990, ENZYME, V44, P42, DOI 10.1159/000468746; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gong PF, 2001, J BIOL CHEM, V276, P27018, DOI 10.1074/jbc.M103658200; Guo JH, 2004, TOXICOL APPL PHARM, V194, P79, DOI 10.1016/j.taap.2003.09.002; Hayashi S, 2004, GENE, V336, P241, DOI 10.1016/j.gene.2004.04.002; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kanezaki R, 2001, J BIOL CHEM, V276, P7278, DOI 10.1074/jbc.M004227200; Kann S, 2005, TOXICOL SCI, V87, P365, DOI 10.1093/toxsci/kfi253; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Ohira M, 1998, GENOMICS, V47, P300, DOI 10.1006/geno.1997.5080; OKINAGA S, 1993, EUR J BIOCHEM, V212, P167, DOI 10.1111/j.1432-1033.1993.tb17647.x; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; SARDANA MK, 1982, J BIOL CHEM, V257, P4806; Sartor M, 2004, BIOTECHNIQUES, V36, P790, DOI 10.2144/04365ST02; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Shan Y, 2004, J BIOL CHEM, V279, P51769, DOI 10.1074/jbc.M409463200; SHIBAHARA S, 1987, J BIOL CHEM, V262, P12889; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spuches AM, 2005, INORG CHEM, V44, P2964, DOI 10.1021/ic048694q; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; SUNDERMAN FW, 1987, ANN NY ACAD SCI, V514, P65; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; TENHUNEN R, 1970, J LAB CLIN MED, V75, P410; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; VILE GF, 1993, J BIOL CHEM, V268, P14678; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; YOSHIDA T, 1978, J BIOL CHEM, V253, P4230; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	48	54	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22363	22370		10.1074/jbc.M801784200	http://dx.doi.org/10.1074/jbc.M801784200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18550526	Green Published, hybrid			2022-12-25	WOS:000258321000004
J	Shenoy, SK; Xiao, KH; Venkataramanan, V; Snyder, PM; Freedman, NJ; Weissman, AM				Shenoy, Sudha K.; Xiao, Kunhong; Venkataramanan, Vidya; Snyder, Peter M.; Freedman, Neil J.; Weissman, Allan M.			Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta(2)-adrenergic receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; DOWN-REGULATION; BETA-ARRESTIN; 7-TRANSMEMBRANE RECEPTORS; PROMOTED UBIQUITINATION; RNA INTERFERENCE; PLASMA-MEMBRANE; ENDOCYTOSIS; TRAFFICKING; LIGASE	Agonist-stimulated beta(2)-adrenergic receptor (beta(2)AR) ubiquitination is a major factor that governs both lysosomal trafficking and degradation of internalized receptors, but the identity of the E3 ubiquitin ligase regulating this process was unknown. Among the various catalytically inactive E3 ubiquitin ligase mutants that we tested, a dominant negative Nedd4 specifically inhibited isoproterenol-induced ubiquitination and degradation of the beta(2)AR in HEK-293 cells. Moreover, siRNA that downregulates Nedd4 expression inhibited beta(2)AR ubiquitination and lysosomal degradation, whereas siRNA targeting the closely related E3 ligases Nedd4-2 or AIP4 did not. Interestingly, beta(2)AR as well as beta-arrestin2, the endocytic and signaling adaptor for the beta(2)AR, interact robustly with Nedd4 upon agonist stimulation. However, beta(2)AR-Nedd4 interaction is ablated when beta-arrestin2 expression is knocked down by siRNA transfection, implicating an essential E3 ubiquitin ligase adaptor role for beta-arrestin2 in mediating beta(2)AR ubiquitination. Notably, beta-arrestin2 interacts with two different E3 ubiquitin ligases, namely, Mdm2 and Nedd4 to regulate distinct steps in beta(2)AR trafficking. Collectively, our findings indicate that the degradative fate of the beta(2)AR in the lysosomal compartments is dependent upon beta-arrestin2-mediated recruitment of Nedd4 to the activated receptor and Nedd4-catalyzed ubiquitination.	[Shenoy, Sudha K.; Xiao, Kunhong; Venkataramanan, Vidya; Freedman, Neil J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Shenoy, Sudha K.; Freedman, Neil J.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Snyder, Peter M.] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52422 USA; [Snyder, Peter M.] Univ Iowa, Coll Med, Dept Physiol, Iowa City, IA 52422 USA; [Snyder, Peter M.] Univ Iowa, Coll Med, Dept Biophys, Iowa City, IA 52422 USA; [Weissman, Allan M.] NCI Frederick, Ctr Canc Res, Lab Prot Dynam & Signaling, Frederick, MD 21702 USA	Duke University; Duke University; University of Iowa; University of Iowa; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Shenoy, SK (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	sudha@receptor-biol.duke.edu	Shenoy, Sudha/AAN-4075-2021; Xiao, Kunhong/AAG-4275-2020	Shenoy, Sudha/0000-0002-2565-4663; Xiao, Kunhong/0000-0002-1069-1226	NHLBI NIH HHS [HL080525, R01 HL080525, R01 HL080525-03, T32 HL007101] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC009392] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BOUVIER M, 1989, J BIOL CHEM, V264, P16786; Cohen BD, 2003, ENDOCRINOLOGY, V144, P4393, DOI 10.1210/en.2002-0063; Cottrell GS, 2006, J BIOL CHEM, V281, P27773, DOI 10.1074/jbc.M603369200; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Dohlman HG, 2002, NATURE, V418, P591, DOI 10.1038/418591a; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Hamilton MH, 2001, J BIOL CHEM, V276, P26324, DOI 10.1074/jbc.M101205200; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Mihalik B, 2003, INT J BIOCHEM CELL B, V35, P992, DOI 10.1016/S1357-2725(02)00277-7; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Moore RH, 1999, J CELL SCI, V112, P329; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104	64	139	147	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22166	22176		10.1074/jbc.M709668200	http://dx.doi.org/10.1074/jbc.M709668200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544533	Green Published, hybrid			2022-12-25	WOS:000258114700036
J	Pietsch, EC; Perchiniak, E; Canutescu, AA; Wang, GL; Dunbrack, RL; Murphy, ME				Pietsch, E. Christine; Perchiniak, Erin; Canutescu, Adrian A.; Wang, Guoli; Dunbrack, Roland L.; Murphy, Maureen E.			Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; BH3 DOMAIN; TRANSCRIPTIONAL ACTIVATION; PROAPOPTOTIC ACTIVITY; CASPASE ACTIVATION; INDUCE APOPTOSIS; FAMILY MEMBERS; CYTOCHROME-C; BCL-2 FAMILY; CELL-DEATH	Genotoxic stress triggers a rapid translocation of p53 to the mitochondria, contributing to apoptosis in a transcription-independent manner. Using immunopurification protocols and mass spectrometry, we previously identified the proapoptotic protein BAK as a mitochondrial p53-binding protein and showed that recombinant p53 directly binds to BAK and can induce its oligomerization, leading to cytochrome c release. In this work we describe a combination of molecular modeling, electrostatic analysis, and site-directed mutagenesis to define contact residues between BAK and p53. Our data indicate that three regions within the core DNA binding domain of p53 make contact with BAK; these are the conserved H2 alpha-helix and the L1 and L3 loop. Notably, point mutations in these regions markedly impair the ability of p53 to oligomerize BAK and to induce transcription-independent cell death. We present a model whereby positively charged residues within the H2 helix and L1 loop of p53 interact with an electronegative domain on the N-terminal alpha-helix of BAK; the latter is known to undergo conformational changes upon BAK activation. We show that mutation of acidic residues in the N-terminal helix impair the ability of BAK to bind to p53. Interestingly, many of the p53 contact residues predicted by our model are also direct DNA contact residues, suggesting that p53 interacts with BAK in a manner analogous to DNA. The combined data point to the H2 helix and L1 and L3 loops of p53 as novel functional domains contributing to transcription-independent apoptosis by this tumor suppressor protein.	[Pietsch, E. Christine; Perchiniak, Erin; Murphy, Maureen E.] Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA; [Canutescu, Adrian A.; Wang, Guoli; Dunbrack, Roland L.] Fox Chase Canc Ctr, Program Biomol Struct & Funct, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center	Murphy, ME (corresponding author), Fox Chase Canc Ctr, Div Med Sci, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Maureen.Murphy@FCCC.edu	Dunbrack, Roland/ABG-7141-2020	Dunbrack, Roland/0000-0001-7674-6667; Murphy, Maureen/0000-0001-7644-7296	NCI NIH HHS [P30 CA006927-44, F32 CA 110713, R01 CA102184, T32 CA 009035, R01 CA102184-04, F32 CA110713-02, F32 CA110713-01, P30 CA 006297, T32 CA009035-33, R01 CA 102184, T32 CA009035] Funding Source: Medline; NIGMS NIH HHS [R01 GM073784-03, R01 GM 73784, R01 GM073784] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102184, T32CA009035, F32CA110713, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073784] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2004, CELL, DOI [DOI 10.1016/S0092-8674(04)00036-4, 10.1016/S0092-8674(04)00036-4]; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Ding HF, 2000, J BIOL CHEM, V275, P38905, DOI 10.1074/jbc.M004714200; Ding HF, 1998, J BIOL CHEM, V273, P28378, DOI 10.1074/jbc.273.43.28378; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Juin P, 2005, CELL CYCLE, V4, P637, DOI 10.4161/cc.4.5.1671; Kakudo Y, 2005, CANCER RES, V65, P2108, DOI 10.1158/0008-5472.CAN-04-2935; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, CANCER RES, V54, P3131; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nemajerova A, 2005, FEBS LETT, V579, P6079, DOI 10.1016/j.febslet.2005.09.074; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Palacios G, 2006, ONCOGENE, V25, P6133, DOI 10.1038/sj.onc.1209641; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Sansome C, 2001, FEBS LETT, V488, P110, DOI 10.1016/S0014-5793(00)02368-1; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Shangary S, 2004, MOL CANCER THER, V3, P1343; Simonen M, 1997, EUR J BIOCHEM, V249, P85, DOI 10.1111/j.1432-1033.1997.t01-1-00085.x; Sot B, 2007, J BIOL CHEM, V282, P29193, DOI 10.1074/jbc.M705544200; Speidel D, 2006, ONCOGENE, V25, P940, DOI 10.1038/sj.onc.1209126; Talos F, 2005, CANCER RES, V65, P9971, DOI 10.1158/0008-5472.CAN-05-1084; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101	51	74	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21294	21304		10.1074/jbc.M710539200	http://dx.doi.org/10.1074/jbc.M710539200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18524770	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000257746100071
J	Amsili, S; Zer, H; Hinderlich, S; Krause, S; Becker-Cohen, M; MacArthur, DG; North, KN; Mitrani-Rosenbaum, S				Amsili, Shira; Zer, Hagit; Hinderlich, Stephan; Krause, Sabine; Becker-Cohen, Michal; MacArthur, Daniel G.; North, Kathryn N.; Mitrani-Rosenbaum, Stella			UDP-N-Acetylglucosamine 2-Epimerase/N-Acetylmannosamine Kinase (GNE) Binds to Alpha-Actinin 1: Novel Pathways in Skeletal Muscle?	PLOS ONE			English	Article								Background: Hereditary inclusion body myopathy (HIBM) is a rare neuromuscular disorder caused by mutations in GNE, the key enzyme in the biosynthetic pathway of sialic acid. While the mechanism leading from GNE mutations to the HIBM phenotype is not yet understood, we searched for proteins potentially interacting with GNE, which could give some insights about novel putative biological functions of GNE in muscle. Methodology/Principal Findings: We used a Surface Plasmon Resonance (SPR)-Biosensor based assay to search for potential GNE interactors in anion exchanged fractions of human skeletal muscle primary culture cell lysate. Analysis of the positive fractions by in vitro binding assay revealed alpha-actinin 1 as a potential interactor of GNE. The direct interaction of the two proteins was assessed in vitro by SPR-Biosensor based kinetics analysis and in a cellular environment by a coimmunoprecipitation assay in GNE overexpressing 293T cells. Furthermore, immunohistochemistry on stretched mouse muscle suggest that both GNE and a-actinin 1 localize to an overlapping but not identical region of the myofibrillar apparatus centered on the Z line. Conclusions/Significance: The interaction of GNE with alpha-actinin 1 might point to its involvement in alpha-actinin mediated processes. In addition these studies illustrate for the first time the expression of the non-muscle form of alpha-actinin, alpha-actinin 1, in mature skeletal muscle tissue, opening novel avenues for its specific function in the sarcomere. Although no significant difference could be detected in the binding kinetics of alpha-actinin 1 with either wild type or mutant GNE in our SPR biosensor based analysis, further investigation is needed to determine whether and how the interaction of GNE with alpha-actinin 1 in skeletal muscle is relevant to the putative muscle-specific function of alpha-actinin 1, and to the muscle-restricted pathology of HIBM.	[Amsili, Shira; Becker-Cohen, Michal; Mitrani-Rosenbaum, Stella] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Zer, Hagit] Hebrew Univ Jerusalem, Inst Life Sci, Biacore Lab, Interdept Equipment Unit, Jerusalem, Israel; [Hinderlich, Stephan] Charite, Campus Benjamin Franklin, Berlin, Germany; [Hinderlich, Stephan] Inst Biochem & Molekularbiol, Berlin, Germany; [Hinderlich, Stephan] Fachbereich Life Sci & Technol, Tech Fachhochschule Berlin, Berlin, Germany; [Krause, Sabine] Ludwig Maximilians Univ Munchen, Friedrich Baur Inst, Neurol Klin & Poliklin, Munich, Germany; [MacArthur, Daniel G.; North, Kathryn N.] Univ Sydney, Childrens Hosp Westmead, Inst Neuromuscular Res, Fac Med, Sydney, NSW, Australia	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Sydney	Amsili, S (corresponding author), Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	stella@cc.huji.ac.il	North, Kathryn N/K-6476-2012; Krause, Sabine/AAJ-1163-2020; MacArthur, Daniel/E-3275-2010	North, Kathryn N/0000-0003-0841-8009; Krause, Sabine/0000-0002-3141-886X; MacArthur, Daniel/0000-0002-5771-2290; Mitrani-Rosenbaum, Stella/0000-0001-5335-8709	German-Israeli Foundation for Research and Development (GIF), Jerusalem, Israel; Association Francaise contre les Myopathies (AFM); Israel Science Foundation (ISF)	German-Israeli Foundation for Research and Development (GIF), Jerusalem, Israel(German-Israeli Foundation for Scientific Research and Development); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported by grants from the German-Israeli Foundation for Research and Development (GIF), Jerusalem, Israel (SM-R;SH;SK), from the Association Francaise contre les Myopathies (AFM) (SM-R) and from the Israel Science Foundation (ISF) (SM-R).	Amsili S, 2007, CELL DEATH DIFFER, V14, P1916, DOI 10.1038/sj.cdd.4402208; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; Argov Zohar, 1998, Current Opinion in Rheumatology, V10, P543, DOI 10.1097/00002281-199811000-00006; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; Broccolini A, 2004, HUM MUTAT, V23, DOI 10.1002/humu.9252; Catimel B, 2005, J PROTEOME RES, V4, P1646, DOI 10.1021/pr050132x; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Eisenberg Iris, 2003, Hum Mutat, V21, P99, DOI 10.1002/humu.9100; ENDO T, 1984, J CELL BIOL, V99, P2322, DOI 10.1083/jcb.99.6.2322; Ghaderi D, 2007, J MOL BIOL, V369, P746, DOI 10.1016/j.jmb.2007.03.037; Goffart S, 2006, CURR GENET, V49, P125, DOI 10.1007/s00294-005-0043-0; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Hinderlich S, 2004, FEBS LETT, V566, P105, DOI 10.1016/j.febslet.2004.04.013; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kelly DF, 2006, J MOL BIOL, V357, P562, DOI 10.1016/j.jmb.2005.12.076; Krause S, 2005, EXP CELL RES, V304, P365, DOI 10.1016/j.yexcr.2004.11.010; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; Malicdan MCV, 2007, HUM MOL GENET, V16, P115, DOI 10.1093/hmg/ddl446; McDonnell JM, 2001, CURR OPIN CHEM BIOL, V5, P572, DOI 10.1016/S1367-5931(00)00251-9; MILLAKE DB, 1989, NUCLEIC ACIDS RES, V17, P6725, DOI 10.1093/nar/17.16.6725; Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6; NOEGEL A, 1987, FEBS LETT, V221, P391, DOI 10.1016/0014-5793(87)80962-6; Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Poch MT, 2004, TOXICOL APPL PHARM, V199, P239, DOI 10.1016/j.taap.2003.12.023; Roden LD, 1996, BIOCHEM BIOPH RES CO, V225, P1073, DOI 10.1006/bbrc.1996.1297; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Tomimitsu H, 2004, NEUROLOGY, V62, P1607, DOI 10.1212/01.WNL.0000123115.23652.6C; Weidemann W, 2006, FEBS LETT, V580, P6649, DOI 10.1016/j.febslet.2006.11.015; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519	33	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2477	10.1371/journal.pone.0002477	http://dx.doi.org/10.1371/journal.pone.0002477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560563	Green Published, gold, Green Submitted			2022-12-25	WOS:000263280700050
J	Burke, T; Page, B; Van Dyk, G; Millspaugh, J; Slotow, R				Burke, Tarryne; Page, Bruce; Van Dyk, Gus; Millspaugh, Josh; Slotow, Rob			Risk and Ethical Concerns of Hunting Male Elephant: Behavioural and Physiological Assays of the Remaining Elephants	PLOS ONE			English	Article								Background: Hunting of male African elephants may pose ethical and risk concerns, particularly given their status as a charismatic species of high touristic value, yet which are capable of both killing people and damaging infrastructure. Methodology/Principal Findings: We quantified the effect of hunts of male elephants on (1) risk of attack or damage (11 hunts), and (2) behavioural (movement dynamics) and physiological (stress hormone metabolite concentrations) responses (4 hunts) in Pilanesberg National Park. For eleven hunts, there were no subsequent attacks on people or infrastructure, and elephants did not break out of the fenced reserve. For three focal hunts, there was an initial flight response by bulls present at the hunting site, but their movements stabilised the day after the hunt event. Animals not present at the hunt (both bulls and herds) did not show movement responses. Physiologically, hunting elephant bulls increased faecal stress hormone levels (corticosterone metabolites) in both those bulls that were present at the hunts (for up to four days post-hunt) and in the broader bull and breeding herd population (for up to one month post-hunt). Conclusions/Significance: As all responses were relatively minor, hunting male elephants is ethically acceptable when considering effects on the remaining elephant population; however bulls should be hunted when alone. Hunting is feasible in relatively small enclosed reserves without major risk of attack, damage, or breakout. Physiological stress assays were more effective than behavioural responses in detecting effects of human intervention. Similar studies should evaluate intervention consequences, inform and improve best practice, and should be widely applied by management agencies.	[Burke, Tarryne; Page, Bruce; Van Dyk, Gus; Slotow, Rob] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Amarula Elephant Res Programme, Durban, South Africa; [Millspaugh, Josh] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO USA	University of Kwazulu Natal; University of Missouri System; University of Missouri Columbia	Burke, T (corresponding author), Univ KwaZulu Natal, Sch Biol & Conservat Sci, Amarula Elephant Res Programme, Durban, South Africa.	slotow@ukzn.ac.za	Slotow, Rob/AAM-9053-2020; Page, Bruce R/G-1245-2010	Page, Bruce R/0000-0001-7979-5229; Slotow, Rob/0000-0001-9469-1508	PPC Cement; Amarula (Distell),; National Research Foundation [2053623]; University of KwaZulu-Natal; Missouri University South African Partnerships Program; MU Alumni Association	PPC Cement; Amarula (Distell),; National Research Foundation; University of KwaZulu-Natal; Missouri University South African Partnerships Program; MU Alumni Association	PPC Cement, Amarula (Distell), National Research Foundation (GUN: 2053623), University of KwaZulu-Natal, Missouri University South African Partnerships Program and the MU Alumni Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acocks J. P. H., 1988, VELD TYPES S AFRICA; BOONZAAIER W. W., 2000, PILANESBERG NATL PAR; BREYTENBACH G, 2001, KOEDOE, V44, P105; BROWN IRF, 1979, COMP BIOCHEM PHYS A, V62, P899, DOI 10.1016/0300-9629(79)90025-2; Creedy J, 2002, J ECON SURV, V16, P1, DOI 10.1111/1467-6419.00158; CUMMING D, 2005, 11 WWFSARPO; Dalmau A, 2007, J WILDLIFE MANAGE, V71, P190, DOI 10.2193/2005-492; DEVILLIERS MS, 1995, P ROY SOC B-BIOL SCI, V262, P215, DOI 10.1098/rspb.1995.0198; Douglas-Hamilton I, 2006, APPL ANIM BEHAV SCI, V100, P87, DOI 10.1016/j.applanim.2006.04.014; Eltringham S. K., 1977, East African Wildlife Journal, V15, P19; HALLMARTIN AJ, 1987, S AFR J SCI, V83, P616; Harper JM, 2000, PHYSIOL BIOCHEM ZOOL, V73, P12, DOI 10.1086/316721; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; Irwin L.L., 1979, P199; Kilpatrick HJ, 1999, WILDLIFE SOC B, V27, P433; KNOKE D, 1980, QUANTITATIVE APPL SO, P9; LANGBAUER WR, 1991, J EXP BIOL, V157, P35; Lecocq Y, 1997, WILDLIFE SOC B, V25, P215; LOTTER HPP, ASSESSMENT IN PRESS, P307; MARTIN RB, 1996, ELEPHANT MANAGEMENT; MBENGA E, 2004, THESIS U KWAZULU NAT; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; Millspaugh JJ, 2000, J WILDLIFE MANAGE, V64, P994, DOI 10.2307/3803209; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Millspaugh JJ, 2003, WILDLIFE SOC B, V31, P399; Millspaugh JJ, 2001, WILDLIFE SOC B, V29, P899; Millspaugh JJ, 2007, J WILDLIFE MANAGE, V71, P1257, DOI 10.2193/2006-015; Moberg G.P., 2000, BIOL ANIMAL STRESS B, V1st; MORGANTINI LE, 1985, J RANGE MANAGE, V38, P77, DOI 10.2307/3899339; Peterson MN, 2004, WILDLIFE SOC B, V32, P310, DOI 10.2193/0091-7648(2004)32[310:AAFDTS]2.0.CO;2; Poole J.H., 1995, DIFFERENCES SEXES, P331; POOLE JH, 1989, ANIM BEHAV, V37, P842, DOI 10.1016/0003-3472(89)90068-7; Pretorius Y., 2004, THESIS U KWAZULU NAT; Reynolds PC, 2001, TOURISM MANAGE, V22, P31, DOI 10.1016/S0261-5177(00)00018-2; Roy C, 2001, J WILDLIFE MANAGE, V65, P808, DOI 10.2307/3803030; Sapolsky R.M., 1987, P291; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; Slotow R., 2001, Koedoe, V44, P85; Sokal R. R, 1981, BIOMETRY; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Western D., 1989, PACHYDERM, V12, P42; Whyte IJ, 1993, PACHYDERM, V16, P72; Zar JH, 1999, BIOSTATISTICAL ANAL	43	27	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2417	10.1371/journal.pone.0002417	http://dx.doi.org/10.1371/journal.pone.0002417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560517	Green Submitted, gold, Green Published			2022-12-25	WOS:000263280700006
J	Abdoul, H; Mallet, V; Pol, S; Fontanet, A				Abdoul, Hendy; Mallet, Vincent; Pol, Stanislas; Fontanet, Arnaud			Serum Alpha-Fetoprotein Predicts Treatment Outcome in Chronic Hepatitis C Patients Regardless of HCV Genotype	PLOS ONE			English	Article								We examined the association between serum alpha-fetoprotein (AFP) level and sustained virological response (SVR) in 93 chronic hepatitis C patients. The SVR rate was much higher among patients with serum AFP levels below rather than above the median value (5.7 ng/ml) (58.7% and 19.2%, respectively; P < 0.0001). Serum AFP should be added to the list of factors predictive of treatment response in chronic hepatitis C.	[Abdoul, Hendy; Fontanet, Arnaud] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Mallet, Vincent; Pol, Stanislas] Univ Paris 05, Hop Cochin, APHP, Unite Hepatol, INSERM U567, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Abdoul, H (corresponding author), Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.	fontanet@pasteur.fr	; Mallet, Vincent/G-4623-2011	, arnaud/0000-0002-5239-6110; Mallet, Vincent/0000-0003-2219-9201				Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Berg T, 2003, HEPATOLOGY, V37, P600, DOI 10.1053/jhep.2003.50106; DABEVA MD, 1993, AM J PATHOL, V143, P1606; GERMAIN L, 1988, CANCER RES, V48, P368; Gupta S, 2003, ANN INTERN MED, V139, P46, DOI 10.7326/0003-4819-139-1-200307010-00012; HALBRECHT I, 1956, NATURE, V178, P794, DOI 10.1038/178794a0; Males S, 2007, ANTIVIR THER, V12, P797; Poynard T, 2000, HEPATOLOGY, V31, P211, DOI 10.1002/hep.510310131; SHIOJIRI N, 1991, CANCER RES, V51, P2611; TAKETA K, 1990, HEPATOLOGY, V12, P1420, DOI 10.1002/hep.1840120625; Tsamandas AC, 2006, LIVER INT, V26, P817, DOI 10.1111/j.1478-3231.2006.01306.x; Yin L, 2002, HISTOL HISTOPATHOL, V17, P65, DOI 10.14670/HH-17.65	12	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2391	10.1371/journal.pone.0002391	http://dx.doi.org/10.1371/journal.pone.0002391			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545682	gold, Green Published, Green Submitted			2022-12-25	WOS:000263248800030
J	MacKenzie, JJ; Gomez, ND; Bhattacharjee, S; Mann, S; Haldar, K				MacKenzie, Julia J.; Gomez, Noe D.; Bhattacharjee, Souvik; Mann, Shaina; Haldar, Kasturi			A Plasmodium falciparum Host-Targeting Motif Functions in Export during Blood Stage Infection of the Rodent Malarial Parasite Plasmodium berghei	PLOS ONE			English	Article								Plasmodium falciparum (P. falciparum) secretes hundreds of proteins-including major virulence proteins-into the host erythrocyte. In order to reach the host cytoplasm, most P. falciparum proteins contain an N terminal host-targeting (HT) motif composed of 11 amino acids. In silico analyses have suggested that the HT motif is conserved throughout the Plasmodium species but experimental evidence only exists for P. falciparum. Here, we show that in the rodent malaria parasite Plasmodium berghei (P. berghei) a reporter-like green fluorescent protein expressed by the parasite can be exported to the erythrocyte cytoplasm in a HT-specific manner. This provides the first experimental proof that the HT motif can function as a signal for protein delivery to the erythrocyte across Plasmodium species. Further, it suggests that P. berghei may serve as a model for validation of P. falciparum secretome proteins. We also show that tubovesicular membranes extend from the vacuolar parasite into the erythrocyte cytoplasm and speculate that these structures may facilitate protein export to the erythrocyte.	[MacKenzie, Julia J.; Gomez, Noe D.; Bhattacharjee, Souvik; Mann, Shaina; Haldar, Kasturi] Northwestern Univ, Dept Pathol & Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	MacKenzie, JJ (corresponding author), Northwestern Univ, Dept Pathol & Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA.	k-haldar@northwestern.edu	Haldar, Kasturi/C-6685-2014		Alliance for Graduate Education and the Professoriate - AGEP;  [R01HL069630];  [R01AI039071];  [P01-PPG 5P01HL078826]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069630, P01HL078826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039071] Funding Source: NIH RePORTER	Alliance for Graduate Education and the Professoriate - AGEP; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the following grants: Haldar (R01HL069630, R01AI039071, P01-PPG 5P01HL078826); Gomez (Alliance for Graduate Education and the Professoriate - AGEP).	Bhattacharjee S, 2008, BLOOD, V111, P2418, DOI 10.1182/blood-2007-09-115279; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Haldar K, 2006, NAT REV MICROBIOL, V4, P922, DOI 10.1038/nrmicro1549; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Lauer SA, 1997, SCIENCE, V276, P1122, DOI 10.1126/science.276.5315.1122; Lopez-Estrano C, 2003, P NATL ACAD SCI USA, V100, P12402, DOI 10.1073/pnas.2133080100; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Waller KL, 2002, MOL BIOCHEM PARASIT, V119, P125, DOI 10.1016/S0166-6851(01)00395-4; Wiser Mark F., 1999, Novartis Foundation Symposium, V226, P199; WISER MF, 1999, NOVART FDN SYMP, V226, P211	18	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2405	10.1371/journal.pone.0002405	http://dx.doi.org/10.1371/journal.pone.0002405			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545649	Green Published, gold, Green Submitted			2022-12-25	WOS:000263248800043
J	Miura, P; Andrews, M; Holcik, M; Jasmin, BJ				Miura, Pedro; Andrews, Meghan; Holcik, Martin; Jasmin, Bernard J.			IRES-Mediated Translation of Utrophin A Is Enhanced by Glucocorticoid Treatment in Skeletal Muscle Cells	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; ENDOPLASMIC-RETICULUM STRESS; PROTEIN MESSENGER-RNA; TRANS-ACTING FACTOR; LONG-TERM BENEFIT; MDX MICE; DEPENDENT TRANSLATION; GENE-TRANSFER; UP-REGULATION; DOUBLE-BLIND	Glucocorticoids are currently the only drug treatment recognized to benefit Duchenne muscular dystrophy (DMD) patients. The nature of the mechanisms underlying the beneficial effects remains incompletely understood but may involve an increase in the expression of utrophin. Here, we show that treatment of myotubes with 6 alpha-methylprednisolone-21 sodium succinate (PDN) results in enhanced expression of utrophin A without concomitant increases in mRNA levels thereby suggesting that translational regulation contributes to the increase. In agreement with this, we show that PDN treatment of cells transfected with monocistronic reporter constructs harbouring the utrophin A 5'UTR, causes an increase in reporter protein expression while leaving levels of reporter mRNAs unchanged. Using bicistronic reporter assays, we further demonstrate that PDN enhances activity of an Internal Ribosome Entry Site (IRES) located within the utrophin A 5'UTR. Analysis of polysomes demonstrate that PDN causes an overall reduction in polysome-associated mRNAs indicating that global translation rates are depressed under these conditions. Importantly, PDN causes an increase in the polysome association of endogenous utrophin A mRNAs and reporter mRNAs harbouring the utrophin A 5'UTR. Additional experiments identified a distinct region within the utrophin A 5'UTR that contains the inducible IRES activity. Together, these studies demonstrate that a translational regulatory mechanism involving increased IRES activation mediates, at least partially, the enhanced expression of utrophin A in muscle cells treated with glucocorticoids. Targeting the utrophin A IRES may thus offer an important and novel therapeutic avenue for developing drugs appropriate for DMD patients.	[Miura, Pedro; Jasmin, Bernard J.] Univ Ottawa, Dept Cellular & Mol Med, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Andrews, Meghan; Holcik, Martin] Childrens Hosp E Ontario, Apoptosis Res Ctr, Ottawa, ON, Canada; [Jasmin, Bernard J.] Ottawa Hosp, Ottawa Hlth Res Inst, Mol Med Program, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Miura, P (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ctr Neuromuscular Dis, Ottawa, ON, Canada.	jasmin@uottawa.ca	Holcik, Martin/E-5372-2011; Holcik, Martin/AAC-6660-2019; Miura, Pedro/N-4604-2013	Holcik, Martin/0000-0002-1922-5299; Miura, Pedro/0000-0002-8434-5027	L'Association Francaise contre les Myopathies; Canadian Institutes of Health Research (CIHR) [Canada Graduate Scholarships Doctoral Award]; Muscular Dystrophy Association-USA; CHEO	L'Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association-USA(Muscular Dystrophy Association); CHEO	This work was supported by grants from the L'Association Francaise contre les Myopathies (AFM) (to B.J.J.), the Canadian Institutes of Health Research (CIHR) (to B.J.J. and M.H.), the Muscular Dystrophy Association-USA (to B.J.J.), and a CHEO feasibility grant (to M.H. and B.J.J.). P.M. was supported by a fellowship from AFM during the course of this work, and is a recipient of a CIHR Canada Graduate Scholarships Doctoral Award.	Ambuhl PM, 1999, J CLIN INVEST, V103, P429, DOI 10.1172/JCI2913; Biggar WD, 2001, J PEDIATR-US, V138, P45, DOI 10.1067/mpd.2001.109601; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Bonet-Kerrache A, 2005, BIOCHEM J, V391, P261, DOI 10.1042/BJ20050024; Bonifati MD, 2000, MUSCLE NERVE, V23, P1344, DOI 10.1002/1097-4598(200009)23:9<1344::AID-MUS4>3.3.CO;2-6; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Campbell Craig, 2003, BMC Neurol, V3, P7, DOI 10.1186/1471-2377-3-7; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; Chakkalakal JV, 2004, HUM MOL GENET, V13, P379, DOI 10.1093/hmg/ddh037; Chakkalakal JV, 2003, P NATL ACAD SCI USA, V100, P7791, DOI 10.1073/pnas.0932671100; COLSON P, 1992, AM J PHYSIOL, V263, pE1054; Cougnon MH, 2002, PFLUG ARCH EUR J PHY, V445, P123, DOI 10.1007/s00424-002-0898-6; Courdier-Fruh I, 2003, NEUROMUSCULAR DISORD, V13, P699, DOI 10.1016/S0960-8966(03)00117-2; Courdier-Fruh I, 2002, NEUROMUSCULAR DISORD, V12, pS95, DOI 10.1016/S0960-8966(02)00089-5; DESILVA S, 1987, ARCH NEUROL-CHICAGO, V44, P818, DOI 10.1001/archneur.1987.00520200022012; Devarajan P, 2000, AM J PHYSIOL-RENAL, V279, pF1132, DOI 10.1152/ajprenal.2000.279.6.F1132; FENICHEL GM, 1991, NEUROLOGY, V41, P1874, DOI 10.1212/WNL.41.12.1874; Fisher I, 2005, FASEB J, V19, P834, DOI 10.1096/fj.04-2511fje; Galy B, 1999, CANCER RES, V59, P165; Gilbert T, 1999, HUM GENE THER, V10, P1299, DOI 10.1089/10430349950017987; Gonzalez-Herrera IG, 2006, FASEB J, V20, P476, DOI 10.1096/fj.04-3314fje; Gramolini AO, 1999, J NEUROPATH EXP NEUR, V58, P235, DOI 10.1097/00005072-199903000-00003; Gramolini AO, 1997, J BIOL CHEM, V272, P8117, DOI 10.1074/jbc.272.13.8117; Henis-Korenblit S, 2002, P NATL ACAD SCI USA, V99, P5400, DOI 10.1073/pnas.082102499; Holcik M, 2005, RNA, V11, P1605, DOI 10.1261/rna.2158605; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Kim YK, 2000, J MOL BIOL, V304, P119, DOI 10.1006/jmbi.2000.4179; KISSEL JT, 1991, NEUROLOGY, V41, P667, DOI 10.1212/WNL.41.5.667; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Lewis SM, 2008, NUCLEIC ACIDS RES, V36, P168, DOI 10.1093/nar/gkm1007; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; LO CV, 1995, CALCIFIED TISSUE INT, V56, P109; Martineau Y, 2004, MOL CELL BIOL, V24, P7622, DOI 10.1128/MCB.24.17.7622-7635.2004; MENDELL JR, 1989, NEW ENGL J MED, V320, P1592, DOI 10.1056/NEJM198906153202405; Miura P, 2006, TRENDS MOL MED, V12, P122, DOI 10.1016/j.molmed.2006.01.002; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Nordsborg N, 2005, J PHYSIOL-LONDON, V567, P583, DOI 10.1113/jphysiol.2005.087031; PASQUINI F, 1995, NEUROMUSCULAR DISORD, V5, P105, DOI 10.1016/0960-8966(94)00042-8; PONTA H, 1985, P NATL ACAD SCI USA, V82, P1020, DOI 10.1073/pnas.82.4.1020; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; RIFAI Z, 1995, AM J PHYSIOL-ENDOC M, V268, pE67, DOI 10.1152/ajpendo.1995.268.1.E67; SARANTOS P, 1994, AM J SURG, V167, P8, DOI 10.1016/0002-9610(94)90047-7; SARNOW P, 1989, P NATL ACAD SCI USA, V86, P5795, DOI 10.1073/pnas.86.15.5795; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE74, DOI 10.1152/ajpendo.2000.279.1.E74; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE76, DOI 10.1152/ajpendo.2000.278.1.E76; Shah OJ, 2002, J BIOL CHEM, V277, P2525, DOI 10.1074/jbc.M105935200; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE1185, DOI 10.1152/ajpendo.2000.279.5.E1185; Shah OJ, 2000, BIOCHEM J, V347, P389, DOI 10.1042/0264-6021:3470389; St-Pierre SJG, 2004, FASEB J, V18, P1937, DOI 10.1096/fj.04-1859fje; Tidball JG, 2004, PEDIATR RES, V56, P831, DOI 10.1203/01.PDR.0000145578.01985.D0; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; VERDI JM, 1990, J BIOL CHEM, V265, P20314; Warnakulasuriyarachchi D, 2004, J BIOL CHEM, V279, P17148, DOI 10.1074/jbc.M308737200; Wehling-Henricks M, 2004, NEUROMUSCULAR DISORD, V14, P483, DOI 10.1016/j.nmd.2004.04.008; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200	58	35	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2309	10.1371/journal.pone.0002309	http://dx.doi.org/10.1371/journal.pone.0002309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545658	gold, Green Published			2022-12-25	WOS:000263248800001
J	Park, JY; Cho, MO; Leonard, S; Calder, B; Mian, IS; Kim, WH; Wijnhoven, S; van Steeg, H; Mitchell, J; van der Horst, GTJ; Hoeijmakers, J; Cohen, P; Vijg, J; Suh, Y				Park, Jung Yoon; Cho, Mi-Ook; Leonard, Shanique; Calder, Brent; Mian, I. Saira; Kim, Woo Ho; Wijnhoven, Susan; van Steeg, Harry; Mitchell, James; van der Horst, Gijsbertus T. J.; Hoeijmakers, Jan; Cohen, Pinchas; Vijg, Jan; Suh, Yousin			Homeostatic Imbalance between Apoptosis and Cell Renewal in the Liver of Premature Aging Xpd(TTD) Mice	PLOS ONE			English	Article							DNA-REPAIR; GENOMIC INSTABILITY; SOMATIC MUTATIONS; LIFE-SPAN; P53; GENE; DEFICIENT; FAS; MECHANISMS; PATHWAYS	Unrepaired or misrepaired DNA damage has been implicated as a causal factor in cancer and aging. Xpd(TTD) mice, harboring defects in nucleotide excision repair and transcription due to a mutation in the Xpd gene (R722W), display severe symptoms of premature aging but have a reduced incidence of cancer. To gain further insight into the molecular basis of the mutant-specific manifestation of age-related phenotypes, we used comparative microarray analysis of young and old female livers to discover gene expression signatures distinguishing Xpd(TTD) mice from their age-matched wild type controls. We found a transcription signature of increased apoptosis in the Xpd(TTD) mice, which was confirmed by in situ immunohistochemical analysis and found to be accompanied by increased proliferation. However, apoptosis rate exceeded the rate of proliferation, resulting in homeostatic imbalance. Interestingly, a metabolic response signature was observed involving decreased energy metabolism and reduced IGF-1 signaling, a major modulator of life span. We conclude that while the increased apoptotic response to endogenous DNA damage contributes to the accelerated aging phenotypes and the reduced cancer incidence observed in the Xpd(TTD) mice, the signature of reduced energy metabolism is likely to reflect a compensatory adjustment to limit the increased genotoxic stress in these mutants. These results support a general model for premature aging in DNA repair deficient mice based on cellular responses to DNA damage that impair normal tissue homeostasis.	[Park, Jung Yoon; Cho, Mi-Ook; Suh, Yousin] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Leonard, Shanique] Univ Texas, Hlth Sci Ctr San Antonio, Barshop Inst Longevity & Aging Stud, Dept Physiol, San Antonio, TX USA; [Calder, Brent; Vijg, Jan] Buck Inst Age Res, Novato, CA USA; [Mian, I. Saira] Lawrence Berkeley Natl Lab, Berkeley, CA USA; [Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Wijnhoven, Susan; van Steeg, Harry] Natl Inst Publ Hlth & Env, Lab Toxicol, Pathol & Genet, Bilthoven, Netherlands; [Mitchell, James; van der Horst, Gijsbertus T. J.; Hoeijmakers, Jan] Erasmus MC, MGC Dept Cell Biol & Genet, Rotterdam, Netherlands; [Cohen, Pinchas] Univ Calif Los Angeles, Los Angeles, CA USA; [Park, Jung Yoon; Cho, Mi-Ook; Suh, Yousin] Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Health San Antonio; Buck Institute for Research on Aging; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Seoul National University (SNU); Erasmus University Rotterdam; Erasmus MC; University of California System; University of California Los Angeles; Yeshiva University; Albert Einstein College of Medicine	Park, JY (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	ysuh@aecom.yu.edu	Hoeijmakers, Jan/AAX-6972-2021; van der Horst, Gijsbertus TJ/E-3661-2015; Kim, Wooho/G-3703-2011	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; 	US National Institute of Health [RO1 AG024391, RO3 AG023292, PO1 AG17242, RO1AG20438, UO1ES11044]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG023292, R01AG020438, R01AG024391, P01AG017242] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the US National Institute of Health (RO1 AG024391 and RO3 AG023292) awarded to YS, and (PO1 AG17242, RO1AG20438, UO1ES11044) awarded to JV.	Andressoo JO, 2006, CELL CYCLE, V5, P2886, DOI 10.4161/cc.5.24.3565; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Bohr VA, 2005, DNA REPAIR, V4, P293, DOI 10.1016/j.dnarep.2004.09.010; Compe E, 2005, MOL CELL BIOL, V25, P6065, DOI 10.1128/MCB.25.14.6065-6076.2005; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Desagher S, 2005, J BIOL CHEM, V280, P5693, DOI 10.1074/jbc.M408971200; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dolle MET, 2006, MUTAT RES-FUND MOL M, V596, P22, DOI 10.1016/j.mrfmmm.2005.11.008; Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; Fraser AG, 2004, NAT GENET, V36, P559, DOI 10.1038/ng1370; Giese H, 1999, ONCOGENE, V18, P1257, DOI 10.1038/sj.onc.1202404; Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hasty P, 2004, AGING CELL, V3, P55, DOI 10.1111/j.1474-9728.2004.00082.x; Hatano E, 2007, J GASTROEN HEPATOL, V22, pS43, DOI 10.1111/j.1440-1746.2006.04645.x; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liedtke C, 2004, J HEPATOL, V40, P874, DOI 10.1016/j.jhep.2004.02.020; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Mak SK, 2004, J BIOL CHEM, V279, P39075, DOI 10.1074/jbc.M406643200; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Papaconstantinou J, 2005, MECH AGEING DEV, V126, P692, DOI 10.1016/j.mad.2005.01.002; Pinkoski MJ, 2000, AM J PHYSIOL-GASTR L, V278, pG354, DOI 10.1152/ajpgi.2000.278.3.G354; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Suh Y, 2006, ANTIOXID REDOX SIGN, V8, P559, DOI 10.1089/ars.2006.8.559; Suh YS, 2000, CANCER RES, V60, P5067; van de Ven M, 2007, MECH AGEING DEV, V128, P58, DOI 10.1016/j.mad.2006.11.011; van de Ven Marieke, 2006, PLoS Genet, V2, pe192, DOI 10.1371/journal.pgen.0020192; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Vijg J, 2006, NATURE, V440, P874, DOI 10.1038/440874a; Vijg J, 2005, AGING CELL, V4, P331, DOI 10.1111/j.1474-9726.2005.00179.x; Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753	42	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2346	10.1371/journal.pone.0002346	http://dx.doi.org/10.1371/journal.pone.0002346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545656	Green Submitted, Green Published, gold			2022-12-25	WOS:000263248800008
J	Fujiwara, M; Marusawa, H; Wang, HQ; Iwai, A; Ikeuchi, K; Imai, Y; Kataoka, A; Nukina, N; Takahashi, R; Chiba, T				Fujiwara, M.; Marusawa, H.; Wang, H-Q; Iwai, A.; Ikeuchi, K.; Imai, Y.; Kataoka, A.; Nukina, N.; Takahashi, R.; Chiba, T.			Parkin as a tumor suppressor gene for hepatocellular carcinoma	ONCOGENE			English	Article						parkin; hepatocellular carcinoma; follistatin	NF-KAPPA-B; DEFICIENT MICE; ACTIVIN; DISEASE; LIVER; EXPRESSION; MECHANISMS; APOPTOSIS; UBIQUITIN; OVARIAN	The parkin was first identified as a gene implicated in autosomal recessive juvenile Parkinsonism. Deregulation of the parkin gene, however, has been observed in various human cancers, suggesting that the parkin gene may be important in tumorigenesis. To gain insight into the physiologic role of parkin, we generated parkin-/- mice lacking exon 3 of the parkin gene. We demonstrated here that parkin-/- mice had enhanced hepatocyte proliferation and developed macroscopic hepatic tumors with the characteristics of hepatocellular carcinoma. Microarray analyses revealed that parkin deficiency caused the alteration of gene expression profiles in the liver. Among them, endogenous follistatin is commonly upregulated in both nontumorous and tumorous liver tissues of parkin deficient mice. Parkin deficiency resulted in suppression of caspase activation and rendered hepatocytes resistant to apoptosis in a follistatin-dependent manner. These results suggested that parkin deficiency caused enhanced hepatocyte proliferation and resistance to apoptosis, resulting in hepatic tumor development, partially through the upregulation of endogenous follistatin. The finding that parkin deficient mice are susceptible to hepatocarcinogenesis provided the first evidence showing that parkin is indeed a tumor suppressor gene.	[Fujiwara, M.; Marusawa, H.; Iwai, A.; Ikeuchi, K.; Chiba, T.] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan; [Wang, H-Q; Takahashi, R.] Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto 6068507, Japan; [Imai, Y.; Kataoka, A.] RIKEN, Brain Sci Inst, Lab Motor Syst Neurodegenerat, Saitama, Japan; [Nukina, N.] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Saitama, Japan	Kyoto University; Kyoto University; RIKEN; RIKEN	Marusawa, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, 54 Kawara Cho, Kyoto 6068507, Japan.	maru@kuhp.kyoto-u.ac.jp; ryosuket@kuhp.kyoto-u.ac.jp	Nukina, Nobuyuki/GPP-6265-2022; Imai, Yuzuru/AAA-6472-2019	Imai, Yuzuru/0000-0003-2924-5231; Marusawa, Hiroyuki/0000-0002-4286-2712				Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100; Chen YG, 2002, EXP BIOL MED, V227, P75, DOI 10.1177/153537020222700201; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; de Groot E, 2000, MOL BIOL REP, V27, P129, DOI 10.1023/A:1007159031000; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Feitelson MA, 2002, ONCOGENE, V21, P2593, DOI 10.1038/sj.onc.1205434; Germann A, 2003, INT J CANCER, V106, P187, DOI 10.1002/ijc.11215; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Grusch M, 2006, J HEPATOL, V45, P673, DOI 10.1016/j.jhep.2006.06.014; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; HULLY JR, 1994, HEPATOLOGY, V20, P854, DOI 10.1002/hep.1840200413; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jiang HB, 2006, J BIOL CHEM, V281, P8591, DOI 10.1074/jbc.M510926200; Kahle PJ, 2004, EMBO REP, V5, P681, DOI 10.1038/sj.embor.7400188; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitao Y, 2007, HUM MOL GENET, V16, P50, DOI 10.1093/hmg/ddl439; Kogure K, 2000, HEPATOLOGY, V31, P916, DOI 10.1053/he.2000.6100; Kong FM, 2000, ONCOGENE, V19, P1572, DOI 10.1038/sj.onc.1203437; Kou T, 2007, INT J CANCER, V120, P469, DOI 10.1002/ijc.22292; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Matsumoto T, 2006, FEBS LETT, V580, P731, DOI 10.1016/j.febslet.2005.12.081; MILLIKIN D, 1991, CANCER RES, V51, P5449; Morett E, 1999, TRENDS BIOCHEM SCI, V24, P229, DOI 10.1016/S0968-0004(99)01381-X; MORITA R, 1991, CANCER RES, V51, P5817; NEGRINI M, 1994, CANCER RES, V54, P1331; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Patella S, 2006, AM J PHYSIOL-GASTR L, V290, pG137, DOI 10.1152/ajpgi.00080.2005; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Picchio MC, 2004, CLIN CANCER RES, V10, P2720, DOI 10.1158/1078-0432.CCR-03-0086; Rodgarkia-Dara C, 2006, MUTAT RES-REV MUTAT, V613, P123, DOI 10.1016/j.mrrev.2006.07.002; Rodriguez C, 2000, GENE CHROMOSOME CANC, V27, P76, DOI 10.1002/(SICI)1098-2264(200001)27:1<76::AID-GCC10>3.0.CO;2-E; Rossmanith W, 2002, MOL CARCINOGEN, V35, P1, DOI 10.1002/mc.10068; Saito S, 1996, CANCER RES, V56, P5586; SCHWALL RH, 1993, HEPATOLOGY, V18, P347, DOI 10.1016/0270-9139(93)90018-I; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Takabe K, 2003, HEPATOLOGY, V38, P1107, DOI 10.1053/jhep.2003.50483; Takahashi R, 2003, ANN NY ACAD SCI, V991, P101; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192; Tibiletti MG, 1996, CANCER RES, V56, P4493; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang F, 2004, GENE CHROMOSOME CANC, V40, P85, DOI 10.1002/gcc.20020; West AB, 2005, TRENDS NEUROSCI, V28, P348, DOI 10.1016/j.tins.2005.05.002; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8	54	158	165	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2008	27	46					6002	6011		10.1038/onc.2008.199	http://dx.doi.org/10.1038/onc.2008.199			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	358BO	18574468	Green Submitted			2022-12-25	WOS:000259891600003
J	Kaufmann, AM; Krise, JP				Kaufmann, Allyn M.; Krise, Jeffrey P.			Niemann-Pick C1 functions in regulating lysosomal amine content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPROTEIN-DERIVED CHOLESTEROL; HAMSTER OVARY CELLS; DISEASE-TYPE-C; INTRACELLULAR-TRANSPORT; GANGLIOSIDE STORAGE; POLYAMINE TRANSPORT; ALDEHYDE LOAD; LIVING CELLS; PROTEIN; ACCUMULATION	Mutations in the late endosomal/lysosomal membrane protein Niemann-Pick C1 (NPC1) are known to cause a generalized block in retrograde vesicle-mediated transport, resulting in the hyper-accumulation of multiple lysosomal cargos. An important, yet often overlooked, category of lysosomal cargo includes the vast array of small molecular weight amine-containing molecules that are substrates for ion trapping in the highly acidic organelle lumen. We show here that the introduction of amine-containing molecules in lysosomes can significantly stimulate NPC1-mediated late endosome/lysosome fusion, and subsequently the secretion of lysosomal cargo. To illustrate the physiological importance of this NPC1-mediated transport pathway, we show that NPC1-deficient cells are more susceptible to the toxic effects of a lysosomotropic polyamine metabolite 3-aminopropanal. Moreover, NPC fibroblasts are shown to have higher levels of polyamine oxidase, an enzyme involved in the formation of 3-aminopropanal. Collectively, these findings provide strong support for a novel functional role for NPC1 and may also provide clues toward understanding NPC disease progression.	[Kaufmann, Allyn M.; Krise, Jeffrey P.] Univ Kansas, Dept Pharmaceut Chem, Sch Pharm, Lawrence, KS 66047 USA	University of Kansas	Krise, JP (corresponding author), Univ Kansas, Dept Pharmaceut Chem, Sch Pharm, 2095 Constant Ave, Lawrence, KS 66047 USA.	krise@ku.edu			NATIONAL CANCER INSTITUTE [R01CA106655] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA106655] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andrews N. W., 2005, SCI STKE, ppe19; Andrews NW, 2000, TRENDS CELL BIOL, V10, P316, DOI 10.1016/S0962-8924(00)01794-3; BACHRACH U, 1966, ANAL BIOCHEM, V17, P38, DOI 10.1016/0003-2697(66)90005-4; Bernstein HG, 1999, PROG NEUROBIOL, V57, P485, DOI 10.1016/S0301-0082(98)00065-3; BOLHUIS PA, 1987, NEUROLOGY, V37, P75, DOI 10.1212/WNL.37.1.75; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Bright NA, 2001, TRAFFIC, V2, P631, DOI 10.1034/j.1600-0854.2001.20906.x; BULYCHEV A, 1978, EXP CELL RES, V115, P343, DOI 10.1016/0014-4827(78)90288-4; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Cullis PM, 1999, CHEM BIOL, V6, P717, DOI 10.1016/S1074-5521(00)80019-8; Dai HQ, 1999, CANCER RES, V59, P4944; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; DAVIS BA, 1989, J CHROMATOGR, V466, P89, DOI 10.1016/S0021-9673(01)84617-3; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Diettrich O, 1998, FEBS LETT, V441, P369, DOI 10.1016/S0014-5793(98)01578-6; Duvvuri M, 2005, BIOCHEMISTRY-US, V44, P15743, DOI 10.1021/bi051759w; Duvvuri M, 2004, J BIOL CHEM, V279, P32367, DOI 10.1074/jbc.M400735200; Duvvuri M, 2004, PHARM RES-DORDR, V21, P26, DOI 10.1023/B:PHAM.0000012148.12516.3f; Duvvuri M, 2005, MOL PHARMACEUT, V2, P440, DOI 10.1021/mp050043s; Erickson RP, 2000, J INHERIT METAB DIS, V23, P54, DOI 10.1023/A:1005650930330; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; FINNIN BC, 1969, J PHARM PHARMACOL, V21, P114, DOI 10.1111/j.2042-7158.1969.tb08207.x; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Garver William S., 2002, Current Molecular Medicine (Hilversum), V2, P485, DOI 10.2174/1566524023362375; GOLDIN E, 1992, BIOCHIM BIOPHYS ACTA, V1127, P303, DOI 10.1016/0005-2760(92)90236-O; Gong YP, 2006, J PHARMACOL EXP THER, V316, P242, DOI 10.1124/jpet.105.089482; Griffiths G, 2002, SEMIN CELL DEV BIOL, V13, P279, DOI 10.1016/S1084-9521(02)00057-5; Ioannou YA, 2005, TRENDS BIOCHEM SCI, V30, P498, DOI 10.1016/j.tibs.2005.07.007; Ivanova S, 1998, J EXP MED, V188, P327, DOI 10.1084/jem.188.2.327; JAHRAUS A, 1994, J CELL SCI, V107, P145; Janne J, 2004, EUR J BIOCHEM, V271, P877, DOI 10.1111/j.1432-1033.2004.04009.x; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Konig G, 2008, MONATSH CHEM, V139, P401, DOI 10.1007/s00706-007-0819-7; LISCUM L, 1990, BIOCHIM BIOPHYS ACTA, V1045, P40, DOI 10.1016/0005-2760(90)90201-8; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Liu YJ, 2000, HUM MOL GENET, V9, P1087, DOI 10.1093/hmg/9.7.1087; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; Masuko T, 2003, J NEUROCHEM, V84, P610, DOI 10.1046/j.1471-4159.2003.01558.x; Morissette G, 2004, J PHARMACOL EXP THER, V310, P395, DOI 10.1124/jpet.104.066084; MORRISON LD, 1995, NEUROSCI LETT, V197, P5, DOI 10.1016/0304-3940(95)11881-V; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Passeggio J, 2005, J BIOL CHEM, V280, P10333, DOI 10.1074/jbc.M413657200; Patterson MC, 2004, BBA-MOL CELL BIOL L, V1685, P77, DOI 10.1016/j.bbalip.2004.08.013; PATTERSON MC, 1993, NEUROLOGY, V43, P61, DOI 10.1212/WNL.43.1_Part_1.61; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; RABINOWITZ S, 1992, J CELL BIOL, V116, P95, DOI 10.1083/jcb.116.1.95; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; ROFF CF, 1991, DEV NEUROSCI-BASEL, V13, P315, DOI 10.1159/000112179; SOLHEIM AE, 1983, BIOCHIM BIOPHYS ACTA, V763, P284, DOI 10.1016/0167-4889(83)90136-2; Somers KL, 2001, J INHERIT METAB DIS, V24, P427, DOI 10.1023/A:1010588112003; Soulet D, 2004, J BIOL CHEM, V279, P49355, DOI 10.1074/jbc.M401287200; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Vincent I, 2003, CURR OPIN NEUROL, V16, P155, DOI 10.1097/00019052-200304000-00006; Virgili M, 2006, NEUROCHEM INT, V48, P201, DOI 10.1016/j.neuint.2005.10.004; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wood PL, 2006, BRAIN RES, V1095, P190, DOI 10.1016/j.brainres.2006.04.038; YANG WCT, 1965, EXP CELL RES, V38, P495, DOI 10.1016/0014-4827(65)90373-3; Yu ZQ, 2004, BRAIN RES, V1016, P163, DOI 10.1016/j.brainres.2004.04.075; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898	64	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24584	24593		10.1074/jbc.M803715200	http://dx.doi.org/10.1074/jbc.M803715200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18591242	hybrid, Green Published			2022-12-25	WOS:000258820000030
J	Stutz, MA; Shattuck, DL; Laederich, MB; Carraway, KL; Sweeney, C				Stutz, M. A.; Shattuck, D. L.; Laederich, M. B.; Carraway, K. L., III; Sweeney, C.			LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII	ONCOGENE			English	Article						EGFRvIII; LRIG1; negative regulator; glioblastoma	GROWTH-FACTOR RECEPTOR; KINASE INHIBITORS; DOWN-REGULATION; CELL CARCINOMA; ACTIVATION; RESISTANCE; GENE; UBIQUITYLATION; EXPRESSION; CANCER	Epidermal growth factor receptor (EGFR) mutation is frequently observed in human cancer and contributes to the growth, survival and therapeutic resistance of tumors. EGFRvIII is an oncogenic EGFR mutant resulting from the deletion of exons 2-7 and is the most common EGFR mutant observed in glioblastoma multiforme, an aggressive brain tumor. EGFRvIII is constitutively active but poorly ubiquitinated, leading to inefficient receptor trafficking to lysosomes and unattenuated oncogenic signaling. The mechanism by which EGFRvIII evades downregulation is not fully understood although recent studies suggest that its interaction with the ubiquitin ligase Cbl may be compromised. In this study, we examine the regulation of EGFRvIII by the recently identified negative regulator, LRIG1, which targets EGFR through recognition of its extracellular domain. Here, we determine whether the extracellular domain deletion in EGFRvIII renders it refractory to LRIG1 regulation. We find that EGFRvIII retains interaction with LRIG1 and is in fact more sensitive to LRIG1 action than wild-type receptor. We demonstrate that LRIG1 regulation of EGFRvIII is distinct from the only other known mechanism of EGFR regulation, Cbl-mediated degradation. Ectopic expression of LRIG1 in EGFRvIII(+) glioblastoma cells opposes EGFRvIII-driven tumor cell proliferation, survival, motility and invasion. Finally, RNAi-mediated silencing of LRIG1 alters EGFRvIII intracellular trafficking and leads to enhanced EGFRvIII expression, suggesting that loss of LRIG1 in tumors may contribute to a permissive environment for EGFRvIII overexpression, contributing to EGFRvIII oncogenesis.	[Stutz, M. A.; Shattuck, D. L.; Laederich, M. B.; Carraway, K. L., III; Sweeney, C.] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA	University of California System; University of California Davis	Sweeney, C (corresponding author), Univ Calif Davis, Ctr Canc, Res Bldg 3,Room 1000,4645 2nd Ave, Sacramento, CA 95817 USA.	casweeney@ucdavis.edu			NIH [CA118384, GM068994]; DOD BCRP [W81XWH-06-1-0772]; NATIONAL CANCER INSTITUTE [R01CA118384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068994] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD BCRP(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Webster Cavenee from the Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, California for the U87MG parental and EGFRvIII expressing glioblastoma cells. We thank Dr Laurel Beckett, Chief of the Division of Biostatistics at UC Davis School of Medicine, for statistical consultation. We thank Carol Oxford, Manager of the UC Davis Optical Biology Core, for her assistance in the flow cytometry experiments. This work was supported by NIH grants CA118384 (CS) and GM068994 (KLC). DLS is a recipient of a DOD BCRP predoctoral fellowship Award no. W81XWH-06-1-0772.	Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Aoki T, 2007, EXPERT OPIN PHARMACO, V8, P3133, DOI 10.1517/14656566.8.18.3133; Cook PW, 1997, J CLIN INVEST, V100, P2286, DOI 10.1172/JCI119766; Davies GC, 2006, ONCOGENE, V25, P6497, DOI 10.1038/sj.onc.1209662; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Grandal MV, 2007, CARCINOGENESIS, V28, P1408, DOI 10.1093/carcin/bgm058; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Han W, 2006, CANCER BIOL THER, V5, P1361, DOI 10.4161/cbt.5.10.3226; Hedman H, 2002, ACTA ONCOL, V41, P352, DOI 10.1080/028418602760169398; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Learn CA, 2004, CLIN CANCER RES, V10, P3216, DOI 10.1158/1078-0432.CCR-03-0521; Lindstrom AK, 2008, INT J GYNECOL CANCER, V18, P312, DOI 10.1111/j.1525-1438.2007.01021.x; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Moscatello DK, 1998, J BIOL CHEM, V273, P200, DOI 10.1074/jbc.273.1.200; Nagane M, 1998, P NATL ACAD SCI USA, V95, P5724, DOI 10.1073/pnas.95.10.5724; Nagane M, 2001, J NEUROSURG, V95, P472, DOI 10.3171/jns.2001.95.3.0472; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Raizer RJ, 2005, J NEURO-ONCOL, V74, P77, DOI 10.1007/s11060-005-0603-7; Rosell R, 2006, CLIN CANCER RES, V12, P7222, DOI 10.1158/1078-0432.CCR-06-0627; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Suzuki Y, 2002, FEBS LETT, V521, P67, DOI 10.1016/S0014-5793(02)02824-7; Sweeney C, 2006, J MAMMARY GLAND BIOL, V11, P89, DOI 10.1007/s10911-006-9015-3; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; Thomasson M, 2003, BRIT J CANCER, V89, P1285, DOI 10.1038/sj.bjc.6601208; VASSAR R, 1991, GENE DEV, V5, P714, DOI 10.1101/gad.5.5.714; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263	34	61	72	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2008	27	43					5741	5752		10.1038/onc.2008.185	http://dx.doi.org/10.1038/onc.2008.185			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	352HM	18542056	Green Accepted			2022-12-25	WOS:000259487100009
J	Tchivilev, I; Madamanchi, NR; Vendrov, AE; Niu, XL; Runge, MS				Tchivilev, Igor; Madamanchi, Nageswara R.; Vendrov, Aleksandr E.; Niu, Xi-Lin; Runge, Marschall S.			Identification of a protective role for protein phosphatase 1c gamma 1 against oxidative stress-induced vascular smooth muscle cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; TUMOR-SUPPRESSOR P53; REACTIVE OXYGEN; OKADAIC ACID; PROTEIN PHOSPHATASE-1; ENDOTHELIAL-CELLS; SIGNAL-TRANSDUCTION; EXPRESSION; ACTIVATION; BAX	The development of therapeutic strategies to inhibit reactive oxygen species (ROS)-mediated damage in blood vessels has been limited by a lack of specific targets for intervention. Targeting ROS-mediated events in the vessel wall is of interest, because ROS play important roles throughout atherogenesis. In early atherosclerosis, ROS stimulate vascular smooth muscle cell (VSMC) growth, whereas in late stages of lesion development, ROS induce VSMC apoptosis, causing atherosclerotic plaque instability. To identify putative protective genes against oxidative stress, mouse aortic VSMC were infected with a retroviral human heart cDNA expression library, and apoptosis was induced in virus-infected cells by 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) treatment. A total of 17 different, complete cDNAs were identified from the DMNQ-resistant VSMC clones by PCR amplification and sequencing. The cDNA encoding PP1c gamma 1 ( catalytic subunit of protein phosphatase 1) was present in several independent DMNQ-resistant VSMC clones. DMNQ increased mitochondrial ROS production, caspase-3/7 activity, DNA fragmentation, and decreased mitochondrial transmembrane potential in VSMC while decreasing PP1c gamma 1 activity and expression. Depletion of PP1c gamma 1 expression by short hairpin RNA significantly enhanced basal as well as DMNQ-induced VSMC apoptosis. PP1c gamma 1 overexpression abrogated DMNQ-induced JNK1 activity, p53Ser(15) phosphorylation, and Bax expression and protected VSMC against DMNQ-induced apoptosis. In addition, PP1c gamma 1 overexpression attenuated DMNQ-induced caspase-3/7 activation and DNA fragmentation. Inhibition of p53 protein expression using small interfering RNA abrogated DMNQ-induced Bax expression and significantly attenuated VSMC apoptosis. Together, these data indicate that PP1c gamma 1 overexpression promotes VSMC survival by interfering with JNK1 and p53 phosphorylation cascades involved in apoptosis.	[Tchivilev, Igor; Madamanchi, Nageswara R.; Vendrov, Aleksandr E.; Niu, Xi-Lin; Runge, Marschall S.] Univ N Carolina, Dept Med, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Runge, MS (corresponding author), Univ N Carolina, Dept Med, Carolina Cardiovasc Biol Ctr, 125 MacNider Hall, Chapel Hill, NC 27599 USA.	mrunge@med.unc.edu	Vendrov, Aleksandr E./AHE-8649-2022; Vendrov, Aleksandr/A-4115-2010; Vendrov, Aleksandr E./ABF-1266-2021	Vendrov, Aleksandr E./0000-0003-4971-8040; Vendrov, Aleksandr/0000-0003-4971-8040; Madamanchi, Nageswara/0000-0003-0590-0908	NHLBI NIH HHS [HL-57352] Funding Source: Medline; NIA NIH HHS [AG 024282] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG024282] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akakura N, 2001, CANCER RES, V61, P6548; BENNETT MR, 1995, J CLIN INVEST, V95, P2266, DOI 10.1172/JCI117917; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Callapina M, 2005, FREE RADICAL BIO MED, V39, P925, DOI 10.1016/j.freeradbiomed.2005.05.009; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Cheng WH, 2003, BIOCHEM J, V370, P927, DOI 10.1042/BJ20021870; Chu SJ, 2006, AM J PHYSIOL-LUNG C, V291, pL983, DOI 10.1152/ajplung.00454.2005; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen PTW, 2002, J CELL SCI, V115, P241; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; FernandezSanchez MT, 1996, FEBS LETT, V398, P106, DOI 10.1016/S0014-5793(96)01192-1; Flogel U, 2004, FASEB J, V18, P1156, DOI 10.1096/fj.03-1382fje; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GJERTSEN BT, 1995, BBA-MOL CELL RES, V1269, P187, DOI 10.1016/0167-4889(95)00117-B; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HammKunzelmann B, 1997, FEBS LETT, V403, P87, DOI 10.1016/S0014-5793(97)00029-X; Haneda M, 2004, FEBS LETT, V567, P171, DOI 10.1016/j.febslet.2004.04.066; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; KIGUCHI K, 1994, CELL GROWTH DIFFER, V5, P995; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Li DWC, 2006, ONCOGENE, V25, P3006, DOI 10.1038/sj.onc.1209334; Li DWC, 1998, EUR J BIOCHEM, V257, P351, DOI 10.1046/j.1432-1327.1998.2570351.x; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Lorens JB, 2001, CURR OPIN BIOTECH, V12, P613, DOI 10.1016/S0958-1669(01)00269-5; Madamanchi NR, 2001, J BIOL CHEM, V276, P18915, DOI 10.1074/jbc.M008802200; Mandal M, 2001, GASTROENTEROLOGY, V120, P71, DOI 10.1053/gast.2001.20897; Martin-Ventura JL, 2004, CIRCULATION, V110, P2216, DOI 10.1161/01.CIR.0000136814.87170.B1; Martin-Ventura JL, 2006, ARTERIOSCL THROM VAS, V26, P1337, DOI 10.1161/01.ATV.0000220108.97208.67; MELLGREN G, 1993, EXP CELL RES, V205, P293, DOI 10.1006/excr.1993.1089; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, ONCOGENE, V9, P1799; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; Moon SK, 2001, AM J PHYSIOL-HEART C, V280, pH2779, DOI 10.1152/ajpheart.2001.280.6.H2779; Morana SJ, 1996, J BIOL CHEM, V271, P18263, DOI 10.1074/jbc.271.30.18263; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Papadakis ES, 2006, FEBS LETT, V580, P1320, DOI 10.1016/j.febslet.2006.01.053; Park WH, 2007, J CELL BIOCHEM, V102, P98, DOI 10.1002/jcb.21280; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Ramachandran A, 2002, BIOL CHEM, V383, P693, DOI 10.1515/BC.2002.071; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sandal T, 2001, CELL DEATH DIFFER, V8, P754, DOI 10.1038/sj.cdd.4400873; Sandau K, 1997, KIDNEY INT, V52, P378, DOI 10.1038/ki.1997.344; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; TAKENAKA I, 1995, J BIOL CHEM, V270, P5405, DOI 10.1074/jbc.270.10.5405; Tamm C, 2004, EUR J NEUROSCI, V19, P2613, DOI 10.1111/j.0953-816X.2004.03391.x; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Turenne GA, 2001, ONCOGENE, V20, P5100, DOI 10.1038/sj.onc.1204665; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Watanabe N, 2003, ARCH BIOCHEM BIOPHYS, V411, P145, DOI 10.1016/S0003-9861(02)00716-6; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Yamamoto K, 2001, CANCER LETT, V168, P173, DOI 10.1016/S0304-3835(01)00532-8; Yan Y, 1997, J BIOL CHEM, V272, P15220, DOI 10.1074/jbc.272.24.15220; Zhang Y, 2007, CLIN CANCER RES, V13, P2855, DOI 10.1158/1078-0432.CCR-06-2090	78	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22193	22205		10.1074/jbc.M803452200	http://dx.doi.org/10.1074/jbc.M803452200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18540044	Green Published, hybrid			2022-12-25	WOS:000258114700039
J	Ancuta, P; Kamat, A; Kunstman, KJ; Kim, EY; Autissier, P; Wurcel, A; Zaman, T; Stone, D; Mefford, M; Morgello, S; Singer, EJ; Wolinsky, SM; Gabuzda, D				Ancuta, Petronela; Kamat, Anupa; Kunstman, Kevin J.; Kim, Eun-Young; Autissier, Patrick; Wurcel, Alysse; Zaman, Tauheed; Stone, David; Mefford, Megan; Morgello, Susan; Singer, Elyse J.; Wolinsky, Steven M.; Gabuzda, Dana			Microbial Translocation Is Associated with Increased Monocyte Activation and Dementia in AIDS Patients	PLOS ONE			English	Article								Elevated plasma lipopolysaccharide (LPS), an indicator of microbial translocation from the gut, is a likely cause of systemic immune activation in chronic HIV infection. LPS induces monocyte activation and trafficking into brain, which are key mechanisms in the pathogenesis of HIV-associated dementia (HAD). To determine whether high LPS levels are associated with increased monocyte activation and HAD, we obtained peripheral blood samples from AIDS patients and examined plasma LPS by Limulus amebocyte lysate (LAL) assay, peripheral blood monocytes by FACS, and soluble markers of monocyte activation by ELISA. Purified monocytes were isolated by FACS sorting, and HIV DNA and RNA levels were quantified by real time PCR. Circulating monocytes expressed high levels of the activation markers CD69 and HLA-DR, and harbored low levels of HIV compared to CD4(+) T-cells. High plasma LPS levels were associated with increased plasma sCD14 and LPS-binding protein (LBP) levels, and low endotoxin core antibody levels. LPS levels were higher in HAD patients compared to control groups, and were associated with HAD independently of plasma viral load and CD4 counts. LPS levels were higher in AIDS patients using intravenous heroin and/or ethanol, or with Hepatitis C virus (HCV) co-infection, compared to control groups. These results suggest a role for elevated LPS levels in driving monocyte activation in AIDS, thereby contributing to the pathogenesis of HAD, and provide evidence that cofactors linked to substance abuse and HCV co-infection influence these processes.	[Ancuta, Petronela; Kamat, Anupa; Mefford, Megan; Gabuzda, Dana] Harvard Univ, Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA; [Kunstman, Kevin J.; Kim, Eun-Young; Wolinsky, Steven M.] Northwestern Univ, Med Sch, Chicago, IL USA; [Autissier, Patrick] Beth Israel Deaconess Med Ctr, Boston, MA USA; [Wurcel, Alysse; Zaman, Tauheed; Stone, David] Lemuel Shattuck Hosp, Jamaica Plain, MA USA; [Morgello, Susan] Mount Sinai Med Ctr, New York, NY USA; [Singer, Elyse J.] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Northwestern University; Harvard University; Beth Israel Deaconess Medical Center; Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Ancuta, P (corresponding author), Harvard Univ, Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA.	dana_gabuzda@dfci.harvard.edu	Wurcel, Alysse/AAZ-6132-2020; Wurcel, Alysse/AAC-5372-2019; Wolinsky, Steven/B-2893-2012	Wurcel, Alysse/0000-0002-8255-8387; Mefford, Megan/0000-0003-4441-7134; Ancuta, Petronela/0000-0003-1922-5640; Wolinsky, Steven/0000-0002-9625-6697; Kim, Eunyoung/0000-0002-7436-7396	NIH [DA016549, MH083588]; Fonds de la Recherche en Sante Quebec (FRSQ); French National Institute of Health and Medical Research (INSERM); Harvard Center for AIDS Research; DFCI/Harvard Center for Cancer Research; NNTC [MH 59745, NS38841, MH59656, NS54591, MH59724];  [NS060611]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083588, R24MH059745, R24MH059724, R24MH059656, U01MH083545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS038841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016549, R21DA026322] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche en Sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); French National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Harvard Center for AIDS Research; DFCI/Harvard Center for Cancer Research; NNTC; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH DA016549 and MH083588. P.A. was supported in part by Fonds de la Recherche en Sante Quebec (FRSQ) and the French National Institute of Health and Medical Research (INSERM). M.M. was supported in part by NS060611. Core facilities were supported by the Harvard Center for AIDS Research and DFCI/Harvard Center for Cancer Research grants. NNTC sites were supported by MH 59745, NS38841, MH59656, NS54591, and MH59724.	Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Almodovar S, 2007, VIROLOGY, V369, P35, DOI 10.1016/j.virol.2007.07.010; Amirayan-Chevillard N, 2000, CLIN EXP IMMUNOL, V120, P107, DOI 10.1046/j.1365-2249.2000.01201.x; Ancuta P, 2006, VIROLOGY, V344, P267, DOI 10.1016/j.virol.2005.10.027; Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Ancuta P, 2006, J IMMUNOL, V176, P5760, DOI 10.4049/jimmunol.176.10.5760; Ancuta P, 2006, J LEUKOCYTE BIOL, V80, P1156, DOI 10.1189/jlb.0206125; Asakura E, 1997, IMMUNOPHARMACOLOGY, V37, P7, DOI 10.1016/S0162-3109(96)00165-8; Bouwman FH, 1998, NEUROLOGY, V50, P1814, DOI 10.1212/WNL.50.6.1814; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Caradonna L, 2002, CURR PHARM DESIGN, V8, P995, DOI 10.2174/1381612024606983; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Chapoval AI, 1998, J LEUKOCYTE BIOL, V63, P245, DOI 10.1002/jlb.63.2.245; Cherner M, 2007, J NEUROVIROL, V13, P23, DOI 10.1080/13550280601089175; COHEN IR, 1966, SCIENCE, V152, P1257, DOI 10.1126/science.152.3726.1257; CROWE S, 2003, J LEUKOCYTE BIOL, V21, P21; Davidson DJ, 2006, J IMMUNOL, V177, P8202, DOI 10.4049/jimmunol.177.11.8202; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Friedman H, 2003, CLIN MICROBIOL REV, V16, P209, DOI 10.1128/CMR.16.2.209-219.2003; Gartner S, 2002, J NEUROVIROL, V8, P69, DOI 10.1080/13550280290049525; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Hutchinson SJ, 1997, QJM-MON J ASSOC PHYS, V90, P685, DOI 10.1093/qjmed/90.11.685; Jirillo E, 2002, J ENDOTOXIN RES, V8, P319, DOI 10.1179/096805102125000641; Kapadia F, 2005, CLIN INFECT DIS, V41, P1027, DOI 10.1086/433175; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kusdra L, 2002, AIDS, V16, P31, DOI 10.1097/00002030-200201040-00005; Letendre S, 2007, J INFECT DIS, V196, P361, DOI 10.1086/519285; Lien E, 1998, BLOOD, V92, P2084, DOI 10.1182/blood.V92.6.2084.418k26_2084_2092; Lucas GM, 2006, AM J EPIDEMIOL, V163, P412, DOI 10.1093/aje/kwj059; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Morgello S, 2005, SEMIN LIVER DIS, V25, P118, DOI 10.1055/s-2005-864787; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Parsons TD, 2006, AIDS, V20, P1591, DOI 10.1097/01.aids.0000238404.16121.47; Peng XH, 2001, J IMMUNOL, V167, P3677, DOI 10.4049/jimmunol.167.7.3677; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; Rankine EL, 2006, EUR J NEUROSCI, V24, P77, DOI 10.1111/j.1460-9568.2006.04891.x; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Ryan LA, 2001, J INFECT DIS, V184, P699, DOI 10.1086/323036; SHEN YN, 1994, CLIN DIAGN LAB IMMUN, V1, P531, DOI 10.1128/CDLI.1.5.531-537.1994; Shiramizu B, 2005, AIDS, V19, P45, DOI 10.1097/00002030-200501030-00005; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Tozzi V, 2005, J NEUROVIROL, V11, P265, DOI 10.1080/13550280590952790; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004; van Marle G, 2002, AIDS, V16, P1905, DOI 10.1097/00002030-200209270-00007; Williams K, 2005, J CLIN INVEST, V115, P2534, DOI 10.1172/JCI22953; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Xaio HP, 2001, BRAIN RES, V896, P36, DOI 10.1016/S0006-8993(00)03247-9; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002; ZieglerHeitbrock HWL, 1996, IMMUNOL TODAY, V17, P424, DOI 10.1016/0167-5699(96)10029-3	64	362	373	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2516	10.1371/journal.pone.0002516	http://dx.doi.org/10.1371/journal.pone.0002516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575590	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288000033
J	McDermott, SR; Kliman, RM				McDermott, Shannon R.; Kliman, Richard M.			Estimation of Isolation Times of the Island Species in the Drosophila simulans Complex from Multilocus DNA Sequence Data	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; NATURAL-SELECTION; DIVERGENCE; GENE; POLYMORPHISM; POPULATION; STERILITY; LINKAGE; RECOMBINATION; CHROMOSOME	Background: The Drosophila simulans species complex continues to serve as an important model system for the study of new species formation. The complex is comprised of the cosmopolitan species, D. simulans, and two island endemics, D. mauritiana and D. sechellia. A substantial amount of effort has gone into reconstructing the natural history of the complex, in part to infer the context in which functional divergence among the species has arisen. In this regard, a key parameter to be estimated is the initial isolation time (t) of each island species. Loci in regions of low recombination have lower divergence within the complex than do other loci, yet divergence from D. melanogaster is similar for both classes. This might reflect gene flow of the low-recombination loci subsequent to initial isolation, but it might also reflect differential effects of changing population size on the two recombination classes of loci when the low-recombination loci are subject to genetic hitchhiking or pseudohitchhiking Methodology/Principal Findings: New DNA sequence variation data for 17 loci corroborate the prior observation from 13 loci that DNA sequence divergence is reduced in genes of low recombination. Two models are presented to estimate t and other relevant parameters (substitution rate correction factors in lineages leading to the island species and, in the case of the 4-parameter model, the ratio of ancestral to extant effective population size) from the multilocus DNA sequence data. Conclusions/Significance: In general, it appears that both island species were isolated at about the same time, here estimated at -250,000 years ago. It also appears that the difference in divergence patterns of genes in regions of low and higher recombination can be reconciled by allowing a modestly larger effective population size for the ancestral population than for extant D. simulans.	[McDermott, Shannon R.; Kliman, Richard M.] Cedar Crest Muhlenberg Coll, Dept Biol Sci, Allentown, PA USA		McDermott, SR (corresponding author), Cedar Crest Muhlenberg Coll, Dept Biol Sci, Allentown, PA USA.	rmkliman@cedarcrest.edu			NIH [R15HG002456]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R15HG002456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The work was supported by NIH grant R15HG002456 to RMK. The sponsors were not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Barbash DA, 2007, GENETICS, V176, P543, DOI 10.1534/genetics.107.072827; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; BIRKY CW, 1988, P NATL ACAD SCI USA, V85, P6414, DOI 10.1073/pnas.85.17.6414; Caccone A, 1996, MOL BIOL EVOL, V13, P1224, DOI 10.1093/oxfordjournals.molbev.a025688; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Comeron JM, 2008, HEREDITY, V100, P19, DOI 10.1038/sj.hdy.6801059; COYNE JA, 1994, J HERED, V85, P224, DOI 10.1093/oxfordjournals.jhered.a111440; Gillespie JH, 2000, GENETICS, V155, P909; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; Hey J, 2002, GENETICS, V160, P595; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Kliman RM, 2000, GENETICS, V156, P1913; LLOPART A, 2008, J MOL EVOL; Macpherson JM, 2007, GENETICS, V177, P2083, DOI 10.1534/genetics.107.080226; Masly JP, 2007, PLOS BIOL, V5, P1890, DOI 10.1371/journal.pbio.0050243; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Noor MAF, 2003, GENETICA, V118, P51, DOI 10.1023/A:1022983023900; Ometto L, 2006, BIOL LETT-UK, V2, P604, DOI 10.1098/rsbl.2006.0521; PALOPOLI MF, 1994, GENETICS, V138, P329; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Tao Y, 2003, EVOLUTION, V57, P2580; Throckmorton L.H., 1975, P421; Ting CT, 2000, P NATL ACAD SCI USA, V97, P5313, DOI 10.1073/pnas.090541597; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; True JR, 1996, GENETICS, V142, P819; Wall JD, 2002, GENETICS, V162, P203; Wang RL, 1997, GENETICS, V147, P1091; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9	32	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2442	10.1371/journal.pone.0002442	http://dx.doi.org/10.1371/journal.pone.0002442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560591	Green Published, gold, Green Submitted			2022-12-25	WOS:000263280700027
J	Penkov, D; Palazzolo, M; Mondino, A; Blasi, F				Penkov, Dmitry; Palazzolo, Martina; Mondino, Anna; Blasi, Francesco			Cytosolic Sequestration of Prep1 Influences Early Stages of T Cell Development	PLOS ONE			English	Article								Objective: Prep1 and Pbx2 are the main homeodomain DNA-binding proteins of the TALE (three amino acid loop extension) family expressed in the thymus. We previously reported reduced Pbx2 expression and defective thymocyte maturation in Prep1 hypomorphic mice. To further investigate the role of this homeodomain DNA-binding protein in T cell development, we generated transgenic mice expressing the N-terminal fragment of Pbx1 (Pbx1NT) under the control of the Lck proximal promoter. Principal Findings: Pbx1NT causes Prep1 cytosolic sequestration, abolishes Prep1-dependent DNA-binding activity and results in reduced Pbx2 expression in developing thymocytes. Transgenic thymi reveal increased numbers of CD4(-) CD8(-) CD44(-) (DN3 and DN4) thymocytes, due to a higher frequency of DN2 and DN4 Pbx1NT thymocytes in the S phase. Transgenic thymocytes however do not accumulate at later stages, as revealed by a normal representation of CD4/CD8 double positive and single positive thymocytes, due to a higher rate of apoptotic cell death of DN4 Pbx1NT thymocytes. Conclusion: The results obtained by genetic (Prep1 hypomorphic) and functional (Pbx1NT transgenic) inactivation of Prep1 support nonredundant roles for this homeodomain protein during different stages of T cell development.	[Penkov, Dmitry; Palazzolo, Martina; Blasi, Francesco] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Mol Genet Unit, Milan, Italy; [Mondino, Anna] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Lymphocyte Activat Unit, Milan, Italy; [Blasi, Francesco] Inst Mol Oncol, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IFOM - FIRC Institute of Molecular Oncology	Penkov, D (corresponding author), Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Mol Genet Unit, Milan, Italy.	mondino.anna@hsr.it; blasi.francesco@hsr.it	Mondino, Anna/K-9434-2016	Mondino, Anna/0000-0003-0833-6927; Blasi, Francesco/0000-0001-9406-1784	Telethon Italia Onlus; AIRC (Italian Association for Cancer Research); FEBS [fellowship]	Telethon Italia Onlus(Fondazione Telethon); AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); FEBS	This work was supported by Telethon Italia Onlus and AIRC (Italian Association for Cancer Research). D. Penkov received a fellowship from FEBS.	Aifantis I, 2006, IMMUNOL REV, V209, P159, DOI 10.1111/j.0105-2896.2006.00343.x; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Berthelsen J, 1996, J BIOL CHEM, V271, P3822; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; Di Rosa P, 2007, DEV BIOL, V311, P324, DOI 10.1016/j.ydbio.2007.08.031; DYER RB, 1995, BIOTECHNIQUES, V19, P192; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Longobardi E, 2003, J BIOL CHEM, V278, P39235, DOI 10.1074/jbc.M304704200; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; Penkov D, 2005, MOL CELL BIOL, V25, P10768, DOI 10.1128/MCB.25.24.10768-10781.2005; Shimizu C, 2001, INT IMMUNOL, V13, P105, DOI 10.1093/intimm/13.1.105	13	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2424	10.1371/journal.pone.0002424	http://dx.doi.org/10.1371/journal.pone.0002424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560600	Green Submitted, gold, Green Published			2022-12-25	WOS:000263280700010
J	Llop-Guevara, A; Colangelo, M; Chu, DK; Moore, CL; Stieber, NA; Walker, TD; Goncharova, S; Coyle, AJ; Lundblad, LKA; O'Byrne, PM; Lovric, M; Jordana, M				Llop-Guevara, Alba; Colangelo, Marc; Chu, Derek K.; Moore, Cheryl Lynn; Stieber, Nicole A.; Walker, Tina D.; Goncharova, Susanna; Coyle, Anthony J.; Lundblad, Lennart K. A.; O'Byrne, Paul M.; Lovric, Miroslav; Jordana, Manel			In Vivo-to-In Silico Iterations to Investigate Aeroallergen-Host Interactions	PLOS ONE			English	Article								Background: Allergic asthma is a complex process arising out of the interaction between the immune system and aeroallergens. Yet, the relationship between aeroallergen exposure, allergic sensitization and disease remains unclear. This knowledge is essential to gain further insight into the origin and evolution of allergic diseases. The objective of this research is to develop a computational view of the interaction between aeroallergens and the host by investigating the impact of dose and length of aeroallergen exposure on allergic sensitization and allergic disease outcomes, mainly airway inflammation and to a lesser extent lung dysfunction and airway remodeling. Methods and Principal Findings: BALB/C mice were exposed intranasally to a range of concentrations of the most pervasive aeroallergen worldwide, house dust mite (HDM), for up to a quarter of their lifespan (20 weeks). Actual biological data delineating the kinetics, nature and extent of responses for local (airway inflammation) and systemic (HDM-specific immunoglobulins) events were obtained. Mathematical equations for each outcome were developed, evaluated, refined through several iterations involving in vivo experimentation, and validated. The models accurately predicted the original biological data and simulated an extensive array of previously unknown responses, eliciting two- and three-dimensional models. Our data demonstrate the non-linearity of the relationship between aeroallergen exposure and either allergic sensitization or airway inflammation, identify thresholds, behaviours and maximal responsiveness for each outcome, and examine inter-variable relationships. Conclusions: This research provides a novel way to visualize allergic responses in vivo and establishes a basic experimental platform upon which additional variables and perturbations can be incorporated into the system.	[Llop-Guevara, Alba; Colangelo, Marc; Chu, Derek K.; Moore, Cheryl Lynn; Stieber, Nicole A.; Walker, Tina D.; Goncharova, Susanna; Coyle, Anthony J.; Jordana, Manel] McMaster Univ, Ctr Gene Therapeut, Div Resp Dis & Allergy, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Coyle, Anthony J.] MedImmune Inc, Dept Inflammat & Autoimmun, Gaithersburg, MD USA; [O'Byrne, Paul M.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Lovric, Miroslav] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada; [Lundblad, Lennart K. A.] Univ Vermont, Vermont Lung Ctr, Burlington, VT USA	McMaster University; AstraZeneca; Medimmune; McMaster University; McMaster University; University of Vermont	Llop-Guevara, A (corresponding author), McMaster Univ, Ctr Gene Therapeut, Div Resp Dis & Allergy, Dept Pathol & Mol Med, Hamilton, ON, Canada.	jordanam@mcmaster.ca	T, E/HII-8943-2022	Llop-Guevara, Alba/0000-0002-7913-9472; O'Byrne, Paul/0000-0003-0979-281X; Lundblad, Lennart/0000-0002-1749-8242; Chu, Derek/0000-0001-8269-4496	Canadian Institutes for Health Research (CIHR); MedImmune Inc; LaCaixa-ICCS (Spain) [scholarship]; Ontario Graduate Scholarship; Senior Canada Research Chair	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); MedImmune Inc(AstraZenecaMedimmune); LaCaixa-ICCS (Spain); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Senior Canada Research Chair	This research was supported by the Canadian Institutes for Health Research (CIHR) and MedImmune Inc. AL-G holds a LaCaixa-ICCS scholarship (Spain) and MC is supported by an Ontario Graduate Scholarship. MJ is a Senior Canada Research Chair.	An G, 2001, SHOCK, V16, P266, DOI 10.1097/00024382-200116040-00006; Anderson Andrew E., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P171, DOI 10.1080/10255840601160484; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Cates Elizabeth C., 2007, V14, P42, DOI 10.1159/000107054; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Cohen IR, 2007, IMMUNOL REV, V216, P232; Custis NJ, 2003, CLIN EXP ALLERGY, V33, P986, DOI 10.1046/j.1365-2222.2003.01706.x; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Deisboeck TS, 2005, MED HYPOTHESES, V65, P785, DOI 10.1016/j.mehy.2005.04.014; FATTOUH R, 2008, AM J RESP CRIT CARE; Greenspan NS, 2007, NAT IMMUNOL, V8, P5, DOI 10.1038/ni0107-5; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Holt PG, 2005, NAT IMMUNOL, V6, P957, DOI 10.1038/ni1005-957; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kirkland MA, 2004, EXP HEMATOL, V32, P511, DOI 10.1016/j.exphem.2004.02.013; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Leigh R, 2002, AM J RESP CELL MOL, V27, P526, DOI 10.1165/rcmb.2002-0048OC; Lundblad LKA, 2007, AM J RESP CRIT CARE, V175, P768, DOI 10.1164/rccm.200610-1410OC; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Oberkampf W.L., 2002, VERIFICATION VALIDAT; Oberkampf WL, 2006, J COMPUT PHYS, V217, P5, DOI 10.1016/j.jcp.2006.03.037; Ohkawara Y, 1997, AM J RESP CELL MOL, V16, P510, DOI 10.1165/ajrcmb.16.5.9160833; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; PLEIS JR, 2006, VITAL HLTH STAT, V10, P1; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; Sakaguchi M, 1996, J ALLERGY CLIN IMMUN, V97, P1040, DOI 10.1016/S0091-6749(96)70255-5; SCHUESSLER TF, 1995, IEEE T BIO-MED ENG, V42, P860, DOI 10.1109/10.412653; Sporik R, 1999, THORAX, V54, P675, DOI 10.1136/thx.54.8.675; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Sporik R, 2001, THORAX, V56, P58; Stampfli MR, 1998, J CLIN INVEST, V102, P1704, DOI 10.1172/JCI4160; Tovey ER, 2003, ALLERGY, V58, P790, DOI 10.1034/j.1398-9995.2003.00228.x; Vodovotz Y, 2006, SHOCK, V26, P235, DOI 10.1097/01.shk.0000225413.13866.fo; Vodovotz Yoram, 2004, Curr Opin Crit Care, V10, P383, DOI 10.1097/01.ccx.0000139360.30327.69; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7	37	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2426	10.1371/journal.pone.0002426	http://dx.doi.org/10.1371/journal.pone.0002426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545674	Green Published, gold, Green Submitted			2022-12-25	WOS:000263248800057
J	Amir-Moazami, O; Alexia, C; Charles, N; Launay, P; Monteiro, RC; Benhamou, M				Amir-Moazami, Omid; Alexia, Catherine; Charles, Nicolas; Launay, Pierre; Monteiro, Renato C.; Benhamou, Marc			Phospholipid scramblase 1 modulates a selected set of IgE receptor-mediated mast cell responses through LAT-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; MEMBRANE PHOSPHOLIPID SCRAMBLASE-1; BASOPHILIC LEUKEMIA-CELLS; HIGH-AFFINITY RECEPTOR; GROWTH-FACTOR RECEPTOR; PLASMA-MEMBRANE; BETA-HEXOSAMINIDASE; NEGATIVE REGULATION; CYTOKINE PRODUCTION; FYN KINASE	Engagement of the IgE receptor (Fc epsilon RI) on mast cells leads to the release of preformed and newly formed mediators as well as of cytokines. The signaling pathways responsible for these responses involve tyrosine phosphorylation of multiple proteins. We previously reported the phosphorylation on tyrosine of phospholipid scramblase 1 (PLSCR1) after Fc epsilon RI aggregation. Here, PLSCR1 expression was knocked down in the RBL-2H3 mast cell line using short hairpin RNA. Knocking down PLSCR1 expression resulted in significantly impaired degranulation responses after Fc epsilon RI aggregation and release of vascular endothelial growth factor, whereas release of MCP-1 was minimally affected. The release of neither leukotriene C4 nor prostaglandin D2 was altered by knocking down of PLSCR1. Analysis of Fc epsilon RI-dependent signaling pathways revealed that whereas tyrosine phosphorylation of ERK and Akt was unaffected, tyrosine phosphorylation of LAT was significantly reduced in PLSCR1 knocked down cells. Tyrosine phosphorylation of phospholipase C gamma 1 and consequently the mobilization of calcium were also significantly reduced in these cells. In nonactivated mast cells, PLSCR1 was found in part in lipid rafts where it was further recruited after cell activation and was constitutively associated with Lyn and Syk but not with LAT or Fyn. Altogether, these data identify PLSCR1 as a novel amplifier of Fc epsilon RI signaling that acts selectively on the Lyn-initiated LAT/phospholipase C gamma 1/calcium axis, resulting in potentiation of a selected set of mast cell responses.	[Amir-Moazami, Omid; Alexia, Catherine; Charles, Nicolas; Launay, Pierre; Monteiro, Renato C.; Benhamou, Marc] Univ Paris 07, INSERM, Fac Med Xavier Bichat, U699, F-75018 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Benhamou, M (corresponding author), Univ Paris 07, INSERM, Fac Med Xavier Bichat, U699, 16 Rue Henri Huchard, F-75018 Paris, France.	Marc.Benhamou@inserm.fr	CHARLES, Nicolas/S-2214-2019; Monteiro, Renato C/U-8633-2017; CHARLES, Nicolas/P-5430-2014; Launay, Pierre/AAH-7076-2019	CHARLES, Nicolas/0000-0002-5416-5834; Monteiro, Renato C/0000-0001-5202-5646; CHARLES, Nicolas/0000-0002-5416-5834; Benhamou, Marc/0000-0001-7763-3795	Association pour l'Utilisation du Rein Artificie; Fondation de France [2002004544]; Ministere de l' Enseignement Superieur et de la Recherche	Association pour l'Utilisation du Rein Artificie; Fondation de France(Fondation de France); Ministere de l' Enseignement Superieur et de la Recherche	This work was supported in part by Association pour l'Utilisation du Rein Artificiel and by Grant 2002004544 (to M. B.) from the Fondation de France. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked" advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a Ministere de l' Enseignement Superieur et de la Recherche grant.	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Ben-Efraim I, 2004, BIOCHEMISTRY-US, V43, P3518, DOI 10.1021/bi0356911; BENHAMOU M, 1992, J BIOL CHEM, V267, P7310; BENHAMOU M, 1990, P NATL ACAD SCI USA, V87, P5327, DOI 10.1073/pnas.87.14.5327; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; BENHAMOU M, 1986, J IMMUNOL, V136, P1385; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Charles N, 2004, J BIOL CHEM, V279, P12312, DOI 10.1074/jbc.M309456200; Choi OH, 1996, NATURE, V380, P634; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; EISEMAN E, 1992, NATURE, V355, P78; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hernandez-Hansen V, 2005, J IMMUNOL, V175, P7880, DOI 10.4049/jimmunol.175.12.7880; HIRASAWA N, 1995, J IMMUNOL, V154, P5391; Holowka D, 2005, BBA-MOL CELL RES, V1746, P252, DOI 10.1016/j.bbamcr.2005.06.007; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Kantari C, 2007, BLOOD, V110, P4086, DOI 10.1182/blood-2007-03-080457; Kato N, 2002, BIOCHEMISTRY-US, V41, P8068, DOI 10.1021/bi016022v; Kraft S, 2004, INT ARCH ALLERGY IMM, V135, P62, DOI 10.1159/000080231; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Launay P, 1998, J LEUKOCYTE BIOL, V63, P636, DOI 10.1002/jlb.63.5.636; Leung WH, 2007, J IMMUNOL, V179, P95, DOI 10.4049/jimmunol.179.1.95; Malaviya R, 2001, IMMUNOL REV, V179, P16, DOI 10.1034/j.1600-065X.2001.790102.x; Malbec O, 2004, J IMMUNOL, V173, P5086, DOI 10.4049/jimmunol.173.8.5086; Martin S, 2000, INT ARCH ALLERGY IMM, V123, P249, DOI 10.1159/000024451; METZGER H, 1991, CLIN EXP ALLERGY, V21, P269, DOI 10.1111/j.1365-2222.1991.tb01658.x; MINOGUCHI K, 1994, J BIOL CHEM, V269, P16902; Nanjundan M, 2003, J BIOL CHEM, V278, P37413, DOI 10.1074/jbc.M306182200; Olivera A, 2006, J BIOL CHEM, V281, P2515, DOI 10.1074/jbc.M508931200; Olivera A, 2007, IMMUNITY, V26, P287, DOI 10.1016/j.immuni.2007.02.008; PAOLINI R, 1991, NATURE, V353, P855, DOI 10.1038/353855a0; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Pastorelli C, 2001, J BIOL CHEM, V276, P20407, DOI 10.1074/jbc.M100790200; Pennock JL, 2006, CHEM IMMUNOL ALLERGY, V90, P128, DOI 10.1159/000088885; Pombo I, 2003, FEBS LETT, V550, P144, DOI 10.1016/S0014-5793(03)00864-0; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; Rivera J, 2001, INT ARCH ALLERGY IMM, V124, P137, DOI 10.1159/000053692; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Saitoh S, 2003, J EXP MED, V198, P831, DOI 10.1084/jem.20030574; Smrz D, 2008, J BIOL CHEM, V283, P10904, DOI 10.1074/jbc.M710386200; STEINHOFF MM, 1980, BIOCHIM BIOPHYS ACTA, V618, P28, DOI 10.1016/0005-2760(80)90050-8; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; TOLONE G, 1978, BRIT J EXP PATHOL, V59, P105; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Wen RR, 2002, J IMMUNOL, V169, P6743, DOI 10.4049/jimmunol.169.12.6743; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Wiedmer T, 2004, P NATL ACAD SCI USA, V101, P13296, DOI 10.1073/pnas.0405354101; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P11251, DOI 10.1073/pnas.91.23.11251; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223	58	27	28	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25514	25523		10.1074/jbc.M705320200	http://dx.doi.org/10.1074/jbc.M705320200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18579528	hybrid			2022-12-25	WOS:000259012700047
J	Jung, YY; Kim, HJ; Min, SH; Rhee, SG; Jeong, WJ				Jung, Yuyeon; Kim, Hojin; Min, Sun Hee; Rhee, Sue Goo; Jeong, Woojin			Dynein light chain LC8 negatively regulates NF-kappa B through the redox-dependent interaction with I kappa B alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NADPH OXIDASE; TYROSINE PHOSPHORYLATION; TRANSCRIPTION FACTOR; CYTOPLASMIC DYNEIN; INDUCED ACTIVATION; TNF-ALPHA; PROTEIN; INHIBITOR; INDUCTION	Redox regulation of nuclear factor kappa B (NF-kappa B) has been described, but the molecular mechanism underlying such regulation has remained unclear. We recently showed that a novel disulfide reductase, TRP14, inhibits tumor necrosis factor alpha (TNF alpha)-induced NF-kappa B activation, and we identified the dynein light chain LC8, which interacts with the NF-kappa B inhibitor I kappa B alpha, as a potential substrate of TRP14. We now show the molecular mechanism by which NF-kappa B activation is redox-dependently regulated through LC8. LC8 inhibited TNF alpha-induced NF-kappa B activation in HeLa cells by interacting with I kappa B alpha and thereby preventing its phosphorylation by I kappa B kinase (IKK), without affecting the activity of IKK itself. TNF alpha induced the production of reactive oxygen species, which oxidized LC8 to a homodimer linked by the reversible formation of a disulfide bond between the Cys(2) residues of each subunit and thereby resulted in its dissociation from I kappa B alpha. Butylated hydroxyanisol, an antioxidant, and diphenyleneiodonium, an inhibitor of NADPH oxidase, attenuated the phosphorylation and degradation of I kappa B alpha by TNF alpha stimulation. In addition LC8 inhibited NF-kappa B activation by other stimuli including interleukin-1 beta and lipopolysaccharide, both of which generated reactive oxygen species. Furthermore, TRP14 catalyzed reduction of oxidized LC8. Together, our results indicate that LC8 binds I kappa B alpha in a redox-dependent manner and thereby prevents its phosphorylation by IKK. TRP14 contributes to this inhibitory activity by maintaining LC8 in a reduced state.	[Rhee, Sue Goo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Life Sci, Seoul 120750, South Korea; Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University	Rhee, SG (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Life Sci, Sci Bldg C,Rm 102,11-1 Daehyun Dong, Seoul 120750, South Korea.	rheesg@ewha.ac.kr; jeongw@ewha.ac.kr			Korean government (the Ministry of Education and Human Resources Development) [KRF-2006-311C00414]; Ewha Womans University Research; Bio R D Program [M10642040002-07N4204-00210]; National Core Research Center Program [R15-2006-020]; Korea Science and Engineering Foundation; Brain Korea 21 Scholars Program; Ministry of Education, Science and Technology	Korean government (the Ministry of Education and Human Resources Development)(Korean Government); Ewha Womans University Research; Bio R D Program; National Core Research Center Program; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Brain Korea 21 Scholars Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Research Foundation Grant KRF-2006-311C00414 from the Korean government (the Ministry of Education and Human Resources Development), a Ewha Womans University Research Grant of 2005, Bio R & D Program Grant M10642040002-07N4204-00210 (to S.G.R.) and M10642040002-07N4204-00210 ( to W. J.), National Core Research Center Program Grant R15-2006-020 through the Korea Science and Engineering Foundation funded by the Ministry of Education, Science and Technology, and funds from the Brain Korea 21 Scholars Program (to Y. J. and S. H. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Brigelius-Flohe R, 2004, ARCH BIOCHEM BIOPHYS, V423, P66, DOI 10.1016/j.abb.2003.12.008; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; Dick T, 1996, MOL CELL BIOL, V16, P1966; Donze O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e46; Fan CG, 2003, J BIOL CHEM, V278, P2072, DOI 10.1074/jbc.M206718200; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fenwick C, 2000, SCIENCE, V287, P869, DOI 10.1126/science.287.5454.869; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; HAYASHI T, 1993, J BIOL CHEM, V268, P11380; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huxford T, 2006, METHOD ENZYMOL, V407, P527, DOI 10.1016/S0076-6879(05)07042-4; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Jeong W, 2004, J BIOL CHEM, V279, P3151, DOI 10.1074/jbc.M307959200; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; Kutuk O, 2003, TRENDS MOL MED, V9, P549, DOI 10.1016/j.molmed.2003.10.007; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Lu JQ, 2005, BIOCHEM BIOPH RES CO, V331, P153, DOI 10.1016/j.bbrc.2005.03.128; McIntyre KW, 2003, ARTHRITIS RHEUM-US, V48, P2652, DOI 10.1002/art.11131; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Phillis R, 1996, DEVELOPMENT, V122, P2955; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Tateishi Y, 2008, BIOCHEM BIOPH RES CO, V366, P301, DOI 10.1016/j.bbrc.2007.11.039; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; Wilson MJ, 2001, CELL MOTIL CYTOSKEL, V49, P229, DOI 10.1002/cm.1036; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999	56	74	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23863	23871		10.1074/jbc.M803072200	http://dx.doi.org/10.1074/jbc.M803072200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579519	Green Published, hybrid			2022-12-25	WOS:000258638900041
J	Keren, I; Klipcan, L; Bezawork-Geleta, A; Kolton, M; Shaya, F; Ostersetzer-Biran, O				Keren, Ido; Klipcan, Liron; Bezawork-Geleta, Ayenachew; Kolton, Max; Shaya, Felix; Ostersetzer-Biran, Oren			Characterization of the molecular basis of group II intron RNA recognition by CRS1-CRM domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; MULTIPLE SEQUENCE ALIGNMENT; SINGLE-STRANDED-DNA; PRE-MESSENGER-RNA; ESCHERICHIA-COLI; SPLICING FACTORS; KH DOMAINS; MAIZE CHLOROPLASTS; BINDING PROTEINS; CRM DOMAIN	CRM (chloroplast RNA splicing and ribosome maturation) is a recently recognized RNA-binding domain of ancient origin that has been retained in eukaryotic genomes only within the plant lineage. Whereas in bacteria CRM domains exist as single domain proteins involved in ribosome maturation, in plants they are found in a family of proteins that contain between one and four repeats. Several members of this family with multiple CRM domains have been shown to be required for the splicing of specific plastidic group II introns. Detailed biochemical analysis of one of these factors in maize, CRS1, demonstrated its high affinity and specific binding to the single group II intron whose splicing it facilitates, the plastid-encoded atpF intron RNA. Through its association with two intronic regions, CRS1 guides the folding of atpF intron RNA into its predicted "catalytically active" form. To understand how multiple CRM domains cooperate to achieve high affinity sequence-specific binding to RNA, we analyzed the RNA binding affinity and specificity associated with each individual CRM domain in CRS1; whereas CRM3 bound tightly to the RNA, CRM1 associated specifically with a unique region found within atpF intron domain I. CRM2, which demonstrated only low binding affinity, also seems to form specific interactions with regions localized to domains I, III, and IV. We further show that CRM domains share structural similarities and RNA binding characteristics with the well known RNA recognition motif domain.	[Keren, Ido; Klipcan, Liron; Bezawork-Geleta, Ayenachew; Kolton, Max; Shaya, Felix; Ostersetzer-Biran, Oren] Agr Res Org, Inst Plant Sci, IL-50250 Bet Dagan, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Ostersetzer-Biran, O (corresponding author), Agr Res Org, Inst Plant Sci, POB 6, IL-50250 Bet Dagan, Israel.	biranos@volcani.agri.gov.il	/AAM-4620-2021; Kolton, Max/J-1753-2019; Bezawork-Geleta, A/J-9567-2012; keren, ido/I-7727-2019	Kolton, Max/0000-0002-8166-3572; keren, ido/0000-0002-1872-8337; Bezawork-Geleta, Ayenachew/0000-0001-5404-5093; Bezawork-Geleta, Ayenachew/0000-0003-2739-8023				Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Aravind L, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r64; Asakura Y, 2007, PLANT CELL, V19, P3864, DOI 10.1105/tpc.107.055160; Asakura Y, 2006, PLANT PHYSIOL, V142, P1656, DOI 10.1104/pp.106.088096; Barkan A., 2004, MOL BIOL BIOTECHNOLO, P281, DOI DOI 10.1007/978-1-4020-3166-3_; Barkan A, 2007, RNA, V13, P55, DOI 10.1261/rna.139607; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Braddock DT, 2002, EMBO J, V21, P3476, DOI 10.1093/emboj/cdf352; Brykailo MA, 2007, NUCLEIC ACIDS RES, V35, P1108, DOI 10.1093/nar/gkl1160; Deprez C, 2005, J MOL BIOL, V346, P1047, DOI 10.1016/j.jmb.2004.12.028; Efimov AV, 1997, PROTEINS, V28, P241, DOI 10.1002/(SICI)1097-0134(199706)28:2<241::AID-PROT12>3.0.CO;2-I; ElAntak L, 2007, J BIOL CHEM, V282, P8165, DOI 10.1074/jbc.M610860200; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Huang YPJ, 2003, J MOL BIOL, V327, P521, DOI 10.1016/S0022-2836(03)00061-5; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jenkins BD, 1997, PLANT CELL, V9, P283, DOI 10.1105/tpc.9.3.283; Jenkins BD, 2001, EMBO J, V20, P872, DOI 10.1093/emboj/20.4.872; Jiang M, 2007, J BACTERIOL, V189, P3434, DOI 10.1128/JB.00090-07; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lau CK, 2003, CURR BIOL, V13, P933, DOI 10.1016/S0960-9822(03)00328-2; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Liu DJ, 2004, J BIOMOL NMR, V29, P391, DOI 10.1023/B:JNMR.0000032524.62229.93; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ostersetzer O, 2005, PLANT CELL, V17, P241, DOI 10.1105/tpc.104.027516; Ostheimer GJ, 2003, EMBO J, V22, P3919, DOI 10.1093/emboj/cdg372; Ostheimer GJ, 2002, STRUCTURE, V10, P1593, DOI 10.1016/S0969-2126(02)00886-9; Peled-Zehavi H, 2001, MOL CELL BIOL, V21, P5232, DOI 10.1128/MCB.21.15.5232-5241.2001; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; SHAMOO Y, 1995, NUCLEIC ACIDS RES, V23, P725, DOI 10.1093/nar/23.5.725; Terribilini M, 2006, RNA, V12, P1450, DOI 10.1261/rna.2197306; Till B, 2001, RNA, V7, P1227, DOI 10.1017/S1355838201010445; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Watkins KP, 2007, PLANT CELL, V19, P2606, DOI 10.1105/tpc.107.053736; Willis MA, 2002, PROTEINS, V49, P423, DOI 10.1002/prot.10225; Zhou Y, 2002, J MOL BIOL, V318, P1175, DOI 10.1016/S0022-2836(02)00238-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23333	23342		10.1074/jbc.M710488200	http://dx.doi.org/10.1074/jbc.M710488200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18559344	hybrid			2022-12-25	WOS:000258455400043
J	Dodeller, F; Gottar, M; Huesken, D; Iourgenko, V; Cenni, B				Dodeller, Francis; Gottar, Marie; Huesken, Dieter; Iourgenko, Vadim; Cenni, Bruno			The lysosomal transmembrane protein 9B regulates the activity of inflammatory signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TAK1; IKK; ACTIVATION; UBIQUITIN; TRANSDUCTION; ENDOSOMES; COMPLEXES; KINASE; TAB2	The intracellular signaling pathway by which tumor necrosis factor (TNF) induces its pleiotropic actions is well characterized and includes unique components as well as modules shared with other signaling pathways. In addition to the currently known key effectors, further molecules may however modulate the biological response to TNF. In our attempt to characterize novel regulators of the TNF signaling cascade, we have identified transmembrane protein 9B (TMEM9B, c11orf15) as an important component of TNF signaling and a module shared with the interleukin 1 beta (IL-1 beta) and Toll-like receptor (TLR) pathways. TMEM9B is a glycosylated protein localized in membranes of the lysosome and partially in early endosomes. The expression of TMEM9B is required for the production of proinflammatory cytokines induced by TNF, IL-1 beta, and TLR ligands but not for apoptotic cell death triggered by TNF or Fas ligand. TMEM9B is essential in TNF activation of both the NF-kappa B and MAPK pathways. It acts downstream of RIP1 and upstream of the MAPK and I kappa B kinases at the level of the TAK1 complex. These findings indicate that TMEM9B is a key component of inflammatory signaling pathways and suggest that endosomal or lysosomal compartments regulate these pathways.	[Dodeller, Francis; Gottar, Marie; Huesken, Dieter; Iourgenko, Vadim; Cenni, Bruno] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland	Novartis	Cenni, B (corresponding author), Novartis Pharma AG, CH-4002 Basel, Switzerland.	bruno.cenni@novartis.com		Cenni, Bruno/0000-0002-8603-2032				Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Guijarro MV, 2007, J CELL BIOCHEM, V101, P112, DOI 10.1002/jcb.21163; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kveine M, 2002, BIOCHEM BIOPH RES CO, V297, P912, DOI 10.1016/S0006-291X(02)02228-3; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Palanki MSS, 2002, CURR MED CHEM, V9, P219, DOI 10.2174/0929867023371265; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504	23	36	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21487	21494		10.1074/jbc.M801908200	http://dx.doi.org/10.1074/jbc.M801908200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18541524	hybrid			2022-12-25	WOS:000257898800021
J	Gibbs, AJ; Ohshima, K; Phillips, MJ; Gibbs, MJ				Gibbs, Adrian J.; Ohshima, Kazusato; Phillips, Matthew J.; Gibbs, Mark J.			The Prehistory of Potyviruses: Their Initial Radiation Was during the Dawn of Agriculture	PLOS ONE			English	Article							MOLECULAR EVOLUTION; CLIMATE-CHANGE; DNA-SEQUENCES; VIRUS; COEVOLUTION; RATES; DIVERSITY; SPREAD; PLANTS; GENE	Background: Potyviruses are found world wide, are spread by probing aphids and cause considerable crop damage. Potyvirus is one of the two largest plant virus genera and contains about 15% of all named plant virus species. When and why did the potyviruses become so numerous? Here we answer the first question and discuss the other. Methods and Findings: We have inferred the phylogenies of the partial coat protein gene sequences of about 50 potyviruses, and studied in detail the phylogenies of some using various methods and evolutionary models. Their phylogenies have been calibrated using historical isolation and outbreak events: the plum pox virus epidemic which swept through Europe in the 20th century, incursions of potyviruses into Australia after agriculture was established by European colonists, the likely transport of cowpea aphid-borne mosaic virus in cowpea seed from Africa to the Americas with the 16th century slave trade and the similar transport of papaya ringspot virus from India to the Americas. Conclusions/Significance: Our studies indicate that the partial coat protein genes of potyviruses have an evolutionary rate of about 1.15x10(-4) nucleotide substitutions/site/year, and the initial radiation of the potyviruses occurred only about 6,600 years ago, and hence coincided with the dawn of agriculture. We discuss the ways in which agriculture may have triggered the prehistoric emergence of potyviruses and fostered their speciation.	[Ohshima, Kazusato] Saga Univ, Fac Agr, Lab Plant Virol, Saga, Japan; [Phillips, Matthew J.] Australian Natl Univ, Fac Sci, Sch Bot & Zool, Canberra, ACT, Australia	Saga University; Australian National University		adrian_j_gibbs@hotmail.com	Phillips, Matthew J/J-1365-2012	Phillips, Matthew J/0000-0003-1532-449X				Adams MJ, 2005, ARCH VIROL, V150, P459, DOI 10.1007/s00705-004-0440-6; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; [Anonymous], 1994, POTYVIRIDAE; [Anonymous], 1962, CONSPECTUS APHIDS VE; Bateson MF, 2002, J GEN VIROL, V83, P2575, DOI 10.1099/0022-1317-83-10-2575; BATESON MF, 1994, J GEN VIROL, V75, P3547, DOI 10.1099/0022-1317-75-12-3547; Bawden FC, 1955, ANN APPL BIOL, V42, P140, DOI 10.1111/j.1744-7348.1955.tb02419.x; Bellwood Peter S, 2005, 1 FARMERS ORIGINS AG; Blackman RL, 2000, APHIDS WORLDS CROPS, V2nd, DOI 10.1016/0261-2194(96)89825-5; Bradley R. S., 1999, PALEOCLIMATOLOGY REC; BRAND RJ, 1993, ARCH VIROL, V128, P29, DOI 10.1007/BF01309786; Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075; CHAN SY, 1992, J VIROL, V66, P2057, DOI 10.1128/JVI.66.4.2057-2066.1992; Coulibaly S, 2002, THEOR APPL GENET, V104, P358, DOI 10.1007/s001220100740; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; DIAMOND J, 1997, GUNS GERMS STEELS SH; DIAMOND JM, 2005, COLLAPSE SOC CHOOSE; Domingo E., 1999, ORIGIN EVOLUTION VIR, P263; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy S, 2008, J VIROL, V82, P957, DOI 10.1128/JVI.01929-07; Fara Patricia, 2003, SEX BOT EMPIRE STORY; FARGETTE D, 2008, J VIROL, V82, DOI DOI 10.1128/JVI.012506-012507; Fauquet CM, 2005, VIRUS TAXONOMY CLASS; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; French R.L., 2002, WHEAT STREAK MOSAIC; Gascoigne J., 1994, JOSEPH BANKS ENGLISH; GIBBS AJ, 2008, ARCH VIROLO IN PRESS; GIBBS AJ, 2008, ORIGIN EVOL IN PRESS; Gibbs MJ, 2007, ARCH VIROL, V152, P11, DOI 10.1007/s00705-006-0834-8; GUILDING L, 1825, ACCOUNT BOTANIC GARD; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAGGETT P, 1959, AM ANTIQUITY, V25, P267, DOI 10.2307/277449; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HENZELL T, 2007, AUSTR AGR ITS HIT CH; Hill John, 1768, HORTUS KEWENSIS SIST; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Katzourakis A, 2007, P NATL ACAD SCI USA, V104, P6261, DOI 10.1073/pnas.0700471104; Kenneth F, 2000, CAMBRIDGE WORLD HIST; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Levy L.E., 2000, PLUM POX POTYVIRUS D; Lovejoy Paul E., 2000, TRANSFORMATIONS SLAV; Lukashov VV, 2001, J VIROL, V75, P2729, DOI 10.1128/JVI.75.6.2729-2740.2001; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McKinney H.H., 1937, 442 USDA, P1; MERRILL ED, 1954, BOT COOKS VOYAGES; MILIUS S, 1999, SCI NEWS, V156, P325; Mill Arthur W, 1915, ANN MISSOURI BOT GAR, V2. 1, P185, DOI DOI 10.2307/2990033; Nascimento AVS, 2006, ARCH VIROL, V151, P1797, DOI 10.1007/s00705-006-0755-6; ONG CK, 1993, J VIROL, V67, P6424, DOI 10.1128/JVI.67.11.6424-6431.1993; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; *PALEOCLIM, 2015, PALEOCLIM DAT; Pappu HR, 1997, ARCH VIROL, V142, P1919, DOI 10.1007/s007050050211; Perez-Losada M, 2006, J VIROL, V80, P5663, DOI 10.1128/JVI.00056-06; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; PURCIFULL D, 1984, DESCRIPTIONS PLANT V, V292, P4; PURSEGLOVE JW, 1966, TROPICAL CROPS DICOT; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241; ROBAGLIA C, 1989, J GEN VIROL, V70, P935, DOI 10.1099/0022-1317-70-4-935; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tan ZY, 2005, J GEN VIROL, V86, P501, DOI 10.1099/vir.0.80540-0; Thomas H., 1997, SLAVE TRADE HIST ATL; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; Von Dohlen CD, 2000, BIOL J LINN SOC, V71, P689, DOI 10.1006/bijl.2000.0470; Wace N., 1985, PESTS PARASITES MIGR, P3; Wallis CM, 2007, J GEN VIROL, V88, P2839, DOI 10.1099/vir.0.82814-0; Ward C. W., 1995, MOL BASIS VIRUS EVOL, P477; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	76	125	130	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2523	10.1371/journal.pone.0002523	http://dx.doi.org/10.1371/journal.pone.0002523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575612	Green Published, gold			2022-12-25	WOS:000263288000039
J	Hwang, NS; Varghese, S; Elisseeff, J				Hwang, Nathaniel S.; Varghese, Shyni; Elisseeff, Jennifer			Derivation of Chondrogenically-Committed Cells from Human Embryonic Cells for Cartilage Tissue Regeneration	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-VITRO CHONDROGENESIS; MARROW STROMAL CELLS; ARTICULAR-CARTILAGE; GENE-EXPRESSION; DIFFERENTIATION; CHONDROCYTES; HYDROGELS; CULTURE; GROWTH	Background: Heterogeneous and uncontrolled differentiation of human embryonic stem cells (hESCs) in embryoid bodies (EBs) limits the potential use of hESCs for cell-based therapies. More efficient strategies are needed for the commitment and differentiation of hESCs to produce a homogeneous population of specific cell types for tissue regeneration applications. Methodology/Principal Findings: We report here that significant chondrocytic commitment of feeder-free cultured human embryonic stem cells (FF-hESCs), as determined by gene expression and immunostaining analysis, was induced by co-culture with primary chondrocytes. Furthermore, a dynamic expression profile of chondrocyte-specific genes was observed during monolayer expansion of the chondrogenically-committed cells. Chondrogenically-committed cells synergistically responded to transforming growth factor-beta 1 (TGF-beta 1) and beta 1-integrin activating antibody by increasing tissue mass in pellet culture. In addition, when encapsulated in hydrogels, these cells formed cartilage tissue both in vitro and in vivo. In contrast, the absence of chondrocyte co-culture did not result in an expandable cell population from FF-hESCs. Conclusions/Significance: The direct chondrocytic commitment of FF-hESCs can be induced by morphogenetic factors from chondrocytes without EB formation and homogenous cartilage tissue can be formed in vitro and in vivo.	[Hwang, Nathaniel S.; Varghese, Shyni; Elisseeff, Jennifer] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Hwang, NS (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	jhe@jhu.edu	Elisseeff, Jennifer/A-3324-2010; Hwang, Nathaniel/AAI-3333-2020	Elisseeff, Jennifer/0000-0002-5066-1996; 	Johns Hopkins University (JHU)-Technion Joint Program; Arthritis Foundation	Johns Hopkins University (JHU)-Technion Joint Program(Johns Hopkins University); Arthritis Foundation	This work was supported by funding from the Johns Hopkins University (JHU)-Technion Joint Program and the Arthritis Foundation.	Amit M, 2002, J ANAT, V200, P225, DOI 10.1046/j.1469-7580.2002.00032.x; Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; DAngelo M, 1997, J BONE MINER RES, V12, P1368, DOI 10.1359/jbmr.1997.12.9.1368; De Bari C, 2004, ARTHRITIS RHEUM-US, V50, P142, DOI 10.1002/art.11450; Elisseeff J, 2006, STEM CELLS DEV, V15, P295, DOI 10.1089/scd.2006.15.295; Elisseeff J, 2005, Orthod Craniofac Res, V8, P150, DOI 10.1111/j.1601-6343.2005.00335.x; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Furman BD, 2006, J ORTHOP TRAUMA, V20, P719, DOI 10.1097/01.bot.0000211160.05864.14; Gillogly SD, 2006, J ORTHOP SPORT PHYS, V36, P751, DOI 10.2519/jospt.2006.2409; Hegert C, 2002, J CELL SCI, V115, P4617, DOI 10.1242/jcs.00171; Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B; Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036; Hwang NS, 2007, J CELL PHYSIOL, V212, P281, DOI 10.1002/jcp.21052; Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695; Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Kim MS, 2005, STEM CELLS, V23, P113, DOI 10.1634/stemcells.2004-0110; Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1; Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1; LaPrade RF, 1999, JAMA-J AM MED ASSOC, V281, P876, DOI 10.1001/jama.281.10.876; Lee J, 2007, BIOTECHNOL APPL BIOC, V48, P149, DOI 10.1042/BA20060233; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Nagai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001272; Nakayama N, 2003, J CELL SCI, V116, P2015, DOI 10.1242/jcs.00417; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sharma B, 2007, PLAST RECONSTR SURG, V119, P112, DOI 10.1097/01.prs.0000236896.22479.52; SOLURSH M, 1975, DEV BIOL, V44, P278, DOI 10.1016/0012-1606(75)90398-X; Song L, 2004, CYTOTHERAPY, V6, P596, DOI 10.1080/14653240410005276-1; Takahashi I, 2003, EUR J CELL BIOL, V82, P182, DOI 10.1078/0171-9335-00307; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toh WS, 2007, STEM CELLS, V25, P950, DOI 10.1634/stemcells.2006-0326; Vacanti V, 2005, J CELL PHYSIOL, V205, P194, DOI 10.1002/jcp.20376; Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002; Vats A, 2006, TISSUE ENG, V12, P1687, DOI 10.1089/ten.2006.12.1687; Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018; Zandstra PW, 2001, ANNU REV BIOMED ENG, V3, P275, DOI 10.1146/annurev.bioeng.3.1.275	45	96	102	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2498	10.1371/journal.pone.0002498	http://dx.doi.org/10.1371/journal.pone.0002498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575581	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288000021
J	Takata, N; Hirase, H				Takata, Norio; Hirase, Hajime			Cortical Layer 1 and Layer 2/3 Astrocytes Exhibit Distinct Calcium Dynamics In Vivo	PLOS ONE			English	Article								Cumulative evidence supports bidirectional interactions between astrocytes and neurons, suggesting glial involvement of neuronal information processing in the brain. Cytosolic calcium (Ca2+) concentration is important for astrocytes as Ca2+ surges co-occur with gliotransmission and neurotransmitter reception. Cerebral cortex is organized in layers which are characterized by distinct cytoarchitecture. We asked if astrocyte-dominant layer 1 (L1) of the somatosensory cortex was different from layer 2/3 (L2/3) in spontaneous astrocytic Ca2+ activity and if it was influenced by background neural activity. Using a two-photon laser scanning microscope, we compared spontaneous Ca2+ activity of astrocytic somata and processes in L1 and L2/3 of anesthetized mature rat somatosensory cortex. We also assessed the contribution of background neural activity to the spontaneous astrocytic Ca2+ dynamics by investigating two distinct EEG states("synchronized'' vs. "desynchronized'' states). We found that astrocytes in L1 had nearly twice higher Ca2+ activity than L2/3. Furthermore, Ca2+ fluctuations of processes within an astrocyte were independent in L1 while those in L2/3 were synchronous. Pharmacological blockades of metabotropic receptors for glutamate, ATP, and acetylcholine, as well as suppression of action potentials did not have a significant effect on the spontaneous somatic Ca2+ activity. These results suggest that spontaneous astrocytic Ca2+ surges occurred in large part intrinsically, rather than neural activity-driven. Our findings propose a new functional segregation of layer 1 and 2/3 that is defined by autonomous astrocytic activity.	[Takata, Norio; Hirase, Hajime] RIKEN, Brain Sci Inst, Hirase Res Unit, Neuronal Circuit & Mech Res Grp, Wako, Saitama, Japan	RIKEN	Takata, N (corresponding author), RIKEN, Brain Sci Inst, Hirase Res Unit, Neuronal Circuit & Mech Res Grp, Wako, Saitama, Japan.	takata@brain.riken.jp; hirase@brain.riken.jp	Hirase, Hajime/A-3709-2012	Hirase, Hajime/0000-0003-3806-6905	MEXT of Japan [18053026]; Grant-in-Aid for Young Scientists; HFSP [RGY0073/2006]; RIKEN Brain Science Institute	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant-in-Aid for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); HFSP(Human Frontier Science Program); RIKEN Brain Science Institute	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas from the MEXT of Japan (grant number: 18053026) (H.H.), Grant-in-Aid for Young Scientists (B) (N.T.), HFSP (RGY0073/2006) (H.H.) and RIKEN Brain Science Institute internal research fund (H.H.).	Aguado F, 2002, J NEUROSCI, V22, P9430; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Amzica F, 1999, J NEUROPHYSIOL, V82, P2731, DOI 10.1152/jn.1999.82.5.2731; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Binns KE, 2001, NEUROPHARMACOLOGY, V40, P639, DOI 10.1016/S0028-3908(00)00202-1; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; Deitmer JW, 2006, GLIA, V54, P639, DOI 10.1002/glia.20428; Ding S, 2007, J NEUROSCI, V27, P10674, DOI 10.1523/JNEUROSCI.2001-07.2007; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; FLEISCHHAUER K, 1979, ANAT EMBRYOL, V156, P269, DOI 10.1007/BF00299627; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Kirkwood A, 1999, J NEUROSCI, V19, P1599; KUDO Y, 1993, BIOIMAGES, V1, P159; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Mechawar N, 2000, J COMP NEUROL, V428, P305, DOI 10.1002/1096-9861(20001211)428:2<305::AID-CNE9>3.0.CO;2-Y; Mishima T, 2007, J NEUROSCI METH, V166, P32, DOI 10.1016/j.jneumeth.2007.06.021; Moller C, 2007, COGN SYST RES, V8, P28, DOI 10.1016/j.cogsys.2006.07.001; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perea G, 2005, CELL CALCIUM, V38, P375, DOI 10.1016/j.ceca.2005.06.015; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Porter JT, 1997, PROG NEUROBIOL, V51, P439, DOI 10.1016/S0301-0082(96)00068-8; Schipke CG, 2008, CELL CALCIUM, V43, P285, DOI 10.1016/j.ceca.2007.06.002; Seigneur J, 2006, CEREB CORTEX, V16, P655, DOI 10.1093/cercor/bhj011; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Shipp S, 2007, CURR BIOL, V17, pR443, DOI 10.1016/j.cub.2007.03.044; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Verkhratsky A., 2007, GLIAL NEUROBIOLOGY T; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; Zur Nieden R, 2006, CEREB CORTEX, V16, P676, DOI 10.1093/cercor/bhj013	47	106	107	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2525	10.1371/journal.pone.0002525	http://dx.doi.org/10.1371/journal.pone.0002525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575586	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288000040
J	Sobue, S; Murakami, M; Banno, Y; Ito, H; Kimura, A; Gao, S; Furuhata, A; Takagi, A; Kojima, T; Suzuki, M; Nozawa, Y; Murate, T				Sobue, S.; Murakami, M.; Banno, Y.; Ito, H.; Kimura, A.; Gao, S.; Furuhata, A.; Takagi, A.; Kojima, T.; Suzuki, M.; Nozawa, Y.; Murate, T.			v-Src oncogene product increases sphingosine kinase 1 expression through mRNA stabilization: alteration of AU-rich element-binding proteins	ONCOGENE			English	Article						v-Src; sphingosine kinase 1; gene expression; mRNA half-life; AUF1; HuR	N-TERMINAL KINASE; GENE-EXPRESSION; C ISOFORMS; CELL-LINE; ACTIVATION; HUR; PHOSPHORYLATION; LEUKEMIA; TURNOVER; CANCER	Sphingosine kinase 1 (SPHK1) is overexpressed in solid tumors and leukemia. However, the mechanism of SPHK1 overexpression by oncogenes has not been defined. We found that v-Src-transformed NIH3T3 cells showed a high SPHK1 mRNA, SPHK1 protein and SPHK enzyme activity. siRNA of SPHK1 inhibited the growth of v-Src-NIH3T3, suggesting the involvement of SPHK1 in v-Src-induced oncogenesis. v-Src-NIH3T3 showed activations of protein kinase C-alpha, signal transducers and activators of transcription 3 and c-Jun NH2-terminal kinase. Their inhibition suppressed SPHK1 expression in v-Src-NIH3T3, whereas their overexpression increased SPHK1 mRNA in NIH3T3. Unexpectedly, the nuclear run-on assay and the promoter analysis using 50-promoter region of mouse SPHK1 did not show any significant difference between mock-and v-Src-NIH3T3. Furthermore, the half-life of SPHK1 mRNA in mock-NIH3T3 was nearly 15 min, whereas that of v-SrcNIH3T3 was much longer. Examination of two AU-rich region-binding proteins, AUF1 and HuR, that regulate mRNA decay reciprocally, showed decreased total AUF1 protein associated with increased tyrosine-phosphorylated form and increased serine-phosphorylated HuR protein in v-Src-NIH3T3. Modulation of AUF1 and HuR by their overexpression or siRNA revealed that SPHK1 mRNA in v-Src- and mock-NIH3T3 was regulated reciprocally by these factors. Our results showed, for the first time, a novel mechanism of v-Src-induced SPHK1 overexpression.	[Sobue, S.; Murakami, M.; Ito, H.; Kimura, A.; Gao, S.; Furuhata, A.; Takagi, A.; Kojima, T.; Murate, T.] Nagoya Univ, Grad Sch Hlth Sci, Dept Med Technol, Nagoya, Aichi 4668673, Japan; [Banno, Y.] Gifu Univ, Grad Sch Med, Dept Biochem, Gifu, Japan; [Suzuki, M.] Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Nagoya, Aichi 4668673, Japan; [Nozawa, Y.] Gifu Int Inst Biotechnol, Kakamigahara, Japan	Nagoya University; Gifu University; Nagoya University	Murate, T (corresponding author), Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Higashi Ku, Daiko Minami 1-1-20, Nagoya, Aichi 4668673, Japan.	murate@met.nagoya-u.ac.jp	Kojima, Tetsuhito/I-6271-2014; Suzuki, Motoshi/I-7246-2014	Kojima, Tetsuhito/0000-0002-1905-1065; Suzuki, Motoshi/0000-0003-0682-5006				Akao Y, 2006, BIOCHEM BIOPH RES CO, V342, P1284, DOI 10.1016/j.bbrc.2006.02.070; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Bektas M, 2005, ONCOGENE, V24, P178, DOI 10.1038/sj.onc.1208019; BLOBEL GA, 1991, P NATL ACAD SCI USA, V88, P1162, DOI 10.1073/pnas.88.4.1162; Bonhoure E, 2006, LEUKEMIA, V20, P95, DOI 10.1038/sj.leu.2404023; BORNER C, 1992, J BIOL CHEM, V267, P12900; Bromann PA, 2005, J BIOL CHEM, V280, P10253, DOI 10.1074/jbc.M413806200; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; Cussac D, 2004, BLOOD, V103, P1464; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dehm S, 2001, FEBS LETT, V487, P367, DOI 10.1016/S0014-5793(00)02354-1; Dehm SM, 2004, BIOCHEM CELL BIOL, V82, P263, DOI 10.1139/o03-077; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Fawal M, 2006, BLOOD, V108, P2780, DOI 10.1182/blood-2006-04-014902; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; French KJ, 2003, CANCER RES, V63, P5962; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Gartsbein M, 2006, J CELL SCI, V119, P470, DOI 10.1242/jcs.02744; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Greulich H, 1996, ONCOGENE, V12, P1689; Hanford DS, 1996, MOL ENDOCRINOL, V10, P1719, DOI 10.1210/me.10.12.1719; Karni R, 2002, J BIOL CHEM, V277, P42919, DOI 10.1074/jbc.M206141200; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kloss S, 2004, MOL PHARMACOL, V65, P1440, DOI 10.1124/mol.65.6.1440; Kuo LY, 2006, J CELL PHYSIOL, V207, P729, DOI 10.1002/jcp.20616; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Leclerc Guy J, 2002, Cancer Cell Int, V2, P1, DOI 10.1186/1475-2867-2-1; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Murakami M, 2007, J NEUROCHEM, V102, P1585, DOI 10.1111/j.1471-4159.2007.04673.x; Nakade Y, 2003, BBA-MOL CELL BIOL L, V1635, P104, DOI 10.1016/j.bbalip.2003.11.001; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Park YJ, 2002, MOL CELL ENDOCRINOL, V194, P77, DOI 10.1016/S0303-7207(02)00185-5; Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02; QURESHI SA, 1991, J BIOL CHEM, V266, P10802; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; Shih SC, 1999, J BIOL CHEM, V274, P15407, DOI 10.1074/jbc.274.22.15407; Sobue S, 2006, LEUKEMIA, V20, P2042, DOI 10.1038/sj.leu.2404386; Sobue S, 2005, J NEUROCHEM, V95, P940, DOI 10.1111/j.1471-4159.2005.03399.x; STOECKLE MY, 1989, MOL CELL BIOL, V9, P4738, DOI 10.1128/MCB.9.11.4738; Stofega MR, 1997, CELL GROWTH DIFFER, V8, P113; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Tezuka KI, 1996, J BIOL CHEM, V271, P22713, DOI 10.1074/jbc.271.37.22713; Turkson J, 1999, MOL CELL BIOL, V19, P7519; Vlasova IA, 2005, GENOMICS, V86, P159, DOI 10.1016/j.ygeno.2005.04.013; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; XIE WL, 1995, J BIOL CHEM, V270, P27622, DOI 10.1074/jbc.270.46.27622	51	26	26	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2008	27	46					6023	6033		10.1038/onc.2008.198	http://dx.doi.org/10.1038/onc.2008.198			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	358BO	18574469				2022-12-25	WOS:000259891600005
J	Mambole, AS; Baruch, D; Nusbaum, P; Bigot, S; Suzuki, M; Lesavre, P; Fukuda, M; Halbwachs-Mecarelli, L				Mambole, Agne S.; Baruch, Dominique; Nusbaum, Patrick; Bigot, Sylvain; Suzuki, Misa; Lesavre, Philippe; Fukuda, Minoru; Halbwachs-Mecarelli, Lise			The cleavage of neutrophil leukosialin (CD43) by cathepsin G releases its extracellular domain and triggers its intramembrane proteolysis by presenilin/gamma-secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; CELL-SURFACE EXPRESSION; SIALOPHORIN CD43; DOWN-REGULATION; ALPHA-1-PROTEASE INHIBITOR; ENDOTHELIAL-CELLS; SERINE PROTEASES; GAMMA-SECRETASE; MOLECULE CD43; T-CELLS	The highly negatively charged membrane sialoglycoprotein leukosialin, CD43, is shed during neutrophil activation. This is generally thought to enhance cell adhesion. We here describe two novel consequences of this shedding, during neutrophil activation by phorbol esters or by chemoattractants after TNF- priming. CD43 proteolysis was investigated by Western blotting, using a polyclonal antibody to CD43 intracellular domain. Our data emphasize the importance of a juxtamembranous cleavage of about 50% of membrane CD43 molecules by cathepsin G. Indeed, it is inhibited by alpha 1- antichymotrypsin and cathepsinGinhibitor I and is reproduced by exogenous purified cathepsin G. The resulting membrane- anchored C- terminal fragment, CD43- CTF, becomes susceptible to presenilin/gamma-secretase, which releases CD43 intracytoplasmic domain: preincubation with three different gamma-secretase inhibitors, before PMNtreatment by agonists or by purified cathepsin G, results in the accumulation of CD43-CTF. Because CD43 binds E- selectin, we also investigated the effect of the soluble extracellular domain CD43s, released by cathepsin G juxtamembranous cleavage, on neutrophil adhesion to endothelial cells. A recombinant CD43s- Fc fusion protein inhibited neutrophil E selectindependent adhesion to endothelial cells under flow conditions, while it had no effect on neutrophil static adhesion. We thus propose that, in addition to its potential pro- adhesive role, CD43 proteolysis results in: (i) the release, by cathepsin G, of CD43 extracellular domain, able to inhibit the adhesion of flowing neutrophils on endothelial cells and thus to participate to the natural control of inflammation; (ii) the release and/or the clearance, by presenilin/gamma-secretase, of CD43 intracellular domain, thereby regulating CD43- mediated signaling.	[Mambole, Agne S.; Nusbaum, Patrick; Bigot, Sylvain; Lesavre, Philippe; Halbwachs-Mecarelli, Lise] Hop Necker Enfants Malad, INSERM, U 845, F-75015 Paris, France; [Mambole, Agne S.; Baruch, Dominique; Nusbaum, Patrick; Bigot, Sylvain; Lesavre, Philippe; Halbwachs-Mecarelli, Lise] Univ Paris 05, F-75015 Paris, France; [Baruch, Dominique] INSERM, U765, F-75006 Paris, France; [Suzuki, Misa; Fukuda, Minoru] Burnham Inst Med Res, Canc Res Ctr, La Jolla, CA 92037 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Sanford Burnham Prebys Medical Discovery Institute	Halbwachs-Mecarelli, L (corresponding author), Hop Necker Enfants Malad, INSERM, U 845, 161 Rue Sevres, F-75015 Paris, France.	lise.halbwachs@inserm.fr	baruch, dominique/F-8189-2013; Baruch, Dominique/ABA-1791-2020	Baruch, Dominique/0000-0003-2835-5500	NATIONAL CANCER INSTITUTE [R37CA033000, R01CA033000] Funding Source: NIH RePORTER; NCI NIH HHS [CA 33000, R01 CA033000] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALVAREZ V, 1991, KIDNEY INT, V40, P899, DOI 10.1038/ki.1991.291; Andersson CX, 2005, BIOCHEM J, V387, P377, DOI 10.1042/BJ20041387; Andersson CX, 2004, BIOCHEM BIOPH RES CO, V316, P12, DOI 10.1016/j.bbrc.2004.02.011; BAZIL V, 1994, J IMMUNOL, V152, P1314; BIERHUIZEN MFA, 1994, J BIOL CHEM, V269, P4473; CAMPANERO MR, 1991, EUR J IMMUNOL, V21, P3045, DOI 10.1002/eji.1830211222; Fernandez-Rodriguez J, 2002, TUMOR BIOL, V23, P193, DOI 10.1159/000067252; Fuhlbrigge RC, 2006, BLOOD, V107, P1421, DOI 10.1182/blood-2005-05-2112; Gardiner EE, 2001, BLOOD, V98, P1440, DOI 10.1182/blood.V98.5.1440; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; HalbwachsMecarelli L, 1996, BLOOD, V87, P1200, DOI 10.1182/blood.V87.3.1200.bloodjournal8731200; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Korkmaz B, 2005, AM J RESP CELL MOL, V32, P553, DOI 10.1165/rcmb.2004-0374OC; KUIJPERS TW, 1992, J IMMUNOL, V149, P998; Legendre P, 2006, J THROMB HAEMOST, V4, P236, DOI 10.1111/j.1538-7836.2005.01653.x; LOPEZ S, 1995, CLIN EXP IMMUNOL, V101, P25; Lopez S, 1998, CELL ADHES COMMUN, V5, P151, DOI 10.3109/15419069809040288; MANJUNATH N, 1995, NATURE, V377, P535, DOI 10.1038/377535a0; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Matsumoto M, 2005, J IMMUNOL, V175, P8042, DOI 10.4049/jimmunol.175.12.8042; Mirnics ZK, 2002, BLOOD CELL MOL DIS, V28, P28, DOI 10.1006/bcmd.2002.0486; Mody PD, 2007, BLOOD, V110, P2974, DOI 10.1182/blood-2007-01-065276; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; NATHAN C, 1993, J CELL BIOL, V122, P243, DOI 10.1083/jcb.122.1.243; Nie J, 2004, EXP CELL RES, V296, P145, DOI 10.1016/j.yexcr.2004.02.008; Nusbaum P, 2005, J BIOL CHEM, V280, P5843, DOI 10.1074/jbc.M413405200; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; Park HY, 2006, INT IMMUNOPHARMACOL, V6, P1061, DOI 10.1016/j.intimp.2006.01.019; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Radford DJ, 2001, ARTHRITIS RHEUM, V44, P2851, DOI 10.1002/1529-0131(200112)44:12<2851::AID-ART473>3.0.CO;2-2; REMOLDODONNELL E, 1995, BLOOD, V86, P2395, DOI 10.1182/blood.V86.6.2395.bloodjournal8662395; REMOLDODONNELL E, 1994, J IMMUNOL, V152, P3595; RENESTO P, 1994, J IMMUNOL, V152, P4612; Ridger VC, 2005, AM J PATHOL, V166, P945, DOI 10.1016/S0002-9440(10)62314-0; RIEU P, 1992, EUR J IMMUNOL, V22, P3021, DOI 10.1002/eji.1830221138; SANCHEZMATEOS P, 1995, BLOOD, V86, P2228, DOI 10.1182/blood.V86.6.2228.bloodjournal8662228; SAWADA R, 1994, J BIOL CHEM, V269, P1425; SCHMID K, 1992, P NATL ACAD SCI USA, V89, P663, DOI 10.1073/pnas.89.2.663; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Seveau S, 2000, BLOOD, V95, P2462; SHELLEY CS, 1989, P NATL ACAD SCI USA, V86, P2819, DOI 10.1073/pnas.86.8.2819; Sikut R, 1997, BIOCHEM BIOPH RES CO, V238, P612, DOI 10.1006/bbrc.1997.7334; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Tsuboi S, 2001, BIOESSAYS, V23, P46, DOI 10.1002/1521-1878(200101)23:1<46::AID-BIES1006>3.3.CO;2-V; Walker J, 1999, J IMMUNOL, V162, P4109	46	25	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23627	23635		10.1074/jbc.M710286200	http://dx.doi.org/10.1074/jbc.M710286200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586676	hybrid, Green Published			2022-12-25	WOS:000258638900015
J	Postmus, J; Canelas, AB; Bouwman, J; Bakker, BM; van Gulik, W; de Mattos, MJT; Brul, S; Smits, GJ				Postmus, Jarne; Canelas, Andre B.; Bouwman, Jildau; Bakker, Barbara M.; van Gulik, Walter; de Mattos, M. Joost Teixeira; Brul, Stanley; Smits, Gertien J.			Quantitative analysis of the high temperature-induced glycolytic flux increase in Saccharomyces cerevisiae reveals dominant metabolic regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK RESPONSE; IN-VIVO KINETICS; PYRUVATE-KINASE; GENE-EXPRESSION; STRESS-RESPONSE; ENVIRONMENTAL-CHANGES; MOLECULAR CHAPERONES; MEMBRANE-PROPERTIES; THERMAL ADAPTATION; CHEMOSTAT CULTURE	A major challenge in systems biology lies in the integration of processes occurring at different levels, such as transcription, translation, and metabolism, to understand the functioning of a living cell in its environment. We studied the high temperature-induced glycolytic flux increase in Saccharomyces cerevisiae and investigated the regulatory mechanisms underlying this increase. We used glucose-limited chemostat cultures to separate regulatory effects of temperature from effects on growth rate. Growth at increased temperature (38 C versus 30 C) resulted in a strongly increased glycolytic flux, accompanied by a switch from respiration to a partially fermentative metabolism. We observed an increased flux through all enzymes, ranging from 5- to 10- fold. Wequantified the contributions of direct temperature effects on enzyme activities, the gene expression cascade and shifts in the metabolic network, to the increased flux through each enzyme. To do this we adapted flux regulation analysis. We show that the direct effect of temperature on enzyme kinetics can be included as a separate term. Together with hierarchical regulation and metabolic regulation, this term explains the total flux change between two steady states. Surprisingly, the effect of the cultivation temperature on enzyme catalytic capacity, both directly through the Arrhenius effect and indirectly through adapted gene expression, is only a moderate contribution to the increased glycolytic flux for most enzymes. The changes in flux are therefore largely caused by changes in the interaction of the enzymes with substrates, products, and effectors.	[Postmus, Jarne; Brul, Stanley; Smits, Gertien J.] Univ Amsterdam, Dept Mol Biol & Microbial Food Safety, NL-1018 WV Amsterdam, Netherlands; [Canelas, Andre B.; van Gulik, Walter] Kluyver Lab Biotechnol, NL-2628 BC Delft, Netherlands; [Bouwman, Jildau; Bakker, Barbara M.] Vrije Univ Amsterdam, Dept Mol Cell Physiol, NL-1081 HV Amsterdam, Netherlands; [de Mattos, M. Joost Teixeira] Univ Amsterdam, Dept Mol Microbial Physiol, NL-1018 WV Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam	Smits, GJ (corresponding author), Univ Amsterdam, Dept Mol Biol & Microbial Food Safety, Nieuwe Achtergracht 166, NL-1018 WV Amsterdam, Netherlands.	gertien@science.uva.nl	Smits, Gertien J./I-4327-2014	Smits, Gertien J./0000-0002-8439-7791; Bakker, Barbara/0000-0001-6274-3633				ARRHENIUS S, 1884, RES GALVANIC CONDUCT; BARWELL CJ, 1971, EUR J BIOCHEM, V18, P59, DOI 10.1111/j.1432-1033.1971.tb01214.x; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; BOLES E, 1993, YEAST, V9, P761, DOI 10.1002/yea.320090710; Boy-Marcotte E, 1999, MOL MICROBIOL, V33, P274, DOI 10.1046/j.1365-2958.1999.01467.x; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Daran-Lapujade P, 2004, J BIOL CHEM, V279, P9125, DOI 10.1074/jbc.M309578200; Eastmond DL, 2006, J BIOL CHEM, V281, P32909, DOI 10.1074/jbc.M602454200; Elbing K, 2004, APPL ENVIRON MICROB, V70, P5323, DOI 10.1128/AEM.70.9.5323-5330.2004; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Hochachka PW, 1997, J EXP BIOL, V200, P381; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kim IS, 2006, J MICROBIOL, V44, P492; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; Koebmann BJ, 2002, MOL BIOL REP, V29, P41, DOI 10.1023/A:1020398117281; KONINGS AWT, 1985, RADIAT RES, V102, P86, DOI 10.2307/3576432; Lange HC, 2001, BIOTECHNOL BIOENG, V75, P406, DOI 10.1002/bit.10048; Larsson C, 1997, J BACTERIOL, V179, P7243, DOI 10.1128/jb.179.23.7243-7250.1997; Liu LM, 2006, FEMS YEAST RES, V6, P1117, DOI 10.1111/j.1567-1364.2006.00153.x; MacDonald JA, 2005, FEBS J, V272, P120, DOI 10.1111/j.1432-1033.2004.04388.x; MAEBA P, 1968, J BIOL CHEM, V243, P448; MAGER WH, 1993, BIOCHEM J, V290, P1; MARTIN CE, 1976, BIOCHEMISTRY-US, V15, P5218, DOI 10.1021/bi00669a004; Mashego MR, 2003, BIOTECHNOL BIOENG, V83, P395, DOI 10.1002/bit.10683; MILLER MJ, 1982, J BACTERIOL, V151, P311, DOI 10.1128/JB.151.1.311-327.1982; Morano KA, 1998, CURR OPIN MICROBIOL, V1, P197, DOI 10.1016/S1369-5274(98)80011-8; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; Moro F, 2006, J MOL BIOL, V358, P1367, DOI 10.1016/j.jmb.2006.03.027; MORRIS CN, 1986, BIOCHEM J, V234, P691, DOI 10.1042/bj2340691; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Piper P, 2001, MICROBIOL-SGM, V147, P2635, DOI 10.1099/00221287-147-10-2635; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Reijenga KA, 2001, BIOPHYS J, V80, P626, DOI 10.1016/S0006-3495(01)76043-2; Riezman H, 2004, CELL CYCLE, V3, P61; Rodicio R, 2000, J BIOL CHEM, V275, P40952, DOI 10.1074/jbc.M007131200; Rossell S, 2006, P NATL ACAD SCI USA, V103, P2166, DOI 10.1073/pnas.0509831103; Rossell S, 2005, FEMS YEAST RES, V5, P611, DOI 10.1016/j.femsyr.2004.11.003; Rossell S, 2008, FEMS YEAST RES, V8, P155, DOI 10.1111/j.1567-1364.2007.00282.x; Sasaki T, 2006, J EXP BIOL, V209, P3580, DOI 10.1242/jeb.02426; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SHULMAN RG, 1995, P NATL ACAD SCI USA, V92, P8535, DOI 10.1073/pnas.92.19.8535; SIMOESMENDES B, 1978, Z ALLG MIKROBIOL, V18, P275, DOI 10.1002/jobm.3630180406; Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Spijker S, 2004, FASEB J, V18, P848, DOI 10.1096/fj.03-0612fje; Suarez RK, 2005, J EXP BIOL, V208, P3603, DOI 10.1242/jeb.01778; Tai SL, 2007, J BIOL CHEM, V282, P10243, DOI 10.1074/jbc.M610845200; ter Kuile BH, 2001, FEBS LETT, V500, P169, DOI 10.1016/S0014-5793(01)02613-8; THEVELEIN JM, 1982, P NATL ACAD SCI-BIOL, V79, P3503, DOI 10.1073/pnas.79.11.3503; Thomas S, 1998, EUR J BIOCHEM, V258, P956, DOI 10.1046/j.1432-1327.1998.2580956.x; van Dam JC, 2002, ANAL CHIM ACTA, V460, P209, DOI 10.1016/S0003-2670(02)00240-4; Van Hoek P, 1998, APPL ENVIRON MICROB, V64, P2133; VERDUYN C, 1991, ANTON LEEUW INT J G, V60, P325, DOI 10.1007/BF00430373; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; WALSH MC, 1994, J BACTERIOL, V176, P953, DOI 10.1128/JB.176.4.953-958.1994; Wu L, 2006, METAB ENG, V8, P160, DOI 10.1016/j.ymben.2005.09.005; Wu L, 2006, APPL ENVIRON MICROB, V72, P3566, DOI 10.1128/AEM.72.5.3566-3577.2006; Zaitzeva EA, 1996, APPL BIOCHEM BIOTECH, V61, P67, DOI 10.1007/BF02785689	68	47	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23524	23532		10.1074/jbc.M802908200	http://dx.doi.org/10.1074/jbc.M802908200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18562308	hybrid, Green Published			2022-12-25	WOS:000258638900005
J	Basu, NK; Kole, L; Basu, M; Chakraborty, K; Mitra, PS; Owens, IS				Basu, Nikhil K.; Kole, Labanyamoy; Basu, Mousumi; Chakraborty, Kushal; Mitra, Partha S.; Owens, Ida S.			The major chemical-detoxifying system of UDP-glucuronosyltransferases requires regulated phosphorylation supported by protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CARDIAC MYOCYTES; GLUCURONIDATION; BILIRUBIN; CURCUMIN; INHIBITION; ANTAGONIST; ACTIVATION; EXPRESSION; PROTECTION	Finding rapid, reversible down-regulation of human UDP-glucuronosyltransferases (UGTs) in LS180 cells following curcumin treatment led to the discovery that UGTs require phosphorylation. UGTs, distributed primarily in liver, kidney, and gastrointestinal tract, inactivate aromatic-like metabolites and a vast number of dietary and environmental chemicals, which reduces the risk of toxicities, mutagenesis, and carcinogenesis. Our aim here is to determine relevant kinases and mechanism(s) regulating phosphorylation of constitutive UGTs in LS180 cells and 10 different human UGT cDNA-transfected COS-1 systems. Time- and concentration-dependent inhibition of immunodetectable [P-33] orthophosphate in UGTs and protein kinase C is an element of(PKC is an element of), following treatment of LS180 cells with curcumin or the PKC inhibitor calphostin-C, suggested UGT phosphorylation is supported by active PKC( s). Immunofluorescent and co-immunoprecipitation studies with UGT-transfected cells showed co-localization of UGT1A7His and PKC is an element of and of UGT1A10His and PKC alpha orPKC delta. Inhibition of UGT activity by PKC is an element of-specific antagonist peptide or by PKC is an element of-targeted destruction with PKC is an element of-specific small interference RNA and activation of curcumin-down-regulated UGTs with typical PKC agonists verified a central PKC role in glucuronidation. Moreover, in vitro phosphorylation of nascent UGT1A7His by PKC is an element of confirms it is a bona fide PKC substrate. Finally, catalase or herbimycin-A inhibition of constitutive or hydrogen peroxide-activated UGTs demonstrated that reactive oxygen species-related oxidants act as second messengers in maintaining constitutive PKC-dependent signaling evidently sustaining UGT phosphorylation and activity. Because cells use signal transduction collectively to detect and respond appropriately to environmental changes, this report, combined with our earlier demonstration that specific phospho-groups in UGT1A7 determined substrate selections, suggests regulated phosphorylation allows adaptations regarding differential phosphate utilization by UGTs to function efficiently.	[Basu, Nikhil K.; Kole, Labanyamoy; Basu, Mousumi; Chakraborty, Kushal; Mitra, Partha S.; Owens, Ida S.] NICHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Owens, IS (corresponding author), NICHD, Heritable Disorders Branch, NIH, 9000 Rockville Pike,Bldg 10, Rm 9D-42, Bethesda, MD 20892 USA.	owensi@mail.nih.gov			National Institutes of Health NICHD Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008751] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008751] Funding Source: NIH RePORTER	National Institutes of Health NICHD Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health NICHD Intramural Research Program.	Akhand AK, 1999, J BIOL CHEM, V274, P25821, DOI 10.1074/jbc.274.36.25821; [Anonymous], 1980, GLUCURONIDATION DRUG; Armstrong SC, 1998, J MOL CELL CARDIOL, V30, P61, DOI 10.1006/jmcc.1997.0572; Bastianetto S, 2000, BRIT J PHARMACOL, V131, P711, DOI 10.1038/sj.bjp.0703626; Basu NK, 2007, BIOCHEM BIOPH RES CO, V360, P7, DOI 10.1016/j.bbrc.2007.05.224; Basu NK, 2005, P NATL ACAD SCI USA, V102, P6285, DOI 10.1073/pnas.0407872102; Basu NK, 2004, J BIOL CHEM, V279, P28320, DOI 10.1074/jbc.M401396200; Basu NK, 2004, J BIOL CHEM, V279, P1429, DOI 10.1074/jbc.M306439200; Basu NK, 2003, BIOCHEM BIOPH RES CO, V303, P98, DOI 10.1016/S0006-291X(03)00241-9; CHEN F, 1993, BIOCHEMISTRY-US, V32, P10648, DOI 10.1021/bi00091a015; Chen HW, 1998, BRIT J PHARMACOL, V124, P1029, DOI 10.1038/sj.bjp.0701914; Ciotti M, 1997, PHARMACOGENETICS, V7, P485, DOI 10.1097/00008571-199712000-00007; Ciotti M, 1999, BIOCHEM BIOPH RES CO, V260, P199, DOI 10.1006/bbrc.1999.0453; Ciotti M, 1996, BIOCHEMISTRY-US, V35, P10119, DOI 10.1021/bi960584a; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; DEMPSEY EC, 2000, AM J PHYSIOL, V279, P1429; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Fournes B, 2001, ONCOGENE, V20, P219, DOI 10.1038/sj.onc.1204058; Gopalakrishna R, 2002, J NUTR, V132, p3819S, DOI 10.1093/jn/132.12.3819S; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Harmala-Brasken AS, 2003, ONCOGENE, V22, P7677, DOI 10.1038/sj.onc.1207077; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Jiang LJ, 1998, P NATL ACAD SCI USA, V95, P3483, DOI 10.1073/pnas.95.7.3483; Jobin C, 1999, J IMMUNOL, V163, P3474; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; KELLIS JT, 1984, SCIENCE, V225, P1032, DOI 10.1126/science.6474163; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Kuhnau J, 1976, World Rev Nutr Diet, V24, P117; LANG DR, 1974, BIOCHIM BIOPHYS ACTA, V333, P180, DOI 10.1016/0005-2728(74)90002-4; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Meech R, 1997, CLIN EXP PHARMACOL P, V24, P907, DOI 10.1111/j.1440-1681.1997.tb02718.x; Min DS, 1998, J BIOL CHEM, V273, P29986, DOI 10.1074/jbc.273.45.29986; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Pan Q, 2006, CANCER RES, V66, P9379, DOI 10.1158/0008-5472.CAN-06-2646; RAO CV, 1995, CANCER RES, V55, P259; Rendon-Huerta E, 1999, BIOCHEM J, V344, P469, DOI 10.1042/0264-6021:3440469; Ricciarelli R, 1998, BIOCHEM J, V334, P243, DOI 10.1042/bj3340243; RITTER JK, 1993, J BIOL CHEM, V268, P23573; RITTER JK, 1991, J BIOL CHEM, V266, P1043; RITTER JK, 1990, J BIOL CHEM, V265, P7900; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Surh YJ, 2002, FOOD CHEM TOXICOL, V40, P1091, DOI 10.1016/S0278-6915(02)00037-6; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Wells PG, 2004, DRUG METAB DISPOS, V32, P281, DOI 10.1124/dmd.32.3.281; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Zhang F, 1999, CARCINOGENESIS, V20, P445, DOI 10.1093/carcin/20.3.445	52	27	27	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23048	23061		10.1074/jbc.M800032200	http://dx.doi.org/10.1074/jbc.M800032200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556656	Green Published, hybrid			2022-12-25	WOS:000258455400018
J	Chen, LJ; Wang, K; Shao, YM; Huang, J; Li, XF; Shan, JF; Wu, DQ; Zheng, JJ				Chen, Lijun; Wang, Ke; Shao, Youming; Huang, Jin; Li, Xiaofeng; Shan, Jufang; Wu, Dianqing; Zheng, Jie J.			Structural insight into the mechanisms of Wnt signaling antagonism by Dkk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN DOCKING; DOMAIN; BINDING; DICKKOPF-1; RECEPTORS; PROGRAMS; PATHWAY; HADDOCK; KREMEN; FAMILY	Dickkopf (Dkk) proteins are antagonists of the canonical Wnt signaling pathway and are crucial for embryonic cell fate and bone formation. Wnt antagonism of Dkk requires the binding of the C-terminal cysteine-rich domain of Dkk to the Wnt coreceptor, LRP5/6. However, the structural basis of the interaction between Dkk and low density lipoprotein receptor-related protein (LRP) 5/6 is unknown. In this study, we examined the structure of the Dkk functional domain and elucidated its interactions with LRP5/6. Using NMR spectroscopy, we determined the solution structure of the C-terminal cysteine-rich domain of mouse Dkk2 (Dkk2C). Then, guided by mutagenesis studies, we docked Dkk2C to the YWTD beta-propeller domains of LRP5/6 and showed that the ligand binding site of the third LRP5/6 beta-propeller domain matches Dkk2C best, suggesting that this domain binds to Dkk2C with higher affinity. Such differential binding affinity is likely to play an essential role in Dkk function in the canonical Wnt pathway.	[Chen, Lijun; Shao, Youming; Huang, Jin; Shan, Jufang; Zheng, Jie J.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Wang, Ke; Li, Xiaofeng; Wu, Dianqing] Yale Univ, Dept Pharmacol, Sch Med, New Haven, CT 06520 USA; [Wang, Ke; Li, Xiaofeng; Wu, Dianqing] Yale Univ, Program Vasc Biol & Therapeut, Sch Med, New Haven, CT 06520 USA; [Chen, Lijun] Nankai Univ, Dept Biophys, Tianjin 300071, Peoples R China	St Jude Children's Research Hospital; Yale University; Yale University; Nankai University	Wu, DQ (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale, Memphis, TN 38105 USA.	dan.wu@yale.edu; jie.zheng@stjude.org		huang, jin/0000-0002-0698-1693; Zheng, Jie/0000-0001-6524-6800	NATIONAL CANCER INSTITUTE [R01CA139395, R01CA132317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081492, R01GM112182] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA139395, R01 CA132317, CA132317, R01 CA132317-01A2] Funding Source: Medline; NIAMS NIH HHS [R01 AR051476-02, R01 AR051476-03, AR051476, R01 AR051476-05, R01 AR051476-04, R01 AR051476, R01 AR051476-01A1] Funding Source: Medline; NIGMS NIH HHS [R01 GM081492, R01 GM081492-02, GM081492, R01 GM112182] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Boisbouvier J, 1998, J MOL BIOL, V283, P205, DOI 10.1006/jmbi.1998.2057; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; ECCLES C, 1991, Journal of Biomolecular NMR, V1, P111, DOI 10.1007/BF01877224; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Mendez R, 2005, PROTEINS, V60, P150, DOI 10.1002/prot.20551; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Springer TA, 2002, CURR OPIN STRUC BIOL, V12, P802, DOI 10.1016/S0959-440X(02)00384-6; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Takagi J, 2003, NATURE, V424, P969, DOI 10.1038/nature01873; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; van Dijk ADJ, 2005, FEBS J, V272, P293, DOI 10.1111/j.1742-4658.2004.04473.x; VAN DM, 2006, NUCLEIC ACIDS RES, V34, P3317; VAN TH, 1992, NATURE, V359, P159; VAN TH, 1999, BIOCHIM BIOPHYS ACTA, V1441, P173; Wang K, 2008, J BIOL CHEM, V283, P23371, DOI 10.1074/jbc.M802376200; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004	41	56	70	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23364	23370		10.1074/jbc.M802375200	http://dx.doi.org/10.1074/jbc.M802375200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18524778	Green Published, hybrid			2022-12-25	WOS:000258455400046
J	Lies, M; Maurizi, MR				Lies, Mark; Maurizi, Michael R.			Turnover of endogenous SsrA-tagged proteins mediated by ATP-dependent proteases in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-END RULE; CLPXP DEGRADATION MACHINE; TRANS-TRANSLATION; 10SA RNA; STOP CODONS; STABLE RNA; SYNTHESIS INHIBITORS; TAGGING ACTIVITY; MESSENGER-RNA; PEPTIDE	Formation and degradation of SsrA-tagged proteins enable ribosome recycling and elimination of defective products of incomplete translation. We produced an antibody against the SsrA peptide and used it to measure the amounts of SsrA-tagged proteins in Escherichia coli cells without interfering with tagging or altering the context of the tag added at the ends of nascent polypeptides. SsrA-tagged proteins were present in very small amounts unless a component of the ClpXP protease was missing. From the levels of tagged proteins in cells in which degradation is essentially blocked, we calculate that >= 1 in 200 translation products receives an SsrA tag. ClpXP is responsible for >= 90% of the degradation of SsrA-tagged proteins. The degradation rate in wild type cells is >= 1.4 min(-1) and decreases to similar to 0.10 min(-1) in a clpX mutant. The rate of degradation by ClpXP is decreased similar to 3-fold in mutants lacking the adaptor SspB, whereas degradation by ClpAP is increased 3-5-fold. However, ClpAP degrades SsrA-tagged proteins slowly even in the absence of SspB, possibly because of interference from ClpA-specific substrates. Lon protease degrades SsrA-tagged proteins at a rate of similar to 0.05 min(-1) in the presence or absence of SspB. We conclude that ClpXP, together with SspB, is uniquely adapted for degradation of SsrA-tagged proteins and is responsible for the major part of their degradation in vivo.	[Lies, Mark; Maurizi, Michael R.] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Maurizi, MR (corresponding author), NCI, Cell Biol Lab, NIH, Bldg 37, Rm 2128,37 Convent Dr, Bethesda, MD 20892 USA.	mmaurizi@helix.nih.gov			National Institutes of Health; NATIONAL CANCER INSTITUTE [Z01BC005597, ZIABC005597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was authored, in whole or in part, by National Institutes of Health staff.	Abo T, 2002, GENES CELLS, V7, P629, DOI 10.1046/j.1365-2443.2002.00549.x; Abo T, 2000, EMBO J, V19, P3762, DOI 10.1093/emboj/19.14.3762; Asano K, 2005, NUCLEIC ACIDS RES, V33, P5544, DOI 10.1093/nar/gki871; Bohn C, 2002, MOL GENET GENOMICS, V266, P827, DOI 10.1007/s00438-001-0601-1; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; de la Cruz J, 2001, RNA, V7, P1708; Defenbaugh DA, 2003, J BIOL CHEM, V278, P52333, DOI 10.1074/jbc.M308724200; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Farrell CM, 2005, MOL MICROBIOL, V57, P1750, DOI 10.1111/j.1365-2958.2005.04798.x; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Fredriksson A, 2007, GENE DEV, V21, P862, DOI 10.1101/gad.409407; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Hoskins JR, 2006, P NATL ACAD SCI USA, V103, P909, DOI 10.1073/pnas.0509154103; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Levchenko I, 2005, NAT STRUCT MOL BIOL, V12, P520, DOI 10.1038/nsmb934; Levchenko I, 1997, CELL, V91, P939, DOI 10.1016/S0092-8674(00)80485-7; Maurizi MR, 2002, ARCH BIOCHEM BIOPHYS, V397, P206, DOI 10.1006/abbi.2001.2703; McGinness KE, 2007, J BIOL CHEM, V282, P11465, DOI 10.1074/jbc.M610671200; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; MIZUSAWA S, 1983, P NATL ACAD SCI-BIOL, V80, P358, DOI 10.1073/pnas.80.2.358; MOESTELLER RD, 1980, J BIOL CHEM, V255, P2524; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Muto A, 1996, BIOCHIMIE, V78, P985, DOI 10.1016/S0300-9084(97)86721-1; NEIDHARDT FC, 1987, ESCHERICHIA COLI SAL, V1, P3; O'Handley D, 2002, J MOL BIOL, V322, P311, DOI 10.1016/S0022-2836(02)00755-6; OH BK, 1990, J BACTERIOL, V172, P4708, DOI 10.1128/jb.172.8.4708-4709.1990; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Ranquet C, 2001, P NATL ACAD SCI USA, V98, P10220, DOI 10.1073/pnas.171620598; RAY BK, 1979, MOL GEN GENET, V174, P25, DOI 10.1007/BF00433301; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; Saguy M, 2005, BIOCHIMIE, V87, P897, DOI 10.1016/j.biochi.2005.03.014; Schweder T, 1996, J BACTERIOL, V178, P470, DOI 10.1128/jb.178.2.470-476.1996; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; STOUT V, 1991, J BACTERIOL, V173, P1738, DOI 10.1128/jb.173.5.1738-1747.1991; Sunohara T, 2002, RNA, V8, P1416, DOI 10.1017/S1355838202020198; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; TU GF, 1995, J BIOL CHEM, V270, P9322, DOI 10.1074/jbc.270.16.9322; Ueda K, 2002, GENES CELLS, V7, P509, DOI 10.1046/j.1365-2443.2002.00537.x; Vioque A, 2003, FEMS MICROBIOL LETT, V218, P9, DOI 10.1016/S0378-1097(02)01110-2; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Williams KP, 1999, EMBO J, V18, P5423, DOI 10.1093/emboj/18.19.5423; Withey JH, 2002, CURR OPIN MICROBIOL, V5, P154, DOI 10.1016/S1369-5274(02)00299-0	52	57	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22918	22929		10.1074/jbc.M801692200	http://dx.doi.org/10.1074/jbc.M801692200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550539	Green Published, hybrid			2022-12-25	WOS:000258455400005
J	Ozsoy, HZ; Sivasubramanian, N; Wieder, ED; Pedersen, S; Mann, DL				Ozsoy, Hatice Z.; Sivasubramanian, Natarajan; Wieder, Eric D.; Pedersen, Steen; Mann, Douglas L.			Oxidative stress promotes ligand-independent and enhanced ligand-dependent tumor necrosis factor receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; H2O2 PRODUCTION; DISULFIDE BOND; MELANOMA-CELLS; FREE-RADICALS; TNF; REDOX; EXPRESSION; IDENTIFICATION; SUPERFAMILY	Tumor necrosis factor (TNF) receptor 1 (TNFR1, p55) and 2 (TNFR2, p75) are characterized by several cysteine-rich modules in the extracellular domain, raising the possibility that redox-induced modifications of these cysteine residues might alter TNFR function. To test this possibility, we examined fluorescence resonance energy transfer (FRET) in 293T cells transfected with CFP- and YFP-tagged TNFRs exposed to the thiol oxidant diamide. Treatment with high concentrations of diamide (1 mM) resulted in an increase in the FRET signal that was sensitive to inhibition with the reducing agent dithiothreitol, suggesting that oxidative stress resulted in TNFR self-association. Treatment of cells with low concentrations of diamide (1 mu M) that was not sufficient to provoke TNFR self-association resulted in increased TNF-induced FRET signals relative to the untreatedcells, suggesting that oxidative stress enhanced ligand-dependent TNFR signaling. Similar findings were obtained when the TNFR1- and TNFR2-transfected cells were pretreated with a cell-impermeable oxidase, DsbA, that catalyzes disulfide bond formation between thiol groups on cysteine residues. The changes in TNFR self-association were functionally significant, because pretreating the HeLa cells and 293T cells resulted in increased TNF-induced NF-kappa B activation and TNF-induced expression of I kappa B and syndecan-4 mRNA levels. Although pretreatment with DsbA did not result in an increase in TNF binding to TNFRs, it resulted in increased TNF-induced activation of NF-kappa B, consistent with an allosteric modification of the TNFRs. Taken together, these results suggest that oxidative stress promotes TNFR receptor self-interaction and ligand-independent and enhanced ligand-dependent TNF signaling.	[Ozsoy, Hatice Z.; Sivasubramanian, Natarajan; Mann, Douglas L.] Baylor Coll Med, Winters Ctr Heart Failure Res, Cardiol Sect, Dept Med, Houston, TX 77030 USA; [Pedersen, Steen; Mann, Douglas L.] Baylor Coll Med, Winters Ctr Heart Failure Res, Cardiol Sect, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Wieder, Eric D.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Wieder, Eric D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Mann, DL (corresponding author), Fac Ctr, 1709 Dryden Rd,BCM620,FC 9-83, Houston, TX 77030 USA.	dmann@bcm.tmc.edu	Mann, Douglas Lowell/AAQ-3524-2021	Mann, Douglas/0000-0002-2516-0145; Pedersen, Steen E./0000-0001-8755-8899	National Institutes of Health [P50 HL-O6H, R01 HL58081, R01 HL61543, HL42250]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058081, R01HL061543, R01HL042250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 HL-O6H, R01 HL58081, R01 HL61543, and HL42250.	BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Baumgarten G, 2001, J INFECT DIS, V183, P1617, DOI 10.1086/320712; Bazzoni F, 1995, J INFLAMM, V45, P221; Behura SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/j.ibmb.2006.10.006; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Conner EM, 1996, NUTRITION, V12, P274, DOI 10.1016/S0899-9007(96)00000-8; De Wit R, 2000, FREE RADICAL BIO MED, V28, P28, DOI 10.1016/S0891-5849(99)00199-9; DING AH, 1989, J BIOL CHEM, V264, P3924; Dominici S, 1999, FREE RADICAL BIO MED, V27, P623, DOI 10.1016/S0891-5849(99)00111-2; Dominici S, 2004, ANN NY ACAD SCI, V1030, P62, DOI 10.1196/annals.1329.008; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Gautam A, 2001, MOL THER, V3, P551, DOI 10.1006/mthe.2001.0300; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Knuefermann P, 2002, J BIOL CHEM, V277, P23888, DOI 10.1074/jbc.M202937200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Maellaro E, 2000, J CELL SCI, V113, P2671; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Peus D, 1999, J INVEST DERMATOL, V112, P751, DOI 10.1046/j.1523-1747.1999.00584.x; Robertson SC, 1998, P NATL ACAD SCI USA, V95, P4567, DOI 10.1073/pnas.95.8.4567; Schmid E, 1998, FASEB J, V12, P863, DOI 10.1096/fasebj.12.10.863; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; WATOWICH SS, 1992, P NATL ACAD SCI USA, V89, P2140, DOI 10.1073/pnas.89.6.2140; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262	30	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23419	23428		10.1074/jbc.M802967200	http://dx.doi.org/10.1074/jbc.M802967200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18544535	Green Published, hybrid			2022-12-25	WOS:000258455400051
J	Osenkowski, P; Ye, W; Wang, R; Wolfe, MS; Selkoe, DJ				Osenkowski, Pamela; Ye, Wenjuan; Wang, Rong; Wolfe, Michael S.; Selkoe, Dennis J.			Direct and potent regulation of gamma-secretase by its lipid microenvironment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; IN-VIVO; MEMBRANE-PROTEINS; TOTAL CHOLESTEROL; CELL-SURFACE; BETA-PROTEIN; PRESENILIN; COMPLEX; RECONSTITUTION	gamma-Secretase is an unusual and ubiquitous aspartyl protease with an intramembrane catalytic site that cleaves many type-I integral membrane proteins, most notably APP and Notch. Several reports suggest that cleavage of APP to produce the A beta peptide is regulated in part by lipids. As gamma-secretase is a multi-pass protein complex with 19 transmembrane domains, it is likely that the local lipid composition of the membrane can regulate gamma-activity. To determine the direct contribution of the lipid microenvironment to gamma-secretase activity, we purified the human protease from overexpressing mammalian cells, reconstituted it in vesicles of varying lipid composition, and examined the effects of individual phospholipids, sphingolipids, cholesterol, and complex lipid mixtures on substrate cleavage. A conventional gamma-activity assay was modified to include a detergent-removal step to facilitate proteoliposome formation, and this increased baseline activity over 2-fold. Proteoliposomes containing sphingolipids significantly increased gamma-secretase activity over a phosphatidylcholine-only baseline, whereas the addition of phosphatidylinositol significantly decreased activity. Addition of soluble cholesterol in the presence of phospholipids and sphingolipids robustly increased the cleavage of APP- and Notch-like substrates in a dose-dependent manner. Reconstitution of gamma-secretase in complex lipid mixtures revealed that a lipid raft-like composition supported the highest level of activity compared with other membrane compositions. Taken together, these results demonstrate that membrane lipid composition is a direct and potent modulator of gamma-secretase and that cholesterol, in particular, plays a major regulatory role.	[Osenkowski, Pamela; Ye, Wenjuan; Wolfe, Michael S.; Selkoe, Dennis J.] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Osenkowski, Pamela; Ye, Wenjuan; Wolfe, Michael S.; Selkoe, Dennis J.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Wang, Rong] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Icahn School of Medicine at Mount Sinai	Wolfe, MS (corresponding author), Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	mwolfe@rics.bwh.harvard.edu; dselkoe@rics.bwh.harvard.edu	Wang, Rong/A-8721-2009		NIA NIH HHS [AG00222-15, AG15379, AG17574] Funding Source: Medline; NINDS NIH HHS [NS41355] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015379, R01AG017574] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEEL AJ, 2008, CELL MOL LIFE SCI; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; Burns M, 2003, J NEUROSCI, V23, P5645; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hartmann T, 2007, J NEUROCHEM, V103, P159, DOI 10.1111/j.1471-4159.2007.04715.x; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; KADOWAKI H, 1994, J LIPID RES, V35, P1956; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kalanj S, 1991, Neurol Croat, V40, P269; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; LEVY D, 1990, BIOCHIM BIOPHYS ACTA, V1025, P179, DOI 10.1016/0005-2736(90)90096-7; NITSCH RM, 1992, P NATL ACAD SCI USA, V89, P1671, DOI 10.1073/pnas.89.5.1671; Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rigaud JL, 2002, BRAZ J MED BIOL RES, V35, P753, DOI 10.1590/S0100-879X2002000700001; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; SANDERMANN H, 1978, BIOCHIM BIOPHYS ACTA, V515, P209, DOI 10.1016/0304-4157(78)90015-1; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; STOKES CE, 1987, J NEUROCHEM, V48, P1018, DOI 10.1111/j.1471-4159.1987.tb05619.x; SVENNERHOLM L, 1994, J NEUROCHEM, V62, P1039; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247; Vance DE, 2002, BIOCH LIPIDS LIPOPRO; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Wells K, 1995, NEUROCHEM RES, V20, P1329, DOI 10.1007/BF00992508; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wrigley JDJ, 2005, J BIOL CHEM, V280, P12523, DOI 10.1074/jbc.M413086200; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Zha Q, 2004, MOL PSYCHIATR, V9, P946, DOI 10.1038/sj.mp.4001509	53	209	214	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22529	22540		10.1074/jbc.M801925200	http://dx.doi.org/10.1074/jbc.M801925200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18539594	Green Published, hybrid			2022-12-25	WOS:000258321000021
J	Doege, H; Grimm, D; Falcon, A; Tsang, B; Storm, TA; Xu, H; Ortegon, AM; Kazantzis, M; Kay, MA; Stahl, A				Doege, Holger; Grimm, Dirk; Falcon, Alaric; Tsang, Bernice; Storm, Theresa A.; Xu, Hui; Ortegon, Angelica M.; Kazantzis, Melissa; Kay, Mark A.; Stahl, Andreas			Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves Hyperglycemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID TRANSPORT PROTEIN; INSULIN-RESISTANCE; UNITED-STATES; MICE; STEATOSIS; OBESITY; INHIBITION; PREVALENCE; MECHANISM; VECTORS	Non-alcoholic fatty liver disease is a serious health problem linked to obesity and type 2 diabetes. To investigate the biological outcome and therapeutic potential of hepatic fatty acid uptake inhibition, we utilized an adeno-associated virus-mediated RNA interference technique to knock down the expression of hepatic fatty acid transport protein 5 in vivo prior to or after establishing non-alcoholic fatty liver disease in mice. Using this approach, we demonstrate here the ability to achieve specific, non-toxic, and persistent knockdown of fatty acid transport protein 5 in mouse livers from a single adeno-associated virus injection, resulting in a marked reduction of hepatic dietary fatty acid uptake, reduced caloric uptake, and concomitant protection from diet-induced non-alcoholic fatty liver disease. Importantly, knockdown of fatty acid transport protein 5 was also able to reverse already established non-alcoholic fatty liver disease, resulting in significantly improved whole-body glucose homeostasis. Thus, continued activity of hepatic fatty acid transport protein 5 is required to sustain caloric uptake and fatty acid flux into the liver during high fat feeding and may present a novel avenue for the treatment of non-alcoholic fatty liver disease.	[Falcon, Alaric; Ortegon, Angelica M.; Kazantzis, Melissa; Stahl, Andreas] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Doege, Holger] Palo Alto Med Fdn, Res Inst, Palo Alto, CA 94301 USA; [Doege, Holger; Tsang, Bernice] Stanford Univ, Dept GI Hepatol, Stanford, CA 94305 USA; [Grimm, Dirk; Storm, Theresa A.; Xu, Hui; Kay, Mark A.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Grimm, Dirk; Storm, Theresa A.; Xu, Hui; Kay, Mark A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California Berkeley; Palo Alto Medical Foundation Research Institute; Stanford University; Stanford University; Stanford University	Stahl, A (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 119 Morgan Hall, Berkeley, CA 94720 USA.	AStahl@Berkeley.edu		Kay, Mark/0000-0002-2799-2615	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078424, R01DK066336, R56DK066336] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK78424, DK066336] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Doege H, 2006, GASTROENTEROLOGY, V130, P1245, DOI 10.1053/j.gastro.2006.02.006; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; FOLCH J, 1957, J BIOL CHEM, V226, P497; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Laurin J, 1996, HEPATOLOGY, V23, P1464; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; STREMMEL W, 1989, J HEPATOL, V9, P374, DOI 10.1016/0168-8278(89)90148-7; Westerbacka J, 2005, J CLIN ENDOCR METAB, V90, P2804, DOI 10.1210/jc.2004-1983; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783	31	108	115	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22186	22192		10.1074/jbc.M803510200	http://dx.doi.org/10.1074/jbc.M803510200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18524776	Green Published, hybrid			2022-12-25	WOS:000258114700038
J	Smith, L; Smallwood, N; Altman, A; Liedtke, CM				Smith, Laura; Smallwood, Nicole; Altman, Amnon; Liedtke, Carole M.			PKC delta acts upstream of SPAK in the activation of NKCC1 by hyperosmotic stress in human airway epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; ALANINE-RICH KINASE; NA-K-2CL COTRANSPORTER; PROTEIN-KINASE; NA+-K+-2CL(-) COTRANSPORTER; WNK KINASES; PHOSPHORYLATION; LOCALIZATION; EXPRESSION; SUBSTRATE	Airway epithelial Na-K-2Cl (NKCC1) cotransport is activated through hormonal stimulation and hyperosmotic stress via a protein kinase C (PKC) delta-mediated intracellular signaling pathway. Down-regulation of PKC delta prevents activation of NKCC1 expressed in Calu-3 cells. Previous studies of this signaling pathway identified coimmunoprecipitation of PKC delta with SPAK (Ste20-related proline alanine-rich kinase). We hypothesize that endogenous PKC delta activates SPAK, which subsequently activates NKCC1 through phosphorylation. Double-stranded silencing RNA directed against SPAK reduced SPAK protein expression by 65.8% and prevented increased phosphorylation of NKCC1 and functional activation of NKCC1 during hyperosmotic stress, measured as bumetanide-sensitive basolateral to apical 86Rb flux. Using recombinant proteins, we demonstrate direct binding of PKC delta to SPAK, PKC delta-mediated activation of SPAK, binding of SPAK to the amino terminus of NKCC1 (NT-NKCC1, amino acids 1-286), and competitive inhibition of SPAK-NKCC1 binding by a peptide encoding a SPAK binding site on NT-NKCC1. The carboxyl terminus of SPAK (amino acids 316-548) pulls down endogenous NKCC1 from Calu-3 total cell lysates and glutathione S-transferase-tagged NT-NKCC1 pulls down endogenous SPAK. In intact cells, hyperosmotic stress increased phosphorylated PKC delta, indicating activation of PKC delta, and activity of endogenous SPAK kinase. Inhibition of PKC delta activity with rottlerin blocked the increase in SPAK kinase activity. The results indicate that PKC delta acts upstream of SPAK to increase activity of NKCC1 during hyperosmotic stress.	[Smith, Laura; Smallwood, Nicole; Liedtke, Carole M.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Smith, Laura; Smallwood, Nicole; Liedtke, Carole M.] Case Western Reserve Univ, Dept Physiol, Cleveland, OH 44106 USA; [Smith, Laura; Smallwood, Nicole; Liedtke, Carole M.] Case Western Reserve Univ, Dept Biophys, Cleveland, OH 44106 USA; [Altman, Amnon] La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; La Jolla Institute for Immunology	Liedtke, CM (corresponding author), Case Western Reserve Univ, Dept Pediat, 2109 Adelbert Rd,824 BRB, Cleveland, OH 44106 USA.	carole.liedtke@case.edu			NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058598] Funding Source: NIH RePORTER; NCI NIH HHS [CA-35299] Funding Source: Medline; NHLBI NIH HHS [HL-58598] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andersen GO, 2004, AM J PHYSIOL-HEART C, V286, pH1354, DOI 10.1152/ajpheart.00549.2003; Cai H, 2006, KIDNEY INT, V69, P2162, DOI 10.1038/sj.ki.5000333; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; Crouch JJ, 1997, J HISTOCHEM CYTOCHEM, V45, P773, DOI 10.1177/002215549704500601; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Galan A, 2005, NEUROSCIENCE, V133, P245, DOI 10.1016/j.neuroscience.2005.02.025; Goto S, 1997, BRAIN RES, V765, P324, DOI 10.1016/S0006-8993(97)00679-3; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kurihara K, 2002, AM J PHYSIOL-CELL PH, V282, pC817, DOI 10.1152/ajpcell.00352.2001; Kurihara K, 1999, AM J PHYSIOL-CELL PH, V277, pC1184, DOI 10.1152/ajpcell.1999.277.6.C1184; Lenart B, 2004, J NEUROSCI, V24, P9585, DOI 10.1523/JNEUROSCI.2569-04.2004; Li YQ, 2004, EMBO J, V23, P1112, DOI 10.1038/sj.emboj.7600125; Liedtke CM, 2005, J BIOL CHEM, V280, P25491, DOI 10.1074/jbc.M504473200; Liedtke CM, 2003, AM J PHYSIOL-CELL PH, V284, pC487, DOI 10.1152/ajpcell.00357.2002; Liedtke CM, 2002, BBA-MOL CELL RES, V1589, P77, DOI 10.1016/S0167-4889(01)00189-6; Liedtke CM, 2001, AM J PHYSIOL-LUNG C, V280, pL739, DOI 10.1152/ajplung.2001.280.4.L739; Liedtke CM, 1997, AM J PHYSIOL-CELL PH, V273, pC1632, DOI 10.1152/ajpcell.1997.273.5.C1632; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Marshall WS, 2005, J EXP BIOL, V208, P1063, DOI 10.1242/jeb.01491; Mizuta K, 1997, HEARING RES, V106, P154, DOI 10.1016/S0378-5955(97)00010-5; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173, DOI 10.1152/ajpcell.1997.272.1.C173; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Smallwood ND, 2005, AM J PHYSIOL-CELL PH, V288, pC906, DOI 10.1152/ajpcell.00484.2004; Sung KW, 2000, J NEUROSCI, V20, P7531; Ushiro H, 1998, ARCH BIOCHEM BIOPHYS, V355, P233, DOI 10.1006/abbi.1998.0736; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093	42	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22147	22156		10.1074/jbc.M801752200	http://dx.doi.org/10.1074/jbc.M801752200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550547	Green Published, hybrid			2022-12-25	WOS:000258114700034
J	Schmidt, A; Gruber, K; Kratky, C; Lamzin, VS				Schmidt, Andrea; Gruber, Karl; Kratky, Christoph; Lamzin, Victor S.			Atomic resolution crystal structures and quantum chemistry meet to reveal subtleties of hydroxynitrile lyase catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; HEVEA-BRASILIENSIS; (S)-HYDROXYNITRILE LYASE; ACTIVE-SITE; MECHANISM; BOND; (S)-CYANOHYDRINS; REFINEMENT; PROGRAM	Hydroxynitrile lyases are versatile enzymes that enantiospecifically cope with cyanohydrins, important intermediates in the production of various agrochemicals or pharmaceuticals. We determined four atomic resolution crystal structures of hydroxynitrile lyase from Hevea brasiliensis: one native and three complexes with acetone, isopropyl alcohol, and thiocyanate. We observed distinct distance changes among the active site residues related to proton shifts upon substrate binding. The combined use of crystallography and ab initio quantum chemical calculations allowed the determination of the protonation states in the enzyme active site. We show that His(235) of the catalytic triad must be protonated in order for catalysis to proceed, and we could reproduce the cyanohydrin synthesis in ab initio calculations. We also found evidence for the considerable pK(a) shifts that had been hypothesized earlier. We envision that this knowledge can be used to enhance the catalytic properties and the stability of the enzyme for industrial production of enantiomerically pure cyanohydrins.	[Schmidt, Andrea; Lamzin, Victor S.] DESY, EMBL Hamburg, D-22607 Hamburg, Germany; [Gruber, Karl; Kratky, Christoph] Karl Franzens Univ Graz, Inst Chem, A-8010 Graz, Austria	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Graz	Schmidt, A (corresponding author), DESY, EMBL Hamburg, Notkestr 85, D-22607 Hamburg, Germany.	andrea@embl-hamburg.de	Gruber, Karl/GPP-6706-2022	Gruber, Karl/0000-0002-3485-9740; Lamzin, Victor/0000-0002-6058-7793				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bauer M, 1999, BIOTECHNOL BIOENG, V62, P20, DOI 10.1002/(SICI)1097-0290(19990105)62:1&lt;20::AID-BIT3&gt;3.0.CO;2-I; Conn EE, 1981, BIOCH PLANTS COMPREH; EFFENBERGER F, 1994, ANGEW CHEM INT EDIT, V33, P1555, DOI 10.1002/anie.199415551; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Gartler G, 2007, J BIOTECHNOL, V129, P87, DOI 10.1016/j.jbiotec.2006.12.009; Gruber K, 2004, J BIOL CHEM, V279, P20501, DOI 10.1074/jbc.M401575200; Gruber K, 1999, BIOL CHEM, V380, P993, DOI 10.1515/BC.1999.123; Hanefeld U, 2001, BBA-PROTEIN STRUCT M, V1544, P133, DOI 10.1016/S0167-4838(00)00212-0; Hasslacher M, 1997, PROTEINS, V27, P438; Hasslacher M, 1996, J BIOL CHEM, V271, P5884, DOI 10.1074/jbc.271.10.5884; Hickel A, 1996, PHYSIOL PLANTARUM, V98, P891, DOI 10.1111/j.1399-3054.1996.tb06700.x; Johnson DV, 1997, TETRAHEDRON, V53, P617, DOI 10.1016/S0040-4020(96)01023-X; Johnson DV, 2000, CURR OPIN CHEM BIOL, V4, P103, DOI 10.1016/S1367-5931(99)00059-9; JOHNSON DV, 1998, ADV BIOCHEM ENG BIOT, V63, P31; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEMPIER N, 1995, TETRAHEDRON-ASYMMETR, V6, P845, DOI 10.1016/0957-4166(95)00085-4; KLEMPIER N, 1993, TETRAHEDRON LETT, V34, P4769, DOI 10.1016/S0040-4039(00)74084-6; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRUSE CG, 1992, CHIRALITY IND; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1993, GRASP; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Sheldrick G. M., 1997, SHELXL 97; Stranzl GR, 2004, J BIOL CHEM, V279, P3699, DOI 10.1074/jbc.M306814200; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Wagner UG, 1996, ACTA CRYSTALLOGR D, V52, P591, DOI 10.1107/S0907444995016830; Wagner UG, 1996, STRUCTURE, V4, P811, DOI 10.1016/S0969-2126(96)00088-3; Wajant H, 1996, BIOL CHEM, V377, P611; Zuegg J, 1999, PROTEIN SCI, V8, P1990, DOI 10.1110/ps.8.10.1990	33	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21827	21836		10.1074/jbc.M801056200	http://dx.doi.org/10.1074/jbc.M801056200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18524775	hybrid			2022-12-25	WOS:000257898800056
J	Qi, Z; Miller, GW; Voit, EO				Qi, Zhen; Miller, Gary W.; Voit, Eberhard O.			Computational Systems Analysis of Dopamine Metabolism	PLOS ONE			English	Article							PARKINSONS-DISEASE; MONOAMINE-OXIDASE; ACETYLCHOLINE-RECEPTORS; ALPHA-SYNUCLEIN; MOUSE MODEL; MICE; IRON; LOCOMOTION; LAW; CATECHOLAMINES	A prominent feature of Parkinson's disease (PD) is the loss of dopamine in the striatum, and many therapeutic interventions for the disease are aimed at restoring dopamine signaling. Dopamine signaling includes the synthesis, storage, release, and recycling of dopamine in the presynaptic terminal and activation of pre- and post-synaptic receptors and various downstream signaling cascades. As an aid that might facilitate our understanding of dopamine dynamics in the pathogenesis and treatment in PD, we have begun to merge currently available information and expert knowledge regarding presynaptic dopamine homeostasis into a computational model, following the guidelines of biochemical systems theory. After subjecting our model to mathematical diagnosis and analysis, we made direct comparisons between model predictions and experimental observations and found that the model exhibited a high degree of predictive capacity with respect to genetic and pharmacological changes in gene expression or function. Our results suggest potential approaches to restoring the dopamine imbalance and the associated generation of oxidative stress. While the proposed model of dopamine metabolism is preliminary, future extensions and refinements may eventually serve as an in silico platform for prescreening potential therapeutics, identifying immediate side effects, screening for biomarkers, and assessing the impact of risk factors of the disease.	[Qi, Zhen; Voit, Eberhard O.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Qi, Zhen; Miller, Gary W.] Emory Univ, Rollins Sch Publ Hlth, Dept Env & Occupat Hlth, Atlanta, GA USA; [Qi, Zhen; Miller, Gary W.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; Emory University; Rollins School Public Health; Emory University	Qi, Z (corresponding author), Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.	eberhard.voit@bme.gatech.edu	Qi, Zhen/A-6273-2011		Woodruff Health Science Center; NIH [U54-ES012068]; Georgia Research Alliance; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870, U54ES012068] Funding Source: NIH RePORTER	Woodruff Health Science Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a Woodruff Health Science Center Fund grant, NIH grant number U54-ES012068, and an endowment from the Georgia Research Alliance.	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Alves R, 2004, PROTEINS, V56, P354, DOI 10.1002/prot.20110; Andersen JK, 2004, J ALZHEIMERS DIS, V6, pS47; ANTON AH, 1964, J PHARMACOL EXP THER, V145, P326; Barbano PE, 2007, P NATL ACAD SCI USA, V104, P19169, DOI 10.1073/pnas.0709955104; BARBEAU A, 1961, ARCH NEUROL-CHICAGO, V4, P97, DOI 10.1001/archneur.1961.00450070099011; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; CARLSSON A, 1959, PHARMACOL REV, V11, P490; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chen K, 2004, J BIOL CHEM, V279, P39645, DOI 10.1074/jbc.M405550200; Colebrooke RE, 2006, EUR J NEUROSCI, V24, P2622, DOI 10.1111/j.1460-9568.2006.05143.x; Doudet DJ, 1997, EUR J PHARMACOL, V334, P31, DOI 10.1016/S0014-2999(97)01157-6; Faucheux BA, 2003, J NEUROCHEM, V86, P1142, DOI 10.1046/j.1471-4159.2003.01923.x; Fernandez E, 2006, PLOS COMPUT BIOL, V2, P1619, DOI 10.1371/journal.pcbi.0020176; Fernandez HH, 2007, CLIN NEUROPHARMACOL, V30, P150, DOI 10.1097/01.WNF.0000240956.49315.BE; Fumagalli F, 1998, Adv Pharmacol, V42, P179; Gesi M, 2001, PHARMACOL TOXICOL, V89, P217, DOI 10.1034/j.1600-0773.2001.d01-151.x; Glatt CE, 2006, HUM MOL GENET, V15, P299, DOI 10.1093/hmg/ddi445; Goldman AI, 2007, GRAZER PHILOS STUD, V74, P1; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Hakansson K, 2004, PARKINSONISM RELAT D, V10, P281, DOI 10.1016/j.parkreldis.2004.02.010; Huotari M, 2002, EUR J NEUROSCI, V15, P246, DOI 10.1046/j.0953-816x.2001.01856.x; Huotari M, 2002, J PHARMACOL EXP THER, V303, P1309, DOI 10.1124/jpet.102.043042; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; JUSTICE JB, 1988, J NEUROSCI METH, V22, P239, DOI 10.1016/0165-0270(88)90045-3; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaur D, 2007, NEUROBIOL AGING, V28, P907, DOI 10.1016/j.neurobiolaging.2006.04.003; Kaushik P, 2007, J COMPUT NEUROSCI, V22, P147, DOI 10.1007/s10827-006-0004-8; Kawahara K, 2008, J BIOL CHEM, V283, P6979, DOI 10.1074/jbc.M710418200; Kim DS, 2000, J NEUROSCI, V20, P4405, DOI 10.1523/JNEUROSCI.20-12-04405.2000; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Leung TW, 2006, INT J STROKE, V1, P20, DOI 10.1111/j.1747-4949.2005.00014.x; Lindskog M, 2006, PLOS COMPUT BIOL, V2, P1045, DOI 10.1371/journal.pcbi.0020119; Matsunaga J, 1999, J BIOL CHEM, V274, P3268, DOI 10.1074/jbc.274.6.3268; Mooslehner KA, 2001, MOL CELL BIOL, V21, P5321, DOI 10.1128/MCB.21.16.5321-5331.2001; NAPOLITANO A, 1995, EUR J PHARMACOL, V273, P215, DOI 10.1016/0014-2999(94)00682-W; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Phillips JM, 2006, EUR J NEUROSCI, V23, P151, DOI 10.1111/j.1460-9568.2005.04550.x; Przeslawski R, 2005, GLOBAL CHANGE BIOL, V11, P515, DOI 10.1111/j.1365-2486.2005.00918.x; Quik M, 2006, J PHARMACOL EXP THER, V316, P481, DOI 10.1124/jpet.105.094375; SANO I, 1959, BIOCHIM BIOPHYS ACTA, V32, P586, DOI 10.1016/0006-3002(59)90652-3; SATO K, 1994, NEUROSCI LETT, V173, P59, DOI 10.1016/0304-3940(94)90149-X; SAVAGEAU MA, 1987, MATH BIOSCI, V87, P83, DOI 10.1016/0025-5564(87)90035-6; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P370, DOI 10.1016/S0022-5193(69)80027-5; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; SAVAGEAU MA, 1970, J THEOR BIOL, V26, P215, DOI 10.1016/S0022-5193(70)80013-3; SAVAGEAU MA, 1976, BIOCHEMICAL SYSTEMS, P199; Schomburg I, 2002, TRENDS BIOCHEM SCI, V27, P54, DOI 10.1016/S0968-0004(01)02027-8; SCHULZ AR, 1994, ENZYME KINETICS; Shoulson I, 1998, ANN NEUROL, V44, pS160, DOI 10.1002/ana.410440724; Sossi V, 2007, ANN NEUROL, V62, P468, DOI 10.1002/ana.21204; Stocchi F, 2006, NEUROLOGY, V67, pS24, DOI 10.1212/WNL.67.7_suppl_2.S24; Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C; Sun YF, 2001, ACTA PHARMACOL SIN, V22, P243; Takahashi N, 1997, P NATL ACAD SCI USA, V94, P9938, DOI 10.1073/pnas.94.18.9938; TORRES NV, 2002, PATHWAY ANAL OPTIMIZ, pP14; Tyce G M, 1990, J Neural Transm Suppl, V29, P233; Voit EO, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3454323; VOIT EO, 1993, ENVIRONMETRICS, V4, P153, DOI 10.1002/env.3170040203; Voit EO, 2004, BIOINFORMATICS, V20, P1670, DOI 10.1093/bioinformatics/bth140; VOIT EO, 2000, COMPUTATIONAL ANAL B, pR12; VOIT EO, 1991, CONONICAL NONLINEAR, pR11; von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007; Youdim MBH, 2006, BRIT J PHARMACOL, V147, pS287, DOI 10.1038/sj.bjp.0706464; Yuan Hong, 2007, Neurosci Bull, V23, P125, DOI 10.1007/s12264-007-0018-x	65	53	54	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2444	10.1371/journal.pone.0002444	http://dx.doi.org/10.1371/journal.pone.0002444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18568086	Green Published, Green Submitted, gold			2022-12-25	WOS:000263280700029
J	Sun, C; Dobi, A; Mohamed, A; Li, H; Thangapazham, RL; Furusato, B; Shaheduzzaman, S; Tan, SH; Vaidyanathan, G; Whitman, E; Hawksworth, DJ; Chen, Y; Nau, M; Patel, V; Vahey, M; Gutkind, JS; Sreenath, T; Petrovics, G; Sesterhenn, IA; McLeod, DG; Srivastava, S				Sun, C.; Dobi, A.; Mohamed, A.; Li, H.; Thangapazham, R. L.; Furusato, B.; Shaheduzzaman, S.; Tan, S-H; Vaidyanathan, G.; Whitman, E.; Hawksworth, D. J.; Chen, Y.; Nau, M.; Patel, V.; Vahey, M.; Gutkind, J. S.; Sreenath, T.; Petrovics, G.; Sesterhenn, I. A.; McLeod, D. G.; Srivastava, S.			TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation	ONCOGENE			English	Article						ERG; prostate cancer; oncogene; C-MYC; PSA; TMPRSS2-ERG	ETS TRANSCRIPTION FACTOR; ANDROGEN RECEPTOR; EXPRESSION; REARRANGEMENTS; LEUKEMIA; TARGETS; ADULTS; GENES; ERG	The high prevalence of TMPRSS2-ERG rearrangements (similar to 60%) in prostate cancer (CaP) leads to androgenic induction of the ETS-related gene (ERG) expression. However, the biological functions of ERG overexpression in CaP remain to be understood. ERG knockdown in TMPRSS2-ERG expressing CaP cells induced striking morphological changes and inhibited cell growth both in cell culture and SCID mice. Evaluation of the transcriptome and specific gene promoters in ERG siRNA-treated cells and investigation of gene expression signatures of human prostate tumors revealed ERG-mediated activation of C-MYC oncogene and the repression of prostate epithelial differentiation genes (PSA and SLC45A3/Prostein). Taken together, these data combining cell culture and animal models and human prostate tumors reveal that ERG overexpression in prostate tumor cells may contribute to the neoplastic process by activating C-MYC and by abrogating prostate epithelial differentiation as indicated by prostate epithelial specific markers.	[Sun, C.; Dobi, A.; Mohamed, A.; Li, H.; Thangapazham, R. L.; Furusato, B.; Shaheduzzaman, S.; Tan, S-H; Vaidyanathan, G.; Whitman, E.; Hawksworth, D. J.; Chen, Y.; Sreenath, T.; Petrovics, G.; McLeod, D. G.; Srivastava, S.] Uniformed Serv Univ Hlth Sci, Ctr Prostate Dis Res, Dept Surg, Rockville, MD 20852 USA; [Furusato, B.; Sesterhenn, I. A.] Armed Forces Inst Pathol, Dept Genitourinary Pathol, Washington, DC 20306 USA; [Whitman, E.; Hawksworth, D. J.; McLeod, D. G.] Walter Reed Army Med Ctr, Urol Serv, Dept Surg, Washington, DC 20307 USA; [Nau, M.; Vahey, M.] Walter Reed Army Inst Res, Div Retrovirol, Rockville, MD USA; [Patel, V.; Gutkind, J. S.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, Natl Inst Hlth, Bethesda, MD USA; [Dobi, A.; Sesterhenn, I. A.; McLeod, D. G.; Srivastava, S.] US Mil Canc Inst, Washington, DC USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Srivastava, S (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Prostate Dis Res, Dept Surg, 1530 E Jefferson St, Rockville, MD 20852 USA.	ssrivastava@cpdr.org	Jackson, Benjamin L/C-4297-2012; Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016; Tan, Shyh-Han/I-7037-2013	Gutkind, J. Silvio/0000-0002-5150-4482; Tan, Shyh-Han/0000-0001-8250-7005; Furusato, Bungo/0000-0003-4614-9882; Petrovics, Gyorgy/0000-0003-3732-284X	US Army Medical Research and Materiel Command; NIH Grants [RO1 DK065977, RO1 CA106653]; NATIONAL CANCER INSTITUTE [R01CA106653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065977] Funding Source: NIH RePORTER	US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NIH Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Authors express sincere thanks to Ms Lakshmi Ravindranath, Ms Atekelt Y Tadese, Ms Suma Ravulapalli and Mr Christopher Cook for their superb technical support of this study. The prostate tissue specimens used in this study were obtained under an IRB-approved protocol at Walter Reed Army Medical Center. This work was funded by the CPDR through an ongoing grant from the US Army Medical Research and Materiel Command, NIH Grants RO1 DK065977 to S. S and G. P. and RO1 CA106653 to S. S. and A. D. The views expressed in this manuscript are those of the authors and do not reflect the official policy of the Department of the Army, Department of Defense or the US Government.	Baldus CD, 2006, J CLIN ONCOL, V24, P4714, DOI 10.1200/JCO.2006.06.1580; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Demichelis F, 2007, J CLIN PATHOL, V60, P1185, DOI 10.1136/jcp.2007.046557; Furusato B, 2008, MODERN PATHOL, V21, P67, DOI 10.1038/modpathol.3800981; Iljin K, 2006, CANCER RES, V66, P10242, DOI 10.1158/0008-5472.CAN-06-1986; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Korenchuk S, 2001, IN VIVO, V15, P163; Lin BY, 1999, CANCER RES, V59, P4180; Marcucci G, 2005, CURR OPIN HEMATOL, V12, P68, DOI 10.1097/01.moh.0000149608.29685.d1; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; MEULIA T, 1992, MOL CELL BIOL, V12, P4590, DOI 10.1128/MCB.12.10.4590; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Owczarek CM, 2004, GENE, V324, P65, DOI 10.1016/j.gene.2003.09.047; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; Scherf M, 2005, BRIEF BIOINFORM, V6, P287, DOI 10.1093/bib/6.3.287; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; SHAHEDUZZAMAN S, 2007, CANCER BIOL THER, V6, P1; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Turner DP, 2008, EXPERT REV ANTICANC, V8, P33, DOI 10.1586/14737140.8.1.33; Witte JS, 2007, NAT GENET, V39, P579, DOI 10.1038/ng0507-579	22	184	197	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 11	2008	27	40					5348	5353		10.1038/onc.2008.183	http://dx.doi.org/10.1038/onc.2008.183			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	346UW	18542058	Green Accepted			2022-12-25	WOS:000259096100007
J	Hasegawa, T; Enomoto, A; Kato, T; Kawai, K; Miyamoto, R; Jijiwa, M; Ichihara, M; Ishida, M; Asai, N; Murakumo, Y; Ohara, K; Niwa, Y; Goto, H; Takahashi, M				Hasegawa, T.; Enomoto, A.; Kato, T.; Kawai, K.; Miyamoto, R.; Jijiwa, M.; Ichihara, M.; Ishida, M.; Asai, N.; Murakumo, Y.; Ohara, K.; Niwa, Y.; Goto, H.; Takahashi, M.			Roles of induced expression of MAPK phosphatase-2 in tumor development in RET-MEN2A transgenic mice	ONCOGENE			English	Article						RET; MEN2A; MKP-2; cell proliferation; cell cycle	ACTIVATED PROTEIN-KINASE; CELL-CYCLE ARREST; NEOPLASIA TYPE 2B; RET PROTOONCOGENE; LACKING GDNF; HIRSCHSPRUNGS-DISEASE; TERMINAL KINASE; THYROID-CANCER; 2A MUTATION; GENE	Germline mutations in the RET tyrosine kinase gene are responsible for the development of multiple endocrine neoplasia 2A and 2B (MEN2A and MEN2B). However, knowledge of the fundamental principles that determine the mutant RET-mediated signaling remains elusive. Here, we report increased expression of mitogen-activated protein kinase phosphatase-2 (MKP-2) in carcinomas developed in transgenic mice carrying RET with the MEN2A mutation (RET-MEN2A). The expression of MKP-2 was not only induced by RET-MEN2A or RET-MEN2B mutant proteins but also by the activation of endogenous RET by its ligand, glial cell line-derived neurotrophic factor (GDNF). MKP-2 expression was also evident in the MKK-f cell line, which was established from a mammary tumor developed in a RET- MEN2A transgenic mouse. Inhibition of MKP-2 attenuated the in vitro and in vivo proliferation of MKK-f cells, which was mediated by the suppression of cyclin B1 expression. Furthermore, we found that MKP-2 is highly expressed in medullary thyroid carcinomas derived from MEN2A patients. These findings suggest that the increased expression of MKP-2 may play a crucial role in oncogenic signaling downstream of mutant RET, leading to deregulation of cell cycle.	[Hasegawa, T.; Enomoto, A.; Kato, T.; Kawai, K.; Miyamoto, R.; Jijiwa, M.; Ishida, M.; Asai, N.; Murakumo, Y.; Ohara, K.; Takahashi, M.] Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Hasegawa, T.; Ohara, K.; Niwa, Y.; Goto, H.] Nagoya Univ, Grad Sch Med, Dept Gastroenterol, Nagoya, Aichi 4668550, Japan; [Enomoto, A.] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4668550, Japan; [Ichihara, M.] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 487, Japan; [Takahashi, M.] Nagoya Univ, Grad Sch Med, Div Mol Pathol, Ctr Neurol Dis & Cancer, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University; Nagoya University; Chubu University; Nagoya University	Takahashi, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	mtakaha@med.nagoya-u.ac.jp	Takahashi, Masahide/AAN-4770-2020; TAKAHASHI, Masahide/I-7244-2014; ASAI, Naoya/I-7377-2014; Enomoto, Atsushi/I-7272-2014; Kumi, Kawai/I-6275-2014	Takahashi, Masahide/0000-0002-2803-2683; Enomoto, Atsushi/0000-0002-9206-6116; Kumi, Kawai/0000-0002-7772-2605	21st Century Center of Excellence (COE) Research; Scientific Research (A); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	21st Century Center of Excellence (COE) Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scientific Research (A)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K Hirose (Nagoya University) for providing the pNAMA shRNA expression vector, S Nakamura (Nagoya University Hospital) for providing sporadic and MEN2A MTC specimens and C Suzuki (Nagoya University) and T Urano (Shimane University) for helpful discussion. We also thank YGotoh (Tokyo University) for providing active MAPKK (pSR alpha-Delta SESE-MAPKK) and MKK6 (pcDNA3.1(+)-MKK6-EE) plasmids. This study was supported by Grants-in-Aid for The 21st Century Center of Excellence (COE) Research, Scientific Research (A) and Scientific Research on Priority Area 'Cancer' commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to MT).	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Asai N, 2006, PATHOL INT, V56, P164, DOI 10.1111/j.1440-1827.2006.01942.x; ASAI N, 1995, MOL CELL BIOL, V15, P1613; Cadalbert L, 2005, CELL SIGNAL, V17, P1254, DOI 10.1016/j.cellsig.2005.01.003; CARLSON KM, 1994, P NATL ACAD SCI USA, V91, P1579, DOI 10.1073/pnas.91.4.1579; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Eng C, 1999, J CLIN ONCOL, V17, P380, DOI 10.1200/JCO.1999.17.1.380; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Fukuda T, 2005, GENES CELLS, V10, P655, DOI 10.1111/j.1365-2443.2005.00866.x; Gimm O, 1997, J CLIN ENDOCR METAB, V82, P3902, DOI 10.1210/jc.82.11.3902; GUAN KL, 1995, J BIOL CHEM, V270, P7197, DOI 10.1074/jbc.270.13.7197; Hassan KA, 2002, CANCER RES, V62, P6414; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; Kao GD, 1997, CANCER RES, V57, P753; Kawai K, 2000, CANCER RES, V60, P5254; Kawai K, 2003, CANCER SCI, V94, P992, DOI 10.1111/j.1349-7006.2003.tb01390.x; Kodama Y, 2005, CANCER SCI, V96, P143, DOI 10.1111/j.1349-7006.2005.00023.x; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Park M, 2000, CANCER RES, V60, P542; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Porter Lisa A, 2003, Prog Cell Cycle Res, V5, P335; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Rosenthal A, 1999, NEURON, V22, P201, DOI 10.1016/S0896-6273(00)81077-6; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Santana C, 2002, MUTAT RES-FUND MOL M, V508, P49, DOI 10.1016/S0027-5107(02)00172-0; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Shen WH, 2006, CANCER RES, V66, P6033, DOI 10.1158/0008-5472.CAN-05-3878; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Smith DP, 1997, ONCOGENE, V15, P1213, DOI 10.1038/sj.onc.1201481; Soria JC, 2000, CANCER RES, V60, P4000; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Taylor WR, 1999, MOL BIOL CELL, V10, P3607, DOI 10.1091/mbc.10.11.3607; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Uchida M, 2006, J CELL SCI, V119, P3067, DOI 10.1242/jcs.03043; Wang JL, 2007, J BIOL CHEM, V282, P18521, DOI 10.1074/jbc.M610538200; Watanabe T, 2002, AM J PATHOL, V161, P249, DOI 10.1016/S0002-9440(10)64176-4; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yuan J, 2006, ONCOGENE, V25, P1753, DOI 10.1038/sj.onc.1209202; Yuan JP, 2004, ONCOGENE, V23, P5843, DOI 10.1038/sj.onc.1207757	52	24	24	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2008	27	43					5684	5695		10.1038/onc.2008.182	http://dx.doi.org/10.1038/onc.2008.182			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	352HM	18542059				2022-12-25	WOS:000259487100004
J	Durfee, LA; Kelley, ML; Huibregtse, JM				Durfee, Larissa A.; Kelley, Melissa L.; Huibregtse, Jon M.			The basis for selective E1-E2 interactions in the ISG15 conjugation system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; HUMAN-CELLS; E2 ENZYME; IDENTIFICATION; E1; DEGRADATION; TARGETS; PARKIN; DETERMINANTS; RECRUITMENT	E1 and E2 enzymes coordinate the first steps in conjugation of ubiquitin (Ub) and ubiquitin-like proteins (Ubls). ISG15 is an interferon-alpha/beta-induced Ubl, and the E1 and E2 enzymes for ISG15 conjugation are Ube1L and UbcH8, respectively. UbcH7 is the most closely related E2 to UbcH8, yet it does not function in ISG15 conjugation in vivo, while both UbcH7 and UbcH8 have been reported to function in Ub conjugation. Kinetic analyses of wild-type and chimeric E2s were performed to determine the basis for preferential activation of UbcH8 by Ube1L and to determine whether UbcH8 is activated equally well by Ube1L and E1(Ub) (Ube1). K-m determinations confirmed the strong preference of Ube1L for UbcH8 over UbcH7 (a 29-fold K-m difference), similar to the preference of E1(Ub) for UbcH7 over UbcH8 (a 36- fold K-m difference). Thioester assays of chimeric E2s identified two structural elements within residues 1-39 of UbcH8 that play a major role in defining Ube1L-UbcH8 specificity: the alpha 1-helix and the beta 1-beta 2 region. The C-terminal ubiquitin fold domain (UFD) of Ube1L was required for transfer of ISG15 to UbcH8 and for binding of Ube1L to UbcH8. Replacement of the Ube1L UFD with that from E1(Ub) resulted in preferential transfer of ISG15 to UbcH7. Together, these results indicate that Ube1L discriminates between UbcH8 and closely related Ub E2s based on specific interactions between the Ube1L UFD and determinants within the N-terminal region of UbcH8.	[Durfee, Larissa A.; Kelley, Melissa L.; Huibregtse, Jon M.] Univ Texas Austin, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Huibregtse, JM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, 2500 Speedway, Austin, TX 78712 USA.	huibreg@mail.utexas.edu			NCI [CA072943]; NATIONAL CANCER INSTITUTE [R01CA072943] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA072943 (to J.M.H.) from NCI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Beaudenon S, 2005, METHOD ENZYMOL, V398, P3, DOI 10.1016/S0076-6879(05)98001-4; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Chin LS, 2002, J BIOL CHEM, V277, P35071, DOI 10.1074/jbc.M203300200; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Fortier JM, 2006, J IMMUNOL, V176, P6454, DOI 10.4049/jimmunol.176.11.6454; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Groettrup M, 2008, TRENDS BIOCHEM SCI, V33, P230, DOI 10.1016/j.tibs.2008.01.005; HAAS AL, 2006, PROTEIN DEGRADATION, P103; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Huang J, 2006, FEBS LETT, V580, P940, DOI 10.1016/j.febslet.2005.09.105; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Moynihan TP, 1996, MAMM GENOME, V7, P520, DOI 10.1007/s003359900155; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Niwa J, 2001, BIOCHEM BIOPH RES CO, V281, P706, DOI 10.1006/bbrc.2001.4414; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PITLUK ZW, 1995, MOL CELL BIOL, V15, P1210; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Winn PJ, 2004, STRUCTURE, V12, P1563, DOI 10.1016/j.str.2004.06.017; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	39	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23895	23902		10.1074/jbc.M804069200	http://dx.doi.org/10.1074/jbc.M804069200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18583345	hybrid, Green Published			2022-12-25	WOS:000258638900044
J	Segura, JM; Guillaume, P; Mark, S; Dojcinovic, D; Johannsen, A; Bosshard, G; Angelov, G; Legler, DF; Vogel, H; Luescher, IF				Segura, Jean-Manuel; Guillaume, Philippe; Mark, Silke; Dojcinovic, Danijel; Johannsen, Alexandre; Bosshard, Giovanna; Angelov, Georgi; Legler, Daniel F.; Vogel, Horst; Luescher, Immanuel F.			Increased mobility of major histocompatibility complex I-peptide complexes decreases the sensitivity of antigen recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOTOXIC T-LYMPHOCYTES; SINGLE-PARTICLE TRACKING; SUPRAMOLECULAR ACTIVATION CLUSTER; CELL-RECEPTOR MICROCLUSTERS; RESONANCE ENERGY-TRANSFER; IMMUNOLOGICAL SYNAPSE; ENDOPLASMIC-RETICULUM; TARGET-CELLS; ANOMALOUS DIFFUSION; MEMBRANE-PROTEINS	CD8(+) cytotoxic T lymphocytes (CTL) can recognize and kill target cells expressing only a few cognate major histocompatibility complex (MHC) I-peptide complexes. This high sensitivity requires efficient scanning of a vast number of highly diverse MHC I-peptide complexes by the T cell receptor in the contact site of transient conjugates formed mainly by nonspecific interactions of ICAM-1 and LFA-1. Tracking of single H-2K(d) molecules loaded with fluorescent peptides on target cells and nascent conjugates with CTL showed dynamic transitions between states of free diffusion and immobility. The immobilizations were explained by association of MHC I-peptide complexes with ICAM-1 and strongly increased their local concentration in cell adhesion sites and hence their scanning by T cell receptor. In nascent immunological synapses cognate complexes became immobile, whereas noncognate ones diffused out again. Interfering with this mobility modulation-based concentration and sorting of MHC I-peptide complexes strongly impaired the sensitivity of antigen recognition by CTL, demonstrating that it constitutes a new basic aspect of antigen presentation by MHCI molecules.	[Segura, Jean-Manuel; Guillaume, Philippe; Mark, Silke; Dojcinovic, Danijel; Johannsen, Alexandre; Bosshard, Giovanna; Angelov, Georgi; Luescher, Immanuel F.] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; [Segura, Jean-Manuel; Vogel, Horst] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland; [Legler, Daniel F.] Univ Konstanz, Biotechnol Inst Thurgau, CH-8280 Kreuzlingen, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Luescher, IF (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland.	Immanuel.Luescher@licr.unil.ch	Vogel, Horst/AAJ-5490-2021	Legler, Daniel F./0000-0001-8610-4764	Swiss National Foundation [310000-108251]; internal Ecole Polytechnique Federale de Lausanne	Swiss National Foundation(Swiss National Science Foundation (SNSF)); internal Ecole Polytechnique Federale de Lausanne	This work was supported in part by Grant 310000-108251 from Swiss National Foundation (to I. F. L.) and internal Ecole Polytechnique Federale de Lausanne grants (to H. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Angelov GS, 2006, J IMMUNOL, V176, P3356, DOI 10.4049/jimmunol.176.6.3356; Bacso Z, 2002, BIOCHEM BIOPH RES CO, V290, P635, DOI 10.1006/bbrc.2001.6246; Bodnar A, 2003, INT IMMUNOL, V15, P331, DOI 10.1093/intimm/dxg042; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Capps GG, 2004, BIOPHYS J, V86, P2896, DOI 10.1016/S0006-3495(04)74341-6; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; Cebecauer M, 2005, J BIOL CHEM, V280, P23820, DOI 10.1074/jbc.M500654200; Damjanovich S, 1998, CYTOMETRY, V33, P225, DOI 10.1002/(SICI)1097-0320(19981001)33:2<225::AID-CYTO18>3.0.CO;2-W; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; EDIDIN M, 1994, P NATL ACAD SCI USA, V91, P3378, DOI 10.1073/pnas.91.8.3378; GAO XM, 1993, EUR J IMMUNOL, V23, P653, DOI 10.1002/eji.1830230312; Gaspar R, 2001, J IMMUNOL, V166, P5078, DOI 10.4049/jimmunol.166.8.5078; Georgiou G, 2002, BIOPHYS J, V82, P1828, DOI 10.1016/S0006-3495(02)75533-1; HUANG JH, 1994, IMMUNITY, V1, P607, DOI 10.1016/1074-7613(94)90050-7; Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103; JAULIN C, 1992, J IMMUNOL, V149, P3990; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lebedeva T, 2005, CURR OPIN IMMUNOL, V17, P251, DOI 10.1016/j.coi.2005.04.008; Lebedeva T, 2004, IMMUNOLOGY, V113, P460, DOI 10.1111/j.1365-2567.2004.01985.x; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Legler DF, 2001, FASEB J, V15, P1601, DOI 10.1096/fj.00-0841fje; LOPEZ JA, 1992, J IMMUNOL, V149, P3827; LUESCHER IF, 1995, IMMUNITY, V3, P51, DOI 10.1016/1074-7613(95)90158-2; MANN DW, 1989, J IMMUNOL, V142, P318; Marwali MR, 2004, J IMMUNOL, V173, P2960, DOI 10.4049/jimmunol.173.5.2960; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; O'Keefe JP, 2005, J IMMUNOL, V175, P5581, DOI 10.4049/jimmunol.175.9.5581; Pentcheva T, 2001, J IMMUNOL, V166, P6625, DOI 10.4049/jimmunol.166.11.6625; Perez JB, 2006, J MOL BIOL, V363, P918, DOI 10.1016/j.jmb.2006.08.036; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SIMPSON E, 1994, IMMUNOLOGY, V81, P132; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Smith PR, 1999, BIOPHYS J, V76, P3331, DOI 10.1016/S0006-3495(99)77486-2; Somersalo K, 2004, J CLIN INVEST, V113, P49, DOI 10.1172/JCI200419337; Suzuki J, 2007, BLOOD, V109, P168, DOI 10.1182/blood-2005-12-020164; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tang Q, 2003, BIOPHYS J, V84, P400, DOI 10.1016/S0006-3495(03)74860-7; Umemura YM, 2008, BIOPHYS J, V95, P435, DOI 10.1529/biophysj.107.123018; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vrljic M, 2002, BIOPHYS J, V83, P2681, DOI 10.1016/S0006-3495(02)75277-6; Yachi PP, 2007, J EXP MED, V204, P2747, DOI 10.1084/jem.20062610; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zamoyska R, 1996, INT IMMUNOL, V8, P551, DOI 10.1093/intimm/8.4.551; Zhang YN, 2006, IMMUNOL RES, V35, P151, DOI 10.1385/IR:35:1:151	51	20	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24254	24263		10.1074/jbc.M803549200	http://dx.doi.org/10.1074/jbc.M803549200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579518	hybrid, Green Published			2022-12-25	WOS:000258638900079
J	Vogiatzi, T; Xilouri, M; Vekrellis, K; Stefanis, L				Vogiatzi, Tereza; Xilouri, Maria; Vekrellis, Kostas; Stefanis, Leonidas			Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; CORTICAL-NEURONS; PROTEIN-DEGRADATION; RNA INTERFERENCE; PC12 CELLS; DEATH; PROTEASOME; GENE; AGGREGATION; INHIBITOR	alpha-Synuclein ( ASYN) is crucial in Parkinson disease ( PD) pathogenesis. Increased levels of wild type ( WT) ASYN expression are sufficient to cause PD in humans. The manner of posttranscriptional regulation of ASYN levels is controversial. Previously, we had shown that WT ASYN can be degraded by chaperone- mediated autophagy ( CMA) in isolated liver lysosomes. Whether this occurs in a cellular and, in particular, in a neuronal cell context is unclear. Using a mutantASYNform that lacks the CMA recognition motif and RNA interference against the rate- limiting step in the CMA pathway, Lamp2a, we show here that CMA is indeed involved in WT ASYN degradation in PC12 and SH- SY5Y cells, and in primary cortical and midbrain neurons. However, the extent of involvement varies between cell types, potentially because of differences in compensatory mechanisms. CMA inhibition leads to an accumulation of soluble high molecular weight and detergent- insoluble species of ASYN, suggesting that CMA dysfunction may play a role in the generation of such aberrant species in PD. ASYN and Lamp2a are developmentally regulated in parallel in cortical neuron cultures and in vivo in the central nervous system, and they physically interact as indicated by co- immunoprecipitation. In contrast to previous reports, inhibition of macroautophagy, but not the proteasome, also leads toWTASYN accumulation, suggesting that this lysosomal pathway is also involved in normal ASYN turnover. These results indicate thatCMAand macroautophagy are important pathways for WT ASYN degradation in neurons and underline the importance of CMA as degradation machinery in the nervous system.	[Vogiatzi, Tereza; Xilouri, Maria; Vekrellis, Kostas; Stefanis, Leonidas] Acad Athens, Biomed Res Fdn, Div Basic Neurosci, Athens 11527, Greece; [Stefanis, Leonidas] Univ Athens, Sch Med, Attikon Hosp, Dept Neurol 2, Athens 12462, Greece	Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon	Stefanis, L (corresponding author), Acad Athens, Biomed Res Fdn, Div Basic Neurosci, 4 Soranou Efesiou St, Athens 11527, Greece.	lstefanis@bioacademy.gr	Stefanis, Leonidas/AAD-7192-2019	Xilouri, Maria/0000-0001-7038-0780	NINDS NIH HHS [R21 NS 055693] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS055693] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ancolio K, 2000, NEUROSCI LETT, V285, P79, DOI 10.1016/S0304-3940(00)01049-1; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Clough RL, 2007, FASEB J, V21, P596, DOI 10.1096/fj.06-7111com; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2000, J CELL SCI, V113, P4441; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dietrich P, 2003, MOL CELL NEUROSCI, V24, P430, DOI 10.1016/S1044-7431(03)00201-X; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Franklin JL, 1998, J CELL BIOL, V142, P1313, DOI 10.1083/jcb.142.5.1313; Furuta K, 1999, ARCH BIOCHEM BIOPHYS, V365, P75, DOI 10.1006/abbi.1999.1147; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; HART PD, 1991, J EXP MED, V174, P881, DOI 10.1084/jem.174.4.881; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Kiffin R, 2007, J CELL SCI, V120, P782, DOI 10.1242/jcs.001073; KONECKI DS, 1995, BIOCHEM BIOPH RES CO, V215, P757, DOI 10.1006/bbrc.1995.2528; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rideout HJ, 2003, J NEUROCHEM, V84, P803, DOI 10.1046/j.1471-4159.2003.01574.x; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singleton A, 2004, LANCET, V364, P1105, DOI 10.1016/S0140-6736(04)17117-1; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Stefanis L, 1999, J NEUROSCI, V19, P6235; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200	42	476	485	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23542	23556		10.1074/jbc.M801992200	http://dx.doi.org/10.1074/jbc.M801992200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18566453	hybrid, Green Published			2022-12-25	WOS:000258638900007
J	Roussel, X; Bechade, G; Kriznik, A; Van Dorsselaer, A; Sanglier-Cianferani, S; Branlant, G; Rahuel-Clermont, S				Roussel, Xavier; Bechade, Guillaume; Kriznik, Alexandre; Van Dorsselaer, Alain; Sanglier-Cianferani, Sarah; Branlant, Guy; Rahuel-Clermont, Sophie			Evidence for the formation of a covalent thiosulfinate intermediate with peroxiredoxin in the catalytic mechanism of sulfiredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; PHENYL BENZENETHIOLSULFINATE; MAMMALIAN SULFIREDOXIN; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; REDUCTION; HYDROLYSIS; SULPHIREDOXIN; ANTIOXIDANT	The typical 2-Cys peroxiredoxins are thiol-peroxidases involved in the physiology of hydrogen peroxide not only as a toxic but also as a signaling molecule. Coordination of these functions depends on the sulfinylation of the catalytic Cys, a modification reversed by ATP-dependent sulfiredoxin, which specifically reduces the sulfinic acid group of overoxidized 2-Cys peroxiredoxins into a sulfenic acid. Sulfiredoxin was originally proposed to operate by covalent catalysis, with formation of a peroxiredoxin-sulfiredoxin intermediate linked by a thiosulfinate bond between the catalytic Cys of both partners, a hypothesis rejected by a study of the human enzyme. To settle the argument, we investigated the catalytic mechanism of Saccharomyces cerevisiae sulfiredoxin, by the characterization of the nature and kinetics of formation of the protein species formed between sulfiredoxin and its substrate in the presence of ATP, using mutants of the non-essential Cys residues of both proteins. We observed the formation of a dithiothreitol-reducible peroxiredoxin-sulfiredoxin species using SDS-PAGE and Western blot analysis, and its mass was shown to correspond to a thiosulfinate complex by high resolution mass spectrometry coupled to liquid chromatography. We next measured indirectly and directly a rate constant of formation of the thiosulfinate species of similar to 2 min(-1), for both wild-type and mutant sulfiredoxins, at least equal to the steady-state rate constant of the reaction, with a stoichiometry of 1:1 relative to peroxiredoxin. Taken altogether, our results strongly argue in favor of the formation of a covalent thiosulfinate peroxiredoxin-sulfiredoxin species as an intermediate on the catalytic pathway.	[Roussel, Xavier; Kriznik, Alexandre; Branlant, Guy; Rahuel-Clermont, Sophie] Nancy Univ, Fac Sci, Unite Mixte Rech, CNRS UHP Maturat Acide Ribonucle & Enzymol Mol 75, F-54506 Vandoeuvre Les Nancy, France; [Bechade, Guillaume; Van Dorsselaer, Alain; Sanglier-Cianferani, Sarah] Ecole Chim Polymeres & Mat, Dept Analyt Sci,UMR,CNRS ULP 7178, Lab Spectrometrie Masse Bioorgan, Inst Pluridisciplinaire Hubert Curien, F-67087 Strasbourg, France	Universite de Lorraine	Branlant, G (corresponding author), Nancy Univ, Fac Sci, Unite Mixte Rech, CNRS UHP Maturat Acide Ribonucle & Enzymol Mol 75, Bld Aiguillettes,BP 239, F-54506 Vandoeuvre Les Nancy, France.	guy.branlant@maem.uhp-nancy.fr; sophie.rahuel@maem.uhp-nancy.fr	Kriznik, Alexandre/S-1523-2019; Rahuel-Clermont, Sophie/AAB-3451-2020	Kriznik, Alexandre/0000-0003-2627-8273; Rahuel-Clermont, Sophie/0000-0001-5143-0105; Bechade, Guillaume/0000-0002-3087-7132; Cianferani, Sarah/0000-0003-4013-4129; Roussel, Xavier/0000-0003-2923-4559				BANIK U, 1990, BIOCHEM J, V266, P611; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Glauser DA, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-54; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; KICE JL, 1974, J AM CHEM SOC, V96, P8015, DOI 10.1021/ja00833a029; KICE JL, 1979, J ORG CHEM, V44, P1918, DOI 10.1021/jo01326a005; KICE JL, 1974, J AM CHEM SOC, V96, P8009, DOI 10.1021/ja00833a028; Lee DY, 2006, BIOCHEMISTRY-US, V45, P15301, DOI 10.1021/bi061824h; Liu XP, 2006, CELL RES, V16, P287, DOI 10.1038/sj.cr.7310036; Lundell N, 1999, ANAL BIOCHEM, V266, P31, DOI 10.1006/abio.1998.2919; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; Nagy P, 2007, CHEM RES TOXICOL, V20, P1364, DOI 10.1021/tx700168z; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; VENIAMIN N, 2000, J MASS SPECTROM, V35, P572; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405	31	44	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22371	22382		10.1074/jbc.M800493200	http://dx.doi.org/10.1074/jbc.M800493200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18552404	Green Published, hybrid			2022-12-25	WOS:000258321000005
J	Yao, P; Zhou, XL; He, R; Xue, MQ; Zheng, YG; Wang, YF; Wang, ED				Yao, Peng; Zhou, Xiao-Long; He, Ran; Xue, Mei-Qin; Zheng, Yong-Gang; Wang, Yue-Fei; Wang, En-Duo			Unique residues crucial for optimal editing in yeast cytoplasmic leucyl-tRNA synthetase are revealed by using a novel knockout yeast strain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO SELECTION; ESCHERICHIA-COLI; GENETIC-CODE; AMINO-ACIDS; MITOCHONDRIAL; DOMAIN; AMINOACYLATION; RECOGNITION; EXPRESSION; TRNA(LEU)	Leucyl-tRNA synthetase (LeuRS) contains an editing domain that discriminates leucine from noncognate amino acids to ensure translational fidelity. In this study, a knock-out strain for Saccharomyces cerevisiae LeuRS was constructed to analyze in vivo the tRNA aminoacylation properties of S. cerevisiae and human cytoplasmic LeuRSs. The activities of several editing-defective mutants of ycLeuRS were determined in vitro and compared with those obtained in vivo in a complementation assay performed in the knock-out strain. The editing activities of these mutants were analyzed in the presence of either norvaline, a leucine analogue, or AN2690, a specific inhibitor that targets the editing active site. In general, the in vivo data are consistent with those obtained in vitro. Our results show that ycLeuRS post-transfer editing plays a crucial role in the establishment of the aminoacylation fidelity. When impaired, the viability of cells bearing editing-defective mutants is drastically decreased in the presence of noncognate amino acid. This study also emphasizes the crucial function of some semi-conserved residues around the editing site in modulating the editing efficiency. The assay system can be used to test the effect of compounds that potentially target the aminoacylation or editing active site of fungal LeuRS.	[Yao, Peng; Zhou, Xiao-Long; He, Ran; Xue, Mei-Qin; Zheng, Yong-Gang; Wang, Yue-Fei; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Grad Sch,State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, ED (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Grad Sch,State Key Lab Mol Biol, Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	edwang@sibs.ac.cn	Zheng, Yonggang/B-5009-2011; Yao, Peng/G-5218-2015; Yao, Peng/J-4492-2013; Yao, Peng/Y-8047-2019	Yao, Peng/0000-0003-1022-3948; Yao, Peng/0000-0002-7029-8629; Yao, Peng/0000-0002-1145-3967				Ador L, 1999, J MOL BIOL, V288, P231, DOI 10.1006/jmbi.1999.2679; Apostol I, 1997, J BIOL CHEM, V272, P28980, DOI 10.1074/jbc.272.46.28980; Bacher JM, 2005, P NATL ACAD SCI USA, V102, P1697, DOI 10.1073/pnas.0409064102; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Betha AK, 2007, BIOCHEMISTRY-US, V46, P6258, DOI 10.1021/bi061965j; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JF, 1999, PROTEIN EXPRES PURIF, V15, P115, DOI 10.1006/prep.1998.0999; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Geslain R, 2000, RNA, V6, P434, DOI 10.1017/S1355838200992331; Hendrickson TL, 2003, MOL B INT U, P34; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JAKUBOWSKI H, 1991, EMBO J, V10, P593, DOI 10.1002/j.1460-2075.1991.tb07986.x; Karkhanis VA, 2007, J BACTERIOL, V189, P8765, DOI 10.1128/JB.01215-07; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; KITAMOTO K, 1988, J BACTERIOL, V170, P2683, DOI 10.1128/jb.170.6.2683-2686.1988; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Mocibob M, 2008, ARCH BIOCHEM BIOPHYS, V470, P129, DOI 10.1016/j.abb.2007.11.014; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; Schimmel P, 2001, COLD SPRING HARB SYM, V66, P161, DOI 10.1101/sqb.2001.66.161; Senger B, 2001, J MOL BIOL, V311, P205, DOI 10.1006/jmbi.2001.4844; Soma A, 1996, J MOL BIOL, V263, P707, DOI 10.1006/jmbi.1996.0610; Soma A, 1998, NUCLEIC ACIDS RES, V26, P4374, DOI 10.1093/nar/26.19.4374; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Turner RJ, 2000, J BIOL CHEM, V275, P27681; Wang CC, 2003, BIOCHEMISTRY-US, V42, P1646, DOI 10.1021/bi025964c; Wang CC, 1999, J BIOL CHEM, V274, P16508, DOI 10.1074/jbc.274.23.16508; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Xu MG, 2004, BIOCHEM BIOPH RES CO, V318, P11, DOI 10.1016/j.bbrc.2004.03.180; Xu MG, 2002, J BIOL CHEM, V277, P41590, DOI 10.1074/jbc.M205126200; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618	42	25	27	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22591	22600		10.1074/jbc.M801181200	http://dx.doi.org/10.1074/jbc.M801181200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18550527	hybrid			2022-12-25	WOS:000258321000028
J	Guastafierro, T; Cecchinelli, B; Zampieri, M; Reale, A; Riggio, G; Sthandier, O; Zupi, G; Calabrese, L; Caiafa, P				Guastafierro, Tiziana; Cecchinelli, Barbara; Zampieri, Michele; Reale, Anna; Riggio, Giuseppe; Sthandier, Olga; Zupi, Gabriella; Calabrese, Lilia; Caiafa, Paola			CCCTC-binding factor activates PARP-1 affecting DNA methylation machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; ADP-RIBOSE POLYMERS; POLY(ADP-RIBOSE) GLYCOHYDROLASE; CELL-DEATH; QUANTITATIVE-ANALYSIS; MAMMALIAN-CELLS; CTCF; CHROMATIN; INHIBITION; TRANSCRIPTION	Our previous data have shown that in L929 mouse fibroblasts the control of methylation pattern depends in part on poly(ADP-ribosyl) ation and that ADP-ribose polymers (PARs), both present on poly(ADP-ribosyl) ated PARP-1 and/or protein-free, have an inhibitory effect on Dnmt1 activity. Here we show that transient ectopic overexpression of CCCTC-binding factor (CTCF) induces PAR accumulation, PARP-1, and CTCF poly(ADP-ribosyl) ation in the same mouse fibroblasts. The persistence in time of a high PAR level affects the DNA methylation machinery; the DNA methyltransferase activity is inhibited with consequences for the methylation state of genome, which becomes diffusely hypomethylated affecting centromeric minor satellite and B1 DNA repeats. In vitro data show that CTCF is able to activate PARP-1 automodification even in the absence of nicked DNA. Our new finding that CTCF is able per se to activate PARP-1 automodification in vitro is of great interest as so far a burst of poly(ADP-ribosyl) ated PARP-1 has generally been found following introduction of DNA strand breaks. CTCF is unable to inhibitDNMT1activity, whereas poly(ADP-ribosyl) ated PARP-1 plays this inhibitory role. These data suggest that CTCF is involved in the cross-talk between poly(ADP-ribosyl) ation and DNA methylation and underscore the importance of a rapid reversal of PARP activity, as DNA methylation pattern is responsible for an important epigenetic code.	[Guastafierro, Tiziana; Cecchinelli, Barbara; Zampieri, Michele; Reale, Anna; Riggio, Giuseppe; Sthandier, Olga; Caiafa, Paola] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, I-00161 Rome, Italy; [Calabrese, Lilia] Univ Roma La Sapienza, Dept Biochem Sci, I-00161 Rome, Italy; [Guastafierro, Tiziana; Zampieri, Michele; Reale, Anna; Riggio, Giuseppe; Caiafa, Paola] Fondaz Cenci Bolognetti, Inst Pasteur, I-00161 Rome, Italy; [Zupi, Gabriella] Regina Elena Inst Canc Res, Expt Chemotherapy Lab, I-00158 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Caiafa, P (corresponding author), Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Viale Regina Elena 324, I-00161 Rome, Italy.	caiafa@bce.uniroma1.it	Reale, Anna/J-5933-2016; Zampieri, Michele/AGF-5460-2022; Zampieri, Michele/F-7099-2013; guastafeierro, tiziana/J-8006-2016	Reale, Anna/0000-0001-8988-2342; Zampieri, Michele/0000-0002-6799-2492; Zampieri, Michele/0000-0002-6799-2492; guastafeierro, tiziana/0000-0001-9433-2759				ALTHAUS FR, 1992, J CELL SCI, V102, P663; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Beneke S, 2007, NUCLEIC ACIDS RES, V35, P7456, DOI 10.1093/nar/gkm735; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Bonicalzi ME, 2003, BIOL CELL, V95, P635, DOI 10.1016/j.biolcel.2003.10.003; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; BRAUN SA, 1994, EUR J BIOCHEM, V220, P369, DOI 10.1111/j.1432-1033.1994.tb18633.x; Carbone M, 2006, J MOL BIOL, V363, P773, DOI 10.1016/j.jmb.2006.05.077; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; D'Alessio AC, 2006, BIOCHEM CELL BIOL, V84, P463, DOI 10.1139/O06-090; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; De Capoa A, 1999, FASEB J, V13, P89; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ethier C, 2007, APOPTOSIS, V12, P2037, DOI 10.1007/s10495-007-0127-z; Fahrer J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm944; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Griesenbeck J, 1999, FEBS LETT, V443, P20, DOI 10.1016/S0014-5793(98)01671-8; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karymov MA, 2001, FASEB J, V15, P2631, DOI 10.1096/fj.01-0345com; Klenova E, 2005, CELL CYCLE, V4, P96, DOI 10.4161/cc.4.1.1398; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Ohashi S, 2003, BIOCHEM BIOPH RES CO, V307, P915, DOI 10.1016/S0006-291X(03)01272-5; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; PANZETER PL, 1992, BIOCHEMISTRY-US, V31, P1379, DOI 10.1021/bi00120a014; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Rasko JEJ, 2001, CANCER RES, V61, P6002; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; REALINI CA, 1992, J BIOL CHEM, V267, P18858; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Schmid C, 2001, MOL HUM REPROD, V7, P903, DOI 10.1093/molehr/7.10.903; Shieh WM, 1998, J BIOL CHEM, V273, P30069, DOI 10.1074/jbc.273.46.30069; Torrano V, 2006, J CELL SCI, V119, P1746, DOI 10.1242/jcs.02890; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zardo G, 1999, FASEB J, V13, P1518, DOI 10.1096/fasebj.13.12.1518; Zardo G, 2002, FASEB J, V16, P1319, DOI 10.1096/fj.01-0827fje; Zardo G, 1998, J BIOL CHEM, V273, P16517, DOI 10.1074/jbc.273.26.16517; Zardo G, 1997, BIOCHEMISTRY-US, V36, P7937, DOI 10.1021/bi970241s; ZARDO G, 1999, GENE THER MOL BIOL, V4, P291	57	105	113	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21873	21880		10.1074/jbc.M801170200	http://dx.doi.org/10.1074/jbc.M801170200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18539602	Green Published, hybrid			2022-12-25	WOS:000258114700006
J	Oh-Oka, K; Nakatogawa, H; Ohsumi, Y				Oh-oka, Kyoko; Nakatogawa, Hitoshi; Ohsumi, Yoshinori			Physiological pH and acidic phospholipids contribute to substrate specificity in lipidation of Atg8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO RECONSTITUTION; UBIQUITIN-LIKE PROTEINS; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; MAMMALIAN HOMOLOG; CRYSTAL-STRUCTURE; E2 ENZYME; AUTOPHAGY; CONJUGATION; GABARAP	Yeast Atg8 and its mammalian homolog LC3 are ubiquitin-like proteins involved in autophagy, a primary pathway for degradation of cytosolic constituents in vacuoles/lysosomes. Whereas the lipid phosphatidylethanolamine (PE) was identified as the sole in vivo target of their conjugation reactions, in vitro studies showed that the same system can mediate the conjugation of these proteins with phosphatidylserine as efficiently as with PE. Here, we show that, in contrast to PE conjugation, the in vitro phosphatidylserine conjugation of Atg8 is markedly suppressed at physiological pH. Furthermore, the addition of acidic phospholipids to liposomes also results in the preferential formation of the Atg8-PE conjugate. We have successfully captured authentic thioester intermediates, allowing us to elucidate which step in the conjugation reaction is affected by these changes in pH and membrane lipid composition. We propose that these factors contribute to the selective formation of Atg8-PE in the cell.	[Oh-oka, Kyoko; Nakatogawa, Hitoshi; Ohsumi, Yoshinori] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; [Oh-oka, Kyoko; Nakatogawa, Hitoshi; Ohsumi, Yoshinori] Grad Univ Adv Studies, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Nakatogawa, Hitoshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Ohsumi, Y (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan.	yohsumi@nibb.ac.jp	Nakatogawa, Hitoshi/D-5155-2015; Ohsumi, Yoshinori/C-6449-2009	Nakatogawa, Hitoshi/0000-0002-5828-0741; Ohsumi, Yoshinori/0000-0003-2384-2166				CEVC G, 1993, PHOSPHOLIPIDS HDB, P512; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Fujioka Y, 2008, J BIOL CHEM, V283, P1921, DOI 10.1074/jbc.M706214200; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Krick R, 2006, FEBS LETT, V580, P4632, DOI 10.1016/j.febslet.2006.07.041; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nemoto T, 2003, J BIOL CHEM, V278, P39517, DOI 10.1074/jbc.M300550200; Obara K, 2008, GENES CELLS, V13, P537, DOI 10.1111/j.1365-2443.2008.01188.x; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Valli M, 2005, APPL ENVIRON MICROB, V71, P1515, DOI 10.1128/AEM.71.3.1515-1521.2005; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	32	40	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21847	21852		10.1074/jbc.M801836200	http://dx.doi.org/10.1074/jbc.M801836200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544538	hybrid			2022-12-25	WOS:000258114700003
J	Becker, HM; Deitmer, JW				Becker, Holger M.; Deitmer, Joachim W.			Nonenzymatic proton handling by carbonic anhydrase II during H+-lactate cotransport via monocarboxylate transporter 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; HYDROPHOBIC POCKET; SKELETAL-MUSCLE; O-18 EXCHANGE; BINDING-SITE; SURFACE; MCT1; EXPRESSION; MEMBRANE; NEURONS	Carbonic anhydrase (CA) is a ubiquitous enzyme catalyzing the equilibration of carbon dioxide, protons, and bicarbonate. For several acid/base-coupled membrane carriers it has been shown that the catalytic activity of CA supports transport activity, an interaction coined "transport metabolon." We have reported that CA isoform II (CAII) enhances lactate transport activity of the monocarboxylate transporter isoform I (MCT1) expressed in Xenopus oocytes, which does not require CAII catalytic activity (Becker, H. M., Fecher-Trost, C., Hirnet, D., Sultemeyer, D., and Deitmer, J. W. (2005) J. Biol. Chem. 280, 39882-39889). Coexpression of MCT1 with either wild type CAII or the catalytically inactive mutant CAII-V143Y similarly enhanced MCT1 activity, although injection of CAI or coexpression of an N-terminal mutant of CAII had no effect on MCT1 transport activity, demonstrating a specific, nonenzymatic action of CAII on lactate transport via MCT1. If the H+ gradient was set to dominate the rate of lactate transport by applying low concentrations of lactate at a high H+ concentration, the effect of CAII was largest. We tested the hypothesis of whether CAII helps to shuttle H+ along the inner face of the cell membrane by measuring the pH change with fluorescent dye in different areas of interest during focal lactate application. Intracellular pH shifts decayed from the focus of lactate application to more distant sites much less when CAII had been injected. We present a hypothetical model in which the effective movement of H+ into the bulk cytosol is increased by CAII, thus slowing the dissipation of the H+ gradient across the cell membrane, which drives MCT1 activity.	[Becker, Holger M.; Deitmer, Joachim W.] Tech Univ Kaiserslautern, FB Biol, Abt Allgemeine Zool, D-67653 Kaiserslautern, Germany	University of Kaiserslautern	Becker, HM (corresponding author), Tech Univ Kaiserslautern, FB Biol, Abt Allgemeine Zool, POB 3049, D-67653 Kaiserslautern, Germany.	h.becker@biologie.uni-kl.de	Becker, Holger/AAB-4322-2020					ALEXANDER RS, 1991, BIOCHEMISTRY-US, V30, P11064, DOI 10.1021/bi00110a008; ALEXIEV U, 1995, P NATL ACAD SCI USA, V92, P372, DOI 10.1073/pnas.92.2.372; BADGER MR, 1989, PLANT PHYSIOL, V89, P51, DOI 10.1104/pp.89.1.51; Barros LF, 2007, BIOPHYS J, V92, P3878, DOI 10.1529/biophysj.106.100925; Becker HM, 2004, J BIOL CHEM, V279, P28057, DOI 10.1074/jbc.M402401200; Becker HM, 2004, BIOPHYS J, V86, P235, DOI 10.1016/S0006-3495(04)74099-0; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2007, J BIOL CHEM, V282, P13508, DOI 10.1074/jbc.M700066200; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Bouzier-Sore AK, 2006, EUR J NEUROSCI, V24, P1687, DOI 10.1111/j.1460-9568.2006.05056.x; Branden M, 2006, P NATL ACAD SCI USA, V103, P19766, DOI 10.1073/pnas.0605909103; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Brooks GA, 1998, COMP BIOCHEM PHYS B, V120, P89, DOI 10.1016/S0305-0491(98)00025-X; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; FIERKE CA, 1991, BIOCHEMISTRY-US, V30, P11054, DOI 10.1021/bi00110a007; Galic S, 2003, BIOCHEM J, V376, P413, DOI 10.1042/BJ20030799; Gopta OA, 1999, P NATL ACAD SCI USA, V96, P13159, DOI 10.1073/pnas.96.23.13159; Gross E, 2002, J PHYSIOL-LONDON, V544, P679, DOI 10.1113/jphysiol.2002.029777; Gutman M, 2006, PHOTOCH PHOTOBIO SCI, V5, P531, DOI 10.1039/b515887g; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hashimoto T, 2005, J PHYSIOL-LONDON, V567, P121, DOI 10.1113/jphysiol.2005.087411; HEBERLE J, 1992, P NATL ACAD SCI USA, V89, P5996, DOI 10.1073/pnas.89.13.5996; HEBERLE J, 1994, NATURE, V370, P379, DOI 10.1038/370379a0; JAMESKRACKE MR, 1992, J CELL PHYSIOL, V151, P596, DOI 10.1002/jcp.1041510320; Juel C, 2001, EUR J APPL PHYSIOL, V86, P12, DOI 10.1007/s004210100517; Juel C, 2003, J PHYSIOL-LONDON, V548, P639, DOI 10.1113/jphysiol.2002.035899; KRAFTE DS, 1989, J NEUROSCI METH, V26, P211, DOI 10.1016/0165-0270(89)90118-0; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; McMurtrie HL, 2004, J ENZYM INHIB MED CH, V19, P231, DOI 10.1080/14756360410001704443; Nett W, 1996, BIOPHYS J, V71, P394, DOI 10.1016/S0006-3495(96)79240-8; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pfeuffer J, 2005, J MAGN RESON, V177, P129, DOI 10.1016/j.jmr.2005.07.010; Pushkin A, 2004, J PHYSIOL-LONDON, V559, P55, DOI 10.1113/jphysiol.2004.065110; Roy A, 2007, J PHYS CHEM B, V111, P10563, DOI 10.1021/jp073499t; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; Scozzafava A, 2002, BIOORG MED CHEM LETT, V12, P1177, DOI 10.1016/S0960-894X(02)00121-X; Silverman DN, 2007, ACCOUNTS CHEM RES, V40, P669, DOI 10.1021/ar7000588; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Sterling D, 2001, JOP, V2, P165; Stewart AK, 1999, J PHYSIOL-LONDON, V516, P209, DOI 10.1111/j.1469-7793.1999.209aa.x; SULTEMEYER DF, 1990, PLANT PHYSIOL, V94, P1250, DOI 10.1104/pp.94.3.1250; Svichar N, 2003, GLIA, V41, P415, DOI 10.1002/glia.10187; TAOKA S, 1994, J BIOL CHEM, V269, P17988; Vanysek P., 1999, CRC HDB CHEM PHYS, P93; Vaughan-Jones RD, 2002, J PHYSIOL-LONDON, V541, P139, DOI 10.1113/jphysiol.2001.013267; Vince JW, 2000, BIOCHEMISTRY-US, V39, P5527, DOI 10.1021/bi992564p; Vince JW, 2000, BIOCHEMISTRY-US, V39, P13344, DOI 10.1021/bi0015111; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Wetzel P, 2001, J PHYSIOL-LONDON, V531, P743, DOI 10.1111/j.1469-7793.2001.0743h.x; ZAMPIGHI GA, 1995, J MEMBRANE BIOL, V148, P65	53	74	74	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21655	21667		10.1074/jbc.M802134200	http://dx.doi.org/10.1074/jbc.M802134200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539591	hybrid			2022-12-25	WOS:000257898800039
J	Niapour, M; Yu, Y; Berger, SA				Niapour, Maryam; Yu, Yongmao; Berger, Stuart A.			Regulation of calpain activity by c-Myc through calpastatin and promotion of transformation in c-Myc-negative cells by calpastatin suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; PROTEASOME INHIBITORS; MEDIATED PROTEOLYSIS; TARGET GENES; EXPRESSION; ADHESION; GROWTH; FIBROBLASTS; PHENOTYPES; INDUCTION	The c-Myc transcription factor is commonly dysregulated in cancer. c-Myc also sensitizes cells to apoptosis induced by a variety of toxic events. c-Myc turnover is rapid and mediated by the proteasome and intracellular calpains. Therefore, c-Myc accumulation could contribute to cell death associated with protease inhibitors. We investigated the response of c-Myc-positive and c-Myc-negative rat fibroblast cells to proteasome and calpain inhibitors. Apoptosis induced by the proteasome inhibitor, epoxomycin, was c-Myc-independent, whereas apoptosis induced by the calpain inhibitor, PD150606, or by knockdown of calpain small subunit 1 (CPNS1) was strongly dependent on c-Myc. HL60 cells knocked down for c-Myc expression exhibited reduced calpain activity and decreased sensitivity to PD150606 but not epoxomycin. Calpain inhibitor- or CPNS1 knockdown-induced apoptosis in c-Myc-positive fibroblasts was associated with cell detachment and could be prevented by plating cells on fibronectin, suggesting an anoikis phenomenon. c-Myc stimulated calpain activity by suppressing calpastatin expression, the endogenous calpain inhibitor. Knockdown of calpastatin in c-Myc-negative cells led to a restoration of calpain activity, enhanced cell growth, cell cycle redistribution, anchorage independence, and tumorigenicity in immunodeficient mice. Taken together, these results indicate that c-Myc regulates calpain activity through calpastatin; apoptosis induced by calpain inhibition is dependent on c-Myc, and calpastatin knockdown promotes transformation in c-Myc-negative cells.	Univ Hlth Network, Arthrit & Immune Disorder Res Ctr, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Berger, SA (corresponding author), Univ Hlth Network, Arthrit & Immune Disorder Res Ctr, Toronto Med Discovery Tower,8th Floor,Rm 8-354,1, Toronto, ON M5G 1L7, Canada.	Berger@UHNRES.UTORONTO.CA						Albihn A, 2006, J CELL BIOCHEM, V98, P1597, DOI 10.1002/jcb.20816; Berns K, 2000, ONCOGENE, V19, P3330, DOI 10.1038/sj.onc.1203639; Chana JS, 1999, BRIT J OPHTHALMOL, V83, P110, DOI 10.1136/bjo.83.1.110; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Crouch DH, 1996, ONCOGENE, V12, P2689; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eischen CM, 2001, ONCOGENE, V20, P6983, DOI 10.1038/sj.onc.1204892; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; GIBSON AW, 1995, EXP CELL RES, V218, P351, DOI 10.1006/excr.1995.1166; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guan N, 2006, INT J ONCOL, V29, P655; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; KELEKAR A, 1986, MOL CELL BIOL, V6, P7, DOI 10.1128/MCB.6.1.7; Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lewis BC, 2000, CANCER RES, V60, P6178; Li HQ, 2004, BBA-MOL CELL RES, V1691, P91, DOI 10.1016/j.bbamcr.2003.12.006; Louro ID, 2002, CANCER RES, V62, P5867; Maclean KH, 2003, MOL CELL BIOL, V23, P7256, DOI 10.1128/MCB.23.20.7256-7270.2003; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Mitchell KO, 2000, CANCER RES, V60, P6318; Nass SJ, 1997, BREAST CANCER RES TR, V44, P1, DOI 10.1023/A:1005858611585; Niapour M, 2007, CYTOM PART A, V71A, P475, DOI 10.1002/cyto.a.20399; Nikiforov MA, 2000, ONCOGENE, V19, P4828, DOI 10.1038/sj.onc.1203880; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Orlowski RZ, 1998, CANCER RES, V58, P4342; Orre RS, 2001, J BIOL CHEM, V276, P1794, DOI 10.1074/jbc.M008560200; PRAGNELL IB, 1985, PROC R SOC SER B-BIO, V226, P107, DOI 10.1098/rspb.1985.0085; Prathapam T, 2006, P NATL ACAD SCI USA, V103, P2695, DOI 10.1073/pnas.0511186103; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Rogulski KR, 2005, P NATL ACAD SCI USA, V102, P18968, DOI 10.1073/pnas.0507902102; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Small GW, 2002, ARCH BIOCHEM BIOPHYS, V400, P151, DOI 10.1016/S0003-9861(02)00005-X; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Watson JD, 2002, J BIOL CHEM, V277, P36921, DOI 10.1074/jbc.M201493200; WATT F, 1993, NUCLEIC ACIDS RES, V21, P5092, DOI 10.1093/nar/21.22.5092; Witkowski JM, 2002, BLOOD, V100, P1802, DOI 10.1182/blood-2001-11-0073; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; WRIGHT TC, 1977, P NATL ACAD SCI USA, V74, P258, DOI 10.1073/pnas.74.1.258; Xu Y, 2002, J BIOL CHEM, V277, P21474, DOI 10.1074/jbc.M111689200; Yin XY, 2002, J BIOL CHEM, V277, P19998, DOI 10.1074/jbc.M200860200; Zhu DM, 2000, CLIN CANCER RES, V6, P2456; Zhu HB, 2005, ONCOGENE, V24, P4993, DOI 10.1038/sj.onc.1208683; ZHU W, 1995, BIOCHEM BIOPH RES CO, V214, P1130, DOI 10.1006/bbrc.1995.2403	59	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21371	21381		10.1074/jbc.M801462200	http://dx.doi.org/10.1074/jbc.M801462200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18544539	hybrid			2022-12-25	WOS:000257898800008
J	Madsen, BE; Ramos, EM; Boulard, M; Duda, K; Overgaard, J; Nordsmark, M; Wiuf, C; Hansen, LL				Madsen, Bo Eskerod; Ramos, Eliana Marisa; Boulard, Mathieu; Duda, Katarzyna; Overgaard, Jens; Nordsmark, Marianne; Wiuf, Carsten; Hansen, Lise Lotte			Germline Mutation in RNASEL Predicts Increased Risk of Head and Neck, Uterine Cervix and Breast Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROSTATE-CANCER; HUMAN-PAPILLOMAVIRUS; 2-5A-DEPENDENT RNASE; PROTEIN-SYNTHESIS; GENETIC-ANALYSIS; ASSOCIATION; EXPRESSION; INHIBITOR; APOPTOSIS	The Background: Ribonuclease L (RNASEL), encoding the 29-59-oligoadenylate (2-5A)-dependent RNase L, is a key enzyme in the interferon induced antiviral and anti-proliferate pathway. Mutations in RNASEL segregate with the disease in prostate cancer families and specific genotypes are associated with an increased risk of prostate cancer. Infection by human papillomavirus (HPV) is the major risk factor for uterine cervix cancer and for a subset of head and neck squamous cell carcinomas (HNSCC). HPV, Epstein Barr virus (EBV) and sequences from mouse mammary tumor virus ( MMTV) have been detected in breast tumors, and the presence of integrated SV40 T/t antigen in breast carcinomas correlates with an aggressive phenotype and poor prognosis. A genetic predisposition could explain why some viral infections persist and induce cancer, while others disappear spontaneously. This points at RNASEL as a strong susceptibility gene. Methodology/Principal Findings: To evaluate the implication of an abnormal activity of RNase L in the onset and development of viral induced cancers, the study was initiated by searching for germline mutations in patients diagnosed with uterine cervix cancer. The rationale behind is that close to 100% of the cervix cancer patients have a persistent HPV infection, and if a defective RNase L were responsible for the lack of ability to clear the HPV infection, we would expect to find a wide spectrum of mutations in these patients, leading to a decreased RNase L activity. The HPV genotype was established in tumor DNA from 42 patients diagnosed with carcinoma of the uterine cervix and somatic tissue from these patients was analyzed for mutations by direct sequencing of all coding and regulatory regions of RNASEL. Fifteen mutations, including still uncharacterized, were identified. The genotype frequencies of selected single nucleotide polymorphisms (SNPs) established in the cervix cancer patients were compared between 382 patients with head and neck squamous cell carcinomas (HNSCC), 199 patients with primary unilateral breast cancer and 502 healthy Danish control individuals. We found that the genotype frequencies of only one of the 15 mutations, the yet uncharacterized 5'UTR mutation rs3738579 differed significantly between cancer patients and control individuals (P-value: 4.43 x 10(-5)). Conclusion/Significance: In conclusion, we have discovered an increased risk, a heterozygous advantage and thereby a protective effect linked to the RNASEL SNP rs3738579. This effect is found for patients diagnosed with carcinoma of the uterine cervix, HNSCC, and breast cancer thus pointing at RNASEL as a general marker for cancer risk and not restricted to familial prostate cancer.	[Ramos, Eliana Marisa; Boulard, Mathieu; Duda, Katarzyna; Hansen, Lise Lotte] Univ Aarhus, Inst Human Genet, Aarhus, Denmark; [Madsen, Bo Eskerod; Wiuf, Carsten] Univ Aarhus, Bioinformat Res Ctr, Aarhus, Denmark; [Overgaard, Jens; Nordsmark, Marianne] Univ Hosp Aarhus, Dept Expt Clin Oncol, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Madsen, BE (corresponding author), Univ Aarhus, Inst Human Genet, Aarhus, Denmark.	Lotte@humgen.au.dk	Hansen, Lise Lotte/I-3377-2016; Wiuf, Carsten/H-6320-2011; Boulard, Matthieu/H-8923-2017	Hansen, Lise Lotte/0000-0001-7915-2506; Wiuf, Carsten/0000-0002-1302-4445; Boulard, Matthieu/0000-0001-5135-8529	The Danish Cancer Research Foundation; The Danish Medical Research Council; The Novo Nordic; The John and Birthe Meyer; The Boje Benzon; The Aarhus University Research; The A.P. Moller and Wife Foundations; Frits, Georg and Marie Cecilie Gluds grant; The Danish Cancer Society	The Danish Cancer Research Foundation; The Danish Medical Research Council(Danish Medical Research Council); The Novo Nordic; The John and Birthe Meyer; The Boje Benzon; The Aarhus University Research; The A.P. Moller and Wife Foundations; Frits, Georg and Marie Cecilie Gluds grant; The Danish Cancer Society(Danish Cancer Society)	Financial support was provided by The Danish Cancer Research Foundation, The Danish Medical Research Council, The Novo Nordic, The John and Birthe Meyer, The Boje Benzon, The Aarhus University Research and The A.P. Moller and Wife Foundations and Frits, Georg and Marie Cecilie Gluds grant. The Danish Cancer Society supported C.W.	An HJ, 2004, MOD PATHOL; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartsch DK, 2005, INT J CANCER, V117, P718, DOI 10.1002/ijc.21254; Bisbal C, 2000, MOL CELL BIOL, V20, P4959, DOI 10.1128/MCB.20.14.4959-4969.2000; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; Choi YL, 2007, TUMOR BIOL, V28, P327, DOI 10.1159/000124238; DILONARDO A, 1992, BREAST CANCER RES TR, V21, P95, DOI 10.1007/BF01836955; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Dong BH, 2001, RNA, V7, P361, DOI 10.1017/S1355838201002230; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Halder A, 2005, INDIAN J MED RES, V122, P434; Hansen LL, 1998, APMIS, V106, P371, DOI 10.1111/j.1699-0463.1998.tb01359.x; Hansen LL, 1998, CANCER RES, V58, P2166; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; Hoglund M, 2002, CANCER RES, V62, P2675; HOVANESSIAN AG, 1977, NATURE, V268, P537, DOI 10.1038/268537a0; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kruger S, 2005, LANCET ONCOL, V6, P566, DOI 10.1016/S1470-2045(05)70253-9; Kubbutat MHG, 1998, TRENDS MICROBIOL, V6, P173, DOI 10.1016/S0966-842X(98)01267-0; Lawson JS, 2006, FUTURE MICROBIOL, V1, P33, DOI 10.2217/17460913.1.1.33; Le Roy F, 2005, NAT STRUCT MOL BIOL, V12, P505, DOI 10.1038/nsmb944; Li HH, 2006, CLIN CANCER RES, V12, P5713, DOI 10.1158/1078-0432.CCR-05-2799; Li XL, 2007, J BIOL CHEM, V282, P7950, DOI 10.1074/jbc.M607939200; Liang SL, 2006, IUBMB LIFE, V58, P508, DOI 10.1080/15216540600838232; LILIENFELD AM, 1955, CANCER, V8, P875, DOI 10.1002/1097-0142(1955)8:5<875::AID-CNCR2820080504>3.0.CO;2-Z; Liu CY, 2002, J BIOL CHEM, V277, P18346, DOI 10.1074/jbc.M112454200; Maier C, 2005, BRIT J CANCER, V92, P1159, DOI 10.1038/sj.bjc.6602401; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Naik S, 1998, NUCLEIC ACIDS RES, V26, P1522, DOI 10.1093/nar/26.6.1522; Nakazato H, 2003, BRIT J CANCER, V89, P691, DOI 10.1038/sj.bjc.6601075; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patmore HS, 2004, BRIT J CANCER, V90, P1976, DOI 10.1038/sj.bjc.6601756; Ragin CCR, 2007, INT J CANCER, V121, P1813, DOI 10.1002/ijc.22851; Rennert H, 2005, CANCER EPIDEM BIOMAR, V14, P949, DOI 10.1158/1055-9965.EPI-04-0637; Rennert H, 2002, AM J HUM GENET, V71, P981, DOI 10.1086/342775; Rokman A, 2002, AM J HUM GENET, V70, P1299, DOI 10.1086/340450; Rusch L, 2000, J INTERF CYTOK RES, V20, P1091, DOI 10.1089/107999000750053762; Sevinc A, 2004, ANTICANCER RES, V24, P2547; Silverman RH, 2003, BIOCHEMISTRY-US, V42, P1805, DOI 10.1021/bi027147i; Tanaka N, 2004, EMBO J, V23, P3929, DOI 10.1038/sj.emboj.7600420; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Thomas M, 1996, ONCOGENE, V13, P265; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Wang L, 2002, AM J HUM GENET, V71, P116, DOI 10.1086/341281; Wiklund F, 2004, CLIN CANCER RES, V10, P7150, DOI 10.1158/1078-0432.CCR-04-0982; Xiang Y, 2003, CANCER RES, V63, P6795; Zhou AM, 2005, J INTERF CYTOK RES, V25, P595, DOI 10.1089/jir.2005.25.595; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	54	38	40	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2492	10.1371/journal.pone.0002492	http://dx.doi.org/10.1371/journal.pone.0002492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575592	Green Published, gold			2022-12-25	WOS:000263288000017
J	Balleza, E; Alvarez-Buylla, ER; Chaos, A; Kauffman, S; Shmulevich, I; Aldana, M				Balleza, Enrique; Alvarez-Buylla, Elena R.; Chaos, Alvaro; Kauffman, Stuart; Shmulevich, Ilya; Aldana, Maximino			Critical Dynamics in Genetic Regulatory Networks: Examples from Four Kingdoms	PLOS ONE			English	Article							EXPRESSION; MODELS; ROBUSTNESS; EVOLUTION; BEHAVIOR; CRP	The coordinated expression of the different genes in an organism is essential to sustain functionality under the random external perturbations to which the organism might be subjected. To cope with such external variability, the global dynamics of the genetic network must possess two central properties. (a) It must be robust enough as to guarantee stability under a broad range of external conditions, and (b) it must be flexible enough to recognize and integrate specific external signals that may help the organism to change and adapt to different environments. This compromise between robustness and adaptability has been observed in dynamical systems operating at the brink of a phase transition between order and chaos. Such systems are termed critical. Thus, criticality, a precise, measurable, and well characterized property of dynamical systems, makes it possible for robustness and adaptability to coexist in living organisms. In this work we investigate the dynamical properties of the gene transcription networks reported for S. cerevisiae, E. coli, and B. subtilis, as well as the network of segment polarity genes of D. melanogaster, and the network of flower development of A. thaliana. We use hundreds of microarray experiments to infer the nature of the regulatory interactions among genes, and implement these data into the Boolean models of the genetic networks. Our results show that, to the best of the current experimental data available, the five networks under study indeed operate close to criticality. The generality of this result suggests that criticality at the genetic level might constitute a fundamental evolutionary mechanism that generates the great diversity of dynamically robust living forms that we observe around us.	[Balleza, Enrique; Aldana, Maximino] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico; [Alvarez-Buylla, Elena R.; Chaos, Alvaro] Univ Nacl Autonoma Mexico, Inst Ecol, San Nicolas de Los Garza, Mexico; [Kauffman, Stuart] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada; [Shmulevich, Ilya] Inst Syst Biol, Seattle, WA USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Calgary; Institute for Systems Biology (ISB)	Balleza, E (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico.	max@fis.unam.mx	Balleza, Enrique/GZG-2287-2022; Aldana, Maximino/D-9372-2017	Balleza, Enrique/0000-0003-0769-7130; Aldana, Maximino/0000-0002-3419-6641; Alvarez-Buylla Roces, Maria Elena/0000-0002-7938-6473	National Institute of Health [GM070600, GM072855, P50 GM076547]; CONACyT [P47836-F, CO1.41848/A-1, CO1.0538/A-1, CO1.0435.B-1]; PAPIIT-UNAM [IN112407-3, IN230002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547, R01GM072855, R21GM070600] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the National Institute of Health grants GM070600 (I.S. and S.A.K.), GM072855 (I.S.), and P50 GM076547 (I.S.), CONACyT grants P47836-F (M.A.), CO1.41848/A-1, CO1.0538/A-1 and CO1.0435.B-1 (E.R.A.B.), and PAPIIT-UNAM grants IN112407-3 (M.A.) and IN230002 (E.R.A.B.). E.B. and A.C. acknowledge CONACyT for Ph.D. scholarships.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Aldana M, 2003, PERSPECTIVES AND PROBLEMS IN NONLINEAR SCIENCE, P23; Aldana M, 2003, PHYSICA D, V185, P45, DOI 10.1016/S0167-2789(03)00174-X; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Arakawa A, 2006, NAT PHYS, V2, P373, DOI 10.1038/nphys323; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Chaves M, 2006, IEE P SYST BIOL, V153, P154, DOI 10.1049/ip-syb:20050079; Chialvo DR, 2006, NAT PHYS, V2, P301, DOI 10.1038/nphys300; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; DERRIDA B, 1986, EUROPHYS LETT, V2, P739, DOI 10.1209/0295-5075/2/10/001; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Harrelson GL, 2002, ATHLET THER TODAY, V7, P23, DOI 10.1123/att.7.5.23; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Heimpel M, 1997, NATURE, V388, P865, DOI 10.1038/42232; HOHENBERG PC, 1977, REV MOD PHYS, V49, P435, DOI 10.1103/RevModPhys.49.435; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Just W, 2004, PHYSICA D, V197, P211, DOI 10.1016/j.physd.2004.07.002; Karlsson F, 2007, PHYSICA A, V384, P747, DOI 10.1016/j.physa.2007.05.050; KAUFFMAN S, HOME UNIVERSE; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Kioussis D, 2005, NATURE, V435, P579, DOI 10.1038/435579a; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Makita Y, 2004, NUCLEIC ACIDS RES, V32, pD75, DOI 10.1093/nar/gkh074; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Mendoza L, 2000, J THEOR BIOL, V204, P311, DOI 10.1006/jtbi.2000.2014; Nehaniv CL, 2003, BIOSYSTEMS, V69, P77, DOI 10.1016/S0303-2647(02)00130-2; Nikolajewa S, 2007, BIOSYSTEMS, V90, P40, DOI 10.1016/j.biosystems.2006.06.007; Nykter M, 2008, P NATL ACAD SCI USA, V105, P1897, DOI 10.1073/pnas.0711525105; Ostojic S, 2006, NATURE, V439, P828, DOI 10.1038/nature04549; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Peters O, 2006, NAT PHYS, V2, P393, DOI 10.1038/nphys314; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; Serra R, 2007, J THEOR BIOL, V246, P449, DOI 10.1016/j.jtbi.2007.01.012; Serra R, 2004, J THEOR BIOL, V227, P149, DOI 10.1016/j.jtbi.2003.10.018; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Shmulevich I, 2005, P NATL ACAD SCI USA, V102, P13439, DOI 10.1073/pnas.0506771102; Shmulevich I, 2003, P NATL ACAD SCI USA, V100, P10734, DOI 10.1073/pnas.1534782100; Smolen P, 2000, B MATH BIOL, V62, P247, DOI 10.1006/bulm.1999.0155; Turcotte DL, 1999, REP PROG PHYS, V62, P1377, DOI 10.1088/0034-4885/62/10/201; Wagner GP., 2005, ROBUSTNESS EVOLVABIL; Werner G, 2007, BIOSYSTEMS, V90, P496, DOI 10.1016/j.biosystems.2006.12.001; Yuh Chiou-Hwa, 2001, P73; Zhang ZG, 2005, J BACTERIOL, V187, P980, DOI 10.1128/JB.187.3.980-990.2005	50	127	128	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2456	10.1371/journal.pone.0002456	http://dx.doi.org/10.1371/journal.pone.0002456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560561	Green Published, Green Submitted, gold			2022-12-25	WOS:000263280700038
J	Naseem, R; Webb, M				Naseem, Riffat; Webb, Michelle			Analysis of the DNA Binding Activity of BRCA1 and Its Modulation by the Tumour Suppressor p53	PLOS ONE			English	Article								Background: The breast cancer susceptibility protein, BRCA1 functions to maintain the integrity of the genome. The exact mechanisms by which it does so, however, remain unclear. The ability of BRCA1 to bind directly to DNA suggests a more direct role. However, little research has been conducted to understand the functional relevance of this characteristic of BRCA1. In this study we examine the DNA substrate specificity of BRCA1 and how this may be controlled by one of its interacting partners, p53. Methodology/Principal Findings: Using competition gel retardation assays we have examined the ability of residues 230534 of BRCA1 to discriminate between different synthetic DNA substrates that mimic those recognised by the DNA damage response i.e. four-way junction DNA, mismatch containing DNA, bulge containing DNA and linear DNA. Of those tested the highest affinity observed was for four-way junction DNA, with a 20 fold excess of each of the other synthetic DNA's unable to compete for any of the bound BRCA1 230-534. We also observed a higher affinity for C: C and bulge containing DNA compared to linear duplex and G: T containing DNA. BRCA1 230-534 also has interaction sites for the tumour suppressor p53 and we show that titration of this complex into the DNA binding assays significantly reduces the affinity of BRCA1 for DNA. Conclusions/Significance: In this paper we show that BRCA1 can discriminate between different types of DNA damage and we discuss the implications of this with respect to its function in DNA repair. We also show that the DNA binding activity can be inhibited by the tumour suppressor p53 and suggest that this may prevent genome destabilizing events such as HR between non-homologous sequences.	[Naseem, Riffat] Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff, S Glam, Wales; [Webb, Michelle] Univ Manchester, Sch Med, Ctr Mol Med, Manchester, Lancs, England	Cardiff University; University of Manchester	Naseem, R (corresponding author), Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff, S Glam, Wales.	michelle.webb@manchester.ac.uk		Webb, Michelle/0000-0002-3228-7558	BBSRC	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by the BBSRC. They had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ALANI E, 1995, GENE DEV, V9, P234, DOI 10.1101/gad.9.2.234; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chen GC, 2001, BIOCHEM BIOPH RES CO, V284, P507, DOI 10.1006/bbrc.2001.5003; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Davalos AR, 2003, J CELL BIOL, V162, P1197, DOI 10.1083/jcb.200304016; Degtyareva N, 2001, J BIOL CHEM, V276, P8778, DOI 10.1074/jbc.M006795200; DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0; Folias A, 2002, HUM MOL GENET, V11, P2591, DOI 10.1093/hmg/11.21.2591; Foray N, 2003, EMBO J, V22, P2860, DOI 10.1093/emboj/cdg274; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; KOONIN VF, 1996, NAT GENET, V13, P266; Lee SM, 1997, J BIOL CHEM, V272, P7532, DOI 10.1074/jbc.272.11.7532; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Linke SP, 2003, CANCER RES, V63, P2596; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Mark WY, 2005, J MOL BIOL, V345, P275, DOI 10.1016/j.jmb.2004.10.045; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Moynahan ME, 2001, CANCER RES, V61, P4842; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Sturdy A, 2004, J MOL BIOL, V340, P469, DOI 10.1016/j.jmb.2004.05.005; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Wang Y, 2000, GENE DEV, V14, P927; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Wyman C, 2004, DNA REPAIR, V3, P827, DOI 10.1016/j.dnarep.2004.03.037; Yang Q, 2002, J BIOL CHEM, V277, P31980, DOI 10.1074/jbc.M204111200; Yun S, 2004, NUCLEIC ACIDS RES, V32, P6479, DOI 10.1093/nar/gkh986; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	36	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2336	10.1371/journal.pone.0002336	http://dx.doi.org/10.1371/journal.pone.0002336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545657	Green Published, Green Submitted, gold			2022-12-25	WOS:000263248800006
J	Roberge, C; Blanchet, S; Dodson, JJ; Guderley, H; Bernatchez, L				Roberge, Christian; Blanchet, Simon; Dodson, Julian J.; Guderley, Helga; Bernatchez, Louis			Disturbance of Social Hierarchy by an Invasive Species: A Gene Transcription Study	PLOS ONE			English	Article								Background: Ecological and evolutionary changes in native populations facing invasion by exotic species are increasingly reported. Recently, it has been shown that competition with exotic rainbow trout (Oncorhynchus mykiss) disrupts dominance hierarchies within groups of native Atlantic salmon (Salmo salar). The genetic and molecular actors underlying phenotypic plasticity are poorly understood. Methodology: Here, we aimed at identifying the genetic and molecular actors contributing to this plastic loss of dominance hierarchies as well as at identifying genes implicated in behaviours related to social dominance. By using microarrays, we compared the genome-wide gene transcription profiles in brains of dominant versus subordinate juvenile Atlantic salmon in presence or absence of a competitive rainbow trout. Principal Findings: Adding the trout competitor resulted in dominant and subordinate salmon being more similar, both behaviourally and at the level of brain gene transcription patterns. Genes for which transcription levels differed between dominant and subordinate salmon in the absence of exotic trout were mainly over-expressed in dominant salmon and included genes implicated in protein turnover, neuronal structural change and oxygen transport. Conclusions/Significance: Our study provides one of the few examples demonstrating a close interplay between behavioural plasticity and gene transcription, therefore contributing to the understanding of the molecular mechanisms underlying these processes in an ecologically relevant context.	[Roberge, Christian; Blanchet, Simon; Dodson, Julian J.; Guderley, Helga; Bernatchez, Louis] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Blanchet, Simon] Univ Paul Sabatier, CNRS, Lab Evol Diversite Biol, Toulouse, France	Laval University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Roberge, C (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	christian.roberge.1@ulaval.ca	Blanchet, Simon/A-2313-2010; Blanchet, Simon/D-4850-2013; Blanchet, Simon/AAA-5871-2019	Blanchet, Simon/0000-0002-3843-589X; Blanchet, Simon/0000-0002-3843-589X; Bernatchez, Louis/0000-0002-8085-9709	Science and Engineering Research Canada; Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) [scholarship]	Science and Engineering Research Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT)	This work was supported by a research grant from Science and Engineering Research Canada (NSERC strategic program) to L.B., H.G. and J.J. Dodson, and by a scholarship from the Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) to C.R. This study is a contribution to the research programmes of the CIRSA (Centre Inter-universitaire de Recherche sur le Saumon Atlantique), the RAQ (Reseau Aquaculture Quebec) as well as of Quebec-Ocean.	Aubin-Horth N, 2005, J HERED, V96, P261, DOI 10.1093/jhered/esi030; Aubin-Horth N, 2007, MOL ECOL, V16, P1349, DOI 10.1111/j.1365-294X.2007.03249.x; BENNETT E, 1994, J NEUROCHEM, V63, P1616; Blanchet S, 2007, OECOLOGIA, V152, P569, DOI 10.1007/s00442-007-0668-4; Chiavegatto S, 2003, HORM BEHAV, V44, P233, DOI 10.1016/j.yhbeh.2003.02.002; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Crawford SS, 2008, REV FISH BIOL FISHER, V18, P313, DOI 10.1007/s11160-007-9079-1; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Draghici S., 2003, DATA ANAL TOOLS DNA; Edwards AC, 2006, PLOS GENET, V2, P1386, DOI 10.1371/journal.pgen.0020154; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; Garant D, 2003, EVOLUTION, V57, P1133; Gilmour KM, 2005, INTEGR COMP BIOL, V45, P263, DOI 10.1093/icb/45.2.263; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Hofmann HA, 2003, J NEUROBIOL, V54, P272, DOI 10.1002/neu.10172; Kerr MK, 2002, STAT SINICA, V12, P203; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Lawler JJ, 2006, FRONT ECOL ENVIRON, V4, P473, DOI 10.1890/1540-9295(2006)4[473:CSAYRC]2.0.CO;2; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lund SG, 2000, J EXP BIOL, V203, P2219; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; METCALFE NB, 1989, PROC R SOC SER B-BIO, V236, P7, DOI 10.1098/rspb.1989.0009; Miczek KA, 2003, HORM BEHAV, V44, P242, DOI 10.1016/j.yhbeh.2003.04.002; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Nemes JP, 2000, HUM MOL GENET, V9, P1543, DOI 10.1093/hmg/9.10.1543; Oliveira RF, 2001, NATURE, V409, P475, DOI 10.1038/35054128; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Overli O, 1999, BRAIN BEHAV EVOLUT, V54, P263, DOI 10.1159/000006627; Owens IPF, 2006, TRENDS ECOL EVOL, V21, P356, DOI 10.1016/j.tree.2006.03.014; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Roberge C, 2006, MOL ECOL, V15, P9, DOI 10.1111/j.1365-294X.2005.02807.x; Roberge C, 2007, MOL IMMUNOL, V44, P1374, DOI 10.1016/j.molimm.2006.05.005; Sloman KA, 2002, CAN J ZOOL, V80, P1221, DOI [10.1139/z02-105, 10.1139/Z02-105]; Sneddon LU, 2005, PHYSIOL BIOCHEM ZOOL, V78, P695, DOI 10.1086/432141; Sorensen C, 2007, BRAIN BEHAV EVOLUT, V70, P239, DOI 10.1159/000105487; SPECKNER W, 1989, J EXP BIOL, V141, P133; St-Cyr J, 2008, MOL ECOL, V17, P1850, DOI 10.1111/j.1365-294X.2008.03696.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Trainor BC, 2007, BEHAV BRAIN RES, V179, P314, DOI 10.1016/j.bbr.2007.02.014; von Schalburg KR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-126; WINBERG S, 1993, COMP BIOCHEM PHYS C, V106, P597, DOI 10.1016/0742-8413(93)90216-8; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; ZAR JH, 1999, STAT INTRO USING R	49	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2408	10.1371/journal.pone.0002408	http://dx.doi.org/10.1371/journal.pone.0002408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545706	Green Submitted, gold, Green Published			2022-12-25	WOS:000263248800046
J	Surcel, A; Koshland, D; Ma, H; Simpson, RT				Surcel, Alexandra; Koshland, Douglas; Ma, Hong; Simpson, Robert T.			Cohesin Interaction with Centromeric Minichromosomes Shows a Multi-Complex Rod-Shaped Structure	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; COILED-COIL TETRAMER; SMC PROTEINS; IN-VIVO; DNA; CONDENSIN; YEAST; COMPACTION; BINDING; IDENTIFICATION	Cohesin is the protein complex responsible for maintaining sister chromatid cohesion. Cohesin interacts with centromeres and specific loci along chromosome arms known as Chromosome Attachment Regions (CARs). The cohesin holocomplex contains four subunits. Two of them, Smc1p (Structural maintenance of chromosome 1 protein) and Smc3p, are long coiled-coil proteins, which heterodimerize with each other at one end. They are joined together at the other end by a third subunit, Scc1p, which also binds to the fourth subunit, Scc3p. How cohesin interacts with chromosomes is not known, although several models have been proposed, in part on the basis of in vitro assembly of purified cohesin proteins. To be able to observe in vivo cohesin-chromatin interactions, we have modified a Minichromosome Affinity Purification (MAP) method to isolate a CAR-containing centromeric minichromosome attached to in vivo assembled cohesin. Transmission Electron Microscopy (TEM) analysis of these minichromosomes suggests that cohesin assumes a rod shape and interacts with replicated minichromosome at one end of that rod. Additionally, our data implies that more than one cohesin molecule interacts with each pair of replicated minichromsomes. These molecules seem to be packed into a single thick rod, suggesting that the Smc1p and Smc3p subunits may interact extensively.	[Surcel, Alexandra; Ma, Hong; Simpson, Robert T.] Penn State Univ, Huck Inst Life Sci, Intercoll Grad Program in Cell & Dev Biol, University Pk, PA USA; [Koshland, Douglas] Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Inst, Baltimore, MD USA; [Ma, Hong] Penn State Univ, Dept Biol, University Pk, PA USA; [Simpson, Robert T.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Carnegie Institution for Science; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Surcel, A (corresponding author), Penn State Univ, Huck Inst Life Sci, Intercoll Grad Program in Cell & Dev Biol, University Pk, PA USA.	hxm16@psu.edu			NIH; Department of Biochemistry and Molecular Biology; Huck Institutes of the Life Sciences, Department of Biology, the Pennsylvania State University; Howard Hughes Medical Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biochemistry and Molecular Biology; Huck Institutes of the Life Sciences, Department of Biology, the Pennsylvania State University; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Funding was provided by a NIH grant to R.T.S., by the Department of Biochemistry and Molecular Biology to A. S., and by the Huck Institutes of the Life Sciences, and the Department of Biology, the Pennsylvania State University, to H.M. Additional support was provided by the Howard Hughes Medical Institute to D.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov AT, 1998, J BIOL CHEM, V273, P24088, DOI 10.1074/jbc.273.37.24088; Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Bazett-Jones DP, 2002, MOL CELL, V9, P1183, DOI 10.1016/S1097-2765(02)00546-4; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Burgess SA, 2004, J STRUCT BIOL, V146, P205, DOI 10.1016/j.jsb.2003.10.005; Case RB, 2004, SCIENCE, V305, P222, DOI 10.1126/science.1098225; Cobbe N, 2004, MOL BIOL EVOL, V21, P332, DOI 10.1093/molbev/msh023; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Deng YQ, 2007, PROTEIN SCI, V16, P323, DOI 10.1110/ps.062590807; Deng YQ, 2006, STRUCTURE, V14, P247, DOI 10.1016/j.str.2005.10.010; Ducker CE, 2000, EMBO J, V19, P400, DOI 10.1093/emboj/19.3.400; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Gilliland WD, 2005, CELL, V123, P371, DOI 10.1016/j.cell.2005.10.018; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Liu J, 2006, BIOCHEMISTRY-US, V45, P15224, DOI 10.1021/bi061914m; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Milutinovich M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030012; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Ohbayashi T, 2007, BIOCHEM BIOPH RES CO, V356, P699, DOI 10.1016/j.bbrc.2007.03.037; Pati D, 2002, MOL CELL BIOL, V22, P8267, DOI 10.1128/MCB.22.23.8267-8277.2002; SORGER PK, 1994, J CELL BIOL, V127, P995, DOI 10.1083/jcb.127.4.995; Strachan T, 2005, CURR OPIN GENET DEV, V15, P258, DOI 10.1016/j.gde.2005.04.005; Strick TR, 2004, CURR BIOL, V14, P874, DOI 10.1016/j.cub.2004.04.038; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Wang X, 2001, NUCLEIC ACIDS RES, V29, P1943, DOI 10.1093/nar/29.9.1943; White GE, 2006, J STRUCT BIOL, V154, P111, DOI 10.1016/j.jsb.2006.01.001; Whitson SR, 2005, J MOL BIOL, V350, P319, DOI 10.1016/j.jmb.2005.05.002	43	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2453	10.1371/journal.pone.0002453	http://dx.doi.org/10.1371/journal.pone.0002453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545699	gold, Green Published, Green Submitted			2022-12-25	WOS:000263248800060
J	Masini, E; Vannacci, A; Failli, P; Mastroianni, R; Giannini, L; Vinci, MC; Uliva, C; Motterlini, R; Mannaioni, PF				Masini, Emanuela; Vannacci, Alfredo; Failli, Paola; Mastroianni, Rosanna; Giannini, Lucia; Vinci, Maria Cristina; Uliva, Caterina; Motterlini, Roberto; Mannaioni, Pier Francesco			A carbon monoxide-releasing molecule (CORM-3) abrogates polymorphonuclear granulocyte-induced activation of endothelial cells and mast cells	FASEB JOURNAL			English	Article						neutrophils; formyl-methionyl peptides; integrins; ICAM-1; reactive oxygen species	FORMYLMETHIONYL-LEUCYL-PHENYLALANINE; HISTAMINE-RELEASE; HUMAN-NEUTROPHILS; SUPEROXIDE ANION; HEME OXYGENASE-1; NITRIC-OXIDE; EXPRESSION; CO; MODULATION; ADHESION	We hypothesized that circulating polymorphonuclear granulocytes (PMNs), vascular endothelial cells (ECs), and perivascular mast cells (MCs) may initiate and sustain the inflammatory response through the generation of the superoxide anion (O-2 center dot(-)) by PMNs primed by inflammatory stimuli, which in turn evoked the overexpression of adhesion molecules from ECs and release of histamine by MCs. To pin-point the role of carbon monoxide (CO) in curbing vascular inflammation, we studied the effect of a water-soluble CO-releasing molecule [tricarbonylchloro-glycinate-ruthenium (II); CORM-3] on an experimental model of vascular inflammation. The model consists of coincubating formyl-methionyl peptide (fMLP)-primed human PMNs with rat ECs or with rat MCs. The effects of CORM-3 were evaluated by measuring the generation of O-2 center dot(-) and the expression of CD11b in fMLP-primed PMNs; the expression of ICAM-1 and CD203c in ECs and MCs, respectively; and the release of histamine from MCs. Our results show that the chemotactic peptide fMLP primes PMNs to generate O-2 center dot(-) and overexpress CD11b, both events being central to the inflammatory process, while CORM-3 significantly decreases these events (IC50 = 1.66 mu M for O-2 center dot(-) production; 1.20 mu M for CD11b expression in human PMNs). The experiments also show that fMLP-primed PMNs increase the CD54 expression by coincubated ECs, and the expression of CD203c and the release of histamine by coincubated MCs. Once again, CORM-3 abolishes these events (IC50 = 6.78 mu M for CD54 expression in ECs; 1.18 mu M for CD203 expression; 1.15 mu M for histamine release in MCs). Thus, CORM-3 exerts a powerful anti-inflammatory action by down-regulating the oxidative burst in PMNs, the overexpression of adhesion molecules in PMNs and ECs, the release of histamine, and the overexpression of an activation marker by MCs.	[Masini, Emanuela; Vannacci, Alfredo; Failli, Paola; Mastroianni, Rosanna; Giannini, Lucia; Vinci, Maria Cristina; Uliva, Caterina; Mannaioni, Pier Francesco] Univ Florence, Dept Preclin & Clin Pharmacol, I-50139 Florence, Italy; [Motterlini, Roberto] Northwick Pk Inst Med Res, Dept Surg Res, Vasc Biol Unit, Harrow, Middx, England	University of Florence; Imperial College London	Mannaioni, PF (corresponding author), Univ Florence, Dept Preclin & Clin Pharmacol, Viale G Pieraccini 6, I-50139 Florence, Italy.	pierfrancesco.mannaioni@unifi.it	Motterlini, Roberto/Q-1890-2019; Motterlini, Roberto/G-2489-2013; Vinci, Maria Cristina/E-7401-2016; Vannacci, Alfredo/A-1708-2008	Motterlini, Roberto/0000-0003-2684-2612; Motterlini, Roberto/0000-0003-2684-2612; Vinci, Maria Cristina/0000-0001-6323-147X; Vannacci, Alfredo/0000-0001-5259-2026; Failli, Paola/0000-0003-3879-9068	Ente Cassa di Risparmio, Florence, Italy	Ente Cassa di Risparmio, Florence, Italy	These investigations were supported by a grant from Ente Cassa di Risparmio, Florence, Italy.	Abraham NG, 2002, HEME OXYGENASE BIOL; Andersson JA, 2002, ALLERGY, V57, P718, DOI 10.1034/j.1398-9995.2002.23593.x; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; Bani-Hani MG, 2006, J PHARMACOL EXP THER, V318, P1315, DOI 10.1124/jpet.106.104729; BLANDINA P, 1980, J PHYSIOL-LONDON, V301, P281, DOI 10.1113/jphysiol.1980.sp013205; Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; Chlopicki S, 2006, CARDIOVASC RES, V71, P393, DOI 10.1016/j.cardiores.2006.03.011; Cines DB, 1998, BLOOD, V91, P3527; Cirillo P, 2007, J VASC RES, V44, P460, DOI 10.1159/000106464; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Di Pascoli M, 2006, BIOCHEM BIOPH RES CO, V340, P935, DOI 10.1016/j.bbrc.2005.12.082; Failli P, 2000, BRIT J PHARMACOL, V130, P1468, DOI 10.1038/sj.bjp.0703453; FANTOZZI R, 1983, AGENTS ACTIONS, V13, P218, DOI 10.1007/BF01967336; FANTOZZI R, 1984, AGENTS ACTIONS, V14, P441, DOI 10.1007/BF01973846; FANTOZZI R, 1985, AGENTS ACTIONS, V16, P260, DOI 10.1007/BF01983155; FANTOZZI R, 1986, AGENTS ACTIONS, V18, P155, DOI 10.1007/BF01988009; Foresti R, 2004, BRIT J PHARMACOL, V142, P453, DOI 10.1038/sj.bjp.0705825; Freitas A, 2006, BRIT J PHARMACOL, V149, P345, DOI 10.1038/sj.bjp.0706882; Hayashi S, 1999, CIRC RES, V85, P663, DOI 10.1161/01.RES.85.8.663; Jaggar JH, 2002, CIRC RES, V91, P610, DOI 10.1161/01.RES.0000036900.76780.95; Johnson TR, 2003, ANGEW CHEM INT EDIT, V42, P3722, DOI 10.1002/anie.200301634; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; KREMZNER LT, 1961, BIOCHIM BIOPHYS ACTA, V50, P364, DOI 10.1016/0006-3002(61)90339-0; Mannaioni PF, 2006, INFLAMM RES, V55, P261, DOI 10.1007/s00011-006-0084-y; MANNAIONI PF, 1988, FREE RADICAL BIO MED, V5, P177, DOI 10.1016/0891-5849(88)90080-9; Masini E, 2004, ENDOCRINOLOGY, V145, P1106, DOI 10.1210/en.2003-0833; Milovanova T, 2006, AM J PHYSIOL-CELL PH, V290, pC66, DOI 10.1152/ajpcell.00094.2005; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; Motterlini R, 2005, EXPERT OPIN INV DRUG, V14, P1305, DOI 10.1517/13543784.14.11.1305; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Mugnai S, 1997, BRIT J PHARMACOL, V122, P1345, DOI 10.1038/sj.bjp.0701521; Ndisang JF, 2001, BRIT J PHARMACOL, V134, P1689, DOI 10.1038/sj.bjp.0704427; Ndisang JF, 1999, IMMUNOPHARMACOLOGY, V43, P65, DOI 10.1016/S0162-3109(99)00045-4; Neto JS, 2006, AM J PHYSIOL-RENAL, V290, pF324, DOI 10.1152/ajprenal.00026.2005; Ning W, 2005, AM J PHYSIOL-LUNG C, V289, pL268, DOI 10.1152/ajplung.00168.2004; OHMORI H, 1979, BIOCHEM PHARMACOL, V28, P333, DOI 10.1016/0006-2952(79)90524-0; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Rucker M, 2001, SURGERY, V129, P292, DOI 10.1067/msy.2001.111079; Sawle P, 2006, J PHARMACOL EXP THER, V318, P403, DOI 10.1124/jpet.106.101758; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; Srisook K, 2006, BIOCHEM PHARMACOL, V71, P307, DOI 10.1016/j.bcp.2005.10.042; Stein AB, 2005, J MOL CELL CARDIOL, V38, P127, DOI 10.1016/j.yjmcc.2004.10.006; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Uemura K, 2005, BIOCHEM BIOPH RES CO, V334, P661, DOI 10.1016/j.bbrc.2005.06.142; Vachharajani TJ, 2000, AM J PHYSIOL-HEART C, V278, pH1613, DOI 10.1152/ajpheart.2000.278.5.H1613; Vannacci A, 2004, INFLAMM RES, V53, pS9, DOI 10.1007/s00011-003-0303-8; Vannacci A, 2003, EUR J PHARMACOL, V465, P289, DOI 10.1016/S0014-2999(03)01489-4; Vera T, 2005, J AM SOC NEPHROL, V16, P950, DOI 10.1681/ASN.2004090736; Vinci MC, 2004, BIOCHEM PHARMACOL, V67, P277, DOI 10.1016/j.bcp.2003.09.007; WONG K, 1981, CAN J PHYSIOL PHARM, V59, P915, DOI 10.1139/y81-141; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yu HP, 2006, AM J PHYSIOL-LUNG C, V291, pL400, DOI 10.1152/ajplung.00537.2005	52	25	27	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3380	3388		10.1096/fj.08-107110	http://dx.doi.org/10.1096/fj.08-107110			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18556460				2022-12-25	WOS:000258761300030
J	Meador, JA; Zhao, M; Su, Y; Narayan, G; Geard, CR; Balajee, AS				Meador, J. A.; Zhao, M.; Su, Y.; Narayan, G.; Geard, C. R.; Balajee, A. S.			Histone H2AX is a critical factor for cellular protection against DNA alkylating agents	ONCOGENE			English	Article						histone H2AX; poly(ADP) ribose polymerase 1; base excision repair; alkylation DNA damage; chromosomal instability; mitogen-activated protein kinase	DOUBLE-STRAND BREAKS; IONIZING-RADIATION; CYCLE ARREST; HUMAN-CELLS; POLY(ADP-RIBOSE) POLYMERASE-1; GENOMIC INSTABILITY; COMPLEX-FORMATION; DEPENDENT MANNER; GAMMA-H2AX FOCI; MISMATCH REPAIR	Histone H2A variant H2AX is a dose-dependent suppressor of oncogenic chromosome translocations. H2AX participates in DNA double-strand break repair, but its role in other DNA repair pathways is not known. In this study, role of H2AX in cellular response to alkylation DNA damage was investigated. Cellular sensitivity to two monofunctional alkylating agents (methyl methane sulfonate and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)) was dependent on H2AX dosage, and H2AX null cells were more sensitive than heterozygous cells. In contrast to wild-type cells, H2AX-deficient cells displayed extensive apoptotic death due to a lack of cell-cycle arrest at G(2)/M phase. Lack of G(2)/M checkpoint in H2AX null cells correlated well with increased mitotic irregularities involving anaphase bridges and gross chromosomal instability. Observation of elevated poly(ADP) ribose polymerase 1 (PARP-1) cleavage suggests that MNNG-induced apoptosis occurs by PARP-1-dependent manner in H2AX-deficient cells. Consistent with this, increased activities of PARP and poly(ADP) ribose (PAR) polymer synthesis were detected in both H2AX heterozygous and null cells. Further, we demonstrate that the increased PAR synthesis and apoptotic death induced by MNNG in H2AX-deficient cells are due to impaired activation of mitogen-activated protein kinase pathway. Collectively, our novel study demonstrates that H2AX, similar to PARP-1, confers cellular protection against alkylation-induced DNA damage. Therefore, targeting either PARP-1 or histone H2AX may provide an effective way of maximizing the chemotherapeutic value of alkylating agents for cancer treatment.	[Meador, J. A.; Zhao, M.; Su, Y.; Narayan, G.; Geard, C. R.; Balajee, A. S.] Columbia Univ, Med Ctr, Dept Radiat Oncol, Coll Phys & Surg,Ctr Radiol Res, New York, NY 10032 USA	Columbia University	Balajee, AS (corresponding author), Columbia Univ, Med Ctr, Dept Radiat Oncol, Coll Phys & Surg,Ctr Radiol Res, VC 11,Room 239,168th St,630 West, New York, NY 10032 USA.	ab836@columbia.edu			US Department of Energy; Office of Sciences (BER) [DE-FG02-05ER64055]; CRG [DE-FG 02-05ER 64054]; NIH/NCI [5P01CA49062-16]; NATIONAL CANCER INSTITUTE [P01CA049062] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); Office of Sciences (BER)(United States Department of Energy (DOE)); CRG; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the generous gift of mouse ES cells proficient and deficient in H2AX from Dr CH Bassing and Dr FW Alt at the Department of Genetics, The CBR Institute for Biomedical Research, The Children's Hospital, Harvard Medical School, Boston, MA, USA. This study was partially supported by a research grant from US Department of Energy, Office of Sciences (BER) awarded to ASB (DE-FG02-05ER64055) and CRG (DE-FG 02-05ER 64054). ASB and CRG acknowledge the financial support received from NIH/NCI (5P01CA49062-16).	Aebi S, 1997, CLIN CANCER RES, V3, P1763; Balajee AS, 2004, EXP CELL RES, V300, P320, DOI 10.1016/j.yexcr.2004.07.022; Balajee AS, 2001, NUCLEIC ACIDS RES, V29, P1341, DOI 10.1093/nar/29.6.1341; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Beardsley DI, 2005, MOL PHARMACOL, V68, P1049, DOI 10.1124/mol.105.013888; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chou YH, 2007, FOOD CHEM TOXICOL, V45, P1356, DOI 10.1016/j.fct.2007.01.012; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Ethier C, 2007, APOPTOSIS, V12, P2037, DOI 10.1007/s10495-007-0127-z; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Horton JK, 2005, J BIOL CHEM, V280, P15773, DOI 10.1074/jbc.M413841200; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; Karran P, 2003, BIOCHIMIE, V85, P1149, DOI 10.1016/j.biochi.2003.10.007; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Lomax ME, 2004, BIOCHEMISTRY-US, V43, P11017, DOI 10.1021/bi049560r; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Mischo HE, 2005, J BIOL CHEM, V280, P9586, DOI 10.1074/jbc.M411444200; MITRA S, 1993, PROG NUCLEIC ACID RE, V44, P109, DOI 10.1016/S0079-6603(08)60218-4; Ochs K, 1999, CANCER RES, V59, P1544; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Yan Y, 2007, ONCOGENE, V26, P4689, DOI 10.1038/sj.onc.1210268	42	34	35	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2008	27	43					5662	5671		10.1038/onc.2008.187	http://dx.doi.org/10.1038/onc.2008.187			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	352HM	18542054				2022-12-25	WOS:000259487100002
J	Gan, GL; Yi, H; Chen, MR; Sun, L; Li, WX; Wu, YL; Ding, JP				Gan, Geliang; Yi, Hong; Chen, Maorong; Sun, Liang; Li, Wenxin; Wu, Yingliang; Ding, Jiuping			Structural basis for toxin resistance of beta 4-associated calcium-activated potassium (BK) channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; ADRENAL CHROMAFFIN CELLS; AUXILIARY BETA-SUBUNITS; LARGE-CONDUCTANCE; MOLECULAR-BASIS; SMOOTH-MUSCLE; CHARYBDOTOXIN; VOLTAGE; INACTIVATION; PEPTIDE	The functional diversity of large conductance Ca2+ - and voltage-dependent K+ (BK) channels arises mainly from co-assembly of the pore-forming mSlo alpha subunits with four tissue-enriched auxiliary beta subunits. The structural basis of the interaction between alpha subunits with beta subunits is not well understood. Using computational and experimental methods, we demonstrated that four mSlo turrets decentralized distally from the channel pore to provide a wide open conformation and that the mSlo and h beta 4 subunits together formed a "helmet" containing three basic residues (Lys-120, Arg-121, and Lys-125), which impeded the entry of charybdotoxin ( ChTX) by both the electrostatic interaction and limited space. In addition, the tyrosine insert mutant (in100Y) showed 56% inhibition, with a K-d = 17 nM, suggesting that the h beta 4 lacks an external ChTX-binding site (Tyr-100). We also found that mSlo had an internal binding site (Tyr-294) in the alpha subunits that could "permanently" block 15% of mSlo+h beta 4 currents in the presence of 100 nM ChTX. These findings provide a better understanding of the diverse interactions between alpha and beta subunits and will improve the design of channel inhibitors.	[Yi, Hong; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Gan, Geliang; Chen, Maorong; Sun, Liang; Ding, Jiuping] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Wu, YL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	ylwu@whu.edu.cn; jpding@mail.hust.edu.cn	Chen, Maorong/AAF-4006-2019; Sun, Liang/D-4857-2018	Chen, Maorong/0000-0003-3744-8864; Sun, Liang/0000-0002-7817-5121	National Science Foundation of China [30770522, 30470449, 30530140, 30770519]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science Foundation of China Grants 30770522, 30470449, 30530140, and 30770519. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Ding JP, 1998, BIOPHYS J, V74, P268, DOI 10.1016/S0006-3495(98)77785-9; Gao YD, 2003, PROTEINS, V52, P146, DOI 10.1002/prot.10341; Hanner M, 1997, P NATL ACAD SCI USA, V94, P2853, DOI 10.1073/pnas.94.7.2853; Jin P, 2002, J BIOL CHEM, V277, P43724, DOI 10.1074/jbc.M205795200; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Naranjo D, 1996, NEURON, V16, P123, DOI 10.1016/S0896-6273(00)80029-X; PARK CS, 1992, BIOCHEMISTRY-US, V31, P7749, DOI 10.1021/bi00149a002; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Thompson J, 2000, BIOPHYS J, V78, P2382, DOI 10.1016/S0006-3495(00)76782-8; Uebele VN, 2000, J BIOL CHEM, V275, P23211, DOI 10.1074/jbc.M910187199; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Xia XM, 2000, J NEUROSCI, V20, P4890; Yao J, 2006, ACTA PHARMACOL SIN, V27, P945, DOI 10.1111/j.1745-7254.2006.00385.x; Yi H, 2008, PROTEINS, V70, P844, DOI 10.1002/prot.21706; Yi H, 2007, J PROTEOME RES, V6, P611, DOI 10.1021/pr060368g; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932	26	32	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24177	24184		10.1074/jbc.M800179200	http://dx.doi.org/10.1074/jbc.M800179200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18559348	Green Published, hybrid			2022-12-25	WOS:000258638900071
J	Sabbatini, ME; Chen, X; Ernst, SA; Williams, JA				Sabbatini, Maria E.; Chen, Xuequn; Ernst, Stephen A.; Williams, John A.			Rap1 activation plays a regulatory role in pancreatic amylase secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; NUCLEOTIDE-RELEASING PROTEIN; CA2+-INDUCED CA2+ RELEASE; CYCLIC-AMP; SELECTIVE INHIBITOR; BINDING PROTEINS; CAMP; EPAC; CELL; CALCIUM	Rap1 is a member of the Ras superfamily of small GTP-binding proteins and is localized on pancreatic zymogen granules. The current study was designed to determine whether GTP-Rap1 is involved in the regulation of amylase secretion. Rap1A/B and the two Rap1 guanine nucleotide exchange factors, Epac1 and CalDAG-GEF III, were identified in mouse pancreatic acini. A fraction of both Rap1 and Epac1 colocalized with amylase in zymogen granules, but only Rap1 was integral to the zymogen granule membranes. Stimulation with cholecystokinin (CCK), carbachol, and vasoactive intestinal peptide all induced Rap1 activation, as did calcium ionophore A23187, phorbol ester, forskolin, 8-bromo-cyclic AMP, and the Epac-specific cAMP analog 8-pCPT-2'-O-Me-cAMP. The phospholipase C inhibitor U-73122 abolished carbachol- but not forskolin-induced Rap1 activation. Co-stimulation with carbachol and 8-pCPT-2'-O-Me-cAMP led to an additive effect on Rap1 activation, whereas a synergistic effect was seen on amylase release. Although the protein kinase A inhibitor H-89 abolished forskolin-stimulated CREB phosphorylation, it did not modify forskolin-induced GTP-Rap1 levels, excluding PKA participation. Overexpression of Rap1 GTPase-activating protein, which blocked Rap1 activation, reduced the effect of 8-bromo-cyclic AMP, 8-pCPT-2'-O-Me-cAMP, and vasoactive intestinal peptide on amylase release by 60% and reduced CCK-as well as carbachol-stimulated pancreatic amylase release by 40%. These findings indicate that GTP-Rap1 is required for pancreatic amylase release. Rap1 activation not only mediates the cAMP-evoked response via Epac1 but is also involved in CCK- and carbachol-induced amylase release, with their action most likely mediated by CalDAG-GEF III.	[Sabbatini, Maria E.; Chen, Xuequn; Williams, John A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ernst, Stephen A.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sabbatini, ME (corresponding author), 7744 Med Sci Bldg 2,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	mesabba@umich.edu		Williams, John/0000-0002-6063-7615; Sabbatini, Maria Eugenia/0000-0001-7100-2482	National Institutes of Health [DK-41128]; Michigan Gastrointestinal Peptide Center [P30 DK-34933]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R01DK041128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Gastrointestinal Peptide Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-41128 (to J.A.W.). This work was also supported by Michigan Gastrointestinal Peptide Center Grant P30 DK-34933. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Amano R, 2007, J REPROD DEVELOP, V53, P127, DOI 10.1262/jrd.18077; Bi Y, 2005, AM J PHYSIOL-CELL PH, V289, pC22, DOI 10.1152/ajpcell.00395.2004; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; BURNHAM DB, 1988, BIOCHIM BIOPHYS ACTA, V969, P33, DOI 10.1016/0167-4889(88)90085-7; BURNHAM DB, 1984, AM J PHYSIOL, V246, pG500, DOI 10.1152/ajpgi.1984.246.5.G500; BURNHAM DB, 1984, J PHYSIOL-LONDON, V349, P475, DOI 10.1113/jphysiol.1984.sp015168; Chaudhuri A, 2007, AM J PHYSIOL-GASTR L, V292, pG1403, DOI 10.1152/ajpgi.00478.2005; Chen XQ, 2002, J BIOL CHEM, V277, P18002, DOI 10.1074/jbc.M201248200; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Chen XQ, 2004, BIOCHEM BIOPH RES CO, V323, P1157, DOI 10.1016/j.bbrc.2004.08.212; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; D'Silva NJ, 1998, AM J PHYSIOL-CELL PH, V274, pC1667, DOI 10.1152/ajpcell.1998.274.6.C1667; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dremier S, 2007, ENDOCRINOLOGY, V148, P4612, DOI 10.1210/en.2007-0540; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FISCHER TH, 1990, J BIOL CHEM, V265, P19405; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; GOKE B, 1992, AM J PHYSIOL, V262, pC493, DOI 10.1152/ajpcell.1992.262.2.C493; Guo FF, 2001, J BIOL CHEM, V276, P25568, DOI 10.1074/jbc.M101277200; Gupta M, 2005, J BIOL CHEM, V280, P8109, DOI 10.1074/jbc.M413697200; HEISLER S, 1983, CAN J PHYSIOL PHARM, V61, P1168, DOI 10.1139/y83-174; JAMIESON JD, 1967, J CELL BIOL, V34, P597, DOI 10.1083/jcb.34.2.597; Kang GX, 2005, J PHYSIOL-LONDON, V566, P173, DOI 10.1113/jphysiol.2005.087510; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; LEROSEY I, 1991, BIOCHEM BIOPH RES CO, V175, P430, DOI 10.1016/0006-291X(91)91582-W; Li J, 2007, MOL ENDOCRINOL, V21, P159, DOI 10.1210/me.2006-0340; M'Rabet L, 1998, BLOOD, V92, P2133, DOI 10.1182/blood.V92.6.2133.418k19_2133_2140; McLeod SJ, 1998, J BIOL CHEM, V273, P29218, DOI 10.1074/jbc.273.44.29218; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; NAGATA K, 1995, BRIT J HAEMATOL, V90, P180; Pinxteren JA, 2000, BIOCHIMIE, V82, P385, DOI 10.1016/S0300-9084(00)00197-8; QUILLIAM LA, 1991, J IMMUNOL, V147, P1628; Sabbatini ME, 2003, AM J PHYSIOL-GASTR L, V285, pG929, DOI 10.1152/ajpgi.00010.2003; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Shimomura H, 2004, ARCH BIOCHEM BIOPHYS, V431, P124, DOI 10.1016/j.abb.2004.07.021; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; WILLIAMS JA, 1978, AM J PHYSIOL, V235, pE517, DOI 10.1152/ajpendo.1978.235.5.E517; Williams JA, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1337; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; Zwartkruis FJT, 1999, EXP CELL RES, V253, P157, DOI 10.1006/excr.1999.4695	57	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23884	23894		10.1074/jbc.M800754200	http://dx.doi.org/10.1074/jbc.M800754200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577515	Green Published, hybrid			2022-12-25	WOS:000258638900043
J	Hu, SJ; Ren, G; Liu, JL; Zhao, ZA; Yu, YS; Su, RW; Ma, XH; Ni, H; Lei, W; Yang, ZM				Hu, Shi-Jun; Ren, Gang; Liu, Ji-Long; Zhao, Zhen-Ao; Yu, Yong-Sheng; Su, Ren-Wei; Ma, Xing-Hong; Ni, Hua; Lei, Wei; Yang, Zeng-Ming			MicroRNA expression and regulation in mouse uterus during embryo implantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTERINE RECEPTIVITY; GENE-EXPRESSION; MAMMALIAN MICRORNAS; STAT3 ACTIVATION; RECK; RNA; IDENTIFICATION; REVEALS; TARGETS; CELLS	MicroRNAs (miRNAs) are 21-24-nucleotide non-coding RNAs found in diverse organisms. Although hundreds of miRNAs have been cloned or predicted, only very few miRNAs have been functionally characterized. Embryo implantation is a crucial step in mammalian reproduction. Many genes have been shown to be significantly changed in mouse uterus during embryo implantation. However, miRNA expression profiles in the mouse uterus between implantation sites and inter-implantation sites are still unknown. In this study, miRNA microarray was used to examine differential expression of miRNAs in the mouse uterus between implantation sites and inter-implantation sites. Compared with inter-implantation sites, there were 8 up-regulated miRNAs at implantation sites, which were confirmed by both Northern blot and in situ hybridization. miR-21 was highly expressed in the subluminal stromal cells at implantation sites on day 5 of pregnancy. Because miR-21 was not detected in mouse uterus during pseudopregnancy and under delayed implantation, miR-21 expression at implantation sites was regulated by active blastocysts. Furthermore, we showed that Reck was the target gene of miR-21. Our data suggest that miR-21 may play a key role during embryo implantation.	[Hu, Shi-Jun; Yang, Zeng-Ming] Xiamen Univ, Coll Life Sci, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China; [Hu, Shi-Jun; Ren, Gang; Liu, Ji-Long; Zhao, Zhen-Ao; Yu, Yong-Sheng; Su, Ren-Wei; Ma, Xing-Hong; Ni, Hua; Lei, Wei; Yang, Zeng-Ming] NE Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China	Xiamen University; Northeast Agricultural University - China	Yang, ZM (corresponding author), Xiamen Univ, Coll Life Sci, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China.	zmyang@xmu.edu.cn	Yang, ZM/G-4627-2010; Lei, Wei/I-3640-2014; Hu, Shijun/I-5818-2012; Lei, Wei/N-7611-2013	Lei, Wei/0000-0002-8342-8859; Ren, Gang/0000-0002-2555-7804; Liu, Ji-Long/0000-0002-6948-2576; Hu, Shijun/0000-0002-0068-8429	National Basic Research Program of China [2006CB504005, 2006CB944006]; Chinese National Natural Science Foundation [30570198, 30770244]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2006CB504005 and 2006CB944006 and Chinese National Natural Science Foundation Grants 30570198 and 30770244.	Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447; Beuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118; Brown JR, 2005, DRUG DISCOV TODAY, V10, P595, DOI 10.1016/S1359-6446(05)03399-4; Castoldi M, 2007, METHODS, V43, P146, DOI 10.1016/j.ymeth.2007.04.009; Catalano RD, 2005, P NATL ACAD SCI USA, V102, P8585, DOI 10.1073/pnas.0502343102; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Cheng JG, 2001, P NATL ACAD SCI USA, V98, P8680, DOI 10.1073/pnas.151180898; Cheon YP, 2002, MOL ENDOCRINOL, V16, P2853, DOI 10.1210/me.2002-0270; Clark JCM, 2007, CANCER METAST REV, V26, P675, DOI 10.1007/s10555-007-9093-8; Das SK, 1997, DEV GENET, V21, P44, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;44::AID-DVG5&gt;3.0.CO;2-8; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Edwards RG, 1995, HUM REPROD, V10, P60, DOI 10.1093/humrep/10.suppl_2.60; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HARVEY MB, 1995, DEVELOPMENT, V121, P1005; Herrler Andreas, 2003, Reprod Biomed Online, V6, P244; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Ma XH, 2006, J BIOL CHEM, V281, P9351, DOI 10.1074/jbc.M511512200; Marsh EE, 2008, FERTIL STERIL, V89, P1771, DOI 10.1016/j.fertnstert.2007.05.074; Massirer KB, 2006, BIOESSAYS, V28, P449, DOI 10.1002/bies.20406; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Ni H, 2002, BIOL REPROD, V67, P351, DOI 10.1095/biolreprod67.1.351; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reese J, 2001, J BIOL CHEM, V276, P44137, DOI 10.1074/jbc.M107563200; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Simizu S, 2005, CANCER RES, V65, P7455, DOI 10.1158/0008-5472.CAN-04-4446; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takenaka K, 2004, EUR J CANCER, V40, P1617, DOI 10.1016/j.ejca.2004.02.028; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang TS, 2007, GENE CHROMOSOME CANC, V46, P336, DOI 10.1002/gcc.20415; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	54	178	198	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23473	23484		10.1074/jbc.M800406200	http://dx.doi.org/10.1074/jbc.M800406200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556655	hybrid			2022-12-25	WOS:000258455400056
J	Koh, CS; Navrot, N; Didierjean, C; Rouhier, N; Hirasawa, M; Knaff, DB; Wingsle, G; Samian, R; Jacquot, JP; Corbier, C; Gelhaye, E				Koh, Cha San; Navrot, Nicolas; Didierjean, Claude; Rouhier, Nicolas; Hirasawa, Masakazu; Knaff, David B.; Wingsle, Gunnar; Samian, Razip; Jacquot, Jean-Pierre; Corbier, Catherine; Gelhaye, Eric			An atypical catalytic mechanism involving three cysteines of thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; CRYSTAL-STRUCTURE; FUNCTIONAL-CHARACTERIZATION; CHLAMYDOMONAS-REINHARDTII; GLUTATHIONE PEROXIDASES; REDOX POTENTIALS; DIFFRACTION DATA; ACTIVE-SITE; SYSTEM; EXPRESSION	Unlike other thioredoxins h characterized so far, a poplar thioredoxin of the h type, PtTrxh4, is reduced by glutathione and glutaredoxin (Grx) but not NADPH: thioredoxin reductase (NTR). PtTrxh4 contains three cysteines: one localized in an N-terminal extension (Cys(4)) and two (Cys(58) and Cys(61)) in the classical thioredoxin active site ( (57)WCGPC(61)). The property of a mutant in which Cys(58) was replaced by serine demonstrates that it is responsible for the initial nucleophilic attack during the catalytic cycle. The observation that the C4S mutant is inactive in the presence of Grx but fully active when dithiothreitol is used as a reductant indicates that Cys(4) is required for the regeneration of PtTrxh4 by Grx. Biochemical and x-ray crystallographic studies indicate that two intramolecular disulfide bonds involving Cys(58) can be formed, linking it to either Cys(61) or Cys(4). We propose thus a four-step disulfide cascade mechanism involving the transient glutathionylation of Cys(4) to convert this atypical thioredoxin h back to its active reduced form.	[Gelhaye, Eric] Nancy Univ, Fac Sci & Tech, INRA, UHP,UMR 1136, F-54506 Vandoeuvre Les Nancy, France; [Koh, Cha San; Didierjean, Claude] Univ Henri Poincare, CNRS, LCM3B, Equipe Biocristallog,UMR 7036, F-54506 Vandoeuvre Les Nancy, France; [Corbier, Catherine] Nancy Univ, Fac Sci & Tech, Equipe PB2P, URAFPA, F-54506 Vandoeuvre Les Nancy, France; [Hirasawa, Masakazu; Knaff, David B.] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Hirasawa, Masakazu; Knaff, David B.] Texas Tech Univ, Ctr Biotechnol & Genom, Lubbock, TX 79409 USA; [Koh, Cha San; Samian, Razip] Univ Sains Malaysia, Sch Biol, Minden 11800, Penang, Malaysia; [Wingsle, Gunnar] Swedish Univ Agr Sci, Fac Forestry, Dept Forest Genet & Plant Physiol, SE-90183 Umea, Sweden	INRAE; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; Universite de Lorraine; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Universiti Sains Malaysia; Swedish University of Agricultural Sciences	Gelhaye, E (corresponding author), Nancy Univ, Fac Sci & Tech, INRA, UHP,UMR 1136, BP 239, F-54506 Vandoeuvre Les Nancy, France.	gelhaye@lcb.uhp-nancy.fr	gelhaye, eric/K-7390-2013; Samian, Mohammed Razip/A-7074-2011; DIDIERJEAN, Claude/L-1493-2013; Jacquot, Jean-Pierre/A-1571-2012	gelhaye, eric/0000-0002-0699-9113; DIDIERJEAN, Claude/0000-0002-3176-8974; Jacquot, Jean-Pierre/0000-0003-4975-8587; Rouhier, Nicolas/0000-0002-2036-7884; Navrot, Nicolas/0000-0002-2141-1808	Robert A. Welch Foundation [D-0710]	Robert A. Welch Foundation(The Welch Foundation)	This work was supported in part by Grant D-0710 (to D. B. K.) from the Robert A. Welch Foundation.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Brehelin C, 2004, PHOTOSYNTH RES, V79, P295, DOI 10.1023/B:PRES.0000017165.55488.ca; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Cheng ZY, 2007, BIOCHEMISTRY-US, V46, P7875, DOI 10.1021/bi700442r; Coudevylle N, 2005, BIOCHEMISTRY-US, V44, P2001, DOI 10.1021/bi047816n; CRAWFORD NA, 1989, ARCH BIOCHEM BIOPHYS, V271, P223, DOI 10.1016/0003-9861(89)90273-7; Deiana L, 1999, FREE RADICAL RES, V31, P237, DOI 10.1080/10715769900300801; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Friemann R, 2003, FEBS LETT, V554, P301, DOI 10.1016/S0014-5793(03)01173-6; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Gelhaye E, 2004, P NATL ACAD SCI USA, V101, P14545, DOI 10.1073/pnas.0405282101; Gelhaye E, 2004, PLANT PHYSIOL BIOCH, V42, P265, DOI 10.1016/j.plaphy.2004.03.002; Gelhaye E, 2003, FEBS LETT, V555, P443, DOI 10.1016/S0014-5793(03)01301-2; Hirasawa M, 2000, BIOCHEMISTRY-US, V39, P3344, DOI 10.1021/bi9916731; HOLMGREN A, 1975, P NATL ACAD SCI USA, V72, P2305, DOI 10.1073/pnas.72.6.2305; JACQUOT JP, 1994, J MOL BIOL, V235, P1357, DOI 10.1006/jmbi.1994.1091; Juttner J, 2000, EUR J BIOCHEM, V267, P7109, DOI 10.1046/j.1432-1327.2000.01811.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kleywegt GJ, 1997, ACTA CRYSTALLOGR D, V53, P179, DOI 10.1107/S0907444996012279; Koh CS, 2007, J MOL BIOL, V370, P512, DOI 10.1016/j.jmb.2007.04.031; KRAUSE G, 1991, J BIOL CHEM, V266, P4056; Krimm I, 1998, EUR J BIOCHEM, V255, P185, DOI 10.1046/j.1432-1327.1998.2550185.x; Laloi C, 2001, P NATL ACAD SCI USA, V98, P14144, DOI 10.1073/pnas.241340898; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; Masuda S, 2002, P NATL ACAD SCI USA, V99, P7078, DOI 10.1073/pnas.102013099; Menchise V, 2001, BIOCHEM J, V359, P65, DOI 10.1042/0264-6021:3590065; Meyer Y, 2002, METHOD ENZYMOL, V347, P394; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peterson FC, 2005, PROTEIN SCI, V14, P2195, DOI 10.1110/ps.051477905; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Rouhier N, 2004, PLANT PHYSIOL, V134, P1027, DOI 10.1104/pp.103.035865; Rouhier N, 2002, FEBS LETT, V511, P145, DOI 10.1016/S0014-5793(01)03302-6; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Rouhier N, 2002, PROTEIN EXPRES PURIF, V24, P234, DOI 10.1006/prep.2001.1574; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; SAARINEN M, 1995, STRUCTURE, V3, P1097, DOI 10.1016/S0969-2126(01)00245-3; Saviano M, 2000, BIOPOLYMERS, V53, P200, DOI 10.1002/(SICI)1097-0282(200002)53:2<200::AID-BIP10>3.0.CO;2-L; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; Schmidt H, 2003, J BIOL CHEM, V278, P46329, DOI 10.1074/jbc.M305338200; Schurmann P, 2003, ANTIOXID REDOX SIGN, V5, P69, DOI 10.1089/152308603321223559; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wangensteen OS, 2001, BBA-PROTEIN STRUCT M, V1547, P156, DOI 10.1016/S0167-4838(01)00178-9; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2	59	38	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23062	23072		10.1074/jbc.M802093200	http://dx.doi.org/10.1074/jbc.M802093200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18552403	Green Published, hybrid			2022-12-25	WOS:000258455400019
J	Pettersson, F; Hanna, N; Lagodich, M; Dupere-Richer, D; Couture, MC; Choi, C; Miller, WH				Pettersson, Filippa; Hanna, Nessrine; Lagodich, Marina; Dupere-Richer, Daphne; Couture, Marie-Claude; Choi, Catherine; Miller, Wilson H., Jr.			Rexinoids modulate steroid and xenobiotic receptor activity by increasing its protein turnover in a calpain-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; OVERCOMES MULTIDRUG-RESISTANCE; CELL LUNG-CANCER; NUCLEAR RECEPTOR; MAMMARY-CARCINOMA; SELECTIVE LIGAND; BEXAROTENE LGD1069; TARGRETIN PREVENTS; PACLITAXEL TAXOL; PROSTATE-CANCER	The steroid and xenobiotic receptor SXR (human pregnane X receptor) is a nuclear receptor that plays a key role in the body's detoxification response by regulating genes involved in drug metabolism and transport. SXR ligands include a wide range of compounds, which induce transcription of SXR target genes via activation of a heterodimeric transcription factor consisting of SXR and the related nuclear receptor retinoid X receptor (RXR). We investigated the effect of RXR-selective ligands, rexinoids, on SXR/RXR activity. In agreement with previous reports, we found that rexinoids are weak activators of SXR, but we also found that they can antagonize SXR activation by the potent SXR agonist rifampicin. This antagonism included suppression of rifampicin-induced expression of SXR target genes, as well as reduced binding of SXR/RXR to SXR response elements both in vivo and in vitro. Interestingly, two rexinoids, bexarotene (LGD1069/Targretin (R)) and LG100268, caused a rapid and sustained decrease in the protein levels of both SXR and RXR. The decrease in SXR level was due to an enhanced rate of protein degradation and was dependent on calpain activity, as opposed to rexinoid-induced RXR degradation, which is mediated via the proteasome. Thus, we have demonstrated a novel, rexinoid-modulated mechanism regulating SXR protein stability, which may explain why rexinoids are only weak activators of SXR/RXR-mediated transcription, despite reports that they bind to SXR with high affinity. We suggest that the ability of rexinoids to induce degradation of both SXR and RXR, in combination with competition for binding to SXR, can also explain why rexinoids antagonize the activation of SXR by drugs like rifampicin.	[Pettersson, Filippa; Hanna, Nessrine; Lagodich, Marina; Dupere-Richer, Daphne; Couture, Marie-Claude; Choi, Catherine; Miller, Wilson H., Jr.] McGill Univ, Lady Davis Inst Med Res, Segal Canc Ctr, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University	Miller, WH (corresponding author), McGill Univ, Lady Davis Inst Med Res, Segal Canc Ctr, Sir Mortimer B Davis Jewish Hosp, Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	wmiller@ldi.jgh.mcgill.ca	Dupéré-Richer, Daphne/AAF-9922-2021					Ahuja HS, 2003, J BIOL REG HOMEOS AG, V17, P29; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Bischoff ED, 1998, CANCER RES, V58, P479; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; Casas F, 2003, FASEB J, V17, P426, DOI 10.1096/fj.02-0732com; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Gottardis MM, 1996, CANCER RES, V56, P5566; Govindan R, 2006, J CLIN ONCOL, V24, P4848, DOI 10.1200/JCO.2006.07.7404; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Kassam A, 2003, J BIOL CHEM, V278, P10028, DOI 10.1074/jbc.M208312200; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Kim HT, 2006, CANCER RES, V66, P12009, DOI 10.1158/0008-5472.CAN-05-2515; Kopf E, 2000, J BIOL CHEM, V275, P33280, DOI 10.1074/jbc.M002840200; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Libertini SJ, 2007, CANCER RES, V67, P9001, DOI 10.1158/0008-5472.CAN-07-1072; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Masuyama H, 2005, MOL ENDOCRINOL, V19, P1170, DOI 10.1210/me.2004-0434; Masuyama H, 2002, ENDOCRINOLOGY, V143, P55, DOI 10.1210/en.143.1.55; MatsushimaNishiwaki R, 1996, BIOCHEM BIOPH RES CO, V225, P946, DOI 10.1006/bbrc.1996.1276; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Nagaoka R, 2006, ENDOCRINE, V30, P261, DOI 10.1007/s12020-006-0003-6; Osburn DL, 2001, MOL CELL BIOL, V21, P4909, DOI 10.1128/MCB.21.15.4909-4918.2001; PARIAT M, 1995, BIOL CELL, V84, P107; Pelley RP, 2006, CANCER RES, V66, P11754, DOI 10.1158/0008-5472.CAN-06-2918; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Pignatello MA, 1997, TOXICOL APPL PHARM, V142, P319, DOI 10.1006/taap.1996.8047; Small GW, 2002, ARCH BIOCHEM BIOPHYS, V400, P151, DOI 10.1016/S0003-9861(02)00005-X; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Szanto A, 2004, CELL DEATH DIFFER, V11, pS126, DOI 10.1038/sj.cdd.4401533; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Teng S, 2003, DRUG METAB DISPOS, V31, P1296, DOI 10.1124/dmd.31.11.1296; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; Wu K, 2002, CANCER EPIDEM BIOMAR, V11, P467; Yen WC, 2006, PROSTATE, V66, P305, DOI 10.1002/pros.20347; Yen WC, 2005, MOL CANCER THER, V4, P824, DOI 10.1158/1535-7163.MCT-05-0018; Yen WC, 2004, CLIN CANCER RES, V10, P8656, DOI 10.1158/1078-0432.CCR-04-0979; Yen WC, 2004, BREAST CANCER RES TR, V88, P141, DOI 10.1007/s10549-004-1426-5; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807	44	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21945	21952		10.1074/jbc.M710358200	http://dx.doi.org/10.1074/jbc.M710358200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544536	hybrid			2022-12-25	WOS:000258114700014
J	Upadhyay, A; Burman, JD; Clark, EA; Leung, E; Isenman, DE; van den Elsen, JMH; Bagby, S				Upadhyay, Abhishek; Burman, Julia D.; Clark, Elizabeth A.; Leung, Elisa; Isenman, David E.; van den Elsen, Jean M. H.; Bagby, Stefan			Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOTAXIS INHIBITORY PROTEIN; COMPLEMENT INHIBITOR; SURFACE PROTEIN; CHEMICAL-SHIFT; XPLOR-NIH; EVASION; IGG; SYSTEM; IMMUNOLOGY; EXPRESSION	Among the recently discovered Staphylococcus aureus immune evasion proteins, Sbi is unique in its ability to interact with components of both the adaptive and innate immune systems of the host. Sbi domains I and II (Sbi-I and Sbi-II) bind IgG. Sbi domain IV (residues 198 - 266) binds the central complement protein C3. When linked to Sbi-III, Sbi-IV induces a futile consumption of complement via alternative pathway activation, whereas isolated Sbi-IV specifically inhibits the alternative pathway without complement consumption. Here we have determined the three- dimensional structure of Sbi-IV by NMR spectroscopy, showing that Sbi-IV adopts a three- helix bundle fold similar to those of the S. aureus complement inhibitors Efb-C, Ehp, and SCIN. The H-1-N-15 HSQC spectrum of Sbi-III indicates that this domain, essential for futile complement consumption, is natively unfolded, at least when isolated from the rest of Sbi. Sbi-IV and Sbi-III-IV both bind C3dg with 1: 1 stoichiometry and submicromolar affinity. Despite low overall sequence identity, Sbi possesses the same residues as Efb at two positions essential for Efb-C binding to C3d. Mutation to alanine of either of these residues, Arg-231 and Asn-238, abolishes both Sbi-IV binding to C3dg and Sbi-IV alternative pathway inhibition. The almost complete conservation of Sbi-III and Sbi-IV amino acid sequences across more than 30 strains isolated from human and animal hosts indicates that the unique mechanism of Sbi in complement system subversion is a feature of infections of both humans and economically important animals.	[Upadhyay, Abhishek; Burman, Julia D.; Clark, Elizabeth A.; van den Elsen, Jean M. H.; Bagby, Stefan] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Leung, Elisa; Isenman, David E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Bath; University of Toronto	van den Elsen, JMH (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssjmhve@bath.ac.uk; bsssb@bath.ac.uk	van den Elsen, Jean/D-9274-2011	Bagby, Stefan/0000-0003-2302-9511; van den Elsen, Jean/0000-0002-0367-1956	Biotechnology and Biological Sciences Research Council [BBS/B/12121] Funding Source: Medline; Medical Research Council [MC_U117533887] Funding Source: Medline; Wellcome Trust [076124] Funding Source: Medline; MRC [MC_U117533887] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Atkins KL, 2008, MOL IMMUNOL, V45, P1600, DOI 10.1016/j.molimm.2007.10.021; Bestebroer J, 2007, BLOOD, V109, P2936, DOI 10.1182/blood-2006-06-015461; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chavakis T, 2002, NAT MED, V8, P687, DOI 10.1038/nm728; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; FRIES LF, 1984, J EXP MED, V160, P1640, DOI 10.1084/jem.160.6.1640; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; JIANG H, 2004, MOL IMMUNOL, V41, P252; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Lutz HU, 2006, MOL IMMUNOL, V43, P2, DOI 10.1016/j.molimm.2005.06.020; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Postma B, 2004, J IMMUNOL, V172, P6994, DOI 10.4049/jimmunol.172.11.6994; Prat C, 2006, J IMMUNOL, V177, P8017, DOI 10.4049/jimmunol.177.11.8017; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2007, J IMMUNOL, V179, P2989, DOI 10.4049/jimmunol.179.5.2989; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Sato S, 2004, P NATL ACAD SCI USA, V101, P6952, DOI 10.1073/pnas.0401396101; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wright AJ, 2007, MOL IMMUNOL, V44, P2507, DOI 10.1016/j.molimm.2006.12.022; Zhang LH, 1999, MICROBIOL-UK, V145, P177, DOI 10.1099/13500872-145-1-177; Zhang LH, 1998, MICROBIOL-UK, V144, P985, DOI 10.1099/00221287-144-4-985; Zhang LH, 2000, FEMS IMMUNOL MED MIC, V28, P211, DOI 10.1111/j.1574-695X.2000.tb01479.x	41	35	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22113	22120		10.1074/jbc.M802636200	http://dx.doi.org/10.1074/jbc.M802636200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550524	Green Published, hybrid			2022-12-25	WOS:000258114700030
J	Perrino, FW; de Silva, U; Harvey, S; Pryor, EE; Cole, DW; Hollis, T				Perrino, Fred W.; de Silva, Udesh; Harvey, Scott; Pryor, Edward E., Jr.; Cole, Daniel W.; Hollis, Thomas			Cooperative DNA binding and communication across the dimer interface in the TREX2 3 '-> 5 '-exonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; NUCLEIC ACID INTERACTIONS; FAMILIAL CHILBLAIN LUPUS; MEDIATED CELL-DEATH; EXONUCLEASE TREX1; POLYMERASE-DELTA; PROOFREADING EXONUCLEASE; RECOMBINANT PROTEINS; STRUCTURAL BASIS; 3' TERMINI	The activity of human TREX2-catalyzed 3' -> 5'-deoxyribonuclease has been analyzed in steady-state and single turnover kinetic assays and in equilibrium DNA binding studies. These kinetic data provide evidence for cooperative DNA binding within TREX2 and for coordinated catalysis between the TREX2 active sites supporting a model for communication between the protomers of a TREX2 dimer. Mobile loops positioned adjacent to the active sites provide the major DNA binding contribution and facilitate subsequent binding into the active sites. Mutations of three arginine residues on these loops cause decreased TREX2 activities by up to 60-fold. Steady-state kinetic assays of these arginine to alanine TREX2 variants result in increased Km values for DNA substrate with no effect on k(cat) values indicating contributions exclusively to DNA binding by all three of the loop arginines. TREX2 heterodimers were prepared to determine whether exonuclease activity in one protomer is communicated to the opposing protomer. Evidence for communication across the dimer interface is provided by the 7-fold lower catalytic activity measured in the TREX2(WT/H188A) heterodimer compared with the TREX2(WT) homodimer, contrasting the 2-fold lower activity measured in the TREX2(WT/R163A,R165A,R167A) heterodimer. The measured activity in TREX2(WT/H188A) heterodimer indicates that defective catalysis in one protomer reduces activity in the opposing protomer. A DNA binding analysis of TREX2 and the heterodimers indicates a cooperative binding effect within the TREX2 protomer. Finally, single turnover kinetic assays identify DNA binding as the rate-limiting step in TREX2 catalysis.	[Perrino, Fred W.; de Silva, Udesh; Harvey, Scott; Pryor, Edward E., Jr.; Cole, Daniel W.; Hollis, Thomas] Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University School of Medicine	Perrino, FW (corresponding author), Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wfubmc.edu		Pryor, Edward/0000-0001-8328-9126	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 069962] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albertson TM, 2006, CURR BIOL, V16, pR209, DOI 10.1016/j.cub.2006.02.031; BARNES MH, 1995, GENE, V165, P45, DOI 10.1016/0378-1119(95)00530-J; Beard WA, 2000, MUTAT RES-DNA REPAIR, V460, P231, DOI 10.1016/S0921-8777(00)00029-X; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Breyer WA, 2000, NAT STRUCT BIOL, V7, P1125; Brucet M, 2007, J BIOL CHEM, V282, P14547, DOI 10.1074/jbc.M700236200; Bujalowski W, 2006, CHEM REV, V106, P556, DOI 10.1021/cr040462l; Chen MJ, 2007, CANCER RES, V67, P9077, DOI 10.1158/0008-5472.CAN-07-1146; Chen MJ, 2007, NUCLEIC ACIDS RES, V35, P2682, DOI 10.1093/nar/gkm151; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; DeRose EF, 2002, BIOCHEMISTRY-US, V41, P94, DOI 10.1021/bi0114170; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goldsby RE, 2002, P NATL ACAD SCI USA, V99, P15560, DOI 10.1073/pnas.232340999; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hamdan S, 2002, STRUCTURE, V10, P535, DOI 10.1016/S0969-2126(02)00738-4; Harrigan JA, 2007, MECH AGEING DEV, V128, P259, DOI 10.1016/j.mad.2006.12.005; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Hill T. L., 1985, COOPERATIVITY THEORY; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Inamdar KV, 2002, RADIAT RES, V157, P306, DOI 10.1667/0033-7587(2002)157[0306:ROPDET]2.0.CO;2; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2117, DOI 10.1021/bi952344l; Jezewska MJ, 2003, BIOCHEMISTRY-US, V42, P5955, DOI 10.1021/bi030046f; Jezewska MJ, 1998, J MOL BIOL, V284, P1113, DOI 10.1006/jmbi.1998.2252; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; LINDAHL T, 1969, J BIOL CHEM, V244, P5014; LOHMAN TM, 1991, METHOD ENZYMOL, V208, P258; Marti TM, 2004, CELL MOL LIFE SCI, V61, P336, DOI 10.1007/s00018-003-3223-4; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; McElhinny SAN, 2006, CELL CYCLE, V5, P958, DOI 10.4161/cc.5.9.2736; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Miller H, 1996, BIOCHEMISTRY-US, V35, P12919, DOI 10.1021/bi960326d; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; PERRINO FW, 1994, J BIOL CHEM, V269, P16357; Perrino FW, 2004, ADV ENZYME REGUL, V44, P37, DOI 10.1016/j.advenzreg.2003.11.010; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Saecker RM, 2002, CURR OPIN STRUC BIOL, V12, P311, DOI 10.1016/S0959-440X(02)00326-3; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Strauss BS, 1997, NUCLEIC ACIDS RES, V25, P806, DOI 10.1093/nar/25.4.806; Taft-Benz SA, 1998, NUCLEIC ACIDS RES, V26, P4005, DOI 10.1093/nar/26.17.4005; Townson SA, 2007, STRUCTURE, V15, P449, DOI 10.1016/j.str.2007.03.002; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	54	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21441	21452		10.1074/jbc.M803629200	http://dx.doi.org/10.1074/jbc.M803629200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18534978	Green Published, hybrid			2022-12-25	WOS:000257898800016
J	Buchholz, K; Rahlfs, S; Schirmer, RH; Becker, K; Matuschewski, K				Buchholz, Kathrin; Rahlfs, Stefan; Schirmer, R. Heiner; Becker, Katja; Matuschewski, Kai			Depletion of Plasmodium berghei Plasmoredoxin Reveals a Non-Essential Role for Life Cycle Progression of the Malaria Parasite	PLOS ONE			English	Article								Proliferation of the pathogenic Plasmodium asexual blood stages in host erythrocytes requires an exquisite capacity to protect the malaria parasite against oxidative stress. This function is achieved by a complex antioxidant defence system composed of redox-active proteins and low MW antioxidants. Here, we disrupted the P. berghei plasmoredoxin gene that encodes a parasite-specific 22 kDa member of the thioredoxin superfamily. The successful generation of plasmoredoxin knockout mutants in the rodent model malaria parasite and phenotypic analysis during life cycle progression revealed a non-vital role in vivo. Our findings suggest that plasmoredoxin fulfils a specialized and dispensable role for Plasmodium and highlights the need for target validation to inform drug development strategies.	[Buchholz, Kathrin; Rahlfs, Stefan; Becker, Katja] Univ Giessen, Interdisciplinary Res Ctr, Giessen, Germany; [Buchholz, Kathrin; Schirmer, R. Heiner] Univ Heidelberg, Biochem Ctr, Heidelberg, Germany; [Buchholz, Kathrin; Matuschewski, Kai] Heidelberg Univ, Sch Med, Dept Parasitol, Heidelberg, Germany	Justus Liebig University Giessen; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Buchholz, K (corresponding author), Univ Giessen, Interdisciplinary Res Ctr, Giessen, Germany.	becker.katja@gmx.de; Kai.Matuschewski@med.uni-heidelberg.de	Buchholz, Kathrin/O-3217-2017	Matuschewski, Kai/0000-0001-6147-8591	Deutsche Forschungsgemeinschaft;  [SFB 544];  [B2];  [B10];  [BE1540/4-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; ; ; 	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 544, B2 and B10 as well as BE1540/4-4).	Becker K, 2005, MOLECULAR APPROACHES TO MALARIA, P365; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Becker K, 2003, EUR J BIOCHEM, V270, P1057, DOI 10.1046/j.1432-1033.2003.03495.x; Boucher IW, 2006, MOL MICROBIOL, V61, P948, DOI 10.1111/j.1365-2958.2006.05303.x; Buchholz K, 2008, ANTIMICROB AGENTS CH, V52, P183, DOI 10.1128/AAC.00773-07; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Collinson EJ, 2002, J BIOL CHEM, V277, P16712, DOI 10.1074/jbc.M111686200; Draculic T, 2000, MOL MICROBIOL, V36, P1167, DOI 10.1046/j.1365-2958.2000.01948.x; Ginsburg H, 1998, BIOCHEM PHARMACOL, V56, P1305, DOI 10.1016/S0006-2952(98)00184-1; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; JANSE CJ, 1994, INT J PARASITOL, V24, P589, DOI 10.1016/0020-7519(94)90150-3; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Krauth-Siegel RL, 2005, ANGEW CHEM INT EDIT, V44, P690, DOI 10.1002/anie.200300639; Krnajski Z, 2002, J BIOL CHEM, V277, P25970, DOI 10.1074/jbc.M203539200; Luikenhuis S, 1998, MOL BIOL CELL, V9, P1081, DOI 10.1091/mbc.9.5.1081; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; MUELLER EGD, 1991, J BIOL CHEM, V43, P9194; Muller S, 2003, REDOX REP, V8, P251, DOI 10.1179/135100003225002853; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Nickel C, 2005, BIOL CHEM, V386, P1129, DOI 10.1515/BC.2005.129; Nickel C, 2006, ANTIOXID REDOX SIGN, V8, P1227, DOI 10.1089/ars.2006.8.1227; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Ortenberg R, 2004, P NATL ACAD SCI USA, V101, P7439, DOI 10.1073/pnas.0401965101; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Rahlfs S, 2006, MINI-REV MED CHEM, V6, P163, DOI 10.2174/138955706775475911; Rahlfs S, 2003, REDOX REP, V8, P246, DOI 10.1179/135100003225002844; Rahlfs S, 2002, CELL MOL LIFE SCI, V59, P1024, DOI 10.1007/s00018-002-8484-9; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; RUSSEL M, 1988, P NATL ACAD SCI USA, V85, P990, DOI 10.1073/pnas.85.4.990; Sobolewski P, 2005, INFECT IMMUN, V73, P6704, DOI 10.1128/IAI.73.10.6704-6710.2005; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Thathy Vandana, 2002, Methods Mol Med, V72, P317, DOI 10.1385/1-59259-271-6:317; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618	36	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2474	10.1371/journal.pone.0002474	http://dx.doi.org/10.1371/journal.pone.0002474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575607	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288000006
J	Dalmasso, G; Nguyen, HTT; Yan, YT; Charrier-Hisamuddin, L; Sitaraman, SV; Merlin, D				Dalmasso, Guillaume; Nguyen, Hang Thi Thu; Yan, Yutao; Charrier-Hisamuddin, Laetitia; Sitaraman, Shanthi V.; Merlin, Didier			Butyrate Transcriptionally Enhances Peptide Transporter PepT1 Expression and Activity	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; NHE3 GENE PROMOTER; NF-KAPPA-B; HPEPT1 EXPRESSION; HUMAN INTESTINE; COLONIC-MUCOSA; RAT; CANCER; LOCALIZATION; METABOLISM	Background: PepT1, an intestinal epithelial apical di/tripeptide transporter, is normally expressed in the small intestine and induced in colon during chronic inflammation. This study aimed at investigating PepT1 regulation by butyrate, a short-chain fatty acid produced by commensal bacteria and accumulated inside inflamed colonocyte. Results: We found that butyrate treatment of human intestinal epithelial Caco2-BBE cells increased human PepT1 (hPepT1) promoter activity in a dose- and time-dependent manner, with maximal activity observed in cells treated with 5 mM butyrate for 24 h. Under this condition, hPepT1 promoter activity, mRNA and protein expression levels were increased as assessed by luciferase assay, real-time RT-PCR and Western blot, respectively. hPepT1 transport activity was accordingly increased by similar to 2.5-fold. Butyrate did not alter hPepT1 mRNA half-life indicating that butyrate acts at the transcriptional level. Molecular analyses revealed that Cdx2 is the most important transcription factor for butyrate-induced increase of hPepT1 expression and activity in Caco2-BBE cells. Butyrate-activated Cdx2 binding to hPepT1 promoter was confirmed by gel shift and chromatin immunoprecipitation. Moreover, Caco2-BBE cells overexpressing Cdx2 exhibited greater hPepT1 expression level than wild-type cells. Finally, treatment of mice with 5 mM butyrate added to drinking water for 24 h increased colonic PepT1 mRNA and protein expression levels, as well as enhanced PepT1 transport activity in colonic apical membranes vesicles. Conclusions: Collectively, our results demonstrate that butyrate increases PepT1 expression and activity in colonic epithelial cells, which provides a new understanding of PepT1 regulation during chronic inflammation.	[Dalmasso, Guillaume; Nguyen, Hang Thi Thu; Yan, Yutao; Charrier-Hisamuddin, Laetitia; Sitaraman, Shanthi V.; Merlin, Didier] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA	Emory University	Dalmasso, G (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	nguye9@emory.edu	Dalmasso, Guillaume/N-2443-2018; Nguyen, Hang/N-2441-2018	Dalmasso, Guillaume/0000-0002-3433-870X; Nguyen, Hang/0000-0001-7431-5126	National Institutes of Health of Diabetes and Digestive and Kidney Diseases [R24-DK-064399, RO1-DK061941-02, RO1-DK55850]; Crohn's and Colitis Foundation of America [research fellowship, carrier development award]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061941, R01DK055850, R24DK064399] Funding Source: NIH RePORTER	National Institutes of Health of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health of Diabetes and Digestive and Kidney Diseases under a center grant (R24-DK-064399), RO1-DK061941-02 (to D. Merlin), RO1-DK55850 (to S. Sitaraman). G. Dalmasso and Y. Yan are recipient of a research fellowship award from the Crohn's and Colitis Foundation of America. L. Charrier-Hisamuddin is a recipient of a carrier development award from the Crohn's and Colitis Foundation of America.	Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Ahmad MS, 2000, GUT, V46, P493, DOI 10.1136/gut.46.4.493; BOEDIGER WE, 1996, GUT, V38, P792; Buyse M, 2002, AM J PHYSIOL-CELL PH, V283, pC1795, DOI 10.1152/ajpcell.00186.2002; Buyse M, 2002, J BIOL CHEM, V277, P28182, DOI 10.1074/jbc.M203281200; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Charrier L, 2006, LAB INVEST, V86, P490, DOI 10.1038/labinvest.3700413; CLAUSEN MR, 1994, GASTROENTEROLOGY, V106, P423, DOI 10.1016/0016-5085(94)90601-7; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; CUMMINGS JH, 1981, GUT, V22, P763, DOI 10.1136/gut.22.9.763; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dalmasso G, 2008, GASTROENTEROLOGY, V134, P166, DOI 10.1053/j.gastro.2007.10.026; Daly K, 2005, BIOCHEM SOC T, V33, P733, DOI 10.1042/BST0330733; DANIEL H, 1991, J BIOL CHEM, V266, P19917; DeCastro M, 2005, MOL BRAIN RES, V142, P28, DOI 10.1016/j.molbrainres.2005.09.002; Den Hond E, 1998, GASTROENTEROLOGY, V115, P584; Domon-Dell C, 2002, GUT, V50, P525, DOI 10.1136/gut.50.4.525; Engelhardt W V, 1989, Acta Vet Scand Suppl, V86, P103; Fei YJ, 1998, PROG NUCLEIC ACID RE, V58, P239; GAMET L, 1992, INT J CANCER, V52, P286, DOI 10.1002/ijc.2910520222; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Kiela PR, 2007, AM J PHYSIOL-CELL PH, V293, pC64, DOI 10.1152/ajpcell.00277.2006; Kiela PR, 2001, AM J PHYSIOL-GASTR L, V281, pG947, DOI 10.1152/ajpgi.2001.281.4.G947; Mandal M, 2001, GASTROENTEROLOGY, V120, P71, DOI 10.1053/gast.2001.20897; MCINTYRE A, 1993, GUT, V34, P386, DOI 10.1136/gut.34.3.386; Merlin D, 1998, J CLIN INVEST, V102, P2011, DOI 10.1172/JCI4179; Merlin D, 2001, GASTROENTEROLOGY, V120, P1666, DOI 10.1053/gast.2001.24845; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Mutoh H, 2005, INT J DEV BIOL, V49, P867, DOI 10.1387/ijdb.052016hm; Nduati V, 2007, J BIOL CHEM, V282, P1359, DOI 10.1074/jbc.M604267200; Ogihara H, 1999, HISTOCHEM J, V31, P169, DOI 10.1023/A:1003515413550; Ogihara H, 1996, BIOCHEM BIOPH RES CO, V220, P848, DOI 10.1006/bbrc.1996.0493; ROEDIGER WEW, 1980, LANCET, V2, P712; RONG LA, 1995, J BIOL CHEM, V270, P6456, DOI 10.1074/jbc.270.12.6456; Ruemmele FM, 2003, GUT, V52, P94, DOI 10.1136/gut.52.1.94; Sai Y, 1996, FEBS LETT, V392, P25, DOI 10.1016/0014-5793(96)00778-8; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Shah P, 2006, BRAIN RES, V1107, P13, DOI 10.1016/j.brainres.2006.05.097; Shi B, 2006, J SURG RES, V136, P38, DOI 10.1016/j.jss.2006.05.025; Shi B, 2006, DIGEST DIS SCI, V51, P2087, DOI 10.1007/s10620-005-9067-z; Shimakura J, 2005, AM J PHYSIOL-GASTR L, V289, pG471, DOI 10.1152/ajpgi.00025.2005; Shimakura J, 2006, BIOCHEM PHARMACOL, V71, P1581, DOI 10.1016/j.bcp.2006.03.001; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Silberg DG, 2002, GASTROENTEROLOGY, V122, P689, DOI 10.1053/gast.2002.31902; Smith DE, 1998, PHARM RES-DORDR, V15, P1244, DOI 10.1023/A:1011996009332; Tanaka N, 1998, SURF REV LETT, V5, P723, DOI 10.1142/S0218625X98001092; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thu Nguyen HT, 2007, AM J PHYSIOL-GASTR L, V293, pG1155, DOI 10.1152/ajpgi.00334.2007; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; VIDALI G, 1978, P NATL ACAD SCI USA, V75, P2239, DOI 10.1073/pnas.75.5.2239; WRONG O, 1965, CLIN SCI, V28, P357; Zeissig S, 2007, GASTROENTEROLOGY, V132, P236, DOI 10.1053/j.gastro.2006.10.033; Ziegler TR, 2002, AM J CLIN NUTR, V75, P922, DOI 10.1093/ajcn/75.5.922	53	69	73	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2476	10.1371/journal.pone.0002476	http://dx.doi.org/10.1371/journal.pone.0002476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575574	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000008
J	Elisaphenko, EA; Kolesnikov, NN; Shevchenko, AI; Rogozin, IB; Nesterova, TB; Brockdorff, N; Zakian, SM				Elisaphenko, Eugeny A.; Kolesnikov, Nikolay N.; Shevchenko, Alexander I.; Rogozin, Igor B.; Nesterova, Tatyana B.; Brockdorff, Neil; Zakian, Suren M.			A Dual Origin of the Xist Gene from a Protein-Coding Gene and a Set of Transposable Elements	PLOS ONE			English	Article								X-chromosome inactivation, which occurs in female eutherian mammals is controlled by a complex X-linked locus termed the X-inactivation center (XIC). Previously it was proposed that genes of the XIC evolved, at least in part, as a result of pseudogenization of protein-coding genes. In this study we show that the key XIC gene Xist, which displays fragmentary homology to a protein-coding gene Lnx3, emerged de novo in early eutherians by integration of mobile elements which gave rise to simple tandem repeats. The Xist gene promoter region and four out of ten exons found in eutherians retain homology to exons of the Lnx3 gene. The remaining six Xist exons including those with simple tandem repeats detectable in their structure have similarity to different transposable elements. Integration of mobile elements into Xist accompanies the overall evolution of the gene and presumably continues in contemporary eutherian species. Additionally we showed that the combination of remnants of protein-coding sequences and mobile elements is not unique to the Xist gene and is found in other XIC genes producing non-coding nuclear RNA.	[Elisaphenko, Eugeny A.; Kolesnikov, Nikolay N.; Shevchenko, Alexander I.; Rogozin, Igor B.; Zakian, Suren M.] Russian Acad Sci, Inst Cytol & Genet, Siberian Dept, Novosibirsk 630090, Russia; [Rogozin, Igor B.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD USA; [Nesterova, Tatyana B.] Imperial Coll, Fac Med, Clin Sci Ctr, Med Res Council, London, England; [Brockdorff, Neil] Univ Oxford, Dept Biochem, Oxford, England	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford	Elisaphenko, EA (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Dept, Novosibirsk 630090, Russia.	zakian@bionet.nsc.ru	Elisaphenko, Eugeny/V-5115-2018; Shevchenko, Alexander I./T-3400-2018; Kolesnikov, Nikolay/N-7569-2015; Zakian, Suren/J-2196-2018; Elisafenko, Eugeny/AAD-5901-2020	Kolesnikov, Nikolay/0000-0001-7005-0888; Elisafenko, Eugeny/0000-0002-3204-8178; Zakian, Suren/0000-0003-2448-6511; Nesterova, Tatyana/0000-0001-7740-4386; Rogozin, Igor/0000-0003-0802-4851; Brockdorff, Neil/0000-0003-4838-2653	Russian Foundation for Fundamental Research [06-04-48337-a, 08-04-00346-a]; Russian Academy of Sciences [10.8]; Intramural Research Program of the National Library of Medicine at National Institutes of Health/DHHS; MRC [MC_U120031757] Funding Source: UKRI; Medical Research Council [MC_U120031757] Funding Source: researchfish	Russian Foundation for Fundamental Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Intramural Research Program of the National Library of Medicine at National Institutes of Health/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the Russian Foundation for Fundamental Research (grants no. 06-04-48337-a and 08-04-00346-a), Russian Academy of Sciences foundation program for Molecular and Cellular Biology and by grant 10.8 from the Interdisciplinary Integration Project of the Siberian Division of the Russian Academy of Sciences. I.B.R. was supported in part by the Intramural Research Program of the National Library of Medicine at National Institutes of Health/DHHS.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Britten RJ, 2004, P NATL ACAD SCI USA, V101, P16825, DOI 10.1073/pnas.0406985101; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Brown CJ, 1996, SOMAT CELL MOLEC GEN, V22, P403, DOI 10.1007/BF02369896; Chang SC, 2006, FRONT BIOSCI-LANDMRK, V11, P852, DOI 10.2741/1842; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Davidow LS, 2007, CHROMOSOME RES, V15, P137, DOI 10.1007/s10577-007-1121-6; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Elnitski L, 2002, GENOMICS, V80, P681, DOI 10.1006/geno.2002.7018; Glazko GV, 2005, TRENDS GENET, V21, P89, DOI 10.1016/j.tig.2004.12.006; Hore TA, 2007, CHROMOSOME RES, V15, P147, DOI 10.1007/s10577-007-1119-0; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Johnston CM, 2002, GENOMICS, V80, P236, DOI 10.1006/geno.2002.6819; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shevchenko AI, 2007, CHROMOSOME RES, V15, P127, DOI 10.1007/s10577-006-1115-9; Smit A.F.A., REPEATMASKER; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yen ZC, 2007, GENOMICS, V90, P453, DOI 10.1016/j.ygeno.2007.07.002	28	117	123	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2521	10.1371/journal.pone.0002521	http://dx.doi.org/10.1371/journal.pone.0002521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575625	gold, Green Submitted, Green Published			2022-12-25	WOS:000263288000037
J	Tarasov, KV; Tarasova, YS; Tam, WL; Riordon, DR; Elliott, ST; Kania, G; Li, JL; Yamanaka, S; Crider, DG; Testa, G; Li, RA; Lim, B; Stewart, CL; Liu, Y; Van Eyk, JE; Wersto, RP; Wobus, AM; Boheler, KR				Tarasov, Kirill V.; Tarasova, Yelena S.; Tam, Wai Leong; Riordon, Daniel R.; Elliott, Steven T.; Kania, Gabriela; Li, Jinliang; Yamanaka, Satoshi; Crider, David G.; Testa, Gianluca; Li, Ronald A.; Lim, Bing; Stewart, Colin L.; Liu, Yie; Van Eyk, Jennifer E.; Wersto, Robert P.; Wobus, Anna M.; Boheler, Kenneth R.			B-MYB Is Essential for Normal Cell Cycle Progression and Chromosomal Stability of Embryonic Stem Cells	PLOS ONE			English	Article								Background: The transcription factor B-Myb is present in all proliferating cells, and in mice engineered to remove this gene, embryos die in utero just after implantation due to inner cell mass defects. This lethal phenotype has generally been attributed to a proliferation defect in the cell cycle phase of G1. Methodology/Principal Findings: In the present study, we show that the major cell cycle defect in murine embryonic stem (mES) cells occurs in G2/M. Specifically, knockdown of B-Myb by short-hairpin RNAs results in delayed transit through G2/M, severe mitotic spindle and centrosome defects, and in polyploidy. Moreover, many euploid mES cells that are transiently deficient in B-Myb become aneuploid and can no longer be considered viable. Knockdown of B-Myb in mES cells also decreases Oct4 RNA and protein abundance, while over-expression of B-MYB modestly up-regulates pou5f1 gene expression. The coordinated changes in B-Myb and Oct4 expression are due, at least partly, to the ability of B-Myb to directly modulate pou5f1 gene promoter activity in vitro. Ultimately, the loss of B-Myb and associated loss of Oct4 lead to an increase in early markers of differentiation prior to the activation of caspase-mediated programmed cell death. Conclusions/Significance: Appropriate B-Myb expression is critical to the maintenance of chromosomally stable and pluripotent ES cells, but its absence promotes chromosomal instability that results in either aneuploidy or differentiation-associated cell death.	[Tarasov, Kirill V.; Tarasova, Yelena S.; Riordon, Daniel R.; Li, Jinliang; Yamanaka, Satoshi; Crider, David G.; Testa, Gianluca; Boheler, Kenneth R.] NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; [Tam, Wai Leong; Lim, Bing] Genome Inst Singapore, Singapore, Singapore; [Elliott, Steven T.; Van Eyk, Jennifer E.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Kania, Gabriela; Wobus, Anna M.] Leibniz Inst Plant Genet & Crop Plant Res, In vitro Differentiat Grp, Gatersleben, Germany; [Li, Ronald A.] Univ Calif Davis, Stem Cell Inst, Lab Stem Cell Engn & Bioelectricity, Davis, CA USA; [Lim, Bing] Harvard Med Sch, Harvard Inst Med, Boston, MA USA; [Stewart, Colin L.] NCI, Canc & Dev Biol Lab, Frederick, MD USA; [Liu, Yie] NIH, NIA, Lab Mol Genet, Baltimore, MD USA; [Wersto, Robert P.] NIH, NIA, Flow Cytometry Grp, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Johns Hopkins University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of California System; University of California Davis; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Tarasov, KV (corresponding author), NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA.	bohelerk@grc.nia.nih.gov	Liu, Yie/AAO-2092-2020; Tam, Wai Leong/P-1497-2019; Kania, Gabriela/E-8715-2017; /AAB-9217-2021; Li, Ronald/E-9833-2010	Tam, Wai Leong/0000-0003-2365-5264; Kania, Gabriela/0000-0003-3788-4594; Li, Jinliang/0000-0002-3018-0570; Tarasov, Kirill/0000-0001-7799-4670	Intramural Research Program of the NIA/NIH [R01 HL72857]; German Research Foundation [Wo 503/3-3]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085434, R01HL072857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000847, Z01AG000618] Funding Source: NIH RePORTER	Intramural Research Program of the NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); German Research Foundation(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the NIA/NIH (KRB, RPW), the German Research Foundation (Wo 503/3-3: AMW), and NIH grants (R01 HL72857: RAL).	Bessa M, 2001, ONCOGENE, V20, P3376, DOI 10.1038/sj.onc.1204439; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Charrasse S, 2000, ONCOGENE, V19, P2986, DOI 10.1038/sj.onc.1203618; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Davidson CJ, 2005, GENETICS, V169, P215, DOI 10.1534/genetics.104.034132; Debiak M, 2004, DNA REPAIR, V3, P359, DOI 10.1016/j.dnarep.2003.11.013; Elliott ST, 2004, PROTEOMICS, V4, P3813, DOI 10.1002/pmic.200300820; Garcia P, 2006, J CELL SCI, V119, P1483, DOI 10.1242/jcs.02870; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Grassilli E, 1999, CANCER RES, V59, P2451; Iwai N, 2001, ONCOGENE, V20, P1425, DOI 10.1038/sj.onc.1204236; Joaquin M, 2003, CELL MOL LIFE SCI, V60, P2389, DOI 10.1007/s00018-003-3037-4; Johnson LR, 2002, J BIOL CHEM, V277, P4088, DOI 10.1074/jbc.M105112200; Lang G, 2005, IMMUNOLOGY, V114, P25, DOI 10.1111/j.1365-2567.2004.02073.x; Li XL, 2002, MOL CELL BIOL, V22, P3663, DOI 10.1128/MCB.22.11.3663-3673.2002; Manak JR, 2002, P NATL ACAD SCI USA, V99, P7438, DOI 10.1073/pnas.122231599; Manak R, 2007, NAT CELL BIOL, V9, P581, DOI 10.1038/ncb1580; Mantel C, 2007, BLOOD, V109, P4518, DOI 10.1182/blood-2006-10-054247; NAKAGOSHI H, 1992, ONCOGENE, V7, P1233; Ness SA, 2003, BLOOD CELL MOL DIS, V31, P192, DOI 10.1016/S1079-9796(03)00151-7; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Schubert S, 2004, ONCOGENE, V23, P1392, DOI 10.1038/sj.onc.1207255; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; SNOW MHL, 1978, J EMBRYOL EXP MORPH, V47, P39; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; TARASOV KV, 2008, CELLS TISSUES ORGANS, V27; Tarasova YS, 2006, EMBRYONIC STEM CELLS, P130; Tashiro S, 2004, J BIOL CHEM, V279, P17715, DOI 10.1074/jbc.M310561200; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Wang YS, 2005, P NATL ACAD SCI USA, V102, P10256, DOI 10.1073/pnas.0504635102; Wersto RP, 1998, J VIROL, V72, P9491, DOI 10.1128/JVI.72.12.9491-9502.1998; Wobus A M, 2002, Methods Mol Biol, V185, P127; WOBUS AM, 1994, IN VITRO CELL DEV-AN, V30A, P425; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013	42	75	75	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2478	10.1371/journal.pone.0002478	http://dx.doi.org/10.1371/journal.pone.0002478			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575582	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288000009
J	Ciani, AC; Cermelli, P; Zanzotto, G				Ciani, Andrea Camperio; Cermelli, Paolo; Zanzotto, Giovanni			Sexually Antagonistic Selection in Human Male Homosexuality	PLOS ONE			English	Article							BIRTH-ORDER; ORIENTATION; CONFLICT; EVOLUTION; LINKAGE; FAMILY; CHROMOSOME; SPECIATION; BEHAVIOR; INSECTS	Several lines of evidence indicate the existence of genetic factors influencing male homosexuality and bisexuality. In spite of its relatively low frequency, the stable permanence in all human populations of this apparently detrimental trait constitutes a puzzling 'Darwinian paradox'. Furthermore, several studies have pointed out relevant asymmetries in the distribution of both male homosexuality and of female fecundity in the parental lines of homosexual vs. heterosexual males. A number of hypotheses have attempted to give an evolutionary explanation for the long-standing persistence of this trait, and for its asymmetric distribution in family lines; however a satisfactory understanding of the population genetics of male homosexuality is lacking at present. We perform a systematic mathematical analysis of the propagation and equilibrium of the putative genetic factors for male homosexuality in the population, based on the selection equation for one or two diallelic loci and Bayesian statistics for pedigree investigation. We show that only the two-locus genetic model with at least one locus on the X chromosome, and in which gene expression is sexually antagonistic (increasing female fitness but decreasing male fitness), accounts for all known empirical data. Our results help clarify the basic evolutionary dynamics of male homosexuality, establishing this as a clearly ascertained sexually antagonistic human trait.	[Ciani, Andrea Camperio] Univ Padua, Dipartimento Psicol Gen, Padua, Italy; [Cermelli, Paolo] Univ Turin, Dipartimento Mat, Turin, Italy; [Zanzotto, Giovanni] Univ Padua, Dipartimento Metodi Modelli Mat Sci Appl, Padua, Italy	University of Padua; University of Turin; University of Padua	Ciani, AC (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.	andrea.camperio@unipd.it	Cermelli, Paolo/C-7042-2011; Ciani, Andrea Camperio/A-8290-2013	Ciani, Andrea Camperio/0000-0002-4689-1799; Cermelli, Paolo/0000-0002-2181-8800				Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist G., 2005, SEXUAL CONFLICTS; Bailey JM, 1999, BEHAV GENET, V29, P79, DOI 10.1023/A:1021652204405; Blanchard R, 2004, J THEOR BIOL, V230, P173, DOI 10.1016/j.jtbi.2004.04.021; Bobrow D, 2001, EVOL HUM BEHAV, V22, P361, DOI 10.1016/S1090-5138(01)00074-5; Camperio-Ciani A, 2004, P ROY SOC B-BIOL SCI, V271, P2217, DOI 10.1098/rspb.2004.2872; CIANI AC, 2008, MALE HOMOSEXUALITY P; CIANI AC, 2008, SEX MED IN PRESS; Dawkins R, 1976, SELFISH GENE; Dawood K, 2000, ARCH SEX BEHAV, V29, P155, DOI 10.1023/A:1001955721992; EDWARDS AWF, 2000, FDN MATH GENETICS; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Gavrilets S, 2006, P ROY SOC B-BIOL SCI, V273, P3031, DOI 10.1098/rspb.2006.3684; GETZ WM, 1993, J THEOR BIOL, V162, P515, DOI 10.1006/jtbi.1993.1102; Hamer D., 1994, SCI DESIRE SEARCH GA; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; Hofbauer J., 1988, THEORY EVOLUTION DYN; HU S, 1995, NAT GENET, V11, P248, DOI 10.1038/ng1195-248; HUTCHINSON GE, 1959, AM NAT, V93, P81, DOI 10.1086/282059; IEMMOLA F, 2008, ARCH SEX BE IN PRESS; Judson O., 2003, TATIANAS SEX ADVICE; King M, 2005, ARCH SEX BEHAV, V34, P117, DOI 10.1007/s10508-005-1006-8; MACINTYRE F, 1993, BIOSYSTEMS, V31, P223, DOI 10.1016/0303-2647(93)90051-D; Martin OY, 2003, NATURE, V423, P979, DOI 10.1038/nature01752; McKnight J., 1997, STRAIGHT SCI HOMOSEX; Miller EM, 2000, ARCH SEX BEHAV, V29, P1, DOI 10.1023/A:1001836320541; Muscarella F, 2000, J HOMOSEXUAL, V40, P51, DOI 10.1300/J082v40n01_03; Mustanski BS, 2005, HUM GENET, V116, P272, DOI 10.1007/s00439-004-1241-4; Oliver B, 2004, BIOESSAYS, V26, P543, DOI 10.1002/bies.20034; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; PARKER GA, 1979, INSECTS, P123; Pattatucci AM, 1998, HUM BIOL, V70, P367; Pillard RC, 1998, HUM BIOL, V70, P347; PILLARD RC, 1981, ARCH SEX BEHAV, V10, P465, DOI 10.1007/BF01541437; PILLARD RC, 1982, ARCH SEX BEHAV, V11, P511, DOI 10.1007/BF01542476; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Reeve HK, 2003, P NATL ACAD SCI USA, V100, P1089, DOI 10.1073/pnas.0337427100; Rice G, 1999, SCIENCE, V284, P665, DOI 10.1126/science.284.5414.665; Rice WR, 2000, P NATL ACAD SCI USA, V97, P12953, DOI 10.1073/pnas.97.24.12953; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Savolainen V, 2007, NATURE, V445, P158, DOI 10.1038/445158b; TRIVERS RL, 1974, AM ZOOL, V14, P249; Trivers RL., 1972, SEXUAL SELECTION DES; VANDERLAAN DP, 2007, ARCH SEX BEHAV; Vasey PL, 2007, P ROY SOC B-BIOL SCI, V274, P1437, DOI 10.1098/rspb.2007.0120; WEINRICH J, 1987, SEXUAL LANDSCAPES; Wilson E.O., 1975, P1	49	51	51	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2282	10.1371/journal.pone.0002282	http://dx.doi.org/10.1371/journal.pone.0002282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406FP	18560521	Green Submitted, Green Published, gold			2022-12-25	WOS:000263280700001
J	Skov, V; Glintborg, D; Knudsen, S; Tan, Q; Jensen, T; Kruse, TA; Beck-Nielsen, H; Hojlund, K				Skov, Vibe; Glintborg, Dorte; Knudsen, Steen; Tan, Qihua; Jensen, Thomas; Kruse, Torben A.; Beck-Nielsen, Henning; Hojlund, Kurt			Pioglitazone Enhances Mitochondrial Biogenesis and Ribosomal Protein Biosynthesis in Skeletal Muscle in Polycystic Ovary Syndrome	PLOS ONE			English	Article							FATTY-ACID OXIDATION; INSULIN-RESISTANCE; ROSIGLITAZONE TREATMENT; GENE-EXPRESSION; MICROARRAY DATA; ADIPOSE-TISSUE; PPAR-GAMMA; AMP KINASE; METABOLISM; WOMEN	Insulin resistance is a common metabolic abnormality in women with PCOS and leads to an elevated risk of type 2 diabetes. Studies have shown that thiazolidinediones (TZDs) improve metabolic disturbances in PCOS patients. We hypothesized that the effect of TZDs in PCOS is, in part, mediated by changes in the transcriptional profile of muscle favoring insulin sensitivity. Using Affymetrix microarrays, we examined the effect of pioglitazone (30 mg/day for 16 weeks) on gene expression in skeletal muscle of 10 obese women with PCOS metabolically characterized by a euglycemic-hyperinsulinemic clamp. Moreover, we explored gene expression changes between these PCOS patients before treatment and 13 healthy women. Treatment with pioglitazone improved insulin-stimulated glucose metabolism and plasma adiponectin, and reduced fasting serum insulin (all P<0.05). Global pathway analysis using Gene Map Annotator and Pathway Profiler (GenMAPP 2.1) and Gene Set Enrichment Analysis (GSEA 2.0.1) revealed a significant upregulation of genes representing mitochondrial oxidative phosphorylation (OXPHOS), ribosomal proteins, mRNA processing reactome, translation factors, and proteasome degradation in PCOS after pioglitazone therapy. Quantitative real-time PCR suggested that upregulation of OXPHOS genes was mediated by an increase in PGC-1a expression (P<0.05). Pretreatment expression of genes representing OXPHOS and ribosomal proteins was down-regulated in PCOS patients compared to healthy women. These data indicate that pioglitazone therapy restores insulin sensitivity, in part, by a coordinated upregulation of genes involved in mitochondrial OXPHOS and ribosomal protein biosynthesis in muscle in PCOS. These transcriptional effects of pioglitazone may contribute to prevent the onset of type 2 diabetes in these women.	[Skov, Vibe; Tan, Qihua; Kruse, Torben A.] Univ So Denmark, Dept Biochem Genet & Pharmacol, Odense Univ Hosp, Odense, Denmark; [Glintborg, Dorte; Beck-Nielsen, Henning; Hojlund, Kurt] Odense Univ Hosp, Diabetes Res Ctr, Dept Endocrinol, Odense, Denmark; [Knudsen, Steen; Jensen, Thomas] Med Prognosis Inst Aps, Horsholm, Denmark; [Tan, Qihua] Univ So Denmark, Inst Publ Hlth, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Skov, V (corresponding author), Univ So Denmark, Dept Biochem Genet & Pharmacol, Odense Univ Hosp, Odense, Denmark.	vibe.skov@ouh.regionsyddanmark.dk; k.hojlund@dadlnet.dk	Tan, Qihua/AAG-2582-2019; Tan, Qihua/F-1349-2015; Glintborg, Dorte/AAE-3676-2019	Tan, Qihua/0000-0003-3194-0030; Tan, Qihua/0000-0003-3194-0030; Glintborg, Dorte/0000-0002-8338-8025	Novo Nordisk Foundation; Danish Diabetes Association; Danish Medical Research Council	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Association; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants from the Novo Nordisk Foundation, the Danish Diabetes Association, and the Danish Medical Research Council.	Auer H, 2003, NAT GENET, V35, P292, DOI 10.1038/ng1203-292; Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Barazzoni R, 2004, CURR OPIN CLIN NUTR, V7, P97, DOI 10.1097/00075197-200401000-00015; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Brettenthaler N, 2004, J CLIN ENDOCR METAB, V89, P3835, DOI 10.1210/jc.2003-031737; Brunmair B, 2001, DIABETES, V50, P2309, DOI 10.2337/diabetes.50.10.2309; Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Glintborg D, 2006, FERTIL STERIL, V86, P385, DOI 10.1016/j.fertnstert.2005.12.067; Halvatsiotis P, 2002, DIABETES, V51, P2395, DOI 10.2337/diabetes.51.8.2395; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hojlund K, 2008, DIABETES, V57, P357, DOI 10.2337/db07-0706; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jove M, 2004, J LIPID RES, V45, P113, DOI 10.1194/jlr.M300208-JLR200; Kim YB, 2002, DIABETES, V51, P443, DOI 10.2337/diabetes.51.2.443; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Lessard SJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE251, DOI 10.1152/ajpendo.00096.2005; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Loviscach M, 2000, DIABETOLOGIA, V43, P304, DOI 10.1007/s001250050048; Mensink M, 2007, INT J OBESITY, V31, P1302, DOI 10.1038/sj.ijo.0803567; Miyazaki Y, 2003, DIABETES, V52, P1943, DOI 10.2337/diabetes.52.8.1943; Miyazaki Y, 2001, DIABETES CARE, V24, P710, DOI 10.2337/diacare.24.4.710; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Pagel-Langenickel I, 2007, AM J PHYSIOL-HEART C, V293, pH2659, DOI 10.1152/ajpheart.00782.2007; Pasquali R, 2006, EUR J ENDOCRINOL, V154, P763, DOI 10.1530/eje.1.02156; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Proud CG, 2006, BIOCHEM SOC T, V34, P213, DOI 10.1042/BST0340213; Rasmussen BB, 2006, FASEB J, V20, P768, DOI 10.1096/fj.05-4607fje; Rome S, 2003, J BIOL CHEM, V278, P18063, DOI 10.1074/jbc.M300293200; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Skov V, 2007, DIABETES, V56, P2349, DOI 10.2337/db07-0275; Sreenivasulu K., 2002, Gene Expression Patterns, V2, P51, DOI 10.1016/S0925-4773(02)00357-X; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wilmsen HM, 2003, AM J PHYSIOL-ENDOC M, V285, pE354, DOI 10.1152/ajpendo.00491.2001; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu XX, 2007, ENDOCRINE, V31, P5, DOI 10.1007/s12020-007-0007-x; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	51	64	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2466	10.1371/journal.pone.0002466	http://dx.doi.org/10.1371/journal.pone.0002466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560589	Green Published, Green Submitted, gold			2022-12-25	WOS:000263280700047
J	Agudelo-Romero, P; Carbonell, P; Perez-Amador, MA; Elena, SF				Agudelo-Romero, Patricia; Carbonell, Pablo; Perez-Amador, Miguel A.; Elena, Santiago F.			Virus Adaptation by Manipulation of Host's Gene Expression	PLOS ONE			English	Article							LONG-DISTANCE MOVEMENT; TURNIP-MOSAIC-VIRUS; ARABIDOPSIS RTM1; INFECTION; MICROARRAY; EVOLUTION; RADIATION; COMMUNITY; PROTEINS; BACTERIA	Viruses adapt to their hosts by evading defense mechanisms and taking over cellular metabolism for their own benefit. Alterations in cell metabolism as well as side-effects of antiviral responses contribute to symptoms development and virulence. Sometimes, a virus may spill over from its usual host species into a novel one, where usually will fail to successfully infect and further transmit to new host. However, in some cases, the virus transmits and persists after fixing beneficial mutations that allow for a better exploitation of the new host. This situation would represent a case for a new emerging virus. Here we report results from an evolution experiment in which a plant virus was allowed to infect and evolve on a naive host. After 17 serial passages, the viral genome has accumulated only five changes, three of which were non-synonymous. An amino acid substitution in the viral VPg protein was responsible for the appearance of symptoms, whereas one substitution in the viral P3 protein the epistatically contributed to exacerbate severity. DNA microarray analyses show that the evolved and ancestral viruses affect the global patterns of host gene expression in radically different ways. A major difference is that genes involved in stress and pathogen response are not activated upon infection with the evolved virus, suggesting that selection has favored viral strategies to escape from host defenses.	[Agudelo-Romero, Patricia; Carbonell, Pablo; Perez-Amador, Miguel A.; Elena, Santiago F.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Elena, SF (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain.	sfelena@ibmcp.upv.es	Agudelo-Romero, Patricia/K-4625-2015; Elena, Santiago F./A-4191-2011; Carbonell-Bejerano, Pablo/AAX-3509-2021; Perez-Amador, Miguel A./J-7123-2012; Carbonell-Bejerano, Pablo/L-6699-2017	Agudelo-Romero, Patricia/0000-0002-3703-4111; Elena, Santiago F./0000-0001-8249-5593; Carbonell-Bejerano, Pablo/0000-0002-7266-9665; Perez-Amador, Miguel A./0000-0003-4518-3544; Carbonell-Bejerano, Pablo/0000-0002-7266-9665	Spanish MEC-FEDER [BFU2006-14819-C02-01/BMC]; Generalitat Valenciana [ACOMP07/263]; EMBO Young Investigator Program; Spanish Ministerio de Educacion y Ciencia [fellowships]	Spanish MEC-FEDER(Spanish GovernmentEuropean Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); Spanish Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by grants BFU2006-14819-C02-01/BMC (Spanish MEC-FEDER), ACOMP07/263 (Generalitat Valenciana), and the EMBO Young Investigator Program to SFE. PAR and PC received fellowships from the Spanish Ministerio de Educacion y Ciencia.	Adams MJ, 2005, MOL PLANT PATHOL, V6, P471, DOI 10.1111/J.1364-3703.2005.00296.X; Al-Shahrour F, 2005, BIOINFORMATICS, V21, P2988, DOI 10.1093/bioinformatics/bti457; [Anonymous], 1994, POTYVIRIDAE; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Bueso E, 2007, PLANT J, V52, P1052, DOI 10.1111/j.1365-313X.2007.03305.x; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Carrasco P, 2007, J VIROL METHODS, V139, P181, DOI 10.1016/j.jviromet.2006.09.020; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Chisholm ST, 2000, P NATL ACAD SCI USA, V97, P489, DOI 10.1073/pnas.97.1.489; Chisholm ST, 2001, PLANT PHYSIOL, V127, P1667, DOI 10.1104/pp.010479; Choi IR, 2005, J GEN VIROL, V86, P2605, DOI 10.1099/vir.0.81081-0; DOLJA VV, 1992, P NATL ACAD SCI USA, V89, P10208, DOI 10.1073/pnas.89.21.10208; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Golem S, 2003, MOL PLANT MICROBE IN, V16, P681, DOI 10.1094/MPMI.2003.16.8.681; Grinde B, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-24; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Ishihara T, 2004, PLANT CELL PHYSIOL, V45, P470, DOI 10.1093/pcp/pch057; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KLECZKOWSKI A, 1950, J GEN MICROBIOL, V4, P53, DOI 10.1099/00221287-4-1-53; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Leong WF, 2005, MICROBES INFECT, V7, P248, DOI 10.1016/j.micinf.2004.11.004; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Martinez I, 2007, J GEN VIROL, V88, P570, DOI 10.1099/vir.0.82187-0; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; ONATESANCHEZ L, 2007, PLANT PHYSIOL, V128, P1313; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Sambrook J, 2001, MOL CLONING LAB MANU; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Suehiro N, 2004, J GEN VIROL, V85, P2087, DOI 10.1099/vir.0.79825-0; Tilman D., 1982, Monographs in Population Biology, pi; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urcuqui-Inchima S, 2001, VIRUS RES, V74, P157, DOI 10.1016/S0168-1702(01)00220-9; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Yang CL, 2007, MOL PLANT MICROBE IN, V20, P358, DOI 10.1094/MPMI-20-4-0358; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	43	63	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2397	10.1371/journal.pone.0002397	http://dx.doi.org/10.1371/journal.pone.0002397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545680	Green Published, gold, Green Submitted			2022-12-25	WOS:000263248800035
J	Polonelli, L; Ponton, J; Elguezabal, N; Moragues, MD; Casoli, C; Pilotti, E; Ronzi, P; Dobroff, AS; Rodrigues, EG; Juliano, MA; Maffei, DL; Magliani, W; Conti, S; Travassos, LR				Polonelli, Luciano; Ponton, Jose; Elguezabal, Natalia; Dolores Moragues, Maria; Casoli, Claudio; Pilotti, Elisabetta; Ronzi, Paola; Dobroff, Andrey S.; Rodrigues, Elaine G.; Juliano, Maria A.; Maffei, Domenico Leonardo; Magliani, Walter; Conti, Stefania; Travassos, Luiz R.			Antibody Complementarity-Determining Regions (CDRs) Can Display Differential Antimicrobial, Antiviral and Antitumor Activities	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODIES; MONOCLONAL-ANTIBODY; THERAPEUTIC ACTIVITY; SYNTHETIC PEPTIDE; CANDIDA-ALBICANS; IN-VITRO; ANTIIDIOTYPIC ANTIBODIES; HIV-1 REPLICATION; HEAVY-CHAIN; CELLS	Background: Complementarity-determining regions (CDRs) are immunoglobulin (Ig) hypervariable domains that determine specific antibody (Ab) binding. We have shown that synthetic CDR-related peptides and many decapeptides spanning the variable region of a recombinant yeast killer toxin-like antiidiotypic Ab are candidacidal in vitro. An alanine-substituted decapeptide from the variable region of this Ab displayed increased cytotoxicity in vitro and/or therapeutic effects in vivo against various bacteria, fungi, protozoa and viruses. The possibility that isolated CDRs, represented by short synthetic peptides, may display antimicrobial, antiviral and antitumor activities irrespective of Ab specificity for a given antigen is addressed here. Methodology/Principal Findings: CDR-based synthetic peptides of murine and human monoclonal Abs directed to: a) a protein epitope of Candida albicans cell wall stress mannoprotein; b) a synthetic peptide containing well-characterized B-cell and T-cell epitopes; c) a carbohydrate blood group A substance, showed differential inhibitory activities in vitro, ex vivo and/or in vivo against C. albicans, HIV-1 and B16F10-Nex2 melanoma cells, conceivably involving different mechanisms of action. Antitumor activities involved peptide-induced caspase-dependent apoptosis. Engineered peptides, obtained by alanine substitution of Ig CDR sequences, and used as surrogates of natural point mutations, showed further differential increased/unaltered/decreased antimicrobial, antiviral and/or antitumor activities. The inhibitory effects observed were largely independent of the specificity of the native Ab and involved chiefly germline encoded CDR1 and CDR2 of light and heavy chains. Conclusions/Significance: The high frequency of bioactive peptides based on CDRs suggests that Ig molecules are sources of an unlimited number of sequences potentially active against infectious agents and tumor cells. The easy production and low cost of small sized synthetic peptides representing Ig CDRs and the possibility of peptide engineering and chemical optimization associated to new delivery mechanisms are expected to give rise to a new generation of therapeutic agents.	[Polonelli, Luciano; Maffei, Domenico Leonardo; Magliani, Walter; Conti, Stefania] Univ Parma, Sez Microbiol, Dipartimento Patol, I-43100 Parma, Italy; [Ponton, Jose; Elguezabal, Natalia] Univ Basque Country, Fac Med Odontol, Dept Inmunol, Microbiol Parasitol, Bilbao, Spain; [Dolores Moragues, Maria] Univ Basque Country, Dept Enfermeria I, Bilbao, Spain; [Casoli, Claudio; Ronzi, Paola] Univ Milan, Dipartimento Sci Cliniche L Sacco, Sez Malattie Infettive Immunopatol, Milan, Italy; [Pilotti, Elisabetta] Univ Studi Parma, Dipartimento Clin Med, Nefrol Sci Prev, Parma, Italy; [Dobroff, Andrey S.; Rodrigues, Elaine G.; Travassos, Luiz R.] Univ Fed Sao Paulo, Departamento Microbiol, Imunol Parasitol, Unidade Oncol Expt, Sao Paulo, Brazil; [Juliano, Maria A.] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil	University of Parma; University of Basque Country; University of Basque Country; University of Milan; University of Parma; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Polonelli, L (corresponding author), Univ Parma, Sez Microbiol, Dipartimento Patol, I-43100 Parma, Italy.	luiztravassos@gmail.com	Rodrigues, Elaine Guadelupe/ABB-6632-2021; Elguezabal, Natalia/ABF-8199-2021; Conti, Stefania/N-3558-2015; Rodrigues, Elaine G/H-3688-2014; Moragues, Maria D/F-5264-2010; Dobroff, Andrey/A-9814-2016; Travassos, Luiz R/J-3631-2012; Travassos, Luiz/V-2467-2019	Rodrigues, Elaine Guadelupe/0000-0002-3248-3081; Conti, Stefania/0000-0001-9973-8352; Moragues, Maria D/0000-0002-7272-8610; Dobroff, Andrey/0000-0003-2162-9951; Elguezabal, Natalia/0000-0002-8765-5477	Department of Education, Universities and Research, Basque Goverment [IT-264-07]; FAPESP, Sao Paulo, Brazil [06/50634-2]; Istituto Superiore di Sanita, National Research Project on A.I.D.S. [50G.30, 40D.14]; Cariparma Banking Foundation [2004.0190]; Brazilian National Research Council [research fellowship]	Department of Education, Universities and Research, Basque Goverment; FAPESP, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Istituto Superiore di Sanita, National Research Project on A.I.D.S.; Cariparma Banking Foundation; Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Department of Education, Universities and Research, Basque Goverment (grant IT-264-07), FAPESP 06/50634-2 grant, Sao Paulo, Brazil; Istituto Superiore di Sanita, National Research Project on A.I.D.S. (grants 50G.30 and 40D.14, ELVIS Italian Network on LTNP), and the Cariparma Banking Foundation (grant 2004.0190). Funding agencies had no role in the design and development of the research work. LRT and EGR are recipients of a research fellowship from the Brazilian National Research Council (CNPq).	Barcellini W, 2000, J LEUKOCYTE BIOL, V68, P693; BOST KL, 1985, P NATL ACAD SCI USA, V82, P1372, DOI 10.1073/pnas.82.5.1372; Bourgeois C, 1998, J VIROL, V72, P807, DOI 10.1128/JVI.72.1.807-810.1998; Brena S, 2007, INFECT IMMUN, V75, P3680, DOI 10.1128/IAI.01840-06; Casoli C, 2000, BLOOD, V95, P2760, DOI 10.1182/blood.V95.9.2760.009k04_2760_2769; Casoli C, 2006, AIDS, V20, P975, DOI 10.1097/01.aids.0000222068.14878.0d; Cenci E, 2004, CELL MICROBIOL, V6, P953, DOI 10.1111/j.1462-5822.2004.00413.x; Cenci E, 2002, INFECT IMMUN, V70, P2375, DOI 10.1128/IAI.70.5.2375-2382.2002; Conti S, 1998, J INFECT DIS, V177, P807, DOI 10.1086/517815; Cutuli M, 2000, J LEUKOCYTE BIOL, V67, P233, DOI 10.1002/jlb.67.2.233; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; de Soultrait VR, 2003, CURR MED CHEM, V10, P1765; Dorfman T, 2006, J BIOL CHEM, V281, P28529, DOI 10.1074/jbc.M602732200; Eisenhardt SU, 2007, BLOOD, V109, P3521, DOI 10.1182/blood-2006-03-007179; Feng Y, 1998, J BIOL CHEM, V273, P5625, DOI 10.1074/jbc.273.10.5625; Fiori PL, 2006, J ANTIMICROB CHEMOTH, V57, P891, DOI 10.1093/jac/dkl051; GRANT S, 1992, CANCER RES, V52, P6270; Huther A, 2007, AIDS REV, V9, P208; Jackson NAC, 1999, J GEN VIROL, V80, P225, DOI 10.1099/0022-1317-80-1-225; Kabat E. A., 1991, NIH PUBLICATION; LEVI M, 1993, P NATL ACAD SCI USA, V90, P4374, DOI 10.1073/pnas.90.10.4374; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Magliani W, 1997, NAT BIOTECHNOL, V15, P155, DOI 10.1038/nbt0297-155; Monnet C, 1999, J BIOL CHEM, V274, P3789, DOI 10.1074/jbc.274.6.3789; Moragues MD, 2003, INFECT IMMUN, V71, P5273, DOI 10.1128/IAI.71.9.5273-5279.2003; NICKERSON KG, 1995, J BIOL CHEM, V270, P12457, DOI 10.1074/jbc.270.21.12457; NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119; Omaetxebarria MJ, 2005, CURR MOL MED, V5, P393, DOI 10.2174/1566524054022521; PADLAN EA, 1995, FASEB J, V9, P133, DOI 10.1096/fasebj.9.1.7821752; Park BW, 2000, NAT BIOTECHNOL, V18, P194, DOI 10.1038/72651; Paschoalin T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-44; Polonelli L, 2003, INFECT IMMUN, V71, P6205, DOI 10.1128/IAI.71.11.6205-6212.2003; POLONELLI L, 1993, SCAND J IMMUNOL, V37, P105, DOI 10.1111/j.1365-3083.1993.tb01671.x; Polonelli L, 1996, J IMMUNOL, V156, P1880; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Sagot MA, 2000, MOL IMMUNOL, V37, P423, DOI 10.1016/S0161-5890(00)00060-2; Sambrook J.E.F., 1989, MOL CLONING LAB MANU, P1659; Sevilla MJ, 2006, INFECT IMMUN, V74, P3042, DOI 10.1128/IAI.74.5.3042-3045.2006; Sforca ML, 2005, BIOCHEMISTRY-US, V44, P6440, DOI 10.1021/bi0475323; Travassos LR, 2004, J ANTIMICROB CHEMOTH, V54, P956, DOI 10.1093/jac/dkh430; Tuteja R, 1999, IMMUNOLOGY, V97, P1, DOI 10.1046/j.1365-2567.1999.00743.x; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; WILLIAMS WV, 1991, J BIOL CHEM, V266, P5182; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	45	58	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2371	10.1371/journal.pone.0002371	http://dx.doi.org/10.1371/journal.pone.0002371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545659	Green Published, gold, Green Submitted			2022-12-25	WOS:000263248800013
J	Rokia-Mille, SB; Tinette, S; Engler, G; Arthaud, L; Tares, S; Robichon, A				Rokia-Mille, Selim Ben; Tinette, Sylvette; Engler, Gilbert; Arthaud, Laury; Tares, Sophie; Robichon, Alain			Continued Neurogenesis in Adult Drosophila as a Mechanism for Recruiting Environmental Cue-Dependent Variants	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; BEHAVIOR POLYMORPHISM; SIZE VARIATION; BODY-SIZE; MELANOGASTER; PROLIFERATION; GENE; TIME; EXPRESSION; RECEPTORS	Background: The skills used by winged insects to explore their environment are strongly dependent upon the integration of neurosensory information comprising visual, acoustic and olfactory signals. The neuronal architecture of the wing contains a vast array of different sensors which might convey information to the brain in order to guide the trajectories during flight. In Drosophila, the wing sensory cells are either chemoreceptors or mechanoreceptors and some of these sensors have as yet unknown functions. The axons of these two functionally distinct types of neurons are entangled, generating a single nerve. This simple and accessible coincidental signaling circuitry in Drosophila constitutes an excellent model system to investigate the developmental variability in relation to natural behavioral polymorphisms. Methodology/Principal Findings: A fluorescent marker was generated in neurons at all stages of the Drosophila life cycle using a highly efficient and controlled genetic recombination system that can be induced in dividing precursor cells (MARCM system, flybase web site). It allows fluorescent signals in axons only when the neuroblasts and/or neuronal cell precursors like SOP (sensory organ precursors) undergo division during the precedent steps. We first show that a robust neurogenesis continues in the wing after the adults emerge from the pupae followed by an extensive axonal growth. Arguments are presented to suggest that this wing neurogenesis in the newborn adult flies was influenced by genetic determinants such as the frequency dependent for gene and by environmental cues such as population density. Conclusions: We demonstrate that the neuronal architecture in the adult Drosophila wing is unfinished when the flies emerge from their pupae. This unexpected developmental step might be crucial for generating non-heritable variants and phenotypic plasticity. This might therefore constitute an advantage in an unstable ecological system and explain much regarding the ability of Drosophila to robustly adapt to their environment.	[Rokia-Mille, Selim Ben; Tinette, Sylvette; Engler, Gilbert; Arthaud, Laury; Tares, Sophie; Robichon, Alain] Univ Nice Sophia Antipolis, CNRS, INRA, Dept Biol & Biot Interact, Sophia Antipolis, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Rokia-Mille, SB (corresponding author), Univ Nice Sophia Antipolis, CNRS, INRA, Dept Biol & Biot Interact, Sophia Antipolis, France.	robichon@antibes.inra.fr	TARES, Sophie/AAV-1494-2020	TARES, Sophie/0000-0002-1311-1207; robichon, alain/0000-0003-1075-9646	CNRS (Centre National de Recherche Scientifique); INRA; ANR [2700009]	CNRS (Centre National de Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); INRA; ANR(French National Research Agency (ANR))	This work was supported by CNRS (Centre National de Recherche Scientifique) and a grant from INRA (department of sante des plantes et environnement)and ANR grant 2700009.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bhat KM, 1999, BIOESSAYS, V21, P472, DOI 10.1002/(SICI)1521-1878(199906)21:6<472::AID-BIES4>3.0.CO;2-W; BRADLEY BP, 1980, GENETICS, V95, P1033; Brisson JA, 2006, BIOESSAYS, V28, P747, DOI 10.1002/bies.20436; Cayre M, 2005, EUR J NEUROSCI, V21, P2893, DOI 10.1111/j.1460-9568.2005.04153.x; Cayre M, 2007, CHEM SENSES, V32, P385, DOI 10.1093/chemse/bjm010; Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932; Debat V, 2003, EVOLUTION, V57, P2773, DOI 10.1111/j.0014-3820.2003.tb01519.x; DEBELLE JS, 1989, GENETICS, V123, P157; DeMoed GH, 1997, GENET RES, V70, P35, DOI 10.1017/S0016672397002930; DICKINSON MH, 1987, J NEUROSCI, V7, P4201; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Fowler K, 2002, P ROY SOC B-BIOL SCI, V269, P677, DOI 10.1098/rspb.2001.1931; Frye MA, 2004, CURR OPIN NEUROBIOL, V14, P729, DOI 10.1016/j.conb.2004.10.004; Frye MA, 2004, J EXP BIOL, V207, P123, DOI 10.1242/jeb.00725; Fuerstenberg S, 1998, INT J DEV BIOL, V42, P379; Galindo K, 2001, GENETICS, V159, P1059; GEBHARDT MD, 1992, GENET RES, V60, P87, DOI 10.1017/S0016672300030780; Goldstein AYN, 2005, P NATL ACAD SCI USA, V102, P3834, DOI 10.1073/pnas.0500748102; Hagg T, 2005, TRENDS NEUROSCI, V28, P589, DOI 10.1016/j.tins.2005.08.009; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; Karan D, 2000, EVOLUTION, V54, P1035, DOI 10.1111/j.0014-3820.2000.tb00103.x; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Leopold P, 2004, CELL, V119, P4, DOI 10.1016/j.cell.2004.09.024; Malaterre J, 2003, J NEUROBIOL, V56, P387, DOI 10.1002/neu.10244; Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009; MURRAY MA, 1984, DEV BIOL, V104, P259, DOI 10.1016/0012-1606(84)90082-4; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PALKA J, 1986, J NEUROSCI, V6, P1822; PALKA J, 1993, J NEUROBIOL, V24, P788, DOI 10.1002/neu.480240607; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Reddy GV, 1999, DEVELOPMENT, V126, P4617; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Scotto-Lomassese S, 2002, CURR BIOL, V12, P1001, DOI 10.1016/S0960-9822(02)00889-8; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Sherman A, 2004, J EXP BIOL, V207, P133, DOI 10.1242/jeb.00731; Sokolowski MB, 1997, P NATL ACAD SCI USA, V94, P7373, DOI 10.1073/pnas.94.14.7373; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Stamps J, 2005, ANIM BEHAV, V70, P609, DOI 10.1016/j.anbehav.2004.11.018; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Svetec N, 2005, CURR BIOL, V15, pR790, DOI 10.1016/j.cub.2005.09.034; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Tinette S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-65; Wajnberg E, 1998, J INSECT PHYSIOL, V44, P437, DOI 10.1016/S0022-1910(98)00032-8; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Zwaan BJ, 2000, HEREDITY, V84, P338, DOI 10.1046/j.1365-2540.2000.00677.x	56	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2395	10.1371/journal.pone.0002395	http://dx.doi.org/10.1371/journal.pone.0002395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545694	Green Submitted, Green Published, gold			2022-12-25	WOS:000263248800033
J	Wang, KH; Oakes, ESC; Sauer, RT; Baker, TA				Wang, Kevin H.; Oakes, Elizabeth S. C.; Sauer, Robert T.; Baker, Tania A.			Tuning the strength of a bacterial N-end rule degradation signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLPX-RECOGNITION SIGNALS; ESCHERICHIA-COLI; CHAPERONE CLPA; DNA-DAMAGE; PROTEIN; MACHINE; PROTEOLYSIS; PROTEASES; BINDING; SSPB	The N-end rule is a degradation pathway conserved from bacteria to mammals that links a protein's stability in vivo to the identity of its N-terminal residue. In Escherichia coli, the components of this pathway directly responsible for protein degradation are the ClpAP protease and its adaptor ClpS. We recently demonstrated that ClpAP is able to recognize N-end motifs in the absence of ClpS although with significantly reduced substrate affinity. In this study, a systematic sequence analysis reveals new features of N-end rule degradation signals. To achieve specificity, recognition of an N-end motif by the protease-adaptor complex uses both the identity of the N-terminal residue and a free alpha-amino group. Acidic residues near the first residue decrease substrate affinity, demonstrating that the identity of adjacent residues can affect recognition although significant flexibility is tolerated. However, shortening the distance between the N-end residue and the stably folded portion of a protein prevents degradation entirely, indicating that an N-end signal alone is not always sufficient for degradation. Together, these data define in vitro the sequence and structural requirements for the function of bacterial N-end signals.	[Oakes, Elizabeth S. C.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Wang, Kevin H.; Sauer, Robert T.; Baker, Tania A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), 31 Ames St 68-523, Cambridge, MA 02139 USA.	tabaker@mit.edu		Sauer, Robert/0000-0002-1719-5399	NIAID NIH HHS [AI-16892] Funding Source: Medline; NIGMS NIH HHS [R01 GM049224-17, R01 GM049224, GM-49224] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049224] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BALZI E, 1990, J BIOL CHEM, V265, P7464; Benaroudj N, 2001, BIOCHIMIE, V83, P311, DOI 10.1016/S0300-9084(01)01244-5; Bolon DN, 2004, MOL CELL, V16, P343, DOI 10.1016/j.molcel.2004.10.001; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Levchenko I, 2003, MOL CELL, V12, P365, DOI 10.1016/j.molcel.2003.08.014; LITTLE JW, 1983, J MOL BIOL, V167, P791, DOI 10.1016/S0022-2836(83)80111-9; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Song HK, 2003, MOL CELL, V12, P75, DOI 10.1016/S1097-2765(03)00271-5; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Turgay K, 1998, EMBO J, V17, P6730; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Wah DA, 2003, MOL CELL, V12, P355, DOI 10.1016/S1097-2765(03)00272-7; WALKER GC, 1985, ENVIRON HEALTH PERSP, V62, P115, DOI 10.2307/3430102; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Willam C, 2002, P NATL ACAD SCI USA, V99, P10423, DOI 10.1073/pnas.162119399	33	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24600	24607		10.1074/jbc.M802213200	http://dx.doi.org/10.1074/jbc.M802213200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18550545	hybrid, Green Published			2022-12-25	WOS:000258820000032
J	Koyama, T; Nakaoka, Y; Fujio, Y; Hirota, H; Nishida, K; Sugiyama, S; Okamoto, K; Yamauchi-Takihara, K; Yoshimura, M; Mochizuki, S; Hori, M; Hiran, T; Mochizuki, N				Koyama, Tatsuya; Nakaoka, Yoshikazu; Fujio, Yasushi; Hirota, Hisao; Nishida, Keigo; Sugiyama, Shoko; Okamoto, Kitaro; Yamauchi-Takihara, Keiko; Yoshimura, Michihiro; Mochizuki, Seibu; Hori, Masatsugu; Hiran, Toshio; Mochizuki, Naoki			Interaction of scaffolding adaptor protein Gab1 with tyrosine phosphatase SHP2 negatively regulates IGF-I-dependent myogenic differentiation via the ERK1/2 signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; DOCKING PROTEIN; C-MET; ACTIVATION; KINASE; CYTOKINE; EGF; BINDING; PROLIFERATION	Grb2-associated binder 1 (Gab1) coordinates various receptor tyrosine kinase signaling pathways. Although skeletal muscle differentiation is regulated by some growth factors, it remains elusive whether Gab1 coordinates myogenic signals. Here, we examined the molecular mechanism of insulin-like growth factor-I (IGF-I)-mediated myogenic differentiation, focusing on Gab1 and its downstream signaling. Gab1 underwent tyrosine phosphorylation and subsequent complex formation with protein-tyrosine phosphatase SHP2 upon IGF-I stimulation in C2C12 myoblasts. On the other hand, Gab1 constitutively associated with phosphatidylinositol 3-kinase regulatory subunit p85. To delineate the role of Gab1 in IGF-I-dependent signaling, we examined the effect of adenovirus-mediated forced expression of wild-type Gab1 (Gab1(WT)), mutated Gab1 that is unable to bind SHP2 (Gab1(Delta SHP2)), or mutated Gab1 that is unable to bind p85 (Gab1(Delta p85)), on the differentiation of C2C12 myoblasts. IGF-I-induced myogenic differentiation was enhanced in myoblasts overexpressing Gab1(Delta SHP2), but inhibited in those overexpressing either Gab1WT or Gab1(Delta p85). Conversely, IGF-I-induced extracellular signal-regulated kinase 1/2 (ERK1/2) activation was significantly repressed in myoblasts overexpressing Gab1(Delta SHP2) but enhanced in those overexpressing either Gab1WT or Gab1(Delta p85). Furthermore, small interference RNA-mediated Gab1 knockdown enhanced myogenic differentiation. Overexpression of catalytic-inactive SHP2 modulated IGF-I-induced myogenic differentiation and ERK1/2 activation similarly to that of Gab1(Delta SHP2), suggesting that Gab1-SHP2 complex inhibits IGF-I-dependent myogenesis through ERK1/2. Consistently, the blockade of ERK1/2 pathway reversed the inhibitory effect of Gab1(WT) overexpression on myogenic differentiation, and constitutive activation of the ERK1/2 pathway suppressed the enhanced myogenic differentiation by overexpression of Gab1(Delta SHP2). Collectively, these data suggest that the Gab1-SHP2-ERK1/2 signaling pathway comprises an inhibitory axis for IGF-I-dependent myogenic differentiation.	[Nakaoka, Yoshikazu; Hirota, Hisao; Sugiyama, Shoko; Okamoto, Kitaro; Yamauchi-Takihara, Keiko; Hori, Masatsugu] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Osaka 5650871, Japan; [Koyama, Tatsuya; Nakaoka, Yoshikazu; Mochizuki, Naoki] Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, Osaka 5658565, Japan; [Fujio, Yasushi] Osaka Univ, Dept Clin Pharmacol & Pharmacogenom, Grad Sch Pharmaceut Sci, Osaka 5650871, Japan; [Nishida, Keigo; Hiran, Toshio] RIKEN, Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Koyama, Tatsuya; Yoshimura, Michihiro; Mochizuki, Seibu] Jikei Univ, Sch Med, Div Cardiol, Dept Internal Med,Minato Ku, Tokyo 1058461, Japan; [Hiran, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Lab Dev Immunol, Osaka 5650871, Japan; [Hiran, Toshio] Osaka Univ, Grad Sch Med, Lab Dev Immunol, Osaka 5650871, Japan	Osaka University; National Cerebral & Cardiovascular Center - Japan; Osaka University; RIKEN; Jikei University; Osaka University; Osaka University	Nakaoka, Y (corresponding author), Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Osaka 5650871, Japan.	ynakaoka@imed3.med.osaka-u.ac.jp	Fujio, Yasushi/H-3421-2017; Hirano, Toshio/C-8194-2009	Fujio, Yasushi/0000-0003-0828-2930; 	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labour, and Welfare of Japan; National Institute of Biomedical Innovation; Takeda Medical Research Foundation; Uehara Memorial Foundation; Japan Heart Foundation Young Investigator's Research; Suzuken Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Senri Life Science Foundation; Miyata Cardiology Research Promotion Funds	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Takeda Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Heart Foundation Young Investigator's Research; Suzuken Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Senri Life Science Foundation; Miyata Cardiology Research Promotion Funds	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (to Y. N., K. Y.- T., and N. M.); the Ministry of Health, Labour, and Welfare of Japan (to N. M.); the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (to N. M.); the Takeda Medical Research Foundation (to N. M.); The Uehara Memorial Foundation (to Y. N.); the Japan Heart Foundation Young Investigator's Research Grant (to Y. N.); the Suzuken Memorial Foundation (to Y. N.); the Astellas Foundation for Research on Metabolic Disorders (to Y. N.); the Senri Life Science Foundation (to Y. N.); and the Miyata Cardiology Research Promotion Funds (to Y. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BACH LA, 1995, ENDOCRINOLOGY, V136, P5061, DOI 10.1210/en.136.11.5061; Bard-Chapeau EA, 2005, NAT MED, V11, P567, DOI 10.1038/nm1227; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Cunnick JM, 2002, J BIOL CHEM, V277, P9498, DOI 10.1074/jbc.M110547200; Cunnick JM, 2001, J BIOL CHEM, V276, P24380, DOI 10.1074/jbc.M010275200; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; Deng XB, 2003, J BIOL CHEM, V278, P41347, DOI 10.1074/jbc.M306780200; EWTON DZ, 1994, J CELL PHYSIOL, V161, P277, DOI 10.1002/jcp.1041610212; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Jiang BH, 1998, P NATL ACAD SCI USA, V95, P14179, DOI 10.1073/pnas.95.24.14179; Jin ZG, 2005, J BIOL CHEM, V280, P12305, DOI 10.1074/jbc.M500294200; Kaliman P, 1998, MOL ENDOCRINOL, V12, P66, DOI 10.1210/mend.12.1.0047; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kontaridis MI, 2002, MOL CELL BIOL, V22, P3875, DOI 10.1128/MCB.22.11.3875-3891.2002; Kontaridis MI, 2001, J CELL SCI, V114, P2187; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Meng SS, 2005, BIOCHEM J, V391, P143, DOI 10.1042/BJ20050229; Montagner A, 2005, J BIOL CHEM, V280, P5350, DOI 10.1074/jbc.M410012200; Nakaoka Y, 2003, CIRC RES, V93, P221, DOI 10.1161/01.RES.0000085562.48906.4A; Nakaoka Y, 2007, J CLIN INVEST, V117, P1771, DOI 10.1172/JCI30651; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Sarbassov DD, 1998, MOL ENDOCRINOL, V12, P1870, DOI 10.1210/me.12.12.1870; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Schaeper U, 2007, P NATL ACAD SCI USA, V104, P15376, DOI 10.1073/pnas.0702555104; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Shi ZQ, 1998, J BIOL CHEM, V273, P4904, DOI 10.1074/jbc.273.9.4904; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tortorella LL, 2001, J BIOL CHEM, V276, P13709, DOI 10.1074/jbc.M100091200; Ueyama T, 2000, J MOL CELL CARDIOL, V32, P947, DOI 10.1006/jmcc.2000.1135; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Yamasaki S, 2003, ONCOGENE, V22, P1546, DOI 10.1038/sj.onc.1206284; Yamasaki S, 2001, J BIOL CHEM, V276, P45175, DOI 10.1074/jbc.M105384200; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002; Zito CI, 2004, J CELL PHYSIOL, V199, P227, DOI 10.1002/jcp.10446	50	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24234	24244		10.1074/jbc.M803907200	http://dx.doi.org/10.1074/jbc.M803907200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577518	Green Published, hybrid			2022-12-25	WOS:000258638900077
J	Yuan, BF; Wang, YS				Yuan, Bifeng; Wang, Yinsheng			Mutagenic and cytotoxic properties of 6-thioguanine, S-6-methylthioguanine, and guanine-S-6-sulfonic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ESCHERICHIA-COLI; MISMATCH REPAIR; DNA-POLYMERASES; IN-VIVO; ORGAN-TRANSPLANTATION; SKIN-CANCER; UVA LIGHT; REPLICATION; METHYLATION	Thiopurine drugs, including 6- thioguanine ( SG), 6- mercaptopurine, and azathioprine, are widely employed anticancer agents and immunosuppressants. The formation of SG nucleotides from the thiopurine prodrugs and their subsequent incorporation into nucleic acids are important for the drugs to exert their cytotoxic effects. SG in DNA can be methylated by S- adenosylL- methionine to give S6- methylthioguanine ( S6mG) and oxidized by UVA light to render guanine- S6- sulfonic acid ( SO3HG). Here, we constructed single- stranded M13 shuttle vectors carrying a SG, S6mG, or SO3HG at a unique site and allowed the vectors to propagate in wild- type and bypass polymerasedeficient Escherichia coli cells. Analysis of the replication products by using the competitive replication and adduct bypass and a slightly modified restriction enzyme digestion and post- labeling assays revealed that, although none of the three thionucleosides considerably blocked DNA replication in all transfected E. coli cells, both S6mG and SO3HG were highly mutagenic, which resulted in G3A mutation at frequencies of 94 and 77%, respectively, in wild- type E. coli cells. Deficiency in bypass polymerases does not result in alteration of mutation frequencies of these two lesions. In contrast to what was found from previous steady- state kinetic analysis, our data demonstrated that 6- thioguanine is mutagenic, with G3A transition occurring at a frequency of similar to 10%. The mutagenic properties of 6- thioguanine and its derivatives revealed in the present study offered important knowledge about the biological implications of these thionucleosides.	[Yuan, Bifeng; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem 027, Riverside, CA 92521 USA.	yinsheng.wang@ucr.edu	Yuan, Bi-Feng/K-5803-2013	Yuan, Bi-Feng/0000-0001-5223-4659	NCI NIH HHS [R01 CA 101864] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA101864] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apffel A, 1997, ANAL CHEM, V69, P1320, DOI 10.1021/ac960916h; AQUILINA G, 1989, CARCINOGENESIS, V10, P1219, DOI 10.1093/carcin/10.7.1219; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Delaney JC, 1999, CHEM BIOL, V6, P743, DOI 10.1016/S1074-5521(00)80021-6; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; GREEN MHL, 1989, CARCINOGENESIS, V10, P893, DOI 10.1093/carcin/10.5.893; GRIFFIN S, 1994, BIOCHEMISTRY-US, V33, P4787, DOI 10.1021/bi00182a006; Gu CN, 2007, NUCLEIC ACIDS RES, V35, P3693, DOI 10.1093/nar/gkm247; Gunnarsdottir S, 2003, DRUG METAB DISPOS, V31, P718, DOI 10.1124/dmd.31.6.718; Hong HZ, 2007, NUCLEIC ACIDS RES, V35, P7118, DOI 10.1093/nar/gkm851; Jarosz DF, 2007, TRENDS MICROBIOL, V15, P70, DOI 10.1016/j.tim.2006.12.004; JONES M, 1981, MOL GEN GENET, V184, P562, DOI 10.1007/BF00352542; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; Kroplin T, 2000, EUR J CLIN PHARMACOL, V56, P343, DOI 10.1007/s002280000137; Krynetski EY, 2001, MOL PHARMACOL, V59, P367, DOI 10.1124/mol.59.2.367; LENNARD L, 1992, EUR J CLIN PHARMACOL, V43, P329, DOI 10.1007/BF02220605; LEPAGE GA, 1963, CANCER RES, V23, P1202; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; O'Donovan P, 2005, SCIENCE, V309, P1871, DOI 10.1126/science.1114233; PENN I, 1994, CANCER DETECT PREV, V18, P241; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; PRESENT DH, 1980, NEW ENGL J MED, V302, P981, DOI 10.1056/NEJM198005013021801; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Ramsay HM, 2002, BRIT J DERMATOL, V147, P950, DOI 10.1046/j.1365-2133.2002.04976.x; RAPPAPORT HP, 1993, BIOCHEMISTRY-US, V32, P3047, DOI 10.1021/bi00063a016; Spratt TE, 1997, NUCLEIC ACIDS RES, V25, P3354, DOI 10.1093/nar/25.16.3354; Sutton MD, 2001, P NATL ACAD SCI USA, V98, P8342, DOI 10.1073/pnas.111036998; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Waters TR, 1997, BIOCHEMISTRY-US, V36, P2501, DOI 10.1021/bi9621573; Xu YZ, 1996, TETRAHEDRON, V52, P10737, DOI 10.1016/0040-4020(96)00596-0; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105; Zhang XH, 2007, DNA REPAIR, V6, P344, DOI 10.1016/j.dnarep.2006.11.003	36	34	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23665	23670		10.1074/jbc.M804047200	http://dx.doi.org/10.1074/jbc.M804047200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18591241	Green Published, hybrid			2022-12-25	WOS:000258638900019
J	McFate, T; Mohyeldin, A; Lu, H; Thakar, J; Henriques, J; Halim, ND; Wu, H; Schell, MJ; Tsang, TM; Teahan, O; Zhou, S; Califano, JA; Jeoung, NH; Harris, RA; Verma, A				McFate, Thomas; Mohyeldin, Ahmed; Lu, Huasheng; Thakar, Jay; Henriques, Jeremy; Halim, Nader D.; Wu, Hong; Schell, Michael J.; Tsang, Tsz Mon; Teahan, Orla; Zhou, Shaoyu; Califano, Joseph A.; Jeoung, Nam Ho; Harris, Robert A.; Verma, Ajay			Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; IN-VIVO; AEROBIC GLYCOLYSIS; PROLYL HYDROXYLASE; FACTOR HIF; DICHLOROACETATE; INHIBITION; EXPRESSION; GROWTH; ACID	High lactate generation and low glucose oxidation, despite normal oxygen conditions, are commonly seen in cancer cells and tumors. Historically known as the Warburg effect, this altered metabolic phenotype has long been correlated with malignant progression and poor clinical outcome. However, the mechanistic relationship between altered glucose metabolism and malignancy remains poorly understood. Here we show that inhibition of pyruvate dehydrogenase complex (PDC) activity contributes to the Warburg metabolic and malignant phenotype in human head and neck squamous cell carcinoma. PDC inhibition occurs via enhanced expression of pyruvate dehydrogenase kinase-1 (PDK-1), which results in inhibitory phosphorylation of the pyruvate dehydrogenase alpha(PDH alpha) subunit. We also demonstrate that PDC inhibition in cancer cells is associated with normoxic stabilization of the malignancy-promoting transcription factor hypoxia-inducible factor-1 alpha(HIF-1 alpha) by glycolytic metabolites. Knockdown of PDK-1 via short hairpin RNA lowers PDH alpha phosphorylation, restores PDC activity, reverts the Warburg metabolic phenotype, decreases normoxic HIF-1 alpha expression, lowers hypoxic cell survival, decreases invasiveness, and inhibits tumor growth. PDK-1 is an HIF-1-regulated gene, and these data suggest that the buildup of glycolytic metabolites, resulting from high PDK-1 expression, may in turn promote HIF-1 activation, thus sustaining a feed-forward loop for malignant progression. In addition to providing anabolic support for cancer cells, altered fuel metabolism thus supports a malignant phenotype. Correction of metabolic abnormalities offers unique opportunities for cancer treatment and may potentially synergize with other cancer therapies.	[McFate, Thomas; Mohyeldin, Ahmed; Lu, Huasheng; Thakar, Jay; Henriques, Jeremy; Halim, Nader D.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Wu, Hong; Schell, Michael J.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Tsang, Tsz Mon; Teahan, Orla] Univ London Imperial Coll Sci Technol & Med, Div SORA, Dept Biomol Med, London SW7 2AZ, England; [Zhou, Shaoyu; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD 21204 USA; [Jeoung, Nam Ho; Harris, Robert A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Imperial College London; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Verma, A (corresponding author), Merck & Co Inc, Dept Expt Med, UG4D-34,POB 1000, N Wales, PA 19454 USA.	ajay_verma@merck.com		Schell, Michael/0000-0003-1553-3582; Verma, Ajay/0000-0001-7715-0443; Jeoung, Nam Ho/0000-0002-7584-3761	NATIONAL CANCER INSTITUTE [P50CA096784, R21CA113506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047844] Funding Source: NIH RePORTER; NCI NIH HHS [CA113506, P50 CA96784] Funding Source: Medline; NIDCR NIH HHS [R01DE015939] Funding Source: Medline; NIDDK NIH HHS [DK47844] Funding Source: Medline; NINDS NIH HHS [NS73814] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blum R, 2005, CANCER RES, V65, P999; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Boulatnikov I, 2003, BBA-PROTEINS PROTEOM, V1645, P183, DOI 10.1016/S1570-9639(02)00542-3; Cairns RA, 2007, P NATL ACAD SCI USA, V104, P9445, DOI 10.1073/pnas.0611662104; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hassoun EA, 2003, COMP BIOCHEM PHYS C, V135, P119, DOI 10.1016/S1532-0456(03)00082-6; Hewitson KS, 2007, J BIOL CHEM, V282, P3293, DOI 10.1074/jbc.M608337200; Holmes E, 2006, PLOS MED, V3, P1420, DOI 10.1371/journal.pmed.0030327; Hunt TK, 2007, ANTIOXID REDOX SIGN, V9, P1115, DOI 10.1089/ars.2007.1674; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jeoung NH, 2006, ANAL BIOCHEM, V356, P44, DOI 10.1016/j.ab.2006.06.017; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Knowles HJ, 2003, CANCER RES, V63, P1764; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koukourakis MI, 2007, CANCER BIOL THER, V6, P1476, DOI 10.4161/cbt.6.9.4635; Laughter AR, 2004, TOXICOLOGY, V203, P83, DOI 10.1016/j.tox.2004.06.014; Lee MS, 2001, CANCER RES, V61, P3290; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Mabjeesh NJ, 2007, HISTOL HISTOPATHOL, V22, P559, DOI 10.14670/HH-22.559; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Sattlar UGA, 2007, LAB INVEST, V87, P84, DOI 10.1038/labinvest.3700493; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; STACPOOLE PW, 1992, DIABETES CARE, V15, P785, DOI 10.2337/diacare.15.6.785; Tzeng HF, 2000, CHEM RES TOXICOL, V13, P231, DOI 10.1021/tx990175q; Walenta S, 2004, CURR MED CHEM, V11, P2195, DOI 10.2174/0929867043364711; WARBURG O, 1930, METABOLISM TUMORS; Zhou S, 2003, MUTAGENESIS, V18, P287, DOI 10.1093/mutage/18.3.287; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104; Zou CP, 2001, ONCOGENE, V20, P6820, DOI 10.1038/sj.onc.1204846	45	274	287	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22700	22708		10.1074/jbc.M801765200	http://dx.doi.org/10.1074/jbc.M801765200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18541534	Green Published, hybrid			2022-12-25	WOS:000258321000039
J	Zhang, LB; Lee, JE; Wilusz, J; Wilusz, CJ				Zhang, Libin; Lee, Jerome E.; Wilusz, Jeffrey; Wilusz, Carol J.			The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells - Implications for myotonic dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLET REPEAT; FACTOR-ALPHA; MOLECULAR-BASIS; MIS-REGULATION; MOUSE MODEL; CTG REPEAT; DIFFERENTIATION; EXPRESSION; EXPANSION; MUTATION	Type I myotonic dystrophy(DM1) is caused by a triplet repeat expansion in the 3'-untranslated region (UTR) of the dystrophia myotonia protein kinase (DMPK) gene. Pathogenesis is closely linked with production of a toxic RNA from the mutant allele, which interferes with function of several RNA-binding proteins, including CUGBP1. Here we show that expression of a mutant DMPK 3'-UTR containing 960 CUG repeats is sufficient to increase expression and stability of an mRNA encoding the potent proinflammatory cytokine, tumor necrosis factor (TNF). CUGBP1 specifically recognizes sequences within the TNF 3'-UTR that are dissimilar from its canonical UG-rich binding site. Depletion of CUGBP1 from mouse myoblasts results in increased abundance of TNF mRNA through stabilization of the transcript. Moreover, activation of the protein kinase C pathway by treatment with phorbol ester, which has been shown previously to result in CUGBP1 phosphorylation, also causes TNF mRNA stabilization. Our results suggest that the elevated serum TNF seen in DM1 patients may be derived from muscle where it is induced by expression of toxic DMPK RNA. Importantly, overexpression of this potent cytokine could contribute to the muscle wasting and insulin resistance that are characteristic of this debilitating disease.	[Zhang, Libin; Wilusz, Jeffrey; Wilusz, Carol J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Lee, Jerome E.; Wilusz, Jeffrey; Wilusz, Carol J.] Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Wilusz, CJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, 1682 Campus Delivery, Ft Collins, CO 80523 USA.	cwilusz@colostate.edu	Wilusz, Carol/AAC-2901-2021; Wilusz, Carol/F-7241-2017		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072481] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 072481] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Amack JD, 2001, HUM MOL GENET, V10, P1879, DOI 10.1093/hmg/10.18.1879; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Cosson B, 2006, BIOL CELL, V98, P653, DOI 10.1042/BC20060054; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Johansson A, 2000, J CLIN ENDOCR METAB, V85, P3169, DOI 10.1210/jc.85.9.3169; Jove M, 2006, ENDOCRINOLOGY, V147, P552, DOI 10.1210/en.2005-0440; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; LE MG, 2008, PLOS ONE, V3, pE1466; Li YP, 2001, CURR OPIN RHEUMATOL, V13, P483, DOI 10.1097/00002281-200111000-00005; Liu WL, 1998, AM J PHYSIOL-RENAL, V275, pF361, DOI 10.1152/ajprenal.1998.275.3.F361; Machuca-Tzili L, 2005, MUSCLE NERVE, V32, P1, DOI 10.1002/mus.20301; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mammarella A, 2002, J NEUROL SCI, V201, P59, DOI 10.1016/S0022-510X(02)00193-4; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Marquis J, 2006, BIOCHEM J, V400, P291, DOI 10.1042/BJ20060490; Mercer SE, 2005, J BIOL CHEM, V280, P25788, DOI 10.1074/jbc.M413594200; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308	36	86	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22457	22463		10.1074/jbc.M802803200	http://dx.doi.org/10.1074/jbc.M802803200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18559347	hybrid, Green Published			2022-12-25	WOS:000258321000013
J	Baral, PK; Jajcanin-Jozic, N; Deller, S; Macheroux, P; Abramic, M; Gruber, K				Baral, Pravas Kumar; Jajcanin-Jozic, Nina; Deller, Sigrid; Macheroux, Peter; Abramic, Marija; Gruber, Karl			The first structure of dipeptidyl-peptidase III provides insight into the catalytic mechanism and mode of substrate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STRUCTURE ALIGNMENT; DROSOPHILA-MELANOGASTER; ALANYL AMINOPEPTIDASE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; PURIFICATION; THERMOLYSIN; LIVER; EXOPEPTIDASE; SIMILARITIES	Dipeptidyl-peptidases III (DPP III) are zinc-dependent enzymes that specifically cleave the first two amino acids from the N terminus of different length peptides. In mammals, DPP III is associated with important physiological functions and is a potential biomarker for certain types of cancer. Here, we present the 1.95-angstrom A crystal structure of yeast DPP III representing the prototype for the M49 family of metallopeptidases. It shows a novel fold with two domains forming a wide cleft containing the catalytic metal ion. DPP III exhibits no overall similarity to other metallopeptidases, such as thermolysin and neprilysin, but zinc coordination and catalytically important residues are structurally conserved. Substrate recognition is accomplished by a binding site for the N terminus of the peptide at an appropriate distance from the metal center and by a series of conserved arginine residues anchoring the C termini of different length substrates.	[Baral, Pravas Kumar; Gruber, Karl] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Jajcanin-Jozic, Nina; Abramic, Marija] Rudjer Boskovic Inst, Div Organ Chem & Biochem, HR-10002 Zagreb, Croatia; [Deller, Sigrid; Macheroux, Peter] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	University of Graz; Rudjer Boskovic Institute; Graz University of Technology	Gruber, K (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50-3, A-8010 Graz, Austria.	karl.gruber@uni-graz.at	Jajčanin Jozić, Nina/G-7077-2012; Gruber, Karl/GPP-6706-2022; Macheroux, Peter/AAB-5157-2019	Gruber, Karl/0000-0002-3485-9740; Macheroux, Peter/0000-0002-0242-454X	Austrian Science Fund (FWF) [W 901] Funding Source: researchfish; Austrian Science Fund FWF [W 901] Funding Source: Medline	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF))		ABRAMIC M, 1988, BIOL CHEM H-S, V369, P29, DOI 10.1515/bchm3.1988.369.1.29; Abramic M, 2004, INT J BIOCHEM CELL B, V36, P434, DOI 10.1016/S1357-2725(03)00267-X; Abramic M, 2004, PERIOD BIOL, V106, P161; Abramic M, 2000, BIOL CHEM, V381, P1233, DOI 10.1515/BC.2000.151; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agic D, 2007, BIOORG CHEM, V35, P153, DOI 10.1016/j.bioorg.2006.11.002; Barsun M, 2007, BIOL CHEM, V388, P343, DOI 10.1515/BC.2007.039; Boggon TJ, 2000, STRUCTURE, V8, pR143, DOI 10.1016/S0969-2126(00)00168-4; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; Chen J.-M., 2004, HDB PROTEOLYTIC ENZY, P809; Chiba T, 2003, PEPTIDES, V24, P773, DOI 10.1016/S0196-9781(03)00119-0; DALE GE, 2004, HDB METALLOPROTEINS, P104; Dhanda S, 2007, PROTEIN EXPRES PURIF, V52, P297, DOI 10.1016/j.pep.2006.10.004; ELLIS S, 1967, J BIOL CHEM, V242, P4623; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukasawa K, 1998, BIOCHEM J, V329, P275, DOI 10.1042/bj3290275; Fukasawa K, 1999, BIOCHEMISTRY-US, V38, P8299, DOI 10.1021/bi9904959; Hirose J, 2001, BIOCHEMISTRY-US, V40, P11860, DOI 10.1021/bi0110903; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HUANG JX, 1992, EXP MYCOL, V16, P102, DOI 10.1016/0147-5975(92)90016-K; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LEE CM, 1982, J BIOL CHEM, V257, P2043; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Marie-Claire C, 1998, FEBS LETT, V438, P215, DOI 10.1016/S0014-5793(98)01267-8; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; MATTHEWS BW, 2004, HDB METALLOPROTEINS, P85; Mazzocco C, 2006, FEBS J, V273, P1056, DOI 10.1111/j.1742-4658.2006.05132.x; Mazzocco C, 2003, EUR J BIOCHEM, V270, P3074, DOI 10.1046/j.1432-1033.2003.03689.x; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Ohkubo I, 1999, BIOL CHEM, V380, P1421, DOI 10.1515/BC.1999.182; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pelmenschikov V, 2002, J BIOL INORG CHEM, V7, P284, DOI 10.1007/s007750100295; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Sato Hiroshi, 2003, Masui, V52, P257; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Simaga S, 2003, GYNECOL ONCOL, V91, P194, DOI 10.1016/S0090-8258(03)00462-1; SWANSON AA, 1984, CURR EYE RES, V3, P287, DOI 10.3109/02713688408997211; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; VANHAPERTTULA T, 1988, CLIN CHIM ACTA, V177, P179, DOI 10.1016/0009-8981(88)90140-4; Waeber BNJ, 1990, HYPERTENSION PATHOPH, P2209; Zhang H, 2001, HISTOCHEM J, V33, P511, DOI 10.1023/A:1014943522613	52	64	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22316	22324		10.1074/jbc.M803522200	http://dx.doi.org/10.1074/jbc.M803522200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550518	Green Published, hybrid			2022-12-25	WOS:000258114700050
J	Bradley, CA; Taghibiglou, C; Collingridge, GL; Wang, YT				Bradley, Clarrisa A.; Taghibiglou, Changiz; Collingridge, Graham L.; Wang, Yu Tian			Mechanisms involved in the reduction of GABA(A) receptor alpha 1-subunit expression caused by the epilepsy mutation A322D in the trafficking-competent receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE MYOCLONIC EPILEPSY; ENDOPLASMIC-RETICULUM; ALPHA-1 SUBUNIT; DEPENDENT ENDOCYTOSIS; A RECEPTORS; RAT-BRAIN; DEGRADATION; LOCALIZATION; STABILITY; DYNAMIN	A mutation in the alpha 1-subunit (A322D) of GABA(A)Rs is responsible for juvenile myoclonic epilepsy in a large Canadian family. Previous work has identified that this mutant affects the cell expression and function of recombinant GABAARs, expressed in HEK293 cells. Here we have extended these observations by showing that the mutation promotes association with the endoplasmic reticulum chaperone calnexin and accelerates the degradation rate of the subunits similar to 2.5-fold. We also find that the mutation causes the subunit to be degraded largely by a lysosomal-dependent process. Furthermore, we find that the mutation results in receptors that are inserted into the plasma membrane but are more rapidly endocytosed by a dynamin and caveolin1-dependent mechanism. These results suggest that the mutant subunit can form functional receptors, but that these have a shorter lifetime on the plasma membrane.	[Bradley, Clarrisa A.; Taghibiglou, Changiz; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada; [Bradley, Clarrisa A.; Taghibiglou, Changiz; Collingridge, Graham L.; Wang, Yu Tian] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Collingridge, Graham L.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; [Collingridge, Graham L.] Univ Bristol, Dept Anat, Bristol BS8 1TD, Avon, England; [Collingridge, Graham L.] Univ Bristol, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of British Columbia; University of British Columbia; University of British Columbia; University of Bristol; University of Bristol	Wang, YT (corresponding author), UBC Hosp, Brain Res Ctr, 2211 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	ytwang@brain.ubc.ca	collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015; Wang, Yu Tian/J-8255-2015; Taghibiglou, Changiz/H-4590-2019	Collingridge, Graham L/0000-0002-9572-5359; 	Medical Research Council [G0601813] Funding Source: Medline; MRC [G0601813] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; BRADLEY CA, 2004, SOC NEUROSCI; BULLER AL, 1994, MOL PHARMACOL, V46, P858; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Dalskov SM, 2005, NEUROCHEM INT, V46, P489, DOI 10.1016/j.neuint.2004.11.010; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Fisher JL, 2004, NEUROPHARMACOLOGY, V46, P629, DOI 10.1016/j.neuropharm.2003.11.015; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Gallagher MJ, 2004, J NEUROSCI, V24, P5570, DOI 10.1523/JNEUROSCI.1301-04.2004; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Krampfl K, 2005, EUR J NEUROSCI, V22, P10, DOI 10.1111/j.1460-9568.2005.04168.x; Kubale V, 2007, CELL TISSUE RES, V330, P231, DOI 10.1007/s00441-007-0462-y; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Man HY, 2000, CELL MOL LIFE SCI, V57, P1526, DOI 10.1007/PL00000637; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Taghibiglou C, 2000, J LIPID RES, V41, P499; TEHRANI MHJ, 1993, J NEUROCHEM, V60, P1755; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; WISDEN W, 1992, J NEUROSCI, V12, P1040	33	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22043	22050		10.1074/jbc.M801708200	http://dx.doi.org/10.1074/jbc.M801708200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18534981	hybrid			2022-12-25	WOS:000258114700023
J	Mustafa, G; Ishikawa, Y; Kobayashi, K; Migita, CT; Elias, MD; Nakamura, S; Tagawa, S; Yamada, M				Mustafa, Golam; Ishikawa, Yoshinori; Kobayashi, Kazuo; Migita, Catharina T.; Elias, M. D.; Nakamura, Satsuki; Tagawa, Seiichi; Yamada, Mamoru			Amino acid residues interacting with both the bound quinone and coenzyme, pyrroloquinoline quinone, in Escherichia coli membrane-bound glucose dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; UBIQUINONE-BINDING-SITE; CYTOCHROME BO COMPLEX; PULSE-RADIOLYSIS; FUMARATE REDUCTASE; ACINETOBACTER-CALCOACETICUS; SUCCINATE-DEHYDROGENASE; TRANSIENT FORMATION; NITRITE REDUCTASE; CRYSTAL-STRUCTURE	The Escherichia coli membrane-bound glucose dehydrogenase (mGDH) as the primary component of the respiratory chain possesses a tightly bound ubiquinone (UQ) flanking pyrroloquinoline quinone (PQQ) as a coenzyme. Several mutants for Asp-354, Asp-466, and Lys-493, located close to PQQ, that were constructed by site-specific mutagenesis were characterized by enzymatic, pulse radiolysis, and EPR analyses. These mutants retained almost no dehydrogenase activity or ability of PQQ reduction. CD and high pressure liquid chromatography analyses revealed that K493A, D466N, and D466E mutants showed no significant difference in molecular structure from that of the wild-type mGDH but showed remarkably reduced content of bound UQ. A radiolytically generated hydrated electron (e(aq)(-)) reacted with the bound UQ of the wild enzyme and K493R mutant to form a UQ neutral semiquinone with an absorption maximum at 420 nm. Subsequently, intramolecular electron transfer from the bound UQ semiquinone to PQQ occurred. In K493R, the rate of UQ to PQQ electron transfer is about 4-fold slower than that of the wild enzyme. With D354N and D466N mutants, on the other hand, transient species with an absorption maximum at 440 nm, a characteristic of the formation of a UQ anion radical, appeared in the reaction of e(aq)(-), although the subsequent intramolecular electron transfer was hardly affected. This indicates that D354N and D466N are prevented from protonation of the UQ semiquinone radical. Moreover, EPR spectra showed that mutations on Asp-466 or Lys-493 residues changed the semiquinone state of bound UQ. Taken together, we reported here for the first time the existence of a semiquinone radical of bound UQ in purified mGDH and the difference in protonation of ubisemiquinone radical because of mutations in two different amino acid residues, located around PQQ. Furthermore, based on the present results and the spatial arrangement around PQQ, Asp-466 and Lys-493 are suggested to interact both with the bound UQ and PQQ in mGDH.	[Mustafa, Golam; Migita, Catharina T.; Elias, M. D.; Nakamura, Satsuki; Yamada, Mamoru] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan; [Ishikawa, Yoshinori; Yamada, Mamoru] Yamaguchi Univ, Grad Sch Med, Appl Mol Biosci, Ube, Yamaguchi 7558505, Japan; [Kobayashi, Kazuo; Tagawa, Seiichi] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Yamaguchi University; Yamaguchi University; Osaka University	Yamada, M (corresponding author), Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan.	m-yamada@yamaguchi-u.ac.jp	Kobayashi, Kazuo/H-9279-2012	Kobayashi, Kazuo/0000-0002-5586-9112; Yamada, Mamoru/0000-0003-4354-7324				Abramson J, 2000, NAT STRUCT BIOL, V7, P910; AMEYAMA M, 1985, AGR BIOL CHEM TOKYO, V49, P1227, DOI 10.1080/00021369.1985.10866884; AMEYAMA M, 1981, FEBS LETT, V130, P179, DOI 10.1016/0014-5793(81)81114-3; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Cozier GE, 1999, BIOCHEM J, V340, P639, DOI 10.1042/0264-6021:3400639; Cozier GE, 1995, BIOCHEM J, V312, P679, DOI 10.1042/bj3120679; DUINE JA, 1979, FEBS LETT, V108, P443, DOI 10.1016/0014-5793(79)80584-0; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; Elias MD, 2000, J BIOL CHEM, V275, P7321, DOI 10.1074/jbc.275.10.7321; Elias MD, 2004, J BIOL CHEM, V279, P3078, DOI 10.1074/jbc.M310163200; Elias MD, 2001, J BIOL CHEM, V276, P48356, DOI 10.1074/jbc.M107355200; FULOP V, 1995, CELL, V81, P369, DOI 10.1016/0092-8674(95)90390-9; Gong X, 2003, J BIOL CHEM, V278, P25731, DOI 10.1074/jbc.M302361200; GORDON S, 1964, J AM CHEM SOC, V86, P5343, DOI 10.1021/ja01077a067; Grimaldi S, 2001, BIOCHEMISTRY-US, V40, P1037, DOI 10.1021/bi001641+; Hagerhall C, 1999, J BIOL CHEM, V274, P26157, DOI 10.1074/jbc.274.37.26157; HOMMES RWJ, 1984, FEMS MICROBIOL LETT, V24, P329, DOI 10.1016/0378-1097(84)90274-X; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kobayashi K, 2005, BIOCHEMISTRY-US, V44, P13567, DOI 10.1021/bi051347n; Kobayashi K, 1997, BIOCHEMISTRY-US, V36, P13611, DOI 10.1021/bi971045o; Kobayashi K, 2003, J AM CHEM SOC, V125, P10213, DOI 10.1021/ja036211w; Kobayashi K, 2000, BIOCHEMISTRY-US, V39, P15620, DOI 10.1021/bi0014094; Kobayashi K, 2001, J BIOL CHEM, V276, P39864, DOI 10.1074/jbc.M102537200; Maklashina E, 2006, J BIOL CHEM, V281, P26655, DOI 10.1074/jbc.M602938200; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Matsumoto Y, 2006, J BIOL CHEM, V281, P1905, DOI 10.1074/jbc.M508206200; MATSUSHITA K, 1987, J BACTERIOL, V169, P205, DOI 10.1128/jb.169.1.205-209.1987; Matsushita K, 1997, MICROBIOL-UK, V143, P3149, DOI 10.1099/00221287-143-10-3149; Matsushita K, 1999, BBA-BIOENERGETICS, V1409, P154, DOI 10.1016/S0005-2728(98)00158-3; Miyoshi H, 1999, BBA-BIOENERGETICS, V1412, P29, DOI 10.1016/S0005-2728(99)00009-2; OKUDA J, 2000, J BIOCH MOL BIOL BIO, V4, P415; PETER LJ, 2003, BIOCHIM BIOPHYS ACTA, V1647, P200; SALERNO JC, 1980, BIOCHEM J, V192, P769, DOI 10.1042/bj1920769; SATOWATANABE M, 1994, J BIOL CHEM, V269, P28908; SATOWATANABE M, 1994, J BIOL CHEM, V269, P28899; Sode K, 1997, BIOTECHNOL LETT, V19, P1073, DOI 10.1023/A:1018428224215; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; SUZUKI S, 1994, J AM CHEM SOC, V116, P11145, DOI 10.1021/ja00103a035; VANSCHIE BJ, 1985, J BACTERIOL, V163, P493, DOI 10.1128/JB.163.2.493-499.1985; Yamada M, 1998, J BIOL CHEM, V273, P22021, DOI 10.1074/jbc.273.34.22021; YAMADA M, 1993, J BIOL CHEM, V268, P12812; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	44	14	15	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22215	22221		10.1074/jbc.M800911200	http://dx.doi.org/10.1074/jbc.M800911200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550551	hybrid			2022-12-25	WOS:000258114700041
J	Bueti, D; van Dongen, EV; Walsh, V				Bueti, Domenica; van Dongen, Eelco V.; Walsh, Vincent			The Role of Superior Temporal Cortex in Auditory Timing	PLOS ONE			English	Article							TIME PERCEPTION; NEURAL REPRESENTATION; BRAIN ACTIVATION; INTERNAL CLOCK; VISUAL-CORTEX; BASAL GANGLIA; DURATION; INTERVALS; SYSTEMS; MOTOR	Recently, there has been upsurge of interest in the neural mechanisms of time perception. A central question is whether the representation of time is distributed over brain regions as a function of stimulus modality, task and length of the duration used or whether it is centralized in a single specific and supramodal network. The answers seem to be converging on the former, and many areas not primarily considered as temporal processing areas remain to be investigated in the temporal domain. Here we asked whether the superior temporal gyrus, an auditory modality specific area, is involved in processing of auditory timing. Repetitive transcranial magnetic stimulation was applied over left and right superior temporal gyri while participants performed either a temporal or a frequency discrimination task of single tones. A significant decrease in performance accuracy was observed after stimulation of the right superior temporal gyrus, in addition to an increase in response uncertainty as measured by the Just Noticeable Difference. The results are specific to auditory temporal processing and performance on the frequency task was not affected. Our results further support the idea of distributed temporal processing and speak in favor of the existence of modality specific temporal regions in the human brain.	[Bueti, Domenica; van Dongen, Eelco V.] UCL, Inst Cognit Neurosci, London, England; [Walsh, Vincent] UCL, Dept Psychol, London, England	University of London; University College London; University of London; University College London	Bueti, D (corresponding author), UCL, Inst Cognit Neurosci, London, England.	domenica.bueti@googlemail.com	van Dongen, Eelco V/G-4232-2010; Bueti, Domenica/E-7627-2014	van Dongen, Eelco V/0000-0002-2031-8759; Bueti, Domenica/0000-0001-6660-7241	Leverhulme Trust; Royal Society	Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London)	Domenica Bueti was supported by the Leverhulme Trust; Vincent Walsh was supported by the Royal Society.	Alexander I, 2005, COGN NEUROPSYCHOL, V22, P306, DOI 10.1080/02643290442000356; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Bengtsson SL, 2005, EUR J NEUROSCI, V22, P3255, DOI 10.1111/j.1460-9568.2005.04517.x; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P204, DOI 10.1162/jocn.2008.20017; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P1054, DOI 10.1162/jocn.2008.20060; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Ferrandez AM, 2003, NEUROIMAGE, V19, P1532, DOI 10.1016/S1053-8119(03)00159-9; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Grondin S, 1996, PERCEPT PSYCHOPHYS, V58, P424, DOI 10.3758/BF03206818; GRONDIN S, 1991, PERCEPT PSYCHOPHYS, V49, P245, DOI 10.3758/BF03214309; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Harrington DL, 1998, J NEUROSCI, V18, P1085; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Jahanshahi M, 2006, J NEUROSCI, V26, P12266, DOI 10.1523/JNEUROSCI.2540-06.2006; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P51, DOI 10.1016/S0926-6410(00)00022-7; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Kudo K, 2004, NEUROIMAGE, V22, P1291, DOI 10.1016/j.neuroimage.2004.03.043; Lewis PA, 2006, BEHAV PROCESS, V71, P226, DOI 10.1016/j.beproc.2005.12.009; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; Maquet P, 1996, NEUROIMAGE, V3, P119, DOI 10.1006/nimg.1996.0014; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck WH, 2006, BRAIN RES, V1109, P93, DOI 10.1016/j.brainres.2006.06.031; Melgire M, 2005, BRAIN COGNITION, V58, P119, DOI 10.1016/j.bandc.2004.09.013; MERCHANT H, 2007, J NEUROPHYSIOL; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Penhune VB, 1999, NEUROPSYCHOLOGIA, V37, P315, DOI 10.1016/S0028-3932(98)00075-X; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rao SM, 1997, J NEUROSCI, V17, P5528; Sakai K, 1999, J NEUROSCI, V19, P10074; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Walsh V, 2003, BRADFORD BOOKS, P1; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; Westheimer G, 1999, EXP BRAIN RES, V129, P121, DOI 10.1007/s002210050942; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	45	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2481	10.1371/journal.pone.0002481	http://dx.doi.org/10.1371/journal.pone.0002481			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IK	18575615	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288000011
J	Desmond, C; Bland, RM; Boyce, G; Coovadia, HM; Coutsoudis, A; Rollins, N; Newell, ML				Desmond, Chris; Bland, Ruth M.; Boyce, Gerard; Coovadia, Hoosen M.; Coutsoudis, Anna; Rollins, Nigel; Newell, Marie-Louise			Scaling-Up Exclusive Breastfeeding Support Programmes: The Example of KwaZulu-Natal	PLOS ONE			English	Article							CHILD HIV TRANSMISSION; UNINFECTED WOMEN; PREVALENCE; HEALTH	Background: Exclusive breastfeeding (EBF) for six months is the mainstay of global child health and the preferred feeding option for HIV-infected mothers for whom replacement feeding is inappropriate. Promotion of community-level EBF requires effective personnel and management to ensure quality counselling and support for women. We present a costing and cost effectiveness analysis of a successful intervention to promote EBF in high HIV prevalence area in South Africa, and implications for scale-up in the province of KwaZulu-Natal. Methods and Findings: The costing of the intervention as implemented was calculated, in addition to the modelling of the costs and outcomes associated with running the intervention at provincial level under three different scenarios: full intervention (per protocol), simplified version (half the number of visits compared to the full intervention; more clinic compared to home visits) and basic version (one third the number of visits compared to the full intervention; all clinic and no home visits). Implementation of the full scenario costs R95 million ($14 million) per annum; the simplified version R47 million ($7 million) and the basic version R4 million ($2 million). Although the cost of the basic scenario is less than one tenth of the cost of the simplified scenario, modelled effectiveness of the full and simplified versions suggest they would be 10 times more effective compared to the basic intervention. A further analysis modelled the costs per increased month of EBF due to each intervention: R337 ($ 48), R206 ($29), and R616 ($88) for the full, simplified and basic scenarios respectively. In addition to the average cost effectiveness the incremental cost effectiveness ratios associated with moving from the less effective scenarios to the more effective scenarios were calculated and reported: Nothing - Basic R616 ($88), Basic Simplified R162 ($23) and Simplified - Full R879 ($126). Conclusions: The simplified scenario, with a combination of clinic and home visits, is the most efficient in terms of cost per increased month of EBF and has the lowest incremental cost effectiveness ratio.	[Desmond, Chris; Boyce, Gerard] Human Sci Res Council, Durban, South Africa; [Bland, Ruth M.; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Stud, Somkhele, South Africa; [Bland, Ruth M.] Glasgow Univ, Div Dev Med, Glasgow, Lanark, Scotland; [Coovadia, Hoosen M.] Univ KwaZulu Natal, Ctr HIV AIDS Network, Somkhele, South Africa; [Coutsoudis, Anna; Rollins, Nigel] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Somkhele, South Africa; [Newell, Marie-Louise] UCL, Ctr Paediat Epidemiol & Biostat, Inst Child Hlth, London, England	Human Sciences Research Council-South Africa; University of Kwazulu Natal; University of Glasgow; University of Kwazulu Natal; University of Kwazulu Natal; University of London; University College London	Desmond, C (corresponding author), Human Sci Res Council, Durban, South Africa.	rbland@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Bland, Ruth/0000-0003-1675-9268	Wellcome Trust [063009/Z/00/2]; Africa Centre [050534, 077760Z/05/B]	Wellcome Trust(Wellcome TrustEuropean Commission); Africa Centre	Wellcome Trust supported this study (Grant #063009/Z/00/2) and the Africa Centre (Grant #050534 and #077760Z/05/B).	BLAND R, 2008, AIDS IN PRESS; Bland RM, 2007, CLIN INFECT DIS, V45, P1502, DOI 10.1086/523320; Bland RM, 2007, B WORLD HEALTH ORGAN, V85, P289, DOI 10.2471/BLT.06.032441; Bland RM, 2002, ACTA PAEDIATR, V91, P704, DOI 10.1080/080352502760069151; Chopra M, 2002, SAMJ S AFR MED J, V92, P298; COOVADIA H, 2007, LANCET, V369, P1607; Coutinho SB, 2005, LANCET, V366, P1094, DOI 10.1016/S0140-6736(05)67421-1; CREEK T, 2006, ROLE INFANT FEEDING; Drummond MF, 2015, METHODS EC EVALUATIO; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; *KWAZULU NAT PROV, 2006, PROV SAL SCAL FACS C; *KWAZULU NAT PROV, 2003, PROT PHAS IMPL COMPR; LATHAM MC, 2001, CURRENT STATUS PROTE; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Rice BD, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-160; Schack-Nielsen L, 2006, CURR OPIN CLIN NUTR, V9, P289, DOI 10.1097/01.mco.0000222114.84159.79; SKORDIS J, 2000, J HLTH EC, V21, P405; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; Taha TE, 2006, B WORLD HEALTH ORGAN, V84, P546, DOI 10.2471/BLT.05.027664; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; *UNAIDS WHO, 2005, AIDS EP UPD; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; *WHO, 2002, NUTR AD EXCL BREASTF; *WHO UNICEF UNAIDS, 2000, HIV INF FEED COUNS T; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; World Health Organization, 2001, OPT DUR EXCL BREASTF; World Health Organization & Unicef, 1993, BREASTF COUNS TRAIN	29	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2454	10.1371/journal.pone.0002454	http://dx.doi.org/10.1371/journal.pone.0002454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560596	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000263280700036
J	Destouches, D; El Khoury, D; Hamma-Kourbali, Y; Krust, B; Albanese, P; Katsoris, P; Guichard, G; Briand, JP; Courty, J; Hovanessian, AG				Destouches, Damien; El Khoury, Diala; Hamma-Kourbali, Yamina; Krust, Bernard; Albanese, Patricia; Katsoris, Panagiotis; Guichard, Gilles; Briand, Jean Paul; Courty, Jose; Hovanessian, Ara G.			Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin	PLOS ONE			English	Article							PENTAMERIC PSEUDOPEPTIDE HB-19; BINDING PROTEIN; IN-VIVO; HIV; PLEIOTROPHIN; INHIBITION; PARTICLES; INDUCTION; ANCHORAGE; MEMBRANE	Background: Emerging evidences suggest that nucleolin expressed on the cell surface is implicated in growth of tumor cells and angiogenesis. Nucleolin is one of the major proteins of the nucleolus, but it is also expressed on the cell surface where is serves as a binding protein for variety of ligands implicated in cell proliferation, differentiation, adhesion, mitogenesis and angiogenesis. Methodology/Principal Findings: By using a specific antagonist that binds the C-terminal tail of nucleolin, the HB-19 pseudopeptide, here we show that the growth of tumor cells and angiogenesis are suppressed in various in vitro and in vivo experimental models. HB-19 inhibited colony formation in soft agar of tumor cell lines, impaired migration of endothelial cells and formation of capillary-like structures in collagen gel, and reduced blood vessel branching in the chick embryo chorioallantoic membrane. In athymic nude mice, HB-19 treatment markedly suppressed the progression of established human breast tumor cell xenografts in nude mice, and in some cases eliminated measurable tumors while displaying no toxicity to normal tissue. This potent antitumoral effect is attributed to the direct inhibitory action of HB-19 on both tumor and endothelial cells by blocking and down regulating surface nucleolin, but without any apparent effect on nucleolar nucleolin. Conclusion/Significance: Our results illustrate the dual inhibitory action of HB-19 on the tumor development and the neovascularization process, thus validating the cell-surface expressed nucleolin as a strategic target for an effective cancer drug. Consequently, the HB-19 pseudopeptide provides a unique candidate to consider for innovative cancer therapy.	[Destouches, Damien; Hamma-Kourbali, Yamina; Albanese, Patricia; Courty, Jose] Univ Paris Est, CNRS, UMR 7149, Creteil, France; [El Khoury, Diala; Krust, Bernard; Hovanessian, Ara G.] Univ Paris 05, CNRS UPR 2228, Paris, France; [Katsoris, Panagiotis] Univ Patras, Lab Mol Pharmacol, Patras, Greece; [Guichard, Gilles; Briand, Jean Paul] Inst Biol Mol Cellulaire, CNRS UPR 9021, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite; University of Patras	Destouches, D (corresponding author), Univ Paris Est, CNRS, UMR 7149, Creteil, France.	ara.hovanessian@univ-paris5.fr	Courty, Jose/Q-3702-2018; GUICHARD, Gilles/I-3858-2016; Destouches, Damien/R-2430-2018; Hamma-Kourbali, Yamina/R-3692-2018	GUICHARD, Gilles/0000-0002-2584-7502; Destouches, Damien/0000-0003-4959-2580; Hamma-Kourbali, Yamina/0000-0002-2754-8928	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche: Emergence et Maturation de projets de Biotechnologie a fort Potentiel de valorisation (ANR:EMBP)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche: Emergence et Maturation de projets de Biotechnologie a fort Potentiel de valorisation (ANR:EMBP)(French National Research Agency (ANR))	This work was supported by "Centre National de la Recherche Scientifique" (CNRS) and "Agence Nationale de la Recherche: Emergence et Maturation de projets de Biotechnologie a fort Potentiel de valorisation" (ANR:EMBP), France. D.E.K was supported in part by CNRS, Lebanon.	Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bernard-Pierrot I, 2002, J BIOL CHEM, V277, P32071, DOI 10.1074/jbc.M202747200; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; Carpentier M, 2005, BIOCHEMISTRY-US, V44, P5804, DOI 10.1021/bi047831s; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Dumler I, 1999, CURR BIOL, V9, P1468, DOI 10.1016/S0960-9822(00)80116-5; Fahling M, 2005, BBA-GENE STRUCT EXPR, V1731, P32, DOI 10.1016/j.bbaexp.2005.08.005; Folkman J, 2007, BLOOD, V110, P2786, DOI 10.1182/blood-2007-08-102178; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fu ZM, 2005, J PROTEOME RES, V4, P1583, DOI 10.1021/pr0501158; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; GhisolfiNieto L, 1996, J MOL BIOL, V260, P34, DOI 10.1006/jmbi.1996.0380; Grinstein E, 2002, J EXP MED, V196, P1067, DOI 10.1084/jem.20011053; Grinstein E, 2006, J BIOL CHEM, V281, P22223, DOI 10.1074/jbc.M513335200; Haemmerling GJ, 2006, CELL CYCLE, V5, P509, DOI 10.4161/cc.5.5.2517; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Huang Y, 2006, BLOOD, V107, P3564, DOI 10.1182/blood-2005-07-2961; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; KLEINMAN HK, 1991, ARCH BIOCHEM BIOPHYS, V290, P320, DOI 10.1016/0003-9861(91)90547-V; Krust B, 2001, P NATL ACAD SCI USA, V98, P14090, DOI 10.1073/pnas.221467298; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Nisole S, 2002, J BIOL CHEM, V277, P20877, DOI 10.1074/jbc.M110024200; Nisole S, 2002, EXP CELL RES, V276, P155, DOI 10.1006/excr.2002.5522; Nisole S, 1999, J BIOL CHEM, V274, P27875, DOI 10.1074/jbc.274.39.27875; Otake Y, 2005, MOL PHARMACOL, V67, P319, DOI 10.1124/mol.104.006080; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; PEPPER MS, 1990, J CELL BIOL, V111, P743, DOI 10.1083/jcb.111.2.743; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Re RN, 2006, BIOESSAYS, V28, P943, DOI 10.1002/bies.20459; Ribatti D, 2007, LEUKEMIA, V21, P1606, DOI 10.1038/sj.leu.2404756; Ribatti D, 2007, HISTOL HISTOPATHOL, V22, P285, DOI 10.14670/HH-22.285; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rouet V, 2005, J BIOL CHEM, V280, P32792, DOI 10.1074/jbc.M504492200; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Shi HB, 2007, BLOOD, V110, P2899, DOI 10.1182/blood-2007-01-064428; Shibata Y, 2002, MOL CELL BIOL, V22, P6788, DOI 10.1128/MCB.22.19.6788-6796.2002; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; STEPANOVA V, 2008, BLOOD IN PRESS; STORCK S, 2007, SUBCELL BIOCH, V41; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tanaka Shinji, 2006, Int J Clin Oncol, V11, P82, DOI 10.1007/s10147-006-0566-5; Tate A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-197; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200	48	117	126	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2518	10.1371/journal.pone.0002518	http://dx.doi.org/10.1371/journal.pone.0002518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560571	Green Published, gold, Green Submitted			2022-12-25	WOS:000263280700062
J	Perfettini, JL; Nardacci, R; Bourouba, M; Subra, F; Gros, L; Seror, C; Manic, G; Rosselli, F; Amendola, A; Masdehors, P; Chessa, L; Novelli, G; Ojcius, DM; Siwicki, JK; Chechlinska, M; Auclair, C; Regueiro, JR; de The, H; Gougeon, ML; Piacentini, M; Kroemer, G				Perfettini, Jean-Luc; Nardacci, Roberta; Bourouba, Mehdi; Subra, Frederic; Gros, Laurent; Seror, Claire; Manic, Gwenola; Rosselli, Filippo; Amendola, Alessandra; Masdehors, Peggy; Chessa, Luciana; Novelli, Giuseppe; Ojcius, David M.; Siwicki, Jan Konrad; Chechlinska, Magdalena; Auclair, Christian; Regueiro, Jose R.; de The, Hugues; Gougeon, Marie-Lise; Piacentini, Mauro; Kroemer, Guido			Critical Involvement of the ATM-Dependent DNA Damage Response in the Apoptotic Demise of HIV-1-Elicited Syncytia	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; GLYCOPROTEIN COMPLEX; HIV-1 INFECTION; P53; INDUCTION; ACTIVATION; NBS1; PHOSPHORYLATION; REPLICATION; INTEGRATION	DNA damage can activate the oncosuppressor protein ataxia telangiectasia mutated (ATM), which phosphorylates the histone H2AX within characteristic DNA damage foci. Here, we show that ATM undergoes an activating phosphorylation in syncytia elicited by the envelope glycoprotein complex (Env) of human immunodeficiency virus-1 (HIV-1) in vitro. This was accompanied by aggregation of ATM in discrete nuclear foci that also contained phospho-histone H2AX. DNA damage foci containing phosphorylated ATM and H2AX were detectable in syncytia present in the brain or lymph nodes from patients with HIV-1 infection, as well as in a fraction of blood leukocytes, correlating with viral status. Knockdown of ATM or of its obligate activating factor NBS1 (Nijmegen breakage syndrome 1 protein), as well as pharmacological inhibition of ATM with KU-55933, inhibited H2AX phosphorylation and prevented Env-elicited syncytia from undergoing apoptosis. ATM was found indispensable for the activation of MAP kinase p38, which catalyzes the activating phosphorylation of p53 on serine 46, thereby causing p53 dependent apoptosis. Both wild type HIV-1 and an HIV-1 mutant lacking integrase activity induced syncytial apoptosis, which could be suppressed by inhibiting ATM. HIV-1-infected T lymphoblasts from patients with inactivating ATM or NBS1 mutations also exhibited reduced syncytial apoptosis. Altogether these results indicate that apoptosis induced by a fusogenic HIV-1 Env follows a pro-apoptotic pathway involving the sequential activation of ATM, p38MAPK and p53.	[Perfettini, Jean-Luc; Bourouba, Mehdi; Seror, Claire; Manic, Gwenola; Kroemer, Guido] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France; [Nardacci, Roberta; Amendola, Alessandra; Piacentini, Mauro] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy; [Subra, Frederic; Gros, Laurent; Auclair, Christian] Ecole Normale Superieure Cachan, CNRS UMR 8113 LBPA, Cachan, France; [Rosselli, Filippo] Inst Gustave Roussy, CNRS FRE2939, Villejuif, France; [Masdehors, Peggy; Gougeon, Marie-Lise] Inst Pasteur, Dept Infect & Epidemiol, Biotherapy & Vaccine Unit, Paris, France; [Chessa, Luciana] Univ Roma La Sapienza, Fac Med 2, Rome, Italy; [Novelli, Giuseppe] Univ Roma Tor Vergata, Dept Biopathol & Diagnos Imag, Rome, Italy; [Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Siwicki, Jan Konrad; Chechlinska, Magdalena] M Sklodowska Curie Memorial Canc Ctr, Inst Oncol, Dept Immunol, Warsaw, Poland; [Regueiro, Jose R.] Univ Complutense, Fac Med, Madrid, Spain; [de The, Hugues] Univ Paris 07, Hop St Louis, CNRS UPR 9051, Paris, France; [Piacentini, Mauro] Univ Roma Tor Vergata, Dept Biol, Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; IRCCS Lazzaro Spallanzani; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Sapienza University Rome; University of Rome Tor Vergata; University of California System; University of California Merced; Maria Sklodowska-Curie National Research Institute of Oncology; Complutense University of Madrid; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Rome Tor Vergata	Perfettini, JL (corresponding author), Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France.	kroemer@igr.fr	Chechlinska, Magdalena/AAB-9059-2020; Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/T-8822-2019; Regueiro, José R./B-5499-2014; Filippo, Rosselli/AAO-6393-2020; Novelli, Giuseppe/GQB-3329-2022; Amendola, Alessandra/ABC-2753-2021; Amendola, Alessandra/K-8835-2016; Kroemer, Guido/AAY-9859-2020; Bourouba, Mehdi/AAC-3615-2020; KROEMER, Guido/B-4263-2013; Piacentini, Mauro/I-2411-2016; Manic, Gwenola/J-8496-2018; Nardacci, Roberta/K-6555-2016; Chechlinska, Magdalena/ABB-9653-2020; Ojcius, David/ABE-6557-2020; PERFETTINI, Jean-Luc/N-4699-2017	Chechlinska, Magdalena/0000-0001-6139-1234; Novelli, Giuseppe/0000-0002-7781-602X; Regueiro, José R./0000-0001-8442-7762; Filippo, Rosselli/0000-0003-1080-5745; Novelli, Giuseppe/0000-0002-7781-602X; Amendola, Alessandra/0000-0002-7063-0222; Amendola, Alessandra/0000-0002-7063-0222; KROEMER, Guido/0000-0002-9334-4405; Piacentini, Mauro/0000-0003-2919-1296; Nardacci, Roberta/0000-0002-9209-1207; PERFETTINI, Jean-Luc/0000-0002-2427-2604; Manic, Gwenola/0000-0003-3759-8029; Ojcius, David/0000-0003-1461-4495; Siwicki, Jan Konrad/0000-0002-5083-3022	LNC; ANRS; Sidaction; European Commission; Istituto Superiore di Sanita [N40F60]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	LNC; ANRS(ANRSFrench National Research Agency (ANR)); Sidaction; European Commission(European CommissionEuropean Commission Joint Research Centre); Istituto Superiore di Sanita; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work has been supported by a special grant from LNC, as well as grants by ANRS, Sidaction and the European Commission (RIGHT, ACTIVE P53, ApoSys) (to G.K.), Istituto Superiore di Sanita (N40F60, Ricerca Corrente e Finalizzate Ministerio della Salute, COFIN from MIUR and AIRC).	Agarwal RP, 1997, MUTAT RES-GEN TOX EN, V390, P223, DOI 10.1016/S1383-5718(97)00014-4; Badley AD, 2000, BLOOD, V96, P2951, DOI 10.1182/blood.V96.9.2951.h8002951_2951_2964; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Brown EJ, 2003, CELL CYCLE, V2, P188, DOI 10.4161/cc.2.3.395; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Camerini D, 2000, J VIROL, V74, P3196, DOI 10.1128/JVI.74.7.3196-3204.2000; Castedo M, 2005, BIOCHEM BIOPH RES CO, V331, P701, DOI 10.1016/j.bbrc.2005.03.188; Castedo M, 2001, J EXP MED, V194, P1097, DOI 10.1084/jem.194.8.1097; Castedo M, 2002, EMBO J, V21, P4070, DOI 10.1093/emboj/cdf391; Cook JE, 2005, ANN NEUROL, V57, P795, DOI 10.1002/ana.20479; Costes SV, 2007, PLOS COMPUT BIOL, V3, P1477, DOI 10.1371/journal.pcbi.0030155; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Daniel R, 2003, P NATL ACAD SCI USA, V100, P4778, DOI 10.1073/pnas.0730887100; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Difilippantonio S, 2007, J EXP MED, V204, P1003, DOI 10.1084/jem.20070319; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Etemad-Moghadam B, 2000, J VIROL, V74, P4433, DOI 10.1128/JVI.74.9.4433-4440.2000; Ferri KF, 2000, EXP CELL RES, V261, P119, DOI 10.1006/excr.2000.5062; Garden GA, 2004, FASEB J, V18, P1141, DOI 10.1096/fj.04-1676fje; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gougeon ML, 2005, CELL DEATH DIFFER, V12, P845, DOI 10.1038/sj.cdd.4401616; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Hamers FF, 2004, LANCET, V364, P83, DOI 10.1016/S0140-6736(04)16594-X; Jayadev S, 2007, J NEUROIMMUNE PHARM, V2, P359, DOI 10.1007/s11481-007-9095-x; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Kopka J, 2002, PEDIATR RES, V52, P475, DOI [10.1203/01.0000028056.74614.E0, 10.1203/00006450-200210000-00004]; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Nardacci R, 2005, AM J PATHOL, V167, P695, DOI 10.1016/S0002-9440(10)62044-5; Nunnari G, 2005, VIROLOGY, V335, P177, DOI 10.1016/j.virol.2005.02.015; PANTALEO G, 1995, NAT MED, V1, P118, DOI 10.1038/nm0295-118; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; Perfettini JL, 2004, J EXP MED, V199, P629, DOI 10.1084/jem.20031216; Rivero-Carmena M, 2000, INT IMMUNOL, V12, P927, DOI 10.1093/intimm/12.6.927; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Saito H, 2002, GYNECOL OBSTET INVES, V53, P46, DOI 10.1159/000049424; Scheller C, 2001, VIROLOGY, V282, P48, DOI 10.1006/viro.2000.0811; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Siwicki JK, 2003, EXP CELL RES, V287, P178, DOI 10.1016/S0014-4827(03)00140-X; Skalka AM, 2005, CELL DEATH DIFFER, V12, P971, DOI 10.1038/sj.cdd.4401573; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Wyen C, 2004, JAIDS-J ACQ IMM DEF, V37, P1263, DOI 10.1097/01.qai.0000136093.47316.f3; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998; You ZS, 2007, NAT CELL BIOL, V9, P311, DOI 10.1038/ncb1651; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	54	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2458	10.1371/journal.pone.0002458	http://dx.doi.org/10.1371/journal.pone.0002458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560558	Green Published, gold			2022-12-25	WOS:000263280700039
J	Garcia-Contreras, R; Zhang, XS; Kim, Y; Wood, TK				Garcia-Contreras, Rodolfo; Zhang, Xue-Song; Kim, Younghoon; Wood, Thomas K.			Protein Translation and Cell Death: The Role of Rare tRNAs in Biofilm Formation and in Activating Dormant Phage Killer Genes	PLOS ONE			English	Article								We discovered previously that the small Escherichia coli proteins Hha (hemolysin expression modulating protein) and the adjacent, poorly-characterized YbaJ are important for biofilm formation; however, their roles have been nebulous. Biofilms are intricate communities in which cell signaling often converts single cells into primitive tissues. Here we show that Hha decreases biofilm formation dramatically by repressing the transcription of rare codon tRNAs which serves to inhibit fimbriae production and by repressing to some extent transcription of fimbrial genes fimA and ihfA. In vivo binding studies show Hha binds to the rare codon tRNAs argU, ileX, ileY, and proL and to two prophage clusters D1P12 and CP4-57. Real-time PCR corroborated that Hha represses argU and proL, and Hha type I fimbriae repression is abolished by the addition of extra copies of argU, ileY, and proL. The repression of transcription of rare codon tRNAs by Hha also leads to cell lysis and biofilm dispersal due to activation of prophage lytic genes rzpD, yfjZ, appY, and alpA and due to induction of ClpP/ClpX proteases which activate toxins by degrading antitoxins. YbaJ serves to mediate the toxicity of Hha. Hence, we have identified that a single protein (Hha) can control biofilm formation by limiting fimbriae production as well as by controlling cell death. The mechanism used by Hha is the control of translation via the availability of rare codon tRNAs which reduces fimbriae production and activates prophage lytic genes. Therefore, Hha acts as a toxin in conjunction with co-transcribed YbaJ (TomB) that attenuates Hha toxicity.	[Garcia-Contreras, Rodolfo; Zhang, Xue-Song; Kim, Younghoon; Wood, Thomas K.] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA; [Wood, Thomas K.] Texas A&M Univ, Dept Biol, College Stn, TX USA; [Wood, Thomas K.] Texas A&M Univ, Zachry Dept Civil Engn, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Garcia-Contreras, R (corresponding author), Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA.	Thomas.Wood@chemail.tamu.edu	Garcia-Contreras, Rodolfo/AAI-3548-2020; Wood, Thomas/GWZ-2481-2022	Wood, Thomas/0000-0001-8962-8571; Wood, Thomas/0000-0002-6258-529X; Zhang, Xue-Song/0000-0001-5080-0098	NIH [5R01EB003872-05]; ARO [W911NF-06-1-0408]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003872] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARO; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the NIH (5R01EB003872-05) and the ARO (W911NF-06-1-0408). The funding agencies did not participate in the work.	ABRAHAM JM, 1985, P NATL ACAD SCI USA, V82, P5724, DOI 10.1073/pnas.82.17.5724; Atlung T, 1997, MOL MICROBIOL, V24, P7, DOI 10.1046/j.1365-2958.1997.3151679.x; AVIV M, 1994, MOL MICROBIOL, V14, P1021, DOI 10.1111/j.1365-2958.1994.tb01336.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balsalobre C, 1999, J BACTERIOL, V181, P3018, DOI 10.1128/JB.181.10.3018-3024.1999; BANSAL T, 2007, INFECT IMMUN; Barrios AFG, 2006, BIOTECHNOL BIOENG, V93, P188, DOI 10.1002/bit.20681; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BLANCO A, 1991, FEMS MICROBIOL LETT, V81, P221; Brown JM, 2003, J BACTERIOL, V185, P6600, DOI 10.1128/JB.185.22.6600-6608.2003; CARMONA M, 1993, MOL MICROBIOL, V9, P1011, DOI 10.1111/j.1365-2958.1993.tb01230.x; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; Delgado-Olivares L, 2006, BIOCHIMIE, V88, P793, DOI 10.1016/j.biochi.2006.01.007; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; Dobrindt U, 2002, MOL GENET GENOMICS, V267, P370, DOI 10.1007/s00438-002-0668-3; Domka J, 2006, APPL ENVIRON MICROB, V72, P2449, DOI 10.1128/AEM.72.4.2449-2459.2006; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; DORMAN CJ, 1987, J BACTERIOL, V169, P3840, DOI 10.1128/jb.169.8.3840-3843.1987; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fahlen TF, 2001, J BACTERIOL, V183, P6620, DOI 10.1128/JB.183.22.6620-6629.2001; Forns N, 2005, FEMS MICROBIOL LETT, V251, P75, DOI 10.1016/j.femsle.2005.07.027; Frumerie C, 2005, VIROLOGY, V332, P284, DOI 10.1016/j.virol.2004.11.015; GALLY DL, 1994, J BACTERIOL, V176, P5665, DOI 10.1128/JB.176.18.5665-5672.1994; Gally DL, 1996, MOL MICROBIOL, V21, P725, DOI 10.1046/j.1365-2958.1996.311388.x; Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x; GODESSART N, 1988, J GEN MICROBIOL, V134, P2779; GOOSEN N, 1995, MOL MICROBIOL, V16, P1, DOI 10.1111/j.1365-2958.1995.tb02386.x; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; Herzberg M, 2006, J BACTERIOL, V188, P587, DOI 10.1128/JB.188.2.587-598.2006; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; KAWULA TH, 1991, J BACTERIOL, V173, P4116, DOI 10.1128/jb.173.13.4116-4123.1991; KIRBY JE, 1994, J BACTERIOL, V176, P2068, DOI 10.1128/jb.176.7.2068-2081.1994; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KOHNO K, 1994, J BIOCHEM-TOKYO, V115, P1113, DOI 10.1093/oxfordjournals.jbchem.a124466; Leathart JBS, 1998, MOL MICROBIOL, V28, P371, DOI 10.1046/j.1365-2958.1998.00802.x; Lee J, 2007, J MOL BIOL, V373, P11, DOI 10.1016/j.jmb.2007.07.037; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Madrid C, 2007, MOL MICROBIOL, V63, P7, DOI 10.1111/j.1365-2958.2006.05497.x; Maeda T, 2008, MICROB BIOTECHNOL, V1, P30, DOI 10.1111/j.1751-7915.2007.00003.x; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Mai-Prochnow A, 2004, APPL ENVIRON MICROB, V70, P3232, DOI 10.1128/AEM.70.6.3232-3238.2004; MIKULSKIS AV, 1994, MOL MICROBIOL, V11, P77, DOI 10.1111/j.1365-2958.1994.tb00291.x; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; MIRELMAN D, 1980, J CLIN MICROBIOL, V11, P328, DOI 10.1128/JCM.11.4.328-331.1980; Mourino M, 1996, INFECT IMMUN, V64, P2881; Nieto JM, 2000, MOL GEN GENET, V263, P349, DOI 10.1007/s004380051178; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Pruss BM, 2006, J BACTERIOL, V188, P3731, DOI 10.1128/JB.01780-05; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Ren DC, 2005, APPL ENVIRON MICROB, V71, P4022, DOI 10.1128/AEM.71.7.4022-4034.2005; Ren DC, 2004, BIOTECHNOL BIOENG, V88, P630, DOI 10.1002/bit.20259; Ritter A, 1997, MOL MICROBIOL, V25, P871, DOI 10.1111/j.1365-2958.1997.mmi517.x; SAIER MH, 1995, FEBS LETT, V362, P1, DOI 10.1016/0014-5793(95)00185-C; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schembri MA, 1998, MOL GEN GENET, V259, P336, DOI 10.1007/s004380050820; Schembri MA, 2002, MOL GENET GENOMICS, V267, P721, DOI 10.1007/s00438-002-0705-2; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Sharma VK, 2004, J BACTERIOL, V186, P7290, DOI 10.1128/JB.186.21.7290-7301.2004; Srividhya KV, 2007, J BIOSCIENCES, V32, P979, DOI 10.1007/s12038-007-0097-x; SWENSON DL, 1994, MOL GEN GENET, V244, P216, DOI 10.1007/BF00283525; Tamini Y, 2004, INVEST OPHTH VIS SCI, V45, P3904, DOI 10.1167/iovs.04-0628; Tinker JK, 2000, INFECT IMMUN, V68, P3305, DOI 10.1128/IAI.68.6.3305-3313.2000; Tinker JK, 2001, MOL MICROBIOL, V40, P757, DOI 10.1046/j.1365-2958.2001.02430.x; Tu Q, 2003, FEMS MICROBIOL LETT, V221, P269, DOI 10.1016/S0378-1097(03)00204-0; VIVERO A, 2007, J BACTERIOL; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; YEH KS, 1995, J BACTERIOL, V177, P6861, DOI 10.1128/jb.177.23.6861-6865.1995; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06	77	82	89	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2394	10.1371/journal.pone.0002394	http://dx.doi.org/10.1371/journal.pone.0002394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545668	Green Published, gold			2022-12-25	WOS:000263248800032
J	Hatori, M; Le, H; Vollmers, C; Keding, SR; Tanaka, N; Schmedt, C; Jegla, T; Panda, S				Hatori, Megumi; Le, Hiep; Vollmers, Christopher; Keding, Sheena Racheal; Tanaka, Nobushige; Schmedt, Christian; Jegla, Timothy; Panda, Satchidananda			Inducible Ablation of Melanopsin-Expressing Retinal Ganglion Cells Reveals Their Central Role in Non-Image Forming Visual Responses	PLOS ONE			English	Article								Rod/cone photoreceptors of the outer retina and the melanopsin-expressing retinal ganglion cells ( mRGCs) of the inner retina mediate non-image forming visual responses including entrainment of the circadian clock to the ambient light, the pupillary light reflex ( PLR), and light modulation of activity. Targeted deletion of the melanopsin gene attenuates these adaptive responses with no apparent change in the development and morphology of the mRGCs. Comprehensive identification of mRGCs and knowledge of their specific roles in image-forming and non-image forming photoresponses are currently lacking. We used a Cre-dependent GFP expression strategy in mice to genetically label the mRGCs. This revealed that only a subset of mRGCs express enough immunocytochemically detectable levels of melanopsin. We also used a Cre-inducible diphtheria toxin receptor ( iDTR) expression approach to express the DTR in mRGCs. mRGCs develop normally, but can be acutely ablated upon diphtheria toxin administration. The mRGC-ablated mice exhibited normal outer retinal function. However, they completely lacked non-image forming visual responses such as circadian photoentrainment, light modulation of activity, and PLR. These results point to the mRGCs as the site of functional integration of the rod/cone and melanopsin phototransduction pathways and as the primary anatomical site for the divergence of image-forming and non-image forming photoresponses in mammals.	[Hatori, Megumi; Le, Hiep; Vollmers, Christopher; Keding, Sheena Racheal; Tanaka, Nobushige; Panda, Satchidananda] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Schmedt, Christian] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Jegla, Timothy] Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Cell Biol, La Jolla, CA USA	Salk Institute; Novartis; Scripps Research Institute	Hatori, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	satchin@salk.edu	Buch, Thorsten/P-1659-2019; Panda, Satchidananda/J-6891-2012; Waisman, Ari/C-7383-2015; Hatori, Megumi/GTY-3770-2022	Buch, Thorsten/0000-0002-2236-9074; Waisman, Ari/0000-0003-4304-8234; Jegla, Timothy/0000-0001-8616-2390; Hatori, Megumi/0000-0001-7888-158X	Pew Scholars Program in Biomedical Sciences; Dana Foundation; Whitehall Foundation; NIH [EY016807]; GNF; NATIONAL EYE INSTITUTE [R01EY016807] Funding Source: NIH RePORTER	Pew Scholars Program in Biomedical Sciences; Dana Foundation; Whitehall Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GNF; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	MH, HL, CV, SK, and SP were supported by Pew Scholars Program in Biomedical Sciences, Dana Foundation, Whitehall Foundation and NIH grant EY016807. CS and TJ were supported by funding from GNF. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Bennett CL, 2007, TRENDS IMMUNOL, V28, P525, DOI 10.1016/j.it.2007.08.011; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; CRAWLEY JN, 2000, WHATS WRONG MY MOUSE, P65; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; De Haro L, 2006, J BIOL RHYTHM, V21, P507, DOI 10.1177/0748730406294767; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Keeler CE, 1927, AM J PHYSIOL, V81, P107, DOI 10.1152/ajplegacy.1927.81.1.107; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 1999, J COMP PHYSIOL A, V184, P423, DOI 10.1007/s003590050341; Mrosovsky N, 2001, J BIOL RHYTHM, V16, P585, DOI 10.1177/074873001129002277; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Nayak SK, 2007, CELL MOL LIFE SCI, V64, P144, DOI 10.1007/s00018-006-5581-1; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Panda S, 2007, NEURON, V53, P619, DOI 10.1016/j.neuron.2007.02.017; Panda Satchidananda, 2003, Novartis Found Symp, V253, P73; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Siepka SM, 2005, METHOD ENZYMOL, V393, P230, DOI 10.1016/S0076-6879(05)93008-5; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Van Gelder RN, 2005, METHOD ENZYMOL, V393, P746, DOI 10.1016/S0076-6879(05)93039-5	41	205	206	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2451	10.1371/journal.pone.0002451	http://dx.doi.org/10.1371/journal.pone.0002451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545654	gold, Green Published, Green Submitted			2022-12-25	WOS:000263248800059
J	Hoehl, S; Wiese, L; Striano, T				Hoehl, Stefanie; Wiese, Lisa; Striano, Tricia			Young Infants' Neural Processing of Objects Is Affected by Eye Gaze Direction and Emotional Expression	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; FACIAL EXPRESSIONS; SPECIES FOLLOW; FACE; ATTENTION; RECOGNITION; AMYGDALA; BRAIN; FEAR; POTENTIALS	Eye gaze is an important social cue which is used to determine another person's focus of attention and intention to communicate. In combination with a fearful facial expression eye gaze can also signal threat in the environment. The ability to detect and understand others' social signals is essential in order to avoid danger and enable social evaluation. It has been a matter of debate when infants are able to use gaze cues and emotional facial expressions in reference to external objects. Here we demonstrate that by 3 months of age the infant brain differentially responds to objects as a function of how other people are reacting to them. Using event-related electrical brain potentials (ERPs), we show that an indicator of infants' attention is enhanced by an adult's expression of fear toward an unfamiliar object. The infant brain showed an increased Negative central (Nc) component toward objects that had been previously cued by an adult's eye gaze and frightened facial expression. Our results further suggest that infants' sensitivity cannot be due to a general arousal elicited by a frightened face with eye gaze directed at an object. The neural attention system of 3 month old infants is sensitive to an adult's eye gaze direction in combination with a fearful expression. This early capacity may lay the foundation for the development of more sophisticated social skills such as social referencing, language, and theory of mind.	[Hoehl, Stefanie; Wiese, Lisa] Max Planck Inst Human Cognit & Brain Sci, Neurocognit & Dev Grp, Leipzig, Germany; [Striano, Tricia] CUNY, Hunter Coll, New York, NY USA	Max Planck Society; City University of New York (CUNY) System; Hunter College (CUNY)	Hoehl, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Neurocognit & Dev Grp, Leipzig, Germany.	tstriano@hunter.cuny.edu	Hoehl, Stefanie/N-2452-2014	Hoehl, Stefanie/0000-0003-0472-0374	Federal Ministry of Education [Sofja Kovalevskaja Award]; Alexander von Humboldt Foundation [Sofja Kovalevskaja Award]	Federal Ministry of Education; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This research was supported by the Sofja Kovalevskaja Award granted by the Alexander von Humboldt Foundation and donated by the Federal Ministry of Education to T.S.	Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brauer J, 2005, J COMP PSYCHOL, V119, P145, DOI 10.1037/0735-7036.119.2.145; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Casey BJ, 1997, DEV PSYCHOBIOL, V30, P61, DOI 10.1002/(SICI)1098-2302(199701)30:1<61::AID-DEV6>3.3.CO;2-B; COURCHESNE E, 1981, CHILD DEV, V52, P804, DOI 10.2307/1129080; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; CSIBRA G, BRIT J DEV IN PRESS; Csibra G, 2006, ATTENTION PERFORM, P249; D'Entremont B, 1997, INFANT BEHAV DEV, V20, P569, DOI 10.1016/S0163-6383(97)90048-5; de Haan M, 2003, INT J PSYCHOPHYSIOL, V51, P45, DOI 10.1016/S0167-8760(03)00152-1; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; FEINMAN S, 1992, SOCIAL REFERENCING S; George N, 2001, NEUROIMAGE, V13, P1102, DOI 10.1006/nimg.2001.0769; Gliga T, 2007, PROG BRAIN RES, V164, P323, DOI 10.1016/S0079-6123(07)64018-7; Grossmann T, 2005, NEUROREPORT, V16, P1825, DOI 10.1097/01.wnr.0000185964.34336.b1; Grossmann T, 2007, BRAIN COGNITION, V64, P30, DOI 10.1016/j.bandc.2006.10.002; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; HOEHL S, CHILD DEV IN PRESS; Hood BM, 1998, PSYCHOL SCI, V9, P131, DOI 10.1111/1467-9280.00024; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Latane B., 1970, UNRESPONSIVE BYSTAND; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Leppanen JM, 2007, CHILD DEV, V78, P232, DOI 10.1111/j.1467-8624.2007.00994.x; Leppanen JM, 2006, ADV CHILD DEV BEHAV, V34, P207, DOI 10.1016/S0065-2407(06)80008-X; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Moses LJ, 2001, CHILD DEV, V72, P718, DOI 10.1111/1467-8624.00311; Mumme DL, 2003, CHILD DEV, V74, P221, DOI 10.1111/1467-8624.00532; Nelson CA, 1996, DEV PSYCHOBIOL, V29, P577; Nelson CA, 1998, PERCEPTUAL DEV VISUA, P287; Nelson Charles A., 1994, P269; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Pillay SS, 2006, J AFFECT DISORDERS, V94, P173, DOI 10.1016/j.jad.2006.04.007; Prentice DA, 1996, ADV EXP SOC PSYCHOL, V28, P161, DOI 10.1016/S0065-2601(08)60238-5; Reid VM, 2007, EUR J DEV PSYCHOL, V4, P100, DOI 10.1080/17405620601005648; Reid VM, 2005, EUR J NEUROSCI, V21, P1763, DOI 10.1111/j.1460-9568.2005.03986.x; Reid VM, 2004, NEUROREPORT, V15, P2553, DOI 10.1097/00001756-200411150-00025; Reynolds GD, 2005, DEV PSYCHOL, V41, P598, DOI 10.1037/0012-1649.41.4.598; Richards JE, 2003, DEVELOPMENTAL SCI, V6, P312, DOI 10.1111/1467-7687.00287; SORCE JF, 1985, DEV PSYCHOL, V21, P195, DOI 10.1037/0012-1649.21.1.195; Striano T, 2006, SOC COGN AFFECT NEUR, V1, P87, DOI 10.1093/scan/nsl008; Tomasello M, 1999, ANIM BEHAV, V58, P769, DOI 10.1006/anbe.1999.1192; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; Vaish A, 2004, DEVELOPMENTAL SCI, V7, P261, DOI 10.1111/j.1467-7687.2004.00344.x; Vuilleumier P, 2002, CURR OPIN PSYCHIATR, V15, P291, DOI 10.1097/00001504-200205000-00011; WALDEN TA, 1988, CHILD DEV, V59, P1230, DOI 10.2307/1130486; WalkerAndrews AS, 1997, PSYCHOL BULL, V121, P437, DOI 10.1037/0033-2909.121.3.437; Woodward AL, 2003, DEVELOPMENTAL SCI, V6, P297, DOI 10.1111/1467-7687.00286	51	65	66	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2389	10.1371/journal.pone.0002389	http://dx.doi.org/10.1371/journal.pone.0002389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	405UD	18545689	gold, Green Published			2022-12-25	WOS:000263248800028
J	Iwai, Y; Hemmi, H; Mizenina, O; Kuroda, S; Suda, K; Steinman, RM				Iwai, Yoshiko; Hemmi, Hiroaki; Mizenina, Olga; Kuroda, Shoko; Suda, Koji; Steinman, Ralph M.			An IFN-gamma-IL-18 Signaling Loop Accelerates Memory CD8(+) T Cell Proliferation	PLOS ONE			English	Article								Rapid proliferation is one of the important features of memory CD8(+) T cells, ensuring rapid clearance of reinfection. Although several cytokines such as IL-15 and IL-7 regulate relatively slow homeostatic proliferation of memory T cells during the maintenance phase, it is unknown how memory T cells can proliferate more quickly than naive T cells upon antigen stimulation. To examine antigen-specific CD8(+) T cell proliferation in recall responses in vivo, we targeted a model antigen, ovalbumin(OVA), to DEC-205(+) dendritic cells (DCs) with a CD40 maturation stimulus. This led to the induction of functional memory CD8(+) T cells, which showed rapid proliferation and multiple cytokine production (IFN-gamma, IL-2, TNF-alpha) during the secondary challenge to DC-targeted antigen. Upon antigen-presentation, IL-18, an IFN-gamma-inducing factor, accumulated at the DC:T cell synapse. Surprisingly, IFN-gamma receptors were required to augment IL-18 production from DCs. Mice genetically deficient for IL-18 or IFN-gamma-receptor 1 also showed delayed expansion of memory CD8(+) T cells in vivo. These results indicate that a positive regulatory loop involving IFN-gamma and IL-18 signaling contributes to the accelerated memory CD8(+) T cell proliferation during a recall response to antigen presented by DCs.	[Iwai, Yoshiko; Hemmi, Hiroaki; Mizenina, Olga; Suda, Koji; Steinman, Ralph M.] Rockefeller Univ, Lab Cellular Immunol & Physiol, New York, NY 10021 USA; [Iwai, Yoshiko; Hemmi, Hiroaki; Kuroda, Shoko] Tokyo Med & Dental Univ, Med Res Inst, MTT Program, Tokyo, Japan	Rockefeller University; Tokyo Medical & Dental University (TMDU)	Iwai, Y (corresponding author), Rockefeller Univ, Lab Cellular Immunol & Physiol, 1230 York Ave, New York, NY 10021 USA.	steinma@mail.rockefeller.edu	Steinman, Ralph/F-7729-2012		NIH [AI40874, AI 54523]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; JSPS [Postdoctoral Fellowship]; Uehara Memorial Foundation [Research Fellowship]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI054523, R01AI040874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH (AI40874 and AI 54523 to R.M. Steinman) and is funded in part by a grant from the Center for AIDS vaccine discovery and the Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology (SCF) commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. Y. Iwai was the recipient of the JSPS Postdoctoral Fellowship for Research Abroad, and of the Uehara Memorial Foundation Research Fellowship.	Akira S, 2000, CURR OPIN IMMUNOL, V12, P59, DOI 10.1016/S0952-7915(99)00051-5; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Gardella S, 2001, BLOOD, V98, P2152, DOI 10.1182/blood.V98.7.2152; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; ISHIKAWA H, 1993, P NATL ACAD SCI USA, V90, P8204, DOI 10.1073/pnas.90.17.8204; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kamata T, 2000, J IMMUNOL, V165, P1387, DOI 10.4049/jimmunol.165.3.1387; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Okamura H, 1998, ADV IMMUNOL, V70, P281, DOI 10.1016/S0065-2776(08)60389-2; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Rubartelli A., 1997, UNUSUAL SECRETORY PA, P87, DOI [10.1007/978-3-662-22581-3_3, DOI 10.1007/978-3-662-22581-3_3]; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Tough DF, 2001, J IMMUNOL, V166, P6007, DOI 10.4049/jimmunol.166.10.6007; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	37	43	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2404	10.1371/journal.pone.0002404	http://dx.doi.org/10.1371/journal.pone.0002404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545704	gold, Green Submitted, Green Published			2022-12-25	WOS:000263248800042
J	McGrath, J; Iwazaki, T; Eyles, D; Burne, T; Cui, XY; Ko, P; Matsumoto, I				McGrath, John; Iwazaki, Takeshi; Eyles, Darryl; Burne, Thomas; Cui, Xiaoying; Ko, Pauline; Matsumoto, Izuru			Protein Expression in the Nucleus Accumbens of Rats Exposed to Developmental Vitamin D Deficiency	PLOS ONE			English	Article							ADULT-RAT; GENE-EXPRESSION; ALTERS; SCHIZOPHRENIA; NEUROTENSIN; DOPAMINE; HYPERLOCOMOTION; PATHWAYS; CORTEX; SEASON	Introduction: Developmental vitamin D (DVD) deficiency is a candidate risk factor for schizophrenia. Animal models have confirmed that DVD deficiency is associated with a range of altered genomic, proteomic, structural and behavioural outcomes in the rat. Because the nucleus accumbens has been implicated in neuropsychiatric disorders, in the current study we examined protein expression in this region in adult rats exposed to DVD deficiency Methods: Female Sprague Dawley rats were maintained on a vitamin D deficient diet for 6 weeks, mated and allowed to give birth, after which a diet containing vitamin D was reintroduced. Male adult offspring (n = 8) were compared to control male (n = 8). 2-D gel electrophoresis-based proteomics and mass spectroscopy were used to investigate differential protein expression. Results: There were 35 spots, mapped to 33 unique proteins, which were significantly different between the two groups. Of these, 22 were down-regulated and 13 up-regulated. The fold changes were uniformly small, with the largest FC being -1.67. Within the significantly different spots, three calcium binding proteins (calbindin1, calbindin2 and hippocalcin) were altered. Other proteins associated with DVD deficiency related to mitochondrial function, and the dynamin-like proteins. Conclusions: Developmental vitamin D deficiency was associated with subtle changes in protein expression in the nucleus accumbens. Disruptions in pathways related to calcium-binding proteins and mitochondrial function may underlie some of the behavioural features associated with animal models of developmental vitamin D deficiency	[McGrath, John; Eyles, Darryl; Burne, Thomas; Cui, Xiaoying; Ko, Pauline] Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Richlands, Australia; [McGrath, John] Univ Queensland, Dept Psychiat, St Lucia, Qld, Australia; [McGrath, John; Eyles, Darryl; Burne, Thomas; Cui, Xiaoying; Ko, Pauline] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Iwazaki, Takeshi; Matsumoto, Izuru] Univ Sydney, Dept Pathol, Sydney, NSW, Australia; [Matsumoto, Izuru] Asahiyama Hosp, Dept Psychiat, Sapporo, Hokkaido, Japan	Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; University of Sydney	McGrath, J (corresponding author), Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Richlands, Australia.	john_mcgrath@qcmhr.uq.edu.au	Eyles, Darryl W/X-3386-2018; McGrath, John Joseph/G-5493-2010; Burne, Thomas H/C-5656-2009	Eyles, Darryl W/0000-0002-5023-7095; McGrath, John Joseph/0000-0002-4792-6068; Burne, Thomas H/0000-0003-3502-9789	National Health and Medical Research Council; Schizophrenia Research Institute	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute	This project was supported by the National Health and Medical Research Council and the Schizophrenia Research Institute. Neither agency had any further role in study design, analysis and interpretation of data, writing of the report or decision to submit the manuscript for publication.	ALEXANDERKAUFMA.A, 2005, DIFFERENTIAL PROTEIN; Almeras L, 2007, PROTEOMICS, V7, P769, DOI 10.1002/pmic.200600392; Andrade EC, 2007, CURR OPIN MOL THER, V9, P270; Beasley CL, 2006, PROTEOMICS, V6, P3414, DOI 10.1002/pmic.200500069; Becker A, 2005, BEHAV BRAIN RES, V161, P306, DOI 10.1016/j.bbr.2005.02.015; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boules M, 2007, CNS DRUGS, V21, P13, DOI 10.2165/00023210-200721010-00002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burne THJ, 2004, BEHAV BRAIN RES, V154, P549, DOI 10.1016/j.bbr.2004.03.023; Caceda R, 2006, PEPTIDES, V27, P2385, DOI 10.1016/j.peptides.2006.04.024; Cheng SS, 2006, INT J ADV MANUF TECH, V28, P142, DOI 10.1007/s00170-004-2330-1; Christakos S, 2007, J STEROID BIOCHEM, V103, P405, DOI 10.1016/j.jsbmb.2006.12.079; Cui XY, 2007, INT J DEV NEUROSCI, V25, P227, DOI 10.1016/j.ijdevneu.2007.03.006; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; Escamilla M, 2007, PHARMACOGENOMICS, V8, P691, DOI 10.2217/14622416.8.7.691; Eyles D, 2007, J STEROID BIOCHEM, V103, P538, DOI 10.1016/j.jsbmb.2006.12.096; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; Feron F, 2005, BRAIN RES BULL, V65, P141, DOI 10.1016/j.brainresbull.2004.12.007; Ferraro L, 2007, BRAIN RES REV, V55, P144, DOI 10.1016/j.brainresrev.2007.03.006; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Joseph MH, 2003, NEUROSCI BIOBEHAV R, V27, P527, DOI 10.1016/j.neubiorev.2003.09.001; Kapur S, 2003, PROG NEURO-PSYCHOPH, V27, P1081, DOI 10.1016/j.pnpbp.2003.09.004; Kesby JP, 2006, BIOL PSYCHIAT, V60, P591, DOI 10.1016/j.biopsych.2006.02.033; Ko P, 2004, DEV BRAIN RES, V153, P61, DOI 10.1016/j.devbrainres.2004.07.013; Kyosseva SV, 2004, PROG NEURO-PSYCHOPH, V28, P997, DOI 10.1016/j.pnpbp.2004.05.017; Lauer M, 2001, J NEURAL TRANSM, V108, P645, DOI 10.1007/s007020170042; Lee BD, 2007, PSYCHIAT RES, V150, P1, DOI 10.1016/j.psychres.2006.06.001; Lewis DA, 2007, INT REV NEUROBIOL, V78, P109, DOI 10.1016/S0074-7742(06)78004-7; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; McGrath J, 1999, SCHIZOPHR RES, V40, P173, DOI 10.1016/S0920-9964(99)00052-3; MEREDITH GE, 2008, BRAIN STRUCTURE FUNC; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; O'Loan J, 2007, PSYCHONEUROENDOCRINO, V32, P227, DOI 10.1016/j.psyneuen.2006.12.006; Oliveira V, 2005, FEBS J, V272, P2978, DOI 10.1111/j.1742-4658.2005.04692.x; Paspalas CD, 2006, EUR J NEUROSCI, V24, P1395, DOI 10.1111/j.1460-9568.2006.05023.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Prensa L, 2003, J COMP NEUROL, V460, P345, DOI 10.1002/cne.10627; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Saha S, 2006, ACTA PSYCHIAT SCAND, V114, P36, DOI 10.1111/j.1600-0447.2005.00742.x; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; SCORRANO L, 2007, NOVART FDN SYMP, V287, P55; Scorrano Luca, 2007, Novartis Found Symp, V287, P47; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thompson TL, 1997, NEUROSCI LETT, V229, P145, DOI 10.1016/S0304-3940(97)00450-3; Vawter MP, 2004, NEUROCHEM RES, V29, P1245, DOI 10.1023/B:NERE.0000023611.99452.47; Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Zhou WX, 2002, MOL BRAIN RES, V100, P75, DOI 10.1016/S0169-328X(02)00134-1	50	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2383	10.1371/journal.pone.0002383	http://dx.doi.org/10.1371/journal.pone.0002383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545652	Green Submitted, Green Published, gold			2022-12-25	WOS:000263248800022
J	Asprodites, N; Zheng, L; Geng, D; Velasco-Gonzalez, C; Sanchez-Perez, L; Davila, E				Asprodites, Nicole; Zheng, Liqin; Geng, Degui; Velasco-Gonzalez, Cruz; Sanchez-Perez, Luis; Davila, Eduardo			Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity	FASEB JOURNAL			English	Article						T cell activation; costimulation; immunotherapy	TOLL-LIKE RECEPTORS; CELL-ACTIVATION; RHEUMATOID-ARTHRITIS; DIFFERENTIAL ROLES; DENDRITIC CELLS; CANCER-THERAPY; IFN-GAMMA; ANTIGEN; TLR2; EXPRESSION	Toll-like receptors (TLRs) are among the fundamental molecules that alert the immune system to the presence of an infection by recognizing pathogen-associated molecules. Much of our understanding regarding TLR function stems from the study of innate immune cells. Recent studies by several groups, including ours, have shown that TLRs can function as costimulatory receptors for antigen-specific T cells, resulting in enhanced T-cell survival and increased expression of effector molecules. We report that the ligation of the TLR1/2 heterodimer on OT-1 cytotoxic T-lymphocytes (CTL) but not TLR2(-/-)OT-1 T cells increased cytolytic activity in vitro and in vivo. On the basis of these data, we tested the hypothesis that TLR1/2 stimulation on CTLs would enhance antitumor activity in a therapeutic model of B16-Ova melanoma. Adoptive OT-1 T-cell transfer into wild-type and MyD88(-/-) mice, followed by injection with TLR1/2 ligand, resulted in a synergistic antitumor effect, which correlated with the induction of CD8 T cells specific to various tumor antigens. In contrast, mice receiving TLR2-/-OT-1 T cells and TLR1/2 ligand showed minimal therapeutic efficacy. These findings emphasize the physiological significance of TLR2 engagement on CTLs and could make possible new approaches for the development of effective immunotherapies by manipulating TLR signaling within CTLs.	[Davila, Eduardo] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA; [Asprodites, Nicole; Zheng, Liqin; Geng, Degui; Davila, Eduardo] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Velasco-Gonzalez, Cruz] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA 70112 USA; [Sanchez-Perez, Luis] Duke Univ, Med Ctr, Durham, NC USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Duke University	Davila, E (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, CSRB Rm 454,533 Bolivar, New Orleans, LA 70112 USA.	edavil@lsuhsc.edu			National Institutes of Health Center for Biomedical Research Center Excellence [1P20 RR021970]; Louisiana Cancer Research Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021970] Funding Source: NIH RePORTER	National Institutes of Health Center for Biomedical Research Center Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Cancer Research Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Research was supported by at National Institutes of Health Center for Biomedical Research Center Excellence grant (1P20 RR021970) and the Louisiana Cancer Research Consortium. The authors declare no competing financial interests.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Bendigs S, 1999, EUR J IMMUNOL, V29, P1209, DOI 10.1002/(SICI)1521-4141(199904)29:04<1209::AID-IMMU1209>3.0.CO;2-J; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Cottalorda A, 2006, EUR J IMMUNOL, V36, P1684, DOI 10.1002/eji.200636181; Davila E, 2000, J IMMUNOL, V165, P539, DOI 10.4049/jimmunol.165.1.539; Davila E, 2005, J IMMUNOL, V174, P7292, DOI 10.4049/jimmunol.174.11.7292; Davila E, 2003, CANCER RES, V63, P3281; Davila E, 2002, BLOOD, V100, P2537, DOI 10.1182/blood-2002-02-0401; Dudley ME, 2003, NAT REV CANCER, V3, P666, DOI 10.1038/nrc1167; Dudley ME, 2001, J IMMUNOTHER, V24, P363, DOI 10.1097/00002371-200107000-00012; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gelman AE, 2006, IMMUNITY, V25, P783, DOI 10.1016/j.immuni.2006.08.023; Ghosh TK, 2006, CELL IMMUNOL, V243, P48, DOI 10.1016/j.cellimm.2006.12.002; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Ingalls RR, 2000, J ENDOTOXIN RES, V6, P411, DOI 10.1177/09680519000060050301; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jahrsdorfer B, 2002, J LEUKOCYTE BIOL, V72, P83; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; Leen AM, 2007, ANNU REV IMMUNOL, V25, P243, DOI 10.1146/annurev.immunol.25.022106.141527; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lugo-Villarino G, 2005, P NATL ACAD SCI USA, V102, P13248, DOI 10.1073/pnas.0506638102; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; Matsuguchi T, 2000, BLOOD, V95, P1378, DOI 10.1182/blood.V95.4.1378.004k08_1378_1385; Mokuno Y, 2000, J IMMUNOL, V165, P931, DOI 10.4049/jimmunol.165.2.931; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Prins RM, 2006, J IMMUNOL, V176, P157, DOI 10.4049/jimmunol.176.1.157; Ronaghy A, 2002, J IMMUNOL, V168, P51, DOI 10.4049/jimmunol.168.1.51; Schwarz K, 2003, EUR J IMMUNOL, V33, P1465, DOI 10.1002/eji.200323919; Sobek V, 2004, ARTHRITIS RES THER, V6, pR433, DOI 10.1186/ar1212; Tabiasco J, 2006, J IMMUNOL, V177, P8708, DOI 10.4049/jimmunol.177.12.8708; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Terato K, 1995, AUTOIMMUNITY, V22, P137, DOI 10.3109/08916939508995311; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; Yi AK, 1996, J IMMUNOL, V157, P4918; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje; Zhang T, 2004, FASEB J, V18, P600, DOI 10.1096/fj.03-0881fje; Zheng LQ, 2008, BLOOD, V111, P2704, DOI 10.1182/blood-2007-07-104141	49	66	68	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3628	3637		10.1096/fj.08-108274	http://dx.doi.org/10.1096/fj.08-108274			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18587008	Green Published			2022-12-25	WOS:000259642600024
J	Korkaya, H; Paulson, A; Iovino, F; Wicha, MS				Korkaya, H.; Paulson, A.; Iovino, F.; Wicha, M. S.			HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion	ONCOGENE			English	Article						breast cancer; cancer stem cells; HER2; PI3-K/Akt pathway; ALDH	BREAST-CANCER CELLS; STEM-CELLS; TRASTUZUMAB RESISTANCE; SELF-RENEWAL; IN-VITRO; GENE; AMPLIFICATION; HERCEPTIN; CARCINOMA; PATHWAY	The cancer stem cell hypothesis proposes that cancers arise in stem/progenitor cells through disregulation of self-renewal pathways generating tumors, which are driven by a component of 'tumor-initiating cells' retaining stem cell properties. The HER2 gene is amplified in 20-30% of human breast cancers and has been implicated in mammary tumorigenesis as well as in mediating aggressive tumor growth and metastasis. We demonstrate that HER2 overexpression drives mammary carcinogenesis, tumor growth and invasion through its effects on normal and malignant mammary stem cells. HER2 overexpression in normal mammary epithelial cells (NMEC) increases the proportion of stem/progenitor cells as demonstrated by in vitro mammosphere assays and the expression of stem cell marker aldehyde dehydrogenase (ALDH) as well as by generation of hyperplastic lesions in humanized fat pads of NOD (nucleotide-binding oligomerization domain)/SCID (severe combined immunodeficient) mice. Overexpression of HER2 in a series of breast carcinoma cell lines increases the ALDH-expressing 'cancer stem cell' population which displays increased expression of stem cell regulatory genes, increased invasion in vitro and increased tumorigenesis in NOD/SCID mice. The effects of HER2 overexpression on breast cancer stem cells are blocked by trastuzumab in sensitive, but not resistant, cell lines, an effect mediated by the PI3-kinase/Akt pathway. These studies provide support for the cancer stem cell hypothesis by suggesting that the effects of HER2 amplification on carcinogenesis, tumorigenesis and invasion may be due to its effects on normal and malignant mammary stem/progenitor cells. Furthermore, the clinical efficacy of trastuzumab may relate to its ability to target the cancer stem cell population in HER2-amplified tumors.	[Korkaya, H.; Paulson, A.; Iovino, F.; Wicha, M. S.] Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Korkaya, H (corresponding author), Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, 1500 E Med Ctr Dr,7110 CCGC, Ann Arbor, MI 48109 USA.	hkorkaya@med.umich.edu	Korkaya, Hasan/C-2201-2009; Iovino, Flora/K-8834-2016; Wicha, Max/AAE-7268-2019; Korkaya, Hasan/GRY-1016-2022; Korkaya, Hasan/ABD-6282-2020	Iovino, Flora/0000-0002-6374-5582; Korkaya, Hasan/0000-0002-0719-5862; Paulson, Amanda/0000-0003-3118-4618	NIH [CA129765, CA101860]; University of Michigan Cancer Center NIH [5 P 30 CA46592]; Taubman Institute; NATIONAL CANCER INSTITUTE [R01CA101860, R01CA129765, P30CA046592] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Center NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taubman Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Dr Thomas Giordano and the University of Michigan Cancer Center Flow Cytometry core for their assistance, Dr Bruce Boman, Dr Emmanuelle Charafe-Jauffret, Dr Gabriela Dontu, Dr Suling Liu and Dr Christophe Ginestier for their advice and critical review of this manuscript. The HER2 construct is a generous gift from Dr Ignatoski. This work was supported by NIH Grants CA129765 and CA101860 and in part by the University of Michigan Cancer Center NIH support Grant 5 P 30 CA46592 and by the Taubman Institute.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ALLRED DC, 1994, BREAST CANCER RES TR, V32, P13, DOI 10.1007/BF00666202; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Beuzeboc P, 1999, B CANCER, V86, P544; Burstein HJ, 2001, J CLIN ONCOL, V19, P2722, DOI 10.1200/JCO.2001.19.10.2722; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Korkaya H, 2007, BIODRUGS, V21, P299, DOI 10.2165/00063030-200721050-00002; Kucab JE, 2005, BREAST CANCER RES, V7, pR796, DOI 10.1186/bcr1294; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Miller KD, 2004, ONCOLOGIST, V9, P16, DOI 10.1634/theoncologist.9-suppl_3-16; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; Park K, 2006, HISTOPATHOLOGY, V48, P702, DOI 10.1111/j.1365-2559.2006.02403.x; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Seidman AD, 2001, J CLIN ONCOL, V19, P2587, DOI 10.1200/JCO.2001.19.10.2587; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Tanner M, 2004, MOL CANCER THER, V3, P1585; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Welham MJ, 2007, BIOCHEM SOC T, V35, P225, DOI 10.1042/BST0350225; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Xu RL, 2002, MODERN PATHOL, V15, P116, DOI 10.1038/modpathol.3880503	31	425	456	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2008	27	47					6120	6130		10.1038/onc.2008.207	http://dx.doi.org/10.1038/onc.2008.207			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	360UJ	18591932	Green Submitted, Green Accepted, Bronze, Green Published			2022-12-25	WOS:000260083100005
J	Arachiche, A; Augereau, O; Decossas, M; Pertuiset, C; Gontier, E; Letellier, T; Dachary-Prigent, J				Arachiche, Amal; Augereau, Olivier; Decossas, Marion; Pertuiset, Claire; Gontier, Etienne; Letellier, Thierry; Dachary-Prigent, Jeanne			Localization of PTP-1B, SHP-2, and Src exclusively in rat brain mitochondria and functional consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT TYROSINE PHOSPHORYLATION; OXIDATIVE-PHOSPHORYLATION; PROTEIN-KINASE; COMPLEX-I; CAMP; PHOSPHATASE; HEART; IDENTIFICATION	An immunodetection study of protein tyrosine phosphatase 1B (PTP-1B), SHP-2, and Src in isolated mitochondria from different rat tissues (brain, muscle, heart, liver, and kidney) revealed their exclusive localization in the brain. Given this result, we sought whether mitochondria respond to ATP and to the general tyrosine phosphatase inhibitor orthovanadate and found little or no change in the tyrosine phosphorylation profile of mitochondria from muscle, heart, liver, and kidney. In contrast, ATP induced an enhancement in the tyrosine-phosphorylated protein profile of brain mitochondria, which was further greatly enhanced with orthovanadate and which disappeared when Src was inhibited with two inhibitors: PP2 and PP1. Importantly, we found that in brain mitochondria, ATP addition induced Src autophosphorylation at Tyr-416 in its catalytic site, leading to its activation, whereas the regulatory Tyr-527 site remained unphosphorylated. Functional implications were addressed by measurements of the enzymatic activity of each of the oxidative phosphorylation complexes in brain mitochondria in the presence of ATP. We found an increase in complex I, III, and IV activity and a decrease in complex V activity, partially reversed by Src inhibition, demonstrating that the complexes are Src substrates. These results complemented and reinforced our initial study showing that respiration of brain mitochondria was partially dependent on tyrosine phosphorylation. Therefore, the present data suggest a possible control point in the regulation of respiration by tyrosine phosphorylation of the complexes mediated by Src auto-activation.	[Arachiche, Amal; Augereau, Olivier; Pertuiset, Claire; Letellier, Thierry; Dachary-Prigent, Jeanne] Univ Bordeaux 2, INSERM Physiopathol Mitochondriale U688, F-33076 Bordeaux, France; [Decossas, Marion; Gontier, Etienne] Univ Bordeaux 2, Pole Microscopie Elect, Serv Commun Microscopie, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Dachary-Prigent, J (corresponding author), Univ Bordeaux 2, INSERM Physiopathol Mitochondriale U688, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	jeanne.dachary@u-bordeaux2.fr		decossas, marion/0000-0003-0810-4309	INSERM; Universite Victor Segalen-Bordeaux 2; Fondation de France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Victor Segalen-Bordeaux 2; Fondation de France(Fondation de France)	This work was supported in part by grants from INSERM, the Universite Victor Segalen-Bordeaux 2, and the Fondation de France.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Augereau O, 2005, CELL MOL LIFE SCI, V62, P1478, DOI 10.1007/s00018-005-5005-7; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Benard G, 2008, INT J BIOCHEM CELL B, V40, P1543, DOI 10.1016/j.biocel.2007.11.023; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; CLARK JB, 1970, J BIOL CHEM, V245, P4724; Devin A, 2007, AM J PHYSIOL-CELL PH, V292, pC52, DOI 10.1152/ajpcell.00208.2006; Di Pancrazio F, 2006, PROTEOMICS, V6, P921, DOI 10.1002/pmic.200500077; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; JOHNSON D, 1958, NATURE, V181, P701, DOI 10.1038/181701a0; JUMELLELACLAU M, 1993, BIOCHIM BIOPHYS ACTA, V1141, P90, DOI 10.1016/0005-2728(93)90193-J; Kipp JL, 2001, ENDOCRINE, V15, P165, DOI 10.1385/ENDO:15:2:165; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Lewandrowski U, 2008, FEBS LETT, V582, P1104, DOI 10.1016/j.febslet.2008.02.077; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; MORGANHUGHES JA, 1990, BIOCHIM BIOPHYS ACTA, V1018, P217, DOI 10.1016/0005-2728(90)90252-Y; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Papa S, 2002, BIOSCIENCE REP, V22, P3, DOI 10.1023/A:1016004921277; RIMOLDI M, 1982, J NEUROL, V227, P201, DOI 10.1007/BF00313387; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045; Salvi M, 2005, FREE RADICAL BIO MED, V38, P1267, DOI 10.1016/j.freeradbiomed.2005.02.006; Salvi M, 2004, CELL MOL LIFE SCI, V61, P2393, DOI 10.1007/s00018-004-4211-z; Salvi M, 2002, BBA-MOL CELL RES, V1589, P181, DOI 10.1016/S0167-4889(02)00174-X; Sardanelli AM, 1995, FEBS LETT, V377, P470, DOI 10.1016/0014-5793(95)01407-1; SOLAINI G, 1993, EUR J BIOCHEM, V214, P729, DOI 10.1111/j.1432-1033.1993.tb17974.x; Sun GQ, 1998, ONCOGENE, V17, P1587, DOI 10.1038/sj.onc.1202076; TECHNIKOVADOBROVA Z, 1994, FEBS LETT, V350, P187, DOI 10.1016/0014-5793(94)00760-8	34	59	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24406	24411		10.1074/jbc.M709217200	http://dx.doi.org/10.1074/jbc.M709217200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18583343	hybrid, Green Published			2022-12-25	WOS:000258820000015
J	He, YW; Hryciw, DH; Carroll, ML; Myers, SA; Whitbread, AK; Kumar, S; Poronnik, P; Hooper, JD				He, Yaowu; Hryciw, Deanne H.; Carroll, Melanie L.; Myers, Stephen A.; Whitbread, Astrid K.; Kumar, Sharad; Poronnik, Philip; Hooper, John D.			The ubiquitin-protein ligase Nedd4-2 differentially interacts with and regulates members of the Tweety family of chloride ion channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; MELANOGASTER GENE TWEETY; SODIUM-CHANNEL; ALBUMIN UPTAKE; HUMAN HOMOLOG; WW DOMAINS; ENAC; CELLS; DEGRADATION; ENDOCYTOSIS	The Tweety proteins comprise a family of chloride ion channels with three members identified in humans (TTYH1-3) and orthologues in fly and murine species. In humans, increased TTYH2 expression is associated with cancer progression, whereas fly Tweety is associated with developmental processes. Structurally, Tweety proteins are characterized by five membranespanning domains and N-glycan modifications important for trafficking to the plasma membrane, where these proteins are oriented with the amino terminus located extracellularly and the carboxyl terminus cytoplasmically. In addition to N-glycosylation, ubiquitination mediated by the HECT type E3 ubiquitin ligase Nedd4-2 is a post-translation modification important in regulating membrane proteins. In the present study, we performed a comprehensive analysis of the ability of each of TTYH1-3 to interact with Nedd4-2 and to be ubiquitinated and regulated by this ligase. Our data indicate that Nedd4-2 binds to two family members, TTYH2 and TTYH3, which contain consensus PY ((L/P)PXY) binding sites for HECT type E3 ubiquitin ligases, but not to TTYH1, which lacks this motif. Consistently, Nedd4-2 ubiquitinates both TTYH2 and TTYH3. Importantly, we have shown that endogenous TTYH2 and Nedd4-2 are binding partners and demonstrated that the TTYH2PY motif is essential for these interactions. We have also shown that Nedd4-2-mediated ubiquitination of TTYH2 is a critical regulator of cell surface and total cellular levels of this protein. These data, indicating that Nedd4-2 differentially interacts with and regulates TTYH1-3, will be important for understanding mechanisms controlling Tweety proteins in physiology and disease.	[He, Yaowu; Carroll, Melanie L.; Myers, Stephen A.; Whitbread, Astrid K.; Hooper, John D.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [He, Yaowu; Carroll, Melanie L.; Myers, Stephen A.; Whitbread, Astrid K.; Hooper, John D.] Queensland Univ Technol, Sch Life Sci, Kelvin Grove, Qld 4059, Australia; [Hryciw, Deanne H.; Poronnik, Philip] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Kumar, Sharad] Inst Med & Vet Sci, Hanson Inst, Adelaide, SA 5000, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Queensland; Hanson Institute; Institute Medical & Veterinary Science Australia	Hooper, JD (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Corner Musk Ave & Blamey St, Kelvin Grove, Qld 4059, Australia.	jd.hooper@qut.edu.au	Hooper, John/C-1481-2016; Kumar, Sharad/AAX-7787-2020; Hryciw, Deanne/P-2642-2019	Hooper, John/0000-0003-1054-8486; Kumar, Sharad/0000-0001-7126-9814; Hryciw, Deanne/0000-0003-1697-8890; Whitbread, Astrid/0000-0003-2307-9252; HE, Yaowu/0000-0002-7828-263X; Poronnik, Philip/0000-0002-6246-528X; Myers, Stephen/0000-0003-4793-3820	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council of Australia grants (to J.D.H., P.P., and S.K.) and a fellowship (to J.D.H.) and Australian Research Council grants ( to P. P. and S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Campbell HD, 2000, GENOMICS, V68, P89, DOI 10.1006/geno.2000.6259; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Devuyst Olivier, 2005, Nephron Physiology, V99, P69; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; He YW, 2008, BIOCHEM J, V412, P45, DOI 10.1042/BJ20071722; Hooper JD, 1999, CANCER RES, V59, P3199; Hryciw DH, 2006, INT J BIOCHEM CELL B, V38, P1036, DOI 10.1016/j.biocel.2005.09.009; Hryciw DH, 2003, J BIOL CHEM, V278, P40169, DOI 10.1074/jbc.M307890200; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Maleszka R, 1996, P NATL ACAD SCI USA, V93, P447, DOI 10.1073/pnas.93.1.447; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Miller JH, 2003, BIOPHYS J, V84, P2781, DOI 10.1016/S0006-3495(03)75082-6; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nath D, 1999, J CELL SCI, V112, P579; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Rae FK, 2001, GENOMICS, V77, P200, DOI 10.1006/geno.2001.6629; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Simon P, 2007, CELL PHYSIOL BIOCHEM, V20, P715, DOI 10.1159/000110432; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Suzuki M, 2004, J BIOL CHEM, V279, P22461, DOI 10.1074/jbc.M313813200; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; Toiyama Y, 2007, WORLD J GASTROENTERO, V13, P2717, DOI 10.3748/wjg.v13.i19.2717; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Yip PM, 1998, MOL BIOL CELL, V9, P277, DOI 10.1091/mbc.9.2.277; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	47	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24000	24010		10.1074/jbc.M803361200	http://dx.doi.org/10.1074/jbc.M803361200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577513	Green Published, hybrid			2022-12-25	WOS:000258638900056
J	Pyarajan, S; Matejovic, G; Pratt, JC; Baksh, S; Burakoff, SJ				Pyarajan, Saiju; Matejovic, Gabriel; Pratt, Joanne C.; Baksh, Shairaz; Burakoff, Steven J.			Interleukin-3 (IL-3)-induced c-fos activation is modulated by gab2-calcineurin interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAFFOLDING ADAPTER GAB2; BINDING-PROTEINS; HEMATOPOIETIC-CELLS; DOCKING PROTEIN; BREAST-CANCER; CA2+ INFLUX; CALCINEURIN; PATHWAY; PROLIFERATION; EXPRESSION	Interleukin-3 (IL-3) regulates cell growth by affecting various processes such as cell death, survival, and proliferation. Cues from the external environment are sensed by surface receptors, and complex signaling mechanisms arise within the cells, leading to specific functional outcomes. In this study, we demonstrate that the cytokine IL-3 induces the activation of the Ca2+-dependent phosphatase, calcineurin (Cn). Furthermore Cn dephosphorylates Gab2, resulting in c-fos activation and cell proliferation. We also report that there is a direct interaction between Cn and Gab2 upon IL-3 stimulation, and Akt can regulate this interaction.	[Pyarajan, Saiju; Matejovic, Gabriel; Burakoff, Steven J.] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Baksh, Shairaz] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2N8, Canada	New York University; University of Alberta	Pyarajan, S (corresponding author), Mt Sinai Sch Med, 1 Gustave L Levy Pl,Box 1130, New York, NY 10029 USA.	saiju.pyarajan@mssm.edu	Baksh, Shairaz/GRX-2106-2022					Baksh S, 2000, SEMIN IMMUNOL, V12, P405, DOI 10.1006/smim.2000.0221; Baksh S, 2000, ONCOGENE, V19, P2820, DOI 10.1038/sj.onc.1203585; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Daly RJ, 2002, ONCOGENE, V21, P5175, DOI 10.1038/sj.onc.1205522; Dorsey JF, 2002, BLOOD, V99, P1388, DOI 10.1182/blood.V99.4.1388; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Gu HH, 1997, J BIOL CHEM, V272, P16421, DOI 10.1074/jbc.272.26.16421; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Li SL, 1996, J MOL ENDOCRINOL, V16, P229, DOI 10.1677/jme.0.0160229; Liu JO, 2003, BIOCHEM BIOPH RES CO, V311, P1103, DOI 10.1016/j.bbrc.2003.10.020; Lynch DK, 2002, EMBO J, V21, P72, DOI 10.1093/emboj/21.1.72; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Miyakawa Y, 2001, J BIOL CHEM, V276, P2494, DOI 10.1074/jbc.M002633200; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Palaga T, 2004, INT IMMUNOPHARMACOL, V4, P953, DOI 10.1016/j.intimp.2004.04.006; Pratt JC, 2000, J IMMUNOL, V165, P4158, DOI 10.4049/jimmunol.165.8.4158; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yao XQ, 1999, LIFE SCI, V65, P55, DOI 10.1016/S0024-3205(99)00218-0; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Zhang Y, 2007, BLOOD, V110, P116, DOI 10.1182/blood-2006-11-060707	29	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23505	23509		10.1074/jbc.C800087200	http://dx.doi.org/10.1074/jbc.C800087200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586679	hybrid, Green Published			2022-12-25	WOS:000258638900002
J	Rodius, S; Chaloin, O; Moes, M; Schaffner-Reckinger, E; Landrieu, I; Lippens, G; Lin, MH; Zhang, J; Kieffer, N				Rodius, Sophie; Chaloin, Olivier; Moes, Michele; Schaffner-Reckinger, Elisabeth; Landrieu, Isabelle; Lippens, Guy; Lin, Minghui; Zhang, Ji; Kieffer, Nelly			The Talin rod IBS2 alpha-helix interacts with the beta 3 integrin cytoplasmic tail membrane-proximal helix by establishing charge complementary salt bridges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VINCULIN-BINDING-SITE; TYROSINE PHOSPHORYLATION; FOCAL ADHESIONS; ACTININ BINDING; DOMAIN; ACTIVATION; PROTEINS; IDENTIFICATION; BETA(3); ALPHA(IIB)BETA(3)	Talin establishes a major link between integrins and actin filaments and contains two distinct integrin binding sites: one, IBS1, located in the talin head domain and involved in integrin activation and a second, IBS2, that maps to helix 50 of the talin rod domain and is essential for linking integrin beta subunits to the cytoskeleton (Moes, M., Rodius, S., Coleman, S. J., Monkley, S. J., Goormaghtigh, E., Tremuth, L., Kox, C., van der Holst, P. P., Critchley, D. R., and Kieffer, N. ( 2007) J. Biol. Chem. 282, 17280 17288). Through the combined approach of mutational analysis of the beta 3 integrin cytoplasmic tail and the talin rod IBS2 site, SPR binding studies, as well as site-specific antibody inhibition experiments, we provide evidence that the integrin beta 3-talin rod interaction relies on a helix-helix association between alpha-helix 50 of the talin rod domain and the membrane-proximal alpha-helix of the beta 3 integrin cytoplasmic tail. Moreover, charge complementarity between the highly conserved talin rod IBS2 lysine residues and integrin beta 3 glutamic acid residues is necessary for this interaction. Our results support a model in which talin IBS2 binds to the same face of the beta 3 subunit cytoplasmic helix as the integrin alpha IIb cytoplasmic tail helix, suggesting that IBS2 can only interact with the beta 3 subunit following integrin activation.	[Lin, Minghui; Zhang, Ji; Kieffer, Nelly] Shanghai Jiao Tong Univ, CNRS LIS124, RuiJin Hosp, French Chinese Res Ctr Life Sci & Genom, Shanghai 200025, Peoples R China; [Rodius, Sophie; Moes, Michele; Schaffner-Reckinger, Elisabeth; Kieffer, Nelly] Univ Luxembourg, CNRS, GDRE ITI, Lab Biol & Physiol Integree, L-1511 Luxembourg, Luxembourg; [Chaloin, Olivier] Inst Biol Mol & Cellulaire, CNRS, UPR 9021, F-67084 Strasbourg, France; [Landrieu, Isabelle; Lippens, Guy] Univ Lille 1, Unite Glycobiol Struct & Fonct, CNRS, UMR 8576, F-59655 Villeneuve Dascq, France	Shanghai Jiao Tong University; University of Luxembourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Kieffer, N (corresponding author), Shanghai Jiao Tong Univ, CNRS LIS124, RuiJin Hosp, French Chinese Res Ctr Life Sci & Genom, Shanghai 200025, Peoples R China.	nkieffer@pt.lu	Landrieu, Isabelle/AAF-8495-2019	Landrieu, Isabelle/0000-0002-4883-2637; Lippens, Guy/0000-0002-8236-0901	EU Marie Curie Research Training Network; HPRN-CT-2002-00253; Fondation Luxembourgeoise contre le Cancer ( Luxembourg); University of Luxembourg	EU Marie Curie Research Training Network(European Commission); HPRN-CT-2002-00253; Fondation Luxembourgeoise contre le Cancer ( Luxembourg); University of Luxembourg	This work was supported in part by funds from the EU Marie Curie Research Training Network (EC project HPRN-CT-2002-00253), the Fondation Luxembourgeoise contre le Cancer ( Luxembourg), and the University of Luxembourg. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Altmann SM, 2002, STRUCTURE, V10, P1085, DOI 10.1016/S0969-2126(02)00808-0; Bass MD, 2002, BIOCHEM J, V362, P761, DOI 10.1042/0264-6021:3620761; Bodeau AL, 2001, J CELL SCI, V114, P2795; Brett TJ, 2006, NAT STRUCT MOL BIOL, V13, P121, DOI 10.1038/nsmb1043; Broderick MJF, 2002, J STRUCT BIOL, V137, P184, DOI 10.1006/jsbi.2002.4465; BURRIDGE K, 1983, CELL MOTIL CYTOSKEL, V3, P405, DOI 10.1002/cm.970030509; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Craig SW, 1996, CURR OPIN CELL BIOL, V8, P74, DOI 10.1016/S0955-0674(96)80051-2; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Giancotti FG, 2000, NAT CELL BIOL, V2, pE13, DOI 10.1038/71397; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; KROEMKER M, 1994, FEBS LETT, V355, P259, DOI 10.1016/0014-5793(94)01216-4; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; Liu SC, 2000, J CELL SCI, V113, P3563; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; MCGREGOR A, 1994, BIOCHEM J, V301, P225, DOI 10.1042/bj3010225; Moes M, 2007, J BIOL CHEM, V282, P17280, DOI 10.1074/jbc.M611846200; OTEY CA, 1993, J BIOL CHEM, V268, P21193; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Pierce MM, 2005, BIOCHEMISTRY-US, V44, P321, DOI 10.1021/bi047964d; Reddy KB, 1998, J BIOL CHEM, V273, P35039, DOI 10.1074/jbc.273.52.35039; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Tremuth L, 2004, J BIOL CHEM, V279, P22258, DOI 10.1074/jbc.M400947200; Ulmer TS, 2003, BIOCHEMISTRY-US, V42, P8307, DOI 10.1021/bi034384s; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Woodside DG, 2002, J BIOL CHEM, V277, P39401, DOI 10.1074/jbc.M207657200; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Ylanne Jari, 2001, Cell Mol Biol Lett, V6, P234; Zhao RY, 2004, ARCH IMMUNOL THER EX, V52, P348	43	46	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24212	24223		10.1074/jbc.M709704200	http://dx.doi.org/10.1074/jbc.M709704200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577523	hybrid, Green Published			2022-12-25	WOS:000258638900075
J	Camacho, M; Machado, JD; Alvarez, J; Borges, R				Camacho, Marcial; Machado, Jose D.; Alvarez, Javier; Borges, Ricardo			Intravesicular calcium release mediates the motion and exocytosis of secretory organelles - A study with adrenal chromaffin cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; H+-ATPASE; GRANULES; VESICLES; CATECHOLAMINES; INHIBITORS; BINDING; STORAGE; CHROMOGRANINS; BAFILOMYCINS	Secretory vesicles of sympathetic neurons and chromaffin granules maintain a pH gradient toward the cytosol (pH 5.5 versus 7.2) promoted by the V-ATPase activity. This gradient of pH is also responsible for the accumulation of amines and Ca2+ because their transporters use H+ as the counter ion. We have recently shown that alkalinization of secretory vesicles slowed down exocytosis, whereas acidification caused the opposite effect. In this paper, we measure the alkalinization of vesicular pH, caused by the V-ATPase inhibitor bafilomycin A1, by total internal reflection fluorescence microscopy in cells overexpressing the enhanced green fluorescent protein-labeled synaptobrevin (VAMP2-EGFP) protein. The disruption of the vesicular gradient of pH caused the leak of Ca2+, measured with fura-2. Fluorimetric measurements, using the dye Oregon green BAPTA-2, showed that bafilomycin directly released Ca2+ from freshly isolated vesicles. The Ca2+ released from vesicles to the cytosol dramatically increased the granule motion of chromaffin- or PC12-derived granules and triggered exocytosis (measured by amperometry). We conclude that the gradient of pH of secretory vesicles might be involved in the homeostatic regulation of cytosolic Ca2+ and in two of the major functions of secretory cells, vesicle motion and exocytosis.	[Camacho, Marcial; Machado, Jose D.; Borges, Ricardo] Univ La Laguna, Unidad Farmacol, Fac Med, E-38071 San Cristobal la Laguna, Spain; [Alvarez, Javier] Inst Biol & Genet Mol, E-47005 Valladolid, Spain	Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM)	Machado, JD (corresponding author), Univ La Laguna, Unidad Farmacol, Fac Med, E-38071 San Cristobal la Laguna, Spain.	jdmacha@ull.es	Machado, José David/N-5210-2014; Borges, Ricardo/N-3250-2014; Alvarez, Javier/K-8210-2014	Machado, José David/0000-0003-3531-7051; Borges, Ricardo/0000-0003-3413-4392; Alvarez, Javier/0000-0003-0636-5521; Camacho Perez, Marcial/0000-0002-2367-1259				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Allersma MW, 2006, MOL BIOL CELL, V17, P2424, DOI 10.1091/mbc.E05-10-0938; Allersma MW, 2004, MOL BIOL CELL, V15, P4658, DOI 10.1091/mbc.E04-02-0149; BOROWITZ JL, 1967, J CELL PHYSIOL, V69, P311, DOI 10.1002/jcp.1040690307; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Buchanan CM, 2001, BIOCHEM J, V360, P431, DOI 10.1042/0264-6021:3600431; BULENDA D, 1985, BIOCHEMISTRY-US, V24, P7760, DOI 10.1021/bi00347a039; Camacho M, 2006, J NEUROCHEM, V96, P324, DOI 10.1111/j.1471-4159.2005.03526.x; Drose S, 1997, J EXP BIOL, V200, P1; Gagliardi S, 1998, J MED CHEM, V41, P1883, DOI 10.1021/jm9707838; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAIGH JR, 1993, NEUROREPORT, V4, P571, DOI 10.1097/00001756-199305000-00028; HAIGH JR, 1989, BIOCHEM J, V259, P485, DOI 10.1042/bj2590485; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Haynes CL, 2006, BIOPHYS CHEM, V123, P20, DOI 10.1016/j.bpc.2006.04.005; HELLE KB, 1985, ACTA PHYSIOL SCAND, V123, P21, DOI 10.1111/j.1748-1716.1985.tb07556.x; JANKOWSKI JA, 1993, J BIOL CHEM, V268, P14694; JOHANNES L, 1994, EMBO J, V13, P2029, DOI 10.1002/j.1460-2075.1994.tb06476.x; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Machado JD, 2000, J BIOL CHEM, V275, P20274, DOI 10.1074/jbc.M000930200; Machado JD, 2002, CIRC RES, V91, P830, DOI 10.1161/01.RES.0000039530.30495.6F; Mahapatra NR, 2004, J BIOL CHEM, V279, P51107, DOI 10.1074/jbc.M408742200; Moreno A, 2005, CELL CALCIUM, V37, P555, DOI 10.1016/j.ceca.2005.02.002; Mundorf ML, 1999, J NEUROCHEM, V73, P2397, DOI 10.1046/j.1471-4159.1999.0732397.x; Mundorf ML, 2000, J BIOL CHEM, V275, P9136, DOI 10.1074/jbc.275.13.9136; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; Segura F, 2000, J NEUROSCI METH, V103, P151, DOI 10.1016/S0165-0270(00)00309-5; SMITH AD, 1967, BIOCHEM J, V103, P480, DOI 10.1042/bj1030480; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Taupenot L, 2005, J BIOL CHEM, V280, P3885, DOI 10.1074/jbc.M408197200; VIDEEN JS, 1992, J BIOL CHEM, V267, P3066; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WILSON SP, 1995, ANAL BIOCHEM, V226, P212, DOI 10.1006/abio.1995.1216; WINKLER H, 1980, NEUROSCIENCE, V5, P1803, DOI 10.1016/0306-4522(80)90031-7; WINKLER H, 1993, J ANAT, V183, P237; YOO SH, 1991, J BIOL CHEM, V266, P7740	40	43	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22383	22389		10.1074/jbc.M800552200	http://dx.doi.org/10.1074/jbc.M800552200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18562320	hybrid			2022-12-25	WOS:000258321000006
J	Kota, S; Sabbah, A; Chang, TH; Harnack, R; Xiang, Y; Meng, X; Bose, S				Kota, Srikanth; Sabbah, Ahmed; Chang, Te Hung; Harnack, Rosalinda; Xiang, Yan; Meng, Xiangzhi; Bose, Santanu			Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappa B- mediated innate antiviral response against human respiratory syncytial virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG EPITHELIAL-CELLS; MULTIPLE SIGNALING PATHWAYS; INFECTION IN-VITRO; GENE-EXPRESSION; BETA-DEFENSINS; TYPE-3 INFECTION; TRANSCRIPTIONAL REGULATION; ALVEOLAR MACROPHAGES; HEPARAN-SULFATE; RNA VIRUSES	Human respiratory syncytial virus (RSV) constitutes a highly pathogenic virus that infects lung epithelial cells to cause a wide spectrum of respiratory diseases. Our recent studies have revealed the existence of an interferon-alpha/beta-independent, innate antiviral response against RSV that was dependent on activation of NF-kappa B. We demonstrated that NF-kappa B inducing pro-inflammatory cytokines like tumor necrosis factor-alpha(TNF) confers potent antiviral function against RSV in an NF-kappa B-dependent fashion, independent of interferon-alpha/beta. During our efforts to study this pathway, we identified HBD2 (human beta-defensin-2), a soluble secreted cationic protein as an antiviral factor induced during NF-kappa B-dependent innate antiviral activity in human lung epithelial cells. Our results demonstrated that HBD2 is induced by TNF and RSV in an NF-kappa B-dependent manner. Induction of HBD2 in infected cells was mediated by the paracrine/autocrine action of TNF produced upon RSV infection. HBD2 plays a critical role during host defense, because purified HBD2 drastically inhibited RSV infection. We also show that the antiviral mechanism of HBD2 involves blocking of viral cellular entry possibly because of destabilization/disintegration of the viral envelope. The important role of HBD2 in the innate response was also evident from loss of antiviral activity of TNF upon HBD2 silencing by short interfering RNA. The in vivo physiological relevance of HBD2 in host defense was apparent from induction of murine beta-defensin-4 (murine counterpart of HBD2) in lung tissues of RSV-infected mice. Thus, HBD2 functions as an antiviral molecule during NF-kappa B-dependent innate antiviral immunity mediated by the autocrine/paracrine action of TNF.	[Kota, Srikanth; Sabbah, Ahmed; Chang, Te Hung; Harnack, Rosalinda; Xiang, Yan; Meng, Xiangzhi; Bose, Santanu] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Bose, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, 7703 Floyd Curl Dr,MC-7758, San Antonio, TX 78229 USA.	bose@uthscsa.edu		Xiang, Yan/0000-0002-7633-1629	NCI NIH HHS [CA129246] Funding Source: Medline; NIAID NIH HHS [AI069062] Funding Source: Medline; NIDCR NIH HHS [T32-DE14318] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA129246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Arns CW, 2003, BRAZ J MED BIOL RES, V36, P213, DOI 10.1590/S0100-879X2003000200008; Atreya PL, 1999, VIROLOGY, V261, P227, DOI 10.1006/viro.1999.9835; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Basu M, 2006, J GEN VIROL, V87, P2653, DOI 10.1099/vir.0.82039-0; BECKER S, 1991, J IMMUNOL, V147, P4307; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Bitko V, 1997, VIROLOGY, V232, P369, DOI 10.1006/viro.1997.8582; Bohling A, 2006, BIOCHEMISTRY-US, V45, P5663, DOI 10.1021/bi052026e; Bose S, 2004, J VIROL, V78, P8146, DOI 10.1128/JVI.78.15.8146-8158.2004; Bose S, 2003, J INTERF CYTOK RES, V23, P401, DOI 10.1089/107999003322277810; Bose S, 2003, P NATL ACAD SCI USA, V100, P10890, DOI 10.1073/pnas.1832775100; Bose S, 2002, VIROLOGY, V298, P73, DOI 10.1006/viro.2002.1484; Bose S, 2001, J VIROL, V75, P1984, DOI 10.1128/JVI.75.4.1984-1989.2001; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; Brown G, 2002, J GEN VIROL, V83, P611, DOI 10.1099/0022-1317-83-3-611; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; CAMERINIOTERO RD, 1975, EUR J BIOCHEM, V53, P343, DOI 10.1111/j.1432-1033.1975.tb04074.x; Carpenter LR, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-5; Chavez-Bueno S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-46; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; CHIPPS BE, 1993, PEDIATR INFECT DIS J, V12, P653, DOI 10.1097/00006454-199308000-00006; Choudhary S, 2005, J VIROL, V79, P8948, DOI 10.1128/JVI.79.14.8948-8959.2005; COLLINS PL, 2001, FIELDS VIROLOGY, P1443; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; FRANKEULLMANN G, 1995, J IMMUNOL, V154, P268; Garofalo RP, 2000, AM J RESP CELL MOL, V23, P581, DOI 10.1165/ajrcmb.23.5.f204; Garofalo RP, 2001, J INFECT DIS, V184, P393, DOI 10.1086/322788; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Hao HN, 2001, J NEUROCHEM, V77, P1027, DOI 10.1046/j.1471-4159.2001.00305.x; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; Hiratsuka T, 1998, BIOCHEM BIOPH RES CO, V249, P943, DOI 10.1006/bbrc.1998.9239; Jia HP, 2000, J BIOL CHEM, V275, P33314, DOI 10.1074/jbc.M006603200; Krisanaprakornkit S, 2000, INFECT IMMUN, V68, P2907, DOI 10.1128/IAI.68.5.2907-2915.2000; Krisanaprakornkit S, 1998, INFECT IMMUN, V66, P4222; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; LICHTENSTEIN AK, 1988, J IMMUNOL, V140, P2686; McDermott AM, 2003, INVEST OPHTH VIS SCI, V44, P1859, DOI 10.1167/iovs.02-0787; McNamara PS, 2004, EUR RESPIR J, V23, P106, DOI 10.1183/09031936.03.00048103; Mejias A, 2005, ANTIMICROB AGENTS CH, V49, P4700, DOI 10.1128/AAC.49.11.4700-4707.2005; Meng XZ, 2006, VIROLOGY, V353, P220, DOI 10.1016/j.virol.2006.05.032; MEROLLA R, 1995, AM J RESP CRIT CARE, V152, P1358, DOI 10.1164/ajrccm.152.4.7551395; MIDULLA F, 1993, J INFECT DIS, V168, P1515, DOI 10.1093/infdis/168.6.1515; Mineshiba J, 2005, FEMS IMMUNOL MED MIC, V45, P37, DOI 10.1016/j.femsim.2005.01.008; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Neuzil KM, 1996, AM J MED SCI, V311, P201, DOI 10.1097/00000441-199605000-00001; O'Neil DA, 1999, J IMMUNOL, V163, P6718; PANUSKA JR, 1990, AM J PHYSIOL, V259, pL396, DOI 10.1152/ajplung.1990.259.6.L396; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Proud D, 2004, J IMMUNOL, V172, P4637, DOI 10.4049/jimmunol.172.7.4637; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Raj PA, 2002, FEMS MICROBIOL LETT, V206, P9, DOI 10.1111/j.1574-6968.2002.tb10979.x; Rivas-Santiago B, 2005, INFECT IMMUN, V73, P4505, DOI 10.1128/IAI.73.8.4505-4511.2005; Ross DJ, 2004, TRANSPLANTATION, V78, P1222, DOI 10.1097/01.TP.0000137265.18491.75; Sakai S, 1997, J MED VIROL, V53, P145, DOI 10.1002/(SICI)1096-9071(199710)53:2<145::AID-JMV6>3.0.CO;2-9; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Seo SH, 2002, J VIROL, V76, P1071, DOI 10.1128/JVI.76.3.1071-1076.2002; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Sheeran P, 1999, PEDIATR INFECT DIS J, V18, P115, DOI 10.1097/00006454-199902000-00007; Shiba H, 2003, BIOCHEM BIOPH RES CO, V306, P867, DOI 10.1016/S0006-291X(03)01075-1; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Sinha S, 2003, ANTIMICROB AGENTS CH, V47, P494, DOI 10.1128/AAC.47.2.494-500.2003; Soukup JM, 2003, CLIN IMMUNOL, V107, P178, DOI 10.1016/S1521-6616(03)00038-X; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005; Tamura M, 2000, J VIROL, V74, P11589, DOI 10.1128/JVI.74.24.11589-11597.2000; Tomita T, 2002, RESPIROLOGY, V7, P305, DOI 10.1046/j.1440-1843.2002.00415.x; Tsutsumi H, 1999, J LEUKOCYTE BIOL, V66, P99, DOI 10.1002/jlb.66.1.99; Tsutsumi-Ishii Y, 2002, J LEUKOCYTE BIOL, V71, P154; UEBA O, 1978, ACTA MED OKAYAMA, V32, P265; Veldhuizen EJA, 2008, MOL IMMUNOL, V45, P386, DOI 10.1016/j.molimm.2007.06.001; Wietek C, 2007, TRENDS BIOCHEM SCI, V32, P311, DOI 10.1016/j.tibs.2007.05.003; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185	82	96	106	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22417	22429		10.1074/jbc.M710415200	http://dx.doi.org/10.1074/jbc.M710415200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18567888	Green Published, hybrid			2022-12-25	WOS:000258321000010
J	Smerdel-Ramoya, A; Zanotti, S; Deregowski, V; Canalis, E				Smerdel-Ramoya, Anna; Zanotti, Stefano; Deregowski, Valerie; Canalis, Ernesto			Connective tissue growth factor enhances osteoblastogenesis in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MORPHOGENETIC-PROTEIN; TARGET GENE HES-1; TWISTED-GASTRULATION; INHIBITS OSTEOBLASTOGENESIS; SIGNALING PATHWAYS; RNA INTERFERENCE; FACTOR CTGF; DIFFERENTIATION; NOTCH; WNT	Connective tissue growth factor (CTGF), a member of the CCN family of proteins, is expressed by osteoblasts, but its function in cells of the osteoblastic lineage has not been established. We investigated the effects of CTGF overexpression by transducing murine ST-2 stromal cells with a retroviral vector, where CTGF is under the control of the cytomegalovirus promoter. Overexpression of CTGF in ST-2 cells increased alkaline phosphatase activity, osteocalcin and alkaline phosphatase mRNA levels, and mineralized nodule formation. CTGF overexpression decreased the effect of bone morphogenetic protein-2 on Smad 1/5/8 phosphorylation and of Wnt 3 on cytosolic beta-catenin,indicating that the stimulatory effect on osteoblastogenesis was unrelated to BMP and Wnt signaling. CTGF overexpression suppressed Notch signaling and induced the transcription of hairy and E (spl)-1 (HES)-1, by Notch-independent mechanisms. CTGF induced nuclear factor of activated T cells (NFAT) transactivation by a calcineurin-dependent mechanism. Down-regulation of CTGF enhanced Notch signaling and decreased HES-1 transcription and NFAT transactivation. Similar effects were observed following forced CTGF overexpression, the addition of CTGF protein, or the transduction of ST-2 cells with a retroviral vector expressing HES-1. In conclusion, CTGF enhances osteoblastogenesis, possibly by inhibiting Notch signaling and inducing HES-1 transcription and NFAT transactivation.	[Smerdel-Ramoya, Anna; Zanotti, Stefano; Deregowski, Valerie; Canalis, Ernesto] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA; [Canalis, Ernesto] Univ Connecticut, Sch Med, Farmington, CT 06030 USA	Saint Francis Hospital & Medical Center; University of Connecticut	Canalis, E (corresponding author), St Francis Hosp & Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA.	ecanalis@stfranciscare.org	Zanotti, Stefano/C-6006-2009		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR021707, R37AR021707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227, R01DK042424] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR21707, R01 AR021707] Funding Source: Medline; NIDDK NIH HHS [DK42424, R01 DK042424, DK45227] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Brigstock DR, 2003, J CLIN PATHOL-MOL PA, V56, P127, DOI 10.1136/mp.56.2.127; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; Curry CL, 2006, LAB INVEST, V86, P842, DOI 10.1038/labinvest.3700442; DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474, DOI 10.3181/00379727-80-19661; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P3875, DOI 10.1210/en.2005-0053; Gazzerro E, 2006, BONE, V39, P1252, DOI 10.1016/j.bone.2006.06.028; Ghosh-Choudhury Nandini, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P345; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kawaki H, 2008, BIOCHEM BIOPH RES CO, V366, P450, DOI 10.1016/j.bbrc.2007.11.155; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044; Latinkic BV, 2003, DEVELOPMENT, V130, P2429, DOI 10.1242/dev.00449; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Mercurio S, 2004, DEVELOPMENT, V131, P2137, DOI 10.1242/dev.01045; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Nosaka T, 2003, MOL CELL BIOL, V23, P2969, DOI 10.1128/MCB.23.8.2969-2980.2003; Otsuka E, 1999, AM J PHYSIOL-CELL PH, V277, pC132, DOI 10.1152/ajpcell.1999.277.1.C132; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; Pereira RC, 2004, ENDOCRINOLOGY, V145, P1952, DOI 10.1210/en.2003-0868; Pereira RC, 2000, AM J PHYSIOL-ENDOC M, V279, pE570, DOI 10.1152/ajpendo.2000.279.3.E570; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Smerdel-Ramoya A, 2007, J BONE MINER RES, V22, pS51; Stockhausen MT, 2005, EXP CELL RES, V310, P218, DOI 10.1016/j.yexcr.2005.07.011; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; Strom A, 1997, GENE DEV, V11, P3168, DOI 10.1101/gad.11.23.3168; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200	61	41	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22690	22699		10.1074/jbc.M710140200	http://dx.doi.org/10.1074/jbc.M710140200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18583340	Green Published, hybrid			2022-12-25	WOS:000258321000038
J	Stienstra, R; Duval, C; Keshtkar, S; van der Laak, J; Kersten, S; Muller, M				Stienstra, Rinke; Duval, Caroline; Keshtkar, Shohreh; van der Laak, Jeroen; Kersten, Sander; Muller, Michael			Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; INSULIN-RESISTANCE; OBESITY; GENE; DIFFERENTIATION; POLARIZATION; INFLAMMATION; ADIPOCYTES; MUSCLE	Obesity is associated with infiltration of macrophages into adipose tissue. Adipose macrophages may contribute to an elevated inflammatory status by secreting a variety of proinflammatory mediators, including tumor necrosis factor alpha and interleukin-6 (IL-6). Recent data suggest that during diet-induced obesity the phenotypeofadipose-resident macrophages changes from alternatively activated macrophages toward a more classical and pro-inflammatory phenotype. Here, we explore the effect of peroxisome proliferator-activated receptor gamma activation on obesity-induced inflammation in 129SV mice fed a high fat diet for 20 weeks. High fat feeding increased bodyweight gain, adipose tissue mass, and liver triglycerides. Rosiglitazone treatment further increased adipose mass, reduced liver triglycerides, and changed adipose tissue morphology toward smaller adipocytes. Surprisingly, rosiglitazone markedly increased the number of macrophages in adipose tissue, as shown by immunohistochemical analysis and quantification of macrophage marker genes CD68 and F4/80 +. In adipose tissue, markers for classically activated macrophages including IL-18 were down-regulated, whereas markers characteristic for alternatively activated macrophages (arginase 1, IL-10) were up-regulated by rosiglitazone. Importantly, conditioned media from rosiglitazone-treated alternatively activated macrophages neutralized the inhibitory effect of macrophages on 3T3-L1 adipocyte differentiation, suggesting that alternatively activated macrophages may be involved in mediating the effects of rosiglitazone on adipose tissue morphology and mass. Our results suggest that short term rosiglitazone treatment increases infiltration of alternatively activated macrophages in adipose tissue. The alternatively activated macrophages might play a role in peroxisome proliferator-activated receptor gamma-dependent expansion and remodeling of adipose tissue.	[Stienstra, Rinke; Duval, Caroline; Keshtkar, Shohreh; Kersten, Sander; Muller, Michael] Univ Wageningen & Res Ctr, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 EV Wageningen, Netherlands; [Stienstra, Rinke; Duval, Caroline; Keshtkar, Shohreh; Kersten, Sander; Muller, Michael] Top Inst Food & Nutr, Wageningen, Netherlands; [van der Laak, Jeroen] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 GA Nijmegen, Netherlands	Wageningen University & Research; Top Institute Food & Nutrition; Radboud University Nijmegen	Muller, M (corresponding author), Univ Wageningen & Res Ctr, Div Human Nutr, Nutr Metab & Genom Grp, POB 8129, NL-6700 EV Wageningen, Netherlands.	michael.muller@wur.nl	Kersten, Sander/A-1116-2011; van der Laak, Jeroen AWM/D-3057-2015; Muller, Michael/B-5795-2008; Muller, Michael/M-5724-2019; Stienstra, Rinke/A-4763-2015	Kersten, Sander/0000-0003-4488-7734; van der Laak, Jeroen AWM/0000-0001-7982-0754; Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Stienstra, Rinke/0000-0001-6729-7193				Berthiaume M, 2004, AM J PHYSIOL-REG I, V287, pR1116, DOI 10.1152/ajpregu.00339.2004; Bodles AM, 2006, J LIPID RES, V47, P2080, DOI 10.1194/jlr.M600235-JLR200; Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696; Charo IF, 2007, CELL METAB, V6, P96, DOI 10.1016/j.cmet.2007.07.006; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hammarstedt A, 2005, PROSTAG LEUKOTR ESS, V73, P65, DOI 10.1016/j.plefa.2005.04.008; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Koutnikova H, 2003, P NATL ACAD SCI USA, V100, P14457, DOI 10.1073/pnas.2336090100; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Liu XJ, 2005, BIOINFORMATICS, V21, P3637, DOI 10.1093/bioinformatics/bti583; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mandard S, 2007, CELL MOL LIFE SCI, V64, P1145, DOI 10.1007/s00018-007-7006-1; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Oakes ND, 2001, DIABETES, V50, P1158, DOI 10.2337/diabetes.50.5.1158; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Reaven GM, 2006, AM J CLIN NUTR, V83, P1237, DOI 10.1093/ajcn/83.6.1237; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687; Stienstra R, 2007, PPAR RES, V2007, DOI 10.1155/2007/95974; Swain SL, 2001, J EXP MED, V194, pF11, DOI 10.1084/jem.194.3.F11; Tan GD, 2005, DIABETOLOGIA, V48, P83, DOI 10.1007/s00125-004-1619-9; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	32	150	152	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22620	22627		10.1074/jbc.M710314200	http://dx.doi.org/10.1074/jbc.M710314200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18541527	hybrid			2022-12-25	WOS:000258321000031
J	White, UA; Stewart, WC; Mynatt, RL; Stephens, JM				White, Ursula A.; Stewart, William C.; Mynatt, Randall L.; Stephens, Jacqueline M.			Neuropoietin attenuates adipogenesis and induces insulin resistance in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; NECROSIS-FACTOR-ALPHA; CYTOKINE SIGNAL TRANSDUCER; RECEPTOR OB-R; ONCOSTATIN-M; 3T3-L1 ADIPOCYTES; CNTF RECEPTOR; LEPTIN RECEPTOR; TRANSCRIPTIONAL REPRESSION	Recent findings have implicated gp 130 receptor ligands, particularly ciliary neurotrophic factor (CNTF), as potential antiobesity therapeutics. Neuropoietin (NP) is a recently discovered cytokine in the gp130 family that shares functional and structural features with CNTF and signals via the CNTF receptor tripartite complex comprised of CNTFR alpha, LIF receptor, and gp130. NP plays a role in the development of the nervous system, but the effects of NP on adipocytes have not been previously examined. Because CNTF exerts anti-obesogenic effects in adipocytes and NP shares the same receptor complex, we investigated the effects of NP on adipocyte development and insulin action. Using cultured 3T3-L1 adipocytes, we observed that NP has the ability to block adipogenesis in a dose- and time-dependent manner. We also observed that cultured adipocytes, as well as murine adipose tissue, are highly responsive to acute NP treatment. Rodents injected with NP had a substantial increase in STAT3 tyrosine phosphorylation and ERK 1 and 2 activation. We also observed the induction of SOCS-3 mRNA in 3T3-L1 adipocytes following NP treatment. Unlike CNTF, our studies have revealed that NP also substantially attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. In addition, NP blocks insulin action in adipose tissue in vivo. These observations are supported by data demonstrating that NP impairs insulin signaling via decreased activation of both IRS-1 and Akt. In summary, we have observed that both adipocytes in vitro and in vivo are highly responsive to NP, and this cytokine has the ability to affect insulin signaling in fat cells. These novel observations suggest that NP, unlike CNTF, may not be a viable obesity therapeutic.	[White, Ursula A.; Stephens, Jacqueline M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Stewart, William C.] Middle Tennessee State Univ, Murfreesboro, TN 37132 USA; [Mynatt, Randall L.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Middle Tennessee State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Stephens, JM (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jsteph1@lsu.edu	Stephens, Jacqueline M/R-5217-2018; White, Ursula/N-1997-2017; Mynatt, Randall L/N-1980-2017	Mynatt, Randall L/0000-0003-4399-0019	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, R01DK052968] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK072476, R01DK52968] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; Auernhammer CJ, 2003, ENDOCRINOLOGY, V144, P1202, DOI 10.1210/en.2002-220933; Bjorbaek C, 1999, ENDOCRINOLOGY, V140, P2035, DOI 10.1210/en.140.5.2035; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Blanchard F, 2001, J BIOL CHEM, V276, P47038, DOI 10.1074/jbc.M107971200; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; Bousquet C, 1999, J CLIN INVEST, V104, P1277, DOI 10.1172/JCI7924; Ceresa BP, 1996, J BIOL CHEM, V271, P12121, DOI 10.1074/jbc.271.21.12121; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Febbraio MA, 2007, J CLIN INVEST, V117, P841, DOI 10.1172/JCI30453; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Gloaguen I, 1997, P NATL ACAD SCI USA, V94, P6456, DOI 10.1073/pnas.94.12.6456; Harp JB, 2001, BIOCHEM BIOPH RES CO, V281, P907, DOI 10.1006/bbrc.2001.4460; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hogan JC, 2005, J ENDOCRINOL, V185, P485, DOI 10.1677/joe.1.05980; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Magrangeas F, 2001, BIOCHEM J, V353, P223, DOI 10.1042/0264-6021:3530223; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Miller RG, 1996, NEUROLOGY, V47, P1329, DOI 10.1212/WNL.47.5.1329; Miyaoka Y, 2006, J BIOL CHEM, V281, P37913, DOI 10.1074/jbc.M606089200; Nakashima K, 1997, FEBS LETT, V401, P49, DOI 10.1016/S0014-5793(96)01430-5; Nakashima K, 1997, FEBS LETT, V403, P79, DOI 10.1016/S0014-5793(97)00013-6; Oh H, 1998, J BIOL CHEM, V273, P9703, DOI 10.1074/jbc.273.16.9703; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Robledo O, 1997, J BIOL CHEM, V272, P4855, DOI 10.1074/jbc.272.8.4855; Sleeman M W, 2000, Pharm Acta Helv, V74, P265, DOI 10.1016/S0031-6865(99)00050-3; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Song HY, 2007, INT J BIOCHEM CELL B, V39, P439, DOI 10.1016/j.biocel.2006.07.014; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; STEPHENS JM, 1992, J BIOL CHEM, V267, P13580; Stephens JM, 1998, J BIOL CHEM, V273, P31408, DOI 10.1074/jbc.273.47.31408; Stephens JM, 1996, J BIOL CHEM, V271, P10441, DOI 10.1074/jbc.271.18.10441; Stewart WC, 1999, BBA-MOL CELL RES, V1452, P188, DOI 10.1016/S0167-4889(99)00129-9; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Zvonic S, 2004, J BIOL CHEM, V279, P47572, DOI 10.1074/jbc.M403998200; Zvonic S, 2003, J BIOL CHEM, V278, P2228, DOI 10.1074/jbc.M205871200	51	19	20	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22505	22512		10.1074/jbc.M710462200	http://dx.doi.org/10.1074/jbc.M710462200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18562323	Green Published, hybrid			2022-12-25	WOS:000258321000019
J	Ji, ZY; Mei, FC; Miller, AL; Thompson, EB; Cheng, XD				Ji, Zhenyu; Mei, Fang C.; Miller, Aaron L.; Thompson, E. Brad; Cheng, Xiaodong			Protein kinase A (PKA) isoform RII beta mediates the synergistic killing effect of cAMP and glucocorticoid in acute lymphoblastic leukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I REGULATORY SUBUNIT; MOLECULAR-CLONING; INDUCED APOPTOSIS; GENE-EXPRESSION; CYCLIC-AMP; CATALYTIC SUBUNIT; LYMPHOID-CELLS; RESISTANCE; ACTIVATION; SENSITIVITY	Protein kinase A (PKA) or cAMP-dependent protein kinase (cAPK) mediates the synergistic effects of cAMP-and glucocorticoid (GC)-induced apoptosis in lymphoid cells. Using two human acute lymphoblastic leukemia cell (CEM) clones with respective GC-sensitive and GC-resistant phenotypes, we discovered that the PKA regulatory subunit isoform RII beta is preferentially expressed in the GC-sensitive clone C7-14 cells, whereas other intracellular cAMP receptors, including the exchange proteins directly activated by cAMP (Epac), are expressed at similar levels in both GC-sensitive and GC-resistant clones. High RII beta expression level in C7-14 cells is associated with elevated total PKA cellular activity and cAMP sensitivity, which consequently lead to an increased basal PKA activity. cAMP analogs that selectively activate type II PKA recapitulate the effects of forskolin of promoting apoptosis and antagonizing AKT/PKB activity in both GC-sensitive and GC-resistant clones, whereas type I PKA-selective agonists do not. Furthermore, down-regulation of RII beta leads to increased AKT/PKB activation and enhanced GC resistance in C7-14 cells. These results demonstrate that PKA RII beta is responsible for increased GC sensitivity, critical for cAMP-mediated synergistic cell killing in CEM cells, and may represent a novel therapeutic target for GC-resistant lymphoid malignancy.	[Ji, Zhenyu; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Galveston, Med Branch, Dept Pharmacol & Toxicol, Sch Med,Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA; [Miller, Aaron L.; Thompson, E. Brad] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Sch Med,Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Cheng, XD (corresponding author), Univ Texas Galveston, Med Branch, Dept Pharmacol & Toxicol, Sch Med,Sealy Ctr Canc Cell Biol, 301 Univ Blvd, Galveston, TX 77555 USA.	xcheng@utmb.edu	Cheng, Xiaodong/O-8176-2019	Cheng, Xiaodong/0000-0002-3479-1694	NATIONAL CANCER INSTITUTE [R01CA041407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071505, T90DK070109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170] Funding Source: NIH RePORTER; NCI NIH HHS [CA041407] Funding Source: Medline; NIDDK NIH HHS [1 T90 DK070109-01, 1 R90 DK071505-01] Funding Source: Medline; NIGMS NIH HHS [GM066170] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAVO JA, 1974, P NATL ACAD SCI USA, V71, P3580, DOI 10.1073/pnas.71.9.3580; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; Brandon EP, 1998, J NEUROSCI, V18, P3639; Cheng XD, 2001, J BIOL CHEM, V276, P4102, DOI 10.1074/jbc.M006447200; ChoChung YS, 1995, CRIT REV ONCOL HEMAT, V21, P33, DOI 10.1016/1040-8428(94)00166-9; CLEGG CH, 1988, P NATL ACAD SCI USA, V85, P3703, DOI 10.1073/pnas.85.11.3703; DANELMOORE L, 1993, LEUKEMIA RES, V17, P501, DOI 10.1016/0145-2126(93)90125-5; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Hongo T, 1997, BLOOD, V89, P2959, DOI 10.1182/blood.V89.8.2959; JAHNSEN T, 1986, J BIOL CHEM, V261, P2352; Ji ZY, 2007, J BIOL CHEM, V282, P37370, DOI 10.1074/jbc.M703697200; Kaspers GJL, 1998, BLOOD, V92, P259, DOI 10.1182/blood.V92.1.259.413k21_259_266; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; KLUMPER E, 1995, BLOOD, V86, P3861, DOI 10.1182/blood.V86.10.3861.bloodjournal86103861; Kofler R, 2003, J ENDOCRINOL, V178, P19, DOI 10.1677/joe.0.1780019; Kofler R, 2000, HISTOCHEM CELL BIOL, V114, P1; LEE DC, 1983, P NATL ACAD SCI-BIOL, V80, P3608, DOI 10.1073/pnas.80.12.3608; Medh RD, 1998, CANCER RES, V58, P3684; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Miller AL, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-3; Miller AL, 2005, MOL ENDOCRINOL, V19, P1569, DOI 10.1210/me.2004-0528; MOALLI PA, 1994, LEUKEMIA LYMPHOMA, V15, P363, DOI 10.3109/10428199409049738; Myklebust JH, 1999, J CELL PHYSIOL, V180, P71; NORMAN MR, 1977, CANCER RES, V37, P3785; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Tissing WJE, 2003, LEUKEMIA, V17, P17, DOI 10.1038/sj.leu.2402733; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200	31	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21920	21925		10.1074/jbc.M803193200	http://dx.doi.org/10.1074/jbc.M803193200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544528	Green Published, hybrid			2022-12-25	WOS:000258114700011
J	Yang, LL; Kombu, RS; Kasumov, T; Zhu, SH; Cendrowski, AV; David, F; Anderson, VE; Kelleher, JK; Brunengraber, H				Yang, Lili; Kombu, Rajan S.; Kasumov, Takhar; Zhu, Shu-Han; Cendrowski, Andrea V.; David, France; Anderson, Vernon E.; Kelleher, Joanne K.; Brunengraber, Henri			Metabolomic and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle - I. Interrelation between gluconeogenesis and cataplerosis; Formation of methoxamates from aminooxyacetate and ketoacids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFUSED RAT-LIVER; LIPOGENESIS; KIDNEY; HEPATOCYTES; INHIBITION; PYRUVATE; GLUCOSE; PHOSPHOENOLPYRUVATE; PRODUCTS; ZONATION	We conducted a study coupling metabolomics and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle. Rat livers were perfused with lactate or pyruvate +/- aminooxyacetate or mercaptopicolinate in the presence of 40% enriched (NaHCO3)-C-13. Other livers were perfused with dimethyl [1,4-C-13(2)] succinate +/- mercaptopicolinate. In this first of two companion articles, we show that a substantial fraction of gluconeogenic carbon leaves the liver as citric acid cycle intermediates, mostly alpha-ketoglutarate. The efflux of gluconeogenic carbon ranges from 10 to 200% of the rate of liver gluconeogenesis. This cataplerotic efflux of gluconeogenic carbon may contribute to renal gluconeogenesis in vivo. Multiple crossover analyses of concentrations of gluconeogenic intermediates and redox measurements expand previous reports on the regulation of gluconeogenesis and the effects of inhibitors. We also demonstrate the formation of adducts from the condensation, in the liver, of (i) aminooxyacetate with pyruvate, alpha-ketoglutarate, and oxaloacetate and (ii) mercaptopicolinate and pyruvate. These adducts may exert metabolic effects unrelated to their effect on gluconeogenesis.	[Brunengraber, Henri] Case Western Reserve Univ, Sch Med WG48, Dept Nutr, Cleveland, OH 44106 USA; [Anderson, Vernon E.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Kelleher, Joanne K.] MIT, Dept Chem Engn, Cambridge, MA 02154 USA	Case Western Reserve University; Case Western Reserve University; Massachusetts Institute of Technology (MIT)	Brunengraber, H (corresponding author), Case Western Reserve Univ, Sch Med WG48, Dept Nutr, 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxb8@case.edu	Kombu, Rajan/A-6752-2008; Anderson, Vernon/W-2673-2019	Anderson, Vernon Emmett/0000-0002-1699-7621	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER; NIDDK NIH HHS [R33DK070291] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bederman IR, 2004, J BIOL CHEM, V279, P43207, DOI 10.1074/jbc.M403838200; BLACKSHEAR PJ, 1975, BIOCHEM J, V148, P353, DOI 10.1042/bj1480353b; Borek E, 1936, J AM CHEM SOC, V58, P2020, DOI 10.1021/ja01301a058; Brunengraber H, 1997, ANNU REV NUTR, V17, P559, DOI 10.1146/annurev.nutr.17.1.559; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; CHANCE B, 1959, J BIOL CHEM, V234, P3036; COOPER AJL, 1983, ANNU REV BIOCHEM, V52, P187, DOI 10.1146/annurev.bi.52.070183.001155; CORNELL NW, 1984, BIOCHEM J, V220, P707, DOI 10.1042/bj2200707; EKBERG K, 1995, J BIOL CHEM, V270, P21715, DOI 10.1074/jbc.270.37.21715; ESENMO E, 1992, AM J PHYSIOL, V263, pE36, DOI 10.1152/ajpendo.1992.263.1.E36; FOLCH J, 1951, J BIOL CHEM, V191, P819; Fridman E, 2005, CURR OPIN PLANT BIOL, V8, P242, DOI 10.1016/j.pbi.2005.03.004; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Hellerstein MK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1146, DOI 10.1152/ajpendo.1999.276.6.E1146; JOMAINBAUM M, 1976, J BIOL CHEM, V251, P37; JUNGERMANN K, 1987, Diabetes Metabolism Reviews, V3, P269; KEECH DB, 1963, J BIOL CHEM, V238, P2609; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; LANDAU BR, 1995, AM J PHYSIOL-ENDOC M, V269, pE18, DOI 10.1152/ajpendo.1995.269.1.E18; LARDY HA, 1965, P NATL ACAD SCI USA, V53, P1410, DOI 10.1073/pnas.53.6.1410; LONGSHAW ID, 1972, EUR J BIOCHEM, V25, P366, DOI 10.1111/j.1432-1033.1972.tb01705.x; Meyer C, 1999, DIABETES, V48, P943, DOI 10.2337/diabetes.48.5.943; NISHIITS.JM, 1967, BIOCHEM J, V103, P852, DOI 10.1042/bj1030852; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; OCHS RS, 1980, BIOCHIM BIOPHYS ACTA, V632, P260, DOI 10.1016/0304-4165(80)90084-7; PREVIS SF, 1995, J BIOL CHEM, V270, P19806, DOI 10.1074/jbc.270.34.19806; Puchowicz MA, 1999, AM J PHYSIOL-ENDOC M, V277, pE1022, DOI 10.1152/ajpendo.1999.277.6.E1022; Rochfort S, 2005, J NAT PROD, V68, P1813, DOI 10.1021/np050255w; ROGNSTAD R, 1970, BIOCHEM J, V116, P483, DOI 10.1042/bj1160483; ROGNSTAD R, 1974, ARCH BIOCHEM BIOPHYS, V161, P638, DOI 10.1016/0003-9861(74)90348-8; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1875; ROGNSTAD R, 1984, ARCH BIOCHEM BIOPHYS, V230, P605, DOI 10.1016/0003-9861(84)90441-7; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; VENEZIAL.CM, 1970, BIOCHEMISTRY-US, V9, P3960, DOI 10.1021/bi00822a014; Weckwerth W, 2005, DRUG DISCOV TODAY, V10, P1551, DOI 10.1016/S1359-6446(05)03609-3; Weckwerth W, 2004, P NATL ACAD SCI USA, V101, P7809, DOI 10.1073/pnas.0303415101; Yang DW, 2000, AM J PHYSIOL-ENDOC M, V278, pE469, DOI 10.1152/ajpendo.2000.278.3.E469; Yang LL, 2008, J BIOL CHEM, V283, P21988, DOI 10.1074/jbc.M803455200; Yang L, 2006, METABOLOMICS, V2, P85, DOI 10.1007/s11306-006-0019-1	41	32	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21978	21987		10.1074/jbc.M803454200	http://dx.doi.org/10.1074/jbc.M803454200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544527	Green Published, hybrid			2022-12-25	WOS:000258114700017
J	Saeed, U; Durgadoss, L; Valli, RK; Joshi, DC; Joshi, PG; Ravindranath, V				Saeed, Uzma; Durgadoss, Lalitha; Valli, R. Khader; Joshi, Dinesh C.; Joshi, Preeti G.; Ravindranath, Vijayalakshmi			Knockdown of Cytosolic Glutaredoxin 1 Leads to Loss of Mitochondrial Membrane Potential: Implication in Neurodegenerative Diseases	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; EXCITATORY AMINO-ACID; COMPLEX-I; THIOLTRANSFERASE GLUTAREDOXIN; CONSTITUTIVE EXPRESSION; MIXED DISULFIDES; MOTOR-NEURONS; CALF THYMUS; GLUTATHIONE; THIOREDOXIN	Mitochondrial dysfunction including that caused by oxidative stress has been implicated in the pathogenesis of neurodegenerative diseases. Glutaredoxin 1 (Grx1), a cytosolic thiol disulfide oxido-reductase, reduces glutathionylated proteins to protein thiols and helps maintain redox status of proteins during oxidative stress. Grx1 downregulation aggravates mitochondrial dysfunction in animal models of neurodegenerative diseases, such as Parkinson's and motor neuron disease. We examined the mechanism underlying the regulation of mitochondrial function by Grx1. Downregulation of Grx1 by shRNA results in loss of mitochondrial membrane potential (MMP), which is prevented by the thiol antioxidant, alpha-lipoic acid, or by cyclosporine A, an inhibitor of mitochondrial permeability transition. The thiol groups of voltage dependent anion channel (VDAC), an outer membrane protein in mitochondria but not adenosine nucleotide translocase (ANT), an inner membrane protein, are oxidized when Grx1 is downregulated. We then examined the effect of beta-N-oxalyl amino-L-alanine (L-BOAA), an excitatory amino acid implicated in neurolathyrism (a type of motor neuron disease), that causes mitochondrial dysfunction. Exposure of cells to L-BOAA resulted in loss of MMP, which was prevented by overexpression of Grx1. Grx1 expression is regulated by estrogen in the CNS and treatment of SH-SY5Y cells with estrogen upregulated Grx1 and protected from L-BOAA mediated MMP loss. Our studies demonstrate that Grx1, a cytosolic oxidoreductase, helps maintain mitochondrial integrity and prevents MMP loss caused by oxidative insult. Further, downregulation of Grx1 leads to mitochondrial dysfunction through oxidative modification of the outer membrane protein, VDAC, providing support for the critical role of Grx1 in maintenance of MMP.	[Saeed, Uzma; Durgadoss, Lalitha; Valli, R. Khader; Ravindranath, Vijayalakshmi] Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Nainwal Mode, Manesar, India; [Joshi, Dinesh C.; Joshi, Preeti G.] National Inst Mental Hlth & Neurosci, Dept Biophys, Bangalore, Karnataka, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Saeed, U (corresponding author), Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Nainwal Mode, Manesar, India.	vijir@nbrc.ac.in		Joshi, Dinesh/0000-0003-1158-7890	National Brain Research Center, Manesar, Haryana, India	National Brain Research Center, Manesar, Haryana, India	The work done in this study was funded by the National Brain Research Center, Manesar, Haryana, India.	Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Balijepalli S, 1999, NEUROSCI LETT, V272, P203, DOI 10.1016/S0304-3940(99)00593-5; Bambrick LL, 2008, BRAIN RES, V1188, P9, DOI 10.1016/j.brainres.2007.10.045; Beal M Flint, 2007, Novartis Found Symp, V287, P183; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Borgne-Sanchez A, 2007, CELL DEATH DIFFER, V14, P422, DOI 10.1038/sj.cdd.4402018; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Diwakar L, 2007, NEUROCHEM INT, V51, P37, DOI 10.1016/j.neuint.2007.03.008; Diwakar L, 2007, NEUROCHEM INT, V50, P418, DOI 10.1016/j.neuint.2006.09.014; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Fernando MR, 2006, FASEB J, V20, P2645, DOI 10.1096/fj.06-5919fje; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278; Haouzi D, 2002, APOPTOSIS, V7, P395, DOI 10.1023/A:1020026923038; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Joensson Thomas J., 2007, V44, P115; Karunakaran S, 2007, BRAIN RES, V1185, P8, DOI 10.1016/j.brainres.2007.09.019; Kenchappa RS, 2004, FASEB J, V18, P1102, DOI 10.1096/fj.03-1075fje; Kenchappa RS, 2003, FASEB J, V17, P717, DOI 10.1096/fj.02-0771fje; Kenchappa RS, 2002, J NEUROSCI, V22, P8402; Kim R, 2006, J PATHOL, V208, P319, DOI 10.1002/path.1885; Kim R, 2005, ONCOL REP, V14, P595; Ludolph AC, 1996, J NEUROL SCI, V139, P53, DOI 10.1016/0022-510X(96)00122-0; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; LUTHMAN M, 1982, J BIOL CHEM, V257, P6686; LUTHMAN M, 1979, P NATL ACAD SCI USA, V76, P2158, DOI 10.1073/pnas.76.5.2158; MANNERVIK B, 1975, BIOCHEM J, V149, P785, DOI 10.1042/bj1490785; MIEYAL JJ, 1995, GLUTATHIONYL SPECIFI, P305; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; PADILLA CA, 1995, EUR J BIOCHEM, V227, P27, DOI 10.1111/j.1432-1033.1995.tb20356.x; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; ROSS SM, 1989, J NEUROCHEM, V53, P710, DOI 10.1111/j.1471-4159.1989.tb11762.x; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sen I, 2008, NEUROCHEM INT, V52, P247, DOI 10.1016/j.neuint.2007.06.028; Solans A, 2006, HUM MOL GENET, V15, P3063, DOI 10.1093/hmg/ddl248; SPENCER PS, 1986, LANCET, V2, P1066, DOI 10.1016/S0140-6736(86)90468-X; Sriram K, 1998, J NEUROSCI, V18, P10287; Sriram K, 1997, BRAIN RES, V749, P44, DOI 10.1016/S0006-8993(96)01271-1; Wells W W, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P149; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang ZQ, 2007, MOL BIOL CELL, V18, P4681, DOI 10.1091/mbc.E06-12-1161	47	64	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2459	10.1371/journal.pone.0002459	http://dx.doi.org/10.1371/journal.pone.0002459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560520	Green Submitted, Green Published, gold			2022-12-25	WOS:000263280700040
J	Li, JX; Wu, HB; Hong, J; Xu, XQ; Yang, HL; Wu, BX; Wang, YP; Zhu, JH; Lai, R; Jiang, XG; Lin, DH; Prescott, MC; Rees, HH				Li, Jianxu; Wu, Hongbing; Hong, Jing; Xu, Xueqing; Yang, Hailong; Wu, Bingxian; Wang, Yipeng; Zhu, Jianhua; Lai, Ren; Jiang, Xinguo; Lin, Donghai; Prescott, Mark C.; Rees, Huw H.			Odorranalectin Is a Small Peptide Lectin with Potential for Drug Delivery and Targeting	PLOS ONE			English	Article								Background: Lectins are sugar-binding proteins that specifically recognize sugar complexes. Based on the specificity of protein-sugar interactions, different lectins could be used as carrier molecules to target drugs specifically to different cells which express different glycan arrays. In spite of lectin's interesting biological potential for drug targeting and delivery, a potential disadvantage of natural lectins may be large size molecules that results in immunogenicity and toxicity. Smaller peptides which can mimic the function of lectins are promising candidates for drug targeting. Principal Findings: Small peptide with lectin-like behavior was screened from amphibian skin secretions and its structure and function were studied by NMR, NMR-titration, SPR and mutant analysis. A lectin-like peptide named odorranalectin was identified from skin secretions of Odorrana grahami. It was composed of 17 aa with a sequence of YASPKCFRYPNGVLACT. L-fucose could specifically inhibit the haemagglutination induced by odorranalectin. (125)I-odorranalectin was stable in mice plasma. In experimental mouse models, odorranalectin was proved to mainly conjugate to liver, spleen and lung after i.v. administration. Odorranalectin showed extremely low toxicity and immunogenicity in mice. The small size and single disulfide bridge of odorranalectin make it easy to manipulate for developing as a drug targeting system. The cyclic peptide of odorranalectin disclosed by solution NMR study adopts a beta-turn conformation stabilized by one intramolecular disulfide bond between Cys6-Cys16 and three hydrogen bonds between Phe7-Ala15, Tyr9-Val13, Tyr9-Gly12. Residues K5, C6, F7, C16 and T17 consist of the binding site of L-fucose on odorranalectin determined by NMR titration and mutant analysis. The structure of odorranalectin in bound form is more stable than in free form. Conclusion: These findings identify the smallest lectin so far, and show the application potential of odorranalectin for drug delivery and targeting. It also disclosed a new strategy of amphibian anti-infection.	[Li, Jianxu; Xu, Xueqing; Yang, Hailong; Wang, Yipeng; Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming, Yunnan, Peoples R China; [Wu, Hongbing; Wu, Bingxian; Zhu, Jianhua; Jiang, Xinguo] Fudan Univ, Sch Pharm, Shanghai, Peoples R China; [Hong, Jing; Lin, Donghai] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China; [Prescott, Mark C.; Rees, Huw H.] Univ Liverpool, Sch Biol Sci, Liverpool, Merseyside, England; [Li, Jianxu; Hong, Jing; Xu, Xueqing; Wang, Yipeng] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Fudan University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Liverpool; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, JX (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming, Yunnan, Peoples R China.	rlai@mail.kiz.ac.cn; xgjiang@shmu.edu.cn; dhlin@mail.shcnc.ac.cn	Li, Jianxu/I-5723-2013; Wang, Yipeng/AAA-1499-2020; yang, hailong/GXH-9625-2022	Wang, Yipeng/0000-0003-1385-4470; 	Ministry of Science and Technology of the People's Republic of China [2007AA02Z192]; Chinese Academy of Sciences [KSCX2-YW-G-024, KSCX2-YW-R-20]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by 2007AA02Z192 from the Ministry of Science and Technology of the People's Republic of China, and KSCX2-YW-G-024, KSCX2-YW-R-20 from the Chinese Academy of Sciences.	BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; Bies C, 2004, ADV DRUG DELIVER REV, V56, P425, DOI 10.1016/j.addr.2003.10.030; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ezekowitz RA, 2003, J INFECT DIS, V187, pS335, DOI 10.1086/374746; KAWAGISHI H, 1990, BIOCHIM BIOPHYS ACTA, V1034, P247, DOI 10.1016/0304-4165(90)90045-X; KAWAGISHI H, 1994, FEBS LETT, V340, P56, DOI 10.1016/0014-5793(94)80172-X; Kobayashi Y, 2004, J BIOL CHEM, V279, P53048, DOI 10.1074/jbc.M407997200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lehr CM, 2004, ADV DRUG DELIVER REV, V56, P419, DOI 10.1016/j.addr.2003.10.013; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Lu SY, 1999, J PROTEIN CHEM, V18, P609, DOI 10.1023/A:1020663619657; Nadesalingam J, 2005, J IMMUNOL, V175, P1785, DOI 10.4049/jimmunol.175.3.1785; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Robinson MA, 2004, P NATL ACAD SCI USA, V101, P14527, DOI 10.1073/pnas.0303574101; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; SHARON N, 1972, SCIENCE, V177, P949, DOI 10.1126/science.177.4053.949; SHORE A, 1959, J PHARMACOL EXP THER, V127, P182; Sobal G, 2004, NUCL MED BIOL, V31, P381, DOI 10.1016/j.nucmedbio.2003.10.010; Tchernychev B, 1996, FEBS LETT, V397, P139, DOI 10.1016/S0014-5793(96)01154-4; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; WESTERHOFF HV, 1995, EUR J BIOCHEM, V228, P257; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xu XQ, 2006, TOXICON, V47, P459, DOI 10.1016/j.toxicon.2006.01.002; Yan H, 2001, ANTIMICROB AGENTS CH, V45, P1558, DOI 10.1128/AAC.45.5.1558-1560.2001; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	32	60	66	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2381	10.1371/journal.pone.0002381	http://dx.doi.org/10.1371/journal.pone.0002381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18584053	Green Published, gold, Green Submitted			2022-12-25	WOS:000263248800021
J	Wotton, S; Terry, A; Kilbey, A; Jenkins, A; Herzyk, P; Cameron, E; Neil, JC				Wotton, S.; Terry, A.; Kilbey, A.; Jenkins, A.; Herzyk, P.; Cameron, E.; Neil, J. C.			Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival	ONCOGENE			English	Article						Runx; adhesion; survival; microarray; transcription	DEPENDENT ACTIVATION; FUSION PROTEIN; REPRESSION; LEUKEMIA; CBFA1; DISRUPTION; RESISTANCE; EXPRESSION; MOLECULES; MECHANISM	The Runx genes are important in development and cancer, where they can act either as oncogenes or tumour suppressors. We compared the effects of ectopic Runx expression in established fibroblasts, where all three genes produce an indistinguishable phenotype entailing epithelioid morphology and increased cell survival under stress conditions. Gene array analysis revealed a strongly overlapping transcriptional signature, with no examples of opposing regulation of the same target gene. A common set of 50 highly regulated genes was identified after further filtering on regulation by inducible RUNX1-ER. This set revealed a strong bias toward genes with annotated roles in cancer and development, and a preponderance of targets encoding extracellular or surface proteins, reflecting the marked effects of Runx on cell adhesion. Furthermore, in silico prediction of resistance to glucocorticoid growth inhibition was confirmed in fibroblasts and lymphoid cells expressing ectopic Runx. The effects of fibroblast expression of common RUNX1 fusion oncoproteins (RUNX1-ETO, TEL-RUNX1 and CBFB-MYH11) were also tested. Although two direct Runx activation target genes were repressed (Ncam1 and Rgc32), the fusion proteins appeared to disrupt the regulation of downregulated targets (Cebpd, Id2 and Rgs2) rather than impose constitutive repression. These results elucidate the oncogenic potential of the Runx family and reveal novel targets for therapeutic inhibition.	[Wotton, S.; Terry, A.; Kilbey, A.; Jenkins, A.; Cameron, E.; Neil, J. C.] Univ Glasgow, Inst Comparat Med, Mol Oncol Lab, Fac Vet Med, Glasgow G61 1QH, Lanark, Scotland; [Herzyk, P.] Univ Glasgow, Inst Biomed & Life Sci, Sir Henry Wellcome Funct Genom Facil, Glasgow G61 1QH, Lanark, Scotland	University of Glasgow; University of Glasgow	Wotton, S (corresponding author), Univ Glasgow, Inst Comparat Med, Mol Oncol Lab, Fac Vet Med, Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland.	S.Wotton@vet.gla.ac.uk; j.c.neil@vet.gla.ac.uk			Cancer Research, UK; Leukaemia Research Fund of Great Britain	Cancer Research, UK(Cancer Research UK); Leukaemia Research Fund of Great Britain	We thank Scott Hiebert (Vanderbilt Cancer Centre, TN, USA) for RUNX1/ETO and CBFB-MYH11 plasmids, Alan Friedman (Johns Hopkins University, MD, USA) for the AML-ER plasmid and Olivier Bernard (INSERM, Paris, France) for the TEL/RUNX1 construct. We are grateful to Torsten Schaller for the murine Runx3 cDNA and to Monica Stewart and Karen Blyth for helpful comments. This work was supported by a programme grant from Cancer Research, UK, and the Leukaemia Research Fund of Great Britain.	Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; Bianchini R, 2006, J PHARMACOL EXP THER, V319, P887, DOI 10.1124/jpet.106.108480; Bleicher RJ, 2002, BBA-MOL CELL BIOL L, V1585, P172, DOI 10.1016/S1388-1981(02)00338-4; Blyth K, 2006, CANCER RES, V66, P2195, DOI 10.1158/0008-5472.CAN-05-3558; BLYTH K, 1995, ONCOGENE, V10, P1717; Blyth K, 2001, ONCOGENE, V20, P295, DOI 10.1038/sj.onc.1204090; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Breitling Rainer, 2005, Journal of Bioinformatics and Computational Biology, V3, P1171, DOI 10.1142/S0219720005001442; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fenrick R, 1999, MOL CELL BIOL, V19, P6566; Fukushima-Nakase Y, 2005, BLOOD, V105, P4298, DOI 10.1182/blood-2004-08-3372; Huang XM, 1999, NAT STRUCT BIOL, V6, P624; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Javed A, 2000, J CELL SCI, V113, P2221; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jiang HM, 2005, MOL CELL BIOL, V25, P10675, DOI 10.1128/MCB.25.24.10675-10683.2005; Kilbey A, 2007, CANCER RES, V67, P11263, DOI 10.1158/0008-5472.CAN-07-3016; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Linggi B, 2002, NAT MED, V8, P743, DOI 10.1038/nm726; Lou JR, 2000, ONCOGENE, V19, P2695, DOI 10.1038/sj.onc.1203588; Lutterbach B, 2000, J BIOL CHEM, V275, P651, DOI 10.1074/jbc.275.1.651; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; Miething C, 2007, P NATL ACAD SCI USA, V104, P4594, DOI 10.1073/pnas.0604716104; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Stewart M, 2002, J VIROL, V76, P4364, DOI 10.1128/JVI.76.9.4364-4369.2002; Stewart M, 1997, P NATL ACAD SCI USA, V94, P8646, DOI 10.1073/pnas.94.16.8646; Swantek D, 2004, DEVELOPMENT, V131, P2281, DOI 10.1242/dev.01109; Terry A, 2004, GENE, V336, P115, DOI 10.1016/j.gene.2004.04.015; Vaillant F, 2002, J IMMUNOL, V169, P2866, DOI 10.4049/jimmunol.169.6.2866; Vaillant F, 1999, ONCOGENE, V18, P7124, DOI 10.1038/sj.onc.1203202; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wotton S, 2002, CANCER RES, V62, P7181; Wotton SF, 2004, ONCOGENE, V23, P5476, DOI 10.1038/sj.onc.1207729	47	50	50	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 2	2008	27	44					5856	5866		10.1038/onc.2008.195	http://dx.doi.org/10.1038/onc.2008.195			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	355QC	18560354	Green Accepted			2022-12-25	WOS:000259722400009
J	Flierl, MA; Rittirsch, D; Nadeau, BA; Day, DE; Zetoune, FS; Sarma, JV; Huber-Lang, MS; Ward, PA				Flierl, Michael A.; Rittirsch, Daniel; Nadeau, Brian A.; Day, Danielle E.; Zetoune, Firas S.; Sarma, J. Vidya; Huber-Lang, Markus S.; Ward, Peter A.			Functions of the complement components C3 and C5 during sepsis	FASEB JOURNAL			English	Article						survival; cytokines; chemokines; colony-forming units; CH-50	INFLAMMATORY RESPONSE SYNDROME; WHOLE-BLOOD MODEL; THYMOCYTE APOPTOSIS; ACTIVATION PATHWAY; OXIDATIVE BURST; INNATE IMMUNITY; CECAL LIGATION; BRAIN-INJURY; MICE; MORTALITY	Activation of the complement system is a key event in the pathogenesis of sepsis. Nevertheless, the exact mechanisms remain inadequately understood. In the current study, we examined the role of complement C3 and C5 in sepsis in wild-type and C3- or C5-deficient mice induced by cecal ligation and puncture. When compared to wild-type mice, C5(-/-) showed identical survival, and C3(-/-) presented significantly reduced survival. Interestingly, this was associated with significant decreases in plasma levels of proinflammatory mediators. Moreover, although septic C3(-/-) animals displayed a 10-fold increase of blood-borne bacteria, C5(-/-) animals exhibited a 400-fold increase in bacteremia when compared to wild-type mice. These effects were linked to the inability of C5(-/-) mice to assemble the terminal membrane attack complex (MAC), as determined by complement hemolytic activity (CH-50). Surprisingly, although negative control C3(-/-) mice failed to generate the MAC, significant increases of MAC formation was found in septic C3- mice. In conclusion, our data corroborate that hemolytic complement activity is essential for control of bacteremia in septic mice. Thus, during sepsis, blockade of C5a or its receptors (rather than C5) seems a more promising strategy, because C5a-blockade still allows for MAC formation while the adverse effects of C5a are prevented.	[Flierl, Michael A.; Rittirsch, Daniel; Nadeau, Brian A.; Day, Danielle E.; Zetoune, Firas S.; Sarma, J. Vidya; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Huber-Lang, Markus S.] Univ Ulm, Sch Med, Dept Trauma Hand & Reconstruct Surg, Ulm, Germany	University of Michigan System; University of Michigan; Ulm University	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd, Ann Arbor, MI 48109 USA.	pward@umich.edu	Huber-Lang, Markus/AAJ-2209-2020	Rittirsch, Daniel/0000-0002-1185-2431	U.S. National Institutes of Health [GM29507, GM61656, HL-31963]; Deutsche Forschnngsgemeinschaft [DFG HU 823/2-1, HU 823/2-2, DFG HU 823/2-3]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029507, R01GM061656, R01GM029507] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschnngsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Beverly Schumann and Sue Scott for the preparation of this manuscript. This work was supported by U.S. National Institutes of Health grants GM29507, GM61656, and HL-31963 (to P.A.W.) and Deutsche Forschnngsgemeinschaft grants DFG HU 823/2-1, HU 823/2-2, and DFG HU 823/2-3 (to M.H.-L.).	ALPER CA, 1972, LANCET, V2, P1179; ALPER CA, 1976, J CLIN INVEST, V57, P222, DOI 10.1172/JCI108263; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Ashare A, 2005, AM J PHYSIOL-LUNG C, V288, pL633, DOI 10.1152/ajplung.00231.2004; BAKER CC, 1983, SURGERY, V94, P331; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Bone RC, 1996, CRIT CARE MED, V24, P163, DOI 10.1097/00003246-199601000-00026; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Brekke OL, 2007, J LEUKOCYTE BIOL, V81, P1404, DOI 10.1189/jlb.0806538; Buras JA, 2004, IMMUNOBIOLOGY, V209, P629, DOI 10.1016/j.imbio.2004.09.004; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Ebong SJ, 1999, SHOCK, V12, P118, DOI 10.1097/00024382-199908000-00005; Fischer MB, 1997, J IMMUNOL, V159, P976; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Gerard C, 2003, NEW ENGL J MED, V348, P167, DOI 10.1056/NEJMcibr022995; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Guo RF, 2000, J CLIN INVEST, V106, P1271, DOI 10.1172/JCI10793; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; HACK CE, 1989, AM J MED, V86, P20, DOI 10.1016/0002-9343(89)90224-6; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Huber-Lang MS, 2002, FASEB J, V16, P1567, DOI 10.1096/fj.02-0209com; Huber-Lang MS, 2002, J IMMUNOL, V169, P3223, DOI 10.4049/jimmunol.169.6.3223; Huber-Lang MS, 2001, FASEB J, V15, P568; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V52, P1; Laudes IJ, 2002, AM J PATHOL, V160, P1867, DOI 10.1016/S0002-9440(10)61133-9; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Mollnes TE, 2002, BLOOD, V100, P1869; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; NAKAE H, 1994, RES COMMUN CHEM PATH, V84, P189; Nakae H, 1996, SURG TODAY, V26, P225, DOI 10.1007/BF00311579; NEWMAN SL, 1985, J EXP MED, V161, P1414, DOI 10.1084/jem.161.6.1414; Osuchowski MF, 2007, J IMMUNOL, V179, P623, DOI 10.4049/jimmunol.179.1.623; Prodeus AP, 1997, NATURE, V390, P172, DOI 10.1038/36586; REID KBM, 1981, ANNU REV BIOCHEM, V50, P433, DOI 10.1146/annurev.bi.50.070181.002245; Remick DG, 2005, SHOCK, V24, P7, DOI 10.1097/01.shk.0000191384.34066.85; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Remick DG, 2003, CURR PHARM DESIGN, V9, P75, DOI 10.2174/1381612033392567; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Riedemann NC, 2002, FASEB J, V16, P887, DOI 10.1096/fj.02-0033fje; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; ROSENFELD SI, 1976, J CLIN INVEST, V57, P1626, DOI 10.1172/JCI108433; Santucci L, 1996, GASTROENTEROLOGY, V111, P736, DOI 10.1053/gast.1996.v111.pm8780580; Sprong T, 2003, BLOOD, V102, P3702, DOI 10.1182/blood-2003-03-0703; Stove S, 1996, CLIN DIAGN LAB IMMUN, V3, P175; VANDIJK H, 1980, J IMMUNOL METHODS, V39, P257; Wang Q, 1998, J Gastrointest Surg, V2, P537, DOI 10.1016/S1091-255X(98)80054-1; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Yang H, 2005, J IMMUNOL, V175, P2018, DOI 10.4049/jimmunol.175.3.2018	55	58	67	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3483	3490		10.1096/fj.08-110595	http://dx.doi.org/10.1096/fj.08-110595			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18587006	Green Submitted, Green Published			2022-12-25	WOS:000259642600010
J	Meiss, E; Konno, H; Groth, G; Hisabori, T				Meiss, Erik; Konno, Hiroki; Groth, Georg; Hisabori, Toru			Molecular processes of inhibition and stimulation of ATP synthase caused by the phytotoxin tentoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST COUPLING FACTOR-1; CATALYTIC SITE; NUCLEOTIDE-BINDING; ADENOSINE-TRIPHOSPHATASE; SPINACH CHLOROPLAST; KINETIC-ANALYSIS; F-1 MOTOR; F-1-ATPASE; F1-ATPASE; ROTATION	F-1-ATPase is the smallest mechanical motor known. Tentoxin, a cyclic peptide produced by phytopathogenic fungi, inactivates the F-1 motor in sensitive plants at nanomolar to micromolar concentrations, whereas higher concentrations surpass the natural activity of the enzyme. Single molecule studies now have clarified the molecular steps involved in both processes. Inactivation delays the dwell time of a single step in the complete 360 turn and results in an asymmetric rotation of the central rotor subunit. In contrast, rotation in the stimulated F-1 particle is smooth and accompanied by strongly reduced ADP inhibition. Our study provides for the first time the direct observation of a noncompetitively inhibited state of the enzyme and directly visualizes the regulation of the molecular motor by an external natural compound. In addition, the ADP release step during catalysis was revealed by analysis of the single molecule rotation behavior. Hence, tentoxin is a sophisticated molecular tool to mark and control certain catalytic steps within the reaction pathway of the molecular F-1 motor.	[Meiss, Erik; Konno, Hiroki; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Meiss, Erik; Groth, Georg] Univ Dusseldorf, Inst Biochem Pflanzen, D-40225 Dusseldorf, Germany	Tokyo Institute of Technology; Heinrich Heine University Dusseldorf	Hisabori, T (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Hisabori, Toru/E-5205-2014	Hisabori, Toru/0000-0003-2046-0277				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; AVNI A, 1992, SCIENCE, V257, P1245, DOI 10.1126/science.1387730; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; CARLIER MF, 1979, BIOCHEMISTRY-US, V18, P3446, DOI 10.1021/bi00583a002; DAHSE I, 1994, J PLANT PHYSIOL, V143, P615, DOI 10.1016/S0176-1617(11)81147-8; Groth G, 2002, P NATL ACAD SCI USA, V99, P3464, DOI 10.1073/pnas.052546099; Groth G, 2002, J BIOL CHEM, V277, P20117, DOI 10.1074/jbc.C200168200; GUERRERO KJ, 1990, J BIOL CHEM, V265, P16280; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; HISABORI T, 1993, J BIOCHEM-TOKYO, V114, P808, DOI 10.1093/oxfordjournals.jbchem.a124260; HISABORI T, 1992, J BIOL CHEM, V267, P4551; HU NM, 1993, J BIOL CHEM, V268, P8536; Jault JM, 1995, BIOCHEMISTRY-US, V34, P16412, DOI 10.1021/bi00050a023; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; MILGROM YM, 1990, BIOCHIM BIOPHYS ACTA, V1020, P43, DOI 10.1016/0005-2728(90)90091-H; Mitome N, 2002, EUR J BIOCHEM, V269, P53, DOI 10.1046/j.0014-2956.2002.02623.x; Mochimaru M, 1997, FEBS LETT, V419, P23, DOI 10.1016/S0014-5793(97)01421-X; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; OHTA S, 1980, J BIOCHEM-TOKYO, V87, P1609, DOI 10.1093/oxfordjournals.jbchem.a132904; OHTA Y, 1993, PLANT CELL PHYSIOL, V34, P523; Pavlova P, 2004, J BIOL CHEM, V279, P9685, DOI 10.1074/jbc.C400014200; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Santolini J, 1999, J BIOL CHEM, V274, P849, DOI 10.1074/jbc.274.2.849; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; SHOSHAN V, 1978, BIOCHIM BIOPHYS ACTA, V504, P108, DOI 10.1016/0005-2728(78)90010-5; STEELE JA, 1976, P NATL ACAD SCI USA, V73, P2245, DOI 10.1073/pnas.73.7.2245; Stiggall D L, 1979, Methods Enzymol, V55, P308; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Tucker WC, 2001, BIOCHEMISTRY-US, V40, P7542, DOI 10.1021/bi0105227; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; YOSHIDA M, 1983, J BIOL CHEM, V258, P4407; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	40	27	28	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24594	24599		10.1074/jbc.M802574200	http://dx.doi.org/10.1074/jbc.M802574200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18579520	Green Published, hybrid			2022-12-25	WOS:000258820000031
J	Madonna, S; Scarponi, C; De Pita, O; Albanesi, C				Madonna, Stefania; Scarponi, Claudia; De Pita, Ornella; Albanesi, Cristina			Suppressor of cytokine signaling 1 inhibits IFN-gamma inflammatory signaling in human keratinocytes by sustaining ERK1/2 activation	FASEB JOURNAL			English	Article						skin inflammation; antiinflammatory pathways; skin immune responses; RAS; RAF-1; p120RasGAP	TRANSCRIPTIONAL ACTIVATION; CHEMOKINE EXPRESSION; PHOSPHORYLATION; KINASE; GROWTH; STAT1; PROLIFERATION; PATHWAY; PROTEINS; BLOCKADE	IFN-gamma is a pleiotropic cytokine importantly involved in the development of skin inflammatory responses. Epidermal keratinocytes are extremely susceptible to IFN-gamma action, but, once transduced with the suppressors of cytokine signaling ( SOCS) 1 molecule, they can no longer express a number of IFN-gamma inducible signal transducer and activator of transcription ( STAT) 1-dependent genes. Extracellular-signal-regulated kinase (ERK)1/2 pathway is also involved in the protection of keratinocytes from the proinflammatory effect of IFN-gamma. Here we show that, after IFN-gamma stimulation, SOCS1 inhibited IFN-gamma receptor and STAT1 phosphorylation but maintained ERK1/2 activation. SOCS1 was also necessary for the IFN-gamma-induced RAS and Raf-1 activities in keratinocytes. The enhanced ERK1/2 pathway in SOCS1-overexpressing keratinocytes was in part responsible for their inability to respond to IFN-gamma, in terms of CXCL10 and CCL2 production, and for the high production of CXCL8. Moreover, SOCS1 interacted with the RAS inhibitor p120 RasGAP and promoted its degradation after IFN-gamma stimulation. We hypothesize that SOCS1 functions as suppressor of IFN-gamma signaling, not only by inhibiting STAT1 activation but also by sustaining ERK1/2-dependent antiinflammatory pathways.	[Madonna, Stefania; Scarponi, Claudia; De Pita, Ornella; Albanesi, Cristina] IDI IRCCS, Immunol Lab, I-00167 Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Albanesi, C (corresponding author), IDI IRCCS, Immunol Lab, Via Monti Creta 104, I-00167 Rome, Italy.	c.albanesi@idi.it	Madonna, stefania/AAC-3381-2022; Albanesi, Cristina/K-4699-2016	Albanesi, Cristina/0000-0002-7537-6833	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health. We thank Dr. A. Cavani and Prof. G. Girolomoni for the critical reading of this manuscript.	Ala-aho R, 2000, ONCOGENE, V19, P248, DOI 10.1038/sj.onc.1203306; Albanesi C, 2000, J IMMUNOL, V165, P1395, DOI 10.4049/jimmunol.165.3.1395; Albanesi C, 1999, J IMMUNOL, V162, P494; Albanesi Cristina, 2005, Current Drug Targets - Inflammation and Allergy, V4, P329, DOI 10.2174/1568010054022033; Ben-Zvi T, 2006, J CELL SCI, V119, P380, DOI 10.1242/jcs.02740; Bos JD, 2005, BRIT J DERMATOL, V152, P1098, DOI 10.1111/j.1365-2133.2005.06645.x; Cacalano NA, 2001, NAT CELL BIOL, V3, P460, DOI 10.1038/35074525; Dajee M, 2002, ONCOGENE, V21, P1527, DOI 10.1038/sj.onc.1205287; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Federici M, 2002, J IMMUNOL, V169, P434, DOI 10.4049/jimmunol.169.1.434; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Gough DJ, 2007, J BIOL CHEM, V282, P938, DOI 10.1074/jbc.M607674200; Han YL, 2001, J CLIN INVEST, V108, P425, DOI 10.1172/JCI12629; He Y, 2006, J BIOL CHEM, V281, P5559, DOI 10.1074/jbc.M512338200; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; Knisz J, 2007, J ALLERGY CLIN IMMUN, V119, P739, DOI 10.1016/j.jaci.2006.12.620; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mascia F, 2003, AM J PATHOL, V163, P303, DOI 10.1016/S0002-9440(10)63654-1; Mujtaba MG, 2005, J IMMUNOL, V175, P5077, DOI 10.4049/jimmunol.175.8.5077; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Nguyen VAT, 2000, BIOCHEM J, V349, P427, DOI 10.1042/0264-6021:3490427; Pastore S, 2005, J IMMUNOL, V174, P5047, DOI 10.4049/jimmunol.174.8.5047; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Sah JF, 2002, J BIOL CHEM, V277, P9728, DOI 10.1074/jbc.M110897200; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; vanderGeer P, 1997, MOL CELL BIOL, V17, P1840, DOI 10.1128/MCB.17.4.1840; Waiboci LW, 2007, J IMMUNOL, V178, P5058, DOI 10.4049/jimmunol.178.8.5058; Wang DK, 2005, J BIOL CHEM, V280, P16393, DOI 10.1074/jbc.M413897200; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang XL, 2005, EUR J IMMUNOL, V35, P3258, DOI 10.1002/eji.200526116	37	49	52	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3287	3297		10.1096/fj.08-106831	http://dx.doi.org/10.1096/fj.08-106831			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18556463				2022-12-25	WOS:000258761300021
J	Box, JA; Bunch, JT; Zappulla, DC; Glynn, EF; Baumann, P				Box, Jessica A.; Bunch, Jeremy T.; Zappulla, David C.; Glynn, Earl F.; Baumann, Peter			A flexible template boundary element in the RNA subunit of fission yeast telomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERASE; DOMINANT DYSKERATOSIS-CONGENITA; SECONDARY STRUCTURE; SCHIZOSACCHAROMYCES-POMBE; REVERSE-TRANSCRIPTASE; TETRAHYMENA TELOMERASE; APLASTIC-ANEMIA; DNA; RECOGNITION; MUTATIONS	Telomerase adds telomeric repeat sequences to chromosome ends using a short region of its RNA subunit as a template. Telomerase RNA subunits are phylogenetically highly divergent, and different strategies have evolved to demarcate the boundary of the template region. The recent identification of the gene encoding telomerase RNA in the fission yeast Schizosaccharomyces pombe (ter1(+)) has opened the door for structure-function analyses in a model that shares many features with the telomere maintenance machinery of higher eukaryotes. Here we describe a structural element in TER1 that defines the 5' boundary of the template. Disruption of a predicted long range base pairing interaction between template-adjacent nucleotides and a sequence further upstream resulted in reverse transcription beyond the template region and caused telomere shortening. Normal telomere length was restored by combining complementary nucleotide substitutions in both elements, showing that base pairing, not a specific sequence, limits reverse transcription beyond the template. The template boundary described here resembles that of budding yeasts and some mammalian telomerases. However, unlike any previously characterized boundary element, part of the paired region overlaps with the template itself, thus necessitating disruption of these interactions during most reverse transcription cycles. We show that changes in the paired region directly affect the length of individual telomeric repeat units. Our data further illustrate that marginal alignment of the telomeric 3' end with RNA sequences downstream of the template is responsible for primer slippage, causing incorporation of strings of guanosines at the start of a subset of repeats.	[Box, Jessica A.; Bunch, Jeremy T.; Glynn, Earl F.; Baumann, Peter] Stowers Inst Med Res, Kansas City, MO USA; [Box, Jessica A.; Bunch, Jeremy T.; Glynn, Earl F.; Baumann, Peter] Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Baumann, Peter] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Kansas; University of Kansas Medical Center	Baumann, P (corresponding author), Stowers Inst, 1000 E 50th St, Kansas City, MO 64110 USA.	peb@stowers-institute.org	Zappulla, David/C-7818-2009	Zappulla, David/0000-0001-8242-3493; Baumann, Peter/0000-0003-4892-1485	National Institutes of Health [K99GM80400]; Stowers Institute for Medical Research; Pew Scholars in the Biomedical Sciences Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM080400, R00GM080400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; Pew Scholars in the Biomedical Sciences Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant K99GM80400 (to D. C. Z.). This work was also supported by the Stowers Institute for Medical Research and a Pew Scholars in the Biomedical Sciences Award (to P. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ares M, 2008, NAT STRUCT MOL BIOL, V15, P18, DOI 10.1038/nsmb0108-18; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; AUTEXIER C, 1995, GENE DEV, V9, P2227, DOI 10.1101/gad.9.18.2227; Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Bunch JT, 2005, MOL CELL BIOL, V25, P5567, DOI 10.1128/mcb.25.13.5567-5578.2005; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chen JL, 2004, TRENDS BIOCHEM SCI, V29, P183, DOI 10.1016/j.tibs.2004.02.003; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Cohn M, 1998, CURR GENET, V33, P83, DOI 10.1007/s002940050312; Collins K, 1999, ANNU REV BIOCHEM, V68, P187, DOI 10.1146/annurev.biochem.68.1.187; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Croy JE, 2006, J MOL BIOL, V361, P80, DOI 10.1016/j.jmb.2006.06.002; Dandjinou AT, 2004, CURR BIOL, V14, P1148, DOI 10.1016/j.cub.2004.05.054; Forstemann K, 2001, MOL CELL BIOL, V21, P7277, DOI 10.1128/MCB.21.21.7277-7286.2001; Haering CH, 2000, P NATL ACAD SCI USA, V97, P6367, DOI 10.1073/pnas.130187397; Hiraoka Y, 1998, TRENDS BIOCHEM SCI, V23, P126, DOI 10.1016/S0968-0004(98)01176-1; Konig P, 1997, TRENDS BIOCHEM SCI, V22, P43, DOI 10.1016/S0968-0004(97)01008-6; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Lin J, 2004, P NATL ACAD SCI USA, V101, P14713, DOI 10.1073/pnas.0405879101; LINGNER J, 1994, GENE DEV, V8, P1984, DOI 10.1101/gad.8.16.1984; McCormickGraham M, 1997, EMBO J, V16, P3233, DOI 10.1093/emboj/16.11.3233; MCCORMICKGRAHAM M, 1995, NUCLEIC ACIDS RES, V23, P1091, DOI 10.1093/nar/23.7.1091; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; ROMERO DP, 1991, CELL, V67, P343, DOI 10.1016/0092-8674(91)90186-3; Seto AG, 2003, RNA, V9, P1323, DOI 10.1261/rna.5570803; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; Trujillo KM, 2005, J BIOL CHEM, V280, P9119, DOI 10.1074/jbc.M414511200; Tzfati Y, 2000, SCIENCE, V288, P863, DOI 10.1126/science.288.5467.863; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354; Wellinger RJ, 1997, EUR J CANCER, V33, P735, DOI 10.1016/S0959-8049(97)00067-1; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101	39	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24224	24233		10.1074/jbc.M802043200	http://dx.doi.org/10.1074/jbc.M802043200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18574244	Green Published, hybrid			2022-12-25	WOS:000258638900076
J	Kitajima-Ihara, T; Furutani, Y; Suzuki, D; Ihara, K; Kandori, H; Homma, M; Sudo, Y				Kitajima-Ihara, Tomomi; Furutani, Yuji; Suzuki, Daisuke; Ihara, Kunio; Kandori, Hideki; Homma, Michio; Sudo, Yuki			Salinibacter sensory rhodopsin - Sensory rhodopsin I-like protein from a eubacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHARAONIS PHOBORHODOPSIN; NATRONOBACTERIUM-PHARAONIS; STRUCTURAL-CHANGES; HALOBACTERIAL TRANSDUCER; COGNATE TRANSDUCER; TRANSIENT MOVEMENT; MUTATION ANALYSIS; CHARGED RESIDUES; PROTON PUMP; HELIX F	Halobacterium salinarum sensory rhodopsin I ( HsSRI), a dual receptor regulating both negative and positive phototaxis in haloarchaea, transmits light signals through changes in proteinprotein interactions with its transducer, halobacterial transducer protein I ( HtrI). Haloarchaea also have another sensor pigment, sensory rhodopsin II ( SRII), which functions as a receptor regulating negative phototaxis. Compared with HsSRI, the signal relay mechanism of SRII is well characterized because SRII from Natronomonus pharaonis ( NpSRII) is much more stable than HsSRI and HsSRII, especially in dilute salt solutions and is much more resistant to detergents. Two genes encoding SRI homologs were identified from the genome sequence of the eubacterium Salinibacter ruber. Those sequences are distantly related to HsSRI (similar to 40% identity) and contain most of the amino acid residues identified as necessary for its function. To determine whether those genes encode functional protein( s), we cloned and expressed them in Escherichia coli. One of them ( SrSRI) was expressed well as a recombinant protein having alltrans retinal as a chromophore. UV- Vis, low- temperature UVVis, pH- titration, and flash photolysis experiments revealed that the photochemical properties of SrSRI are similar to those of HsSRI. In addition to the expression system, the high stability of SrSRI makes it possible to prepare large amounts of protein and enables studies of mutant proteins that will allow new approaches to investigate the photosignaling process of SRI- HtrI.	[Kitajima-Ihara, Tomomi; Suzuki, Daisuke; Homma, Michio; Sudo, Yuki] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Furutani, Yuji; Kandori, Hideki] Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Nagoya University; Nagoya University; Nagoya Institute of Technology	Sudo, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	4sudo@bunshi4.bio.nagoya-u.ac.jp	Sudo, Yuki/AGY-0493-2022; IHARA, Kunio/D-1952-2011; Furutani, Yuji/J-8337-2019	Sudo, Yuki/0000-0001-8155-9356; Furutani, Yuji/0000-0001-5284-8773				Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; BOGOMOLNI RA, 1982, P NATL ACAD SCI-BIOL, V79, P6250, DOI 10.1073/pnas.79.20.6250; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; HAZEMOTO N, 1983, BIOPHYS J, V44, P59, DOI 10.1016/S0006-3495(83)84277-5; Hippler-Mreyen S, 2003, J MOL BIOL, V330, P1203, DOI 10.1016/S0022-2836(03)00656-9; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; IMAMOTO Y, 1992, BIOCHEMISTRY-US, V31, P2523, DOI 10.1021/bi00124a012; Iwata T, 2003, BIOCHEMISTRY-US, V42, P8183, DOI 10.1021/bi0345135; Jung KH, 1998, J BACTERIOL, V180, P2033, DOI 10.1128/JB.180.8.2033-2042.1998; KAMO N, 1985, ARCH BIOCHEM BIOPHYS, V238, P90, DOI 10.1016/0003-9861(85)90144-4; Kandori H, 2002, J PHYS CHEM A, V106, P2091, DOI 10.1021/jp012447f; Kandori H, 2001, BIOCHEMISTRY-US, V40, P9238, DOI 10.1021/bi0103819; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; OLSON KD, 1992, PHOTOCHEM PHOTOBIOL, V56, P1181, DOI 10.1111/j.1751-1097.1992.tb09743.x; OLSON KD, 1995, P NATL ACAD SCI USA, V92, P3185, DOI 10.1073/pnas.92.8.3185; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; PETTEI MJ, 1977, BIOCHEMISTRY-US, V16, P1955, DOI 10.1021/bi00628a031; RUDOLPH J, 1995, EMBO J, V14, P4249, DOI 10.1002/j.1460-2075.1995.tb00099.x; SASAKI J, 2008, PHOTOCHEM P IN PRESS; Sasaki J, 2007, MOL MICROBIOL, V66, P1321, DOI 10.1111/j.1365-2958.2007.05983.x; Sasaki J, 2007, BIOPHYS J, V92, P4045, DOI 10.1529/biophysj.106.101121; SCHARF B, 1992, BIOCHEMISTRY-US, V31, P12486, DOI 10.1021/bi00164a027; SEIDEL R, 1995, P NATL ACAD SCI USA, V92, P3036, DOI 10.1073/pnas.92.7.3036; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Shimono K, 2001, BBA-BIOMEMBRANES, V1515, P92, DOI 10.1016/S0005-2736(01)00394-7; SPUDICH EN, 1982, P NATL ACAD SCI-BIOL, V79, P4308, DOI 10.1073/pnas.79.14.4308; Spudich JL, 1996, CURR OPIN CELL BIOL, V8, P452, DOI 10.1016/S0955-0674(96)80020-2; Spudich JL, 2002, CURR OPIN STRUC BIOL, V12, P540, DOI 10.1016/S0959-440X(02)00359-7; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; SPUDICH JL, 1995, BIOPHYS CHEM, V56, P165, DOI 10.1016/0301-4622(95)00029-W; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Sudo Y, 2006, J MOL BIOL, V357, P1274, DOI 10.1016/j.jmb.2006.01.061; Sudo Y, 2005, J AM CHEM SOC, V127, P16036, DOI 10.1021/ja056203a; Sudo Y, 2005, BIOCHEMISTRY-US, V44, P6144, DOI 10.1021/bi047573z; Sudo Y, 2004, BIOCHEMISTRY-US, V43, P13748, DOI 10.1021/bi048803c; Sudo Y, 2003, BIOCHEMISTRY-US, V42, P14166, DOI 10.1021/bi035678g; Sudo Y, 2003, PHOTOCHEM PHOTOBIOL, V78, P511, DOI 10.1562/0031-8655(2003)078<0511:IONPPS>2.0.CO;2; Sudo Y, 2002, BIOPHYS J, V83, P427, DOI 10.1016/S0006-3495(02)75180-1; Sudo Y, 2001, BIOPHYS J, V80, P916, DOI 10.1016/S0006-3495(01)76070-5; Sudo Y, 2007, J BIOL CHEM, V282, P15550, DOI 10.1074/jbc.M701271200; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Sudo Y, 2006, J BIOL CHEM, V281, P34239, DOI 10.1074/jbc.M605907200; TAKAHASHI T, 1990, BIOCHEMISTRY-US, V29, P8467, DOI 10.1021/bi00488a038; Trivedi VD, 2003, BIOCHEMISTRY-US, V42, P13887, DOI 10.1021/bi034399q; TSUDA M, 1982, BIOCHEM BIOPH RES CO, V108, P970; Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008; Wegener AA, 2001, EMBO J, V20, P5312, DOI 10.1093/emboj/20.19.5312; YAN B, 1990, BIOPHYS J, V57, P807, DOI 10.1016/S0006-3495(90)82600-X; YAO VJ, 1992, P NATL ACAD SCI USA, V89, P11915, DOI 10.1073/pnas.89.24.11915; Yoshida H, 2004, PHOTOCH PHOTOBIO SCI, V3, P537, DOI 10.1039/b315454h; Zhang XN, 1997, BIOPHYS J, V73, P1516, DOI 10.1016/S0006-3495(97)78183-9	56	47	49	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23533	23541		10.1074/jbc.M802990200	http://dx.doi.org/10.1074/jbc.M802990200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18566451	Green Published, hybrid			2022-12-25	WOS:000258638900006
J	Burton, CR; Meredith, JE; Barten, DM; Goldstein, ME; Krause, CM; Kieras, CJ; Sisk, L; Iben, LG; Polson, C; Thompson, MW; Lin, XA; Corsa, J; Fiedler, T; Pierdomenico, M; Cao, Y; Roach, AH; Cantone, JL; Ford, MJ; Drexler, DM; Olson, RE; Yang, MG; Bergstrom, CP; McElhone, KE; Bronson, JJ; Macor, JE; Blat, Y; Grafstrom, RH; Stern, AM; Seiffert, DA; Zaczek, R; Albright, CF; Toyn, JH				Burton, Catherine R.; Meredith, Jere E.; Barten, Donna M.; Goldstein, Margi E.; Krause, Carol M.; Kieras, Cathy J.; Sisk, Lisa; Iben, Lawrence G.; Polson, Craig; Thompson, Mark W.; Lin, Xu-Alan; Corsa, Jason; Fiedler, Tracey; Pierdomenico, Maria; Cao, Yang; Roach, Arthur H.; Cantone, Joseph L.; Ford, Michael J.; Drexler, Dieter M.; Olson, Richard E.; Yang, Michael G.; Bergstrom, Carl P.; McElhone, Kate E.; Bronson, Joanne J.; Macor, John E.; Blat, Yuval; Grafstrom, Robert H.; Stern, Andrew M.; Seiffert, Dietmar A.; Zaczek, Robert; Albright, Charles F.; Toyn, Jeremy H.			The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; INTRAMEMBRANE CLEAVAGE; ZETA-CLEAVAGE; A-BETA; PRESENILIN; IDENTIFICATION; MUTATIONS; MECHANISM; BINDING	The amyloid-beta(A beta) peptide, which likely plays a key role in Alzheimer disease, is derived from the amyloid-beta precursor protein (APP) through consecutive proteolytic cleavages by beta-site APP-cleaving enzyme and gamma-secretase. Unexpectedly gamma-secretase inhibitors can increase the secretion of A beta peptides under some circumstances. This "A beta rise" phenomenon, the same inhibitor causing an increase in A beta at low concentrations but inhibition at higher concentrations, has been widely observed. Here we show that the A beta rise depends on the beta-secretase-derived C-terminal fragment of APP (beta CTF) or C99 levels with low levels causing rises. In contrast, the N-terminally truncated form of A beta, known as "p3," formed by alpha-secretase cleavage, did not exhibit a rise. In addition to the A beta rise, low beta CTF or C99 expression decreased gamma-secretase inhibitor potency. This " potency shift" may be explained by the relatively high enzyme to substrate ratio under conditions of low substrate because increased concentrations of inhibitor would be necessary to affect substrate turnover. Consistent with this hypothesis, gamma-secretase inhibitor radioligand occupancy studies showed that a high level of occupancy was correlated with inhibition of A beta under conditions of low substrate expression. The A beta rise was also observed in rat brain after dosing with the gamma-secretase inhibitor BMS-299897. The A beta rise and potency shift are therefore relevant factors in the development of gamma-secretase inhibitors and can be evaluated using appropriate choices of animal and cell culture models. Hypothetical mechanisms for the A beta rise, including the "incomplete processing" and endocytic models, are discussed.	[Burton, Catherine R.; Meredith, Jere E.; Barten, Donna M.; Goldstein, Margi E.; Krause, Carol M.; Kieras, Cathy J.; Sisk, Lisa; Iben, Lawrence G.; Polson, Craig; Thompson, Mark W.; Lin, Xu-Alan; Corsa, Jason; Fiedler, Tracey; Pierdomenico, Maria; Cao, Yang; Roach, Arthur H.; Zaczek, Robert; Albright, Charles F.; Toyn, Jeremy H.] Bristol Myers Squibb Co, Neurosci Biol, Wallingford, CT 06492 USA; [Cantone, Joseph L.; Ford, Michael J.; Drexler, Dieter M.] Bristol Myers Squibb Co, Discovery Analyt Sci, Wallingford, CT 06492 USA; [Olson, Richard E.; Yang, Michael G.; Bergstrom, Carl P.; McElhone, Kate E.; Bronson, Joanne J.; Macor, John E.] Bristol Myers Squibb Co, Discovery Chem, Wallingford, CT 06492 USA; [Blat, Yuval; Grafstrom, Robert H.; Stern, Andrew M.; Seiffert, Dietmar A.] Bristol Myers Squibb Co, Res & Dev, Chem Enzymol, Pennington, NJ 08534 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Toyn, JH (corresponding author), Bristol Myers Squibb Co, Neurosci Biol, 5 Res Pkwy, Wallingford, CT 06492 USA.	jeremy.toyn@bms.com	Grafström, Roland C/N-7217-2016	Drexler, Dieter/0000-0003-2877-7973; Stern, Andrew/0000-0002-8437-2957				Barten DM, 2005, J PHARMACOL EXP THER, V312, P635, DOI 10.1124/jpet.104.075408; Barten Donna M, 2006, Drugs R D, V7, P87, DOI 10.2165/00126839-200607020-00003; Bateman RJ, 2007, J AM SOC MASS SPECTR, V18, P997, DOI 10.1016/j.jasms.2007.02.009; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; Clarke EE, 2006, J BIOL CHEM, V281, P31279, DOI 10.1074/jbc.M605051200; Dong YZ, 2006, FASEB J, V20, P331, DOI 10.1096/fj.05-4524fje; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Durkin JT, 1999, J BIOL CHEM, V274, P20499, DOI 10.1074/jbc.274.29.20499; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Goldstein ME, 2007, J PHARMACOL EXP THER, V323, P102, DOI 10.1124/jpet.107.125492; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Higaki JN, 1999, J MED CHEM, V42, P3889, DOI 10.1021/jm990009f; HUNG AY, 1993, J BIOL CHEM, V268, P22959; Iben LG, 2007, J BIOL CHEM, V282, P36829, DOI 10.1074/jbc.M707002200; Kaether C, 2004, J CELL BIOL, V167, P809, DOI 10.1083/jcb.200410090; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Klafki HW, 1996, J BIOL CHEM, V271, P28655, DOI 10.1074/jbc.271.45.28655; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; KUENTZEL SL, 1993, BIOCHEM J, V295, P367, DOI 10.1042/bj2950367; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Moore CL, 2000, ANN NY ACAD SCI, V920, P197; Prasad CVC, 2007, BIOORG MED CHEM LETT, V17, P4006, DOI 10.1016/j.bmcl.2007.04.082; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Sato T, 2005, FEBS LETT, V579, P2907, DOI 10.1016/j.febslet.2005.04.037; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Siemers E, 2005, CLIN NEUROPHARMACOL, V28, P126, DOI 10.1097/01.wnf.0000167360.27670.29; Steinhilb ML, 2002, J NEUROCHEM, V80, P1019, DOI 10.1046/j.0022-3042.2002.00764.x; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yamazaki T, 1997, BIOCHEMISTRY-US, V36, P8377, DOI 10.1021/bi970209y; Yang MG, 2007, BIOORG MED CHEM LETT, V17, P3910, DOI 10.1016/j.bmcl.2007.04.102; Zhang LL, 1999, J BIOL CHEM, V274, P8966, DOI 10.1074/jbc.274.13.8966; Zhang LL, 2001, BIOCHEMISTRY-US, V40, P5049, DOI 10.1021/bi0028800; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200; Zhao GJ, 2007, J NEUROCHEM, V100, P1234, DOI 10.1111/j.1471-4159.2006.04302.x	53	53	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22992	23003		10.1074/jbc.M804175200	http://dx.doi.org/10.1074/jbc.M804175200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18574238	hybrid			2022-12-25	WOS:000258455400012
J	Kanungo, AK; Hao, ZY; Elia, AJ; Mak, TW; Henderson, JT				Kanungo, Anish Kumar; Hao, Zhenyue; Elia, Andrew James; Mak, Tak Wah; Henderson, Jeffrey Theodore			Inhibition of apoptosome activation protects injured motor neurons from cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; AXOTOMY-INDUCED DEATH; CYTOCHROME-C BINDING; DIFFERENTIAL REQUIREMENT; MITOCHONDRIAL RELEASE; CASPASE ACTIVATION; FACTOR AIF; MOTONEURONS; PATHWAYS; SURVIVAL	Within the mammalian central nervous system many forms of neurodegenerative injury are regulated via programmed cell death, a highly conserved program of cellular suicide. Programmed cell death is regulated by multiple signaling pathways, which have been identified within mammalian cells, although several lines of evidence suggest that the intrinsic pathway predominately regulates the death of motor neurons following acute injury in vivo. We have tested this hypothesis by performing facial axotomies on cytochrome c knock-in mice containing a point mutation in the genomic locus of cytochrome c resulting in a lysine to alanine conversion at position 72 of the protein. The introduced mutation inhibits the ability of cytochrome c to induce the formation of the apoptosome, a protein complex that is principally required for the activation of the intrinsic pathway, but does not alter its function in oxidative phosphorylation. Homozygous cytochrome c knock-in mutants displayed a significant enhancement in motor neuron survival following injury when compared with littermate controls, thus establishing the apoptosome as a viable target for protecting motor neurons from neural injury. However, protection of facial motor neurons differs from that previously reported in mice either overexpressing anti-apoptotic or lacking pro-apoptotic members of the Bcl-2 family, which are thought to regulate several aspects of mitochondrial dysfunction including the release of cytochrome c from the mitochondria to the cytoplasm. Therefore, these results directly demonstrate for the first time the influence of the apoptosome on injury-induced neuronal programmed cell death in vivo isolated from upstream Bcl-2 family-mediated effects.	[Henderson, Jeffrey Theodore] Univ Toronto, Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada; [Hao, Zhenyue; Elia, Andrew James; Mak, Tak Wah] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Henderson, JT (corresponding author), Univ Toronto, Fac Pharm, Dept Pharmaceut Sci, 144 Coll St,Rm 903, Toronto, ON M5S 3M2, Canada.	jeff.henderson@utoronto.ca						Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Alberi S, 1996, P NATL ACAD SCI USA, V93, P3978, DOI 10.1073/pnas.93.9.3978; Arnoult D, 2003, EMBO J, V22, P4385, DOI 10.1093/emboj/cdg423; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bao Q, 2005, CELL CYCLE, V4, P1001, DOI 10.4161/cc.4.8.1849; Benedict MA, 2000, J BIOL CHEM, V275, P8461, DOI 10.1074/jbc.275.12.8461; Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; Cande C, 2004, CELL DEATH DIFFER, V11, P591, DOI 10.1038/sj.cdd.4401400; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; CLATTERBUCK RE, 1994, J COMP NEUROL, V342, P45, DOI 10.1002/cne.903420106; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Colussi PA, 1999, IMMUNOL CELL BIOL, V77, P58, DOI 10.1046/j.1440-1711.1999.00788.x; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DeBilbao F, 1996, NEUROSCIENCE, V71, P1111, DOI 10.1016/0306-4522(95)00505-6; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; Ekert PG, 2005, CURR OPIN CELL BIOL, V17, P626, DOI 10.1016/j.ceb.2005.09.001; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Guegan C, 2003, J CLIN INVEST, V111, P153, DOI 10.1172/JCI200317610; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Henderson JT, 1996, CYTOKINE, V8, P784, DOI 10.1006/cyto.1996.0104; Houde C, 2004, J NEUROSCI, V24, P9977, DOI 10.1523/JNEUROSCI.3356-04.2004; Houenou LJ, 1996, CELL TISSUE RES, V286, P219, DOI 10.1007/s004410050690; Keramaris E, 2005, J BIOL CHEM, V280, P1132, DOI 10.1074/jbc.M410127200; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Oppenheim RW, 2001, J NEUROSCI, V21, P4752, DOI 10.1523/JNEUROSCI.21-13-04752.2001; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; OPPENHEIM RW, 1989, TRENDS NEUROSCI, V12, P252, DOI 10.1016/0166-2236(89)90021-0; Papadakis ES, 2006, FEBS LETT, V580, P1320, DOI 10.1016/j.febslet.2006.01.053; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; RIEDL SJ, 2007, NAT REV MOL CELL BIO; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Sendtner M, 1997, J NEUROSCI, V17, P6999; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; SNIDER WD, 1992, J NEUROBIOL, V23, P1231, DOI 10.1002/neu.480230913; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Ugolini G, 2003, J NEUROSCI, V23, P8526; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Woo M, 2000, CELL RES, V10, P267, DOI 10.1038/sj.cr.7290054; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; YAN Q, 1993, J NEUROBIOL, V24, P1555, DOI 10.1002/neu.480241202; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200; Zhao ZQ, 2004, EXP NEUROL, V190, P356, DOI 10.1016/j.expneurol.2004.06.015	71	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22105	22112		10.1074/jbc.M800988200	http://dx.doi.org/10.1074/jbc.M800988200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550520	hybrid			2022-12-25	WOS:000258114700029
J	Ozden, S; Lucas-Hourani, M; Ceccaldi, PE; Basak, A; Valentine, M; Benjannet, S; Hamelin, J; Jacob, Y; Mamchaoui, K; Mouly, V; Despres, P; Gessain, A; Butler-Browne, G; Chretien, M; Tangy, F; Vidalain, PO; Seidah, NG				Ozden, Simona; Lucas-Hourani, Marianne; Ceccaldi, Pierre-Emmanuel; Basak, Ajoy; Valentine, Menogh; Benjannet, Suzanne; Hamelin, Josee; Jacob, Yves; Mamchaoui, Kamel; Mouly, Vincent; Despres, Philippe; Gessain, Antoine; Butler-Browne, Gillian; Chretien, Michel; Tangy, Frederic; Vidalain, Pierre-Olivier; Seidah, Nabil G.			Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors - Impairment of the maturation of the E2 surface glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEMLIKI-FOREST-VIRUS; PROPROTEIN CONVERTASES; MEMBRANE-FUSION; WEAK BASES; CHLOROQUINE; CLEAVAGE; MOUSE; IDENTIFICATION; CONSEQUENCES; ACTIVATION	Chikungunya virus (CHIKV) is a mosquito-transmitted Alphavirus that causes in humans an acute infection characterized by polyarthralgia, fever, myalgia, and headache. Since 2005 this virus has been responsible for an epidemic outbreak of unprecedented magnitude. By analogy with other alphaviruses, it is thought that cellular proteases are able to process the viral precursor protein E3E2 to produce the receptor-binding E2 protein that associates as a heterodimer with E1. Destabilization of the heterodimer by exposure to low pH allows viral fusion and infection. We show that among a large panel of proprotein convertases, membranous furin but also PC5B can process E3E2 from African CHIKV strains at the HRQRR(64) down arrow ST site, whereas a CHIKV strain of Asian origin is cleaved at RRQRR(64) down arrow SI by membranous and soluble furin, PC5A, PC5B, and PACE4 but not by PC7 or SKI-1. Using fluorogenic model peptides and recombinant convertases, we observed that the Asian strain E3E2 model peptide is cleaved most efficiently by furin and PC5A. This cleavage was also observed in CHIKV-infected cells and could be blocked by furin inhibitor decanoyl-RVKR-chloromethyl ketone. This inhibitor was compared with chloroquine for its ability to inhibit CHIKV spreading in myoblast cell cultures, a cell-type previously described as a natural target of this virus. Our results demonstrate the role of furin-like proteases in the processing of CHIKV particles and point out new approaches to inhibit this infection.	[Benjannet, Suzanne; Hamelin, Josee; Chretien, Michel; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Ozden, Simona; Ceccaldi, Pierre-Emmanuel; Gessain, Antoine] Inst Pasteur, CNRS, URA 3015, Unite Epidemiol & Physiopathol Virus Oncogenes, F-75724 Paris, France; [Lucas-Hourani, Marianne; Tangy, Frederic; Vidalain, Pierre-Olivier] Inst Pasteur, CNRS, URA 3015, Lab Genom Virale & Vaccinat, F-75724 Paris, France; [Basak, Ajoy; Valentine, Menogh] Ottawa Hlth Res Inst, Reg Prot Chem Ctr, Chron Dis Program, Ottawa, ON K1Y 4E9, Canada; [Jacob, Yves] Inst Pasteur, Unite Postulante Genet Papillomavirus & Canc Huma, F-75724 Paris, France; [Mamchaoui, Kamel; Mouly, Vincent; Butler-Browne, Gillian] Univ Paris 06, UMR S 787, F-75634 Paris, France; [Mamchaoui, Kamel; Mouly, Vincent; Butler-Browne, Gillian] Univ Paris 06, INSERM, U787, F-75634 Paris, France; [Despres, Philippe] Inst Pasteur, Unite Interact Mol Flavivirus Hotes, F-75724 Paris, France	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Ottawa; Ottawa Hospital Research Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Vidalain, Pierre-Olivier/F-9778-2019; Seidah, Nabil/I-3596-2013; CECCALDI, Pierre-Emmanuel/J-6628-2017; Mouly, Gillian/G-6595-2017	Vidalain, Pierre-Olivier/0000-0003-3082-7407; Seidah, Nabil/0000-0001-6503-9342; CECCALDI, Pierre-Emmanuel/0000-0002-2736-2314; butler-browne, gillian/0000-0002-3431-242X; CHRETIEN, Michel/0000-0002-8588-4460; Mamchaoui, kamel/0000-0002-0323-9290; Mouly, Vincent/0000-0003-3809-4033; Jacob, Yves/0000-0001-9125-2374				BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; Basak S, 2006, PROTEIN PEPTIDE LETT, V13, P863, DOI 10.2174/092986606778256199; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Bergeron E, 2005, BIOCHEM BIOPH RES CO, V326, P554, DOI 10.1016/j.bbrc.2004.11.063; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; Bolt G, 2000, VIRUS RES, V68, P25, DOI 10.1016/S0168-1702(00)00149-0; Brehin AC, 2008, VIROLOGY, V371, P185, DOI 10.1016/j.virol.2007.09.028; BRIGHTON SW, 1984, S AFR MED J, V66, P217; CASSELL S, 1984, J VIROL, V52, P857, DOI 10.1128/JVI.52.3.857-864.1984; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; DECROLY E, 1994, J BIOL CHEM, V269, P12240; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; Ferreira DF, 2000, J MED MICROBIOL, V49, P313, DOI 10.1099/0022-1317-49-4-313; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HEIDNER HW, 1994, J VIROL, V68, P8064, DOI 10.1128/JVI.68.12.8064-8070.1994; Heidner HW, 1996, J VIROL, V70, P2069, DOI 10.1128/JVI.70.3.2069-2073.1996; HELENIUS A, 1982, J GEN VIROL, V58, P47, DOI 10.1099/0022-1317-58-1-47; Klimstra WB, 1999, J VIROL, V73, P6299, DOI 10.1128/JVI.73.8.6299-6306.1999; Komiyama T, 2005, ANTIMICROB AGENTS CH, V49, P3875, DOI 10.1128/AAC.49.9.3875-3882.2005; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; Mavalankar D, 2007, LANCET INFECT DIS, V7, P306, DOI 10.1016/S1473-3099(07)70091-9; MAYNE JT, 1984, VIROLOGY, V134, P338, DOI 10.1016/0042-6822(84)90302-7; Mohan A, 2006, INDIAN J MED RES, V124, P471; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; PASQUATO A, 2008, J MOL NEURO IN PRESS; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; SALMINEN A, 1992, J CELL BIOL, V116, P349, DOI 10.1083/jcb.116.2.349; Savarino A, 2004, JAIDS-J ACQ IMM DEF, V35, P223, DOI 10.1097/00126334-200403010-00002; Savarino A, 2007, LANCET INFECT DIS, V7, P633, DOI 10.1016/S1473-3099(07)70217-7; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Stroher U, 2007, J INFECT DIS, V196, pS271, DOI 10.1086/520592; Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701; Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; Weaver S., 2005, TOPLEY WILSONS MICRO; Xiao Y, 2008, VIROLOGY, V372, P384, DOI 10.1016/j.virol.2007.10.036; Zhang XY, 2003, J VIROL, V77, P2981, DOI 10.1128/JVI.77.5.2981-2989.2003; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	46	101	104	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21899	21908		10.1074/jbc.M802444200	http://dx.doi.org/10.1074/jbc.M802444200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18559340	hybrid			2022-12-25	WOS:000258114700009
J	Sacchi, S; Bernasconi, M; Martineau, M; Mothet, JP; Ruzzene, M; Pilone, MS; Pollegioni, L; Molla, G				Sacchi, Silvia; Bernasconi, Mariagrazia; Martineau, Magalie; Mothet, Jean-Pierre; Ruzzene, Maria; Pilone, Mirella S.; Pollegioni, Loredano; Molla, Gianluca			pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase - Effect on schizophrenia susceptibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-D-ASPARTATE; NMDA RECEPTORS; GENE G72; PROTEIN; LOCALIZATION; PEROXISOMES; ASTROCYTES; BRAIN; ACTIVATION; EXPRESSION	Human genes coding for pLG72 and D-amino acid oxidase have recently been linked to the onset of schizophrenia. pLG72 was proposed as an activator of the human FAD-containing flavoprotein D-amino acid oxidase (hDAAO). In the brain this oxidizes D-serine, a potent activator of N-methyl-D-aspartate receptor. We have investigated the mechanistic regulation of hDAAO by pLG72. Immunohistochemical analyses revealed that hDAAO and pLG72 are both expressed in astrocytes of the human cortex, where they most likely interact, considering their partial overlapping subcellular distribution and their coimmunoprecipitation. We demonstrated that the specific in vitro interaction of the two proteins yields a complex composed of 2 hDAAO homodimers and 2 pLG72 molecules. Binding of pLG72 did not affect the kinetic properties and FAD binding ability of hDAAO; instead, a time-dependent loss of hDAAO activity in the presence of an excess of pLG72 was found. The binding affects the tertiary structure of hDAAO, altering the amount of the active form. We finally demonstrated that overexpression of hDAAO in glioblastoma cells decreases the levels of D-serine, an effect that is null when pLG72 is coexpressed. These data indicate that pLG72 acts as a negative effector of hDAAO. Therefore, a decrease in the synaptic concentration of D-serine as the result of an anomalous increase in hDAAO activity related to hypoexpression of pLG72 may represent a molecular mechanism by which hDAAO and pLG72 are involved in schizophrenia susceptibility.	[Sacchi, Silvia; Bernasconi, Mariagrazia; Pilone, Mirella S.; Pollegioni, Loredano; Molla, Gianluca] Univ Insubria, Dept Biotechnol & Mol Sci, I-21100 Varese, Italy; [Martineau, Magalie; Mothet, Jean-Pierre] INSERM, Bordeaux Neurosci Res Ctr, U862, F-33077 Bordeaux, France; [Martineau, Magalie; Mothet, Jean-Pierre] Univ Bordeaux 2, F-33077 Bordeaux, France; [Ruzzene, Maria] Univ Padua, Dept Biol Chem, I-35121 Padua, Italy; [Ruzzene, Maria] Univ Padua, Consiglio Nazl Ric Inst Neurosci, I-35121 Padua, Italy	University of Insubria; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Padua; University of Padua	Pollegioni, L (corresponding author), Univ Insubria, Dept Biotechnol & Mol Sci, Via JH Dunant 3, I-21100 Varese, Italy.	loredano.pollegioni@uninsubria.it	Mothet, Jean-Pierre/ABE-3066-2020	Ruzzene, Maria/0000-0001-8712-8151; Molla, Gianluca/0000-0003-3688-3397; SACCHI, SILVIA/0000-0002-2338-2561; Martineau, Magalie/0000-0003-1817-2372; MOTHET, Jean-Pierre/0000-0003-4991-0614; POLLEGIONI, LOREDANO/0000-0003-1733-7243				Almond SL, 2006, MOL CELL NEUROSCI, V32, P324, DOI 10.1016/j.mcn.2006.05.003; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Cristiano L, 2001, J NEUROCYTOL, V30, P671, DOI 10.1023/A:1016525716209; Detera-Wadleigh SD, 2006, BIOL PSYCHIAT, V60, P106, DOI 10.1016/j.biopsych.2006.01.019; Katsuki H, 2004, J PHARMACOL EXP THER, V311, P836, DOI 10.1124/jpet.104.070912; Kvajo M, 2008, MOL PSYCHIATR, V13, P685, DOI 10.1038/sj.mp.4002052; Lang C, 2001, J MICROSC-OXFORD, V203, P303, DOI 10.1046/j.1365-2818.2001.00899.x; Martineau M, 2006, TRENDS NEUROSCI, V29, P481, DOI 10.1016/j.tins.2006.06.008; Molla G, 2006, PROTEIN EXPRES PURIF, V46, P150, DOI 10.1016/j.pep.2005.08.003; Molla G, 2006, FEBS LETT, V580, P2358, DOI 10.1016/j.febslet.2006.03.045; Molla G, 1998, PROTEIN EXPRES PURIF, V14, P289, DOI 10.1006/prep.1998.0956; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Owen MJ, 2004, MOL PSYCHIATR, V9, P14, DOI 10.1038/sj.mp.4001444; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Park HK, 2006, J BIOCHEM, V139, P295, DOI 10.1093/jb/mvj036; Pilone MS, 2000, CELL MOL LIFE SCI, V57, P1732, DOI 10.1007/PL00000655; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; Puyal J, 2006, J COMP NEUROL, V497, P610, DOI 10.1002/cne.21016; Ruzzene M, 1999, FEBS LETT, V461, P32, DOI 10.1016/S0014-5793(99)01409-X; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Snyder SH, 2000, NEUROCHEM RES, V25, P553, DOI 10.1023/A:1007586314648; Stevens ER, 2003, P NATL ACAD SCI USA, V100, P6789, DOI 10.1073/pnas.1237052100; Tsai GC, 1998, BIOL PSYCHIAT, V44, P1081, DOI 10.1016/S0006-3223(98)00279-0; Urai Y, 2002, NEUROSCI LETT, V324, P101, DOI 10.1016/S0304-3940(02)00184-2; USUDA N, 1986, J HISTOCHEM CYTOCHEM, V34, P1709, DOI 10.1177/34.12.2878022; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wu SZ, 2004, ANN NY ACAD SCI, V1035, P133, DOI 10.1196/annals.1332.009; YAGI K, 1956, NATURE, V177, P891, DOI 10.1038/177891a0; Yang Y, 2003, J NEUROSURG, V98, P397, DOI 10.3171/jns.2003.98.2.0397; Yue WH, 2007, NEUROSCI LETT, V416, P96, DOI 10.1016/j.neulet.2007.01.056	34	123	123	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22244	22256		10.1074/jbc.M709153200	http://dx.doi.org/10.1074/jbc.M709153200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544534	Green Published, hybrid			2022-12-25	WOS:000258114700044
J	Ho, TTG; Merajver, SD; Lapiere, CM; Nusgens, BV; Deroanne, CF				Ho, T. T. Giang; Merajver, Sofia D.; Lapiere, Charles M.; Nusgens, Betty V.; Deroanne, Christophe F.			RhoA-GDP regulates RhoB protein stability - Potential involvement of RhoGDI alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; DISSOCIATION INHIBITOR; CLOSTRIDIUM-DIFFICILE; INDUCED APOPTOSIS; CANCER-CELLS; MAP KINASE; IN-VITRO; TOXIN-B; GTPASES; EXPRESSION	RhoA plays a significant role in actin stress fibers formation. However, silencing RhoA alone or RhoA and RhoC did not completely suppress the stress fibers suggesting a residual "Rho-like" activity. RhoB, the third member of the Rho subclass, is a short-lived protein barely detectable in basal conditions. In various cell types, the silencing of RhoA induced a strong up-regulation of both total and active RhoB protein levels that were rescued by re-expressing RhoA and related to an enhanced half-life of the protein. The RhoA-dependent regulation of RhoB does not depend on the activity of RhoA but is mediated by its GDP-bound form. The stabilization of RhoB was not dependent on isoprenoid biosynthesis, Rho kinase, extracellular signal-regulated kinase, p38 mitogen-activated kinase, or phosphatidylinositol 3'-OH kinase pathways but required RhoGDI alpha. The forced expression of RhoGDI alpha increased RhoB half-life, whereas its knock-down antagonized the induction of RhoB following RhoA silencing. Moreover, a RhoA mutant (RhoAR68E) unable to bind RhoGDI alpha was significantly less efficient as compared with wild-type RhoA in reversing RhoB up-regulation upon RhoA silencing. These results suggest that, in basal conditions, RhoGDI alpha is rate-limiting and the suppression of RhoA makes it available to stabilize RhoB. Our results highlight RhoGDI alpha dependent cross-talks that regulate the stability of RhoGTPases.	[Ho, T. T. Giang; Lapiere, Charles M.; Nusgens, Betty V.; Deroanne, Christophe F.] Univ Liege, GIGA R, Lab Connect Tissue Biol, B-4000 Sart Tilman Par Liege, Belgium; [Merajver, Sofia D.] Univ Michigan, Ctr Comprehens Canc, Breast & Ovarian Canc Risk Evaluat Program, Ann Arbor, MI 48109 USA	University of Liege; University of Michigan System; University of Michigan	Deroanne, CF (corresponding author), Univ Liege, GIGA R, Lab Connect Tissue Biol, Tour Pathologie B23-3, B-4000 Sart Tilman Par Liege, Belgium.	c.deroanne@ulg.ac.be						Adnane J, 2002, CLIN CANCER RES, V8, P2225; Arozarena I, 2001, J BIOL CHEM, V276, P21878, DOI 10.1074/jbc.M011383200; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Chaplet ML, 2004, BIOCHEM J, V384, P591, DOI 10.1042/BJ20040380; Couderc B, 2008, CANCER GENE THER, V15, P456, DOI 10.1038/cgt.2008.12; Delarue FL, 2007, ONCOGENE, V26, P633, DOI 10.1038/sj.onc.1209819; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Deroanne C, 2003, J CELL SCI, V116, P1367, DOI 10.1242/jcs.00308; Deroanne CF, 2005, J CELL SCI, V118, P1173, DOI 10.1242/jcs.01707; Di-Poi N, 2001, BIOCHEMISTRY-US, V40, P10014, DOI 10.1021/bi010289c; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Du W, 1999, CANCER RES, V59, P5492; Faure J, 2001, BIOCHIMIE, V83, P409, DOI 10.1016/S0300-9084(01)01263-9; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fritz G, 1997, J BIOL CHEM, V272, P30637, DOI 10.1074/jbc.272.49.30637; Genth H, 2006, FEBS LETT, V580, P3565, DOI 10.1016/j.febslet.2006.04.100; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213; Huelsenbeck J, 2007, BIOCHEMISTRY-US, V46, P4923, DOI 10.1021/bi602465z; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Mazieres J, 2005, EXP CELL RES, V304, P354, DOI 10.1016/j.yexcr.2004.10.019; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; PULVERER B, 2003, NAT CELL BIOL, V5, P489; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Stamatakis K, 2002, J BIOL CHEM, V277, P49389, DOI 10.1074/jbc.M204049200; Wong KW, 2006, J BIOL CHEM, V281, P40379, DOI 10.1074/jbc.M605387200; Yoshida M, 2001, ARTERIOSCL THROM VAS, V21, P1165, DOI 10.1161/hq0701.092143; Zalcman G, 1996, J BIOL CHEM, V271, P30366, DOI 10.1074/jbc.271.48.30366; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175	39	58	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21588	21598		10.1074/jbc.M710033200	http://dx.doi.org/10.1074/jbc.M710033200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18524772	hybrid, Green Submitted			2022-12-25	WOS:000257898800032
J	Zhou, XB; Wulfsen, I; Lutz, S; Utku, E; Sausbier, U; Ruth, P; Wieland, T; Korth, M				Zhou, Xiao-Bo; Wulfsen, Iris; Lutz, Susanne; Utku, Emine; Sausbier, Ulrike; Ruth, Peter; Wieland, Thomas; Korth, Michael			M-2 muscarinic receptors induce airway smooth muscle activation via a dual, G beta gamma-mediated inhibition of large conductance Ca2+-activated K+ channel activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; RAT UTERINE MYOCYTES; BKCA CHANNEL; PHOSPHOINOSITIDE METABOLISM; CHOLINERGIC INHIBITION; POTASSIUM CHANNELS; ADENYLYL-CYCLASE; KNOCKOUT MICE; BINDING; SUBTYPES	Airway smooth muscle is richly endowed with muscarinic receptors of the M-2 and M-3 subtype. Stimulation of these receptors inhibits large conductance calcium-activated K+ (BK) channels, a negative feed back regulator, in a pertussis toxin-sensitive manner and thus facilitates contraction. The underlying mechanism, however, is unknown. We therefore studied the activity of bovine trachea BK channels in HEK293 cells expressing the M-2 or M-3 receptor (M2R or M3R). In M2R- but not (MR)-R-3-expressing cells, maximal effective concentrations of carbamoylcholine (CCh) inhibited whole cell BK currents by 53%. This M2R- induced inhibition was abolished by pertussis toxin treatment or overexpression of the G beta gamma scavenger transducin-alpha. In inside-out patches, direct application of 300 nM purified G beta gamma decreased channel open probability by 55%. The physical interaction of G beta gamma with BK channels was confirmed by co-immunoprecipitation. Interestingly, inhibition of phospholipase C as well as protein kinase C activities also reversed the CCh effect but to a smaller (similar to 20%) extent. Mouse tracheal cells responded similarly to CCh, purified G beta gamma and phospholipase C/protein kinase C inhibition as M2R-expressing HEK293 cells. Our results demonstrate that airway M(2)Rs inhibit BK channels by a dual, G beta gamma-mediated mechanism, a direct membrane-delimited interaction, and the activation of the phospholipase C/protein kinase C pathway.	[Zhou, Xiao-Bo; Wulfsen, Iris; Utku, Emine; Korth, Michael] Univ Klinikum Hamburg Eppendorf, Inst Pharmakol Pharmazeuten, D-20246 Hamburg, Germany; [Sausbier, Ulrike; Ruth, Peter] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Lutz, Susanne; Wieland, Thomas] Heidelberg Univ, Med Fak Mannheim, Inst Expt & Klin Pharmakol & Toxikol, D-68169 Mannheim, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg	Korth, M (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Pharmakol Pharmazeuten, Martinistr 52, D-20246 Hamburg, Germany.	korth@uke.uni-hamburg.de	Wieland, Thomas/Q-1506-2019; Zhou, Xiaobo/AAH-4320-2019; Wieland, Thomas/G-1772-2012	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261				ASHKENAZI A, 1987, SCIENCE, V238, P672, DOI 10.1126/science.2823384; Barman SA, 2004, AM J PHYSIOL-LUNG C, V286, pL149, DOI 10.1152/ajplung.00207.2003; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; Caulfield MP, 1998, PHARMACOL REV, V50, P279; DE WM, 1997, NATURE, V385, P446; DELLACQUA ML, 1993, J BIOL CHEM, V268, P5676; Eglen RM, 1996, PHARMACOL REV, V48, P531; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FERNANDES LB, 1992, J PHARMACOL EXP THER, V262, P119; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; GRANDORDY BM, 1986, J PHARMACOL EXP THER, V238, P273; HADDAD EB, 1994, AM J PHYSIOL, V266, pL642, DOI 10.1152/ajplung.1994.266.6.L642; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; JONES CA, 1987, AM J PHYSIOL, V253, pC97, DOI 10.1152/ajpcell.1987.253.1.C97; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KUME H, 1992, P NATL ACAD SCI USA, V89, P11051, DOI 10.1073/pnas.89.22.11051; KUME H, 1991, AM J PHYSIOL, V261, pC1204, DOI 10.1152/ajpcell.1991.261.6.C1204; KUME H, 1995, AM J PHYSIOL-LUNG C, V268, pL221, DOI 10.1152/ajplung.1995.268.2.L221; Liu GX, 2004, EMBO J, V23, P2196, DOI 10.1038/sj.emboj.7600228; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; MAK JCW, 1993, LIFE SCI, V53, P1501, DOI 10.1016/0024-3205(93)90624-C; MAK JCW, 1990, AM REV RESPIR DIS, V141, P1559, DOI 10.1164/ajrccm/141.6.1559; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; MEURS H, 1988, EUR J PHARMACOL, V156, P271, DOI 10.1016/0014-2999(88)90331-7; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; OFFERMANNS S, 1994, MOL PHARMACOL, V45, P890; ROFFEL A F, 1990, Pulmonary Pharmacology, V3, P47, DOI 10.1016/0952-0600(90)90009-8; ROFFEL AF, 1990, BRIT J PHARMACOL, V99, P293, DOI 10.1111/j.1476-5381.1990.tb14697.x; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; SANDMANN J, 1991, J BIOL CHEM, V266, P6031; SANKARY RM, 1988, AM REV RESPIR DIS, V138, P145, DOI 10.1164/ajrccm/138.1.145; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Schubert R, 1999, AM J PHYSIOL-CELL PH, V276, pC648, DOI 10.1152/ajpcell.1999.276.3.C648; Shipston MJ, 1996, J PHYSIOL-LONDON, V493, P665, DOI 10.1113/jphysiol.1996.sp021413; Steffens F, 2003, MOL ENDOCRINOL, V17, P2103, DOI 10.1210/me.2003-0047; Stengel PW, 2002, AM J PHYSIOL-REG I, V282, pR1443, DOI 10.1152/ajpregu.00486.2001; Stengel PW, 2000, J PHARMACOL EXP THER, V292, P877; Taguchi K, 2000, BIOL PHARM BULL, V23, P1450; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; Voigt N, 2007, CARDIOVASC RES, V74, P426, DOI 10.1016/j.cardiores.2007.02.009; WIELAND T, 1991, EUR J BIOCHEM, V196, P707, DOI 10.1111/j.1432-1033.1991.tb15869.x; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhou XB, 2000, J PHYSIOL-LONDON, V524, P339, DOI 10.1111/j.1469-7793.2000.t01-1-00339.x; Zhou XB, 1996, J BIOL CHEM, V271, P19760, DOI 10.1074/jbc.271.33.19760; Zhou XB, 2001, J BIOL CHEM, V276, P43239, DOI 10.1074/jbc.M104202200; Zhou XB, 2007, MOL ENDOCRINOL, V21, P740, DOI 10.1210/me.2006-0220	55	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21036	21044		10.1074/jbc.M800447200	http://dx.doi.org/10.1074/jbc.M800447200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18524769	Green Published, hybrid			2022-12-25	WOS:000257746100045
J	Wei, B; Chen, Z; Zhang, X; Feldman, M; Dong, XZ; Doran, R; Zhao, BL; Yin, WX; Kotlikoff, MI; Ji, GJ				Wei, Bin; Chen, Zheng; Zhang, Xu; Feldman, Morris; Dong, Xian-zhi; Doran, Robert; Zhao, Bao-Lu; Yin, Wen-xuan; Kotlikoff, Michael I.; Ji, Guangju			Nitric Oxide Mediates Stretch-Induced Ca2+Release via Activation of Phosphatidylinositol 3-Kinase-Akt Pathway in Smooth Muscle	PLOS ONE			English	Article								Background: Hollow smooth muscle organs such as the bladder undergo significant changes in wall tension associated with filling and distension, with attendant changes in muscle tone. Our previous study indicated that stretch induces Ca2+ release occurs in the form of Ca2+ sparks and Ca2+ waves in urinary bladder myocytes. While, the mechanism underlying stretch-induced Ca2+ release in smooth muscle is unknown. Methodology/Principal Findings: We examined the transduction mechanism linking cell stretch to Ca2+ release. The probability and frequency of Ca2+ sparks induced by stretch were closely related to the extent of cell extension and the time that the stretch was maintained. Experiments in tissues and single myocytes indicated that mechanical stretch significantly increases the production of nitric oxide (NO) and the amplitude and duration of muscle contraction. Stretch-induced Ca2+ sparks and contractility increases were abrogated by the NO inhibitor L-NAME and were also absent in eNOS knockout mice. Furthermore, exposure of eNOS null mice to exogenously generated NO induced Ca2+ sparks. The soluble guanylyl cyclase inhibitor ODQ did not inhibit SICR, but this process was effectively blocked by the PI3 kinase inhibitors LY494002 and wortmannin; the phosphorylation of Akt and eNOS were up-regulated by 204 +/- 28.6% and 258 +/- 36.8% by stretch, respectively. Moreover, stretch significantly increased the eNOS protein expression level. Conclusions/Significance: Taking together, these results suggest that stretch-induced Ca2+ release is NO dependent, resulting from the activation of PI3K/Akt pathway in smooth muscle.	[Wei, Bin; Chen, Zheng; Zhang, Xu; Dong, Xian-zhi; Zhao, Bao-Lu; Yin, Wen-xuan; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Feldman, Morris; Doran, Robert; Kotlikoff, Michael I.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Cornell University	Wei, B (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China.	mik7@cornell.edu; gj28@ibp.ac.cn	Wei, Bin/M-2017-2014; chen, zheng/J-4600-2014	chen, zheng/0000-0003-2161-6106; Ji, Guangju/0000-0001-8626-3490; , zheng/0000-0001-7129-6644	National Institute of Health [DK072277, HL045239]; National Foundation of Science and Technology [30670505]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072277] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health Grants NIH DK072277 and HL045239 (to M.I.K.), National Foundation of Science and Technology #30670505 (to G.J.J.).	Alvarez BV, 1999, CIRC RES, V85, P716, DOI 10.1161/01.RES.85.8.716; ANNUNZIATO L, 2006, AM J PHYSIOL-CELL PH, V290, pC233; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Cao YL, 2005, METHOD ENZYMOL, V396, P77, DOI 10.1016/S0076-6879(05)96008-4; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; Collier ML, 2000, J GEN PHYSIOL, V115, P653, DOI 10.1085/jgp.115.5.653; Dikalov S, 2005, METHOD ENZYMOL, V396, P597, DOI 10.1016/S0076-6879(05)96052-7; Eu JP, 1999, BIOCHEM PHARMACOL, V57, P1079, DOI 10.1016/S0006-2952(98)00360-8; Fritz N, 2007, J CELL SCI, V120, P3784, DOI 10.1242/jcs.009415; Hidalgo C, 2005, PHILOS T R SOC B, V360, P2237, DOI 10.1098/rstb.2005.1759; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; Ji GJ, 2004, J GEN PHYSIOL, V123, P377, DOI 10.1085/jgp.200308999; Ji GJ, 2002, J GEN PHYSIOL, V119, P533, DOI 10.1085/jgp.20028514; KIRBER MT, 1988, PFLUG ARCH EUR J PHY, V412, P339, DOI 10.1007/BF01907549; Kojda G, 1999, CARDIOVASC RES, V42, P206, DOI 10.1016/S0008-6363(98)00315-0; Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578; Malan D, 2004, FASEB J, V18, P1108, DOI 10.1096/fj.03-1158fje; Morita H, 2007, J PHARMACOL SCI, V103, P417, DOI 10.1254/jphs.FP0061332; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nowicki PT, 2007, J PEDIATR-US, V150, P40, DOI 10.1016/j.jpeds.2006.09.029; Petroff MGV, 2001, NAT CELL BIOL, V3, P867, DOI 10.1038/ncb1001-867; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Secondo A, 2006, AM J PHYSIOL-CELL PH, V290, pC233, DOI 10.1152/ajpcell.00231.2005; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Stoyanovsky D, 1997, CELL CALCIUM, V21, P19, DOI 10.1016/S0143-4160(97)90093-2; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; van der Wees CGC, 2006, PFLUG ARCH EUR J PHY, V451, P588, DOI 10.1007/s00424-005-1402-x; Wellner M C, 1993, EXS, V66, P93; WELLNER MC, 1994, J PHYSIOL-LONDON, V480, P439, DOI 10.1113/jphysiol.1994.sp020373; Xin HB, 1999, J BIOL CHEM, V274, P15315, DOI 10.1074/jbc.274.22.15315	31	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2526	10.1371/journal.pone.0002526	http://dx.doi.org/10.1371/journal.pone.0002526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575589	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000041
J	Giri, PK; Schorey, JS				Giri, Pramod K.; Schorey, Jeffrey S.			Exosomes Derived from M-Bovis BCG Infected Macrophages Activate Antigen-Specific CD4(+) and CD8(+) T Cells In Vitro and In Vivo	PLOS ONE			English	Article								Activation of both CD4(+) and CD8(+) T cells is required for an effective immune response to an M. tuberculosis infection. However, infected macrophages are poor antigen presenting cells and may be spatially separated from recruited T cells, thus limiting antigen presentation within a granuloma. Our previous studies showed that infected macrophages release from cells small membrane-bound vesicles called exosomes which contain mycobacterial lipid components and showed that these exosomes could stimulate a pro-inflammatory response in naive macrophages. In the present study we demonstrate that exosomes stimulate both CD4+ and CD8+ splenic T cells isolated from mycobacteria-sensitized mice. Although the exosomes contain MHC I and II as well as costimulatory molecules, maximum stimulation of T cells required prior incubation of exosomes with antigen presenting cells. Exosomes isolated from M. bovis and M. tuberculosis infected macrophages also stimulated activation and maturation of mouse bone marrow-derived dendritic cells. Interestingly, intranasal administration of mice with exosomes isolated from M. bovis BCG infected macrophages induce the generation of memory CD4+ and CD8+ T cells. The isolated T cells also produced IFN-gamma upon restimulation with BCG antigens. The release of exosomes from infected macrophages may overcome some of the defects in antigen presentation associated with mycobacterial infections and we suggest that exosomes may be a promising M. tuberculosis vaccine candidate.	[Giri, Pramod K.; Schorey, Jeffrey S.] Univ Notre Dame, Dept Biol Sci, Eck Ctr Global Hlth & Infect Dis, Notre Dame, IN 46556 USA	University of Notre Dame	Giri, PK (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Ctr Global Hlth & Infect Dis, Notre Dame, IN 46556 USA.	Schorey.1@nd.edu			National Institute of Allergy and Infectious Diseases [AI056979, AI052439]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056979, R01AI052439] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported through grants AI056979 and AI052439 from the National Institute of Allergy and Infectious Diseases (JSS).	Aline F, 2004, INFECT IMMUN, V72, P4127, DOI 10.1128/IAI.72.7.4127-4137.2004; Amigorena S, 2000, MEDICINA-BUENOS AIRE, V60, P51; Andersen P, 2005, MICROBES INFECT, V7, P911, DOI 10.1016/j.micinf.2005.03.013; ANDERSEN P, 1994, IMMUNOBIOLOGY, V191, P537, DOI 10.1016/S0171-2985(11)80460-2; Andre F, 2004, ANN ONCOL, V15, P141, DOI 10.1093/annonc/mdh918; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Chackerian AA, 2001, INFECT IMMUN, V69, P2666, DOI 10.1128/IAI.69.4.2666-2674.2001; Chang ST, 2005, P NATL ACAD SCI USA, V102, P4530, DOI 10.1073/pnas.0500362102; Chaput N, 2006, J LEUKOCYTE BIOL, V80, P471, DOI 10.1189/jlb.0206094; Colino J, 2007, INFECT IMMUN, V75, P220, DOI 10.1128/IAI.01217-06; COSULICH ME, 1987, P NATL ACAD SCI USA, V84, P4205, DOI 10.1073/pnas.84.12.4205; Dorer DE, 2007, CELL MICROBIOL, V9, P544, DOI 10.1111/j.1462-5822.2006.00810.x; Esser MT, 2003, VACCINE, V21, P419, DOI 10.1016/S0264-410X(02)00407-3; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; GERCKEN J, 1994, INFECT IMMUN, V62, P3472, DOI 10.1128/IAI.62.8.3472-3478.1994; Harding CV, 2003, CURR OPIN IMMUNOL, V15, P112, DOI 10.1016/S0952-7915(02)00008-0; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Marino S, 2004, J IMMUNOL, V173, P494, DOI 10.4049/jimmunol.173.1.494; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rhoades E, 2003, MOL MICROBIOL, V48, P875, DOI 10.1046/j.1365-2958.2003.03473.x; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Sable SB, 2007, CLIN IMMUNOL, V122, P239, DOI 10.1016/j.clim.2006.10.010; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Sud D, 2006, J IMMUNOL, V176, P4296, DOI 10.4049/jimmunol.176.7.4296; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Wieckowski E, 2006, IMMUNOL RES, V36, P247, DOI 10.1385/IR:36:1:247; Woodworth JSM, 2006, CRIT REV IMMUNOL, V26, P317, DOI 10.1615/CritRevImmunol.v26.i4.30	40	167	180	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2461	10.1371/journal.pone.0002461	http://dx.doi.org/10.1371/journal.pone.0002461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560543	Green Published, gold, Green Submitted			2022-12-25	WOS:000263280700042
J	West, JB; Sobek, A; Ehleringer, JR				West, Jason B.; Sobek, Adam; Ehleringer, James R.			A Simplified GIS Approach to Modeling Global Leaf Water Isoscapes	PLOS ONE			English	Article							OXYGEN-ISOTOPE RATIOS; STABLE-ISOTOPES; STOMATAL SENSITIVITY; ATMOSPHERIC CO2; DELTA-D; 3-DIMENSIONAL SYNTHESIS; INTERSPECIFIC VARIATION; TERRESTRIAL VEGETATION; MECHANISTIC MODEL; O-18 ENRICHMENT	The stable hydrogen (delta H-2) and oxygen (delta O-18) isotope ratios of organic and inorganic materials record biological and physical processes through the effects of substrate isotopic composition and fractionations that occur as reactions proceed. At large scales, these processes can exhibit spatial predictability because of the effects of coherent climatic patterns over the Earth's surface. Attempts to model spatial variation in the stable isotope ratios of water have been made for decades. Leaf water has a particular importance for some applications, including plant organic materials that record spatial and temporal climate variability and that may be a source of food for migrating animals. It is also an important source of the variability in the isotopic composition of atmospheric gases. Although efforts to model global-scale leaf water isotope ratio spatial variation have been made (especially of delta O-18), significant uncertainty remains in models and their execution across spatial domains. We introduce here a Geographic Information System (GIS) approach to the generation of global, spatially-explicit isotope landscapes ( = isoscapes) of "climate normal'' leaf water isotope ratios. We evaluate the approach and the resulting products by comparison with simulation model outputs and point measurements, where obtainable, over the Earth's surface. The isoscapes were generated using biophysical models of isotope fractionation and spatially continuous precipitation isotope and climate layers as input model drivers. Leaf water delta O-18 isoscapes produced here generally agreed with latitudinal averages from GCM/biophysical model products, as well as mean values from point measurements. These results show global-scale spatial coherence in leaf water isotope ratios, similar to that observed for precipitation and validate the GIS approach to modeling leaf water isotopes. These results demonstrate that relatively simple models of leaf water enrichment combined with spatially continuous precipitation isotope ratio and climate data layers yield accurate global leaf water estimates applicable to important questions in ecology and atmospheric science.	[West, Jason B.; Ehleringer, James R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Sobek, Adam] Univ Utah, Dept Geography, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	West, JB (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	jwest@biology.utah.edu	West, Jason B/G-8833-2012; Ehleringer, James/G-1780-2010	West, Jason/0000-0002-7811-8020	Office of National Drug Control Policy (ONDCP); Technical Support Working Group (TSWG); Terrestrial Carbon Processes (TCP) program by the office of Science (BER), U.S. Department of Energy [DE-FG03-00ER63012]	Office of National Drug Control Policy (ONDCP); Technical Support Working Group (TSWG); Terrestrial Carbon Processes (TCP) program by the office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE))	Financial support was provided by the Office of National Drug Control Policy (ONDCP), the Technical Support Working Group (TSWG), and the Terrestrial Carbon Processes (TCP) program by the office of Science (BER), U.S. Department of Energy under Grant No. DE-FG03-00ER63012.	Addington RN, 2004, TREE PHYSIOL, V24, P561, DOI 10.1093/treephys/24.5.561; BAERTSCHI P, 1976, EARTH PLANET SC LETT, V31, P341, DOI 10.1016/0012-821X(76)90115-1; Ball J.T., 1987, PROGR PHOTOSYNTHESIS, P221, DOI [10.1007/978-94-017-0519-6_48, DOI 10.1007/978-94-017-0519-6_48]; Barbour MM, 2007, FUNCT PLANT BIOL, V34, P83, DOI 10.1071/FP06228; Barbour MM, 2004, PLANT CELL ENVIRON, V27, P107, DOI 10.1046/j.0016-8025.2003.01132.x; Barbour MM, 2004, OECOLOGIA, V138, P426, DOI 10.1007/s00442-003-1449-3; Barnard RL, 2007, PLANT CELL ENVIRON, V30, P539, DOI 10.1111/j.1365-3040.2007.01654.x; BENDER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P363, DOI 10.1029/94GB00724; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Brandes E, 2007, PLANT CELL ENVIRON, V30, P113, DOI 10.1111/j.1365-3040.2006.01609.x; Brooks JR, 2002, J AGR FOOD CHEM, V50, P6413, DOI 10.1021/jf020594k; Buckley TN, 2005, NEW PHYTOL, V168, P275, DOI 10.1111/j.1469-8137.2005.01543.x; Bunn AG, 2006, EARTH INTERACT, V10; Cappa CD, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003597; Casale JF, 2005, J FORENSIC SCI, V50, P1315; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5873, DOI 10.1029/96JD02361; Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5857, DOI 10.1029/96JD02360; Coplen TB, 2002, PURE APPL CHEM, V74, P1987, DOI 10.1351/pac200274101987; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; Cramer W, 1999, GLOBAL CHANGE BIOL, V5, P1, DOI 10.1046/j.1365-2486.1999.00009.x; CUNTZ M, 2003, J GEOPHYS RES, V108; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Darling WG, 2004, QUATERNARY SCI REV, V23, P743, DOI 10.1016/j.quascirev.2003.06.016; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; DONGMANN G, 1974, RADIAT ENVIRON BIOPH, V11, P219, DOI 10.1007/BF01323191; Easterling DR, 2000, J GEOPHYS RES-ATMOS, V105, P20101, DOI 10.1029/2000JD900166; Ewers BE, 2005, PLANT CELL ENVIRON, V28, P660, DOI 10.1111/j.1365-3040.2005.01312.x; Farquhar G. D., 1993, Stable isotopes and plant carbon-water relations., P47; Farquhar GD, 2005, FUNCT PLANT BIOL, V32, P293, DOI 10.1071/FP04232; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; Farquhar GD, 2003, PLANT CELL ENVIRON, V26, P801; FLANAGAN LB, 1991, PLANT PHYSIOL, V96, P588, DOI 10.1104/pp.96.2.588; Formica VA, 2004, ECOLOGY, V85, P1125, DOI 10.1890/03-0029; FRANCEY RJ, 1987, NATURE, V327, P495, DOI 10.1038/327495a0; Gan KS, 2003, PLANT CELL ENVIRON, V26, P1479, DOI 10.1046/j.1365-3040.2003.01070.x; Gillon J, 2001, SCIENCE, V291, P2584, DOI 10.1126/science.1056374; Hansson S, 1997, ECOLOGY, V78, P2249, DOI 10.2307/2265961; Helliker BR, 2000, P NATL ACAD SCI USA, V97, P7894, DOI 10.1073/pnas.97.14.7894; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; Hobson KA, 1999, OECOLOGIA, V120, P397, DOI 10.1007/s004420050872; Hobson KA, 1999, P NATL ACAD SCI USA, V96, P8003, DOI 10.1073/pnas.96.14.8003; Hoffmann G, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002059; JACOB H, 1991, TELLUS B, V43, P291, DOI 10.1034/j.1600-0889.1991.t01-2-00003.x; Jahren AH, 2003, GEOLOGY, V31, P463, DOI 10.1130/0091-7613(2003)031<0463:HEFTME>2.0.CO;2; KEELING RF, 1995, REV GEOPHYS, V33, P1253, DOI 10.1029/95RG00438; Knouft JH, 2006, ECOLOGY, V87, pS29, DOI 10.1890/0012-9658(2006)87[29:PAOTEO]2.0.CO;2; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Lai CH, 2006, CURR OPIN OBSTET GYN, V18, P29; Lee H, 2006, TELLUS B, V58, P293, DOI 10.1111/j.1600-0889.2006.00191.x; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Liu WG, 2005, ORG GEOCHEM, V36, P851, DOI 10.1016/j.orggeochem.2005.01.006; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; Lohammar T., 1980, Ecological Bulletins, V32, P505; LUO YH, 1992, PLANT PHYSIOL, V99, P348, DOI 10.1104/pp.99.1.348; Maherali H, 2003, PLANT CELL ENVIRON, V26, P1297, DOI 10.1046/j.1365-3040.2003.01054.x; MAJOUBE M, 1971, J CHIM PHYS PCB, V68, P1423, DOI 10.1051/jcp/1971681423; Masarie KA, 2001, J GEOPHYS RES-ATMOS, V106, P20445, DOI 10.1029/2000JD000023; McKechnie AE, 2004, OECOLOGIA, V140, P191, DOI 10.1007/s00442-004-1564-9; MERLIVAT L, 1978, J CHEM PHYS, V69, P2864, DOI 10.1063/1.436884; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Ogee J, 2007, PLANT CELL ENVIRON, V30, P367, DOI 10.1111/j.1365-3040.2006.01621.x; Ogrinc N, 2003, ANAL BIOANAL CHEM, V376, P424, DOI 10.1007/s00216-003-1804-6; Oren R, 1999, PLANT CELL ENVIRON, V22, P1515, DOI 10.1046/j.1365-3040.1999.00513.x; Pearcy R. W., 1989, Plant physiological ecology: field methods and instrumentation.; Riley WJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001878; Roden JS, 1999, PLANT PHYSIOL, V120, P1165, DOI 10.1104/pp.120.4.1165; Roden JS, 2000, GEOCHIM COSMOCHIM AC, V64, P21, DOI 10.1016/S0016-7037(99)00195-7; Rossmann A, 2001, FOOD REV INT, V17, P347, DOI 10.1081/FRI-100104704; Sachse D, 2006, ORG GEOCHEM, V37, P469, DOI 10.1016/j.orggeochem.2005.12.003; Scott RL, 2006, GLOBAL CHANGE BIOL, V12, P311, DOI 10.1111/j.1365-2486.2005.01093.x; Seibt U, 2006, PLANT CELL ENVIRON, V29, P928, DOI 10.1111/j.1365-3040.2005.01474.x; Smita Joshi, 2006, AIDS Res Ther, V3, P4, DOI 10.1186/1742-6405-3-4; Strong M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028307; Terwilliger VJ, 2002, GEOCHIM COSMOCHIM AC, V66, P3887, DOI 10.1016/S0016-7037(02)00964-X; Tsujimura M, 2007, J HYDROL, V333, P35, DOI 10.1016/j.jhydrol.2006.07.025; Wang LB, 2005, REMOTE SENS ENVIRON, V95, P453, DOI 10.1016/j.rse.2005.01.006; Wang XF, 1998, GLOBAL CHANGE BIOL, V4, P835, DOI 10.1046/j.1365-2486.1998.00197.x; Welker JM, 2000, HYDROL PROCESS, V14, P1449, DOI [10.1002/1099-1085(20000615)14:8<1449::AID-HYP993>3.0.CO;2-7, 10.1002/1099-1085(20000615)14:8&lt;1449::AID-HYP993&gt;3.0.CO;2-7]; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; WEST JB, 2007, J AGR FOOD CHEM; Williams DG, 2000, ECOL MONOGR, V70, P517, DOI 10.1890/0012-9615(2000)070[0517:IAIVFS]2.0.CO;2; YAKIR D, 1989, GEOCHIM COSMOCHIM AC, V53, P2769, DOI 10.1016/0016-7037(89)90147-6; YAKIR D, 1994, PLANT CELL ENVIRON, V17, P73, DOI 10.1111/j.1365-3040.1994.tb00267.x; Yakir D, 1996, NATURE, V380, P515, DOI 10.1038/380515a0; YAKIR D, 1990, PLANT CELL ENVIRON, V13, P49, DOI 10.1111/j.1365-3040.1990.tb01298.x; Yoshimura K, 2006, GLOBAL PLANET CHANGE, V51, P90, DOI 10.1016/j.gloplacha.2005.12.007; Zhou L, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002510	89	77	78	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2447	10.1371/journal.pone.0002447	http://dx.doi.org/10.1371/journal.pone.0002447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560592	gold, Green Submitted, Green Published			2022-12-25	WOS:000263280700032
J	Galli, S; Arciuch, VGA; Poderoso, C; Converso, DP; Zhou, QQ; Joffe, EBD; Cadenas, E; Boczkowski, J; Carreras, MC; Poderoso, JJ				Galli, Soledad; Antico Arciuch, Valeria Gabriela; Poderoso, Cecilia; Converso, Daniela Paola; Zhou, Qiongqiong; de Kier Joffe, Elisa Bal; Cadenas, Enrique; Boczkowski, Jorge; Carreras, Maria Cecilia; Poderoso, Juan Jose			Tumor Cell Phenotype Is Sustained by Selective MAPK Oxidation in Mitochondria	PLOS ONE			English	Article							CYSTEINE-SULFINIC ACID; ACTIVATED PROTEIN-KINASES; OXIDE SYNTHASE ACTIVITY; N-TERMINAL KINASE; HYDROGEN-PEROXIDE; REACTIVE OXYGEN; SITE CYSTEINE; APOPTOSIS; PROLIFERATION; PEROXIREDOXIN	Mitochondria are major cellular sources of hydrogen peroxide (H2O2), the production of which is modulated by oxygen availability and the mitochondrial energy state. An increase of steady-state cell H2O2 concentration is able to control the transition from proliferating to quiescent phenotypes and to signal the end of proliferation; in tumor cells thereby, low H2O2 due to defective mitochondrial metabolism can contribute to sustain proliferation. Mitogen-activated protein kinases (MAPKs) orchestrate signal transduction and recent data indicate that are present in mitochondria and regulated by the redox state. On these bases, we investigated the mechanistic connection of tumor mitochondrial dysfunction, H2O2 yield, and activation of MAPKs in LP07 murine tumor cells with confocal microscopy, in vivo imaging and directed mutagenesis. Two redox conditions were examined: low 1 mu M H2O2 increased cell proliferation in ERK1/2-dependent manner whereas high 50 mu M H2O2 arrested cell cycle by p38 and JNK1/2 activation. Regarding the experimental conditions as a three-compartment model (mitochondria, cytosol, and nuclei), the different responses depended on MAPKs preferential traffic to mitochondria, where a selective activation of either ERK1/2 or p38-JNK1/2 by co-localized upstream kinases (MAPKKs) facilitated their further passage to nuclei. As assessed by mass spectra, MAPKs activation and efficient binding to cognate MAPKKs resulted from oxidation of conserved ERK1/2 or p38-JNK1/2 cysteine domains to sulfinic and sulfonic acids at a definite H2O2 level. Like this, high H2O2 or directed mutation of redox-sensitive ERK2 Cys(214) impeded binding to MEK1/2, caused ERK2 retention in mitochondria and restricted shuttle to nuclei. It is surmised that selective cysteine oxidations adjust the electrostatic forces that participate in a particular MAPK-MAPKK interaction. Considering that tumor mitochondria are dysfunctional, their inability to increase H2O2 yield should disrupt synchronized MAPK oxidations and the regulation of cell cycle leading cells to remain in a proliferating phenotype.	[Galli, Soledad; Antico Arciuch, Valeria Gabriela; Converso, Daniela Paola; Carreras, Maria Cecilia; Poderoso, Juan Jose] Univ Buenos Aires, Univ Hosp, Lab Oxygen Metab, Buenos Aires, DF, Argentina; [Poderoso, Cecilia] Univ Buenos Aires, Fac Med, Dept Human Biochem, Buenos Aires, DF, Argentina; [Zhou, Qiongqiong; Cadenas, Enrique] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA; [de Kier Joffe, Elisa Bal] Univ Buenos Aires, Inst Oncol Angel H Roffo, Buenos Aires, DF, Argentina; [Boczkowski, Jorge] Hop Bichat Claude Bernard, Unite INSERM 700, Paris, France; [Carreras, Maria Cecilia] Univ Buenos Aires, Sch Pharm & Biochem, Dept Clin Biochem, Buenos Aires, DF, Argentina; [Poderoso, Juan Jose] Univ Buenos Aires, Univ Hosp, Dept Med, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Southern California; University of Buenos Aires; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Buenos Aires; University of Buenos Aires	Galli, S (corresponding author), Univ Buenos Aires, Univ Hosp, Lab Oxygen Metab, Buenos Aires, DF, Argentina.	jpoderos@fmed.uba.ar	Boczkowski, Jorge/S-7474-2018	Boczkowski, Jorge/0000-0001-6619-5785	Fundacion Perez Companc, University of Buenos Aires [M073]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [5495]; Agencia Nacional para la Promocion Cientifica y Tecnologica [8468]; NIH [5R01AG016718]	Fundacion Perez Companc, University of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional para la Promocion Cientifica y Tecnologica(ANPCyT); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from Fundacion Perez Companc, University of Buenos Aires (Ubacyt M073), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (PIP 5495), Agencia Nacional para la Promocion Cientifica y Tecnologica (Foncyt, PICT 8468), and NIH (NIA) 5R01AG016718.	Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; BOVERIS A, 2000, NITRIC OXIDE BIOL PA, P355; Boveris A, 1997, OXYGEN GENE EXPRESSI, P1; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Carreras MC, 2007, AM J PHYSIOL-CELL PH, V292, pC1569, DOI 10.1152/ajpcell.00248.2006; Carreras MC, 2004, HEPATOLOGY, V40, P157, DOI 10.1002/hep.20255; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen DB, 2003, MOL CELL ENDOCRINOL, V200, P141, DOI 10.1016/S0303-7207(02)00379-9; Chodosh LA, 2002, NEW ENGL J MED, V347, P134, DOI 10.1056/NEJMcibr020712; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Galli S, 2003, CANCER RES, V63, P6370; Heerdt BG, 2003, CANCER RES, V63, P6311; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hochbaum D, 2003, J BIOL CHEM, V278, P33738, DOI 10.1074/jbc.M305208200; Hou YZ, 2007, J BIOL CHEM, V282, P9279, DOI 10.1074/jbc.M608523200; Jacob C, 2006, BIOL CHEM, V387, P1385, DOI 10.1515/BC.2006.174; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Kreft M, 2004, COMPUT METH PROG BIO, V74, P63, DOI 10.1016/S0169-2607(03)00071-3; Lee YJ, 2003, EXP CELL RES, V291, P251, DOI 10.1016/S0014-4827(03)00391-4; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pantano C, 2003, J BIOL CHEM, V278, P44091, DOI 10.1074/jbc.M308487200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Ramsey MR, 2006, NAT CELL BIOL, V8, P1213, DOI 10.1038/ncb1106-1213; Riobo NA, 2002, J BIOL CHEM, V277, P42447, DOI 10.1074/jbc.M204580200; Robinson MJ, 2002, J BIOL CHEM, V277, P5094, DOI 10.1074/jbc.M110935200; Sanchez-Ceja SG, 2006, LUNG CANCER, V54, P163, DOI 10.1016/j.lungcan.2006.07.012; Seo M, 2002, J BIOL CHEM, V277, P24197, DOI 10.1074/jbc.M201717200; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Soltys BJ, 1999, TRENDS BIOCHEM SCI, V24, P174, DOI 10.1016/S0968-0004(99)01390-0; Sumbayev VV, 2005, ARCH BIOCHEM BIOPHYS, V436, P406, DOI 10.1016/j.abb.2005.02.021; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Urtreger AJ, 2001, INT J ONCOL, V18, P639; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	54	50	51	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2379	10.1371/journal.pone.0002379	http://dx.doi.org/10.1371/journal.pone.0002379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545666	Green Published, gold, Green Submitted			2022-12-25	WOS:000263248800019
J	Bettayeb, K; Oumata, N; Echalier, A; Ferandin, Y; Endicott, JA; Galons, H; Meijer, L				Bettayeb, K.; Oumata, N.; Echalier, A.; Ferandin, Y.; Endicott, J. A.; Galons, H.; Meijer, L.			CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases	ONCOGENE			English	Article						cyclin-dependent kinase; kinase inhibitor; roscovitine; CR8; CDK9; cyclin	R-ROSCOVITINE; PROTEIN-KINASES; CELL-CYCLE; IN-VITRO; TARGETS; CYC202; CDC2; PHARMACOKINETICS; PHOSPHORYLATION; OLOMOUCINE	Among the ten pharmacological inhibitors of cyclin-dependent kinases (CDKs) currently in clinical trials, the purine roscovitine (CYC202, Seliciclib) is undergoing phase 2 trials against non-small-cell lung and nasopharyngeal cancers. An extensive medicinal chemistry study, designed to generate more potent analogues of roscovitine, led to the identification of an optimal substitution at the N6 position (compound CR8). An extensive selectivity study (108 kinases) highlights the exquisite selectivity of CR8 for CDK1/2/3/5/7/9. CR8 was 2- to 4-fold more potent than (R)-roscovitine at inhibiting these kinases. Cocrystal structures of (R)-CR8 and (R)-roscovitine with pCDK2/cyclin A showed that both inhibitors adopt essentially identical positions. The cellular effects of CR8 and (R)-roscovitine were investigated in human neuroblastoma SH-SY5Y cells. CR8 inhibited the phosphorylation of CDK1 and 9 substrates, with a 25-50 times higher potency compared to (R)-roscovitine. CR8 was consistently more potent than (R)-roscovitine at inducing apoptotic cell death parameters: 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium reduction ( 40-fold), lactate dehydrogenase release (35-fold), caspases activation (68-fold) and poly-(ADP-ribose) polymerase cleavage (50-fold). This improved cell death-inducing activity of CR8 over (R)-roscovitine was observed in 25 different cell lines. Altogether these results show that second-generation analogues of (R)-roscovitine can be designed with improved antitumor potential.	[Oumata, N.; Galons, H.] Univ Paris 05, INSERM, U648, Lab Chim Organ 2, F-75270 Paris 06, France; [Bettayeb, K.; Ferandin, Y.; Meijer, L.] CNRS, Cell Cycle Grp, Biol Stn, Bretagne, France; [Echalier, A.; Endicott, J. A.] Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); University of Oxford	Galons, H (corresponding author), Univ Paris 05, INSERM, U648, Lab Chim Organ 2, 4 Ave Observ, F-75270 Paris 06, France.	herve.galons@univ-paris5.fr; meijer@sb-roscoff.fr		, laurent/0000-0003-3511-4916; Endicott, Jane/0000-0003-4868-0116	EEC [FP6-2002]; 'Canceropole Grand-Ouest'; 'Institut National du Cancer' (INCa 'Cancer Detection d'innovations 20060); 'Association France-Alzheimer Finistere'; 'Ligue Nationale contre le Cancer (Comite du Finistere)'; 'Ministere de la Recherche'; Association pour la Recherche sur le Cancer; Institut National du Cancer	EEC; 'Canceropole Grand-Ouest'; 'Institut National du Cancer' (INCa 'Cancer Detection d'innovations 20060)(Institut National du Cancer (INCA) France); 'Association France-Alzheimer Finistere'; 'Ligue Nationale contre le Cancer (Comite du Finistere)'; 'Ministere de la Recherche'(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France)	We are grateful to J Boix, C Guillouzo and J Mester for cell lines, G Ponzio for the human foreskin primary. broblasts, Dr Michael Kubbutat (ProQinase, Freiburg, Germany) and Sir Philip Cohen (Dundee, UK) for the selectivity panel assays and to the beamline scientists at the ESRF (ID14-EH-2 and ID14-EH-1) for providing excellent facilities for crystal data collection. This research was supported by grants from the EEC (FP6-2002-Life Sciences and Health, PRO-KINASE Research Project) (LM, JE), the 'Canceropole Grand-Ouest' grant (LM), the 'Institut National du Cancer' (INCa 'Cancer Detection d'innovations 20060) (LM), the 'Association France-Alzheimer Finistere' (LM) and the 'Ligue Nationale contre le Cancer (Comite du Finistere)' (LM). KB was supported by a fellowship from the 'Ministere de la Recherche' and from the 'Association pour la Recherche sur le Cancer'. NO benefited from a PhD fellowship from the 'Institut National du Cancer'. The structures of pCDK2/cyclin A/(R)-roscovitine, and pCDK2/cyclin A/(R)-CR8 have been deposited in the PDB with accession number codes 3DDQ and 3DDP, respectively.	Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Becker F, 2004, CHEM BIOL, V11, P211, DOI 10.1016/j.chembiol.2004.02.001; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Benson C, 2007, BRIT J CANCER, V96, P29, DOI 10.1038/sj.bjc.6603509; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Cai DP, 2006, CANCER RES, V66, P9270, DOI 10.1158/0008-5472.CAN-06-1758; Chang YT, 1999, CHEM BIOL, V6, P361, DOI 10.1016/S1074-5521(99)80048-9; de la Motte S, 2004, INT J CLIN PHARM TH, V42, P232; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fischer PM, 2005, EXPERT OPIN INV DRUG, V14, P457, DOI 10.1517/13543784.14.4.457; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Guzi Timothy, 2004, Curr Opin Investig Drugs, V5, P1311; Haesslein Jean-Luc, 2002, Current Topics in Medicinal Chemistry, V2, P1037, DOI 10.2174/1568026023393291; Hallaert DYH, 2007, CELL DEATH DIFFER, V14, P1958, DOI 10.1038/sj.cdd.4402211; Havlicek L, 1997, J MED CHEM, V40, P408, DOI 10.1021/jm960666x; Kapasi AJ, 2008, J VIROL, V82, P394, DOI 10.1128/JVI.01681-07; Knippschild U, 2005, ONKOLOGIE, V28, P508, DOI 10.1159/000087137; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Kostich M, 2002, GENOME BIOL, V3; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Legraverend M, 2000, J MED CHEM, V43, P1282, DOI 10.1021/jm9911130; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; McClue SJ, 2008, DRUG METAB DISPOS, V36, P561, DOI 10.1124/dmd.107.019232; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meijer L, 2003, ACCOUNTS CHEM RES, V36, P417, DOI 10.1021/ar0201198; Meijer L, 2006, MONOGRAPHS ENZYME IN, V2, P187; Misra RN, 2006, DRUG FUTURE, V31, P43, DOI 10.1358/dof.2006.031.01.953584; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niedner RH, 2006, PROTEINS, V63, P78, DOI 10.1002/prot.20825; Nutley BP, 2005, MOL CANCER THER, V4, P125; OUMATA N, 2008, J MED CHEM IN PRESS; Payton M, 2006, CANCER RES, V66, P4299, DOI 10.1158/0008-5472.CAN-05-2507; Raynaud FI, 2005, CLIN CANCER RES, V11, P4875, DOI 10.1158/1078-0432.CCR-04-2264; Reinhardt J, 2007, PROTEIN EXPRES PURIF, V54, P101, DOI 10.1016/j.pep.2007.02.020; Ribas J, 2006, ONCOGENE, V25, P6304, DOI 10.1038/sj.onc.1209648; Ribas J, 2004, EXP CELL RES, V295, P9, DOI 10.1016/j.yexcr.2003.12.019; Ribas J, 2006, EXP CELL RES, V312, P2394, DOI 10.1016/j.yexcr.2006.04.021; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; SMITH PJ, 2006, CDK INHIBITORS CYCLI, V2; Tang L, 2005, J BIOL CHEM, V280, P31220, DOI 10.1074/jbc.M500805200; Vandromme L, 2006, BIOORG MED CHEM LETT, V16, P3144, DOI 10.1016/j.bmcl.2006.03.060; Vita M, 2005, EUR J PHARM SCI, V25, P91, DOI 10.1016/j.ejps.2005.02.001	51	141	144	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 2	2008	27	44					5797	5807		10.1038/onc.2008.191	http://dx.doi.org/10.1038/onc.2008.191			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	355QC	18574471				2022-12-25	WOS:000259722400004
J	Merched, AJ; Ko, K; Gotlinger, KH; Serhan, CN; Chan, L				Merched, Aksam J.; Ko, Kerry; Gotlinger, Katherine H.; Serhan, Charles N.; Chan, Lawrence			Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators	FASEB JOURNAL			English	Article						lipoxygenase; innate immunity	SCAVENGER RECEPTOR-A; ANTIINFLAMMATORY ACTIONS; PROTECTIN D1; 12/15-LIPOXYGENASE; EXPRESSION; 5-LIPOXYGENASE; CELLS; MACROPHAGES; ABSENCE; LESIONS	Atherosclerosis is now recognized as an inflammatory disease involving the vascular wall. Recent results indicate that acute inflammation does not simply passively resolve as previously assumed but is actively terminated by a homeostatic process that is governed by specific lipid-derived mediators initiated by lipoxygenases. Experiments with animals and humans support a proinflammatory role for the 5-lipoxygenase system. In contrast, results from animal experiments show a range of responses with the 12/15-lipoxygenase pathways in atherosclerosis. To date, the only two clinical epidemiology human studies both support an antiatherogenic role for 12/15-lipoxygenase downstream actions. We tested the hypothesis that atherosclerosis results from a failure in the resolution of local inflammation by analyzing apolipoprotein E-deficient mice with 1) global leukocyte 12/15-lipoxygenase deficiency, 2) normal enzyme expression, or 3) macrophage-specific 12/15-lipoxygenase overexpression. Results from these indicate that 12/15-lipoxygenase expression protects mice against atherosclerosis via its role in the local biosynthesis of lipid mediators, including lipoxin A(4), resolvin D1, and protectin D1. These mediators exert potent agonist actions on macrophages and vascular endothelial cells that can control the magnitude of the local inflammatory response. Taken together, these findings suggest that a failure of local endogenous resolution mechanisms may underlie the unremitting inflammation that fuels atherosclerosis.	[Merched, Aksam J.] Baylor Coll Med, Dept Mol & Cellular Biol, Div Endocrinol Diabet & Metab, Houston, TX 77030 USA; [Chan, Lawrence] Baylor Coll Med, Dept Med, Div Endocrinol Diabet & Metab, Houston, TX 77030 USA; [Chan, Lawrence] St Lukes Episcopal Hosp, Houston, TX 77030 USA; [Gotlinger, Katherine H.; Serhan, Charles N.] Harvard Univ, Dept Anesthesiol Perioperat & Pain Med, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury,Med Sch, Boston, MA 02115 USA	Baylor College of Medicine; Baylor College of Medicine; Saint Lukes Episcopal Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Merched, AJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Div Endocrinol Diabet & Metab, 1 Baylor Plaza,N52011, Houston, TX 77030 USA.	amerched@bcm.edu		Merched, Aksam/0000-0003-4030-4538	American Heart Association [0465093Y, 0730172N]; National Institutes of Health [P50 DE016191, HL-51386]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr. Colin Funk (University of Pcnnsylvania, Philadelphia, PA, USA) for sending 12/15-LO<SUP>-/-</SUP> mice that we used for pilot experiments before purchasing them from Jackson Laboratory for the definitive experiments. This work was supported by American Heart Association grants to A.M. (0465093Y and 0730172N) and grants from the National Institutes of Health (P50 DE016191 to C.N.S., and HL-51386 to L.C.).	Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Assimes TL, 2008, ATHEROSCLEROSIS, V198, P136, DOI 10.1016/j.atherosclerosis.2007.09.003; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; BREZINSKI DA, 1992, CIRCULATION, V86, P56, DOI 10.1161/01.CIR.86.1.56; Cyrus T, 2001, CIRCULATION, V103, P2277; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; Fadok VA, 2001, SEMIN IMMUNOL, V13, P365, DOI 10.1006/smim.2001.0333; George J, 2001, CIRCULATION, V104, P1646, DOI 10.1161/hc3901.095772; Goh J, 2003, GASTROENTEROLOGY, V124, P1043, DOI 10.1053/gast.2003.50154; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Hachicha M, 1999, J EXP MED, V189, P1923, DOI 10.1084/jem.189.12.1923; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Helgadottir A, 2005, AM J HUM GENET, V76, P505, DOI 10.1086/428066; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Hong S, 2007, J AM SOC MASS SPECTR, V18, P128, DOI 10.1016/j.jasms.2006.09.002; HORVAI A, 1995, P NATL ACAD SCI USA, V92, P5391, DOI 10.1073/pnas.92.12.5391; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lu Y, 2006, THESCIENTIFICWORLDJO, V6, P589, DOI 10.1100/tsw.2006.118; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Merched AJ, 2004, CIRCULATION, V110, P3830, DOI 10.1161/01.CIR.0000148681.01282.89; Merched AJ, 2003, ARTERIOSCL THROM VAS, V23, P1608, DOI 10.1161/01.ATV.0000084825.88022.53; Miller KM, 2001, MOL ECOL NOTES, V1, P131, DOI 10.1046/j.1471-8278.2001.00048.x; Miller YI, 2003, MOL BIOL CELL, V14, P4196, DOI 10.1091/mbc.E03-02-0063; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Munger KA, 1999, P NATL ACAD SCI USA, V96, P13375, DOI 10.1073/pnas.96.23.13375; Oka K, 2001, CIRCULATION, V103, P1274; Pouliot M, 2000, BIOCHEMISTRY-US, V39, P4761, DOI 10.1021/bi992551b; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; Reardon CA, 2003, ARTERIOSCL THROM VAS, V23, P1449, DOI 10.1161/01.ATV.0000079793.58054.2E; Reilly KB, 2004, J BIOL CHEM, V279, P9440, DOI 10.1074/jbc.M303857200; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; SERHAN CN, 1990, METHOD ENZYMOL, V187, P167; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; Sodin-Semrl S, 2000, J IMMUNOL, V164, P2660, DOI 10.4049/jimmunol.164.5.2660; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1989, ARTERIOSCLEROSIS, V9, pI19; Tang JJ, 2005, AM J PATHOL, V167, P901, DOI 10.1016/S0002-9440(10)62061-5; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wittwer J, 2007, CLIN CHEM LAB MED, V45, P487, DOI 10.1515/CCLM.2007.103	52	319	397	2	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3595	3606		10.1096/fj.08-112201	http://dx.doi.org/10.1096/fj.08-112201			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18559988	Green Published			2022-12-25	WOS:000259642600021
J	Mao, HZ; Abraham, CG; Krishnakumar, AM; Weber, J				Mao, Hui Z.; Abraham, Christopher G.; Krishnakumar, Arathianand M.; Weber, Joachim			A functionally important hydrogen-bonding network at the beta(DP)/alpha(DP) interface of ATP synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F-1-ATPASE; 3 CATALYTIC SITES; NUCLEOTIDE-BINDING; REGULATORY PROTEIN; BETA-SUBUNIT; EPSILON-SUBUNIT; DELTA-SUBUNIT; F1-ATPASE; HYDROLYSIS; IDENTIFICATION	ATP synthase uses a unique rotary mechanism to couple ATP synthesis and hydrolysis to transmembrane proton translocation. The F-1 subcomplex has three catalytic nucleotide binding sites, one on each beta subunit, at the interface to the adjacent alpha subunit. In the x-ray structure of F1 (Abrahams, J. P., Leslie, A. G. W., Lutter, R., and Walker, J. E. (1994) Nature 370, 621 628), the three catalytic beta/alpha interfaces differ in the extent of inter-subunit interactions between the C termini of the beta and alpha subunits. At the closed beta(DP)/alpha(DP) interface, a hydrogen-bonding network is formed between both subunits, which is absent at the more open beta(TP)/alpha(TP) interface and at the wide open beta(E)/alpha(E) interface. The hydrogen-bonding network reaches from beta L328 (Escherichia coli numbering) and beta Q441 via alpha Q399, eta R398, and alpha E402 to beta R394, and ends in a cation/pi interaction between beta R394 and alpha F406. Using mutational analysis in E. coli ATP synthase, the functional importance of the beta(DP)/alpha(DP) hydrogen-bonding network is demonstrated. Its elimination results in a severely impaired enzyme but has no pronounced effect on the binding affinities of the catalytic sites. A possible role for the hydrogen-bonding network in coupling of ATP synthesis/hydrolysis and rotation will be discussed.	[Mao, Hui Z.; Abraham, Christopher G.; Krishnakumar, Arathianand M.; Weber, Joachim] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Weber, J (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Box 41061, Lubbock, TX 79409 USA.	joachim.weber@ttuhsc.edu			National Institutes of Health Grant [GM071462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071462] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071462 (to J. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ahmad Z, 2004, J BIOL CHEM, V279, P31505, DOI 10.1074/jbc.M404621200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Clark-Walker GD, 2000, BBA-PROTEIN STRUCT M, V1478, P125, DOI 10.1016/S0167-4838(00)00003-0; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Gao YQ, 2003, P NATL ACAD SCI USA, V100, P11339, DOI 10.1073/pnas.1334188100; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; HICKS DB, 1990, J BIOL CHEM, V265, P20547; Ichikawa N, 2005, J BIOCHEM, V138, P201, DOI 10.1093/jb/mvi116; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; LEE RSF, 1989, FEBS LETT, V253, P269, DOI 10.1016/0014-5793(89)80973-1; LEE RSF, 1991, BIOCHEMISTRY-US, V30, P6842, DOI 10.1021/bi00242a006; Leslie AGW, 2000, PHILOS T ROY SOC B, V355, P465, DOI 10.1098/rstb.2000.0588; Lobau S, 1998, BIOCHEMISTRY-US, V37, P10846, DOI 10.1021/bi9807153; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Nadanaciva S, 2000, BIOCHEMISTRY-US, V39, P9583, DOI 10.1021/bi000941o; Nadanaciva S, 1999, J BIOL CHEM, V274, P7052, DOI 10.1074/jbc.274.11.7052; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200; PERLIN DS, 1983, J BIOL CHEM, V258, P9793; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; RAO R, 1988, J BIOL CHEM, V263, P5569; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; SENIOR AE, 1983, BIOCHEM J, V210, P395, DOI 10.1042/bj2100395; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; vanRaaij MJ, 1996, P NATL ACAD SCI USA, V93, P6913, DOI 10.1073/pnas.93.14.6913; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Wang YM, 2007, J BIOL CHEM, V282, P8228, DOI 10.1074/jbc.M609635200; Weber J, 2003, J BIOL CHEM, V278, P13409, DOI 10.1074/jbc.M212037200; Weber J, 2002, J BIOL CHEM, V277, P18390, DOI 10.1074/jbc.M201047200; Weber J, 2004, METHOD ENZYMOL, V380, P132; WEBER J, 1992, BIOCHEMISTRY-US, V31, P5112, DOI 10.1021/bi00137a004; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; Weber J, 1996, J BIOL CHEM, V271, P18711, DOI 10.1074/jbc.271.31.18711; Weber J, 2001, J BIOL CHEM, V276, P35422, DOI 10.1074/jbc.M104946200; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	49	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24781	24788		10.1074/jbc.M804142200	http://dx.doi.org/10.1074/jbc.M804142200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18579516	Green Published, hybrid			2022-12-25	WOS:000258820000046
J	Otero, JE; Dai, S; Foglia, D; Alhawagri, M; Vacher, J; Pasparakis, M; Abu-Amer, Y				Otero, Jesse E.; Dai, Simon; Foglia, Domenica; Alhawagri, Muhammad; Vacher, Jean; Pasparakis, Manolis; Abu-Amer, Yousef			Defective Osteoclastogenesis by IKK beta-null Precursors Is a Result of Receptor Activator of NF-kappa B Ligand (RANKL)-induced JNK-dependent Apoptosis and Impaired Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; KINASE PHOSPHATASE; ALPHA; MICE; INHIBITOR; SUBUNIT; PHOSPHORYLATION; OSTEOPETROSIS; PEPTIDE; PATHWAY		[Otero, Jesse E.; Dai, Simon; Foglia, Domenica; Alhawagri, Muhammad; Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63110 USA; [Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Vacher, Jean] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Pasparakis, Manolis] Univ Cologne, D-50674 Cologne, Germany	Washington University (WUSTL); Washington University (WUSTL); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Cologne	Abu-Amer, Y (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, 1 Barnes Jewish Hosp Plaza,Suite 11300,Box 8233, St Louis, MO 63110 USA.	abuamery@wudosis.wustl.edu	Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017	Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966	National Institutes of health [AR049192, AR054326]; Ruth L. Kirschstein Predoctoral National Research Service Award [AR055392-01]; Shriners Hospital for Children [8510, 8570]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054326, R01AR049192, R01AR047443, F31AR055392] Funding Source: NIH RePORTER	National Institutes of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein Predoctoral National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR049192 and AR054326 (to Y. A.-A.). This work was also supported by Ruth L. Kirschstein Predoctoral National Research Service Award AR055392-01 (to J. E. O.) and Shriners Hospital for Children Grants 8510 and 8570 (to Y. A.-A).	Abbas S, 2003, J BIOL CHEM, V278, P20077, DOI 10.1074/jbc.M208619200; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Bharti AC, 2004, J BIOL CHEM, V279, P6065, DOI 10.1074/jbc.M308062200; Chaisson ML, 2004, J BIOL CHEM, V279, P54841, DOI 10.1074/jbc.M406392200; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Teitelbaum SL, 2004, J CLIN INVEST, V114, P463, DOI 10.1172/JCI200422644; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	29	33	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24546	24553		10.1074/jbc.M800434200	http://dx.doi.org/10.1074/jbc.M800434200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18567579	hybrid, Green Published			2022-12-25	WOS:000258820000071
J	Footer, MJ; Lyo, JK; Theriot, JA				Footer, Matthew J.; Lyo, John K.; Theriot, Julie A.			Close packing of Listeria monocytogenes ActA, a natively unfolded protein, enhances F-actin assembly without dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; ARP2/3 COMPLEX; N-WASP; SHIGELLA-FLEXNERI; SURFACE; MOTILITY; BINDING; NUCLEATION; DOMAIN; ACTIVATION	Studies of the biochemistry of Listeria monocytogenes virulence protein ActA have typically focused on the behavior of bacteria in complex systems or on the characterization of the protein after expression and purification. Although prior in vivo work has proposed that ActA forms dimers on the surface of L. monocytogenes, dimerization has not been demonstrated in vitro, and little consideration has been given to the surface environment where ActA performs its pivotal role in bacterial actin-based motility. We have synthesized and characterized an ActA dimer and provide evidence that the two ActA molecules do not interact with each other even when tethered together. However, we also demonstrate that artificial dimers provide superior activation of actin nucleation by the Arp2/3 complex compared with monomers and that increased activation of the Arp2/3 complex by dimers may be a general property of Arp2/3 activators. It appears that the close packing (similar to 19 nm) of ActA molecules on the surface of L. monocytogenes is so dense that the kinetics of actin nucleation mimic that of synthetic ActA dimers. We also present observations indicating that ActA is a natively unfolded protein, largely random coil that is responsible for many of the unique physical properties of ActA including its extended structure, aberrant mobility during SDS-PAGE, and ability to resist irreversible denaturation upon heating.	[Theriot, Julie A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Footer, Matthew J.; Lyo, John K.; Theriot, Julie A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Lyo, John K.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Stanford University; Stanford University; Cornell University	Footer, MJ (corresponding author), 279 Campus Dr,B477, Stanford, CA 94305 USA.	footer@stanford.edu	Theriot, Julie/HHN-2034-2022	Theriot, Julie/0000-0002-2334-2535	National Institutes of Health [R01-AI36929]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036929, R37AI036929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI36929. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adler A J, 1973, Methods Enzymol, V27, P675; Auerbuch V, 2003, MOL MICROBIOL, V49, P1361, DOI 10.1046/j.1365-2958.2003.03639.x; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; BELYI YF, 1992, MED MICROBIOL IMMUN, V181, P283, DOI 10.1007/BF00198848; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Cameron LA, 2004, MOL BIOL CELL, V15, P2312, DOI 10.1091/mbc.E03-12-0913; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Cicchetti G, 1999, J BIOL CHEM, V274, P33616, DOI 10.1074/jbc.274.47.33616; Cohn E., 1943, PROTEINS AMINO ACIDS, P157; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P177; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P45; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; KOCKS C, 1993, J CELL SCI, V105, P699; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; KOCKS C, 1995, MOL MICROBIOL, V18, P413, DOI 10.1111/j.1365-2958.1995.mmi_18030413.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lauer P, 2001, MOL MICROBIOL, V42, P1163, DOI 10.1046/j.1365-2958.2001.02677.x; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lide D. R., 2008, CRC HDB CHEM PHYS, P4; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Loessner MJ, 1996, APPL ENVIRON MICROB, V62, P3057, DOI 10.1128/AEM.62.8.3057-3060.1996; Machner MP, 2001, J BIOL CHEM, V276, P40096, DOI 10.1074/jbc.M104279200; MAKAROV AA, 1994, BIOPOLYMERS, V34, P1123, DOI 10.1002/bip.360340816; Marienfeld S, 1997, ANTON LEEUW INT J G, V72, P291, DOI 10.1023/A:1000578811089; Matias VRF, 2006, J BACTERIOL, V188, P1011, DOI 10.1128/JB.188.3.1011-1021.2006; Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x; Mendelson R, 1997, P NATL ACAD SCI USA, V94, P8533, DOI 10.1073/pnas.94.16.8533; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mourrain P, 1997, P NATL ACAD SCI USA, V94, P10034, DOI 10.1073/pnas.94.19.10034; Murray CL, 2008, J VIROL, V82, P1294, DOI 10.1128/JVI.01815-07; Nielsen MM, 2007, BIOPHYS J, V92, P3674, DOI 10.1529/biophysj.106.101238; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; PARKER W, 1992, BIOPHYS J, V61, P1435, DOI 10.1016/S0006-3495(92)81949-5; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; PISTOR S, 1995, CURR BIOL, V5, P517, DOI 10.1016/S0960-9822(95)00104-7; Pistor S, 2000, J CELL SCI, V113, P3277; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; RADIVOJAC P, 2008, PAC S BIOCOMPUT, V8, P216; Rafelski SM, 2006, MOL MICROBIOL, V59, P1262, DOI 10.1111/j.1365-2958.2006.05025.x; Rafelski SM, 2005, BIOPHYS J, V89, P2146, DOI 10.1529/biophysj.105.061168; REYNOLDS JA, 1970, P NATL ACAD SCI USA, V66, P1002, DOI 10.1073/pnas.66.3.1002; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; ROMERO P, 1997, P IEEE INT C NEUR NE; Rucker AL, 2002, PROTEIN SCI, V11, P980, DOI 10.1110/ps.4550102; Ruzza P, 2004, J PEPT SCI, V10, P423, DOI 10.1002/psc.558; Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Shetron-Rama LM, 2002, INFECT IMMUN, V70, P1087, DOI 10.1128/IAI.70.3.1087-1096.2002; Skoble J, 2000, J CELL BIOL, V150, P527, DOI 10.1083/jcb.150.3.527; SMITH GA, 1995, MOL MICROBIOL, V17, P945, DOI 10.1111/j.1365-2958.1995.mmi_17050945.x; Smith GA, 1996, J CELL BIOL, V135, P647, DOI 10.1083/jcb.135.3.647; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steffen P, 2000, CELL MOTIL CYTOSKEL, V45, P58; Tarini M, 2006, IEEE T VIS COMPUT GR, V12, P1237, DOI 10.1109/TVCG.2006.115; Theriot JA, 1998, METHOD ENZYMOL, V298, P114, DOI 10.1016/S0076-6879(98)98013-2; TIFFANY ML, 1973, BIOPOLYMERS, V12, P575, DOI 10.1002/bip.1973.360120310; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Upadhyaya A, 2003, P NATL ACAD SCI USA, V100, P4521, DOI 10.1073/pnas.0837027100; Volkman BF, 2002, CELL, V111, P565, DOI 10.1016/S0092-8674(02)01076-0; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Werten MWT, 2001, PROTEIN ENG, V14, P447, DOI 10.1093/protein/14.6.447; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	77	25	25	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23852	23862		10.1074/jbc.M803448200	http://dx.doi.org/10.1074/jbc.M803448200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577520	hybrid, Green Published			2022-12-25	WOS:000258638900040
J	Neidt, EM; Skau, CT; Kovar, DR				Neidt, Erin M.; Skau, Colleen T.; Kovar, David R.			The cytokinesis formins from the nematode worm and fission yeast differentially mediate actin filament assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; CELL-DIVISION; CONTRACTILE RING; CAPPING PROTEIN; HOMOLOGY-2 DOMAIN; C-ELEGANS; BUNDLING ACTIVITY; ARP2/3 COMPLEX; ADP-ACTIN; PROFILIN	Formins drive actin filament assembly for diverse cellular processes including motility, establishing polarity, and cell division. To investigate the mechanism of contractile ring assembly in animal cells, we directly compared the actin assembly properties of formins required for cytokinesis in the nematode worm early embryo (CYK-1) and fission yeast (Cdc12p). Like Cdc12p and most other formins, CYK-1 nucleates actin filament assembly and remains processively associated with the elongating barbed end while facilitating the addition of profilin-actin above the theoretical diffusion-limited rate. However, specific properties differ significantly between Cdc12p and CYK-1. Cdc12p efficiently nucleates filaments that in the presence of profilin elongate at approximately the same rate as control filaments without formin (similar to 10.0 subunits/s). CYK-1 is an inefficient nucleator but allows filaments to elongate profilin-actin 6-fold faster than Cdc12p (similar to 60 subunits/s). Both Cdc12p and CYK-1 bind to pre-assembled actin filaments with low nanomolar affinity, but CYK-1 dissociates 2 orders of magnitude more quickly. However, CYK-1 rapidly re-associates with free barbed ends. Cdc12p allows barbed ends to elongate in the presence of excess capping protein, whereas capping protein inhibits CYK-1-mediated actin assembly. Therefore, these evolutionarily diverse formins can drive contractile ring assembly by a generally similar mechanism, but cells with unique dimensions and physical parameters might require proteins with carefully tuned actin assembly properties.	[Neidt, Erin M.; Skau, Colleen T.; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Kovar, David R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Kovar, DR (corresponding author), 920 E 58th St,Suite 915 E, Chicago, IL 60637 USA.	drkovar@uchicago.edu			National Institutes of Health [GM-079265]; Edward Mallinckrodt, Jr. Foundation; Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt, Jr. Foundation; Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-079265. This work was also supported by an Edward Mallinckrodt, Jr. Foundation grant and a Cancer Research Foundation grant (to D.R.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Andrianantoandro E, 2001, J MOL BIOL, V312, P721, DOI 10.1006/jmbi.2001.5005; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; BALASUBRAMANIAN MK, 1994, J CELL BIOL, V125, P1289, DOI 10.1083/jcb.125.6.1289; Balasubramanian MK, 1998, GENETICS, V149, P1265; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; Chang F, 1996, J CELL SCI, V109, P131; Chang F, 1999, CURR BIOL, V9, P849, DOI 10.1016/S0960-9822(99)80372-8; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Kitayama C, 1997, J CELL BIOL, V137, P1309, DOI 10.1083/jcb.137.6.1309; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; May KM, 1997, CELL MOTIL CYTOSKEL, V38, P385, DOI 10.1002/(SICI)1097-0169(1997)38:4<385::AID-CM8>3.0.CO;2-2; McCollum D, 1996, EMBO J, V15, P6438, DOI 10.1002/j.1460-2075.1996.tb01035.x; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Michelot A, 2006, CURR BIOL, V16, P1924, DOI 10.1016/j.cub.2006.07.054; Morrell JL, 1999, MOL BIOL CELL, V10, P4201, DOI 10.1091/mbc.10.12.4201; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Oegema Karen, 2006, WormBook, P1, DOI 10.1895/wormbook.1.72.1; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217; Polet D, 2006, CELL MOTIL CYTOSKEL, V63, P14, DOI 10.1002/cm.20102; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Sohrmann M, 1996, GENE DEV, V10, P2707, DOI 10.1101/gad.10.21.2707; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Swan KA, 1998, J CELL SCI, V111, P2017; Takaine M, 2007, J BIOL CHEM, V282, P21683, DOI 10.1074/jbc.M611371200; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Werner M, 2007, CURR BIOL, V17, P1286, DOI 10.1016/j.cub.2007.06.070; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yonetani A, 2008, MOL BIOL CELL, V19, P2208, DOI 10.1091/mbc.E07-07-0731; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	61	50	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23872	23883		10.1074/jbc.M803734200	http://dx.doi.org/10.1074/jbc.M803734200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577519	hybrid, Green Published			2022-12-25	WOS:000258638900042
J	Balogi, Z; Cheregi, O; Giese, KC; Juhasz, K; Vierling, E; Vass, I; Vigh, L; Horvath, I				Balogi, Zsolt; Cheregi, Ottilia; Giese, Kim C.; Juhasz, Kata; Vierling, Elizabeth; Vass, Imre; Vigh, Laszlo; Horvath, Ibolya			A mutant small heat shock protein with increased thylakoid association provides an elevated resistance against UV-B damage in Synechocystis 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II; IN-VIVO; ALPHA-CRYSTALLIN; D1 PROTEIN; MEMBRANE; LIPIDS; CYANOBACTERIUM; EXPRESSION; REPAIR; SITE	Besides acting as molecular chaperones, the amphitropic small heat shock proteins (sHsps) are suggested to play an additional role in membrane quality control. We investigated sHsp membrane function in the model cyanobacterium Synechocystis sp. PPC 6803 using mutants of the single sHsp from this organism, Hsp17. We examined mutants in the N-terminal arm, L9P and Q16R, for altered interaction with thylakoid and lipid membranes and examined the effects of these mutations on thylakoid functions. These mutants are unusual in that they retain their oligomeric state and chaperone activity in vitro but fail to confer thermotolerance in vivo. We found that both mutant proteins had dramatically altered membrane/lipid interaction properties. Whereas L9P showed strongly reduced binding to thylakoid and model membranes, Q16R was almost exclusively membrane-associated, properties that may be the cause of reduced heat tolerance of cells carrying these mutations. Among the lipid classes tested, Q16R displayed the highest interaction with negatively charged SQDG. In Q16R cells a specific alteration of the thylakoid-embedded Photosystem II ( PSII) complex was observed. Namely, the binding of plastoquinone and quinone analogue acceptors to the Q(B) site was modified. In addition, the presence of Q16R dramatically reduced UV-B damage of PSII activity because of enhanced PSII repair. We suggest these effects occur at least partly because of increased interaction of Q16R with SQDG in the PSII complex. Our findings further support the model that membrane association is a functional property of sHsps and suggest sHsps as a possible biotechnological tool to enhance UV protection of photosynthetic organisms.	[Balogi, Zsolt; Juhasz, Kata; Vigh, Laszlo; Horvath, Ibolya] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Cheregi, Ottilia; Vass, Imre] Hungarian Acad Sci, Biol Res Ctr, Dept Plant Biol, H-6701 Szeged, Hungary; [Giese, Kim C.; Vierling, Elizabeth] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Arizona	Horvath, I (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, POB 521, H-6701 Szeged, Hungary.	hibi@brc.hu	Multhoff, Gabriele/AAW-9796-2021; Juhasz, Kata/ABB-9246-2020; Vass, Imre/AAS-6171-2021	Multhoff, Gabriele/0000-0002-2616-3137; Vass, Imre/0000-0003-4987-7842; Vierling, Elizabeth/0000-0002-0066-4881	National Institutes of Health [1 R03 TW006154-01A1]; European Union [SOLAR-H2, 212508]; FOGARTY INTERNATIONAL CENTER [R03TW006154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R03 TW006154-01A1 (to E.V. and L.V.). This work was also supported by European Union Grant SOLAR-H2, 212508 (to O.C. and I.V.).	Ahn YJ, 2006, PLANT CELL ENVIRON, V29, P95, DOI 10.1111/j.1365-3040.2005.01403.x; Allahverdiyeva Y, 2004, EUR J BIOCHEM, V271, P3523, DOI 10.1111/j.0014-2956.2004.04287.x; Balogi Z, 2005, ARCH BIOCHEM BIOPHYS, V436, P346, DOI 10.1016/j.abb.2005.02.018; BARBATO R, 1992, J CELL BIOL, V119, P325, DOI 10.1083/jcb.119.2.325; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Cheregi O, 2007, BBA-BIOENERGETICS, V1767, P820, DOI 10.1016/j.bbabio.2006.11.016; Chowdary TK, 2007, BIOCHEM J, V401, P437, DOI 10.1042/BJ20061046; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Giese KC, 2004, J BIOL CHEM, V279, P32674, DOI 10.1074/jbc.M404455200; Giese KC, 2005, P NATL ACAD SCI USA, V102, P18896, DOI 10.1073/pnas.0506169103; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Glatz A, 1999, PLANT PHYSIOL BIOCH, V37, P1, DOI 10.1016/S0981-9428(99)80061-8; Horvath I, 1998, P NATL ACAD SCI USA, V95, P3513, DOI 10.1073/pnas.95.7.3513; Huang LX, 2002, J BACTERIOL, V184, P6845, DOI 10.1128/JB.184.24.6845-6858.2002; JOLIOT A, 1964, CR HEBD ACAD SCI, V258, P4622; KANERVO E, 1995, FEBS LETT, V364, P239, DOI 10.1016/0014-5793(95)00404-W; Kanervo E, 1997, PLANT PHYSIOL, V114, P841, DOI 10.1104/pp.114.3.841; KOMENDA J, 1995, BIOCHEMISTRY-US, V34, P9625, DOI 10.1021/bi00029a040; Lee AG, 2005, MOL BIOSYST, V1, P203, DOI 10.1039/b504527d; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Lee S, 2000, CURR MICROBIOL, V40, P283, DOI 10.1007/s002849910056; Li Y, 2004, RAPID COMMUN MASS SP, V18, P135, DOI 10.1002/rcm.1288; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; Nakamoto H, 2000, FEBS LETT, V483, P169, DOI 10.1016/S0014-5793(00)02097-4; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Rhee KH, 1997, NATURE, V389, P522, DOI 10.1038/39103; Sass L, 1997, PHOTOSYNTH RES, V54, P55, DOI 10.1023/A:1005895924892; SATOH K, 1995, PLANT CELL PHYSIOL, V36, P597; Silva P, 2003, PLANT CELL, V15, P2152, DOI 10.1105/tpc.012609; SKINNER MK, 1983, BIOCHEM J, V209, P281, DOI 10.1042/bj2090281; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Torok Z, 1997, P NATL ACAD SCI USA, V94, P2192, DOI 10.1073/pnas.94.6.2192; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Tsvetkova NM, 2002, P NATL ACAD SCI USA, V99, P13504, DOI 10.1073/pnas.192468399; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Vass I, 1999, BIOCHEMISTRY-US, V38, P12786, DOI 10.1021/bi991094w; VASS I, 1996, HDB PHOTOSYNTHESIS, P931; Vass I, 2007, COMPR SER PHOTOCH, V8, P393; VIGH L, 1993, P NATL ACAD SCI USA, V90, P9090, DOI 10.1073/pnas.90.19.9090; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325	42	45	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22983	22991		10.1074/jbc.M710400200	http://dx.doi.org/10.1074/jbc.M710400200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18574246	hybrid, Green Published			2022-12-25	WOS:000258455400011
J	Bannister, RA; Grabner, M; Beam, KG				Bannister, Roger A.; Grabner, Manfred; Beam, Kurt G.			The alpha(1S) III-IV loop influences 1,4-dihydropyridine receptor gating but is not directly involved in excitation-contraction coupling interactions with the type 1 ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE DIHYDROPYRIDINE RECEPTOR; DYSGENIC SKELETAL-MUSCLE; CHANNEL BETA-SUBUNIT; SLOW CALCIUM CURRENT; CARBOXYL-TERMINUS; CA2+ CHANNELS; EXPRESSION; CURRENTS; MUTATION; ABSENCE	In skeletal muscle, coupling between the 1,4-dihydropyridine receptor (DHPR) and the type 1 ryanodine receptor (RyR1) underlies excitation-contraction (EC) coupling. The III-IV loop of the DHPR alpha(1S) subunit binds to a segment of RyR1 in vitro, and mutations in the III-IV loop alter the voltage dependence of EC coupling, raising the possibility that this loop is directly involved in signal transmission from the DHPR to RyR1. To clarify the role of the alpha(1S) III-IV loop in EC coupling, we examined the functional properties of a chimera (GFP-alpha(1S)[III-IVa]) in which the III-IV loop of the divergent alpha(1A) isoform replaced that of alpha(1S). Dysgenic myotubes expressing GFP-alpha(1S)[III-IVa] yielded myoplasmic Ca2+ transients that activated at similar to 10 mV more hyperpolarized potentials and that were similar to 65% smaller than those of GFP-alpha(1S). A similar reduction was observed in voltage-dependent charge movements for GFP-alpha(1S)[III-IVa], indicating that the chimeric channels trafficked less well to the membrane but that those that were in the membrane functioned as efficiently in EC coupling as GFP-alpha(1S). Relative to GFP-alpha(1S), L-type currents mediated by GFP-alpha(1S)[III-IVa] were similar to 40% smaller and activated at similar to 5 mV more hyperpolarized potentials. The altered gating of GFP-alpha(1S)[III-IVa] was accentuated by exposure to +/- Bay K 8644, which caused a much larger hyperpolarizing shift in activation compared with its effect on GFP-alpha(1S). Taken together, our observations indicate that the alpha(1S) III-IV loop is not directly involved in EC coupling but does influence DHPR gating transitions important both for EC coupling and activation of L-type conductance.	[Bannister, Roger A.; Beam, Kurt G.] Univ Colorado Denver, Dept Physiol & Biophys, Aurora, CO 80045 USA; [Grabner, Manfred] Innsbruck Med Univ, Dept Med Genet Clin & Mol Pharmacol, A-6020 Innsbruck, Austria	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Medical University of Innsbruck	Beam, KG (corresponding author), Univ Colorado Denver, Dept Physiol & Biophys, POB 6511,Mail Stop F8307, Aurora, CO 80045 USA.	kurt.beam@uchsc.edu	Tuluc, Petronel/C-2527-2011		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR044750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024444] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR44750] Funding Source: Medline; NINDS NIH HHS [NS24444] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS BA, 1994, J GEN PHYSIOL, V104, P985, DOI 10.1085/jgp.104.5.985; ADAMS BA, 1989, J GEN PHYSIOL, V94, P429, DOI 10.1085/jgp.94.3.429; ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; Ahern CA, 2001, BIOPHYS J, V81, P3294, DOI 10.1016/S0006-3495(01)75963-2; Avila G, 2000, J GEN PHYSIOL, V115, P467, DOI 10.1085/jgp.115.4.467; Avila G, 2001, J BIOL CHEM, V276, P17732, DOI 10.1074/jbc.M009685200; Bannister RA, 2008, BIOPHYS J, V94, P2631, DOI 10.1529/biophysj.107.116467; Bannister RA, 2005, BIOPHYS J, V88, p640A; Bannister RA, 2005, BIOCHEM BIOPH RES CO, V336, P134, DOI 10.1016/j.bbrc.2005.08.047; Bannister RA, 2007, J MUSCLE RES CELL M, V28, P275, DOI 10.1007/s10974-007-9118-5; BEAM KG, 1986, NATURE, V320, P168, DOI 10.1038/320168a0; Beam KG, 1997, METHOD CELL BIOL, V52, P283, DOI 10.1016/S0091-679X(08)60384-2; BEAM KG, 2004, MYOLOGY, P257; Beurg M, 1999, BIOPHYS J, V77, P2953, DOI 10.1016/S0006-3495(99)77128-6; CACHELIN AB, 1983, NATURE, V304, P462, DOI 10.1038/304462a0; Carbonneau L, 2005, BIOPHYS J, V89, P243, DOI 10.1529/biophysj.104.056218; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; DELCOUR AH, 1993, SCIENCE, V259, P980, DOI 10.1126/science.8094902; DIRKSEN RT, 1995, J GEN PHYSIOL, V105, P227, DOI 10.1085/jgp.105.2.227; Flucher BE, 2000, J CELL BIOL, V151, P467, DOI 10.1083/jcb.151.2.467; Freise D, 2000, J BIOL CHEM, V275, P14476, DOI 10.1074/jbc.275.19.14476; Gach MP, 2008, BIOPHYS J, V94, P3023, DOI 10.1529/biophysj.107.118893; GARCI AK, 2007, J PHYSL, V586, P727; GARCIA J, 1994, J GEN PHYSIOL, V103, P125, DOI 10.1085/jgp.103.1.125; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Kugler G, 2004, J BIOL CHEM, V279, P4721, DOI 10.1074/jbc.M307538200; Leong P, 1998, J BIOL CHEM, V273, P29958, DOI 10.1074/jbc.273.45.29958; LLINAS RR, 1989, ANN NY ACAD SCI, V560, P103, DOI 10.1111/j.1749-6632.1989.tb24084.x; Lorenzon NM, 2007, J GEN PHYSIOL, V130, P379, DOI 10.1085/jgp.200609730; Lorenzon NM, 2004, J BIOL CHEM, V279, P44057, DOI 10.1074/jbc.M405318200; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Obermair GJ, 2005, J BIOL CHEM, V280, P2229, DOI 10.1074/jbc.M411501200; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Proenza C, 2000, J BIOL CHEM, V275, P23169, DOI 10.1074/jbc.M003389200; SANGUINETTI MC, 1984, J MOL CELL CARDIOL, V16, P667, DOI 10.1016/S0022-2828(84)80631-8; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Sencer S, 2001, J BIOL CHEM, V276, P38237; Sheridan DC, 2006, P NATL ACAD SCI USA, V103, P19760, DOI 10.1073/pnas.0609473103; Sheridan DC, 2004, BIOPHYS J, V87, P929, DOI 10.1529/biophysj.104.043810; Sheridan DC, 2003, BIOPHYS J, V85, P3739, DOI 10.1016/S0006-3495(03)74790-0; Sheridan DC, 2003, BIOPHYS J, V84, P220, DOI 10.1016/S0006-3495(03)74844-9; Slavik KJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1475, DOI 10.1152/ajpcell.1997.272.5.C1475; Strube C, 1996, BIOPHYS J, V71, P2531, DOI 10.1016/S0006-3495(96)79446-8; Takekura H, 2004, MOL BIOL CELL, V15, P5408, DOI 10.1091/mbc.E04-05-0414; TANABE T, 1990, NATURE, V344, P451, DOI 10.1038/344451a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; THOMAS G, 1985, CIRC RES, V56, P87, DOI 10.1161/01.RES.56.1.87; Ursu D, 2001, J PHYSIOL-LONDON, V533, P367, DOI 10.1111/j.1469-7793.2001.0367a.x; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Weiss RG, 2004, AM J PHYSIOL-CELL PH, V287, pC1094, DOI 10.1152/ajpcell.00173.2004; Wilkens CM, 2001, J GEN PHYSIOL, V118, P495, DOI 10.1085/jgp.118.5.495; Wilkens CM, 2001, P NATL ACAD SCI USA, V98, P5892, DOI 10.1073/pnas.101618098	58	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23217	23223		10.1074/jbc.M804312200	http://dx.doi.org/10.1074/jbc.M804312200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556650	Green Published, hybrid			2022-12-25	WOS:000258455400035
J	Radzimanowski, J; Ravaud, S; Schlesinger, S; Koch, J; Beyreuther, K; Sinning, I; Wild, K				Radzimanowski, Jens; Ravaud, Stephanie; Schlesinger, Sabine; Koch, Joachim; Beyreuther, Konrad; Sinning, Irmgard; Wild, Klemens			Crystal structure of the human Fe65-PTB1 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; PHOSPHOTYROSINE-BINDING DOMAIN; BETA-PROTEIN; FE65; RECOGNITION; INTERNALIZATION; DISABLED-1; DISTINCT; IRS-1; MOTIF	The neuronal adaptor protein Fe65 is involved in brain development, Alzheimer disease amyloid precursor protein (APP) signaling, and proteolytic processing of APP. It contains three protein-protein interaction domains, one WW domain, and a unique tandem array of phosphotyrosine-binding (PTB) domains. The N-terminal PTB domain (Fe65-PTB1) was shown to interact with a variety of proteins, including the low density lipoprotein receptor-related protein (LRP-1), the ApoEr2 receptor, and the histone acetyltransferase Tip60. We have determined the crystal structures of human Fe65-PTB1 in its apo- and in a phosphate-bound form at 2.2 and 2.7 angstrom resolution, respectively. The overall fold shows a PTB-typical pleckstrin homology domain superfold. Although Fe65-PTB1 has been classified on an evolutionary basis as a Dab-like PTB domain, it contains attributes of other PTB domain subfamilies. The phosphotyrosine-binding pocket resembles IRS-like PTB domains, and the bound phosphate occupies the binding site of the phosphotyrosine (Tyr(P)) within the canonical NPXpY recognition motif. In addition Fe65-PTB1 contains a loop insertion between helix alpha 2 and strand beta 2 (alpha 2/beta 2 loop) similar to members of the Shc-like PTB domain subfamily. The structural comparison with the Dab1-PTB domain reveals a putative phospholipid-binding site opposite the peptide binding pocket. We suggest Fe65-PTB1 to interact with its target proteins involved in translocation and signaling of APP in a phosphorylation- dependent manner.	[Radzimanowski, Jens; Ravaud, Stephanie; Schlesinger, Sabine; Sinning, Irmgard; Wild, Klemens] Heidelberg Univ, Biochem Ctr, INF328, D-69120 Heidelberg, Germany; [Koch, Joachim] Goethe Univ Frankfurt, Bioctr, Inst Biochem, D-69438 Frankfurt, Germany; [Beyreuther, Konrad] Heidelberg Univ, Ctr Mol Biol, INF282, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Goethe University Frankfurt; Ruprecht Karls University Heidelberg	Wild, K (corresponding author), Heidelberg Univ, Biochem Ctr, INF328, D-69120 Heidelberg, Germany.	klemens.wild@bzh.uni-heidelberg.de	Sinning, Irmgard/A-2982-2010		Deutsche Forschungsgemeinschaft [WI2649/1-1, WI2649/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants WI2649/1-1 and WI2649/1-2 ( to K. W.).	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Farooq A, 1999, J BIOL CHEM, V274, P6114, DOI 10.1074/jbc.274.10.6114; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Hass MR, 2005, J BIOL CHEM, V280, P36895, DOI 10.1074/jbc.M502861200; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Holm L, 1996, METHOD ENZYMOL, V266, P653; Howell BW, 1999, MOL CELL BIOL, V19, P5179; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; KOCH J, 2002, SPRING LAB MAN, P69; KOO EH, 1994, J BIOL CHEM, V269, P17386; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Radzimanowski J, 2008, ACTA CRYSTALLOGR F, V64, P382, DOI 10.1107/S174430910800835X; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Santiard-Baron D, 2005, J NEUROCHEM, V93, P330, DOI 10.1111/j.1471-4159.2005.03026.x; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Stolt PC, 2004, BIOCHEMISTRY-US, V43, P10979, DOI 10.1021/bi049092l; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Sumioka A, 2005, J BIOL CHEM, V280, P42364, DOI 10.1074/jbc.M504278200; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128; Zambrano N, 2001, J BIOL CHEM, V276, P19787, DOI 10.1074/jbc.M100792200; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0	54	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23113	23120		10.1074/jbc.M800861200	http://dx.doi.org/10.1074/jbc.M800861200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550529	hybrid			2022-12-25	WOS:000258455400024
J	Kwon, MS; Do Lee, S; Kim, JA; Colla, E; Choi, YJ; Suh, PG; Kwon, HM				Kwon, Min Seong; Do Lee, Sang; Kim, Jeong-Ah; Colla, Emanuela; Choi, Yu Jeong; Suh, Pann-Ghil; Kwon, H. Moo			Novel nuclear localization signal regulated by ambient tonicity in vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEIN; TRANSCRIPTION FACTOR TONEBP; SYSTEMIC HYPERTONICITY; DOWN-REGULATION; OSMOTIC-STRESS; EXPRESSION; KINASE; EXPORT; PHOSPHORYLATION; DIMERIZATION	TonEBP is a Rel domain-containing transcription factor implicated in adaptive immunity, viral replication, and cancer. In the mammalian kidney, TonEBP is a central regulator of water homeostasis. Animals deficient in TonEBP suffer from life-threatening dehydration due to renal water loss. Ambient tonicity (effective osmolality) is the prominent signal for TonEBP in a bidirectional manner; TonEBP activity decreases in hypotonicity, whereas it increases in hypertonicity. Here we found that TonEBP displayed nuclear export in response to hypotonicity and nuclear import in response to hypertonicity. The nuclear export of TonEBP was not mediated by the nuclear export receptor CRM1 or discrete nuclear export signal. In contrast, a dominant nuclear localization signal (NLS) was found in a small region of 16 amino acid residues. When short peptides containing the NLS were fused to constitutively cytoplasmic proteins, the fusion proteins displayed tonicity-dependent nucleocytoplasmic trafficking like TonEBP. Thus, tonicity-dependent activation of the NLS is crucial in the nucleocytoplasmic trafficking of TonEBP. The novel NLS is present only in the vertebrates, indicating that it developed late in evolution.	[Kwon, Min Seong; Do Lee, Sang; Kim, Jeong-Ah; Colla, Emanuela; Kwon, H. Moo] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Choi, Yu Jeong; Suh, Pann-Ghil] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea	University System of Maryland; University of Maryland Baltimore; Pohang University of Science & Technology (POSTECH)	Kwon, HM (corresponding author), 22 S Greene St,Suite N3W143, Baltimore, MD 21201 USA.	mkwon@medicine.umaryland.edu	Suh, Pann-Ghill/F-3610-2010; Lee-Kwon, Whaseon/D-6021-2011; Colla, Emanuela/H-2483-2013	Colla, Emanuela/0000-0002-4755-7450	NIDDK NIH HHS [DK61677] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061677] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Cha JH, 2001, J AM SOC NEPHROL, V12, P2221, DOI 10.1681/ASN.V12112221; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; Ha H, 2003, J BIOL CHEM, V278, P18573, DOI 10.1074/jbc.M212626200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Jeon US, 2007, AM J PHYSIOL-RENAL, V293, pF408, DOI 10.1152/ajprenal.00502.2006; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Lee SD, 2002, BIOCHEM BIOPH RES CO, V294, P968, DOI 10.1016/S0006-291X(02)00572-7; Lim SW, 2007, J AM SOC NEPHROL, V18, P421, DOI 10.1681/ASN.2006060664; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Loyher ML, 2004, NEUROSCIENCE, V124, P89, DOI 10.1016/j.neuroscience.2003.10.025; Maallem S, 2006, NEUROSCIENCE, V137, P51, DOI 10.1016/j.neuroscience.2005.07.037; Maouyo D, 2002, AM J PHYSIOL-RENAL, V282, pF802, DOI 10.1152/ajprenal.00123.2001; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Nakahara S, 2006, CANCER RES, V66, P9995, DOI 10.1158/0008-5472.CAN-06-1772; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Ranjbar S, 2006, PLOS PATHOG, V2, P1176, DOI 10.1371/journal.ppat.0020130; Stroud JC, 2002, NAT STRUCT BIOL, V9, P90, DOI 10.1038/nsb749; Tong EHY, 2006, J BIOL CHEM, V281, P23870, DOI 10.1074/jbc.M602556200; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200; Zhang Z, 2005, AM J PHYSIOL-RENAL, V289, pF506, DOI 10.1152/ajprenal.00417.2004; Zhu JY, 1999, NATURE, V398, P256, DOI 10.1038/18473; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	37	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22400	22409		10.1074/jbc.M710550200	http://dx.doi.org/10.1074/jbc.M710550200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18579527	hybrid, Green Published			2022-12-25	WOS:000258321000008
J	Li, Y; Bevilacqua, E; Chiribau, CB; Majumder, M; Wang, CP; Croniger, CM; Snider, MD; Johnson, PF; Hatzoglou, M				Li, Yi; Bevilacqua, Elena; Chiribau, Calin-Bogdan; Majumder, Mithu; Wang, Chuanping; Croniger, Colleen M.; Snider, Martin D.; Johnson, Peter F.; Hatzoglou, Maria			Differential control of the CCAAT/enhancer-binding protein beta (C/EBP beta) products liver-enriched transcriptional activating protein (LAP) and liver- enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; SITE-MEDIATED TRANSLATION; AMINO-ACID TRANSPORTER; ER STRESS; ARGININE/LYSINE TRANSPORTER; NEGATIVE FEEDBACK; NF-Y; PHOSPHORYLATION; INDUCTION; CHOP	The accumulation of unfolded proteins in the endoplasmic reticulum (ER) triggers a stress response program that protects cells early in the response and can lead to apoptosis during prolonged stress. The basic leucine zipper transcription factor, CCAAT/enhancer-binding protein beta (C/EBP beta), is one of the genes with increased expression during ER stress. Translation of the C/EBP beta mRNA from different initiation codons leads to the synthesis of two transcriptional activators (LAP-1 and -2) and a transcriptional repressor (LIP). The LIP/LAP ratio is a critical factor in C/EBP beta-mediated gene transcription. It is shown here that the LIP/LAP ratio decreased by 5-fold during the early phase of ER stress and increased by 20-fold during the late phase, mostly because of changes in LIP levels. The early decrease in LIP required degradation via the proteasome pathway and phosphorylation of the translation initiation factor, eIF2 alpha. The increased LIP levels during the late phase were due to increased synthesis and increased stability of the protein. It is proposed that regulation of synthesis and degradation rates during ER stress controls the LIP/LAP ratio. The importance of C/EBP beta in the ER-stress response program was demonstrated using C/EBP beta-deficient mouse embryonic fibroblasts. It is shown that C/EBP beta attenuates expression of pro-survival ATF4 target genes in late ER stress and enhances expression of cell death-associated genes downstream of CHOP. The inhibitory effect of LIP on ATF4-induced transcription was demonstrated for the cat-1 amino acid transporter gene. We conclude that regulation of LIP/LAP ratios during ER stress is a novel mechanism for modulating the cellular stress response.	[Li, Yi; Bevilacqua, Elena; Chiribau, Calin-Bogdan; Majumder, Mithu; Wang, Chuanping; Croniger, Colleen M.; Hatzoglou, Maria] Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA; [Snider, Martin D.] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; [Johnson, Peter F.] NCI Frederick, Basic Res Lab, Natl Inst Hlth, Frederick, MD 21702 USA	Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Hatzoglou, M (corresponding author), Case Western Reserve Univ, Dept Nutr, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	mxh8@case.edu	Johnson, Peter/A-1940-2012	Johnson, Peter/0000-0002-4145-4725; Li, Yi/0000-0002-5048-6075	NATIONAL CANCER INSTITUTE [ZIABC010328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075040, R01DK060596, R01DK053307, R37DK060596] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [DK075040, R01 DK075040-03, R01 DK075040, DK053307, DK060596] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Baer M, 2000, J BIOL CHEM, V275, P26582, DOI 10.1074/jbc.M004268200; Basu A, 2002, INT J ONCOL, V21, P597; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Bruhat A, 2002, J BIOL CHEM, V277, P48107, DOI 10.1074/jbc.M206149200; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Calkhoven CF, 2000, GENE DEV, V14, P1920; Chen C, 2005, BIOCHEM J, V391, P649, DOI 10.1042/BJ20050882; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; CHODOSH LA, 2001, CURRENT PROTOCOLS MO; Croniger CM, 2001, J BIOL CHEM, V276, P629, DOI 10.1074/jbc.M007576200; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Dudaronek JM, 2007, J IMMUNOL, V179, P7262, DOI 10.4049/jimmunol.179.11.7262; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Fernandez J, 2003, J BIOL CHEM, V278, P50000, DOI 10.1074/jbc.M305903200; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hai T, 1999, GENE EXPRESSION, V7, P321; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hu B, 2004, J IMMUNOL, V173, P4661, DOI 10.4049/jimmunol.173.7.4661; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kapadia R, 2006, J NEUROCHEM, V98, P1718, DOI 10.1111/j.1471-4159.2006.04056.x; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Millward CA, 2007, DIABETES, V56, P161, DOI 10.2337/db06-0310; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; RAUGHT B, 1995, MOL ENDOCRINOL, V9, P1223, DOI 10.1210/me.9.9.1223; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rorth P, 2000, MOL CELL, V6, P23; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Selim E, 2007, MOL IMMUNOL, V44, P1218, DOI 10.1016/j.molimm.2006.06.006; Shang J, 2004, BIOCHEM BIOPH RES CO, V317, P390, DOI 10.1016/j.bbrc.2004.03.058; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sok J, 1999, MOL CELL BIOL, V19, P495; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Yerlikaya A, 2008, BIOCHEM J, V412, P579, DOI 10.1042/BJ20080324; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zahnow CA, 2002, BREAST CANCER RES, V4, P109, DOI 10.1186/bcr428; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	80	71	79	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22443	22456		10.1074/jbc.M801046200	http://dx.doi.org/10.1074/jbc.M801046200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18550528	hybrid, Green Published			2022-12-25	WOS:000258321000012
J	Ehteshami, M; Beilhartz, GL; Scarth, BJ; Tchesnokov, EP; McCormick, S; Wynhoven, B; Harrigan, PR; Gotte, M				Ehteshami, Maryam; Beilhartz, Greg L.; Scarth, Brian J.; Tchesnokov, Egor P.; McCormick, Suzanne; Wynhoven, Brian; Harrigan, P. Richard; Gotte, Matthias			Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3 '-azido-3 '-deoxythymidine through both RNase H-dependent and -independent mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE ACTIVE-SITE; DOUBLE-STRANDED DNA; DRUG-RESISTANCE; ANGSTROM RESOLUTION; PRIMER UNBLOCKING; CRYSTAL-STRUCTURE; TRANSLOCATION STATUS; ANALOG INHIBITORS; DUAL RESISTANCE	Thymidine analogue-associated mutations (TAMs) in reverse transcriptase (RT) of the human immunodeficiency virus type 1 (HIV-1) cause resistance to 3'-azido-3'-deoxythymidine (AZT) through excision of the incorporated monophosphate. Mutations in the connection domain of HIV-1 RT can augment AZT resistance. It has been suggested that these mutations compromise RNase H cleavage, providing more time for AZT excision to occur. However, the underlying mechanism remains elusive. Here, we focused on connection mutations N348I and A360V that are frequently observed in clinical samples of treatment-experienced patients. We show that both N348I and A360V, in combination with TAMs, decrease the efficiency of RNase H cleavage and increase excision of AZT in the presence of the pyrophosphate donor ATP. The TAMs/N348I/A360V mutant accumulates transiently formed, shorter hybrids that can rebind to RT before the template is irreversibly degraded. These hybrids dissociate selectively from the RNase H-competent complex, whereas binding in the polymerase-competent mode is either not affected with N348I or modestly improved with A360V. Both connection domain mutations can compensate for TAM-mediated deficits in processive DNA synthesis, and experiments with RNase H negative mutant enzymes confirman RNase H-independent contribution to increased levels of resistance to AZT. Moreover, the combination of diminished RNase H cleavage and increased processivity renders the use of both PPi and ATP advantageous, whereas classic TAMs solely enhance the ATP-dependent reaction. Taken together, our findings demonstrate that distinct, complementary mechanisms can contribute to higher levels of excision of AZT, which in turn can amplify resistance to this drug.	[Ehteshami, Maryam; Beilhartz, Greg L.; Scarth, Brian J.; Tchesnokov, Egor P.; McCormick, Suzanne; Gotte, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Wynhoven, Brian; Harrigan, P. Richard] St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada	McGill University; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca						ARTS EJ, 1994, J BIOL CHEM, V269, P14672; Basavapathruni A, 2006, CURR PHARM DESIGN, V12, P1857, DOI 10.2174/138161206776873617; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Brehm JH, 2007, J VIROL, V81, P7852, DOI 10.1128/JVI.02203-06; Cane PA, 2007, AIDS, V21, P447, DOI 10.1097/QAD.0b013e3280129964; Cingolani A, 2002, AIDS, V16, P369, DOI 10.1097/00002030-200202150-00008; Cristofaro JV, 2002, BIOCHEMISTRY-US, V41, P10968, DOI 10.1021/bi025871v; De Clercq E, 2007, Verh K Acad Geneeskd Belg, V69, P81; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; El Safadi Y, 2007, APPL MICROBIOL BIOT, V75, P723, DOI 10.1007/s00253-007-0919-7; FURFINE ES, 1991, J BIOL CHEM, V266, P406; Gotte M, 2006, CURR PHARM DESIGN, V12, P1867, DOI 10.2174/138161206776873626; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; Gotte M, 1998, J BIOL CHEM, V273, P10139, DOI 10.1074/jbc.273.17.10139; GOTTE M, 1995, EMBO J, V14, P833, DOI 10.1002/j.1460-2075.1995.tb07061.x; Gotte M, 2000, J VIROL, V74, P3579, DOI 10.1128/JVI.74.8.3579-3585.2000; Gotte M, 2007, PLOS MED, V4, P1858, DOI 10.1371/journal.pmed.0040346; Gotte Matthias, 2004, Expert Rev Anti Infect Ther, V2, P707, DOI 10.1586/14789072.2.5.707; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Harrigan PR, 2002, J VIROL, V76, P6836, DOI 10.1128/JVI.76.13.6836-6840.2002; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Ilina T, 2008, ADV PHARMACOL, V56, P121, DOI 10.1016/S1054-3589(07)56005-9; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Johnson Victoria A, 2008, Top HIV Med, V16, P62; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kemp SD, 1998, J VIROL, V72, P5093, DOI 10.1128/JVI.72.6.5093-5098.1998; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lanchy JM, 1996, EMBO J, V15, P7178, DOI 10.1002/j.1460-2075.1996.tb01109.x; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Marchand B, 2004, INT J BIOCHEM CELL B, V36, P1823, DOI 10.1016/j.biocel.2004.02.029; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, ANTIMICROB AGENTS CH, V51, P2911, DOI 10.1128/AAC.00314-07; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Meyer PR, 2007, J MOL BIOL, V369, P41, DOI 10.1016/j.jmb.2007.03.006; Meyer PR, 2002, ANTIMICROB AGENTS CH, V46, P1540, DOI 10.1128/AAC.46.5.1540-1545.2002; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2000, ANTIMICROB AGENTS CH, V44, P3465, DOI 10.1128/AAC.44.12.3465-3472.2000; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nikolenko GN, 2005, P NATL ACAD SCI USA, V102, P2093, DOI 10.1073/pnas.0409823102; Ntemgwa M, 2007, ANTIMICROB AGENTS CH, V51, P3861, DOI 10.1128/AAC.00646-07; Palaniappan C, 1997, J BIOL CHEM, V272, P11157, DOI 10.1074/jbc.272.17.11157; Radzio J, 2008, MOL PHARMACOL, V73, P601, DOI 10.1124/mol.107.038596; Ray AS, 2003, BIOCHEMISTRY-US, V42, P8831, DOI 10.1021/bi034435l; Ren J, 2005, TRENDS PHARMACOL SCI, V26, P4, DOI 10.1016/j.tips.2004.11.003; Santos AFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001781; Sarafianos SG, 1999, CHEM BIOL, V6, pR137, DOI 10.1016/S1074-5521(99)80071-4; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; SCHATZ O, 1990, EMBO J, V9, P1171, DOI 10.1002/j.1460-2075.1990.tb08224.x; Schultz SJ, 2008, VIRUS RES, V134, P86, DOI 10.1016/j.virusres.2007.12.007; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; Smith AJ, 2006, CURR PHARM DESIGN, V12, P1827, DOI 10.2174/138161206776873572; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Tural C, 2002, AIDS, V16, P209, DOI 10.1097/00002030-200201250-00010; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335; Zelina S, 2008, ANTIMICROB AGENTS CH, V52, P157, DOI 10.1128/AAC.00904-07; Zolopa AR, 2005, CLIN INFECT DIS, V41, P92, DOI 10.1086/430706	60	68	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22222	22232		10.1074/jbc.M803521200	http://dx.doi.org/10.1074/jbc.M803521200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18547911	Green Published, hybrid			2022-12-25	WOS:000258114700042
J	Fenske, SA; Yesilaltay, A; Pal, R; Daniels, K; Rigotti, A; Krieger, M; Kocher, O				Fenske, Sara A.; Yesilaltay, Ayce; Pal, Rinku; Daniels, Kathleen; Rigotti, Attilio; Krieger, Monty; Kocher, Olivier			Overexpression of the PDZ1 domain of PDZK1 blocks the activity of hepatic scavenger receptor, class B, type I by altering its abundance and cellular localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; SR-BI; TARGETED DISRUPTION; CHOLESTEROL EFFLUX; LIPID-METABOLISM; APOLIPOPROTEIN-E; HDL CHOLESTEROL; EXPRESSION; PROTEIN; GENE	PDZK1 is a four-PDZ domain-containing scaffold protein that, via its first PDZ domain (PDZ1), binds to the C terminus of the high density lipoprotein (HDL) receptor scavenger receptor, class B, type I (SR-BI). Abolishing PDZK1 expression in PDZK1 knock-out (KO) mice leads to a post-transcriptional, tissue-specific decrease in SR-BI protein level and an increase in total plasma cholesterol carried in abnormally large HDL particles. Here we show that, although hepatic overexpression of PDZK1 restored normal SR-BI protein abundance and function in PDZK1 KO mice, hepatic overexpression of only the PDZ1 domain was not sufficient to restore normal SR-BI function. In wild-type mice, overexpression of the PDZ1 domain overcame the activity of the endogenous hepatic PDZK1, resulting in a 75% reduction in hepatic SR-BI protein levels and intracellular mislocalization of the remaining SR-BI. As a consequence, the plasma lipoproteins in PDZ1 transgenic mice resembled those in PDZK1 KO mice (hypercholesterolemia due to large HDL). These results indicate that the PDZ1 domain can control the abundance and localization, and therefore the function, of hepatic SR-BI and that structural features of PDZK1 in addition to its SR-BI-binding PDZ1 domain are required for normal hepatic SR-BI regulation.	[Fenske, Sara A.; Yesilaltay, Ayce; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA; [Pal, Rinku; Daniels, Kathleen; Kocher, Olivier] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Pal, Rinku; Daniels, Kathleen; Kocher, Olivier] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Rigotti, Attilio] Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Santiago 8330024, Chile	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Pontificia Universidad Catolica de Chile	Krieger, M (corresponding author), MIT, Dept Biol, Rm 68-483,77 Massachusetts Ave, Cambridge, MA 02139 USA.	krieger@mit.edu; okocher@bidmc.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077780, P01HL066105, R01HL064737, R01HL052212] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64737, HL66105, HL077780, HL52212] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Eckhardt ERM, 2006, J BIOL CHEM, V281, P4348, DOI 10.1074/jbc.M513154200; Eckhardt ERM, 2004, J BIOL CHEM, V279, P14372, DOI 10.1074/jbc.M313793200; Fu T, 2003, J BIOL CHEM, V278, P52559, DOI 10.1074/jbc.M310892200; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mardones P, 2001, J LIPID RES, V42, P170; Meurs I, 2005, EXP HEMATOL, V33, P1309, DOI 10.1016/j.exphem.2005.07.004; Miettinen HE, 2001, J CLIN INVEST, V108, P1717, DOI 10.1172/JCI13288; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; Out R, 2005, J LIPID RES, V46, P1172, DOI 10.1194/jlr.M400361-JLR200; Out R, 2004, J BIOL CHEM, V279, P18401, DOI 10.1074/jbc.M401170200; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; REAVEN E, 1984, J CLIN INVEST, V74, P1384, DOI 10.1172/JCI111549; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; STEIN Y, 1983, BIOCHIM BIOPHYS ACTA, V752, P98, DOI 10.1016/0005-2760(83)90237-0; Treguier M, 2007, BBA-MOL CELL BIOL L, V1771, P129, DOI 10.1016/j.bbalip.2006.12.004; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Van Eck M, 2008, J LIPID RES, V49, P136, DOI 10.1194/jlr.M700355-JLR200; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Wang PJ, 2005, J BIOL CHEM, V280, P30143, DOI 10.1074/jbc.M503969200; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241; Webb NR, 1997, J LIPID RES, V38, P1490; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; Zhang XH, 2007, ENDOCRINOLOGY, V148, P5295, DOI 10.1210/en.2007-0376; Zimetti F, 2006, J LIPID RES, V47, P605, DOI 10.1194/jlr.M500466-JLR200	51	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22097	22104		10.1074/jbc.M800029200	http://dx.doi.org/10.1074/jbc.M800029200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544532	Green Published, hybrid			2022-12-25	WOS:000258114700028
J	Granum, S; Andersen, TCB; Sorlie, M; Jorgensen, M; Koll, L; Berge, T; Lea, T; Fleckenstein, B; Spurkland, A; Sundvold-Gjerstad, V				Granum, Stine; Andersen, Thorny Cesilie Bie; Sorlie, Morten; Jorgensen, Marit; Koll, Lise; Berge, Tone; Lea, Tor; Fleckenstein, Burkhard; Spurkland, Anne; Sundvold-Gjerstad, Vibeke			Modulation of Lck function through multisite docking to T cell-specific adapter protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE HCK; ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; SH2 DOMAIN; PROCESSIVE PHOSPHORYLATION; BINDING-SITES; C-SRC; ACTIVATION; ZAP-70; SUBSTRATE	T cell-specific adapter protein (TSAd), encoded by the SH2D2A gene, interacts with Lck through its C terminus and thus modulates Lck activity. Here we mapped Lck phosphorylation and interaction sites on TSAd and evaluated their functional importance. The three C-terminal TSAd tyrosines Tyr(280), Tyr(290), and Tyr(305) were phosphorylated by Lck and functioned as docking sites for the Lck Src homology 2 (SH2) domain. Binding affinities of the TSAd Tyr(P)(280) and Tyr(P)(290) phosphopeptides to the isolated Lck SH2 domain were similar to that observed for the Lck Tyr(P)(505) phosphopeptide, whereas the TSAd Tyr(P)(305) peptide displayed a 10-fold higher affinity. The proline-rich Lck SH3-binding site on TSAd as well as the Lck SH2 domain were required for efficient tyrosine phosphorylation of TSAd by Lck. Interaction sites on TSAd for both Lck SH2 and Lck SH3 were necessary for TSAd-mediated modulation of proximal TCR signaling events. We found that 20-30% of TSAd molecules are phosphorylated in activated T cells and that the proportion of TSAd to Lck molecules in such cells is similar to 1:1. Therefore, in activated T cells, a considerable number of Lck molecules may potentially be engaged by TSAd. In conclusion, Lck binds to TSAd prolines and phosphorylates and interacts with the three C-terminal TSAd tyrosines. We propose that through multivalent interactions with Lck, TSAd diverts Lck from phosphorylating other substrates, thus modulating its functional activity through substrate competition.	[Granum, Stine; Andersen, Thorny Cesilie Bie; Koll, Lise; Berge, Tone; Sundvold-Gjerstad, Vibeke] Univ Oslo, Inst Basic Med Sci, Dept Anat, N-0317 Oslo, Norway; [Sorlie, Morten; Lea, Tor] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Jorgensen, Marit; Lea, Tor; Fleckenstein, Burkhard; Spurkland, Anne] Natl Hosp Norway, Med Ctr, Inst Immunol, N-0027 Oslo, Norway	University of Oslo; Norwegian University of Life Sciences; University of Oslo; National Hospital Norway	Granum, S (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, Box 1105, N-0317 Oslo, Norway.	stine.granum@medisin.uio.no	Spurkland, Anne/L-3369-2019	Spurkland, Anne/0000-0003-4421-0766				AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; Choi YB, 1999, J IMMUNOL, V163, P5242; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Dai KZ, 2004, J IMMUNOL, V172, P6144, DOI 10.4049/jimmunol.172.10.6144; Denny MF, 2000, MOL CELL BIOL, V20, P1426, DOI 10.1128/MCB.20.4.1426-1435.2000; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; Drappa J, 2003, J EXP MED, V198, P809, DOI 10.1084/jem.20021358; Granum S, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-15; HIRAI H, 1990, P NATL ACAD SCI USA, V87, P8592, DOI 10.1073/pnas.87.21.8592; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Kolltveit KM, 2008, MOL IMMUNOL, V45, P2380, DOI 10.1016/j.molimm.2007.11.005; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; LEMMON MA, 1994, BIOCHEMISTRY-US, V33, P5070, DOI 10.1021/bi00183a010; Liu HH, 2006, ACTA PHYS-CHIM SIN, V22, P868, DOI 10.3866/PKU.WHXB20060720; Marti F, 2006, J EXP MED, V203, P281, DOI 10.1084/jem.20051637; Marti F, 2005, IMMUNOL LETT, V97, P235, DOI 10.1016/j.imlet.2004.10.021; MARTI F, 2004, CLIN INVEST MED, V37; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; Methi T, 2007, EUR J IMMUNOL, V37, P2539, DOI 10.1002/eji.200636973; Miller WT, 2003, ACCOUNTS CHEM RES, V36, P393, DOI 10.1021/ar020116v; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; Mustelin T, 2002, FRONT BIOSCI-LANDMRK, V7, pD918, DOI 10.2741/musteli1; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Park DS, 2001, BIOCHEM BIOPH RES CO, V284, P275, DOI 10.1006/bbrc.2001.4957; Patwardhan P, 2007, CELL SIGNAL, V19, P2218, DOI 10.1016/j.cellsig.2007.06.006; Pellicena P, 1998, J BIOL CHEM, V273, P15325, DOI 10.1074/jbc.273.25.15325; Pellicena P, 2001, J BIOL CHEM, V276, P28190, DOI 10.1074/jbc.M100055200; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Rajagopal K, 1999, J EXP MED, V190, P1657, DOI 10.1084/jem.190.11.1657; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; Simeoni L, 2004, CURR OPIN IMMUNOL, V16, P304, DOI 10.1016/j.coi.2004.03.001; Spurkland A, 1998, J BIOL CHEM, V273, P4539, DOI 10.1074/jbc.273.8.4539; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Sun WY, 2001, J BIOL CHEM, V276, P5093, DOI 10.1074/jbc.M003719200; Sundvold V, 2000, J IMMUNOL, V165, P2927, DOI 10.4049/jimmunol.165.6.2927; Sundvold-Gjerstad V, 2005, EUR J IMMUNOL, V35, P1612, DOI 10.1002/eji.200425638; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; VEILLETTE A, 1990, ONCOGENE, V5, P1455; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; WEIL R, 1994, J BIOL CHEM, V269, P22830; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xing LZ, 2004, MOL CELL BIOL, V24, P4581, DOI 10.1128/MCB.24.10.4581-4592.2004; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	54	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21909	21919		10.1074/jbc.M800871200	http://dx.doi.org/10.1074/jbc.M800871200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18541536	hybrid			2022-12-25	WOS:000258114700010
J	Sama, MA; Mathis, DM; Furman, JL; Abdul, HM; Artiushin, IA; Kraner, SD; Norris, CM				Sama, Michelle A.; Mathis, Diana M.; Furman, Jennifer L.; Abdul, Hafiz Mohmmad; Artiushin, Irina A.; Kraner, Susan D.; Norris, Christopher M.			Interleukin-1 beta-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE ASTROCYTES; GLUTAMATE TRANSPORT; CALCIUM-CHANNELS; TRANSCRIPTIONAL REGULATION; NEURODEGENERATIVE DISEASE; INFLAMMATORY CYTOKINE; INTRACELLULAR CALCIUM; HIPPOCAMPAL-NEURONS; CORTICAL ASTROCYTES; ALZHEIMERS-DISEASE	Interleukin-1 beta (IL-1 beta) and the Ca2+/calmodulin-dependent protein phosphatase, calcineurin, have each been shown to play an important role in neuroinflammation. However, whether these signaling molecules interact to coordinate immune/inflammatory processes and neurodegeneration has not been investigated. Here, we show that exogenous application of IL-1 beta (10 ng/ml) recruited calcineurin/NFAT (nuclear factor of activated T cells) activation in primary astrocyte-enriched cultures within minutes, through a pathway involving IL-1 receptors and L-type Ca2+ channels. Adenovirus-mediated delivery of the NFAT inhibitor, VIVIT, suppressed the IL-1 beta-dependent induction of several inflammatory mediators and/or markers of astrocyte activation, including tumor necrosis factor alpha, granulocyte/ macrophage colony-stimulating factor, and vimentin. Expression of an activated form of calcineurin in one set of astrocyte cultures also triggered the release of factors that, in turn, stimulated NFAT activity in a second set of "naive" astrocytes. This effect was prevented when calcineurin-expressing cultures co-expressed VIVIT, suggesting that the calcineurin/ NFAT pathway coordinates positive feedback signaling between astrocytes. In the presence of astrocytes and neurons, 48-h delivery of IL-1 beta was associated with several excitotoxic effects, including NMDA receptor-dependent neuronal death, elevated extracellular glutamate, and hyperexcitable synaptic activity. Each of these effects were reversed or ameliorated by targeted delivery of VIVIT to astrocytes. IL-1 beta also caused an NFAT-dependent reduction in excitatory amino acid transporter levels, indicating a possible mechanism for IL-1 beta-mediated excitotoxicity. Taken together, the results have potentially important implications for the propagation and maintenance of neuroinflammatory signaling processes associated with many neurodegenerative conditions and diseases.	[Norris, Christopher M.] Univ Kentucky, Coll Dent, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Mathis, Diana M.] Univ Kentucky, Grad Ctr Gerontol, Lexington, KY 40536 USA; [Abdul, Hafiz Mohmmad; Artiushin, Irina A.; Norris, Christopher M.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky	Norris, CM (corresponding author), Univ Kentucky, Coll Dent, Dept Mol & Biomed Pharmacol, 131 Sanders Brown Bldg,800 S Limestone St, Lexington, KY 40536 USA.	cnorr2@uky.edu		Kraner, Susan/0000-0002-1062-4007	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010836, R01AG027297, K01AG024190] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR020171, RR020171] Funding Source: Medline; NIAMS NIH HHS [AR046477] Funding Source: Medline; NIA NIH HHS [AG 024190, K01 AG024190, R01 AG027297, AG 027297, AG010836] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abdul HM, 2006, J NEUROCHEM, V96, P1322, DOI 10.1111/j.1471-4159.2005.03647.x; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; ALOISI F, 1992, J IMMUNOL, V149, P2358; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; BARRES BA, 1989, J NEUROSCI, V9, P3169; Basu A, 2005, J CEREBR BLOOD F MET, V25, P17, DOI 10.1038/sj.jcbfm.9600002; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Beskina O, 2007, AM J PHYSIOL-CELL PH, V293, pC1103, DOI 10.1152/ajpcell.00249.2007; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blalock EM, 2003, J NEUROSCI, V23, P3807; Boycott HE, 2008, GLIA, V56, P998, DOI 10.1002/glia.20673; Burgos M, 2007, GLIA, V55, P1437, DOI 10.1002/glia.20555; Campbell SL, 2004, NEUROSCIENCE, V127, P625, DOI 10.1016/j.neuroscience.2004.05.030; Casamenti F, 1999, NEUROSCIENCE, V91, P831, DOI 10.1016/S0306-4522(98)00680-0; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; D'ascenzo M, 2004, GLIA, V45, P354, DOI 10.1002/glia.10336; Dineley KT, 2007, NEUROBIOL LEARN MEM, V88, P217, DOI 10.1016/j.nlm.2007.03.010; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Fernandez AM, 2007, J NEUROSCI, V27, P8745, DOI 10.1523/JNEUROSCI.1002-07.2007; Fiedler B, 2002, P NATL ACAD SCI USA, V99, P11363, DOI 10.1073/pnas.162100799; Fogal B, 2007, J NEUROSCI, V27, P10094, DOI 10.1523/JNEUROSCI.2459-07.2007; Foster TC, 2001, J NEUROSCI, V21, P4066, DOI 10.1523/JNEUROSCI.21-11-04066.2001; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Gohda J, 2005, EMBO J, V24, P790, DOI 10.1038/sj.emboj.7600564; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Halpain S, 1998, J NEUROSCI, V18, P9835; Hashimoto T, 1998, J NEUROCHEM, V70, P1289; Henze C, 2005, J NEUROCHEM, V95, P1069, DOI 10.1111/j.1471-4159.2005.03416.x; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; John GR, 2001, J NEUROSCI, V21, P4134, DOI 10.1523/JNEUROSCI.21-12-04134.2001; John GR, 1999, P NATL ACAD SCI USA, V96, P11613, DOI 10.1073/pnas.96.20.11613; Keller JN, 1996, J NEUROCHEM, V67, P2300; Kim SY, 2003, J NEUROCHEM, V87, P1485, DOI 10.1046/j.1471-4159.2003.02128.x; Kim Y, 2004, BIOCHEM BIOPH RES CO, V314, P695, DOI 10.1016/j.bbrc.2003.12.153; Kordula T, 2000, J NEUROSCI, V20, P7510; Labourdette Gerard, 2002, P157; LANGLEY D, 1994, GLIA, V12, P128, DOI 10.1002/glia.440120206; Lee SC, 1995, BRAIN BEHAV IMMUN, V9, P345, DOI 10.1006/brbi.1995.1032; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Lund P, 1986, METHOD ENZYMAT AN, P357; Luo C, 1996, MOL CELL BIOL, V16, P3955; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mallolas J, 2006, J EXP MED, V203, P711, DOI 10.1084/jem.20051979; Mansuy IM, 2006, TRENDS NEUROSCI, V29, P679, DOI 10.1016/j.tins.2006.10.004; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; MATHIS DM, 2007, C M SOC NEUROSCI ABS, V37, P360; Matsuda T, 1998, J NEUROCHEM, V70, P2004; Molina-Holgado F, 2003, J NEUROSCI, V23, P6470; Moynagh PN, 2005, J ANAT, V207, P265, DOI 10.1111/j.1469-7580.2005.00445.x; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; Norris CM, 2006, J NEUROPHYSIOL, V96, P2488, DOI 10.1152/jn.00593.2005; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Norris CM, 2002, NEUROSCIENCE, V110, P213, DOI 10.1016/S0306-4522(01)00574-7; NORRIS CM, 2008, NEUROBIOL A IN PRESS; Oka T, 2005, MOL CELL BIOL, V25, P6649, DOI 10.1128/MCB.25.15.6649-6659.2005; Pita I, 1999, INT J DEV NEUROSCI, V17, P813, DOI 10.1016/S0736-5748(99)00063-5; Pizzo P, 2001, J NEUROCHEM, V79, P98, DOI 10.1046/j.1471-4159.2001.00539.x; Porter NM, 1997, J NEUROSCI, V17, P5629; Prow NA, 2008, J NEUROCHEM, V105, P1276, DOI 10.1111/j.1471-4159.2008.05230.x; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Ringheim GE, 2004, J NEUROIMMUNOL, V147, P43, DOI 10.1016/j.jneuroim.2003.10.013; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Saito S, 2000, J BIOL CHEM, V275, P34528, DOI 10.1074/jbc.M002844200; SALTER MW, 1995, J NEUROSCI, V15, P2961; SAMA MA, 2006, SOC NEUROSCI ABS, V36; SAMA MA, 2007, NEURODEGENER DIS S1, V4, P636; Scemes E, 2000, MOL NEUROBIOL, V22, P167, DOI 10.1385/MN:22:1-3:167; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; SHAO Y, 1995, CELL CALCIUM, V17, P187, DOI 10.1016/0143-4160(95)90033-0; Sharifullina E, 2006, J PHYSIOL-LONDON, V572, P407, DOI 10.1113/jphysiol.2005.100412; Sheng JG, 1996, NEUROBIOL AGING, V17, P761; Srinivasan D, 2004, J NEUROSCI, V24, P6482, DOI 10.1523/JNEUROSCI.5712-03.2004; Su ZZ, 2003, P NATL ACAD SCI USA, V100, P1955, DOI 10.1073/pnas.0136555100; Taigen T, 2000, P NATL ACAD SCI USA, V97, P1196, DOI 10.1073/pnas.97.3.1196; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Tsukada S, 2005, NEUROPHARMACOLOGY, V48, P479, DOI 10.1016/j.neuropharm.2004.11.006; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; TWEARDY DJ, 1990, J IMMUNOL, V144, P2233; Van Eldik LJ, 2007, INT REV NEUROBIOL, V82, P277, DOI 10.1016/S0074-7742(07)82015-0; Vinade L, 1997, DEV BRAIN RES, V104, P11, DOI 10.1016/S0165-3806(97)00114-4; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang ZY, 2003, VIROLOGY, V312, P60, DOI 10.1016/S0042-6822(03)00181-8; Westenbroek RE, 1998, J NEUROSCI, V18, P2321; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yang TTC, 2006, J BIOL CHEM, V281, P11541, DOI 10.1074/jbc.M511214200; Yatani A, 2001, J MOL CELL CARDIOL, V33, P249, DOI 10.1006/jmcc.2000.1296; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yu HX, 2007, CARDIOVASC DRUG REV, V25, P175, DOI 10.1111/j.1527-3466.2007.00011.x; Zaheer A, 2002, BIOCHEM BIOPH RES CO, V294, P238, DOI 10.1016/S0006-291X(02)00467-9; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092	100	87	93	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21953	21964		10.1074/jbc.M800148200	http://dx.doi.org/10.1074/jbc.M800148200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18541537	Green Published, hybrid			2022-12-25	WOS:000258114700015
J	Nelson, CD; Kovacs, JJ; Nobles, KN; Whalen, EJ; Lefkowitz, RJ				Nelson, Christopher D.; Kovacs, Jeffery J.; Nobles, Kelly N.; Whalen, Erin J.; Lefkowitz, Robert J.			beta-arrestin scaffolding of phosphatidylinositol 4-phosphate 5-kinase I alpha promotes agonist-stimulated sequestration of the beta 2-adrenergic receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CLATHRIN-MEDIATED ENDOCYTOSIS; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; PLASMA-MEMBRANE; PHOSPHOINOSITIDE REGULATION; ACTIN CYTOSKELETON; KINASE; ACTIVATION; DESENSITIZATION	Members of the seven-transmembrane receptor (7TMR) superfamily are sequestered from the plasma membrane following stimulation both to limit cellular responses as well as to initiate novel G protein-independent signaling pathways. The best studied mechanism for 7TMR internalization is via clathrin-coated pits, where clathrin and adaptor protein complex 2 nucleate and polymerize upon encountering the membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) to form the outer layer of the clathrin-coated vesicle. Activated receptors are recruited to clathrin-coated pits by beta-arrestins, scaffolding proteins that interact with agonist-occupied 7TMRs as well as adaptor protein complex 2 and clathrin. We report here that following stimulation of the beta 2-adrenergic receptor (beta 2-AR), a prototypical 7TMR, beta-arrestins bind phosphatidylinositol 4-phosphate 5-kinase (PIP5K) I alpha, a PIP2-producing enzyme. Furthermore, beta-arrestin2 is required to form a complex with PIP5K I alpha and agonist- occupied beta 2-AR, and beta-arrestins synergize with the kinase to produce PIP2 in response to isoproterenol stimulation. Interestingly, beta-arrestins themselves bind PIP2, and a beta-arrestin mutant deficient in PIP2 binding no longer internalizes 7TMRs, fails to interact with PIP5K I alpha, and is not associated with PIP kinase activity assayed in vitro. However, a chimeric protein in which the core kinase domain of PIP5K I alpha has been fused to the same beta-arrestin mutant rescues internalization of beta 2-ARs. Collectively, these data support a model in which beta-arrestins direct the localization of PIP5K I alpha and PIP2 production to agonist- activated 7TMRs, thereby regulating receptor internalization.	[Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Howard Hughes Med Inst, Durham, NC 27710 USA; [Nelson, Christopher D.; Kovacs, Jeffery J.; Whalen, Erin J.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kovacs, Jeffery J.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Howard Hughes Med Inst, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021		Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL016037, R01 HL070631, HL 70631, HL 16037, R01 HL016037-35, R01 HL070631-04] Funding Source: Medline; NIAID NIH HHS [T32 AI007217-26, T32 AI007217] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL070631, R01HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007217] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Baker JG, 2002, BRIT J PHARMACOL, V137, P400, DOI 10.1038/sj.bjp.0704855; Barbieri MA, 2001, J BIOL CHEM, V276, P47212, DOI 10.1074/jbc.C100490200; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Kawasaki T, 2008, BIOCHEM J, V409, P471, DOI 10.1042/BJ20070755; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin HC, 1997, J BIOL CHEM, V272, P25999, DOI 10.1074/jbc.272.41.25999; Loijens JC, 1996, ADV ENZYME REGUL, V36, P115, DOI 10.1016/0065-2571(95)00005-4; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Nelson CD, 2007, SCIENCE, V315, P663, DOI 10.1126/science.1134562; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Petrofski JA, 2003, J MOL CELL CARDIOL, V35, P1167, DOI 10.1016/S0022-2828(03)00243-8; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Sechi AS, 2000, J CELL SCI, V113, P3685; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	53	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21093	21101		10.1074/jbc.M800431200	http://dx.doi.org/10.1074/jbc.M800431200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18534983	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000257746100051
J	Lundby, A; Mutoh, H; Dimitrov, D; Akemann, W; Knopfel, T				Lundby, Alicia; Mutoh, Hiroki; Dimitrov, Dimitar; Akemann, Walther; Knopfel, Thomas			Engineering of a Genetically Encodable Fluorescent Voltage Sensor Exploiting Fast Ci-VSP Voltage-Sensing Movements	PLOS ONE			English	Article								Ci-VSP contains a voltage-sensing domain (VSD) homologous to that of voltage-gated potassium channels. Using charge displacement ('gating' current) measurements we show that voltage-sensing movements of this VSD can occur within 1 ms in mammalian membranes. Our analysis lead to development of a genetically encodable fluorescent protein voltage sensor (VSFP) in which the fast, voltage-dependent conformational changes of the Ci-VSP voltage sensor are transduced to similarly fast fluorescence read-outs.	[Lundby, Alicia; Mutoh, Hiroki; Dimitrov, Dimitar; Akemann, Walther; Knopfel, Thomas] RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dynam, Wako, Saitama, Japan; [Lundby, Alicia] Univ Copenhagen, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark	RIKEN; Danmarks Grundforskningsfond; University of Copenhagen	Lundby, A (corresponding author), RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dynam, Wako, Saitama, Japan.	ricksteinhardt@berkeley.edu	Mutoh, Hiroki/D-5240-2009; Knöpfel, Thomas/B-1128-2008; Lundby, Alicia/H-3322-2013; Akemann, Walther/A-7593-2011	Knöpfel, Thomas/0000-0002-5718-0765; Akemann, Walther/0000-0002-4978-4665; Lundby, Alicia/0000-0002-1612-6041	RIKEN BSI; NIH [NS057631]; Danish Cardiovascular Research Academy; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS057631] Funding Source: NIH RePORTER	RIKEN BSI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Cardiovascular Research Academy; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by RIKEN BSI intramural funds, NIH grant NS057631 and a stipend from Danish Cardiovascular Research Academy to AL.	Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Knopfel T, 2006, TRENDS NEUROSCI, V29, P160, DOI 10.1016/j.tins.2006.01.004; Kohout SC, 2008, NAT STRUCT MOL BIOL, V15, P106, DOI 10.1038/nsmb1320; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; VILLALBAGALEA CA, 2008, BIOPHYS J, V94, P1362; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618	12	123	127	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2514	10.1371/journal.pone.0002514	http://dx.doi.org/10.1371/journal.pone.0002514			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575613	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000031
J	Silva, N; Smith, WC				Silva, Nathan; Smith, William C.			Inverse Correlation of Population Similarity and Introduction Date for Invasive Ascidians	PLOS ONE			English	Article								The genomes of many marine invertebrates, including the purple sea urchin and the solitary ascidians Ciona intestinalis and Ciona savignyi, show exceptionally high levels of heterozygosity, implying that these populations are highly polymorphic. Analysis of the C. savignyi genome found little evidence to support an elevated mutation rate, but rather points to a large population size contributing to the polymorphism level. In the present study, the relative genetic polymorphism levels in sampled populations of ten different ascidian species were determined using a similarity index generated by AFLP analysis. The goal was to determine the range of polymorphism within the populations of different species, and to uncover factors that may contribute to the high level of polymorphism. We observe that, surprisingly, the levels of polymorphism within these species show a negative correlation with the reported age of invasive populations, and that closely related species show substantially different levels of genetic polymorphism. These findings show exceptions to the assumptions that invasive species start with a low level of genetic polymorphism that increases over time and that closely related species have similar levels of genetic polymorphism.	[Silva, Nathan; Smith, William C.] Univ Calif Santa Barbara, Interdept Grad Program Marine Sci, Santa Barbara, CA 93106 USA; [Smith, William C.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Silva, N (corresponding author), Univ Calif Santa Barbara, Interdept Grad Program Marine Sci, Santa Barbara, CA 93106 USA.	w_smith@lifesci.ucsb.edu			NIH [HD038701]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038701] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was supported by a grant from the NIH to WCS (HD038701).	[Anonymous], [No title captured]; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Blake T., 1999, J AGR GENOMICS, V4; Blum JC, 2007, J EXP MAR BIOL ECOL, V342, P5, DOI 10.1016/j.jembe.2006.10.010; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2005, METHOD ENZYMOL, V395, P145, DOI 10.1016/S0076-6879(05)95010-6; Cayer D., 1999, J SHELLFISH RES, V18, P327; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Han KP, 2002, MAR BIOTECHNOL, V4, P141, DOI 10.1007/s10126-001-0080-8; Innan H, 1999, GENETICS, V151, P1157; Jiang D, 2005, BIOL BULL-US, V209, P107, DOI 10.2307/3593128; Lambert CC, 1998, MAR BIOL, V130, P675, DOI 10.1007/s002270050289; Lambert CC, 2003, MAR ECOL PROG SER, V259, P145, DOI 10.3354/meps259145; LAMBERT CC, 1967, BIOL BULL, V132, P222, DOI 10.2307/1539890; MILKMAN R, 1967, BIOL BULL, V132, P229, DOI 10.2307/1539891; Ritter W.E., 1917, U CALIFORNIA PUBLICA, V16, P439; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Turon X, 2004, MOL PHYLOGENET EVOL, V33, P309, DOI 10.1016/j.ympev.2004.06.011; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wright S, 1978, VARIABILITY NATURAL; Yund PO, 2002, MAR BIOL, V141, P955, DOI 10.1007/s00227-002-0894-6	27	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2552	10.1371/journal.pone.0002552	http://dx.doi.org/10.1371/journal.pone.0002552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575620	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288000052
J	Lindner, A; Cairns, SD; Cunningham, CW				Lindner, Alberto; Cairns, Stephen D.; Cunningham, Clifford W.			From Offshore to Onshore: Multiple Origins of Shallow-Water Corals from Deep-Sea Ancestors	PLOS ONE			English	Article							LIKELIHOOD APPROACH; DIVERSITY; EVOLUTION; PATTERNS; HYDROZOA; COELENTERATA; DIVERGENCE; STATES; SHELF	Shallow-water tropical reefs and the deep sea represent the two most diverse marine environments. Understanding the origin and diversification of this biodiversity is a major quest in ecology and evolution. The most prominent and well-supported explanation, articulated since the first explorations of the deep sea, holds that benthic marine fauna originated in shallow, onshore environments, and diversified into deeper waters. In contrast, evidence that groups of marine organisms originated in the deep sea is limited, and the possibility that deep-water taxa have contributed to the formation of shallow-water communities remains untested with phylogenetic methods. Here we show that stylasterid corals (Cnidaria: Hydrozoa: Stylasteridae)-the second most diverse group of hard corals-originated and diversified extensively in the deep sea, and subsequently invaded shallow waters. Our phylogenetic results show that deep-water stylasterid corals have invaded the shallow-water tropics three times, with one additional invasion of the shallow-water temperate zone. Our results also show that anti-predatory innovations arose in the deep sea, but were not involved in the shallow-water invasions. These findings are the first robust evidence that an important group of tropical shallow-water marine animals evolved from deep-water ancestors.	[Lindner, Alberto] Univ Sao Paulo, Ctr Biol Marinha, Sao Paulo, Brazil; [Cairns, Stephen D.] Smithsonian Inst, Natl Museum Natural Hist, Washington, DC USA; [Cunningham, Clifford W.] Duke Univ, Biol Dept, Durham, NC USA	Universidade de Sao Paulo; Smithsonian Institution; Duke University	Lindner, A (corresponding author), Univ Sao Paulo, Ctr Biol Marinha, Sao Paulo, Brazil.	alindner@usp.br	Lindner, Alberto/E-1946-2013; Cunningham, Clifford/B-9807-2014	Lindner, Alberto/0000-0003-3288-0885; Cunningham, Clifford/0000-0002-5434-5122	National Science Foundation [DEB-9978086]; Society for Integrative and Comparative Biology [grant-in-aid of research]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BEX0917-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [06/02960-8/60327-0]	National Science Foundation(National Science Foundation (NSF)); Society for Integrative and Comparative Biology; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by a National Science Foundation grant (NSF PEET DEB-9978086) to CWC and SDC and by a Society for Integrative and Comparative Biology grant-in-aid of research, a scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES BEX0917-0), and a postdoctoral fellowship and grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 06/02960-8/60327-0) to AL.	Allen J.A., 1983, P29; Bell R, 2002, J SCI MED SPORT, V5, P32, DOI 10.1016/S1440-2440(02)80295-X; Bernecker M., 1990, Facies, V22, P103, DOI 10.1007/BF02536947; BOTTJER D J, 1988, Palaios, V3, P540, DOI 10.2307/3514444; Briggs JC, 2004, J BIOGEOGR, V31, P525, DOI 10.1046/j.1365-2699.2003.00939.x; CACCHIONE DA, 1984, J SEDIMENT PETROL, V54, P1280; CAIRNS SD, 1983, B MAR SCI, V33, P427; CAIRNS SD, 1982, J NAT HIST, V16, P71, DOI 10.1080/00222938200770051; Cairns SD, 2007, B MAR SCI, V81, P311; Cairns Stephen D., 1992, Scientia Marina, V56, P125; CLARKE AH, 1962, DEEP-SEA RES, V9, P291, DOI 10.1016/0011-7471(62)90012-8; Collins AG, 2000, SCI MAR, V64, P5, DOI 10.3989/scimar.2000.64s15; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; DAVIS RA, 1977, PRINCIPLES OCEANOGRA; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Govindarajan AF, 2005, MAR BIOL, V146, P213, DOI 10.1007/s00227-004-1434-3; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; Hessler R., 1983, EVOLUTION TIME SPACE, P227; HESSLER RR, 1967, DEEP-SEA RES, V14, P65; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jablonski D, 2005, J EXP ZOOL PART B, V304B, P504, DOI 10.1002/jez.b.21075; JABLONSKI D, 1983, SCIENCE, V222, P1123, DOI 10.1126/science.222.4628.1123; JABLONSKI D, 1991, SCIENCE, V252, P1831, DOI 10.1126/science.252.5014.1831; Jacobs DK, 1998, P NATL ACAD SCI USA, V95, P9396, DOI 10.1073/pnas.95.16.9396; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; Lorz AN, 2003, J MAR BIOL ASSOC UK, V83, P785, DOI 10.1017/S002531540300780Xh; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Madsen F. J., 1961, Galathea Report, V4, P177; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; MIGLIETTA MP, 2005, THESIS DUKE U; Miller KJ, 2004, AQUAT CONSERV, V14, P75, DOI 10.1002/aqc.597; Moseley H. N., 1880, NATURE, V21, P543; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; STANLEY G D JR, 1988, Palaios, V3, P233; Stone RP, 2006, CORAL REEFS, V25, P229, DOI 10.1007/s00338-006-0091-z; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Vermeij G.J, 1987, EVOLUTION ESCALATION; WOLFF T, 1960, DEEP-SEA RES, V6, P95; Yuasa HJ, 2001, GENE, V279, P205, DOI 10.1016/S0378-1119(01)00755-7	46	93	96	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2429	10.1371/journal.pone.0002429	http://dx.doi.org/10.1371/journal.pone.0002429			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560569	Green Published, Green Submitted, gold			2022-12-25	WOS:000263280700014
J	Albanese, A; Arosio, D; Terreni, M; Cereseto, A				Albanese, Alberto; Arosio, Daniele; Terreni, Mariaelena; Cereseto, Anna			HIV-1 Pre-Integration Complexes Selectively Target Decondensed Chromatin in the Nuclear Periphery	PLOS ONE			English	Article								Integration of the double-stranded DNA copy of the HIV-1 genome into host chromosomal DNA is a requirement for efficient viral replication. Integration preferentially occurs within active transcription units, however chromosomal site specificity does not correlate with any strong primary sequence. To investigate whether the nuclear architecture may affect viral integration we have developed an experimental system where HIV-1 viral particles can be visualized within the nuclear compartment. Fluorescently labeled HIV-1 virions were engineered by fusing integrase, the viral protein that catalyzes the integration reaction, to fluorescent proteins. Viral tests demonstrate that the infectivity of fluorescent virions, including the integration step, is not altered as compared to wild-type virus. 3-D confocal microscopy allowed a detailed analysis of the spatial and temporal distribution of the pre-integration complexes (PICs) within the nucleus at different moments following infection; the fluorescently labeled PICs preferentially distribute in decondensed areas of the chromatin with a striking positioning in the nuclear periphery, while heterochromatin regions are largely disfavored. These observations provide a first indication of how the nuclear architecture may initially orient the selection of retroviral integration sites.	[Albanese, Alberto; Terreni, Mariaelena; Cereseto, Anna] Scuola Normale Super Pisa, Mol Biol Lab, Pisa, Italy; [Albanese, Alberto; Arosio, Daniele; Terreni, Mariaelena; Cereseto, Anna] Scuola Normale Superiore, CNR INFM, NEST, Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Scuola Normale Superiore di Pisa	Albanese, A (corresponding author), Scuola Normale Super Pisa, Mol Biol Lab, Pisa, Italy.	d.arosio@sns.it; cereseto@sns.it	arosio, daniele/B-3160-2012	Cereseto, Anna/0000-0003-4453-2597	National Research Program on AIDS of the Istituto Superiore di Sanita; Fondazione Cassa di Risparmio di Pisa	National Research Program on AIDS of the Istituto Superiore di Sanita; Fondazione Cassa di Risparmio di Pisa	This work was supported by grants from the National Research Program on AIDS of the Istituto Superiore di Sanita and from the Fondazione Cassa di Risparmio di Pisa.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Bhattacharya D, 2006, BIOPHYS J, V91, P2326, DOI 10.1529/biophysj.105.079343; Brown P. O., 1997, P161; Carteau S, 1998, J VIROL, V72, P4005, DOI 10.1128/JVI.72.5.4005-4014.1998; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Cereseto A, 2004, AIDS REV, V6, P13; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Crise B, 2005, J VIROL, V79, P12199, DOI 10.1128/JVI.79.19.12199-12204.2005; GOODENOW MM, 1987, J VIROL, V61, P2489, DOI 10.1128/JVI.61.8.2489-2498.1987; Gorisch SM, 2005, J CELL SCI, V118, P5825, DOI 10.1242/jcs.02689; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Holmes-Son ML, 2000, J VIROL, V74, P11548, DOI 10.1128/JVI.74.24.11548-11556.2000; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kang YB, 2006, J VIROL, V80, P8820, DOI 10.1128/JVI.00719-06; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Limon A, 2002, J VIROL, V76, P10598, DOI 10.1128/JVI.76.21.10598-10607.2002; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; PANET A, 1977, CELL, V11, P933, DOI 10.1016/0092-8674(77)90304-X; ROBINSON HL, 1986, J VIROL, V57, P28, DOI 10.1128/JVI.57.1.28-36.1986; ROHDEWOHLD H, 1987, J VIROL, V61, P336, DOI 10.1128/JVI.61.2.336-343.1987; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Stevens SW, 1996, J VIROL, V70, P6459, DOI 10.1128/JVI.70.9.6459-6462.1996; Taganov KD, 2004, J VIROL, V78, P5848, DOI 10.1128/JVI.78.11.5848-5855.2004; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; VIJAYA S, 1986, J VIROL, V60, P683, DOI 10.1128/JVI.60.2.683-692.1986; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Weidemann T, 2003, J MOL BIOL, V334, P229, DOI 10.1016/j.jmb.2003.08.063; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; WU XY, 1995, J VIROL, V69, P3389, DOI 10.1128/JVI.69.6.3389-3398.1995; Zhang H, 1996, J VIROL, V70, P2809, DOI 10.1128/JVI.70.5.2809-2824.1996	42	91	96	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2413	10.1371/journal.pone.0002413	http://dx.doi.org/10.1371/journal.pone.0002413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545681	gold, Green Submitted, Green Published			2022-12-25	WOS:000263248800050
J	Bilal, E; Rabadan, R; Alexe, G; Fuku, N; Ueno, H; Nishigaki, Y; Fujita, Y; Ito, M; Arai, Y; Hirose, N; Ruckenstein, A; Bhanot, G; Tanaka, M				Bilal, Erhan; Rabadan, Raul; Alexe, Gabriela; Fuku, Noriyuki; Ueno, Hitomi; Nishigaki, Yutaka; Fujita, Yasunori; Ito, Masafumi; Arai, Yasumichi; Hirose, Nobuyoshi; Ruckenstein, Andrei; Bhanot, Gyan; Tanaka, Masashi			Mitochondrial DNA Haplogroup D4a Is a Marker for Extreme Longevity in Japan	PLOS ONE			English	Article							SELECTION; SUBUNITS; N9A	We report results from the analysis of complete mitochondrial DNA (mtDNA) sequences from 112 Japanese semi-supercentenarians (aged above 105 years) combined with previously published data from 96 patients in each of three nondisease phenotypes: centenarians (99-105 years of age), healthy non-obese males, obese young males and four disease phenotypes, diabetics with and without angiopathy, and Alzheimer's and Parkinson's disease patients. We analyze the correlation between mitochondrial polymorphisms and the longevity phenotype using two different methods. We first use an exhaustive algorithm to identify all maximal patterns of polymorphisms shared by at least five individuals and define a significance score for enrichment of the patterns in each phenotype relative to healthy normals. Our study confirms the correlations observed in a previous study showing enrichment of a hierarchy of haplogroups in the D clade for longevity. For the extreme longevity phenotype we see a single statistically significant signal: a progressive enrichment of certain "beneficial'' patterns in centenarians and semi-supercentenarians in the D4a haplogroup. We then use Principal Component Spectral Analysis of the SNP-SNP Covariance Matrix to compare the measured eigenvalues to a Null distribution of eigenvalues on Gaussian datasets to determine whether the correlations in the data (due to longevity) arises from some property of the mutations themselves or whether they are due to population structure. The conclusion is that the correlations are entirely due to population structure (phylogenetic tree). We find no signal for a functional mtDNA SNP correlated with longevity. The fact that the correlations are from the population structure suggests that hitch-hiking on autosomal events is a possible explanation for the observed correlations.	[Bilal, Erhan; Bhanot, Gyan] Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08855 USA; [Rabadan, Raul; Bhanot, Gyan] Simons Ctr Syst Biol, Inst Advanced Study, Princeton, NJ USA; [Alexe, Gabriela] Broad Inst MIT & Harvard, Cambridge, MA USA; [Fuku, Noriyuki; Ueno, Hitomi; Nishigaki, Yutaka; Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longevity & Hlth, Tokyo, Japan; [Fujita, Yasunori; Ito, Masafumi] Gifu Int Inst Biotechnol, Dept Longevity & Aging Res, Gifu, Japan; [Arai, Yasumichi; Hirose, Nobuyoshi] Keio Univ, Sch Med, Dept Geriat Med, Tokyo, Japan; [Ruckenstein, Andrei] Boston Univ, Dept Phys, Boston, MA USA; [Bhanot, Gyan] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Rutgers State University New Brunswick; Institute for Advanced Study - USA; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tokyo Metropolitan Institute of Gerontology; Keio University; Boston University; Rutgers State University New Brunswick	Bilal, E (corresponding author), Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08855 USA.	mtanaka@tmig.or.jp	Rabadan, Raul/AAZ-7367-2020	Rabadan, Raul/0000-0001-7946-9255; Fuku, Noriyuki/0000-0001-7792-5835	Ministry of Education, Culture, Sports, Science, and Technology of Japan [A-15200051, C-18590317, B-18700541]; Third-Term Comprehensive 10-year Strategy for Cancer Control; Nervous and Mental Disorders of the Ministry of Health, Labour, and Welfare of Japan [17A-10]; Kao Research Council for the Study of Healthcare Science; Takeda Science Foundation [I-2007, II-2007]; Longevity Science of Ministry of Health, Labour, and Welfare of Japan; Cancer Institute of New Jersey; NJ Commission for Cancer Research; Center for Clinical and Translational Sciences at the Robert Wood Johnson Medical School, New Brunswick, NJ; Simons Foundation; Ambrose Monell Foundation; Leon Levy Foundation; National Institutes of Health	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Third-Term Comprehensive 10-year Strategy for Cancer Control(Ministry of Health, Labour and Welfare, Japan); Nervous and Mental Disorders of the Ministry of Health, Labour, and Welfare of Japan; Kao Research Council for the Study of Healthcare Science; Takeda Science Foundation(Takeda Science Foundation (TSF)); Longevity Science of Ministry of Health, Labour, and Welfare of Japan; Cancer Institute of New Jersey; NJ Commission for Cancer Research; Center for Clinical and Translational Sciences at the Robert Wood Johnson Medical School, New Brunswick, NJ; Simons Foundation; Ambrose Monell Foundation; Leon Levy Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by Grants-in-Aid for Scientific Research (A-15200051 to MT and C-18590317 to YN), and a Grant-in-Aid for Young Scientists (B-18700541 to NF) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by a grant from the Third-Term Comprehensive 10-year Strategy for Cancer Control (to MT), by grant 17A-10 from the program Research Grants for Nervous and Mental Disorders of the Ministry of Health, Labour, and Welfare of Japan (to MT) as well as by a grant from Kao Research Council for the Study of Healthcare Science (to YN) and by grants from Takeda Science Foundation (I-2007 to MT and II-2007 to YN). The work of NH was supported by a grant for Longevity Science of Ministry of Health, Labour, and Welfare of Japan. The work of GB was supported by grants from the Cancer Institute of New Jersey and the NJ Commission for Cancer Research. The work of EB was supported by funds from the Center for Clinical and Translational Sciences at the Robert Wood Johnson Medical School, New Brunswick, NJ. RR was supported by the Simons Foundation, the Ambrose Monell Foundation, the Leon Levy Foundation, and the National Institutes of Health.	Alexe G, 2004, DISCRETE APPL MATH, V145, P11, DOI 10.1016/j.dam.2003.09.004; ALEXE G, 2007, PRINCIPAL COMP UNPUB; Alexe G, 2007, HUM GENET, V121, P347, DOI 10.1007/s00439-007-0330-6; Alexe G, 2006, ANN OPER RES, V148, P189, DOI 10.1007/s10479-006-0084-x; Bandelt H.J., 2006, HUMAN MITOCHONDRIAL; Barrientos A, 2000, MOL BIOL EVOL, V17, P1508, DOI 10.1093/oxfordjournals.molbev.a026250; Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210; Bayona-Bafaluy MP, 2005, MOL BIOL EVOL, V22, P716, DOI 10.1093/molbev/msi059; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hawkes K, 2004, NATURE, V428, P128, DOI 10.1038/428128a; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; JOLIFFE T, 2002, PRINCIPAL COMPONENT; Kaufmann L., 1990, FINDING GROUPS DATA; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Tanaka M, 2007, DIABETES, V56, P518, DOI 10.2337/db06-1105; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; WHO, 2006, WORLD HLTH REP	30	72	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2421	10.1371/journal.pone.0002421	http://dx.doi.org/10.1371/journal.pone.0002421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545700	gold, Green Published, Green Submitted			2022-12-25	WOS:000263248800056
J	Kishida, T				Kishida, Takushi			Pattern of the Divergence of Olfactory Receptor Genes during Tetrapod Evolution	PLOS ONE			English	Article								The olfactory receptor (OR) multigene family is responsible for the sense of smell in vertebrate species. OR genes are scattered widely in our chromosomes and constitute one of the largest gene families in eutherian genomes. Some previous studies revealed that eutherian OR genes diverged mainly during early mammalian evolution. However, the exact period when, and the ecological reason why eutherian ORs strongly diverged has remained unclear. In this study, I performed a strict data mining effort for marsupial opossum OR sequences and bootstrap analyses to estimate the periods of chromosomal migrations and gene duplications of OR genes during tetrapod evolution. The results indicate that chromosomal migrations occurred mainly during early vertebrate evolution before the monotreme-placental split, and that gene duplications occurred mainly during early mammalian evolution between the bird-mammal split and marsupial-placental split, coinciding with the reduction of opsin genes in primitive mammals. It could be thought that the previous chromosomal dispersal allowed the OR genes to subsequently expand easily, and the nocturnal adaptation of early mammals might have triggered the OR gene expansion.	Kyoto Univ, Dept Zool, Kyoto, Japan	Kyoto University	Kishida, T (corresponding author), Kyoto Univ, Dept Zool, Kyoto, Japan.	Takushi@kishida.mbox.media.kyoto-u.ac.jp	Kishida, Takushi/H-3381-2012	Kishida, Takushi/0000-0002-2220-7892				Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Aloni R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r88; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; Bowmaker JK, 2006, CURR BIOL, V16, pR484, DOI 10.1016/j.cub.2006.06.016; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Collin Shaun P, 2004, Clin Exp Optom, V87, P217; Davies WL, 2007, CURR BIOL, V17, pR161, DOI 10.1016/j.cub.2007.01.037; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Grus WE, 2007, MOL BIOL EVOL, V24, P2153, DOI 10.1093/molbev/msm157; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kishida T, 2007, BIOLOGY LETT, V3, P428, DOI 10.1098/rsbl.2007.0191; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; NEI M, 2000, MOL EVOLUTION PHYLOG, P175; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Olender Tsviya, 2004, Genet Mol Res, V3, P545; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Rouquier S, 1998, NAT GENET, V18, P243, DOI 10.1038/ng0398-243; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satoh G, 2005, GENESIS, V41, P47, DOI 10.1002/gene.20082; Suga H, 1999, FEBS LETT, V453, P346, DOI 10.1016/S0014-5793(99)00749-8; Suga H, 1997, FEBS LETT, V412, P540, DOI 10.1016/S0014-5793(97)00639-X; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535	32	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2385	10.1371/journal.pone.0002385	http://dx.doi.org/10.1371/journal.pone.0002385			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18568087	Green Submitted, Green Published, gold			2022-12-25	WOS:000263248800024
J	Singh, R; Tian, BW; Kostarelos, K				Singh, Ravi; Tian, Bowen; Kostarelos, Kostas			Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo	FASEB JOURNAL			English	Article						gene therapy; liposome; cancer; nanoengineering; immunology; nanomedicine	POLYMER-COATED ADENOVIRUS; MEDIATED GENE-TRANSFER; CATIONIC LIPOSOMES; NEUTRALIZING ANTIBODY; TRANSGENE EXPRESSION; CIRCULATION TIME; SURFACE-CHARGE; VECTORS; CANCER; CELLS	Recombinant adenovirus (Ad) is a powerful tool in gene therapy. However, the ability to deliver Ad by systemic administration is limited due to rapid clearance from blood circulation, transfection of nontarget tissues, toxicity, and immunogenicity. To address these limitations, we developed an artificially enveloped Ad vector prepared by self-assembly of lipid bilayers around the Ad capsid. The physicochemical and structural features of the enveloped Ad vector can be altered according to the type of lipid used without the need for genetic modification or conjugation chemistry. Here we engineered 4 different types of artificially enveloped Ad using cationic, neutral, fusogenic, and PEGylated lipids to form the envelopes and obtained extended blood circulation times following i.v. administration and reduced vector immunogenicity. Moreover, the PEGylated lipid-enveloped Ad was capable of specifically delivering genes via the systemic circulation to solid tumors subcutaneously implanted in the absence of high levels of gene transfer to the liver and spleen. This provides the basis for the development of a novel vector platform for systemic delivery of Ad to disseminated targets. Furthermore, the artificial envelopment of Ad presented herein is an illustration of a general strategy to modulate the biological function of nonenveloped viruses and may have implications broader than gene therapy.	[Singh, Ravi; Tian, Bowen; Kostarelos, Kostas] Univ London, Sch Pharm, Ctr Drug Delivery Res, Nanomed Lab, London WC1N 1AX, England	University of London; University College London; University of London School of Pharmacy	Kostarelos, K (corresponding author), Univ London, Sch Pharm, Ctr Drug Delivery Res, Nanomed Lab, 29-39 Brunswick Sq, London WC1N 1AX, England.	kostas.kostarelos@pharmacy.ac.uk	Kostarelos, Kostas/AAP-6879-2021; Singh, Ravi/B-1221-2010; Singh, Ravi N/A-5740-2011	Kostarelos, Kostas/0000-0002-2224-6672; Singh, Ravi N/0000-0003-0750-1804				Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Alemany R, 1999, EXP CELL RES, V252, P1, DOI 10.1006/excr.1999.4623; Anklesaria P, 2000, CURR OPIN MOL THER, V2, P426; Arulsudar N, 2003, J DRUG TARGET, V11, P187, DOI 10.1080/10611860310001615415; Bauerschmitz GJ, 2002, INT J ONCOL, V21, P1161; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Brandao JG, 2003, VACCINE, V21, P2268, DOI 10.1016/S0264-410X(03)00050-1; Campbell RB, 2002, CANCER RES, V62, P6831; Chen MY, 2005, J NEUROSURG, V103, P311, DOI 10.3171/jns.2005.103.2.0311; Chuah Marinee K. L., 2003, Current Gene Therapy, V3, P527, DOI 10.2174/1566523034578140; Clark PR, 1999, CANCER GENE THER, V6, P437, DOI 10.1038/sj.cgt.7700074; Croyle MA, 2002, HUM GENE THER, V13, P1887, DOI 10.1089/104303402760372972; de Chermont QL, 2007, P NATL ACAD SCI USA, V104, P9266, DOI 10.1073/pnas.0702427104; Dechecchi MC, 2001, J VIROL, V75, P8772, DOI 10.1128/JVI.75.18.8772-8780.2001; Douglas JT, 1996, NAT BIOTECHNOL, V14, P1574, DOI 10.1038/nbt1196-1574; Fang BL, 2003, CURR OPIN MOL THER, V5, P475; Fasbender A, 1997, J BIOL CHEM, V272, P6479, DOI 10.1074/jbc.272.10.6479; Fisher KD, 2001, GENE THER, V8, P341, DOI 10.1038/sj.gt.3301389; Fisher KD, 2007, J DRUG TARGET, V15, P546, DOI 10.1080/10611860701501014; Fukuhara H, 2003, ORAL ONCOL, V39, P601, DOI 10.1016/S1368-8375(03)00047-2; Gabizon AA, 2006, J LIPOSOME RES, V16, P175, DOI 10.1080/08982100600848769; Gomez-Navarro J, 2000, Lancet Oncol, V1, P148, DOI 10.1016/S1470-2045(00)00030-9; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Green NK, 2002, CANCER GENE THER, V9, P1036, DOI 10.1038/sj.cgt.7700541; Hama S, 2006, MOL THER, V13, P786, DOI 10.1016/j.ymthe.2005.10.007; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Huang YZ, 2005, BIOL PHARM BULL, V28, P387, DOI 10.1248/bpb.28.387; Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9; Kanerva A, 2004, INT J CANCER, V110, P475, DOI 10.1002/ijc.20129; Kim J, 2002, J VIROL, V76, P1892, DOI 10.1128/JVI.76.4.1892-1903.2002; KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H; KRAMP WJ, 1979, INFECT IMMUN, V25, P771, DOI 10.1128/IAI.25.2.771-773.1979; Krasnici S, 2003, INT J CANCER, V105, P561, DOI 10.1002/ijc.11108; Kunisawa J, 2005, J CONTROL RELEASE, V105, P344, DOI 10.1016/j.jconrel.2005.03.020; Lee EM, 2004, J CANCER RES CLIN, V130, P169, DOI 10.1007/s00432-003-0521-z; Lee SG, 2000, CANCER GENE THER, V7, P1329, DOI 10.1038/sj.cgt.0236; Levchenko TS, 2002, INT J PHARMACEUT, V240, P95, DOI 10.1016/S0378-5173(02)00129-1; Litzinger DC, 1996, BBA-BIOMEMBRANES, V1281, P139, DOI 10.1016/0005-2736(95)00268-5; Ma Z, 2002, GENE THER, V9, P176, DOI 10.1038/sj.gt.3301636; Martin K, 2003, MOL THER, V8, P485, DOI 10.1016/S1525-0016(03)00182-5; MeunierDurmort C, 1997, BBA-BIOMEMBRANES, V1330, P8, DOI 10.1016/S0005-2736(97)00133-8; Morral N, 2002, HUM GENE THER, V13, P143, DOI 10.1089/10430340152712692; Moura SP, 2005, LANGMUIR, V21, P10160, DOI 10.1021/la0504614; Ni SH, 2005, HUM GENE THER, V16, P664, DOI 10.1089/hum.2005.16.664; O'Riordan CR, 1999, HUM GENE THER, V10, P1349, DOI 10.1089/10430349950018021; Parker AL, 2005, J DRUG TARGET, V13, P39, DOI 10.1080/10611860400020449; Pearce OMT, 2005, ANGEW CHEM INT EDIT, V44, P1057, DOI 10.1002/anie.200461832; Qiu CB, 1998, HUM GENE THER, V9, P507, DOI 10.1089/hum.1998.9.4-507; RICHARDSON VJ, 1978, J NUCL MED, V19, P1049; Rivera AA, 2004, GENE THER, V11, P1694, DOI 10.1038/sj.gt.3302346; Roux E, 2004, J CONTROL RELEASE, V94, P447, DOI 10.1016/j.jconrel.2003.10.024; Russell WC, 2000, J GEN VIROL, V81, P2573, DOI 10.1099/0022-1317-81-11-2573; Shayakhmetov DM, 2005, J VIROL, V79, P1053, DOI 10.1128/JVI.79.2.1053-1061.2005; Singh R, 2008, ACS NANO, V2, P1040, DOI 10.1021/nn8000565; Snoeys J, 2006, MOL THER, V13, P98, DOI 10.1016/j.ymthe.2005.06.477; Steel JC, 2007, EUR J PHARM SCI, V30, P398, DOI 10.1016/j.ejps.2006.12.004; Steel JC, 2005, J VIROL METHODS, V126, P31, DOI 10.1016/j.jviromet.2005.01.017; Tao NJ, 2001, MOL THER, V3, P28, DOI 10.1006/mthe.2000.0227; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Weissig V, 1998, PHARMACEUT RES, V15, P1552, DOI 10.1023/A:1011951016118; Wickham TJ, 2000, GENE THER, V7, P110, DOI 10.1038/sj.gt.3301115; Wolff G, 1997, J VIROL, V71, P624, DOI 10.1128/JVI.71.1.624-629.1997; Worgall S, 1997, HUM GENE THER, V8, P1675, DOI 10.1089/hum.1997.8.14-1675; Worgall S, 1997, HUM GENE THER, V8, P37, DOI 10.1089/hum.1997.8.1-37; Wu HJ, 2002, HUM GENE THER, V13, P1647, DOI 10.1089/10430340260201734; Yamashita M, 2007, INT J CANCER, V121, P1690, DOI 10.1002/ijc.22852; Yotnda P, 2002, MOL THER, V5, P233, DOI 10.1006/mthe.2002.0545; YUAN F, 1995, CANCER RES, V55, P3752	68	39	41	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2008	22	9					3389	3402		10.1096/fj.08-103275	http://dx.doi.org/10.1096/fj.08-103275			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18556649				2022-12-25	WOS:000258761300031
J	Fu, Y; Buryanovskyy, L; Zhang, Z				Fu, Yue; Buryanovskyy, Leonid; Zhang, Zhongtao			Quinone reductase 2 is a catechol quinone reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE-N-METHYLTRANSFERASE; IDIOPATHIC PARKINSONS-DISEASE; REDOX-CYCLING QUINOPROTEIN; DT-DIAPHORASE; NQO2 GENE; CRYSTAL-STRUCTURE; OXIDOREDUCTASE-2 NQO2; TYROSINE-HYDROXYLASE; ENZYMATIC OXIDATION; POLYMORPHISM	The functions of quinone reductase 2 have eluded researchers for decades even though a genetic polymorphism is associated with various neurological disorders. Employing enzymatic studies using adrenochrome as a substrate, we show that quinone reductase 2 is specific for the reduction of adrenochrome, whereas quinone reductase 1 shows no activity. We also solved the crystal structure of quinone reductase 2 in complexes with dopamine and adrenochrome, two compounds that are structurally related to catecholamine quinones. Detailed structural analyses delineate the mechanism of quinone reductase 2 specificity toward catechol quinones in comparison with quinone reductase 1; a side-chain rotational difference between quinone reductase 1 and quinone reductase 2 of a single residue, phenylalanine 106, determines the specificity of enzymatic activities. These results infer functional differences between two homologous enzymes and indicate that quinone reductase 2 could play important roles in the regulation of catecholamine oxidation processes that may be involved in the etiology of Parkinson disease.	[Fu, Yue; Buryanovskyy, Leonid; Zhang, Zhongtao] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	New York Medical College	Zhang, Z (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	Zhongtao_zhang@nymc.edu		zhang, zhongtao/0000-0002-1910-4753	National Institutes of Health (NINDS) [R01 NS051548]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051548] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS051548 (NINDS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AKSOY S, 1994, J BIOL CHEM, V269, P14835; Aoyama K, 2001, NEUROSCI LETT, V298, P78, DOI 10.1016/S0304-3940(00)01723-7; Asanuma M, 2006, EXPERT REV NEUROTHER, V6, P1313, DOI 10.1586/14737175.6.9.1313; BACQ ZM, 1950, ARCH INT PHYS BIOCH, V57, P271, DOI 10.3109/13813455009144910; BAEZ S, 1995, BIOCHEM MOL MED, V56, P37, DOI 10.1006/bmme.1995.1054; Baez S, 1997, BIOCHEM J, V324, P25, DOI 10.1042/bj3240025; Bergamaschi E, 2001, AM J RESP CRIT CARE, V163, P1426, DOI 10.1164/ajrccm.163.6.2006056; Bianchet MA, 2008, VITAM HORM, V78, P63, DOI 10.1016/S0083-6729(07)00004-0; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buryanovskyy L, 2004, BIOCHEMISTRY-US, V43, P11417, DOI 10.1021/bi049162o; Calamini B, 2008, BIOCHEM J, V413, P81, DOI 10.1042/BJ20071373; Cavalieri EL, 2004, ANN NY ACAD SCI, V1028, P247, DOI 10.1196/annals.1322.029; CHEN HH, 1992, BIOCHEM J, V284, P855, DOI 10.1042/bj2840855; Chen S, 2000, FREE RADICAL BIO MED, V29, P276, DOI 10.1016/S0891-5849(00)00308-7; Clairmont A, 1999, CARCINOGENESIS, V20, P1235, DOI 10.1093/carcin/20.7.1235; Dinkova-Kostova LT, 2000, FREE RADICAL BIO MED, V29, P231, DOI 10.1016/S0891-5849(00)00300-2; Faig M, 2000, P NATL ACAD SCI USA, V97, P3177, DOI 10.1073/pnas.050585797; Fleming RA, 2002, PHARMACOGENETICS, V12, P31, DOI 10.1097/00008571-200201000-00005; Foster CE, 2000, FREE RADICAL BIO MED, V29, P241, DOI 10.1016/S0891-5849(00)00299-9; Foster CE, 1999, BIOCHEMISTRY-US, V38, P9881, DOI 10.1021/bi990799v; Fu Y, 2005, BIOCHEM BIOPH RES CO, V336, P332, DOI 10.1016/j.bbrc.2005.08.081; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Haque ME, 2003, BBA-GEN SUBJECTS, V1619, P39, DOI 10.1016/S0304-4165(02)00440-3; Harada S, 2003, PSYCHIAT GENET, V13, P205, DOI 10.1097/00041444-200312000-00003; Harada S, 2001, BIOCHEM BIOPH RES CO, V288, P887, DOI 10.1006/bbrc.2001.5868; Hastings TG, 1996, ADV EXP MED BIOL, V387, P97; HASTINGS TG, 1995, J NEUROCHEM, V64, P919; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Iskander K, 2006, J BIOL CHEM, V281, P30917, DOI 10.1074/jbc.M605809200; JAISWAL AK, 1990, BIOCHEMISTRY-US, V29, P1899, DOI 10.1021/bi00459a034; Jiang Xiao-hua, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P120; Kang YH, 2004, METHOD ENZYMOL, V382, P380; Kiyohara C, 2005, GENET MED, V7, P463, DOI 10.1097/01.GIM.0000177530.55043.c1; Knox RJ, 2000, CANCER RES, V60, P4179; Krajinovic M, 2002, INT J CANCER, V97, P230, DOI 10.1002/ijc.1589; Kuhn DM, 1998, J NEUROSCI, V18, P7111; Kuhn DM, 1999, J NEUROCHEM, V73, P1309, DOI 10.1046/j.1471-4159.1999.0731309.x; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; LI RB, 1995, P NATL ACAD SCI USA, V92, P8846, DOI 10.1073/pnas.92.19.8846; LIAO S, 1961, BIOCHEM BIOPH RES CO, V4, P208, DOI 10.1016/0006-291X(61)90272-8; LIAO S, 1962, J BIOL CHEM, V237, P2981; Long DJ, 2002, J BIOL CHEM, V277, P46131, DOI 10.1074/jbc.M208675200; Ohgake S, 2005, ADDICT BIOL, V10, P145, DOI 10.1080/13556210500123423; Okada S, 2005, NEUROSCI LETT, V375, P178, DOI 10.1016/j.neulet.2004.11.009; Okubo T, 2003, ALCOHOL CLIN EXP RES, V27, p68S, DOI 10.1097/01.ALC.0000078616.63296.41; Ostrousky O, 2003, TISSUE ANTIGENS, V62, P483, DOI 10.1046/j.1399-0039.2003.00133.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons RB, 2003, NEUROSCI LETT, V342, P13, DOI 10.1016/S0304-3940(03)00218-0; Ross D, 2004, METHOD ENZYMOL, V382, P115; Shao M, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P122; Smith MT, 1999, P NATL ACAD SCI USA, V96, P7624, DOI 10.1073/pnas.96.14.7624; Smythies J, 1998, BBA-GEN SUBJECTS, V1380, P159, DOI 10.1016/S0304-4165(97)00131-1; Spencer JPE, 1998, J NEUROCHEM, V71, P2112; Sulzer D, 1999, NEUROTOX RES, V1, P181, DOI 10.1007/BF03033289; Takagi S, 2002, ANTICANCER RES, V22, P2749; van Muiswinkel FL, 2004, NEUROBIOL AGING, V25, P1253, DOI 10.1016/j.neurobiolaging.2003.12.010; Wang W, 2004, FREE RADICAL BIO MED, V37, P1231, DOI 10.1016/j.freeradbiomed.2004.06.042; Wang W, 2008, J GERONTOL A-BIOL, V63, P127, DOI 10.1093/gerona/63.2.127; Whitehead RE, 2001, J NEUROCHEM, V76, P1242, DOI 10.1046/j.1471-4159.2001.00125.x; Wu KB, 1997, ARCH BIOCHEM BIOPHYS, V347, P221, DOI 10.1006/abbi.1997.0344; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Zafar KS, 2006, MOL PHARMACOL, V70, P1079, DOI 10.1124/mol.106.024703; Zhang JH, 2003, WORLD J GASTROENTERO, V9, P1390, DOI 10.3748/wjg.v9.i7.1390; Zhao QJ, 1997, P NATL ACAD SCI USA, V94, P1669, DOI 10.1073/pnas.94.5.1669	65	41	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23829	23835		10.1074/jbc.M801371200	http://dx.doi.org/10.1074/jbc.M801371200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579530	Green Published, hybrid			2022-12-25	WOS:000258638900037
J	Furukawa, Y; Kaneko, K; Yamanaka, K; O'Halloran, TV; Nukina, N				Furukawa, Yoshiaki; Kaneko, Kumi; Yamanaka, Koji; O'Halloran, Thomas V.; Nukina, Nobuyuki			Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU/ZN SUPEROXIDE-DISMUTASE; PROTEIN-DISULFIDE-ISOMERASE; MOTOR-NEURON DEGENERATION; COPPER-BINDING-SITE; ALS-LINKED SOD1; TRANSGENIC MICE; MUTANT SOD1; CU,ZN-SUPEROXIDE DISMUTASE; SPINAL-CORDS; MUTATIONS	Dominant mutations in Cu,Zn-superoxide dismutase (SOD1) cause a familial form of amyotrophic lateral sclerosis (fALS), and aggregation of mutant SOD1 has been proposed to play a role in neurodegeneration. A growing body of evidence suggests that fALS-causing mutations destabilize the native structure of SOD1, leading to aberrant protein interactions for aggregation. SOD1 becomes stabilized and enzymatically active after copper and zinc binding and intramolecular disulfide formation, but it remains unknown which step(s) in the SOD1 maturation process is important in the pathological aggregation. In this study we have shown that apoSOD1 without disulfide is the most facile state for formation of amyloid-like fibrillar aggregates. fALS mutations impair either zinc binding, disulfide formation, or both, leading to accumulation of the aggregation-prone, apo, and disulfide-reduced SOD1. Moreover, we have found that the copper chaperone for SOD1 (CCS) facilitates maturation of SOD1 and that CCS overexpression ameliorates intracellular aggregation of mutant SOD1 in vivo. Based on our in vivo and in vitro results, we propose that facilitation of post-translational modifications is a promising strategy to reduce SOD1 aggregation in the cell.	[Furukawa, Yoshiaki; Kaneko, Kumi; Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan; [Yamanaka, Koji] RIKEN, Brain Sci Inst, Yamanaka Res Unit, Wako, Saitama 3510198, Japan; [O'Halloran, Thomas V.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA	RIKEN; RIKEN; Northwestern University	Furukawa, Y (corresponding author), 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	furukawa@brain.riken.jp; nukina@brain.riken.jp	Furukawa, Yoshiaki/F-2871-2014; Nukina, Nobuyuki/GPP-6265-2022; Yamanaka, Koji/H-5806-2011; Yamanaka, Koji/ABD-1034-2020; O'Halloran, Thomas/ABE-6125-2021	Furukawa, Yoshiaki/0000-0002-1918-372X; Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035; O'Halloran, Thomas/0000-0001-8732-5059	Scientific Research on Priority Areas Research on Pathomechanisms of Brain Disorders [17025044]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [18031044, 18770143]; Ministry of Health, Welfare, and Labor, Japan; Nakabayashi Trust for ALS Research	Scientific Research on Priority Areas Research on Pathomechanisms of Brain Disorders(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Labor, Japan(Ministry of Health, Labour and Welfare, Japan); Nakabayashi Trust for ALS Research	This work was supported by Grant-in-aid 17025044 for Scientific Research on Priority Areas Research on Pathomechanisms of Brain Disorders (to N.N.) and Grants-in-aid 18031044 and 18770143 (to Y.F.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant-in-aid for the Research on Measures for Intractable Diseases from the Ministry of Health, Welfare, and Labor, Japan (to N.N.), and by the Nakabayashi Trust for ALS Research (to Y.F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Banci L, 1995, EUR J BIOCHEM, V234, P855, DOI 10.1111/j.1432-1033.1995.855_a.x; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Bertini I, 1998, ADV INORG CHEM, V45, P127, DOI 10.1016/S0898-8838(08)60026-4; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Carroll MC, 2006, J BIOL CHEM, V281, P28648, DOI 10.1074/jbc.M600138200; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Crow JP, 1997, J NEUROCHEM, V69, P1945; Crow JP, 1997, J NEUROCHEM, V69, P1936; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shivaprasad S, 2006, J BIOL CHEM, V281, P993, DOI 10.1074/jbc.M505091200; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Stieber A, 2000, J NEUROL SCI, V173, P53, DOI 10.1016/S0022-510X(99)00300-7; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104; Zhang H, 2003, J BIOL CHEM, V278, P24078, DOI 10.1074/jbc.M302051200	58	156	158	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24167	24176		10.1074/jbc.M802083200	http://dx.doi.org/10.1074/jbc.M802083200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18552350	Green Published, hybrid			2022-12-25	WOS:000258638900070
J	Nikonov, A; Juronen, E; Ustav, M				Nikonov, Andrei; Juronen, Erkki; Ustav, Mart			Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DE-NOVO; BINDING-SITE; IDENTIFICATION; REPLICATION; INITIATION; NS5B; COMPLEX; CLEAVAGE; REGION	The hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp), encoded by nonstructural protein 5B (NS5B), is absolutely essential for the viral replication. Here we describe the development, characterization, and functional properties of the panel of monoclonal antibodies (mAbs) and specifically describe the mechanism of action of two mAbs inhibiting the NS5B RdRp activity. These mAbs recognize and bind to distinct linear epitopes in the fingers subdomain of NS5B. The mAb 8B2 binds the N-terminal epitope of the NS5B and inhibits both primer-dependent and de novo RNA synthesis. mAb 8B2 selectively inhibits elongation of RNA chains and enhances the RNA template binding by NS5B. In contrast, mAb 7G8 binds the epitope that contains motif G conserved in viral RdRps and inhibits only primer-dependent RNA synthesis by specifically targeting the initiation of RNA synthesis, while not interfering with the binding of template RNA by NS5B. To reveal the importance of the residues of mAb 7G8 epitope for the initiation of RNA synthesis, we performed site-directed mutagenesis and extensively characterized the functionality of the HCV RdRp motif G. Comparison of the mutation effects in both in vitro primer-dependent RdRp assay and cellular transient replication assay suggested that mAb7G8 epitope amino acid residues are involved in the interaction of template-primer or template with HCV RdRp. The data presented here allowed us to describe the functionality of the epitopes of mAbs 8B2 and 7G8 in the HCV RdRp activity and suggest that the epitopes recognized by these mAbs may be useful targets for antiviral drugs.	[Nikonov, Andrei; Ustav, Mart] Univ Tartu, Dept Biomed Technol, Inst Technol, EE-50411 Tartu, Estonia; [Juronen, Erkki; Ustav, Mart] Univ Tartu, Inst Gen & Mol Pathol, Lab Mol Pathol, EE-50411 Tartu, Estonia	University of Tartu; University of Tartu	Ustav, M (corresponding author), Univ Tartu, Dept Biomed Technol, Inst Technol, Nooruse 1, EE-50411 Tartu, Estonia.	mart.ustav@ut.ee	Nikonov, Andrei/G-3421-2015; Ustav, Mart/G-6484-2017	Nikonov, Andrei/0000-0003-2121-8984; 	Estonian Science Foundation [5998, 5999]; Basic Science Committee [SF0182566]	Estonian Science Foundation; Basic Science Committee	This work was supported by Grants 5998 and 5999 from Estonian Science Foundation and by Target Financial Project SF0182566 from Basic Science Committee. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; AKAIKE H, 1992, No To Hattatsu, V24, P127; Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Binder M, 2007, J VIROL, V81, P5270, DOI 10.1128/JVI.00032-07; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; BORMAN AM, 1994, EMBO J, V13, P3149, DOI 10.1002/j.1460-2075.1994.tb06613.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradrick SS, 2006, NUCLEIC ACIDS RES, V34, P1293, DOI 10.1093/nar/gkl019; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Deval J, 2007, J BIOL CHEM, V282, P16907, DOI 10.1074/jbc.M701973200; Dhanak D, 2002, J BIOL CHEM, V277, P38322, DOI 10.1074/jbc.M205566200; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Dutartre H, 2005, J BIOL CHEM, V280, P6359, DOI 10.1074/jbc.M410191200; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Gu BH, 2003, J BIOL CHEM, V278, P16602, DOI 10.1074/jbc.M210891200; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Imbert I, 2006, EMBO J, V25, P4933, DOI 10.1038/sj.emboj.7601368; JURONEN E, 1991, J IMMUNOL METHODS, V136, P103, DOI 10.1016/0022-1759(91)90255-E; Juronen E, 1996, HYBRIDOMA, V15, P77, DOI 10.1089/hyb.1996.15.77; Kaldalu N, 2000, BIOTECHNIQUES, V28, P456, DOI 10.2144/00283st02; Kang SM, 2008, J VIRAL HEPATITIS, V15, P305, DOI 10.1111/j.1365-2893.2007.00945.x; Kao CC, 2000, J VIROL, V74, P11121, DOI 10.1128/JVI.74.23.11121-11128.2000; Kim YC, 2005, J BIOL CHEM, V280, P38011, DOI 10.1074/jbc.M508145200; Koch Uwe, 2006, Infectious Disorders - Drug Targets, V6, P31, DOI 10.2174/187152606776056724; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Love RA, 2003, J VIROL, V77, P7575, DOI 10.1128/JVI.77.13.7575-7581.2003; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; MIKAELIAN I, 1992, NUCLEIC ACIDS RES, V20, P376, DOI 10.1093/nar/20.2.376; Moradpour D, 2002, J BIOL CHEM, V277, P593, DOI 10.1074/jbc.M108748200; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; Oh JW, 2000, J BIOL CHEM, V275, P17710, DOI 10.1074/jbc.M908781199; Pauwels F, 2007, J VIROL, V81, P6909, DOI 10.1128/JVI.01543-06; PERZ JP, 2004, 425 ANN M INF DIS SO, P214; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PFAFF E, 1982, EMBO J, V1, P869, DOI 10.1002/j.1460-2075.1982.tb01262.x; PILIPENKO EV, 1989, NUCLEIC ACIDS RES, V17, P5701, DOI 10.1093/nar/17.14.5701; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Qin WP, 2001, HEPATOLOGY, V33, P728, DOI 10.1053/jhep.2001.22765; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SELBY MJ, 1994, VIROLOGY, V204, P114, DOI 10.1006/viro.1994.1515; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; Thompson AA, 2007, J MOL BIOL, V366, P1459, DOI 10.1016/j.jmb.2006.11.070; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Windisch MP, 2005, J VIROL, V79, P13778, DOI 10.1128/JVI.79.21.13778-13793.2005	66	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24089	24102		10.1074/jbc.M803422200	http://dx.doi.org/10.1074/jbc.M803422200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18574240	hybrid, Green Published			2022-12-25	WOS:000258638900063
J	Obara, K; Sekito, T; Niimi, K; Ohsumi, Y				Obara, Keisuke; Sekito, Takayuki; Niimi, Kaori; Ohsumi, Yoshinori			The Atg18-Atg2 complex is recruited to autophagic membranes via phosphatidylinositol 3-phosphate and exerts an essential function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FLUORESCENT PROTEIN; MAMMALIAN-CELLS; YEAST; TRANSPORT; 3-KINASE; MUTANTS; VACUOLE; 3,5-BISPHOSPHATE; LOCALIZATION	Atg18 is essential for both autophagy and the regulation of vacuolar morphology. The latter process is mediated by phosphatidylinositol 3,5-bisphosphate binding, which is dispensable for autophagy. Atg18 also binds to phosphatidylinositol 3-phosphate ( PtdIns( 3) P) in vitro. Here, we investigate the relationship between PtdIns( 3) P-binding of Atg18 and autophagy. Using an Atg18 variant, Atg18(FTTG), which is unable to bind phosphoinositides, we found that PtdIns( 3) P binding of Atg18 is essential for full activity in both selective and nonselective autophagy. Atg18( FTTG) formed a complex with Atg2 in a normal manner, and Atg18-Atg2 complex formation occurred in cells in the absence of PtdIns( 3) P, indicating that Atg18-Atg2 complex formation is independent of PtdIns(3)P-binding of Atg18. Atg18 localized to endosomes, the vacuolar membrane, and autophagic membranes, whereas Atg18( FTTG) did not localize to these structures. The localization of Atg2 to autophagic membranes was also lost in Atg18( FTTG) cells. These data indicate that PtdIns( 3) P-binding of Atg18 is involved in directing the Atg18-Atg2 complex to autophagic membranes. Connection of a 2 x FYVE domain, a specific PtdIns(3)P-binding domain, to the C terminus of Atg18( FTTG) restored the localization of Atg18-Atg2 to autophagic membranes and full autophagic activity, indicating that PtdIns(3)P-binding by Atg18 is dispensable for the function of the Atg18-Atg2 complex but is required for its localization. This also suggests that PtdIns( 3) P does not act allosterically on Atg18. Taken together, Atg18 forms a complex with Atg2 irrespective of PtdIns( 3) P binding, associates tightly to autophagic membranes by interacting with PtdIns( 3) P, and plays an essential role.	[Obara, Keisuke; Niimi, Kaori; Ohsumi, Yoshinori] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; [Sekito, Takayuki] Ehime Univ, Dept Appl Biosci, Fac Agr, Matsuyama, Ehime 7908566, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Ehime University	Ohsumi, Y (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Nishigonaka 38,Myodaiji Cho, Okazaki, Aichi 4448585, Japan.	yohsumi@nibb.ac.jp	Obara, Keisuke/A-3824-2012; Ohsumi, Yoshinori/C-6449-2009	Ohsumi, Yoshinori/0000-0003-2384-2166	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15002012]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research 15002012 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; BROWN WJ, 1995, J CELL BIOL, V130, P781, DOI 10.1083/jcb.130.4.781; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; DAVIDSON HW, 1995, J CELL BIOL, V130, P797, DOI 10.1083/jcb.130.4.797; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Kaiser C., 1994, METHODS YEAST GENETI; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Krick R, 2006, FEBS LETT, V580, P4632, DOI 10.1016/j.febslet.2006.07.041; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Obara K, 2008, GENES CELLS, V13, P537, DOI 10.1111/j.1365-2443.2008.01188.x; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Shintani T, 2001, J BIOL CHEM, V276, P30452, DOI 10.1074/jbc.M102346200; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Takenawa T, 2001, J CELL SCI, V114, P1801; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wang CW, 2001, J BIOL CHEM, V276, P30442, DOI 10.1074/jbc.M102342200; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	33	209	217	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23972	23980		10.1074/jbc.M803180200	http://dx.doi.org/10.1074/jbc.M803180200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586673	Green Published, hybrid			2022-12-25	WOS:000258638900053
J	Samavati, L; Lee, I; Mathes, I; Lottspeich, F; Huttemann, M				Samavati, Lobelia; Lee, Icksoo; Mathes, Isabella; Lottspeich, Friedrich; Huttemann, Maik			Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED SIGNAL-TRANSDUCTION; PROTEIN-KINASE-A; TNF-ALPHA; MITOCHONDRIAL-DNA; MYOCARDIAL-ISCHEMIA; INDUCED APOPTOSIS; SEPTIC SHOCK; SEPSIS; RESPIRATION; MECHANISMS	Mitochondrial oxidative phosphorylation provides most cellular energy. As part of this process, cytochrome c oxidase (CcO) pumps protons across the inner mitochondrial membrane, contributing to the generation of the mitochondrial membrane potential, which is used by ATP synthase to produce ATP. During acute inflammation, as in sepsis, aerobic metabolism appears to malfunction and switches to glycolytic energy production. The pro-inflammatory cytokine tumor necrosis factor alpha(TNF alpha) has been shown to play a central role in inflammation. We hypothesized that TNF alpha-triggered cell signaling targets CcO, which is a central enzyme of the aerobic energy metabolism and can be regulated through phosphorylation. Using total bovine and murine hepatocyte homogenates TNF alpha treatment led to an similar to 60% reduction in CcO activity. In contrast, there was no direct effect of TNF alpha on CcO activity using isolated mitochondria and purified CcO, indicating that a TNF alpha-triggered intracellular signaling cascade mediates CcO inhibition. CcO isolated after TNF alpha treatment showed tyrosine phosphorylation on CcO catalytic subunit I and was similar to 50 and 70% inhibited at high cytochrome c concentrations in the presence of allosteric activator ADP and inhibitor ATP, respectively. CcO phosphorylation occurs on tyrosine 304 as demonstrated with a phosphoepitope-specific antibody. Furthermore, the mitochondrial membrane potential was decreased in H2.35 cells in response to TNF alpha. Concomitantly, cellular ATP was more than 35 and 64% reduced in murine hepatocytes and H2.35 cells. We postulate that an important contributor in TNF alpha-mediated pathologies, such as sepsis, is energy paucity, which parallels the poor tissue oxygen extraction and utilization found in such patients.	[Lee, Icksoo; Huttemann, Maik] Wayne State Univ, Ctr Mol Med & Genet, Sch Med, Detroit, MI 48201 USA; [Samavati, Lobelia] Wayne State Univ, Sch Med, Div Pulm Crit Care & Sleep Med, Dept Med, Detroit, MI 48201 USA; [Mathes, Isabella; Lottspeich, Friedrich] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Wayne State University; Wayne State University; Max Planck Society	Huttemann, M (corresponding author), Wayne State Univ, Ctr Mol Med & Genet, Sch Med, 3214 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.	mhuttema@med.wayne.edu		Huttemann, Maik/0000-0001-6310-7081				Acin-Perez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021; Arnold S, 1998, EUR J BIOCHEM, V252, P325, DOI 10.1046/j.1432-1327.1998.2520325.x; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Bender E, 2000, FEBS LETT, V466, P130, DOI 10.1016/S0014-5793(99)01773-1; Berg S, 2003, CRIT CARE MED, V31, P1203, DOI 10.1097/01.CCM.0000059647.92390.92; Boneh A, 2006, CELL MOL LIFE SCI, V63, P1236, DOI 10.1007/s00018-005-5585-2; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brunori M, 2005, J INORG BIOCHEM, V99, P324, DOI 10.1016/j.jinorgbio.2004.10.011; Busquets S, 2003, CYTOKINE, V22, P1, DOI 10.1016/S1043-4666(03)00098-X; Callahan LA, 2005, J APPL PHYSIOL, V99, P1120, DOI 10.1152/japplphysiol.01157.2004; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Griffioen G, 2002, CURR GENET, V41, P199, DOI 10.1007/s00294-002-0308-9; Huttemann M, 2007, FEBS J, V274, P5737, DOI 10.1111/j.1742-4658.2007.06093.x; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Huttemann M, 2003, GENE, V312, P95, DOI 10.1016/S0378-1119(03)00604-8; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; KADENBACH B, 1986, METHOD ENZYMOL, V126, P32; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; Kimura H, 2006, LIFE SCI, V78, P1901, DOI 10.1016/j.lfs.2005.08.040; KREYMANN G, 1993, CRIT CARE MED, V21, P1012, DOI 10.1097/00003246-199307000-00015; Kunz WS, 2000, J BIOL CHEM, V275, P27741; Ledgerwood EC, 1998, LAB INVEST, V78, P1583; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Lee I, 2001, EUR J BIOCHEM, V268, P6329, DOI 10.1046/j.0014-2956.2001.02602.x; Lee I, 2006, BIOCHEMISTRY-US, V45, P9121, DOI 10.1021/bi060585v; LEE MD, 1987, P NATL ACAD SCI USA, V84, P2590, DOI 10.1073/pnas.84.9.2590; Levy RJ, 2004, SHOCK, V21, P110, DOI 10.1097/01.shk.0000108400.56565.ab; LIN RY, 1995, J BIOL CHEM, V270, P27804, DOI 10.1074/jbc.270.46.27804; Liu HT, 2004, J IMMUNOL, V172, P1907, DOI 10.4049/jimmunol.172.3.1907; Liu ZG, 2005, CELL RES, V15, P24, DOI 10.1038/sj.cr.7290259; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1011, DOI 10.1016/j.joca.2006.03.008; Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Napiwotzki J, 1997, BIOL CHEM, V378, P1013, DOI 10.1515/bchm.1997.378.9.1013; Newhall KJ, 2006, CURR BIOL, V16, P321, DOI 10.1016/j.cub.2005.12.031; Palacios-Callender M, 2004, P NATL ACAD SCI USA, V101, P7630, DOI 10.1073/pnas.0401723101; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Rosser DM, 1995, J APPL PHYSIOL, V79, P1878, DOI 10.1152/jappl.1995.79.6.1878; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singer M, 2005, CRIT CARE MED, V33, pS539, DOI 10.1097/01.CCM.0000186080.13402.96; Steenaart NAE, 1997, FEBS LETT, V415, P294, DOI 10.1016/S0014-5793(97)01145-9; TRACEY KJ, 1987, SURG GYNECOL OBSTET, V164, P415; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; VONJAGOW G, 1972, FEBS LETT, V24, P278, DOI 10.1016/0014-5793(72)80372-7; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200; Zhu JX, 2006, CYTOKINE, V34, P96, DOI 10.1016/j.cyto.2006.04.010	58	134	137	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21134	21144		10.1074/jbc.M801954200	http://dx.doi.org/10.1074/jbc.M801954200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18534980	Green Published, hybrid			2022-12-25	WOS:000257746100055
J	Dettenhofer, M; Zhou, F; Leder, P				Dettenhofer, Markus; Zhou, Fen; Leder, Philip			Formin 1-Isoform IV Deficient Cells Exhibit Defects in Cell Spreading and Focal Adhesion Formation	PLOS ONE			English	Article								Background: Regulation of the cytoskeleton is a central feature of cell migration. The formin family of proteins controls the rate of actin nucleation at its barbed end. Thus, formins are predicted to contribute to several important cell processes such as locomotion, membrane ruffling, vesicle endocytosis, and stress fiber formation and disassociation. Methodology/Principal Findings: In this study we investigated the functional role of Formin1-isoform4 (Fmn1-IV) by using genetically null primary cells that displayed augmented protrusive behaviour during wound healing and delayed cell spreading. Cells deficient of Fmn1-IV also showed reduced efficiency of focal adhesion formation. Additionally, we generated an enhanced green fluorescence protein (EGFP)-fused Fmn1-IV knock-in mouse to monitor the endogenous subcellular localization of Fmn1-IV. Its localization was found within the cytoplasm and along microtubules, yet it was largely excluded from adherens junctions. Conclusions/Significance: It was determined that Fmn1-IV, as an actin nucleator, contributes to protrusion of the cell's leading edge and focal adhesion formation, thus contributing to cell motility.	[Dettenhofer, Markus; Zhou, Fen; Leder, Philip] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Dettenhofer, M (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mdettenh@genetics.med.harvard.edu	Dettenhofer, Markus/ABB-9840-2021	Dettenhofer, Markus/0000-0003-1972-7026	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Funding in part through the Howard Hughes Medical Institute.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Chan DC, 1996, J BIOL CHEM, V271, P23472, DOI 10.1074/jbc.271.38.23472; CHAN DC, 1995, DEVELOPMENT, V121, P3151; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Feierbach B, 2004, J CELL BIOL, V165, P697, DOI 10.1083/jcb.200403090; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; JACKSONGRUSBY L, 1992, GENE DEV, V6, P29, DOI 10.1101/gad.6.1.29; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; MAAS RL, 1990, NATURE, V346, P853, DOI 10.1038/346853a0; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; O'Rourke DA, 2000, J AM SOC NEPHROL, V11, P2212, DOI 10.1681/ASN.V11122212; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Takaishi K, 2000, BIOCHEM BIOPH RES CO, V274, P68, DOI 10.1006/bbrc.2000.3102; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; WOYCHIK RP, 1990, NATURE, V346, P850, DOI 10.1038/346850a0; WynshawBoris A, 1997, MOL MED, V3, P372, DOI 10.1007/BF03401684; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311; Yayoshi-Yamamoto S, 2000, MOL CELL BIOL, V20, P6872, DOI 10.1128/MCB.20.18.6872-6881.2000; Zhou F, 2006, EXP CELL RES, V312, P1119, DOI 10.1016/j.yexcr.2005.12.035; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	40	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2497	10.1371/journal.pone.0002497	http://dx.doi.org/10.1371/journal.pone.0002497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560567	gold, Green Published, Green Submitted			2022-12-25	WOS:000263280700057
J	Faca, VM; Ventura, AP; Fitzgibbon, MP; Pereira-Faca, SR; Pitteri, SJ; Green, AE; Ireton, RC; Zhang, Q; Wang, H; O'Briant, KC; Drescher, CW; Schummer, M; McIntosh, MW; Knudsen, BS; Hanash, SM				Faca, Vitor M.; Ventura, Aviva P.; Fitzgibbon, Mathew P.; Pereira-Faca, Sandra R.; Pitteri, Sharon J.; Green, Ann E.; Ireton, Renee C.; Zhang, Qing; Wang, Hong; O'Briant, Kathy C.; Drescher, Charles W.; Schummer, Michel; McIntosh, Martin W.; Knudsen, Beatrice S.; Hanash, Samir M.			Proteomic Analysis of Ovarian Cancer Cells Reveals Dynamic Processes of Protein Secretion and Shedding of Extra-Cellular Domains	PLOS ONE			English	Article								Background: Elucidation of the repertoire of secreted and cell surface proteins of tumor cells is relevant to molecular diagnostics, tumor imaging and targeted therapies. We have characterized the cell surface proteome and the proteins released into the extra-cellular milieu of three ovarian cancer cell lines, CaOV3, OVCAR3 and ES2 and of ovarian tumor cells enriched from ascites fluid. Methodology and Findings: To differentiate proteins released into the media from protein constituents of media utilized for culture, cells were grown in the presence of [(13)C]-labeled lysine. A biotinylation-based approach was used to capture cell surface associated proteins. Our general experimental strategy consisted of fractionation of proteins from individual compartments followed by proteolytic digestion and LC-MS/MS analysis. In total, some 6,400 proteins were identified with high confidence across all specimens and fractions. Conclusions and Significance: Protein profiles of the cell lines had substantial similarity to the profiles of human ovarian cancer cells from ascites fluid and included protein markers known to be associated with ovarian cancer. Proteomic analysis indicated extensive shedding from extra-cellular domains of proteins expressed on the cell surface, and remarkably high secretion rates for some proteins (nanograms per million cells per hour). Cell surface and secreted proteins identified by in-depth proteomic profiling of ovarian cancer cells may provide new targets for diagnosis and therapy.	[Faca, Vitor M.; Ventura, Aviva P.; Fitzgibbon, Mathew P.; Pereira-Faca, Sandra R.; Pitteri, Sharon J.; Green, Ann E.; Ireton, Renee C.; Zhang, Qing; Wang, Hong; O'Briant, Kathy C.; Drescher, Charles W.; Schummer, Michel; McIntosh, Martin W.; Knudsen, Beatrice S.; Hanash, Samir M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Faca, VM (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	shanash@fhcrc.org	Faça, Vitor M/A-3989-2013	Pitteri, Sharon/0000-0002-3119-873X; FACA, VITOR MARCEL/0000-0003-3205-7944	The Canary Foundation	The Canary Foundation	This study was funded by The Canary Foundation. The funding organization did not have any role in data collection or analysis, decision to publish, or preparation of the manuscript.	Aletti GD, 2007, MAYO CLIN PROC, V82, P751; An HJ, 2006, J PROTEOME RES, V5, P1082, DOI 10.1021/pr050461p; Bengtsson S, 2007, J PROTEOME RES, V6, P1440, DOI 10.1021/pr060593y; Choi H, 2008, J PROTEOME RES, V7, P47, DOI 10.1021/pr700747q; De Wever O, 2007, CLIN EXP METASTAS, V24, P685, DOI 10.1007/s10585-007-9104-8; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; Faca V, 2007, BIOTECHNIQUES, V43, P279, DOI 10.2144/000112541; Gagne JP, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-16; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Goonewardene TI, 2007, LANCET ONCOL, V8, P813, DOI 10.1016/S1470-2045(07)70273-5; Gortzak-Uzan L, 2008, J PROTEOME RES, V7, P339, DOI 10.1021/pr0703223; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; KARLAN BY, 1994, GYNECOL ONCOL, V53, P70; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; LAU DHM, 1991, CANCER RES, V51, P5181; Lin YW, 2006, INT J GYNECOL CANCER, V16, P139, DOI 10.1111/j.1525-1438.2006.00475.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Maatta M, 2007, ANTICANCER RES, V27, P2753; Morita A, 2006, PROTEOMICS, V6, P5880, DOI 10.1002/pmic.200500708; Moshkovskii SA, 2005, PROTEOMICS, V5, P3790, DOI 10.1002/pmic.200401205; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Schwartz DR, 2002, CANCER RES, V62, P4722; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937; Young TW, 2007, CLIN CANCER RES, V13, P3848, DOI 10.1158/1078-0432.CCR-07-0337	39	105	107	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2425	10.1371/journal.pone.0002425	http://dx.doi.org/10.1371/journal.pone.0002425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560578	gold, Green Published, Green Submitted			2022-12-25	WOS:000263280700011
J	Mutalima, N; Molyneux, E; Jaffe, H; Kamiza, S; Borgstein, E; Mkandawire, N; Liomba, G; Batumba, M; Lagos, D; Gratrix, F; Boshoff, C; Casabonne, D; Carpenter, LM; Newton, R				Mutalima, Nora; Molyneux, Elizabeth; Jaffe, Harold; Kamiza, Steve; Borgstein, Eric; Mkandawire, Nyengo; Liomba, George; Batumba, Mkume; Lagos, Dimitrios; Gratrix, Fiona; Boshoff, Chris; Casabonne, Delphine; Carpenter, Lucy M.; Newton, Robert			Associations between Burkitt Lymphoma among Children in Malawi and Infection with HIV, EBV and Malaria: Results from a Case-Control Study	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; PLASMODIUM-FALCIPARUM; ANTIBODY-RESPONSES; CANCER; RISK; UGANDA; ADULTS; BLOOD	Background: Burkitt lymphoma, a childhood cancer common in parts of sub-Saharan Africa, has been associated with Epstein Barr Virus (EBV) and malaria, but its association with human immunodeficiency virus (HIV) is not clear. Methodology/Principal Findings: We conducted a case-control study of Burkitt lymphoma among children (aged <= 15 years) admitted to the pediatric oncology unit in Blantyre, Malawi between July 2005 and July 2006. Cases were 148 children diagnosed with Burkitt lymphoma and controls were 104 children admitted with non-malignant conditions or cancers other than hematological malignancies and Kaposi sarcoma. Interviews were conducted and serological samples tested for antibodies against HIV, EBV and malaria. Odds ratios for Burkitt lymphoma were estimated using unconditional logistic regression adjusting for sex, age, and residential district. Cases had a mean age of 7.1 years and 60% were male. Cases were more likely than controls to be HIV positive (Odds ratio (OR)) = 12.4, 95% Confidence Interval (CI) 1.3 to 116.2, p = 0.03). ORs for Burkitt lymphoma increased with increasing antibody titers against EBV (p = 0.001) and malaria (p = 0.01). Among HIV negative participants, cases were thirteen times more likely than controls to have raised levels of both EBV and malaria antibodies (OR = 13.2; 95% CI 3.8 to 46.6; p = 0.001). Reported use of mosquito nets was associated with a lower risk of Burkitt lymphoma (OR = 0.2, 95% CI, 0.03 to 0.9, p = 0.04). Conclusions: Our findings support prior evidence that EBV and malaria act jointly in the pathogenesis of Burkitt lymphoma, suggesting that malaria prevention may decrease the risk of Burkitt lymphoma. HIV may also play a role in the etiology of this childhood tumor.	[Mutalima, Nora; Jaffe, Harold; Carpenter, Lucy M.] Univ Oxford, Dept Publ Hlth, Oxford, England; [Molyneux, Elizabeth] Coll Med, Dept Pediat, Blantyre, Malawi; [Kamiza, Steve; Liomba, George] Coll Med, Dept Histopathol, Blantyre, Malawi; [Borgstein, Eric; Mkandawire, Nyengo] Coll Med, Dept Surg, Blantyre, Malawi; [Batumba, Mkume] Coll Med, Dept Ophthalmol, Blantyre, Malawi; [Lagos, Dimitrios; Gratrix, Fiona; Boshoff, Chris] UCL, Wolfson Inst Biomed Res, London, England; [Casabonne, Delphine] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Newton, Robert] Univ York, Dept Hlth Sci, Epidemiol & Genet Unit, York, N Yorkshire, England	University of Oxford; University of Malawi; University of Malawi; University of Malawi; University of Malawi; University of London; University College London; University of Oxford; University of York - UK	Mutalima, N (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford, England.	nora.mutalima@gmail.com	Casabonne, Delphine/H-6425-2014	Lagos, Dimitris/0000-0003-0637-281X	Cancer Research UK; Medical Research Council [G0800168] Funding Source: researchfish; MRC [G0800168] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Support for this work was provided by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKENJI TN, 1994, J PARASITOL, V80, P895, DOI 10.2307/3283437; Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; Akre O, 1999, INT J CANCER, V82, P1; BIGGAR RJ, 1979, INT J CANCER, V23, P330, DOI 10.1002/ijc.2910230310; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; BURKITT D, 1958, BRIT J SURG, V46, P218, DOI 10.1002/bjs.18004619704; Carpenter LM, 2008, INT J CANCER, V122, P1319, DOI 10.1002/ijc.23254; Chokunonga E, 2000, INT J CANCER, V85, P54, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;54::AID-IJC10&gt;3.0.CO;2-D; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; DALLDORF G, 1964, PERSPECT BIOL MED, V7, P435; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; Douek Daniel C., 2003, AIDS Reviews, V5, P172; DZAMALALA C, 2005, CANC EPIDEMIC MALAWI; EGAN AF, 1995, INFECT IMMUN, V63, P456, DOI 10.1128/IAI.63.2.456-466.1995; GESER A, 1989, AM J EPIDEMIOL, V129, P740, DOI 10.1093/oxfordjournals.aje.a115189; GESER A, 1982, INT J CANCER, V29, P397, DOI 10.1002/ijc.2910290406; GESER A, 1985, BURKITTS LYMPHOMA HU, P205; HADDOW AJ, 1970, BURKITTS LYMPHOMA, P198; HENLE G, 1969, J NATL CANCER I, V43, P1147; Higgins CD, 2007, J INFECT DIS, V195, P474, DOI 10.1086/510854; IARC, 1997, IARC MON EV CARC RIS; *IARC, 2003, CANC AFR EP PREV, P427; KAFUKO GW, 1970, INT J CANCER, V6, P1, DOI 10.1002/ijc.2910060102; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; LAM KMC, 1991, LANCET, V337, P876, DOI 10.1016/0140-6736(91)90203-2; Lazzi S, 1998, HUM PATHOL, V29, P1285, DOI 10.1016/S0046-8177(98)90258-1; LENGELER C, 1998, COCHRANE DB SYST REV; Mathanga DP, 2005, AM J TROP MED HYG, V73, P622, DOI 10.4269/ajtmh.2005.73.622; Mbulaiteye SM, 2006, J INFECT DIS, V193, P422, DOI 10.1086/499277; Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910; MORROW RH, 1974, CANCER RES, V34, P1211; MORROW RH, 1976, JNCI-J NATL CANCER I, V56, P479, DOI 10.1093/jnci/56.3.479; MORROW RH, 1976, CANCER RES, V36, P667; Morrow RH, 1982, CANCER EPIDEMIOL, V779-94; Moutschen M, 2007, VACCINE, V25, P4697, DOI 10.1016/j.vaccine.2007.04.008; National Statistics Office (Malawi) Measure DHS ORC Macro, 2005, MAL DEM HLTH SURV 20; Newton R, 2001, INT J CANCER, V92, P622, DOI 10.1002/1097-0215(20010601)92:5&lt;622::AID-IJC1256&gt;3.0.CO;2-K; Newton R, 2006, BRIT J CANCER, V94, P1504, DOI 10.1038/sj.bjc.6603100; OLWENY CLM, 1977, JNCI-J NATL CANCER I, V58, P1191, DOI 10.1093/jnci/58.5.1191; Parkin DM, 2000, AIDS, V14, P2929, DOI 10.1097/00002030-200012220-00015; Rasti N, 2005, SCAND J IMMUNOL, V61, P461, DOI 10.1111/j.1365-3083.2005.01589.x; SHIRAMIZU B, 1991, BLOOD, V77, P1516; Sinfield RL, 2007, PEDIATR BLOOD CANCER, V48, P515, DOI 10.1002/pbc.20917; Slutsker L, 1996, AM J TROP MED HYG, V55, P71, DOI 10.4269/ajtmh.1996.55.71; *STATACORP REL 200, 2007, INT STAT 9 2 WIND VE; Verra F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000978; WHITTLE HC, 1990, CLIN EXP IMMUNOL, V80, P213, DOI 10.1111/j.1365-2249.1990.tb05236.x; Yamey G, 2000, BRIT MED J, V320, P1228, DOI 10.1136/bmj.320.7244.1228; [No title captured]	50	80	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2505	10.1371/journal.pone.0002505	http://dx.doi.org/10.1371/journal.pone.0002505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560562	Green Published, Green Submitted, gold			2022-12-25	WOS:000263280700061
J	Peterson, AT; Stewart, A; Mohamed, KI; Araujo, MB				Peterson, A. Townsend; Stewart, Aimee; Mohamed, Kamal I.; Araujo, Miguel B.			Shifting Global Invasive Potential of European Plants with Climate Change	PLOS ONE			English	Article								Global climate change and invasions by nonnative species rank among the top concerns for agents of biological loss in coming decades. Although each of these themes has seen considerable attention in the modeling and forecasting communities, their joint effects remain little explored and poorly understood. We developed ecological niche models for 1804 species from the European flora, which we projected globally to identify areas of potential distribution, both at present and across 4 scenarios of future (2055) climates. As expected from previous studies, projections based on the CGCM1 climate model were more extreme than those based on the HadCM3 model, and projections based on the a2 emissions scenario were more extreme than those based on the b2 emissions scenario. However, less expected were the highly nonlinear and contrasting projected changes in distributional areas among continents: increases in distributional potential in Europe often corresponded with decreases on other continents, and species seeing expanding potential on one continent often saw contracting potential on others. In conclusion, global climate change will have complex effects on invasive potential of plant species. The shifts and changes identified in this study suggest strongly that biological communities will see dramatic reorganizations in coming decades owing to shifting invasive potential by nonnative species.	[Peterson, A. Townsend; Stewart, Aimee] Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; [Mohamed, Kamal I.] SUNY Coll Oswego, Dept Biol Sci, Oswego, NY USA; [Araujo, Miguel B.] CSIC, Natl Museum Nat Sci, Biodivers & Evol Biol Dept, Madrid, Spain	University of Kansas; State University of New York (SUNY) System; State University of New York (SUNY) - Oswego; Consejo Superior de Investigaciones Cientificas (CSIC)	Peterson, AT (corresponding author), Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA.	town@ku.edu	Araújo, Miguel B/B-6117-2008; Peterson, A. Townsend/I-5697-2013	Araújo, Miguel B/0000-0002-5107-7265; Peterson, A. Townsend/0000-0003-0243-2379				Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P17, DOI 10.1111/j.1466-822X.2004.00128.x; Araujo MB, 2003, GLOBAL ECOL BIOGEOGR, V12, P5, DOI 10.1046/j.1466-822X.2003.00314.x; Bakkenes M, 2002, GLOBAL CHANGE BIOL, V8, P390, DOI 10.1046/j.1354-1013.2001.00467.x; Benning TL, 2002, P NATL ACAD SCI USA, V99, P14246, DOI 10.1073/pnas.162372399; Berry PM, 2002, GLOBAL ECOL BIOGEOGR, V11, P453, DOI 10.1111/j.1466-8238.2002.00304.x; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; *CRIA, 2007, OPENMODELLER VERS; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Erasmus BFN, 2002, GLOBAL CHANGE BIOL, V8, P679, DOI 10.1046/j.1365-2486.2002.00502.x; Flato GM, 2000, CLIM DYNAM, V16, P451, DOI 10.1007/s003820050339; Hampe A, 2004, GLOBAL ECOL BIOGEOGR, V13, P469, DOI 10.1111/j.1466-822X.2004.00090.x; Hoffmann MH, 2001, FLORA, V196, P395, DOI 10.1016/S0367-2530(17)30076-2; Huntley B, 2004, ECOL LETT, V7, P417, DOI 10.1111/j.1461-0248.2004.00598.x; Iguchi K, 2004, T AM FISH SOC, V133, P845, DOI 10.1577/T03-172.1; IPCC, 2001, CLIM DAT ARCH; Jalas J., 1972, ATLAS FLORAE EUROPAE; Lahti Tapani, 1999, Acta Botanica Fennica, V162, P5; LAWTON JH, 1986, PHILOS T ROY SOC B, V314, P607, DOI 10.1098/rstb.1986.0076; Martin WK, 1996, EMU, V96, P166, DOI 10.1071/MU9960166; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; *NAS, 2002, PRED INV NON PLANTS; New M., 1997, 1961 1990 MEAN MONTH; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2004, CAN J ZOOL, V82, P851, DOI 10.1139/Z04-064; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; PETERSON AT, 2005, CLIMATE CHANGE BIODI, P211; POPE VD, 2002, IMPACT NEW PHYS PARA; RICHARDSON DM, 1992, S AFR J SCI, V88, P380; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Skov F, 2000, TAXON, V49, P503, DOI 10.2307/1224346; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; *USDA, 2007, PLANTS DAT; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WILLIAMSON M, 1996, BIOLO INVASIONS	54	54	54	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2441	10.1371/journal.pone.0002441	http://dx.doi.org/10.1371/journal.pone.0002441			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560572	Green Published, Green Submitted, gold			2022-12-25	WOS:000263280700026
J	Agarwal, V; Kommaddi, RP; Valli, K; Ryder, D; Hyde, TM; Kleinman, JE; Strobel, HW; Ravindranath, V				Agarwal, Varsha; Kommaddi, Reddy P.; Valli, Khader; Ryder, Daniel; Hyde, Thomas M.; Kleinman, Joel E.; Strobel, Henry W.; Ravindranath, Vijayalakshmi			Drug Metabolism in Human Brain: High Levels of Cytochrome P4503A43 in Brain and Metabolism of Anti-Anxiety Drug Alprazolam to Its Active Metabolite	PLOS ONE			English	Article								Cytochrome P450 (P450) is a super-family of drug metabolizing enzymes. P450 enzymes have dual function; they can metabolize drugs to pharmacologically inactive metabolites facilitating their excretion or biotransform them to pharmacologically active metabolites which may have longer half-life than the parent drug. The variable pharmacological response to psychoactive drugs typically seen in population groups is often not accountable by considering dissimilarities in hepatic metabolism. Metabolism in brain specific nuclei may play a role in pharmacological modulation of drugs acting on the CNS and help explain some of the diverse response to these drugs seen in patient population. P450 enzymes are also present in brain where drug metabolism can take place and modify therapeutic action of drugs at the site of action. We have earlier demonstrated an intrinsic difference in the biotransformation of alprazolam (ALP) in brain and liver, relatively more alpha-hydroxy alprazolam (alpha-OHALP) is formed in brain as compared to liver. In the present study we show that recombinant CYP3A43 metabolizes ALP to both alpha-OHALP and 4-hydroxy alprazolam (4-OHALP) while CYP3A4 metabolizes ALP predominantly to its inactive metabolite, 4-OHALP. The expression of CYP3A43 mRNA in human brain samples correlates with formation of relatively higher levels of alpha-OH ALP indicating that individuals who express higher levels of CYP3A43 in the brain would generate larger amounts of alpha-OHALP. Further, the expression of CYP3A43 was relatively higher in brain as compared to liver across different ethnic populations. Since CYP3A enzymes play a prominent role in the metabolism of drugs, the higher expression of CYP3A43 would generate metabolite profile of drugs differentially in human brain and thus impact the pharmacodynamics of psychoactive drugs at the site of action.	[Agarwal, Varsha; Kommaddi, Reddy P.; Valli, Khader; Ravindranath, Vijayalakshmi] Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Nainwal Mode, Manesar, India; [Ryder, Daniel; Strobel, Henry W.] Univ Texas, Med Sch, Dept Biochem & Mol Biol, Houston, TX USA; [Hyde, Thomas M.; Kleinman, Joel E.] NIMH, NIH, DIRP, Sect Neuropathol,Clin Brain Disorders Branch, Bethesda, MD USA	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); University of Texas System; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Agarwal, V (corresponding author), Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Nainwal Mode, Manesar, India.	vijir@nbrc.ac.in			National Institutes of Health [MH 70054]; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002903, ZICMH002903, R01MH070054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grant MH 70054 to HWS and VR.	ANANDATHEERTHAVARADA HK, 1990, BRAIN RES, V536, P339, DOI 10.1016/0006-8993(90)90047-F; Chinta SJ, 2002, MOL BRAIN RES, V103, P49, DOI 10.1016/S0169-328X(02)00177-8; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Domanski TL, 2001, MOL PHARMACOL, V59, P386, DOI 10.1124/mol.59.2.386; Fukasawa T, 2007, J CLIN PHARM THER, V32, P333, DOI 10.1111/j.1365-2710.2007.00829.x; Gellner K, 2001, PHARMACOGENETICS, V11, P111, DOI 10.1097/00008571-200103000-00002; GREENBLATT DJ, 1993, CLIN PHARMACOKINET, V24, P453, DOI 10.2165/00003088-199324060-00003; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Haining RL, 2007, PHARMACOL THERAPEUT, V113, P537, DOI 10.1016/j.pharmthera.2006.11.005; Hirota N, 2001, BIOPHARM DRUG DISPOS, V22, P53, DOI 10.1002/bdd.261; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Kevil CG, 1997, BIOCHEM BIOPH RES CO, V238, P277, DOI 10.1006/bbrc.1997.7284; Kommaddi RP, 2007, J NEUROCHEM, V102, P867, DOI 10.1111/j.1471-4159.2007.04599.x; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Meyer RP, 2007, CURR DRUG METAB, V8, P297, DOI 10.2174/138920007780655478; OZHEMIR V, 2000, PHARMACOGENETICS, V5, P373; Pai H. V., 2002, Pharmacogenomics Journal, V2, P243, DOI 10.1038/sj.tpj.6500115; Park JY, 2006, CLIN PHARMACOL THER, V79, P590, DOI 10.1016/j.clpt.2006.02.008; PARK JY, 2006, CLIN PHARMACOL THER, V6, P715; Ravindranath V, 2006, J NEURAL TRANSM-SUPP, P167; RAVINDRANATH V, 1989, BRAIN RES, V496, P331, DOI 10.1016/0006-8993(89)91083-4; SCHUETZ JD, 1993, J CLIN INVEST, V92, P1018, DOI 10.1172/JCI116607; SETHY VH, 1982, J PHARM PHARMACOL, V34, P115, DOI 10.1111/j.2042-7158.1982.tb04197.x; Wennerholm A, 2005, EUR J CLIN PHARMACOL, V61, P113, DOI 10.1007/s00228-004-0861-x; Westlind A, 2001, BIOCHEM BIOPH RES CO, V281, P1349, DOI 10.1006/bbrc.2001.4505; Williams ET, 2004, J PHARMACOL EXP THER, V311, P728, DOI 10.1124/jpet.104.068908	27	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2337	10.1371/journal.pone.0002337	http://dx.doi.org/10.1371/journal.pone.0002337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545703	Green Published, Green Submitted, gold			2022-12-25	WOS:000263248800007
J	Muller, M; Fink, K; Geisel, J; Kahl, F; Jilge, B; Reimann, J; Mach, N; Autenrieth, IB; Frick, JS				Mueller, Martina; Fink, Kerstin; Geisel, Julia; Kahl, Frauke; Jilge, Burghardt; Reimann, Joerg; Mach, Nicolas; Autenrieth, Ingo B.; Frick, Julia S.			Intestinal Colonization of IL-2 Deficient Mice with Non-Colitogenic B. vulgatus Prevents DC Maturation and T-Cell Polarization	PLOS ONE			English	Article							DENDRITIC CELLS; IN-VIVO; INFLAMMATION; COLITIS; DISEASE; CCR7; LIPOPOLYSACCHARIDE; DIFFERENTIATION; INTERLEUKIN-6; INHIBITION	Background: IL-2 deficient (IL-2(-/-)) mice mono-colonized with E. coli mpk develop colitis whereas IL-2(-/-)-mice mono-colonized with B. vulgatus mpk do not and are even protected from E. coli mpk induced colitis. Methodology/Principal Findings: We investigated if mono-colonization with E. coli mpk or B. vulgatus mpk differentially modulates distribution, activation and maturation of intestinal lamina propria (LP) dendritic cells (DC). LP DC in mice mono-colonized with protective B. vulgatus mpk or co-colonized with E. coli mpk/B. vulgatus mpk featured a semi-mature LP DC phenotype (CD40(lo)CD80(lo)MHC-IIhi) whereas mono-colonization with colitogenic E. coli mpk induced LP DC activation and maturation prior to onset of colitis. Accordingly, chemokine receptor (CCR) 7 surface expression was more strikingly enhanced in mesenteric lymph node DC from E. coli mpk than B. vulgatus mpk mono- or co-colonized mice. Mature but not semi-mature LP DC promoted Th1 polarization. As B. vulgatus mpk promotes differentiation of semi-mature DC presumably by IL-6, mRNA and protein expression of IL-6 was investigated in LP DC. The data demonstrated that IL-6 mRNA and protein was increased in LP DC of B. vulgatus mpk as compared to E. coli mpk mono- colonized IL-2(-/-)-mice. The B. vulgatus mpk mediated suppression of CCR7 expression and DC migration was abolished in IL-6(-/-)-DC in vitro. Conclusions/Significance: From this data we conclude that the B. vulgatus triggered IL-6 secretion by LP DC in absence of proinflammatory cytokines such as IL-12 or TNF-alpha induces a semi-mature LP DC phenotype, which might prevent T-cell activation and thereby the induction of colitis in IL-2(-/-)-mice. The data provide new evidence that IL-6 might act as an immune regulatory cytokine in the mucosa by targeting intestinal DC.	[Mueller, Martina; Fink, Kerstin; Geisel, Julia; Kahl, Frauke; Autenrieth, Ingo B.; Frick, Julia S.] Univ Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany; [Jilge, Burghardt; Reimann, Joerg] Univ Ulm, Ulm, Germany; [Mach, Nicolas] Geneva Univ Hosp, Oncol Div, Geneva, Switzerland	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ulm University; University of Geneva	Muller, M (corresponding author), Univ Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany.	julia-stefanie.frick@med.uni-tuebingen.de	mach, nicolas/AAZ-5302-2021	Frick, Julia-Stefanie/0000-0002-7662-7956	Deutsche Forschungsgemeinschaft [AU 103/13-2]; IZKF Tubingen (BMBF)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Tubingen (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Deutsche Forschungsgemeinschaft (AU 103/13-2) and the IZKF Tubingen (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Autenrieth IB, 1997, GUT, V41, P793, DOI 10.1136/gut.41.6.793; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Betti M, 2006, ANN ONCOL, V17, P235; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Frick JS, 2006, EUR J IMMUNOL, V36, P1537, DOI 10.1002/eji.200635840; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; Geisel J, 2007, J IMMUNOL, V179, P5811, DOI 10.4049/jimmunol.179.9.5811; Hegde S, 2004, FASEB J, V18, P1439, DOI 10.1096/fj.03-0969fje; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Kitamura H, 2005, IMMUNITY, V23, P491, DOI 10.1016/j.immuni.2005.09.010; Krajina T, 2004, EUR J IMMUNOL, V34, P705, DOI 10.1002/eji.200324463; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MacDonald TT, 2000, SCAND J IMMUNOL, V51, P2; Mach N, 2000, CANCER RES, V60, P3239; Mahanty S, 2003, J IMMUNOL, V170, P2797, DOI 10.4049/jimmunol.170.6.2797; MANSHEIM BJ, 1978, J IMMUNOL, V120, P72; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; NAIR BC, 1983, J PERIODONTAL RES, V18, P40, DOI 10.1111/j.1600-0765.1983.tb00333.x; Naito Y, 2004, INT J MOL MED, V14, P191; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Schultz M, 1999, AM J PHYSIOL-GASTR L, V276, pG1461, DOI 10.1152/ajpgi.1999.276.6.G1461; Sousa CRE, 2001, IMMUNITY, V14, P495; Taguchi H, 2002, J MED MICROBIOL, V51, P336, DOI 10.1099/0022-1317-51-4-336; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Waidmann M, 2003, GASTROENTEROLOGY, V125, P162, DOI 10.1016/S0016-5085(03)00672-3; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Yanagihara S, 1998, J IMMUNOL, V161, P3096	40	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2376	10.1371/journal.pone.0002376	http://dx.doi.org/10.1371/journal.pone.0002376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545662	Green Submitted, Green Published, gold			2022-12-25	WOS:000263248800017
J	Shen, HB; Chou, JJ				Shen, Hongbin; Chou, James J.			MemBrain: Improving the Accuracy of Predicting Transmembrane Helices	PLOS ONE			English	Article								Prediction of transmembrane helices (TMH) in alpha helical membrane proteins provides valuable information about the protein topology when the high resolution structures are not available. Many predictors have been developed based on either amino acid hydrophobicity scale or pure statistical approaches. While these predictors perform reasonably well in identifying the number of TMHs in a protein, they are generally inaccurate in predicting the ends of TMHs, or TMHs of unusual length. To improve the accuracy of TMH detection, we developed a machine-learning based predictor, MemBrain, which integrates a number of modern bioinformatics approaches including sequence representation by multiple sequence alignment matrix, the optimized evidence-theoretic K-nearest neighbor prediction algorithm, fusion of multiple prediction window sizes, and classification by dynamic threshold. MemBrain demonstrates an overall improvement of about 20% in prediction accuracy, particularly, in predicting the ends of TMHs and TMHs that are shorter than 15 residues. It also has the capability to detect N-terminal signal peptides. The MemBrain predictor is a useful sequence-based analysis tool for functional and structural characterization of helical membrane proteins; it is freely available at http://chou.med.harvard.edu/bioinf/MemBrain/.	[Shen, Hongbin; Chou, James J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shen, HB (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	james_chou@hms.harvard.edu	Chou, James/AAD-6230-2022; Chou, James J/N-9840-2013	Chou, James/0000-0002-4442-0344; Chou, James J/0000-0002-4442-0344	NIH and the Pew Scholars Program in the Biomedical Sciences	NIH and the Pew Scholars Program in the Biomedical Sciences	This work was supported by the NIH and the Pew Scholars Program in the Biomedical Sciences awarded to J.J.C.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Chamberlain AK, 2004, J MOL BIOL, V339, P471, DOI 10.1016/j.jmb.2004.03.072; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cserzo M, 2004, BIOINFORMATICS, V20, P136, DOI 10.1093/bioinformatics/btg394; Cuthbertson JM, 2005, PROTEIN ENG DES SEL, V18, P295, DOI 10.1093/protein/gzi032; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; MAKIVIRTA A, 1991, COMPUT METH PROG BIO, V34, P139, DOI 10.1016/0169-2607(91)90039-V; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shafer G., 1976, MATH THEORY EVIDENCE, VVolume 1; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411; Zhou HY, 2003, PROTEIN SCI, V12, P1547, DOI 10.1110/ps.0305103; Zouhal LM, 1998, IEEE T SYST MAN CY C, V28, P263, DOI 10.1109/5326.669565	26	90	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2399	10.1371/journal.pone.0002399	http://dx.doi.org/10.1371/journal.pone.0002399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545655	Green Published, gold, Green Submitted			2022-12-25	WOS:000263248800037
J	Jo, OD; Martin, J; Bernath, A; Masri, J; Lichtenstein, A; Gera, J				Jo, Oak D.; Martin, Jheralyn; Bernath, Andrew; Masri, Janine; Lichtenstein, Alan; Gera, Joseph			Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function through Akt signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING-PROTEINS; FORKHEAD TRANSCRIPTION FACTOR; STRAND ANNEALING ACTIVITY; TRANS-ACTING FACTORS; MESSENGER-RNA; HNRNP A1; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; SUBCELLULAR-DISTRIBUTION; TRANSLATIONAL CONTROL; MEDIATED TRANSLATION	The translation of the cyclin D1 and c-myc mRNAs occurs via internal ribosome entry site (IRES)-mediated initiation under conditions of reduced eIF-4F complex formation and Akt activity. Here we identify hnRNP A1 as an IRES trans-acting factor that regulates cyclin D1 and c-myc IRES activity, depending on the Akt status of the cell. hnRNP A1 binds both IRESs in vitro and in intact cells and enhances in vitro IRES-dependent reporter expression. Akt regulates this IRES activity by inducing phosphorylation of hnRNP A1 on serine 199. Serine 199-phosphorylated hnRNP A1 binds to the IRESs normally but is unable to support IRES activity in vitro. Reducing expression levels of hnRNP A1 or overexpressing a dominant negative version of the protein markedly inhibits rapamycin-stimulated IRES activity in cells and correlated with redistribution of cyclin D1 and c-myc transcripts from heavy polysomes to monosomes. Importantly, knockdown of hnRNP A1 also renders quiescent Akt-containing cells sensitive to rapamycin-induced G(1) arrest. These results support a role for hnRNP A1 in mediating rapamycin-induced alterations of cyclin D1 and c-myc IRES activity in an Akt-dependent manner and provide the first direct link between Akt and the regulation of IRES activity.	[Jo, Oak D.; Martin, Jheralyn; Bernath, Andrew; Masri, Janine; Lichtenstein, Alan; Gera, Joseph] Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA 91343 USA; [Lichtenstein, Alan; Gera, Joseph] David Geffen Sch Med, Dept Med, Los Angeles, CA 90048 USA; [Lichtenstein, Alan] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90048 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Gera, J (corresponding author), Univ Calif Los Angeles, Dept Res & Dev, Med Ctr, 16111 Plummer St 151,Bldg 1,Rm C111A, Los Angeles, CA 91343 USA.	gera@ucla.edu		Gera, Joseph/0000-0002-2908-6894	NCI NIH HHS [R01CA109312, P30 CA016042, R01CA111448, CA-16042] Funding Source: Medline; NIAID NIH HHS [P30 AI028697, AI-28697] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111448, R01CA109312, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; COBIANCHI F, 1993, NUCLEIC ACIDS RES, V21, P949, DOI 10.1093/nar/21.4.949; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Gera JF, 2002, METHOD ENZYMOL, V350, P499, DOI 10.1016/S0076-6879(02)50981-2; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; Hay DC, 2001, MOL CELL BIOL, V21, P3482, DOI 10.1128/MCB.21.10.3482-3490.2001; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; HENICS T, 1994, J BIOL CHEM, V269, P5377; Holcik M, 2003, MOL CELL BIOL, V23, P280, DOI 10.1128/MCB.23.1.280-288.2003; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Hsu JH, 2001, BLOOD, V98, P2853, DOI 10.1182/blood.V98.9.2853; IDRISS H, 1994, BIOCHEMISTRY-US, V33, P11382, DOI 10.1021/bi00203a037; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Kress E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-8; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Le Quesne JPC, 2001, J MOL BIOL, V310, P111, DOI 10.1006/jmbi.2001.4745; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; MICHAEL WM, 1995, CELL, V83, P415; Mitchell SA, 2005, GENE DEV, V19, P1556, DOI 10.1101/gad.339105; Mitchell SA, 2001, MOL CELL BIOL, V21, P3364, DOI 10.1128/MCB.21.10.3364-3374.2001; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; PINOLROMA S, 1991, SCIENCE, V253, P312, DOI 10.1126/science.1857966; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Schultz DE, 1996, J BIOL CHEM, V271, P14134, DOI 10.1074/jbc.271.24.14134; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Sharma A, 2007, J BIOL CHEM, V282, P9505, DOI 10.1074/jbc.M608874200; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Svitkin YV, 1996, EMBO J, V15, P7147, DOI 10.1002/j.1460-2075.1996.tb01106.x; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Wang RW, 2006, CELL SIGNAL, V18, P1722, DOI 10.1016/j.cellsig.2006.01.020; Wang X, 2006, CELL DEATH DIFFER, V13, P2099, DOI 10.1038/sj.cdd.4401969; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yi MY, 2000, J VIROL, V74, P6459, DOI 10.1128/JVI.74.14.6459-6468.2000	55	83	87	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23274	23287		10.1074/jbc.M801185200	http://dx.doi.org/10.1074/jbc.M801185200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562319	Green Published, hybrid			2022-12-25	WOS:000258455400040
J	Lu, ZP; Sack, MN				Lu, Zhongping; Sack, Michael N.			ATF-1 is a hypoxia-responsive transcriptional activator of skeletal muscle mitochondrial-uncoupling protein 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR-I; OXIDATIVE STRESS; BINDING-PROTEIN; PROMOTER REGION; FACTOR CREB; FATTY-ACID; GENE; UCP3; OVEREXPRESSION; EXPRESSION	Hypoxia induces oxidative damage in skeletal muscle. Uncoupling protein 3 (UCP3) is the skeletal muscle enriched uncoupling protein and has previously been shown to confer resistance against oxidative stress. We show that hypoxia robustly up-regulates skeletal muscle UCP3 and that the absence of UCP3 in primary skeletal myocytes exacerbates hypoxia-induced reactive oxygen species generation. In this context, we reasoned that the investigation of the regulation of UCP3 may identify novel hypoxia-responsive regulatory pathways that modulate intrinsic anti-oxidant defenses. By screening a transcription factor array of 704 full-length cDNAs in murine C2C12 myoblasts following cotransfection of a murine UCP3 promoter-luciferase construct and myoD we identified numerous candidate regulatory factors that up-regulate UCP3. Active transcription factor-1 (ATF-1) was identified, and as this transcription factor is a known component of a multiprotein hypoxia-induced regulatory complex, we explored its role in hypoxia-mediated UCP3 up-regulation. Site-directed mutagenesis and chromatin immunoprecipitation assays identify a 10-bp region required for ATF-1 induction of UCP3 promoter activity. Hypoxia promotes the phosphorylation of ATF-1, and the knockdown of ATF-1 by shRNA prevents hypoxia-mediated up-regulation of UCP3. Pharmacologic inhibition of p38 MAP kinase prevents both hypoxia-mediated ATF-1 phosphorylation and UCP3 up-regulation. PKA signaling does not modulate hypoxia-induced UCP3 up-regulation and neither does HIF-1 alpha activation by cobalt chloride. In conclusion, ATF-1, via p38 MAP kinase activation, functions as a novel regulatory pathway driving UCP3 expression. These data reinforce the role of ATF-1 as a hypoxia-responsive trans-activator and identifies a novel regulatory program that may modulate cellular responses to oxygen-deficit.	[Lu, Zhongping; Sack, Michael N.] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sack, MN (corresponding author), NHLBI, Translat Med Branch, NIH, Bldg 10 CRC,Rm 5-3150,10 Ctr Dr, Bethesda, MD 20892 USA.	sackm@nhlbi.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005199, ZIAHL005199] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Beitner-Johnson D, 2001, CELL SIGNAL, V13, P23, DOI 10.1016/S0898-6568(00)00128-5; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; BRINDLE P, 1995, P NATL ACAD SCI USA, V92, P10521, DOI 10.1073/pnas.92.23.10521; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; Costford SR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1304, DOI 10.1152/ajpendo.00401.2005; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Flandin P, 2005, FEBS LETT, V579, P3411, DOI 10.1016/j.febslet.2005.04.084; Fujimura Y, 2001, ONCOGENE, V20, P6653, DOI 10.1038/sj.onc.1204684; Garcia-Martinez C, 2001, FASEB J, V15, P2033, DOI 10.1096/fj.00-0828fje; Jean D, 2000, ONCOGENE, V19, P2721, DOI 10.1038/sj.onc.1203569; Kim DH, 2007, J BIOCHEM MOL BIOL, V40, P921; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Koechlin C, 2005, THORAX, V60, P834, DOI 10.1136/thx.2004.037531; KVIETIKOVA I, 1995, NUCLEIC ACIDS RES, V23, P4542, DOI 10.1093/nar/23.22.4542; Magalhaes J, 2005, J APPL PHYSIOL, V99, P1247, DOI 10.1152/japplphysiol.01324.2004; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McLeod CJ, 2005, J BIOL CHEM, V280, P33470, DOI 10.1074/jbc.M505258200; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; PONGUBALA JMR, 1995, J BIOL CHEM, V270, P10304, DOI 10.1074/jbc.270.17.10304; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rosenberg D, 2002, ANN NY ACAD SCI, V968, P65, DOI 10.1111/j.1749-6632.2002.tb04327.x; Sack MN, 2006, CARDIOVASC RES, V72, P210, DOI 10.1016/j.cardiores.2006.07.010; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Sen CK, 2006, CARDIOVASC RES, V71, P280, DOI 10.1016/j.cardiores.2006.01.003; Shimokawa T, 1998, BIOCHEM BIOPH RES CO, V246, P287, DOI 10.1006/bbrc.1998.8600; Solanes G, 2000, FASEB J, V14, P2141; Solanes G, 2005, BIOCHEM J, V386, P505, DOI 10.1042/BJ20041073; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; Talbot DA, 2005, BBA-BIOENERGETICS, V1709, P150, DOI 10.1016/j.bbabio.2005.07.001; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Tu N, 2000, LIFE SCI, V67, P2267, DOI 10.1016/S0024-3205(00)00802-X; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Zhou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE622, DOI 10.1152/ajpendo.2000.279.3.E622	41	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23410	23418		10.1074/jbc.M801236200	http://dx.doi.org/10.1074/jbc.M801236200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18579531	Green Published, hybrid			2022-12-25	WOS:000258455400050
J	Rodriguez-Almazan, C; Arreola, R; Rodriguez-Larrea, D; Aguirre-Lopez, B; de Gomez-Puyou, MT; Perez-Montfort, R; Costas, M; Gomez-Puyou, A; Torres-Larios, A				Rodriguez-Almazan, Claudia; Arreola, Rodrigo; Rodriguez-Larrea, David; Aguirre-Lopez, Beatrice; de Gomez-Puyou, Marietta Tuena; Perez-Montfort, Ruy; Costas, Miguel; Gomez-Puyou, Armando; Torres-Larios, Alfredo			Structural basis of human triosephosphate isomerase deficiency: Mutation E104D is related to alterations of a conserved water network at the dimer interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIOSE-PHOSPHATE ISOMERASE; CRYSTAL-STRUCTURE; PROTEIN; RESOLUTION; TIM; NEURODEGENERATION; ASSOCIATION; GLYCOLYSIS; INSIGHTS; FORM	Human triosephosphate isomerase deficiency is a rare autosomal disease that causes premature death of homozygous individuals. The most frequent mutation that leads to this illness is in position 104, which involves a conservative change of a Glu for Asp. Despite the extensive work that has been carried out on the E104D mutant enzyme in hemolysates and whole cells, the molecular basis of this disease is poorly understood. Here, we show that the purified, recombinant mutant enzyme E104D, while exhibiting normal catalytic activity, shows impairments in the formation of active dimers and low thermostability and monomerizes under conditions in which the wild type retains its dimeric form. The crystal structure of the E104D mutant at 1.85 angstrom resolution showed that its global structure was similar to that of the wild type; however, residue 104 is part of a conserved cluster of 10 residues, five from each subunit. An analysis of the available high resolution structures of TIM dimers revealed that this cluster forms a cavity that possesses an elaborate conserved network of buried water molecules that bridge the two subunits. In the E104D mutant, a disruption of contacts of the amino acid side chains in the conserved cluster leads to a perturbation of the water network in which the water-protein and water-water interactions that join the two monomers are significantly weakened and diminished. Thus, the disruption of this solvent system would stand as the underlying cause of the deficiency.	[Rodriguez-Almazan, Claudia; Arreola, Rodrigo; Aguirre-Lopez, Beatrice; de Gomez-Puyou, Marietta Tuena; Perez-Montfort, Ruy; Gomez-Puyou, Armando; Torres-Larios, Alfredo] Univ Nacl Autonoma Mexico, Dept Bioquim, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Rodriguez-Larrea, David; Costas, Miguel] Univ Granada, Fac Ciencias, Dept Quim Fis, Granada 18071, Spain	Universidad Nacional Autonoma de Mexico; University of Granada	Torres-Larios, A (corresponding author), Univ Nacl Autonoma Mexico, Dept Bioquim, Inst Fisiol Celular, Ciudad Univ,Apartado Postal 70-243, Mexico City 04510, DF, Mexico.	torres@ifc.unam.mx	Rodriguez-Larrea, David/ABH-3171-2020	Rodriguez-Larrea, David/0000-0002-5580-7413; Perez-Montfort, Ruy/0000-0003-0810-1159; Arreola, Rodrigo/0000-0003-2417-418X; Costas, Miguel/0000-0001-8604-6381; Torres-Larios, Alfredo/0000-0002-0702-350X	Consejo Nacional de Ciencia y Tecnologia [60127-Q, 41328-Q, 49872]; Programa de Apoyo a Proyectos de Investigacione Innovacion Tecnologica; Ministerio de Educacion y Ciencia de Espana; DGAPAUNAM; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacione Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Ministerio de Educacion y Ciencia de Espana(Spanish Government); DGAPAUNAM(Universidad Nacional Autonoma de Mexico); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by Consejo Nacional de Ciencia y Tecnologia Grants 60127-Q, 41328-Q, and 49872 and Programa de Apoyo a Proyectos de Investigacione Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico, Grant IN200507.; Supported by the Ministerio de Educacion y Ciencia de Espana and DGAPAUNAM;; Data were collected at the SE Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. The critical reading of Anne-Catherine Dock-Bregeon, Alfonso Mondragon, Kerren Swinger, Andrew Swinger, and Jonathan Ipsaro is greatly acknowledged. The technical assistance of Nallely Cabrera and Anita Vega-Miranda is kindly appreciated.	Ahmed N, 2003, BBA-MOL BASIS DIS, V1639, P121, DOI 10.1016/j.bbadis.2003.08.002; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Ationu A, 1999, BLOOD, V94, P3193, DOI 10.1182/blood.V94.9.3193.421k26_3193_3198; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAAR IO, 1986, P NATL ACAD SCI USA, V83, P7903, DOI 10.1073/pnas.83.20.7903; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gayathri P, 2007, ACTA CRYSTALLOGR D, V63, P206, DOI 10.1107/S0907444906046488; Gnerer JP, 2006, P NATL ACAD SCI USA, V103, P14987, DOI 10.1073/pnas.0606887103; Hollan S, 1997, P NATL ACAD SCI USA, V94, P10362, DOI 10.1073/pnas.94.19.10362; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kinoshita T, 2005, ACTA CRYSTALLOGR F, V61, P346, DOI 10.1107/S1744309105008341; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; Mainfroid V, 1996, J MOL BIOL, V257, P441, DOI 10.1006/jmbi.1996.0174; MANDE SC, 1994, PROTEIN SCI, V3, P810, DOI 10.1002/pro.5560030510; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Olah J, 2005, BIOCHEM J, V392, P675, DOI 10.1042/BJ20050993; Orosz F, 2000, P NATL ACAD SCI USA, V97, P1026, DOI 10.1073/pnas.97.3.1026; Orosz F, 2001, BLOOD, V98, P3106, DOI 10.1182/blood.V98.10.3106; Orosz F, 1996, J THEOR BIOL, V182, P437, DOI 10.1006/jtbi.1996.0184; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P83, DOI 10.1023/B:MCBI.0000009860.86969.72; Ralser M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000030; Raschke TM, 2006, CURR OPIN STRUC BIOL, V16, P152, DOI 10.1016/j.sbi.2006.03.002; Repiso Ada, 2002, Haematologica, V87, pECR12; Rodier F, 2005, PROTEINS, V60, P36, DOI 10.1002/prot.20478; Schneider AS, 2000, BEST PRACT RES CL HA, V13, P119, DOI 10.1053/beha.2000.0061; Shanthi V., 2003, Journal of Applied Crystallography, V36, P167, DOI 10.1107/S0021889802019489; Shi YH, 2005, J BIOL CHEM, V280, P41805, DOI 10.1074/jbc.M505181200; Sumathi K, 2006, NUCLEIC ACIDS RES, V34, pW128, DOI 10.1093/nar/gkl036; Walden H, 2001, J MOL BIOL, V306, P745, DOI 10.1006/jmbi.2000.4433; WALEY SG, 1973, BIOCHEM J, V135, P165, DOI 10.1042/bj1350165; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; ZABORI S, 1980, Z NATURFORSCH C, V35, P999; Zomosa-Signoret V, 2003, BIOCHEMISTRY-US, V42, P3311, DOI 10.1021/bi0206560	43	63	65	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23254	23263		10.1074/jbc.M802145200	http://dx.doi.org/10.1074/jbc.M802145200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562316	hybrid			2022-12-25	WOS:000258455400058
J	Thomas, CJ; Tall, GG; Adhikari, A; Sprang, SR				Thomas, Celestine J.; Tall, Gregory G.; Adhikari, Anirban; Sprang, Stephen R.			Ric-8A catalyzes guanine nucleotide exchange on G alpha(i1) bound to the GPR/GoLoco exchange inhibitor AGS3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INDEPENDENT ACTIVATORS; G-PROTEIN SIGNALING-3; G-ALPHA; CORTICAL LOCALIZATION; ASYMMETRIC DIVISION; DROSOPHILA RIC-8; MITOTIC SPINDLE; PLASMA-MEMBRANE; ELEGANS; GTP	Microtubule pulling forces that govern mitotic spindle movement of chromosomes are tightly regulated by G-proteins. A host of proteins, including G alpha subunits, Ric-8, AGS3, regulators of G-protein signalings, and scaffolding proteins, coordinate this vital cellular process. Ric-8A, acting as a guanine nucleotide exchange factor, catalyzes the release of GDP from various G alpha(.)GDP subunits and forms a stable nucleotide-free Ric-8A: G alpha complex. AGS3, a guanine nucleotide dissociation inhibitor (GDI), binds and stabilizes G alpha subunits in their GDP-bound state. Because Ric-8A and AGS3 may recognize and compete for G alpha(.)GDP in this pathway, we probed the interactions of a truncated AGS3 (AGS3-C; containing only the residues responsible for GDI activity), with Ric-8A: G alpha(i1) and that of Ric-8A with the AGS3-C:G alpha(.)(i1)GDP complex. Pulldown assays, gel filtration, isothermal titration calorimetry, and rapid mixing stopped-flow fluorescence spectroscopy indicate that Ric-8A catalyzes the rapid release of GDP from AGS3-C:G alpha(.)(i1)GDP. Thus, Ric-8A forms a transient ternary complex with AGS3-C:G alpha(.)(i1)GDP. Subsequent dissociation of AGS3-C and GDP from G alpha(i1) yields a stable nucleotide free Ric-8A(.)G alpha(i1) complex that, in the presence of GTP, dissociates to yield Ric-8A and G alpha(.)(i1)GTP. AGS3-C does not induce dissociation of the Ric-8A(.)G alpha(i1) complex, even when present at very high concentrations. The action of Ric-8A on AGS3:G alpha(.)(i1)GDP ensures unidirectional activation of G alpha subunits that cannot be reversed by AGS3.	[Thomas, Celestine J.; Sprang, Stephen R.] Univ Montana, Ctr Bimol Struct & Dynam, Missoula, MT 59812 USA; [Thomas, Celestine J.; Sprang, Stephen R.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Tall, Gregory G.] Univ Rochester, Dept Physiol & Pharmacol, Med Ctr, Rochester, NY 14642 USA; [Adhikari, Anirban] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of Rochester; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sprang, SR (corresponding author), Univ Montana, Ctr Bimol Struct & Dynam, Missoula, MT 59812 USA.	stephen.sprang@umontana.edu			NIDDK NIH HHS [R01-DK46371, R56 DK046371] Funding Source: Medline; NIGMS NIH HHS [GM34497] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046371, R56DK046371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034497, R37GM034497] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Bastiani Carol, 2006, WormBook, P1; Bergmann DC, 2003, DEVELOPMENT, V130, P5731, DOI 10.1242/dev.00839; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; BLUMER JB, 2008, ENDOCRINOLO IN PRESS; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bringmann H, 2007, CURR BIOL, V17, P185, DOI 10.1016/j.cub.2006.11.070; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cho H, 2008, CELL CYCLE, V7, P573, DOI 10.4161/cc.7.5.5526; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goulding MB, 2007, J CELL BIOL, V178, P1177, DOI 10.1083/jcb.200703159; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Hampoelz B, 2004, CELL, V119, P453, DOI 10.1016/j.cell.2004.10.025; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Lanier SM, 2004, BIOL CELL, V96, P369, DOI 10.1016/j.biolcel.2004.03.012; LEE E, 1994, METHOD ENZYMOL, V237, P146; MANNING DR, 2003, SCI STKE, pPE35; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Nishimura A, 2006, GENES CELLS, V11, P487, DOI 10.1111/j.1365-2443.2006.00959.x; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2007, ADV PROTEIN CHEM, V74, P67, DOI 10.1016/S0065-3233(07)74002-0; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reynolds NK, 2005, GENETICS, V169, P651, DOI 10.1534/genetics.104.031286; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008	49	48	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23150	23160		10.1074/jbc.M802422200	http://dx.doi.org/10.1074/jbc.M802422200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18541531	Green Published, hybrid			2022-12-25	WOS:000258455400028
J	Heikaus, CC; Stout, JR; Sekharan, MR; Eakin, CM; Rajagopal, P; Brzovic, PS; Beavo, JA; Klevit, RE				Heikaus, Clemens C.; Stout, Joseph R.; Sekharan, Monica R.; Eakin, Catherine M.; Rajagopal, Ponni; Brzovic, Peter S.; Beavo, Joseph A.; Klevit, Rachel E.			Solution structure of the cGMP binding GAF domain from phosphodiesterase 5 - Insights into nucleotide specificity, dimerization, and cGMP-dependent conformational change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOBACTERIAL ADENYLYL-CYCLASE; TORSION ANGLE DYNAMICS; PROTEIN STRUCTURES; REGULATORY DOMAIN; CATALYTIC DOMAIN; CHEMICAL-SHIFT; A DOMAIN; NMR; ASSIGNMENT; PDE5	Phosphodiesterase 5 (PDE5) controls intracellular levels of cGMP through its regulation of cGMP hydrolysis. Hydrolytic activity of the C-terminal catalytic domain is increased bycGMP binding to the N-terminal GAF A domain. We present theNMR solution structure of the cGMP-bound PDE5A GAF A domain. The cGMP orientation in the buried binding pocket was defined through 37 intermolecular nuclear Overhauser effects. Comparison withGAFdomains from PDE2A and adenylyl cyclase cyaB2 reveals a conserved overall domain fold of a six-stranded beta-sheet and four alpha-helices that form a well defined cGMP binding pocket. However, the nucleotide coordination is distinct with a series of altered binding contacts. The structure suggests that nucleotide binding specificity is provided by Asp-196, which is positioned to form two hydrogen bonds to the guanine ring of cGMP. An alanine mutation of Asp-196 disrupts cGMP binding and increases cAMP affinity in constructs containing only GAF A causing an altered cAMP-bound structural conformation. NMRstudies on the tandem GAF domains reveal a flexible GAF A domain in the absence of cGMP, and indicate a large conformational change upon ligand binding. Furthermore, we identify a region of similar to 20 residues directly N-terminal of GAF A as critical for tight dimerization of the tandem GAF domains. The features of the PDE5 regulatory domain revealed here provide an initial structural basis for future investigations of the regulatory mechanism of PDE5 and the design of GAF-specific regulators of PDE5 function.	[Heikaus, Clemens C.; Stout, Joseph R.; Sekharan, Monica R.; Eakin, Catherine M.; Rajagopal, Ponni; Brzovic, Peter S.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Beavo, Joseph A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Sekharan, Monica R.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Rutgers State University New Brunswick	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	klevit@u.washington.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X	NHLBI NIH HHS [1 P01 HL44948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bischoff E, 2001, J UROLOGY, V165, P1316, DOI 10.1016/S0022-5347(01)69891-4; Blount MA, 2006, MOL PHARMACOL, V70, P1822, DOI 10.1124/mol.106.028688; Boolell M, 1996, Int J Impot Res, V8, P47; Bruder S, 2006, J BIOL CHEM, V281, P19969, DOI 10.1074/jbc.M603374200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cann M, 2007, MOL MICROBIOL, V64, P461, DOI 10.1111/j.1365-2958.2007.05669.x; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; CHARBONNEAU H, 1990, P NATL ACAD SCI USA, V87, P288, DOI 10.1073/pnas.87.1.288; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fink TL, 1999, J BIOL CHEM, V274, P34613, DOI 10.1074/jbc.274.49.34613; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; FRANCIS SH, 2007, CYCLIC NUCLEOTIDE PH, P131; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HANDA N, 2008, J BIOL CHEM     0513; Hebert MC, 1998, J BIOL CHEM, V273, P5557, DOI 10.1074/jbc.273.10.5557; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; HURLEY JH, 2003, SCI STKE, pPE1; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kleywegt G. J., 1995, CCP4 ESF EACBM NEWSL, V31, P45; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez Sergio E, 2002, Mol Interv, V2, P317, DOI 10.1124/mi.2.5.317; Padma-Nathan H, 2001, INT J IMPOT RES, V13, P2, DOI 10.1038/sj.ijir.3900631; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Rybalkin SD, 2002, J BIOL CHEM, V277, P3310, DOI 10.1074/jbc.M106562200; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sekharan MR, 2005, J BIOMOL NMR, V33, P75, DOI 10.1007/s10858-005-1615-5; STROOP SD, 1991, J BIOL CHEM, V266, P23802; Sung BJ, 2003, NATURE, V425, P98, DOI 10.1038/nature01914; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; THOMAS MK, 1990, J BIOL CHEM, V265, P14964; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turko IV, 1996, J BIOL CHEM, V271, P22240, DOI 10.1074/jbc.271.36.22240; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wu AY, 2004, J BIOL CHEM, V279, P37928, DOI 10.1074/jbc.M404287200; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zoraghi R, 2005, J BIOL CHEM, V280, P12051, DOI 10.1074/jbc.M413611200	52	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22749	22759		10.1074/jbc.M801577200	http://dx.doi.org/10.1074/jbc.M801577200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18534985	Green Published, hybrid			2022-12-25	WOS:000258321000043
J	Lockridge, O; Xue, WH; Gaydess, A; Grigoryan, H; Ding, SJ; Schopfer, LM; Hinrichs, SH; Masson, P				Lockridge, Oksana; Xue, Weihua; Gaydess, Andrea; Grigoryan, Hasmik; Ding, Shi-Jian; Schopfer, Lawrence M.; Hinrichs, Steven H.; Masson, Patrick			Pseudo-esterase activity of human albumin - Slow turnover on tyrosine 411 and stable acetylation of 82 residues including 59 lysines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SERUM-ALBUMIN; ARYL ACYLAMIDASE ACTIVITY; PARA-NITROPHENYL ACETATE; EPSILON-N-ACETYLLYSINE; ACETYLSALICYLIC-ACID; CRYSTAL-STRUCTURE; HUMAN PLASMA; ASPIRIN; BINDING; PROTEIN	Human albumin is thought to hydrolyze esters because multiple equivalents of product are formed for each equivalent of albumin. Esterase activity with p-nitrophenyl acetate has been attributed to turnover at tyrosine 411. However, p-nitrophenyl acetate creates multiple, stable, acetylated adducts, a property contrary to turnover. Our goal was to identify residues that become acetylated by p-nitrophenyl acetate and determine the relationship between stable adduct formation and turnover. Fatty acid-free human albumin was treated with 0.5mM p-nitrophenyl acetate for 5 min to 2 weeks, or with 10mMp-nitrophenyl acetate for 48 h to 2 weeks. Aliquots were digested with pepsin, trypsin, or GluC and analyzed by mass spectrometry to identify labeled residues. Only Tyr-411 was acetylated within the first 5 min of reaction with 0.5 mM p-nitrophenyl acetate. After 0.5 -6 h there was partial acetylation of 16 -17 residues including Asp-1, Lys-4, Lys-12, Tyr-411, Lys-413, and Lys-414. Treatment with 10 mM p-nitrophenyl acetate resulted in acetylation of 59 lysines, 10 serines, 8 threonines, 4 tyrosines, and Asp-1. When Tyr-411 was blocked with diisopropylfluorophosphate or chlorpyrifos oxon, albumin had normal esterase activity with beta-naphthyl acetate as visualized on a nondenaturing gel. However, after 82 residues had been acetylated, esterase activity was almost completely inhibited. The half-life for deacetylation of Tyr-411 at pH 8.0, 22 degrees C was 61 +/- 4 h. Acetylated lysines formed adducts that were even more stable. In conclusion, the pseudo-esterase activity of albumin is the result of irreversible acetylation of 82 residues and is not the result of turnover.	[Lockridge, Oksana; Xue, Weihua; Grigoryan, Hasmik; Schopfer, Lawrence M.] Univ Nebraska, Med Ctr, Eppley Inst, Omaha, NE 68198 USA; [Ding, Shi-Jian; Hinrichs, Steven H.] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Masson, Patrick] Ctr Rech, Serv Sante Armees, Unite Enzymol, F-38702 La Tronche, France	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Masson, P (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst, Omaha, NE 68198 USA.	olockrid@unmc.edu	Grigoryan, Hasmik/G-6996-2014; Masson, Patrick YM/J-3964-2013; Masson, Patrick/AAA-7213-2019	Masson, Patrick YM/0000-0002-7837-3662; Masson, Patrick/0000-0002-7837-3662	NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058056] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA36727] Funding Source: Medline; NINDS NIH HHS [U01 NS058056-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLFREY VG, 1984, METHOD ENZYMOL, V107, P224; Brunmark P, 1997, CHEM RES TOXICOL, V10, P880, DOI 10.1021/tx9700782; CASIDA JE, 1959, BIOCHIM BIOPHYS ACTA, V36, P411, DOI 10.1016/0006-3002(59)90184-2; De Vriese C, 2007, ENDOCRINOLOGY, V148, P2355, DOI 10.1210/en.2006-1281; DUBOISPRESLE N, 1995, MOL PHARMACOL, V47, P647; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Georges H, 2000, CHIRALITY, V12, P53; GERSHEY EL, 1968, J BIOL CHEM, V243, P5018; HAWKINS D, 1968, SCIENCE, V160, P780, DOI 10.1126/science.160.3829.780; Jiao KS, 2001, ANAL BIOCHEM, V293, P43, DOI 10.1006/abio.2001.5118; KWON CH, 1987, CANCER RES, V47, P1505; Lapko VN, 2001, PROTEIN SCI, V10, P1130, DOI 10.1110/ps.40901; Li B, 2005, BIOCHEM PHARMACOL, V70, P1673, DOI 10.1016/j.bcp.2005.09.002; Li B, 2008, CHEM RES TOXICOL, V21, P421, DOI 10.1021/tx700339m; Li B, 2007, ANAL BIOCHEM, V361, P263, DOI 10.1016/j.ab.2006.11.018; Macdonald JM, 1999, BIOCHEM PHARMACOL, V57, P1233, DOI 10.1016/S0006-2952(99)00039-8; Manoharan I, 2006, ARCH BIOCHEM BIOPHYS, V452, P186, DOI 10.1016/j.abb.2006.06.003; Masson P, 2007, J ENZYM INHIB MED CH, V22, P463, DOI 10.1080/14756360701383932; MEANS GE, 1975, BIOCHEMISTRY-US, V14, P4989, DOI 10.1021/bi00693a031; MEANS GE, 1979, ARCH BIOCHEM BIOPHYS, V194, P526, DOI 10.1016/0003-9861(79)90647-7; MORIKAWA M, 1979, JPN J PHARMACOL, V29, P581, DOI 10.1254/jjp.29.581; Nachon F, 2005, BIOCHEMISTRY-US, V44, P1154, DOI 10.1021/bi048238d; OIKAWA A, 1967, BIOCHEM J, V104, P947, DOI 10.1042/bj1040947; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; RAINSFORD KD, 1980, EUR J CLIN INVEST, V10, P413, DOI 10.1111/j.1365-2362.1980.tb00054.x; Riordan J F, 1972, Methods Enzymol, V25, P500, DOI 10.1016/S0076-6879(72)25046-7; ROTH GJ, 1978, J BIOL CHEM, V253, P3782; Sakurai Y, 2004, PHARM RES-DORDR, V21, P285, DOI 10.1023/B:PHAM.0000016241.84630.06; Salvi A, 1997, DRUG METAB DISPOS, V25, P395; SANGER F, 1945, BIOCHEM J, V39, P507, DOI 10.1042/bj0390507; Sanger F., 1963, P CHEM SOC, V5, P76; Sogorb MA, 2004, ARCH TOXICOL, V78, P629, DOI 10.1007/s00204-004-0584-x; Sogorb MA, 1998, ARCH TOXICOL, V72, P219, DOI 10.1007/s002040050492; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; TILDON JT, 1972, J BIOL CHEM, V247, P1265; TOVE SB, 1962, BIOCHIM BIOPHYS ACTA, V57, P230, DOI 10.1016/0006-3002(62)91115-0; VIOLAND BN, 1994, PROTEIN SCI, V3, P1089, DOI 10.1002/pro.5560030712; WALKER JE, 1976, FEBS LETT, V66, P173, DOI 10.1016/0014-5793(76)80496-6; Watanabe H, 2000, BIOCHEM J, V349, P813, DOI 10.1042/bj3490813; Williams NH, 2007, ARCH TOXICOL, V81, P627, DOI 10.1007/s00204-007-0191-8; Yang F, 2007, J STRUCT BIOL, V157, P348, DOI 10.1016/j.jsb.2006.08.015	41	89	95	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22582	22590		10.1074/jbc.M802555200	http://dx.doi.org/10.1074/jbc.M802555200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18577514	Green Published			2022-12-25	WOS:000258321000027
J	Hauenstein, SI; Hou, YM; Perona, JJ				Hauenstein, Scott I.; Hou, Ya-Ming; Perona, John J.			The homotetrameric phosphoseryl-tRNA synthetase from Methanosarcina mazei exhibits half-of-the-sites activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CYSTEINE BIOSYNTHESIS; CRYSTAL-STRUCTURE; GENETIC-CODE; THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; SUBUNIT STRUCTURE; PROTEIN-SYNTHESIS; LIGAND-BINDING; AMINO-ACIDS; RECOGNITION	Synthesis of cysteinyl-tRNA(Cys) in methanogenic archaea proceeds by a two-step pathway in which tRNACys is first aminoacylated with phosphoserine by phosphoseryl-tRNA synthetase (SepRS). Characterization of SepRS from the mesophile Methanosarcina mazei by gel filtration and nondenaturing mass spectrometry shows that the native enzyme exists as an alpha 4 tetramer when expressed at high levels in Escherichia coli. However, active site titrations monitored by ATP/PPi burst kinetics, together with analysis of tRNA binding stoichiometry by fluorescence spectroscopy, show that the tetrameric enzyme binds two tRNAs and that only two of the four chemically equivalent subunits catalyze formation of phosphoseryl adenylate. Therefore, the phenomenon of half-of-the-sites activity, previously described for synthesis of 1 mol of tyrosyl adenylate by the dimeric class I tyrosyl-tRNA synthetase, operates as well in this homotetrameric class II tRNA synthetase. Analysis of cognate and noncognate reactions by ATP/PPi and aminoacylation kinetics strongly suggests that SepRS is able to discriminate against the noncognate amino acids glutamate, serine, and phosphothreonine without the need for a separate hydrolytic editing site. tRNACys binding to SepRS also enhances the capacity of the enzyme to discriminate among amino acids, indicating the existence of functional connectivity between the tRNA and amino acid binding sites of the enzyme.	[Hauenstein, Scott I.; Perona, John J.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Hauenstein, Scott I.; Perona, John J.] Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA; [Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Jefferson University	Perona, JJ (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	perona@chem.ucsb.edu		Hou, Ya-Ming/0000-0001-6546-2597	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063713, R01GM066267] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM066267, GM63713] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambrogelly A, 2005, FEBS LETT, V579, P6017, DOI 10.1016/j.febslet.2005.09.025; Arnez JG, 1999, J MOL BIOL, V286, P1449, DOI 10.1006/jmbi.1999.2562; BEDOUELLE H, 1990, BIOCHIMIE, V72, P589, DOI 10.1016/0300-9084(90)90122-W; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; BRICK P, 1987, J MOL BIOL, V194, P287, DOI 10.1016/0022-2836(87)90376-7; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; Chen ZD, 1996, BIOTECHNIQUES, V21, P820; Christian T, 2004, J MOL BIOL, V339, P707, DOI 10.1016/j.jmb.2004.04.025; dePouplana LR, 1997, BIOCHEMISTRY-US, V36, P15041, DOI 10.1021/bi971788+; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Ehlers C, 2005, MOL GENET GENOMICS, V273, P290, DOI 10.1007/s00438-005-1128-7; FASIOLO F, 1977, EUR J BIOCHEM, V73, P7, DOI 10.1111/j.1432-1033.1977.tb11286.x; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P13, DOI 10.1021/bi00672a003; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Fukunaga R, 2007, NAT STRUCT MOL BIOL, V14, P272, DOI 10.1038/nsmb1219; Giles K, 2004, RAPID COMMUN MASS SP, V18, P2401, DOI 10.1002/rcm.1641; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Guth E, 2005, BIOCHEMISTRY-US, V44, P3785, DOI 10.1021/bi047923h; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; HANKE T, 1974, EUR J BIOCHEM, V43, P601, DOI 10.1111/j.1432-1033.1974.tb03447.x; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hohn MJ, 2006, P NATL ACAD SCI USA, V103, P18095, DOI 10.1073/pnas.0608762103; Hou YM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj018; HOU YM, 1993, P NATL ACAD SCI USA, V90, P6776, DOI 10.1073/pnas.90.14.6776; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; Kamtekar S, 2007, P NATL ACAD SCI USA, V104, P2620, DOI 10.1073/pnas.0611504104; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; KOMATSOULIS GA, 1993, BIOCHEMISTRY-US, V32, P7435, DOI 10.1021/bi00080a014; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P53; Lipman RSA, 2003, BIOCHEMISTRY-US, V42, P7487, DOI 10.1021/bi0344533; Liu CP, 2007, J MOL BIOL, V367, P1063, DOI 10.1016/j.jmb.2007.01.050; Maeder DL, 2006, J BACTERIOL, V188, P7922, DOI 10.1128/JB.00810-06; MOSYAK L, 1995, NAT STRUCT BIOL, V2, P537, DOI 10.1038/nsb0795-537; MOSYAK L, 1993, BIOCHIMIE, V75, P1091, DOI 10.1016/0300-9084(93)90008-G; MULVEY RS, 1977, BIOCHEMISTRY-US, V16, P4005, DOI 10.1021/bi00637a011; O'Donoghue P, 2005, P NATL ACAD SCI USA, V102, P19003, DOI 10.1073/pnas.0509617102; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; PUTNEY SD, 1981, J BIOL CHEM, V256, P198; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Sankaranarayanan R, 2001, ACTA BIOCHIM POL, V48, P323; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Sherlin LD, 2001, RNA, V7, P1671; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1; Tumbula DL, 2000, NATURE, V407, P106, DOI 10.1038/35024120; Uter NT, 2005, J BIOL CHEM, V280, P23966, DOI 10.1074/jbc.M414259200; Uter NT, 2004, P NATL ACAD SCI USA, V101, P14396, DOI 10.1073/pnas.0404017101; WARD WHJ, 1988, BIOCHEMISTRY-US, V27, P1041, DOI 10.1021/bi00403a029; WARD WHJ, 1988, BIOCHEMISTRY-US, V27, P5525, DOI 10.1021/bi00415a021; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373	57	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21997	22006		10.1074/jbc.M801838200	http://dx.doi.org/10.1074/jbc.M801838200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18559342	hybrid, Green Published			2022-12-25	WOS:000258114700019
J	Michelet, L; Zaffagnini, M; Vanacker, H; Le Marechal, P; Marchand, C; Schroda, M; Lemaire, SD; Decottignies, P				Michelet, Laure; Zaffagnini, Mirko; Vanacker, Helene; Le Marechal, Pierre; Marchand, Christophe; Schroda, Michael; Lemaire, Stephane D.; Decottignies, Paulette			In vivo targets of S-thiolation in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; DISULFIDE-ISOMERASE RB60; PSBA MESSENGER-RNA; ENDOPLASMIC-RETICULUM; PROTEOMIC ANALYSIS; REDOX-REGULATION; PHOSPHOGLYCERATE KINASE; ARABIDOPSIS-THALIANA; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GLUTATHIONYLATED PROTEINS	Glutathionylation is the major form of S-thiolation in cells. This reversible redox post-translational modification consists of the formation of a mixed disulfide between a free thiol on a protein and a molecule of glutathione. This recently described modification, which is considered to occur under oxidative stress, can protect cysteine residues from irreversible oxidation, and alter positively or negatively the activity of diverse proteins. This modification and its targets have been mainly studied in non-photosynthetic organisms so far. We report here the first proteomic approach performed in vivo on photosynthetically competent cells, using the eukaryotic unicellular green alga Chlamydomonas reinhardtii with radiolabeled [S-35] cysteine to label the glutathione pool and diamide as oxidant. This method allowed the identification of 25 targets, mainly chloroplastic, involved in various metabolic processes. Several targets are related to photosynthesis, such as the Calvin cycle enzymes phosphoglycerate kinase and ribose-5-phosphate isomerase. A number of targets, such as chaperones and peroxiredoxins, are related to stress responses. The glutathionylation of HSP70B, chloroplastic 2-Cys peroxiredoxin and isocitrate lyase was confirmed in vitro on purified proteins and the targeted residues were identified.	[Michelet, Laure; Zaffagnini, Mirko; Vanacker, Helene; Lemaire, Stephane D.] Univ Paris 11, CNRS, UMR 8618, Inst Biotechnol Plantes, F-91405 Orsay, France; [Le Marechal, Pierre; Marchand, Christophe; Decottignies, Paulette] Univ Paris 11, CNRS, UMR 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France; [Schroda, Michael] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg	Lemaire, SD (corresponding author), Univ Paris 11, CNRS, UMR 8618, Inst Biotechnol Plantes, Batiment 630, F-91405 Orsay, France.	stephane.lemaire@u-psud.fr	Lemaire, Stéphane D/A-3530-2008; MARCHAND, Christophe H/B-5854-2008; Schroda, Michael/A-2651-2015	Lemaire, Stéphane D/0000-0001-6442-0547; MARCHAND, Christophe H/0000-0002-0729-3841; Schroda, Michael/0000-0001-6872-0483; Zaffagnini, Mirko/0000-0001-5115-0859				Alergand T, 2006, PLANT CELL PHYSIOL, V47, P540, DOI 10.1093/pcp/pcj023; Balmer Y, 2004, P NATL ACAD SCI USA, V101, P2642, DOI 10.1073/pnas.0308583101; Balmer Y, 2004, PHOTOSYNTH RES, V79, P275, DOI 10.1023/B:PRES.0000017207.88257.d4; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Cotgreave IA, 2002, METHOD ENZYMOL, V348, P175, DOI 10.1016/S0076-6879(02)48636-3; Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; DANON A, 1994, SCIENCE, V266, P1717, DOI 10.1126/science.7992056; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Dixon DP, 2005, BIOCHEMISTRY-US, V44, P7696, DOI 10.1021/bi047324a; Dixon DP, 2005, PLANT PHYSIOL, V138, P2233, DOI 10.1104/pp.104.058917; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fratelli M, 2004, EXPERT REV PROTEOMIC, V1, P365, DOI 10.1586/14789450.1.3.365; Fratelli M, 2003, PROTEOMICS, V3, P1154, DOI 10.1002/pmic.200300436; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Gelhaye E, 2004, P NATL ACAD SCI USA, V101, P14545, DOI 10.1073/pnas.0405282101; Ghezzi P, 2005, ANTIOXID REDOX SIGN, V7, P964, DOI 10.1089/ars.2005.7.964; Gopalan G, 2004, P NATL ACAD SCI USA, V101, P13945, DOI 10.1073/pnas.0405240101; Goyer A, 2002, EUR J BIOCHEM, V269, P272, DOI 10.1046/j.0014-2956.2001.02648.x; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He XD, 2000, J BIOL CHEM, V275, P13250, DOI 10.1074/jbc.275.18.13250; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Hoppe G, 2004, EXP EYE RES, V78, P1085, DOI 10.1016/j.exer.2004.02.001; Hosoda A, 2003, J BIOL CHEM, V278, P2669, DOI 10.1074/jbc.M208346200; Hunter SC, 1998, ARCH BIOCHEM BIOPHYS, V359, P170, DOI 10.1006/abbi.1998.0900; Ikegami A, 2007, J BIOL CHEM, V282, P19282, DOI 10.1074/jbc.M703324200; Ito H, 2003, PLANT CELL PHYSIOL, V44, P655, DOI 10.1093/pcp/pcg098; Kovari Z, 2002, BIOCHEMISTRY-US, V41, P8796, DOI 10.1021/bi020210j; Kozaki AK, 2001, J BIOL CHEM, V276, P39919, DOI 10.1074/jbc.M103525200; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; KUNTZ GWK, 1982, METHOD ENZYMOL, V90, P103; KUNTZ GWK, 1982, METHOD ENZYMOL, V90, P110; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; Levitan A, 2005, P NATL ACAD SCI USA, V102, P6225, DOI 10.1073/pnas.0500676102; Lima A, 2006, P NATL ACAD SCI USA, V103, P12631, DOI 10.1073/pnas.0605452103; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Liu CM, 2005, MOL BIOL CELL, V16, P1165, DOI 10.1091/mbc.E04-08-0736; Liu CM, 2007, PLANT J, V50, P265, DOI 10.1111/j.1365-313X.2007.03047.x; Maattanen P, 2006, BIOCHEM CELL BIOL, V84, P881, DOI 10.1139/O06-186; Maeda K, 2004, BIOCHEM J, V378, P497, DOI 10.1042/BJ20031634; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Marchand C, 2004, PROTEOMICS, V4, P2696, DOI 10.1002/pmic.200400805; Meyer AJ, 2005, PHOTOSYNTH RES, V86, P435, DOI 10.1007/s11120-005-8425-1; Michelet L, 2005, P NATL ACAD SCI USA, V102, P16478, DOI 10.1073/pnas.0507498102; Michelet L, 2006, PHOTOSYNTH RES, V89, P225, DOI 10.1007/s11120-006-9096-2; Noguera-Mazon V, 2006, J BIOL CHEM, V281, P31736, DOI 10.1074/jbc.M602188200; Ogawa K, 2005, ANTIOXID REDOX SIGN, V7, P973, DOI 10.1089/ars.2005.7.973; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Rochaix J. D., 1988, PLANT MOL BIOL PRACT, P253; Rouhier N, 2005, FREE RADICAL BIO MED, V38, P1413, DOI 10.1016/j.freeradbiomed.2004.07.037; Rouhier N, 2005, ANTIOXID REDOX SIGN, V7, P919, DOI 10.1089/ars.2005.7.919; Rua J, 2002, FUNGAL GENET BIOL, V35, P223, DOI 10.1006/fgbi.2001.1324; SASAKI Y, 1995, PLANT PHYSIOL, V108, P445, DOI 10.1104/pp.108.2.445; Sasaki Y, 1997, P NATL ACAD SCI USA, V94, P11096, DOI 10.1073/pnas.94.20.11096; Schroda M, 2004, PHOTOSYNTH RES, V82, P221, DOI 10.1007/s11120-004-2216-y; Schwarz O, 1997, J BIOL CHEM, V272, P16924, DOI 10.1074/jbc.272.27.16924; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shenton D, 2002, J BIOL CHEM, V277, P16853, DOI 10.1074/jbc.M200559200; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; Trebitsh T, 2001, P NATL ACAD SCI USA, V98, P12289, DOI 10.1073/pnas.211440698; Trebitsh T, 2000, MOL CELL BIOL, V20, P1116, DOI 10.1128/MCB.20.4.1116-1123.2000; Vignols F, 2005, P NATL ACAD SCI USA, V102, P16729, DOI 10.1073/pnas.0506880102; Willmund F, 2005, PLANT PHYSIOL, V138, P2310, DOI 10.1104/pp.105.063578; Wong JH, 2004, PHYTOCHEMISTRY, V65, P1629, DOI 10.1016/j.phytochem.2004.05.010; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x	71	88	91	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21571	21578		10.1074/jbc.M802331200	http://dx.doi.org/10.1074/jbc.M802331200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18534986	hybrid			2022-12-25	WOS:000257898800030
J	Hensler, ME; Miyamoto, S; Nizet, V				Hensler, Mary E.; Miyamoto, Shigeki; Nizet, Victor			Group B Streptococcal beta-Hemolysin/Cytolysin Directly Impairs Cardiomyocyte Viability and Function	PLOS ONE			English	Article							CORONARY VASOCONSTRICTION; MYOCARDIAL-CONTRACTILITY; HEMOLYSIN; SEPSIS; AGALACTIAE; INFECTION; INJURY; ENDOCARDITIS; PATHOGENESIS; DYSFUNCTION	Background: Group B Streptococcus (GBS) is a leading cause of neonatal sepsis where myocardial dysfunction is an important contributor to poor outcome. Here we study the effects of the GBS pore-forming beta-hemolysin/cytolysin (Bh/c) exotoxin on cardiomyocyte viability, contractility, and calcium transients. Methodology/Principal Findings: HL-1 cardiomyocytes exposed to intact wild-type (WT) or isogenic Delta beta h/c mutant GBS, or to cell-free extracts from either strain, were assessed for viability by trypan blue exclusion and for apoptosis by TUNEL staining. Functionality of exposed cardiomyocytes was analyzed by visual quantitation of the rate and extent of contractility. Mitochondrial membrane polarization was measured in TMRE-loaded cells exposed to GBS beta h/c. Effects of GBS beta h/c on calcium transients were studied in fura-2AM-loaded primary rat ventricular cardiomyocytes. Exposure of HL-1 cardiomyocytes to either WT GBS or beta h/c extracts significantly reduced both rate and extent of contractility and later induced necrotic and apoptotic cell death. No effects on cardiomyocyte viability or function were observed after treatment with Delta beta h/c mutant bacteria or extracts. The beta h/c toxin was associated with complete and rapid loss of detectable calcium transients in primary neonatal rat ventricular cardiomyocytes and induced a loss of mitochondrial membrane polarization. These effects on viability and function were abrogated by the beta h/c inhibitor, dipalmitoyl phosphatidylcholine (DPPC). Conclusions/Significance: Our data show a rapid loss of cardiomyocyte viability and function induced by GBS beta h/c, and these deleterious effects are inhibited by DPPC, a normal constituent of human pulmonary surfactant. These findings have clinical implications for the cardiac dysfunction observed in neonatal GBS infections.	[Hensler, Mary E.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Miyamoto, Shigeki] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hensler, ME (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Nizet, Victor/AAF-3190-2019; Miyamoto, Shigeki/L-4004-2019	Nizet, Victor/0000-0003-3847-0422	American Heart Association [Career Investigator Award]; NIH [HD051796]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051796] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by an American Heart Association Career Investigator Award and NIH Grant HD051796 (both to VN).	Baltimore RS, 2007, SEMIN PERINATOL, V31, P33, DOI 10.1053/j.semperi.2007.01.005; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; delMoral T, 1996, PEDIATR RES, V40, P469; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; GALLAGHER PG, 1986, REV INFECT DIS, V8, P175; Gibbs RS, 2004, OBSTET GYNECOL, V104, P1062, DOI 10.1097/01.AOG.0000144128.03913.c2; Gibson RL, 1999, PEDIATR RES, V45, P626, DOI 10.1203/00006450-199905010-00003; Gottschalk B, 2006, J BACTERIOL, V188, P5984, DOI 10.1128/JB.00768-05; Grandel U, 2006, CRIT CARE MED, V34, P118, DOI 10.1097/01.CCM.0000190626.71045.16; Griffiths B B, 1992, Microbios, V69, P17; Heath PGT, 2004, LANCET, V363, P292, DOI 10.1016/S0140-6736(03)15389-5; Henneke P, 2001, J IMMUNOL, V167, P7069, DOI 10.4049/jimmunol.167.12.7069; Henneke P, 2006, SEMIN FETAL NEONAT M, V11, P333, DOI 10.1016/j.siny.2006.03.003; Hensler ME, 2005, J INFECT DIS, V191, P1287, DOI 10.1086/428946; Herting E, 1997, ARCH DIS CHILD-FETAL, V76, pF3, DOI 10.1136/fn.76.1.F3; Herting E, 2000, PEDIATRICS, V106, P957, DOI 10.1542/peds.106.5.957; Larche J, 2006, J AM COLL CARDIOL, V48, P377, DOI 10.1016/j.jacc.2006.02.069; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; MARCHLEWICZ BA, 1980, INFECT IMMUN, V30, P805; Maruyama R, 2006, AM J PHYSIOL-HEART C, V290, pH1493, DOI 10.1152/ajpheart.00669.2005; MENKE JA, 1979, J PEDIATR-US, V94, P467, DOI 10.1016/S0022-3476(79)80603-4; Miyamoto S, 2005, J BIOL CHEM, V280, P38505, DOI 10.1074/jbc.M505223200; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Nizet V, 1996, INFECT IMMUN, V64, P3818, DOI 10.1128/IAI.64.9.3818-3826.1996; PAYNE NR, 1988, PEDIATR INFECT DIS J, V7, P836; PEEVY KJ, 1985, PEDIATR RES, V19, P511, DOI 10.1203/00006450-198506000-00001; Pettersson K, 2007, SEMIN FETAL NEONAT M, V12, P193, DOI 10.1016/j.siny.2007.01.010; Pribble C G, 1991, ASAIO Trans, V37, P33, DOI 10.1097/00002480-199101000-00010; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Puliti M, 2000, J INFECT DIS, V182, P824, DOI 10.1086/315773; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Ring A, 2002, J INFECT DIS, V185, P1745, DOI 10.1086/340818; RUNKLE B, 1984, PEDIATR RES, V18, P874, DOI 10.1203/00006450-198409000-00014; Sambola A, 2002, CLIN INFECT DIS, V34, P1576, DOI 10.1086/340538; Sibelius U, 2003, CRIT CARE MED, V31, P683, DOI 10.1097/01.CCM.0000050072.69509.06; Sibelius U, 2000, CIRCULATION, V101, P78, DOI 10.1161/01.CIR.101.1.78; Spellerberg B, 1999, J BACTERIOL, V181, P3212, DOI 10.1128/JB.181.10.3212-3219.1999; VonHunolstein C, 1997, INFECT IMMUN, V65, P4017, DOI 10.1128/IAI.65.10.4017-4021.1997; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003	42	25	26	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2446	10.1371/journal.pone.0002446	http://dx.doi.org/10.1371/journal.pone.0002446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560574	gold, Green Submitted, Green Published			2022-12-25	WOS:000263280700031
J	Kerse, N; Flicker, L; Pfaff, JJ; Draper, B; Lautenschlager, NT; Sim, M; Snowdon, J; Almeida, OP				Kerse, Ngaire; Flicker, Leon; Pfaff, Jon J.; Draper, Brian; Lautenschlager, Nicola T.; Sim, Moira; Snowdon, John; Almeida, Osvaldo P.			Falls, Depression and Antidepressants in Later Life: A Large Primary Care Appraisal	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; GENERAL-PRACTICE; RISK-FACTORS; PREVENTING FALLS; OLDER-PEOPLE; POPULATION; METAANALYSIS; MEDICATIONS; REGISTERS; ACCURACY	Background: Depression and falls are common and co-exist for older people. Safe management of each of these conditions is important to quality of life. Methods: A cross-sectional survey was used to examine medication use associated with injurious and non-injurious falls in 21,900 community-dwelling adults, aged 60 years or over from 383 Australian general practices recruited for the DEPS-GP Project. Falls and injury from falls, medication use, depressive symptoms (Primary Health Questionnaire (PHQ-9)), clinical morbidity, suicidal ideation and intent, health status (SF-12 Health Survey), demographic and lifestyle information was reported in a standardised survey. Findings: Respondents were 71.8 years (sd 7.7) of age and 58.4% were women. 24% 11% and 8% reported falls, fall related injury, and sought medical attention respectively. Antidepressant use (odds ratio, OR: 1.46; 95% confidence interval, 95% CI: 1.25, 1.70), questionable depression (5-14 on PHQ OR: 1.32, 95% CI: 1.13, 1.53) and clinically significant symptoms of depression (15 or more on PHQ OR: 1.70, 95% CI: 1.14, 1.50) were independently associated with multiple falls. SSRI use was associated with the highest risk of multiple falls (OR: 1.66, 95% CI: 1.36, 2.02) amongst all psychotropic medications. Similar associations were observed for injurious falls. Over 60% of those with four accumulated risk factors had multiple falls in the previous year (OR: 3.40, 95% CI: 1.79, 6.45); adjusted for other demographic and health factors. Interpretation: Antidepressant use (particularly SSRIs) was strongly associated with falls regardless of presence of depressive symptoms. Strategies to prevent falls should become a routine part of the management of older people with depression.	[Kerse, Ngaire] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Flicker, Leon; Pfaff, Jon J.; Lautenschlager, Nicola T.; Almeida, Osvaldo P.] Univ W Australia, W Australian Ctr Hlth & Ageing, Perth, WA, Australia; [Draper, Brian] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Sim, Moira] Edith Cowan Univ, Sch Nursing, Grad Higher Degree Syst Program, Midwifery & Postgrad Med, Perth, WA, Australia; [Snowdon, John] Univ Sydney, Discipline Psychol Med, Sydney, NSW, Australia	University of Auckland; University of Western Australia; University of New South Wales Sydney; Edith Cowan University; University of Sydney	Kerse, N (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Fac Med & Hlth Sci, Auckland 1, New Zealand.	n.kerse@auckland.ac.nz	Kerse, Ngaire/AFF-8119-2022; Almeida, Osvaldo P./A-4925-2008; Sim, Moira/D-5120-2013; Flicker, Leon/A-9039-2008; Flicker, Leon/AAE-1530-2022	Almeida, Osvaldo P./0000-0002-8689-6199; Sim, Moira/0000-0001-5962-6639; Flicker, Leon/0000-0002-3650-0475; Lautenschlager, Nicola/0000-0003-4850-7794				Afifi M, 2006, SAUDI MED J, V27, P128; Arfken CL, 2001, INT PSYCHOGERIATR, V13, P85, DOI 10.1017/S1041610201007487; *AUSTR BUR STAT, 1995, NATL HLTH SURV SF 36; Becker C, 2006, OSTEOPOROSIS INT, V17, P410, DOI 10.1007/s00198-005-0001-1; Bergland A, 2000, Physiother Res Int, V5, P33, DOI 10.1002/pri.182; BRUCE ML, 1994, SOC PSYCH PSYCH EPID, V29, P165; Buchner DM, 1996, J GERONTOL A-BIOL, V51, pM297, DOI 10.1093/gerona/51A.6.M297; BURKER EJ, 1995, PSYCHOL AGING, V10, P104, DOI 10.1037/0882-7974.10.1.104; Campbell AJ, 2005, BMJ-BRIT MED J, V331, P817, DOI 10.1136/bmj.38601.447731.55; CAMPBELL AJ, 1985, J EPIDEMIOL COMMUN H, V39, P337, DOI 10.1136/jech.39.4.337; CAMPBELL AJ, 1989, J GERONTOL, V44, pM112, DOI 10.1093/geronj/44.4.m112; Campbell AJ, 1999, J AM GERIATR SOC, V47, P850, DOI 10.1111/j.1532-5415.1999.tb03843.x; COBB JS, 1983, BRIT MED J, V287, P1434, DOI 10.1136/bmj.287.6403.1434; DIFFORD F, 1985, BRIT MED J, V290, P519, DOI 10.1136/bmj.290.6467.519; Elley CR, 2003, BRIT MED J, V326, P793, DOI 10.1136/bmj.326.7393.793; Gillespie LD, 2006, COCHRANE DB SYST REV, P4; GRANEK E, 1987, J AM GERIATR SOC, V35, P503, DOI 10.1111/j.1532-5415.1987.tb01395.x; Guideline for the prevention of falls in older persons, 2001, J AM GERIATR SOC, V49, P664, DOI DOI 10.1046/J.1532-5415.2001.49115.X; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Hien LT, 2005, J AM GERIATR SOC, V53, P1290, DOI 10.1111/j.1532-5415.2005.53403.x; HORNBROOK MC, 1994, GERONTOLOGIST, V34, P16, DOI 10.1093/geront/34.1.16; Hull B P, 1999, Aust Fam Physician, V28, P55; Hybels CF, 2003, CLIN GERIATR MED, V19, P663, DOI 10.1016/S0749-0690(03)00042-9; Jorgensen L, 2002, STROKE, V33, P542, DOI 10.1161/hs0202.102375; KOENIG HG, 1993, PSYCHOSOMATICS, V34, P61, DOI 10.1016/S0033-3182(93)71928-3; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; Menz HB, 2006, J GERONTOL A-BIOL, V61, P866, DOI 10.1093/gerona/61.8.866; Oakley-Browne M., 2006, RAU HINENGARO NZ MEN; OCONNER P, 1988, NEW ENGL J MED, V338, P592; Pope D, 1996, J PUBLIC HEALTH MED, V18, P6, DOI 10.1093/oxfordjournals.pubmed.a024464; Raymont A., 2004, 1 MIN HLTH; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; Robertson MC, 2002, J AM GERIATR SOC, V50, P905, DOI 10.1046/j.1532-5415.2002.50218.x; ROBSON J, 1995, BRIT J GEN PRACT, V45, P463; SCRIVENER G, 1995, BRIT MED J, V311, P163, DOI 10.1136/bmj.311.6998.163; SHELDON MG, 1984, J ROY COLL GEN PRACT, V34, P269; Simonsick EM, 1999, J AM GERIATR SOC, V47, P672, DOI 10.1111/j.1532-5415.1999.tb01588.x; SINGH N, 2005, J GERONTOL, V768, pM76; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stel VS, 2004, AGE AGEING, V33, P58, DOI 10.1093/ageing/afh028; THAPA PB, 1995, AM J EPIDEMIOL, V142, P202, DOI 10.1093/oxfordjournals.aje.a117619; Turcu A, 2004, GERONTOLOGY, V50, P303, DOI 10.1159/000079128; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Whooley MA, 1999, ARCH INTERN MED, V159, P484, DOI 10.1001/archinte.159.5.484; Williamson MK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-42; World Health Organisation, 2005, FRUIT VEG HLTH JOINT; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	102	105	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2423	10.1371/journal.pone.0002423	http://dx.doi.org/10.1371/journal.pone.0002423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406FP	18560599	Green Published, gold			2022-12-25	WOS:000263280700009
J	Kuehl, HS; Elzner, C; Moebius, Y; Boesch, C; Walsh, PD				Kuehl, Hjalmar S.; Elzner, Caroline; Moebius, Yasmin; Boesch, Christophe; Walsh, Peter D.			The Price of Play: Self-Organized Infant Mortality Cycles in Chimpanzees	PLOS ONE			English	Article							TRANSMISSION; PARAMETERS; SEVERITY; DYNAMICS; PATTERNS; MEASLES; SPREAD; FOOD	Chimpanzees have been used extensively as a model system for laboratory research on infectious diseases. Ironically, we know next to nothing about disease dynamics in wild chimpanzee populations. Here, we analyze long-term demographic and behavioral data from two habituated chimpanzee communities in Tai National Park, Cote d'Ivoire, where previous work has shown respiratory pathogens to be an important source of infant mortality. In this paper we trace the effect of social connectivity on infant mortality dynamics. We focus on social play which, as the primary context of contact between young chimpanzees, may serve as a key venue for pathogen transmission. Infant abundance and mortality rates at Tai cycled regularly and in a way that was not well explained in terms of environmental forcing. Rather, infant mortality cycles appeared to self-organize in response to the ontogeny of social play. Each cycle started when the death of multiple infants in an outbreak synchronized the reproductive cycles of their mothers. A pulse of births predictably arrived about twelve months later, with social connectivity increasing over the following two years as the large birth cohort approached the peak of social play. The high social connectivity at this play peak then appeared to facilitate further outbreaks. Our results provide the first evidence that social play has a strong role in determining chimpanzee disease transmission risk and the first record of chimpanzee disease cycles similar to those seen in human children. They also lend more support to the view that infectious diseases are a major threat to the survival of remaining chimpanzee populations.	[Kuehl, Hjalmar S.; Elzner, Caroline; Moebius, Yasmin; Boesch, Christophe; Walsh, Peter D.] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Max Planck Society	Kuehl, HS (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	kuehl@eva.mpg.de			Swiss National Science Foundation; Max Planck Society	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	The Swiss National Science Foundation funded long-term data collection for this study. Max Planck Society funded data collection and data analysis.	Anderson DP, 2005, BIOTROPICA, V37, P631, DOI 10.1111/j.1744-7429.2005.00080.x; ANDERSON R M, 1991; Bernstein JA, 2004, J ALLERGY CLIN IMMUN, V114, P1116, DOI 10.1016/j.jaci.2004.08.030; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Boesch C, 2000, CHIMPANZEES TAI FORE; BOLKER BM, 1993, P ROY SOC B-BIOL SCI, V251, P75, DOI 10.1098/rspb.1993.0011; Brent L, 2003, BEHAVIOUR, V140, P209, DOI 10.1163/156853903321671505; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chapman CA, 2006, AM J PHYS ANTHROPOL, V131, P525, DOI 10.1002/ajpa.20477; Crowcroft N S, 1999, Commun Dis Public Health, V2, P234; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; FORMENTY P, 1997, J INFECT DIS, V179, P120; GOG J, 2004, P R SOC, V269, P671; Hanamura S, 2008, PRIMATES, V49, P77, DOI 10.1007/s10329-007-0054-1; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; HOLBERG CJ, 1991, AM J EPIDEMIOL, V133, P1135, DOI 10.1093/oxfordjournals.aje.a115826; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Katzenberg MA, 1996, YEARB PHYS ANTHROPOL, V39, P177; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Leendertz FH, 2004, NATURE, V430, P451, DOI 10.1038/nature02722; Lehmann J, 2008, INT J PRIMATOL, V29, P65, DOI 10.1007/s10764-007-9230-9; Lonsdorf EV, 2006, AM J PRIMATOL, V68, P897, DOI 10.1002/ajp.20296; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; MIKOLAJCZYK RT, 2007, EPIDEMIOL INFECT, P1; Nelson RJ, 2004, TRENDS IMMUNOL, V25, P187, DOI 10.1016/j.it.2004.02.001; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pellegrini A. D., 2005, NATURE PLAY GREAT AP; Preziosi MP, 2002, AM J EPIDEMIOL, V155, P891, DOI 10.1093/aje/155.10.891; RICHARDSON DK, 1993, PEDIATRICS, V91, P969; SCRIMSHAW NS, 2007, AM J CLIN NUTR, V66, pS464; Sugiyama Y, 2004, AM J PHYS ANTHROPOL, V124, P154, DOI 10.1002/ajpa.10345; Sultan B, 2005, PLOS MED, V2, P43, DOI 10.1371/journal.pmed.0020006; van Baalen M, 2001, AM NAT, V157, P512, DOI 10.1086/319933; WALD ER, 1988, J PEDIATR-US, V112, P540, DOI 10.1016/S0022-3476(88)80164-1; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Wallis J, 1999, INT J PRIMATOL, V20, P803, DOI 10.1023/A:1020879700286; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; World Health Organization, 2007, WORLD HLTH REP 2007	44	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2440	10.1371/journal.pone.0002440	http://dx.doi.org/10.1371/journal.pone.0002440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406FP	18560519	gold, Green Submitted, Green Published			2022-12-25	WOS:000263280700025
J	Yeo, TW; Lampah, DA; Gitawati, R; Tjitra, E; Kenangalem, E; Granger, DL; Weinberg, JB; Lopansri, BK; Price, RN; Celermajer, DS; Duffull, SB; Anstey, NM				Yeo, Tsin W.; Lampah, Daniel A.; Gitawati, Retno; Tjitra, Emiliana; Kenangalem, Enny; Granger, Donald L.; Weinberg, J. Brice; Lopansri, Bert K.; Price, Ric N.; Celermajer, David S.; Duffull, Stephen B.; Anstey, Nicholas M.			Safety Profile of L-Arginine Infusion in Moderately Severe Falciparum Malaria	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT VASODILATION; NITRIC-OXIDE; CEREBRAL MALARIA; DYSFUNCTION; CHILDREN; HYPERKALEMIA; MANAGEMENT; THERAPY; HUMANS; TRIAL	Background: L-arginine infusion improves endothelial function in malaria but its safety profile has not been described in detail. We assessed clinical symptoms, hemodynamic status and biochemical parameters before and after a single L-arginine infusion in adults with moderately severe malaria. Methodology and Findings: In an ascending dose study, adjunctive intravenous L-arginine hydrochloride was infused over 30 minutes in doses of 3 g, 6 g and 12 g to three separate groups of 10 adults hospitalized with moderately severe Plasmodium falciparum malaria in addition to standard quinine therapy. Symptoms, vital signs and selected biochemical measurements were assessed before, during, and for 24 hours after infusion. No new or worsening symptoms developed apart from mild discomfort at the intravenous cannula site in two patients. There was a dose-response relationship between increasing mg/kg dose and the maximum decrease in systolic (rho = 0.463; Spearman's, p = 0.02) and diastolic blood pressure (r = 0.42; Pearson's, p = 0.02), and with the maximum increment in blood potassium (r = 0.70, p < 0.001) and maximum decrement in bicarbonate concentrations (r = 0.53, p = 0.003) and pH (r = 0.48, p = 0.007). At the highest dose (12 g), changes in blood pressure and electrolytes were not clinically significant, with a mean maximum decrease in mean arterial blood pressure of 6 mmHg (range: 0-11; p < 0.001), mean maximal increase in potassium of 0.5 mmol/L (range 0.2-0.7 mmol/L; p, 0.001), and mean maximal decrease in bicarbonate of 3 mEq/L (range 1-7; p < 0.01) without a significant change in pH. There was no significant dose-response relationship with blood phosphate, lactate, anion gap and glucose concentrations. All patients had an uncomplicated clinical recovery. Conclusions/Significance: Infusion of up to 12g of intravenous L-arginine hydrochloride over 30 minutes is well tolerated in adults with moderately severe malaria, with no clinically important changes in hemodynamic or biochemical status. Trials of adjunctive L-arginine can be extended to phase 2 studies in severe malaria. Trial Registration: ClinicalTrials.gov NCT00147368	[Yeo, Tsin W.; Price, Ric N.; Anstey, Nicholas M.] Charles Darwin Univ, Menzies Sch Hlth Res, Int Hlth Div, Darwin, NT 0909, Australia; [Lampah, Daniel A.; Kenangalem, Enny] Natl Inst Hlth Res & Dev Res Program, Menzies Sch Hlth Res, Dist Minist Hlth, Timika, Papua, Indonesia; [Gitawati, Retno; Tjitra, Emiliana] Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Granger, Donald L.; Lopansri, Bert K.] Univ Utah, VA Med Ctr, Div Infect Dis, Salt Lake City, UT USA; [Weinberg, J. Brice] Duke Univ, Sch Med, VA Med Ctr, Div Hematol Oncol, Durham, NC USA; [Price, Ric N.; Anstey, Nicholas M.] Royal Darwin Hosp, Div Med, Darwin, NT, Australia; [Price, Ric N.] John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Vaccinol & Trop Med, Oxford, England; [Celermajer, David S.] Univ Sydney, Royal Prince Alfred Hosp, Dept Cardiol, Dept Med, Sydney, NSW, Australia; [Duffull, Stephen B.] Univ Otago, Sch Pharm, Dunedin, New Zealand	Charles Darwin University; Menzies School of Health Research; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; Utah System of Higher Education; University of Utah; Duke University; University of Oxford; University of Sydney; University of Otago	Yeo, TW (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Int Hlth Div, Darwin, NT 0909, Australia.	anstey@menzies.edu.au	Duffull, Stephen/ABF-8474-2020; Yeo, Tsin Wen/F-9505-2015	Duffull, Stephen/0000-0002-6545-9408; Price, Richard/0000-0003-2000-2874	Wellcome Trust [GR071614MA]; National Health and Medical Research Council of Australia [283321, 290208]; Tudor Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Tudor Foundation	The study was funded by the Wellcome Trust (ICRG GR071614MA), the National Health and Medical Research Council of Australia (NHMRC ICRG ID 283321 and NHMRC 290208) and the Tudor Foundation. The sponsors had no role in the design or conduct of the study.	Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; BAKER GL, 1991, SOUTH MED J, V84, P381, DOI 10.1097/00007611-199103000-00018; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bode-Boger SM, 1998, BRIT J CLIN PHARMACO, V46, P489, DOI 10.1046/j.1365-2125.1998.00803.x; Boger RH, 2001, ANNU REV PHARMACOL, V41, P79, DOI 10.1146/annurev.pharmtox.41.1.79; BUSHINSKY DA, 1978, ANN INTERN MED, V89, P632, DOI 10.7326/0003-4819-89-5-632; CREAGER MA, 1992, J CLIN INVEST, V90, P1248, DOI 10.1172/JCI115987; DAVIS TME, 1993, T ROY SOC TROP MED H, V87, P49, DOI 10.1016/0035-9203(93)90416-N; DE CR, 1995, J CLIN INVEST, V96, P60; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; DICKERMAN HW, 1964, AM J PHYSIOL, V206, P403, DOI 10.1152/ajplegacy.1964.206.2.403; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Faiz MA, 2005, LANCET, V366, P717; Galban C, 2000, CRIT CARE MED, V28, P643, DOI 10.1097/00003246-200003000-00007; Giugliano D, 1997, J CLIN INVEST, V99, P433, DOI 10.1172/JCI119177; HERTZ P, 1972, ARCH INTERN MED, V130, P778, DOI 10.1001/archinte.130.5.778; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Kalil AC, 2006, CRIT CARE MED, V34, P2719, DOI 10.1097/01.CCM.0000242757.26245.03; Koller-Strametz J, 1999, KIDNEY INT, V55, P1871, DOI 10.1046/j.1523-1755.1999.00415.x; Lopansri BK, 2003, LANCET, V361, P676, DOI 10.1016/S0140-6736(03)12564-0; LORENTE JA, 1993, CRIT CARE MED, V21, P1287, DOI 10.1097/00003246-199309000-00010; Luiking YC, 2007, CRIT CARE MED, V35, pS557, DOI 10.1097/01.CCM.0000279191.44730.A2; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MADDEN HP, 1988, J SURG RES, V44, P658, DOI 10.1016/0022-4804(88)90097-2; Maitland K, 2005, CLIN INFECT DIS, V40, P9, DOI 10.1086/426022; MASSARA F, 1980, J ENDOCRINOL INVEST, V3, P177, DOI 10.1007/BF03348247; MEHTA S, 1995, CIRCULATION, V92, P1539, DOI 10.1161/01.CIR.92.6.1539; Mohanty S, 2006, INDIAN J MED RES, V124, P245; NAKAKI T, 1990, LANCET, V336, P696, DOI 10.1016/0140-6736(90)92196-O; PALMER JP, 1975, DIABETES, V24, P735, DOI 10.2337/diabetes.24.8.735; Pasvol G, 2005, INFECT DIS CLIN N AM, V19, P211, DOI 10.1016/j.idc.2004.10.007; Planche T, 2005, TRENDS PARASITOL, V21, P562, DOI 10.1016/j.pt.2005.09.010; Ratcliff A, 2007, LANCET, V369, P757, DOI 10.1016/S0140-6736(07)60160-3; Schlaich MP, 2000, CLIN SCI, V99, P293, DOI 10.1042/CS20000041; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Serirom S, 2003, AM J PATHOL, V162, P1651, DOI 10.1016/S0002-9440(10)64299-X; TIWARY CM, 1973, NEW ENGL J MED, V288, P218; Tjitra E, 2001, AM J TROP MED HYG, V65, P309, DOI 10.4269/ajtmh.2001.65.309; WHITE NJ, 1983, NEW ENGL J MED, V309, P61, DOI 10.1056/NEJM198307143090201; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; YEO TW, 2008, J INFECT DI IN PRESS	41	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2347	10.1371/journal.pone.0002347	http://dx.doi.org/10.1371/journal.pone.0002347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545693	Green Submitted, Green Published, gold			2022-12-25	WOS:000263248800009
J	Hossain, MS; Ozaki, T; Wang, H; Nakagawa, A; Takenobu, H; Ohira, M; Kamijo, T; Nakagawara, A				Hossain, M. S.; Ozaki, T.; Wang, H.; Nakagawa, A.; Takenobu, H.; Ohira, M.; Kamijo, T.; Nakagawara, A.			N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1(NLRR1) gene in neuroblastoma	ONCOGENE			English	Article						c-myc; neuroblastoma; N-MYC; NLRR1; proliferation; transactivation	MOUSE NERVOUS-SYSTEM; DNA-BINDING; EXPRESSION; PROTEIN; ONCOGENE; ZIPPER; AMPLIFICATION; ASSOCIATION; PROGRESSION; ACTIVATION	Neuronal leucine-rich repeat protein-1(NLRR1) gene encodes a type I transmembrane protein with unknown function. We have previously described that NLRR1 gene is highly expressed in unfavorable neuroblastomas as compared with favorable tumors and its higher expression levels correlate significantly with poor clinical outcome. In this study, we have found that NLRR1 gene is one of direct target genes for N-MYC and its gene product contributes to N-MYC-dependent growth promotion in neuroblastoma. Expression levels of NLRR1 were significantly associated with those of N-MYC in various neuroblastoma cell lines as well as primary neuroblastoma tissues. Indeed, enforced expression of N-MYC resulted in a remarkable induction of the endogenous NLRR1. Consistent with these results, we have identified two functional E-boxes within the promoter region and intron 1 of NLRR1 gene. Intriguingly, c-myc also transactivated NLRR1 gene. Enforced expression of NLRR1 promoted cell proliferation and rendered cells resistant to serum deprivation. In support with these observations, small-interfering RNA-mediated knock-down of the endogenous NLRR1-reduced growth rate and sensitized cells to serum starvation. Collectively, our present findings provide a novel insight into understanding molecular mechanisms behind aggressive neuroblastoma with N-MYC amplification.	[Hossain, M. S.; Ozaki, T.; Wang, H.; Takenobu, H.; Ohira, M.; Kamijo, T.; Nakagawara, A.] Chiba Canc Ctr, Res Inst, Div Biochem, Chuoh Ku, Chiba 2608717, Japan; [Hossain, M. S.; Ozaki, T.; Nakagawara, A.] Chiba Univ, Grad Sch Med, Dept Mol Biol & Oncol, Chiba, Japan; [Wang, H.] China Med Univ, ShengJing Hosp, Dept Pediat, Shenyang, Peoples R China; [Nakagawa, A.] Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo, Japan	Chiba Cancer Center; Chiba University; China Medical University; National Center for Child Health & Development - Japan	Nakagawara, A (corresponding author), Chiba Canc Ctr, Res Inst, Div Biochem, Chuoh Ku, 666-2 Nitona, Chiba 2608717, Japan.	akiranak@chiba-cc.jp			Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology, Japan; Uehara Memorial Foundation; Hisamitsu Pharmaceutical Co	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Hisamitsu Pharmaceutical Co	We are grateful to Dr M Schwab for providing the expression plasmid for N-MYC. We thank Ms Y Nakamura for technical assistance. This work was supported in part by a Grant-in-Aid from the Ministry of Health, Labour and Welfare for Third Term Comprehensive Control Research for Cancer, a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan, a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science, Uehara Memorial Foundation and Hisamitsu Pharmaceutical Co.	ALEX R, 1992, NUCLEIC ACIDS RES, V20, P2257, DOI 10.1093/nar/20.9.2257; Bando T, 2005, MOL CELL BIOL, V25, P4166, DOI 10.1128/MCB.25.10.4166-4175.2005; BERNARDS R, 1986, CELL, V47, P667, DOI 10.1016/0092-8674(86)90509-X; Blackwood EM, 1992, CURR OPIN GENET DEV, V2, P227, DOI 10.1016/S0959-437X(05)80278-3; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; BRODEUR GM, 1992, AM J PEDIAT HEMATOL, V14, P111; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Fukamachi K, 2002, J BIOL CHEM, V277, P43549, DOI 10.1074/jbc.C200502200; Hamano S, 2004, INT J ONCOL, V24, P1457; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lutz W, 1996, ONCOGENE, V13, P803; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NEGRONI A, 1991, CELL GROWTH DIFFER, V2, P511; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Taguchi A, 1996, MOL BRAIN RES, V35, P31, DOI 10.1016/0169-328X(95)00178-U; Taniguchi H, 1996, MOL BRAIN RES, V36, P45, DOI 10.1016/0169-328X(95)00243-L; TORRES R, 1992, Current Opinion in Cell Biology, V4, P468, DOI 10.1016/0955-0674(92)90013-3; Truscott M, 2007, J BIOL CHEM, V282, P30216, DOI 10.1074/jbc.M702328200; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985	26	31	34	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2008	27	46					6075	6082		10.1038/onc.2008.200	http://dx.doi.org/10.1038/onc.2008.200			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	358BO	18591937				2022-12-25	WOS:000259891600010
J	Mavroidis, M; Panagopoulou, P; Kostavasili, I; Weisleder, N; Capetanaki, Y				Mavroidis, Manolis; Panagopoulou, Panagiota; Kostavasili, Ioanna; Weisleder, Noah; Capetanaki, Yassemi			A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization	FASEB JOURNAL			English	Article						intercalated discs; IF proteolysis; transgenic mice	MICE LACKING DESMIN; INTERMEDIATE-FILAMENTS; SKELETAL MYOPATHY; MEMBRANE INTERACTIONS; NULL CARDIOMYOPATHY; SITE-SPECIFICITY; PLASMA-MEMBRANE; GENE; CARDIOMYOCYTES; CYTOSKELETON	A missense mutation (Ile 451 to Met) at the tail domain of the muscle-specific intermediate filament protein desmin has been suggested to be a genetic cause of dilated cardiomyopathy. The Ile451Met mutation is located inside a conserved motif in the desmin tail domain, believed to have a potential role in the lateral packing of type III intermediate filaments. Nevertheless, the role of the type III intermediate filament tail domain remains elusive. To further study the role of this domain in the function of cardiomyocytes and in the development of cardiomyopathy, we generated transgenic mice expressing the mutant desmin(I451M) in the cardiac tissue. Analysis of hearts from transgenic animals revealed that mutant desmin loses its Z-disc localization but it can still associate with the intercalated discs, which, however, have an altered architecture, resembling other examples of dilated cardiomyoplathy. This is the first report demonstrating a critical role of the desmin head and tail domains in the formation of the IF scaffold around Z discs. It is further suggested that in cardiomyocytes, an interplay between desmin tail and head domains is taking place, which potentially protects the amino terminus of desmin from specific proteases. The fact that the association with intercalated discs seems unchanged suggests that this association must take place through the desmin tail, in contrast to the head domain that is most possibly involved in the Z-disc binding.	[Mavroidis, Manolis; Panagopoulou, Panagiota; Kostavasili, Ioanna; Weisleder, Noah; Capetanaki, Yassemi] Acad Athens, Biomed Res Fdn, Ctr Basic Res, Div Cell Biol, Athens, Greece	Academy of Athens	Capetanaki, Y (corresponding author), Soranou Efesiou 4, Athens 11527, Greece.	ycapetanaki@bioacademy.gr	Weisleder, Noah L/A-7098-2013	Weisleder, Noah L/0000-0002-2619-8022; Mavroidis, Manolis/0000-0002-3870-3954; Weisleder, Noah/0000-0003-2710-3088	SCOR NIH [HL-98]; Greek Secretariat of Research and Development [EPAN-YB22, PEP-ATT-39, PENED-01ED371]	SCOR NIH; Greek Secretariat of Research and Development	The authors thank Dr. M. Samiotaki (Fleming Research Center, Athens, Greece) and Drs. K. Vougas and A. Vlachou (Biomedical Research Foundation, Academy of Athens, Athens, Greece) for mass spectroscopy analysis; Dr. M. Fountoulakis (Hoffmann-La Roche, Basel, Switzerland) for automated Edman degradation; and Dr. N. Kostomitsopoulos (Biomedical Research Foundation, Academy of Athens) for rabbit immunization. This work was supported by grant SCOR NIH SCOR NIH HL-98, and grants EPAN-YB22, PEP-ATT-39, and PENED-01ED371 from the Greek Secretariat of Research and Development to Y.C. This work is dedicated to the memory of K. Karagiaouris.	Arbustini E, 2006, EUR J HEART FAIL, V8, P477, DOI 10.1016/j.ejheart.2005.11.003; Bar H, 2006, EXP CELL RES, V312, P1554, DOI 10.1016/j.yexcr.2006.01.021; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102; Bar H, 2007, HUM MUTAT, V28, P374, DOI 10.1002/humu.20459; BIRKENBERGER L, 1990, J CELL BIOL, V111, P2063, DOI 10.1083/jcb.111.5.2063; Cameron BM, 1996, ST HEAL T, V29, P447; Capetanaki Y, 1998, Subcell Biochem, V31, P463; Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; CARY RB, 1994, J CELL SCI, V107, P1609; Dagvadorj A, 2004, J NEUROL, V251, P143, DOI 10.1007/s00415-004-0289-3; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; Dalakas MC, 2003, NEUROMUSCULAR DISORD, V13, P252, DOI 10.1016/S0960-8966(02)00271-7; Fountoulakis M, 2005, J MOL CELL CARDIOL, V38, P461, DOI 10.1016/j.yjmcc.2004.12.008; Franke WW, 2006, EUR J CELL BIOL, V85, P69, DOI 10.1016/j.ejcb.2005.11.003; GEORGATOS SD, 1987, P NATL ACAD SCI USA, V84, P6780, DOI 10.1073/pnas.84.19.6780; GEORGATOS SD, 1985, J CELL BIOL, V100, P1962, DOI 10.1083/jcb.100.6.1962; Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033; Goudeau B, 2006, HUM MUTAT, V27, P906, DOI 10.1002/humu.20351; Haubold K, 2003, CELL MOTIL CYTOSKEL, V54, P105, DOI 10.1002/cm.10090; HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X; Hofner M, 2007, DIFFERENTIATION, V75, P605, DOI 10.1111/j.1432-0436.2007.00162.x; Hollrigl A, 2002, FEBS LETT, V523, P229, DOI 10.1016/S0014-5793(02)02995-2; Kaplan SR, 2004, CARDIOVASC PATHOL, V13, P26, DOI 10.1016/S1054-8807(03)00107-8; KAUFMANN E, 1985, J MOL BIOL, V185, P733, DOI 10.1016/0022-2836(85)90058-0; KOUKLIS PD, 1991, J CELL BIOL, V114, P773, DOI 10.1083/jcb.114.4.773; Kouloumenta A, 2007, J BIOL CHEM, V282, P35211, DOI 10.1074/jbc.M704733200; Lapouge K, 2006, J CELL SCI, V119, P4974, DOI 10.1242/jcs.03255; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; Liu JB, 2006, J MOL CELL CARDIOL, V40, P451, DOI 10.1016/j.yjmcc.2005.12.011; Mavroidis M, 2002, AM J PATHOL, V160, P943, DOI 10.1016/S0002-9440(10)64916-4; Milner DJ, 1999, J MOL CELL CARDIOL, V31, P2063, DOI 10.1006/jmcc.1999.1037; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; NELSON WJ, 1982, J BIOL CHEM, V257, P5544; Olive M, 2004, J NEUROL SCI, V219, P125, DOI 10.1016/j.jns.2004.01.007; Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516; Perriard JC, 2003, TRENDS CARDIOVAS MED, V13, P30, DOI 10.1016/S1050-1738(02)00209-8; Selcen D, 2004, BRAIN, V127, P439, DOI 10.1093/brain/awh052; SHOEMAN RL, 1993, BIOESSAYS, V15, P605, DOI 10.1002/bies.950150906; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Taylor MRG, 2007, CIRCULATION, V115, P1244, DOI 10.1161/CIRCULATIONAHA.106.646778; Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446; Weisleder N, 2004, J MOL CELL CARDIOL, V36, P121, DOI 10.1016/j.yjmcc.2003.10.010; Weisleder N, 2004, P NATL ACAD SCI USA, V101, P769, DOI 10.1073/pnas.0303202101; Zerefos PG, 2006, PROTEOMICS, V6, P4346, DOI 10.1002/pmic.200500671	49	30	30	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2008	22	9					3318	3327		10.1096/fj.07-088724	http://dx.doi.org/10.1096/fj.07-088724			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18539904	Green Published			2022-12-25	WOS:000258761300024
J	Choi, JY; Guengerich, FP				Choi, Jeong-Yun; Guengerich, F. Peter			Kinetic analysis of translesion synthesis opposite bulky N-2- and O-6-alkylguanine DNA adducts by human DNA polymerase REV1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; STEADY-STATE KINETICS; YEAST REV1; ESCHERICHIA-COLI; PROTEIN-TEMPLATE; BIOCHEMICAL BASIS; KLENOW FRAGMENT; REPLICATION; FIDELITY; O-6-METHYLGUANINE	REV1, a Y family DNA polymerase ( pol), is involved in replicative bypass past DNA lesions, so- called translesion DNA synthesis. In addition to a structural role as a scaffold protein, REV1 has been proposed to play a catalytic role as a dCTP transferase in translesion DNA synthesis past abasic and guanine lesions in eukaryotes. To better understand the catalytic function of REV1 in guanine lesion bypass, purified recombinant human REV1 was studied with two series of guanine lesions, N2- alkylG adducts (in oligonucleotides) ranging in size from methyl ( Me) to CH2(6- benzo[ a] pyrenyl) (BP) and O-6- alkylG adducts ranging from Me to 4- oxo- 4-( 3- pyridyl) butyl ( Pob). REV1 readily produced 1- base incorporation oppositeGand allGadducts except for O6- PobG, which caused almost complete blockage. Steadystate kinetic parameters ( kcat/ Km) were similar for insertion of dCTP opposite G and N2- G adducts but were severely reduced opposite the O-6-G adducts. REV1 showed apparent pre- steadystate burst kinetics for dCTP incorporation only opposite N2- BPG and little, if any, opposite G, N2- benzyl (Bz) G, or O6- BzG. The maximal polymerization rate ( kpol 0.9 s-1) opposite N2-BPG was almost the same as opposite G, with only slightly decreased binding affinity to dCTP (2.5-fold). REV1 boundN2- BPG- adductedDNA3- fold more tightly than unmodified G- containing DNA. These results and the lack of an elemental effect ((Sp)- 2'- deoxycytidine 5'-O-( 1- thiotriphosphate)) suggest that the late steps after product formation ( possibly product release) become rate- limiting in catalysis opposite N2-BPG. Weconclude that human REV1, apparently the slowest Y family polymerase, is kinetically highly tolerant to N2- adduct at G but not to O-6-adducts.	[Choi, Jeong-Yun] Ewha Womans Univ, Sch Med, Dept Pharmacol, Seoul 158710, South Korea; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Ewha Womans University; Vanderbilt University; Vanderbilt University	Choi, JY (corresponding author), Ewha Womans Univ, Sch Med, Dept Pharmacol, 911-1 Mok 6 Dong, Seoul 158710, South Korea.	jychoi@ewha.ac.kr			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, R01ES010375] Funding Source: NIH RePORTER; NIEHS NIH HHS [P30 ES 000267, R01 ES 010375] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BORER PN, 1975, HDB BIOCH MOL BIOL, P589; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2006, CHEM RES TOXICOL, V19, P879, DOI 10.1021/tx060051v; Choi JY, 2006, J BIOL CHEM, V281, P25297, DOI 10.1074/jbc.M605699200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Choi JY, 2004, J BIOL CHEM, V279, P19217, DOI 10.1074/jbc.M313759200; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Furge LL, 1997, BIOCHEMISTRY-US, V36, P6475, DOI 10.1021/bi9627267; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; GOTH R, 1974, P NATL ACAD SCI USA, V71, P639, DOI 10.1073/pnas.71.3.639; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Guo DY, 2004, NUCLEIC ACIDS RES, V32, P1122, DOI 10.1093/nar/gkh279; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; Howell CA, 2007, BIOCHEMISTRY-US, V46, P13451, DOI 10.1021/bi701429v; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P10466, DOI 10.1073/pnas.0503859102; Lin WS, 1999, NUCLEIC ACIDS RES, V27, P4468, DOI 10.1093/nar/27.22.4468; LOVELESS A, 1969, NATURE, V223, P206, DOI 10.1038/223206a0; MEEHAN T, 1979, NATURE, V277, P410, DOI 10.1038/277410a0; Moriya M, 1996, BIOCHEMISTRY-US, V35, P16646, DOI 10.1021/bi9608875; Nair DT, 2008, STRUCTURE, V16, P239, DOI 10.1016/j.str.2007.12.009; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pauly GT, 2002, CHEM RES TOXICOL, V15, P165, DOI 10.1021/tx0101245; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Suo ZC, 1999, BIOCHEMISTRY-US, V38, P715, DOI 10.1021/bi981854n; Terashima I, 2001, BIOCHEMISTRY-US, V40, P4106, DOI 10.1021/bi002719p; TURESKY RJ, 1994, CHEM RES TOXICOL, V7, P752, DOI 10.1021/tx00042a007; Upton DC, 2006, CHEM RES TOXICOL, V19, P960, DOI 10.1021/tx060084a; Upton DC, 2006, MUTAT RES-FUND MOL M, V599, P1, DOI 10.1016/j.mrfmmm.2005.12.014; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; van Holde K. E., 1998, PRINCIPLES PHYS BIOC, P587; Wang LJ, 1997, CHEM RES TOXICOL, V10, P562, DOI 10.1021/tx9602067; Washington MT, 2004, MOL CELL BIOL, V24, P6900, DOI 10.1128/MCB.24.16.6900-6906.2004; Washington MT, 2003, MOL CELL BIOL, V23, P5107, DOI 10.1128/MCB.23.14.5107-5112.2003; Wolfle WT, 2005, MOL CELL BIOL, V25, P7137, DOI 10.1128/MCB.25.16.7137-7143.2005; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1027, DOI 10.1021/bi011495n; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; Yasui M, 2001, NUCLEIC ACIDS RES, V29, P1994, DOI 10.1093/nar/29.9.1994; Zhang YB, 2002, NUCLEIC ACIDS RES, V30, P1630, DOI 10.1093/nar/30.7.1630	56	55	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23645	23655		10.1074/jbc.M801686200	http://dx.doi.org/10.1074/jbc.M801686200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18591245	hybrid, Green Published			2022-12-25	WOS:000258638900017
J	Escalera, J; von Hehn, CA; Bessac, BF; Sivula, M; Jordt, SE				Escalera, Jasmine; von Hehn, Christian A.; Bessac, Bret F.; Sivula, Michael; Jordt, Sven-Eric			TRPA1 mediates the noxious effects of natural sesquiterpene deterrents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID RECEPTOR-1 ANTAGONIST; ION-CHANNEL TRPA1; CHEMICAL DEFENSE; COVALENT MODIFICATION; ANALGESIC PROPERTIES; TERPENOIDS; DIALDEHYDE; PHARMACOLOGY; ACTIVATION; FLIPR	Plants, fungi, and animals generate a diverse array of deterrent natural products that induce avoidance behavior in biological adversaries. The largest known chemical family of deterrents are terpenes characterized by reactive alpha,beta-unsaturated dialdehyde moieties, including the drimane sesquiterpenes and other terpene species. Deterrent sesquiterpenes are potent activators of mammalian peripheral chemosensory neurons, causing pain and neurogenic inflammation. Despite their widespread synthesis and medicinal use as desensitizing analgesics, their molecular targets remain unknown. Here we show that isovelleral, a noxious fungal sesquiterpene, excites sensory neurons through activation of TPRA1, an ion channel involved in inflammatory pain signaling. TRPA1 is also activated by polygodial, a drimane sesquiterpene synthesized by plants and animals. TRPA1-deficient mice show greatly reduced nocifensive behavior in response to isovelleral, indicating that TRPA1 is the major receptor for deterrent sesquiterpenes in vivo. Isovelleral and polygodial represent the first fungal and animal small molecule agonists of nociceptive transient receptor potential channels.	[Escalera, Jasmine; von Hehn, Christian A.; Bessac, Bret F.; Sivula, Michael; Jordt, Sven-Eric] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Jordt, SE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,POB 208066, New Haven, CT 06520 USA.	sven.jordt@yale.edu	Jordt, Sven-Eric/ABE-6517-2020; Bessac, Bret/AAZ-1550-2020	Jordt, Sven-Eric/0000-0001-6171-5622; Bessac, Brett/0000-0002-0522-4455	National Institutes of Health; NIEHS [1F31ES015932]; Outstanding New Environmental Scientists (ONES) [ES015056]; Connecticut Department of Public Health [2007-0161 BIOMED]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015674, R01ES015056, F31ES015932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Outstanding New Environmental Scientists (ONES); Connecticut Department of Public Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NIEHS, Outstanding New Environmental Scientists (ONES) program Grant ES015056 (to S.E.J.) and NIEHS Predoctoral Fellowship 1F31ES015932 (to J.E.). This work was also supported by Connecticut Department of Public Health Grant 2007-0161 BIOMED (to S. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abe M, 2002, BIOSCI BIOTECH BIOCH, V66, P2698, DOI 10.1271/bbb.66.2698; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Andre E, 2006, BIOCHEM PHARMACOL, V71, P1248, DOI 10.1016/j.bcp.2005.12.030; Andre E, 2004, NEUROPHARMACOLOGY, V46, P590, DOI 10.1016/j.neuropharm.2003.10.008; Asakawa Y, 2001, CHEM PHARM BULL, V49, P1380, DOI 10.1248/cpb.49.1380; BAKER R, 1978, J CHEM SOC CHEM COMM, P410, DOI 10.1039/c39780000410; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; BARNES CS, 1962, AUST J CHEM, V15, P322, DOI 10.1071/CH9620322; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; CAMAZINE S, 1984, MYCOLOGIA, V76, P355, DOI 10.2307/3793113; CAMAZINE SM, 1983, J CHEM ECOL, V9, P1439, DOI 10.1007/BF00990749; Cechinel V, 1998, J ETHNOPHARMACOL, V62, P223, DOI 10.1016/S0378-8741(98)00069-5; CIMINO G, 1983, SCIENCE, V219, P1237, DOI 10.1126/science.219.4589.1237; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; ISHII T, 2007, FREE RADICAL RES, V41, P1; Jansen BJM, 2004, NAT PROD REP, V21, P449, DOI 10.1039/b311170a; Jerman JC, 2000, BRIT J PHARMACOL, V130, P916, DOI 10.1038/sj.bjp.0703390; JONASSOHN M, 1996, THESIS LUND U LUND; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; KAO JPY, 1994, METHOD CELL BIOL, V40, P155; KUBO I, 1981, EXPERIENTIA, V37, P1063, DOI 10.1007/BF02085009; KUBO I, 1976, J CHEM SOC CHEM COMM, P1013, DOI 10.1039/c39760001013; LANGENHEIM JH, 1994, J CHEM ECOL, V20, P1223, DOI 10.1007/BF02059809; LIST PH, 1969, ARCHIV PHARM BERICHT, V302, P125, DOI 10.1002/ardp.19693020208; Liu L, 1997, NEUROSCI LETT, V228, P29, DOI 10.1016/S0304-3940(97)00358-3; Long JD, 2006, MAR ECOL PROG SER, V307, P199, DOI 10.3354/meps307199; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; MAGNUSSON G, 1972, TETRAHEDRON LETT, V13, P1105; MCCALLION RF, 1982, PLANTA MED, V44, P134, DOI 10.1055/s-2007-971422; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Ohta T, 2005, BIOCHEM PHARMACOL, V71, P173, DOI 10.1016/j.bcp.2005.09.028; Pomonis JD, 2003, J PHARMACOL EXP THER, V306, P387, DOI 10.1124/jpet.102.046268; PONHOLD J, 1942, ARCH DERMATOL RES, V182, P732; Ralevic V, 2003, BIOCHEM PHARMACOL, V65, P143, DOI 10.1016/S0006-2952(02)01451-X; Smart D, 2001, EUR J PHARMACOL, V417, P51, DOI 10.1016/S0014-2999(01)00901-3; Socolsky C, 2005, CHEM BIODIVERS, V2, P1105, DOI 10.1002/cbdv.200590079; Story GM, 2006, NEURON, V50, P177, DOI 10.1016/j.neuron.2006.04.009; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Szallasi A, 1996, BRIT J PHARMACOL, V119, P283, DOI 10.1111/j.1476-5381.1996.tb15983.x; Szallasi A, 1998, EUR J PHARMACOL, V356, P81, DOI 10.1016/S0014-2999(98)00514-7; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Valenzano KJ, 2003, J PHARMACOL EXP THER, V306, P377, DOI 10.1124/jpet.102.045674; Wilkins CK, 2001, ENVIRON HEALTH PERSP, V109, P937, DOI 10.2307/3454995; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	55	69	72	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24136	24144		10.1074/jbc.M710280200	http://dx.doi.org/10.1074/jbc.M710280200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18550530	hybrid, Green Published			2022-12-25	WOS:000258638900067
J	Kabuta, T; Furuta, A; Aoki, S; Furuta, K; Wada, K				Kabuta, Tomohiro; Furuta, Akiko; Aoki, Shunsuke; Furuta, Koh; Wada, Keiji			Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL HYDROLASE; ALPHA-SYNUCLEIN; LEWY BODIES; NEURODEGENERATIVE DISEASES; SUSCEPTIBILITY GENE; STRUCTURAL BASIS; L1; DEGRADATION; DEMENTIA; MUTATION	Parkinson disease (PD) is the most common neurodegenerative movement disorder. An increase in the amount of alpha-synuclein protein could constitute a cause of PD. alpha-Synuclein is degraded at least partly by chaperone-mediated autophagy (CMA). The I93M mutation in ubiquitin C-terminal hydrolase L1 (UCH- L1) is associated with familial PD. However, the relationship between alpha-synuclein and UCH- L1 in the pathogenesis of PD has remained largely unclear. In this study, we found that UCH- L1 physically interacts with LAMP-2A, the lysosomal receptor for CMA, and Hsc70 and Hsp90, which can function as components of the CMA pathway. These interactions were abnormally enhanced by the I93M mutation and were independent of the monoubiquitin binding of UCH- L1. In a cell-free system, UCH- L1 directly interacted with the cytosolic region of LAMP-2A. Expression of I93M UCH- L1 in cells induced the CMA inhibition-associated increase in the amount of alpha-synuclein. Our findings may provide novel insights into the molecular links between alpha-synuclein and UCH-L1 and suggest that aberrant interaction of mutant UCH- L1 with CMA machinery, at least partly, underlies the pathogenesis of PD associated with I93M UCH-L1.	[Kabuta, Tomohiro; Furuta, Akiko; Aoki, Shunsuke; Wada, Keiji] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 1878502, Japan; [Furuta, Koh] Natl Canc Ctr, Div Clin Labs, Chuo Ku, Tokyo 1040045, Japan	National Center for Neurology & Psychiatry - Japan; National Cancer Center - Japan	Kabuta, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	kabuta@ncnp.go.jp; wada@ncnp.go.jp	Wada, Keiji/AAV-1500-2021; Kabuta, Tomohiro/B-2948-2015; Aoki, Shunsuke/A-3059-2011	Kabuta, Tomohiro/0000-0002-3058-2596; 	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; New Energy and Industrial Technology Development Organization, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); New Energy and Industrial Technology Development Organization, Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science; a research grant in priority area research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; grants- in- aid for scientific research from the Ministry of Health, Labor, and Welfare, Japan; and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation and the New Energy and Industrial Technology Development Organization, Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Agarraberes FA, 2001, J CELL SCI, V114, P2491; Baba M, 1998, AM J PATHOL, V152, P879; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Eskelinen EL, 2005, TRAFFIC, V6, P1058, DOI 10.1111/j.1600-0854.2005.00337.x; Finn PF, 2005, J BIOL CHEM, V280, P25864, DOI 10.1074/jbc.M502456200; Healy DG, 2006, ANN NEUROL, V59, P627, DOI 10.1002/ana.20757; Healy DG, 2004, CELL TISSUE RES, V318, P189, DOI 10.1007/s00441-004-0917-3; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Maraganore DM, 2004, ANN NEUROL, V55, P512, DOI 10.1002/ana.20017; Naito S, 2006, BIOCHEM BIOPH RES CO, V339, P717, DOI 10.1016/j.bbrc.2005.11.066; Nishikawa K, 2003, BIOCHEM BIOPH RES CO, V304, P176, DOI 10.1016/S0006-291X(03)00555-2; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; PERTOFT H, 1978, BIOCHEM J, V174, P309, DOI 10.1042/bj1740309; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Setsuie R, 2007, NEUROCHEM INT, V50, P119, DOI 10.1016/j.neuint.2006.07.015; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Solano SM, 2000, ANN NEUROL, V47, P201, DOI 10.1002/1531-8249(200002)47:2<201::AID-ANA10>3.0.CO;2-F; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	41	173	178	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23731	23738		10.1074/jbc.M801918200	http://dx.doi.org/10.1074/jbc.M801918200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18550537	Green Published, hybrid			2022-12-25	WOS:000258638900027
J	Lampert, A; O'Reilly, AO; Dib-Hajj, SD; Tyrrell, L; Wallace, BA; Waxman, SG				Lampert, Angelika; O'Reilly, Andrias O.; Dib-Hajj, Sulayman D.; Tyrrell, Lynda; Wallace, B. A.; Waxman, Stephen G.			A pore-blocking hydrophobic motif at the cytoplasmic aperture of the closed-state Na(v)1.7 channel is disrupted by the erythromelalgia-associated F1449V mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNELS; OF-FUNCTION MUTATION; DORSAL-ROOT-GANGLIA; POTASSIUM CHANNEL; ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; ION-CHANNEL; K+ CHANNEL; CONFORMATIONAL-CHANGES; FAST INACTIVATION	Sodium channel Na(v)1.7 has recently elicited considerable interest as a key contributor to human pain. Gain-of-function mutations of Nav1.7 produce painful disorders, whereas loss-offunction Nav1.7 mutations produce insensitivity to pain. The inherited erythromelalgia Nav1.7/F1449V mutation, within the C terminus of domain III/transmembrane helix S6, shifts channel activation by -7.2 mV and accelerates time to peak, leading to nociceptor hyperexcitability. We constructed a homology model of Nav1.7, based on the KcsA potassium channel crystal structure, which identifies four phylogenetically conserved aromatic residues that correspond to DIII/F1449 at the C-terminal end of each of the four S6 helices. The model predicted that changes in side-chain size of residue 1449 alter the pore's cytoplasmic aperture diameter and reshape inter-domain contact surfaces that contribute to closed state stabilization. To test this hypothesis, we compared activation of wild-type and mutant Nav1.7 channels F1449V/L/Y/W by whole cell patch clamp analysis. All but the F1449V mutation conserve the voltage dependence of activation. Compared with wild type, time to peak was shorter in F1449V, similar in F1449L, but longer for F1449Y and F1449W, suggesting that a bulky, hydrophobic residue is necessary for normal activation. We also substituted the corresponding aromatic residue of S6 in each domain individually with valine, to mimic the naturally occurring Nav1.7 mutation. We show that DII/F960V and DIII/F1449V, but not DI/Y405V or DIV/F1752V, regulate Nav1.7 activation, consistent with well established conformational changes in DII and DIII. We propose that the four aromatic residues contribute to the gate at the cytoplasmic pore aperture, and that their ring side chains form a hydrophobic plug which stabilizes the closed state of Nav1.7.	[O'Reilly, Andrias O.; Wallace, B. A.] Univ London, Dept Crystallog, Birkbeck Coll, London WC1E 7HX, England; [Lampert, Angelika; Dib-Hajj, Sulayman D.; Tyrrell, Lynda; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Lampert, Angelika; Dib-Hajj, Sulayman D.; Tyrrell, Lynda; Waxman, Stephen G.] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT 06510 USA; [Lampert, Angelika; Dib-Hajj, Sulayman D.; Tyrrell, Lynda; Waxman, Stephen G.] Vet Affairs Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT 06516 USA	University of London; Birkbeck University London; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Wallace, BA (corresponding author), Univ London, Dept Crystallog, Birkbeck Coll, London WC1E 7HX, England.	b.Wallace@mail.cryst.bbk.ac.uk; Stephen.Waxman@yale.edu	Lampert, Angelika/F-7198-2010; Waxman, Stephen/Z-2507-2019; O'Reilly, Andrias/AAC-7628-2022; Wallace, B A/C-3753-2008	Lampert, Angelika/0000-0001-6319-6272; Waxman, Stephen/0000-0001-5718-7177; O'Reilly, Andrias/0000-0003-3449-2368; Wallace, B A/0000-0001-9649-5092	Rehabilitation Research Service and Medical Research Service; Department of Veterans Affairs; National Multiple Sclerosis Society; Erythromelalgia Association; UK Biotechnology and Biological Sciences and Research Council; Biotechnology and Biological Sciences Research Council [BB/C500628/1] Funding Source: researchfish	Rehabilitation Research Service and Medical Research Service; Department of Veterans Affairs(US Department of Veterans Affairs); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Erythromelalgia Association; UK Biotechnology and Biological Sciences and Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the Rehabilitation Research Service and Medical Research Service, Department of Veterans Affairs, the National Multiple Sclerosis Society, and the Erythromelalgia Association. The work in the laboratory of B. A. W. was supported by grants from the UK Biotechnology and Biological Sciences and Research Council. The Center for Neuroscience and Regeneration Research is a Collaboration of the Paralyzed Veterans of America and the United Spinal Association with Yale University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmad S, 2007, HUM MOL GENET, V16, P2114, DOI 10.1093/hmg/ddm160; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chanda B, 2004, J GEN PHYSIOL, V123, P217, DOI 10.1085/jgp.200308971; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Choi JS, 2006, NEUROLOGY, V67, P1563, DOI 10.1212/01.wnl.0000231514.33603.1e; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cosconati S, 2007, J MED CHEM, V50, P1504, DOI 10.1021/jm061245a; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cronin NB, 2005, BIOCHEMISTRY-US, V44, P441, DOI 10.1021/bi048741q; Cronin NB, 2003, J BIOL CHEM, V278, P10675, DOI 10.1074/jbc.M208356200; CUMMINS TR, 1993, NEURON, V10, P667, DOI 10.1016/0896-6273(93)90168-Q; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; DEVOR M, 1990, J NEUROPHYSIOL, V64, P1733, DOI 10.1152/jn.1990.64.6.1733; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Guda P, 2007, BIOCHEM BIOPH RES CO, V352, P292, DOI 10.1016/j.bbrc.2006.10.190; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han CY, 2006, ANN NEUROL, V59, P553, DOI 10.1002/ana.20776; Harty TP, 2006, J NEUROSCI, V26, P12566, DOI 10.1523/JNEUROSCI.3424-06.2006; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Holyoake J, 2004, EUR BIOPHYS J BIOPHY, V33, P238, DOI 10.1007/s00249-003-0355-2; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lampert A, 2006, J BIOL CHEM, V281, P36029, DOI 10.1074/jbc.M607637200; Lipkind GM, 2000, BIOCHEMISTRY-US, V39, P8161, DOI 10.1021/bi000486w; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; MCPHEE JC, 1994, P NATL ACAD SCI USA, V91, P12346, DOI 10.1073/pnas.91.25.12346; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; Ranatunga KM, 2001, EUR BIOPHYS J BIOPHY, V30, P295, DOI 10.1007/s002490100134; Rice ASC, 2006, ANNU REV MED, V57, P535, DOI 10.1146/annurev.med.57.121304.131324; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Scheib H, 2006, J MOL MODEL, V12, P813, DOI 10.1007/s00894-005-0066-y; Sheets PL, 2007, J PHYSIOL-LONDON, V581, P1019, DOI 10.1113/jphysiol.2006.127027; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smith MR, 1997, BIOPHYS J, V73, P1885, DOI 10.1016/S0006-3495(97)78219-5; Stansfeld PJ, 2007, PROTEINS, V68, P568, DOI 10.1002/prot.21400; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Tikhonov DB, 2008, J BIOL CHEM, V283, P17594, DOI 10.1074/jbc.M800141200; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Usherwood PNR, 2007, FEBS LETT, V581, P5485, DOI 10.1016/j.febslet.2007.10.057; WALL PD, 1983, PAIN, V17, P321, DOI 10.1016/0304-3959(83)90164-1; WALL PD, 1974, NATURE, V248, P740, DOI 10.1038/248740a0; Waxman SG, 2005, TRENDS MOL MED, V11, P555, DOI 10.1016/j.molmed.2005.10.004; Waxman SG, 2001, NAT REV NEUROSCI, V2, P652, DOI 10.1038/35090026; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	60	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24118	24127		10.1074/jbc.M802900200	http://dx.doi.org/10.1074/jbc.M802900200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18550534	Green Published, hybrid			2022-12-25	WOS:000258638900065
J	Malanovic, N; Streith, I; Wolinski, H; Rechberger, G; Kohlwein, SD; Tehlivets, O				Malanovic, Nermina; Streith, Ingo; Wolinski, Heimo; Rechberger, Gerald; Kohlwein, Sepp D.; Tehlivets, Oksana			S-Adenosyl-L-homocysteine hydrolase, key enzyme of methylation metabolism, regulates phosphatidylcholine synthesis and triacylglycerol homeostasis in yeast - Implications for homocysteine as a risk factor of atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; PHOSPHOLIPID-METABOLISM; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; SULFUR ASSIMILATION; ADENOSYLHOMOCYSTEINE; ADENOSYLMETHIONINE; DEFICIENCY; METHYLTRANSFERASE	In eukaryotes, S-adenosyl-L-homocysteine hydrolase (Sah1) offers a single way for degradation of S-adenosyl-L-homocysteine, a product and potent competitive inhibitor of S-adenosyl-L-methionine (AdoMet)-dependent methyltransferases. Denovophosphatidylcholine(PC)synthesisrequiresthreeAdoMet-dependent methylation steps. Here we show that down-regulation of SAH1 expression in yeast leads to accumulation of S-ad-enosyl-L-homocysteine and decreased de novo PC synthesis in vivo. This decrease is accompanied by an increase in triacylglycerol (TG) levels, demonstrating that Sah1-regulated methylation has a major impact on cellular lipid homeostasis. TG accumulation is also observed in cho2 and opi3 mutants defective in methylation of phosphatidylethanolamine to PC, confirming that PC de novo synthesis and TG synthesis are metabolically coupled through the efficiency of the phospholipid methylation reaction. Indeed, because both types of lipids share phosphatidic acid as a precursor, we find in cells with down-regulated Sah1 activity major alterations in the expression of the INO1 gene as well as in the localization of Opi1, a negative regulatory factor of phospholipid synthesis, which binds and is retained in the endoplasmic reticulum membrane by phosphatidic acid in conjunction with VAMP/synaptobrevin-associated protein, Scs2. The addition of homocysteine, by the reversal of the Sah1-catalyzed reaction, also leads to TG accumulation in yeast, providing an attractive model for the role of homocysteine as a risk factor of atherosclerosis in humans.	[Malanovic, Nermina; Streith, Ingo; Wolinski, Heimo; Rechberger, Gerald; Kohlwein, Sepp D.; Tehlivets, Oksana] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Graz	Tehlivets, O (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50-2, A-8010 Graz, Austria.	oksana.tehlivets@uni-graz.at	; Malanovic, Nermina/ACF-9103-2022	Tehlivets, Oksana/0000-0003-1650-5014; Rechberger, Gerald N./0000-0002-0071-317X; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Wolinski, Heimo/0000-0002-1583-6092; Malanovic, Nermina/0000-0002-2903-9369	Austrian Science Fund FWF [P18094-B14, F3005]; Austrian Science Fund (FWF) [F 3005] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF, Project P18094-B14 (to O.T.) and Project SFB Lipotox (F3005) ( to S. D. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; Baric I, 2005, J INHERIT METAB DIS, V28, P885, DOI 10.1007/s10545-005-0192-9; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; BRETON A, 1977, J BACTERIOL, V132, P224, DOI 10.1128/JB.132.1.224-232.1977; Buist NRM, 2006, J INHERIT METAB DIS, V29, P538, DOI 10.1007/s10545-006-0240-0; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Christopher SA, 2002, MOL GENET METAB, V75, P335, DOI 10.1016/S1096-7192(02)00003-3; Davis CD, 2007, NUTR REV, V65, P88, DOI [10.1111/j.1753-4887.2007.tb00285.x, 10.1301/nr.2007.feb.88-94]; Dayal S, 2001, CIRC RES, V88, P1203, DOI 10.1161/hh1101.092180; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; DELAHABA G, 1959, J BIOL CHEM, V234, P603; Detich N, 2003, J BIOL CHEM, V278, P20812, DOI 10.1074/jbc.M211813200; Finkelstein JD, 2006, J NUTR, V136, p1750S, DOI 10.1093/jn/136.6.1750S; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Gellekink H, 2005, CLIN CHEM, V51, P1487, DOI 10.1373/clinchem.2004.046995; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GREENBERG ML, 1982, MOL GEN GENET, V186, P157, DOI 10.1007/BF00331845; Hansen J, 2000, MOL GEN GENET, V263, P535, DOI 10.1007/s004380051199; Hartz CS, 2006, J NUTR, V136, P3005, DOI 10.1093/jn/136.12.3005; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HOFFMAN DR, 1980, J BIOL CHEM, V255, P822; Isa Y, 2006, J NUTR SCI VITAMINOL, V52, P479, DOI 10.3177/jnsv.52.479; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Kerins DM, 2001, AM J CLIN NUTR, V74, P723; Kharbanda KK, 2007, WORLD J GASTROENTERO, V13, P4947, DOI 10.3748/wjg.v13.i37.4947; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lee H, 1998, BIOL REPROD, V58, P1437, DOI 10.1095/biolreprod58.6.1437; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lindsay H, 1996, BIOCHEM J, V320, P473, DOI 10.1042/bj3200473; Loehrer FMT, 2001, ATHEROSCLEROSIS, V154, P147, DOI 10.1016/S0021-9150(00)00449-4; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; MCGEE TP, 1994, J BACTERIOL, V176, P6861, DOI 10.1128/JB.176.22.6861-6868.1994; MCGRAW P, 1989, GENETICS, V122, P317; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; Mizunuma M, 2004, P NATL ACAD SCI USA, V101, P6086, DOI 10.1073/pnas.0308314101; Moffatt BA, 2002, PLANT PHYSIOL, V128, P812, DOI 10.1104/pp.010880; Mushegian AR, 1998, GENOME RES, V8, P590, DOI 10.1101/gr.8.6.590; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Pan HJ, 2006, FEBS LETT, V580, P5953, DOI 10.1016/j.febslet.2006.09.066; Sas B, 1999, J CHROMATOGR A, V864, P179, DOI 10.1016/S0021-9673(99)01025-0; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Stead LM, 2006, AM J CLIN NUTR, V83, P5; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Tehlivets O, 2004, FEBS LETT, V577, P501, DOI 10.1016/j.febslet.2004.10.057; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1990, J BIOL CHEM, V265, P15518; Vance DE, 2006, FEBS LETT, V580, P5430, DOI 10.1016/j.febslet.2006.06.025; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Vollset SE, 2001, AM J CLIN NUTR, V74, P130; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOLFE MS, 1991, J MED CHEM, V34, P1521, DOI 10.1021/jm00109a001; Wolinski Heimo, 2008, V457, P151, DOI 10.1007/978-1-59745-261-8_11; Zaina S, 2005, J NUTR, V135, P5, DOI 10.1093/jn/135.1.5	62	58	61	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23989	23999		10.1074/jbc.M800830200	http://dx.doi.org/10.1074/jbc.M800830200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18591246	Green Published, hybrid			2022-12-25	WOS:000258638900055
J	Nikaido, E; Yamaguchi, A; Nishino, K				Nikaido, Eiji; Yamaguchi, Akihito; Nishino, Kunihiko			AcrAB multidrug efflux pump regulation in Salmonella enterica serovar typhimurium by RamA in response to environmental signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; LEVEL FLUOROQUINOLONE RESISTANCE; RAW-MILK CHEESE; ESCHERICHIA-COLI; DRUG-RESISTANCE; FATTY-ACIDS; BILE-SALTS; EXPRESSION; GENES; TRANSPORTER	Salmonella enterica serovar Typhimurium has at least nine multidrug efflux pumps. Among these pumps, AcrAB is effective in generating drug resistance and has wide substrate specificity. Here we report that indole, bile, and an Escherichia coli conditioned medium induced the AcrAB pump in Salmonella through a specific regulator, RamA. The RamA-binding sites were located in the upstream regions of acrAB and tolC. RamA was required for indole induction of acrAB. Other regulators of acrAB such as MarA, SoxS, Rob, SdiA, and AcrR did not contribute to acrAB induction by indole in Salmonella. Indole activated ramA transcription, and overproduction of RamA caused increased acrAB expression. In contrast, induction of ramA was not required for induction of acrAB by bile. Cholic acid binds to RamA, and we suggest that bile acts by altering pre-existing RamA. This points to two different AcrAB regulatory modes through RamA. Our results suggest that RamA controls the Salmonella AcrAB-TolC multidrug efflux system through dual regulatory modes in response to environmental signals.	[Nikaido, Eiji; Yamaguchi, Akihito; Nishino, Kunihiko] Osaka Univ, Dept Cell Membrane Biol, Inst Sci & Ind Res, Osaka 5670047, Japan; [Nikaido, Eiji; Yamaguchi, Akihito; Nishino, Kunihiko] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka 5670047, Japan; [Nishino, Kunihiko] Japan Sci & Technol Corp, PRESTO, Tokyo 1020075, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Yamaguchi, A (corresponding author), Osaka Univ, Dept Cell Membrane Biol, Inst Sci & Ind Res, Osaka 5670047, Japan.	akihito@sanken.osaka-u.ac.jp; nishino@sanken.osaka-u.ac.jp			Takeda Science Foundation; Inamori Foundation; Japan Science and Technology Agency; Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Takeda Science Foundation, Inamori Foundation, the PRESTO program of the Japan Science and Technology Agency (to K. N.), the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Society for the Promotion of Science (to A. Y. and K. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abouzeed YM, 2008, ANTIMICROB AGENTS CH, V52, P2428, DOI 10.1128/AAC.00084-08; AHMED M, 1994, J BIOL CHEM, V269, P28506; Baca-DeLancey RR, 1999, P NATL ACAD SCI USA, V96, P4610, DOI 10.1073/pnas.96.8.4610; Batta AK, 2002, J CHROMATOGR B, V775, P153, DOI 10.1016/S1570-0232(02)00289-1; Baucheron S, 2004, J ANTIMICROB CHEMOTH, V53, P657, DOI 10.1093/jac/dkh122; Baucheron S, 2002, MICROB DRUG RESIST, V8, P281, DOI 10.1089/10766290260469543; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Chollet R, 2004, ANTIMICROB AGENTS CH, V48, P2518, DOI 10.1128/AAC.48.7.2518-2523.2004; Cloeckaert A, 2001, VET RES, V32, P291, DOI 10.1051/vetres:2001105; Cody SH, 1999, JAMA-J AM MED ASSOC, V281, P1805, DOI 10.1001/jama.281.19.1805; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies A, 1996, Commun Dis Rep CDR Rev, V6, pR159; DAVIS RW, 1980, ADV BACTERIAL GENET, P100; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P1145, DOI 10.1128/AAC.48.4.1145-1150.2004; ELLEDGE SJ, 1989, GENE DEV, V3, P185, DOI 10.1101/gad.3.2.185; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Grein T, 1999, IRISH MED J, V92, P238; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Hernandez-Urzua E, 2007, ARCH MICROBIOL, V187, P67, DOI 10.1007/s00203-006-0175-8; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hosek G., 1997, Morbidity and Mortality Weekly Report, V46, P308; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; KOMATSU T, 1990, J BACTERIOL, V172, P4082, DOI 10.1128/jb.172.7.4082-4089.1990; Lacroix FJC, 1996, FEMS MICROBIOL LETT, V135, P161, DOI 10.1016/0378-1097(95)00443-2; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; LOMOVSKAYA O, 1995, J BACTERIOL, V177, P2328, DOI 10.1128/jb.177.9.2328-2334.1995; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Martin RG, 2002, MOL MICROBIOL, V44, P1611, DOI 10.1046/j.1365-2958.2002.02985.x; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Miller JH., 1972, EXPT MOL GENETICS; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Ng LK, 1999, ANTIMICROB AGENTS CH, V43, P3018, DOI 10.1128/AAC.43.12.3018; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Nishino K, 2007, J BACTERIOL, V189, P9066, DOI 10.1128/JB.01045-07; Olliver A, 2005, ANTIMICROB AGENTS CH, V49, P289, DOI 10.1128/AAC.49.1.289-301.2005; Olliver A, 2004, FEMS MICROBIOL LETT, V238, P267, DOI 10.1016/j.femsle.2004.07.046; Paulsen IT, 2001, J MOL MICROB BIOTECH, V3, P145; Piddock LJV, 2002, FEMS MICROBIOL REV, V26, P3, DOI 10.1016/S0168-6445(01)00076-6; Prouty AM, 2004, MICROBIOL-SGM, V150, P775, DOI 10.1099/mic.0.26769-0; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Randall LP, 2002, RES VET SCI, V72, P87, DOI 10.1053/rvsc.2001.0537; Rosenberg EY, 2003, MOL MICROBIOL, V48, P1609, DOI 10.1046/j.1365-2958.2003.03531.x; Scherer CA, 2001, PRINCIPLES BACTERIAL, P266; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Schuldiner S, 2006, NATURE, V443, P156, DOI 10.1038/443156b; SONNENWIRTH AC, 1980, ENTERIC BACTERIA BAC, P645; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Threlfall EJ, 1997, MICROB DRUG RESIST, V3, P263, DOI 10.1089/mdr.1997.3.263; Threlfall EJ, 1996, LANCET, V347, P1053, DOI 10.1016/S0140-6736(96)90199-3; van der Straaten T, 2004, INFECT IMMUN, V72, P996, DOI 10.1128/IAI.72.2.996-1003.2004; van der Straaten T, 2004, ANTIMICROB AGENTS CH, V48, P2292, DOI 10.1128/AAC.48.6.2292-2294.2004; Villar RG, 1999, JAMA-J AM MED ASSOC, V281, P1811, DOI 10.1001/jama.281.19.1811; YANOFSKY C, 1991, J BACTERIOL, V173, P6009, DOI 10.1128/jb.173.19.6009-6017.1991; Yassien MA, 2002, ANTIMICROB AGENTS CH, V46, P360, DOI 10.1128/AAC.46.2.360-366.2002; Yu EW, 2003, J BACTERIOL, V185, P5657, DOI 10.1128/JB.185.19.5657-5664.2003; Zgurskaya HI, 2000, MOL MICROBIOL, V37, P219, DOI 10.1046/j.1365-2958.2000.01926.x	60	156	164	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24245	24253		10.1074/jbc.M804544200	http://dx.doi.org/10.1074/jbc.M804544200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577510	Green Published, hybrid			2022-12-25	WOS:000258638900078
J	Signorell, A; Rauch, M; Jelk, J; Ferguson, MAJ; Butikofer, P				Signorell, Aita; Rauch, Monika; Jelk, Jennifer; Ferguson, Michael A. J.; Buetikofer, Peter			Phosphatidylethanolamine in Trypanosoma brucei is organized in two separate pools and is synthesized exclusively by the Kennedy pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PROCYCLIC CULTURE FORMS; PHOSPHOLIPID BIOSYNTHESIS; MAMMALIAN-CELLS; BLOOD-STREAM; FATTY-ACID; PHOSPHATIDYLSERINE; SPECIFICITY; METABOLISM; LIPIDS	Phosphatidylethanolamine is a major phospholipid class of all eukaryotic cells. It can be synthesized via the CDP-ethanolamine branch of the Kennedy pathway, by decarboxylation of phosphatidylserine, or by base exchange with phosphatidylserine. The contributions of these pathways to total phosphatidylethanolamine synthesis have remained unclear. Although Trypanosoma brucei, the causative agent of human and animal trypanosomiasis, has served as a model organism to elucidate the entire reaction sequence for glycosylphosphatidylinositol biosynthesis, the pathways for the synthesis of the major phospholipid classes have received little attention. Wenowshow that disruption of the CDP- ethanolamine branch of the Kennedy pathway using RNA interference results in dramatic changes in phosphatidylethanolamine, phosphatidylserine, and phosphatidylcholine. By targeting individual enzymes of the pathway, we demonstrate that de novo phosphatidylethanolamine synthesis in T. brucei procyclic forms is strictly dependent on the CDPethanolamine route. Interestingly, the last step in the Kennedy pathway can be mediated by two separate activities leading to two distinct pools of phosphatidylethanolamine, consisting of predominantly alk- 1- enyl- acyl- or diacyl- type molecular species. In addition, we show that phosphatidylserine in T. brucei procyclic forms is synthesized exclusively by base exchange with phosphatidylethanolamine.	[Signorell, Aita; Rauch, Monika; Jelk, Jennifer; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Ferguson, Michael A. J.] Univ Dundee, Div Biol Chem & Drug Discovery, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland	University of Bern; University of Dundee	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	peter.buetikofer@mci.unibe.ch		Ferguson, Michael/0000-0003-1321-8714	Wellcome Trust [071463] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arikketh D, 2008, J BIOL CHEM, V283, P12888, DOI 10.1074/jbc.M800714200; Bakovic M, 2007, BIOCHEM CELL BIOL, V85, P283, DOI 10.1139/O07-006; Birner R, 2003, INT REV CYTOL, V225, P273, DOI 10.1016/S0074-7696(05)25007-6; Bleijerveld OB, 2007, J BIOL CHEM, V282, P28362, DOI 10.1074/jbc.M703786200; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; BRUN R, 1979, ACTA TROP, V36, P289; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P148, DOI 10.1016/j.bbalip.2004.09.005; Butikofer P, 1997, BIOCHEM J, V326, P415; BUTIKOFER P, 1989, BLOOD, V73, P1699; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; DIXON H, 1970, COMP BIOCHEM PHYSIOL, V33, P111, DOI 10.1016/0010-406X(70)90487-1; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Ferguson MAJ, 2000, P NATL ACAD SCI USA, V97, P10673, DOI 10.1073/pnas.97.20.10673; Ford DA, 2003, J LIPID RES, V44, P554, DOI 10.1194/jlr.M200426-JLR200; Guler JL, 2008, MOL MICROBIOL, V67, P1125, DOI 10.1111/j.1365-2958.2008.06112.x; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; KANFER J, 1964, J BIOL CHEM, V239, P1720; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Martin KL, 2006, MOL MICROBIOL, V61, P89, DOI 10.1111/j.1365-2958.2006.05216.x; Martin KL, 2006, BIOCHEM J, V396, P287, DOI 10.1042/BJ20051825; MENON AK, 1993, EMBO J, V12, P1907, DOI 10.1002/j.1460-2075.1993.tb05839.x; Munro S, 2004, NAT CELL BIOL, V6, P469, DOI 10.1038/ncb0604-469; NIKAWA J, 1981, BIOCHIM BIOPHYS ACTA, V665, P420, DOI 10.1016/0005-2760(81)90254-X; OPPERDOES FR, 1984, FEBS LETT, V169, P35, DOI 10.1016/0014-5793(84)80284-7; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; PATNAIK PK, 1993, MOL BIOCHEM PARASIT, V58, P97, DOI 10.1016/0166-6851(93)90094-E; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; RIFKIN MR, 1995, J BIOL CHEM, V270, P16160, DOI 10.1074/jbc.270.27.16160; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Signorell A, 2008, J BIOL CHEM, V283, P20320, DOI 10.1074/jbc.M802430200; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; van Hellemond JJ, 2006, FEBS LETT, V580, P5552, DOI 10.1016/j.febslet.2006.07.056; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Vial HJ, 2003, MOL BIOCHEM PARASIT, V126, P143, DOI 10.1016/S0166-6851(02)00281-5; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	43	46	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23636	23644		10.1074/jbc.M803600200	http://dx.doi.org/10.1074/jbc.M803600200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18587155	hybrid, Green Published			2022-12-25	WOS:000258638900016
J	Xia, ZX; Webster, A; Du, FY; Piatkov, K; Ghislain, M; Varshavsky, A				Xia, Zanxian; Webster, Ailsa; Du, Fangyong; Piatkov, Konstantin; Ghislain, Michel; Varshavsky, Alexander			Substrate-binding sites of UBR1, the ubiquitin ligase of the N-end rule pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-PROTEIN TRANSFERASE; MICE LACKING; TRANSCRIPTIONAL REPRESSION; RECOGNITION COMPONENT; MEDIATED DEGRADATION; ESCHERICHIA-COLI; COHESIN SUBUNIT; SHUTTLE VECTORS; SPECIFICITY; YEAST	Substrates of a ubiquitin-dependent proteolytic system called the N-end rule pathway include proteins with destabilizing N-terminal residues. N-recognins, the pathway's ubiquitin ligases, contain three substrate-binding sites. The type-1 site is specific for basic N-terminal residues (Arg, Lys, and His). The type-2 site is specific for bulky hydrophobic N-terminal residues (Trp, Phe, Tyr, Leu, and Ile). We show here that the type-1/2 sites of UBR1, the sole N-recognin of the yeast Saccharomyces cerevisiae, are located in the first similar to 700 residues of the 1,950-residue UBR1. These sites are distinct in that they can be selectively inactivated by mutations, identified through a genetic screen. Mutations inactivating the type-1 site are in the previously delineated similar to 70-residue UBR motif characteristic of N-recognins. Fluorescence polarization and surface plasmon resonance were used to determine that UBR1 binds, with a K-d of similar to 1 mu M, to either type-1 or type-2 destabilizing N-terminal residues of reporter peptides but does not bind to a stabilizing N-terminal residue such as Gly. A third substrate-binding site of UBR1 targets an internal degron of CUP9, a transcriptional repressor of peptide import. We show that the previously demonstrated in vivo dependence of CUP9 ubiquitylation on the binding of cognate dipeptides to the type-1/2 sites of UBR1 can be reconstituted in a completely defined in vitro system. We also found that purified UBR1 and CUP9 interact nonspecifically and that specific binding ( which involves, in particular, the binding by cognate dipeptides to the UBR1 type-1/2 sites) can be restored either by a chaperone such as EF1A or through macromolecular crowding.	[Xia, Zanxian; Piatkov, Konstantin; Varshavsky, Alexander] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Webster, Ailsa] Celltech R&D, Slough SL1 4EN, Berks, England; [Du, Fangyong] Yale Univ, Dept Microbial Pathogenesis, New Haven, CT 06536 USA; [Ghislain, Michel] Univ Louvain, Grp Physiol Biochem, B-1348 Louvain, Belgium	California Institute of Technology; Celltech Group Ltd; Yale University	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu			National Institutes of Health [DK39520, GM31530]; Ellison Medical Foundation; Sandler Program for Asthma Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039520, R01DK039520, R56DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Sandler Program for Asthma Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK39520 and GM31530 (to A.V.). This work was also supported by the Ellison Medical Foundation and the Sandler Program for Asthma Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALAGRAMAM K, 1995, MOL MICROBIOL, V15, P225, DOI 10.1111/j.1365-2958.1995.tb02237.x; An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; Ausubel F.M., 2006, CURRENT PROTOCOLS MO; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1995, J BIOL CHEM, V270, P12065, DOI 10.1074/jbc.270.20.12065; BAKER RT, 1991, P NATL ACAD SCI USA, V87, P2374; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; Catic A, 2007, EMBO J, V26, P3474, DOI 10.1038/sj.emboj.7601772; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; DEGROOT RJ, 1991, P NATL ACAD SCI USA, V88, P8967, DOI 10.1073/pnas.88.20.8967; DELTITO BJD, 1995, J BACTERIOL, V177, P7086, DOI 10.1128/jb.177.24.7086-7091.1995; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Dong XS, 2007, PROTEIN SCI, V16, P528, DOI 10.1110/ps.062616107; DU F, 2001, THESIS CALIFORNIA I; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Garzon M, 2007, FEBS LETT, V581, P3189, DOI 10.1016/j.febslet.2007.06.005; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Halaris A, 2007, CNS DRUGS, V21, P885, DOI 10.2165/00023210-200721110-00002; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Inobe T, 2008, CURR OPIN STRUC BIOL, V18, P43, DOI 10.1016/j.sbi.2007.12.014; JARVIS TC, 1990, J BIOL CHEM, V265, P15160; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju DD, 2007, BBA-MOL CELL RES, V1773, P1672, DOI 10.1016/j.bbamcr.2007.04.012; Kwak KS, 2004, CANCER RES, V64, P8193, DOI 10.1158/0008-5472.CAN-04-2102; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Lloyd AG, 2007, VIROLOGY, V360, P129, DOI 10.1016/j.virol.2006.10.007; Lupas AN, 2003, J STRUCT BIOL, V141, P77, DOI 10.1016/S1047-8477(02)00582-8; Lynch M, 2007, ORIGINS GENOME ARCHI; Maeda H, 2007, J BIOL CHEM, V282, P26956, DOI 10.1074/jbc.M703436200; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Moore JMR, 2004, J BIOL CHEM, V279, P27584, DOI 10.1074/jbc.M403453200; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Redd MJ, 1997, J BIOL CHEM, V272, P11193; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Seeliger MA, 2003, NAT STRUCT BIOL, V10, P718, DOI 10.1038/nsb962; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SHRADER TE, 1993, J BACTERIOL, V175, P4364, DOI 10.1128/JB.175.14.4364-4374.1993; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Stary S, 2003, PLANT PHYSIOL, V133, P1360, DOI 10.1104/pp.103.029272; Stevens SW, 2000, METHOD ENZYMOL, V318, P385; Suto K, 2006, EMBO J, V25, P5942, DOI 10.1038/sj.emboj.7601433; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2007, J BIOL CHEM, V282, P18510, DOI 10.1074/jbc.M701894200; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Van Regenmortel M H V, 2003, Dev Biol (Basel), V112, P141; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Watanabe K, 2007, NATURE, V449, P867, DOI 10.1038/nature06167; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yoshida S, 2002, PLANT J, V32, P129, DOI 10.1046/j.1365-313X.2002.01407.x; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	86	77	78	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24011	24028		10.1074/jbc.M802583200	http://dx.doi.org/10.1074/jbc.M802583200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18566452	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000258638900057
J	Kapoor, P; Sahasrabuddhe, AA; Kumar, A; Mitra, K; Siddiqi, MI; Gupta, CM				Kapoor, Prabodh; Sahasrabuddhe, Amogh A.; Kumar, Ashutosh; Mitra, Kalyan; Siddiqi, Mohammad Imran; Gupta, Chhitar M.			An unconventional form of actin in protozoan hemoflagellate, Leishmania	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ACTIN; F-ACTIN; MOLECULAR-DYNAMICS; TRYPANOSOMA-BRUCEI; FLAGELLAR POCKET; MUSCLE ACTIN; LIFE-CYCLE; WILD-TYPE; PROTEIN; POLYMERIZATION	Leishmania actin was cloned, overexpressed in baculovirusinsect cell system, and purified to homogeneity. The purified protein polymerized optimally in the presence of Mg2+ and ATP, but differed from conventional actins in its following properties: (i) it did not polymerize in the presence of Mg2+ alone, (ii) it polymerized in a restricted range of pH 7.0 -8.5, (iii) its critical concentration for polymerization was found to be 3 -4-fold lower than of muscle actin, (iv) it predominantly formed bundles rather than single filaments at pH 8.0, (v) it displayed considerably higher ATPase activity during polymerization, (vi) it did not inhibit DNase-I activity, and (vii) it did not bind the F-actin-binding toxin phalloidin or the actin polymerization disrupting agent Latrunculin B. Computational and molecular modeling studies revealed that the observed unconventional behavior of Leishmania actin is related to the diverged amino acid stretches in its sequence, which may lead to changes in the overall charge distribution on its solvent-exposed surface, ATP binding cleft, Mg2+ binding sites, and the hydrophobic loop that is involved in monomer-monomer interactions. Phylogenetically, it is related to ciliate actins, but to the best of our knowledge, no other actin with such unconventional properties has been reported to date. It is therefore suggested that actin in Leishmania may serve as a novel target for design of new antileishmanial drugs.	[Kapoor, Prabodh; Sahasrabuddhe, Amogh A.; Kumar, Ashutosh; Siddiqi, Mohammad Imran; Gupta, Chhitar M.] Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India; [Mitra, Kalyan] Cent Drug Res Inst, Electron Microscopy Unit, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Gupta, CM (corresponding author), Cent Drug Res Inst, Div Mol & Struct Biol, Chattar Manzil Palace,MG Rd, Lucknow 226001, Uttar Pradesh, India.	drcmg@sify.com		Gupta, Dr.Chhitar M/0000-0002-7290-627X				Ahmed SA, 2007, ORG LETT, V9, P4773, DOI 10.1021/ol7020675; [Anonymous], 2005, PHYLIP PHYLOGENY INF; BALBER AE, 1990, CRIT REV IMMUNOL, V10, P177; Barry D, 2007, TRYPANOSOMES GENOME, P239; BLIKSTAD I, 1978, CELL, V15, P935, DOI 10.1016/0092-8674(78)90277-5; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buzan J, 1999, P NATL ACAD SCI USA, V96, P2823, DOI 10.1073/pnas.96.6.2823; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; CARLIER MF, 1986, J BIOL CHEM, V261, P778; CARLIER MF, 1988, FEBS LETT, V235, P211, DOI 10.1016/0014-5793(88)81264-X; CHANG KP, 1983, INT REV CYTOL, P267; Chen MM, 2007, CURR OPIN CELL BIOL, V19, P326, DOI 10.1016/j.ceb.2007.04.009; COOPER JA, 1983, BIOCHEMISTRY-US, V22, P2193, DOI 10.1021/bi00278a021; DRUBIN DG, 1993, MOL BIOL CELL, V4, P1277, DOI 10.1091/mbc.4.12.1277; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; FEI W, 1989, BIOPHYS J, V55, P293, DOI 10.1016/S0006-3495(89)82804-8; Frieden C, 2000, BIOCHEM BIOPH RES CO, V271, P464, DOI 10.1006/bbrc.2000.2650; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gheorghe DM, 2008, J BIOL CHEM, V283, P15037, DOI 10.1074/jbc.M710332200; GLASER TA, 1988, P NATL ACAD SCI USA, V85, P7602, DOI 10.1073/pnas.85.20.7602; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; HIRONO M, 1989, P NATL ACAD SCI USA, V86, P75, DOI 10.1073/pnas.86.1.75; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikkai Takamitsu, 2000, IUBMB Life, V49, P77, DOI 10.1080/713803584; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KILLICKKENDRICK R, 1990, ANN PARASIT HUM COMP, V65, P37, DOI 10.1051/parasite/1990651037; Kudryashov DS, 2005, P NATL ACAD SCI USA, V102, P13105, DOI 10.1073/pnas.0506429102; MARTONOSI A, 1964, J BIOL CHEM, V239, P1057; MEZA I, 1983, J BIOL CHEM, V258, P3936; MITCHELL EJ, 1985, J CELL SCI, V73, P279; MORTARA RA, 1989, J PROTOZOOL, V36, P8; Nayak RC, 2005, MOL BIOCHEM PARASIT, V143, P152, DOI 10.1016/j.molbiopara.2005.06.001; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; Ozaki LS, 1984, GENES ANTIGENS PARAS, P165; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Raza S, 2007, MOL BIOCHEM PARASIT, V153, P216, DOI 10.1016/j.molbiopara.2007.02.007; Reisler E, 2007, J BIOL CHEM, V282, P36133, DOI 10.1074/jbc.R700030200; Reisler E, 1993, CURR OPIN CELL BIOL, V5, P41, DOI 10.1016/S0955-0674(05)80006-7; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sahasrabuddhe AA, 2004, MOL BIOCHEM PARASIT, V134, P105, DOI 10.1016/j.molbiopara.2003.11.008; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; Sehring IM, 2007, J CELL SCI, V120, P177, DOI 10.1242/jcs.03313; SHETERLINE P, 1994, PROTEIN PROFILE, V1, P1; Shi HF, 2000, RNA, V6, P1069, DOI 10.1017/S1355838200000297; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trooskens G, 2005, BIOINFORMATICS, V21, P3801, DOI 10.1093/bioinformatics/bti590; UYEMURA DG, 1978, J BIOL CHEM, V253, P9088; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; WEBSTER P, 1993, PARASITOL TODAY, V9, P201, DOI 10.1016/0169-4758(93)90008-4; WEGNER A, 1975, BIOPHYS CHEM, V3, P215, DOI 10.1016/0301-4622(75)80013-5; Wen KK, 2002, J BIOL CHEM, V277, P41101, DOI 10.1074/jbc.M204025200; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Zeng ZZ, 1997, BIOCHEM BIOPH RES CO, V231, P499, DOI 10.1006/bbrc.1996.5923; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215; [No title captured]	69	24	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22760	22773		10.1074/jbc.M800213200	http://dx.doi.org/10.1074/jbc.M800213200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18539603	hybrid			2022-12-25	WOS:000258321000044
J	Kim, Y; Lee, YS; Choe, J; Lee, H; Kim, YM; Jeoung, D				Kim, Youngmi; Lee, Yun-Sil; Choe, Jongseon; Lee, Hansoo; Kim, Young-Myeong; Jeoung, Dooil			CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NADPH OXIDASE ACTIVATION; BREAST-CANCER CELLS; HYALURONAN-CD44 INTERACTION; MATRIX METALLOPROTEINASE-2; MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; CYTOSKELETON FUNCTION; EGF RECEPTOR	Hyaluronic acid ( HA) is known to play an important role in motility of tumor cells. However, the molecular mechanisms associated with HA-promoted melanoma cell motility are not fully understood. Treatment of cells with HA was shown to increase the production of reactive oxygen species (ROS) in a CD44-dependent manner. Antioxidants, such asN-acetyl-L-cysteine and seleno-L-methionine, prevented HA from enhancing cell motility. Protein kinase C (PKC)-alpha and PKC delta were responsible for increased Rac1 activity, production of ROS, and mediated HA-promoted cell motility. HA increased Rac1 activity via CD44, PKC alpha, and PKC delta. Transfection with dominant negative and constitutive active Rac1 mutants demonstrated that Rac1 was responsible for the increased production of ROS and cell motility by HA. Inhibition of NADPH oxidase by diphenylene iodonium and down-regulation of p47(Phox) and p67(Phox) decreased the ROS level, suggesting that NADPH oxidase is the main source of ROS production. Rac1 increased phosphorylation of FAK. FAK functions downstream of and is necessary for HA-promoted cell motility. Secretion and expression of MMP-2 were increased by treatment with HA via the action of PKC alpha, PKC delta, and Rac1 and the production of ROS and FAK. Ilomastat, an inhibitor of MMP-2, exerted a negative effect on HA-promoted cell motility. HA increased interaction between CD44 and epidermal growth factor receptor ( EGFR). AG1478, an inhibitor of EGFR, decreased phosphorylation of PKC alpha, PKC delta, and Rac1 activity and suppressed induction of p47Phox and p67Phox. These results suggest that CD44-EGFR interaction is necessary for HA-promoted cell motility by regulating PKC signaling. EGFR-Akt interaction promoted by HA was responsible for the increased production of ROS and HA-promoted cell motility. In summary, HA promotes CD44-EGFR interaction, which in turn activates PKC signaling, involving Akt, Rac1, Phox, and the production of ROS, FAK, and MMP-2, to enhance melanoma cell motility.	[Kim, Youngmi; Lee, Hansoo; Jeoung, Dooil] Kangwon Natl Univ, Sch Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea; [Lee, Yun-Sil] Korea Inst Radiol & Med Sci, Lab Radiat Effect, Div Radiat Biol, Seoul 139706, South Korea; [Choe, Jongseon; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Chunchon 200701, South Korea	Kangwon National University; Korea Institute of Radiological & Medical Sciences; Kangwon National University	Jeoung, D (corresponding author), Kangwon Natl Univ, Sch Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850				Aye MM, 2004, INT J CANCER, V112, P738, DOI 10.1002/ijc.20497; BARTOLAZZI A, 1994, J EXP MED, V180, P53, DOI 10.1084/jem.180.1.53; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P29654, DOI 10.1074/jbc.M403608200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; Cary LA, 1996, J CELL SCI, V109, P1787; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chang EJ, 2007, J CELL SCI, V120, P166, DOI 10.1242/jcs.03310; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Chaturvedi LS, 2007, J BIOL CHEM, V282, P14, DOI 10.1074/jbc.M605817200; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; Cook AC, 2006, J BIOL CHEM, V281, P24381, DOI 10.1074/jbc.M602694200; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; DOCHERTY NG, 2006, AM J PHYSIOL, V290, pR1202; Ellis IR, 2007, EXP CELL RES, V313, P732, DOI 10.1016/j.yexcr.2006.11.016; Fan CY, 2005, BIOCHEM J, V390, P761, DOI 10.1042/BJ20050287; Felty Q, 2005, BIOCHEMISTRY-US, V44, P6900, DOI 10.1021/bi047629p; Fitzgerald KA, 2000, J IMMUNOL, V164, P2053, DOI 10.4049/jimmunol.164.4.2053; Frey RS, 2006, J BIOL CHEM, V281, P16128, DOI 10.1074/jbc.M508810200; Galli A, 2005, HEPATOLOGY, V41, P1074, DOI 10.1002/hep.20683; Gomes JAP, 2004, BRIT J OPHTHALMOL, V88, P821, DOI 10.1136/bjo.2003.027573; GUO Y, 1994, CANCER RES, V154, P1561; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; HU T, 2005, AM J PHYSIOL, V289, pR816; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Kim HR, 2004, CANCER RES, V64, P4569, DOI 10.1158/0008-5472.CAN-04-0202; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Kim KH, 2007, FEBS LETT, V581, P3303, DOI 10.1016/j.febslet.2007.06.012; Kim MS, 2005, INT J ONCOL, V27, P839; Mahrouf M, 2006, BIOCHEM PHARMACOL, V72, P176, DOI 10.1016/j.bcp.2006.04.027; Migita K, 2005, FEBS LETT, V579, P3119, DOI 10.1016/j.febslet.2005.04.071; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Moldovan L, 2006, CARDIOVASC RES, V71, P236, DOI 10.1016/j.cardiores.2006.05.003; Mountain DJH, 2007, AM J PHYSIOL-CELL PH, V292, pC867, DOI 10.1152/ajpcell.00161.2006; Mummert ME, 2003, MOL CANCER THER, V2, P295; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Murai T, 2006, BIOCHEM J, V395, P65, DOI 10.1042/BJ20050582; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Pan J, 2005, J CELL PHYSIOL, V202, P536, DOI 10.1002/jcp.20151; Park MJ, 2002, CANCER RES, V62, P6318; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schroder K, 2007, ARTERIOSCL THROM VAS, V27, P1736, DOI 10.1161/ATVBAHA.107.142117; Singh R, 2007, MOL THER, V15, P369, DOI 10.1038/sj.mt.6300050; Sohara Y, 2001, MOL BIOL CELL, V12, P1859, DOI 10.1091/mbc.12.6.1859; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; SPHENOY NG, 2003, J IMMUNOL, V171, P3734; Takahashi T, 2004, J ORAL PATHOL MED, V33, P224, DOI 10.1111/j.0904-2512.2004.00024.x; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622; Ugolev Y, 2006, J BIOL CHEM, V281, P19204, DOI 10.1074/jbc.M600042200; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Zhang QG, 2006, J NEUROCHEM, V98, P1886, DOI 10.1111/j.1471-4159.2006.04020.x; Zhang X, 1999, P NATL ACAD SCI USA, V96, P9021, DOI 10.1073/pnas.96.16.9021	71	105	106	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22513	22528		10.1074/jbc.M708319200	http://dx.doi.org/10.1074/jbc.M708319200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18577517	hybrid			2022-12-25	WOS:000258321000020
J	Higgins, MK				Higgins, Matthew K.			The structure of a chondroitin sulfate-binding domain important in placental malaria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; FALCIPARUM-VAR GENES; PLASMODIUM-FALCIPARUM; RECEPTOR-BINDING; VAR2CSA; IDENTIFICATION; ANTIBODIES; ADHESION	Adhesive PfEMP1 proteins are displayed on the surface of malaria-infected red blood cells. They play a critical role in the disease, tethering infected cells away from destruction by the spleen and causing many severe symptoms. A molecular understanding of how these domains maintain their binding properties while evading immune detection will be important in developing therapeutics. In malaria of pregnancy, domains from the var2csa-encoded PfEMP1 protein interact with chondroitin sulfate on the placenta surface. This causes accumulation of infected red blood cells, leading to placental inflammation and block of blood flow to the developing fetus. This is associated with maternal anemia, low birth weight, and premature delivery and can lead to the death of mother and child. Here I present the structure of the chondroitin sulfate-binding DBL3X domain from a var2csa-encoded PfEMP1 protein. The domain adopts a fold similar to malarial invasion proteins, with extensive loop insertions. One loop is flexible in the unliganded structure but observed in the presence of sulfate or disaccharide, where it completes a sulfate-binding site. This loop, and others surrounding this putative carbohydrate-binding site, are flexible and polymorphic, perhaps protecting the binding site from immune detection. This suggests a model for how the domain maintains ligand binding while evading the immune response and will guide future drug and vaccine development.	Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Higgins, MK (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.			Higgins, Matthew/0000-0002-2870-1955	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Badaut C, 2007, MOL BIOCHEM PARASIT, V151, P89, DOI 10.1016/j.molbiopara.2006.10.010; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Duffy PE, 2007, PARASITOLOGY, V134, P1877, DOI 10.1017/S0031182007000170; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Higgins MK, 2008, ACTA CRYSTALLOGR F, V64, P221, DOI 10.1107/S1744309108004211; Hviid L, 2007, PARASITOLOGY, V134, P1871, DOI 10.1017/S0031182007000121; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rowe JA, 2004, MOL MICROBIOL, V53, P1011, DOI 10.1111/j.1365-2958.2004.04256.x; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith JD, 1998, MOL BIOCHEM PARASIT, V97, P133, DOI 10.1016/S0166-6851(98)00145-5; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	38	78	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21842	21846		10.1074/jbc.C800086200	http://dx.doi.org/10.1074/jbc.C800086200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550531	hybrid, Green Published			2022-12-25	WOS:000258114700002
J	Viparelli, F; Cassese, A; Doti, N; Paturzo, F; Marasco, D; Dathan, NA; Monti, SM; Basile, G; Ungaro, P; Sabatella, M; Miele, C; Teperino, R; Consiglio, E; Pedone, C; Beguinot, F; Formisano, P; Ruvo, M				Viparelli, Francesca; Cassese, Angela; Doti, Nunzianna; Paturzo, Flora; Marasco, Daniela; Dathan, Nina A.; Monti, Simona M.; Basile, Giancarlo; Ungaro, Paola; Sabatella, Marco; Miele, Claudia; Teperino, Raffaele; Consiglio, Eduardo; Pedone, Carlo; Beguinot, Francesco; Formisano, Pietro; Ruvo, Menotti			Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GLUCOSE-METABOLISM; PEA-15; EXPRESSION; PHOSPHORYLATION; ASTROCYTES; APOPTOSIS; DEATH; GENE; SECRETION	Phosphoprotein enriched in diabetes/phosphoprotein enriched in astrocytes (PED/PEA-15) is overexpressed in several tissues of individuals affected by type 2 diabetes. In intact cells and in transgenic animal models, PED/PEA-15 overexpression impairs insulin regulation of glucose transport, and this is mediated by its interaction with the C-terminal D4 domain of phospholipase D1 (PLD1) and the consequent increase of protein kinase C-alpha activity. Here we show that interfering with the interaction of PED/PEA-15 with PLD1 in L6 skeletal muscle cells overexpressing PED/PEA-15 (L6(PED/PEA-15)) restores insulin sensitivity. Surface plasmon resonance and ELISA-like assays show that PED/PEA-15 binds in vitro the D4 domain with high affinity (K-D = 0.37 +/- 0.13 mu M), and a PED/PEA-15 peptide, spanning residues 1-24, PED-(1-24), is able to compete with the PED/PEA-15-D4 recognition. When loaded into L6(PED/PEA-15) cells and in myocytes derived from PED/PEA-15-overexpressing transgenic mice, PED-(1-24) abrogates the PED/PEA-15-PLD1 interaction and reduces protein kinase C-alpha activity to levels similar to controls. Importantly, the peptide restores insulin-stimulated glucose uptake by similar to 70%. Similar results are obtained by expression of D4 in L6(PED/PEA-15). All these findings suggest that disruption of the PED/PEA-15-PLD1 molecular interaction enhances insulin sensitivity in skeletal muscle cells and indicate that PED/PEA-15 as an important target for type 2 diabetes.	[Cassese, Angela; Paturzo, Flora; Ungaro, Paola; Miele, Claudia; Teperino, Raffaele; Consiglio, Eduardo; Beguinot, Francesco; Formisano, Pietro] CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, I-80134 Naples, Italy; [Viparelli, Francesca; Doti, Nunzianna; Marasco, Daniela; Dathan, Nina A.; Monti, Simona M.; Sabatella, Marco; Pedone, Carlo; Ruvo, Menotti] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy; [Viparelli, Francesca; Pedone, Carlo] Univ Naples Federico 2, Dipartimento Sci Biol, I-80131 Naples, Italy; [Cassese, Angela; Paturzo, Flora; Ungaro, Paola; Miele, Claudia; Teperino, Raffaele; Consiglio, Eduardo; Beguinot, Francesco; Formisano, Pietro] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Doti, Nunzianna] Univ Naples 2, Dipartimento Biochim & Biofis, I-80134 Naples, Italy; [Basile, Giancarlo] Tecnogen SpA, Localita La Fagianeria, I-81015 Piana Di Monte Verna, Caserta, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli	Formisano, P (corresponding author), CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, I-80134 Naples, Italy.	fpietro@unina.it; menotti.ruvo@unina.it	Doti, Nunzianna/ABC-9948-2020; Marasco, Daniela/H-4848-2015; Formisano, Pietro/J-4237-2018; Monti, Simona M/J-5214-2012; MONTI, SIMONA MARIA/GQQ-0129-2022	Marasco, Daniela/0000-0002-6618-2949; MONTI, SIMONA MARIA/0000-0001-9647-7089; Formisano, Pietro/0000-0001-7020-6870; Teperino, Raffaele/0000-0001-8815-1409	Telethon [GGP04041] Funding Source: Medline; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Telethon(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		ARAUJO H, 1993, J BIOL CHEM, V268, P5911; BESTERMAN JM, 1986, P NATL ACAD SCI USA, V83, P6785, DOI 10.1073/pnas.83.18.6785; BONADONNA RC, 1991, DIABETES METAB, V17, P112; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Condorelli G, 2001, DIABETES, V50, P1244, DOI 10.2337/diabetes.50.6.1244; Condorelli G, 1998, EMBO J, V17, P3858, DOI 10.1093/emboj/17.14.3858; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Condorelli G, 2002, J BIOL CHEM, V277, P11013, DOI 10.1074/jbc.M110934200; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; Estelles A, 1999, DEV BIOL, V216, P16, DOI 10.1006/dbio.1999.9510; Fiory F, 2005, MOL CELL BIOL, V25, P10803, DOI 10.1128/MCB.25.24.10803-10814.2005; Fiory F, 2004, J BIOL CHEM, V279, P11137, DOI 10.1074/jbc.M308751200; Formisano P, 2005, ONCOGENE, V24, P7012, DOI 10.1038/sj.onc.1208871; Hill JM, 2002, EMBO J, V21, P6494, DOI 10.1093/emboj/cdf641; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Krueger J, 2005, MOL BIOL CELL, V16, P3552, DOI 10.1091/mbc.E04-11-1007; Kubes M, 1998, J NEUROCHEM, V71, P1307; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Mercado Maria M, 2002, Curr Diab Rep, V2, P83, DOI 10.1007/s11892-002-0063-9; Miele C, 2007, DIABETES, V56, P622, DOI 10.2337/db06-1260; Owen KR, 2007, CURR OPIN GENET DEV, V17, P239, DOI 10.1016/j.gde.2007.04.003; Slaaby R, 2000, BIOCHEM J, V351, P613, DOI 10.1042/0264-6021:3510613; Trencia A, 2004, J BIOL CHEM, V279, P46566, DOI 10.1074/jbc.M406317200; Trencia A, 2003, MOL CELL BIOL, V23, P4511, DOI 10.1128/MCB.23.13.4511-4521.2003; Valentino R, 2006, DIABETOLOGIA, V49, P3058, DOI 10.1007/s00125-006-0455-5; Vigliotta G, 2004, MOL CELL BIOL, V24, P5005, DOI 10.1128/MCB.24.11.5005-5015.2004; Viparelli F, 2008, PROTEIN EXPRES PURIF, V59, P302, DOI 10.1016/j.pep.2008.02.012; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200; Zhang Y, 2000, J BIOL CHEM, V275, P35224, DOI 10.1074/jbc.M003329200	29	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21769	21778		10.1074/jbc.M803771200	http://dx.doi.org/10.1074/jbc.M803771200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18541525	hybrid			2022-12-25	WOS:000257898800050
J	Lindholm, E; Bakhtadze, E; Cilio, C; Agardh, E; Groop, L; Agardh, CD				Lindholm, Eero; Bakhtadze, Ekaterina; Cilio, Corrado; Agardh, Elisabet; Groop, Leif; Agardh, Carl-David			Association between LTA, TNF and AGER Polymorphisms and Late Diabetic Complications	PLOS ONE			English	Article								Background: Several candidate genes on the short arm of chromosome 6 including the HLA locus, TNF, LTA and AGER could be associated with late diabetic complications. The aim of our study was therefore to explore whether polymorphisms (TNF 308 G -> A, LTA T60N C -> A and AGER -374 T -> A) in these genes alone or together (as haplotypes) increased the risk for diabetic complications. Methodology/Principal Findings: The studied polymorphisms were genotyped in 742 type 1 and 2957 type 2 diabetic patients as well as in 206 non-diabetic control subjects. The Haploview program was used to analyze putative linkage disequilibrium between studied polymorphisms. The TNF, LTA and AGER polymorphisms were associated with the HLA-DQB1 risk genotypes. The AGER -374 A allele was more common in type 1 diabetic patients with than without diabetic nephropathy (31.2 vs. 28.4%, p=0.007). In a logistic regression analysis, the LTA but not the AGER polymorphism was associated with diabetic nephropathy (OR 2.55[1.11-5.86], p=0.03). The AGER -374 A allele was associated with increased risk of sight threatening retinopathy in type 2 diabetic patients (1.65[1.11-2.45], p=0.01) and also with increased risk for macrovascular disease in type 1 diabetic patients (OR 2.05[1.19-3.54], p=0.01), but with decreased risk for macrovascular disease in type 2 diabetic patients (OR 0.66[0.49-0.90], p=0.009). The TNF A allele was associated with increased risk for macrovascular complications in type 2 (OR 1.53 [1.04-2.25], p=0.03, but not in type 1 diabetic patients. Conclusions/Significance: The association between diabetic complications and LTA, TNF and AGER polymorphisms is complex, with partly different alleles conferring susceptibility in type 1 and type 2 diabetic patients. We can not exclude the possibility that the genes are part of a large haplotype block that also includes HLA-DQB1 risk genotypes.	[Lindholm, Eero; Bakhtadze, Ekaterina; Cilio, Corrado; Agardh, Elisabet; Groop, Leif; Agardh, Carl-David] Lund Univ, Univ Hosp MAS, Dept Clin Sci, Lund, Sweden	Lund University; Skane University Hospital	Lindholm, E (corresponding author), Lund Univ, Univ Hosp MAS, Dept Clin Sci, Lund, Sweden.	Eero.Lindholm@med.lu.se		Lindholm, Eero/0000-0002-8869-681X	Skane County Council Research and Development Foundation; Medical Research Council of Lundberg	Skane County Council Research and Development Foundation; Medical Research Council of Lundberg	This study was supported by Skane County Council Research and Development Foundation and the Medical Research Council of Lundberg.	Agardh D, 1996, DIABETOLOGIA, V39, P1313, DOI 10.1007/s001250050575; ASSELBERGS FW, 2006, CLIN SCI LOND; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernard V, 2003, CLIN CHEM LAB MED, V41, P511, DOI 10.1515/CCLM.2003.077; DAHLEN GH, 1993, EUR J IMMUNOGENET, V20, P95, DOI 10.1111/j.1744-313X.1993.tb00098.x; Dalla Vestra M, 2005, J AM SOC NEPHROL, V16, pS78, DOI 10.1681/ASN.2004110961; dos Santos KG, 2005, MOL GENET METAB, V85, P149, DOI 10.1016/j.ymgme.2005.02.010; Dyck R, 2003, AM J NEPHROL, V23, P178, DOI 10.1159/000070747; Falcone C, 2005, CLIN CHIM ACTA, V354, P111, DOI 10.1016/j.cccn.2004.11.021; GUSTAVSSON C, 2007, J DIABETES IN PRESS; Hudson BI, 2001, DIABETES, V50, P1505, DOI 10.2337/diabetes.50.6.1505; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2002, AM J PATHOL, V160, P1683, DOI 10.1016/S0002-9440(10)61115-7; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P974, DOI 10.1111/j.1471-8286.2006.01456.x; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Kumaramanickavel A, 2001, DIABETES RES CLIN PR, V54, P89, DOI 10.1016/S0168-8227(01)00269-8; Laki J, 2007, MOL IMMUNOL, V44, P648, DOI 10.1016/j.molimm.2006.01.011; Li HY, 2003, J CLIN ENDOCR METAB, V88, P2767, DOI 10.1210/jc.2002-020506; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lindholm E, 2006, DIABETOLOGIA, V49, P2745, DOI 10.1007/s00125-006-0412-3; Makhatadze NJ, 1998, HUM IMMUNOL, V59, P571, DOI 10.1016/S0198-8859(98)00056-1; Manchanda PK, 2006, CLIN CHIM ACTA, V370, P152, DOI 10.1016/j.cca.2006.02.002; Navarro JF, 2005, NEPHROL DIAL TRANSPL, V20, P2601, DOI 10.1093/ndt/gfi155; Noble JA, 1996, AM J HUM GENET, V59, P1134; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Padovani JC, 2000, THROMB RES, V100, P263, DOI 10.1016/S0049-3848(00)00315-7; Pettersson-Fernholm K, 2003, DIABETES, V52, P891, DOI 10.2337/diabetes.52.3.891; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Single RM, 2002, GENET EPIDEMIOL, V22, P186, DOI 10.1002/gepi.0163; Um JY, 2003, J MOL NEUROSCI, V21, P167, DOI 10.1385/JMN:21:2:167; Vlassara H, 2003, MT SINAI J MED, V70, P232; Wang YY, 2005, NEPHROL DIAL TRANSPL, V20, P2733, DOI 10.1093/ndt/gfi101; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495; Zeggini E, 2005, DIABETOLOGIA, V48, P2013, DOI 10.1007/s00125-005-1902-4	34	68	68	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2546	10.1371/journal.pone.0002546	http://dx.doi.org/10.1371/journal.pone.0002546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575614	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288000049
J	Miozzi, L; Piro, RM; Rosa, F; Ala, U; Silengo, L; Di Cunto, F; Provero, P				Miozzi, Laura; Piro, Rosario Michael; Rosa, Fabio; Ala, Ugo; Silengo, Lorenzo; Di Cunto, Ferdinando; Provero, Paolo			Functional Annotation and Identification of Candidate Disease Genes by Computational Analysis of Normal Tissue Gene Expression Data	PLOS ONE			English	Article							MUTATIONS; MICROARRAY; FAMILIES; GENOME	Background: High-throughput gene expression data can predict gene function through the "guilt by association'' principle: coexpressed genes are likely to be functionally associated. Methodology/Principal Findings: We analyzed publicly available expression data on normal human tissues. The analysis is based on the integration of data obtained with two experimental platforms (microarrays and SAGE) and of various measures of dissimilarity between expression profiles. The building blocks of the procedure are the Ranked Coexpression Groups (RCG), small sets of tightly coexpressed genes which are analyzed in terms of functional annotation. Functionally characterized RCGs are selected by means of the majority rule and used to predict new functional annotations. Functionally characterized RCGs are enriched in groups of genes associated to similar phenotypes. We exploit this fact to find new candidate disease genes for many OMIM phenotypes of unknown molecular origin. Conclusions/Significance: We predict new functional annotations for many human genes, showing that the integration of different data sets and coexpression measures significantly improves the scope of the results. Combining gene expression data, functional annotation and known phenotype-gene associations we provide candidate genes for several genetic diseases of unknown molecular basis.	[Miozzi, Laura] CNR, Inst Plant Virol, I-10126 Turin, Italy; [Piro, Rosario Michael; Ala, Ugo; Silengo, Lorenzo; Di Cunto, Ferdinando; Provero, Paolo] Univ Turin, Mol Biotechnol Ctr, Dept Genet, Biol & Biochem, Turin, Italy; [Rosa, Fabio] ISI Fdn, Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Turin	Miozzi, L (corresponding author), CNR, Inst Plant Virol, I-10126 Turin, Italy.	paolo.provero@unito.it	Piro, Rosario M./AAT-6937-2020; Miozzi, Laura/AAY-2139-2020; Di Cunto, Ferdinando/K-5575-2016; Miozzi, Laura/AAW-9296-2021; Rosa, Fabio/AGI-6840-2022; Ala, Ugo/K-2029-2016; Provero, Paolo/AAC-1930-2019	Piro, Rosario M./0000-0002-3066-7397; Miozzi, Laura/0000-0003-0410-8230; Miozzi, Laura/0000-0003-0410-8230; Rosa, Fabio/0000-0002-8335-4482; Ala, Ugo/0000-0001-5408-6397; di cunto, ferdinando/0000-0001-9367-6357	Regione Piemonte CIPE Program; Italian Ministry of University and Research; CRT Foundation, Turin [Lagrange Fellowship]	Regione Piemonte CIPE Program(Regione Piemonte); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); CRT Foundation, Turin	This work was funded by the Regione Piemonte CIPE Program to LS and by the Italian Ministry of University and Research through the FIRB program to FDC and PP. LM and PP were partially supported by a Lagrange Fellowship of the CRT Foundation, Turin. The funders did not play any active role in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	[Anonymous], ONLINE MENDELIAN INH; [Anonymous], GENE ONTOLOGY; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Garvey SM, 2006, ANN HUM GENET, V70, P414, DOI 10.1111/j.1469-1809.2005.00252.x; Griffith OL, 2005, GENOMICS, V86, P476, DOI 10.1016/j.ygeno.2005.06.009; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Krakowiak PA, 2003, HUM MOL GENET, V12, P1631, DOI 10.1093/hmg/ddg172; Lefevre C, 2006, HUM MOL GENET, V15, P767, DOI 10.1093/hmg/ddi491; Michaelides M, 2005, BRIT J OPHTHALMOL, V89, P198, DOI 10.1136/bjo.2004.050773; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; STEINLEIN O, 1992, GENOMICS, V12, P69, DOI 10.1016/0888-7543(92)90408-K; Sulko J, 2005, AM J MED GENET A, V137A, P292, DOI 10.1002/ajmg.a.30881; Udar N, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9109; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; van Helden J, 2004, BIOINFORMATICS, V20, P399, DOI 10.1093/bioinformatics/btg425; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Wutz K, 2002, EUR J HUM GENET, V10, P449, DOI 10.1038/sj.ejhg.5200828; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; COMP GENE EXPRESSION; CANC GENOME ANATOMY; SAGE LIB FINDER	28	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2439	10.1371/journal.pone.0002439	http://dx.doi.org/10.1371/journal.pone.0002439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560577	gold, Green Published			2022-12-25	WOS:000263280700024
J	Pattyn, E; Verhee, A; Uyttendaele, I; Piessevaux, J; Timmerman, E; Gevaert, K; Vandekerckhove, J; Peelman, F; Tavernier, J				Pattyn, Els; Verhee, Annick; Uyttendaele, Isabel; Piessevaux, Julie; Timmerman, Evy; Gevaert, Kris; Vandekerckhove, Joel; Peelman, Frank; Tavernier, Jan			HyperISGylation of Old World Monkey ISG15 in Human Cells	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; ANTIVIRAL MOLECULE; STIMULATED GENE-15; ACTIVATING ENZYME; E2 ENZYME; INTERFERON; CONJUGATION; IDENTIFICATION; VIRUS; ISGYLATION	Background: ISG15 is an Ubiquitin-like protein, highly induced by Type I Interferons. Upon the cooperative activity of specific Ubiquitinating enzymes, ISG15 can be conjugated to its substrates. Increasing evidence points to a role for protein ISGylation in anti-viral and anti-tumoral defense. Principal Findings: We identified ISG15 from Old World Monkeys (OWm) as a hyper-efficient protein modifier. Western blot analysis visualized more efficient conjugation of OWmISG15 relative to HuISG15 in human (Hu), monkey and mouse (Mo) cell-lines. Moreover, the substrates of OWmISG15 identified upon Tandem Affinity Purification followed by LC-MS/MS identification largely outnumbered these of HuISG15 itself. Several Ubiquitin-Conjugating enzymes were identified as novel ISGylated substrates. Introduction of a N89D mutation in HuISG15 improved its ISGylation capacity, and additional Q31K/T33A/D133N mutations yielded a HuISG15 variant with an ISGylation efficiency comparable to OWmISG15. Homology modeling and structural superposition situate N89 in the interaction interface with the Activating enzyme. Analysis of the UbE1L residues in this interface revealed a striking homology between OWmUbE1L and HuUbE1, the Activating enzyme of Ubiquitin. In line with this observation, we found efficient activation of AgmISG15, but not HuISG15 or MoISG15, by HuUbE1, thus providing a likely explanation for OWm hyperISGylation. Conclusions: This study discloses the poor conjugation competence of HuISG15 compared to OWmISG15 and maps the critical determinants for efficient conjugation. HyperISGylation may greatly assist ISGylation studies and may enhance its function as positive regulator of Interferon-related immune responses or as anti-tumoral modulator.	[Pattyn, Els; Verhee, Annick; Uyttendaele, Isabel; Piessevaux, Julie; Timmerman, Evy; Gevaert, Kris; Vandekerckhove, Joel; Peelman, Frank; Tavernier, Jan] VIB, Dept Med Prot Res, Ghent, Belgium; [Pattyn, Els; Verhee, Annick; Uyttendaele, Isabel; Piessevaux, Julie; Timmerman, Evy; Gevaert, Kris; Vandekerckhove, Joel; Peelman, Frank; Tavernier, Jan] Univ Ghent, Dept Biochem, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Pattyn, E (corresponding author), VIB, Dept Med Prot Res, Ghent, Belgium.	Jan.Tavernier@UGent.be	Gevaert, Kris/D-6489-2017; Tavernier, Jan/AAG-3636-2019; Gevaert, Kris/AAE-4212-2019; Gevaert, Kris/H-3637-2013	Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283	Fund for Scientific Research-Flanders [3G003106, 3G007606]; Ghent University [GOA 12051401]; European Union Interaction Proteome	Fund for Scientific Research-Flanders(FWO); Ghent University(Ghent University); European Union Interaction Proteome(European Commission)	This work was supported by grants from the Fund for Scientific Research-Flanders (N 3G003106 and 3G007606 and a personal grant to IU), grant IUAP-6 N P6:28 and from Ghent University (GOA 12051401). KG and JV acknowledge support by research grants from the Fund for Scientific Research- Flanders and the European Union Interaction Proteome (6th Framework Program).	Barten R, 2001, TRENDS IMMUNOL, V22, P52, DOI 10.1016/S1471-4906(00)01802-0; BAZZIGHER L, 1992, VIROLOGY, V186, P154, DOI 10.1016/0042-6822(92)90069-2; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; Catic A, 2005, TRENDS BIOCHEM SCI, V30, P600, DOI 10.1016/j.tibs.2005.09.002; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Dao CT, 2005, FRONT BIOSCI-LANDMRK, V10, P2701, DOI 10.2741/1730; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; Gevaert K, 2002, MOL CELL PROTEOMICS, V1, P896, DOI 10.1074/mcp.M200061-MCP200; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; GRAHAM RW, 1989, MOL CELL BIOL, V9, P268, DOI 10.1128/MCB.9.1.268; Haas A.L., 2006, PROTEIN DEGRADATION; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; LINDNER HA, 2007, ARCH BIOCH BIOPHYS; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; McDade TW, 1999, AM J HUM BIOL, V11, P705, DOI 10.1002/(SICI)1520-6300(199911/12)11:6<705::AID-AJHB1>3.0.CO;2-G; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Okamoto Y, 2003, CANCER RES, V63, P4167; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; Pitha-Rowe I, 2004, J BIOL CHEM, V279, P18178, DOI 10.1074/jbc.M309259200; Potter JL, 1999, J BIOL CHEM, V274, P25061, DOI 10.1074/jbc.274.35.25061; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; STAES A, 2008, PROTEOMICS; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Takeuchi T, 2006, BIOCHEM BIOPH RES CO, V348, P473, DOI 10.1016/j.bbrc.2006.07.076; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhang Xu, 2007, Fudan Xuebao (Yixueban), V34, P580; Zhang YB, 2007, DEV COMP IMMUNOL, V31, P232, DOI 10.1016/j.dci.2006.05.015; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200; Zou WG, 2005, BIOCHEM BIOPH RES CO, V336, P61, DOI 10.1016/j.bbrc.2005.08.038	62	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2427	10.1371/journal.pone.0002427	http://dx.doi.org/10.1371/journal.pone.0002427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560560	Green Published, gold, Green Submitted			2022-12-25	WOS:000263280700012
J	Fisher, AC; DeLisa, MP				Fisher, Adam C.; DeLisa, Matthew P.			Laboratory Evolution of Fast-Folding Green Fluorescent Protein Using Secretory Pathway Quality Control	PLOS ONE			English	Article								Green fluorescent protein (GFP) has undergone a long history of optimization to become one of the most popular proteins in all of cell biology. It is thermally and chemically robust and produces a pronounced fluorescent phenotype when expressed in cells of all types. Recently, a superfolder GFP was engineered with increased resistance to denaturation and improved folding kinetics. Here we report that unlike other well-folded variants of GFP (e. g., GFPmut2), superfolder GFP was spared from elimination when targeted for secretion via the SecYEG translocase. This prompted us to hypothesize that the folding quality control inherent to this secretory pathway could be used as a platform for engineering similar 'superfolded' proteins. To test this, we targeted a combinatorial library of GFPmut2 variants to the SecYEG translocase and isolated several superfolded variants that accumulated in the cytoplasm due to their enhanced folding properties. Each of these GFP variants exhibited much faster folding kinetics than the parental GFPmut2 protein and one of these, designated superfast GFP, folded at a rate that even exceeded superfolder GFP. Remarkably, these GFP variants exhibited little to no loss in specific fluorescence activity relative to GFPmut2, suggesting that the process of superfolding can be accomplished without altering the proteins' normal function. Overall, we demonstrate that laboratory evolution combined with secretory pathway quality control enables sampling of largely unexplored amino-acid sequences for the discovery of artificial, high-performance proteins with properties that are unparalleled in their naturally occurring analogues.	[Fisher, Adam C.; DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [DeLisa, Matthew P.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA	Cornell University; Cornell University	Fisher, AC (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	md255@cornell.edu	DeLisa, Matthew/AAE-7361-2019	DeLisa, Matthew/0000-0003-3226-1566	National Science Foundation CAREER Award [0449080]; NYSTAR James D. Watson Investigator Award	National Science Foundation CAREER Award(National Science Foundation (NSF)); NYSTAR James D. Watson Investigator Award	This work was supported by a National Science Foundation CAREER Award (BES #0449080) and a NYSTAR James D. Watson Investigator Award (both to MPD).	Andrews BT, 2007, J MOL BIOL, V373, P476, DOI 10.1016/j.jmb.2007.07.071; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Fisher AC, 2004, J BACTERIOL, V186, P7467, DOI 10.1128/JB.186.22.7467-7473.2004; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; GENTZ R, 1988, J BACTERIOL, V170, P2212, DOI 10.1128/jb.170.5.2212-2220.1988; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; Huber D, 2005, P NATL ACAD SCI USA, V102, P18872, DOI 10.1073/pnas.0509583102; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101; Jackson SE, 2006, EXPERT REV PROTEOMIC, V3, P545, DOI 10.1586/14789450.3.5.545; Jonda S, 1999, EMBO J, V18, P3271, DOI 10.1093/emboj/18.12.3271; Kiss C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl681; KUMAMOTO CA, 1988, J BIOL CHEM, V263, P11554; KUMAMOTO CA, 1985, J BACTERIOL, V163, P267, DOI 10.1128/JB.163.1.267-274.1985; Lansbury PT, 2001, NAT BIOTECHNOL, V19, P112, DOI 10.1038/84355; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; LIU GP, 1989, P NATL ACAD SCI USA, V86, P9213, DOI 10.1073/pnas.86.23.9213; Liu JW, 2006, PROTEIN EXPRES PURIF, V47, P258, DOI 10.1016/j.pep.2005.11.019; Lu CH, 2004, BIOTECHNOL PROGR, V20, P1634, DOI 10.1021/bp049751l; Maxwell KL, 1999, PROTEIN SCI, V8, P1908, DOI 10.1110/ps.8.9.1908; MEERMAN HJ, 1994, BIO-TECHNOL, V12, P1107, DOI 10.1038/nbt1194-1107; MEERMAN HJ, 1994, ANN NY ACAD SCI, V721, P292, DOI 10.1111/j.1749-6632.1994.tb47402.x; Nomen N, 2007, J MOL BIOL, V372, P422, DOI 10.1016/j.jmb.2007.07.003; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Schlicht M, 2006, APPL ENVIRON MICROB, V72, P5637, DOI 10.1128/AEM.00739-06; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Vendruscolo M, 2007, NATURE, V449, P555, DOI 10.1038/449555a; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4; WEISS JB, 1990, J BACTERIOL, V172, P3023, DOI 10.1128/jb.172.6.3023-3029.1990; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	46	53	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2351	10.1371/journal.pone.0002351	http://dx.doi.org/10.1371/journal.pone.0002351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545653	gold, Green Published, Green Submitted			2022-12-25	WOS:000263248800011
J	Greene, JM; Burwitz, BJ; Blasky, AJ; Mattila, TL; Hong, JJ; Rakasz, EG; Wiseman, RW; Hasenkrug, KJ; Skinner, PJ; O'Connor, SL; O'Connor, DH				Greene, Justin M.; Burwitz, Benjamin J.; Blasky, Alex J.; Mattila, Teresa L.; Hong, Jung Joo; Rakasz, Eva G.; Wiseman, Roger W.; Hasenkrug, Kim J.; Skinner, Pamela J.; O'Connor, Shelby L.; O'Connor, David H.			Allogeneic Lymphocytes Persist and Traffic in Feral MHC-Matched Mauritian Cynomolgus Macaques	PLOS ONE			English	Article								Background: Thus far, live attenuated SIV has been the most successful method for vaccinating macaques against pathogenic SIV challenge; however, it is not clear what mechanisms are responsible for this protection. Adoptive transfer studies in mice have been integral to understanding live attenuated vaccine protection in models like Friend virus. Previous adoptive transfers in primates have failed as transferred cells are typically cleared within hours after transfer. Methodology/Principal Findings: Here we describe adoptive transfer studies in Mauritian origin cynomolgus macaques (MCM), a non-human primate model with limited MHC diversity. Cells transferred between unrelated MHC-matched macaques persist for at least fourteen days but are rejected within 36 hours in MHC-mismatched macaques. Cells trafficked from the blood to peripheral lymphoid tissues within 12 hours of transfer. Conclusions/Significance: MHC-matched MCM provide the first viable primate model for adoptive transfer studies. Because macaques infected with SIV are the best model for HIV/AIDS pathogenesis, we can now directly study the correlates of protective immune responses to AIDS viruses. For example, plasma viral loads following pathogenic SIV challenge are reduced by several orders of magnitude in macaques previously immunized with attenuated SIV. Adoptive transfer of lymphocyte subpopulations from vaccinated donors into SIV-naive animals may define the immune mechanisms responsible for protection and guide future vaccine development.	[Greene, Justin M.; Burwitz, Benjamin J.; O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Blasky, Alex J.; Rakasz, Eva G.; Wiseman, Roger W.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Mattila, Teresa L.; Hong, Jung Joo; Skinner, Pamela J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN USA; [Hasenkrug, Kim J.] NIH, NIAID, Rocky Mountain Lab, Lab Persistent Viral Dis, Hamilton, MT USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Greene, JM (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.	doconnor@primate.wisc.edu	Rakasz, Eva G/H-9197-2019	o'connor, david/0000-0003-2139-470X; Skinner, Pamela/0000-0003-3388-1687	International AIDS Vaccine Initiative (IAVI) [133-JH10]; NIH [1R21AI068488-01A2, RR021745-01A1]; National Center for Research Resources (NCRR) [P51 RR000167]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR021745, C06RR015459, P51RR000167, C06RR020141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000753, ZIAAI001100, R21AI068488] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative (IAVI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by International AIDS Vaccine Initiative (IAVI) grant 133-JH10; and NIH grants 1R21AI068488-01A2 and RR021745-01A1. This publication was made possible in part by grant number P51 RR000167 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01.	Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Berger C, 2004, BLOOD, V103, P1261, DOI 10.1182/blood-2003-08-2908; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Bernstein WB, 2004, CLIN IMMUNOL, V111, P262, DOI 10.1016/j.clim.2004.03.004; BEX F, 1994, BLOOD, V84, P3317; Chea S, 2005, J VIROL, V79, P3748, DOI 10.1128/JVI.79.6.3748-3757.2005; Cohen J, 2007, SCIENCE, V318, P1048, DOI 10.1126/science.318.5853.1048; de Groot N, 2004, J IMMUNOL, V172, P6152, DOI 10.4049/jimmunol.172.10.6152; DeMaria MA, 2000, EUR J HAEMATOL, V65, P245, DOI 10.1034/j.1600-0609.2000.065004245.x; Dittmer U, 1999, J VIROL, V73, P3753, DOI 10.1128/JVI.73.5.3753-3757.1999; Dittmer U, 1999, NAT MED, V5, P189, DOI 10.1038/5550; Dittmer Ulf, 2001, Current Molecular Medicine (Hilversum), V1, P431, DOI 10.2174/1566524013363591; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Hasenkrug KJ, 2007, FRONT BIOSCI-LANDMRK, V12, P1544, DOI 10.2741/2167; HOFFMANN C, 2007, BR J HAEMATOL; Hofmann-Lehmann R, 2003, AIDS, V17, P157, DOI 10.1097/00002030-200301240-00004; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; Johnson RP, 2002, VACCINE, V20, P1985, DOI 10.1016/S0264-410X(02)00083-X; JOSEPH A, 2008, J VIROL; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; KESTLER HW, 1988, NATURE, V331, P619, DOI 10.1038/331619a0; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Levine BL, 2002, NAT MED, V8, P47, DOI 10.1038/nm0102-47; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; McKinney DM, 1999, J IMMUNOL, V163, P861; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; O'Connor SL, 2007, IMMUNOGENETICS, V59, P449, DOI 10.1007/s00251-007-0209-7; Onlamoon N, 2007, J MED PRIMATOL, V36, P206, DOI 10.1111/j.1600-0684.2007.00238.x; Penedo MCT, 2005, IMMUNOGENETICS, V57, P198, DOI 10.1007/s00251-005-0787-1; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Schmitz JE, 1998, BLOOD, V92, P198, DOI 10.1182/blood.V92.1.198.413k13_198_206; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; SLEZAK SE, 1989, J IMMUNOL METHODS, V117, P205, DOI 10.1016/0022-1759(89)90142-7; Tan R, 1998, AIDS, V12, P2240; Tan RS, 1999, BLOOD, V93, P1506, DOI 10.1182/blood.V93.5.1506.405a38_1506_1510; Villinger F, 2002, BLOOD, V99, P590, DOI 10.1182/blood.V99.2.590; Walker Bruce D, 2007, Top HIV Med, V15, P134; Walker RE, 2000, BLOOD, V96, P467; Watanabe ME, 2003, NAT MED, V9, P376, DOI 10.1038/nm0403-376b; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006	47	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2384	10.1371/journal.pone.0002384	http://dx.doi.org/10.1371/journal.pone.0002384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545705	gold, Green Published			2022-12-25	WOS:000263248800023
J	Einstein, FH; Fishman, S; Bauman, J; Thompson, RF; Huffman, DM; Atzmon, G; Barzilai, N; Muzumdar, RH				Einstein, Francine H.; Fishman, Sigal; Bauman, Jeffery; Thompson, Reid F.; Huffman, Derek M.; Atzmon, Gil; Barzilai, Nir; Muzumdar, Radhika H.			Enhanced activation of a "nutrient-sensing" pathway with age contributes to insulin resistance	FASEB JOURNAL			English	Article						hexosamine biosynthetic pathway; calorie restriction	HEPATIC GLUCOSE-PRODUCTION; CALORIC RESTRICTION; DIABETIC RATS; GENE-EXPRESSION; IN-VIVO; LEPTIN; TISSUE; HYPERGLYCEMIA; ACCUMULATION; SECRETION	Calorie restriction improves life span whereas nutrient excess leads to obesity and unfavorable metabolic consequences, supporting the role for a cellular "nutrient sensor" in aging. Hexosamine biosynthetic pathway (HBP) is a candidate nutrient-sensing pathway. We hypothesized that altered nutrient sensing (by HBP) with age may provide a link among aging, nutrient flux, and insulin resistance. Using a hyperinsulinemic clamp in young rats, we show that experimental activation of HBP, through the systemic infusion of glucosamine, induced severe insulin resistance (36% decline in peripheral insulin action; P < 0.05), increased adipose tissue gene expression of fat-derived peptides (PAI-1 by 4-fold, angiotensinogen 3-fold, leptin 2-fold, resistin 4-fold, and adiponectin 4-fold; P < 0.01 compared with young saline-infused), and enhanced glycosylation of transcription factors, thus mimicking a physiological and biological phenotype of aging. We further demonstrate a greater activation of nutrient-sensing HBP with age in both old ad libitum-fed and calorie-restricted rats. Interestingly, old calorie-restricted animals rapidly develop insulin resistance when exposed to glucosamine, despite their "young" phenotype. These results suggest that altered nutrient sensing by HBP with age may be the link among nutrients, insulin resistance, and age-related diabetes.	[Einstein, Francine H.; Fishman, Sigal; Bauman, Jeffery; Thompson, Reid F.; Huffman, Derek M.; Atzmon, Gil; Barzilai, Nir; Muzumdar, Radhika H.] Albert Einstein Coll Med, Inst Aging Res, Dept Med, Bronx, NY 10461 USA; [Einstein, Francine H.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10461 USA; [Barzilai, Nir] Albert Einstein Coll Med, Inst Aging Res, Dept Mol Biol, Bronx, NY 10461 USA; [Muzumdar, Radhika H.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; [Muzumdar, Radhika H.] Montefiore Med Ctr, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Barzilai, N (corresponding author), Albert Einstein Coll Med, Inst Aging Res, Dept Med, Belfer Bldg,Suite 701,1300 Morris Pk Ave, Bronx, NY 10461 USA.	barzilai@aecom.yu.edu	Muzumdar, Radhika/D-9860-2014	Thompson, Reid/0000-0003-3661-5296	U.S. National Institutes of Health [P01-AG021654, R01-AG18381]; American Association of Obstetricians anti-Gynecologists Foundation/Society of Maternal-Fetal Medicine [K08-AG027462]; Albert Einstein Diabetes Research and Training Center [DK 20541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG021654, K08AG027462, R01AG018381] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association of Obstetricians anti-Gynecologists Foundation/Society of Maternal-Fetal Medicine; Albert Einstein Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the U.S. National Institutes of Health to N.B. (P01-AG021654 and R01-AG18381) and to R.H.M. (K08-AG027462), from the American Association of Obstetricians anti Gynecologists Foundation/Society of Maternal-Fetal Medicine to F.H.E., and by the Core Laboratories of the Albert Einstein Diabetes Research and Training Center (DK 20541).	Anderson RM, 2006, EXP GERONTOL, V41, P1247, DOI 10.1016/j.exger.2006.10.019; ANUMULA KR, 1991, ANAL BIOCHEM, V197, P113, DOI 10.1016/0003-2697(91)90365-Z; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; Barzilai N, 1999, DIABETES, V48, P94, DOI 10.2337/diabetes.48.1.94; Corton JC, 2005, J GERONTOL A-BIOL, V60, P1494, DOI 10.1093/gerona/60.12.1494; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Einstein FH, 2005, DIABETES, V54, P672, DOI 10.2337/diabetes.54.3.672; Fishman S, 2007, FASEB J, V21, P53, DOI 10.1096/fj.06-6557com; Gabriely I, 2002, DIABETES, V51, P1016, DOI 10.2337/diabetes.51.4.1016; Gabriely I, 2002, ATHEROSCLEROSIS, V160, P115, DOI 10.1016/S0021-9150(01)00574-3; Gazdag AC, 2000, AM J PHYSIOL-REG I, V278, pR504, DOI 10.1152/ajpregu.2000.278.2.R504; GIACCARI A, 1989, J CHROMATOGR-BIOMED, V497, P69, DOI 10.1016/0378-4347(89)80006-4; GIACCARI A, 1992, J CLIN INVEST, V89, P36, DOI 10.1172/JCI115583; Goldberg HJ, 2006, ENDOCRINOLOGY, V147, P222, DOI 10.1210/en.2005-0523; Goldberg HJ, 2002, J BIOL CHEM, V277, P33833, DOI 10.1074/jbc.M112331200; Gupta G, 2000, AM J PHYSIOL-ENDOC M, V278, pE985, DOI 10.1152/ajpendo.2000.278.6.E985; Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; IWASAKI K, 1988, J GERONTOL, V43, pB13, DOI 10.1093/geronj/43.1.B13; KAPAHI P, 2004, SCI AGING KNOWLEDGE, pPE34; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Muzumdar R, 2003, FASEB J, V17, P1130, DOI 10.1096/fj.02-0991fje; Muzumdar RH, 2006, DIABETES, V55, P2788, DOI 10.2337/db06-0318; Obici S, 2002, J CLIN INVEST, V109, P1599, DOI 10.1172/JCI0215258; ROSSETTI L, 1993, J CLIN INVEST, V92, P2963, DOI 10.1172/JCI116919; ROSSETTI L, 1990, J CLIN INVEST, V85, P1785, DOI 10.1172/JCI114636; ROSSETTI L, 1995, J CLIN INVEST, V96, P132, DOI 10.1172/JCI118013; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; Rossetti L, 2000, ENDOCRINOLOGY, V141, P1922, DOI 10.1210/en.141.6.1922; Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407	32	43	44	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2008	22	10					3450	3457		10.1096/fj.08-109041	http://dx.doi.org/10.1096/fj.08-109041			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18566293	Green Published			2022-12-25	WOS:000259642600007
J	Mahoney, DJ; Mikecz, K; Ali, T; Mabilleau, G; Benayahu, D; Plaas, A; Milner, CM; Day, AJ; Sabokbar, A				Mahoney, David J.; Mikecz, Katalin; Ali, Tariq; Mabilleau, Guillaume; Benayahu, Dafna; Plaas, Anna; Milner, Caroline M.; Day, Anthony J.; Sabokbar, Afsaneh			TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; FACTOR-STIMULATED GENE-6; MORPHOGENETIC PROTEIN ANTAGONIST; HYALURONAN-BINDING PROTEIN; COLLAGEN-INDUCED ARTHRITIS; LINK MODULE; EXTRACELLULAR-MATRIX; IN-VITRO; OSTEOPROTEGERIN LIGAND; DIFFERENTIATION FACTOR	TSG-6 is an inflammation-induced protein that is produced at pathological sites, including arthritic joints. In animal models of arthritis, TSG-6 protects against joint damage; this has been attributed to its inhibitory effects on neutrophil migration and plasmin activity. Here we investigated whether TSG-6 can directly influence bone erosion. Our data reveal that TSG-6 inhibits RANKL-induced osteoclast differentiation/activation from human and murine precursor cells, where elevated dentine erosion by osteoclasts derived from TSG-6(-/)-mice is consistent with the very severe arthritis seen in these animals. However, the long bones from unchallenged TSG-6(-/)-mice were found to have higher trabecular mass than controls, suggesting that in the absence of inflammation TSG-6 has a role in bone homeostasis; we have detected expression of the TSG-6 protein in the bone marrow of unchallenged wild type mice. Furthermore, we have observed that TSG-6 can inhibit bone morphogenetic protein-2 (BMP-2)-mediated osteoblast differentiation. Interaction analysis revealed that TSG-6 binds directly to RANKL and to BMP-2 (as well as other osteogenic BMPs but not BMP-3) via composite surfaces involving its Link and CUB modules. Consistent with this, the full-length protein is required for maximal inhibition of osteoblast differentiation and osteoclast activation, although the isolated Link module retains significant activity in the latter case. We hypothesize that TSG-6 has dual roles in bone remodeling; one protective, where it inhibits RANKL-induced bone erosion in inflammatory diseases such as arthritis, and the other homeostatic, where its interactions with BMP-2 and RANKL help to balance mineralization by osteoblasts and bone resorption by osteoclasts.	[Ali, Tariq; Milner, Caroline M.; Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Mahoney, David J.; Mabilleau, Guillaume; Plaas, Anna; Sabokbar, Afsaneh] Univ Oxford, Nuffield Dept Orthopaed Surg, Botnar Res Ctr, Oxford OX3 7LD, England; [Mahoney, David J.; Ali, Tariq; Milner, Caroline M.; Day, Anthony J.] Univ Oxford, Dept Biochem, MRC Immunochem Unit, Oxford OX1 3QU, England; [Mikecz, Katalin] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Benayahu, Dafna] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Plaas, Anna] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA	University of Manchester; University of Oxford; University of Oxford; Rush University; Tel Aviv University; Sackler Faculty of Medicine; Rush University	Milner, CM (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	caroline.milner@manchester.ac.uk; anthony.day@mancheste.ac.uk; afsie.sabokbar@ndos.ox.ac.uk	Day, Anthony/O-1658-2015; Milner, Caroline M/P-5526-2015; Mabilleau, Guillaume/M-8261-2018	Day, Anthony/0000-0002-1415-3134; Milner, Caroline M/0000-0001-7355-9655; Mabilleau, Guillaume/0000-0003-1445-329X; Mikecz, Katalin/0000-0003-1506-4296	Arthritis and Research Campaign [16539, 17950]; ISIS Innovation [POC 228]; National Institutes of Health NIAMS [AR051163]; CellProm Project, FP6th of the European Community [NMP4CT-2004-500039]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051163] Funding Source: NIH RePORTER	Arthritis and Research Campaign(Versus Arthritis); ISIS Innovation; National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); CellProm Project, FP6th of the European Community; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Arthritis and Research Campaign Grants 16539 and 17950 (to A. J. D. and C. M. M. and to A. S., A. J. D., and C. M. M., respectively) and ISIS Innovation, Oxford Grant POC 228 (to A. S. and A. J. D.). This work was also supported by National Institutes of Health NIAMS Grant AR051163 (to K. M.). Funding was also received from the CellProm Project, FP6th of the European Community (NMP4CT-2004-500039 (to D. B.)). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Benayahu D, 1996, CALCIFIED TISSUE INT, V59, P254, DOI 10.1007/s002239900119; BENAYAHU D, 1994, J CELL BIOCHEM, V56, P62, DOI 10.1002/jcb.240560111; BENAYAHU D, 1995, BIOCHEM BIOPH RES CO, V210, P197, DOI 10.1006/bbrc.1995.1646; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Bonucci E, 2001, MARC MALPIG SYMP SER, V7, P129; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Davidson ENB, 2006, ANN RHEUM DIS, V65, P1414, DOI 10.1136/ard.2005.045971; Davidson ENB, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2305; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fried A, 1996, J CELL BIOCHEM, V62, P476, DOI 10.1002/(SICI)1097-4644(19960915)62:4<476::AID-JCB5>3.0.CO;2-J; Fujimoto T, 2002, AM J PATHOL, V160, P1495, DOI 10.1016/S0002-9440(10)62575-8; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Inoue I, 2006, J PHARMACOL SCI, V100, P205, DOI 10.1254/jphs.FMJ05004X5; Itonaga I, 2000, ANN RHEUM DIS, V59, P26, DOI 10.1136/ard.59.1.26; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kehlen A, 2003, ARTHRITIS RES THER, V5, pR186, DOI 10.1186/ar762; Kingsley D M, 2001, Novartis Found Symp, V232, P213; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Koike N, 2007, J BIOL CHEM, V282, P15843, DOI 10.1074/jbc.M701570200; Kondo Y, 2001, J BONE MINER METAB, V19, P352, DOI 10.1007/s007740170004; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Kuznetsova SA, 2005, J BIOL CHEM, V280, P30899, DOI 10.1074/jbc.M500701200; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Kuznetsova SA, 2006, J CELL SCI, V119, P4499, DOI 10.1242/jcs.03171; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Levine AJ, 2006, CELL CYCLE, V5, P1069, DOI 10.4161/cc.5.10.2771; Lorensen WE., 1987, ACM SIGGRAPH COMPUTE, P163, DOI [10.1145/37401.37422, DOI 10.1145/37401.37422]; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; Mahoney DJ, 2001, J BIOL CHEM, V276, P22764, DOI 10.1074/jbc.M100666200; Maier R, 1996, ARTHRITIS RHEUM, V39, P552, DOI 10.1002/art.1780390403; Margerie D, 1997, OSTEOARTHR CARTILAGE, V5, P129, DOI 10.1016/S1063-4584(97)80006-4; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Nakamura A, 2007, BONE, V40, P305, DOI 10.1016/j.bone.2006.09.001; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Ohazama A, 2005, J DENT RES, V84, P603, DOI 10.1177/154405910508400704; Page G, 2005, ARTHRITIS RHEUM-US, V52, P2307, DOI 10.1002/art.21211; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; PARTRIDGE NC, 1980, FEBS LETT, V115, P139, DOI 10.1016/0014-5793(80)80744-7; Plaas A, 2007, OSTEOARTHR CARTILAGE, V15, P719, DOI 10.1016/j.joca.2006.12.008; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Reddi AH, 2001, ARTHRITIS RES, V3, P1; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Sabokbar A, 2003, METH MOLEC MED, V80, P101; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Schneeweis LA, 2005, J BIOL CHEM, V280, P41155, DOI 10.1074/jbc.M506366200; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; TAKEUCHI Y, 1993, J BONE MINER RES, V8, P823; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; TSUKAHARA S, 2006, BIOCHEM J, V15, P595; Wan DC, 2007, J BIOL CHEM, V282, P26450, DOI 10.1074/jbc.M703282200; Wani MR, 1999, ENDOCRINOLOGY, V140, P1927, DOI 10.1210/en.140.4.1927; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200; Zhu WQ, 2007, J CRANIO MAXILL SURG, V35, P103, DOI 10.1016/j.jcms.2006.12.001	89	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25952	25962		10.1074/jbc.M802138200	http://dx.doi.org/10.1074/jbc.M802138200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18586671	Green Published, hybrid			2022-12-25	WOS:000259200100023
J	Li, HW; Gao, YX; Qi, YF; Katovich, MJ; Jiang, N; Braseth, LN; Scheuer, DA; Shi, P; Sumners, C				Li, Hongwei; Gao, Yongxin; Qi, Yanfei; Katovich, Michael J.; Jiang, Nan; Braseth, Leah N.; Scheuer, Deborah A.; Shi, Peng; Sumners, Colin			Macrophage migration inhibitory factor in hypothalamic paraventricular nucleus neurons decreases blood pressure in spontaneously hypertensive rats	FASEB JOURNAL			English	Article						angiotensin II; thiol-protein oxidoreductase; hypertension	ROSTRAL VENTROLATERAL MEDULLA; ANGIOTENSIN-II; CARDIOVASCULAR-DISEASE; NEUROGENIC HYPERTENSION; BRAIN NUCLEI; PVN; PROJECTIONS; RECEPTORS; INCREASES; SALT	Macrophage migration inhibitory factor (MIF) expression is increased by angiotensin II (Ang II) within paraventricular nucleus (PVN) neurons of normotensive rats and acts via its intrinsic thiol protein oxidoreductase (TPOR) to counterregulate the central nervous system-mediated pressor action of Ang II. Considering that the PVN-mediated actions of Ang II are enhanced in spontaneously hypertensive rats (SHRs) and contribute to the development of hypertension in these animals, we investigated this MIF regulatory mechanism in SHRs. Here, we have demonstrated that Ang II failed to increase MIF protein expression in the PVN of SHRs. Furthermore, although basal levels of MIF protein and mRNA were similar in the PVN of SHRs and normotensive rats, immunostaining revealed that MIF was either absent from or diminished in PVN neurons of SHRs. AAV2-mediated increases in MIF expression within PVN neurons of young (8 wk old) SHRs produced a chronic attenuation of hypertension and cardiac hypertrophy. However, similar AAV2-mediated transduction of [C60S]-MIF, which lacks TPOR activity, did not alter the development of hypertension or cardiac hypertrophy in SHRs. Collectively, these findings suggest that a lack of MIF expression within PVN neurons contributes to the development of hypertension and cardiac hypertrophy in SHRs.	[Sumners, Colin] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Li, Hongwei; Gao, Yongxin; Jiang, Nan; Braseth, Leah N.; Scheuer, Deborah A.; Shi, Peng; Sumners, Colin] Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA; [Qi, Yanfei; Katovich, Michael J.] Univ Florida, Dept Pharmacodynam, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Sumners, C (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Box 100274,1600 SW Archer Rd, Gainesville, FL 32610 USA.	csumners@ufl.edu	JIANG, NAN/AHB-1945-2022	Sumners, Colin/0000-0002-9689-2255	National Institutes of Health [HL-076803]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL-076803 (C.S.). We thank Arseniy Shabashvili for technical assistance.	Akine A, 2003, AUTON NEUROSCI-BASIC, V108, P17, DOI 10.1016/j.autneu.2003.08.009; Allen AM, 2002, HYPERTENSION, V39, P275, DOI 10.1161/hy0202.104272; [Anonymous], [No title captured]; Auricchio A, 2001, HUM GENE THER, V12, P71, DOI 10.1089/104303401450988; Barik S, 1993, Methods Mol Biol, V15, P277, DOI 10.1385/0-89603-244-2:277; Benarroch EE, 2005, CLIN AUTON RES, V15, P254, DOI 10.1007/s10286-005-0290-7; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chen QH, 2001, AM J PHYSIOL-REG I, V281, pR1844, DOI 10.1152/ajpregu.2001.281.6.R1844; Ferguson AV, 2001, EXP BIOL MED, V226, P85, DOI 10.1177/153537020122600205; Gong Y, 2004, BRAIN RES PROTOC, V14, P18, DOI 10.1016/j.brainresprot.2004.08.001; Grassi G, 2004, HYPERTENSION, V43, P154, DOI 10.1161/01.HYP.0000109870.99110.7e; GUTKIND JS, 1988, AM J PHYSIOL, V255, pH646, DOI 10.1152/ajpheart.1988.255.3.H646; HARDING JW, 1987, BRAIN RES, V410, P130, DOI 10.1016/S0006-8993(87)80033-1; Ito S, 2003, HYPERTENSION, V41, P744, DOI 10.1161/01.HYP.0000052944.54349.7B; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Kudrin A, 2008, IMMUNOL CELL BIOL, V86, P232, DOI 10.1038/sj.icb.7100133; Li HW, 2006, FASEB J, V20, P1748, DOI 10.1096/fj.06-5836fje; Li YF, 2006, AM J PHYSIOL-REG I, V290, pR1035, DOI 10.1152/ajpregu.00338.2004; Matsuura T, 2006, J NEUROPHYSIOL, V95, P1042, DOI 10.1152/jn.00499.2005; McKinley MJ, 2001, CLIN EXP PHARMACOL P, V28, P990, DOI 10.1046/j.1440-1681.2001.03592.x; MEYER JM, 1990, EXP NEUROL, V107, P164, DOI 10.1016/0014-4886(90)90154-K; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Osborn JW, 2007, CURR HYPERTENS REP, V9, P228, DOI 10.1007/s11906-007-0041-3; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Reja V, 2006, CLIN EXP PHARMACOL P, V33, P690, DOI 10.1111/j.1440-1681.2006.04420.x; Reyes BAS, 2005, EUR J NEUROSCI, V22, P93, DOI 10.1111/j.1460-9568.2005.04197.x; Rohr UP, 2002, J VIROL METHODS, V106, P81, DOI 10.1016/S0166-0934(02)00138-6; SAWCHENKO PE, 1987, BRAIN RES, V437, P253, DOI 10.1016/0006-8993(87)91641-6; Schlaich MP, 2004, HYPERTENSION, V43, P169, DOI 10.1161/01.HYP.0000103160.35395.9E; Stocker SD, 2006, J COMP NEUROL, V494, P673, DOI 10.1002/cne.20835; Stocker SD, 2004, AM J PHYSIOL-REG I, V287, pR1172, DOI 10.1152/ajpregu.00394.2004; Sun CW, 2007, HYPERTENSION, V49, P528, DOI 10.1161/01.HYP.0000257877.11495.cb; Sun CW, 2004, J NEUROSCI, V24, P9944, DOI 10.1523/JNEUROSCI.2856-04.2004; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Thiele M, 2005, ANTIOXID REDOX SIGN, V7, P1234, DOI 10.1089/ars.2005.7.1234; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Yu Y, 2007, CIRC RES, V101, P304, DOI 10.1161/CIRCRESAHA.107.148940; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125; Zimmerman MC, 2002, CIRC RES, V91, P1038, DOI 10.1161/01.RES.0000043501.47934.FA	39	29	30	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2008	22	9					3175	3185		10.1096/fj.08-108662	http://dx.doi.org/10.1096/fj.08-108662			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18535252	Green Published			2022-12-25	WOS:000258761300010
J	Navaratna, D; Menicucci, G; Maestas, J; Srinivasan, R; McGuire, P; Das, A				Navaratna, Deepti; Menicucci, Gina; Maestas, Joann; Srinivasan, Ramprasad; McGuire, Paul; Das, Arup			A peptide inhibitor of the urokinase/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes	FASEB JOURNAL			English	Article						VE-cadherin; extracellular proteinases; vascular permeability	UROKINASE PLASMINOGEN-ACTIVATOR; GLYCATION END-PRODUCTS; MATRIX METALLOPROTEINASES; ENDOTHELIAL PERMEABILITY; GENE-EXPRESSION; OXIDANT STRESS; CELL-SURFACE; PROTEOLYSIS; RETINOPATHY; REPERFUSION	One of the major complications of diabetes is the alteration of the blood-retinal barrier, leading to retinal edema and consequent vision loss. The aim of this study was to evaluate the role of the urokinase plasminogen activator (uPA)/uPA receptor ( uPAR) system in the regulation of retinal vascular permeability. Biochemical, molecular, and histological techniques were used to examine the role of uPA and uPAR in the regulation of retinal vascular permeability in diabetic rats and cultured retinal endothelial cells. The increased retinal vascular permeability in diabetic rats was associated with a decrease in vascular endothelial (VE)-cadherin expression in retinal vessels. Treatment with the uPA/uPAR-inhibiting peptide (angstrom 6) was shown to reduce diabetes-induced permeability and the loss of VE-cadherin. The increased permeability of cultured cells in response to advanced glycation end products (AGEs) was significantly inhibited with angstrom 6. Treatment of endothelial cells with specific matrix metalloproteinases or AGEs resulted in loss of VE-cadherin from the cell surface, which could be inhibited by angstrom 6. uPA/uPAR physically interacts with AGEs/receptor for advanced glycation end products on the cell surface and regulates its activity. uPA and its receptor uPAR play important roles in the alteration of the blood-retinal barrier through proteolytic degradation of VE-cadherin. The ability of angstrom 6 to block retinal vascular permeability in diabetes suggests a potential therapeutic approach for the treatment of diabetic macular edema.	[McGuire, Paul; Das, Arup] Univ New Mexico, Dept Surg, Hlth Sci Ctr, Div Ophthalmol, Albuquerque, NM 87131 USA; [Navaratna, Deepti; Menicucci, Gina; Maestas, Joann; Srinivasan, Ramprasad; McGuire, Paul; Das, Arup] Univ New Mexico, Dept Cell Biol & Physiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Das, Arup] New Mexico VA Hlth Care Syst, Albuquerque, NM USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Das, A (corresponding author), Univ New Mexico, Dept Surg, Hlth Sci Ctr, Div Ophthalmol, MSC 5610-10,1, Albuquerque, NM 87131 USA.	adas@unm.edu			Juvenile Diabetes Research Foundation International [1-2006-36]; National Institutes of Health [RO1 EY12604]; NATIONAL EYE INSTITUTE [R01EY012604] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Angstrom Pharmaceuticals for the kind gift of the angstrom 6 peptide used for these studies. This work was supported by Juvenile Diabetes Research Foundation International 1-2006-36 and National Institutes of Health grant RO1 EY12604.	Alexander JS, 2002, J ANAT, V200, P561, DOI 10.1046/j.1469-7580.2002.00057.x; Alfano D, 2005, THROMB HAEMOSTASIS, V93, P205, DOI 10.1160/TH04-09-0592; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; Carden D, 1998, AM J PHYSIOL-HEART C, V275, pH385, DOI 10.1152/ajpheart.1998.275.2.H385; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Dagher Z, 2004, DIABETES, V53, P2404, DOI 10.2337/diabetes.53.9.2404; Danielsen CC, 1998, J MOL CELL CARDIOL, V30, P1431; Ehringer WD, 2000, INFLAMMATION, V24, P175, DOI 10.1023/A:1007037711339; El-Remessy AB, 2003, AM J PATHOL, V162, P1995, DOI 10.1016/S0002-9440(10)64332-5; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; Etoh T, 2001, AM J PHYSIOL-HEART C, V281, pH987, DOI 10.1152/ajpheart.2001.281.3.H987; Franco P, 2006, J CELL SCI, V119, P3424, DOI 10.1242/jcs.03067; Giebel SJ, 2005, LAB INVEST, V85, P597, DOI 10.1038/labinvest.3700251; Harhaj NS, 2006, INVEST OPHTH VIS SCI, V47, P5106, DOI 10.1167/iovs.06-0322; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Jo M, 2002, J BIOL CHEM, V277, P12479, DOI 10.1074/jbc.M111147200; Klein R, 1998, OPHTHALMOLOGY, V105, P1801, DOI 10.1016/S0161-6420(98)91020-X; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Li JF, 1998, J BIOL CHEM, V273, P30870, DOI 10.1074/jbc.273.47.30870; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makowski GS, 1998, INFLAMMATION, V22, P287, DOI 10.1023/A:1022300216202; McGuire PG, 2003, INVEST OPHTH VIS SCI, V44, P2736, DOI 10.1167/iovs.02-1160; NAVARATNA D, 2007, DIABETES, V56, P1; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; Salzmann J, 2000, BRIT J OPHTHALMOL, V84, P1091, DOI 10.1136/bjo.84.10.1091; SMITH JR, 1994, INFLAMMATION, V18, P193, DOI 10.1007/BF01534560; SMITH JR, 1994, P W PHARMACOL SOC, V37, P3; TADA H, 1994, DIABETES RES CLIN PR, V24, P33, DOI 10.1016/0168-8227(94)90083-3; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Wachtel M, 1999, J CELL SCI, V112, P4347; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; YAN SD, 1994, J BIOL CHEM, V269, P9889	37	38	40	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2008	22	9					3310	3317		10.1096/fj.08-110155	http://dx.doi.org/10.1096/fj.08-110155			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18559877	Green Published			2022-12-25	WOS:000258761300023
J	Wong, SLA; Chan, WM; Chan, HYE				Wong, S. L. Alan; Chan, Wing Man; Chan, H. Y. Edwin			Sodium dodecyl sulfate-insoluble oligomers are involved in polyglutamine degeneration	FASEB JOURNAL			English	Article						aggregate; Drosophila; neurodegeneration; solubility	HISTONE DEACETYLASE INHIBITORS; N-TERMINAL HUNTINGTIN; PROTEIN AGGREGATION; EXPANSION PROTEINS; GENE-EXPRESSION; PRONE PROTEINS; DISEASE; DROSOPHILA; NEURODEGENERATION; SUPPRESSION	In polyglutamine (polyQ) degeneration, disease protein that carries an expanded polyQ tract is neurotoxic. Expanded polyQ protein exists in different conformations that display distinct solubility properties. In this study, an inducible transgenic Drosophila model is established to define the pathogenic form of polyQ protein at an early stage of degeneration in vivo. We show that microscopic polyQ aggregates are neither pathogenic nor protective. Further, no toxic effect of sodium dodecyl sulfate (SDS)-soluble polyQ protein is observed in our model. By means of filtration, 2 forms of SDS-insoluble protein species are identified according to their size. Coexpression of an ATPase-defective form of the molecular chaperone Hsc70 (Hsc70-K71S) selectively reduces the abundance of the large SDS-insoluble polyQ species, but such modulation has no modifying effects on degeneration. Notably, we detect a distinct Hsc70-K71S-resistant, small, SDS-insoluble polyQ oligomeric species that is closely correlated with degeneration. Our data highlight the toxic role of SDS-insoluble oligomers in polyQ degeneration in vivo.	[Chan, H. Y. Edwin] Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China; [Wong, S. L. Alan; Chan, Wing Man; Chan, H. Y. Edwin] Chinese Univ Hong Kong, Lab Drosophila Res, Shatin, Hong Kong, Peoples R China; [Wong, S. L. Alan; Chan, Wing Man; Chan, H. Y. Edwin] Chinese Univ Hong Kong, Mol Biotechnol Programme, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, HYE (corresponding author), Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China.	hyechan@cuhk.edu.hk	Chan, Edwin/A-9478-2011	Chan, Edwin/0000-0003-4307-474X; Wong, Alan S.L./0000-0003-1790-3233	Hong Kong Research Grants Council [CUHK4314/03M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	We thank E. Chen for making the pUAST-EGFP-polyQ76-FLAG construct, J. Lam for performing initial characterization on EGFP-polyQ76-FLAG transgenic lines, A. Li for the excellent technical assistance on the AFM analysis, M. Feder for antibodies, and C. O'Kane and members of the Laboratory of Drosophila Research for critical comments on the manuscript. This work was supported by the Hong Kong Research Grants Council (CUHK4314/03M).	Agrawal N, 2005, P NATL ACAD SCI USA, V102, P3777, DOI 10.1073/pnas.0500055102; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Berger Z, 2005, HUM MOL GENET, V14, P3003, DOI 10.1093/hmg/ddi331; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Brignull HR, 2007, ADV EXP MED BIOL, V594, P167; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chan HYE, 2002, HUM MOL GENET, V11, P2895, DOI 10.1093/hmg/11.23.2895; Diaz-Hernandez M, 2004, J NEUROSCI, V24, P9361, DOI 10.1523/JNEUROSCI.2365-04.2004; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Hoffner G, 2005, J NEUROCHEM, V95, P125, DOI 10.1111/j.1471-4159.2005.03348.x; Huen NYM, 2007, CEREBELLUM, V6, P111, DOI 10.1080/14734220600996480; Huen NYM, 2005, BIOCHEM BIOPH RES CO, V334, P1074, DOI 10.1016/j.bbrc.2005.07.008; Iuchi S, 2003, P NATL ACAD SCI USA, V100, P2409, DOI 10.1073/pnas.0437660100; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Klucken J, 2004, BIOCHEM BIOPH RES CO, V325, P367, DOI 10.1016/j.bbrc.2004.10.037; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; MCGUIRE SE, 2004, SCI STKE, P16; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Mukai H, 2005, P NATL ACAD SCI USA, V102, P10887, DOI 10.1073/pnas.0409283102; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rub U, 2006, BRAIN PATHOL, V16, P218, DOI 10.1111/j.1750-3639.2006.00022.x; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Slepko N, 2006, P NATL ACAD SCI USA, V103, P14367, DOI 10.1073/pnas.0602348103; Slow EJ, 2006, TRENDS GENET, V22, P408, DOI 10.1016/j.tig.2006.05.008; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; VELAZQUEZ JM, 1983, J CELL BIOL, V96, P286, DOI 10.1083/jcb.96.1.286; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Weydt P, 2006, EXPERT OPIN THER TAR, V10, P505, DOI 10.1517/14728222.10.4.505; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; Wong SLA, 2005, BIOCHEM BIOPH RES CO, V337, P720, DOI 10.1016/j.bbrc.2005.09.098; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	54	26	26	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3348	3357		10.1096/fj.07-103887	http://dx.doi.org/10.1096/fj.07-103887			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18559990				2022-12-25	WOS:000258761300027
J	Ozturk, SB; Kinzy, TG				Ozturk, Sedide B.; Kinzy, Terri Goss			Guanine nucleotide exchange factor independence of the G-protein eEF1A through novel mutant forms and biochemical properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; ELONGATION FACTOR-I; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; EF-TU; YEAST; MUTATIONS; ELEMENTS; DOMAIN	Most G-proteins require a guanine nucleotide exchange factor (GEF) to regulate a variety of critical cellular processes. Interestingly, a small number of G-proteins switch between the active and inactive forms without a GEF. Translation elongation factor 1A (eEF1A) normally requires the GEF eEF1B alpha to accelerate nucleotide dissociation. However, several mutant forms of eEF1A are functional independent of this essential regulator in vivo. GEF-independent eEF1A mutations localize close to the G-protein motifs that are crucial for nucleotide binding. Kinetic analysis demonstrated that reduced GDP affinity correlates with wild type growth and high translation activities of GEF-independent mutants. Furthermore, the mutant forms show an 11-22-fold increase in rates of GDP dissociation from eEF1A compared with the wild type protein. All mutant forms have dramatically enhanced stability at elevated temperatures. This, coupled with data demonstrating that eEF1A is also more stable in the presence of nucleotides, suggests that both the GEF and nucleotide have stabilizing effects on eEF1A. The biochemical properties of these eEF1A mutants provide insight into the mechanism behind GEF-independent G-protein function.	[Ozturk, Sedide B.; Kinzy, Terri Goss] Univ Med & Dent New Jersey, Dept Mol Genet Microbiol & Immunol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kinzy, TG (corresponding author), Univ Med & Dent New Jersey, Dept Mol Genet Microbiol & Immunol, Robert Wood Johnson Med Sch, 675 Hoes Ln, Piscataway, NJ 08854 USA.	kinzytg@umdnj.edu		Kinzy, Terri/0000-0003-1394-9226	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057483, GM 57483] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANAND M, 2001, S QUANT BIOL, V66, P439; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Bhate M, 2002, BIOCHEMISTRY-US, V41, P6539, DOI 10.1021/bi020070d; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burke D., 2000, METHODS YEAST GENETI; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; CARVALHO MDD, 1984, ARCH BIOCHEM BIOPHYS, V234, P603, DOI 10.1016/0003-9861(84)90310-2; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DeLano W, 2002, PYMOL 0 99; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; FERGUSON KM, 1986, J BIOL CHEM, V259, P8693; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HIRAGA K, 1993, FEBS LETT, V316, P165, DOI 10.1016/0014-5793(93)81208-H; KINZY TG, 1995, GENETICS, V141, P481; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; LAPADAT MA, 1989, J BIOL CHEM, V264, P5510; LUCASLEN.J, 1966, P NATL ACAD SCI USA, V55, P1562, DOI 10.1073/pnas.55.6.1562; Lutz S, 2002, N-S ARCH PHARMACOL, V365, P50, DOI 10.1007/s00210-001-0500-3; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; OLAREWAJU O, 2004, RNA BIOL, V1, P12; Ozturk SB, 2006, GENETICS, V174, P651, DOI 10.1534/genetics.106.059899; PERCZEL A, 1991, PROTEIN ENG, V4, P669, DOI 10.1093/protein/4.6.669; Pisareva VP, 2007, BIOCHEMISTRY-US, V46, P2622, DOI 10.1021/bi062134g; Pittman YR, 2006, J BIOL CHEM, V281, P19457, DOI 10.1074/jbc.M601076200; SAHA SK, 1986, J BIOL CHEM, V261, P2599; Sanderova H, 2004, PROTEIN SCI, V13, P89, DOI 10.1110/ps.03272504; SCHIRMAIER F, 1984, EMBO J, V3, P3311, DOI 10.1002/j.1460-2075.1984.tb02295.x; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Thanbichler M, 2000, J BIOL CHEM, V275, P20458, DOI 10.1074/jbc.M002496200; Toyn JH, 2000, YEAST, V16, P553, DOI 10.1002/(SICI)1097-0061(200004)16:6<553::AID-YEA554>3.0.CO;2-7; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Unneberg P, 2001, PROTEINS, V42, P460, DOI 10.1002/1097-0134(20010301)42:4<460::AID-PROT50>3.0.CO;2-U; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Zavialov A. V., 2005, J BIOL-LONDON, V4, P9	41	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23244	23253		10.1074/jbc.M801095200	http://dx.doi.org/10.1074/jbc.M801095200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562321	hybrid, Green Published			2022-12-25	WOS:000258455400038
J	Shao, ZY; Blodgett, JAV; Circello, BT; Eliot, AC; Woodyer, R; Li, GY; van der Donk, WA; Metcalf, WW; Zhao, HM				Shao, Zengyi; Blodgett, Joshua A. V.; Circello, Benjamin T.; Eliot, Andrew C.; Woodyer, Ryan; Li, Gongyong; van der Donk, Wilfred A.; Metcalf, William W.; Zhao, Huimin			Biosynthesis of 2-hydroxyethylphosphonate, an unexpected intermediate common to multiple phosphonate biosynthetic pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-P BOND; PHOSPHINOTHRICIN-TRIPEPTIDE; SACCHAROMYCES-CEREVISIAE; ALCOHOL-DEHYDROGENASE; ESCHERICHIA-COLI; NATURAL-PRODUCTS; GENE-CLUSTER; FOSFOMYCIN; MECHANISM; PHOSPHONOACETALDEHYDE	Phosphonic acids encompass a common yet chemically diverse class of natural products that often possess potent biological activities. Here we report that, despite the significant structural differences among many of these compounds, their biosynthetic routes contain an unexpected common intermediate, 2-hydroxyethyl-phosphonate, which is synthesized from phosphonoacetaldehyde by a distinct family of metal-dependent alcohol dehydrogenases (ADHs). Although the sequence identity of the ADH family members is relatively low (34-37%), in vitro biochemical characterization of the homologs involved in biosynthesis of the antibiotics fosfomycin, phosphinothricin tripeptide, and dehydrophos (formerly A53868) unequivocally confirms their enzymatic activities. These unique ADHs have exquisite substrate specificity, unusual metal requirements, and an unprecedented monomeric quaternary structure. Further, sequence analysis shows that these ADHs form a monophyletic group along with additional family members encoded by putative phosphonate biosynthetic gene clusters. Thus, the reduction of phosphonoacetaldehyde to hydroxyethyl-phosphonate may represent a common step in the biosynthesis of many phosphonate natural products, a finding that lends insight into the evolution of phosphonate biosynthetic pathways and the chemical structures of new C-P containing secondary metabolites.	[Circello, Benjamin T.; Metcalf, William W.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Shao, Zengyi; Zhao, Huimin] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Shao, Zengyi; Zhao, Huimin] Univ Illinois, Dept Biomol Engn, Urbana, IL 61801 USA; [van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Blodgett, Joshua A. V.] Harvard Univ, Dept Biol Chem, Sch Med, Boston, MA 02115 USA; [Blodgett, Joshua A. V.] Harvard Univ, Dept Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Eliot, Andrew C.] Dupont Cent Res & Dev, Wilmington, DE 19880 USA; [Woodyer, Ryan] zuChem Inc, Peoria, IL 61604 USA; [Li, Gongyong] Shanghai Chemspec Corp, Dept R&D, Shanghai 200333, Peoples R China; [van der Donk, Wilfred A.; Zhao, Huimin] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; DuPont; University of Illinois System; University of Illinois Urbana-Champaign	Metcalf, WW (corresponding author), Univ Illinois, Dept Microbiol, B103 CLSL,601 S Goodwin Ave, Urbana, IL 61801 USA.	metcalf@uiuc.edu; zhao5@uiuc.edu	Blodgett, Joshua/AAW-8242-2020; Blodgett, Joshua/G-9355-2011; van der Donk, Wilfred/K-2961-2015	Blodgett, Joshua/0000-0002-7080-5870; Blodgett, Joshua/0000-0002-7080-5870; van der Donk, Wilfred/0000-0002-5467-7071	NIGMS NIH HHS [GM067725, GM059334, GM077596, P01 GM077596, GM070421] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM077596, T32GM070421, R01GM067725, R01GM059334] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGUDELO MI, 1983, BIOL BULL, V165, P100, DOI 10.2307/1541357; ALIJAH R, 1991, APPL MICROBIOL BIOT, V34, P749; BARRY RJ, 1988, BIOCHEM BIOPH RES CO, V153, P177, DOI 10.1016/S0006-291X(88)81205-1; Blodgett JAV, 2005, ANTIMICROB AGENTS CH, V49, P230, DOI 10.1128/AAC.49.1.230-240.2005; Blodgett JAV, 2007, NAT CHEM BIOL, V3, P480, DOI 10.1038/nchembio.2007.9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CONWAY T, 1989, J BACTERIOL, V171, P3754, DOI 10.1128/jb.171.7.3754-3759.1989; Crow JP, 1997, J NEUROCHEM, V69, P1936; DREWKE C, 1988, BIOCHIM BIOPHYS ACTA, V950, P54, DOI 10.1016/0167-4781(88)90072-3; Farh L, 2001, J BIOCHEM-TOKYO, V130, P627, DOI 10.1093/oxfordjournals.jbchem.a003028; Fields SC, 1999, TETRAHEDRON, V55, P12237, DOI 10.1016/S0040-4020(99)00701-2; Hilderbrand R. L., 1983, ROLE PHOSPHONATES LI; IMAI S, 1985, AGR BIOL CHEM TOKYO, V49, P873, DOI 10.1080/00021369.1985.10866818; ISBELL AF, 1969, J ORG CHEM, V34, P755, DOI 10.1021/jo01255a067; Montella C, 2005, J BACTERIOL, V187, P4957, DOI 10.1128/JB.187.14.4957-4966.2005; Nakashita H, 1997, J ANTIBIOT, V50, P212, DOI 10.7164/antibiotics.50.212; QUIN LD, 1965, BIOCHEMISTRY-US, V4, P324, DOI 10.1021/bi00878a022; REEVES DS, 1992, INFECTION, V20, pS313, DOI 10.1007/BF01710022; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; Ruzheinikov SN, 2001, STRUCTURE, V9, P789, DOI 10.1016/S0969-2126(01)00645-1; SEIDEL HM, 1988, NATURE, V335, P457, DOI 10.1038/335457a0; Seto H, 1999, NAT PROD REP, V16, P589, DOI 10.1039/a809398i; Stein GE, 1999, INT J FERTIL WOMEN M, V44, P104; Thompson C J, 1995, Biotechnology, V28, P197; van Wageningen AMA, 1998, CHEM BIOL, V5, P155, DOI 10.1016/S1074-5521(98)90060-6; Whitteck JT, 2007, ANGEW CHEM INT EDIT, V46, P9089, DOI 10.1002/anie.200703810; Woodyer RD, 2007, CHEM COMMUN, P359, DOI 10.1039/b614678c; Woodyer RD, 2006, CHEM BIOL, V13, P1171, DOI 10.1016/j.chembiol.2006.09.007	28	39	43	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23161	23168		10.1074/jbc.M801788200	http://dx.doi.org/10.1074/jbc.M801788200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18544530	hybrid, Green Published			2022-12-25	WOS:000258455400029
J	Shawkat, S; Karima, R; Tojo, T; Tadakuma, H; Saitoh, SI; Akashi-Takamura, S; Miyake, K; Funatsu, T; Matsushima, K				Shawkat, Samia; Karima, Risuke; Tojo, Tadashi; Tadakuma, Hisashi; Saitoh, Shin-Ichiroh; Akashi-Takamura, Sachiko; Miyake, Kensuke; Funatsu, Takashi; Matsushima, Kouji			Visualization of the molecular dynamics of lipopolysaccharide on the plasma membrane of murine macrophages by total internal reflection fluorescence microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; GRAM-NEGATIVE BACTERIA; SINGLE-MOLECULE; CELL-SURFACE; SIGNAL-TRANSDUCTION; DENDRITIC CELLS; SEPTIC SHOCK; LIVING CELLS; TLR4; LPS	The molecular action of Alexa 594-labeled lipopolysaccharide (LPS) from Escherichia coli was examined on living peritoneal macrophages of C57BL/6 mice by total internal reflection fluorescence microscope (TIRFM), and the molecular kinetics of LPS was analyzed. TIRFM visualization of the action of fluorescence-labeled LPS revealed an increase in the mean fluorescence intensity of LPS on the plasma membrane of wild type macrophages at 60 min after administration, indicating the oligomerization of LPS after binding to the macrophages. Additionally, a time-dependent sharp decrease in the mean diffusion coefficient of LPS was observed. On the other hand, both mean fluorescence intensity and diffusion coefficient of LPS in cases of TLR4(-/-), MD2(-/-), MyD880(-/-), and TRIF-/- macrophages were significantly different from the corresponding values of wild type macrophage, whereas differences were also noticed among these molecule-deficient macrophages. Furthermore, statistical analysis indicated the major role of receptors (TLR4 and MD2) and intracellular signaling molecules (MyD88 and TRIF) in oligomerization and lowering of the diffusion rate of LPS on the plasma membrane of murine macrophages, respectively.	[Shawkat, Samia; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1130033, Japan; [Karima, Risuke] Univ Tokyo, Ctr Environm Sci, Tokyo 1130033, Japan; [Saitoh, Shin-Ichiroh; Akashi-Takamura, Sachiko; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Div Infect Genet, Tokyo 1088639, Japan; [Tojo, Tadashi; Tadakuma, Hisashi; Funatsu, Takashi] Waseda Univ, Sch Sci & Engn, Dept Phys, Tokyo 1698555, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Waseda University	Matsushima, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	koujim@m.u-tokyo.ac.jp	Funatsu, Takashi/Q-1404-2015	Funatsu, Takashi/0000-0002-9656-8308	Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo	Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo	We thank Yuya Terashima and Mikiya Otsuji (Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo) for kind assistance in operating TIRFM.	Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Allersma MW, 2004, MOL BIOL CELL, V15, P4658, DOI 10.1091/mbc.E04-02-0149; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Demuro A, 2004, BIOPHYS J, V86, P3250, DOI 10.1016/S0006-3495(04)74373-8; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Iino R, 2001, J FLUORESC, V11, P187, DOI 10.1023/A:1012297000742; Jeyaseelan S, 2007, J IMMUNOL, V178, P3153, DOI 10.4049/jimmunol.178.5.3153; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kitchens RL, 1998, J IMMUNOL, V160, P1920; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Llobet A, 2003, NEURON, V40, P1075, DOI 10.1016/S0896-6273(03)00765-7; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Rescigno M, 2002, EUR J IMMUNOL, V32, P2800, DOI 10.1002/1521-4141(2002010)32:10<2800::AID-IMMU2800>3.0.CO;2-5; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sako Y, 2003, J PHARMACOL SCI, V93, P253, DOI 10.1254/jphs.93.253; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Toomre D, 2001, TRENDS CELL BIOL, V11, P298, DOI 10.1016/S0962-8924(01)02027-X; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Visintin A, 2006, J LEUKOCYTE BIOL, V80, P1584, DOI 10.1189/jlb.0606388; Yang DM, 2003, J MICROSC-OXFORD, V209, P223, DOI 10.1046/j.1365-2818.2003.01129.x	32	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22962	22971		10.1074/jbc.M801366200	http://dx.doi.org/10.1074/jbc.M801366200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18567586	hybrid			2022-12-25	WOS:000258455400009
J	Zhang, H; Rider, SD; Henderson, JT; Fountain, M; Chuang, K; Kandachar, V; Simons, A; Edenberg, HJ; Romero-Severson, J; Muir, WM; Ogas, J				Zhang, Heng; Rider, Stanley Dean, Jr.; Henderson, James T.; Fountain, Matthew; Chuang, King; Kandachar, Vasundhara; Simons, Alexis; Edenberg, Howard J.; Romero-Severson, Jeanne; Muir, William M.; Ogas, Joe			The CHD3 remodeler PICKLE promotes trimethylation of histone H3 lysine 27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING ARABIDOPSIS SEEDS; POLYCOMB GROUP-COMPLEXES; TRITHORAX GROUP PROTEINS; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; DNA METHYLATION; EMBRYO DEVELOPMENT; TRANSCRIPTION FACTOR; REPRESS EXPRESSION; GIBBERELLIN	CHD3 proteins are ATP-dependent chromatin remodelers that contribute to repression of developmentally regulated genes in both animal and plant systems. In animals, this repression has been linked to a multiple subunit complex, Mi-2/ NuRD, whose constituents include aCHD3protein, a histone deacetylase, and a methylCpG-binding domain protein. In Arabidopsis, PICKLE ( PKL) codes for a CHD3 protein that acts during germination to repress expression of seed-associated genes. Repression of seed-associated traits is promoted in pkl seedlings by the plant growth regulator gibberellin (GA). We undertook a microarray analysis to determine how PKL and GA act to promote the transition from seed to seedling. We found that PKL and GA actin separate pathways to repress expression of seed-specific genes. Comparison of genomic datasets revealed that PKL-dependent genes are enriched for trimethylation of histone H3 lysine 27 (H3K27me3), a repressive epigenetic mark. Chromatin immunoprecipitation studies demonstrate that PKL promotes H3K27me3 in both germinating seedlings and in adult plants but do not identify a connection between PKL dependent expression and acetylation levels. Taken together, our analyses illuminate a new pathway by which CHD3 remodelers contribute to repression in eukaryotes.	[Zhang, Heng; Rider, Stanley Dean, Jr.; Henderson, James T.; Fountain, Matthew; Chuang, King; Kandachar, Vasundhara; Simons, Alexis; Ogas, Joe] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Edenberg, Howard J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Edenberg, Howard J.] Indiana Univ, Sch Med, Ctr Med Genom, Indianapolis, IN 46202 USA; [Romero-Severson, Jeanne] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Muir, William M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Notre Dame; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ogas, J (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ Ave, W Lafayette, IN 47907 USA.	ogas@purdue.edu	Romero-Severson, Jeanne/B-5259-2011	Romero-Severson, Jeanne/0000-0003-4112-7238; Zhang, Heng/0000-0002-1541-3890; Ogas, Joe/0000-0002-1332-7729; Edenberg, Howard/0000-0003-0344-9690	NIGMS NIH HHS [5R01 GM59770-08, R01GM059770-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059770] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; [Anonymous], 1995, PLANT HORMONES PHYSL, DOI DOI 10.1007/978-94-011-0473-9; BARENDSE GWM, 1986, PHYSIOL PLANTARUM, V67, P315, DOI 10.1111/j.1399-3054.1986.tb02463.x; Benhamed M, 2006, PLANT CELL, V18, P2893, DOI 10.1105/tpc.106.043489; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; CHURCHILL GA, 1994, GENETICS, V138, P963; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Gazzarrini S, 2004, DEV CELL, V7, P373, DOI 10.1016/j.devcel.2004.06.017; Girke T, 2000, PLANT PHYSIOL, V124, P1570, DOI 10.1104/pp.124.4.1570; Goeres DC, 2007, PLANT CELL, V19, P1549, DOI 10.1105/tpc.106.047621; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guitton AE, 2005, INT J DEV BIOL, V49, P707, DOI 10.1387/ijdb.051990ag; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Henderson JT, 2004, PLANT PHYSIOL, V134, P995, DOI 10.1104/pp.103.030148; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P399, DOI 10.1093/pcp/pci048; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li HC, 2005, PLANT J, V44, P1010, DOI 10.1111/j.1365-313X.2005.02602.x; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Muir W M, 2006, J Data Sci, V4, P323; Ng DWK, 2006, PLANT CELL, V18, P119, DOI 10.1105/tpc.105.037010; Ogas J, 1999, P NATL ACAD SCI USA, V96, P13839, DOI 10.1073/pnas.96.24.13839; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Pien S, 2007, BBA-GENE STRUCT EXPR, V1769, P375, DOI 10.1016/j.bbaexp.2007.01.010; Rider SD, 2004, PLANTA, V219, P489, DOI 10.1007/s00425-004-1254-1; Rider SD, 2003, PLANT J, V35, P33, DOI 10.1046/j.1365-313X.2003.01783.x; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sheldon CC, 2006, PLANT J, V45, P871, DOI 10.1111/j.1365-313X.2006.02652.x; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Tian L, 2005, GENETICS, V169, P337, DOI 10.1534/genetics.104.033142; To A, 2006, PLANT CELL, V18, P1642, DOI 10.1105/tpc.105.039925; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Tsukagoshi H, 2005, PLANT PHYSIOL, V138, P675, DOI 10.1104/pp.104.057752; Tsukagoshi H, 2007, P NATL ACAD SCI USA, V104, P2543, DOI 10.1073/pnas.0607940104; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	63	105	111	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22637	22648		10.1074/jbc.M802129200	http://dx.doi.org/10.1074/jbc.M802129200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18539592	Green Published, hybrid			2022-12-25	WOS:000258321000033
J	Desai, R; Kronengold, J; Mei, J; Forman, SA; Kaczmarek, LK				Desai, Rooma; Kronengold, Jack; Mei, Jianfeng; Forman, Stuart A.; Kaczmarek, Leonard K.			Protein kinase C modulates inactivation of Kv3.3 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THRESHOLD POTASSIUM CHANNEL; AUDITORY NEURONS; TRAPEZOID BODY; MEDIAL NUCLEUS; MOUSE-BRAIN; PHOSPHORYLATION; LOCALIZATION; SUBUNITS; CELLS; ORGANIZATION	Modulation of some Kv3 family potassium channels by protein kinase C (PKC) regulates their amplitude and kinetics and adjusts firing patterns of auditory neurons in response to stimulation. Nevertheless, little is known about the modulation of Kv3.3, a channel that is widely expressed throughout the nervous system and is the dominant Kv3 family member in auditory brainstem. We have cloned the cDNA for the Kv3.3 channel from mouse brain and have expressed it in a mammalian cell line and in Xenopus oocytes to characterize its biophysical properties and modulation by PKC. Kv3.3 currents activate at positive voltages and undergo inactivation with time constants of 150-250 ms. Activators of PKC increased current amplitude and removed inactivation of Kv3.3 currents, and a specific PKC pseudosubstrate inhibitor peptide prevented the effects of the activators. Elimination of the first 78 amino acids of the N terminus of Kv3.3 produced noninactivating currents suggesting that PKC modulates N-type inactivation, potentially by phosphorylation of sites in this region. To identify potential phosphorylation sites, we investigated the response of channels in which serines in this N-terminal domain were subjected to mutagenesis. Our results suggest that serines at positions 3 and 9 are potential PKC phosphorylation sites. Computer simulations of model neurons suggest that phosphorylation of Kv3.3 by PKC may allow neurons to maintain action potential height during stimulation at high frequencies, and may therefore contribute to stimulus-induced changes in the intrinsic excitability of neurons such as those of the auditory brainstem.	[Desai, Rooma; Kronengold, Jack; Mei, Jianfeng; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Desai, Rooma; Forman, Stuart A.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA	Yale University; Yale University; Harvard University; Massachusetts General Hospital	Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	leonard.kaczmarek@yale.edu	Forman, Stuart/Q-6590-2019	Forman, Stuart/0000-0001-6340-2478	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001919] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-01919] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Akemann W, 2006, J NEUROSCI, V26, P4602, DOI 10.1523/JNEUROSCI.5204-05.2006; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; BROWNELL WE, 1975, BRAIN RES, V94, P413, DOI 10.1016/0006-8993(75)90226-7; Chang SY, 2007, J COMP NEUROL, V502, P953, DOI 10.1002/cne.21353; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; DESAI R, 2005, SOC NEUR ABSTR, V846, P2; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fernandez FR, 2003, J BIOL CHEM, V278, P40890, DOI 10.1074/jbc.M304235200; Forman SA, 1997, BIOPHYS J, V72, P2170, DOI 10.1016/S0006-3495(97)78860-X; Frohman Michael A., 1995, P381; GHANSHANI S, 1992, GENOMICS, V12, P190, DOI 10.1016/0888-7543(92)90365-Y; GOLDMANWOHL DS, 1994, J NEUROSCI, V14, P511; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Kaczmarek LK, 2005, HEARING RES, V206, P133, DOI 10.1016/j.heares.2004.11.023; KANEMASA T, 1995, J NEUROPHYSIOL, V74, P207, DOI 10.1152/jn.1995.74.1.207; Kopp-Scheinpflug C, 2003, JARO-J ASSOC RES OTO, V4, P1, DOI 10.1007/s10162-002-2010-5; Li W, 2001, J COMP NEUROL, V437, P196, DOI 10.1002/cne.1279; Liu SQJ, 1998, J NEUROSCI, V18, P8758; Lorenzo PS, 1997, J BIOL CHEM, V272, P33338, DOI 10.1074/jbc.272.52.33338; Macica CM, 2003, J NEUROSCI, V23, P1133, DOI 10.1523/JNEUROSCI.23-04-01133.2003; Macica CM, 2001, J NEUROSCI, V21, P1160; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; MORENO H, 1995, J NEUROSCI, V15, P5486; Perney TM, 1997, J COMP NEUROL, V386, P178; Rae JL, 2000, EXP EYE RES, V70, P339, DOI 10.1006/exer.1999.0796; Richardson FC, 2000, HEARING RES, V147, P21, DOI 10.1016/S0378-5955(00)00117-9; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Rudy B, 1999, ANN NY ACAD SCI, V868, P304, DOI 10.1111/j.1749-6632.1999.tb11295.x; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; WU SH, 1993, HEARING RES, V68, P189, DOI 10.1016/0378-5955(93)90123-I; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	39	30	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22283	22294		10.1074/jbc.M801663200	http://dx.doi.org/10.1074/jbc.M801663200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18539595	Green Published, hybrid			2022-12-25	WOS:000258114700047
J	Fila, C; Metz, C; van der Sluijs, P				Fila, Claudia; Metz, Corina; van der Sluijs, Peter			Juglone inactivates cysteine-rich proteins required for progression through mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL ISOMERASE PIN1; DEPENDENT PROLINE ISOMERIZATION; CELL-CYCLE; CIS/TRANS ISOMERASES; PHOSPHORYLATION; INHIBITION; DEPHOSPHORYLATION; CHECKPOINT; TUBULIN; KINASE	The parvulin peptidyl-prolyl isomerase Pin1 catalyzes cis-trans isomerization of p(S/T)-P bonds and might alter conformation and function of client proteins. Since the trans conformation of p(S/T)-P bonds is preferred by protein phosphatase 2A (PP2A), Pin1 may facilitate PP2A-mediated dephosphorylation. Juglone irreversibly inhibits parvulins and is often used to study the function of Pin1 in vivo. The drug prevents dephosphorylation of mitotic phosphoproteins, perhaps because they bind Pin1 and are dephosphorylated by PP2A. We show here however that juglone inhibited post-mitotic dephosphorylation and the exit of mitosis, independent of Pin1. This effect involved covalent modification of sulfhydryl groups in proteins essential for metaphase/anaphase transition. Particularly cytoplasmic proteins with a high cysteine content were vulnerable to the drug. Alkylation of sulfhydryl groups altered the conformation of such proteins, as evidenced by the disappearance of antibody epitopes on tubulin and the mitotic checkpoint component BubR1. The latter activates the anaphase-promoting complex/cyclosome, which degrades regulatory proteins, such as cyclin B1 and securins, and is required for mitotic exit. Indeed, juglone-treated cells failed to assemble a mitotic spindle, which correlated with perturbed microtubule dynamics, loss of immunodetectable tubulin, and formation of tubulin aggregates. Juglone also prevented degradation of cyclin B1, independently of the Mps1-controlled mitotic spindle checkpoint. Since juglone affected cell cycle progression at several levels, more specific drugs need to be developed for studies of Pin1 function in vivo.	[Fila, Claudia; Metz, Corina; van der Sluijs, Peter] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	van der Sluijs, P (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, AZU G02-525,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	p.vandersluijs@umcutrecht.nl						Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Albert AL, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-22; BAILLY E, 1991, NATURE, V350, P715, DOI 10.1038/350715a0; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chao SH, 2001, NUCLEIC ACIDS RES, V29, P767, DOI 10.1093/nar/29.3.767; Daum S, 2006, ANGEW CHEM INT EDIT, V45, P7454, DOI 10.1002/anie.200601569; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Esnault S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000226; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; FREW T, 1995, ANTI-CANCER DRUG DES, V10, P347; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Galas MC, 2006, J BIOL CHEM, V281, P19296, DOI 10.1074/jbc.M601849200; Gerez L, 2000, MOL BIOL CELL, V11, P2201, DOI 10.1091/mbc.11.7.2201; He JQ, 2003, ONCOGENE, V22, P4524, DOI 10.1038/sj.onc.1206767; He JQ, 2001, J BIOL CHEM, V276, P41559, DOI 10.1074/jbc.M106859200; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; Kamei H, 1998, CANCER BIOTHER RADIO, V13, P185, DOI 10.1089/cbr.1998.13.185; Kesavapany S, 2007, MOL BIOL CELL, V18, P3645, DOI 10.1091/mbc.E07-03-0237; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; KURIYAMA R, 1974, J BIOCHEM-TOKYO, V76, P651, DOI 10.1093/oxfordjournals.jbchem.a130609; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Ma J, 2007, ONCOGENE, V26, P5145, DOI 10.1038/sj.onc.1210323; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; MUTO N, 1987, BIOCHEM BIOPH RES CO, V146, P487, DOI 10.1016/0006-291X(87)90555-9; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Paulsen MT, 2005, TOXICOL APPL PHARM, V209, P1, DOI 10.1016/j.taap.2005.03.005; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Pfeiffer E, 1996, CHEM-BIOL INTERACT, V102, P37, DOI 10.1016/0009-2797(96)03730-1; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rippmann JF, 2000, CELL GROWTH DIFFER, V11, P409; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Santa-Maria I, 2005, BBA-MOL BASIS DIS, V1740, P472, DOI 10.1016/j.bbadis.2004.11.024; Schmid FX, 2002, ADV PROTEIN CHEM, V59, P243; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Stockwell BR, 1999, CHEM BIOL, V6, P71, DOI 10.1016/S1074-5521(99)80004-0; Van Hoof C, 2004, CANCER CELL, V5, P105, DOI 10.1016/S1535-6108(04)00027-3; VANDERSLUIJS P, 1992, EMBO J, V11, P4379, DOI 10.1002/j.1460-2075.1992.tb05538.x; Varga Z, 1996, BIOCHEM BIOPH RES CO, V218, P828, DOI 10.1006/bbrc.1996.0147; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Wildemann D, 2006, J MED CHEM, V49, P2147, DOI 10.1021/jm060036n; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zhang Y, 2007, ACS CHEM BIOL, V2, P320, DOI 10.1021/cb7000044; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	55	46	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21714	21724		10.1074/jbc.M710264200	http://dx.doi.org/10.1074/jbc.M710264200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539601	hybrid			2022-12-25	WOS:000257898800045
J	Peshenko, IV; Olshevskaya, EV; Dizhoor, AM				Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.			Binding of guanylyl cyclase activating protein 1 (GCAP1) to retinal guanylyl cyclase (RetGC1) - The role of individual EF-hands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CALCIUM-SENSOR; ALPHA SUBUNITS; OUTER SEGMENTS; DEGENERATION; VERTEBRATE; RODS; DOMAIN; CA2+; PHOTORECEPTORS	Guanylyl cyclase activating protein 1 (GCAP1), after substitution of Ca2+ by Mg2+ in its EF-hands, stimulates photoreceptor guanylyl cyclase, RetGC1, in response to light. We inactivated metal binding in individual EF-hands of GCAP1 tagged with green fluorescent protein to assess their role in GCAP1 binding to RetGC1 in co-transfected HEK293 cells. When expressed alone, GCAP1 was uniformly distributed throughout the cytoplasm and the nuclei of the cells, but when co-expressed with either fluorescently tagged or non-tagged RetGC1, it co-localized with the cyclase in the membranes. The co-localization did not occur when the C-terminal portion of RetGC1, containing its regulatory and catalytic domains, was removed. Mutations that preserved Mg2+ binding in all three metal-binding EF-hands did not affect GCAP1 association with the cyclase in live cells. Locking EF-hand 4 in its apo-conformation, incapable of binding either Ca2+ or Mg2+, had no effect on GCAP1 association with the cyclase. In contrast to EF-hand 4, inactivation of EF-hand 3 reduced the efficiency of the co-localization, and inactivation of EF-hand 2 drastically suppressed GCAP1 binding to the cyclase. These results directly demonstrate that metal binding in EF-hand 2 is crucial for GCAP1 attachment to RetGC1, and that in EF-hand 3 it is less critical, although it enhances the efficiency of the GCAP1 docking on the target enzyme. Metal binding in EF-hand 4 has no role in the primary attachment of GCAP1 to the cyclase, and it only triggers the activator-to-inhibitor functional switch in GCAP1.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Penn Coll Optometry, Hafter Res Labs, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Penn Coll Optometry, Hafter Res Labs, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@pco.edu		Dizhoor, Alexander/0000-0001-6770-9186	NEI NIH HHS [EY 11522] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chen CH, 2003, J PHYSIOL-LONDON, V553, P125, DOI 10.1113/jphysiol.2003.053280; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1999, METHODS, V19, P521, DOI 10.1006/meth.1999.0894; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Duda T, 2005, BIOCHEMISTRY-US, V44, P7336, DOI 10.1021/bi050068x; DURONIO RJ, 1991, J BIOL CHEM, V266, P10498; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; Hwang JY, 2004, EUR J BIOCHEM, V271, P3785, DOI 10.1111/j.1432-1033.2004.04320.x; Hwang JY, 2002, BIOCHEMISTRY-US, V41, P13021, DOI 10.1021/bi026618y; KOCH KW, 1991, J BIOL CHEM, V266, P8634; Krylov DM, 1999, J BIOL CHEM, V274, P10833, DOI 10.1074/jbc.274.16.10833; Lange C, 1999, FEBS LETT, V460, P27, DOI 10.1016/S0014-5793(99)01312-5; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; Mountjoy KG, 2001, PHYSIOL GENOMICS, V5, P11, DOI 10.1152/physiolgenomics.2001.5.1.11; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; Olshevskaya EV, 2002, MOL CELL BIOCHEM, V230, P139, DOI 10.1023/A:1014248208584; OttoBruc A, 1997, BIOCHEMISTRY-US, V36, P4295, DOI 10.1021/bi963000d; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Quitterer U, 2001, J BIOL CHEM, V276, P6763, DOI 10.1074/jbc.M007727200; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Sokal I, 2001, J BIOL CHEM, V276, P43361, DOI 10.1074/jbc.M103614200; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Vogel A, 2007, BBA-BIOMEMBRANES, V1768, P3171, DOI 10.1016/j.bbamem.2007.08.024; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Yu H, 1999, J BIOL CHEM, V274, P15547, DOI 10.1074/jbc.274.22.15547	43	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21747	21757		10.1074/jbc.M801899200	http://dx.doi.org/10.1074/jbc.M801899200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18541533	Green Published, hybrid			2022-12-25	WOS:000257898800048
J	Yang, LL; Wang, SX; Sung, B; Lim, G; Mao, JR				Yang, Liling; Wang, Shuxing; Sung, Backil; Lim, Grewo; Mao, Jianren			Morphine induces ubiquitin-proteasome activity and glutamate transporter degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C6 GLIOMA-CELLS; ABNORMAL PAIN SENSITIVITY; SURFACE EXPRESSION; RECEPTOR ANTAGONIST; GLIOBLASTOMA CELLS; NEUROPATHIC PAIN; LIGASE NEDD4-2; BETA-ARRESTIN; PTEN; TOLERANCE	Glutamate transporters play a crucial role in physiological glutamate homeostasis, neurotoxicity, and glutamatergic regulation of opioid tolerance. However, how the glutamate transporter turnover is regulated remains poorly understood. Here we show that chronic morphine exposure induced posttranscriptional down-regulation of the glutamate transporter EAAC1 in C6 glioma cells with a concurrent decrease in glutamate uptake and increase in proteasome activity, which were blocked by the selective proteasome inhibitor MG-132 or lactacystin but not the lysosomal inhibitor chloroquin. At the cellular level, chronic morphine induced the PTEN (phosphatase and tensin homolog deleted on chromosome Ten)-mediated up-regulation of the ubiquitin E3 ligase Nedd4 via cAMP/protein kinase A signaling, leading to EAAC1 ubiquitination and proteasomal degradation. Either Nedd4 or PTEN knockdown with small interfering RNA prevented the morphine-induced EAAC1 degradation and decreased glutamate uptake. These data indicate that cAMP/protein kinase A signaling serves as an intracellular regulator upstream to the activation of the PTEN/Nedd4-mediated ubiquitin-proteasome system activity that is critical for glutamate transporter turnover. Under an in vivo condition, chronic morphine exposure also induced posttranscriptional down-regulation of the glutamate transporter EAAC1, which was prevented by MG-132, and transcriptional up-regulation of PTEN and Nedd4 within the spinal cord dorsal horn. Thus, inhibition of the ubiquitin-proteasome-mediated glutamate transporter degradation may be an important mechanism for preventing glutamate overexcitation and may offer a new strategy for treating certain neurological disorders and improving opioid therapy in chronic pain management.	[Yang, Liling; Wang, Shuxing; Sung, Backil; Lim, Grewo; Mao, Jianren] Harvard Univ, Sch Med, Dept Anesthesia & Crit Care, Massachusetts Gen Hosp,MGH Ctr Translat Pain Res, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Mao, JR (corresponding author), Harvard Univ, Sch Med, Dept Anesthesia & Crit Care, Massachusetts Gen Hosp,MGH Ctr Translat Pain Res, WACC 324,15 Parkman St, Boston, MA 02114 USA.	jmao@partners.org			NIDA NIH HHS [R01 DA 08835] Funding Source: Medline; NINDS NIH HHS [NS 45681, NS 42661] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045681, R01NS042661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008835] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; Boehmer C, 2003, J NEUROCHEM, V86, P1181, DOI 10.1046/j.1471-4159.2003.01937.x; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 1998, J NEUROCHEM, V70, P1819; Chang CJ, 2004, J BIOL CHEM, V279, P29841, DOI 10.1074/jbc.M401488200; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Davis KE, 1998, J NEUROSCI, V18, P2475; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Dowd LA, 1996, J NEUROCHEM, V67, P508, DOI 10.1046/j.1471-4159.1996.67020508.x; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Gegelashvili G, 2001, Prog Brain Res, V132, P267; Gintzler AR, 2000, MOL NEUROBIOL, V21, P21, DOI 10.1385/MN:21:1-2:021; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ingram SL, 1998, J NEUROSCI, V18, P10269; Ji SP, 2006, NAT MED, V12, P324, DOI 10.1038/nm1349; Joazeiro CAP, 2000, SCIENCE, V289, P2061, DOI 10.1126/science.289.5487.2061; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Lievens JC, 2000, GLIA, V29, P222, DOI 10.1002/(SICI)1098-1136(20000201)29:3<222::AID-GLIA4>3.0.CO;2-0; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; MAO J, 1994, J NEUROSCI, V14, P2301; Mao JR, 2002, PAIN, V100, P213, DOI 10.1016/S0304-3959(02)00422-0; Mao JR, 2002, J NEUROSCI, V22, P8312; Mao JR, 2002, J NEUROSCI, V22, P7650; Mennerick S, 1999, J NEUROSCI, V19, P9242; Mitrovic AD, 1999, NEUROCHEM INT, V34, P101, DOI 10.1016/S0197-0186(98)00066-7; Morrison SJ, 2002, NAT MED, V8, P16, DOI 10.1038/nm0102-16; Moss A, 2002, J NEUROSCI, V22, P1363, DOI 10.1523/JNEUROSCI.22-04-01363.2002; Musatov S, 2004, P NATL ACAD SCI USA, V101, P3627, DOI 10.1073/pnas.0308289101; Nakagawa T, 2001, EUR J PHARMACOL, V419, P39, DOI 10.1016/S0014-2999(01)00965-7; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Palos TP, 1996, MOL BRAIN RES, V37, P297, DOI 10.1016/0169-328X(95)00331-L; Park MJ, 2002, CANCER RES, V62, P6318; Pham N, 2001, J BIOL CHEM, V276, P46995, DOI 10.1074/jbc.M108373200; Rolfe M, 1997, J MOL MED-JMM, V75, P5, DOI 10.1007/s001090050081; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sims KD, 2000, J BIOL CHEM, V275, P5228, DOI 10.1074/jbc.275.7.5228; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sung BK, 2003, J NEUROSCI, V23, P2899; Thomson LM, 2006, NEUROSCI LETT, V407, P64, DOI 10.1016/j.neulet.2006.08.004; TISEO PJ, 1993, J PHARMACOL EXP THER, V264, P1090; Tolkacheva T, 2001, CANCER RES, V61, P4985; Trotti D, 2001, J BIOL CHEM, V276, P576, DOI 10.1074/jbc.M003779200; Trotti D, 2002, ADV EXP MED BIOL, V513, P225; TRUJILLO KA, 1991, SCIENCE, V251, P85, DOI 10.1126/science.1824728; Vorwerk CK, 2000, INVEST OPHTH VIS SCI, V41, P3615; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Wojcik C, 2004, STROKE, V35, P1506, DOI 10.1161/01.STR.0000126891.93919.4e; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yang WB, 2002, J BIOL CHEM, V277, P38350, DOI 10.1074/jbc.M202052200	60	40	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21703	21713		10.1074/jbc.M800809200	http://dx.doi.org/10.1074/jbc.M800809200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539596	Green Published, hybrid			2022-12-25	WOS:000257898800044
J	Yao, J; Bajjalieh, SM				Yao, Jia; Bajjalieh, Sandra M.			Synaptic vesicle protein 2 binds adenine nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUGAR-TRANSPORT REGULATION; SUBSTRATE RECOGNITION; IDENTIFICATION; SV2; DETERMINANTS; SUPERFAMILY; RESIDUES; SEQUENCE	Synaptic vesicle protein 2 (SV2) is required for normal calcium-regulated secretion of hormones and neurotransmitters. Neurons lacking the two most widely expressed isoforms, SV2A and SV2B, have a reduced readily releasable pool of synaptic vesicles, indicating that SV2 contributes to vesicle priming. The presence of putative ATP-binding sites in SV2 suggested that SV2 might be an ATP-binding protein. To explore this, we examined the binding of the photoaffinity reagent 8-azidoATP[gamma] biotin to purified, recombinant SV2 in the presence and absence of other nucleotides. Our results indicate that SV2A and SV2B bind nucleotides, with the highest affinity for adenine-containing nucleotides. SV2A contains two binding sites located in the cytoplasmic domains preceding the first and seventh transmembrane domains. These results suggest that SV2-mediated vesicle priming could be regulated by adenine nucleotides, which might provide a link between cellular energy levels and regulated secretion.	[Yao, Jia; Bajjalieh, Sandra M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Bajjalieh, SM (corresponding author), Univ Washington, Dept Pharmacol, 1959 NE Pacific St,Box 357750, Seattle, WA 98195 USA.	bajjalie@u.washington.edu	Yao, Jia/E-8711-2011; Yao, Jia/D-3484-2009	Yao, Jia/0000-0003-3235-5351	NIMH NIH HHS [R01 MH 059842] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059842] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; BUCKLEY KM, 1987, J CELL BIOL, V105, P2447, DOI 10.1083/jcb.105.6.2447; Burre J, 2006, PROTEOMICS, V6, P6250, DOI 10.1002/pmic.200600357; CARRUTHERS A, 1989, BIOCHEMISTRY-US, V28, P8337, DOI 10.1021/bi00447a011; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Henderson PJF, 1993, CURR OPIN CELL BIOL, V5, P708, DOI 10.1016/0955-0674(93)90144-F; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Janz R, 1998, J NEUROSCI, V18, P9269; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kim MH, 2000, J BIOL CHEM, V275, P6175, DOI 10.1074/jbc.275.9.6175; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; Levine KB, 1998, BIOCHEMISTRY-US, V37, P12221, DOI 10.1021/bi980585y; Lezzi M, 2005, J CELL SCI, V118, P5647, DOI 10.1242/jcs.02658; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; PETER D, 1994, J BIOL CHEM, V269, P7231; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000	29	31	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20628	20634		10.1074/jbc.M800738200	http://dx.doi.org/10.1074/jbc.M800738200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18524768	Green Published, hybrid			2022-12-25	WOS:000257746100003
J	Navis, M; Matas, DE; Rachinger, A; Koning, FA; van Swieten, P; Kootstra, NA; Schuitemaker, H				Navis, Marjon; Matas, Diana Edo; Rachinger, Andrea; Koning, Fransje A.; van Swieten, Peter; Kootstra, Neeltje A.; Schuitemaker, Hanneke			Molecular Evolution of Human Immunodeficiency Virus Type 1 upon Transmission between Human Leukocyte Antigen Disparate Donor-Recipient Pairs	PLOS ONE			English	Article							T-CELL RESPONSES; ESCAPE VARIANTS; GENETIC-VARIATION; IMMUNE-RESPONSES; HIV-1 INFECTION; VIRAL ESCAPE; IN-VIVO; REVERSION; GAG; LYMPHOCYTES	Background: To address evolution of HIV-1 after transmission, we studied sequence dynamics in and outside predicted epitopes of cytotoxic T lymphocytes (CTL) in subtype B HIV-1 variants that were isolated from 5 therapy-naive horizontal HLA-disparate donor-recipient pairs from the Amsterdam Cohort Studies on HIV-1 infection and AIDS. Methodology/Principal Findings: In the first weeks after transmission, the majority of donor-derived mutations in and outside donor-HLA-restricted epitopes in Gag, Env, and Nef, were preserved in the recipient. Reversion to the HIV-1 subtype B consensus sequence of mutations in-and outside donor-HLA-restricted CTL epitopes, and new mutations away from the consensus B sequence mostly within recipient-HLA-restricted epitopes, contributed equally to the early sequence changes. In the subsequent period (1-2 years) after transmission, still only a low number of both reverting and forward mutations had occurred. During subsequent long-term follow-up, sequence dynamics were dominated by forward mutations, mostly (50-85%) in recipient-HLA-restricted CTL epitopes. At the end of long-term follow-up, on average 43% of the transmitted CTL escape mutations in donor-HLA-restricted epitopes had reverted to the subtype B consensus sequence. Conclusions/Significance: The relatively high proportion of long-term preserved mutations after transmission points to a lack of back selection even in the absence of CTL pressure, which may lead to an accumulating loss of critical CTL epitopes. Our data are supportive for a continuous adaptation of HIV-1 to host immune pressures which may have implications for vaccine design.	[Navis, Marjon; Matas, Diana Edo; Rachinger, Andrea; Koning, Fransje A.; van Swieten, Peter; Kootstra, Neeltje A.; Schuitemaker, Hanneke] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Ctr Infect Dis & Immun Amsterdam CINIMA,Landstein, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Navis, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Ctr Infect Dis & Immun Amsterdam CINIMA,Landstein, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.schuitemaker@amc.uva.nl		Kootstra, Neeltje A./0000-0001-9429-7754	Landsteiner Foundation for Blood Transfusion Research [0317]; Netherlands AIDS fund [6006]; Sanquin Netherlands Blood Supply Foundation; Academic Medical Center Amsterdam; The Netherlands Organization for Scientific Research [901-02-222, 916.36.024]	Landsteiner Foundation for Blood Transfusion Research; Netherlands AIDS fund; Sanquin Netherlands Blood Supply Foundation; Academic Medical Center Amsterdam; The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	MN is financially supported by Landsteiner Foundation for Blood Transfusion Research (grant 0317), DEM is financially supported by the Netherlands AIDS fund (grant 6006) and the Sanquin Netherlands Blood Supply Foundation, AR is supported by Academic Medical Center Amsterdam, FAK and NK are financially supported by The Netherlands Organization for Scientific Research (grants 901-02-222 and 916.36.024, respectively). None of the funders of the here described study had a role in the design or conduct of the study, nor in the collection, analysis, or interpretation of the data, and also not in the preparation, review, or approval of the manuscript. The Amsterdam Cohort Studies are financially supported by the Netherlands National Institute for Public Health and the Environment.	Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Altman JD, 2004, NAT MED, V10, P229, DOI 10.1038/nm0304-229; Barouch DH, 2003, J VIROL, V77, P7367, DOI 10.1128/JVI.77.13.7367-7375.2003; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Blaak H, 1997, J INFECT DIS, V176, P1383, DOI 10.1086/517327; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Coffin JM, 1996, AIDS, V10, pS75; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; FRAHM N, 2005, HIV MOL IMMUNOLOGY, P3; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Herbeck JT, 2006, J VIROL, V80, P1637, DOI 10.1128/JVI.80.4.1637-1644.2006; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Jansen CA, 2005, EUR J IMMUNOL, V35, P150, DOI 10.1002/eji.200425487; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kent SJ, 1997, J INFECT DIS, V176, P1188, DOI 10.1086/514112; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; KOENIG WJ, 1995, PLAST RECONSTR SURG, V95, P1; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; *LOS AL NAT LAB, 2006, LAUR060036 LOS AL NA; Milicic A, 2005, J VIROL, V79, P13953, DOI 10.1128/JVI.79.22.13953-13962.2005; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6024, DOI 10.1073/pnas.87.16.6024; Peyerl FW, 2003, J VIROL, V77, P12572, DOI 10.1128/JVI.77.23.12572-12578.2003; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pillay T, 2005, J VIROL, V79, P12100, DOI 10.1128/JVI.79.18.12100-12105.2005; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; REIMANN KA, 1994, J VIROL, V68, P2362, DOI 10.1128/JVI.68.4.2362-2370.1994; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Merino V, 2005, J IMMUNOL, V175, P6976, DOI 10.4049/jimmunol.175.10.6976; Sanchez-Merino V, 2008, J INFECT DIS, V197, P300, DOI 10.1086/524845; Scheliens IMM, 2008, AIDS, V22, P33, DOI 10.1097/QAD.0b013e3282f15622; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Smith Stephen M, 2004, Retrovirology, V1, P8, DOI 10.1186/1742-4690-1-8; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; vantWout AB, 1997, J CLIN INVEST, V100, P2325, DOI 10.1172/JCI119771; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wout ABVT, 1998, AIDS, V12, P1169, DOI 10.1097/00002030-199810000-00009; Yeh WW, 2006, J VIROL, V80, P8168, DOI 10.1128/JVI.00068-06	57	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2422	10.1371/journal.pone.0002422	http://dx.doi.org/10.1371/journal.pone.0002422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560583	Green Submitted, gold, Green Published			2022-12-25	WOS:000263280700008
J	Braun, A; McArdle, J; Jones, J; Nechaev, V; Zalewski, C; Brewer, C; Drayna, D				Braun, Allen; McArdle, Joe; Jones, Jennifer; Nechaev, Vladimir; Zalewski, Christopher; Brewer, Carmen; Drayna, Dennis			Tune Deafness: Processing Melodic Errors Outside of Conscious Awareness as Reflected by Components of the Auditory ERP	PLOS ONE			English	Article							CONGENITAL AMUSIA; FREQUENCY; RECOGNITION; KNOWLEDGE; GENETICS; HEARING; CORTEX; P300	Tune deafness (TD) is a central auditory processing disorder characterized by the inability to discriminate pitch, reproduce melodies or to recognize deviations in melodic structure, in spite of normal hearing. The cause of the disorder is unknown. To identify a pathophysiological marker, we ascertained a group of severely affected TD patients using the Distorted Tunes Test, an ecologically valid task with a longstanding history, and used electrophysiological methods to characterize the brain's responses to correct and incorrect melodic sequences. As expected, we identified a neural correlate of patients' unawareness of melodic distortions: deviant notes modulated long-latency auditory evoked potentials and elicited a mismatch negativity in controls but not in affected subjects. However a robust P300 was elicited by deviant notes, suggesting that, as in blindsight, TD subjects process stimuli that they cannot consciously perceive. Given the high heritability of TD, these patients may make it possible to use genetic methods to study cellular and molecular mechanisms underlying conscious awareness.	[Braun, Allen; McArdle, Joe; Nechaev, Vladimir] Natl Inst Deafness & Other Commun Disorders, Language Sect, NIH, Bethesda, MD USA; [Jones, Jennifer; Drayna, Dennis] NIH, National Inst Deafness & Other Commun Disorders, Sect Syst Biol Commun Disorders, Bethesda, MD USA; [Zalewski, Christopher; Brewer, Carmen] NIH, Natl Inst Deafness & Other Commun Disorders, Audiol Unit, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Braun, A (corresponding author), Natl Inst Deafness & Other Commun Disorders, Language Sect, NIH, Bethesda, MD USA.	brauna@nidcd.nih.gov			Intramural Program of the National Institute on Deafness and other Communications Disroders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000031, ZIADC000046, Z01DC000031, ZIADC000064, Z01DC000064, Z01DC000046] Funding Source: NIH RePORTER	Intramural Program of the National Institute on Deafness and other Communications Disroders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Intramural Program of the National Institute on Deafness and other Communications Disroders.	Alain C, 1999, PSYCHOPHYSIOLOGY, V36, P737, DOI 10.1111/1469-8986.3660737; Allen J, 2000, PERCEPT PSYCHOPHYS, V62, P1383, DOI 10.3758/BF03212140; BASAREROGLU C, 1992, INT J PSYCHOPHYSIOL, V13, P161, DOI 10.1016/0167-8760(92)90055-G; Brattico E, 2006, BRAIN RES, V1117, P162, DOI 10.1016/j.brainres.2006.08.023; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Garde MM, 2000, CORTEX, V36, P71, DOI 10.1016/S0010-9452(08)70837-2; Hillyard SA, 1998, CURR OPIN NEUROBIOL, V8, P202, DOI 10.1016/S0959-4388(98)80141-4; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; JOHNSON R, 2008, ADV PSYCHOPHYSIOLOGY, P69; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; KALMUS H, 1980, ANN HUM GENET, V43, P369, DOI 10.1111/j.1469-1809.1980.tb01571.x; Koelsch S, 2003, J COGNITIVE NEUROSCI, V15, P1149, DOI 10.1162/089892903322598111; KOIKE KJ, 1994, OTOLARYNG HEAD NECK, V111, P625, DOI 10.1016/S0194-5998(94)70531-3; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Loui P, 2008, CURR BIOL, V18, pR331, DOI 10.1016/j.cub.2008.02.045; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; *NEUR INC, 1998, NEUR; Nittono H, 2000, BIOL PSYCHOL, V52, P1, DOI 10.1016/S0301-0511(99)00042-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PALLER KA, 1992, PSYCHOPHYSIOLOGY, V29, P202, DOI 10.1111/j.1469-8986.1992.tb01686.x; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; SCHACTER DL, 1992, P NATL ACAD SCI USA, V89, P11113, DOI 10.1073/pnas.89.23.11113; TRANEL D, 1985, SCIENCE, V228, P1453, DOI 10.1126/science.4012303; Weiskrantz L, 2003, PROG BRAIN RES, V144, P229, DOI 10.1016/S0079-6123(03)14401-6	29	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2349	10.1371/journal.pone.0002349	http://dx.doi.org/10.1371/journal.pone.0002349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	405UD	18545651	Green Published, Green Submitted, gold			2022-12-25	WOS:000263248800010
J	Joensson, TJ; Murray, MS; Johnson, LC; Lowther, WT				Joensson, Thomas J.; Murray, Michael S.; Johnson, Lynnette C.; Lowther, W. Todd			Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; MAMMALIAN SULFIREDOXIN; CRYSTALLOGRAPHY; SULPHIREDOXIN; MECHANISM; RECOVERY	Sulfiredoxin (Srx) catalyzes a novel enzymatic reaction, the reduction of protein cysteine sulfinic acid, Cys-SO2-. This reaction is unique to the typical 2-Cys peroxiredoxins (Prx) and plays a role in peroxide-mediated signaling by regulating the activity of Prxs. Two mechanistic schemes have been proposed that differ regarding the first step of the reaction. This step involves either the direct transfer of the gamma-phosphate of ATP to the Prx molecule or through Srx acting as a phosphorylated intermediary. In an effort to clarify this step of the Srx reaction, we have determined the 1.8 angstrom resolution crystal structure of Srx in complex with ATP and Mg2+. This structure reveals the role of the Mg2+ ion to position the gamma-phosphate toward solvent, thus preventing an in-line attack by the catalytic residue Cys-99 of Srx. A model of the quaternary complex is consistent with this proposal. Furthermore, phosphorylation studies on several site-directed mutants of Srx and Prx, including the Prx-Asp mimic of the Prx-SO2- species, support a mechanism where phosphorylation of Prx-SO2- is the first chemical step.	[Lowther, W. Todd] Wake Forest Univ, Struct Biol Ctr, Sch Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University	Lowther, WT (corresponding author), Wake Forest Univ, Struct Biol Ctr, Sch Med, Winston Salem, NC 27157 USA.	tlowther@wfubmc.edu		Furdui, Cristina M./0000-0003-3771-7999	United States Department of Energy; National Institutes of Health [R01GM072866]; American Heart Association Postdoctoral Fellowship [0725399U]	United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM072866 (to W.T.L.). This work was also supported by American Heart Association Postdoctoral Fellowship 0725399U (to T.J.J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.; We thank the staff of NSLS and beamline X4A for their assistance during data collection and the RapiData course. National Synchrotron Light Source is supported by the United States Department of Energy and National Institutes of Health.	Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Joensson Thomas J., 2007, V44, P115; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Jonsson TJ, 2005, BIOCHEMISTRY-US, V44, P8634, DOI 10.1021/bi050131i; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PALMIERI F, 1979, BIOCHIM BIOPHYS ACTA, V555, P531, DOI 10.1016/0005-2736(79)90407-3; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Purich DL, 2002, METHOD ENZYMOL, V354, P168; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; WEAST RC, 1983, CRC HDB CHEM PHYS, pC719; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	32	89	89	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23846	23851		10.1074/jbc.M803244200	http://dx.doi.org/10.1074/jbc.M803244200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579529	Green Published, hybrid			2022-12-25	WOS:000258638900039
J	Schug, ZT; da Fonseca, PCA; Bhanumathy, CD; Wagner, L; Zhang, XC; Bailey, B; Morris, EP; Yule, DI; Joseph, SK				Schug, Zachary T.; da Fonseca, Paula C. A.; Bhanumathy, Cunnigaiper D.; Wagner, Larry, II; Zhang, Xianchao; Bailey, Bradley; Morris, Edward P.; Yule, David I.; Joseph, Suresh K.			Molecular characterization of the inositol 1,4,5-trisphosphate receptor pore-forming segment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL RYANODINE RECEPTOR; INWARD RECTIFIER CHANNEL; CENTRAL CORE DISEASE; LIGAND-BINDING SITE; POTASSIUM-CHANNEL; K+ CHANNEL; CA2+ RELEASE; ION PERMEATION; TRISPHOSPHATE RECEPTORS; FUNCTIONAL-PROPERTIES	Specific residues in the putative pore helix, selectivity filter, and S6 transmembrane helix of the inositol 1,4,5-trisphosphate receptor were mutated in order to examine their effects on channel function. Mutation of 5 of 8 highly conserved residues in the pore helix/selectivity filter region inactivated the channel (C2533A, G2541A, G2545A, G2546A, and G2547A). Of the remaining three mutants, C2527A and R2543A were partially active and G2549A behaved like wild type receptor. Mutation of a putative glycine hinge residue in the S6 helix (G2586A) or a putative gating residue at the cytosolic end of S6 helix (F2592A) had minimal effects on function, although channel function was inactivated by G2586P and F2592D mutations. The mutagenesis data are interpreted in the context of a structural homology model of the inositol 1,4,5-trisphosphate receptor.	[Schug, Zachary T.; Bhanumathy, Cunnigaiper D.; Zhang, Xianchao; Bailey, Bradley; Joseph, Suresh K.] Thomas Jefferson Univ, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA; [da Fonseca, Paula C. A.; Morris, Edward P.] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; [Wagner, Larry, II] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Jefferson University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Rochester	Joseph, SK (corresponding author), Thomas Jefferson Univ, Dept Pathol & Cell Biol, 1020 Locust St JAH 230A, Philadelphia, PA 19107 USA.	suresh.joseph@jefferson.edu		Schug, Zachary/0000-0003-4197-8227; da Fonseca, Paula/0000-0001-8656-5747; Morris, Edward/0000-0003-3544-0041	British Heart Foundation [PG/07/076/23480] Funding Source: Medline; Cancer Research UK Funding Source: Medline; NIAAA NIH HHS [T32 AA 07463] Funding Source: Medline; NIDCR NIH HHS [DE 14765] Funding Source: Medline; NIDDK NIH HHS [DK 54568, DK 34804] Funding Source: Medline; Wellcome Trust Funding Source: Medline	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		Avila G, 2003, J GEN PHYSIOL, V121, P277, DOI 10.1085/jgp.200308791; Berridge MJ, 2006, BIOCHEM SOC T, V34, P228, DOI 10.1042/BST0340228; Bhanumathy CD, 2006, J BIOL CHEM, V281, P3722, DOI 10.1074/jbc.M509966200; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Chen SRW, 2002, BIOPHYS J, V82, P2436, DOI 10.1016/S0006-3495(02)75587-2; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Dart C, 1998, J PHYSIOL-LONDON, V511, P25, DOI 10.1111/j.1469-7793.1998.025bi.x; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Du GG, 2004, BIOCHEM J, V382, P557, DOI 10.1042/BJ20040580; Du GG, 2001, J BIOL CHEM, V276, P31760, DOI 10.1074/jbc.M102751200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Iqbalsyah TM, 2006, PROTEIN SCI, V15, P1945, DOI 10.1110/ps.062271506; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Khan MT, 2007, J BIOL CHEM, V282, P32983, DOI 10.1074/jbc.M705183200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LABOISSIERE MCA, 1995, J BIOL CHEM, V270, P28006; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Sackin H, 2005, BIOPHYS J, V88, P2597, DOI 10.1529/biophysj.104.051474; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Seebohm G, 2005, J PHYSIOL-LONDON, V563, P359, DOI 10.1113/jphysiol.2004.080887; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; Srikanth S, 2004, BIOPHYS J, V86, P3634, DOI 10.1529/biophysj.104.040121; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Tikhonov DB, 2004, BIOPHYS J, V87, P1526, DOI 10.1529/biophysj.103.037770; TINKER A, 1993, J GEN PHYSIOL, V102, P1107, DOI 10.1085/jgp.102.6.1107; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Welch W, 2004, BIOPHYS J, V87, P2335, DOI 10.1529/biophysj.104.044180; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	57	111	111	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2939	2948		10.1074/jbc.M706645200	http://dx.doi.org/10.1074/jbc.M706645200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18534977	hybrid			2022-12-25	WOS:000252622300050
J	Jonsson, TJ; Tsang, AW; Lowther, WT; Furdui, CM				Jonsson, Thomas J.; Tsang, Allen W.; Lowther, W. Todd; Furdui, Cristina M.			Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION MASS-SPECTROMETRY; ESCHERICHIA-COLI; OXIDATIVE STRESS; ENZYME CATALYSIS; MECHANISM	The reversible oxidation of the active site cysteine in typical 2-Cys peroxiredoxins (Prx) to sulfinic acid during oxidative stress plays an important role in peroxide-mediated cell signaling. The catalytic retroreduction of Prx-SO2- by sulfiredoxin (Srx) has been proposed to proceed through two novel reaction intermediates, a sulfinic phosphoryl ester and protein-based thiosulfinate. Two scenarios for the repair mechanism have been suggested that differ in the second step of the reaction. The attack of Srx or GSH on the Prx-SO2PO32- intermediate would result in either the formation of Prx-Cys-S(=O)-S-Cys-Srx or the formation of Prx-Cys-S(=O)-S-G thiosulfinates, respectively. To elucidate the mechanism of Prx repair, we monitored the reduction of human PrxII-SO2- using rapid chemical quench methodology and electrospray ionization time-of-flight mass spectrometry. An O-18 exchange study revealed that the Prx sulfinic acid phosphoryl ester is rapidly formed and hydrolyzed (k = 0.35 min(-1)). Furthermore, we observed the exclusive formation of a thiosulfinate linkage between Prx and Srx(k = 1.4 min(-1)) that collapses to the disulfide-bonded Srx-Prx species (k = 0.14 min(-1)). Thus, the kinetic and chemical competences of the first two steps in the Srx reaction have been demonstrated. It is clear, however, that GSH may influence thiosulfinate formation and that GSH and Srx may play additional roles in the resolution of the thiosulfinate intermediate.	[Jonsson, Thomas J.; Lowther, W. Todd] Wake Forest Univ, Bowman Gray Sch Med, Ctr Struct Biol, Winston Salem, NC 27157 USA; [Jonsson, Thomas J.; Lowther, W. Todd] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Tsang, Allen W.; Furdui, Cristina M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Lowther, WT (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Struct Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	tlowther@wfubmc.edu; cfurdui@wfubmc.edu		Furdui, Cristina M./0000-0003-3771-7999	National Institutes of Health [R01GM072866]; American Heart Association [0725399U, SDG 0730069N]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM072866 (to W. T. L.). This work was also supported by American Heart Association Postdoctoral Fellowship 0725399U (to T. J. J.) and American Heart Association Grant SDG 0730069N (to C. M. F.).	Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bothner B, 2000, J BIOL CHEM, V275, P13455, DOI 10.1074/jbc.275.18.13455; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Furdui C. M., 2006, MOL CELL, V17, P1; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Gross JW, 2000, BIOCHEMISTRY-US, V39, P13633, DOI 10.1021/bi001963d; Jacob C, 2006, NAT PROD REP, V23, P851, DOI 10.1039/b609523m; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Jonsson TJ, 2005, BIOCHEMISTRY-US, V44, P8634, DOI 10.1021/bi050131i; KICE JL, 1974, J AM CHEM SOC, V96, P8015, DOI 10.1021/ja00833a029; Konermann L, 1997, BIOCHEMISTRY-US, V36, P5554, DOI 10.1021/bi970046d; Li ZL, 2005, ANAL BIOCHEM, V343, P35, DOI 10.1016/j.ab.2005.04.021; Li ZL, 2003, J AM CHEM SOC, V125, P9938, DOI 10.1021/ja0354768; Paiva AA, 1997, BIOCHEMISTRY-US, V36, P15472, DOI 10.1021/bi971883i; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Roussel X, 2008, J BIOL CHEM, V283, P22371, DOI 10.1074/jbc.M800493200; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Shen CX, 2002, J AGR FOOD CHEM, V50, P2644, DOI 10.1021/jf011013e; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	25	89	89	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22890	22894		10.1074/jbc.C800124200	http://dx.doi.org/10.1074/jbc.C800124200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18579529	Green Published, hybrid			2022-12-25	WOS:000258455400002
